HAS/0006-10-04_ct-2828_tussipax_.pdf
HAS/0006-10-04_ct-3057_pertrofran_.pdf
HAS/0006-11-07_ct-3199_sustiva.pdf
HAS/0006-11-08_ct-2653_iskedyl.pdf
HAS/1995-10-01_santpubl.pdf
HAS/1996-01-14_paq.pdf
HAS/1997-09-01_Hemogram.pdf
HAS/1998-03-31_toxico.pdf
HAS/1998-03-31_toxicolong.pdf
HAS/1998-10-31_suicideVF.pdf
HAS/1998-10-31_suicidecourt.pdf
HAS/1998-12-31_prostate.PSA.pdf
HAS/1998-12-31_psa3.pdf
HAS/1998-12-31_psa4p.pdf
HAS/1999-01-15_douleur1.pdf
HAS/1999-03-01_mamo.pdf
HAS/1999-04-14_alccol2.pdf
HAS/1999-04-14_alcool.court.pdf
HAS/1999-06-01_reseaux.pdf
HAS/1999-12-31_entorse_rap.pdf
HAS/1999-12-31_recosentors.pdf
HAS/2000-01-01_HIV.pdf
HAS/2000-01-01_VIH_rap.pdf
HAS/2000-01-01_VIH_recos.pdf
HAS/2000-01-01_analiterat.pdf
HAS/2000-01-09_oesclim_.pdf
HAS/2000-01-10_ct010321.pdf
HAS/2000-01-10_ct010610.pdf
HAS/2000-01-31_088-Hyperth.pdf
HAS/2000-01-31_hyperthy_rap.pdf
HAS/2000-01-31_hyperthy_recos.pdf
HAS/2000-01-31_incontin.pdf
HAS/2000-01-31_incontinrecos.pdf
HAS/2000-01-31_lombal.pdf
HAS/2000-01-31_lombreco.pdf
HAS/2000-01-31_low_back_pain.pdf
HAS/2000-01-31_urinary_incontinence.pdf
HAS/2000-02-29_acute_pain_paediatric_outpatients.pdf
HAS/2000-02-29_aspcourt.pdf
HAS/2000-02-29_asplong.pdf
HAS/2000-02-29_doulenf4.pdf
HAS/2000-02-29_doulenfrap2.pdf
HAS/2000-02-29_park.pdf
HAS/2000-02-29_parkcourt.pdf
HAS/2000-03-01_Physiotherapy.pdf
HAS/2000-03-01_massokine.pdf
HAS/2000-03-01_massokine_recos.pdf
HAS/2000-03-31_abdig.pdf
HAS/2000-03-31_abdigrecos.pdf
HAS/2000-03-31_enteral.nutrition.pdf
HAS/2000-05-23_ct010329.pdf
HAS/2000-07-01_methodes.pdf
HAS/2000-10-01_Douleur_sujet_age_Recos.pdf
HAS/2000-10-01_doulpersag.pdf
HAS/2000-10-01_suicicourt.pdf
HAS/2000-10-01_suicideVF.pdf
HAS/2000-10-01_suicilong.pdf
HAS/2000-11-08_ct010389.pdf
HAS/2000-12-01_chronic_low_back_pain.pdf
HAS/2000-12-01_lombaldec2000.pdf
HAS/2000-12-01_lombalgie_dec2000_recos.pdf
HAS/2000-12-20_ct010300.pdf
HAS/2001-01-01_hepatite.pdf
HAS/2001-01-01_hepatitis_C.pdf
HAS/2001-01-01_vhc_rapport_final_formate-_recommandations.pdf
HAS/2001-01-09_ct010011.pdf
HAS/2001-01-09_ct010055.pdf
HAS/2001-01-09_ct010324.pdf
HAS/2001-01-09_ct010326.pdf
HAS/2001-01-09_ct010335.pdf
HAS/2001-01-09_ct010342.pdf
HAS/2001-01-09_ct010345.pdf
HAS/2001-01-09_ct010346.pdf
HAS/2001-01-09_ct010355.pdf
HAS/2001-01-09_ct010356.pdf
HAS/2001-01-09_ct010377.pdf
HAS/2001-01-09_ct010626.pdf
HAS/2001-01-09_ct010635.pdf
HAS/2001-01-09_ct010651.pdf
HAS/2001-01-09_ct010656.pdf
HAS/2001-01-09_ct010659.pdf
HAS/2001-01-09_ct010661.pdf
HAS/2001-01-09_ct010678.pdf
HAS/2001-01-09_ct010711.pdf
HAS/2001-01-10_ct010018.pdf
HAS/2001-01-10_ct010046.pdf
HAS/2001-01-10_ct010048.pdf
HAS/2001-01-10_ct010091.pdf
HAS/2001-01-10_ct010105.pdf
HAS/2001-01-10_ct010106.pdf
HAS/2001-01-10_ct010393.pdf
HAS/2001-01-10_ct010417.pdf
HAS/2001-01-10_ct010632.pdf
HAS/2001-01-10_ct010641.pdf
HAS/2001-01-23_ct010004.pdf
HAS/2001-01-23_ct010019.pdf
HAS/2001-01-23_ct010022.pdf
HAS/2001-01-23_ct010075.pdf
HAS/2001-01-23_ct010076.pdf
HAS/2001-01-23_ct010080.pdf
HAS/2001-01-23_ct010081.pdf
HAS/2001-01-23_ct010093.pdf
HAS/2001-01-23_ct010302.pdf
HAS/2001-01-23_ct010303.pdf
HAS/2001-01-23_ct010315.pdf
HAS/2001-01-23_ct010318.pdf
HAS/2001-01-23_ct010320.pdf
HAS/2001-01-23_ct010322.pdf
HAS/2001-01-23_ct010334.pdf
HAS/2001-01-23_ct010350.pdf
HAS/2001-01-23_ct010365.pdf
HAS/2001-01-23_ct010373.pdf
HAS/2001-01-23_ct010385.pdf
HAS/2001-01-23_ct010415.pdf
HAS/2001-01-23_ct010604.pdf
HAS/2001-01-23_ct010612.pdf
HAS/2001-01-23_ct010623.pdf
HAS/2001-01-23_ct010634.pdf
HAS/2001-01-23_ct010640.pdf
HAS/2001-01-23_ct010670.pdf
HAS/2001-01-23_ct010682.pdf
HAS/2001-01-23_ct010688.pdf
HAS/2001-01-23_ct010692.pdf
HAS/2001-01-24_ct010088.pdf
HAS/2001-02-06_ct010006.pdf
HAS/2001-02-06_ct010025.pdf
HAS/2001-02-06_ct010030.pdf
HAS/2001-02-06_ct010031.pdf
HAS/2001-02-06_ct010032.pdf
HAS/2001-02-06_ct010033.pdf
HAS/2001-02-06_ct010039.pdf
HAS/2001-02-06_ct010040.pdf
HAS/2001-02-06_ct010042.pdf
HAS/2001-02-06_ct010047.pdf
HAS/2001-02-06_ct010052.pdf
HAS/2001-02-06_ct010053.pdf
HAS/2001-02-06_ct010058.pdf
HAS/2001-02-06_ct010069.pdf
HAS/2001-02-06_ct010072.pdf
HAS/2001-02-06_ct010095.pdf
HAS/2001-02-06_ct010097.pdf
HAS/2001-02-06_ct010098.pdf
HAS/2001-02-06_ct010304.pdf
HAS/2001-02-06_ct010310.pdf
HAS/2001-02-06_ct010311.pdf
HAS/2001-02-06_ct010327.pdf
HAS/2001-02-06_ct010328.pdf
HAS/2001-02-06_ct010363.pdf
HAS/2001-02-06_ct010371.pdf
HAS/2001-02-06_ct010398.pdf
HAS/2001-02-06_ct010407.pdf
HAS/2001-02-06_ct010606.pdf
HAS/2001-02-06_ct010616.pdf
HAS/2001-02-06_ct010624.pdf
HAS/2001-02-06_ct010636.pdf
HAS/2001-02-06_ct010649.pdf
HAS/2001-02-06_ct010655.pdf
HAS/2001-02-06_ct010662.pdf
HAS/2001-02-06_ct010663.pdf
HAS/2001-02-06_ct010672.pdf
HAS/2001-02-06_ct010683.pdf
HAS/2001-02-06_ct020960.pdf
HAS/2001-02-13_ct010021.pdf
HAS/2001-02-20_ct010020.pdf
HAS/2001-02-20_ct010043.pdf
HAS/2001-02-20_ct010061.pdf
HAS/2001-02-20_ct010305.pdf
HAS/2001-02-20_ct010306.pdf
HAS/2001-02-20_ct010307.pdf
HAS/2001-02-20_ct010349.pdf
HAS/2001-02-20_ct010359.pdf
HAS/2001-02-20_ct010382.pdf
HAS/2001-02-20_ct010384.pdf
HAS/2001-02-20_ct010386.pdf
HAS/2001-02-20_ct010387.pdf
HAS/2001-02-20_ct010644.pdf
HAS/2001-02-20_ct010645.pdf
HAS/2001-02-20_ct010647.pdf
HAS/2001-02-20_ct010680.pdf
HAS/2001-02-21_ct010083.pdf
HAS/2001-02-28_alc2.pdf
HAS/2001-02-28_alcool2.pdf
HAS/2001-02-28_endoscopdigrap.pdf
HAS/2001-02-28_endoscopdigrecos.pdf
HAS/2001-02-28_gastro_endoscopy.pdf
HAS/2001-02-28_ivg_2001_-_argumentaire_2001_2011-04-28_15-32-48_847.pdf
HAS/2001-02-28_ivg_2001_-_recommandations_revues_2010_2011-04-28_15-29-11_241.pdf
HAS/2001-03-06_ct010007.pdf
HAS/2001-03-06_ct010009.pdf
HAS/2001-03-06_ct010024.pdf
HAS/2001-03-06_ct010044.pdf
HAS/2001-03-06_ct010056.pdf
HAS/2001-03-06_ct010057.pdf
HAS/2001-03-06_ct010068.pdf
HAS/2001-03-06_ct010101.pdf
HAS/2001-03-06_ct010339.pdf
HAS/2001-03-06_ct010364.pdf
HAS/2001-03-06_ct010372.pdf
HAS/2001-03-06_ct010388.pdf
HAS/2001-03-06_ct010390.pdf
HAS/2001-03-06_ct010399.pdf
HAS/2001-03-06_ct010602.pdf
HAS/2001-03-06_ct010615.pdf
HAS/2001-03-06_ct010666.pdf
HAS/2001-03-06_ct010694.pdf
HAS/2001-03-06_ct010705.pdf
HAS/2001-03-07_ct010086.pdf
HAS/2001-03-07_ct010087.pdf
HAS/2001-03-20_ct010013.pdf
HAS/2001-03-20_ct010037.pdf
HAS/2001-03-20_ct010059.pdf
HAS/2001-03-20_ct010060.pdf
HAS/2001-03-20_ct010073.pdf
HAS/2001-03-20_ct010074.pdf
HAS/2001-03-20_ct010096.pdf
HAS/2001-03-20_ct010340.pdf
HAS/2001-03-20_ct010348.pdf
HAS/2001-03-20_ct010352.pdf
HAS/2001-03-20_ct010354.pdf
HAS/2001-03-20_ct010357.pdf
HAS/2001-03-20_ct010360.pdf
HAS/2001-03-20_ct010392.pdf
HAS/2001-03-20_ct010401.pdf
HAS/2001-03-20_ct010403.pdf
HAS/2001-03-20_ct010408.pdf
HAS/2001-03-20_ct010605.pdf
HAS/2001-03-20_ct010618.pdf
HAS/2001-03-20_ct010628.pdf
HAS/2001-03-20_ct010638.pdf
HAS/2001-03-20_ct010652.pdf
HAS/2001-03-20_ct010665.pdf
HAS/2001-03-20_ct010668.pdf
HAS/2001-03-20_ct010690.pdf
HAS/2001-03-20_ct010695.pdf
HAS/2001-03-21_ct010625.pdf
HAS/2001-03-27_ct010008.pdf
HAS/2001-03-27_ct010343.pdf
HAS/2001-03-27_ct010629.pdf
HAS/2001-03-27_ct010660.pdf
HAS/2001-03-31_coif.rot.rap.pdf
HAS/2001-03-31_coiffe_des_rotateurs-_synthese_2006_12_19__14_27_37_158.pdf
HAS/2001-03-31_coiffe_des_rotateurs_-_recommandations.pdf
HAS/2001-03-31_osteoporose_synthese.pdf
HAS/2001-03-31_prevenir_fractures_osteoporose.pdf
HAS/2001-04-03_ct010035.pdf
HAS/2001-04-03_ct010038.pdf
HAS/2001-04-03_ct010049.pdf
HAS/2001-04-03_ct010050.pdf
HAS/2001-04-03_ct010070.pdf
HAS/2001-04-03_ct010078.pdf
HAS/2001-04-03_ct010100.pdf
HAS/2001-04-03_ct010312.pdf
HAS/2001-04-03_ct010313.pdf
HAS/2001-04-03_ct010316.pdf
HAS/2001-04-03_ct010317.pdf
HAS/2001-04-03_ct010332.pdf
HAS/2001-04-03_ct010337.pdf
HAS/2001-04-03_ct010351.pdf
HAS/2001-04-03_ct010361.pdf
HAS/2001-04-03_ct010378.pdf
HAS/2001-04-03_ct010409.pdf
HAS/2001-04-03_ct010413.pdf
HAS/2001-04-03_ct010414.pdf
HAS/2001-04-03_ct010617.pdf
HAS/2001-04-03_ct010622.pdf
HAS/2001-04-03_ct010637.pdf
HAS/2001-04-03_ct010686.pdf
HAS/2001-04-03_ct010687.pdf
HAS/2001-04-03_ct010691.pdf
HAS/2001-04-03_ct010697.pdf
HAS/2001-04-17_ct010014.pdf
HAS/2001-04-17_ct010029.pdf
HAS/2001-04-17_ct010036.pdf
HAS/2001-04-17_ct010054.pdf
HAS/2001-04-17_ct010104.pdf
HAS/2001-04-17_ct010330.pdf
HAS/2001-04-17_ct010336.pdf
HAS/2001-04-17_ct010338.pdf
HAS/2001-04-17_ct010366.pdf
HAS/2001-04-17_ct010394.pdf
HAS/2001-04-17_ct010395.pdf
HAS/2001-04-17_ct010397.pdf
HAS/2001-04-17_ct010406.pdf
HAS/2001-04-17_ct010416.pdf
HAS/2001-04-17_ct010603.pdf
HAS/2001-04-17_ct010613.pdf
HAS/2001-04-17_ct010630.pdf
HAS/2001-04-17_ct010642.pdf
HAS/2001-04-17_ct010643_infanrix_polio_hib.pdf
HAS/2001-04-17_ct010684.pdf
HAS/2001-04-18_ct010084.pdf
HAS/2001-04-18_ct010085.pdf
HAS/2001-04-18_ct010089.pdf
HAS/2001-04-24_ct010391.pdf
HAS/2001-04-30_Orthophonie.pdf
HAS/2001-04-30_Orthophrecos.pdf
HAS/2001-04-30_Podologie.rap.pdf
HAS/2001-04-30_ergoth_rap.pdf
HAS/2001-04-30_ergoth_recos.pdf
HAS/2001-04-30_podologie.recos.pdf
HAS/2001-05-08_ct010001.pdf
HAS/2001-05-08_ct010002.pdf
HAS/2001-05-08_ct010079.pdf
HAS/2001-05-08_ct010319.pdf
HAS/2001-05-08_ct010331.pdf
HAS/2001-05-08_ct010362.pdf
HAS/2001-05-08_ct010368.pdf
HAS/2001-05-08_ct010376.pdf
HAS/2001-05-08_ct010381.pdf
HAS/2001-05-08_ct010400.pdf
HAS/2001-05-08_ct010405.pdf
HAS/2001-05-08_ct010601.pdf
HAS/2001-05-08_ct010614.pdf
HAS/2001-05-08_ct010667.pdf
HAS/2001-05-08_ct010677.pdf
HAS/2001-05-08_ct010685.pdf
HAS/2001-05-08_ct010689.pdf
HAS/2001-05-08_ct010698.pdf
HAS/2001-05-29_ct010010.pdf
HAS/2001-05-29_ct010016.pdf
HAS/2001-05-29_ct010017.pdf
HAS/2001-05-29_ct010023.pdf
HAS/2001-05-29_ct010027.pdf
HAS/2001-05-29_ct010028.pdf
HAS/2001-05-29_ct010041.pdf
HAS/2001-05-29_ct010062.pdf
HAS/2001-05-29_ct010063.pdf
HAS/2001-05-29_ct010064.pdf
HAS/2001-05-29_ct010066.pdf
HAS/2001-05-29_ct010067.pdf
HAS/2001-05-29_ct010077.pdf
HAS/2001-05-29_ct010082.pdf
HAS/2001-05-29_ct010092.pdf
HAS/2001-05-29_ct010099.pdf
HAS/2001-05-29_ct010130.pdf
HAS/2001-05-29_ct010131.pdf
HAS/2001-05-29_ct010314.pdf
HAS/2001-05-29_ct010325.pdf
HAS/2001-05-29_ct010353.pdf
HAS/2001-05-29_ct010358.pdf
HAS/2001-05-29_ct010367.pdf
HAS/2001-05-29_ct010370.pdf
HAS/2001-05-29_ct010374.pdf
HAS/2001-05-29_ct010383.pdf
HAS/2001-05-29_ct010404.pdf
HAS/2001-05-29_ct010419.pdf
HAS/2001-05-29_ct010620.pdf
HAS/2001-05-29_ct010621.pdf
HAS/2001-05-29_ct010627.pdf
HAS/2001-05-29_ct010631.pdf
HAS/2001-05-29_ct010639.pdf
HAS/2001-05-29_ct010648.pdf
HAS/2001-05-29_ct010653.pdf
HAS/2001-05-29_ct010654.pdf
HAS/2001-05-29_ct010657.pdf
HAS/2001-05-29_ct010658.pdf
HAS/2001-05-29_ct010671.pdf
HAS/2001-05-29_ct010675.pdf
HAS/2001-05-29_ct010681.pdf
HAS/2001-05-29_ct010696.pdf
HAS/2001-05-29_ct010712.pdf
HAS/2001-05-30_ct010090.pdf
HAS/2001-05-31_asthma_education.pdf
HAS/2001-05-31_asthme.rap.pdf
HAS/2001-05-31_education_adulte_asthmatique_-_argumentaire.pdf
HAS/2001-05-31_education_adulte_asthmatique_-_recommandations.pdf
HAS/2001-05-31_education_asthmatique_adulte_-_synthese.pdf
HAS/2001-05-31_mieux_vivre_avec_son_asthme.pdf
HAS/2001-06-01_sclerose3.pdf
HAS/2001-06-12_ct010012.pdf
HAS/2001-06-12_ct010015.pdf
HAS/2001-06-12_ct010051.pdf
HAS/2001-06-12_ct010071.pdf
HAS/2001-06-12_ct010308.pdf
HAS/2001-06-12_ct010309.pdf
HAS/2001-06-12_ct010323.pdf
HAS/2001-06-12_ct010341.pdf
HAS/2001-06-12_ct010347.pdf
HAS/2001-06-12_ct010375.pdf
HAS/2001-06-12_ct010380.pdf
HAS/2001-06-12_ct010396.pdf
HAS/2001-06-12_ct010600.pdf
HAS/2001-06-12_ct010619.pdf
HAS/2001-06-12_ct010650.pdf
HAS/2001-06-12_ct010664.pdf
HAS/2001-06-12_ct010693.pdf
HAS/2001-06-19_ct010301.pdf
HAS/2001-06-19_ct010410.pdf
HAS/2001-06-19_ct010633.pdf
HAS/2001-06-19_ct010674.pdf
HAS/2001-06-23_ct010005.pdf
HAS/2001-06-26_ct010003.pdf
HAS/2001-06-26_ct010026.pdf
HAS/2001-06-26_ct010034.pdf
HAS/2001-06-26_ct010045.pdf
HAS/2001-06-26_ct010065.pdf
HAS/2001-06-26_ct010094.pdf
HAS/2001-06-26_ct010111.pdf
HAS/2001-06-26_ct010119.pdf
HAS/2001-06-26_ct010126.pdf
HAS/2001-06-26_ct010149.pdf
HAS/2001-06-26_ct010152.pdf
HAS/2001-06-26_ct010154.pdf
HAS/2001-06-26_ct010344.pdf
HAS/2001-06-26_ct010369.pdf
HAS/2001-06-26_ct010379.pdf
HAS/2001-06-26_ct010402.pdf
HAS/2001-06-26_ct010669.pdf
HAS/2001-06-26_ct010699.pdf
HAS/2001-07-10_ct010108.pdf
HAS/2001-07-10_ct010109.pdf
HAS/2001-07-10_ct010112.pdf
HAS/2001-07-10_ct010118.pdf
HAS/2001-07-10_ct010121.pdf
HAS/2001-07-10_ct010122.pdf
HAS/2001-07-10_ct010124.pdf
HAS/2001-07-10_ct010132.pdf
HAS/2001-07-10_ct010135.pdf
HAS/2001-07-10_ct010144.pdf
HAS/2001-07-10_ct010148.pdf
HAS/2001-07-10_ct010150.pdf
HAS/2001-07-10_ct010151.pdf
HAS/2001-07-10_ct010156.pdf
HAS/2001-07-10_ct010159.pdf
HAS/2001-07-10_ct010160.pdf
HAS/2001-07-10_ct010162.pdf
HAS/2001-07-10_ct010749.pdf
HAS/2001-07-10_pp020046.pdf
HAS/2001-07-11_ct010795.pdf
HAS/2001-08-31_Antenatal_prevention.pdf
HAS/2001-08-31_prevention_antenatale_du_risque_infectieux_bacterien_-_ar.pdf
HAS/2001-08-31_prevention_antenatale_du_risque_infectieux_bacterien_-_rec.pdf
HAS/2001-08-31_prevention_antenatale_du_risque_infectieux_bacterien_-_syn.pdf
HAS/2001-09-01_recosneuropatho.pdf
HAS/2001-09-01_rpc_ivresse_argumentaire_mel_2006.pdf
HAS/2001-09-01_rpc_ivresse_reco_mel_2006.pdf
HAS/2001-09-01_rpc_ivresse_synthese_mel_2006.pdf
HAS/2001-09-04_ct010107.pdf
HAS/2001-09-04_ct010110.pdf
HAS/2001-09-04_ct010113.pdf
HAS/2001-09-04_ct010114.pdf
HAS/2001-09-04_ct010115.pdf
HAS/2001-09-04_ct010116.pdf
HAS/2001-09-04_ct010117.pdf
HAS/2001-09-04_ct010120.pdf
HAS/2001-09-04_ct010123.pdf
HAS/2001-09-04_ct010125.pdf
HAS/2001-09-04_ct010127.pdf
HAS/2001-09-04_ct010128.pdf
HAS/2001-09-04_ct010134.pdf
HAS/2001-09-04_ct010136.pdf
HAS/2001-09-04_ct010137.pdf
HAS/2001-09-04_ct010138.pdf
HAS/2001-09-04_ct010139.pdf
HAS/2001-09-04_ct010140.pdf
HAS/2001-09-04_ct010141.pdf
HAS/2001-09-04_ct010142.pdf
HAS/2001-09-04_ct010143.pdf
HAS/2001-09-04_ct010145.pdf
HAS/2001-09-04_ct010146.pdf
HAS/2001-09-04_ct010153.pdf
HAS/2001-09-04_ct010155.pdf
HAS/2001-09-04_ct010157.pdf
HAS/2001-09-04_ct010158.pdf
HAS/2001-09-04_ct010161.pdf
HAS/2001-09-04_ct010719.pdf
HAS/2001-09-04_ct010720.pdf
HAS/2001-09-04_ct010722.pdf
HAS/2001-09-04_ct010726.pdf
HAS/2001-09-04_ct010744.pdf
HAS/2001-09-04_ct010746.pdf
HAS/2001-09-04_ct010798.pdf
HAS/2001-09-04_ct021060_myocet_50_mg.pdf
HAS/2001-09-04_ct032594.pdf
HAS/2001-09-05_ct010796.pdf
HAS/2001-09-18_ct010129.pdf
HAS/2001-09-18_ct010133.pdf
HAS/2001-09-18_ct010147.pdf
HAS/2001-09-18_ct010715.pdf
HAS/2001-09-18_ct010721.pdf
HAS/2001-09-18_ct010725.pdf
HAS/2001-09-18_ct010745.pdf
HAS/2001-09-18_ct010797.pdf
HAS/2001-09-18_ct010799.pdf
HAS/2001-10-02_ct010752.pdf
HAS/2001-10-02_ct010755.pdf
HAS/2001-10-02_ct010761.pdf
HAS/2001-10-09_ct010742.pdf
HAS/2001-10-09_ct010748.pdf
HAS/2001-10-09_ct010750.pdf
HAS/2001-10-09_ct010758.pdf
HAS/2001-10-09_ct010760.pdf
HAS/2001-10-09_ct020843.pdf
HAS/2001-10-16_ct010718.pdf
HAS/2001-10-16_ct010723.pdf
HAS/2001-10-16_ct010724.pdf
HAS/2001-10-16_ct010741.pdf
HAS/2001-10-16_ct010743.pdf
HAS/2001-10-16_ct010747.pdf
HAS/2001-10-16_ct010751.pdf
HAS/2001-10-16_ct010754.pdf
HAS/2001-10-16_ct010756.pdf
HAS/2001-10-16_ct010757.pdf
HAS/2001-10-16_ct010759.pdf
HAS/2001-10-16_ct010762.pdf
HAS/2001-10-31_Escarres_court.pdf
HAS/2001-10-31_escarresdef_long.pdf
HAS/2001-10-31_pressure_ulcers.pdf
HAS/2001-11-01_reseauxsoins.pdf
HAS/2001-11-06_ct010714.pdf
HAS/2001-11-06_ct010716.pdf
HAS/2001-11-06_ct010717.pdf
HAS/2001-11-06_ct010740.pdf
HAS/2001-11-06_ct010788.pdf
HAS/2001-11-06_ct010800.pdf
HAS/2001-11-06_ct020906.pdf
HAS/2001-11-06_herpes_court.pdf
HAS/2001-11-06_herpes_long.pdf
HAS/2001-11-06_pp020036.pdf
HAS/2001-11-06_pp020040.pdf
HAS/2001-11-06_pp020041.pdf
HAS/2001-11-06_pp020109.pdf
HAS/2001-11-20_ct010765.pdf
HAS/2001-11-20_ct010769.pdf
HAS/2001-11-20_ct010776.pdf
HAS/2001-11-20_ct010783.pdf
HAS/2001-11-20_ct010784.pdf
HAS/2001-11-20_ct010785.pdf
HAS/2001-11-20_ct010794.pdf
HAS/2001-11-20_ct010801.pdf
HAS/2001-11-20_ct010802.pdf
HAS/2001-11-20_ct010803.pdf
HAS/2001-11-20_ct020811.pdf
HAS/2001-11-27_ct010763.pdf
HAS/2001-11-27_ct010764.pdf
HAS/2001-11-27_ct010766.pdf
HAS/2001-11-27_ct010768.pdf
HAS/2001-11-27_ct010770.pdf
HAS/2001-11-27_ct010771.pdf
HAS/2001-11-27_ct010772.pdf
HAS/2001-11-27_ct010774.pdf
HAS/2001-11-27_ct010777.pdf
HAS/2001-11-27_ct010779.pdf
HAS/2001-11-27_ct010780.pdf
HAS/2001-11-27_ct010781.pdf
HAS/2001-11-27_ct010786.pdf
HAS/2001-11-27_ct010787.pdf
HAS/2001-11-27_ct010789.pdf
HAS/2001-11-27_ct010791.pdf
HAS/2001-11-27_ct010792.pdf
HAS/2001-11-27_ct010793.pdf
HAS/2001-11-27_ct020804.pdf
HAS/2001-11-27_ct020805.pdf
HAS/2001-11-27_ct020810.pdf
HAS/2001-11-27_ct020835.pdf
HAS/2001-11-27_ct020851.pdf
HAS/2001-11-27_pp020035.pdf
HAS/2001-11-27_pp020042.pdf
HAS/2001-11-27_pp020043.pdf
HAS/2001-11-27_pp020048.pdf
HAS/2001-11-27_pp020053.pdf
HAS/2001-11-27_pp020054.pdf
HAS/2001-12-04_ct020829.pdf
HAS/2001-12-11_ct010767.pdf
HAS/2001-12-11_ct010775.pdf
HAS/2001-12-11_ct010778.pdf
HAS/2001-12-11_ct010782.pdf
HAS/2001-12-11_ct010790.pdf
HAS/2001-12-11_ct020806.pdf
HAS/2001-12-11_ct020807_inomax.pdf
HAS/2001-12-11_ct020808.pdf
HAS/2001-12-11_ct020809.pdf
HAS/2001-12-11_ct020816.pdf
HAS/2001-12-11_ct020817.pdf
HAS/2001-12-11_ct020818.pdf
HAS/2001-12-11_ct020824.pdf
HAS/2001-12-11_ct020834.pdf
HAS/2001-12-11_ct020844.pdf
HAS/2001-12-11_ct020848.pdf
HAS/2001-12-11_ct020855.pdf
HAS/2001-12-11_ct020859.pdf
HAS/2001-12-11_ct020860.pdf
HAS/2001-12-12_ct010773.pdf
HAS/2001-12-18_ct020813.pdf
HAS/2001-12-18_ct020814.pdf
HAS/2001-12-18_ct020820.pdf
HAS/2001-12-18_ct020823.pdf
HAS/2001-12-18_ct020825.pdf
HAS/2001-12-18_ct020836.pdf
HAS/2001-12-18_ct020837.pdf
HAS/2001-12-18_ct020838.pdf
HAS/2001-12-18_ct020839.pdf
HAS/2001-12-18_ct020841.pdf
HAS/2001-12-18_ct020842.pdf
HAS/2001-12-18_ct020861.pdf
HAS/2001-12-18_ct020862.pdf
HAS/2001-12-18_ct020889.pdf
HAS/2001-12-18_ct020896.pdf
HAS/2001-12-18_pp020031.pdf
HAS/2001-12-18_pp020058.pdf
HAS/2001-12-18_pp020061.pdf
HAS/2001-12-18_pp020064.pdf
HAS/2001-12-18_pp020073.pdf
HAS/2001-12-18_pp020076.pdf
HAS/2001-12-18_pp020084.pdf
HAS/2001-12-18_pp020092.pdf
HAS/2001-12-18_pp020103.pdf
HAS/2001-12-18_pp020105.pdf
HAS/2001-12-18_pp020106.pdf
HAS/2001-12-18_pp020113.pdf
HAS/2001-12-18_pp020118.pdf
HAS/2001-12-19_ct020821.pdf
HAS/2002-01-01_cancer.sein.mammo.pdf
HAS/2002-01-08_ct020812.pdf
HAS/2002-01-08_ct020819.pdf
HAS/2002-01-08_ct020822.pdf
HAS/2002-01-08_ct020826.pdf
HAS/2002-01-08_ct020827.pdf
HAS/2002-01-08_ct020830.pdf
HAS/2002-01-08_ct020831.pdf
HAS/2002-01-08_ct020832.pdf
HAS/2002-01-08_ct020833.pdf
HAS/2002-01-08_ct020845.pdf
HAS/2002-01-08_ct020846.pdf
HAS/2002-01-08_ct020847.pdf
HAS/2002-01-08_ct020849.pdf
HAS/2002-01-08_ct020850.pdf
HAS/2002-01-08_ct020852.pdf
HAS/2002-01-08_ct020853.pdf
HAS/2002-01-08_ct020854.pdf
HAS/2002-01-08_ct020856.pdf
HAS/2002-01-08_ct020867.pdf
HAS/2002-01-08_ct020868.pdf
HAS/2002-01-08_ct020883.pdf
HAS/2002-01-08_ct020884.pdf
HAS/2002-01-08_ct020885.pdf
HAS/2002-01-08_ct020899.pdf
HAS/2002-01-08_ct020908.pdf
HAS/2002-01-08_pp020034.pdf
HAS/2002-01-08_pp020059.pdf
HAS/2002-01-08_pp020071.pdf
HAS/2002-01-08_pp020072.pdf
HAS/2002-01-08_pp020075.pdf
HAS/2002-01-08_pp020107.pdf
HAS/2002-01-08_pp020116.pdf
HAS/2002-01-08_pp020131.pdf
HAS/2002-01-09_ct020874.pdf
HAS/2002-01-22_ct020815.pdf
HAS/2002-01-22_ct020828.pdf
HAS/2002-01-22_ct020840.pdf
HAS/2002-01-22_ct020857.pdf
HAS/2002-01-22_ct020858.pdf
HAS/2002-01-22_ct020865.pdf
HAS/2002-01-22_ct020876.pdf
HAS/2002-01-22_ct020877.pdf
HAS/2002-01-22_ct020891.pdf
HAS/2002-01-22_ct020898.pdf
HAS/2002-01-22_ct020903.pdf
HAS/2002-01-22_ct020904.pdf
HAS/2002-01-22_ct020907.pdf
HAS/2002-01-22_ct021022.pdf
HAS/2002-01-29_pp020030.pdf
HAS/2002-01-29_pp020032.pdf
HAS/2002-01-29_pp020037.pdf
HAS/2002-01-29_pp020044.pdf
HAS/2002-01-29_pp020056.pdf
HAS/2002-01-29_pp020079.pdf
HAS/2002-01-29_pp020114.pdf
HAS/2002-02-01_ACR.pdf
HAS/2002-02-01_VHC.pdf
HAS/2002-02-01_agree_user_manual_23_item_instrument.pdf
HAS/2002-02-01_grille.pdf
HAS/2002-02-01_hepatite_C.pdf
HAS/2002-02-04_ct031366.pdf
HAS/2002-02-05_ct020911.pdf
HAS/2002-02-05_ct020923.pdf
HAS/2002-02-05_ct020929.pdf
HAS/2002-02-05_ct020943.pdf
HAS/2002-02-05_ct020957.pdf
HAS/2002-02-05_ct020978.pdf
HAS/2002-02-06_ct020875.pdf
HAS/2002-02-19_ct020863.pdf
HAS/2002-02-19_ct020864.pdf
HAS/2002-02-19_ct020866.pdf
HAS/2002-02-19_ct020869.pdf
HAS/2002-02-19_ct020870.pdf
HAS/2002-02-19_ct020871.pdf
HAS/2002-02-19_ct020872.pdf
HAS/2002-02-19_ct020878.pdf
HAS/2002-02-19_ct020879.pdf
HAS/2002-02-19_ct020880.pdf
HAS/2002-02-19_ct020881.pdf
HAS/2002-02-19_ct020882.pdf
HAS/2002-02-19_ct020886.pdf
HAS/2002-02-19_ct020887.pdf
HAS/2002-02-19_ct020888.pdf
HAS/2002-02-19_ct020890.pdf
HAS/2002-02-19_ct020892.pdf
HAS/2002-02-19_ct020893.pdf
HAS/2002-02-19_ct020894.pdf
HAS/2002-02-19_ct020895.pdf
HAS/2002-02-19_ct020897.pdf
HAS/2002-02-19_ct020900.pdf
HAS/2002-02-19_ct020901.pdf
HAS/2002-02-19_ct020902.pdf
HAS/2002-02-19_ct020905.pdf
HAS/2002-02-19_ct020909.pdf
HAS/2002-02-19_ct020913.pdf
HAS/2002-02-19_ct020914.pdf
HAS/2002-02-19_ct020917.pdf
HAS/2002-02-19_ct020920.pdf
HAS/2002-02-19_ct020930.pdf
HAS/2002-02-19_ct020931.pdf
HAS/2002-02-19_ct020935.pdf
HAS/2002-02-19_ct020937.pdf
HAS/2002-02-19_ct020938.pdf
HAS/2002-02-19_ct020939.pdf
HAS/2002-02-19_ct020944.pdf
HAS/2002-02-19_ct020945.pdf
HAS/2002-02-19_ct020947.pdf
HAS/2002-02-19_ct020948.pdf
HAS/2002-02-19_ct020954.pdf
HAS/2002-02-19_ct020959.pdf
HAS/2002-02-19_pp020033.pdf
HAS/2002-02-19_pp020038.pdf
HAS/2002-02-19_pp020060.pdf
HAS/2002-02-19_pp020074.pdf
HAS/2002-02-19_pp020187.pdf
HAS/2002-02-20_ct020924.pdf
HAS/2002-02-20_ct020925.pdf
HAS/2002-02-20_ct020926.pdf
HAS/2002-02-25_pp020096.pdf
HAS/2002-02-25_pp020136.pdf
HAS/2002-03-05_ct020910.pdf
HAS/2002-03-05_ct020927.pdf
HAS/2002-03-05_ct020928.pdf
HAS/2002-03-05_ct020940.pdf
HAS/2002-03-05_ct020942.pdf
HAS/2002-03-05_ct020946.pdf
HAS/2002-03-05_ct020949.pdf
HAS/2002-03-05_ct020950.pdf
HAS/2002-03-05_ct020955.pdf
HAS/2002-03-05_ct020956.pdf
HAS/2002-03-05_ct020982.pdf
HAS/2002-03-05_ct021002.pdf
HAS/2002-03-05_ct021007.pdf
HAS/2002-03-12_pp020009.pdf
HAS/2002-03-12_pp020010.pdf
HAS/2002-03-12_pp020039.pdf
HAS/2002-03-19_ct020912.pdf
HAS/2002-03-19_ct020915.pdf
HAS/2002-03-19_ct020916.pdf
HAS/2002-03-19_ct020918.pdf
HAS/2002-03-19_ct020919.pdf
HAS/2002-03-19_ct020921.pdf
HAS/2002-03-19_ct020922.pdf
HAS/2002-03-19_ct020932.pdf
HAS/2002-03-19_ct020933.pdf
HAS/2002-03-19_ct020934.pdf
HAS/2002-03-19_ct020936.pdf
HAS/2002-03-19_ct020941.pdf
HAS/2002-03-19_ct020951.pdf
HAS/2002-03-19_ct020952.pdf
HAS/2002-03-19_ct020953.pdf
HAS/2002-03-19_ct020958.pdf
HAS/2002-03-19_ct020966.pdf
HAS/2002-03-19_ct020972.pdf
HAS/2002-03-19_ct020974.pdf
HAS/2002-03-19_ct020983.pdf
HAS/2002-03-19_ct020985.pdf
HAS/2002-03-19_ct020986.pdf
HAS/2002-03-19_ct020992.pdf
HAS/2002-03-19_ct021001.pdf
HAS/2002-03-19_ct021006.pdf
HAS/2002-03-19_ct021008.pdf
HAS/2002-03-19_ct021021.pdf
HAS/2002-03-19_ct021023.pdf
HAS/2002-03-19_ct021024.pdf
HAS/2002-03-19_solian_100_mg-200_mg-400_mg_ri.pdf
HAS/2002-03-20_ct020995.pdf
HAS/2002-03-26_pp020013.pdf
HAS/2002-03-26_pp020057.pdf
HAS/2002-04-02_ct020962.pdf
HAS/2002-04-02_ct020963.pdf
HAS/2002-04-02_ct020965.pdf
HAS/2002-04-02_ct020967.pdf
HAS/2002-04-02_ct020968.pdf
HAS/2002-04-02_ct020973.pdf
HAS/2002-04-02_ct020976.pdf
HAS/2002-04-02_ct020988.pdf
HAS/2002-04-02_ct020993.pdf
HAS/2002-04-02_ct020996.pdf
HAS/2002-04-02_ct020997.pdf
HAS/2002-04-02_ct021000.pdf
HAS/2002-04-02_ct021004.pdf
HAS/2002-04-02_ct021005.pdf
HAS/2002-04-02_ct021010.pdf
HAS/2002-04-02_ct021011.pdf
HAS/2002-04-02_ct021012.pdf
HAS/2002-04-02_ct021013_protoxyde_dazote_air_products_medical__saga_medi_205.pdf
HAS/2002-04-02_ct021014.pdf
HAS/2002-04-02_ct021016.pdf
HAS/2002-04-02_ct021018.pdf
HAS/2002-04-02_ct021025.pdf
HAS/2002-04-02_ct021026.pdf
HAS/2002-04-02_ct021027.pdf
HAS/2002-04-02_ct021031.pdf
HAS/2002-04-06_demarche_qualite_2006_10_06__10_16_43_41.pdf
HAS/2002-04-23_ct020961.pdf
HAS/2002-04-23_ct020964.pdf
HAS/2002-04-23_ct020969.pdf
HAS/2002-04-23_ct020970.pdf
HAS/2002-04-23_ct020971.pdf
HAS/2002-04-23_ct020975.pdf
HAS/2002-04-23_ct020977.pdf
HAS/2002-04-23_ct020979.pdf
HAS/2002-04-23_ct020980.pdf
HAS/2002-04-23_ct020981.pdf
HAS/2002-04-23_ct020984.pdf
HAS/2002-04-23_ct020987.pdf
HAS/2002-04-23_ct020989.pdf
HAS/2002-04-23_ct020990.pdf
HAS/2002-04-23_ct020991.pdf
HAS/2002-04-23_ct020994.pdf
HAS/2002-04-23_ct020998.pdf
HAS/2002-04-23_ct020999.pdf
HAS/2002-04-23_ct021003.pdf
HAS/2002-04-23_ct021009.pdf
HAS/2002-04-23_ct021015.pdf
HAS/2002-04-23_ct021017.pdf
HAS/2002-04-23_ct021019.pdf
HAS/2002-04-23_ct021020.pdf
HAS/2002-04-23_ct021028.pdf
HAS/2002-04-23_ct021029.pdf
HAS/2002-04-23_ct021030.pdf
HAS/2002-04-23_ct021044_diviseq.pdf
HAS/2002-04-23_ct021046_eupantol_40mg_2ri.pdf
HAS/2002-04-23_ct021048_flecaine_lp.pdf
HAS/2002-04-23_ct032595.pdf
HAS/2002-04-23_fludex_15mg_ri.pdf
HAS/2002-04-23_fraxiparine_2850_5700_7600_9500_avril_2002_ri.pdf
HAS/2002-04-23_imigrane_cp_et_susp._nasale_ri_2002.pdf
HAS/2002-04-23_inipomp_40_mg_ri.pdf
HAS/2002-04-23_lovenox_6000_8000_10000_avril_2002_ri.pdf
HAS/2002-05-01_Allaitement_rap.pdf
HAS/2002-05-01_Allaitement_recos.pdf
HAS/2002-05-01_Frottis_anglais.pdf
HAS/2002-05-01_Parodontopathies_rap.pdf
HAS/2002-05-01_Parodontopathies_recos.pdf
HAS/2002-05-01_VV Mai03-Parodont ENG.pdf
HAS/2002-05-01_breastfeeding_guidelines.pdf
HAS/2002-05-01_frottis_final_-_fiche_de_synth_350se_2006_11_20__19_46_10_585.pdf
HAS/2002-05-01_frottis_final_-_recommandations.pdf
HAS/2002-05-14_ct021037_carteol_lp_2.pdf
HAS/2002-05-14_ct021212.pdf
HAS/2002-05-14_ct032593.pdf
HAS/2002-05-14_josir_ri_2002.pdf
HAS/2002-05-14_mosil_gamme.pdf
HAS/2002-05-14_omix_ri_2002.pdf
HAS/2002-05-14_paracetamol_codeine_gnr_400_mg_ri.pdf
HAS/2002-05-14_saizen_eit_ri.pdf
HAS/2002-05-14_sophidone_lp_4-8-16-24_mg_ri.pdf
HAS/2002-05-14_vastarel_35mg.pdf
HAS/2002-05-21_pp020012.pdf
HAS/2002-05-21_pp020014.pdf
HAS/2002-05-21_pp020029.pdf
HAS/2002-05-28_ct021033_avadene.pdf
HAS/2002-05-28_ct021034_betoptic_ri.pdf
HAS/2002-05-28_ct021041_dalacine_nelleposo.pdf
HAS/2002-05-28_ct021042_dexagrane_collyre.pdf
HAS/2002-05-28_ct021092.pdf
HAS/2002-05-28_larmabak09_pour_centri.pdf
HAS/2002-05-28_mopral_20_mg_eit.pdf
HAS/2002-05-28_ozidia_ri.pdf
HAS/2002-05-28_physiogyne_1_mg_ri.pdf
HAS/2002-05-28_protexel_50u.pdf
HAS/2002-05-28_tavanic3corrig_351.pdf
HAS/2002-05-28_zoltum_20_mg_eit.pdf
HAS/2002-06-01_avc_param_351dical_argumentaire_version_2006.pdf
HAS/2002-06-01_avc_param_351dical_fiche_de_synth_350se_version_2006.pdf
HAS/2002-06-01_avc_param_351dical_recommandations_version_2006.pdf
HAS/2002-06-01_education_asthmatique_enfant_-_version_finale_du_22_10_02_recommandations.pdf
HAS/2002-06-01_education_asthmatique_enfantversion_finale_du_22_10_02_argumentaire.pdf
HAS/2002-06-01_education_asthmatique_enfrant_version_finale_du_22_10_02_synthese.pdf
HAS/2002-06-04_pp020080.pdf
HAS/2002-06-11_ct021032_atrovent_nasal_.pdf
HAS/2002-06-11_ct021035.pdf
HAS/2002-06-11_ct021036_bronchokod_750_mg_ri.pdf
HAS/2002-06-11_ct021040.pdf
HAS/2002-06-11_ct021043_diprivan_2.pdf
HAS/2002-06-11_ct021047_fivasa_800_mg_inscription.pdf
HAS/2002-06-11_ct021108.pdf
HAS/2002-06-11_ct021113.pdf
HAS/2002-06-11_ct021127.pdf
HAS/2002-06-11_ct021138.pdf
HAS/2002-06-11_micardis_plus.pdf
HAS/2002-06-11_novofemme.pdf
HAS/2002-06-11_pritor_plus_40mg.pdf
HAS/2002-06-11_propofol_baxter_1.pdf
HAS/2002-06-11_propofol_lipuro_2002.pdf
HAS/2002-06-11_zovirax_200_mg_cpr_et_susp_buv_ri.pdf
HAS/2002-06-11_zovirax_250_mg_-_500_mg_inj_ri.pdf
HAS/2002-06-11_zovirax_5_pour_cent_cr_350me_ri.pdf
HAS/2002-06-11_zovirax_800_mg_cpr_et_susp_buv_ri.pdf
HAS/2002-06-11_zovirax_pom_ophtalm_ri.pdf
HAS/2002-06-18_pp020011.pdf
HAS/2002-06-25_ct021038_cefotaxime_dakota_pharm051et2givim.pdf
HAS/2002-06-25_ct021045_estradiol_ggam_375_et_75.pdf
HAS/2002-06-25_ct021084.pdf
HAS/2002-06-25_ct021085.pdf
HAS/2002-06-25_ct021086.pdf
HAS/2002-06-25_ct021087.pdf
HAS/2002-06-25_ct021088.pdf
HAS/2002-06-25_ct021089.pdf
HAS/2002-06-25_ct021090.pdf
HAS/2002-06-25_ct021091.pdf
HAS/2002-06-25_ct021100.pdf
HAS/2002-06-25_ct021104.pdf
HAS/2002-06-25_ct021105.pdf
HAS/2002-06-25_ct021106.pdf
HAS/2002-06-25_ct021111.pdf
HAS/2002-06-25_ct021114.pdf
HAS/2002-06-25_ct021121.pdf
HAS/2002-06-25_ct021126.pdf
HAS/2002-06-25_ct021131.pdf
HAS/2002-06-25_ct021135.pdf
HAS/2002-06-25_ct021136.pdf
HAS/2002-06-25_ct021137.pdf
HAS/2002-06-25_ct021140.pdf
HAS/2002-06-25_ct021142.pdf
HAS/2002-06-25_ct021146.pdf
HAS/2002-06-25_ct021153.pdf
HAS/2002-06-25_ct021154.pdf
HAS/2002-06-25_ct021156.pdf
HAS/2002-06-25_ct021157.pdf
HAS/2002-07-01_orthodontie_rap.pdf
HAS/2002-07-01_orthodontie_recos.pdf
HAS/2002-07-02_pp020015.pdf
HAS/2002-07-09_ct021081.pdf
HAS/2002-07-09_ct021082.pdf
HAS/2002-07-09_ct021083.pdf
HAS/2002-07-09_ct021093.pdf
HAS/2002-07-09_ct021094.pdf
HAS/2002-07-09_ct021095.pdf
HAS/2002-07-09_ct021096.pdf
HAS/2002-07-09_ct021097.pdf
HAS/2002-07-09_ct021101.pdf
HAS/2002-07-09_ct021102.pdf
HAS/2002-07-09_ct021103.pdf
HAS/2002-07-09_ct021107.pdf
HAS/2002-07-09_ct021109.pdf
HAS/2002-07-09_ct021110.pdf
HAS/2002-07-09_ct021112.pdf
HAS/2002-07-09_ct021115.pdf
HAS/2002-07-09_ct021116.pdf
HAS/2002-07-09_ct021117.pdf
HAS/2002-07-09_ct021118.pdf
HAS/2002-07-09_ct021119.pdf
HAS/2002-07-09_ct021120.pdf
HAS/2002-07-09_ct021122.pdf
HAS/2002-07-09_ct021123.pdf
HAS/2002-07-09_ct021124.pdf
HAS/2002-07-09_ct021125.pdf
HAS/2002-07-09_ct021128.pdf
HAS/2002-07-09_ct021129.pdf
HAS/2002-07-09_ct021130.pdf
HAS/2002-07-09_ct021132.pdf
HAS/2002-07-09_ct021133.pdf
HAS/2002-07-09_ct021134.pdf
HAS/2002-07-09_ct021139.pdf
HAS/2002-07-09_ct021141.pdf
HAS/2002-07-09_ct021143.pdf
HAS/2002-07-09_ct021144.pdf
HAS/2002-07-09_ct021145.pdf
HAS/2002-07-09_ct021147.pdf
HAS/2002-07-09_ct021148.pdf
HAS/2002-07-09_ct021149.pdf
HAS/2002-07-09_ct021150.pdf
HAS/2002-07-09_ct021151.pdf
HAS/2002-07-09_ct021152.pdf
HAS/2002-07-09_ct021163.pdf
HAS/2002-07-10_ct021098.pdf
HAS/2002-07-10_ct021099.pdf
HAS/2002-09-01_AVC_Medical_rap.pdf
HAS/2002-09-01_VV_Oct03_AVC.pdf
HAS/2002-09-01_VV_mai_03_renal_failure.pdf
HAS/2002-09-01_argumentaireinn-mel_2006.pdf
HAS/2002-09-01_avc_m_351dical_-fiche_de_synth_350se-2006.pdf
HAS/2002-09-01_evaluation_du_debit_de_filtration_glomerulaire_et_du_dosage_de_la_creatininemie_dans_le_diagnostic_de_la_maladie_renale_chronique_chez_ladulte_-_fiche_buts.pdf
HAS/2002-09-01_irc_chez_ladulte_2002-_recommandations.pdf
HAS/2002-09-01_irc_chez_ladulte_2002_-_argumentaire.pdf
HAS/2002-09-01_irc_chez_ladulte_2002_-_synth_350se.pdf
HAS/2002-09-01_recommandations_2006_10_27__20_02_3_927.pdf
HAS/2002-09-01_recos-_inn-_mel_2006.pdf
HAS/2002-09-01_synthese-_inn_-_mel2006.pdf
HAS/2002-09-03_ct021159.pdf
HAS/2002-09-03_ct021161.pdf
HAS/2002-09-03_ct021166.pdf
HAS/2002-09-03_ct021167.pdf
HAS/2002-09-03_ct021168.pdf
HAS/2002-09-03_ct021169.pdf
HAS/2002-09-03_ct021174.pdf
HAS/2002-09-03_ct021181.pdf
HAS/2002-09-03_ct021182.pdf
HAS/2002-09-03_ct021183.pdf
HAS/2002-09-03_ct021185.pdf
HAS/2002-09-03_ct021189.pdf
HAS/2002-09-03_ct021190.pdf
HAS/2002-09-03_ct021194.pdf
HAS/2002-09-03_ct021202.pdf
HAS/2002-09-03_ct021203.pdf
HAS/2002-09-03_ct021208.pdf
HAS/2002-09-03_ct021211.pdf
HAS/2002-09-03_ct021213.pdf
HAS/2002-09-03_ct021214.pdf
HAS/2002-09-03_ct021219.pdf
HAS/2002-09-03_ct021220.pdf
HAS/2002-09-03_ct021221.pdf
HAS/2002-09-03_ct021225.pdf
HAS/2002-09-04_ct021176.pdf
HAS/2002-09-04_ct021177.pdf
HAS/2002-09-10_ct021164.pdf
HAS/2002-09-10_ct021165.pdf
HAS/2002-09-10_ct021204.pdf
HAS/2002-09-10_ct021205.pdf
HAS/2002-09-10_ct021209.pdf
HAS/2002-09-10_ct021210.pdf
HAS/2002-09-10_ct021216.pdf
HAS/2002-09-10_ct021224.pdf
HAS/2002-09-10_ct021226.pdf
HAS/2002-09-10_pp020093.pdf
HAS/2002-09-10_pp020095.pdf
HAS/2002-09-10_pp020121.pdf
HAS/2002-09-17_ct021158.pdf
HAS/2002-09-17_ct021160.pdf
HAS/2002-09-17_ct021173.pdf
HAS/2002-09-17_ct021178.pdf
HAS/2002-09-17_ct021179.pdf
HAS/2002-09-17_ct021186.pdf
HAS/2002-09-17_ct021187.pdf
HAS/2002-09-17_ct021188.pdf
HAS/2002-09-17_ct021191.pdf
HAS/2002-09-17_ct021192.pdf
HAS/2002-09-17_ct021193.pdf
HAS/2002-09-17_ct021199.pdf
HAS/2002-09-17_ct021200.pdf
HAS/2002-09-17_ct021201.pdf
HAS/2002-09-17_ct021215.pdf
HAS/2002-09-17_ct021217.pdf
HAS/2002-09-17_ct031245.pdf
HAS/2002-09-17_ct031252.pdf
HAS/2002-09-17_ct031262.pdf
HAS/2002-09-17_ct031276.pdf
HAS/2002-09-17_ct031279.pdf
HAS/2002-09-24_pp020135.pdf
HAS/2002-10-01_ct021170.pdf
HAS/2002-10-01_ct021171.pdf
HAS/2002-10-01_ct021172.pdf
HAS/2002-10-01_ct021175.pdf
HAS/2002-10-01_ct021184.pdf
HAS/2002-10-01_ct021195.pdf
HAS/2002-10-01_ct021196.pdf
HAS/2002-10-01_ct021197.pdf
HAS/2002-10-01_ct021198.pdf
HAS/2002-10-01_ct021206.pdf
HAS/2002-10-01_ct021207.pdf
HAS/2002-10-01_ct021218.pdf
HAS/2002-10-01_ct021222.pdf
HAS/2002-10-01_ct021223.pdf
HAS/2002-10-01_ct031241.pdf
HAS/2002-10-01_ct031267.pdf
HAS/2002-10-01_ct031268.pdf
HAS/2002-10-01_ct031275.pdf
HAS/2002-10-02_ct031293.pdf
HAS/2002-10-08_pp020016.pdf
HAS/2002-10-08_pp020018.pdf
HAS/2002-10-08_pp020023.pdf
HAS/2002-10-08_pp020025.pdf
HAS/2002-10-08_pp020026.pdf
HAS/2002-10-08_pp020027.pdf
HAS/2002-10-08_pp020028.pdf
HAS/2002-10-08_pp020049.pdf
HAS/2002-10-08_pp020050.pdf
HAS/2002-10-08_pp020051.pdf
HAS/2002-10-08_pp020077.pdf
HAS/2002-10-08_pp020094.pdf
HAS/2002-10-08_pp020151.pdf
HAS/2002-10-08_pp020424.pdf
HAS/2002-10-15_ct021180.pdf
HAS/2002-10-15_ct031244.pdf
HAS/2002-10-15_ct031249.pdf
HAS/2002-10-15_ct031261.pdf
HAS/2002-10-15_ct031266.pdf
HAS/2002-10-15_ct031274.pdf
HAS/2002-10-15_ct031277.pdf
HAS/2002-10-15_ct031283.pdf
HAS/2002-10-15_ct031284.pdf
HAS/2002-10-15_ct031287.pdf
HAS/2002-10-15_ct031288.pdf
HAS/2002-10-15_ct031296.pdf
HAS/2002-10-15_ct031331.pdf
HAS/2002-10-15_pp020117.pdf
HAS/2002-10-16_ct031238.pdf
HAS/2002-11-05_ct031240.pdf
HAS/2002-11-05_ct031242.pdf
HAS/2002-11-05_ct031250.pdf
HAS/2002-11-05_ct031254.pdf
HAS/2002-11-05_ct031255.pdf
HAS/2002-11-05_ct031256.pdf
HAS/2002-11-05_ct031257.pdf
HAS/2002-11-05_ct031263.pdf
HAS/2002-11-05_ct031264.pdf
HAS/2002-11-05_ct031269.pdf
HAS/2002-11-05_ct031272.pdf
HAS/2002-11-05_ct031273.pdf
HAS/2002-11-05_ct031281.pdf
HAS/2002-11-05_ct031282.pdf
HAS/2002-11-05_ct031289.pdf
HAS/2002-11-05_ct031291.pdf
HAS/2002-11-05_ct031295.pdf
HAS/2002-11-05_ct031311.pdf
HAS/2002-11-05_pp020019.pdf
HAS/2002-11-05_pp020020.pdf
HAS/2002-11-05_pp020022.pdf
HAS/2002-11-05_pp020139.pdf
HAS/2002-11-05_pp020143.pdf
HAS/2002-11-05_pp020148.pdf
HAS/2002-11-06_ct031239.pdf
HAS/2002-11-19_ct031246.pdf
HAS/2002-11-19_ct031247.pdf
HAS/2002-11-19_ct031248.pdf
HAS/2002-11-19_ct031251.pdf
HAS/2002-11-19_ct031253.pdf
HAS/2002-11-19_ct031258.pdf
HAS/2002-11-19_ct031259.pdf
HAS/2002-11-19_ct031260.pdf
HAS/2002-11-19_ct031270.pdf
HAS/2002-11-19_ct031278.pdf
HAS/2002-11-19_ct031280.pdf
HAS/2002-11-19_ct031286.pdf
HAS/2002-11-19_ct031294.pdf
HAS/2002-11-19_ct031319.pdf
HAS/2002-11-19_ct031321.pdf
HAS/2002-11-19_ct031323.pdf
HAS/2002-11-19_ct031332.pdf
HAS/2002-11-19_ct031354.pdf
HAS/2002-11-20_ct031290.pdf
HAS/2002-11-26_pp020008.pdf
HAS/2002-11-26_pp020078.pdf
HAS/2002-11-26_pp020110.pdf
HAS/2002-11-26_pp020111.pdf
HAS/2002-11-26_pp020112.pdf
HAS/2002-12-01_Postpartum_guidelines.pdf
HAS/2002-12-01_post_partum_rap.pdf
HAS/2002-12-01_recos_finales_post_partum_2006.pdf
HAS/2002-12-01_synthese_post_partum.pdf
HAS/2002-12-01_txt_soins_palliatifs_argumentaire_mise_en_ligne_2006.pdf
HAS/2002-12-01_txt_soins_palliatifs_recommandations_finales_mise_en_ligne.pdf
HAS/2002-12-03_ct031243.pdf
HAS/2002-12-03_ct031312.pdf
HAS/2002-12-03_ct031313.pdf
HAS/2002-12-03_ct031330.pdf
HAS/2002-12-10_pp020130.pdf
HAS/2002-12-17_ct031265.pdf
HAS/2002-12-17_ct031271.pdf
HAS/2002-12-17_ct031285.pdf
HAS/2002-12-17_ct031292.pdf
HAS/2002-12-17_ct031297.pdf
HAS/2002-12-17_ct031298.pdf
HAS/2002-12-17_ct031299.pdf
HAS/2002-12-17_ct031302.pdf
HAS/2002-12-17_ct031303.pdf
HAS/2002-12-17_ct031304.pdf
HAS/2002-12-17_ct031306.pdf
HAS/2002-12-17_ct031308.pdf
HAS/2002-12-17_ct031310.pdf
HAS/2002-12-17_ct031315.pdf
HAS/2002-12-17_ct031316.pdf
HAS/2002-12-17_ct031317.pdf
HAS/2002-12-17_ct031318.pdf
HAS/2002-12-17_ct031322.pdf
HAS/2002-12-17_ct031324.pdf
HAS/2002-12-17_ct031325.pdf
HAS/2002-12-17_ct031326.pdf
HAS/2002-12-17_ct031327.pdf
HAS/2002-12-17_ct031328.pdf
HAS/2002-12-17_ct031329.pdf
HAS/2002-12-17_ct031333.pdf
HAS/2002-12-17_ct031334.pdf
HAS/2002-12-17_ct031335.pdf
HAS/2002-12-17_ct031336.pdf
HAS/2002-12-17_ct031338.pdf
HAS/2002-12-17_ct031342.pdf
HAS/2002-12-17_ct031346.pdf
HAS/2002-12-17_ct031361.pdf
HAS/2002-12-18_ct031305.pdf
HAS/2002-12-18_ct031309.pdf
HAS/2002-12-18_ct031337.pdf
HAS/2003-01-01_urticaire_court.pdf
HAS/2003-01-01_urticaire_long.pdf
HAS/2003-01-07_ct031301.pdf
HAS/2003-01-07_ct031320.pdf
HAS/2003-01-07_ct031339.pdf
HAS/2003-01-07_ct031348.pdf
HAS/2003-01-13_ct031486.pdf
HAS/2003-01-14_pp020066.pdf
HAS/2003-01-14_pp020067.pdf
HAS/2003-01-14_pp020082.pdf
HAS/2003-01-14_pp020083.pdf
HAS/2003-01-14_pp020108.pdf
HAS/2003-01-14_pp020133.pdf
HAS/2003-01-14_pp020134.pdf
HAS/2003-01-15_Mucovisc_pneumo_infectio_court.pdf
HAS/2003-01-15_Mucovisc_pneumo_infectio_long.pdf
HAS/2003-01-15_cystic_fibrosis_2_guidelines.pdf
HAS/2003-01-15_cystic_fibrosis_guidelines.pdf
HAS/2003-01-15_mucovisc_nutrition-gastro_long.pdf
HAS/2003-01-15_mucovisc_nutrition_gastro_court.pdf
HAS/2003-01-21_ct031300.pdf
HAS/2003-01-21_ct031307.pdf
HAS/2003-01-21_ct031314.pdf
HAS/2003-01-21_ct031340.pdf
HAS/2003-01-21_ct031341.pdf
HAS/2003-01-21_ct031344.pdf
HAS/2003-01-21_ct031350.pdf
HAS/2003-01-21_ct031351.pdf
HAS/2003-01-21_ct031355.pdf
HAS/2003-01-21_ct031360.pdf
HAS/2003-01-21_ct031362.pdf
HAS/2003-01-21_ct031364.pdf
HAS/2003-01-21_ct031369.pdf
HAS/2003-02-01_Chlamydia2_abstract.pdf
HAS/2003-02-01_Chlamydia_tome1_rap.pdf
HAS/2003-02-01_Chlamydia_tome1_synth.pdf
HAS/2003-02-01_Chlamydia_tome2_rap.pdf
HAS/2003-02-01_Chlamydia_tome2_synth.pdf
HAS/2003-02-01_diabete_rap_2003.pdf
HAS/2003-02-01_diabete_synth_2003.pdf
HAS/2003-02-04_ct031345.pdf
HAS/2003-02-04_ct031349.pdf
HAS/2003-02-04_ct031352.pdf
HAS/2003-02-04_ct031357.pdf
HAS/2003-02-04_ct031365.pdf
HAS/2003-02-04_ct031367.pdf
HAS/2003-02-04_ct031368.pdf
HAS/2003-02-04_ct031378.pdf
HAS/2003-02-04_pp020140.pdf
HAS/2003-02-04_pp020179.pdf
HAS/2003-02-18_ct031347.pdf
HAS/2003-02-18_ct031356.pdf
HAS/2003-02-18_ct031359.pdf
HAS/2003-02-18_ct031370.pdf
HAS/2003-02-18_ct031384.pdf
HAS/2003-02-25_pp020062.pdf
HAS/2003-02-25_pp020063.pdf
HAS/2003-02-25_pp020085.pdf
HAS/2003-02-25_pp020086.pdf
HAS/2003-02-25_pp020087.pdf
HAS/2003-02-25_pp020088.pdf
HAS/2003-02-25_pp020119.pdf
HAS/2003-02-25_pp020122.pdf
HAS/2003-02-25_pp020124.pdf
HAS/2003-02-25_pp020129.pdf
HAS/2003-02-25_pp020172.pdf
HAS/2003-02-25_pp020181.pdf
HAS/2003-03-01_hbp_2003_argumentaire.pdf
HAS/2003-03-01_hbp_2003_recommandations.pdf
HAS/2003-03-01_hbp_2003_synthese.pdf
HAS/2003-03-01_prostatic_hyperplasia.pdf
HAS/2003-03-04_ct031353.pdf
HAS/2003-03-04_ct031363.pdf
HAS/2003-03-04_ct031374.pdf
HAS/2003-03-04_ct031377.pdf
HAS/2003-03-04_ct031379.pdf
HAS/2003-03-04_ct031380.pdf
HAS/2003-03-04_ct031381.pdf
HAS/2003-03-05_ct031373.pdf
HAS/2003-03-11_pp020132.pdf
HAS/2003-03-18_ct031358.pdf
HAS/2003-03-18_ct031372.pdf
HAS/2003-03-18_ct031376.pdf
HAS/2003-03-25_pp020069.pdf
HAS/2003-03-25_pp020115.pdf
HAS/2003-03-25_pp020126.pdf
HAS/2003-03-25_pp020152.pdf
HAS/2003-03-25_pp020180.pdf
HAS/2003-04-01_ct031371.pdf
HAS/2003-04-08_pp020141.pdf
HAS/2003-04-08_pp020142.pdf
HAS/2003-04-08_pp020233.pdf
HAS/2003-04-08_pp020252.pdf
HAS/2003-04-15_Thrombophilia_guidelines.pdf
HAS/2003-04-15_Thrombophilie_grossesse_ long.pdf
HAS/2003-04-15_Thrombophilie_grossesse_court.pdf
HAS/2003-04-15_ct031382.pdf
HAS/2003-04-15_ct031383.pdf
HAS/2003-04-15_ct031398.pdf
HAS/2003-04-15_ct031400.pdf
HAS/2003-04-15_ct031401.pdf
HAS/2003-04-15_ct031412.pdf
HAS/2003-04-29_pp020089.pdf
HAS/2003-04-29_pp020090.pdf
HAS/2003-04-29_pp020091.pdf
HAS/2003-04-29_pp020150.pdf
HAS/2003-05-01_argumentaire1_2006_12_01__10_19_53_157.pdf
HAS/2003-05-01_argumentaire_cervicalgie_mel_2006.pdf
HAS/2003-05-01_female_incontinence.pdf
HAS/2003-05-01_fiche_de_synth_350se_2006_12_01__10_19_28_399.pdf
HAS/2003-05-01_physioth_common_neck_pain_guidelines.pdf
HAS/2003-05-01_recommandations_cervicalgies_mel_2006_2006_12_28__11_50_51_550.pdf
HAS/2003-05-01_recommandations_mise_en_page_2006_2006_12_01__10_19_39_825.pdf
HAS/2003-05-01_synthese_cervicalgies_mel_2006.pdf
HAS/2003-05-06_ct-031446_levitra_.pdf
HAS/2003-05-06_ct031385.pdf
HAS/2003-05-06_ct031387.pdf
HAS/2003-05-06_ct031388.pdf
HAS/2003-05-06_ct031389.pdf
HAS/2003-05-06_ct031393.pdf
HAS/2003-05-06_ct031394.pdf
HAS/2003-05-06_ct031395.pdf
HAS/2003-05-06_ct031396.pdf
HAS/2003-05-06_ct031397.pdf
HAS/2003-05-06_ct031399.pdf
HAS/2003-05-06_ct031402.pdf
HAS/2003-05-06_ct031405.pdf
HAS/2003-05-06_ct031409.pdf
HAS/2003-05-06_ct031410.pdf
HAS/2003-05-20_ct031386.pdf
HAS/2003-05-20_ct031390.pdf
HAS/2003-05-20_ct031391.pdf
HAS/2003-05-20_ct031392.pdf
HAS/2003-05-20_ct031407.pdf
HAS/2003-05-20_ct031418.pdf
HAS/2003-05-20_ct031422.pdf
HAS/2003-05-20_ct031429.pdf
HAS/2003-05-20_pp020070.pdf
HAS/2003-05-20_pp020081.pdf
HAS/2003-05-20_pp020137.pdf
HAS/2003-05-20_pp020138.pdf
HAS/2003-05-20_pp020149.pdf
HAS/2003-05-20_pp020157.pdf
HAS/2003-05-20_pp020232.pdf
HAS/2003-06-10_pp020100.pdf
HAS/2003-06-10_pp020101.pdf
HAS/2003-06-10_pp020102.pdf
HAS/2003-06-10_pp020104.pdf
HAS/2003-06-10_pp020145.pdf
HAS/2003-06-10_pp020146.pdf
HAS/2003-06-10_pp020147.pdf
HAS/2003-06-17_ct-031436_aciclovir_aguettant_.pdf
HAS/2003-06-17_ct031403.pdf
HAS/2003-06-17_ct031404.pdf
HAS/2003-06-17_ct031406.pdf
HAS/2003-06-17_ct031408.pdf
HAS/2003-06-17_ct031411.pdf
HAS/2003-06-17_ct031420.pdf
HAS/2003-06-17_ct031421.pdf
HAS/2003-06-17_ct031430.pdf
HAS/2003-06-17_ct031431.pdf
HAS/2003-06-17_ct031432.pdf
HAS/2003-06-17_ct031434.pdf
HAS/2003-07-01_ct-031437_avodart.pdf
HAS/2003-07-01_ct031413.pdf
HAS/2003-07-01_ct031415.pdf
HAS/2003-07-01_ct031416.pdf
HAS/2003-07-01_ct031423.pdf
HAS/2003-07-01_ct031424.pdf
HAS/2003-07-01_ct031433.pdf
HAS/2003-07-01_pp020155.pdf
HAS/2003-07-01_pp020158.pdf
HAS/2003-07-01_pp020163.pdf
HAS/2003-07-01_pp020190.pdf
HAS/2003-07-01_pp020256.pdf
HAS/2003-07-15_ct-031440_epitomax_eit_mono_2003_.pdf
HAS/2003-07-15_ct-031441_fludesoxyglucose_iba_.pdf
HAS/2003-07-15_ct-031442_glivec_.pdf
HAS/2003-07-15_ct-031449_tavanic.pdf
HAS/2003-07-15_ct031419.pdf
HAS/2003-07-15_ct031425.pdf
HAS/2003-07-15_ct031427.pdf
HAS/2003-07-15_pp020156.pdf
HAS/2003-07-15_pp020161.pdf
HAS/2003-07-15_pp020164.pdf
HAS/2003-07-22_ct-031438_cancidas_.pdf
HAS/2003-07-22_ct-031439_cozaar_50_mg_et_100_mg_.pdf
HAS/2003-07-22_ct-031443_hyperhes.pdf
HAS/2003-07-22_ct-031444_invanz_.pdf
HAS/2003-07-22_ct-031445_lantus_enfant_.pdf
HAS/2003-07-22_ct-031447_lodales_20_mg_-_40_mg_.pdf
HAS/2003-07-22_ct-031450_tetrofosmin_.pdf
HAS/2003-07-22_ct-031451_visudyne15_mg_.pdf
HAS/2003-07-22_ct-031452_ytracis_.pdf
HAS/2003-07-22_ct-031453_zocor_20_mg_-_40_mg_.pdf
HAS/2003-07-22_ct031414.pdf
HAS/2003-07-22_ct031417.pdf
HAS/2003-07-22_ct031426.pdf
HAS/2003-07-22_ct031428.pdf
HAS/2003-07-22_ct031435.pdf
HAS/2003-09-01_anaes_argumentaire_chimioth_351rapie-2.pdf
HAS/2003-09-01_anaes_fiche_de_synth_350se_chimioth_351rapie-2.pdf
HAS/2003-09-01_anaes_recommandations_chimioth_351rapie-2.pdf
HAS/2003-09-01_at_home_chemotherapy_guidelines_2006_11_20__12_27_55_544.pdf
HAS/2003-09-09_pp020065.pdf
HAS/2003-09-09_pp020068.pdf
HAS/2003-09-09_pp020097.pdf
HAS/2003-09-09_pp020098.pdf
HAS/2003-09-09_pp020099.pdf
HAS/2003-09-09_pp020128.pdf
HAS/2003-09-09_pp020255.pdf
HAS/2003-09-23_pp020178.pdf
HAS/2003-10-02_Hepatitis_B_guidelines.pdf
HAS/2003-10-02_VHB_recos.pdf
HAS/2003-10-02_guideCC.pdf
HAS/2003-10-07_pp020160.pdf
HAS/2003-10-07_pp020162.pdf
HAS/2003-10-07_pp020165.pdf
HAS/2003-10-07_pp020174.pdf
HAS/2003-10-14_ct031454.pdf
HAS/2003-10-14_ct031457.pdf
HAS/2003-10-14_ct031459.pdf
HAS/2003-10-14_ct031461.pdf
HAS/2003-10-14_ct031463.pdf
HAS/2003-10-14_ct031464.pdf
HAS/2003-10-14_ct031466.pdf
HAS/2003-10-14_ct031467.pdf
HAS/2003-10-14_ct031656.pdf
HAS/2003-10-21_pp020123.pdf
HAS/2003-10-21_pp020125.pdf
HAS/2003-10-21_pp020144.pdf
HAS/2003-10-21_pp020153.pdf
HAS/2003-10-28_ct031455.pdf
HAS/2003-10-28_ct031458.pdf
HAS/2003-10-28_ct031462.pdf
HAS/2003-10-28_ct031465.pdf
HAS/2003-10-28_ct031480.pdf
HAS/2003-10-28_ct031485.pdf
HAS/2003-10-28_ct031493.pdf
HAS/2003-10-29_ct031456.pdf
HAS/2003-11-04_pp020154.pdf
HAS/2003-11-04_pp020192.pdf
HAS/2003-11-04_pp020257.pdf
HAS/2003-11-04_pp020287.pdf
HAS/2003-11-04_pp020288.pdf
HAS/2003-11-04_pp020353.pdf
HAS/2003-11-11_ct031460.pdf
HAS/2003-11-11_ct031477.pdf
HAS/2003-11-11_ct031484.pdf
HAS/2003-11-18_pp020175.pdf
HAS/2003-11-25_ct031468.pdf
HAS/2003-11-25_ct031469.pdf
HAS/2003-11-25_ct031470.pdf
HAS/2003-11-25_ct031472.pdf
HAS/2003-11-25_ct031473.pdf
HAS/2003-11-25_ct031481.pdf
HAS/2003-11-25_ct031482.pdf
HAS/2003-11-25_ct031483.pdf
HAS/2003-11-25_ct031487.pdf
HAS/2003-11-25_ct031488.pdf
HAS/2003-11-25_ct031492.pdf
HAS/2003-12-01_AVC_Retour_Recos.pdf
HAS/2003-12-01_Traitement_orthop_dento_faciale_rap.pdf
HAS/2003-12-01_Traitement_orthop_dento_faciale_recos.pdf
HAS/2003-12-02_pp020166.pdf
HAS/2003-12-02_pp020167.pdf
HAS/2003-12-02_pp020168.pdf
HAS/2003-12-02_pp020191.pdf
HAS/2003-12-09_ct031471.pdf
HAS/2003-12-09_ct031474.pdf
HAS/2003-12-09_ct031475.pdf
HAS/2003-12-09_ct031478.pdf
HAS/2003-12-09_ct031479.pdf
HAS/2003-12-09_ct031490.pdf
HAS/2003-12-09_ct031499.pdf
HAS/2003-12-10_ct031476.pdf
HAS/2003-12-11_Saturnisme_court.pdf
HAS/2003-12-11_Saturnisme_long.pdf
HAS/2003-12-16_ct031500.pdf
HAS/2003-12-16_pp020176.pdf
HAS/2003-12-16_pp020177.pdf
HAS/2003-12-16_pp020182.pdf
HAS/2003-12-16_pp020183.pdf
HAS/2003-12-16_pp020184.pdf
HAS/2003-12-16_pp020185.pdf
HAS/2003-12-16_pp020300.pdf
HAS/2004-01-01_argumentaire_final_rpc_ventriculomegalie.pdf
HAS/2004-01-01_argumentaire_pied_du_nourrisson_mel_2006.pdf
HAS/2004-01-01_congenital_foot_deformity.pdf
HAS/2004-01-01_fiche_synthese_recos_pied_du_nourrisson_maj_mai_2006.pdf
HAS/2004-01-01_recommandations_pied_du_nourrisson_mel_2006.pdf
HAS/2004-01-01_recos_finales_ventriculomegaile.pdf
HAS/2004-01-06_pp020169.pdf
HAS/2004-01-06_pp020235.pdf
HAS/2004-01-06_pp020279.pdf
HAS/2004-01-13_ct031489.pdf
HAS/2004-01-13_ct031491.pdf
HAS/2004-01-13_ct031494.pdf
HAS/2004-01-13_ct031495.pdf
HAS/2004-01-13_ct031496.pdf
HAS/2004-01-13_ct031497.pdf
HAS/2004-01-13_ct031498.pdf
HAS/2004-01-13_ct031501.pdf
HAS/2004-01-13_ct031502.pdf
HAS/2004-01-13_ct031504.pdf
HAS/2004-01-13_ct031506.pdf
HAS/2004-01-13_ct031509.pdf
HAS/2004-01-13_ct031511.pdf
HAS/2004-01-13_ct031514.pdf
HAS/2004-01-13_ct031518.pdf
HAS/2004-01-20_pp020173.pdf
HAS/2004-01-20_pp020234.pdf
HAS/2004-01-27_ct031503.pdf
HAS/2004-01-27_ct031510.pdf
HAS/2004-01-27_ct031512.pdf
HAS/2004-01-27_ct031520.pdf
HAS/2004-01-27_ct031521.pdf
HAS/2004-01-27_ct031526.pdf
HAS/2004-01-27_ct031528.pdf
HAS/2004-01-27_ct031533.pdf
HAS/2004-01-27_ct031534.pdf
HAS/2004-01-27_ct031536.pdf
HAS/2004-01-27_ct031537.pdf
HAS/2004-01-27_ct031540.pdf
HAS/2004-01-27_ct031543.pdf
HAS/2004-02-03_pp020170.pdf
HAS/2004-02-03_pp020171.pdf
HAS/2004-02-03_pp020188.pdf
HAS/2004-02-03_pp020189.pdf
HAS/2004-02-03_pp020193.pdf
HAS/2004-02-03_pp020248.pdf
HAS/2004-02-03_pp020249.pdf
HAS/2004-02-03_pp020250.pdf
HAS/2004-02-03_pp020251.pdf
HAS/2004-02-03_pp020276.pdf
HAS/2004-02-10_ct031505.pdf
HAS/2004-02-10_ct031507.pdf
HAS/2004-02-10_ct031513.pdf
HAS/2004-02-10_ct031515.pdf
HAS/2004-02-10_ct031516.pdf
HAS/2004-02-10_ct031517.pdf
HAS/2004-02-10_ct031519.pdf
HAS/2004-02-10_ct031522.pdf
HAS/2004-02-10_ct031525.pdf
HAS/2004-02-10_ct031535.pdf
HAS/2004-02-10_ct031539.pdf
HAS/2004-02-14_Accompagnement_court.pdf
HAS/2004-02-14_Accompagnement_long.pdf
HAS/2004-02-17_pp020278.pdf
HAS/2004-02-24_ct031523.pdf
HAS/2004-02-24_ct031524.pdf
HAS/2004-02-24_ct031527.pdf
HAS/2004-02-24_ct031530.pdf
HAS/2004-02-24_ct031531.pdf
HAS/2004-02-24_ct031538.pdf
HAS/2004-02-24_ct031552.pdf
HAS/2004-02-24_ct031554.pdf
HAS/2004-02-24_ct031615.pdf
HAS/2004-02-24_ct031616.pdf
HAS/2004-02-24_ct031630.pdf
HAS/2004-02-24_ct031635.pdf
HAS/2004-02-24_ct031636.pdf
HAS/2004-02-24_ct031637.pdf
HAS/2004-02-24_ct031638.pdf
HAS/2004-02-25_ct031508.pdf
HAS/2004-03-01_Basal_cell_carcinoma_guidelines.pdf
HAS/2004-03-01_Cancer_sein_prog_depistage_rap.pdf
HAS/2004-03-01_Cancer_sein_prog_depitage_Synth.pdf
HAS/2004-03-01_argumantaire.pdf
HAS/2004-03-01_fiche_de_synth_350se_2006_10_27__19_23_54_957.pdf
HAS/2004-03-01_recommandations_v2.pdf
HAS/2004-03-02_pp020247.pdf
HAS/2004-03-09_ct031532.pdf
HAS/2004-03-09_ct031541.pdf
HAS/2004-03-09_ct031542.pdf
HAS/2004-03-09_ct031553.pdf
HAS/2004-03-09_ct031581.pdf
HAS/2004-03-10_ct031529.pdf
HAS/2004-03-16_pp020194.pdf
HAS/2004-03-16_pp020240.pdf
HAS/2004-03-16_pp020272.pdf
HAS/2004-03-23_ct031544.pdf
HAS/2004-03-23_ct031547.pdf
HAS/2004-03-23_ct031551.pdf
HAS/2004-03-23_ct031557.pdf
HAS/2004-03-24_ct031546.pdf
HAS/2004-03-30_pp020226.pdf
HAS/2004-03-30_pp020227.pdf
HAS/2004-03-30_pp020270.pdf
HAS/2004-03-30_pp020294.pdf
HAS/2004-04-01_Endoscopy_guidelines.pdf
HAS/2004-04-01_Epilepsies_court.pdf
HAS/2004-04-01_Epilepsies_long.pdf
HAS/2004-04-01_Hemochromatose_rap.pdf
HAS/2004-04-01_Hemochromatose_synth.pdf
HAS/2004-04-01_endoscopie_2004_argumentaire_mise_en_forme_2006_2006_12_01__18_10_7_691.pdf
HAS/2004-04-01_endoscopie_2004_recommandations_mise_en_forme_2006.pdf
HAS/2004-04-01_fiche_de_synthese_endoscopie_digestive_2004.pdf
HAS/2004-04-01_haemochromatosis_abstract.pdf
HAS/2004-04-06_ct031545.pdf
HAS/2004-04-06_ct031548.pdf
HAS/2004-04-06_ct031549.pdf
HAS/2004-04-06_ct031550.pdf
HAS/2004-04-06_ct031555.pdf
HAS/2004-04-06_ct031556.pdf
HAS/2004-04-06_ct031558.pdf
HAS/2004-04-06_ct031561.pdf
HAS/2004-04-06_ct031565.pdf
HAS/2004-04-13_pp020231.pdf
HAS/2004-04-13_pp020253.pdf
HAS/2004-04-13_pp020254.pdf
HAS/2004-04-13_pp020258.pdf
HAS/2004-04-13_pp020265.pdf
HAS/2004-04-27_ct031562.pdf
HAS/2004-04-27_ct031564.pdf
HAS/2004-04-27_ct031576.pdf
HAS/2004-04-27_pp020186.pdf
HAS/2004-04-27_pp020237.pdf
HAS/2004-04-27_pp020277.pdf
HAS/2004-04-27_pp020286.pdf
HAS/2004-04-27_pp020289.pdf
HAS/2004-04-27_pp020292.pdf
HAS/2004-04-27_pp020301.pdf
HAS/2004-04-27_pp020345.pdf
HAS/2004-04-27_pp020358.pdf
HAS/2004-05-01_DSI_Guide_methodologique.pdf
HAS/2004-05-01_DSI_Rap.pdf
HAS/2004-05-01_Hormone_replacement_therapy_guidelines.pdf
HAS/2004-05-01_ths_argumentaire.pdf
HAS/2004-05-01_ths_rap.pdf
HAS/2004-05-01_ths_rapport_final_corrige_mtev_-_messages_cles.pdf
HAS/2004-05-01_ths_rapport_final_corrige_mtev_-_orientations_generales_2006_10_25__15_41_5_415.pdf
HAS/2004-05-03_TIAs.pdf
HAS/2004-05-03_ait_-_criteres_devaluation_et_d_amelioration_des_pratiques.pdf
HAS/2004-05-03_ait_argumentaire_2006.pdf
HAS/2004-05-03_ait_recos_2006.pdf
HAS/2004-05-03_fiche_de_synth_350se_2006_10_27__18_04_20_308.pdf
HAS/2004-05-03_guide_programme_depistage_rap.pdf
HAS/2004-05-03_screening_prog_guide.pdf
HAS/2004-05-04_ct031559.pdf
HAS/2004-05-04_ct031560.pdf
HAS/2004-05-04_ct031563.pdf
HAS/2004-05-04_ct031579.pdf
HAS/2004-05-11_pp020230.pdf
HAS/2004-05-11_pp020238.pdf
HAS/2004-05-11_pp020262.pdf
HAS/2004-05-11_pp020284.pdf
HAS/2004-05-11_pp020290.pdf
HAS/2004-05-11_pp020293.pdf
HAS/2004-05-11_pp020342.pdf
HAS/2004-05-12_pp020246.pdf
HAS/2004-05-18_ct031571.pdf
HAS/2004-05-18_ct031575.pdf
HAS/2004-05-18_ct031577.pdf
HAS/2004-05-18_ct031578.pdf
HAS/2004-05-18_ct031584.pdf
HAS/2004-05-18_ct031585.pdf
HAS/2004-05-25_pp020228.pdf
HAS/2004-05-25_pp020239.pdf
HAS/2004-05-25_pp020242.pdf
HAS/2004-05-25_pp020271.pdf
HAS/2004-06-01_TSO_ long.pdf
HAS/2004-06-01_TSO_court.pdf
HAS/2004-06-01_ct031570.pdf
HAS/2004-06-01_ct031573.pdf
HAS/2004-06-01_ct031583.pdf
HAS/2004-06-01_ct031586.pdf
HAS/2004-06-01_ct031587.pdf
HAS/2004-06-01_ct031588.pdf
HAS/2004-06-01_ct031592.pdf
HAS/2004-06-01_ct031605.pdf
HAS/2004-06-01_guideCC.pdf
HAS/2004-06-01_opiaces_recos.pdf
HAS/2004-06-01_pp020236.pdf
HAS/2004-06-01_pp020280.pdf
HAS/2004-06-01_pp020356.pdf
HAS/2004-06-02_ct031574.pdf
HAS/2004-06-11_Amblyopie_rap.pdf
HAS/2004-06-11_Amblyopie_recos.pdf
HAS/2004-06-11_VV_Mai03-Amblyopie_ENG.pdf
HAS/2004-06-15_ct031568.pdf
HAS/2004-06-15_ct031569.pdf
HAS/2004-06-15_ct031572.pdf
HAS/2004-06-15_ct031582.pdf
HAS/2004-06-15_ct031589.pdf
HAS/2004-06-15_ct031590.pdf
HAS/2004-06-15_ct031594.pdf
HAS/2004-06-15_ct031596.pdf
HAS/2004-06-15_ct031597.pdf
HAS/2004-06-15_ct031601.pdf
HAS/2004-06-18_ct031580.pdf
HAS/2004-06-18_humira_fit_14122012.pdf
HAS/2004-06-22_ct031941.pdf
HAS/2004-06-22_ct031969.pdf
HAS/2004-06-22_ct032049.pdf
HAS/2004-06-22_ct032110.pdf
HAS/2004-06-22_ct032114.pdf
HAS/2004-06-29_ct031591.pdf
HAS/2004-06-29_ct031593.pdf
HAS/2004-06-29_ct031595.pdf
HAS/2004-06-29_ct031599.pdf
HAS/2004-06-29_ct031602.pdf
HAS/2004-06-29_ct031603.pdf
HAS/2004-06-29_ct032004.pdf
HAS/2004-06-29_ct032005.pdf
HAS/2004-06-29_ct032059.pdf
HAS/2004-06-29_ct032061.pdf
HAS/2004-06-29_ct032073.pdf
HAS/2004-06-29_ct032082.pdf
HAS/2004-06-29_ct032090.pdf
HAS/2004-06-29_ct032120.pdf
HAS/2004-06-29_ct032121.pdf
HAS/2004-06-29_ct032130.pdf
HAS/2004-06-29_ct032183.pdf
HAS/2004-06-29_pp020275.pdf
HAS/2004-06-30_ct031610.pdf
HAS/2004-06-30_ct032013.pdf
HAS/2004-06-30_diagnostic_de_losteoporose_chez_les_femmes_menopausees_rapport_2004.pdf
HAS/2004-06-30_diagnostic_de_losteoporose_en_rhumatologie_chez_les_femmes_menopausees_referentiel_2004.pdf
HAS/2004-06-30_osteoporose_synthese.pdf
HAS/2004-06-30_prevenir_fractures_osteoporose.pdf
HAS/2004-07-01_Cost_of_quality.pdf
HAS/2004-07-01_Cost_quality_non-quality.pdf
HAS/2004-07-01_Couts_qualite2_2004_Rap.pdf
HAS/2004-07-01_Couts_qualite_2004_Synth.pdf
HAS/2004-07-01_Reseaux_2004.pdf
HAS/2004-07-06_ct031598.pdf
HAS/2004-07-06_ct031600.pdf
HAS/2004-07-06_ct031604.pdf
HAS/2004-07-06_ct031939.pdf
HAS/2004-07-06_ct031955.pdf
HAS/2004-07-06_ct031957.pdf
HAS/2004-07-06_ct031964.pdf
HAS/2004-07-06_ct031997.pdf
HAS/2004-07-06_ct032017.pdf
HAS/2004-07-06_ct032039.pdf
HAS/2004-07-06_ct032063.pdf
HAS/2004-07-06_ct032074.pdf
HAS/2004-07-06_ct032078.pdf
HAS/2004-07-06_ct032107.pdf
HAS/2004-07-06_ct032118.pdf
HAS/2004-07-06_ct032134.pdf
HAS/2004-07-06_ct032136.pdf
HAS/2004-07-06_ct032137.pdf
HAS/2004-07-06_ct032164.pdf
HAS/2004-07-06_ct032182.pdf
HAS/2004-07-20_ct031607.pdf
HAS/2004-07-20_ct031608.pdf
HAS/2004-07-20_ct031609.pdf
HAS/2004-07-20_ct031611.pdf
HAS/2004-07-20_ct031612.pdf
HAS/2004-07-20_ct031613.pdf
HAS/2004-07-20_ct031614.pdf
HAS/2004-07-20_ct031624.pdf
HAS/2004-07-20_pp020195.pdf
HAS/2004-07-20_pp020196.pdf
HAS/2004-07-20_pp020197.pdf
HAS/2004-07-20_pp020199.pdf
HAS/2004-07-20_pp020200.pdf
HAS/2004-07-20_pp020201.pdf
HAS/2004-07-20_pp020202.pdf
HAS/2004-07-20_pp020203.pdf
HAS/2004-07-20_pp020204.pdf
HAS/2004-07-20_pp020205.pdf
HAS/2004-07-20_pp020206.pdf
HAS/2004-07-20_pp020207.pdf
HAS/2004-07-20_pp020208.pdf
HAS/2004-07-20_pp020209.pdf
HAS/2004-07-20_pp020210.pdf
HAS/2004-07-20_pp020211.pdf
HAS/2004-07-20_pp020212.pdf
HAS/2004-07-20_pp020213.pdf
HAS/2004-07-20_pp020214.pdf
HAS/2004-07-20_pp020215.pdf
HAS/2004-07-20_pp020216.pdf
HAS/2004-07-20_pp020217.pdf
HAS/2004-07-20_pp020218.pdf
HAS/2004-07-20_pp020219.pdf
HAS/2004-07-20_pp020220.pdf
HAS/2004-07-20_pp020221.pdf
HAS/2004-07-20_pp020222.pdf
HAS/2004-07-20_pp020223.pdf
HAS/2004-07-20_pp020224.pdf
HAS/2004-08-31_ct031619.pdf
HAS/2004-08-31_ct031620.pdf
HAS/2004-08-31_ct031622.pdf
HAS/2004-08-31_ct031623.pdf
HAS/2004-08-31_ct031625.pdf
HAS/2004-08-31_ct031626.pdf
HAS/2004-08-31_ct032001.pdf
HAS/2004-08-31_ct032002.pdf
HAS/2004-08-31_ct032042.pdf
HAS/2004-08-31_ct032091.pdf
HAS/2004-08-31_ct032094.pdf
HAS/2004-08-31_ct032101.pdf
HAS/2004-08-31_ct032119.pdf
HAS/2004-08-31_ct032153.pdf
HAS/2004-08-31_pp020241.pdf
HAS/2004-08-31_pp020243.pdf
HAS/2004-08-31_pp020245.pdf
HAS/2004-08-31_pp020259.pdf
HAS/2004-08-31_pp020260.pdf
HAS/2004-08-31_pp020261.pdf
HAS/2004-08-31_pp020267.pdf
HAS/2004-09-01_ACR.pdf
HAS/2004-09-01_CCQ_guidelines.pdf
HAS/2004-09-01_CMV_rap.pdf
HAS/2004-09-01_CMV_synth.pdf
HAS/2004-09-01_Cancer_prostate_GB_Guidelines.pdf
HAS/2004-09-01_Cardiovascular_risk_abstract.pdf
HAS/2004-09-01_IRC_2006_fiche.pdf
HAS/2004-09-01_IRC_2006_rap.pdf
HAS/2004-09-01_IRC_2006_recos.pdf
HAS/2004-09-01_Risque_cardio_vasculaire_rap.pdf
HAS/2004-09-01_Risque_cardo_vasculaire_synth.pdf
HAS/2004-09-01_argumentaire_asthme_2006_11_20__20_47_59_456.pdf
HAS/2004-09-01_asthma_follow-up_guidelines.pdf
HAS/2004-09-01_ccq_argumentaire.pdf
HAS/2004-09-01_ccq_fiche_de_synth_350se.pdf
HAS/2004-09-01_ccq_recos.pdf
HAS/2004-09-01_chronic_renal_failure_guidelines.pdf
HAS/2004-09-01_cytomegalovirus_abstract.pdf
HAS/2004-09-01_depist_cancer_sein_epp_rap.pdf
HAS/2004-09-01_depist_cancer_sein_epp_ref.pdf
HAS/2004-09-01_evaluation_du_debit_de_filtration_glomerulaire_et_du_dosage_de_la_creatininemie_dans_le_diagnostic_de_la_maladie_renale_chronique_chez_ladulte_-_fiche_buts.pdf
HAS/2004-09-01_fiche_de_synth_350se_asthme.pdf
HAS/2004-09-01_information_kp_argumentaire.pdf
HAS/2004-09-01_information_kp_fiche_de_synth_350se.pdf
HAS/2004-09-01_information_kp_recommandations-2006.pdf
HAS/2004-09-01_mamo.pdf
HAS/2004-09-01_recommandations_asthme.pdf
HAS/2004-09-14_ct031621.pdf
HAS/2004-09-14_ct031645.pdf
HAS/2004-09-14_ct031646.pdf
HAS/2004-09-14_ct031650.pdf
HAS/2004-09-14_ct031651.pdf
HAS/2004-09-14_ct031683.pdf
HAS/2004-09-14_ct031708.pdf
HAS/2004-09-14_ct031940.pdf
HAS/2004-09-14_ct031971.pdf
HAS/2004-09-14_ct032128.pdf
HAS/2004-09-14_ct032138.pdf
HAS/2004-09-14_ct032146.pdf
HAS/2004-09-14_pp020264.pdf
HAS/2004-09-14_pp020349.pdf
HAS/2004-09-15_ct031648.pdf
HAS/2004-09-15_humira_fit_14122012.pdf
HAS/2004-09-28_ct031641.pdf
HAS/2004-09-28_ct031644.pdf
HAS/2004-09-28_ct031647.pdf
HAS/2004-09-28_ct031653.pdf
HAS/2004-09-28_ct031655.pdf
HAS/2004-09-28_pp020244.pdf
HAS/2004-09-28_pp020266.pdf
HAS/2004-09-28_pp020268.pdf
HAS/2004-09-29_ct031643.pdf
HAS/2004-10-12_ct031649.pdf
HAS/2004-10-12_ct031652.pdf
HAS/2004-10-12_ct031654.pdf
HAS/2004-10-12_ct031665.pdf
HAS/2004-10-12_ct031676.pdf
HAS/2004-10-12_ct031681.pdf
HAS/2004-10-12_ct032085.pdf
HAS/2004-10-12_ct032149.pdf
HAS/2004-10-12_ct032178.pdf
HAS/2004-10-12_ct032179.pdf
HAS/2004-10-12_ct032180.pdf
HAS/2004-10-12_ct032181.pdf
HAS/2004-10-19_pp020263.pdf
HAS/2004-10-19_pp020269.pdf
HAS/2004-10-19_pp020281.pdf
HAS/2004-10-19_pp020296.pdf
HAS/2004-10-19_pp020367.pdf
HAS/2004-10-19_pp020369.pdf
HAS/2004-10-26_ct031659.pdf
HAS/2004-10-26_ct031661.pdf
HAS/2004-10-26_ct031663.pdf
HAS/2004-10-26_ct031664.pdf
HAS/2004-10-26_ct031670.pdf
HAS/2004-10-26_ct031671.pdf
HAS/2004-10-26_ct031672.pdf
HAS/2004-10-26_ct031673.pdf
HAS/2004-10-26_ct031674.pdf
HAS/2004-10-26_ct031675.pdf
HAS/2004-10-26_ct031677.pdf
HAS/2004-10-26_ct031678.pdf
HAS/2004-10-26_ct031679.pdf
HAS/2004-10-26_ct031680.pdf
HAS/2004-10-26_ct031682.pdf
HAS/2004-10-26_ct031684.pdf
HAS/2004-10-26_ct031685.pdf
HAS/2004-10-27_ct031662.pdf
HAS/2004-10-27_ct031692.pdf
HAS/2004-11-01_EPP_Soins _Infirmiers _Domicile_rap.pdf
HAS/2004-11-01_EPP_Soins _Infirmiers_Domicile_ref.pdf
HAS/2004-11-01_HPP_rapport.pdf
HAS/2004-11-01_HPP_recos.pdf
HAS/2004-11-01_Info_consentement_odontologie_rap.pdf
HAS/2004-11-01_Info_consentement_odontologie_ref.pdf
HAS/2004-11-01_Obesite_recos.pdf
HAS/2004-11-01_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2004-11-01_dossier_soins_infirmiers_du_malade_a_domicile_rapport_2004_2010-10-05_15-39-7_361.pdf
HAS/2004-11-01_dossier_soins_infirmiers_du_malade_a_domicile_referentiel_2004_2010-10-05_15-38-55_142.pdf
HAS/2004-11-01_entorse_rap.pdf
HAS/2004-11-01_information_et_consentement_du_patient_majeur_et_non_sous_tutelle_dans_le_cadre_de_lexercice_liberal_rapport_2004_2010-10-18_16-03-42_36.pdf
HAS/2004-11-01_information_et_consentement_du_patient_majeur_et_non_sous_tutelle_dans_le_cadre_de_lexercice_liberal_referentiel_2004_2010-10-18_16-04-16_331.pdf
HAS/2004-11-01_obesite_-_prise_en_charge_chirurgicale_chez_ladulte_-_synthese_des_recommandations.pdf
HAS/2004-11-01_postpartum_haemorrhage_guidelines.pdf
HAS/2004-11-01_prise_en_charge_de_lobesite_de_lenfant_diagnostic_et_identification_des_facteurs_de_risque_rapport_2004.pdf
HAS/2004-11-01_prise_en_charge_de_lobesite_de_lenfant_diagnostic_et_identification_des_facteurs_de_risque_referentiel_2004_2010-10-21_16-21-7_777.pdf
HAS/2004-11-01_recommandation_obesite_-_prise_en_charge_chirurgicale_chez_ladulte.pdf
HAS/2004-11-01_recommandations_pour_la_tenue_dudossier_de_soins_infirmiers_du_malade_a_domicile_1997.pdf
HAS/2004-11-01_recosentors.pdf
HAS/2004-11-01_reeducation_de_lentorse_externe_de_la_cheville_rapport_2004.pdf
HAS/2004-11-01_reeducation_de_lentorse_externe_de_la_cheville_referentiel_2004.pdf
HAS/2004-11-02_pp020418.pdf
HAS/2004-11-09_ct031657.pdf
HAS/2004-11-09_ct031658.pdf
HAS/2004-11-09_ct031660.pdf
HAS/2004-11-09_ct031666.pdf
HAS/2004-11-09_ct031669.pdf
HAS/2004-11-09_ct031695.pdf
HAS/2004-11-09_ct031700.pdf
HAS/2004-11-09_ct031701.pdf
HAS/2004-11-09_ct031707.pdf
HAS/2004-11-16_pp020309.pdf
HAS/2004-11-16_pp020343.pdf
HAS/2004-11-23_ct031686.pdf
HAS/2004-11-23_ct031691.pdf
HAS/2004-11-23_ct031693.pdf
HAS/2004-11-23_ct031699.pdf
HAS/2004-11-23_ct031703.pdf
HAS/2004-11-23_ct031720.pdf
HAS/2004-11-24_Hepatitis_B_sclerosis.pdf
HAS/2004-11-30_compte-rendu__operatoire_generique_chirurgie_orthopedique__traumatologique_referentiel_2004_210.85_ko.pdf
HAS/2004-11-30_depistage_orthodontique__ref.pdf
HAS/2004-11-30_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2004-11-30_epp_cro_generique_ortho_rap_2010-08-17_10-02-7_303.pdf
HAS/2004-11-30_epp_episode20depressif_rap.pdf
HAS/2004-11-30_epp_episode_depressif_ref.pdf
HAS/2004-11-30_fiche_dexamen_orthodontique.pdf
HAS/2004-11-30_guide_medecin_troubles_anxieux.pdf
HAS/2004-11-30_liste_ald_troubles_anxieux.pdf
HAS/2004-11-30_orthodontie_denture_tempraire_rap.pdf
HAS/2004-11-30_orthodontie_rap.pdf
HAS/2004-11-30_pp020273.pdf
HAS/2004-11-30_pp020285.pdf
HAS/2004-11-30_pp020303.pdf
HAS/2004-11-30_pp020304.pdf
HAS/2004-11-30_pp020346.pdf
HAS/2004-11-30_rpc_depression_2002_-_mel_2006_-_recommandations._2006_12_27__16_20_34_967.pdf
HAS/2004-11-30_sterilisation_des_dispositifs_medicaux_la_conduite_des_cycles_de_sterilisation_rapport_2004.pdf
HAS/2004-11-30_sterilisation_des_dispositifs_medicaux_la_conduite_des_cycles_de_sterilisation_referentiel_2004.pdf
HAS/2004-12-01_Garde_vue_court.pdf
HAS/2004-12-01_Garde_vue_long.pdf
HAS/2004-12-01_Liberte_aller_venir_court.pdf
HAS/2004-12-01_Liberte_aller_venir_long.pdf
HAS/2004-12-01_Sortie_monde_hospitalier_eco.pdf
HAS/2004-12-01_cepp_-_425_forfait_7.pdf
HAS/2004-12-01_garde_a_vue_gb.pdf
HAS/2004-12-01_guideCC.pdf
HAS/2004-12-07_ct031687.pdf
HAS/2004-12-07_ct031688.pdf
HAS/2004-12-07_ct031689.pdf
HAS/2004-12-07_ct031690.pdf
HAS/2004-12-07_ct031702.pdf
HAS/2004-12-07_ct031704.pdf
HAS/2004-12-07_ct031706.pdf
HAS/2004-12-07_ct031709.pdf
HAS/2004-12-07_ct031711.pdf
HAS/2004-12-07_ct031716.pdf
HAS/2004-12-07_ct031719.pdf
HAS/2004-12-07_ct031724.pdf
HAS/2004-12-07_ct031747.pdf
HAS/2004-12-07_ct031936.pdf
HAS/2004-12-07_ct031938.pdf
HAS/2004-12-07_ct031961.pdf
HAS/2004-12-07_ct031973.pdf
HAS/2004-12-07_ct031978.pdf
HAS/2004-12-07_ct032057.pdf
HAS/2004-12-07_ct032066.pdf
HAS/2004-12-07_ct032067.pdf
HAS/2004-12-07_ct032069.pdf
HAS/2004-12-07_ct032083.pdf
HAS/2004-12-07_ct032103.pdf
HAS/2004-12-07_ct032135.pdf
HAS/2004-12-07_ct032166.pdf
HAS/2004-12-07_ct032170.pdf
HAS/2004-12-08_ct031710.pdf
HAS/2004-12-14_pp020274.pdf
HAS/2004-12-14_pp020282.pdf
HAS/2004-12-14_pp020283.pdf
HAS/2004-12-14_pp020291.pdf
HAS/2004-12-14_pp020295.pdf
HAS/2004-12-14_pp020344.pdf
HAS/2004-12-14_pp020364.pdf
HAS/2004-12-14_pp020370.pdf
HAS/2004-12-15_Sortie_monde_hospitalier_court.pdf
HAS/2004-12-15_Sortie_monde_hospitalier_long.pdf
HAS/2004-12-15_guideCC.pdf
HAS/2004-12-21_ct031694.pdf
HAS/2004-12-21_ct031696.pdf
HAS/2004-12-21_ct031697.pdf
HAS/2004-12-21_ct031698.pdf
HAS/2004-12-21_ct031712.pdf
HAS/2004-12-21_ct031713.pdf
HAS/2004-12-21_ct031714.pdf
HAS/2004-12-21_ct031717.pdf
HAS/2004-12-21_ct031718.pdf
HAS/2004-12-21_ct031721.pdf
HAS/2004-12-21_ct031740.pdf
HAS/2004-12-21_ct031755.pdf
HAS/2004-12-21_ct031756.pdf
HAS/2004-12-21_ct031793.pdf
HAS/2004-12-27_rps_brochure_2009-08-27_12-17-9_775.pdf
HAS/2004-12-27_rps_guide.pdf
HAS/2005-01-01_Transplantation_hepatique_2005_court.pdf
HAS/2005-01-01_Trnasplantation_hepatique_2005_long.pdf
HAS/2005-01-01_guideCC.pdf
HAS/2005-01-01_liver_transplantation.pdf
HAS/2005-01-04_ct031715.pdf
HAS/2005-01-04_ct031722.pdf
HAS/2005-01-04_ct031728.pdf
HAS/2005-01-04_ct031729.pdf
HAS/2005-01-04_ct031746.pdf
HAS/2005-01-04_ct031753.pdf
HAS/2005-01-04_ct031757.pdf
HAS/2005-01-04_ct032115.pdf
HAS/2005-01-05_ct031762.pdf
HAS/2005-01-18_ct031723.pdf
HAS/2005-01-18_ct031733.pdf
HAS/2005-01-18_ct031734.pdf
HAS/2005-01-18_ct031735.pdf
HAS/2005-01-18_ct031736.pdf
HAS/2005-01-18_ct031737.pdf
HAS/2005-01-18_ct031738.pdf
HAS/2005-01-18_ct031739.pdf
HAS/2005-01-18_ct031741.pdf
HAS/2005-01-18_ct031742.pdf
HAS/2005-01-18_ct031745.pdf
HAS/2005-01-18_ct031748.pdf
HAS/2005-01-18_ct031749.pdf
HAS/2005-01-18_ct031752.pdf
HAS/2005-01-19_ct031732.pdf
HAS/2005-02-01_ct031725.pdf
HAS/2005-02-01_ct031726.pdf
HAS/2005-02-01_ct031730.pdf
HAS/2005-02-01_ct031750.pdf
HAS/2005-02-01_ct031751.pdf
HAS/2005-02-01_ct031754.pdf
HAS/2005-02-15_ct031743.pdf
HAS/2005-02-15_ct031744.pdf
HAS/2005-02-15_ct031758.pdf
HAS/2005-02-15_ct031763.pdf
HAS/2005-02-15_ct031764.pdf
HAS/2005-02-15_ct031766.pdf
HAS/2005-02-15_ct031767.pdf
HAS/2005-02-15_ct031768.pdf
HAS/2005-02-15_ct031769.pdf
HAS/2005-02-15_ct031771.pdf
HAS/2005-02-15_ct031776.pdf
HAS/2005-02-15_ct032117.pdf
HAS/2005-02-16_ct031731.pdf
HAS/2005-02-28_antibio_perioperatoire_ref.pdf
HAS/2005-02-28_impotence_enfant_rap.pdf
HAS/2005-02-28_impotence_fonctionnelle_du_membre_inferieur_chez_lenfant_referentiel_2005.pdf
HAS/2005-02-28_transfusion_en_anesthesie-reanimation_rapport.pdf
HAS/2005-03-01_ct031759.pdf
HAS/2005-03-01_ct031760.pdf
HAS/2005-03-01_ct031773.pdf
HAS/2005-03-01_ct031774.pdf
HAS/2005-03-01_ct031775.pdf
HAS/2005-03-01_ct031779.pdf
HAS/2005-03-01_ct031792.pdf
HAS/2005-03-01_ct031802.pdf
HAS/2005-03-01_ct031806.pdf
HAS/2005-03-01_ct031935.pdf
HAS/2005-03-01_ct031956.pdf
HAS/2005-03-01_ct031958.pdf
HAS/2005-03-01_ct031959.pdf
HAS/2005-03-01_ct031966.pdf
HAS/2005-03-01_ct031967.pdf
HAS/2005-03-01_ct031980.pdf
HAS/2005-03-01_ct031995.pdf
HAS/2005-03-01_ct031999.pdf
HAS/2005-03-01_ct032051.pdf
HAS/2005-03-01_ct032064.pdf
HAS/2005-03-01_ct032077.pdf
HAS/2005-03-01_ct032105.pdf
HAS/2005-03-01_ct032109.pdf
HAS/2005-03-01_ct032116.pdf
HAS/2005-03-01_ct032127.pdf
HAS/2005-03-01_ct032140.pdf
HAS/2005-03-01_ct032142.pdf
HAS/2005-03-01_ct032144.pdf
HAS/2005-03-01_ct032152.pdf
HAS/2005-03-01_ct032184.pdf
HAS/2005-03-01_transmission_prelev_ref.pdf
HAS/2005-03-06_dossier_patient_ref.pdf
HAS/2005-03-15_ct031761.pdf
HAS/2005-03-15_ct031770.pdf
HAS/2005-03-15_ct031772.pdf
HAS/2005-03-15_ct031777.pdf
HAS/2005-03-15_ct031782.pdf
HAS/2005-03-15_ct031783.pdf
HAS/2005-03-15_ct031785.pdf
HAS/2005-03-15_ct031788.pdf
HAS/2005-03-15_ct031790.pdf
HAS/2005-03-15_ct031794.pdf
HAS/2005-03-15_ct031826.pdf
HAS/2005-03-15_ct031845.pdf
HAS/2005-03-15_ct031854.pdf
HAS/2005-03-29_ct031765.pdf
HAS/2005-03-29_ct031778.pdf
HAS/2005-03-29_ct031784.pdf
HAS/2005-03-29_ct031786.pdf
HAS/2005-03-29_ct031787.pdf
HAS/2005-03-29_ct031789.pdf
HAS/2005-03-31_femmes_enceintes_recos.pdf
HAS/2005-03-31_information_pregnant_women.pdf
HAS/2005-03-31_infos_femmes_enceintes_fiche.pdf
HAS/2005-03-31_infos_femmes_enceintes_rap.pdf
HAS/2005-04-01_Hospitalisation_sans_consentement_recos.pdf
HAS/2005-04-01_argumentaire.pdf
HAS/2005-04-01_emergency_involuntary_commitment_guidelines.pdf
HAS/2005-04-01_epaule_douloureuse_recos.pdf
HAS/2005-04-01_fiche_de_synth_350se.pdf
HAS/2005-04-01_hospitalisation_sans_consentement_rap.pdf
HAS/2005-04-01_painful_shoulder_guidelines.pdf
HAS/2005-04-01_painful_shoulder_guidelines_quick_reference_guide_2006_09_12__9_20_42_463.pdf
HAS/2005-04-01_physiotherapy_guidelines.pdf
HAS/2005-04-01_recommandations.pdf
HAS/2005-04-05_pp020297.pdf
HAS/2005-04-05_pp020308.pdf
HAS/2005-04-12_bat_fiche_levocarnil.pdf
HAS/2005-04-12_ct031781.pdf
HAS/2005-04-12_ct031791.pdf
HAS/2005-04-12_ct031795.pdf
HAS/2005-04-12_ct031796.pdf
HAS/2005-04-12_ct031797.pdf
HAS/2005-04-12_ct031798.pdf
HAS/2005-04-12_ct031799.pdf
HAS/2005-04-12_ct031800.pdf
HAS/2005-04-12_ct031801.pdf
HAS/2005-04-12_ct031803.pdf
HAS/2005-04-12_ct031804.pdf
HAS/2005-04-12_ct031805.pdf
HAS/2005-04-12_ct031807.pdf
HAS/2005-04-12_ct031808.pdf
HAS/2005-04-12_ct031815.pdf
HAS/2005-04-12_ct031825.pdf
HAS/2005-04-12_ct031827.pdf
HAS/2005-04-12_ct031828.pdf
HAS/2005-04-12_ct031829.pdf
HAS/2005-04-12_ct031830.pdf
HAS/2005-04-12_ct031831.pdf
HAS/2005-04-12_ct031841.pdf
HAS/2005-04-12_ct031954.pdf
HAS/2005-04-12_ct031963.pdf
HAS/2005-04-12_ct031965.pdf
HAS/2005-04-12_ct031992.pdf
HAS/2005-04-12_ct031993.pdf
HAS/2005-04-12_ct031994.pdf
HAS/2005-04-12_ct032047.pdf
HAS/2005-04-12_ct032079.pdf
HAS/2005-04-12_ct032080.pdf
HAS/2005-04-12_ct032084.pdf
HAS/2005-04-12_ct032095.pdf
HAS/2005-04-12_ct032112.pdf
HAS/2005-04-12_ct032113.pdf
HAS/2005-04-12_ct032132.pdf
HAS/2005-04-12_ct032141.pdf
HAS/2005-04-12_ct032165.pdf
HAS/2005-04-12_ct032168.pdf
HAS/2005-04-13_ct032014.pdf
HAS/2005-04-19_pp020298.pdf
HAS/2005-04-19_pp020299.pdf
HAS/2005-04-19_pp020305.pdf
HAS/2005-04-19_pp020310.pdf
HAS/2005-04-19_pp020319.pdf
HAS/2005-05-01_Dosage_IgE_rap.pdf
HAS/2005-05-01_Dosage_IgE_synth.pdf
HAS/2005-05-01_IgE_abstract.pdf
HAS/2005-05-03_pp020306.pdf
HAS/2005-05-03_pp020307.pdf
HAS/2005-05-03_pp020347.pdf
HAS/2005-05-03_pp020398.pdf
HAS/2005-05-10_ct031809.pdf
HAS/2005-05-10_ct031812.pdf
HAS/2005-05-10_ct031813.pdf
HAS/2005-05-10_ct031814.pdf
HAS/2005-05-10_ct031818.pdf
HAS/2005-05-10_ct031823.pdf
HAS/2005-05-10_ct031937.pdf
HAS/2005-05-10_ct031960.pdf
HAS/2005-05-10_ct031996.pdf
HAS/2005-05-10_ct032000.pdf
HAS/2005-05-10_ct032006.pdf
HAS/2005-05-10_ct032008.pdf
HAS/2005-05-10_ct032010.pdf
HAS/2005-05-10_ct032018.pdf
HAS/2005-05-10_ct032020.pdf
HAS/2005-05-10_ct032021.pdf
HAS/2005-05-10_ct032023.pdf
HAS/2005-05-10_ct032024.pdf
HAS/2005-05-10_ct032025.pdf
HAS/2005-05-10_ct032026.pdf
HAS/2005-05-10_ct032027.pdf
HAS/2005-05-10_ct032028.pdf
HAS/2005-05-10_ct032029.pdf
HAS/2005-05-10_ct032031.pdf
HAS/2005-05-10_ct032032.pdf
HAS/2005-05-10_ct032035.pdf
HAS/2005-05-10_ct032037.pdf
HAS/2005-05-10_ct032041.pdf
HAS/2005-05-10_ct032043.pdf
HAS/2005-05-10_ct032045.pdf
HAS/2005-05-10_ct032052.pdf
HAS/2005-05-10_ct032065.pdf
HAS/2005-05-10_ct032071.pdf
HAS/2005-05-10_ct032076.pdf
HAS/2005-05-10_ct032086.pdf
HAS/2005-05-10_ct032087.pdf
HAS/2005-05-10_ct032088.pdf
HAS/2005-05-10_ct032089.pdf
HAS/2005-05-10_ct032092.pdf
HAS/2005-05-10_ct032093.pdf
HAS/2005-05-10_ct032104.pdf
HAS/2005-05-10_ct032108.pdf
HAS/2005-05-10_ct032131.pdf
HAS/2005-05-10_ct032133.pdf
HAS/2005-05-10_ct032150.pdf
HAS/2005-05-10_ct032151.pdf
HAS/2005-05-10_ct032155.pdf
HAS/2005-05-10_ct032156.pdf
HAS/2005-05-10_ct032157.pdf
HAS/2005-05-10_ct032158.pdf
HAS/2005-05-10_ct032160.pdf
HAS/2005-05-10_ct032161.pdf
HAS/2005-05-10_ct032162.pdf
HAS/2005-05-10_ct032167.pdf
HAS/2005-05-10_ct032169.pdf
HAS/2005-05-10_ct032174.pdf
HAS/2005-05-10_ct032176.pdf
HAS/2005-05-10_ct032177.pdf
HAS/2005-05-11_ct032011.pdf
HAS/2005-05-17_pp020311.pdf
HAS/2005-05-17_pp020313.pdf
HAS/2005-05-17_pp020314.pdf
HAS/2005-05-17_pp020318.pdf
HAS/2005-05-17_pp020323.pdf
HAS/2005-05-24_ct031811.pdf
HAS/2005-05-24_ct031820.pdf
HAS/2005-05-24_ct031833.pdf
HAS/2005-05-24_ct031835.pdf
HAS/2005-05-24_ct031836.pdf
HAS/2005-05-24_ct031837.pdf
HAS/2005-05-24_ct031838.pdf
HAS/2005-05-24_ct031843.pdf
HAS/2005-05-24_ct031844.pdf
HAS/2005-05-24_ct031846.pdf
HAS/2005-05-24_ct031848.pdf
HAS/2005-05-24_ct031849.pdf
HAS/2005-05-24_ct031850.pdf
HAS/2005-05-24_ct031852.pdf
HAS/2005-05-24_ct031853.pdf
HAS/2005-05-24_ct031855.pdf
HAS/2005-05-24_ct031856.pdf
HAS/2005-05-24_ct031857.pdf
HAS/2005-05-24_ct031858.pdf
HAS/2005-05-24_ct031929.pdf
HAS/2005-05-24_ct031930.pdf
HAS/2005-05-24_ct031931.pdf
HAS/2005-05-24_ct031932.pdf
HAS/2005-05-24_ct031933.pdf
HAS/2005-05-24_ct031934.pdf
HAS/2005-05-24_ct031942.pdf
HAS/2005-05-24_ct031944.pdf
HAS/2005-05-24_ct031945.pdf
HAS/2005-05-24_ct031946.pdf
HAS/2005-05-24_ct031947.pdf
HAS/2005-05-24_ct031948.pdf
HAS/2005-05-24_ct031949.pdf
HAS/2005-05-24_ct031950.pdf
HAS/2005-05-24_ct031952.pdf
HAS/2005-05-24_ct031972.pdf
HAS/2005-05-24_ct031976.pdf
HAS/2005-05-24_ct031977.pdf
HAS/2005-05-24_ct031981.pdf
HAS/2005-05-24_ct031983.pdf
HAS/2005-05-24_ct031984.pdf
HAS/2005-05-24_ct031985.pdf
HAS/2005-05-24_ct031986.pdf
HAS/2005-05-24_ct031987.pdf
HAS/2005-05-24_ct031988.pdf
HAS/2005-05-24_ct031989.pdf
HAS/2005-05-24_ct031990.pdf
HAS/2005-05-24_ct031991.pdf
HAS/2005-05-24_ct032038.pdf
HAS/2005-05-24_ct032053.pdf
HAS/2005-05-24_ct032055.pdf
HAS/2005-05-24_ct032058.pdf
HAS/2005-05-24_ct032062.pdf
HAS/2005-05-24_ct032096.pdf
HAS/2005-05-24_ct032097.pdf
HAS/2005-05-24_ct032098.pdf
HAS/2005-05-24_ct032099.pdf
HAS/2005-05-24_ct032100.pdf
HAS/2005-05-24_ct032102.pdf
HAS/2005-05-24_ct032111.pdf
HAS/2005-05-24_ct032125.pdf
HAS/2005-05-24_ct032129.pdf
HAS/2005-05-24_ct032139.pdf
HAS/2005-05-24_ct032143.pdf
HAS/2005-05-24_ct032163.pdf
HAS/2005-05-24_ct032171.pdf
HAS/2005-05-24_miltex_srh_2008-08-07_14-54-4_761.pdf
HAS/2005-05-25_ct032012.pdf
HAS/2005-05-31_Acces_Info_sante_Dec_2005.pdf
HAS/2005-05-31_CHISOL.pdf
HAS/2005-05-31_Contention_eng.pdf
HAS/2005-05-31_Dm.pdf
HAS/2005-05-31_Dossier_patient_psychiatrie_ref.pdf
HAS/2005-05-31_contention.pdf
HAS/2005-05-31_cppa_-_rapport_final_.pdf
HAS/2005-05-31_dossier_cancer_colorectal_en_gastroenterologie_rapport_2005.pdf
HAS/2005-05-31_dossier_cancer_colorectal_en_gastroenterologie_referentiel_2005.pdf
HAS/2005-05-31_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2005-05-31_dossier_du_patient_en_psychiatrie_ambulatoire_rapport_2005.pdf
HAS/2005-05-31_dossier_du_patient_en_psychiatrie_ambulatoire_referentiel_2005.pdf
HAS/2005-05-31_dossier_patient_psychiatrie_rap_2006_10_20__15_39_55_388.pdf
HAS/2005-05-31_episode_despressif_ambulatoire_rap_2006_10_20__16_15_5_239.pdf
HAS/2005-05-31_epp_cro_generique_ortho_rap_2010-08-17_15-06-11_148.pdf
HAS/2005-05-31_guide_colon_version_web.pdf
HAS/2005-05-31_guide_medecin_troubles_anxieux.pdf
HAS/2005-05-31_lap_colon_version_web.pdf
HAS/2005-05-31_liste_ald_troubles_anxieux.pdf
HAS/2005-05-31_methodes.pdf
HAS/2005-05-31_methodes_et_outils_des_demarches_qualite_pour_les_etablissements_de_sante.pdf
HAS/2005-05-31_paq.pdf
HAS/2005-05-31_partogramme.pdf
HAS/2005-05-31_pp020312.pdf
HAS/2005-05-31_pp020315.pdf
HAS/2005-05-31_pp020320.pdf
HAS/2005-05-31_pp020322.pdf
HAS/2005-05-31_pp020361.pdf
HAS/2005-05-31_pp020476.pdf
HAS/2005-05-31_pp020477.pdf
HAS/2005-05-31_pp020478.pdf
HAS/2005-05-31_prescription_des_examens_complementaires_dans_le_reflux_gastro-oesophagien_chez_ladulte_en_gastro-enterologie_rapport_2005.pdf
HAS/2005-05-31_prescription_des_examens_complementaires_dans_le_reflux_gastro-oesophagien_chez_ladulte_en_gastro-enterologie_referentiel_2005.pdf
HAS/2005-05-31_rpc_depression_2002_-_mel_2006_-_recommandations._2006_12_27__16_20_34_967.pdf
HAS/2005-05-31_sondes.pdf
HAS/2005-05-31_su.pdf
HAS/2005-05-31_suicilong.pdf
HAS/2005-06-01_07-042-traceur_liste-adl-avc.pdf
HAS/2005-06-01_07-042_traceur_guide-adl-avc.pdf
HAS/2005-06-01_08-097_gp_acv.pdf
HAS/2005-06-01_AVC.rap.pdf
HAS/2005-06-01_AVC_Medical_rap.pdf
HAS/2005-06-01_AVC_admission_urgences_ref.pdf
HAS/2005-06-01_AVC_synth.pdf
HAS/2005-06-01_Chimio_synth.pdf
HAS/2005-06-01_accident_vasculaire_cerebral__admission_urgences_referentiel_2006.pdf
HAS/2005-06-01_avc_delais_referentiel_2006.pdf
HAS/2005-06-01_avc_information_continuite_soins_referentiel_2006.pdf
HAS/2005-06-01_avc_m_351dical_-fiche_de_synth_350se-2006.pdf
HAS/2005-06-01_avc_organisationnel_referentiel_2006.pdf
HAS/2005-06-01_avc_param_351dical_argumentaire_version_2006.pdf
HAS/2005-06-01_avc_param_351dical_fiche_de_synth_350se_version_2006.pdf
HAS/2005-06-01_avc_param_351dical_recommandations_version_2006.pdf
HAS/2005-06-01_avc_preparation_sortie_referentiel_2006.pdf
HAS/2005-06-01_avc_prevention_complications_referentiel_2006.pdf
HAS/2005-06-01_avc_traitements_referentiel_2006.pdf
HAS/2005-06-01_chimio_eco_gb.pdf
HAS/2005-06-01_chimio_rap.pdf
HAS/2005-06-01_conception_et_role_des_indicateurs_de_qualite_dans_levaluation_des_pratiques_professionnelles_guide_2005.pdf
HAS/2005-06-01_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2005-06-01_maitrise_stat_processus_broc.pdf
HAS/2005-06-01_maitrise_statistique_des_processus_en_sante_guide_2005.pdf
HAS/2005-06-01_preparation_de_la_sortie_du_patient_hospitalise_guide_2001.pdf
HAS/2005-06-01_preparation_de_la_sortie_du_patient_hospitalise_guide_2001_2009-08-31_16-13-36_630.pdf
HAS/2005-06-01_recommandations_2006_10_27__20_02_3_927.pdf
HAS/2005-06-01_unv_synth.pdf
HAS/2005-06-07_cellcept_srh.pdf
HAS/2005-06-07_ct031834.pdf
HAS/2005-06-07_ct031839.pdf
HAS/2005-06-07_ct031840.pdf
HAS/2005-06-07_ct031842.pdf
HAS/2005-06-07_ct031847.pdf
HAS/2005-06-07_ct031851.pdf
HAS/2005-06-07_ct031897.pdf
HAS/2005-06-07_ct031899.pdf
HAS/2005-06-07_ct031905.pdf
HAS/2005-06-07_ct031925.pdf
HAS/2005-06-07_ct031953.pdf
HAS/2005-06-07_ct031968.pdf
HAS/2005-06-07_ct031998.pdf
HAS/2005-06-07_ct032007.pdf
HAS/2005-06-07_ct032022.pdf
HAS/2005-06-07_ct032034.pdf
HAS/2005-06-07_ct032036.pdf
HAS/2005-06-07_ct032040.pdf
HAS/2005-06-07_ct032044.pdf
HAS/2005-06-07_ct032046.pdf
HAS/2005-06-07_ct032050.pdf
HAS/2005-06-07_ct032056.pdf
HAS/2005-06-07_ct032060.pdf
HAS/2005-06-07_ct032070.pdf
HAS/2005-06-07_ct032072.pdf
HAS/2005-06-07_ct032106.pdf
HAS/2005-06-07_ct032122.pdf
HAS/2005-06-07_ct032123.pdf
HAS/2005-06-07_ct032124.pdf
HAS/2005-06-07_ct032126.pdf
HAS/2005-06-07_ct032145.pdf
HAS/2005-06-07_ct032154.pdf
HAS/2005-06-07_ct032159.pdf
HAS/2005-06-07_ct032172.pdf
HAS/2005-06-07_ct032173.pdf
HAS/2005-06-07_ct032175.pdf
HAS/2005-06-08_ct031832.pdf
HAS/2005-06-14_pp020316.pdf
HAS/2005-06-14_pp020317.pdf
HAS/2005-06-14_pp020321.pdf
HAS/2005-06-14_pp020324.pdf
HAS/2005-06-14_pp020325.pdf
HAS/2005-06-14_pp020326.pdf
HAS/2005-06-14_pp020327.pdf
HAS/2005-06-14_pp020328.pdf
HAS/2005-06-14_pp020329.pdf
HAS/2005-06-14_pp020330.pdf
HAS/2005-06-14_pp020331.pdf
HAS/2005-06-14_pp020332.pdf
HAS/2005-06-14_pp020333.pdf
HAS/2005-06-14_pp020334.pdf
HAS/2005-06-14_pp020335.pdf
HAS/2005-06-14_pp020336.pdf
HAS/2005-06-14_pp020337.pdf
HAS/2005-06-14_pp020338.pdf
HAS/2005-06-14_pp020339.pdf
HAS/2005-06-14_pp020340.pdf
HAS/2005-06-14_pp020341.pdf
HAS/2005-06-21_ct031862.pdf
HAS/2005-06-21_ct031863.pdf
HAS/2005-06-21_ct031865.pdf
HAS/2005-06-21_ct031867.pdf
HAS/2005-06-21_ct031868.pdf
HAS/2005-06-21_ct031870.pdf
HAS/2005-06-21_ct031889.pdf
HAS/2005-06-21_ct031890.pdf
HAS/2005-06-21_ct031891.pdf
HAS/2005-06-21_ct031892.pdf
HAS/2005-06-21_ct031894.pdf
HAS/2005-06-21_ct031898.pdf
HAS/2005-06-21_ct031904.pdf
HAS/2005-06-21_ct031907.pdf
HAS/2005-06-21_ct031911.pdf
HAS/2005-06-21_ct031917.pdf
HAS/2005-06-21_ct031918.pdf
HAS/2005-06-21_ct031919.pdf
HAS/2005-06-21_ct031923.pdf
HAS/2005-06-21_ct031924.pdf
HAS/2005-06-21_ct031943.pdf
HAS/2005-06-21_ct031951.pdf
HAS/2005-06-21_ct031970.pdf
HAS/2005-06-21_ct031974.pdf
HAS/2005-06-21_ct031975.pdf
HAS/2005-06-21_ct031982.pdf
HAS/2005-06-21_ct032003.pdf
HAS/2005-06-21_ct032019.pdf
HAS/2005-06-21_ct032048.pdf
HAS/2005-06-21_ct032054.pdf
HAS/2005-06-21_ct032068.pdf
HAS/2005-06-21_duodopa.pdf
HAS/2005-06-22_ct031878.pdf
HAS/2005-06-22_ct031962.pdf
HAS/2005-06-28_pp020350.pdf
HAS/2005-06-28_pp020352.pdf
HAS/2005-06-28_pp020360.pdf
HAS/2005-06-29_ct032075.pdf
HAS/2005-06-29_ct032081.pdf
HAS/2005-06-30_asthme-pediatrie_epp_rap.pdf
HAS/2005-06-30_asthme_pediatrie_epp_ref.pdf
HAS/2005-06-30_education_adulte_asthmatique_-_recommandations.pdf
HAS/2005-06-30_education_asthmatique_enfantversion_finale_du_22_10_02_argumentaire.pdf
HAS/2005-06-30_education_asthmatique_enfrant_version_finale_du_22_10_02_synthese.pdf
HAS/2005-06-30_education_therapeutique_de_lenfant_asthmatique_et_de_sa_famille_en_pediatrie_rapport_2005.pdf
HAS/2005-06-30_education_therapeutique_de_lenfant_asthmatique_et_de_sa_famille_en_pediatrie_referentiel_2005.pdf
HAS/2005-07-01_Allaitement_pediatrie_epp_rap.pdf
HAS/2005-07-01_Allaitement_rap.pdf
HAS/2005-07-01_Allaitement_recos.pdf
HAS/2005-07-01_Allatement_pediatrie_epp_ref.pdf
HAS/2005-07-01_allaitement_epp_synthese.pdf
HAS/2005-07-01_argumentaire_hfe-1_-_final_2006_10_27__14_10_34_101.pdf
HAS/2005-07-01_diabete_gestationnel_rap.pdf
HAS/2005-07-01_diabete_gestationnel_synth.pdf
HAS/2005-07-01_doc.chem.al_22-11-07.pdf
HAS/2005-07-01_fiche_de_synth_350se_hfe-1_finale.pdf
HAS/2005-07-01_gestational_diabetes.pdf
HAS/2005-07-01_hemochromatosis_guidelines_2006_09_12__9_10_9_659.pdf
HAS/2005-07-01_hemochromatosis_quick-reference_guide_2006_09_12__9_10_10_133.pdf
HAS/2005-07-01_recos_hfe-1_-_finale.pdf
HAS/2005-07-05_ct031859.pdf
HAS/2005-07-05_ct031861.pdf
HAS/2005-07-05_ct031866.pdf
HAS/2005-07-05_ct031869.pdf
HAS/2005-07-05_ct031871.pdf
HAS/2005-07-05_ct031874.pdf
HAS/2005-07-05_ct031875.pdf
HAS/2005-07-05_ct031876.pdf
HAS/2005-07-05_ct031877.pdf
HAS/2005-07-05_ct031879.pdf
HAS/2005-07-05_ct031883.pdf
HAS/2005-07-05_ct031884.pdf
HAS/2005-07-05_ct031885.pdf
HAS/2005-07-05_ct031895.pdf
HAS/2005-07-05_ct031896.pdf
HAS/2005-07-05_ct031902.pdf
HAS/2005-07-05_ct031906.pdf
HAS/2005-07-05_ct031908.pdf
HAS/2005-07-05_ct031909.pdf
HAS/2005-07-05_ct031910.pdf
HAS/2005-07-05_ct031913.pdf
HAS/2005-07-05_ct031920.pdf
HAS/2005-07-05_ct031921.pdf
HAS/2005-07-05_ct031922.pdf
HAS/2005-07-05_ct031926.pdf
HAS/2005-07-05_ct032201.pdf
HAS/2005-07-06_ct031887.pdf
HAS/2005-07-12_pp020351.pdf
HAS/2005-07-12_pp020355.pdf
HAS/2005-07-12_pp020357.pdf
HAS/2005-07-12_pp020359.pdf
HAS/2005-07-12_pp020362.pdf
HAS/2005-07-12_pp020363.pdf
HAS/2005-07-12_pp020371.pdf
HAS/2005-07-19_ct031860.pdf
HAS/2005-07-19_ct031864.pdf
HAS/2005-07-19_ct031872.pdf
HAS/2005-07-19_ct031873.pdf
HAS/2005-07-19_ct031880.pdf
HAS/2005-07-19_ct031881.pdf
HAS/2005-07-19_ct031882.pdf
HAS/2005-07-19_ct031886.pdf
HAS/2005-07-19_ct031888.pdf
HAS/2005-07-19_ct031893.pdf
HAS/2005-07-19_ct031901.pdf
HAS/2005-07-19_ct031903.pdf
HAS/2005-07-19_ct031912.pdf
HAS/2005-07-19_ct031914.pdf
HAS/2005-07-19_ct031915.pdf
HAS/2005-07-19_ct031916.pdf
HAS/2005-07-19_ct031927.pdf
HAS/2005-07-19_ct031928.pdf
HAS/2005-07-19_ct032186.pdf
HAS/2005-07-19_ct032203.pdf
HAS/2005-07-19_ct032212.pdf
HAS/2005-07-31_endoscopie_2004_argumentaire_mise_en_forme_2006_2006_12_01__18_10_7_691.pdf
HAS/2005-07-31_endoscopie_2004_recommandations_mise_en_forme_2006.pdf
HAS/2005-07-31_fiche_de_synthese_endoscopie_digestive_2004.pdf
HAS/2005-07-31_risque_coloscopie_epp_rapport_aout_2005.pdf
HAS/2005-07-31_risque_coloscopie_epp_referentiel_aout_2005.pdf
HAS/2005-07-31_vaccination_pediatrie_epp_rapport_2005.pdf
HAS/2005-07-31_vaccination_pediatrie_epp_referentiel_2005.pdf
HAS/2005-09-01_04r22_memo_depistage_enfants_28_jours_a_6_ans_consultations.pdf
HAS/2005-09-01_04r22_memo_depistage_enfants_28_jours_a_6_ans_tests_depistage.pdf
HAS/2005-09-01_04r30_fiche_tech_depistage_enfants_7_a_18_ans_recherche_scoliose.pdf
HAS/2005-09-01_Drepanocytose.rap.pdf
HAS/2005-09-01_Drepanocytose_reco.pdf
HAS/2005-09-01_Lombalgie_2005_rap.pdf
HAS/2005-09-01_Lombalgie_2005_synth.pdf
HAS/2005-09-01_Massokine_lombalgie_abstract.pdf
HAS/2005-09-01_depistages_individuels_28j-6ans-argumentaire_2006.pdf
HAS/2005-09-01_depistages_individuels_28j-6ans_-_propositions_2006_2006_12_28__15_55_46_52.pdf
HAS/2005-09-01_depistages_individuels_7-18_ans_-_argumentaire.pdf
HAS/2005-09-01_depistages_individuels_7-18_ans_-_propositions.pdf
HAS/2005-09-06_ct032185.pdf
HAS/2005-09-06_ct032187.pdf
HAS/2005-09-06_ct032188.pdf
HAS/2005-09-06_ct032189.pdf
HAS/2005-09-06_ct032193.pdf
HAS/2005-09-06_ct032194.pdf
HAS/2005-09-06_ct032195.pdf
HAS/2005-09-06_ct032196.pdf
HAS/2005-09-06_ct032197.pdf
HAS/2005-09-06_ct032198.pdf
HAS/2005-09-06_ct032199.pdf
HAS/2005-09-06_ct032200.pdf
HAS/2005-09-06_ct032204.pdf
HAS/2005-09-06_ct032205.pdf
HAS/2005-09-06_ct032206.pdf
HAS/2005-09-06_ct032207.pdf
HAS/2005-09-06_ct032208.pdf
HAS/2005-09-06_ct032209.pdf
HAS/2005-09-06_ct032210.pdf
HAS/2005-09-06_ct032211.pdf
HAS/2005-09-06_ct032213.pdf
HAS/2005-09-06_ct032214.pdf
HAS/2005-09-06_ct032215.pdf
HAS/2005-09-06_ct032216.pdf
HAS/2005-09-06_ct032217.pdf
HAS/2005-09-06_ct032218.pdf
HAS/2005-09-06_ct032219.pdf
HAS/2005-09-06_ct032222.pdf
HAS/2005-09-06_ct032239.pdf
HAS/2005-09-06_ct032243.pdf
HAS/2005-09-06_ct032245.pdf
HAS/2005-09-06_ct032253.pdf
HAS/2005-09-06_ct032254.pdf
HAS/2005-09-13_pp020365.pdf
HAS/2005-09-13_pp020366.pdf
HAS/2005-09-13_pp020368.pdf
HAS/2005-09-13_pp020372.pdf
HAS/2005-09-13_pp020373.pdf
HAS/2005-09-13_pp020381.pdf
HAS/2005-09-14_ct031979.pdf
HAS/2005-09-14_ct032009.pdf
HAS/2005-09-20_arixtra.pdf
HAS/2005-09-20_ct032190.pdf
HAS/2005-09-20_ct032191.pdf
HAS/2005-09-20_ct032202.pdf
HAS/2005-09-20_ct032220.pdf
HAS/2005-09-20_ct032225.pdf
HAS/2005-09-20_ct032226.pdf
HAS/2005-09-20_ct032228.pdf
HAS/2005-09-20_ct032229.pdf
HAS/2005-09-20_ct032231.pdf
HAS/2005-09-20_ct032236.pdf
HAS/2005-09-20_ct032238.pdf
HAS/2005-09-20_ct032247.pdf
HAS/2005-09-20_ct032248.pdf
HAS/2005-09-20_ct032255.pdf
HAS/2005-09-20_ct032259.pdf
HAS/2005-09-20_ct032264.pdf
HAS/2005-09-27_pp020374.pdf
HAS/2005-09-27_pp020375.pdf
HAS/2005-09-27_pp020376.pdf
HAS/2005-09-27_pp020377.pdf
HAS/2005-09-27_pp020378.pdf
HAS/2005-09-27_pp020379.pdf
HAS/2005-09-27_pp020380.pdf
HAS/2005-09-27_pp020382.pdf
HAS/2005-09-27_pp020411.pdf
HAS/2005-10-01_Cervicalgie_rap.pdf
HAS/2005-10-01_argumentaire_cervicalgie_mel_2006.pdf
HAS/2005-10-01_bilan_kinesitherapique_cervicalgie_referentiel_2005.pdf
HAS/2005-10-01_recommandations_cervicalgies_mel_2006_2006_12_28__11_50_51_550.pdf
HAS/2005-10-01_synthese_cervicalgies_mel_2006.pdf
HAS/2005-10-04_ct032223.pdf
HAS/2005-10-04_ct032224.pdf
HAS/2005-10-04_ct032227.pdf
HAS/2005-10-04_ct032230.pdf
HAS/2005-10-04_ct032232.pdf
HAS/2005-10-04_ct032233.pdf
HAS/2005-10-04_ct032234.pdf
HAS/2005-10-04_ct032235.pdf
HAS/2005-10-04_ct032237.pdf
HAS/2005-10-04_ct032240.pdf
HAS/2005-10-04_ct032241.pdf
HAS/2005-10-04_ct032242.pdf
HAS/2005-10-04_ct032244.pdf
HAS/2005-10-04_ct032246.pdf
HAS/2005-10-04_ct032249.pdf
HAS/2005-10-04_ct032250.pdf
HAS/2005-10-04_ct032251.pdf
HAS/2005-10-04_ct032252.pdf
HAS/2005-10-04_ct032256.pdf
HAS/2005-10-04_ct032257.pdf
HAS/2005-10-04_ct032258.pdf
HAS/2005-10-04_ct032260.pdf
HAS/2005-10-04_ct032261.pdf
HAS/2005-10-04_ct032262.pdf
HAS/2005-10-04_ct032263.pdf
HAS/2005-10-04_ct032276.pdf
HAS/2005-10-04_ct032283.pdf
HAS/2005-10-04_ct032294.pdf
HAS/2005-10-04_ct032415.pdf
HAS/2005-10-11_pp020384.pdf
HAS/2005-10-11_pp020385.pdf
HAS/2005-10-11_pp020388.pdf
HAS/2005-10-11_pp020392.pdf
HAS/2005-10-11_pp020393.pdf
HAS/2005-10-11_pp020395.pdf
HAS/2005-10-11_pp020396.pdf
HAS/2005-10-18_ct032221.pdf
HAS/2005-10-18_ct032272.pdf
HAS/2005-10-18_ct032277.pdf
HAS/2005-10-18_ct032280.pdf
HAS/2005-10-18_ct032284.pdf
HAS/2005-10-18_ct032285.pdf
HAS/2005-10-18_ct032287.pdf
HAS/2005-10-18_ct032292.pdf
HAS/2005-10-18_ct032296.pdf
HAS/2005-10-18_ct032299.pdf
HAS/2005-10-18_ct032304.pdf
HAS/2005-10-18_ct032307.pdf
HAS/2005-10-18_ct032332.pdf
HAS/2005-10-18_ct032334.pdf
HAS/2005-10-18_ct032335.pdf
HAS/2005-10-18_ct032336.pdf
HAS/2005-10-18_ct032350.pdf
HAS/2005-10-18_ct032351.pdf
HAS/2005-10-18_ct032353.pdf
HAS/2005-10-18_ct032354.pdf
HAS/2005-10-18_ct032355.pdf
HAS/2005-10-18_ct032370.pdf
HAS/2005-10-18_ct032380.pdf
HAS/2005-10-18_ct032381.pdf
HAS/2005-10-18_ct032392.pdf
HAS/2005-10-18_ct032393.pdf
HAS/2005-10-18_ct032409.pdf
HAS/2005-10-18_ct032417.pdf
HAS/2005-10-19_ct032281.pdf
HAS/2005-10-19_ct032305.pdf
HAS/2005-10-25_pp020391.pdf
HAS/2005-10-31_Acces_Info_sante_Dec_2005.pdf
HAS/2005-10-31_IRC_2006_fiche.pdf
HAS/2005-10-31_IRC_2006_rap.pdf
HAS/2005-10-31_IRC_2006_recos.pdf
HAS/2005-10-31_maladie_renale_chronique_rapport_novembre_2005_2010-11-29_12-14-23_976.pdf
HAS/2005-10-31_maladie_renale_chronique_referentiel_novembre_2005_2010-11-29_12-13-35_385.pdf
HAS/2005-11-01_Cancer_rectum_fiche.pdf
HAS/2005-11-01_Cancer_rectum_recos.pdf
HAS/2005-11-01_Catheters_veineux_2005_fiche.pdf
HAS/2005-11-01_Catheters_veineux_2005_rap.pdf
HAS/2005-11-01_Catheters_veineux_2005_recos.pdf
HAS/2005-11-01_PMSA_protocoles_crsortie_3.pdf
HAS/2005-11-01_Prevention_chutes_fiche.pdf
HAS/2005-11-01_Prevention_chutes_recos.pdf
HAS/2005-11-01_Puits_Sillons_rap.pdf
HAS/2005-11-01_Puits_Sillons_recos.pdf
HAS/2005-11-01_assessment_of_carie_g_2006_10_25__19_07_42_702.pdf
HAS/2005-11-01_assessment_of_carie_qrg_2006_10_25__19_08_3_643.pdf
HAS/2005-11-01_cancer_du_rectum_2005_algorithme.pdf
HAS/2005-11-01_cancer_du_rectum_2005_formulaire.pdf
HAS/2005-11-01_catheter_veineux_peripheriques_-_criteres_de_qualite.pdf
HAS/2005-11-01_ct032265.pdf
HAS/2005-11-01_ct032266.pdf
HAS/2005-11-01_ct032267.pdf
HAS/2005-11-01_ct032268.pdf
HAS/2005-11-01_ct032269.pdf
HAS/2005-11-01_ct032270.pdf
HAS/2005-11-01_ct032271.pdf
HAS/2005-11-01_ct032273.pdf
HAS/2005-11-01_ct032274.pdf
HAS/2005-11-01_ct032275.pdf
HAS/2005-11-01_ct032278.pdf
HAS/2005-11-01_ct032279.pdf
HAS/2005-11-01_ct032282.pdf
HAS/2005-11-01_ct032288.pdf
HAS/2005-11-01_ct032290.pdf
HAS/2005-11-01_ct032291.pdf
HAS/2005-11-01_ct032297.pdf
HAS/2005-11-01_ct032298.pdf
HAS/2005-11-01_ct032300.pdf
HAS/2005-11-01_ct032301.pdf
HAS/2005-11-01_ct032302.pdf
HAS/2005-11-01_ct032303.pdf
HAS/2005-11-01_ct032306.pdf
HAS/2005-11-01_ct032316.pdf
HAS/2005-11-01_ct032323.pdf
HAS/2005-11-01_ct032326.pdf
HAS/2005-11-01_ct032343.pdf
HAS/2005-11-01_ct032368.pdf
HAS/2005-11-01_ct_1839_atacand_ang.pdf
HAS/2005-11-01_ct_1856_kenzen-ang.pdf
HAS/2005-11-01_ct_1979_spiriva_ang.pdf
HAS/2005-11-01_douleur_chirurgie_buccale_rap.pdf
HAS/2005-11-01_douleur_chirurgie_buccale_recos.pdf
HAS/2005-11-01_douleurs_buccales_synthese_recos.pdf
HAS/2005-11-01_epp_pmsa_aide1.pdf
HAS/2005-11-01_epp_pmsa_aide2.pdf
HAS/2005-11-01_epp_pmsa_aide3.pdf
HAS/2005-11-01_epp_pmsa_aide4.pdf
HAS/2005-11-01_epp_pmsa_aide5.pdf
HAS/2005-11-01_epp_pmsa_aide6.pdf
HAS/2005-11-01_oral_surgery_qrg.pdf
HAS/2005-11-01_pmsa_protocole_bp_1_2006_09_25__10_44_46_691.pdf
HAS/2005-11-01_pmsa_protocole_bp_2.pdf
HAS/2005-11-01_pmsa_protocole_bp_3_2006_09_25__11_07_15_280.pdf
HAS/2005-11-01_pmsa_protocoles_courrier_2.pdf
HAS/2005-11-01_pmsa_protocoles_dossier_1_2006_09_19__10_42_33_137.pdf
HAS/2005-11-01_pmsa_protocoles_dossier_2.pdf
HAS/2005-11-01_pmsa_protocoles_dossier_3.pdf
HAS/2005-11-01_pmsa_protocoles_ordonnance_1_2006_09_19__10_42_33_154.pdf
HAS/2005-11-01_pmsa_protocoles_ordonnance_2.pdf
HAS/2005-11-01_pmsa_protocoles_ordonnance_3.pdf
HAS/2005-11-01_pmsa_protocoles_ordonnance_dossier.pdf
HAS/2005-11-01_pmsa_synth_biblio_2006_08_28__16_44_51_580.pdf
HAS/2005-11-01_pmsa_tout_sur_ces_programmes.pdf
HAS/2005-11-01_prevention_des_chutes_-_algorithme.pdf
HAS/2005-11-01_prevention_des_chutes_-_argumentaire.pdf.pdf
HAS/2005-11-01_prevention_des_chutes_-_points_cles.pdf
HAS/2005-11-01_rapport_psychotropes_version_longue_190208.pdf
HAS/2005-11-01_risque_carieux_synthese_recos.pdf
HAS/2005-11-01_spiriva.pdf
HAS/2005-11-01_traceur_has_fichesynth_sujetage.pdf
HAS/2005-11-02_ct032293.pdf
HAS/2005-11-02_ct032343.pdf
HAS/2005-11-02_ct_1839_atacand_ang.pdf
HAS/2005-11-02_humira_fit_14122012.pdf
HAS/2005-11-08_methodes.pdf
HAS/2005-11-08_paq.pdf
HAS/2005-11-08_pp020386.pdf
HAS/2005-11-08_pp020387.pdf
HAS/2005-11-08_pp020390.pdf
HAS/2005-11-08_pp020394.pdf
HAS/2005-11-08_pp020397.pdf
HAS/2005-11-08_preparation_de_la_sortie_du_patient_hospitalise_guide_2001_2009-08-31_16-13-36_630.pdf
HAS/2005-11-08_preparation_de_la_sortie_du_patient_hospitalise_rapport_acc_2006.pdf
HAS/2005-11-08_sortie_patient_GB.pdf
HAS/2005-11-15_ct032286.pdf
HAS/2005-11-15_ct032289.pdf
HAS/2005-11-15_ct032295.pdf
HAS/2005-11-15_ct032308.pdf
HAS/2005-11-15_ct032309.pdf
HAS/2005-11-15_ct032310.pdf
HAS/2005-11-15_ct032311.pdf
HAS/2005-11-15_ct032312.pdf
HAS/2005-11-15_ct032313.pdf
HAS/2005-11-15_ct032314.pdf
HAS/2005-11-15_ct032315.pdf
HAS/2005-11-15_ct032318.pdf
HAS/2005-11-15_ct032319.pdf
HAS/2005-11-15_ct032320.pdf
HAS/2005-11-15_ct032322.pdf
HAS/2005-11-15_ct032325.pdf
HAS/2005-11-15_ct032327.pdf
HAS/2005-11-15_ct032328.pdf
HAS/2005-11-15_ct032329.pdf
HAS/2005-11-15_ct032330.pdf
HAS/2005-11-15_ct032344.pdf
HAS/2005-11-15_ct032390.pdf
HAS/2005-11-15_ct032398.pdf
HAS/2005-11-15_ct032440.pdf
HAS/2005-11-22_pp020389.pdf
HAS/2005-11-22_pp020408.pdf
HAS/2005-11-29_ct032321.pdf
HAS/2005-11-29_ct032324.pdf
HAS/2005-11-29_ct032337.pdf
HAS/2005-11-29_ct032347.pdf
HAS/2005-11-29_ct032361.pdf
HAS/2005-11-29_ct032365.pdf
HAS/2005-11-29_ct032373.pdf
HAS/2005-11-29_ct032377.pdf
HAS/2005-11-29_ct032387.pdf
HAS/2005-11-29_ct032404.pdf
HAS/2005-11-29_ct032406.pdf
HAS/2005-11-29_ct032410.pdf
HAS/2005-11-29_ct032411.pdf
HAS/2005-11-29_ct032412.pdf
HAS/2005-11-29_ct032549.pdf
HAS/2005-11-29_methodologie_generale_delaboration_des_protocoles_therapeutiques__hors-ghs_.pdf
HAS/2005-12-01_Acces_Info_sante_Dec_2005.pdf
HAS/2005-12-06_pp020401.pdf
HAS/2005-12-06_pp020403.pdf
HAS/2005-12-06_pp020405.pdf
HAS/2005-12-06_pp020407.pdf
HAS/2005-12-06_pp020409.pdf
HAS/2005-12-06_pp020410.pdf
HAS/2005-12-13_ct032338.pdf
HAS/2005-12-13_ct032340.pdf
HAS/2005-12-13_ct032342.pdf
HAS/2005-12-13_ct032345.pdf
HAS/2005-12-13_ct032346.pdf
HAS/2005-12-13_ct032359.pdf
HAS/2005-12-13_ct032360.pdf
HAS/2005-12-13_ct032362.pdf
HAS/2005-12-13_ct032364.pdf
HAS/2005-12-13_ct032367.pdf
HAS/2005-12-13_ct032369.pdf
HAS/2005-12-13_ct032372.pdf
HAS/2005-12-13_ct032382.pdf
HAS/2005-12-13_ct032383.pdf
HAS/2005-12-13_ct032384.pdf
HAS/2005-12-13_ct032385.pdf
HAS/2005-12-13_ct032386.pdf
HAS/2005-12-13_ct032391.pdf
HAS/2005-12-13_ct032396.pdf
HAS/2005-12-13_ct032397.pdf
HAS/2005-12-13_ct032402.pdf
HAS/2005-12-13_ct032403.pdf
HAS/2005-12-13_ct032414.pdf
HAS/2005-12-13_ct032418.pdf
HAS/2005-12-13_ct032419.pdf
HAS/2005-12-13_ct032420.pdf
HAS/2005-12-13_ct032561.pdf
HAS/2005-12-14_ct032357.pdf
HAS/2005-12-20_pp020399.pdf
HAS/2005-12-20_pp020402.pdf
HAS/2005-12-20_pp020404.pdf
HAS/2005-12-20_pp020406.pdf
HAS/2005-12-20_pp020414.pdf
HAS/2006-01-01_Evaluation fonctionnelle_ AVC_kine_rap.pdf
HAS/2006-01-01_Evaluation_ fonctionnelle_ AVC_ref.pdf
HAS/2006-01-01_avc_m_351dical_-fiche_de_synth_350se-2006.pdf
HAS/2006-01-01_avc_param_351dical_argumentaire_version_2006.pdf
HAS/2006-01-01_evaluation_fonctionnelle_de_lavc_rapport_2006.pdf
HAS/2006-01-01_evaluation_fonctionnelle_de_lavc_referentiel_2006.pdf
HAS/2006-01-01_recommandations_2006_10_27__20_02_3_927.pdf
HAS/2006-01-02_argumentaire_version_finale_-_11-01-08.pdf
HAS/2006-01-02_consultation_dietetique_-_critere_de_qualite_-_final_pdf.pdf
HAS/2006-01-02_consultation_dietetique_fiche.pdf
HAS/2006-01-02_consultation_dietetique_recos.pdf
HAS/2006-01-02_dietary_consultation_-_quick_reference_guide_.pdf
HAS/2006-01-02_liste_des_criteres_dietetique_-_pdf_2008_04_18__14_26_16_673.pdf
HAS/2006-01-03_ct032331.pdf
HAS/2006-01-03_ct032348.pdf
HAS/2006-01-03_ct032349.pdf
HAS/2006-01-03_ct032352.pdf
HAS/2006-01-03_ct032363.pdf
HAS/2006-01-03_ct032366.pdf
HAS/2006-01-03_ct032371.pdf
HAS/2006-01-03_ct032374.pdf
HAS/2006-01-03_ct032375.pdf
HAS/2006-01-03_ct032376.pdf
HAS/2006-01-03_ct032378.pdf
HAS/2006-01-03_ct032379.pdf
HAS/2006-01-03_ct032388.pdf
HAS/2006-01-03_ct032389.pdf
HAS/2006-01-03_ct032395.pdf
HAS/2006-01-03_ct032399.pdf
HAS/2006-01-03_ct032400.pdf
HAS/2006-01-03_ct032401.pdf
HAS/2006-01-03_ct032407.pdf
HAS/2006-01-03_ct032408.pdf
HAS/2006-01-03_ct032413.pdf
HAS/2006-01-03_ct032421.pdf
HAS/2006-01-03_ct_1763_rebetol_ang_2007_11_20__12_22_19_961.pdf
HAS/2006-01-03_ct_2029_alfalastin_ang.pdf
HAS/2006-01-04_ct032358.pdf
HAS/2006-01-04_dossier_du_patient_en_odontologie_rapport_2006.pdf
HAS/2006-01-04_dossier_du_patient_en_odontologie_referentiel_2006.pdf
HAS/2006-01-04_dossier_patient_en_odontologie_2000.pdf
HAS/2006-01-04_rapport_dossier_odonto_210206vf.pdf
HAS/2006-01-04_referentiel_dossier_odonto_210206vf.pdf
HAS/2006-01-10_pp020413.pdf
HAS/2006-01-10_pp020416.pdf
HAS/2006-01-10_pp020417.pdf
HAS/2006-01-17_bat_fiche_medrol.pdf
HAS/2006-01-17_ct032341.pdf
HAS/2006-01-17_ct032356.pdf
HAS/2006-01-17_ct032394.pdf
HAS/2006-01-17_ct032422.pdf
HAS/2006-01-17_ct032423.pdf
HAS/2006-01-17_ct032432.pdf
HAS/2006-01-17_ct032438.pdf
HAS/2006-01-17_ct032439.pdf
HAS/2006-01-17_ct032441.pdf
HAS/2006-01-17_ct032442.pdf
HAS/2006-01-17_ct032445.pdf
HAS/2006-01-17_ct032447.pdf
HAS/2006-01-17_ct032451.pdf
HAS/2006-01-18_ct_2893_humira_ang.pdf
HAS/2006-01-18_humira.pdf
HAS/2006-01-18_humira_fit_14122012.pdf
HAS/2006-01-18_liste_85_epp.pdf
HAS/2006-01-18_muriel_dousse__douet_resume_languedoc_roussillon.pdf
HAS/2006-01-18_muriel_dousse_douet_diapo_languedoc_roussillon.pdf
HAS/2006-01-18_nicole_perrier_diapo_paca_corse.pdf
HAS/2006-01-18_nicole_perrier_resume_paca_corse.pdf
HAS/2006-01-18_pierre_mardegan_diapo_midi_pyrenees.pdf
HAS/2006-01-18_pierre_mardegan_resume_midi_pyrenees.pdf
HAS/2006-01-24_pp020412.pdf
HAS/2006-01-24_pp020415.pdf
HAS/2006-01-24_pp020419.pdf
HAS/2006-01-24_pp020420.pdf
HAS/2006-01-24_pp020421.pdf
HAS/2006-01-24_pp020422.pdf
HAS/2006-01-24_pp020423.pdf
HAS/2006-01-24_pp020426.pdf
HAS/2006-01-24_pp020427.pdf
HAS/2006-01-24_pp020428.pdf
HAS/2006-01-24_pp020429.pdf
HAS/2006-01-24_pp020430.pdf
HAS/2006-01-24_pp020431.pdf
HAS/2006-01-24_pp020432.pdf
HAS/2006-01-24_pp020433.pdf
HAS/2006-01-24_pp020434.pdf
HAS/2006-01-24_pp020435.pdf
HAS/2006-01-24_pp020436.pdf
HAS/2006-01-24_pp020437.pdf
HAS/2006-01-24_pp020438.pdf
HAS/2006-01-24_pp020439.pdf
HAS/2006-01-24_pp020440.pdf
HAS/2006-01-24_pp020441.pdf
HAS/2006-01-29_ct-3354_hexatrione_.pdf
HAS/2006-01-29_ct_3354_hexatrione_ang.pdf
HAS/2006-01-31_ct032426.pdf
HAS/2006-01-31_ct032427.pdf
HAS/2006-01-31_ct032428.pdf
HAS/2006-01-31_ct032429.pdf
HAS/2006-01-31_ct032430.pdf
HAS/2006-01-31_ct032431.pdf
HAS/2006-01-31_ct032433.pdf
HAS/2006-01-31_ct032434.pdf
HAS/2006-01-31_ct032435.pdf
HAS/2006-01-31_ct032443.pdf
HAS/2006-01-31_ct032444.pdf
HAS/2006-01-31_ct032448.pdf
HAS/2006-01-31_ct032449.pdf
HAS/2006-01-31_ct032450.pdf
HAS/2006-01-31_ct032452.pdf
HAS/2006-01-31_ct032454.pdf
HAS/2006-01-31_ct032455.pdf
HAS/2006-01-31_ct032460.pdf
HAS/2006-01-31_ct032461.pdf
HAS/2006-01-31_ct032462.pdf
HAS/2006-01-31_ct032463.pdf
HAS/2006-01-31_ct032465.pdf
HAS/2006-01-31_ct032466.pdf
HAS/2006-02-01_ct-1930_orimetene.pdf
HAS/2006-02-01_ct032437.pdf
HAS/2006-02-01_ct032502.pdf
HAS/2006-02-02_Sclerose_laterale_amyothrophique_court.pdf
HAS/2006-02-02_Sclerose_laterale_amyotrophique_long.pdf
HAS/2006-02-02_lateral_sclerosis_guidelines.pdf
HAS/2006-02-14_atimos_-_ct-2244.pdf
HAS/2006-02-14_ct032424.pdf
HAS/2006-02-14_ct032425.pdf
HAS/2006-02-14_ct032446.pdf
HAS/2006-02-14_ct032456.pdf
HAS/2006-02-14_ct032457.pdf
HAS/2006-02-14_ct032458.pdf
HAS/2006-02-14_ct032459.pdf
HAS/2006-02-14_ct032464.pdf
HAS/2006-02-14_ct032467.pdf
HAS/2006-02-14_ct032468.pdf
HAS/2006-02-14_ct032469.pdf
HAS/2006-02-14_ct032470.pdf
HAS/2006-02-14_ct032471.pdf
HAS/2006-02-14_ct032473.pdf
HAS/2006-02-14_ct032474.pdf
HAS/2006-02-14_ct032477.pdf
HAS/2006-02-14_ct032478.pdf
HAS/2006-02-14_ct032479.pdf
HAS/2006-02-14_ct032482.pdf
HAS/2006-02-14_ct032485.pdf
HAS/2006-02-14_ct032488.pdf
HAS/2006-02-14_ct032489.pdf
HAS/2006-02-14_ct032490.pdf
HAS/2006-02-14_ct032492.pdf
HAS/2006-02-14_ct032493.pdf
HAS/2006-02-14_ct032494.pdf
HAS/2006-02-14_ct032495.pdf
HAS/2006-02-14_ct032496.pdf
HAS/2006-02-14_ct032498.pdf
HAS/2006-02-14_ct032499.pdf
HAS/2006-02-14_ct032501.pdf
HAS/2006-02-14_ct032504.pdf
HAS/2006-02-14_ct032505.pdf
HAS/2006-02-14_ct032508.pdf
HAS/2006-02-14_ct032510.pdf
HAS/2006-02-14_ct032514.pdf
HAS/2006-02-14_ct032516.pdf
HAS/2006-02-14_ct032518.pdf
HAS/2006-02-14_ct032519.pdf
HAS/2006-02-14_ct032522.pdf
HAS/2006-02-14_ct032524.pdf
HAS/2006-02-14_ct032528.pdf
HAS/2006-02-14_ct032531.pdf
HAS/2006-02-14_ct032532.pdf
HAS/2006-02-14_ct032533.pdf
HAS/2006-02-14_ct032534.pdf
HAS/2006-02-14_ct032535.pdf
HAS/2006-02-14_ct032536.pdf
HAS/2006-02-14_ct_1808_taxotere_ang.pdf
HAS/2006-02-14_ct_1884_vesicare_ang_.pdf
HAS/2006-02-14_ct_2255_revatio_ang.pdf
HAS/2006-02-15_ct032436.pdf
HAS/2006-02-15_ct032486.pdf
HAS/2006-02-15_ct032507.pdf
HAS/2006-02-15_ct032540.pdf
HAS/2006-02-15_ct_2462_kepivance_ang_2008-07-23_09-35-57_617.pdf
HAS/2006-02-21_pp020425.pdf
HAS/2006-02-21_pp020451.pdf
HAS/2006-02-22_cepp-232.pdf
HAS/2006-02-22_cepp-398.pdf
HAS/2006-02-28_ct032480.pdf
HAS/2006-02-28_ct032481.pdf
HAS/2006-02-28_ct032483.pdf
HAS/2006-02-28_ct032484.pdf
HAS/2006-02-28_ct032491.pdf
HAS/2006-02-28_ct032506.pdf
HAS/2006-02-28_ct032509.pdf
HAS/2006-02-28_ct032511.pdf
HAS/2006-02-28_ct032512.pdf
HAS/2006-02-28_ct032515.pdf
HAS/2006-02-28_ct032517.pdf
HAS/2006-02-28_ct032521.pdf
HAS/2006-02-28_ct032523.pdf
HAS/2006-02-28_ct032526.pdf
HAS/2006-02-28_ct032537.pdf
HAS/2006-02-28_ct032538.pdf
HAS/2006-02-28_ct032539.pdf
HAS/2006-02-28_ct_2413_zyprexa_ang.pdf
HAS/2006-03-01_candesartan.pdf
HAS/2006-03-01_ct032343.pdf
HAS/2006-03-01_ct032368.pdf
HAS/2006-03-01_ct032475.pdf
HAS/2006-03-01_ct032476.pdf
HAS/2006-03-01_ct_2157_azilect_ang.pdf
HAS/2006-03-07_pp020443.pdf
HAS/2006-03-07_pp020444.pdf
HAS/2006-03-07_pp020445.pdf
HAS/2006-03-07_pp020446.pdf
HAS/2006-03-07_pp020447.pdf
HAS/2006-03-07_pp020448.pdf
HAS/2006-03-07_pp020449.pdf
HAS/2006-03-07_pp020450.pdf
HAS/2006-03-07_pp020452.pdf
HAS/2006-03-07_pp020460.pdf
HAS/2006-03-08_cepp-353.pdf
HAS/2006-03-14_bat_fiche_myleran.pdf
HAS/2006-03-14_ct032472.pdf
HAS/2006-03-14_ct032497.pdf
HAS/2006-03-14_ct032500.pdf
HAS/2006-03-14_ct032503.pdf
HAS/2006-03-14_ct032513.pdf
HAS/2006-03-14_ct032525.pdf
HAS/2006-03-14_ct032527.pdf
HAS/2006-03-14_ct032529.pdf
HAS/2006-03-14_ct032530.pdf
HAS/2006-03-14_ct032553.pdf
HAS/2006-03-14_ct032556.pdf
HAS/2006-03-14_ct032557.pdf
HAS/2006-03-14_ct032563.pdf
HAS/2006-03-14_ct032565.pdf
HAS/2006-03-14_ct032575.pdf
HAS/2006-03-14_ct_2253_tarceva_ang.pdf
HAS/2006-03-14_ct_2463_flisint_ang.pdf
HAS/2006-03-14_ct_2784_glucophage_ang.pdf
HAS/2006-03-15_ct032520.pdf
HAS/2006-03-15_ct_2312_pegasys_english.pdf
HAS/2006-03-21_cepp_-_755_genesis_050907.pdf
HAS/2006-03-21_pp020442.pdf
HAS/2006-03-21_pp020454.pdf
HAS/2006-03-21_pp020455.pdf
HAS/2006-03-21_pp020458.pdf
HAS/2006-03-21_pp020459.pdf
HAS/2006-03-21_pp020465.pdf
HAS/2006-03-28_ct032541.pdf
HAS/2006-03-28_ct032542.pdf
HAS/2006-03-28_ct032545.pdf
HAS/2006-03-28_ct032547.pdf
HAS/2006-03-28_ct032548.pdf
HAS/2006-03-28_ct032550.pdf
HAS/2006-03-28_ct032554.pdf
HAS/2006-03-28_ct032558.pdf
HAS/2006-03-28_ct032559.pdf
HAS/2006-03-28_ct032560.pdf
HAS/2006-03-28_ct032564.pdf
HAS/2006-03-28_ct032566.pdf
HAS/2006-03-28_ct032568.pdf
HAS/2006-03-28_ct032571.pdf
HAS/2006-03-28_ct032573.pdf
HAS/2006-03-28_ct032577.pdf
HAS/2006-03-29_ct-2232_percutalgine_.pdf
HAS/2006-03-29_ct032552.pdf
HAS/2006-04-01_AOMI_fiche.pdf
HAS/2006-04-01_AOMI_rap.pdf
HAS/2006-04-01_AOMI_recos.pdf
HAS/2006-04-01_Art29.pdf
HAS/2006-04-04_pp020453.pdf
HAS/2006-04-04_pp020456.pdf
HAS/2006-04-04_pp020461.pdf
HAS/2006-04-04_pp020462.pdf
HAS/2006-04-04_pp020463.pdf
HAS/2006-04-04_pp020464.pdf
HAS/2006-04-05_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2006-04-05_epp_cro_generique_ortho_rap.pdf
HAS/2006-04-05_epp_cro_generique_ortho_ref.pdf
HAS/2006-04-05_proth.hanche.4p.pdf
HAS/2006-04-05_proth.hanche.pdf
HAS/2006-04-11_ct032543.pdf
HAS/2006-04-11_ct032546.pdf
HAS/2006-04-11_ct032555.pdf
HAS/2006-04-11_ct032567.pdf
HAS/2006-04-11_ct032569.pdf
HAS/2006-04-11_ct032570.pdf
HAS/2006-04-11_ct032572.pdf
HAS/2006-04-11_ct032574.pdf
HAS/2006-04-11_ct032576.pdf
HAS/2006-04-11_ct032578.pdf
HAS/2006-04-11_ct_1819_oraqix_ang.pdf
HAS/2006-04-11_ct_2164_fosrenol_ang.pdf
HAS/2006-04-11_ct_2482_aptivus_ang.pdf
HAS/2006-04-12_ct032562.pdf
HAS/2006-04-12_ct032581.pdf
HAS/2006-04-12_ct_2277_nanogam_ang_2008-07-23_09-37-22_785.pdf
HAS/2006-04-13_rapport_prothese_chassis_metallique.pdf
HAS/2006-04-13_synthese_prothese_chassis_metallique.pdf
HAS/2006-04-18_cepp-787restoreavis.pdf
HAS/2006-04-18_cepp-787restorefit.pdf
HAS/2006-04-18_pp020466.pdf
HAS/2006-04-18_pp020468.pdf
HAS/2006-04-18_pp020471.pdf
HAS/2006-04-18_pp020474.pdf
HAS/2006-04-18_pp020482.pdf
HAS/2006-04-18_pp020487.pdf
HAS/2006-04-25_ct032544.pdf
HAS/2006-04-25_ct032580.pdf
HAS/2006-04-25_ct032582.pdf
HAS/2006-04-25_ct032584.pdf
HAS/2006-04-25_ct032587.pdf
HAS/2006-04-25_ct032588.pdf
HAS/2006-04-25_ct032591.pdf
HAS/2006-04-25_ct032605.pdf
HAS/2006-04-25_ct_2054_fendrix_ang.pdf
HAS/2006-04-25_ct_2250_xeloda_ang.pdf
HAS/2006-04-25_ct_2574_remicade_ang.pdf
HAS/2006-04-25_xeloda_srh.pdf
HAS/2006-04-26_ct032583.pdf
HAS/2006-04-26_ct__2556__entocort_ang.pdf
HAS/2006-05-01_guide_exam_rx_oct2006_2007_12_07__12_37_35_794.pdf
HAS/2006-05-01_icamg_m1.pdf
HAS/2006-05-01_icamg_m2.pdf
HAS/2006-05-01_icamg_m3.pdf
HAS/2006-05-01_icamg_p1_2006_10_23__11_54_55_420.pdf
HAS/2006-05-01_icamg_p2.pdf
HAS/2006-05-01_icamg_prog_bp.pdf
HAS/2006-05-01_icamg_prog_es_2411.pdf
HAS/2006-05-01_icamg_synth_biblio.pdf
HAS/2006-05-01_icamg_tout_sur_ces_programmes.pdf
HAS/2006-05-01_long-term_noninvasive_positive_pressure_ventilation_-_quick_reference_guide.pdf
HAS/2006-05-01_rpc_vni_final_argumentaire.pdf
HAS/2006-05-01_ventilation__non_invasive_recos.pdf
HAS/2006-05-01_ventilation_non_invasive_fiche.pdf
HAS/2006-05-02_pp020469.pdf
HAS/2006-05-02_pp020470.pdf
HAS/2006-05-02_pp020473.pdf
HAS/2006-05-02_pp020475.pdf
HAS/2006-05-02_pp020479.pdf
HAS/2006-05-02_pp020481.pdf
HAS/2006-05-02_pp020483.pdf
HAS/2006-05-02_pp020484.pdf
HAS/2006-05-03_pp020498.pdf
HAS/2006-05-09_bonviva.pdf
HAS/2006-05-09_ct032585.pdf
HAS/2006-05-09_ct032586.pdf
HAS/2006-05-09_ct032589.pdf
HAS/2006-05-09_ct032590.pdf
HAS/2006-05-09_ct032601.pdf
HAS/2006-05-09_ct032606.pdf
HAS/2006-05-09_ct032619.pdf
HAS/2006-05-09_ct_2410_inductos_ang.pdf
HAS/2006-05-09_ct_2781_bonviva_ang.pdf
HAS/2006-05-09_ct_2782_xyrem_ang.pdf
HAS/2006-05-10_bat_fiche_zavedos.pdf
HAS/2006-05-10_ct032592.pdf
HAS/2006-05-10_ct032633.pdf
HAS/2006-05-10_ct032739.pdf
HAS/2006-05-10_ct032742.pdf
HAS/2006-05-10_ct032743.pdf
HAS/2006-05-10_ct032753.pdf
HAS/2006-05-10_ct032758.pdf
HAS/2006-05-10_ct032759.pdf
HAS/2006-05-10_ct032797.pdf
HAS/2006-05-10_ct032812.pdf
HAS/2006-05-10_ct032814.pdf
HAS/2006-05-10_ct032815.pdf
HAS/2006-05-10_ct032817.pdf
HAS/2006-05-10_ct032818.pdf
HAS/2006-05-10_ct032824.pdf
HAS/2006-05-10_ct032825.pdf
HAS/2006-05-10_ct_1866_zavedos_ang_2008-07-23_09-31-8_526.pdf
HAS/2006-05-16_pp020467.pdf
HAS/2006-05-16_pp020472.pdf
HAS/2006-05-16_pp020485.pdf
HAS/2006-05-16_pp020486.pdf
HAS/2006-05-17_pp020494.pdf
HAS/2006-05-17_pp020495.pdf
HAS/2006-05-29_ct-3467_procoralan_.pdf
HAS/2006-05-29_ct_3467_procoralan_ang.pdf
HAS/2006-05-30_ct032596.pdf
HAS/2006-05-30_ct032597.pdf
HAS/2006-05-30_ct032598.pdf
HAS/2006-05-30_ct032600.pdf
HAS/2006-05-30_ct032611.pdf
HAS/2006-05-30_ct032614.pdf
HAS/2006-05-30_ct032615.pdf
HAS/2006-05-30_ct032616.pdf
HAS/2006-05-30_ct032621.pdf
HAS/2006-05-30_ct_2078_ticovac_.pdf
HAS/2006-05-30_ct_2171_casodex_ang.pdf
HAS/2006-05-30_ct_2341_noxafil_en_val_ang.pdf
HAS/2006-05-30_ct_2881_ticovac__ang.pdf
HAS/2006-05-31_Allaitement_rap.pdf
HAS/2006-05-31_Allaitement_recos.pdf
HAS/2006-05-31_Psychopathie_rap.pdf
HAS/2006-05-31_Psychopathie_recos.pdf
HAS/2006-05-31_catherine_mimram_resume_reunion.pdf
HAS/2006-05-31_catherine_mimran_diapo_reunion.pdf
HAS/2006-05-31_chemin_clinique_4.pdf
HAS/2006-05-31_chemin_clinique_guide.pdf
HAS/2006-05-31_christiane__anette_resume_guadeloupe.pdf
HAS/2006-05-31_christiane_anette_diapo_martinique.pdf
HAS/2006-05-31_ct032609.pdf
HAS/2006-05-31_ct032717.pdf
HAS/2006-05-31_ct032718.pdf
HAS/2006-05-31_ct032734.pdf
HAS/2006-05-31_ct032735.pdf
HAS/2006-05-31_ct032736_2006_09_26__19_10_45_589.pdf
HAS/2006-05-31_ct032737.pdf
HAS/2006-05-31_ct032740.pdf
HAS/2006-05-31_ct032741.pdf
HAS/2006-05-31_ct032744.pdf
HAS/2006-05-31_ct032745.pdf
HAS/2006-05-31_ct032746.pdf
HAS/2006-05-31_ct032748.pdf
HAS/2006-05-31_ct032749.pdf
HAS/2006-05-31_ct032750.pdf
HAS/2006-05-31_ct032754.pdf
HAS/2006-05-31_ct032757.pdf
HAS/2006-05-31_ct032760.pdf
HAS/2006-05-31_ct032761.pdf
HAS/2006-05-31_ct032762.pdf
HAS/2006-05-31_ct032763.pdf
HAS/2006-05-31_ct032764.pdf
HAS/2006-05-31_ct032765.pdf
HAS/2006-05-31_ct032766.pdf
HAS/2006-05-31_ct032767.pdf
HAS/2006-05-31_ct032768.pdf
HAS/2006-05-31_ct032769.pdf
HAS/2006-05-31_ct032770.pdf
HAS/2006-05-31_ct032771.pdf
HAS/2006-05-31_ct032772_2006_11_02__14_36_7_304.pdf
HAS/2006-05-31_ct032773.pdf
HAS/2006-05-31_ct032774.pdf
HAS/2006-05-31_ct032775.pdf
HAS/2006-05-31_ct032776.pdf
HAS/2006-05-31_ct032777.pdf
HAS/2006-05-31_ct032778.pdf
HAS/2006-05-31_ct032779.pdf
HAS/2006-05-31_ct032780.pdf
HAS/2006-05-31_ct032781.pdf
HAS/2006-05-31_ct032782.pdf
HAS/2006-05-31_ct032783.pdf
HAS/2006-05-31_ct032785.pdf
HAS/2006-05-31_ct032786.pdf
HAS/2006-05-31_ct032787.pdf
HAS/2006-05-31_ct032788.pdf
HAS/2006-05-31_ct032789.pdf
HAS/2006-05-31_ct032790.pdf
HAS/2006-05-31_ct032791.pdf
HAS/2006-05-31_ct032792.pdf
HAS/2006-05-31_ct032793.pdf
HAS/2006-05-31_ct032794.pdf
HAS/2006-05-31_ct032795.pdf
HAS/2006-05-31_ct032796.pdf
HAS/2006-05-31_ct032798.pdf
HAS/2006-05-31_ct032799.pdf
HAS/2006-05-31_ct032800.pdf
HAS/2006-05-31_ct032801.pdf
HAS/2006-05-31_ct032802.pdf
HAS/2006-05-31_ct032803.pdf
HAS/2006-05-31_ct032804.pdf
HAS/2006-05-31_ct032805.pdf
HAS/2006-05-31_ct032806.pdf
HAS/2006-05-31_ct032807.pdf
HAS/2006-05-31_ct032808.pdf
HAS/2006-05-31_ct032809.pdf
HAS/2006-05-31_ct032811.pdf
HAS/2006-05-31_ct032816.pdf
HAS/2006-05-31_ct032819.pdf
HAS/2006-05-31_ct032821.pdf
HAS/2006-05-31_ct032822.pdf
HAS/2006-05-31_ct032828.pdf
HAS/2006-05-31_ct032829.pdf
HAS/2006-05-31_ct032830.pdf
HAS/2006-05-31_ct032831.pdf
HAS/2006-05-31_ct032832.pdf
HAS/2006-05-31_ct032833.pdf
HAS/2006-05-31_ct032834.pdf
HAS/2006-05-31_ct032835.pdf
HAS/2006-05-31_ct032836.pdf
HAS/2006-05-31_ct032837.pdf
HAS/2006-05-31_ct032838.pdf
HAS/2006-05-31_ct032839.pdf
HAS/2006-05-31_ct032840.pdf
HAS/2006-05-31_ct032841.pdf
HAS/2006-05-31_ct032842.pdf
HAS/2006-05-31_ct032844.pdf
HAS/2006-05-31_ct032845.pdf
HAS/2006-05-31_ct032847.pdf
HAS/2006-05-31_ct032848.pdf
HAS/2006-05-31_ct__2532__insuplant_ang.pdf
HAS/2006-05-31_cyrille_colin_diapo_rhone_alpes.pdf
HAS/2006-05-31_cyrille_colin_et_sandrine_touzet_resume_rhone_alpes.pdf
HAS/2006-05-31_delphine_rayrat_resume_poitou_charente_2006_10_16__10_51_54_725.pdf
HAS/2006-05-31_eric_piquenot_et_delphine_rayrat_diapo_poitou_charente_2006_10_16__10_48_50_149.pdf
HAS/2006-05-31_favoriser_lallaitement_maternel_processus_-_evaluation_guide_2006.pdf
HAS/2006-05-31_favoriser_lallaitement_maternel_processus_-_evaluation_synthese_2006.pdf
HAS/2006-05-31_francoise_venditelli_resume_auvergne.pdf
HAS/2006-05-31_francoise_vendittelli_diapo_auvergne.pdf
HAS/2006-05-31_gilbert_paniandy_diapo_reunion.pdf
HAS/2006-05-31_gilbert_paniandy_resume_reunion.pdf
HAS/2006-05-31_gilles_capelier_resume_franche_comte.pdf
HAS/2006-05-31_gilles_capellier_diapo_franche_comte.pdf
HAS/2006-05-31_helene_fury_resume_reunion.pdf
HAS/2006-05-31_isabelle_van__praagh_resume_auvergne.pdf
HAS/2006-05-31_isabelle_van_praagh_diapo_auvergne.pdf
HAS/2006-05-31_jean__paul_briese_et_ludovic_de_gaillande_diapo_paca_corse.pdf
HAS/2006-05-31_liste_85_epp.pdf
HAS/2006-05-31_ludovic_de_gaillande_et_jean_paul_briese_resume_paca_corse.pdf
HAS/2006-05-31_marie_christine_moll_et_alain_le_henaff_diapo_pays_de_la_loire.pdf
HAS/2006-05-31_marie_christine_moll_resume_pays_de_la_loire.pdf
HAS/2006-05-31_martine__pouillart_resume_picardie.pdf
HAS/2006-05-31_martine_pouillart_diapo_picardie.pdf
HAS/2006-05-31_mg708.pdf
HAS/2006-05-31_muriel_dousse__douet_resume_languedoc_roussillon.pdf
HAS/2006-05-31_muriel_dousse_douet_diapo_languedoc_roussillon.pdf
HAS/2006-05-31_philippe_scherpereel_diapo_nord_pas_de_calais.pdf
HAS/2006-05-31_philippe_scherpereel_resume_nord_pas_de_calais.pdf
HAS/2006-05-31_pp020488.pdf
HAS/2006-05-31_pp020489.pdf
HAS/2006-05-31_pp020496.pdf
HAS/2006-05-31_pp020497.pdf
HAS/2006-05-31_psychopathie _05-_textes experts.pdf
HAS/2006-05-31_rdp15chabot.pdf
HAS/2006-05-31_reseaux_de_sante.pdf
HAS/2006-05-31_thierry_lebas_diapo_basse_normandie.pdf
HAS/2006-05-31_thierry_lebas_resume_basse_normandie.pdf
HAS/2006-05-31_va.pdf
HAS/2006-05-31_valerie_carrat_diapo_ile_de_france.pdf
HAS/2006-05-31_valerie_carrat_resume_ile_de_france.pdf
HAS/2006-06-06_ct032599.pdf
HAS/2006-06-06_ct032607.pdf
HAS/2006-06-06_ct032610.pdf
HAS/2006-06-06_ct032612.pdf
HAS/2006-06-06_ct032613.pdf
HAS/2006-06-06_ct032617.pdf
HAS/2006-06-06_ct032618.pdf
HAS/2006-06-06_ct_2135_ledermycine_ang.pdf
HAS/2006-06-07_ct032719.pdf
HAS/2006-06-07_ct032720.pdf
HAS/2006-06-07_ct032721.pdf
HAS/2006-06-07_ct032722.pdf
HAS/2006-06-07_ct032723.pdf
HAS/2006-06-07_ct032724.pdf
HAS/2006-06-07_ct032725.pdf
HAS/2006-06-07_ct032726.pdf
HAS/2006-06-07_ct032727.pdf
HAS/2006-06-07_ct032728.pdf
HAS/2006-06-07_ct032729.pdf
HAS/2006-06-07_ct032730.pdf
HAS/2006-06-07_ct032731.pdf
HAS/2006-06-07_ct032732.pdf
HAS/2006-06-07_ct032733.pdf
HAS/2006-06-07_ct032747.pdf
HAS/2006-06-07_ct032756.pdf
HAS/2006-06-14_cepp-1278.pdf
HAS/2006-06-14_cepp-460_2007_07_10__15_38_32_482.pdf
HAS/2006-06-14_pp020490.pdf
HAS/2006-06-14_pp020491_2006_10_26__16_04_50_319.pdf
HAS/2006-06-14_pp020492.pdf
HAS/2006-06-14_pp020493.pdf
HAS/2006-06-14_pp020499.pdf
HAS/2006-06-20_ct032602.pdf
HAS/2006-06-20_ct032604.pdf
HAS/2006-06-20_ct032608.pdf
HAS/2006-06-20_ct032620.pdf
HAS/2006-06-21_ct032628.pdf
HAS/2006-06-21_ct032637.pdf
HAS/2006-06-21_ct032652.pdf
HAS/2006-06-21_ct032657.pdf
HAS/2006-06-21_ct032658.pdf
HAS/2006-06-21_ct032670.pdf
HAS/2006-06-21_ct032671.pdf
HAS/2006-06-21_ct032681.pdf
HAS/2006-06-21_ct032693.pdf
HAS/2006-06-21_ct032705.pdf
HAS/2006-06-21_ct032713.pdf
HAS/2006-06-21_ct_2272_bonviva_ang.pdf
HAS/2006-06-21_ct_2563_apsor_ang_.pdf
HAS/2006-06-21_ct_2805_granocyte_ang.pdf
HAS/2006-06-21_ct_2831_naglazyme_.pdf
HAS/2006-06-21_granocyte_srh_2008-08-08_11-26-13_317.pdf
HAS/2006-06-21_osteodensitometrie_rapport.pdf
HAS/2006-06-21_osteoporose_synthese.pdf
HAS/2006-06-21_prevenir_fractures_osteoporose.pdf
HAS/2006-06-28_cepp-544.pdf
HAS/2006-06-28_cepp-550.pdf
HAS/2006-06-28_cepp-552.pdf
HAS/2006-06-28_cepp-723.pdf
HAS/2006-06-28_cepp-724.pdf
HAS/2006-06-28_cepp-725.pdf
HAS/2006-06-28_cepp-726.pdf
HAS/2006-06-28_cepp-733.pdf
HAS/2006-06-28_cepp-842.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_1.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_1_2007_01_24__15_04_11_949.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_1_2007_01_24__15_11_2_96.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_1000.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_1000_2007_01_24__15_05_55_263.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_1000_2007_01_24__15_11_55_275.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_1000_2007_01_24__15_31_54_802.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_1000_2007_01_24__15_59_46_37.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_1000_2007_01_25__14_14_37_875.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_500.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_500_2007_01_25__14_00_51_857.pdf
HAS/2006-06-28_cepp_-_anneaux_annexe_2_500_2007_01_25__14_08_20_663.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs_2007_01_25__11_25_36_119.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs_2007_01_25__11_32_45_520.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs_2007_01_25__11_35_6_776.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs_2007_01_25__14_01_32_72.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs_2007_01_25__14_08_57_140.pdf
HAS/2006-06-28_cepp_-_fiche_patient_ccs_2007_01_25__14_15_29_878.pdf
HAS/2006-06-28_cepp_-_fiche_patient_gvc.pdf
HAS/2006-06-28_cepp_-_fiche_patient_gvc_2007_01_25__13_55_20_778.pdf
HAS/2006-06-28_pp020500.pdf
HAS/2006-06-28_pp020503.pdf
HAS/2006-07-01_depistage_et_diagnostic_du_glaucome___problematique_et_perspectives_en_france_resume_inahta.pdf
HAS/2006-07-01_depistage_et_diagnostic_precoce_du_glaucome___problematique_et_perspectives_en_france_rapport.pdf
HAS/2006-07-01_depistage_et_diagnostic_precoce_du_glaucome___problematique_et_perspectives_en_france_synthese.pdf
HAS/2006-07-01_glaucoma_screening_and_early_diagnosis_problems_and_outlook_in_france.pdf
HAS/2006-07-05_ct032622.pdf
HAS/2006-07-05_ct032626.pdf
HAS/2006-07-05_ct032632.pdf
HAS/2006-07-05_ct032634.pdf
HAS/2006-07-05_ct032635.pdf
HAS/2006-07-05_ct032636.pdf
HAS/2006-07-05_ct032645.pdf
HAS/2006-07-05_ct032646.pdf
HAS/2006-07-05_ct032651.pdf
HAS/2006-07-05_ct032653.pdf
HAS/2006-07-05_ct032659.pdf
HAS/2006-07-05_ct032660.pdf
HAS/2006-07-05_ct032662.pdf
HAS/2006-07-05_ct032663.pdf
HAS/2006-07-05_ct032664.pdf
HAS/2006-07-05_ct032668.pdf
HAS/2006-07-05_ct032669.pdf
HAS/2006-07-05_ct032672.pdf
HAS/2006-07-05_ct032676.pdf
HAS/2006-07-05_ct032682.pdf
HAS/2006-07-05_ct032684.pdf
HAS/2006-07-05_ct032692.pdf
HAS/2006-07-05_ct032695.pdf
HAS/2006-07-05_ct032696.pdf
HAS/2006-07-05_ct032697.pdf
HAS/2006-07-05_ct032698.pdf
HAS/2006-07-05_ct032699.pdf
HAS/2006-07-05_ct032700.pdf
HAS/2006-07-05_ct032701.pdf
HAS/2006-07-05_ct032702.pdf
HAS/2006-07-05_ct032703.pdf
HAS/2006-07-05_ct032707.pdf
HAS/2006-07-05_ct032709.pdf
HAS/2006-07-05_ct032710.pdf
HAS/2006-07-05_ct032711.pdf
HAS/2006-07-05_ct032712.pdf
HAS/2006-07-05_ct032714.pdf
HAS/2006-07-05_ct032715.pdf
HAS/2006-07-05_ct032716.pdf
HAS/2006-07-05_ct032751.pdf
HAS/2006-07-05_ct032752.pdf
HAS/2006-07-05_ct032755.pdf
HAS/2006-07-05_ct032784.pdf
HAS/2006-07-05_ct032810.pdf
HAS/2006-07-05_ct032813.pdf
HAS/2006-07-05_ct032820.pdf
HAS/2006-07-05_ct032823.pdf
HAS/2006-07-05_ct032826.pdf
HAS/2006-07-05_ct032827.pdf
HAS/2006-07-05_ct032843.pdf
HAS/2006-07-05_ct032846.pdf
HAS/2006-07-05_didronel.pdf
HAS/2006-07-05_ganfort.pdf
HAS/2006-07-05_methode_acbus.pdf
HAS/2006-07-12_pp020501.pdf
HAS/2006-07-12_pp020502.pdf
HAS/2006-07-12_pp020504.pdf
HAS/2006-07-12_pp020505.pdf
HAS/2006-07-12_pp020506.pdf
HAS/2006-07-18_aide_au_sevrage_tabagique_rapport_2004.pdf
HAS/2006-07-18_aide_au_sevrage_tabagique_referentiel_2004.pdf
HAS/2006-07-18_antibio_perioperatoire_rap.pdf
HAS/2006-07-18_antibio_perioperatoire_ref.pdf
HAS/2006-07-19_ct-2154_morphine_chlorhydrate_lavoisier.pdf
HAS/2006-07-19_ct-2320_endium.pdf
HAS/2006-07-19_ct-2492_androcur.pdf
HAS/2006-07-19_ct-2580_iodence.pdf
HAS/2006-07-19_ct-2719_kenzen.pdf
HAS/2006-07-19_ct-2724_atacand.pdf
HAS/2006-07-19_ct-2821_bactyl.pdf
HAS/2006-07-19_ct-2826_xenical.pdf
HAS/2006-07-19_ct-2867_tramadol_sanofi_aventis.pdf
HAS/2006-07-19_ct-2878_aromasine.pdf
HAS/2006-07-19_ct-2929_sandoglobuline.pdf
HAS/2006-07-19_ct-3031_fenofibrate_ratiopharm.pdf
HAS/2006-07-19_ct-3087_tramadol_contramid.pdf
HAS/2006-07-19_ct-3150_biocidan.pdf
HAS/2006-07-19_ct032623.pdf
HAS/2006-07-19_ct032624.pdf
HAS/2006-07-19_ct032625.pdf
HAS/2006-07-19_ct032629.pdf
HAS/2006-07-19_ct032630.pdf
HAS/2006-07-19_ct032631.pdf
HAS/2006-07-19_ct032638.pdf
HAS/2006-07-19_ct032639.pdf
HAS/2006-07-19_ct032640.pdf
HAS/2006-07-19_ct032641.pdf
HAS/2006-07-19_ct032642.pdf
HAS/2006-07-19_ct032643.pdf
HAS/2006-07-19_ct032644.pdf
HAS/2006-07-19_ct032647.pdf
HAS/2006-07-19_ct032648.pdf
HAS/2006-07-19_ct032649.pdf
HAS/2006-07-19_ct032650.pdf
HAS/2006-07-19_ct032654.pdf
HAS/2006-07-19_ct032656.pdf
HAS/2006-07-19_ct032661.pdf
HAS/2006-07-19_ct032665_2006_11_29__11_15_27_782.pdf
HAS/2006-07-19_ct032666.pdf
HAS/2006-07-19_ct032673.pdf
HAS/2006-07-19_ct032674.pdf
HAS/2006-07-19_ct032675.pdf
HAS/2006-07-19_ct032677.pdf
HAS/2006-07-19_ct032678.pdf
HAS/2006-07-19_ct032679.pdf
HAS/2006-07-19_ct032680.pdf
HAS/2006-07-19_ct032683.pdf
HAS/2006-07-19_ct032685.pdf
HAS/2006-07-19_ct032686.pdf
HAS/2006-07-19_ct032687.pdf
HAS/2006-07-19_ct032688.pdf
HAS/2006-07-19_ct032689.pdf
HAS/2006-07-19_ct032690.pdf
HAS/2006-07-19_ct032691.pdf
HAS/2006-07-19_ct032694.pdf
HAS/2006-07-19_ct032704.pdf
HAS/2006-07-19_ct032706.pdf
HAS/2006-07-19_ct032708.pdf
HAS/2006-07-19_ct_2492_androcur_ang_.pdf
HAS/2006-07-19_ct_2826_xenical_ang.pdf
HAS/2006-07-19_ct_2838_keppra__ang.pdf
HAS/2006-07-19_ct_2878_aromasine_ang.pdf
HAS/2006-07-19_ct__2580_iodence_ang.pdf
HAS/2006-08-31_alain_hermelin_diapo_haute_normandie.pdf
HAS/2006-08-31_alain_hermelin_resume_haute_normandie.pdf
HAS/2006-08-31_alain_vergnenegre_diapo_limousin.pdf
HAS/2006-08-31_alain_vergnenegre_resume_limousin.pdf
HAS/2006-08-31_alice__irani_resume_poitou_charente.pdf
HAS/2006-08-31_alice_irani_diapo_poitou_charente.pdf
HAS/2006-08-31_anissa_chachia_diapo_poitou_charente.pdf
HAS/2006-08-31_anissa_chachia_resume_poitou_charente.pdf
HAS/2006-08-31_anne_marie_durocher_diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_anne_marie_durocher_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_annick_brunot_ojeda_diapo_alsace.pdf
HAS/2006-08-31_annick_brunot_ojedaa_resume_alsace.pdf
HAS/2006-08-31_bernadette_girol_diapo_limousin.pdf
HAS/2006-08-31_bernadette_girol_resume_limousin.pdf
HAS/2006-08-31_bernard__assoun_resume_midi_pyrenees.pdf
HAS/2006-08-31_bernard_assoun_diapo_midi_pyrenees.pdf
HAS/2006-08-31_bernard_denis_diapo_alsace.pdf
HAS/2006-08-31_bernard_denis_resume_alsace.pdf
HAS/2006-08-31_bernard_lorcerie_resume_bourgogne.pdf
HAS/2006-08-31_brigitte_gardrat_et_maryse_cremer_resume_haute_normandie.pdf
HAS/2006-08-31_bruno_perez_resume_paca_corse.pdf
HAS/2006-08-31_carlos_dorado_diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_carlos_dorado_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_catherine_baubri_diapo_poitou_charente.pdf
HAS/2006-08-31_catherine_baubri_resume_poitou_charente.pdf
HAS/2006-08-31_catherine_guignabert_diapo_bourgogne.pdf
HAS/2006-08-31_catherine_guignabert_resume_bourgogne.pdf
HAS/2006-08-31_catherine_mimram_resume_reunion.pdf
HAS/2006-08-31_catherine_mimran_diapo_reunion.pdf
HAS/2006-08-31_chantal_monnier_diapo_franche_comte.pdf
HAS/2006-08-31_chantal_monnier_resume_franche_comte.pdf
HAS/2006-08-31_claude_bourgeaux_diapo_haute_normandie.pdf
HAS/2006-08-31_claude_bourgeaux_resume_haute_normandie.pdf
HAS/2006-08-31_claude_gervais_diapo_languedoc_roussillon.pdf
HAS/2006-08-31_claude_gervais_resume_languedoc_roussillon.pdf
HAS/2006-08-31_cyrille_colin_diapo_rhone_alpes.pdf
HAS/2006-08-31_cyrille_colin_et_sandrine_touzet_resume_rhone_alpes.pdf
HAS/2006-08-31_didier_dewailly_diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_didier_dewailly_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_didier_theis__diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_didier_theis_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_dominique_houlbert_diapo_basse_normandie.pdf
HAS/2006-08-31_dominique_houlbert_resume_basse_normandie.pdf
HAS/2006-08-31_dominique_villate_diapo_limousin.pdf
HAS/2006-08-31_dominique_villate_resume_limousin.pdf
HAS/2006-08-31_eric_tison_diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_eric_tison_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_etienne_dusehu_diapo_picardie.pdf
HAS/2006-08-31_etienne_dusehu_resume_picardie.pdf
HAS/2006-08-31_florence_dubois_diapo_centre.pdf
HAS/2006-08-31_florence_dubois_resume_centre.pdf
HAS/2006-08-31_francis_schneider_diapo_alsace.pdf
HAS/2006-08-31_francis_schneider_resume_alsace.pdf
HAS/2006-08-31_francois_coulomb_diapo_centre.pdf
HAS/2006-08-31_francois_coulomb_resume_centre.pdf
HAS/2006-08-31_francoise_venditelli_resume_auvergne.pdf
HAS/2006-08-31_francoise_vendittelli_diapo_auvergne.pdf
HAS/2006-08-31_frederique_boiron_et_bruno_perez_diapo_paca_corse.pdf
HAS/2006-08-31_frederique_lahire_diapo_champagne_ardenne.pdf
HAS/2006-08-31_frederique_lahire_resume_champagne_ardenne.pdf
HAS/2006-08-31_genevieve_robles_diapo_languedoc_roussillon.pdf
HAS/2006-08-31_genevieve_robles_resume_languedoc_roussillon.pdf
HAS/2006-08-31_gerard_nitenberg_diapo_ile_de_france.pdf
HAS/2006-08-31_gerard_nitenberg_resume_ile_de_france.pdf
HAS/2006-08-31_gilles_capelier_resume_franche_comte.pdf
HAS/2006-08-31_gilles_capellier_diapo_franche_comte.pdf
HAS/2006-08-31_h_petit_diapo_aquitaine.pdf
HAS/2006-08-31_helene_mendizabal_resume_paca_corse..pdf
HAS/2006-08-31_herve_petit_resume_aquitaine.pdf
HAS/2006-08-31_hirsch__et_studer_resume_franche_comte.pdf
HAS/2006-08-31_isabelle_noyon_diapo_guadeloupe.pdf
HAS/2006-08-31_isabelle_noyon_resume_guadeloupe.pdf
HAS/2006-08-31_isabelle_poulain_resume_haute_normandie.pdf
HAS/2006-08-31_isabelle_poullain_diapo_haute_normandie.pdf
HAS/2006-08-31_isabelle_van__praagh_resume_auvergne.pdf
HAS/2006-08-31_isabelle_van_praagh_diapo_auvergne.pdf
HAS/2006-08-31_jacqueline_lavault__et_alain_larome__diapo_bourgogne.pdf
HAS/2006-08-31_jacqueline_lavault__et_alain_larome_resume_bourgogne.pdf
HAS/2006-08-31_jacques_ragni_resume_paca_corse.pdf
HAS/2006-08-31_jean_marc_bereder_diapo_paca_corse.pdf
HAS/2006-08-31_jean_marc_bereder_resume_paca-corse.pdf
HAS/2006-08-31_jean_marie_le_borgne_resume_picardie.pdf
HAS/2006-08-31_jm_leborgne_diapo_picardie.pdf
HAS/2006-08-31_joanna_martinez_diapo_poitou_charente.pdf
HAS/2006-08-31_joanna_martinez_resume_poitou_charente.pdf
HAS/2006-08-31_jose_guiserix__poster_ile_de_la_reunion.pdf
HAS/2006-08-31_jose_guiserix_resume_reunion.pdf
HAS/2006-08-31_jp_hirschet_et_jm_studer_diapo_franche_comte.pdf
HAS/2006-08-31_leila_moret_diapo_pays_de_la_loire.pdf
HAS/2006-08-31_leila_moret_resume_pays_de_la_loire.pdf
HAS/2006-08-31_liste_85_epp.pdf
HAS/2006-08-31_marie_christine_du_boulet_diapo_languedoc_roussillon.pdf
HAS/2006-08-31_marie_christine_hardy_bayle_diapo_ile_de_france.pdf
HAS/2006-08-31_marie_christine_hardy_bayle_resume_ile_de_france.pdf
HAS/2006-08-31_marie_claude_lefort_diapo_pays_de_la_loire_2006_10_16__11_27_21_803.pdf
HAS/2006-08-31_marie_claude_lefort_resume_pays_de_la_loire.pdf
HAS/2006-08-31_marie_paule_chariot_diapo_midi_pyrenees.pdf
HAS/2006-08-31_marie_paule_chariot_resume_midi-pyrenees.pdf
HAS/2006-08-31_maryse_cremer_et_brigitte_gardrat_diapo_haute_normandie.pdf
HAS/2006-08-31_maryvonne_manach_et_joseph__etienne_diapo_bretagne.pdf
HAS/2006-08-31_maryvonne_manach_et_joseph_etienne_resume_bretagne.pdf
HAS/2006-08-31_mc_du_boulet_resume_languedoc_roussillon.pdf
HAS/2006-08-31_michel_pinsard_diapo_poitou_charente.pdf
HAS/2006-08-31_michel_pinsard_resume_poitou_charente.pdf
HAS/2006-08-31_nathalie_thilly_diapo_lorraine.pdf
HAS/2006-08-31_nathalie_thilly_resume_lorraine.pdf
HAS/2006-08-31_nathalie_va_der_mee_marquet_diapo_centre.pdf
HAS/2006-08-31_nathalie_vand_der_mee_marquet_resume_centre.pdf
HAS/2006-08-31_pascale_poullin_diapo_paca_corse.pdf
HAS/2006-08-31_pascale_poullin_resume_paca_corse.pdf
HAS/2006-08-31_philippe_de_chazournes_et_bruno_bourgeon_diapo_reunion.pdf
HAS/2006-08-31_philippe_de_chazournes_resume_reunion.pdf
HAS/2006-08-31_philippe_jaumain_diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_philippe_jaumain_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_philippe_scherpereel_diapo_nord_pas_de_calais.pdf
HAS/2006-08-31_philippe_scherpereel_resume_nord_pas_de_calais.pdf
HAS/2006-08-31_pierre_mardegan_diapo_midi_pyrenees.pdf
HAS/2006-08-31_pierre_mardegan_resume_midi_pyrenees.pdf
HAS/2006-08-31_prise_en_charge_de_la_douleur_post-operatoire_rapport.pdf
HAS/2006-08-31_prise_en_charge_de_la_douleur_post-operatoire_referentiel_2005.pdf
HAS/2006-08-31_samuel_limat_diapo_franche_comte.pdf
HAS/2006-08-31_samuel_limat_resume_franche_comte.pdf
HAS/2006-08-31_serge_favrin_diapo_midi_pyrenees.pdf
HAS/2006-08-31_serge_favrin_resume_midi_pyrenees.pdf
HAS/2006-08-31_serge_gaubert_diapo_alsace.pdf
HAS/2006-08-31_serge_gaubert_resume_alsace.pdf
HAS/2006-08-31_serge_jeandeau_diapo_limousin.pdf
HAS/2006-08-31_serge_jeandeau_resume_limousin_v2.pdf
HAS/2006-08-31_shabnam_zanganeh_artola_diapo_alsace.pdf
HAS/2006-08-31_shaby_zanganeh_resume_alsace.pdf
HAS/2006-08-31_sylvie_touquet__garnaud_resume_centre.pdf
HAS/2006-08-31_sylvie_touquet_diapo_centre.pdf
HAS/2006-08-31_v_bussy_malgrange_diapo_champagne_ardenne.pdf
HAS/2006-08-31_valerie_jeanne_bardou_diapo_paca_corse.pdf
HAS/2006-08-31_valerie_jeanne_bardou_resume_paca_corse.pdf
HAS/2006-08-31_veronique_bussy_malgrange_resume_champagne_ardenne.pdf
HAS/2006-09-06_ct-1875_coltramyl.pdf
HAS/2006-09-06_ct-1950_thiocolchicoside_winthrop.pdf
HAS/2006-09-06_ct-2007_allergodil_2006_10_12__17_01_18_332.pdf
HAS/2006-09-06_ct-2016_edex.pdf
HAS/2006-09-06_ct-2061_botox.pdf
HAS/2006-09-06_ct-2321_temerit.pdf
HAS/2006-09-06_ct-2469_takadol.pdf
HAS/2006-09-06_ct-2495_miorel.pdf
HAS/2006-09-06_ct-2496_thiocolchicoside_fornet.pdf
HAS/2006-09-06_ct-2601_zaditen.pdf
HAS/2006-09-06_ct-2827_nebilox_2006_10_13__12_31_0_712.pdf
HAS/2006-09-06_ct-2859_lasilix.pdf
HAS/2006-09-06_ct-2905_nexavar.pdf
HAS/2006-09-06_ct-2931_rafton.pdf
HAS/2006-09-06_ct-2946_calcos_vitamine_d3.pdf
HAS/2006-09-06_ct-2948_calcium_vitamine_d3_teva.pdf
HAS/2006-09-06_ct-3095_dolko.pdf
HAS/2006-09-06_ct-3104_almide_.pdf
HAS/2006-09-06_ct-3145_lacrifluid.pdf
HAS/2006-09-06_ct-3186_mizollen.pdf
HAS/2006-09-06_ct-3198_paralyoc.pdf
HAS/2006-09-06_ct-3241_novatrex.pdf
HAS/2006-09-06_ct-3288_oxis_turbuhaler.pdf
HAS/2006-09-06_ct-3295_nasalide.pdf
HAS/2006-09-06_ct-3298_metocalcium.pdf
HAS/2006-09-06_ct-3320_myoplege.pdf
HAS/2006-09-06_ct-3321_thiocolchicoside_arrow.pdf
HAS/2006-09-06_ct-3322_thiocolchicoside_biogaran.pdf
HAS/2006-09-06_ct-3323_thiocolchicoside_eg.pdf
HAS/2006-09-06_ct-3325_thiocolchicoside_g_gam.pdf
HAS/2006-09-06_ct-3340_thiocolchicoside_gnr.pdf
HAS/2006-09-06_ct-3342_thiocolchicoside_ivax.pdf
HAS/2006-09-06_ct-3343_thiocolchicoside_merck_qualimed.pdf
HAS/2006-09-06_ct-3345_thiocolchicoside_ratiopharm.pdf
HAS/2006-09-06_ct-3346_thiocolchicoside_sandoz.pdf
HAS/2006-09-06_ct-3347_thiocolchicoside_teva.pdf
HAS/2006-09-06_ct-3353_previscan_.pdf
HAS/2006-09-06_ct-3355_nasacort.pdf
HAS/2006-09-06_ct-3448_endotelon.pdf
HAS/2006-09-06_ct_2391_rafton_ang.pdf
HAS/2006-09-06_ct_2905_nexavar_ang.pdf
HAS/2006-09-06_ct_2914_botox_ang.pdf
HAS/2006-09-06_ct__2918_dysport_ang.pdf
HAS/2006-09-06_dysport_500u_-_eit_-_avis_2_ct-2918.pdf
HAS/2006-09-06_pp020507.pdf
HAS/2006-09-06_pp020508.pdf
HAS/2006-09-19_ct-3107_technescan_pyp.pdf
HAS/2006-09-19_ct_3107_technescan_ang.pdf
HAS/2006-09-20_ct-1724_xenid.pdf
HAS/2006-09-20_ct-1983_engerix_b_.pdf
HAS/2006-09-20_ct-1987_infanrix_quinta_.pdf
HAS/2006-09-20_ct-2460_r.o.rvax_.pdf
HAS/2006-09-20_ct-2591_imovaxpolio_.pdf
HAS/2006-09-20_ct-2725_nureflex.pdf
HAS/2006-09-20_ct-2788_sporanox_.pdf
HAS/2006-09-20_ct-2864_cordarone_.pdf
HAS/2006-09-20_ct-2880_infanrixtetra_2006_11_16__12_04_17_311.pdf
HAS/2006-09-20_ct-3008_myozyme.pdf
HAS/2006-09-20_ct-3420_sibelium_.pdf
HAS/2006-09-20_ct_3008_myozyme_ang_2008-07-23_09-34-24_6.pdf
HAS/2006-09-27_cepp-1095.pdf
HAS/2006-09-27_cepp-469.pdf
HAS/2006-09-27_cepp-804.pdf
HAS/2006-09-27_cepp-861.pdf
HAS/2006-10-04_bat_celltop.pdf
HAS/2006-10-04_bricanil_terbulatine_srh.pdf
HAS/2006-10-04_ct-1312_celltop_.pdf
HAS/2006-10-04_ct-1515_genac_.pdf
HAS/2006-10-04_ct-1541_monosept.pdf
HAS/2006-10-04_ct-1563_indocollyre_.pdf
HAS/2006-10-04_ct-1643_euronac.pdf
HAS/2006-10-04_ct-1812_dicloced.pdf
HAS/2006-10-04_ct-1838_indobiotic_.pdf
HAS/2006-10-04_ct-2119_trileptal_.pdf
HAS/2006-10-04_ct-2152_octim_.pdf
HAS/2006-10-04_ct-2457_bricanyl_.pdf
HAS/2006-10-04_ct-2522_sabril_.pdf
HAS/2006-10-04_ct-2541_clastoban_.pdf
HAS/2006-10-04_ct-2828_fonzylane_.pdf
HAS/2006-10-04_ct-2890_toprec_.pdf
HAS/2006-10-04_ct-2891_zamudol.pdf
HAS/2006-10-04_ct-2922_dilatrane_.pdf
HAS/2006-10-04_ct-2925_temerit_.pdf
HAS/2006-10-04_ct-2928_topalgic_.pdf
HAS/2006-10-04_ct-2934_tamoxifene.pdf
HAS/2006-10-04_ct-2952_nebilox_.pdf
HAS/2006-10-04_ct-2961_copegus_.pdf
HAS/2006-10-04_ct-2964_tedralan_.pdf
HAS/2006-10-04_ct-2979_lomudal_.pdf
HAS/2006-10-04_ct-2982_octanate_.pdf
HAS/2006-10-04_ct-2983_dimegan_.pdf
HAS/2006-10-04_ct-2987_contramal_.pdf
HAS/2006-10-04_ct-3034_clarityne_.pdf
HAS/2006-10-04_ct-3040_kayexalate_.pdf
HAS/2006-10-04_ct-3041_respilene.pdf
HAS/2006-10-04_ct-3052_tuxium.pdf
HAS/2006-10-04_ct-3060_gynergene_cafeine_.pdf
HAS/2006-10-04_ct-3083_betaferon.pdf
HAS/2006-10-04_ct-3109_silomat_.pdf
HAS/2006-10-04_ct-3138_euphylline.pdf
HAS/2006-10-04_ct-3163_hexapneumine_.pdf
HAS/2006-10-04_ct-3179_paxeladine.pdf
HAS/2006-10-04_ct-3180_paderyl.pdf
HAS/2006-10-04_ct-3215_lipidem_.pdf
HAS/2006-10-04_ct-3223_polery.pdf
HAS/2006-10-04_ct-3224_theostat.pdf
HAS/2006-10-04_ct-3243_vitabact.pdf
HAS/2006-10-04_ct-3250_tinset.pdf
HAS/2006-10-04_ct-3251_phenergan_.pdf
HAS/2006-10-04_ct-3257_ventoline__salbumol.pdf
HAS/2006-10-04_ct-3263_trentadil.pdf
HAS/2006-10-04_ct-3296_vegetoserum.pdf
HAS/2006-10-04_ct-3324_neo-codion.pdf
HAS/2006-10-04_ct-3404_luveris_.pdf
HAS/2006-10-04_ct-3466_coteveten.pdf
HAS/2006-10-04_ct-3684_scopolamine_.pdf
HAS/2006-10-04_ct-3755_benzododecinium_.pdf
HAS/2006-10-04_ct_2925_temerit_ang.pdf
HAS/2006-10-04_ct_2952_nebilox_ang.pdf
HAS/2006-10-04_ventoline_srh_2008-08-07_14-50-33_189.pdf
HAS/2006-10-06_cepp-855.pdf
HAS/2006-10-11_cepp-1146.pdf
HAS/2006-10-11_cepp-825.pdf
HAS/2006-10-11_cepp-833.pdf
HAS/2006-10-11_cepp-841.pdf
HAS/2006-10-11_cepp-867.pdf
HAS/2006-10-11_cepp-874.pdf
HAS/2006-10-11_cepp-930.pdf
HAS/2006-10-11_cepp-951.pdf
HAS/2006-10-15_ct-1996_cetrotide.pdf
HAS/2006-10-17_chemin_clinique_cc_synthese.pdf
HAS/2006-10-17_chemin_clinique_guide_2004.pdf
HAS/2006-10-17_ct-3108_tygacyl_.pdf
HAS/2006-10-17_ct-3245_ionsys_.pdf
HAS/2006-10-17_ct_3108_tygacil_ang.pdf
HAS/2006-10-17_ct_3245_ionsys_ang.pdf
HAS/2006-10-17_lesions_mammaires.pdf
HAS/2006-10-17_methodes_et_outils_des_demarches_qualite_pour_les_etablissements_de_sante.pdf
HAS/2006-10-18_ct-1962_rulid_.pdf
HAS/2006-10-18_ct-1993_cotareg_.pdf
HAS/2006-10-18_ct-2051_ikorel_.pdf
HAS/2006-10-18_ct-2052_unicordium.pdf
HAS/2006-10-18_ct-2053_methergin.pdf
HAS/2006-10-18_ct-2058_uridoz_.pdf
HAS/2006-10-18_ct-2059_monuril_.pdf
HAS/2006-10-18_ct-2101_adancor_.pdf
HAS/2006-10-18_ct-2124_bristamox_-_hiconcil_.pdf
HAS/2006-10-18_ct-2179_chloraminophene_.pdf
HAS/2006-10-18_ct-2261_clamoxyl_.pdf
HAS/2006-10-18_ct-2302_peflacine_.pdf
HAS/2006-10-18_ct-2315_rifater_.pdf
HAS/2006-10-18_ct-2316_rifinah_.pdf
HAS/2006-10-18_ct-2356_gentamicine_leurquin_.pdf
HAS/2006-10-18_ct-2387_zomig-zomigoro.pdf
HAS/2006-10-18_ct-2439_logiflox__decalogiflox_.pdf
HAS/2006-10-18_ct-2480_aromasine_.pdf
HAS/2006-10-18_ct-2552_frakidex_.pdf
HAS/2006-10-18_ct-2555_dextrocidine_.pdf
HAS/2006-10-18_ct-2774_symbicort_turbuhaler_.pdf
HAS/2006-10-18_ct-2812_fraxodi_-_fraxiparine_.pdf
HAS/2006-10-18_ct-2872_foradil.pdf
HAS/2006-10-18_ct-2894_nisisco.pdf
HAS/2006-10-18_ct-2927_cubicin_.pdf
HAS/2006-10-18_ct-2958_mosil.pdf
HAS/2006-10-18_ct-3013_artane_.pdf
HAS/2006-10-18_ct-3030_modopar_.pdf
HAS/2006-10-18_ct-3111_dexamethasone_chauvin.pdf
HAS/2006-10-18_ct-3135_erbitux_.pdf
HAS/2006-10-18_ct-3137_gentamicine_chauvin_.pdf
HAS/2006-10-18_ct-3139_rivotril.pdf
HAS/2006-10-18_ct-3156_claramid_.pdf
HAS/2006-10-18_ct-3162_aspirine_ph8.pdf
HAS/2006-10-18_ct-3182_naramig_.pdf
HAS/2006-10-18_ct-3183_cebedexacol_.pdf
HAS/2006-10-18_ct-3184_cebenicol_.pdf
HAS/2006-10-18_ct-3190_maxidrol_.pdf
HAS/2006-10-18_ct-3192_tobrex_.pdf
HAS/2006-10-18_ct-3193_maxidex.pdf
HAS/2006-10-18_ct-3196_mysoline.pdf
HAS/2006-10-18_ct-3216_alyostal_abeille_.pdf
HAS/2006-10-18_ct-3217_albey_abeille_.pdf
HAS/2006-10-18_ct-3221_alyostal_guepe_vespula_.pdf
HAS/2006-10-18_ct-3222_albey_guepe_.pdf
HAS/2006-10-18_ct-3234_levotonine_.pdf
HAS/2006-10-18_ct-3235_dynabac_.pdf
HAS/2006-10-18_ct-3240_sterdex_.pdf
HAS/2006-10-18_ct-3242_kaneuron_.pdf
HAS/2006-10-18_ct-3267_aparoxal_.pdf
HAS/2006-10-18_ct-3289_tegretol_.pdf
HAS/2006-10-18_ct-3290_gardenal_.pdf
HAS/2006-10-18_ct-3291_aredia_.pdf
HAS/2006-10-18_ct-3293_microphta_.pdf
HAS/2006-10-18_ct-3358_bacicoline_.pdf
HAS/2006-10-18_ct-3380_temgesic_.pdf
HAS/2006-10-18_ct-3382_novomix_.pdf
HAS/2006-10-18_ct-3409_parkinane__2006_11_17__13_05_49_374.pdf
HAS/2006-10-18_ct-3464_teveten.pdf
HAS/2006-10-18_ct-3468_daflon_.pdf
HAS/2006-10-18_ct-3493_quinesidine_.pdf
HAS/2006-10-18_ct-3494_beclojet.pdf
HAS/2006-10-18_ct-3547_dexafree_.pdf
HAS/2006-10-18_ct-3587_tolexine.pdf
HAS/2006-10-18_ct-3588_calcium_sandoz_.pdf
HAS/2006-10-18_ct-3589_cacit_vitamine_d3_.pdf
HAS/2006-10-18_ct-3637_korec_.pdf
HAS/2006-10-18_ct-3638_kardegic_.pdf
HAS/2006-10-18_ct-3681_skelid_.pdf
HAS/2006-10-18_ct-3686_rifamycine_chibret_.pdf
HAS/2006-10-18_ct-3688_chibroxine.pdf
HAS/2006-10-18_ct-3689_chibro-cadron.pdf
HAS/2006-10-18_ct-3726_akineton.pdf
HAS/2006-10-18_ct-3727_calcidose_vit_d_.pdf
HAS/2006-10-18_ct-3728_eucalcic_.pdf
HAS/2006-10-18_ct-3733_fludex_.pdf
HAS/2006-10-18_ct-3736_flucon_.pdf
HAS/2006-10-18_ct-3827_gonal_f_.pdf
HAS/2006-10-18_ct-3828_oflocet_-_monoflocet.pdf
HAS/2006-10-18_ct031627.pdf
HAS/2006-10-18_ct031628.pdf
HAS/2006-10-18_ct031629.pdf
HAS/2006-10-18_ct_2927_cubicine_ang_2009-01-15_11-30-23_417.pdf
HAS/2006-10-18_ct_3135_erbitux_ang.pdf
HAS/2006-10-18_nutriflex_lipide.pdf
HAS/2006-10-18_rapport_irs-is.pdf
HAS/2006-10-18_synthese_irs-is.pdf
HAS/2006-10-19_cci.pdf
HAS/2006-10-19_methodes.pdf
HAS/2006-10-19_paq.pdf
HAS/2006-10-25_cepp-1029.pdf
HAS/2006-10-25_cepp-810.pdf
HAS/2006-10-25_cepp-811.pdf
HAS/2006-10-25_cepp-849.pdf
HAS/2006-10-25_cepp-851.pdf
HAS/2006-10-25_cepp-858.pdf
HAS/2006-10-25_cepp-859.pdf
HAS/2006-10-25_cepp-873.pdf
HAS/2006-10-25_cepp-925.pdf
HAS/2006-10-26_cepp-acides-hyaluroniqes-251006_2010-03-10_16-56-37_835.pdf
HAS/2006-11-08_cepp-922.pdf
HAS/2006-11-08_ct-2019_norvir.pdf
HAS/2006-11-08_ct-2202_viramune.pdf
HAS/2006-11-08_ct-2560_flecaine.pdf
HAS/2006-11-08_ct-2776_tanakan_ginkogink_tramisal.pdf
HAS/2006-11-08_ct-2861_lomusol_.pdf
HAS/2006-11-08_ct-2899_proxalyoc_.pdf
HAS/2006-11-08_ct-2909_vfend_.pdf
HAS/2006-11-08_ct-2957_dacryoserum_.pdf
HAS/2006-11-08_ct-2959_fluvermal.pdf
HAS/2006-11-08_ct-2976_deturgylone_.pdf
HAS/2006-11-08_ct-2985_alepsal.pdf
HAS/2006-11-08_ct-3014_mytelase.pdf
HAS/2006-11-08_ct-3028_antibio-synalar_.pdf
HAS/2006-11-08_ct-3029_framyxone__2006_11_30__15_45_42_524.pdf
HAS/2006-11-08_ct-3035_nivaquine.pdf
HAS/2006-11-08_ct-3036_aspegic_.pdf
HAS/2006-11-08_ct-3037_tredemine.pdf
HAS/2006-11-08_ct-3042_glucantime_.pdf
HAS/2006-11-08_ct-3053_derinox_.pdf
HAS/2006-11-08_ct-3088_vitamine_a_dulcis_.pdf
HAS/2006-11-08_ct-3091_combantrin.pdf
HAS/2006-11-08_ct-3097_malocide.pdf
HAS/2006-11-08_ct-3098_pentacarinat.pdf
HAS/2006-11-08_ct-3154_aturgyl_.pdf
HAS/2006-11-08_ct-3157_polydexa.pdf
HAS/2006-11-08_ct-3181_rhinadvil_.pdf
HAS/2006-11-08_ct-3195_panotile_.pdf
HAS/2006-11-08_ct-3218_diluant_physiologique_phenole.pdf
HAS/2006-11-08_ct-3230_solute_physiologique_phenole_.pdf
HAS/2006-11-08_ct-3231_helmintox_.pdf
HAS/2006-11-08_ct-3244_larmes_artificielles_martinet.pdf
HAS/2006-11-08_ct-3258_zentel.pdf
HAS/2006-11-08_ct-3259_sudafed.pdf
HAS/2006-11-08_ct-3294_vitamine_a_faure.pdf
HAS/2006-11-08_ct-3297_pilo_.pdf
HAS/2006-11-08_ct-3446_mabthera.pdf
HAS/2006-11-08_ct-3447_nyogel_.pdf
HAS/2006-11-08_ct-3460_migard_.pdf
HAS/2006-11-08_ct-3461_tigreat_.pdf
HAS/2006-11-08_ct-3492_pivalone.pdf
HAS/2006-11-08_ct-3687_rhinaaxia_.pdf
HAS/2006-11-08_ct-3691_somatuline.pdf
HAS/2006-11-08_ct-3751_pulmicort.pdf
HAS/2006-11-08_ct-3811_asmasal_clickhaler_.pdf
HAS/2006-11-08_ct-3836_quinine_lafran.pdf
HAS/2006-11-08_ct-3876_quinimax_.pdf
HAS/2006-11-08_ct-3932_synagis_.pdf
HAS/2006-11-08_ct_2909_vfend_ang.pdf
HAS/2006-11-08_ct_3446_mabthera_ang.pdf
HAS/2006-11-08_ct_3460_migard_ang_2009-01-15_16-07-49_680.pdf
HAS/2006-11-08_ct_3461_tigreat_ang_2009-01-15_16-09-18_888.pdf
HAS/2006-11-15_ct-2338_xylocaine_gamme_.pdf
HAS/2006-11-15_ct-3032_mantadix_.pdf
HAS/2006-11-15_ct-3050_passiflora_.pdf
HAS/2006-11-15_ct-3100_esperal_.pdf
HAS/2006-11-15_ct-3102_idarac.pdf
HAS/2006-11-15_ct-3112_claragine_.pdf
HAS/2006-11-15_ct-3136_propine_.pdf
HAS/2006-11-15_ct-3149_xylocaine_adrenaline_.pdf
HAS/2006-11-15_ct-3191_betoptic_.pdf
HAS/2006-11-15_ct-3237_otipax.pdf
HAS/2006-11-15_ct-3253_isopto-pilocarpine_.pdf
HAS/2006-11-15_ct-3254_bentos_.pdf
HAS/2006-11-15_ct-3255_aotal_.pdf
HAS/2006-11-15_ct-3731_travatan_.pdf
HAS/2006-11-15_ct-3746_lodales_.pdf
HAS/2006-11-15_ct-3749_comtan_.pdf
HAS/2006-11-21_ct-3011_amoxicilline_teva_.pdf
HAS/2006-11-21_ct-3220_alyostal_guepe_polistes_.pdf
HAS/2006-11-22_cepp-1094.pdf
HAS/2006-11-22_cepp-924.pdf
HAS/2006-11-23_gmed._melanome_231106.pdf
HAS/2006-11-23_melanome_synthese.pdf
HAS/2006-11-23_rapport_strategie_de_diagnostic_precoce_du_melanome.pdf
HAS/2006-11-29_ct-2077_visudyne_.pdf
HAS/2006-11-29_ct-2308_asasantine_.pdf
HAS/2006-11-29_ct-2344_emla_.pdf
HAS/2006-11-29_ct-2819_plurexid.pdf
HAS/2006-11-29_ct-2856_vitalogink_.pdf
HAS/2006-11-29_ct-3089_virophta_.pdf
HAS/2006-11-29_ct-3093_emend.pdf
HAS/2006-11-29_ct-3148_macugen_.pdf
HAS/2006-11-29_ct-3310_lomexin-terlomexin.pdf
HAS/2006-11-29_ct-3518_bonviva_.pdf
HAS/2006-11-29_ct-3524_zymafluor.pdf
HAS/2006-11-29_ct-3735_gadovist.pdf
HAS/2006-11-29_ct-3806_lederfoline_.pdf
HAS/2006-11-29_ct-3833_claventin_.pdf
HAS/2006-11-29_ct-3834_ticarpen.pdf
HAS/2006-11-29_ct-3835_diosmine_.pdf
HAS/2006-11-29_ct-3841_birodogyl.pdf
HAS/2006-11-29_ct-3870_vitalogink_.pdf
HAS/2006-11-29_ct-3873_biocalyptol.pdf
HAS/2006-11-29_ct-3923_izilox_.pdf
HAS/2006-11-29_ct-3930_aerius_.pdf
HAS/2006-11-29_ct_2077_visudyne_ang.pdf
HAS/2006-11-29_ct_3093_emend_ang.pdf
HAS/2006-11-29_ct_3148_macugen_ang.pdf
HAS/2006-11-29_ct_3318_nebido_ang.pdf
HAS/2006-11-29_ct_3518_bonviva_ang.pdf
HAS/2006-11-29_nebido.pdf
HAS/2006-11-30_argumentaire_final_pdf.pdf
HAS/2006-11-30_fiche_de_synthese_finale.pdf
HAS/2006-11-30_managing_venous_leg_ulcers_-_guidelines.pdf
HAS/2006-11-30_managing_venous_leg_ulcers_-_quick_reference_guide.pdf
HAS/2006-11-30_recommandations_finales_pdf.pdf
HAS/2006-12-01_argumentaire_tome1.pdf
HAS/2006-12-01_argumentaire_tome_2.pdf
HAS/2006-12-01_ezetrol0604.pdf
HAS/2006-12-01_fiche_de_synthese_2006_11_27__10_56_45_403.pdf
HAS/2006-12-01_recommandations_2006_11_27__10_56_57_546.pdf
HAS/2006-12-06_actualisation_methode_guide_et_liste__avril_2007_.pdf
HAS/2006-12-06_cepp-846.pdf
HAS/2006-12-06_cepp-846_monarc__implant_pour_colposuspension.pdf
HAS/2006-12-06_cepp-852.pdf
HAS/2006-12-06_cepp-854.pdf
HAS/2006-12-06_cepp-856.pdf
HAS/2006-12-06_cepp-857.pdf
HAS/2006-12-06_cepp-864.pdf
HAS/2006-12-06_cepp-865.pdf
HAS/2006-12-06_cepp-866.pdf
HAS/2006-12-06_cepp-872.pdf
HAS/2006-12-06_cepp-876.pdf
HAS/2006-12-06_cepp-902.pdf
HAS/2006-12-06_methode_guide_ald_traduit.pdf
HAS/2006-12-13_ct-1043_tachosil_.pdf
HAS/2006-12-13_ct-1928_tropicamide_faure_.pdf
HAS/2006-12-13_ct-2489_optiray-optiject.pdf
HAS/2006-12-13_ct-2600_sandostatine_.pdf
HAS/2006-12-13_ct-2986_ludiomil.pdf
HAS/2006-12-13_ct-3009_omnipaque_.pdf
HAS/2006-12-13_ct-3012_surmontil.pdf
HAS/2006-12-13_ct-3023_quitaxon.pdf
HAS/2006-12-13_ct-3047_nalgesic_.pdf
HAS/2006-12-13_ct-3049_castor_equi.pdf
HAS/2006-12-13_ct-3057_pertofran.pdf
HAS/2006-12-13_ct-3086_lindilane.pdf
HAS/2006-12-13_ct-3094_prothiaden_.pdf
HAS/2006-12-13_ct-3113_claradol_codeine.pdf
HAS/2006-12-13_ct-3133_renutryl_.pdf
HAS/2006-12-13_ct-3142_neosynephrine.pdf
HAS/2006-12-13_ct-3153_gastrografine_.pdf
HAS/2006-12-13_ct-3158_otofa_.pdf
HAS/2006-12-13_ct-3160_athymil.pdf
HAS/2006-12-13_ct-3165_floxyfral.pdf
HAS/2006-12-13_ct-3187_lacrypos.pdf
HAS/2006-12-13_ct-3189_atropine_alcon_.pdf
HAS/2006-12-13_ct-3202_diamox_.pdf
HAS/2006-12-13_ct-3203_codoliprane_.pdf
HAS/2006-12-13_ct-3233_algisedal.pdf
HAS/2006-12-13_ct-3252_radioselectan_.pdf
HAS/2006-12-13_ct-3262_hexabrix_.pdf
HAS/2006-12-13_ct-3311_telebrix_gastro_.pdf
HAS/2006-12-13_ct-3312_telebrix_12_sodium_.pdf
HAS/2006-12-13_ct-3313_telebrix_35_.pdf
HAS/2006-12-13_ct-3314_telebrix_hystero_.pdf
HAS/2006-12-13_ct-3315_telebrix_30_meglumine_.pdf
HAS/2006-12-13_ct-3350_fluocyne_.pdf
HAS/2006-12-13_ct-3456_prevenar_.pdf
HAS/2006-12-13_ct-3683_preotact_.pdf
HAS/2006-12-13_ct-3685_mydriaticum.pdf
HAS/2006-12-13_ct-3810_helikit_.pdf
HAS/2006-12-13_ct-3869_paracetamol_codeine_arrow.pdf
HAS/2006-12-13_ct-3915_asmelor_novolizer_.pdf
HAS/2006-12-13_ct-3921_micropaque_.pdf
HAS/2006-12-13_ct-3922_discotrine_.pdf
HAS/2006-12-13_ct-3938_cibadrex.pdf
HAS/2006-12-13_ct-3939_competact_.pdf
HAS/2006-12-13_ct-3941_alphagan_.pdf
HAS/2006-12-13_ct-3943_calprimum_.pdf
HAS/2006-12-13_ct-3945_proctolog_.pdf
HAS/2006-12-13_ct-3947_betagan.pdf
HAS/2006-12-13_ct-3952_olmifon_.pdf
HAS/2006-12-13_ct-3953_carpilo.pdf
HAS/2006-12-13_ct-807_lodine_.pdf
HAS/2006-12-13_ct_3683_preotact_ang.pdf
HAS/2006-12-13_ct_3723_mabthera_ang.pdf
HAS/2006-12-13_ct_3810_helikit_ang.pdf
HAS/2006-12-13_dafalgan_codeine_-_efferalgan_codeine.pdf
HAS/2006-12-13_mabthera.pdf
HAS/2006-12-13_rapport_-_dosage_serique_cll.pdf
HAS/2006-12-13_rapport_detection_de_linterferon-gamma.pdf
HAS/2006-12-13_synthese_-_dosage_serique_cll.pdf
HAS/2006-12-13_synthese_detection_de_linterferon-gamma.pdf
HAS/2006-12-13_xyzall.pdf
HAS/2006-12-15_avis_has_mammo_num.pdf
HAS/2006-12-15_rapport-place_de_la_mammographie_numerique_dans_le_depistage_organise_du_cancer_du_sein.pdf
HAS/2006-12-15_synthese_mammo_numerique.pdf
HAS/2006-12-20_cepp-1014.pdf
HAS/2006-12-20_cepp-1091.pdf
HAS/2006-12-20_cepp-1092.pdf
HAS/2006-12-20_cepp-1096.pdf
HAS/2006-12-20_cepp-1097.pdf
HAS/2006-12-20_cepp-1099_2007_03_22__10_41_55_951.pdf
HAS/2006-12-20_cepp-875.pdf
HAS/2006-12-20_cepp-932.pdf
HAS/2006-12-20_cepp-932_2007_03_26__10_39_2_358.pdf
HAS/2006-12-20_cepp-933.pdf
HAS/2006-12-20_cepp-935.pdf
HAS/2006-12-20_cepp-936.pdf
HAS/2006-12-20_cepp-937.pdf
HAS/2006-12-20_cepp-960.pdf
HAS/2006-12-20_cepp-989.pdf
HAS/2007-01-03_ct-1954_rhinofluimucil_.pdf
HAS/2007-01-03_ct-2525_tanganil_.pdf
HAS/2007-01-03_ct-3021_serc-betaserc_.pdf
HAS/2007-01-03_ct-3039_nocertone_.pdf
HAS/2007-01-03_ct-3056_extovyl_.pdf
HAS/2007-01-03_ct-3058_desernil_sandoz_.pdf
HAS/2007-01-03_ct-3061_sanmigran_.pdf
HAS/2007-01-03_ct-3265_agyrax_.pdf
HAS/2007-01-03_ct-3379_acomplia_.pdf
HAS/2007-01-03_ct-3383_omnitrope_.pdf
HAS/2007-01-03_ct-3451_exubera_.pdf
HAS/2007-01-03_ct-3517_dicodin.pdf
HAS/2007-01-03_ct-3691_somatuline_.pdf
HAS/2007-01-03_ct-3807_oxynorm-oxycontin_.pdf
HAS/2007-01-03_ct-3846_paracetamol_biogaran_.pdf
HAS/2007-01-03_ct-3993_calcium_teva.pdf
HAS/2007-01-03_ct-4018_fortzaar_.pdf
HAS/2007-01-03_ct-4028_verapamil_merck_.pdf
HAS/2007-01-03_ct_3383_omnitrope_ang.pdf
HAS/2007-01-10_cepp-1100_parietex_composite_implant_de_refection_de_paroi_incluant_des_derives.pdf
HAS/2007-01-10_cepp-1224.pdf
HAS/2007-01-10_cepp-1225_2007_03_26__14_19_31_638.pdf
HAS/2007-01-10_cepp-1225_sil_promesh_implant_de_refection_de_paroi.pdf
HAS/2007-01-10_cepp-1256_intramesh_implant_de_refection_de_paroi.pdf
HAS/2007-01-10_cepp-843.pdf
HAS/2007-01-10_cepp-848_2007_03_26__11_59_26_993.pdf
HAS/2007-01-10_cepp-869.pdf
HAS/2007-01-10_cepp-965.pdf
HAS/2007-01-10_cepp-986.pdf
HAS/2007-01-10_cepp-986_safehip_protecteur_de_hanche_.pdf
HAS/2007-01-10_cepp_-_470_et_490_systemes_de_nebulisation_pour_aerosoltherapie.pdf
HAS/2007-01-10_cepp_-_848_4_d_dome_implant_de_refection_de_paroi.pdf
HAS/2007-01-17_ct-1958_texodil_.pdf
HAS/2007-01-17_ct-2024_zinnat__cepazine_.pdf
HAS/2007-01-17_ct-2049_alfatil.pdf
HAS/2007-01-17_ct-2080_orelox_.pdf
HAS/2007-01-17_ct-2254_ciblor_.pdf
HAS/2007-01-17_ct-2260_augmentin_.pdf
HAS/2007-01-17_ct-2540_decapeptyl.pdf
HAS/2007-01-17_ct-2962_nozinan_.pdf
HAS/2007-01-17_ct-2967_moditen-modecate.pdf
HAS/2007-01-17_ct-2968_tercian.pdf
HAS/2007-01-17_ct-2969_piportil.pdf
HAS/2007-01-17_ct-2970_largactil.pdf
HAS/2007-01-17_ct-2971_tiapridral_.pdf
HAS/2007-01-17_ct-2972_havlane_.pdf
HAS/2007-01-17_ct-2973_dogmatil_.pdf
HAS/2007-01-17_ct-2977_neuleptil.pdf
HAS/2007-01-17_ct-2978_victan_.pdf
HAS/2007-01-17_ct-3033_trilifan-retard_.pdf
HAS/2007-01-17_ct-3038_depamide.pdf
HAS/2007-01-17_ct-3103_lexomil_.pdf
HAS/2007-01-17_ct-3106_rohypnol_.pdf
HAS/2007-01-17_ct-3141_nuctalon_.pdf
HAS/2007-01-17_ct-3194_veratran_.pdf
HAS/2007-01-17_ct-3200_seresta_.pdf
HAS/2007-01-17_ct-3201_temesta_.pdf
HAS/2007-01-17_ct-3213_lysanxia_.pdf
HAS/2007-01-17_ct-3238_stresam_.pdf
HAS/2007-01-17_ct-3246_dipiperon_.pdf
HAS/2007-01-17_ct-3247_orap.pdf
HAS/2007-01-17_ct-3248_haldol.pdf
HAS/2007-01-17_ct-3249_semap_.pdf
HAS/2007-01-17_ct-3264_atarax_.pdf
HAS/2007-01-17_ct-3300_neurolithium.pdf
HAS/2007-01-17_ct-3495_stilnox.pdf
HAS/2007-01-17_ct-3544_helikit_.pdf
HAS/2007-01-17_ct-3635_euphon_.pdf
HAS/2007-01-17_ct-3657_tysabri.pdf
HAS/2007-01-17_ct-3658_synedil.pdf
HAS/2007-01-17_ct-3677_daktarin_.pdf
HAS/2007-01-17_ct-3724_xanax_.pdf
HAS/2007-01-17_ct-3823_fluanxol_.pdf
HAS/2007-01-17_ct-3968_dostinex_.pdf
HAS/2007-01-17_ct-3971_micardis_.pdf
HAS/2007-01-17_ct-4010_lithioderm.pdf
HAS/2007-01-17_ct-4035_glucose_cooper_.pdf
HAS/2007-01-17_ct-4036_chlorure_de_sodium_cooper_.pdf
HAS/2007-01-17_ct-4057_doxy_.pdf
HAS/2007-01-17_ct_3657_tysabri_ang.pdf
HAS/2007-01-23_strategies_therapeutiques_aide_sevrage_tabagique_rapport_2007_01_22__16_28_14_826.pdf
HAS/2007-01-23_strategies_therapeutiques_daide_au_sevrage_tabagique__avis_de_la_has.pdf
HAS/2007-01-24_autoanalyse_glycemie_2007_2007_11_13__10_25_9_463.pdf
HAS/2007-01-24_cepp-1279.pdf
HAS/2007-01-24_cepp-638.pdf
HAS/2007-01-24_cepp-830_seprafilm_barriere_anti-adherences.pdf
HAS/2007-01-24_cepp-923.pdf
HAS/2007-01-24_cepp-923_pantorzote_chaussure_thermoformable.pdf
HAS/2007-01-24_cepp-993.pdf
HAS/2007-01-24_dm__autosurveillance__autotraitement.pdf
HAS/2007-01-26_autoanalyse_glycemie_2007.pdf
HAS/2007-01-26_rapport_autotraitement_autocontrole_2009-03-24_14-22-43_653.pdf
HAS/2007-01-30_ct-3695_buccobet.pdf
HAS/2007-01-30_ct_3695_buccobet_ang.pdf
HAS/2007-01-31_3e_bat_rifadine.pdf
HAS/2007-01-31_atrovent_srh.pdf
HAS/2007-01-31_ct-2229_tobradex.pdf
HAS/2007-01-31_ct-2241_cebemyxine.pdf
HAS/2007-01-31_ct-2820_cyteal_.pdf
HAS/2007-01-31_ct-2984_xalatan_.pdf
HAS/2007-01-31_ct-3377_chlorhydrate_de_methadone.pdf
HAS/2007-01-31_ct-3636_ponstyl_.pdf
HAS/2007-01-31_ct-3898_mesocaine_.pdf
HAS/2007-01-31_ct-3916_allergocomod_.pdf
HAS/2007-01-31_ct-3936_aloxi.pdf
HAS/2007-01-31_ct-3937_exocine.pdf
HAS/2007-01-31_ct-3940_ocufen_.pdf
HAS/2007-01-31_ct-3946_lumigan_.pdf
HAS/2007-01-31_ct-3949_dulcilarmes_.pdf
HAS/2007-01-31_ct-3957_dexagrane_.pdf
HAS/2007-01-31_ct-3994_acular_.pdf
HAS/2007-01-31_ct-3995_refresh_.pdf
HAS/2007-01-31_ct-3996_celluvisc_.pdf
HAS/2007-01-31_ct-4019_paracetamol_arrow_.pdf
HAS/2007-01-31_ct-4026_lectil_.pdf
HAS/2007-01-31_ct-4121_rifadine.pdf
HAS/2007-01-31_ct-4128_atrovent_.pdf
HAS/2007-01-31_ct-4141_josacine.pdf
HAS/2007-01-31_ct-4156_doxycycline_.pdf
HAS/2007-01-31_ct_3463_testopatch_.pdf
HAS/2007-01-31_ct_3936_aloxi_ang_2009-06-04_15-58-44_150.pdf
HAS/2007-01-31_fiche_buts_maladie_coeliaque.pdf
HAS/2007-01-31_rapport_maladie_coeliaque.pdf
HAS/2007-01-31_rapport_oxygenotherapie.pdf
HAS/2007-01-31_synthese_maladie_coeliaque.pdf
HAS/2007-01-31_synthese_ohb.pdf
HAS/2007-02-07_cepp-1049.pdf
HAS/2007-02-07_cepp-1150_2007_04_18__10_50_12_498.pdf
HAS/2007-02-07_cepp-1151.pdf
HAS/2007-02-07_cepp-1223.pdf
HAS/2007-02-07_cepp-1257.pdf
HAS/2007-02-07_cepp-817.pdf
HAS/2007-02-07_cepp-862.pdf
HAS/2007-02-07_cepp-928.pdf
HAS/2007-02-07_cepp-934.pdf
HAS/2007-02-07_cepp-953.pdf
HAS/2007-02-07_cepp-966.pdf
HAS/2007-02-07_cepp-967.pdf
HAS/2007-02-07_cepp-968.pdf
HAS/2007-02-07_cepp-969.pdf
HAS/2007-02-07_cepp-970.pdf
HAS/2007-02-07_cepp-989_2007_03_26__10_24_37_452.pdf
HAS/2007-02-07_cepp-990.pdf
HAS/2007-02-07_cepp-990_intra-swing_et_hi-tex.pdf
HAS/2007-02-07_cepp-992_2007_05_24__17_41_52_297.pdf
HAS/2007-02-07_cepp-992_iu_test_5_iu_test_5_bandelettes_urinaires_a_usage_auto-diagnostic_2007_02_15__13_15_42_957.pdf
HAS/2007-02-07_cepp_-_1211_cargum.pdf
HAS/2007-02-14_ct-2974_tranxene_.pdf
HAS/2007-02-14_ct-3027_ikaran_.pdf
HAS/2007-02-14_ct-3096_urbanyl_.pdf
HAS/2007-02-14_ct-3457_tamik_.pdf
HAS/2007-02-14_ct-3739_clinimix_.pdf
HAS/2007-02-14_ct-3785_orgalutran_.pdf
HAS/2007-02-14_ct-4072_vialebex_.pdf
HAS/2007-02-14_ct-4166_gabacet_.pdf
HAS/2007-02-21_cepp-1050.pdf
HAS/2007-02-21_cepp-1069.pdf
HAS/2007-02-21_cepp-1070.pdf
HAS/2007-02-21_cepp-1210.pdf
HAS/2007-02-21_cepp_-_963_j-fast_pds.pdf
HAS/2007-02-28_ct-2159_mucomyst_.pdf
HAS/2007-02-28_ct-2226_mirena.pdf
HAS/2007-02-28_ct-3913_keppra_.pdf
HAS/2007-02-28_ct-3966_spifen_.pdf
HAS/2007-02-28_ct-4002_nureflex_.pdf
HAS/2007-02-28_ct-4011_biafine_.pdf
HAS/2007-02-28_ct-4132_kestin_kestinlyo__2007_05_30__16_58_2_571.pdf
HAS/2007-02-28_ct-4135_telfast_.pdf
HAS/2007-02-28_ct-4223_adrovance.pdf
HAS/2007-02-28_ct-4301_piracetam_biogaran_.pdf
HAS/2007-02-28_ct_3913_keppra_ang.pdf
HAS/2007-03-07_CEPP-1168_CAIRFLOW PM100_07_mars_2007_(1168)_avis.pdf
HAS/2007-03-07_CEPP-926_AXTAIR TRIMODE AUTOMORPHO_07_mars_2007_(926)_avis.pdf
HAS/2007-03-07_cepp-1093.pdf
HAS/2007-03-07_cepp-1098.pdf
HAS/2007-03-07_cepp-1153.pdf
HAS/2007-03-07_cepp-1258.pdf
HAS/2007-03-07_cepp-987.pdf
HAS/2007-03-07_cepp_-_938_variaplot.pdf
HAS/2007-03-11_atbp_-_rapport_final.pdf
HAS/2007-03-11_cci_-_rapport_final.pdf
HAS/2007-03-11_cppa_-_rapport_final_.pdf
HAS/2007-03-11_dpa_-_rapport_final.pdf
HAS/2007-03-11_psp_-_rapport_final.pdf
HAS/2007-03-11_rapport_final_-_partogramme.pdf
HAS/2007-03-11_su.pdf
HAS/2007-03-11_tsu_-_rapport_final.pdf
HAS/2007-03-14_ct-2467_leponex_.pdf
HAS/2007-03-14_ct-2535_monazol_.pdf
HAS/2007-03-14_ct-3026_soriatane_.pdf
HAS/2007-03-14_ct-3090_loxapac_.pdf
HAS/2007-03-14_ct-3812_ticlid_.pdf
HAS/2007-03-14_ct-3871_curacne_.pdf
HAS/2007-03-14_ct-4011_triafine_.pdf
HAS/2007-03-14_ct-4031_exforge.pdf
HAS/2007-03-14_ct-4068_procuta_.pdf
HAS/2007-03-14_ct-4086_physiogine.pdf
HAS/2007-03-14_ct-4152_metoject_.pdf
HAS/2007-03-14_ct-4267_relpax_.pdf
HAS/2007-03-14_ct-4328_seropram_.pdf
HAS/2007-03-14_ct-5126_riamet_.pdf
HAS/2007-03-21_cepp-1009.pdf
HAS/2007-03-21_cepp-1090.pdf
HAS/2007-03-21_cepp-1126.pdf
HAS/2007-03-21_cepp-1169.pdf
HAS/2007-03-28_ct-2276_estalis_.pdf
HAS/2007-03-28_ct-2409_activelle_.pdf
HAS/2007-03-28_ct-2466_climaston_.pdf
HAS/2007-03-28_ct-2801_climara_.pdf
HAS/2007-03-28_ct-2806_femseptcombi_.pdf
HAS/2007-03-28_ct-2807_femsept_.pdf
HAS/2007-03-28_ct-2842_oesclim_.pdf
HAS/2007-03-28_ct-2858_provames_.pdf
HAS/2007-03-28_ct-2913_menorest_.pdf
HAS/2007-03-28_ct-3020_estrapatch_.pdf
HAS/2007-03-28_ct-3734_estreva_.pdf
HAS/2007-03-28_ct-3872_vastarel.pdf
HAS/2007-03-28_ct-3934_trimetazidine_winthrop_.pdf
HAS/2007-03-28_ct-4105_trimetazidine_biogaran.pdf
HAS/2007-03-28_ct-4106_trimetazidine_eg_.pdf
HAS/2007-03-28_ct-4107_trimetazidine_g_gam.pdf
HAS/2007-03-28_ct-4108_trimetazidine_ivax_.pdf
HAS/2007-03-28_ct-4109_trimetazidine_merck_.pdf
HAS/2007-03-28_ct-4110_trimetazidine_qualimed.pdf
HAS/2007-03-28_ct-4112_trimetazidine_ratiopharm.pdf
HAS/2007-03-28_ct-4113_trimetazidine_rpg_.pdf
HAS/2007-03-28_ct-4114_trimetazidine_teva_.pdf
HAS/2007-03-28_ct-4115_trimetazidine_almus_arrow.pdf
HAS/2007-03-28_ct-4117_trimetazidine_sandoz.pdf
HAS/2007-03-28_ct-4139_velcade_.pdf
HAS/2007-04-01_catheter_veineux_peripheriques_-_criteres_de_qualite.pdf
HAS/2007-04-04_cepp-1170.pdf
HAS/2007-04-04_cepp-1218.pdf
HAS/2007-04-04_cepp-1227.pdf
HAS/2007-04-04_cepp-1228.pdf
HAS/2007-04-04_cepp-1229.pdf
HAS/2007-04-04_cepp-1230.pdf
HAS/2007-04-04_cepp-1233.pdf
HAS/2007-04-04_cepp-1260.pdf
HAS/2007-04-04_cepp-1261.pdf
HAS/2007-04-04_cepp-1266.pdf
HAS/2007-04-04_cepp-1273.pdf
HAS/2007-04-04_cepp-1282.pdf
HAS/2007-04-04_cepp-877.pdf
HAS/2007-04-10_evaluation_du_depistage_neonatal_systematique_de_la_surdite_permanente_bilaterale_avis_de_la_has.pdf
HAS/2007-04-10_evaluation_du_depistage_neonatal_systematique_de_la_surdite_permanente_bilaterale_synthese_et_perspectives.pdf
HAS/2007-04-10_rapport_-_evaluation_du_depistage_neonatal_systematique_de_la_surdite_permanente_bilaterale.pdf
HAS/2007-04-18_arthroplastie_discale_lombaire.pdf
HAS/2007-04-18_cepp-1209.pdf
HAS/2007-04-18_cepp-1212.pdf
HAS/2007-04-18_cepp-1216.pdf
HAS/2007-04-18_cepp-790.pdf
HAS/2007-04-18_cepp-860.pdf
HAS/2007-04-18_ct-1971_dolgit_.pdf
HAS/2007-04-18_ct-2075_pannogel_.pdf
HAS/2007-04-18_ct-2146_regranex_.pdf
HAS/2007-04-18_ct-2237_surgestone_.pdf
HAS/2007-04-18_ct-2323_mebevetine_zydus_.pdf
HAS/2007-04-18_ct-2443_titanoreine.pdf
HAS/2007-04-18_ct-2896_perikabiven_.pdf
HAS/2007-04-18_ct-2949_sucralfate_teva_.pdf
HAS/2007-04-18_ct-2963_locoid_.pdf
HAS/2007-04-18_ct-3203_geluprane_doliprane_.pdf
HAS/2007-04-18_ct-3453_dipentum_.pdf
HAS/2007-04-18_ct-3490_minalfene_.pdf
HAS/2007-04-18_ct-3497_vogalene.pdf
HAS/2007-04-18_ct-3590_densical_.pdf
HAS/2007-04-18_ct-3744_calciprat_.pdf
HAS/2007-04-18_ct-3874_anoreine.pdf
HAS/2007-04-18_ct-3899_mebeverine.pdf
HAS/2007-04-18_ct-3954_seglor_.pdf
HAS/2007-04-18_ct-3962_aleve.pdf
HAS/2007-04-18_ct-4020_antarene_.pdf
HAS/2007-04-18_ct-4025_nabucox.pdf
HAS/2007-04-18_ct-4029_gardasil.pdf
HAS/2007-04-18_ct-4094_advil.pdf
HAS/2007-04-18_ct-4095_advil.pdf
HAS/2007-04-18_ct-4123_stromectol_.pdf
HAS/2007-04-18_ct-4136_taxotere_vads.pdf
HAS/2007-04-18_ct-4144_novomix_.pdf
HAS/2007-04-18_ct-4161_fixical__2007_05_07__18_14_31_703.pdf
HAS/2007-04-18_ct-4215_rocephine.pdf
HAS/2007-04-18_ct-4222_gaviscon_.pdf
HAS/2007-04-18_ct-4230_sermion_.pdf
HAS/2007-04-18_ct-4233_pyostacine_.pdf
HAS/2007-04-18_ct-4261_mobic.pdf
HAS/2007-04-18_ct-4266_tracutil_.pdf
HAS/2007-04-18_ct-4321_osmotan_.pdf
HAS/2007-04-18_ct-4325_epitomax_.pdf
HAS/2007-04-18_ct-4344_pritor_.pdf
HAS/2007-04-18_ct-4377_vasobral_.pdf
HAS/2007-04-18_ct-4381_transulose.pdf
HAS/2007-04-18_ct-4389_pritor_plus_.pdf
HAS/2007-04-18_ct-4390_micardis_plus_.pdf
HAS/2007-04-18_ct-4391_albumine_humaine_baxter.pdf
HAS/2007-04-18_ct-4394_coaprovel_.pdf
HAS/2007-04-18_ct-4396_spasmopriv_.pdf
HAS/2007-04-18_ct-4398_influvac__2007_05_21__11_32_27_361.pdf
HAS/2007-04-18_ct-4434_taketiam_.pdf
HAS/2007-04-18_ct-4446_avadene_.pdf
HAS/2007-04-18_ct-4577_zovirax_.pdf
HAS/2007-04-18_ct_4146_fixical_vitamine_d3.pdf
HAS/2007-04-18_gardasil_ct_4029.pdf
HAS/2007-04-19_ea-_recommandations_.pdf
HAS/2007-04-19_ea-_recos_v_en_cp_to.pdf
HAS/2007-04-19_ea_-_argumentaire.pdf
HAS/2007-04-19_ea_-_synthese_des_recommandations.pdf
HAS/2007-04-19_qrg_fundal_pressure_to.pdf
HAS/2007-04-25_ct-2311_propofan.pdf
HAS/2007-04-25_ct-2327_claradol_cafeine_.pdf
HAS/2007-04-25_ct-3084_ideos.pdf
HAS/2007-04-25_ct-3099_di-antalvic.pdf
HAS/2007-04-25_ct-3155_aspegic_.pdf
HAS/2007-04-25_ct-3227_preterax_.pdf
HAS/2007-04-25_ct-3229_fleet_phospho_soda_.pdf
HAS/2007-04-25_ct-3352_subutex_.pdf
HAS/2007-04-25_ct-3730_iomeron_.pdf
HAS/2007-04-25_ct-3825_chibro-proscar_.pdf
HAS/2007-04-25_ct-4027_nalorex_.pdf
HAS/2007-04-25_ct-4096_teoula_-_zofenil_.pdf
HAS/2007-04-25_ct-4221_tanatril_.pdf
HAS/2007-04-25_ct-4239_combivent_.pdf
HAS/2007-04-25_ct-4302_miflasone_.pdf
HAS/2007-04-25_ct-4304_xenetix_.pdf
HAS/2007-04-25_ct-4316_cycladol_.pdf
HAS/2007-04-25_ct-4387_spagulax.pdf
HAS/2007-04-25_ct-4388_spagulax_.pdf
HAS/2007-04-25_ct-4430_gadovist.pdf
HAS/2007-04-25_ct-4437_chlorure_de_sodium-fresenius_.pdf
HAS/2007-04-25_ct-4499_josir_-_mecir_.pdf
HAS/2007-05-02_cepp-1217.pdf
HAS/2007-05-02_cepp-1280.pdf
HAS/2007-05-02_cepp-1288.pdf
HAS/2007-05-03_agenda_sommeil-eveil.pdf
HAS/2007-05-03_caduet.pdf
HAS/2007-05-03_rpc_sftg_insomnie_-_argumentaire_mel.pdf
HAS/2007-05-03_rpc_sftg_insomnie_-_recommandations.pdf
HAS/2007-05-03_rpc_sftg_insomnie_-_synthese_des_recommandations.pdf
HAS/2007-05-08_ct-4129_atarax_.pdf
HAS/2007-05-08_ct_4129_atarax_ang.pdf
HAS/2007-05-09_ct-1824_celebrex_.pdf
HAS/2007-05-09_ct-2030_magnevist.pdf
HAS/2007-05-09_ct-2472_depakote_.pdf
HAS/2007-05-09_ct-2865_zorac_.pdf
HAS/2007-05-09_ct-2877_carbidopa_levodopa_.pdf
HAS/2007-05-09_ct-3016_parlodel_.pdf
HAS/2007-05-09_ct-3024_rosiced_.pdf
HAS/2007-05-09_ct-3199_paracetamol_teva_.pdf
HAS/2007-05-09_ct-3308_locacid_.pdf
HAS/2007-05-09_ct-3319_otrasel.pdf
HAS/2007-05-09_ct-3548_dopergine.pdf
HAS/2007-05-09_ct-3567_multihance_.pdf
HAS/2007-05-09_ct-3690_apokinon_.pdf
HAS/2007-05-09_ct-3877_omniscan_.pdf
HAS/2007-05-09_ct-4258_daivobet.pdf
HAS/2007-05-09_ct-4329_flixovate_.pdf
HAS/2007-05-09_ct-4356_flixotide.pdf
HAS/2007-05-09_ct-4358_flixonase_.pdf
HAS/2007-05-09_ct-4423_duova_.pdf
HAS/2007-05-09_ct-4451_silkis.pdf
HAS/2007-05-09_ct-4505_betahistine_teva.pdf
HAS/2007-05-09_ct-4545_nasonex_.pdf
HAS/2007-05-09_ct-4572_omix_-_omexel_.pdf
HAS/2007-05-09_ct-4595_chibro-proscar_.pdf
HAS/2007-05-09_ct-4608_betahistine_biogaran_.pdf
HAS/2007-05-09_ct-4822_daivonex_.pdf
HAS/2007-05-09_ct_4258_daivobet_ang.pdf
HAS/2007-05-11_lap_pnds_ald17__gaucher_juin_07_2007_06_22__11_14_5_266.pdf
HAS/2007-05-11_ven_gaucher_web.pdf
HAS/2007-05-16_cepp-1102.pdf
HAS/2007-05-16_cepp-1104.pdf
HAS/2007-05-16_cepp-1106.pdf
HAS/2007-05-16_cepp-1152.pdf
HAS/2007-05-16_cepp-1208.pdf
HAS/2007-05-16_cepp-1262.pdf
HAS/2007-05-16_cepp-1284.pdf
HAS/2007-05-16_cepp-1285.pdf
HAS/2007-05-16_cepp-1292.pdf
HAS/2007-05-16_cepp-1302.pdf
HAS/2007-05-16_cepp-1311.pdf
HAS/2007-05-16_cepp-1357.pdf
HAS/2007-05-16_cepp-1363zenithflex1363.pdf
HAS/2007-05-16_cepp-460_2.pdf
HAS/2007-05-16_cepp_-_1101_pulsar_ci100.pdf
HAS/2007-05-16_cepp_-_1103_sonata_ti100.pdf
HAS/2007-05-16_cepp_-_1105_nucleus_freedom.pdf
HAS/2007-05-16_cepp_-_1107_hires_90k.pdf
HAS/2007-05-16_cepp_-_1108_digisonic_sp.pdf
HAS/2007-05-16_rapport_implants_cochleaires.pdf
HAS/2007-05-16_synthese_implants_cochleaires.pdf
HAS/2007-05-21_SCASAMU_M1.pdf
HAS/2007-05-21_SCATabac_M1.pdf
HAS/2007-05-21_argumentaire_pr_non_med_071018.pdf
HAS/2007-05-21_criteres_de_qualite_-_polyarthrite_rhumatoide.pdf
HAS/2007-05-21_criteres_qualite_polyarthrite_rhumatoide_masso_kinesitherapie.pdf
HAS/2007-05-21_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2007-05-21_grille_de_recueil_-_polyarthrite_rhumatoide_et_coordination_pluridisciplinaire.pdf
HAS/2007-05-21_grille_de_recueil_-_polyarthrite_rhumatoide_et_masso-kinesitherapie.pdf
HAS/2007-05-21_icamg_p2_2007_05_15__10_55_42_169.pdf
HAS/2007-05-21_method_process_adaptation_rpc_2.pdf
HAS/2007-05-21_polyarthrite_rhumatoide_-_synthese_de_lensemble_des_recommandations.pdf
HAS/2007-05-21_quick_reference_guide_rheumatoid_arthritis.pdf
HAS/2007-05-21_recos_pr_non_med_071018.pdf
HAS/2007-05-21_rheumatoid_arthritis_guidelines.pdf
HAS/2007-05-21_sca_ambulatoire_m1_2012.pdf
HAS/2007-05-21_sca_diabete_m1_2012.pdf
HAS/2007-05-21_sca_synthese_biblio.pdf
HAS/2007-05-21_sca_tabac_2012.pdf
HAS/2007-05-21_sca_tout_sur_ces_programmes.pdf
HAS/2007-05-21_scaambu_m1.pdf
HAS/2007-05-21_scacardio_m1.pdf
HAS/2007-05-21_scacardio_m2.pdf
HAS/2007-05-21_scacardio_m3.pdf
HAS/2007-05-21_scacardio_m5.pdf
HAS/2007-05-21_scacardio_p1.pdf
HAS/2007-05-21_scadid_m1.pdf
HAS/2007-05-21_scadid_synthese_biblio.pdf
HAS/2007-05-21_scasamu_m2_2007_05_14__13_15_14_878.pdf
HAS/2007-05-21_scasamu_m3.pdf
HAS/2007-05-21_scasamu_m4.pdf
HAS/2007-05-21_scasamu_p1.pdf
HAS/2007-05-21_scatabac_synthese_biblio.pdf
HAS/2007-05-21_synthese_pr_non_med_071018.pdf
HAS/2007-05-22_brochure_scaurg.pdf
HAS/2007-05-22_sca_synthese_biblio.pdf
HAS/2007-05-22_sca_tout_sur_ces_programmes.pdf
HAS/2007-05-22_sca_urgences_m1_2012.pdf
HAS/2007-05-22_scasamu_m4.pdf
HAS/2007-05-22_scaurg_m1.pdf
HAS/2007-05-22_scaurg_m2.pdf
HAS/2007-05-22_scaurg_m3.pdf
HAS/2007-05-22_scaurg_p1.pdf
HAS/2007-05-23_ct-3829_effexor_.pdf
HAS/2007-05-23_ct-3997_tetrazepam_zydus_.pdf
HAS/2007-05-23_ct-3998_tetrazepam_rpg.pdf
HAS/2007-05-23_ct-3999_tetrazepam_teva_.pdf
HAS/2007-05-23_ct-4000_tetrazepam_sandoz_.pdf
HAS/2007-05-23_ct-4001_tetrazepam_winthrop_.pdf
HAS/2007-05-23_ct-4073_tetrazepam_ratiopharm_.pdf
HAS/2007-05-23_ct-4074_tetrazepam_merck_.pdf
HAS/2007-05-23_ct-4075_tetrazepam_ivax_.pdf
HAS/2007-05-23_ct-4076_tetrazepam_g_gam.pdf
HAS/2007-05-23_ct-4077_tetrazepam_eg_.pdf
HAS/2007-05-23_ct-4078_tetrazepam_biogaran_.pdf
HAS/2007-05-23_ct-4079_tetrazepam_arrow_.pdf
HAS/2007-05-23_ct-4080_tetrazepam_almus_.pdf
HAS/2007-05-23_ct-4081_panos_.pdf
HAS/2007-05-23_ct-4439_imovane_.pdf
HAS/2007-05-23_ct-4500_vaxigrip-mutagrip_.pdf
HAS/2007-05-23_ct-4538_fungizone.pdf
HAS/2007-05-23_ct-4547_dexef_.pdf
HAS/2007-05-23_ct-4666_tetagrip.pdf
HAS/2007-05-25_05r24_form_mort_inattendue_du_nourrisson_formulaires_de_consentement_2013-03-14_15-15-0_335.pdf
HAS/2007-05-25_05r24_form_mort_inattendue_du_nourrisson_prise_en_charge_medicale_2013-03-14_15-14-21_518.pdf
HAS/2007-05-25_05r24_proto_mort_inattendue_du_nourrisson_explorations_medicales.pdf
HAS/2007-05-25_05r24_proto_mort_inattendue_du_nourrisson_protocole_d_autopsie.pdf
HAS/2007-05-25_argumentaire_mort_inattendue_nourrisson.pdf
HAS/2007-05-25_recommandations_mort_inattendue_nourrisson.pdf
HAS/2007-05-25_synthese_mort_inattendue_nourrisson.pdf
HAS/2007-05-30_cepp-1265.pdf
HAS/2007-05-30_cepp-1290.pdf
HAS/2007-05-30_cepp-1332.pdf
HAS/2007-05-30_cepp-1355.pdf
HAS/2007-05-31_07-036_sla-guide_sans_lap.pdf
HAS/2007-05-31_pnds_sla_version_web_290507.pdf
HAS/2007-06-06_ct-3459_granions_de_zinc.pdf
HAS/2007-06-06_ct-3697_differine_.pdf
HAS/2007-06-06_ct-3808_efficort.pdf
HAS/2007-06-06_ct-3850_neurontin_.pdf
HAS/2007-06-06_ct-4348_zyprexa_.pdf
HAS/2007-06-06_ct-4501_chlorure_de_sodium_macopharma.pdf
HAS/2007-06-06_ct-4625_lamictal.pdf
HAS/2007-06-06_ct-4640_deprenyl_.pdf
HAS/2007-06-06_ct-4661_ribamylase.pdf
HAS/2007-06-06_ct-4662_megamylase.pdf
HAS/2007-06-06_ct-4790_trimetazidine_zydus_.pdf
HAS/2007-06-06_ct-5599_thiocolchicoside_biogaran_.pdf
HAS/2007-06-06_rapport_evaluation_des_strategies_de_depistage_de_la_trisomie_21.pdf
HAS/2007-06-06_synthese_evaluation_des_strategies_de_depistage_de_la_trisomie_21.pdf
HAS/2007-06-06_trisomie_21_synthese_en_anglais.pdf
HAS/2007-06-13_cepp-1127.pdf
HAS/2007-06-13_cepp-1267.pdf
HAS/2007-06-13_cepp-1268.pdf
HAS/2007-06-13_cepp-1271.pdf
HAS/2007-06-13_cepp-1293.pdf
HAS/2007-06-13_cepp-1370.pdf
HAS/2007-06-13_cepp-763.pdf
HAS/2007-06-13_cepp-839carotidwallstentmonorail.pdf
HAS/2007-06-14_criteres_de_qualite_pour_levaluation_et_lamelioration_de.pdf
HAS/2007-06-14_criteres_de_qualite_pour_levaluation_et_lamelioration_de_des_pratiques_professionnelles_-_synthese.pdf
HAS/2007-06-14_general_method_eval_techno.pdf
HAS/2007-06-14_rapid_assessment_method_eval_actes.pdf
HAS/2007-06-18_ct-4313_saizen_.pdf
HAS/2007-06-20_ct-2322_chondrosulf.pdf
HAS/2007-06-20_ct-2596_structum.pdf
HAS/2007-06-20_ct-2906_diamicron_.pdf
HAS/2007-06-20_ct-3232_verapamil_ivax.pdf
HAS/2007-06-20_ct-3405_amlor_.pdf
HAS/2007-06-20_ct-3454_glucor_.pdf
HAS/2007-06-20_ct-3838_diastabol_.pdf
HAS/2007-06-20_ct-3840_trinipatch__2007_07_18__15_19_8_196.pdf
HAS/2007-06-20_ct-4147_opticron_.pdf
HAS/2007-06-20_ct-4242_bronchodual.pdf
HAS/2007-06-20_ct-4326_lacryvisc_.pdf
HAS/2007-06-20_ct-4327_vexol_.pdf
HAS/2007-06-20_ct-4385_cromoptic_.pdf
HAS/2007-06-20_ct-4422_zophren.pdf
HAS/2007-06-20_ct-4502_glucose_5_p_cent_maco_pharma_.pdf
HAS/2007-06-20_ct-4623_humalog.pdf
HAS/2007-06-20_ct-4623_umuline_.pdf
HAS/2007-06-20_ct-4664_thiocolchicoside_qualimed_.pdf
HAS/2007-06-20_ct-4669_calcidose_.pdf
HAS/2007-06-20_ct-5726_renocis_.pdf
HAS/2007-06-26_denutrition_personne_agee_2007_-_argumentaire.pdf
HAS/2007-06-26_denutrition_personne_agee_2007_-_recommandations.pdf
HAS/2007-06-26_denutrition_personnes_agees_ceapp.pdf
HAS/2007-06-26_malnutrition_elderly_guidelines.pdf
HAS/2007-06-26_malnutrition_elderly_quick_ref_guide.pdf
HAS/2007-06-26_synthese_denutrition_personnes_agees.pdf
HAS/2007-06-27_cepp-1147.pdf
HAS/2007-06-27_cepp-1148.pdf
HAS/2007-06-27_cepp-1149.pdf
HAS/2007-06-27_cepp-1213.pdf
HAS/2007-06-27_cepp-1214optimair7.pdf
HAS/2007-06-27_cepp-1215.pdf
HAS/2007-06-27_cepp-1221promus.pdf
HAS/2007-06-27_cepp-1222xiencev.pdf
HAS/2007-06-27_cepp-1259.pdf
HAS/2007-06-27_cepp-1264exogen4000.pdf
HAS/2007-06-27_cepp-1291.pdf
HAS/2007-06-27_cepp-1304.pdf
HAS/2007-06-27_cepp-1305.pdf
HAS/2007-06-27_cepp-1365.pdf
HAS/2007-06-27_cepp-1396.pdf
HAS/2007-07-02_argumentaire_-_evaluation_a_priori_du_depistage_de_la_syphilis.2.pdf
HAS/2007-07-02_synthese_evaluation_a_priori_du_depistage_de_la_syphilis_en_france_2007_07_02__12_22_51_493.pdf
HAS/2007-07-04_ct-2331_lamisil.pdf
HAS/2007-07-04_ct-2455_amycor.pdf
HAS/2007-07-04_ct-2515_vectarion.pdf
HAS/2007-07-04_ct-2529_amycor_onychoset.pdf
HAS/2007-07-04_ct-3458_orocal_d3.pdf
HAS/2007-07-04_ct-3914_mycoster.pdf
HAS/2007-07-04_ct-3965_becotide.pdf
HAS/2007-07-04_ct-4093_ketum_.pdf
HAS/2007-07-04_ct-4127_pevaryl.pdf
HAS/2007-07-04_ct-4315_symbicort_turbuhaler_.pdf
HAS/2007-07-04_ct-4418_rhinureflex.pdf
HAS/2007-07-04_ct-4507_targretin.pdf
HAS/2007-07-04_ct-4509_sophidone.pdf
HAS/2007-07-04_ct-4550_trusopt.pdf
HAS/2007-07-04_ct-4576_caltrate.pdf
HAS/2007-07-04_ct-4577_caltrate_vitamine_d3.pdf
HAS/2007-07-04_ct-4593_corticetine.pdf
HAS/2007-07-04_ct-4670_octanate_.pdf
HAS/2007-07-04_ct-4824_beconase.pdf
HAS/2007-07-04_ct-4991_ribamylase.pdf
HAS/2007-07-04_ct-5042_lamisil.pdf
HAS/2007-07-11_ald8_guidemedecin_diabetetype1_revunp_vucd.pdf
HAS/2007-07-11_cepp-1071.pdf
HAS/2007-07-11_cepp-1274.pdf
HAS/2007-07-11_cepp-1400.pdf
HAS/2007-07-11_cepp-1412.pdf
HAS/2007-07-11_cepp-1433.pdf
HAS/2007-07-11_cepp-1464.pdf
HAS/2007-07-11_cepp-762.pdf
HAS/2007-07-11_cepp_-_808_avis_general_implant_pour_colposuspension_11_juillet_07.pdf
HAS/2007-07-11_ct-2774_symbicort_turbuhaler_.pdf
HAS/2007-07-11_ct-3288_oxis_turbuhaler.pdf
HAS/2007-07-11_ct032702.pdf
HAS/2007-07-11_ct032703.pdf
HAS/2007-07-11_epp-rapport_de_la_commission-version_finale_pour_mel.pdf
HAS/2007-07-11_epp-recommandations_de_la_commission-version_finale.pdf
HAS/2007-07-11_fiche_bum_bpco_210408.pdf
HAS/2007-07-11_rapport_devaluation_implant_de_renfort_pour_traitement_de_lincontinence_urinaire_deffort_feminine_et_implant_de_renfort_pour_traitement_du_prolapsus_des_organes_pelviens_de_la_femme.pdf
HAS/2007-07-11_rapport_pied_diabetique.pdf
HAS/2007-07-11_referentiel_de_bon_usage_implant_de_renfort_pour_traitement_de_lincontinence_urinaire_deffort_et_implant_de_renfort_pour_traitement_du_prolapsus_des_organes_pelviens_de_la_femme.pdf
HAS/2007-07-11_spiriva.pdf
HAS/2007-07-11_summary_foot_lesions_in_diabetics_2008_04_01__10_15_3_770.pdf
HAS/2007-07-17_ct-4628_noxafil.pdf
HAS/2007-07-17_ct_4628_noxafil__ang.pdf
HAS/2007-07-17_pnds_lap_xp_final_juillet_2007.pdf
HAS/2007-07-17_pnds_xp_anglais_web_2008-11-05_09-45-35_147.pdf
HAS/2007-07-17_pnds_xp_final_juillet_2007.pdf
HAS/2007-07-18_ct-2770_deroxat.pdf
HAS/2007-07-18_ct-3831_menopur.pdf
HAS/2007-07-18_ct-3944_solian.pdf
HAS/2007-07-18_ct-4425_imiject.pdf
HAS/2007-07-18_ct-4514_climodiene.pdf
HAS/2007-07-18_ct-4574_triflucan.pdf
HAS/2007-07-18_ct-4575_diviseq.pdf
HAS/2007-07-18_ct-4639_zelitrex.pdf
HAS/2007-07-18_ct-4795_inexium_.pdf
HAS/2007-07-18_ct-4985_ikaran.pdf
HAS/2007-07-18_ct-4986_tamik.pdf
HAS/2007-08-26_acc_dans_177_etablissements_de_sante_francais_2005.pdf
HAS/2007-09-05_cepp-1361_geltop.pdf
HAS/2007-09-05_cepp-1367_ams_700.pdf
HAS/2007-09-05_cepp-668-infirmiers.pdf
HAS/2007-09-05_cepp-734-pth.pdf
HAS/2007-09-05_cepp_-_1358_deflux.pdf
HAS/2007-09-05_cepp_-_1404_current_rf_dr_2207-30_pis.pdf
HAS/2007-09-05_cepp_-_1405_current_rf_dr_2207-36.pdf
HAS/2007-09-05_cepp_-_1406_current_rf_vr_1207-30.pdf
HAS/2007-09-05_cepp_-_1407_current_rf_vr_1207-36.pdf
HAS/2007-09-05_cepp_-_1408_promote_rf_3213-30.pdf
HAS/2007-09-05_cepp_-_1409_promote_rf_3213-36.pdf
HAS/2007-09-05_cepp_-_1469_stratasis_tf.pdf
HAS/2007-09-05_cepp_-_1526_hylovis_multi.pdf
HAS/2007-09-05_cepp_952_parietex_ugytex.pdf
HAS/2007-09-05_cepp_954_pelvicol_pel_220.pdf
HAS/2007-09-05_cepp_957_parietex_prosup.pdf
HAS/2007-09-05_rapport_devaluation_implant_de_renfort_pour_traitement_de_lincontinence_urinaire_deffort_feminine_et_implant_de_renfort_pour_traitement_du_prolapsus_des_organes_pelviens_de_la_femme.pdf
HAS/2007-09-05_rapport_evaluation_des_protheses_de_hanche.pdf
HAS/2007-09-12_ct-4131_diltiazem_biogaran.pdf
HAS/2007-09-12_ct-4231_corgard_.pdf
HAS/2007-09-12_ct-4426_imigrane_.pdf
HAS/2007-09-12_ct-4504_hemipralon_.pdf
HAS/2007-09-12_ct-4506_insuman_.pdf
HAS/2007-09-12_ct-4741_prestole_.pdf
HAS/2007-09-12_ct-4833_ecazide.pdf
HAS/2007-09-12_ct-4866_calciforte_vitamine_d3_.pdf
HAS/2007-09-12_ct-4868_calciforte_.pdf
HAS/2007-09-12_ct-4870_thiocolchicoside_arrow_.pdf
HAS/2007-09-12_ct-4875_mikelan_.pdf
HAS/2007-09-12_ct-4883_captea_.pdf
HAS/2007-09-12_ct-4933_calcidia_.pdf
HAS/2007-09-12_ct-4934_peridys.pdf
HAS/2007-09-12_ct-4965_isobar.pdf
HAS/2007-09-12_ct-4968_cacit.pdf
HAS/2007-09-12_ct-4977_trasitensine_.pdf
HAS/2007-09-12_ct-4982_orocal_.pdf
HAS/2007-09-12_ct-4984_ostram_.pdf
HAS/2007-09-12_ct-5015_trandate_.pdf
HAS/2007-09-12_ct-5021_naemis_.pdf
HAS/2007-09-19_cepp_-_1275_hips.pdf
HAS/2007-09-19_cepp_-_1331_matrice_410.pdf
HAS/2007-09-19_ct-3467_procoralan_.pdf
HAS/2007-09-19_fiche_bum_procoralan_082007.pdf
HAS/2007-09-24_ct-4029_gardasil.pdf
HAS/2007-09-24_fiche_bum_gardasil.pdf
HAS/2007-09-26_ct-3266_theralene_2007_11_14__12_21_32_230.pdf
HAS/2007-09-26_ct-4088_carbosymag_.pdf
HAS/2007-09-26_ct-4312_caverject.pdf
HAS/2007-09-26_ct-4312_dilrene_.pdf
HAS/2007-09-26_ct-4417_spironolactone.pdf
HAS/2007-09-26_ct-4470_lipanthyl.pdf
HAS/2007-09-26_ct-4548_prozac_.pdf
HAS/2007-09-26_ct-4579_levemir_.pdf
HAS/2007-09-26_ct-4764_dermatrans.pdf
HAS/2007-09-26_ct-4793_epinitril_.pdf
HAS/2007-09-26_ct-4831_nutriflex_lipide_2007_10_22__14_36_30_134.pdf
HAS/2007-09-26_ct-4837_aesculus_.pdf
HAS/2007-09-26_ct-4901_proctolog_.pdf
HAS/2007-09-26_ct-4910_anoreine_.pdf
HAS/2007-09-26_ct-5037_ozidia.pdf
HAS/2007-09-26_ct-5100_actonelcombi_.pdf
HAS/2007-09-27_rapport_devaluation_implant_de_renfort_pour_traitement_de_lincontinence_urinaire_deffort_feminine_et_implant_de_renfort_pour_traitement_du_prolapsus_des_organes_pelviens_de_la_femme.pdf
HAS/2007-09-27_referentiel_de_bon_usage_implant_de_renfort_pour_traitement_de_lincontinence_urinaire_deffort_et_implant_de_renfort_pour_traitement_du_prolapsus_des_organes_pelviens_de_la_femme.pdf
HAS/2007-09-27_synthese_evauation_colposuspension_2009-02-26_12-12-58_662.pdf
HAS/2007-10-03_annexe_1.pdf
HAS/2007-10-03_annexe_1_2007_09_27__14_44_31_56.pdf
HAS/2007-10-03_annexe_2_2007_09_27__14_03_55_791.pdf
HAS/2007-10-03_annexe_2_2007_09_27__14_47_9_16.pdf
HAS/2007-10-03_annexe_2_2007_09_27__14_54_42_599.pdf
HAS/2007-10-03_cepp-1272_recap_magnum.pdf
HAS/2007-10-03_cepp-1360_perimount_magna_ease_modele_3300_tfx.pdf
HAS/2007-10-03_cepp-1434_perimount_magna_mitrale_modele_7000_tfx.pdf
HAS/2007-10-03_cepp-1467_i-stop.pdf
HAS/2007-10-03_cepp-1470_tension-free_vaginal_tape.pdf
HAS/2007-10-03_cepp-1517_silima_direct.pdf
HAS/2007-10-03_cepp-1551_m2a_magnum.pdf
HAS/2007-10-03_cepp-_1491_kph.pdf
HAS/2007-10-03_cepp_-_1397_precise_rx_avec_angioguard.pdf
HAS/2007-10-03_ct-3105_exelon.pdf
HAS/2007-10-03_ct-3132_aricept.pdf
HAS/2007-10-03_ct-3146_reminyl_2007_09_27__14_56_33_421.pdf
HAS/2007-10-03_ct-4352_ebixa.pdf
HAS/2007-10-03_ct-4502_glucose_5_p_cent_maco_pharma_.pdf
HAS/2007-10-03_rapport_devaluation_implant_de_renfort_pour_traitement_de_lincontinence_urinaire_deffort_feminine_et_implant_de_renfort_pour_traitement_du_prolapsus_des_organes_pelviens_de_la_femme.pdf
HAS/2007-10-03_relay_1371.pdf
HAS/2007-10-03_synthese_avis_alzheimer_031007.pdf
HAS/2007-10-03_synthese_avis_alzheimer_031007_2007_10_05__10_24_44_497.pdf
HAS/2007-10-09_participation_patients_5_pays_eur.pdf
HAS/2007-10-09_participation_patients_5_pays_eur_annexes.pdf
HAS/2007-10-10_ct-4589_isofundine.pdf
HAS/2007-10-10_ct-4605_mmrvaxpro_.pdf
HAS/2007-10-10_ct-4626_xyrem_.pdf
HAS/2007-10-10_ct-4801_fumafer_.pdf
HAS/2007-10-10_ct-4810_langoran_.pdf
HAS/2007-10-10_ct-4856_revlimid_.pdf
HAS/2007-10-10_ct-4858_protamine_choay_.pdf
HAS/2007-10-10_ct-4861_celectol_.pdf
HAS/2007-10-10_ct-4864_risordan_.pdf
HAS/2007-10-10_ct-4877_fortrans_.pdf
HAS/2007-10-10_ct-4900_lonoten_.pdf
HAS/2007-10-10_ct-4904_colofoam.pdf
HAS/2007-10-10_ct-4907_kinurea_.pdf
HAS/2007-10-10_ct-4914_detensiel_.pdf
HAS/2007-10-10_ct-4915_tardyferon.pdf
HAS/2007-10-10_ct-4940_seloken.pdf
HAS/2007-10-10_ct-4942_lenitral_.pdf
HAS/2007-10-10_ct-4974_ascofer.pdf
HAS/2007-10-10_ct-5038_kerlone_.pdf
HAS/2007-10-10_ct-5084_zyrtec_.pdf
HAS/2007-10-10_ct-5088_humalog.pdf
HAS/2007-10-10_ct-5115_almogran.pdf
HAS/2007-10-10_ct-5160_isocard_.pdf
HAS/2007-10-16_ct031617.pdf
HAS/2007-10-16_ct031618.pdf
HAS/2007-10-16_ct031631.pdf
HAS/2007-10-16_ct031632.pdf
HAS/2007-10-17_cepp-1375mobidisc.pdf
HAS/2007-10-17_cepp-1516_soft_gastric_band_premium.pdf
HAS/2007-10-17_cepp-1529_metamys.pdf
HAS/2007-10-17_cepp-1531sagb.pdf
HAS/2007-10-17_cepp-1540pinnacleultamet.pdf
HAS/2007-10-17_ct031633.pdf
HAS/2007-10-17_ct031634.pdf
HAS/2007-10-24_ct-2132_introna.pdf
HAS/2007-10-24_ct-2153_pentasa_.pdf
HAS/2007-10-24_ct-2379_rowasa_.pdf
HAS/2007-10-24_ct-3701_forlax_.pdf
HAS/2007-10-24_ct-3822_importal_.pdf
HAS/2007-10-24_ct-4143_entocort_.pdf
HAS/2007-10-24_ct-4155_hepsera_.pdf
HAS/2007-10-24_ct-4378_norset_.pdf
HAS/2007-10-24_ct-4665_co_renitec_.pdf
HAS/2007-10-24_ct-4717_duodopa_.pdf
HAS/2007-10-24_ct-4804_lipanor_.pdf
HAS/2007-10-24_ct-4827_psylia_.pdf
HAS/2007-10-24_ct-4828_eductyl_.pdf
HAS/2007-10-24_ct-4834_sotalex_.pdf
HAS/2007-10-24_ct-4835_questran_.pdf
HAS/2007-10-24_ct-4853_artisial.pdf
HAS/2007-10-24_ct-4863_humira_.pdf
HAS/2007-10-24_ct-4867_befizal_.pdf
HAS/2007-10-24_ct-4879_intetrix_.pdf
HAS/2007-10-24_ct-4885_duphalac_.pdf
HAS/2007-10-24_ct-4888_imodium_.pdf
HAS/2007-10-24_ct-4898_lipur_.pdf
HAS/2007-10-24_ct-4939_propranolol_ratiopharm.pdf
HAS/2007-10-24_ct-4961_laxamalt_.pdf
HAS/2007-10-24_ct-4976_sebivo_.pdf
HAS/2007-10-24_ct-5024_soliris_.pdf
HAS/2007-10-24_ct-5036_salazopyrine_.pdf
HAS/2007-10-24_ct-5071_cystadane.pdf
HAS/2007-10-24_ct-5094_normacol_.pdf
HAS/2007-10-24_ct-5102_moducren_.pdf
HAS/2007-10-24_ct-5103_timacor.pdf
HAS/2007-10-24_ct-5166_betatop_.pdf
HAS/2007-10-24_humira_ct_4863.pdf
HAS/2007-10-24_humira_fit_14122012.pdf
HAS/2007-10-25_diagnostic_neuropathie__argumentaire.pdf
HAS/2007-10-25_diagnostic_neuropathies_peripheriques_recommandations.pdf
HAS/2007-10-25_eval_interventions_ameliorer_pratiques_guide.pdf
HAS/2007-10-25_neuropathies_peripheriques_synthese.pdf
HAS/2007-10-31_cepp-1359essure.pdf
HAS/2007-10-31_cepp-1374epitrain.pdf
HAS/2007-10-31_cepp-1413bardventralex.pdf
HAS/2007-10-31_cepp-1414bardcomposixlowprofile.pdf
HAS/2007-10-31_cepp-1435intraswing.pdf
HAS/2007-10-31_cepp-1438taxuslibertelong.pdf
HAS/2007-10-31_cepp-1463xxl300.pdf
HAS/2007-10-31_cepp-1635thoratecivad.pdf
HAS/2007-10-31_cepp-1672cannesbequilles.pdf
HAS/2007-10-31_essure_2008_01_14__15_44_30_690.pdf
HAS/2007-11-07_ct-2110_verapamil_.pdf
HAS/2007-11-07_ct-4065_motilium_.pdf
HAS/2007-11-07_ct-4607_zeclar-monozeclar_.pdf
HAS/2007-11-07_ct-4684_priorix_.pdf
HAS/2007-11-07_ct-4693_unacim_.pdf
HAS/2007-11-07_ct-4765_beta_adalate_.pdf
HAS/2007-11-07_ct-4789_naxy-mononaxy_.pdf
HAS/2007-11-07_ct-4799_primperan.pdf
HAS/2007-11-07_ct-4808_ursolvan_.pdf
HAS/2007-11-07_ct-4809_plitican_.pdf
HAS/2007-11-07_ct-4829_prokynil_.pdf
HAS/2007-11-07_ct-4830_capergyl_.pdf
HAS/2007-11-07_ct-4838_acidum_phosphoricum_compose_.pdf
HAS/2007-11-07_ct-4839_chelidonium_compose_.pdf
HAS/2007-11-07_ct-4840_moduretic_.pdf
HAS/2007-11-07_ct-4841_hamamelis_compose_.pdf
HAS/2007-11-07_ct-4899_soludactone_.pdf
HAS/2007-11-07_ct-4903_aldalix.pdf
HAS/2007-11-07_ct-4906_anausin_metoclopramide.pdf
HAS/2007-11-07_ct-4917_betnesol_.pdf
HAS/2007-11-07_ct-4941_delursan_.pdf
HAS/2007-11-07_ct-4944_isoptine.pdf
HAS/2007-11-07_ct-5016_siklos_.pdf
HAS/2007-11-07_ct-5072_nitronal.pdf
HAS/2007-11-07_ct-5078_tarka_.pdf
HAS/2007-11-07_ct-5085_innovair_.pdf
HAS/2007-11-07_ct-5086_formodual.pdf
HAS/2007-11-07_ct-5101_modamide_.pdf
HAS/2007-11-07_ct-5186_sonovue_.pdf
HAS/2007-11-13_etp_-_comment_elaborer_un_programme_-_recommandations_juin_2007.pdf
HAS/2007-11-13_etp_-_comment_la_proposer_et_la_realiser_-_recommandations_juin_2007.pdf
HAS/2007-11-13_etp_-_definition_finalites_-_recommandations_juin_2007.pdf
HAS/2007-11-13_etp_-_guide_version_finale_2_pdf.pdf
HAS/2007-11-13_etp_-_liste_objectifs_et_questions_devaluation_de_programme.pdf
HAS/2007-11-13_etp_-_principales_rubriques_du_dossier_patient.pdf
HAS/2007-11-13_therapeutic_patient_education_tpe_-_definition_goals_and_organisation_-_quick_reference_guide.pdf
HAS/2007-11-13_therapeutic_patient_education_tpe_-_developing_a_tpe_programme_-_quick_reference_guide.pdf
HAS/2007-11-13_therapeutic_patient_education_tpe_-_offering_and_providing_tpe_-_quick_reference_guide.pdf
HAS/2007-11-14_cepp-1466leoplus.pdf
HAS/2007-11-14_cepp-1678colekinpdf.pdf
HAS/2007-11-14_cepp-955pelvicol.pdf
HAS/2007-11-14_cepp1685-avisgeneralstimulateurstriplechambre.pdf
HAS/2007-11-27_04r15__proto_hygiene_medical.pdf
HAS/2007-11-27_hygiene_au_cabinet_medical_-_argumentaire.pdf
HAS/2007-11-27_hygiene_au_cabinet_medical_-_recommandations_2007_11_27__18_45_21_278.pdf
HAS/2007-11-27_hygiene_au_cabinet_medical_-_synthese.doc.pdf
HAS/2007-11-28_cepp-1303insynciii8042.pdf
HAS/2007-11-28_cepp-1306contakrenewaltr2_h140_.pdf
HAS/2007-11-28_cepp-1307frontierii5596.pdf
HAS/2007-11-28_cepp-1308avisgenerallits_medicauxaccessoires.pdf
HAS/2007-11-28_cepp-1308rapportlitsmedicauxetaccessoires_2008_02_06__16_08_45_197.pdf
HAS/2007-11-28_cepp-1369systeme3d.pdf
HAS/2007-11-28_cepp-1436excludermodificationinscription.pdf
HAS/2007-11-28_cepp-1439excluderrenouvellementinscription.pdf
HAS/2007-11-28_cepp-1603lorider.pdf
HAS/2007-11-28_cepp-1608dynac.pdf
HAS/2007-11-28_cepp-1679fortissimo.pdf
HAS/2007-11-28_cepp-1680xxl.pdf
HAS/2007-11-28_cepp-1681atlas.pdf
HAS/2007-11-28_cepp-1683octave.pdf
HAS/2007-11-28_cepp-1690contakrenewaltr2_h145.pdf
HAS/2007-11-28_cepp-1696terane.pdf
HAS/2007-11-28_cepp-467-avispiedsrestitutiondenergie.pdf
HAS/2007-12-01_criteres_qualite-pnp.pdf
HAS/2007-12-01_listes_des_criteres_qualite-pnp_-_pdf.pdf
HAS/2007-12-05_ct-1579_zeffix_.pdf
HAS/2007-12-05_ct-1630_clopixol_.pdf
HAS/2007-12-05_ct-4240_caldine.pdf
HAS/2007-12-05_ct-4687_pentoxifylline_teva_.pdf
HAS/2007-12-05_ct-4718_vincarutine_.pdf
HAS/2007-12-05_ct-4770_nati_k_.pdf
HAS/2007-12-05_ct-4797_naftilux_.pdf
HAS/2007-12-05_ct-4807_daonil-hemidaonil_.pdf
HAS/2007-12-05_ct-4859_torental_.pdf
HAS/2007-12-05_ct-4871_gevatran_.pdf
HAS/2007-12-05_ct-4874_miglucan-euglucan.pdf
HAS/2007-12-05_ct-4878_tramisal_.pdf
HAS/2007-12-05_ct-4880_ginkogink_.pdf
HAS/2007-12-05_ct-4882_diffu_k_.pdf
HAS/2007-12-05_ct-4905_carlytene.pdf
HAS/2007-12-05_ct-4946_avlocardyl.pdf
HAS/2007-12-05_ct-4962_di_actane.pdf
HAS/2007-12-05_ct-4970_stagid_.pdf
HAS/2007-12-05_ct-4971_trivastal__2008_01_10__15_44_42_966.pdf
HAS/2007-12-05_ct-4972_glucidoral_.pdf
HAS/2007-12-05_ct-4973_vastarel__2008_01_09__17_19_31_835.pdf
HAS/2007-12-05_ct-4978_hydergine_.pdf
HAS/2007-12-05_ct-5012_vasovist.pdf
HAS/2007-12-05_ct-5034_minidiab_.pdf
HAS/2007-12-05_ct-5035_glibenese_.pdf
HAS/2007-12-05_ct-5091_arixtra_.pdf
HAS/2007-12-05_ct-5116_zaditen_.pdf
HAS/2007-12-05_ct-5141_propofol_lipuro.pdf
HAS/2007-12-05_ct-5146_selozok_.pdf
HAS/2007-12-05_ct-5189_ferrisat_.pdf
HAS/2007-12-05_ct-5199_ixprim_.pdf
HAS/2007-12-05_ct-5204_zaldiar_.pdf
HAS/2007-12-05_ct-5253_eligard_.pdf
HAS/2007-12-07_methode_guide_ald_patient.pdf
HAS/2007-12-12_cepp-1279bcmec121207.pdf
HAS/2007-12-12_cepp-1356biomitralnr-900.pdf
HAS/2007-12-12_cepp-1366precision.pdf
HAS/2007-12-12_cepp-1368anaconda.pdf
HAS/2007-12-12_cepp-1373airalert.pdf
HAS/2007-12-12_cepp-1403urgocellkeo.pdf
HAS/2007-12-12_cepp-1509r-godom.pdf
HAS/2007-12-12_cepp-1520bdsalinexs.pdf
HAS/2007-12-12_cepp-1521harmony.pdf
HAS/2007-12-12_cepp-1532trufilldcsorbit.pdf
HAS/2007-12-12_cepp-1533trufilldcsorbitreduced_distal_loop_coils.pdf
HAS/2007-12-12_cepp-1534adept.pdf
HAS/2007-12-12_cepp-1541therabite.pdf
HAS/2007-12-12_cepp-1642sapien9000tfxtransapicale.pdf
HAS/2007-12-12_cepp-1650corevalvetransfemorale.pdf
HAS/2007-12-12_cepp-1676guardianreal-time.pdf
HAS/2007-12-12_cepp-1682sb750.pdf
HAS/2007-12-12_cepp-1697invacareventurehomefillii.pdf
HAS/2007-12-12_cepp-1700ovatiodr6550.pdf
HAS/2007-12-12_cepp-1701ovatiovr6250.pdf
HAS/2007-12-12_cepp-1706vitality2vrt175.pdf
HAS/2007-12-12_cepp-1707vitality2drt165.pdf
HAS/2007-12-12_cepp-1708contakrenewal4_rfh230.pdf
HAS/2007-12-12_cepp-1709contak_renewal4rfh235h239.pdf
HAS/2007-12-12_cepp-1735sapien9000tfxtransfemorale.pdf
HAS/2007-12-19_bat_fiche_eupantol.pdf
HAS/2007-12-19_ct-3356_lanzor_.pdf
HAS/2007-12-19_ct-3378_ogast.pdf
HAS/2007-12-19_ct-3462_pneumo_23_.pdf
HAS/2007-12-19_ct-3729_inexium_.pdf
HAS/2007-12-19_ct-4119_alpress_.pdf
HAS/2007-12-19_ct-4419_inipomp__2008_01_18__16_33_7_925.pdf
HAS/2007-12-19_ct-4421_eupantol_.pdf
HAS/2007-12-19_ct-4431_immugrip_.pdf
HAS/2007-12-19_ct-4443_fluarix_.pdf
HAS/2007-12-19_ct-4498_viracept_.pdf
HAS/2007-12-19_ct-4604_previgrip_.pdf
HAS/2007-12-19_ct-4637_aldomet_.pdf
HAS/2007-12-19_ct-4854_catapressan_.pdf
HAS/2007-12-19_ct-4884_exacyl.pdf
HAS/2007-12-19_ct-4916_eupressyl_mediatensyl_.pdf
HAS/2007-12-19_ct-4979_estulic_.pdf
HAS/2007-12-19_ct-5205_xalacom_.pdf
HAS/2007-12-19_ct-5227_fragmine_.pdf
HAS/2007-12-19_ct-5268_biorgasept_.pdf
HAS/2007-12-19_ct-5296_xelevia.pdf
HAS/2007-12-19_ct-5299_trinitrine_simple_laleuf_.pdf
HAS/2007-12-20_cepp-1297thoratecpvad.pdf
HAS/2007-12-20_cepp-1298heartmatexve.pdf
HAS/2007-12-20_cepp-1634heartmateii.pdf
HAS/2007-12-24_prise_en_charge_des_complications_des_cirrhoses_-_argumentaire.pdf
HAS/2007-12-24_prise_en_charge_des_complications_des_cirrhoses_-_recommandations_2007_12_21__16_27_7_579.pdf
HAS/2007-12-24_prise_en_charge_des_complications_des_cirrhoses_-_synthese.pdf
HAS/2007-12-24_rapport_audition_at_def_webdec07_.pdf
HAS/2008-01-02_denutrition_personnes_agees_ceapp.pdf
HAS/2008-01-03_cepp-1364endeavor.pdf
HAS/2008-01-03_reply_-_1607.pdf
HAS/2008-01-03_symphony_dr_2550_-_1525.pdf
HAS/2008-01-23_ct-2419_abelite_.pdf
HAS/2008-01-23_ct-3591_exacor_.pdf
HAS/2008-01-23_ct-3969_combivir_.pdf
HAS/2008-01-23_ct-4199_agenerase.pdf
HAS/2008-01-23_ct-4244_isudrine.pdf
HAS/2008-01-23_ct-4794_truvada_.pdf
HAS/2008-01-23_ct-4798_rythmodan_.pdf
HAS/2008-01-23_ct-4832_cipralan_.pdf
HAS/2008-01-23_ct-4857_calciparine_.pdf
HAS/2008-01-23_ct-4869_moxydar_.pdf
HAS/2008-01-23_ct-4894_isorythm_.pdf
HAS/2008-01-23_ct-4895_phosphalugel_.pdf
HAS/2008-01-23_ct-4896_gastropulgite_.pdf
HAS/2008-01-23_ct-4897_gelox_.pdf
HAS/2008-01-23_ct-4953_topaal_.pdf
HAS/2008-01-23_ct-4954_serecor.pdf
HAS/2008-01-23_ct-4956_cordarone_.pdf
HAS/2008-01-23_ct-4958_rythmol_.pdf
HAS/2008-01-23_ct-4959_rocgel_.pdf
HAS/2008-01-23_ct-5247_contracide_.pdf
HAS/2008-01-23_ct-5271_opatanol_.pdf
HAS/2008-01-23_ct-5282_biocoversyl_.pdf
HAS/2008-01-23_ct-5290_naabak-naaxia-naaxiafree_.pdf
HAS/2008-01-23_ct-5295_zymad_.pdf
HAS/2008-01-23_ct-5303_toplexil_.pdf
HAS/2008-01-23_ct-5311_glutril.pdf
HAS/2008-01-23_ct-5337_optison_.pdf
HAS/2008-01-23_zanidip_-_ct-4850.pdf
HAS/2008-01-23_zanidip_ct_4850.pdf
HAS/2008-01-30_cepp-1231flotechimage.pdf
HAS/2008-01-30_cepp-1232flotechsolution.pdf
HAS/2008-01-30_cepp-1535newfill.pdf
HAS/2008-01-30_cepp-1537adaptadrmod._addro1-addrs1-addrl1.pdf
HAS/2008-01-30_cepp-1537adaptadrmod.addr03-addr06.pdf
HAS/2008-01-30_cepp-1691zomajet2vision_2008_02_13__12_37_8_459.pdf
HAS/2008-01-30_cepp-1692zomajetvisionx.pdf
HAS/2008-01-30_cepp-1739paradymsonr8770.pdf
HAS/2008-01-30_cepp-1740paradymdr8550.pdf
HAS/2008-01-30_cepp-1741universal.pdf
HAS/2008-01-30_document_avis_valves_2008.pdf
HAS/2008-01-30_rapport_valves_2008.pdf
HAS/2008-01-30_synthese_valves_2008.pdf
HAS/2008-02-02_consultation_dietetique_-_critere_de_qualite_-_final_pdf.pdf
HAS/2008-02-02_liste_des_criteres_dietetique_-_pdf_2008_04_18__14_26_16_673.pdf
HAS/2008-02-06_ct-1562_dicetel_.pdf
HAS/2008-02-06_ct-3236_acupan.pdf
HAS/2008-02-06_ct-4852_visceralgine_.pdf
HAS/2008-02-06_ct-4950_spasfon_.pdf
HAS/2008-02-06_ct-4964_meteospasmyl_.pdf
HAS/2008-02-06_ct-4966_meteoxane_.pdf
HAS/2008-02-06_ct-4969_fluogel_.pdf
HAS/2008-02-06_ct-5011_debridat_.pdf
HAS/2008-02-06_ct-5203_kineret_.pdf
HAS/2008-02-06_ct-5208_spasfon_lyoc_.pdf
HAS/2008-02-06_ct-5265_neutravera_.pdf
HAS/2008-02-06_ct-5301_cartrex_.pdf
HAS/2008-02-06_ct-5317_cencaran_.pdf
HAS/2008-02-06_ct-5319_theinol.pdf
HAS/2008-02-06_ct-5357_logirene_.pdf
HAS/2008-02-13_avis_gastrectomie_longitudinale.pdf
HAS/2008-02-13_avis_gastrectomie_longitudinale_2008_04_14__16_31_23_198.pdf
HAS/2008-02-13_cepp-1296stratoslv-t.pdf
HAS/2008-02-13_cepp-1444hemicapgenou.pdf
HAS/2008-02-13_cepp-1536revealdx9528.pdf
HAS/2008-02-13_cepp-1560polyflex.pdf
HAS/2008-02-13_cepp-1627durasulcotyle.pdf
HAS/2008-02-13_cepp-1632aorfix.pdf
HAS/2008-02-13_cepp-1651durasulinsert.pdf
HAS/2008-02-13_rapport_gastrectomie_longitudinale.pdf
HAS/2008-02-20_ct-4541_neoral-sandimmun_.pdf
HAS/2008-02-20_ct-4601_plavix_.pdf
HAS/2008-02-20_ct-4803_speciafoldine.pdf
HAS/2008-02-20_ct-4908_tardyferon_.pdf
HAS/2008-02-20_ct-4936_spasmag_.pdf
HAS/2008-02-20_ct-5027_abilify_.pdf
HAS/2008-02-20_ct-5279_binocrit_.pdf
HAS/2008-02-20_ct-5341_cernevit_.pdf
HAS/2008-02-29_lap_vih_finalweb.pdf
HAS/2008-02-29_vih_guidemedecin_version_web.pdf
HAS/2008-03-03_masso-kinesitherapie_apres_prothese_totale_de_genou_-_grille_de_recueil.pdf
HAS/2008-03-03_masso-kinesitherapie_apres_prothese_totale_de_genou_-_liste_de_criteres.pdf
HAS/2008-03-03_masso-kinesitherapie_apres_prothese_totale_de_genou_-_serie_de_criteres_de_qualite.pdf
HAS/2008-03-03_orientation_apres_prothese_totale_de_genou_-_grille_de_recueil.pdf
HAS/2008-03-03_orientation_apres_prothese_totale_de_genou_-_liste_de_criteres.pdf
HAS/2008-03-03_orientation_apres_prothese_totale_de_genou_-_serie_de_criteres_de_qualite.pdf
HAS/2008-03-03_reeducation_genou_ptg_-_argumentaire.pdf
HAS/2008-03-03_reeducation_genou_ptg_-_recommandations.pdf
HAS/2008-03-03_reeducation_genou_ptg_-_synthese_des_recommandations.pdf
HAS/2008-03-05_cervarix_ct_5090.pdf
HAS/2008-03-05_ct-3055_valium__2008_03_28__14_06_35_208.pdf
HAS/2008-03-05_ct-4836_prinivil_.pdf
HAS/2008-03-05_ct-4848_ferograd_.pdf
HAS/2008-03-05_ct-4849_ferrostrane.pdf
HAS/2008-03-05_ct-4957_zestril_.pdf
HAS/2008-03-05_ct-5090_cervarix_.pdf
HAS/2008-03-05_ct-5152_prinivil_.pdf
HAS/2008-03-05_ct-5153_zestril_.pdf
HAS/2008-03-05_ct-5367_apsor.pdf
HAS/2008-03-05_ct-5403_artelac_.pdf
HAS/2008-03-05_ct-5404_zumalgic.pdf
HAS/2008-03-12_chirurgie_des_tendinopathies_rompues_de_la_coiffe_des_rotateurs_-_argumentaire.pdf
HAS/2008-03-12_chirurgie_des_tendinopathies_rompues_de_la_coiffe_des_rotateurs_-_recommandations.pdf
HAS/2008-03-12_chirurgie_des_tendinopathies_rompues_de_la_coiffe_des_rotateurs_-_synthese.pdf
HAS/2008-03-12_reeducation_epaule_-_score_de_constant.pdf
HAS/2008-03-12_surgical_management_of_rotator_cuff_tears_in_adults_-_quick_reference_guide_-_version_anglaise.pdf
HAS/2008-03-12_surgical_management_of_rotator_cuff_tears_in_adults_-_quick_reference_guide_-_version_anglaise_2012-06-19_14-57-2_340.pdf
HAS/2008-03-19_ct-5333_fluorure_de_calcium.pdf
HAS/2008-03-19_ct-5335_sebiprox.pdf
HAS/2008-03-19_ct-5377_xeomin_.pdf
HAS/2008-03-19_ct-5384_avamys_.pdf
HAS/2008-03-19_ct-5406_logroton_.pdf
HAS/2008-04-01_07r04_algo_reeducation_epaule_orientation_du_patient.pdf
HAS/2008-04-01_07r04_form_reeducation_epaule_fiche_de_synthese_du_bilan_2013-03-14_16-20-56_942.pdf
HAS/2008-04-01_07r04_form_reeducation_epaule_prescription_type.pdf
HAS/2008-04-01_anesm_elements-appropriation_inclusionsociale06.pdf
HAS/2008-04-01_anesm_synthese-verte-expressionetparticipationdesusagers.pdf
HAS/2008-04-01_cepp-1393acticonneosphincter.pdf
HAS/2008-04-01_cepp-1394picoelite.pdf
HAS/2008-04-01_cepp-1508matrixpplus.pdf
HAS/2008-04-01_cepp-1643variliteevolution.pdf
HAS/2008-04-01_cepp-898_audioprotheses.pdf
HAS/2008-04-01_cepp-898avisaudioprotheses010408.pdf
HAS/2008-04-01_guideline_post-operative_shoulder_rehabilitation_english_version.pdf
HAS/2008-04-01_masso-kinesitherapie_apres_chirurgie_des_ruptures_de_coiffe_et_arthroplasties_depaule_-_grille_de_recueil.pdf
HAS/2008-04-01_masso-kinesitherapie_apres_chirurgie_des_ruptures_de_coiffe_et_arthroplasties_depaule_-_liste_de_criteres.pdf
HAS/2008-04-01_masso-kinesitherapie_apres_chirurgie_des_ruptures_de_coiffe_et_arthroplasties_depaule_-_serie_de_criteres_de_qualite.pdf
HAS/2008-04-01_orientation_apres_chirurgie_de_ruptures_de_coiffe_et_arthroplaties_depaule_-_grille_de_recueil.pdf
HAS/2008-04-01_orientation_apres_chirurgie_des_ruptures_de_coiffe_et_arthroplasties_depaule_-_liste_de_criteres.pdf
HAS/2008-04-01_orientation_apres_chirurgie_des_ruptures_de_coiffe_et_arthroplasties_depaule_-_serie_de_criteres_de_qualite.pdf
HAS/2008-04-01_quick_reference_guide_post-operative_shoulder_rehabilitation_english_version.pdf
HAS/2008-04-01_reco_expression_participation_usagers.pdf
HAS/2008-04-01_reeducation_epaule_-_argumentaire.pdf
HAS/2008-04-01_reeducation_epaule_-_questionnaire_dash.pdf
HAS/2008-04-01_reeducation_epaule_-_recommandations.pdf
HAS/2008-04-01_reeducation_epaule_-_score_de_constant.pdf
HAS/2008-04-01_reeducation_epaule_-_synthese.pdf
HAS/2008-04-01_reeducation_genou_lca_-_argumentaire.pdf
HAS/2008-04-01_reeducation_genou_lca_-_recommandations.pdf
HAS/2008-04-01_reeducation_genou_lca_-_synthese_des_recommandations.pdf
HAS/2008-04-15_cepp-1538activa.pdf
HAS/2008-04-15_cepp-1582biostar.pdf
HAS/2008-04-15_cepp-1628orthesetypeorm.pdf
HAS/2008-04-15_cepp-1752confientdr.pdf
HAS/2008-04-15_cepp-1758livianmodh240h247.pdf
HAS/2008-04-15_cepp-1759endeavorsprintrx.pdf
HAS/2008-04-15_cepp-1763teligen100drmodf110pdf.pdf
HAS/2008-04-15_cepp-1764teligen100vrmod_f102.pdf
HAS/2008-04-15_cepp-1765cognis100dmodp106.pdf
HAS/2008-04-15_cepp-1766xiencev.pdf
HAS/2008-04-15_cepp-1767promus.pdf
HAS/2008-04-15_cepp-1788cognis100dmodp107.pdf
HAS/2008-04-15_cepp-1790livianmodh245h249.pdf
HAS/2008-04-15_cepp-787restoreavis_2008_05_20__10_24_54_61.pdf
HAS/2008-04-15_cepp-787restorefit_2008_05_20__10_24_55_490.pdf
HAS/2008-04-15_ct-4357_zophren_.pdf
HAS/2008-04-15_zophren_ct_4357.pdf
HAS/2008-04-16_cooperation_cneh_etude_finale_2008_04_16__12_26_17_32.pdf
HAS/2008-04-16_ct-4766_dedrogyl_.pdf
HAS/2008-04-16_ct-4767_sterogyl_.pdf
HAS/2008-04-16_ct-4955_smecta.pdf
HAS/2008-04-16_ct-4963_vitamine_d3_.pdf
HAS/2008-04-16_ct-5197_uvedose.pdf
HAS/2008-04-16_ct-5258_uvesterol_.pdf
HAS/2008-04-16_ct-5309_ceris_.pdf
HAS/2008-04-16_ct-5331_divarius_.pdf
HAS/2008-04-16_ct-5416_tussidane_.pdf
HAS/2008-04-16_ct-5424_glucose_5__.pdf
HAS/2008-04-16_ct-5425_chlorure_de_sodium_.pdf
HAS/2008-04-16_ct-5426_wystamm_.pdf
HAS/2008-04-16_ct-5444_pletal_.pdf
HAS/2008-04-16_ct-5461_triatec_.pdf
HAS/2008-04-16_guide_methodo_tome1_21072010_2010-09-03_14-07-15_44.pdf
HAS/2008-04-16_pletal_ct_5444.pdf
HAS/2008-04-16_rapport_de_synthese_des_evaluations_quantitatives_relatives_aux_nouvelles_formes_de_cooperation_entre_professionnels_de_sant.pdf
HAS/2008-04-16_rapport_etape_cooperation.pdf
HAS/2008-04-16_reco_cooperation_vvd_16_avril_2008_04_16__12_23_31_188.pdf
HAS/2008-04-18_ct-4069_savene_.pdf
HAS/2008-04-18_savene_ct_4069.pdf
HAS/2008-04-24_ct-4512_sutent.pdf
HAS/2008-04-24_sutent_ct_4512.pdf
HAS/2008-04-29_cepp-1539archimedes.pdf
HAS/2008-04-29_cepp-1671conservetotal.pdf
HAS/2008-04-29_cepp-1773avisradiationpompesimplantables.pdf
HAS/2008-04-29_ct-4468_thelin_.pdf
HAS/2008-04-29_ct-4473_tracleer.pdf
HAS/2008-04-29_iasulet_1698.pdf
HAS/2008-04-29_thelin_ct_4468.pdf
HAS/2008-04-29_tracleer_ct_4473.pdf
HAS/2008-04-30_ct-4806_nalcron_.pdf
HAS/2008-04-30_ct-4902_minipress_.pdf
HAS/2008-04-30_ct-5330_tensionorme_.pdf
HAS/2008-04-30_ct-5463_optimark_.pdf
HAS/2008-04-30_keto-diastix_15_avril_2008_1760_avis.pdf
HAS/2008-05-07_ct-4513_januvia.pdf
HAS/2008-05-07_ct-5296_xelevia.pdf
HAS/2008-05-07_fiche_medicament_januvia_mars2008.pdf
HAS/2008-05-13_cepp-1631surgiwrap.pdf
HAS/2008-05-13_cepp-1688rheokneepdf.pdf
HAS/2008-05-13_cepp-1695norian.pdf
HAS/2008-05-13_cepp-1747cypherselect.pdf
HAS/2008-05-13_cepp-1783cypherselectplus.pdf
HAS/2008-05-14_actonel_ct_4544.pdf
HAS/2008-05-14_ct-2337_pepdine_.pdf
HAS/2008-05-14_ct-2611_nizaxid_.pdf
HAS/2008-05-14_ct-3450_azantac_.pdf
HAS/2008-05-14_ct-4544_actonel_osteo_mas.pdf
HAS/2008-05-14_ct-4800_vitamine_b12_delagrange_.pdf
HAS/2008-05-14_ct-4951_raniplex_.pdf
HAS/2008-05-14_ct-4975_vitamine_b12_gerda.pdf
HAS/2008-05-14_ct-5267_xyzall.pdf
HAS/2008-05-14_ct-5368_tubertest_.pdf
HAS/2008-05-14_ct-5376_dodecavit.pdf
HAS/2008-05-14_ct-5524_duspatalin.pdf
HAS/2008-05-20_ct-5029_glivec.pdf
HAS/2008-05-20_glivec_smd_ct_5029.pdf
HAS/2008-05-21_ct-2829_diclofenac_mika_pharma_.pdf
HAS/2008-05-21_ct-3144_sutent.pdf
HAS/2008-05-21_diclofenac_sodique_mika_ct_2829.pdf
HAS/2008-05-21_sutent_ct_3144.pdf
HAS/2008-05-26_rapport_nutrition_parenterale_a_domicile_2009-03-24_14-25-25_13.pdf
HAS/2008-05-26_synthese_rapport_devaluation_nutrition_parenterale_a_domicile.pdf
HAS/2008-05-27_cepp-1633helistenttitan2.pdf
HAS/2008-05-27_cepp-1646eon.pdf
HAS/2008-05-27_cepp-1742synchromedii.pdf
HAS/2008-05-27_cepp-1751mets.pdf
HAS/2008-05-27_cepp-1753integra.pdf
HAS/2008-05-27_cepp-1768bardreadylinkbardquicklink_2008-07-22_17-25-37_98.pdf
HAS/2008-05-27_cepp-1771synvisc-one.pdf
HAS/2008-05-27_cepp-1782zenithtx1tx2.pdf
HAS/2008-05-27_cepp-1791mobidisc.pdf
HAS/2008-05-27_cepp-1793invacareventurehomefilliiperfecto2pdf.pdf
HAS/2008-05-27_cepp_1283_avis_endoprothese_aortique_abdominale.pdf
HAS/2008-05-27_mets-27_mai_2008_1751_synthese_davis.pdf
HAS/2008-05-28_ct-5237_protopic_.pdf
HAS/2008-05-28_ct-5381_humira_.pdf
HAS/2008-05-28_ct-5389_prostigmine_.pdf
HAS/2008-05-28_ct-5467_acide_folique_.pdf
HAS/2008-05-28_ct-5480_rubozinc_.pdf
HAS/2008-05-28_ct-5484_helicobacter_test_infai_.pdf
HAS/2008-05-28_humira_ct_5381.pdf
HAS/2008-05-28_humira_fit_14122012.pdf
HAS/2008-05-29_antibiotic_therapy_and_prevention_of_bacterial_resistance_-_checklists_for_professional_practice_appraisal.pdf
HAS/2008-05-29_antibiotic_therapy_and_prevention_of_bacterial_resistance_-_guidelines.pdf
HAS/2008-05-29_bon_usage_des_antibiotiques_grilles_epp.pdf
HAS/2008-05-29_bon_usage_des_antibiotiques_rapport_complet.pdf
HAS/2008-05-29_bon_usage_des_antibiotiques_recommandations.pdf
HAS/2008-06-01_rapport_irm_vf.pdf
HAS/2008-06-01_synthese_rapports_irm__equipe_cedit.pdf
HAS/2008-06-10_cepp-1530philosiidr-t.pdf
HAS/2008-06-10_cepp-1677physiostimlite.pdf
HAS/2008-06-10_cepp-1744endeavor.pdf
HAS/2008-06-10_cepp-1762interstim.pdf
HAS/2008-06-10_cepp-1772powerlink.pdf
HAS/2008-06-10_cepp-1781zenithflex.pdf
HAS/2008-06-10_cepp_1757_talent_lps_hydro.pdf
HAS/2008-06-11_ct-4037_mag_2_.pdf
HAS/2008-06-11_ct-4802_magneb6_.pdf
HAS/2008-06-11_ct-4935_spasmag_.pdf
HAS/2008-06-11_ct-4967_uvimag_.pdf
HAS/2008-06-11_ct-5010_megamag_.pdf
HAS/2008-06-11_ct-5276_renagel_.pdf
HAS/2008-06-11_ct-5306_efimag_.pdf
HAS/2008-06-11_ct-5387_doxypalu_.pdf
HAS/2008-06-11_ct-5432_reyataz_.pdf
HAS/2008-06-11_ct-5491_actonel_.pdf
HAS/2008-06-11_ct031810.pdf
HAS/2008-06-11_ct031821.pdf
HAS/2008-06-11_ct031822.pdf
HAS/2008-06-11_lesions_meniscales_-_grille_de_recueil_des_criteres_2009-12-30_12-26-18_74.pdf
HAS/2008-06-11_lesions_meniscales_-_liste_de_criteres_de_qualite.pdf
HAS/2008-06-11_lesions_meniscales_-_serie_de_criteres_de_qualite_2009-12-30_12-26-40_991.pdf
HAS/2008-06-11_lesions_meniscales_et_du_ligament_croise_anterieur_-_argumentaire.pdf
HAS/2008-06-11_lesions_meniscales_et_du_ligament_croise_anterieur_-_recommandations.pdf
HAS/2008-06-11_lesions_meniscales_et_du_ligament_croise_anterieur_-_synthese.pdf
HAS/2008-06-11_meniscal_lesions_and_isolated_lesions_anterior_cruciate_ligament_-_guidelines_-_version_anglaise.pdf
HAS/2008-06-11_paludisme_note_de_synthese_2008-06-11_17-46-7_488.pdf
HAS/2008-06-11_synthese_davis_magnesium_seul_-_ct-4037_-_5010_-_5951.pdf
HAS/2008-06-11_treatment_of_meniscal_lesions_and_isolated_lesions_-_quick_reference_guide_-_version_anglaise.pdf
HAS/2008-06-18_avis_anastomose_tubo_tubaire.pdf
HAS/2008-06-18_avis_drilling_ovarien.pdf
HAS/2008-06-18_avis_myomectomie.pdf
HAS/2008-06-18_rapport_anastomose_tubo_tubaire.pdf
HAS/2008-06-18_rapport_drilling__ovarien.pdf
HAS/2008-06-18_rapport_myomectomie.pdf
HAS/2008-06-18_synthese_anastomose_tubo_tubaire.pdf
HAS/2008-06-18_synthese_myomectomie.pdf
HAS/2008-06-18_texte_court_drilling_ovarien.pdf
HAS/2008-06-20_ct032015.pdf
HAS/2008-06-20_ct032016.pdf
HAS/2008-06-24_cepp-1524_isosource_energy_fibre.pdf
HAS/2008-06-24_cepp-1749baha.pdf
HAS/2008-06-24_cepp-1791_mobidisc_avis_2009-02-03_11-08-2_289.pdf
HAS/2008-06-24_cepp-1791_mobidisc_fit.pdf
HAS/2008-06-24_cepp-1800_maverick_fit.pdf
HAS/2008-06-24_cepp-1800_mavericksdc.pdf
HAS/2008-06-24_cepp-1831_protheses_discales_lombaires.pdf
HAS/2008-06-24_cepp-790_prodiscl_avis.pdf
HAS/2008-06-24_cepp-790_prodiscl_fit.pdf
HAS/2008-06-24_cepp-860_sb_charite_avis.pdf
HAS/2008-06-24_cepp-860_sb_charite_fit.pdf
HAS/2008-06-24_cepp_1561_bhr.pdf
HAS/2008-06-24_cepp_1737_asr_xl_head.pdf
HAS/2008-06-24_cepp_1738_asr.pdf
HAS/2008-06-24_cepp_1774_stratos_pro_2008-07-07_14-38-42_592.pdf
HAS/2008-06-24_cepp_1778_visco_maxi.pdf
HAS/2008-06-24_cepp_1779_visco_topi.pdf
HAS/2008-06-24_cepp_1804_nucleus_freedom.pdf
HAS/2008-06-25_ald19_lap_pnds_sni.pdf
HAS/2008-06-25_ct-1751_zerit.pdf
HAS/2008-06-25_ct-4241_atrovent_.pdf
HAS/2008-06-25_ct-4768_becilan_.pdf
HAS/2008-06-25_ct-4769_bevitine_.pdf
HAS/2008-06-25_ct-4932_benerva_.pdf
HAS/2008-06-25_ct-5176_a313_50000ui.pdf
HAS/2008-06-25_ct-5329_prograf_.pdf
HAS/2008-06-25_ct-5515_avodart_.pdf
HAS/2008-06-25_ct-5525_smoflipid.pdf
HAS/2008-06-25_ct-5530_baseal_.pdf
HAS/2008-06-25_ct-5647_atrovent_nasal_.pdf
HAS/2008-06-25_ct-743_zerit.pdf
HAS/2008-06-30_anesm_elements-appropriation_conduitesviolentes06.pdf
HAS/2008-06-30_anesm_synthese-bleu-conduitesviolentes.pdf
HAS/2008-06-30_reco_conduites_violentes.pdf
HAS/2008-07-01_adaptation_emploi_note_methodologique_anesm.pdf
HAS/2008-07-01_anesm_elements-appropriation_bientraitrance06.pdf
HAS/2008-07-01_anesm_elements-appropriation_strategieadaptationalemploi06.pdf
HAS/2008-07-01_anesm_synthese-bientraitance.pdf
HAS/2008-07-01_anesm_synthese-bleu-strategieadaptationemploi.pdf
HAS/2008-07-01_bientraitance_premieres_rencontres_anesm_compte_rendu.pdf
HAS/2008-07-01_elements_appreciation_outils_bientraitance_maltraitance_anesm-2.pdf
HAS/2008-07-01_lettre_de_mission_bientraitance.pdf
HAS/2008-07-01_programme_rencontres_anesm_281108.pdf
HAS/2008-07-01_reco_adaptation_emploi.pdf
HAS/2008-07-01_reco_bientraitance.pdf
HAS/2008-07-01_revue_litterature_bientraitance_anesm.pdf
HAS/2008-07-01_surveillance_des_cirrhoses_non_compliquees_-_criteres_de_qualite.pdf
HAS/2008-07-01_surveillance_des_cirrhoses_non_compliquees_-_grille_de_recueil_des_criteres.pdf
HAS/2008-07-01_surveillance_des_cirrhoses_non_compliquees_-_liste_de_criteres_de_qualite.pdf
HAS/2008-07-02_rapport_implantologie_orale_vd.pdf
HAS/2008-07-02_synthese_implantologie_orale_vd.pdf
HAS/2008-07-03_cepp-1581preciseprorx.pdf
HAS/2008-07-08_cep-1803_elite.pdf
HAS/2008-07-08_cepp_1254_avis_appareils_phototherapie_080708.pdf
HAS/2008-07-08_cepp_1705_lipimix.pdf
HAS/2008-07-08_cepp_1746_custombone.pdf
HAS/2008-07-08_cepp_1756_mepilex.pdf
HAS/2008-07-08_cepp_1826_hiresolutionbionicear.pdf
HAS/2008-07-16_cepp-1300softformpremierglidespgm197.pdf
HAS/2008-07-16_cepp-1301softformoriginalsf100_2008-07-16_12-19-40_492.pdf
HAS/2008-07-16_ct-5511_oliclinomel_.pdf
HAS/2008-07-16_ct_nutrition_parenterale_a_domicile__280508.pdf
HAS/2008-07-22_20080718_referentiel_evaluation__cmr_2008-07-21_11-25-6_521.pdf
HAS/2008-07-22_20080721_tableau_comparatif_referentiels_2008-07-21_11-25-43_247.pdf
HAS/2008-07-28_echelle_asi-annexe_2_des_recommandations.pdf
HAS/2008-07-28_reco_polyconsommations_-_version_finale_2007_12_21__21_47_28_78.pdf
HAS/2008-08-01_05r26_form_surveillance_cirrhose_formulaires_de_bilan_echographique_hepatique.pdf
HAS/2008-08-01_avastin_en_ct__5075_def.pdf
HAS/2008-08-01_baraclude_en_ct3487_val.pdf
HAS/2008-08-01_champix_ct_4154.pdf
HAS/2008-08-01_ct-3054_herceptin_.pdf
HAS/2008-08-01_ct-3381_exjade_.pdf
HAS/2008-08-01_ct-3487_baraclude_.pdf
HAS/2008-08-01_ct-3967_factane_.pdf
HAS/2008-08-01_ct-4058_datscan_.pdf
HAS/2008-08-01_ct-4100_hexvix_.pdf
HAS/2008-08-01_ct-4154_champix_.pdf
HAS/2008-08-01_ct-4216_iasodopa_.pdf
HAS/2008-08-01_ct-4260_inofer_.pdf
HAS/2008-08-01_ct-4347_diacomit_.pdf
HAS/2008-08-01_ct-4513_januvia.pdf
HAS/2008-08-01_ct-4685_zelitrex.pdf
HAS/2008-08-01_ct-4715_relenza.pdf
HAS/2008-08-01_ct-5075_avastin_.pdf
HAS/2008-08-01_ct-5099_exelon_.pdf
HAS/2008-08-01_datscan_ct_4058.pdf
HAS/2008-08-01_diacomit_ct_4347.pdf
HAS/2008-08-01_evoltra.pdf
HAS/2008-08-01_evoltra_ct_3682.pdf
HAS/2008-08-01_exelon_ct_2879.pdf
HAS/2008-08-01_exjade_ct_3381.pdf
HAS/2008-08-01_factane_ct_3967.pdf
HAS/2008-08-01_herceptin__ei_ct_3054.pdf
HAS/2008-08-01_hexvix_ct_4100.pdf
HAS/2008-08-01_iasodopa_ct_4216.pdf
HAS/2008-08-01_inofer_ct_4260.pdf
HAS/2008-08-01_januvia_ct_4513_2010-01-12_16-03-33_31.pdf
HAS/2008-08-01_relenza_ct_4715_2010-01-12_16-19-24_757.pdf
HAS/2008-08-01_surveillance_cirrhose_-_argumentaire.pdf
HAS/2008-08-01_surveillance_cirrhose_-_recommandations_2008_02_13__17_41_31_104.pdf
HAS/2008-08-01_surveillance_cirrhose_-_synthese_2008_02_13__17_41_18_601.pdf
HAS/2008-08-01_surveillance_des_cirrhoses_non_compliquees_-_criteres_de_qualite.pdf
HAS/2008-08-01_surveillance_des_cirrhoses_non_compliquees_-_grille_de_recueil_des_criteres.pdf
HAS/2008-08-01_surveillance_des_cirrhoses_non_compliquees_-_liste_de_criteres_de_qualite.pdf
HAS/2008-08-01_zelitrex_ct_4685.pdf
HAS/2008-08-26_atbp_-_rapport_final.pdf
HAS/2008-08-26_atbp_pth.pdf
HAS/2008-08-26_bon_usage_des_antibiotiques_recommandations.pdf
HAS/2008-09-02_cepp-1755-e-motion.pdf
HAS/2008-09-02_cepp-1801_paradym_crt8750.pdf
HAS/2008-09-02_jlestv-20-32-s300.pdf
HAS/2008-09-02_lombaldec2000.pdf
HAS/2008-09-02_lombalgie_dec2000_recos.pdf
HAS/2008-09-02_resume_j_cogneau_2001.pdf
HAS/2008-09-02_surdosage_en_avk_situations_a_risque_et_accidents_hemorragiques_-_recommandations_v2.pdf
HAS/2008-09-02_surdosage_en_avk_situations_a_risque_et_accidents_hemorragiques_-_synthese_des_recommandations_v2.pdf
HAS/2008-09-03_05r44_exple_surdosage_en_avk_exemple_de_relais_preoperatoire_2013-03-14_16-31-16_391.pdf
HAS/2008-09-03_05r44_info_mg_surdosage_en_avk_document_destine_aux_medecins_generalistes.pdf
HAS/2008-09-03_avc_delais_referentiel_2006.pdf
HAS/2008-09-03_avc_information_continuite_soins_referentiel_2006.pdf
HAS/2008-09-03_avc_organisationnel_referentiel_2006.pdf
HAS/2008-09-03_avc_preparation_sortie_referentiel_2006.pdf
HAS/2008-09-03_avc_prevention_complications_referentiel_2006.pdf
HAS/2008-09-03_avc_traitements_referentiel_2006.pdf
HAS/2008-09-03_canal_carpien_referentiel_2003.pdf
HAS/2008-09-03_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-09-03_dossier_neurologie_referentiel_2003.pdf
HAS/2008-09-03_gp_parkinson_10818_001_008.pdf
HAS/2008-09-03_guide_parcours_de_soins_parkinson.pdf
HAS/2008-09-03_jlestv-20-32-s300.pdf
HAS/2008-09-03_lombal.pdf
HAS/2008-09-03_lombaldec2000.pdf
HAS/2008-09-03_lombalgie_dec2000_recos.pdf
HAS/2008-09-03_lombreco.pdf
HAS/2008-09-03_park.pdf
HAS/2008-09-03_parkcourt.pdf
HAS/2008-09-03_patient_atteint_parkinson_referentiel_2003.pdf
HAS/2008-09-03_surdosage_en_avk_situations_a_risque_et_accidents_hemorragiques_-_recommandations_v2.pdf
HAS/2008-09-03_surdosage_en_avk_situations_a_risque_et_accidents_hemorragiques_-_synthese_des_recommandations_v2.pdf
HAS/2008-09-03_syndromes_parkinsoniens.pdf
HAS/2008-09-03_syndromes_parkinsoniens_liste_actes_presta.pdf
HAS/2008-09-04_08-106_bat_ime_fm_aclasta.pdf
HAS/2008-09-10_document_de_travail._analyse_critique_de_la_litterature.pdf
HAS/2008-09-10_document_de_travail_-_resultats_denquetes_descriptives.pdf
HAS/2008-09-10_rapport_dorientation_analyse_economique_et_organisationnelle.pdf
HAS/2008-09-10_synthese_analyse_economique_et_organisationnelle_education_therapeutique.pdf
HAS/2008-09-16_cepp-1748_genesis.pdf
HAS/2008-09-16_cepp-1796_systane.pdf
HAS/2008-09-16_cepp-1829_restoreadvanced___fit.pdf
HAS/2008-09-16_cepp-1829_restoreadvanced_restoreultra__avis.pdf
HAS/2008-09-16_cepp-1829_restoreultra___fit.pdf
HAS/2008-09-17_document_davis_apolipoa1b.pdf
HAS/2008-09-17_fiche_butm_apolipo.pdf
HAS/2008-09-17_fiche_butm_traitement_endodontique.pdf
HAS/2008-09-17_rapport_apolipoa1b.pdf
HAS/2008-09-17_rapport_traitement_endodontique.pdf
HAS/2008-09-17_texte_court_apolipoa1b.pdf
HAS/2008-09-17_texte_court_traitement_endodontique.pdf
HAS/2008-09-22_05r20_crit_qual_syncope.pdf
HAS/2008-09-22_07r01_exple_arret_des_bzd_courrier_d_information_2013-03-14_16-00-27_646.pdf
HAS/2008-09-22_07r01_form_arret_des_bzd__calendrier_de_suivi_2013-03-14_16-00-6_693.pdf
HAS/2008-09-22_arret_des_bzd_-_agenda_sommeil_-_eveil.pdf
HAS/2008-09-22_arret_des_bzd_-_argumentaire.pdf
HAS/2008-09-22_arret_des_bzd_-_echelle_ecab.pdf
HAS/2008-09-22_arret_des_bzd_-_echelle_ecab_-_document_patient.pdf
HAS/2008-09-22_arret_des_bzd_-_rcp_commun_aux_bzd.pdf
HAS/2008-09-22_arret_des_bzd_-_signes_a_larret_des_bzd.pdf
HAS/2008-09-22_prescription_psychotropes_sujet_age_version_courte_2007_11_07__19_34_38_576.pdf
HAS/2008-09-22_rapport_psychotropes_version_longue_190208.pdf
HAS/2008-09-22_recommandations_bzd_-_version_finale_2008.pdf
HAS/2008-09-22_syncopes_-_argumentaire_2008-07-31_18-37-7_786.pdf
HAS/2008-09-22_syncopes_-_recommandations.pdf
HAS/2008-09-22_syncopes_-_synthese_des_recommandations.pdf
HAS/2008-09-22_synthese_bzd_-_version_finale_2008.pdf
HAS/2008-09-23_guide_de_rth_des_tumeurs_v7_complet.pdf
HAS/2008-09-24_08-098_gp_maladie_corona.pdf
HAS/2008-09-24_HTA_2005_rap.pdf
HAS/2008-09-24_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-09-24_gp_ald_cirrhose_.pdf
HAS/2008-09-24_guide_colon_version_web.pdf
HAS/2008-09-24_guide_maladie_coronarienne_version_web_.pdf
HAS/2008-09-24_hta_patient_adulte_synthese.pdf
HAS/2008-09-24_lap_ald_6_cirrhoses_final.pdf
HAS/2008-09-24_lap_colon_version_web.pdf
HAS/2008-09-24_liste_ald_maladie_coronarienne.pdf
HAS/2008-09-27_Acces_Info_sante_Dec_2005.pdf
HAS/2008-09-27_Infos_femmes_enceintes_fiche.pdf
HAS/2008-09-27_femmes_enceintes_recos.pdf
HAS/2008-09-27_frottis_cervico-uterin_-_2002_-_synthese_des_recommandations_2009-08-13_12-43-41_544.pdf
HAS/2008-09-27_infopat.pdf
HAS/2008-09-27_inforecos.pdf
HAS/2008-09-27_infos_femmes_enceintes_rap.pdf
HAS/2008-09-27_lymphomes_malins_referentiel_2004.pdf
HAS/2008-09-27_maladie_dalzheimer_-_annonce_et_accompagnement_du_diagnostic_-_argumentaire_2009-11-10_09-55-14_154.pdf
HAS/2008-09-27_maladie_dalzheimer_-_annonce_et_accompagnement_du_diagnostic_-_synthese_des_recommandations.pdf
HAS/2008-09-27_recommandation_maladie_alzheimer_annonce_et_accompagnement_du_diagnostic.pdf
HAS/2008-09-29_douleur_sujet_age_recos.pdf
HAS/2008-09-29_doulpersag.pdf
HAS/2008-09-29_dpa_-_rapport_final.pdf
HAS/2008-09-30_cepp-1523_novasource_gi_forte.pdf
HAS/2008-09-30_cepp-1776_contegra.pdf
HAS/2008-09-30_cepp-1830_biovalsalva.pdf
HAS/2008-09-30_cepp-1877_paradym_vr_8250_pis.pdf
HAS/2008-09-30_cepp_1522_novasource_gi_control.pdf
HAS/2008-09-30_cepp_1797_1798_1799_cellosorb_ag__urgotul_ag_urgotul_duo_ag.pdf
HAS/2008-10-01_07-042-traceur_liste-adl-avc.pdf
HAS/2008-10-01_07-042_traceur_guide-adl-avc.pdf
HAS/2008-10-01_08-097_gp_acv.pdf
HAS/2008-10-01_08-098_gp_maladie_corona.pdf
HAS/2008-10-01_AVC_Medical_rap.pdf
HAS/2008-10-01_avc_m_351dical_-fiche_de_synth_350se-2006.pdf
HAS/2008-10-01_avc_param_351dical_argumentaire_version_2006.pdf
HAS/2008-10-01_avc_param_351dical_fiche_de_synth_350se_version_2006.pdf
HAS/2008-10-01_avc_param_351dical_recommandations_version_2006.pdf
HAS/2008-10-01_avc_prise_en_charge_precoce_-_argumentaire.pdf
HAS/2008-10-01_avc_prise_en_charge_precoce_-_contre-indications_de_lateplase.pdf
HAS/2008-10-01_avc_prise_en_charge_precoce_-_recommandations.pdf
HAS/2008-10-01_avc_prise_en_charge_precoce_-_synthese_des_recommandations.pdf
HAS/2008-10-01_avc_prise_en_charge_precose_-_algorithme.pdf
HAS/2008-10-01_guide_maladie_coronarienne_version_web_.pdf
HAS/2008-10-01_liste_ald_maladie_coronarienne.pdf
HAS/2008-10-01_recommandations_2006_10_27__20_02_3_927.pdf
HAS/2008-10-02_abseamed_ins_avis_1_ct-5517.pdf
HAS/2008-10-02_cellcept_-_ct_5616.pdf
HAS/2008-10-02_cyanokit_-_ct-5686.pdf
HAS/2008-10-02_heparine_choay_-_ct-4860.pdf
HAS/2008-10-02_octafix_ct-5518.pdf
HAS/2008-10-02_oxycontin_-_ct-5566.pdf
HAS/2008-10-02_rapport_evaluation_des_protheses_de_hanche.pdf
HAS/2008-10-03_rebetol_-_ct-5293.pdf
HAS/2008-10-04_contention_pa.pdf
HAS/2008-10-04_cppa_-_rapport_final_.pdf
HAS/2008-10-04_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-10-04_su.pdf
HAS/2008-10-05_Audit_clinique_juin_2003.pdf
HAS/2008-10-05_atbp_pth.pdf
HAS/2008-10-05_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-10-05_sortie_patient.pdf
HAS/2008-10-06_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-10-07_fiche_methode_annoncer_une_mauvaise_nouvelle_v1.pdf
HAS/2008-10-07_guide_pnds_fallot.pdf
HAS/2008-10-07_guide_pnds_tac.pdf
HAS/2008-10-07_guide_pnds_tgv_2008-10-07_11-31-38_924.pdf
HAS/2008-10-07_lap_pnds_fallot_220708.pdf
HAS/2008-10-07_lap_pnds_tac_220708.pdf
HAS/2008-10-07_lap_pnds_tgv_220708.pdf
HAS/2008-10-07_lymphomes_malins_referentiel_2004.pdf
HAS/2008-10-07_mauvaisenouvelle_vf.pdf
HAS/2008-10-07_pnds_15_-_cardiopathies_congenitales_complexes_-_tetralogie_de_fallot_et_latresie_pulmonaire_a_septum_ouvert_apso_-_synthese.pdf
HAS/2008-10-07_pnds_16_-_cardiopathies_congenitales_complexes_-_truncus_arteriosus_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2008-10-07_pnds_17_-_cardiopathies_congenitales_complexes_-_transposition_simple_des_gros_vaisseaux_tgv_-_synthese_a_destination_du_med.pdf
HAS/2008-10-07_purpura_thrombopenique_auto-immun_referentiel_2004.pdf
HAS/2008-10-07_rapport_radiographie_bassin.pdf
HAS/2008-10-07_rapport_radiographie_crane_2008-06-30_11-52-59_159.pdf
HAS/2008-10-07_rapport_rx_asp.pdf
HAS/2008-10-07_rapport_rx_thorax.pdf
HAS/2008-10-07_synthese_radiographie_bassin.pdf
HAS/2008-10-07_synthese_radiographie_crane_2008-06-30_11-47-13_723.pdf
HAS/2008-10-07_texte_court_rx_asp.pdf
HAS/2008-10-07_texte_court_rx_thorax.pdf
HAS/2008-10-11_gm_polyarthrite_web.pdf
HAS/2008-10-11_lap_polyarthrite_web.pdf
HAS/2008-10-11_lombal.pdf
HAS/2008-10-11_lombaldec2000.pdf
HAS/2008-10-11_lombalgie_dec2000_recos.pdf
HAS/2008-10-11_lombreco.pdf
HAS/2008-10-14_cepp-1743_embosphere.pdf
HAS/2008-10-14_cepp-1745_embogold.pdf
HAS/2008-10-14_cepp-1775_macroplastique.pdf
HAS/2008-10-14_cepp-1784_nobori.pdf
HAS/2008-10-14_cepp-1889_zenith_flex_pis.pdf
HAS/2008-10-14_cepp-1896_trufill_dcs_orbit.pdf
HAS/2008-10-14_cepp-1897_new-fill.pdf
HAS/2008-10-14_cepp_1827_c-leg_compact.pdf
HAS/2008-10-14_ct031667.pdf
HAS/2008-10-14_ct031668.pdf
HAS/2008-10-14_viraferonpeg_-_ct-4821.pdf
HAS/2008-10-15_avis_has_radiographie_bassin.pdf
HAS/2008-10-15_avis_has_radiographie_crane.pdf
HAS/2008-10-15_fbutm_radio_crane.pdf
HAS/2008-10-15_fbutm_radio_facial.pdf
HAS/2008-10-15_fiche_butm_rx_bassin_pediatrie.pdf
HAS/2008-10-15_fiche_butm_rx_bassin_rhumato.pdf
HAS/2008-10-15_phosphoneuros_-_ct4960.pdf
HAS/2008-10-15_rapport_radiographie_bassin.pdf
HAS/2008-10-15_rapport_radiographie_crane_2008-06-30_11-52-59_159.pdf
HAS/2008-10-15_synthese_radiographie_bassin.pdf
HAS/2008-10-15_synthese_radiographie_crane_2008-06-30_11-47-13_723.pdf
HAS/2008-10-16_dialyse_peritoneale_chronique_chez_ladulte_-_argumentaire.pdf
HAS/2008-10-16_dialyse_peritoneale_chronique_chez_ladulte_-_recommandations.pdf
HAS/2008-10-20_spifen_-_ct-5915.pdf
HAS/2008-10-21_argumentaire_depistage_de_linfection_par_le_vih_en_france_-_modalites_de_realisation_des_tests_de_depistage_2009-08-10_16-06-17_175.pdf
HAS/2008-10-21_hiv_infection_screening_in_france_-_laboratory_tests_and_algorithms-conclusions.pdf
HAS/2008-10-21_recommandations_-_depistage_de_linfection_par_le_vih_en_france_-_modalites_de_realisation_des_tests_de_depistage_2008-10-22_11-55-8_316.pdf
HAS/2008-10-24_adepal_-_ct-5753.pdf
HAS/2008-10-24_fongarex_-_ct-5763.pdf
HAS/2008-10-24_gyno_daktarin_-_ct-5717.pdf
HAS/2008-10-24_gyno_pevaryl_-_ct-5710.pdf
HAS/2008-10-24_microval_-_ct-5761.pdf
HAS/2008-10-24_rimactan_-_ct-5815.pdf
HAS/2008-10-24_stediril_-_ct-5760.pdf
HAS/2008-10-24_thiocolchicoside_-_ct-5596.pdf
HAS/2008-10-24_triella_-_ct-5754.pdf
HAS/2008-10-24_trinordiol_-_ct-5749.pdf
HAS/2008-10-28_aranesp_-_ct-5853.pdf
HAS/2008-10-28_cepp-1770_peristeen.pdf
HAS/2008-10-28_cepp-1802_optive.pdf
HAS/2008-10-28_cepp-1864_mucoclear.pdf
HAS/2008-10-28_cepp-1879_endeavor.pdf
HAS/2008-10-28_cepp-1895_ultra_fast-fix.pdf
HAS/2008-10-28_miflonil_-_ct-5926.pdf
HAS/2008-10-28_oxynorm_-_ct-5917.pdf
HAS/2008-10-28_solumedrol_-_ct-5879.pdf
HAS/2008-10-28_trizivir_-_ct-5500.pdf
HAS/2008-10-28_ziagen_-_ct-5498.pdf
HAS/2008-10-29_avis_rtc.pdf
HAS/2008-10-29_document_avis_endoprothese_fenetree.pdf
HAS/2008-10-29_pethidine_renaudin_-_ct5838.pdf
HAS/2008-10-29_rapport_endoprothese_fenetree.pdf
HAS/2008-10-29_rapport_rtc.pdf
HAS/2008-10-29_texte_court_endoprothese_fenetree.pdf
HAS/2008-10-29_texte_court_rtc.pdf
HAS/2008-10-30_ct-4169_elaprase_.pdf
HAS/2008-10-30_dexambutol_-_ct-5728.pdf
HAS/2008-10-30_elaprase_ct_4169.pdf
HAS/2008-10-30_exelon_-_ct-5099.pdf
HAS/2008-10-30_minidril_-_ct-5759.pdf
HAS/2008-10-30_neulasta_-_ct-5397.pdf
HAS/2008-10-30_privigen_-_ct-5735.pdf
HAS/2008-10-30_scoburen_-_ct-5839.pdf
HAS/2008-10-30_viraferon_-_ct-5292.pdf
HAS/2008-10-30_xalacom_-_ct-5766.pdf
HAS/2008-11-07_adiazine_-_ct-5795.pdf
HAS/2008-11-07_apidra_-_ct-5835.pdf
HAS/2008-11-07_copegus_-_ct-5446.pdf
HAS/2008-11-07_deprenyl_-_ct-5700.pdf
HAS/2008-11-07_disulone_-_ct-5696.pdf
HAS/2008-11-07_extencilline_-_ct-5648.pdf
HAS/2008-11-07_gyno-trosyd_-_ct-5721.pdf
HAS/2008-11-07_pegasys_-_ct-5224.pdf
HAS/2008-11-10_cepp-1395-neuroform3.pdf
HAS/2008-11-11_aloplastine_-_ct-5792.pdf
HAS/2008-11-11_cepp-1951_systemes_nebulisation_aerosoltherapie_181108.pdf
HAS/2008-11-11_eclaran_-_ct-5773_2008-11-26_11-39-26_913.pdf
HAS/2008-11-11_eryfluid_-_ct-5771.pdf
HAS/2008-11-11_erythomycine_-_ct-5698.pdf
HAS/2008-11-11_panoxyl_-_ct-5727.pdf
HAS/2008-11-11_stimycine_-_ct-5724.pdf
HAS/2008-11-12_ebixa_-_ct-5980.pdf
HAS/2008-11-12_ebixa_ct_5980.pdf
HAS/2008-11-15_dossier_anesthesie_rap.pdf
HAS/2008-11-15_dossier_anesthesie_ref.pdf
HAS/2008-11-15_dossier_du_patient_-_fascicule_1_reglementation_et_recommandations_-_2003.pdf
HAS/2008-11-15_dossier_du_patient_-_fascicule_2_realisation_pratique_de_laudit_clinique_-_2003.pdf
HAS/2008-11-15_dossier_du_patient_-_fascicule_3_methodes_damelioration_de_la_qualite_-_2003.pdf
HAS/2008-11-15_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-11-15_ipaqss_20090730_fiche_dan.pdf
HAS/2008-11-18_cepp-1270_w50ev_iarp_si.pdf
HAS/2008-11-18_cepp-1398_mpe.pdf
HAS/2008-11-18_cepp-1402_mat_basic.pdf
HAS/2008-11-18_cepp-1442_proceed.pdf
HAS/2008-11-18_cepp-1462_carplot.pdf
HAS/2008-11-18_cepp-1465_alova.pdf
HAS/2008-11-18_cepp-1549_systam_p161m.pdf
HAS/2008-11-18_cepp-1550_systam_p161m.pdf
HAS/2008-11-18_cepp-1552_vitaform.pdf
HAS/2008-11-18_cepp-1553_pharm__form_coussin.pdf
HAS/2008-11-18_cepp-1554_prima_form.pdf
HAS/2008-11-18_cepp-1555_pharma_form__surmatelas.pdf
HAS/2008-11-18_cepp-1556_systam_p101m.pdf
HAS/2008-11-18_cepp-1557_systam_p102m.pdf
HAS/2008-11-18_cepp-1558_systam_p141m.pdf
HAS/2008-11-18_cepp-1559_endoroll_fix.pdf
HAS/2008-11-18_cepp-1562_systam_p361c.pdf
HAS/2008-11-18_cepp-1629_systam_p314c.pdf
HAS/2008-11-18_cepp-1630_systam_p341c.pdf
HAS/2008-11-18_cepp-1636_pharma_modi.pdf
HAS/2008-11-18_cepp-1637_gelidis.pdf
HAS/2008-11-18_cepp-1638_pharma_plots_3_parties.pdf
HAS/2008-11-18_cepp-1647_systam_p302c.pdf
HAS/2008-11-18_cepp-1648_systam_p301c.pdf
HAS/2008-11-18_cepp-1649_systam_p331c.pdf
HAS/2008-11-18_cepp-1674_systeme_p100.pdf
HAS/2008-11-18_cepp-1693_pharma_oceanis.pdf
HAS/2008-11-18_cepp-1694_dualmesh.pdf
HAS/2008-11-18_cepp-1702_pharma_air.pdf
HAS/2008-11-18_cepp-1704_viscomouss.pdf
HAS/2008-11-18_cepp-1710_gel2d.pdf
HAS/2008-11-18_cepp-1711_gelair2d.pdf
HAS/2008-11-18_cepp-1754_systeme_sofcare_sc840.pdf
HAS/2008-11-18_cepp-1780_handilight.pdf
HAS/2008-11-18_cepp-1792_helipatch.pdf
HAS/2008-11-18_cepp-1805_systeme_eole_supreme_p200.pdf
HAS/2008-11-18_cepp-1868_intra-swing_hi-tex.pdf
HAS/2008-11-18_cepp-1869_surgimesh.pdf
HAS/2008-11-18_cepp-1870_microval-intra.pdf
HAS/2008-11-18_cepp-1871_intramesh_w3.pdf
HAS/2008-11-18_cepp-1872_sil_promesh.pdf
HAS/2008-11-18_cepp-1873_scalamobil.pdf
HAS/2008-11-18_cepp-1875_sepraspray.pdf
HAS/2008-11-18_cepp-1893_parietex_composite.pdf
HAS/2008-11-18_cepp-897_avis_implants_refection_paroi.pdf
HAS/2008-11-18_cepp-931_prevescar_air.pdf
HAS/2008-11-18_cepp-956_parietex_modele_anatomique.pdf
HAS/2008-11-18_cepp-956_parietex_modele_plan.pdf
HAS/2008-11-18_cepp-991_biomeshh.pdf
HAS/2008-11-18_cepp_1639_pharma_plots_3_parties_compresse.pdf
HAS/2008-11-18_reevaluation_des_contraceptifs_oraux_de_3eme_generation.pdf
HAS/2008-11-21_pansements_synthese_rapport.pdf
HAS/2008-11-21_rapport_evaluation_pansements_.pdf
HAS/2008-11-21_synthese_rapport_evaluation_des_pansements.pdf
HAS/2008-11-25_dossier_du_patient_-_fascicule_1_reglementation_et_recommandations_-_2003.pdf
HAS/2008-11-25_dossier_du_patient_-_fascicule_2_realisation_pratique_de_laudit_clinique_-_2003.pdf
HAS/2008-11-25_dossier_du_patient_-_fascicule_3_methodes_damelioration_de_la_qualite_-_2003.pdf
HAS/2008-11-25_dossier_du_patient_amelioration_de_la_qualite_de_la_tenue_et_du_contenu_-_reglementation_et_recommandations_-_2003.pdf
HAS/2008-11-25_methodes_et_outils_des_demarches_qualite_pour_les_etablissements_de_sante.pdf
HAS/2008-11-25_paq.pdf
HAS/2008-11-26_cepp-898avisaudioprotheses010408.pdf
HAS/2008-11-26_rapport_devaluation_audioprotheses.pdf
HAS/2008-11-26_synthese_rapport_devaluation_des_appareils_electroniques_correcteurs_de_surdite_2009-02-26_11-23-31_559.pdf
HAS/2008-11-27_kivexa_-_ct-5499.pdf
HAS/2008-12-01_acomplia_-_ct-5618.pdf
HAS/2008-12-01_anesm_elements-appropriation_attentesdelapersonne06.pdf
HAS/2008-12-01_anesm_elements-appropriation_maltraitanceetablissement06.pdf
HAS/2008-12-01_anesm_elements-appropriation_ouvertureetablissement06.pdf
HAS/2008-12-01_anesm_synthese-attentespersonneetlepp.pdf
HAS/2008-12-01_anesm_synthese-maltraitanceetablissement.pdf
HAS/2008-12-01_anesm_synthese_rbpp-ouvenvironnement.pdf
HAS/2008-12-01_bibliographie_attentes_personne_projet_personnalise__anesm.pdf
HAS/2008-12-01_bibliographie_ouverture_etablissement_environnement_anesm.pdf
HAS/2008-12-01_cepp-1294coaguchek.pdf
HAS/2008-12-01_cepp-1295.pdf
HAS/2008-12-01_elements_appreciation_outils_bientraitance_maltraitance_anesm-3.pdf
HAS/2008-12-01_enquete_maltraitance_esms_anesm.pdf
HAS/2008-12-01_lettre_de_cadrage_ouverture.pdf
HAS/2008-12-01_lettre_de_cadrage_projet.pdf
HAS/2008-12-01_lettre_de_mission_maltraitance_etablissement.pdf
HAS/2008-12-01_liste_lois_et_reglements_projet_de_pour_la_personne_anesm.pdf
HAS/2008-12-01_pirilene_-_ct-_5736.pdf
HAS/2008-12-01_rapport_inr_2009-02-11_11-34-20_386.pdf
HAS/2008-12-01_rapport_lits_medicaux_et_accessoires.pdf
HAS/2008-12-01_reco_maltraitance_etablissement.pdf
HAS/2008-12-01_reco_ouverture.pdf
HAS/2008-12-01_reco_projet.pdf
HAS/2008-12-01_reperes_analytiques_projet_de_pour_la_personne_anesm.pdf
HAS/2008-12-01_revue_litterature_maltraitance_etablissement_anesm.pdf
HAS/2008-12-01_rovalcyte_-_ct-5655.pdf
HAS/2008-12-01_rovalcyte_-_ct-5893.pdf
HAS/2008-12-01_synthese_inr_1437.pdf
HAS/2008-12-01_synthese_rapport_devaluation_lits_medicaux_et_accessoires.pdf
HAS/2008-12-02_cepp-1673_visco_mouss__matelas.pdf
HAS/2008-12-02_cepp-1832_ialuset_plus.pdf
HAS/2008-12-02_cepp-1856_softform_atmos.pdf
HAS/2008-12-02_cepp-1858_taxus_liberte.pdf
HAS/2008-12-02_cepp-1865_cypher_select_plus_2009-01-06_14-46-7_882.pdf
HAS/2008-12-02_cepp-1905_adhesix.pdf
HAS/2008-12-02_cepp-1926_anaconda.pdf
HAS/2008-12-02_cepp-1955_polyflex.pdf
HAS/2008-12-09_lap_syndrome_de_cushing_version_web_051208.pdf
HAS/2008-12-09_pnds_20_-_syndrome_de_cushing_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2008-12-09_pnds_syndrome_de_cushing_version_web_051208.pdf
HAS/2008-12-11_aureomycine_-_ct-5714.pdf
HAS/2008-12-11_mupiderm_-_ct-5830.pdf
HAS/2008-12-11_nerisalic_-_ct-5806.pdf
HAS/2008-12-11_plurexid_-_ct-5713.pdf
HAS/2008-12-11_synalar_-_ct_5719.pdf
HAS/2008-12-11_topsyne_-_ct-5720.pdf
HAS/2008-12-11_trosyd_-_ct-5722.pdf
HAS/2008-12-15_audit_clinique.pdf
HAS/2008-12-15_audit_clinique_2004_4pages.pdf
HAS/2008-12-15_audit_clinique_2004_4pages_2009-10-30_14-28-22_448.pdf
HAS/2008-12-15_audit_clinique_cible_2006_4pages.pdf
HAS/2008-12-15_construction_et_utilisation_des_indicateurs_dans_le_domaine_de_la_sante_-_principes_generaux_guide_2002.pdf
HAS/2008-12-15_meladinine_-_ct-5750.pdf
HAS/2008-12-15_microdoine_-_ct-6007.pdf
HAS/2008-12-15_pipram_fort_-_ct-5651.pdf
HAS/2008-12-15_reussir_un_audit_clinique_et_son_plan_damelioration_guide_2003_2009-10-20_11-09-52_821.pdf
HAS/2008-12-15_rimifon_-_ct-5756.pdf
HAS/2008-12-15_septeal_-_ct-5799.pdf
HAS/2008-12-15_solumedrol_-_ct-5828.pdf
HAS/2008-12-15_structum_-_ct-5465.pdf
HAS/2008-12-15_synacthene_-_ct-5834.pdf
HAS/2008-12-15_syncortyl_-_ct-5646.pdf
HAS/2008-12-15_vitamine_pp_aguettant_-_ct-5874.pdf
HAS/2008-12-16_apurone_-_ct-6148.pdf
HAS/2008-12-16_bactrim_-_ct-5764.pdf
HAS/2008-12-16_basdene_-_ct-5794.pdf
HAS/2008-12-16_betadine_dermique_-_ct-5765.pdf
HAS/2008-12-16_betadine_scrub_-_ct-6248.pdf
HAS/2008-12-16_biafine_-_ct-5791.pdf
HAS/2008-12-16_brufen_-_ct-5982.pdf
HAS/2008-12-16_cepp-1335_kyphxhvr_kyphosfs.pdf
HAS/2008-12-16_cepp-1901_neocate.pdf
HAS/2008-12-16_cepp-1902_neocate_advance.pdf
HAS/2008-12-16_cepp-1928_ol_1000.pdf
HAS/2008-12-16_cepp-1930_prokinetic_energy.pdf
HAS/2008-12-16_colimycine_-_ct-4947.pdf
HAS/2008-12-16_condyline_-_ct-5729.pdf
HAS/2008-12-16_cortancyl_-_ct-5653.pdf
HAS/2008-12-16_cynomel_-_ct_5779.pdf
HAS/2008-12-16_cyteal_-_ct-5802.pdf
HAS/2008-12-16_daivonex_-_ct-6025.pdf
HAS/2008-12-16_dectancyl_-_ct-5650.pdf
HAS/2008-12-16_depo-medrol_-_ct-5829.pdf
HAS/2008-12-16_diprosalic_-_ct-5774.pdf
HAS/2008-12-16_ebixa_-_ct-5952.pdf
HAS/2008-12-16_fonx_-_ct-5730.pdf
HAS/2008-12-16_furadantine_-_ct-5702.pdf
HAS/2008-12-16_furadoine_-_ct-5732.pdf
HAS/2008-12-16_grisefuline_-_ct-5769.pdf
HAS/2008-12-16_hydrocortancyl_-_ct-5739.pdf
HAS/2008-12-16_hydrocortisoneroussel_-_ct-5652.pdf
HAS/2008-12-16_kenacortretard_-_ct-5767.pdf
HAS/2008-12-16_l-thyroxine_serb_-_ct-5737.pdf
HAS/2008-12-17_avis_has_tests_non_invasifs_mesure_fibrose_cirrhose.pdf
HAS/2008-12-17_document_avis_fibrose_cirrhose_dec_2008.pdf
HAS/2008-12-17_rapport_contenu_vesical.pdf
HAS/2008-12-17_texte_court_contenu_vesical.pdf
HAS/2008-12-19_epitopic_-_ct-5597_2008-12-18_15-45-55_151.pdf
HAS/2008-12-19_nerisone_-_ct-5805.pdf
HAS/2008-12-19_rapport_-_place_des_tests_immunologiques_de_recherche_de_sang_occulte_dans_les_selles_ifobt.pdf
HAS/2008-12-19_synthese_-_place_des_tests_immunologiques_de_recherche_de_sang_occulte_dans_les_selles_ifobt.pdf
HAS/2008-12-19_tridesonit_-_ct-5809.pdf
HAS/2008-12-19_ultralan_-_ct-5807.pdf
HAS/2008-12-22_avis_actes_acm.pdf
HAS/2008-12-22_rapport_assistance_ventriculaire.pdf
HAS/2008-12-22_synthese_assistance_ventriculaire.pdf
HAS/2009-01-06_argumentaire_ipp_2009-04-27_14-15-18_458.pdf
HAS/2009-01-06_eupantol_-_ct-6107.pdf
HAS/2009-01-06_inipomp_-_ct-6127.pdf
HAS/2009-01-06_lanzor_-_ct-6173.pdf
HAS/2009-01-06_mopral_-_ct-6171.pdf
HAS/2009-01-06_ogast_-_ct-6170.pdf
HAS/2009-01-06_pariet_-_ct-6149.pdf
HAS/2009-01-06_zoltum_-_ct-6172.pdf
HAS/2009-01-07_synthese_davis_zanextra_-_ct-5889_2009-05-14_10-01-40_742.pdf
HAS/2009-01-07_zanextra_10_mg_10_mg_-_ct-_5889.pdf
HAS/2009-01-07_zanextra_ct_5889.pdf
HAS/2009-01-09_aconitumcompose_-_ct-5667.pdf
HAS/2009-01-09_calcareacompose_-_ct-5666.pdf
HAS/2009-01-09_calendula_-_ct-5661.pdf
HAS/2009-01-09_calendulalhf_-_ct-5662.pdf
HAS/2009-01-09_cinacompose_-_ct-5672.pdf
HAS/2009-01-09_colpotrophine_-_ct-_5819.pdf
HAS/2009-01-09_cutacnyl_-_ct-6046.pdf
HAS/2009-01-09_dakincooperstabilise_-_ct-6049.pdf
HAS/2009-01-09_depo_provera_-_ct-_5822.pdf
HAS/2009-01-09_fasigyne_-_ct-5723.pdf
HAS/2009-01-09_formica_rufacompose_-_ct-5665.pdf
HAS/2009-01-09_graphites_-_ct-5663.pdf
HAS/2009-01-09_matrifen_-_ct-5820.pdf
HAS/2009-01-09_paracetamol_codeine_biogaran_-_ct-_6050.pdf
HAS/2009-01-09_paracetamol_codeine_sandoz_-_ct-6084.pdf
HAS/2009-01-09_rinoclenil_-_ct-6051.pdf
HAS/2009-01-09_rouvax_-_ct-5876.pdf
HAS/2009-01-09_rudivax_-_ct-5875.pdf
HAS/2009-01-12_locatop_locapred_-_ct-5770.pdf
HAS/2009-01-14_celestamine_-_ct-5752.pdf
HAS/2009-01-14_ratiograstim_-_ct-5993.pdf
HAS/2009-01-14_scrofulariacompose_-_ct-5664.pdf
HAS/2009-01-14_tabacumcompose_-_ct-5669.pdf
HAS/2009-01-14_triphosphates_-_ct-5670.pdf
HAS/2009-01-14_trophicreme-_ct-_5740.pdf
HAS/2009-01-14_uraniumcompose_-_ct-5668.pdf
HAS/2009-01-20_cepp-1853_decubiflow100.pdf
HAS/2009-01-20_cepp-1859saniflow2.pdf
HAS/2009-01-20_cepp-1878_kit_k2.pdf
HAS/2009-01-20_cepp-1886_softform_viscomixt.pdf
HAS/2009-01-20_cepp-1887_softform_visco.pdf
HAS/2009-01-20_cepp-1900_optium_beta_cetone.pdf
HAS/2009-01-23_ap_acces_aux_soins_handicap_textes_t1.pdf
HAS/2009-01-23_ap_acces_aux_soins_handicap_textes_t2.pdf
HAS/2009-01-23_audition_publique_acces_soins_personnes_handicap_22_23102008.pdf
HAS/2009-01-23_synthese_ap_acces_soins_personnes_handicap_23102008.pdf
HAS/2009-01-27_betneval_-_ct5796.pdf
HAS/2009-01-27_calendula_boiron_-_ct-5673.pdf
HAS/2009-01-27_dermorelle_-_ct-3015.pdf
HAS/2009-01-27_dermoval_-_ct-5804.pdf
HAS/2009-01-27_gonadotrophine_chorionique_endo_-_ct_5758.pdf
HAS/2009-01-27_pergotime_-_ct_5801.pdf
HAS/2009-01-27_prevenar_-_ct-_4937.pdf
HAS/2009-01-27_secnol_-_ct-5734.pdf
HAS/2009-01-27_silkis_-_ct-6047.pdf
HAS/2009-01-27_vit_e_nepalm_-_ct-4812.pdf
HAS/2009-01-27_vit_e_sandoz_-_ct-4614.pdf
HAS/2009-01-28_avis_hla_b5701_abacavir.pdf
HAS/2009-01-28_avis_rx_asp.pdf
HAS/2009-01-28_document_avis_spondyloplastie.pdf
HAS/2009-01-28_fiche_radio_asp_patho_dig_web.pdf
HAS/2009-01-28_fiche_radio_asp_pedia_web.pdf
HAS/2009-01-28_fiche_radio_asp_urogy_web.pdf
HAS/2009-01-28_lap_vih_finalweb.pdf
HAS/2009-01-28_rapport_hla_b5701_abacavir.pdf
HAS/2009-01-28_rapport_rx_asp.pdf
HAS/2009-01-28_rapport_spondyloplastie.pdf
HAS/2009-01-28_rapport_sutures_digestives.pdf
HAS/2009-01-28_texte_court_hla_b5701_abacavir.pdf
HAS/2009-01-28_texte_court_rx_asp.pdf
HAS/2009-01-28_texte_court_spondyloplastie.pdf
HAS/2009-01-28_texte_court_sutures_digestives.pdf
HAS/2009-01-31_CT-5751_GENTALLINE - CT- 5751.pdf
HAS/2009-02-02_programme_ami_alzheimer.pdf
HAS/2009-02-02_reco_accompagnement_maladie_alzheimer_etablissement_medico_social.pdf
HAS/2009-02-02_references_bibliographiques_reco_accompagnement_maladie_alzheimer_etablissement_medico_social_anesm.pdf
HAS/2009-02-09_artirem_-_ct-5947.pdf
HAS/2009-02-09_danatrol_-_ct-5777.pdf
HAS/2009-02-09_dotarem_-_ct-5445.pdf
HAS/2009-02-09_trophigil-_ct-6261.pdf
HAS/2009-02-09_varivax_-_ct-5892.pdf
HAS/2009-02-09_vitamine_b12_aguettant_-_ct-6251.pdf
HAS/2009-02-11_avis_rx_thorax.pdf
HAS/2009-02-11_fiche_butm_thorax.pdf
HAS/2009-02-11_rapport_rx_thorax.pdf
HAS/2009-02-11_texte_court_rx_thorax.pdf
HAS/2009-02-12_beclomax_100_-_ct-6052.pdf
HAS/2009-02-12_enbrel_-_ct-5041.pdf
HAS/2009-02-17_cepp-1514_airsoftduolight.pdf
HAS/2009-02-17_cepp-1785_ventrassistva-lva3.pdf
HAS/2009-02-17_cepp-1795_metasul.pdf
HAS/2009-02-17_cepp-1898_repelcv.pdf
HAS/2009-02-17_cepp-1899_tens.pdf
HAS/2009-02-17_cepp-1903_durom.pdf
HAS/2009-02-17_cepp-1941_virtuosoiidr.pdf
HAS/2009-02-17_cepp-1942_virtuosoiivr.pdf
HAS/2009-02-17_cepp-_1880_aquatec_orca.pdf
HAS/2009-02-17_immunoglobuline_equine_tetanique_pasteur_-_ct-5923.pdf
HAS/2009-02-18_abilify_-_ct-5831.pdf
HAS/2009-02-18_abilify_ct_5831.pdf
HAS/2009-02-18_foscan_-_ct-5919.pdf
HAS/2009-02-18_foscan_ct_5919.pdf
HAS/2009-02-18_synthese_davis_abilify_-_ct-5831.pdf
HAS/2009-02-20_clomid_-_ct-5776.pdf
HAS/2009-02-20_colprone_-_ct-5643.pdf
HAS/2009-02-20_duphaston_-_ct-5772.pdf
HAS/2009-02-20_equanil_-_ct-5744.pdf
HAS/2009-02-20_equanil_injectable_-_ct-2148.pdf
HAS/2009-02-20_lutenyl_ri93_-ct-_5811.pdf
HAS/2009-02-20_paracetamol_zidus_-_ct-_6028.pdf
HAS/2009-02-20_vaccin_genhevac_b_pasteur_-_ct-5986.pdf
HAS/2009-02-20_vaccintetaniquepasteur_-_ct-5922.pdf
HAS/2009-02-25_cepp-1712invacareplatinum9.pdf
HAS/2009-03-01_le_dossier_medical_en_sante_au_travail_-_grille_de_recueil_des_criteres.pdf
HAS/2009-03-01_le_dossier_medical_en_sante_au_travail_-_liste_des_criteres.pdf
HAS/2009-03-01_le_dossier_medical_en_sante_au_travail_-_serie_de_criteres_de_qualite.pdf
HAS/2009-03-02_rapport_complet_enquete_autorites_anesm_270309-2.pdf
HAS/2009-03-02_rapport_complet_enquete_essms_anesm_2009.pdf
HAS/2009-03-02_rapport_complet_enquete_essms_anesm_270309-2.pdf
HAS/2009-03-02_synthese_enquete_autorites.pdf
HAS/2009-03-02_synthese_enquete_essms.pdf
HAS/2009-03-03_cepp-1515_airsoftduo.pdf
HAS/2009-03-03_cepp-1904_cationorm_2009-03-11_17-54-48_807.pdf
HAS/2009-03-03_cepp-1929_defiance.pdf
HAS/2009-03-03_cepp-1950_zenithfenestrated.pdf
HAS/2009-03-03_cepp-1963_primeadvanced.pdf
HAS/2009-03-03_cepp-2018__endeavor.pdf
HAS/2009-03-03_cepp-2027_endeavor_sprint_rx.pdf
HAS/2009-03-03_cepp-2111_taxus_liberte.pdf
HAS/2009-03-03_cepp_1949_taxus__liberte.pdf
HAS/2009-03-03_noroxine_-_ct-5689.pdf
HAS/2009-03-03_tevagrastim_-_ct-6289.pdf
HAS/2009-03-04_avis__courbure_penis.pdf
HAS/2009-03-04_avis_iu_homme.pdf
HAS/2009-03-04_concerta_-_ct-6222.pdf
HAS/2009-03-04_doxycycline_arrow_-_ct-5854.pdf
HAS/2009-03-04_euthyral_-_ct-5755.pdf
HAS/2009-03-04_rapport_courbure_penis.pdf
HAS/2009-03-04_rapport_iu_homme.pdf
HAS/2009-03-04_synthese_courbure_verge.pdf
HAS/2009-03-04_synthese_iu_homme.pdf
HAS/2009-03-09_ancotil_-_ct-6326.pdf
HAS/2009-03-09_flagyl_-_ct-5645.pdf
HAS/2009-03-09_malarone_-_ct-5988-5989.pdf
HAS/2009-03-09_orgametril_-_ct-_5746.pdf
HAS/2009-03-09_tetralysal_-_ct-6151.pdf
HAS/2009-03-09_thiophenicol_-_ct-5649.pdf
HAS/2009-03-11_cepp-1294coaguchek.pdf
HAS/2009-03-11_cepp-1295.pdf
HAS/2009-03-11_coaguchek__xs_gb.pdf
HAS/2009-03-11_inratio_gb.pdf
HAS/2009-03-16_tilavist_-_ct-6334.pdf
HAS/2009-03-17_CT-5407_INIPOMP - CT-5407.pdf
HAS/2009-03-17_CT-5408_EUPANTOL - CT-5408.pdf
HAS/2009-03-17_CT-6198_TROBICINE - CT-6198.pdf
HAS/2009-03-17_CT-6373_ANAPEN - CT-6373.pdf
HAS/2009-03-17_paracetamol_codeine_eg_-_ct-_6355.pdf
HAS/2009-03-17_timoferol_-_ct-_6372.pdf
HAS/2009-03-17_totapen_-_ct-5712.pdf
HAS/2009-03-23_fiche_de_bon_usage_implants_refection_paroi.pdf
HAS/2009-03-23_rapport_implants_de_refection_de_paroi.pdf
HAS/2009-03-23_synthese_rapport_devaluation_sur_les_implants_de_refection_de_paroi.pdf
HAS/2009-03-26_amiante_environnementale_fiche_medecin_version_finale.pdf
HAS/2009-03-26_fbutm_stimul_cardiaques_100309.pdf
HAS/2009-03-26_rapport_amiante_environnementale_version_finale.pdf
HAS/2009-03-26_synthese_amiante_environnementale_version_finale.pdf
HAS/2009-03-31_CT-5798_KEFORAL - CT-5798.pdf
HAS/2009-03-31_CT-6333_MENAELLE -  CT-6333.pdf
HAS/2009-03-31_calcium_vitamine_d3_teva_-_ct-6431.pdf
HAS/2009-03-31_cepp-1967_cypher_select_plus.pdf
HAS/2009-03-31_daivobet_-_ct-6285.pdf
HAS/2009-03-31_ditropan_-_ct-5768.pdf
HAS/2009-03-31_novopulmon_novolizer_-_ct-6423.pdf
HAS/2009-03-31_ovitrelle_-_ct-_6286.pdf
HAS/2009-03-31_rovamycine_-_ct-5814.pdf
HAS/2009-04-06_note_daccompagnement_le_depistage_neonatal_systematique_de_la_mucoviscidose.pdf
HAS/2009-04-06_rapport_depistage_neonatal_systematique_de_la_mucoviscidose_en_france.pdf
HAS/2009-04-06_rapport_le_recours_a_l_hopital_en_europe_2009-04-03_09-48-38_85.pdf
HAS/2009-04-06_synthese_recours_a_l_hopital.pdf
HAS/2009-04-14_cepp-1890_neurxdpsra-4.pdf
HAS/2009-04-14_cepp-2022_revealdxmod9528.pdf
HAS/2009-04-14_cepp-2023_lpesp.pdf
HAS/2009-04-14_cepp-2048_kinetube.pdf
HAS/2009-04-14_cepp-2056_atrostim.pdf
HAS/2009-04-16_CT-5826_ERY NOURRISSONS - CT- 5826.pdf
HAS/2009-04-16_CT-6364_BINOCRIT - CT-6364.pdf
HAS/2009-04-20_coversyl_ct_4792.pdf
HAS/2009-04-20_ct-4792_coversyl_.pdf
HAS/2009-04-20_ct-5144_increlex_2008_06_04__16_43_21_872.pdf
HAS/2009-04-20_ct-5206_tasigna_.pdf
HAS/2009-04-20_ct-5216_rasilez_.pdf
HAS/2009-04-20_ct-5278_tiorfanor_.pdf
HAS/2009-04-20_ct-5305_renagel_.pdf
HAS/2009-04-20_increlex_ct_5144.pdf
HAS/2009-04-20_rasilez_ct_5216.pdf
HAS/2009-04-20_renagel_ct_5305.pdf
HAS/2009-04-20_tasigna_ct_5206.pdf
HAS/2009-04-20_tiorfanor_ct_5278.pdf
HAS/2009-04-22_rapport_iu_femme.pdf
HAS/2009-04-22_synthese_iu_femme.pdf
HAS/2009-04-23_ald_2_pnds_aplastic_anaemia_ven_web.pdf
HAS/2009-04-23_lap_am_fev09.pdf
HAS/2009-04-23_pnds_21_-_aplasie_medullaire_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2009-04-23_pnds_am_fev09.pdf
HAS/2009-04-26_atbp_-_rapport_final.pdf
HAS/2009-04-26_atbp_pth.pdf
HAS/2009-04-27_CT-6200_VISIPAQUE - CT- 6200.pdf
HAS/2009-04-27_CT-6293_HEXATRIONE - CT-6293.pdf
HAS/2009-04-27_fluocaril_-_ct-6377.pdf
HAS/2009-04-28_CT-6329_ABOTICINE ERYTHROMYCINE - CT-6329.pdf
HAS/2009-04-28_argumentaire_ipp_2009-04-27_14-15-18_458.pdf
HAS/2009-04-28_cepp-2080_lits_medicaux_et_accessoires.pdf
HAS/2009-04-28_dalacine_-_ct-6337.pdf
HAS/2009-04-28_inexium_-_ct-6152.pdf
HAS/2009-04-29_velmetia_-_ct_6479.pdf
HAS/2009-04-29_velmetia_ct_6479.pdf
HAS/2009-05-05_ct-5147_tracleer_.pdf
HAS/2009-05-05_tracleer_ct_5147.pdf
HAS/2009-05-07_07r44_fiche_tech_cirrhose_diagnostic_actualisation_score_de_child_pugh.pdf
HAS/2009-05-07_07r44_fiche_tech_cirrhose_diagnostic_actualisation_tableau_recapitulatif_des_methodes_non_invasives.pdf
HAS/2009-05-07_argumentaire_fibrose_cirrhose_dec_2008.pdf
HAS/2009-05-07_diagnosis_uncomplicated_cirrhosis_english_version.pdf
HAS/2009-05-07_diagnostic_cirrhose_-_argumentaire.pdf
HAS/2009-05-07_diagnostic_cirrhose_-_recommandations.pdf
HAS/2009-05-07_fs_cirrhose_web.pdf
HAS/2009-05-07_teleprescription_-_argumentaire.pdf
HAS/2009-05-07_teleprescription_-_recommandations.pdf
HAS/2009-05-07_teleprescription_-_synthese_des_recommandations.pdf
HAS/2009-05-12_avandamet_-_ct-3161.pdf
HAS/2009-05-12_avandia_-_ct-3161_-_ct-3963.pdf
HAS/2009-05-12_synthese_davis_avandamet-_ct-3161.pdf
HAS/2009-05-12_synthese_davis_avandia_-_ct-3161-3963_2009-05-12_11-46-3_144.pdf
HAS/2009-05-13_CT-6666_OPHTIM - CT-6666.pdf
HAS/2009-05-14_cepp-1993_hydralis.pdf
HAS/2009-05-14_cepp-2049_spirotel.pdf
HAS/2009-05-15_CT-5757_NETROMICINE - CT-5757.pdf
HAS/2009-05-15_CT-6001_NEBCINE - CT-6001.pdf
HAS/2009-05-15_CT-6270_LINCOCINE - CT-6270.pdf
HAS/2009-05-15_CT-6325_TEMERIT -  CT-6325.pdf
HAS/2009-05-15_CT-6328_NEBILOX  - CT-6328.pdf
HAS/2009-05-15_CT-6515_CALCIUM SANDOZ - CT-6515.pdf
HAS/2009-05-15_CT-6547_FLUIDABAK - CT-6547.pdf
HAS/2009-05-15_CT-6548_UNIFLUID - CT-6548.pdf
HAS/2009-05-15_CT-6621_OLMETEC - CT-6621.pdf
HAS/2009-05-15_CT-6653_ALTEIS - CT-6653.pdf
HAS/2009-05-15_CT-6667_CARTEABAK - CT-6667.pdf
HAS/2009-05-15_CT-6668_PILOBLOQ - CT-6668.pdf
HAS/2009-05-15_cepp-1736-splbasko.pdf
HAS/2009-05-15_cepp-2073_zenithflexzenith.pdf
HAS/2009-05-15_durogesic_-_ct-5878.pdf
HAS/2009-05-15_synthese_davis_durogesic_-_ct-5878.pdf
HAS/2009-05-20_document_davis__actes_de_stimulation_phrenique.pdf
HAS/2009-05-20_rapport_stimulation_phrenique_implantee.pdf
HAS/2009-05-20_synthese_rapport_stimulation_phrenique_implantee.pdf
HAS/2009-05-21_avastin_ct_5390.pdf
HAS/2009-05-21_ct-5390_avastin_.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_argumentaire.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_document_dinformation_-_a4.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_document_dinformation_-_livret.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_grille_de_recueil_des_criteres.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_liste_des_criteres_de_qualite.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_recommandations.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_serie_de_criteres_de_qualite.pdf
HAS/2009-05-25_asthme_de_lenfant_de_moins_de_36_mois_-_synthese_des_recommandations.pdf
HAS/2009-05-25_cepp-2024_onyx.pdf
HAS/2009-05-27_abilify_-_ct-6282.pdf
HAS/2009-05-27_cardiocor_-_ct-6670.pdf
HAS/2009-05-27_cardiocor_ct_6670.pdf
HAS/2009-05-27_complications_evolutives_dun_edc_-_recommandations.pdf
HAS/2009-05-27_complications_evolutives_dun_edc_-_synthese.pdf
HAS/2009-05-27_complications_evolutives_edc_-_argumentaire_v2.pdf
HAS/2009-05-27_confidex_-_ct-6478.pdf
HAS/2009-05-27_cp_recos_suspendues_19092011_vdef.pdf
HAS/2009-05-27_ezetrol_-_ct-6429.pdf
HAS/2009-05-27_ezetrol_ct_6429.pdf
HAS/2009-05-27_inegy_-_ct-6442.pdf
HAS/2009-05-27_inegy_ct_6442.pdf
HAS/2009-05-27_multihance_-_ct-6105.pdf
HAS/2009-05-27_multihance_ct_6105.pdf
HAS/2009-05-27_pr_au_debut_-_synthese_septembre_2007.pdf
HAS/2009-05-27_pr_diagnostic_prise_en_charge_initiale_-argumentaire.pdf
HAS/2009-05-27_pr_phase_detat_synthesecollege_septembre_2007.pdf
HAS/2009-05-27_pr_prise_en_charge_en_phase_detat_recommandations.pdf
HAS/2009-05-27_pr_prise_en_charge_en_phase_etat_argumentaire_final.pdf
HAS/2009-05-27_prdiagnostic_prise_en_charge_initiale_-_recommandations_2007_11_30__15_10_8_320.pdf
HAS/2009-05-27_synthese_davis_cardensiel_-_cardiocor.pdf
HAS/2009-05-27_synthese_davis_confidex_-_ct-6478.pdf
HAS/2009-05-27_synthese_davis_eztrol_-_ct-6429.pdf
HAS/2009-05-27_synthese_davis_inegy_-_ct-6442.pdf
HAS/2009-05-27_synthese_davis_multihance_-_ct-6105.pdf
HAS/2009-05-27_synthese_des_resumes_traitements_de_fond.pdf
HAS/2009-05-28_04r04_algo_hypothyroidies_frustes.pdf
HAS/2009-05-28_cepp-1234.pdf
HAS/2009-05-28_cepp-1937_consultacrtd.pdf
HAS/2009-05-28_cepp-1938_concertoiicrtd.pdf
HAS/2009-05-28_cepp-1939_secura_dr.pdf
HAS/2009-05-28_cepp-1940_securavr.pdf
HAS/2009-05-28_cepp-1943_consultacrtd.pdf
HAS/2009-05-28_cepp-1944_securadrcarelink.pdf
HAS/2009-05-28_cepp-1945_securavrcarelink.pdf
HAS/2009-05-28_cepp-1988_analystacceldr.pdf
HAS/2009-05-28_cepp-1989_analystaccelvr.pdf
HAS/2009-05-28_cepp-1990_promoteaccel.pdf
HAS/2009-05-28_cepp-1991_currentaccelvr.pdf
HAS/2009-05-28_cepp-1992_currentacceldr.pdf
HAS/2009-05-28_cepp-958.pdf
HAS/2009-05-28_cepp-959.pdf
HAS/2009-05-28_cp_recos_suspendues_19092011_vdef.pdf
HAS/2009-05-28_crestor_-_ct-5927.pdf
HAS/2009-05-28_dacudoses_-_ct-6569.pdf
HAS/2009-05-28_effizinc_-_ct-6741.pdf
HAS/2009-05-28_hexomedine_-_ct-6734.pdf
HAS/2009-05-28_hta_2005_-_argumentaire.pdf
HAS/2009-05-28_hta_2005_-_recommandations.pdf
HAS/2009-05-28_hypothyroidie_fruste_-_synthese_vf.pdf
HAS/2009-05-28_hypothyroidies_frustes_-_recommandations_vf.pdf
HAS/2009-05-28_hypothyroidies_frustres_-_argumentaire_vf_2007_10_22__12_06_37_21.pdf
HAS/2009-05-28_janumet_-_ct-6403.pdf
HAS/2009-05-28_larmabak_-_ct-6543.pdf
HAS/2009-05-28_movicol_-_ct-4083.pdf
HAS/2009-05-28_subclinical_hypothyroidism_-_qrg_-_version_anglaise.pdf
HAS/2009-05-29_cepp-2047_excluder.pdf
HAS/2009-06-04_fbutm_stimul_cardiaques_100309.pdf
HAS/2009-06-04_rapport_stimulateurs_cardiaques_conventionnels.pdf
HAS/2009-06-04_synthese_rapport_sur_les_stimulateurs_cardiaques_simple_et_double_chambre_1852_2009-02-25_17-35-15_405.pdf
HAS/2009-06-04_thyrozol_-_ct-6654.pdf
HAS/2009-06-09_ct-5245_prialt_.pdf
HAS/2009-06-09_prialt_ct_5245.pdf
HAS/2009-06-10_avis_arthroplastie_genou_assistee_par_ordinateur_2009-07-08_17-16-53_941.pdf
HAS/2009-06-10_cepp-1948_atopiclair.pdf
HAS/2009-06-10_cepp-2051_jarvik2000.pdf
HAS/2009-06-10_document_avis_tomographie_osteoarticulaire.pdf
HAS/2009-06-10_rapport_arthroplastie_genou_assistee_par_ordinateur_2009-07-09_17-46-34_623.pdf
HAS/2009-06-10_texte_court_cao.pdf
HAS/2009-06-11_ct-5315_ecalta_.pdf
HAS/2009-06-11_ecalta_ct_5315.pdf
HAS/2009-06-11_gaviscon_-_ct-5683.pdf
HAS/2009-06-11_isoprinosine_-_ct-5654.pdf
HAS/2009-06-11_paracetamol_codeine_-_ct-6679.pdf
HAS/2009-06-11_prunier_dafrique_mylan_-_ct-6724.pdf
HAS/2009-06-11_prunier_dafrique_qualimed_-_ct-6726.pdf
HAS/2009-06-11_siccafluid_ri_-_ct-6549.pdf
HAS/2009-06-12_cepp-1518_pii.pdf
HAS/2009-06-16_advil_-_ct-6810.pdf
HAS/2009-06-16_argumentaire_ipp_2009-04-27_14-15-18_458.pdf
HAS/2009-06-16_asmelor_-_ct-6743.pdf
HAS/2009-06-16_avandamet_-_ct-6809.pdf
HAS/2009-06-16_ct-2319_cymbalta_.pdf
HAS/2009-06-16_ct-5200_forsteo_2008_03_28__17_10_59_920.pdf
HAS/2009-06-16_cymbalta_ct_2319.pdf
HAS/2009-06-16_emend_-_ct-6520.pdf
HAS/2009-06-16_forsteo_ct_5200.pdf
HAS/2009-06-16_ipp_adulte_juin_2009.pdf
HAS/2009-06-16_polygynax_-_ct-5778.pdf
HAS/2009-06-16_tergynan_-_ct-_5793.pdf
HAS/2009-06-16_viread_-_ct-6085.pdf
HAS/2009-06-17_cosopt_ct_5447.pdf
HAS/2009-06-17_ct-4195_rectogesic_.pdf
HAS/2009-06-17_ct-4469_infracyanine_.pdf
HAS/2009-06-17_ct-4539_luminity.pdf
HAS/2009-06-17_ct-5198_methadone.pdf
HAS/2009-06-17_ct-5447_cosopt_.pdf
HAS/2009-06-17_doc_av_has_ns1.pdf
HAS/2009-06-17_doc_rp_has_ns1.pdf
HAS/2009-06-17_fiche_buts_dengue_pdf_091016_miseenligne.pdf
HAS/2009-06-17_infracyanine_ct_4469.pdf
HAS/2009-06-17_luminity_ct_4539.pdf
HAS/2009-06-17_methadone_ap-hp_ct_5198.pdf
HAS/2009-06-17_rectogesic_ct_4195.pdf
HAS/2009-06-17_texte_court_has_ns1.pdf
HAS/2009-06-18_ct-3292_singulair.pdf
HAS/2009-06-18_ct-3445_pabal_.pdf
HAS/2009-06-18_ct-5573_thalidomide_pharmion_.pdf
HAS/2009-06-18_pabal_ct_3445.pdf
HAS/2009-06-18_singulair__ct_3292.pdf
HAS/2009-06-18_synthese_thalidomide_pdf.pdf
HAS/2009-06-18_thalidomide_pharmion_ct_5573.pdf
HAS/2009-06-22_07r08_exple_chirurgie_obesite_questions_medecin.pdf
HAS/2009-06-22_07r08_fiche_tech_chirurgie_obesite_anneau_gastrique.pdf
HAS/2009-06-22_07r08_fiche_tech_chirurgie_obesite_bypass.pdf
HAS/2009-06-22_07r08_fiche_tech_chirurgie_obesite_derivation_biliopancreatique.pdf
HAS/2009-06-22_07r08_fiche_tech_chirurgie_obesite_gastrectomie.pdf
HAS/2009-06-22_07r08_fiche_tech_chirurgie_obesite_schema_digestion.pdf
HAS/2009-06-22_07r08_fiche_tech_chirurgie_obesite_table_imc.pdf
HAS/2009-06-22_07r08_info_mg_chirurgie_obesite_document_medecin_traitant.pdf
HAS/2009-06-22_07r08_info_pat_chirurgie_obesite_parcours_patient.pdf
HAS/2009-06-22_chirurgie_de_lobesite_-_prise_en_charge_pre_et_postoperatoire_du_patient_-_liste_des_criteres_de_qualite.pdf
HAS/2009-06-22_chirurgie_de_lobesite_-_prise_en_charge_pre_et_postoperatoire_du_patient_-_serie_de_criteres_de_qualite.pdf
HAS/2009-06-22_ct-5225_nexavar_.pdf
HAS/2009-06-22_nexavar_ct_5225.pdf
HAS/2009-06-22_obesite_-_prise_en_charge_chirurgicale_chez_ladulte_-_argumentaire.pdf
HAS/2009-06-22_obesite_-_prise_en_charge_chirurgicale_chez_ladulte_-_synthese_des_recommandations.pdf
HAS/2009-06-22_obesity_surgery_-_guidelines.pdf
HAS/2009-06-22_obesity_surgery_-_information_for_the_general_practitioner.pdf
HAS/2009-06-22_obesity_surgery_-_information_for_the_patients.pdf
HAS/2009-06-22_obesity_surgery_-_quick_reference_guide.pdf
HAS/2009-06-22_reco2clics_obesite_adulte_chirurgie.pdf
HAS/2009-06-22_recommandation_obesite_-_prise_en_charge_chirurgicale_chez_ladulte.pdf
HAS/2009-06-23_cepp-2026_amo.pdf
HAS/2009-06-23_chutes_personnes_agees_synthese.pdf
HAS/2009-06-23_chutes_repetees_personnes_agees_-_argumentaire.pdf
HAS/2009-06-23_chutes_repetees_personnes_agees_-_outil_devaluation_des_pratiques.pdf
HAS/2009-06-23_chutes_repetees_personnes_agees_-_recommandations.pdf
HAS/2009-06-24_cepp-1852-avis_stimulateurs_simple_double_chambre_170209.pdf
HAS/2009-06-24_cepp-1906_avis_stimulateurs_triple_chambre.pdf
HAS/2009-06-24_clottafact_-_ct6697.pdf
HAS/2009-06-24_clottafact_ct_6697.pdf
HAS/2009-06-24_ct-3918_sifrol_.pdf
HAS/2009-06-24_humira_-_ct-6542.pdf
HAS/2009-06-24_humira_ct_6542.pdf
HAS/2009-06-24_sifrol_ct_3918.pdf
HAS/2009-06-24_synthese_davis_clottafact_-_ct-6697.pdf
HAS/2009-06-24_synthese_davis_humira_-_ct-6542.pdf
HAS/2009-06-24_synthese_davis_januvia-xelevia_-_ct-6376-6435.pdf
HAS/2009-06-24_xelevia_-_ct-6435.pdf
HAS/2009-06-24_xelevia_ct_6435.pdf
HAS/2009-06-25_cepp-2075_wallstent.pdf
HAS/2009-06-25_cepp-2079_airedaxdouai.pdf
HAS/2009-06-26_argumentaire_douleur_chronique_aspects_organisationnels.pdf
HAS/2009-06-26_prezista_-_ct-6833.pdf
HAS/2009-06-26_synthese_douleur_chronique_aspects_organisationnels.pdf
HAS/2009-07-01_avis_du_cs_du_12_03_2015_note_indicateurs.pdf
HAS/2009-07-01_guideevaluationternecnesms-2-2_2018-03-16_11-43-30_910.pdf
HAS/2009-07-01_mise_en_oeuvre_evaluation_interne-2_2018-03-16_11-43-30_908.pdf
HAS/2009-07-01_note_orientation_1-2-2_2018-03-16_11-43-30_912.pdf
HAS/2009-07-01_reco_conduite_evaluation_interne_anesm_2018-03-16_11-43-30_905.pdf
HAS/2009-07-03_cepp-2014_ovatio_dr_6550.pdf
HAS/2009-07-03_cepp-2015_ovatio_vr_6250.pdf
HAS/2009-07-03_modiodal_-_ct-2921.pdf
HAS/2009-07-06_kaletra_-_ct-5850.pdf
HAS/2009-07-07_betafact_-_ct-6718.pdf
HAS/2009-07-07_cadens_-_ct-_5379.pdf
HAS/2009-07-07_calcitonine_pharmy_ii_-_ct-4148.pdf
HAS/2009-07-07_calcitonine_sandoz_-_ct-6883.pdf
HAS/2009-07-07_calsyn_-_ct-5321.pdf
HAS/2009-07-07_champix_-_ct-6677.pdf
HAS/2009-07-07_champix_ct_6677.pdf
HAS/2009-07-07_cibacalcine_-_ct-6811.pdf
HAS/2009-07-07_colposeptine-_ct-5818.pdf
HAS/2009-07-07_confusion_aigue_chez_la_personne_agee_-_argumentaire.pdf
HAS/2009-07-07_confusion_aigue_chez_la_personne_agee_-_recommandations_2009-07-08_16-58-24_661.pdf
HAS/2009-07-07_confusion_aigue_chez_la_personne_agee_-_synthese_des_recommandations.pdf
HAS/2009-07-07_ct-5344_suboxone_.pdf
HAS/2009-07-07_divina_-_duova_-_ct-6669.pdf
HAS/2009-07-07_januvia_-_ct-6376.pdf
HAS/2009-07-07_januvia_ct_6376.pdf
HAS/2009-07-07_miacalcic_-_ct-6064.pdf
HAS/2009-07-07_piperacilline-tazobactam_kabi_-_ct-6546.pdf
HAS/2009-07-07_piperacilline-tazobactam_orchid_europe_-_ct-6212.pdf
HAS/2009-07-07_suboxone_ct_5344.pdf
HAS/2009-07-07_synthese_davis_calcitonines_2009-09-25_10-53-2_177.pdf
HAS/2009-07-07_synthese_davis_champix_-_ct-6677_2009-09-22_15-52-30_590.pdf
HAS/2009-07-07_synthese_davis_januvia-xelevia_-_ct-6376-6435.pdf
HAS/2009-07-08_helicobacter_test_infai_-_ct-5950.pdf
HAS/2009-07-08_helicobacter_test_infai_ct_5950.pdf
HAS/2009-07-08_synthese_davis_helicobacter_-_ct-5950.pdf
HAS/2009-07-21_fongamil_creme_-_ct-5697.pdf
HAS/2009-07-21_fongamil_solution_-_ct-5697.pdf
HAS/2009-07-22_avis_sexe_foetal.pdf
HAS/2009-07-22_rapport_sexe_foetal.pdf
HAS/2009-07-22_texte_court_sexe_foetal.pdf
HAS/2009-07-24_cepp-1713_prothese_externe_de_sein.pdf
HAS/2009-07-24_cepp-1852-avis_stimulateurs_simple_double_chambre_170209.pdf
HAS/2009-07-24_cepp-1934_replydr.pdf
HAS/2009-07-24_cepp-1935_adapta-addr03-addr06.pdf
HAS/2009-07-24_cepp-1936_symphonydr2550.pdf
HAS/2009-07-24_cepp-1952_adapta-_addr01-addrs1-addrl1.pdf
HAS/2009-07-24_orencia_-_ct-6601.pdf
HAS/2009-07-24_propofol_lipuro_-_ct-6360.pdf
HAS/2009-07-24_propofol_lipuro_ct_6360.pdf
HAS/2009-07-24_reyataz_-_ct-6283.pdf
HAS/2009-07-24_reyataz_ct_6283.pdf
HAS/2009-07-24_synthese_davis_propofol_lipuro_-_ct-6360.pdf
HAS/2009-07-24_synthese_davis_reyataz_-_ct-6283.pdf
HAS/2009-07-24_xeloda_-_ct-6576.pdf
HAS/2009-07-24_zarzio_-_ct-6825.pdf
HAS/2009-07-28_ct-4442_prezista.pdf
HAS/2009-07-28_prezista_ct_4442.pdf
HAS/2009-07-29_cepp-2074_sir-spheres.pdf
HAS/2009-07-31_cepp-2203_cadence_hp.pdf
HAS/2009-08-03_annexes_-_description_etudes_vd.pdf
HAS/2009-08-03_cepp-1933_incor.pdf
HAS/2009-08-03_cepp-2178_meniscal-cinch.pdf
HAS/2009-08-03_cepp-2201_dyna_c.pdf
HAS/2009-08-03_cepp-2202_dynastep.pdf
HAS/2009-08-03_document_davis_chirurgie_vasculaire_par_coelioscopie.pdf
HAS/2009-08-03_rapport_chir_vasc_coelio_vd.pdf
HAS/2009-08-04_cepp-1443_prestige_lp.pdf
HAS/2009-08-05_ct-5411_savarine_.pdf
HAS/2009-08-05_paludisme_note_de_synthese_2008-06-11_17-46-7_488.pdf
HAS/2009-08-05_savarine_ct_5411.pdf
HAS/2009-08-10_cepp-1644lumaxvrtxl.pdf
HAS/2009-08-10_cepp-1881_lumax_540_dr-t.pdf
HAS/2009-08-10_cepp-1882_lumax_540_hf-t.pdf
HAS/2009-08-10_cepp-1883_lumax_540_vr-t.pdf
HAS/2009-08-10_ct-5310_malarone_.pdf
HAS/2009-08-10_malarone_ct_5310.pdf
HAS/2009-08-10_paludisme_note_de_synthese_2008-06-11_17-46-7_488.pdf
HAS/2009-08-11_ct-5041_enbrel.pdf
HAS/2009-08-11_ct-5266_granudoxy__2008_04_23__15_48_48_276.pdf
HAS/2009-08-11_ct-5288_varilrix_.pdf
HAS/2009-08-11_ct-5375_tamiflu_.pdf
HAS/2009-08-11_enbrel_ct_5041.pdf
HAS/2009-08-11_granudoxy_ct_5266.pdf
HAS/2009-08-11_tamiflu_ct_5375.pdf
HAS/2009-08-11_varilrix_ct_5288.pdf
HAS/2009-08-17_ct-5373_paludrine_.pdf
HAS/2009-08-17_paludisme_note_de_synthese_2008-06-11_17-46-7_488.pdf
HAS/2009-08-17_paludrine_ct_5373.pdf
HAS/2009-08-19_caditar_-_ct-7133.pdf
HAS/2009-08-19_calcium_vitamine_d3_biogaran_-_ct-6272.pdf
HAS/2009-08-19_monocrixolp_-_ct-6359.pdf
HAS/2009-08-19_norlevo_-_ct-6777.pdf
HAS/2009-08-19_orocal_vitamine_d3_-_ct-6834.pdf
HAS/2009-08-19_osseans_vitamine_d3_-_ct-6964.pdf
HAS/2009-08-19_plaquenil_-_ct-6573.pdf
HAS/2009-08-19_virgan_-_ct-6806.pdf
HAS/2009-08-20_ct-5313_lariam_.pdf
HAS/2009-08-20_lariam_ct_5313.pdf
HAS/2009-08-20_paludisme_note_de_synthese_2008-06-11_17-46-7_488.pdf
HAS/2009-08-24_dexeryl_-_ct-6728.pdf
HAS/2009-08-24_oromone-_ct-6812.pdf
HAS/2009-08-24_resikali_-_ct-6433.pdf
HAS/2009-08-24_syntocinon_-_ct-5833.pdf
HAS/2009-08-27_cepp-1606-1931_pieds_restitution_energie.pdf
HAS/2009-08-27_cepp-2076_luxyal.pdf
HAS/2009-09-01_anesm_elements-appropriation_maltraitancedomicile06.pdf
HAS/2009-09-01_anesm_synthese-maltraitancedomicile.pdf
HAS/2009-09-01_cnedimts-2181-rotateur4r57.pdf
HAS/2009-09-01_elements_appreciation_outils_bientraitance_maltraitance_anesm.pdf
HAS/2009-09-01_lesions_meniscales_-_grille_de_recueil_des_criteres_2009-12-30_12-26-18_74.pdf
HAS/2009-09-01_lesions_meniscales_-_liste_de_criteres_de_qualite.pdf
HAS/2009-09-01_lesions_meniscales_-_serie_de_criteres_de_qualite_2009-12-30_12-26-40_991.pdf
HAS/2009-09-01_lettre_de_mission_maltraitance_domicile.pdf
HAS/2009-09-01_reco_maltraitance_a_domicile_anesm.pdf
HAS/2009-09-02_cepp-2058_c-walk_1c40.pdf
HAS/2009-09-02_cepp-2059_springlite_advantage_dp.pdf
HAS/2009-09-02_cepp-2060_universal_2009-08-06_15-46-11_218.pdf
HAS/2009-09-02_cepp-2061_dynamique_plus_1d25.pdf
HAS/2009-09-02_cepp-2062_low_profil.pdf
HAS/2009-09-02_cepp-2063_dynamique_1d10.pdf
HAS/2009-09-02_cepp-2064_low_profil_axtion.pdf
HAS/2009-09-02_cepp-2065_trias_1c30.pdf
HAS/2009-09-02_cepp-2066_greissinger_1a30.pdf
HAS/2009-09-02_cepp-2067_dynamic_motion1d35.pdf
HAS/2009-09-02_cepp-2068_springlite_ii_gold_medal.pdf
HAS/2009-09-02_cepp-2069_lo_rider.pdf
HAS/2009-09-02_cepp-2070_prosymes.pdf
HAS/2009-09-02_cepp-2071_chopart.pdf
HAS/2009-09-02_cepp-2072_g-foot.pdf
HAS/2009-09-08_firazyr_-_ct-5904.pdf
HAS/2009-09-08_firazyr_ct_5904.pdf
HAS/2009-09-08_primalan_-_ct-7084.pdf
HAS/2009-09-08_synthese_davis_firazyr_-_ct_5904.pdf
HAS/2009-09-09_cepp-2085_biomatrix.pdf
HAS/2009-09-09_cepp-2086_nobori.pdf
HAS/2009-09-09_ct-5360_taxotere.pdf
HAS/2009-09-09_helicidine_-_ct-7054.pdf
HAS/2009-09-09_synthese_davis_helicidine_-_ct-8650.pdf
HAS/2009-09-09_taxotere_ct_5360.pdf
HAS/2009-09-10_cepp-1855_promus.pdf
HAS/2009-09-10_cepp-1884_xiencev.pdf
HAS/2009-09-10_cepp-1956_helistent-titan2.pdf
HAS/2009-09-10_cepp-2108_cypher_select_plus.pdf
HAS/2009-09-10_cepp-2110_endeavorsprinttx.pdf
HAS/2009-09-10_cepp_2107-taxus_liberte.pdf
HAS/2009-09-10_cepp_2109-endeavor_2009-09-07_17-14-7_289.pdf
HAS/2009-09-10_cetirizine_biogaran-_ct-6807.pdf
HAS/2009-09-10_cromadoses_-_ct-6854.pdf
HAS/2009-09-11_fiche_pancreatite-aigue_web_2009-09-11_13-04-37_708.pdf
HAS/2009-09-11_rapport_evaluation_de_lamylasemie_2009-07-27_16-57-49_72.pdf
HAS/2009-09-11_texte_court_amylase-lipase_2009-07-27_16-56-8_583.pdf
HAS/2009-09-15_art50_ct_5535.pdf
HAS/2009-09-15_art_50_-_ct-5535.pdf
HAS/2009-09-15_celsentri_ct_5283.pdf
HAS/2009-09-15_ct-5283_celsentri_.pdf
HAS/2009-09-15_ct-5358_tyverb.pdf
HAS/2009-09-15_ct-5464_kaletra_.pdf
HAS/2009-09-15_kaletra_ct_5464.pdf
HAS/2009-09-15_lantus_-_ct-5385.pdf
HAS/2009-09-15_lantus__annexe_etude_post-inscription.pdf
HAS/2009-09-15_lantus_ct_5385.pdf
HAS/2009-09-15_lantus_ri_annexe_population_cible.pdf
HAS/2009-09-15_lenoxe_-_ct-5745.pdf
HAS/2009-09-15_lenoxe_ct_5745.pdf
HAS/2009-09-15_magnesium_vitamine_b6_biogaran_-_ct-6015_2008-12-18_16-02-33_320.pdf
HAS/2009-09-15_magnesium_vitamine_b6_biogaran_ct_6015.pdf
HAS/2009-09-15_mycamine_-_ct-5880.pdf
HAS/2009-09-15_mycamine_ct_5880.pdf
HAS/2009-09-15_otrasel_-_ct-5699.pdf
HAS/2009-09-15_otrasel_ct_5699.pdf
HAS/2009-09-15_piascledine_-_ct-5536.pdf
HAS/2009-09-15_piascledine_ct_5536.pdf
HAS/2009-09-15_synthese_davis_lantus_-_ct-5385.pdf
HAS/2009-09-15_synthese_davis_mycamine_-_ct-5880.pdf
HAS/2009-09-15_synthese_kaletra_pdf.pdf
HAS/2009-09-15_synthese_lenoxe_pdf.pdf
HAS/2009-09-15_synthese_tyverb_pdf_2009-02-06_11-17-20_229.pdf
HAS/2009-09-15_tyverb_ct_5358.pdf
HAS/2009-09-16_advagraf_ct_4886.pdf
HAS/2009-09-16_alimta_-_ct-5800.pdf
HAS/2009-09-16_alimta_ct_5800.pdf
HAS/2009-09-16_azyter_ct_5323.pdf
HAS/2009-09-16_ct-4886_advagraf_.pdf
HAS/2009-09-16_ct-5323_azyter_.pdf
HAS/2009-09-16_inovelon_-_ct-6044.pdf
HAS/2009-09-16_inovelon_ct_6044.pdf
HAS/2009-09-16_meronem_-_ct-5762.pdf
HAS/2009-09-16_meronem_ct_5762.pdf
HAS/2009-09-16_synthese_davis_alimta_-_ct-5800.pdf
HAS/2009-09-16_synthese_davis_inovelon_-_ct-6044.pdf
HAS/2009-09-16_synthese_davis_meronem_-_ct_5762.pdf
HAS/2009-09-17_mabcampath_-_ct-5602.pdf
HAS/2009-09-17_mabcampath_ct_5602.pdf
HAS/2009-09-17_synthese_mabcampath_pdf_2009-02-06_11-28-1_200.pdf
HAS/2009-09-22_ald_31_lap_arthrite_juvenile_web.pdf
HAS/2009-09-22_ct-4791_naropeine_.pdf
HAS/2009-09-22_effexor_-_ct-5420.pdf
HAS/2009-09-22_effexor_ct_5420_2010-09-03_09-44-56_888.pdf
HAS/2009-09-22_mabthera_-_ct-5656.pdf
HAS/2009-09-22_mabthera_ct_5656.pdf
HAS/2009-09-22_magne_b6_-_ct-5954.pdf
HAS/2009-09-22_magne_b6__ct_5954.pdf
HAS/2009-09-22_naropeine_ct_4791.pdf
HAS/2009-09-22_prevenar_-_ct-_5092_2009-04-06_15-07-51_145.pdf
HAS/2009-09-22_prevenar_ct_5092.pdf
HAS/2009-09-22_relistor_-_ct-5881.pdf
HAS/2009-09-22_relistor_ct_5881.pdf
HAS/2009-09-22_synthese_davis_mabthera_-_ct-56556.pdf
HAS/2009-09-22_synthese_davis_magnesium_associe_-_ct-5954-5987.pdf
HAS/2009-09-22_synthese_davis_relistor_-_ct-5881.pdf
HAS/2009-09-22_synthese_effexor_pdf.pdf
HAS/2009-09-23_cepp-2016_pathaphoenix.pdf
HAS/2009-09-23_cepp-2050_lofric.pdf
HAS/2009-09-23_cepp-2112_calcibon.pdf
HAS/2009-09-23_cepp-2208_alber-e-motion_m12_m15.pdf
HAS/2009-09-23_ct-5076_lovenox.pdf
HAS/2009-09-23_ct-5168_invega_.pdf
HAS/2009-09-23_forsteo_-_ct-5572.pdf
HAS/2009-09-23_forsteo_ct_5572.pdf
HAS/2009-09-23_invega_ct_5168.pdf
HAS/2009-09-23_ixiaro_-_ct-6747.pdf
HAS/2009-09-23_ixiaro_ct_6747.pdf
HAS/2009-09-23_lovenox_ct_5076.pdf
HAS/2009-09-23_sevikar-_ct-6175.pdf
HAS/2009-09-23_sevikar_ct_6175.pdf
HAS/2009-09-23_synthese_davis_ixiaro_-_ct-6747.pdf
HAS/2009-09-23_synthese_davis_sevikar_-_ct-6175.pdf
HAS/2009-09-24_atbp_-_rapport_final.pdf
HAS/2009-09-24_atbp_pth.pdf
HAS/2009-09-24_brigitte_gardrat_et_maryse_cremer_resume_haute_normandie.pdf
HAS/2009-09-24_catherine_baubri_diapo_poitou_charente.pdf
HAS/2009-09-24_catherine_baubri_resume_poitou_charente.pdf
HAS/2009-09-24_catherine_guignabert_diapo_bourgogne.pdf
HAS/2009-09-24_catherine_guignabert_resume_bourgogne.pdf
HAS/2009-09-24_fausto_viader_diapo_basse_normandie.pdf
HAS/2009-09-24_fausto_viader_resume_basse_normandie.pdf
HAS/2009-09-24_francois_coulomb_diapo_centre.pdf
HAS/2009-09-24_francois_coulomb_resume_centre.pdf
HAS/2009-09-24_helene_mendizabal_resume_paca_corse..pdf
HAS/2009-09-24_isabelle_girard_buttaz_diapo_nord_pas_de_calais.pdf
HAS/2009-09-24_isabelle_girard_buttaz_resume_nord_pas_de_calais.pdf
HAS/2009-09-24_jeanne_mihura_diapo_midi_pyrenees.pdf
HAS/2009-09-24_jeanne_mihura_resume_midi_pyrenees.pdf
HAS/2009-09-24_laurent_pidhorz_diapo_pays_de_la_loire.pdf
HAS/2009-09-24_laurent_pidorz_resume_pays_de_la_loire.pdf
HAS/2009-09-24_leila_moret_diapo_pays_de_la_loire.pdf
HAS/2009-09-24_leila_moret_resume_pays_de_la_loire.pdf
HAS/2009-09-24_liste_85_epp.pdf
HAS/2009-09-24_maryse_cremer_et_brigitte_gardrat_diapo_haute_normandie.pdf
HAS/2009-09-24_nicole_perrier_diapo_paca_corse.pdf
HAS/2009-09-24_nicole_perrier_resume_paca_corse.pdf
HAS/2009-09-24_olivier_lehiani_diapo_centre.pdf
HAS/2009-09-24_olivier_lehiani_resume_centre.pdf
HAS/2009-09-24_philippe__pellerin_resume_nord_pas_de_calais.pdf
HAS/2009-09-24_philippe_pellerin_diapo_nord_pas_de_calais.pdf
HAS/2009-09-25_aldactazine_-_ct-6982.pdf
HAS/2009-09-25_cromabak_-_ct-6835.pdf
HAS/2009-09-25_gel_larmes_-_ct-6853.pdf
HAS/2009-09-25_geltim_-_ct-6846.pdf
HAS/2009-09-25_sectral_-_ct-6934.pdf
HAS/2009-09-25_timabak_-_ct-6671.pdf
HAS/2009-09-28_cepp-2232_dynaj.pdf
HAS/2009-09-28_cnedimts-2005_silk.pdf
HAS/2009-09-28_cnedimts-2213_tenolig.pdf
HAS/2009-09-28_cnedimts-2249_nucleus5.pdf
HAS/2009-09-28_lacrigel_-_ct-6824.pdf
HAS/2009-10-05_cepp-1906_avis_stimulateurs_triple_chambre.pdf
HAS/2009-10-05_cepp-2175_anthem.pdf
HAS/2009-10-05_forsteo_-_ct-_6739.pdf
HAS/2009-10-05_perical_-_ct-7040.pdf
HAS/2009-10-05_prinzide_-_ct-6836.pdf
HAS/2009-10-05_wytens_-_ct-6961.pdf
HAS/2009-10-06_ventilastin_novolizer_-_ct-7011.pdf
HAS/2009-10-07_evaluation_tens.pdf
HAS/2009-10-13_calcium_vitamine_d3_ratiopharm_-_ct-7018.pdf
HAS/2009-10-13_ct-5257-1_seroplex_.pdf
HAS/2009-10-13_ct-5257-2_seroplex_.pdf
HAS/2009-10-13_ct-5257_seroplex_.pdf
HAS/2009-10-13_ct031639.pdf
HAS/2009-10-13_ct031640.pdf
HAS/2009-10-13_florgynal_-_ct-_7048_2009-10-02_14-34-58_251.pdf
HAS/2009-10-13_lodoz_ri_-_ct-6969.pdf
HAS/2009-10-13_seroplex_ct_5257.pdf
HAS/2009-10-13_seroplex_ct_5257_2010-11-26_14-48-31_227.pdf
HAS/2009-10-13_seroplex_ct_5257_2010-11-26_14-52-15_75.pdf
HAS/2009-10-14_ct031816.pdf
HAS/2009-10-14_ct031817.pdf
HAS/2009-10-14_ct031819.pdf
HAS/2009-10-14_spasmag_-_ct-5951.pdf
HAS/2009-10-14_spasmag_ct_5951.pdf
HAS/2009-10-14_synthese_davis_magnesium_seul_-_ct-4037_-_5010_-_5951.pdf
HAS/2009-10-15_cepp-1957-arthrumh2.pdf
HAS/2009-10-15_cepp-1960-structovial.pdf
HAS/2009-10-15_cepp-1962-synocrom.pdf
HAS/2009-10-15_cepp-2052-ostenil.pdf
HAS/2009-10-15_cepp-2083-sinovial.pdf
HAS/2009-10-15_cepp-2205-goon.pdf
HAS/2009-10-15_cnedimts-1958-synvischylanegf20.pdf
HAS/2009-10-15_cnedimts-1961-adant_2009-10-15_12-41-51_169.pdf
HAS/2009-10-15_cnedimts-1964-suplasyn.pdf
HAS/2009-10-15_cnedimts-2053-orthovisc.pdf
HAS/2009-10-15_cnedimts-2199-zenithtx2proform.pdf
HAS/2009-10-15_cnedimts-2246-xienceprime.pdf
HAS/2009-10-15_synthese_zenith_proform.pdf
HAS/2009-10-19_cepp-638.pdf
HAS/2009-10-19_cnedimts-2253-autosurveillance_et_autotraitement.pdf
HAS/2009-10-19_rapport_autotraitement_autocontrole_2009-03-24_14-22-43_653.pdf
HAS/2009-10-21_argumentaire_depistage_vih_volet_2_vfv_2009-10-21_16-49-13_375.pdf
HAS/2009-10-21_hiv_infection_screening_in_france_-_screening_strategies_-_executive_summary_2010-02-26_10-28-32_643.pdf
HAS/2009-10-21_modigraf_-_ct-7077.pdf
HAS/2009-10-21_modigraf_ct_7077.pdf
HAS/2009-10-21_synthese_davis_modigraf_-_ct-7077.pdf
HAS/2009-10-21_synthese_depistage_vih_volet_2_vfv_2009-10-21_16-48-3_460.pdf
HAS/2009-10-23_azopt_-_ct-6509.pdf
HAS/2009-10-23_diacor_-_ct-7043.pdf
HAS/2009-10-23_gaoptol-_ct-7208.pdf
HAS/2009-10-23_gonal_f_-_ct-7073.pdf
HAS/2009-10-23_octim_minirin_-_ct-6894.pdf
HAS/2009-10-23_pentoxifylline_-_ct-7142.pdf
HAS/2009-10-23_permixon_-_ct-7085.pdf
HAS/2009-10-23_potassium_richard_-_ct-7122.pdf
HAS/2009-10-23_rapport_inlay_onlay.pdf
HAS/2009-10-23_texte_court_inlay_onlay.pdf
HAS/2009-10-26_arixtra_ct_4111.pdf
HAS/2009-10-26_ct-4111_arixtra.pdf
HAS/2009-10-26_nidrel_-_ct-7109.pdf
HAS/2009-10-27_avis_rx_bassin_thorax_traumato.pdf
HAS/2009-10-27_fiche_butm_rx_bassin_traumatisme.pdf
HAS/2009-10-27_rapport_rx_bassin_thorax_traumato.pdf
HAS/2009-10-27_texte_court_rx_bassin_thorax_traumato.pdf
HAS/2009-10-29_document_davis_tests_de_tropisme.pdf
HAS/2009-10-29_rapport_tests_de_tropisme.pdf
HAS/2009-10-29_texte_court_tests_de_tropisme_2009-10-27_18-37-8_317.pdf
HAS/2009-11-01_guide_utilisateur.pdf
HAS/2009-11-01_liste_de_criteres.pdf
HAS/2009-11-02_anesm_elements-appropriation_vie-collectivite06.pdf
HAS/2009-11-02_anesm_synthese-conciliervieetpersonnalisation.pdf
HAS/2009-11-02_bibliographie_vie_en_collectivite_anesm.pdf
HAS/2009-11-02_chondrosulf_-_ct-5565.pdf
HAS/2009-11-02_chondrosulf_ct_5565.pdf
HAS/2009-11-02_elaboration_document_dinformation_des_patients_-_criteres_evaluation.pdf
HAS/2009-11-02_elaboration_document_dinformation_des_patients_-_guide_methodologique.pdf
HAS/2009-11-02_elaboration_document_dinformation_des_patients_-_recommandations.pdf
HAS/2009-11-02_etude_quali_vie_en_collectivite_anesm.pdf
HAS/2009-11-02_how_to_produce_an_information_brochure_-_methodology_guide.pdf
HAS/2009-11-02_how_to_produce_an_information_brochure_-_quick_reference_guide.pdf
HAS/2009-11-02_lettre_de_cadrage_vie_en_collectivite.pdf
HAS/2009-11-02_mieux_vivre_avec_son_asthme_2008-07-15_15-59-23_222.pdf
HAS/2009-11-02_reco_vie_en_collectivite_anesm.pdf
HAS/2009-11-03_actosolv_urokinase_ct_3489.pdf
HAS/2009-11-03_bridion_-_ct-6014.pdf
HAS/2009-11-03_bridion_ct_6014.pdf
HAS/2009-11-03_cnedimts-2087-endobuttonclendobuttonclultra.pdf
HAS/2009-11-03_cnedimts-2179-valiant_2009-11-02_16-36-49_844.pdf
HAS/2009-11-03_cnedimts-2211-mets_2009-11-03_08-32-14_375.pdf
HAS/2009-11-03_ct-3489_actosolv_urokinase.pdf
HAS/2009-11-03_ct-3743_gutron.pdf
HAS/2009-11-03_ct-4627_remicade.pdf
HAS/2009-11-03_gutron_ct_3743.pdf
HAS/2009-11-03_hycamtin_-_ct-5514.pdf
HAS/2009-11-03_hycamtin_ct_5514.pdf
HAS/2009-11-03_mets-06_octobre_2009_2211_synthese_davis_2010-05-07_12-47-49_219.pdf
HAS/2009-11-03_remicade_ct_4627.pdf
HAS/2009-11-03_synthese_davis_bridion_-_ct-6014.pdf
HAS/2009-11-03_synthese_davis_hycamtin_-_ct-5514.pdf
HAS/2009-11-03_valiant-27_octobre__22_decembre_2009_2179_2309_synthese_davis.pdf
HAS/2009-11-04_avis_ballon_intragastrique.pdf
HAS/2009-11-04_rapport_ballon_intragastrique.pdf
HAS/2009-11-04_texte_court_ballon_intragastrique.pdf
HAS/2009-11-05_cnedimts-2180-xpert.pdf
HAS/2009-11-05_cnedimts-2206-eviadrt.pdf
HAS/2009-11-05_cneditms-2204-eviasrt.pdf
HAS/2009-11-09_galvus_-_ct-5731.pdf
HAS/2009-11-09_galvus_ct_5731.pdf
HAS/2009-11-09_intelence_-_ct-6000.pdf
HAS/2009-11-09_intelence_ct_6000.pdf
HAS/2009-11-09_synthese_davis_galvus_-_ct-5731.pdf
HAS/2009-11-09_synthese_davis_intelence_-_ct-6000.pdf
HAS/2009-11-10_aclasta_ct_5082.pdf
HAS/2009-11-10_azilect_-_ct-5435.pdf
HAS/2009-11-10_azilect_ct_5435.pdf
HAS/2009-11-10_busilvex_ct_3958.pdf
HAS/2009-11-10_byetta_ct_4012.pdf
HAS/2009-11-10_cancidas_-_ct-6891.pdf
HAS/2009-11-10_cancidas_ct_6891.pdf
HAS/2009-11-10_clobex_ct_5185.pdf
HAS/2009-11-10_ct-3455_rapamune_.pdf
HAS/2009-11-10_ct-3958_busilvex_.pdf
HAS/2009-11-10_ct-4005_glivec_.pdf
HAS/2009-11-10_ct-4012_byetta.pdf
HAS/2009-11-10_ct-4159_plavix_.pdf
HAS/2009-11-10_ct-4163_dynepo.pdf
HAS/2009-11-10_ct-4432_enantone.pdf
HAS/2009-11-10_ct-4515_orfadin_.pdf
HAS/2009-11-10_ct-4613_umatrope.pdf
HAS/2009-11-10_ct-5082_aclasta_.pdf
HAS/2009-11-10_ct-5185_clobex_.pdf
HAS/2009-11-10_ct-5252_yondelis_.pdf
HAS/2009-11-10_ct-5281_telzir_.pdf
HAS/2009-11-10_ct-5382_neupro_.pdf
HAS/2009-11-10_ct-5417_cubicin.pdf
HAS/2009-11-10_ct-5423_restorvol_.pdf
HAS/2009-11-10_ct-5449_riamet_.pdf
HAS/2009-11-10_ct-824_xigris_.pdf
HAS/2009-11-10_cubicin__ct_5417.pdf
HAS/2009-11-10_doribax_-_ct-5849.pdf
HAS/2009-11-10_doribax_ct_5849.pdf
HAS/2009-11-10_dynepo_ct_4163.pdf
HAS/2009-11-10_enantone_ct_4432.pdf
HAS/2009-11-10_endosta_-_ct-5450.pdf
HAS/2009-11-10_endosta_ct_5450.pdf
HAS/2009-11-10_foscan_-_ct-5910.pdf
HAS/2009-11-10_foscan_ct_5910.pdf
HAS/2009-11-10_glivec_ct_4005.pdf
HAS/2009-11-10_inexium_-_ct-7094.pdf
HAS/2009-11-10_inexium_ct_7094.pdf
HAS/2009-11-10_iressa_-_ct-6839_2009-11-30_10-32-47_442.pdf
HAS/2009-11-10_iressa_ct_6839.pdf
HAS/2009-11-10_kuvan_-_ct-6206.pdf
HAS/2009-11-10_kuvan_ct_6206.pdf
HAS/2009-11-10_lercapress_10_mg_10_mg_-_ct-5908.pdf
HAS/2009-11-10_lercapress_ct_5908.pdf
HAS/2009-11-10_mimpara_-_ct-_6202.pdf
HAS/2009-11-10_mimpara_ct_6202.pdf
HAS/2009-11-10_neupro_ct_5382.pdf
HAS/2009-11-10_orfadin_ct_4515.pdf
HAS/2009-11-10_plavix__ct_4159.pdf
HAS/2009-11-10_pradaxa_-_ct-5528.pdf
HAS/2009-11-10_pradaxa_ct_5528.pdf
HAS/2009-11-10_rapamune_ct_3455.pdf
HAS/2009-11-10_restorvol_ct_5423.pdf
HAS/2009-11-10_riamet_ct_5449.pdf
HAS/2009-11-10_synthese_davis_cancidas_-_ct-6891.pdf
HAS/2009-11-10_synthese_davis_doribax_-_ct-5849.pdf
HAS/2009-11-10_synthese_davis_endosta_-_ct-5450.pdf
HAS/2009-11-10_synthese_davis_inexium_-_ct-7094.pdf
HAS/2009-11-10_synthese_davis_iressa_-_ct-6839_2010-04-01_16-23-14_449.pdf
HAS/2009-11-10_synthese_davis_kuvan_-_ct-6206.pdf
HAS/2009-11-10_synthese_davis_lercapress_ct-5908_2009-05-14_09-53-19_682.pdf
HAS/2009-11-10_synthese_davis_mimpara_-_ct-6202.pdf
HAS/2009-11-10_synthese_davis_xarelto_-_ct-6017.pdf
HAS/2009-11-10_synthese_pradaxa_pdf_2009-02-06_11-50-9_296.pdf
HAS/2009-11-10_synthese_restorvol_pdf.pdf
HAS/2009-11-10_telzir_ct_5281.pdf
HAS/2009-11-10_umatrope_ct_4613.pdf
HAS/2009-11-10_xarelto_-_ct-6017.pdf
HAS/2009-11-10_xarelto_ct_6017.pdf
HAS/2009-11-10_xigris_ct_824.pdf
HAS/2009-11-10_yondelis_ct_5252.pdf
HAS/2009-11-10_zondar_-_ct-5546.pdf
HAS/2009-11-10_zondar_ct_5546.pdf
HAS/2009-11-11_aclasta_-_ct-6147.pdf
HAS/2009-11-11_aclasta_ct_6147.pdf
HAS/2009-11-11_ct-5277_intralipide_.pdf
HAS/2009-11-11_intralipide_ct_5277.pdf
HAS/2009-11-11_synthese_davis_aclasta_-_ct-6147.pdf
HAS/2009-11-16_advagraf_-_ct-6966.pdf
HAS/2009-11-16_amoxicilline_biogaran_-_ct-7180.pdf
HAS/2009-11-16_egery_-_ct-7013.pdf
HAS/2009-11-16_mycostatine_-_ct-6936.pdf
HAS/2009-11-16_omacor_-_ct-7087.pdf
HAS/2009-11-16_oracefal_-_ct-7126.pdf
HAS/2009-11-16_polyionique_-_ct-7207.pdf
HAS/2009-11-16_renvela_-_ct-7124.pdf
HAS/2009-11-16_rosagel_rosacreme_-_ct-6676.pdf
HAS/2009-11-16_spiriva_respimat_-_ct-7010.pdf
HAS/2009-11-16_tamiflu_-_ct-6816.pdf
HAS/2009-11-16_tamiflu_ct_6816.pdf
HAS/2009-11-17_cnedimts-2155-zenith-renu-aaa.pdf
HAS/2009-11-17_cnedimts-2176-zenith.pdf
HAS/2009-11-17_cnedimts-2207-tubulcus.pdf
HAS/2009-11-17_ct-4722_uvadex.pdf
HAS/2009-11-17_ct-5342_vectibix_.pdf
HAS/2009-11-17_ct-5472_pergoveris.pdf
HAS/2009-11-17_endoprotheses_aortiques_abdominales_complement.pdf
HAS/2009-11-17_endoprotheses_aortiques_abdominales_rapport.pdf
HAS/2009-11-17_pergoveris_ct_5472.pdf
HAS/2009-11-17_rebetol_-_ct-5470.pdf
HAS/2009-11-17_rebetol_ct_5470.pdf
HAS/2009-11-17_synthese_davis_rebetol_-_ct-5470.pdf
HAS/2009-11-17_synthese_davis_tandemact_-_ct-5657.pdf
HAS/2009-11-17_synthese_pergoveris_pdf_2009-02-06_11-35-43_660.pdf
HAS/2009-11-17_synthese_zenith_helico.pdf
HAS/2009-11-17_tandemact_-_ct-5657.pdf
HAS/2009-11-17_tandemact_ct_5657.pdf
HAS/2009-11-17_uvadex_ct_4722.pdf
HAS/2009-11-17_vectibix_ct_5342.pdf
HAS/2009-11-17_zenith_renu_27_octobre_2009_2155_synthese_davis.pdf
HAS/2009-11-18_aldara_-_ct-5614.pdf
HAS/2009-11-18_aldara_ct_5614.pdf
HAS/2009-11-18_avastin_-_ct-5479.pdf
HAS/2009-11-18_avastin_ct_5479.pdf
HAS/2009-11-18_neomercazole_-_ct-7213_2009-11-13_10-05-27_691.pdf
HAS/2009-11-18_synthese_davis_aldara_-_ct_5614_2009-04-06_13-34-52_393.pdf
HAS/2009-11-18_synthese_davis_avastin_-_ct-5579.pdf
HAS/2009-11-18_synthese_davis_viraferonpeg_-_ct-5474.pdf
HAS/2009-11-18_viraferon_peg_-_ct-5474.pdf
HAS/2009-11-18_viraferonpeg_ct_5474.pdf
HAS/2009-11-23_klipal_codeine_-_c-t7086.pdf
HAS/2009-11-23_levophta_-_ct-7246.pdf
HAS/2009-11-23_mestinon_-_ct-5914.pdf
HAS/2009-11-23_myfortic_-_ct_7218.pdf
HAS/2009-11-23_odrik_-_ct-7217.pdf
HAS/2009-11-23_paracetamoleg_-_ct-7148.pdf
HAS/2009-11-23_singulair_5_mg_-_10_mg_-_ct-7112.pdf
HAS/2009-11-23_xenetix_-_ct-_7114.pdf
HAS/2009-11-24_calperos_500_-_ct-7118.pdf
HAS/2009-11-24_calperos_d3_-_ct-7308.pdf
HAS/2009-11-26_cnedimts-2212-3c100c-leg.pdf
HAS/2009-11-26_cnedimts-2231-restylane-subq.pdf
HAS/2009-11-26_synthese_3c100_c-leg.pdf
HAS/2009-11-26_synthese_restylane.pdf
HAS/2009-11-30_spondylarthrites_-_diagnostic_-_argumentaire.pdf
HAS/2009-11-30_spondylarthrites_-_recommandations.pdf
HAS/2009-11-30_spondylarthrites_-_synthese_des_recommandations.pdf
HAS/2009-11-30_spondylarthrites_-_traitement_et_suivi_-_argumentaire.pdf
HAS/2009-12-01_chronic_pain_guideline.pdf
HAS/2009-12-01_douleur_chronique_argumentaire.pdf
HAS/2009-12-01_douleur_chronique_recommandations.pdf
HAS/2009-12-01_douleur_chronique_synthese.pdf
HAS/2009-12-01_guide_utilisateur.pdf
HAS/2009-12-01_liste_de_criteres.pdf
HAS/2009-12-02_synthese_davis_victoza_-_ct-7136.pdf
HAS/2009-12-02_victoza_-_ct-7136.pdf
HAS/2009-12-02_victoza_ct_7136.pdf
HAS/2009-12-07_cnedimts-2054-neuroform3.pdf
HAS/2009-12-07_cnedimts-2177-leo-plus.pdf
HAS/2009-12-07_cnedimts-2200-leo-plus.pdf
HAS/2009-12-08_ct-5232_formoair_.pdf
HAS/2009-12-08_ct-5238_xeloda_.pdf
HAS/2009-12-08_formoair_ct_5232.pdf
HAS/2009-12-08_xeloda_ct_5238.pdf
HAS/2009-12-14_cnedimts-2238-physio-stim.pdf
HAS/2009-12-14_cnedimts-2310-xience-prime.pdf
HAS/2009-12-14_cnedimts-2311-promus-element.pdf
HAS/2009-12-14_colopeg_-_ct-7125.pdf
HAS/2009-12-14_ct-5014_synagis.pdf
HAS/2009-12-14_granocyte_-_ct-6510.pdf
HAS/2009-12-14_kytryl_-_ct-6855.pdf
HAS/2009-12-14_pantestone_-_ct-5768_2009-12-14_15-41-38_788.pdf
HAS/2009-12-14_synagis_ct_5014.pdf
HAS/2009-12-15_atimos_ct_5231.pdf
HAS/2009-12-15_atripla_-_ct-6045.pdf
HAS/2009-12-15_atripla_ct_6045.pdf
HAS/2009-12-15_azarga_-_ct-6006.pdf
HAS/2009-12-15_azarga_ct_6006.pdf
HAS/2009-12-15_bemedrex_-_ct-7152.pdf
HAS/2009-12-15_botox_-_ct-7305.pdf
HAS/2009-12-15_botox_ct_7305.pdf
HAS/2009-12-15_ct-5231_atimos_.pdf
HAS/2009-12-15_ct-5270_torisel_.pdf
HAS/2009-12-15_ct-5422_rapydan_.pdf
HAS/2009-12-15_ct-5453_umatrope_.pdf
HAS/2009-12-15_ct-5592_orencia_.pdf
HAS/2009-12-15_ct-5603_volibris_.pdf
HAS/2009-12-15_grazax_-_ct-6775.pdf
HAS/2009-12-15_grazax_ct_6775.pdf
HAS/2009-12-15_lederthrexate_-_ct-7258.pdf
HAS/2009-12-15_orencia_ct_4603.pdf
HAS/2009-12-15_rapydan_ct_5422.pdf
HAS/2009-12-15_synthese_davis_atripla_-_ct-6045.pdf
HAS/2009-12-15_synthese_davis_azarga_-_ct-6006.pdf
HAS/2009-12-15_synthese_davis_botox_-_ct-7305.pdf
HAS/2009-12-15_synthese_davis_grazax_-_ct-6775.pdf
HAS/2009-12-15_synthese_volibris_pdf_2009-02-06_11-54-7_672.pdf
HAS/2009-12-15_torisel_ct_5270.pdf
HAS/2009-12-15_umatrope_ct_5453.pdf
HAS/2009-12-15_volibris_ct_5603.pdf
HAS/2009-12-16_avis__fistule_anale.pdf
HAS/2009-12-16_depistage_prenatal_hepatite_b_argu_vf.pdf
HAS/2009-12-16_depistages_prenatals_obligatoires__synthese_vf.pdf
HAS/2009-12-16_depistages_prenatals_obligatoires_argu_vf.pdf
HAS/2009-12-16_efient_-_ct-6544.pdf
HAS/2009-12-16_efient_ct_6544.pdf
HAS/2009-12-16_intrinsa_-_ct-6937.pdf
HAS/2009-12-16_intrinsa_ct_6937.pdf
HAS/2009-12-16_synthese_davis_efient_-_ct-6544.pdf
HAS/2009-12-16_synthese_davis_intrinsa_-_ct-6937.pdf
HAS/2009-12-22_afinitor_-_ct-7009.pdf
HAS/2009-12-22_afinitor_ct_7009.pdf
HAS/2009-12-22_coveram_-_ct-6938.pdf
HAS/2009-12-22_coveram_ct_6938.pdf
HAS/2009-12-22_ct-4851_lercan_.pdf
HAS/2009-12-22_lercan_ct_4851.pdf
HAS/2009-12-22_meningitec_-_ct-7079.pdf
HAS/2009-12-22_meningitec_ct_7079.pdf
HAS/2009-12-22_synthese_davis_-_coveram_-_ct-6938.pdf
HAS/2009-12-22_synthese_davis_afinitor_-_ct-7009.pdf
HAS/2009-12-22_synthese_davis_menigitec_menjugate_neisvac_-_ct-7079-7081-7129.pdf
HAS/2009-12-24_document_avis_second_avis_en_anatomie_et_cytologie_pathologiques_2009-12-23_12-40-7_858.pdf
HAS/2009-12-24_note_de_cadrage_2nde_lecture_en_anatomie_et_cytologie_pathologiques_2009-07-22_14-41-50_596.pdf
HAS/2009-12-24_rapport_anevrismes_intracraniens_rompus_2009-12-23_18-16-23_801.pdf
HAS/2009-12-24_rapport_second_avis_en_anatomie_et_cytologie_pathologiques.pdf
HAS/2009-12-24_texte_court_anevrismes_intracraniens_rompus_2009-12-23_18-15-56_478.pdf
HAS/2009-12-24_texte_court_second_avis_en_anatomie_et_cytologie_pathologiques_2009-12-23_12-25-6_327.pdf
HAS/2009-12-29_avis_cone_beam_2009-12-28_17-32-47_634.pdf
HAS/2009-12-29_note_de_cadrage___tomographie_volumique_a_faisceau_conique_de_la_face_cone_beam.pdf
HAS/2009-12-29_rapport_cone_beam_version_finale_2009-12-28_17-27-28_610.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_argumentaire.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_calendrier_de_suivi.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_grille_de_recueil_des_crieres.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_liste_des_criteres_de_qualite.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_recommandations.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_serie_de_criteres_de_qualite_2009-12-30_12-18-57_827.pdf
HAS/2009-12-29_suivi_du_transplante_renal_-_synthese_des_recommandations.pdf
HAS/2009-12-29_texte_court_cone_beam_2009-12-28_17-27-51_224.pdf
HAS/2009-12-30_le_dossier_medical_en_sante_au_travail_-_grille_de_recueil_des_criteres.pdf
HAS/2009-12-30_le_dossier_medical_en_sante_au_travail_-_liste_des_criteres.pdf
HAS/2009-12-30_le_dossier_medical_en_sante_au_travail_-_serie_de_criteres_de_qualite.pdf
HAS/2009-12-30_rbpp_-_dossier_medical_en_sante_au_travail_-_argumentaire.pdf
HAS/2009-12-30_rbpp_-_dossier_medical_en_sante_au_travail_-_recommandations.pdf
HAS/2009-12-30_rbpp_-_dossier_medical_en_sante_au_travail_-_synthese_des_recommandations.pdf
HAS/2010-01-04_1k10_22_decembre_2009_1885_synthese_davis.pdf
HAS/2010-01-04_aorfix_08_decembre_2009_2283_synthese_davis.pdf
HAS/2010-01-04_cepp-1443_prestige_lp.pdf
HAS/2010-01-04_clinutren_repair_08_decembre_2009_2244_synthese_davis.pdf
HAS/2010-01-04_cnedimts-1885-dynamique1k10.pdf
HAS/2010-01-04_cnedimts-1891-genous.pdf
HAS/2010-01-04_cnedimts-2019-nutrition-clinique-a-domicile.pdf
HAS/2010-01-04_cnedimts-2077-corcap.pdf
HAS/2010-01-04_cnedimts-2209-codman-enterprise_2009-12-22_17-58-57_977.pdf
HAS/2010-01-04_cnedimts-2236-modulenibd.pdf
HAS/2010-01-04_cnedimts-2237-peptamen.pdf
HAS/2010-01-04_cnedimts-2239-peptamenhn.pdf
HAS/2010-01-04_cnedimts-2244-clinutren-repair.pdf
HAS/2010-01-04_cnedimts-2245-pedimed.pdf
HAS/2010-01-04_cnedimts-2247-exogen-express.pdf
HAS/2010-01-04_cnedimts-2254-zsi375.pdf
HAS/2010-01-04_cnedimts-2283-aorfix.pdf
HAS/2010-01-04_corcap-22-decembre_2009_2077_synthese_davis_2010-05-05_15-37-20_686.pdf
HAS/2010-01-04_modulen_ibd_08_decembre_2009_2236_synthese_davis.pdf
HAS/2010-01-04_peptamen-08_decembre_20009_2237.pdf
HAS/2010-01-04_peptamen_hn-08_decembre_20009_2239.pdf
HAS/2010-01-04_synthese_genous_2010-03-31_17-57-12_613.pdf
HAS/2010-01-04_synthese_pedimed.pdf
HAS/2010-01-04_zsi375-24_novembre_2009_2254_synthese_davis.pdf
HAS/2010-01-05_lettre_de_cadrage_autisme.pdf
HAS/2010-01-05_reco_autisme_anesm.pdf
HAS/2010-01-06_arestal_-_ct-7367.pdf
HAS/2010-01-06_arixtra_-_ct-6774.pdf
HAS/2010-01-06_arixtra_annexe_1.pdf
HAS/2010-01-06_arixtra_annexe_2.pdf
HAS/2010-01-06_arolac_-_ct-7329.pdf
HAS/2010-01-06_beclometasone_teva_-_ct-7324.pdf
HAS/2010-01-06_contracne_-_ct-7360.pdf
HAS/2010-01-06_delidose-_ct-71536.pdf
HAS/2010-01-06_desobel_-_ct_-_7282.pdf
HAS/2010-01-06_folinoral_-_ct-7181.pdf
HAS/2010-01-06_ionitan_-_ct-7352.pdf
HAS/2010-01-06_ketrel_-_ct-7365.pdf
HAS/2010-01-06_lhrh_ferring_-_ct-7132.pdf
HAS/2010-01-06_lovenox_gamme_-_ct-7047.pdf
HAS/2010-01-06_lutrelef_-_ct-_7133.pdf
HAS/2010-01-06_normacol_-_ct-7216.pdf
HAS/2010-01-06_paracetamol_mylan_-_ct-7338.pdf
HAS/2010-01-06_prohance_-_ct-7106.pdf
HAS/2010-01-06_xenid_-_ct-7255.pdf
HAS/2010-01-07_cnedimts-2235-diben.pdf
HAS/2010-01-08_cnedimts-1684-prevention_escarres-projet_de_nomenclature-cahier_des_charges_2010-01-07_17-17-22_580.pdf
HAS/2010-01-14_askina_calgitrol_22_decembre_2009_2282_synhese_davis.pdf
HAS/2010-01-14_cnedimts-2252-peristeenobtal.pdf
HAS/2010-01-14_cnedimts-2282-askinacalgitrolag.pdf
HAS/2010-01-14_cnedimts-2309-valiant.pdf
HAS/2010-01-14_peristeen_12_janvier_2010_2252_synthese_davis.pdf
HAS/2010-01-14_valiant-27_octobre__22_decembre_2009_2179_2309_synthese_davis.pdf
HAS/2010-01-15_avis_cepp_668_07032007.pdf
HAS/2010-01-15_cepp-668-infirmiers.pdf
HAS/2010-01-15_cnedimts-2260-pansement-articles.pdf
HAS/2010-01-18_adiana-12_janvier_2010_2248__synthese_davis.pdf
HAS/2010-01-18_cepp-2084-precision-fit.pdf
HAS/2010-01-18_cepp-precision_2084.pdf
HAS/2010-01-18_cnedimts-2248-adiana.pdf
HAS/2010-01-18_cnedimts-2371-neuroformez3_2010-01-18_15-50-44_853.pdf
HAS/2010-01-18_cnedimts-2374-soprano-armonia.pdf
HAS/2010-01-18_conebilox_-_ct-7313.pdf
HAS/2010-01-18_dermestril_dermestril_septem_-_ct-7312.pdf
HAS/2010-01-18_norprolac_-_ct-6828_2010-01-18_10-28-37_286.pdf
HAS/2010-01-18_synthese_davis_soprano_armonia_2374.pdf
HAS/2010-01-20_innohep_-_ct-6965.pdf
HAS/2010-01-20_rowasa_-_ct-6813.pdf
HAS/2010-01-20_sifrol_-_ct-7328.pdf
HAS/2010-01-21_argumentaire_conditions_telemedecine_udm_vf.pdf
HAS/2010-01-21_cnedimts-2387-nobori.pdf
HAS/2010-01-21_synthese_conditions_telemedecine_udm_vf.pdf
HAS/2010-01-25_cnedimts-1888-allogreffes-vasculaires.pdf
HAS/2010-01-25_cnedimts-1994-allogreffes-osseuses.pdf
HAS/2010-01-25_cnedimts-1995-allogreffes-valvulaires.pdf
HAS/2010-01-25_cnedimts-2281-flow-collector.pdf
HAS/2010-01-26_rapport_devaluation_des_traitements_de_plaies_par_pression_negative_tpn.pdf
HAS/2010-01-26_synthese_devaluation_des_traitements_de_plaies_par_pression_negative_tpn.pdf
HAS/2010-01-26_synthesis_negative-pressure_wound_therapy_evaluation.pdf
HAS/2010-01-27_onytec_-_ct-7347.pdf
HAS/2010-01-27_onytec_ct_7347.pdf
HAS/2010-01-27_synthese_davis_onytec_-_ct-7347.pdf
HAS/2010-01-28_cepp-1777_lars.pdf
HAS/2010-01-28_cepp-2152-articler165-25.pdf
HAS/2010-01-28_cnedimts-1777-lars-epaule.pdf
HAS/2010-01-28_cnedimts-2154-synicem.pdf
HAS/2010-01-28_cnedimts-2241-aquacel.pdf
HAS/2010-01-28_cnedimts-2376-sets-de-produits-de-sante.pdf
HAS/2010-02-02_calsyn_-_ct-7399.pdf
HAS/2010-02-02_cepp-282-lars.pdf
HAS/2010-02-02_desogestrel_biogaran_-_ct-7307.pdf
HAS/2010-02-02_desogestrel_biogaran_-_ct-7596.pdf
HAS/2010-02-02_fivasa_-_ct-7326.pdf
HAS/2010-02-02_hytrine_dysalfa_-_ct-7353.pdf
HAS/2010-02-02_ixel_-_ct-7470.pdf
HAS/2010-02-02_koretic_-_ct-7396.pdf
HAS/2010-02-02_oxis_turbuhaler_-_ct-7473.pdf
HAS/2010-02-02_parapsyllium_-_ct-6823.pdf
HAS/2010-02-02_timolol_alcon_-_ct-7456.pdf
HAS/2010-02-02_trinitrine_mylan_-_ct-7447.pdf
HAS/2010-02-02_xatral_-_ct-7364.pdf
HAS/2010-02-02_zomorph_-_ct-7127.pdf
HAS/2010-02-02_zoxan_-_ct-7333.pdf
HAS/2010-02-03_ossopan_-_ct-7469.pdf
HAS/2010-02-04_cnedimts-2287-neurostimulateurs-implantables-rechargeables.pdf
HAS/2010-02-08_adartrel_-_ct-7444.pdf
HAS/2010-02-08_adartrel_annexe_-_ct-7444.pdf
HAS/2010-02-08_adartrel_ct_7444.pdf
HAS/2010-02-08_avis_contention_du_coeur.pdf
HAS/2010-02-08_avis_gastrectomie_par_coelioscopie.pdf
HAS/2010-02-08_avis_neuromodulation_2010.pdf
HAS/2010-02-08_rapport_gastrectomie_polaire_sup_par_coelioscopie.pdf
HAS/2010-02-08_texte_court_gastrectomie_polaire_sup_par_coelioscopie.pdf
HAS/2010-02-11_fiche_de_bon_usage_implants_incontinence_urinaire.pdf
HAS/2010-02-11_fiche_de_bon_usage_implants_prolapsus_pelvien.pdf
HAS/2010-02-11_fiche_de_bon_usage_implants_refection_paroi.pdf
HAS/2010-02-15_actos_ct_3226.pdf
HAS/2010-02-15_actos_ct_5098.pdf
HAS/2010-02-15_atriance_ct_5162.pdf
HAS/2010-02-15_clinutren_g_09_fevrier_2010_2242_synthese_davis.pdf
HAS/2010-02-15_clinutren_protect_09_fevrier_2010_2243_synthese_davis.pdf
HAS/2010-02-15_cnedimts-2240-sondalisg.pdf
HAS/2010-02-15_cnedimts-2242-clinutreng.pdf
HAS/2010-02-15_cnedimts-2243-clinutrenprotect.pdf
HAS/2010-02-15_cryopreservation_-_argumentaire.pdf
HAS/2010-02-15_cryopreservation_-_recommandations.pdf
HAS/2010-02-15_ct-1039_maxepa_.pdf
HAS/2010-02-15_ct-3197_taxotere__2007_09_07__16_10_21_802.pdf
HAS/2010-02-15_ct-3226_actos_.pdf
HAS/2010-02-15_ct-3738_prograf_.pdf
HAS/2010-02-15_ct-3753_ubit_.pdf
HAS/2010-02-15_ct-3951_loramyc.pdf
HAS/2010-02-15_ct-4164_tegeline_.pdf
HAS/2010-02-15_ct-4386_hycamtin_.pdf
HAS/2010-02-15_ct-4471_keppra.pdf
HAS/2010-02-15_ct-4583_grazax_.pdf
HAS/2010-02-15_ct-5030_glivec.pdf
HAS/2010-02-15_ct-5098_actos_.pdf
HAS/2010-02-15_ct-5162_atriance_.pdf
HAS/2010-02-15_ct-5386_droleptan_.pdf
HAS/2010-02-15_droleptan_ct_5386.pdf
HAS/2010-02-15_glivec_she_ct_5030.pdf
HAS/2010-02-15_grazax_ct_4583.pdf
HAS/2010-02-15_hycamtin__ct_4386.pdf
HAS/2010-02-15_keppra__ct_4471.pdf
HAS/2010-02-15_loramyc_ct_3951.pdf
HAS/2010-02-15_maxepa_ct_1039.pdf
HAS/2010-02-15_prograf_ct_3738.pdf
HAS/2010-02-15_sondalis-09_fevrier_2010_2240.synthese_davis.pdf
HAS/2010-02-15_taxotere_ct_3197.pdf
HAS/2010-02-15_tegeline_ct_4164.pdf
HAS/2010-02-15_ubit_ct_3753.pdf
HAS/2010-02-16_acuilix_-_ct-7463.pdf
HAS/2010-02-16_cetrotide_-_ct-7478.pdf
HAS/2010-02-16_cnedimts-2415_xact.pdf
HAS/2010-02-16_ct-3754_femara_.pdf
HAS/2010-02-16_estima_-_ct_7465.pdf
HAS/2010-02-16_femara_ct_3754.pdf
HAS/2010-02-16_luteran_-_ct-7409.pdf
HAS/2010-02-16_paracetamol_codeine_mylan_-_ct-7415.pdf
HAS/2010-02-16_pariet_-_ct-7330.pdf
HAS/2010-02-16_revia_-_ct-7440.pdf
HAS/2010-02-16_xact-09_fevrier_2010_2415_synthese_davis_2010-06-10_14-39-6_74.pdf
HAS/2010-02-18_rapport_transsexualisme.pdf
HAS/2010-02-19_annexes_du_rapport_devaluation_des_endoprotheses_a_liberation_de_principe_actif.pdf
HAS/2010-02-19_asmabec_clickhaler_-_ct-7493.pdf
HAS/2010-02-19_assessment_of_drug-eluting_stents.pdf
HAS/2010-02-19_avis_has_2251_article_56.pdf
HAS/2010-02-19_evaluation_des_endoprotheses_coronaires_a_liberation_de_principe_actif.pdf
HAS/2010-02-19_meta-analysis_cucherat_2008.pdf
HAS/2010-02-19_ophtim_-_ct-7405.pdf
HAS/2010-02-19_povidone_iodee_mylan_-_ct-7585.pdf
HAS/2010-02-19_synthese_de_levaluation_des_endoprotheses_coronaires_a_liberation_de_principe_actif.pdf
HAS/2010-02-22_fiche_de_bon_usage_traitement_des_plaies_par_pression_negative.pdf
HAS/2010-03-01_children_deafness_-_0_to_6_years_-_guideline.pdf
HAS/2010-03-01_children_deafness_-_0_to_6_years_-_quick_reference_guide.pdf
HAS/2010-03-01_cons_pra_surdite_enfant_conditions_favorables_communication.pdf
HAS/2010-03-01_good_practice-dressings-indications_and_recommended_uses.pdf
HAS/2010-03-01_pansements_synthese_rapport.pdf
HAS/2010-03-01_surdite_de_lenfant_-_0_a_6_ans_-_argumentaire.pdf
HAS/2010-03-01_surdite_de_lenfant_-_0_a_6_ans_-_consultation_publique.pdf
HAS/2010-03-01_surdite_de_lenfant_-_0_a_6_ans_-_recommandations.pdf
HAS/2010-03-01_surdite_de_lenfant_-_0_a_6_ans_-_synthese_des_recommandations.pdf
HAS/2010-03-02_bientraitance_rapport_national_anesm.pdf
HAS/2010-03-02_synthese_bientraitance_rapport_national_anesm.pdf
HAS/2010-03-04_ald_30_gm_ksein_vd.pdf
HAS/2010-03-04_ald_30_gp_ksein_vd_2010-09-27_16-51-2_493.pdf
HAS/2010-03-04_ald_30_lap_ksein_vd.pdf
HAS/2010-03-04_anesm_elements-appropriation_autoriteparentale06.pdf
HAS/2010-03-04_anesm_synthese-orange-autoriteparentale.pdf
HAS/2010-03-04_avis_actualise_orthese_mandibulaire_2009.pdf
HAS/2010-03-04_eludril_-_ct-4952.pdf
HAS/2010-03-04_paroex_-_ct-6256.pdf
HAS/2010-03-04_prexidine_-_ct-6245.pdf
HAS/2010-03-04_rapport_propulsion_mandibulaire.pdf
HAS/2010-03-04_reco_autorite_parentale_anesm.pdf
HAS/2010-03-04_reco_autorite_parentale_anesm_biblio_complete.pdf
HAS/2010-03-04_synthese_davis_bains_de_bouche.pdf
HAS/2010-03-05_actiskenan_-_ct-7154.pdf
HAS/2010-03-05_alodont_-_ct-5025.pdf
HAS/2010-03-05_apsor_-_ct-7248.pdf
HAS/2010-03-05_bigonist_-_ct-7462.pdf
HAS/2010-03-05_clairyg_-_ct-7523.pdf
HAS/2010-03-05_dafalgan-efferalgan_-_ct-7327.pdf
HAS/2010-03-05_doliprane-geluprane-paracetamol_winthrop_-_ct-7466.pdf
HAS/2010-03-05_fenofibrate_ranbaxy_ri_-_ct-7483.pdf
HAS/2010-03-05_givalex_-_ct-5020.pdf
HAS/2010-03-05_glycothymoline_-_ct-4549.pdf
HAS/2010-03-05_skenan_-_ct-7278.pdf
HAS/2010-03-05_suprefact_-_ct-7443.pdf
HAS/2010-03-05_synthese_davis_bains_de_bouche.pdf
HAS/2010-03-08_vercyte_-_ct-7095.pdf
HAS/2010-03-11_ct-3845_metvixia_.pdf
HAS/2010-03-11_ct-5028_glivec_.pdf
HAS/2010-03-11_glivec_ct_5028.pdf
HAS/2010-03-11_metvixia_ct_3845.pdf
HAS/2010-03-11_rhinotrophyl_-_ct-5726.pdf
HAS/2010-03-16_aas_-_argumentaire.pdf
HAS/2010-03-16_aas_-_recommandations.pdf
HAS/2010-03-17_cnedimts-2233-trufill-dcs-orbit.pdf
HAS/2010-03-17_cnedimts-2234-trufill-dcs-orbit.pdf
HAS/2010-03-17_cnedimts-2250-progressiv.pdf
HAS/2010-03-17_cnedimts-2379-eon.pdf
HAS/2010-03-17_cnedimts-2382-allevyn.pdf
HAS/2010-03-17_cnedimts-2385-tridentcrossfire_2010-03-10_15-00-32_514.pdf
HAS/2010-03-17_cnedimts-2386-tridentx3.pdf
HAS/2010-03-17_cnedimts-2416-carbostentchrono_2010-03-10_12-10-23_184.pdf
HAS/2010-03-17_cnedimts-2461-pro-kinetic-energy.pdf
HAS/2010-03-17_eon-23_fevrier_2010_2379_synthese_davis.pdf
HAS/2010-03-17_hadrontherapie_annexe__vf_pdf.pdf
HAS/2010-03-17_hadrontherapie_rapport_preliminaire_vf_pdf.pdf
HAS/2010-03-17_progressiv-23_fevrier_2010_2250_synthese_davis.pdf
HAS/2010-03-19_ct-5077_tarceva_.pdf
HAS/2010-03-19_tarceva_ct_5077.pdf
HAS/2010-03-23_dicetel_-_ct-7638.pdf
HAS/2010-03-23_lasilix_-_ct-7641.pdf
HAS/2010-03-23_pilobloq_-_ct-7477.pdf
HAS/2010-03-23_pulmodexane_-_ct-7476.pdf
HAS/2010-03-23_qvar_autohaler_-_ct-7498.pdf
HAS/2010-03-24_ct-2950_neupro_.pdf
HAS/2010-03-24_ct-3046_ebixa.pdf
HAS/2010-03-24_ct-4070_sprycel_.pdf
HAS/2010-03-24_ct-5114_gadovist_.pdf
HAS/2010-03-24_ct-5302_herceptin_.pdf
HAS/2010-03-24_ct-5359_isentress_.pdf
HAS/2010-03-24_dolenio_-_ct-7041.pdf
HAS/2010-03-24_ebixa_ct_3046.pdf
HAS/2010-03-24_gadovist_ct_5114.pdf
HAS/2010-03-24_herceptin_ct_5302.pdf
HAS/2010-03-24_isentress_ct_5359.pdf
HAS/2010-03-24_neupro_ct_2950.pdf
HAS/2010-03-24_sprycel_ct_4070.pdf
HAS/2010-03-24_synthese_avis_alzheimer_031007_2007_10_05__10_24_44_497.pdf
HAS/2010-03-29_foziretic_-_ct-7451.pdf
HAS/2010-03-29_levothyrox_-_ct-7314.pdf
HAS/2010-03-29_meberine_biogaran_-_ct-7183.pdf
HAS/2010-03-29_osaflexan_-_ct-7573.pdf
HAS/2010-03-29_phocytan_-_ct-7691.pdf
HAS/2010-03-30_abstract_place_of_breast.pdf
HAS/2010-03-30_note_de_cadrage_irm_mammaire_2009-07-30_12-03-37_69.pdf
HAS/2010-03-30_rapport_irm_mammaire_2011-11-10_14-37-1_863.pdf
HAS/2010-03-30_summary_breast_mri.pdf
HAS/2010-03-30_synthese_irm_mammaire.pdf
HAS/2010-03-30_texte_court_irm_mammaire.pdf
HAS/2010-04-02_ald_10_guide_drepano_adulte_web.pdf
HAS/2010-04-02_ald_10_lap_drepano_adulte_web.pdf
HAS/2010-04-02_ald_10_lap_drepano_enfant_web.pdf
HAS/2010-04-02_ald_10_pnds_drepano_enfant_web.pdf
HAS/2010-04-02_pnds_27_-_syndromes_drepanocytaires_majeurs_de_lenfant_et_de_ladolescent_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2010-04-02_pnds_28_-_syndromes_drepanocytaires_majeurs_de_ladulte_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2010-04-05_analyse_qualitative_addictologie_anesm.pdf
HAS/2010-04-05_anesm_elements-appropriation_addictologie06.pdf
HAS/2010-04-05_anesm_synthese-verte-addictologie.pdf
HAS/2010-04-05_lettre_de_cadrage_addictologie-2.pdf
HAS/2010-04-05_reco_addictologie_anesm.pdf
HAS/2010-04-05_resultats_quest_addictologie_anesm.pdf
HAS/2010-04-09_caphosol_06_avril_2010_2378_synthese_davis.pdf
HAS/2010-04-09_cnedimts-1888-allogreffes-vasculaires2.pdf
HAS/2010-04-09_cnedimts-2255_duraheart_lvas_2010-04-08_11-46-49_237.pdf
HAS/2010-04-09_cnedimts-2306-tali_2010-04-08_11-08-3_799.pdf
HAS/2010-04-09_cnedimts-2378-caphosol.pdf
HAS/2010-04-09_tali_06_avril_2010_2306_synthese_davis.pdf
HAS/2010-04-12_c-leg_compact_23_mars_2010_2418_synthese_davis.pdf
HAS/2010-04-12_cetornan_-_ct-7392.pdf
HAS/2010-04-12_cnedimts-1219-allogreffevasculairemarseille.pdf
HAS/2010-04-12_cnedimts-1226-allogreffevalvulairemarseille.pdf
HAS/2010-04-12_cnedimts-1499-allogreffevasculairecryopreserveestismier.pdf
HAS/2010-04-12_cnedimts-1504-allogreffevalvulairecardiaquecryopreserveelyon_2010-04-12_15-47-12_474.pdf
HAS/2010-04-12_cnedimts-1505-allogreffevasculairecryopreserveelyon.pdf
HAS/2010-04-12_cnedimts-1519-allogreffevasculairemontpellier.pdf
HAS/2010-04-12_cnedimts-1542-allogreffevasculairecryopreserveeparis.pdf
HAS/2010-04-12_cnedimts-1543-allogreffevalvulairecryopreserveeparis.pdf
HAS/2010-04-12_cnedimts-2330-saphenamed-ucv.pdf
HAS/2010-04-12_cnedimts-2375-salto.pdf
HAS/2010-04-12_cnedimts-2384tridentx3-28_2010-03-10_14-42-24_468.pdf
HAS/2010-04-12_cnedimts-2418-c-leg-compact.pdf
HAS/2010-04-12_cnedimts-2504-promus-element-long.pdf
HAS/2010-04-12_saphenamed-23_mars_2010_2330_synthese_davis..pdf
HAS/2010-04-14_cnedimts-1495-allogreffedeveinesaphenelyon_2010-04-13_11-19-40_509.pdf
HAS/2010-04-19_ansatipine_-_ct-7280.pdf
HAS/2010-04-19_decan_-_ct-7851.pdf
HAS/2010-04-19_doxycycline_biogaran_-_ct-7359.pdf
HAS/2010-04-19_effizinc_-_ct-7870.pdf
HAS/2010-04-19_iopamiron_-_ct-7348.pdf
HAS/2010-04-19_meliane_moneva_phaeva_-_ct_-_7667.pdf
HAS/2010-04-19_moclamine_-_ct-_8017.pdf
HAS/2010-04-19_praxilene_-_gevatran_-_annexe_-_ct-7713.pdf
HAS/2010-04-19_praxilene_-_gevatran_-_ct-7713.pdf
HAS/2010-04-19_rhophylac_-_ct-7715.pdf
HAS/2010-04-20_androtardyl_-_ct-7660.pdf
HAS/2010-04-20_calcium_vitamine_d3_-_ct-7672.pdf
HAS/2010-04-20_ciloxan_-_ct-7824.pdf
HAS/2010-04-20_cromedil_-_ct-8013.pdf
HAS/2010-04-20_epivir_-_ct-7769.pdf
HAS/2010-04-20_gestodene_ethinylestradiol_biogaran_-_ct-_8021.pdf
HAS/2010-04-20_keal_-_ct-7919.pdf
HAS/2010-04-20_lumigan_-_ct-7850.pdf
HAS/2010-04-20_lysocline_-_ct-5718.pdf
HAS/2010-04-20_mogadon_-_ct-6822.pdf
HAS/2010-04-20_navoban_-_ct-6848.pdf
HAS/2010-04-20_nordaz_-_ct-7669.pdf
HAS/2010-04-20_physiomycine_-_ct-6986.pdf
HAS/2010-04-20_requip_-_ct-7445.pdf
HAS/2010-04-20_tocolion_-_ct-7335.pdf
HAS/2010-04-20_voltaflex_-_ct-7589.pdf
HAS/2010-04-22_avis_nutramigen_aa_-_cnedimts_du_20_avril_2010_2372.pdf
HAS/2010-04-22_nutramigen_20_avril_2010_2372_synthese_davis.pdf
HAS/2010-04-26_ct-4030_curosurf.pdf
HAS/2010-04-26_ct-4617_durogesic_.pdf
HAS/2010-04-26_curosurf__ct_4030.pdf
HAS/2010-04-26_doc_avis_test_genotypique_resistance.pdf
HAS/2010-04-26_durogesic_ct_4617.pdf
HAS/2010-04-26_emtriva_-_ct-6887_2010-04-23_10-18-11_197.pdf
HAS/2010-04-26_keppra_-_ct-5462.pdf
HAS/2010-04-26_loxen_-_ct-7973.pdf
HAS/2010-04-26_puregon_-_ct-7455.pdf
HAS/2010-04-26_rap_test_genotypique_resistance.pdf
HAS/2010-04-26_texte_court_test_genotypique_resistance.pdf
HAS/2010-04-26_xolaam_-_ct-8005.pdf
HAS/2010-04-26_zeffix_-_ct-7768.pdf
HAS/2010-05-03_avis_eflow_rapid_-_cnedimts_du_20_avril_2010_2460.pdf
HAS/2010-05-03_avis_nutramigen_aa_-_cnedimts_du_20_avril_2010_2372_2010-04-26_15-53-3_703.pdf
HAS/2010-05-03_eflow_rapid_20_avril_2010_2460_synthese_davis.pdf
HAS/2010-05-03_osteopure-20_avril_2010_2437_avis.pdf
HAS/2010-05-03_osteopure-29_juin_2010_2437_avis.pdf
HAS/2010-05-04_anesm_elements-appropriation_peps06.pdf
HAS/2010-05-04_anesm_synthese-bleu-pe-ps.pdf
HAS/2010-05-04_avantgarde_chrono_carbostent-20_avril_2010_2506_avis_.pdf
HAS/2010-05-04_lettre_de_cadrage_projet_etablissement_anesm.pdf
HAS/2010-05-04_recapitulatif_recommandations_projet_etablissement_anesm.pdf
HAS/2010-05-04_reco_projet_etablissement_service_anesm.pdf
HAS/2010-05-04_reperes_reco_projet_etablissement_anesm.pdf
HAS/2010-05-05_humira_-_ct7304.pdf
HAS/2010-05-05_humira_ct_7304.pdf
HAS/2010-05-05_humira_fit_14122012.pdf
HAS/2010-05-05_synthese_davis_xilanik_-_ct-7738.pdf
HAS/2010-05-05_xilanik_-_ct-7738.pdf
HAS/2010-05-05_xilanik_ct_7738.pdf
HAS/2010-05-06_endeavor-04_mai_2010_2373_avis.pdf
HAS/2010-05-06_endeavor__endeavor_sprint-04_mai_2010_2373___2377_synthese_davis.pdf
HAS/2010-05-06_endeavor_sprint-04_mai_2010_2377_avis.pdf
HAS/2010-05-06_neurocybernetic_prothesis_ncp-04_mai_2010_2380_avis.pdf
HAS/2010-05-06_realdiet_peptide-04_mai_2010_2414_avis.pdf
HAS/2010-05-06_realdiet_peptide-04_mai_2010_2414_synthese_davis.pdf
HAS/2010-05-07_igiv_myasthenie_art56_avis_has.pdf
HAS/2010-05-07_igiv_myosites_art56_avis_has.pdf
HAS/2010-05-07_is_myosites_art56_avis_has_2010-05-07_16-52-37_390.pdf
HAS/2010-05-07_magnesiumcarence_art56_avis_has.pdf
HAS/2010-05-07_neorecormonhepatitec_art_56_avishas.pdf
HAS/2010-05-07_thalidomide__lichen_plan.pdf
HAS/2010-05-07_thalidomide__maladie_crohn.pdf
HAS/2010-05-07_thalidomide_amylose.pdf
HAS/2010-05-07_thalidomide_aphtose_severe.pdf
HAS/2010-05-07_thalidomide_erytheme_polymorphe.pdf
HAS/2010-05-07_thalidomide_histiocytose.pdf
HAS/2010-05-07_thalidomide_jessner_kanof.pdf
HAS/2010-05-07_thalidomide_lupus_erythemateux_cutane.pdf
HAS/2010-05-07_thalidomide_lymphome_cellules_b.pdf
HAS/2010-05-07_thalidomide_melanome_metastatique.pdf
HAS/2010-05-07_thalidomide_myelome_multiple.pdf
HAS/2010-05-07_thalidomide_pr_juvenile.pdf
HAS/2010-05-07_thalidomide_prurigo_nodulaire.pdf
HAS/2010-05-07_thalidomide_reactions_greffon_hote.pdf
HAS/2010-05-07_thalidomide_reactions_lepreuses.pdf
HAS/2010-05-07_thalidomide_sarcoidose.pdf
HAS/2010-05-07_thalidomide_scleromyxoedeme.pdf
HAS/2010-05-07_thalidomide_splenomegalie_myeloide.pdf
HAS/2010-05-07_thalidomide_syndrome_myelodysplasique.pdf
HAS/2010-05-07_trolamine.pdf
HAS/2010-05-10_consommation_de_cocaine_-_argumentaire.pdf
HAS/2010-05-10_consommation_de_cocaine_-_recommandations.pdf
HAS/2010-05-10_synicem-22_decembre_2009_2154_avis.pdf
HAS/2010-05-10_synicem-22_decembre_2009_2154_synthese_davis.pdf
HAS/2010-05-12_antarene_codeine_-_ct-7588.pdf
HAS/2010-05-12_fareston_-_ct-7772.pdf
HAS/2010-05-12_gonapeptyl_-_ct-7912.pdf
HAS/2010-05-12_implanon_-_ct-8058.pdf
HAS/2010-05-12_progestogel_-_ct-8138_2010-05-11_14-39-29_826.pdf
HAS/2010-05-12_tiorfan_-_tiorfanor_-_ct-7797.pdf
HAS/2010-05-12_utrogestan_-_ct-8002.pdf
HAS/2010-05-12_vitalipide_-_ct-7584.pdf
HAS/2010-05-12_vitalipide_srh.pdf
HAS/2010-05-17_hancock_hc105__hancock_hc150-04_mai_2010_2617_avis.pdf
HAS/2010-05-19_angiox_-_ct-7823.pdf
HAS/2010-05-19_angiox_ct_7823.pdf
HAS/2010-05-19_avaxim160adultes_-_ct-8198.pdf
HAS/2010-05-19_avaxim80pediatriques_-_ct-7771.pdf
HAS/2010-05-19_avaxim_adultes_ct_8198.pdf
HAS/2010-05-19_avaxim_pediatrique_ct_7771.pdf
HAS/2010-05-19_havrix1440adultes_-_ct-8197.pdf
HAS/2010-05-19_havrix_adultes_ct_8197.pdf
HAS/2010-05-19_havrix_nour_enf_ct_7591.pdf
HAS/2010-05-19_havrixnourrissonsetenfants_-_ct-7591.pdf
HAS/2010-05-19_note_de_cadrage_-_photochimiotherapie_extracorporelle.pdf
HAS/2010-05-19_photochimiotherapie_extracorporelle-_documents_davis.pdf
HAS/2010-05-19_photochimiotherapie_extracorporelle-rapport.pdf
HAS/2010-05-19_photochimiotherapie_extracorporelle_-_texte_court.pdf
HAS/2010-05-19_synthese_davis_angiox_-_ct-7823.pdf
HAS/2010-05-19_synthese_davis_avaxim_-_ct-7771.pdf
HAS/2010-05-19_synthese_davis_havrix_-_ct-8197.pdf
HAS/2010-05-27_ams_800_04_mai_2010_2507_avis.pdf
HAS/2010-05-31_chronos_inject_04_mai_2010_2483_avis.pdf
HAS/2010-05-31_chronos_inject_04_mai_2010_2483_synthese_davis.pdf
HAS/2010-05-31_lifevest_04_mai_2010_2305_synthese_davis.pdf
HAS/2010-05-31_lifevest_wcd_3100_04_mai_2010_2305_avis.pdf
HAS/2010-06-01_azopt_-_ct-7484.pdf
HAS/2010-06-01_chlorhydrate_procaine_lavoisier_-_ct-7332.pdf
HAS/2010-06-01_clomipraminemylan_-_ct-7671.pdf
HAS/2010-06-01_ct-4024_lyrica_.pdf
HAS/2010-06-01_densical_-_ct-8029.pdf
HAS/2010-06-01_enoxor_-_ct-7468.pdf
HAS/2010-06-01_gydrelle-_ct-8084.pdf
HAS/2010-06-01_hyalgan_-_ct-7224.pdf
HAS/2010-06-01_isoprinosine_-ct-8088.pdf
HAS/2010-06-01_lyrica_ct_4024.pdf
HAS/2010-06-01_meteospasmyl_-_ct-7543.pdf
HAS/2010-06-01_migpriv_-_ct-7670.pdf
HAS/2010-06-01_mopral_zoltum_-_ct-8102.pdf
HAS/2010-06-01_oroken_-_ct-7461.pdf
HAS/2010-06-01_osteocal_-_ct-8092.pdf
HAS/2010-06-01_paracetamolalmus_-_ct-7944.pdf
HAS/2010-06-01_renitec_-_ct-8129.pdf
HAS/2010-06-01_rilutek_-_ct-7135.pdf
HAS/2010-06-01_verapamilbiogaran_-_ct-8153.pdf
HAS/2010-06-01_vitamine_b1b6_bayer-_ct-8087.pdf
HAS/2010-06-01_vitamine_e_mylan_-_ct-8035.pdf
HAS/2010-06-02_avis_phototherapie_dynamique.pdf
HAS/2010-06-02_colokit_-_ct-8106.pdf
HAS/2010-06-02_colokit_ct_8106.pdf
HAS/2010-06-02_eurobiol_-_ct-7737.pdf
HAS/2010-06-02_multaq_-_ct-7495.pdf
HAS/2010-06-02_synthese_davis_colokit-ct-8106.pdf
HAS/2010-06-02_synthese_davis_eurobiol_-_ct-7737.pdf
HAS/2010-06-07_silodyx_-_ct-8136.pdf
HAS/2010-06-08_fenofibrateteva_-_ct-8145.pdf
HAS/2010-06-08_oravir_-_ct-7472.pdf
HAS/2010-06-08_saphyr_cx-01_juin_2010_2575_avis.pdf
HAS/2010-06-08_saphyr_sp-01_juin_2010_2574_avis.pdf
HAS/2010-06-08_urorec_-_ct-_8135.pdf
HAS/2010-06-09_projet_de_grossesse_informations_messages_de_prevention_examens_a_proposer_-_argumentaire.pdf
HAS/2010-06-09_projet_de_grossesse_informations_messages_de_prevention_examens_a_proposer_-_fiche_de_synthese.pdf
HAS/2010-06-10_xpert-01_juin_2010_2666_avis.pdf
HAS/2010-06-11_igivpemphigus_art56_avis_has.pdf
HAS/2010-06-11_infliximabpemphigus_art56_avis_has.pdf
HAS/2010-06-11_rituximabpemphigus_art56_avishas.pdf
HAS/2010-06-11_scintimun_-_ct-8033.pdf
HAS/2010-06-11_sinemet_-_ct-7692.pdf
HAS/2010-06-14_verapamil_sandoz_-_ct-8177.pdf
HAS/2010-06-15_heartmate_ii-01_juin_2010_2528_avis.pdf
HAS/2010-06-15_heartmate_xe-01_juin_2010_2529_avis.pdf
HAS/2010-06-16_alteis_duo_-_ct-8132.pdf
HAS/2010-06-16_alteisduo_ct_8132.pdf
HAS/2010-06-16_coolmetec_-_ct-8103.pdf
HAS/2010-06-16_coolmetec_ct_8103.pdf
HAS/2010-06-16_creon_-_ct-7972.pdf
HAS/2010-06-16_keppra_-_ct-8027.pdf
HAS/2010-06-16_keppra_ct_8027.pdf
HAS/2010-06-16_synthese_davis_alteis_duo_coolmetec_-_ct-8132.pdf
HAS/2010-06-16_synthese_davis_creon_-_ct-7972.pdf
HAS/2010-06-16_synthese_davis_keppra_-_ct-8027.pdf
HAS/2010-06-22_artotec_-_ct-7474.pdf
HAS/2010-06-22_depistage_du_cancer_de_la_prostate_-_analyse_des_nouvelles_donnees_rapport.pdf
HAS/2010-06-22_peptamen_junior-01_juin_2010_2505_avis.pdf
HAS/2010-06-22_peptamen_junior-01_juin_2010_2505_synthese_davis.pdf
HAS/2010-06-23_avc_prise_en_charge_precoce_-_argumentaire.pdf
HAS/2010-06-23_avc_prise_en_charge_precoce_-_contre-indications_de_lateplase.pdf
HAS/2010-06-23_avc_prise_en_charge_precoce_-_messages_cles_medecine_generale.pdf
HAS/2010-06-23_avc_prise_en_charge_precoce_-_recommandations.pdf
HAS/2010-06-23_avc_prise_en_charge_precoce_-_synthese_des_recommandations.pdf
HAS/2010-06-23_avc_prise_en_charge_precose_-_algorithme.pdf
HAS/2010-06-23_stroke_early_management_-_guidelines_-_english_version.pdf
HAS/2010-06-23_stroke_early_management_-_quick_reference_guide_-_english_version.pdf
HAS/2010-06-24_acticon_neosphincter-15_juin_2010_2458_avis.pdf
HAS/2010-06-24_acticon_neosphincter_15_juin_2010_2458_synhese_davis.pdf
HAS/2010-06-24_activa-15_juin_2010_2503_avis.pdf
HAS/2010-06-24_activa-15_juin_2010_2503_synthese_davis_2011-03-21_12-47-9_24.pdf
HAS/2010-06-24_zenith_flex_aui_aaa-01_juin_2010_2616_avis_2010-06-24_18-41-59_574.pdf
HAS/2010-06-25_guide_methodo_saisine_assurance_maladie_vd.pdf
HAS/2010-06-29_agrippal_-_ct-7078.pdf
HAS/2010-06-29_artisial_-_ct-8028.pdf
HAS/2010-06-29_cardiocor_-_ct-8371.pdf
HAS/2010-06-29_defanyl-_ct-7349.pdf
HAS/2010-06-29_dopacis_-_ct-8292.pdf
HAS/2010-06-29_euphon_-_ct-8344.pdf
HAS/2010-06-29_flector_-_ct-8250.pdf
HAS/2010-06-29_gripguard_-_ct-6733.pdf
HAS/2010-06-29_iopidine_-_ct-8310.pdf
HAS/2010-06-29_klean_prep_-_ct-8176.pdf
HAS/2010-06-30_levofree_-_ct-8108.pdf
HAS/2010-06-30_levofree_ct_8108.pdf
HAS/2010-06-30_revolade_-_ct-8151.pdf
HAS/2010-06-30_revolade_ct_8151.pdf
HAS/2010-06-30_synthese_davis_levofree_-_ct-8108.pdf
HAS/2010-06-30_synthese_davis_revolade_-_ct-_8151.pdf
HAS/2010-07-05_coltramyl_-_ct-8368.pdf
HAS/2010-07-05_dosiseptine_-_ct-7825.pdf
HAS/2010-07-05_samsca_-_ct-7798.pdf
HAS/2010-07-05_samsca_ct_7798.pdf
HAS/2010-07-05_synthese_davis_samsca_-_ct-7798.pdf
HAS/2010-07-05_vitamine_k1_-_ct-8224.pdf
HAS/2010-07-06_adjust-1er_juin_2010_2706_avis.pdf
HAS/2010-07-06_autoset-29_juin_2010_2413_synthese_davis.pdf
HAS/2010-07-06_autoset_cs_2413_english_version.pdf
HAS/2010-07-06_autoset_cs_29_juin_2010_2413_avis.pdf
HAS/2010-07-06_catalyst_29_juin_2010__2746_avis.pdf
HAS/2010-07-09_myozyme_-_ct-7575.pdf
HAS/2010-07-09_myozyme_ct_7575.pdf
HAS/2010-07-09_synthese_davis_myozyme_-_ct-7575.pdf
HAS/2010-07-13_consulta_crt-p-29_juin_2010_2718_avis.pdf
HAS/2010-07-13_dynawalk_m1-15_juin_2010_2707_avis.pdf
HAS/2010-07-13_dynawalk_m2lp-15_juin_2010_2785_avis.pdf
HAS/2010-07-13_dynawalk_m2r-15_juin_2010_2784_avis_2010-07-07_15-48-17_177.pdf
HAS/2010-07-16_cervoxan_-_ct-8147.pdf
HAS/2010-07-16_daivobet_-_ct-8226.pdf
HAS/2010-07-16_ferinject_-_ct8352.pdf
HAS/2010-07-19_abilify_-_ct-7362.pdf
HAS/2010-07-19_dihydroergotamine_amdipharm_-_ct-7113.pdf
HAS/2010-07-20_aredia_-_ct-_8294.pdf
HAS/2010-07-20_circadin_trvs_adulte_art56_avis_has.pdf
HAS/2010-07-21_aclasta_-_ct-7082.pdf
HAS/2010-07-21_aclasta_ct_7082.pdf
HAS/2010-07-21_adcirca_-_ct-7800.pdf
HAS/2010-07-21_annexe_reevaluation_inf_ag_-_sep_2010-08-04_10-01-48_346.pdf
HAS/2010-07-21_clastoban_-_ct-8542.pdf
HAS/2010-07-21_clastoban_-_ct-_8251.pdf
HAS/2010-07-21_clastoban_ct_8251.pdf
HAS/2010-07-21_clastoban_ct_8542.pdf
HAS/2010-07-21_duoplavin_-_ct-8086.pdf
HAS/2010-07-21_duoplavin_ct_8086.pdf
HAS/2010-07-21_extavia_-_ct-8731.pdf
HAS/2010-07-21_extavia_ct_8731_2012-08-27_14-58-23_771.pdf
HAS/2010-07-21_fit_extavia_novartis_pharma.pdf
HAS/2010-07-21_grazax_-_ct-8228.pdf
HAS/2010-07-21_grazax_ct_8228.pdf
HAS/2010-07-21_hintegra_-13_juillet_2010_2381_avis.pdf
HAS/2010-07-21_lytos_-_ct-_7115.pdf
HAS/2010-07-21_lytos_ct_7115.pdf
HAS/2010-07-21_skelid_-_ct-_8175.pdf
HAS/2010-07-21_skelid_ct_8175.pdf
HAS/2010-07-21_synthese_davis__sep_if_beta_copaxone.pdf
HAS/2010-07-21_synthese_davis_adcirca_-_ct-7800.pdf
HAS/2010-07-21_synthese_davis_duoplavin_-_ct-8086.pdf
HAS/2010-07-21_synthese_davis_grazax_-_ct-8228.pdf
HAS/2010-07-22_5_statines-argumentaire_complet_maj_sept_2010.pdf
HAS/2010-07-22_anaconda-13_juillet_2010_2482_avis.pdf
HAS/2010-07-22_annexes_efficacite_et_efficience_des_hypolipemiants_-_une_analyse_centree_sur_les_statines.pdf
HAS/2010-07-22_note_de_cadrage_evaluation_des_medicaments_antihypertenseurset_place_dans_la_strategie_therapeutique.pdf
HAS/2010-07-22_stratos_pro_sidestream-13_juillet_2010_2308_avis.pdf
HAS/2010-07-22_synthese_efficacite_et_efficience_des_hypolipemiants_-_une_analyse_centree_sur_les_statines.pdf
HAS/2010-07-23_circadin_trvs_enfant_art56_avis_has.pdf
HAS/2010-07-23_onsyster-29_juin_2010_2640_avis.pdf
HAS/2010-07-23_onyster_29_juin_2010_2640_synthese_davis.pdf
HAS/2010-07-29_bi_preterax_ancien_noliterax_-_ct-8305.pdf
HAS/2010-07-29_cardensiel_-_ct-8398.pdf
HAS/2010-07-29_fenofibratezydus_-_ct-8385.pdf
HAS/2010-07-29_gammatetanos_-_ct-8376.pdf
HAS/2010-07-29_glucagen_-_ct-7342.pdf
HAS/2010-07-29_loperamide_lyoc_-_ct-8134.pdf
HAS/2010-07-29_mestacine_mynocine_-_ct-8347.pdf
HAS/2010-07-29_novonorm_-_ct-7279.pdf
HAS/2010-07-29_risperdal_-_ct-3496.pdf
HAS/2010-07-29_urion_-_ct-8391.pdf
HAS/2010-07-29_verapamilratiopharm_-_ct-8402.pdf
HAS/2010-07-30_amarel_-_ct-7801.pdf
HAS/2010-07-30_hydrocortisone_upjohn_-_ct-7331.pdf
HAS/2010-07-30_lodine_-_ct-8531.pdf
HAS/2010-07-30_otipax_-_ct-8057.pdf
HAS/2010-07-30_spironolactone_microfine_ratiopharm_-_ct-8535.pdf
HAS/2010-07-30_videx_-_ct-8303.pdf
HAS/2010-07-30_videx_srh.pdf
HAS/2010-08-02_glucophage_-_ct-8010.pdf
HAS/2010-08-02_tavanic_-_ct-8099.pdf
HAS/2010-08-03_aspirine_upsa_-_ct-7412.pdf
HAS/2010-08-03_fenofibratebiogaran_-_ct-8467.pdf
HAS/2010-08-03_kredex_-_ct-8008.pdf
HAS/2010-08-03_zerit_-_ct-8302.pdf
HAS/2010-08-03_zymaduo_-_ct-7361.pdf
HAS/2010-08-05_cognis_100-d_p106__latitude-13_juillet_2010_2259_avis.pdf
HAS/2010-08-05_cognis_100-d_p107__latitude-13_juillet_2010_2531_avis.pdf
HAS/2010-08-05_impact-enteral-13_juillet_2010_2641_avis.pdf
HAS/2010-08-05_oral_impact-13_juillet_2010_2642_avis.pdf
HAS/2010-08-05_teligen_100-dr_f110_latitude-13_juillet_2010_2257_avis.pdf
HAS/2010-08-05_teligen_100-vr_f102_latitude-13_juillet_2010_2258_avis.pdf
HAS/2010-08-05_xience_prime-29_juin_2010_2532_avis.pdf
HAS/2010-08-05_xience_v-29_juin_2010_2533_avis.pdf
HAS/2010-08-05_xience_v___xience_prime-29_juin_2010_2532_2533_synthese_davis.pdf
HAS/2010-08-06_certican_-_ct-8150.pdf
HAS/2010-08-06_cognis_100_d_p108-13_juillet_2010_2665_avis.pdf
HAS/2010-08-06_fortify_dr_cd2233-40_cd2233-40q-13_juillet_2010_2619_avis.pdf
HAS/2010-08-06_fortify_st_dr_cd2235-40_cd2235-40q-13_juillet_2010_2620_avis.pdf
HAS/2010-08-06_fortify_st_vr_cd1235-40_cd1235-40q-13_juillet_2010_2621_avis.pdf
HAS/2010-08-06_fortify_vr_cd1233-40_cd1233-40q-13_juillet_2010_2622_avis.pdf
HAS/2010-08-06_imovane_-_ct-7947.pdf
HAS/2010-08-06_inspra_-_ct-8085.pdf
HAS/2010-08-06_teligen_100_dr_f111-13_juillet_2010_2664_avis.pdf
HAS/2010-08-06_teligen_100_vr_f103-13_juillet_2010_2663-avis.pdf
HAS/2010-08-06_unify_cd3235-40_cd3235-40q-13_juillet_2010_2623_avis.pdf
HAS/2010-08-20_argumentaire_-_depistage_de_linfection_a_helicobacter_pylori.pdf
HAS/2010-08-20_synthese_-_depistage_de_linfection_a_helicobacter_pylori.pdf
HAS/2010-08-25_404_vhp_9_janvier_2002.pdf
HAS/2010-08-25_404_vhp_annexe_1.pdf
HAS/2010-08-25_vph_annexe_2.pdf
HAS/2010-08-25_vph_annexe_3.pdf
HAS/2010-08-25_vph_annexe_4.pdf
HAS/2010-08-25_vph_annexe_5.pdf
HAS/2010-09-03_enantone_-_ct-5460.pdf
HAS/2010-09-03_pentavac_-_ct-3452.pdf
HAS/2010-09-03_solupred_-_ct-7581.pdf
HAS/2010-09-03_viraferonpeg_-_ct-8059.pdf
HAS/2010-09-05_avis_hepatectomie_droite_coelio.pdf
HAS/2010-09-05_rapport_hepatectomie_droite_coelio.pdf
HAS/2010-09-05_texte_court_hepatectomie_droite_coelio.pdf
HAS/2010-09-06_avis_oesophagectomie_par_thoracoscopie.pdf
HAS/2010-09-06_rapport_oesophagectomie_thoracoscopie.pdf
HAS/2010-09-06_texte_court_oesophagectomie_thoracoscopie.pdf
HAS/2010-09-07_apidra_-_ct-8579.pdf
HAS/2010-09-07_atrican_-_ct-8370.pdf
HAS/2010-09-07_benemide_-_ct-8600.pdf
HAS/2010-09-07_biltricide_-_ct-8706.pdf
HAS/2010-09-07_dantrium_-_ct-8624.pdf
HAS/2010-09-07_dermobacter_-_ct-8475.pdf
HAS/2010-09-07_elisor_-_ct-8847.pdf
HAS/2010-09-07_eurelix_-_ct-_8578.pdf
HAS/2010-09-07_faslodex_-_ct-7666.pdf
HAS/2010-09-07_methergin_-_ct-8593.pdf
HAS/2010-09-07_methotrexate_bellon_-_ct-_8473.pdf
HAS/2010-09-07_reyataz_-_ct-7946.pdf
HAS/2010-09-07_tocopa_-_ct-8588.pdf
HAS/2010-09-07_vaqta_25_pediatrique_-_ct-8032.pdf
HAS/2010-09-07_vaqta_50_adultes_-_ct-8541.pdf
HAS/2010-09-07_vasten_-_ct-8637.pdf
HAS/2010-09-07_verapamil_teva_-_ct-_8859.pdf
HAS/2010-09-08_ecalta_-_ct-7773.pdf
HAS/2010-09-08_ecalta_ct_7773.pdf
HAS/2010-09-08_synthese_davis_ecalta_-_ct-7773.pdf
HAS/2010-09-08_synthese_davis_vedrop_-_ct-7918.pdf
HAS/2010-09-08_vedrop_-_ct-7918.pdf
HAS/2010-09-08_vedrop_ct_7918.pdf
HAS/2010-09-12_mesure_col_uterus_inahta_brief_version_anglaise.pdf
HAS/2010-09-12_mesure_col_uterus_texte_court_version_anglaise.pdf
HAS/2010-09-12_mesure_de_la_longueur_du_canal_cervical_du_col_de_luterus_par_echographie_par_voie_vaginale_-_note_de_cadrage.pdf
HAS/2010-09-12_mesure_de_la_longueur_du_col_de_luterus_par_echographie_endovaginale_-_document_davis.pdf
HAS/2010-09-12_mesure_de_la_longueur_du_col_de_luterus_par_echographie_endovaginale_-_rapport.pdf
HAS/2010-09-12_mesure_de_la_longueur_du_col_de_luterus_par_echographie_endovaginale_-_texte_court.pdf
HAS/2010-09-12_synthese_mesure_col_uterus.pdf
HAS/2010-09-16_avis_agenesie_adulte.pdf
HAS/2010-09-16_cadrage_agenesies_dentaires_adulte_2010-05-18_17-35-31_961.pdf
HAS/2010-09-16_extract_dental_agenesis_2011-11-30_17-00-19_744.pdf
HAS/2010-09-16_rapport_agenesie_adulte.pdf
HAS/2010-09-16_summary_dental_agenesies_2011-11-30_17-00-50_153.pdf
HAS/2010-09-16_texte_court_agenesie_adulte.pdf
HAS/2010-09-16_xigris_-_ct-7762.pdf
HAS/2010-09-16_xigris_annexe_-_ct-7762.pdf
HAS/2010-09-21_apranax_-_ct-8598.pdf
HAS/2010-09-21_artinibsa_-_ct-8872.pdf
HAS/2010-09-21_calcium_mylan_-_ct-8500.pdf
HAS/2010-09-21_chlorure_de_sodium_lavoisier_-_ct-8594.pdf
HAS/2010-09-21_civigel_-_ct-8707.pdf
HAS/2010-09-21_cordipatch_-_ct-8643.pdf
HAS/2010-09-21_corvasal_-_ct-8533.pdf
HAS/2010-09-21_cosopt_-_ct-8816.pdf
HAS/2010-09-21_cotriatec_-_ct-8575.pdf
HAS/2010-09-21_decapeptyl_-_ct-7410.pdf
HAS/2010-09-21_efezial_-_ct_-_8597.pdf
HAS/2010-09-21_efudix_-_ct-8589_2010-10-13_12-58-56_699.pdf
HAS/2010-09-21_inegy_-_ct-8476.pdf
HAS/2010-09-21_megace-_ct-_7668.pdf
HAS/2010-09-21_moex_-_ct-8644.pdf
HAS/2010-09-21_multicrome_-_ct-8821.pdf
HAS/2010-09-21_nitridermtts_-_ct-8687_2010-10-13_13-04-17_427.pdf
HAS/2010-09-21_quininevitc_-_ct-8634.pdf
HAS/2010-09-21_synarel_-_ct-6746.pdf
HAS/2010-09-22_cognis_100d_p108_latitude-14_septembre_2010_2831_avis.pdf
HAS/2010-09-22_dynastar-14_septembre_2010_2972_avis.pdf
HAS/2010-09-22_precision-14_septembre_2010_2992_avis.pdf
HAS/2010-09-22_prokinetic-14_septembre_2010_2834_avis.pdf
HAS/2010-09-22_taxus_element-14_septembre_2010_2721_avis.pdf
HAS/2010-09-22_teligen_100dr_f111_latitude-14_septembre_2010_2833_avis.pdf
HAS/2010-09-22_teligen_100vr_f103_latitude-14_septembre_2010_2832_avis.pdf
HAS/2010-09-23_endurant-14_septembre_2010_2554_avis.pdf
HAS/2010-09-23_lovavulo_-_ct-8501.pdf
HAS/2010-09-23_myobock-14_septembre_2010_2534_avis.pdf
HAS/2010-09-23_zenith_flex-zenith-14_septembre_2010_2715_avis.pdf
HAS/2010-09-30_2ebat_fs_synthese_patient_anorexie_2209.pdf
HAS/2010-09-30_3ebat_fs_famillepatient_anorexie_2209.pdf
HAS/2010-09-30_anorexia_nervosa_guidelines_2013-05-15_16-34-42_589.pdf
HAS/2010-09-30_anorexia_nervosa_information.pdf
HAS/2010-09-30_anorexia_nervosa_information_families_and_patients.pdf
HAS/2010-09-30_anorexie_mentale__prise_en_charge_liste_criteres_qualite_2012-02-14_11-54-53_856.pdf
HAS/2010-09-30_anorexie_mentale_prise_en_charge_grille_criteres_qualite_2012-02-14_11-53-34_772.pdf
HAS/2010-09-30_anorexie_mentale_prise_en_charge_guide_criteres_qualite.pdf
HAS/2010-09-30_argu_anorexie_mentale.pdf
HAS/2010-09-30_fs_anorexie_1_cdp_300910.pdf
HAS/2010-09-30_fs_anorexie_2_cdp_300910.pdf
HAS/2010-09-30_fs_anorexie_3_cdp_300910.pdf
HAS/2010-09-30_reco2clics_-_anorexie_-mentale.pdf
HAS/2010-09-30_reco_anorexie_mentale.pdf
HAS/2010-09-30_summary_anorexia_nervosa_1_identification.pdf
HAS/2010-09-30_summary_anorexia_nervosa_2_levels_of_care.pdf
HAS/2010-09-30_summary_anorexia_nervosa_3_hospital_admission.pdf
HAS/2010-09-30_zenith_low_profile-28_septembre_2010_2850_synthese_davis.pdf
HAS/2010-09-30_zenith_low_profile_aaa-28_septembre_2010_2850_avis.pdf
HAS/2010-10-04_analyse_litterature_part1_ethique_anesm.pdf
HAS/2010-10-04_analyse_litterature_part2_ethique_anesm.pdf
HAS/2010-10-04_bibliographie_ethique_anesm.pdf
HAS/2010-10-04_lettre_de_cadrage_ethique_anesm.pdf
HAS/2010-10-04_reco_ethique_anesm.pdf
HAS/2010-10-04_revue_litterature_ethique_anesm.pdf
HAS/2010-10-04_synthese_recommandation_ethique_anesm.pdf
HAS/2010-10-05_adancor_-_ct_9054.pdf
HAS/2010-10-05_alfatil_-_ct-8636.pdf
HAS/2010-10-05_carteol_-_ct-8772.pdf
HAS/2010-10-05_flebogammadif_-_ct-_8791.pdf
HAS/2010-10-05_immucyst_-_ct-8219.pdf
HAS/2010-10-05_ketoderm_-_ct-8014.pdf
HAS/2010-10-05_macrosalb_draximage_-_ct-8638.pdf
HAS/2010-10-05_medronate_draximage_-_ct-_8639.pdf
HAS/2010-10-05_melaxose_-_ct-7108.pdf
HAS/2010-10-05_monoflocet_-_ct-8534.pdf
HAS/2010-10-05_nimotop_-_ct-_8947.pdf
HAS/2010-10-05_ringer_lactate_aguettant_-_ct-8692.pdf
HAS/2010-10-05_rulid_-_ct-8472.pdf
HAS/2010-10-05_scopolamine_cooper_-_ct-8970.pdf
HAS/2010-10-05_stimu-acth_-_ct-8917.pdf
HAS/2010-10-05_transulose_-_ct-8137.pdf
HAS/2010-10-05_uridoz_-_8652.pdf
HAS/2010-10-05_zalerg_-_ct-8871.pdf
HAS/2010-10-06_azilect_-_ct8133.pdf
HAS/2010-10-06_chondrocelect_-_ct_-_8020.pdf
HAS/2010-10-06_chondrocelect_ct_8020.pdf
HAS/2010-10-06_crestor_-_ct-8369.pdf
HAS/2010-10-06_crestor_ct_8367.pdf
HAS/2010-10-06_crestor_ct_8369.pdf
HAS/2010-10-06_crestor_enfant_-_ct-8367.pdf
HAS/2010-10-06_ct021155.pdf
HAS/2010-10-06_fosamax_-_ct-7482.pdf
HAS/2010-10-06_fosamax_ct_7482.pdf
HAS/2010-10-06_fosavance_-_ct-8351.pdf
HAS/2010-10-06_fosavance_ct_8351.pdf
HAS/2010-10-06_synthese_davis_azilect_-_ct-8133.pdf
HAS/2010-10-06_synthese_davis_chondrocelect-_ct-8020.pdf
HAS/2010-10-06_synthese_davis_crestor_enfant-ct-8367.pdf
HAS/2010-10-06_synthese_davis_crestor_prevention_primaire.pdf
HAS/2010-10-06_zometa_-_ct-5593.pdf
HAS/2010-10-08_etp_-_comment_elaborer_un_programme_-_recommandations_juin_2007.pdf
HAS/2010-10-08_etp_-_comment_la_proposer_et_la_realiser_-_recommandations_juin_2007.pdf
HAS/2010-10-08_etp_-_decret_autorisation_programmes_etp.pdf
HAS/2010-10-08_etp_-_definition_finalites_-_recommandations_juin_2007.pdf
HAS/2010-10-08_etp_-_guide_version_finale_2_pdf.pdf
HAS/2010-10-08_etp_grille_aide_evaluation_autorisation_programme_ars_web.pdf
HAS/2010-10-12_cyranose-28_septembre_2010_2912_avis.pdf
HAS/2010-10-12_cyranose_global_system-28_septembre_2010_2743_avis.pdf
HAS/2010-10-12_cyranose_global_system_28_septembre_2010_2743_synthese_davis.pdf
HAS/2010-10-12_promogran-28_septembre_2010_2710_avis.pdf
HAS/2010-10-12_promogran-28_septembre_2010_2710_synthese_davis.pdf
HAS/2010-10-13_corriges_rapport_cariedentaire_version_postcollege-10sept2010.pdf
HAS/2010-10-13_corriges_synthese_carie_dentaire_version_postcollege-10sept2010.pdf
HAS/2010-10-13_durolane_28_septembre_2010_2808_avis.pdf
HAS/2010-10-14_firdapse_-_ct-8001.pdf
HAS/2010-10-14_firdapse_ct_8001.pdf
HAS/2010-10-14_synthese_davis_firdapse_-_ct-_8001.pdf
HAS/2010-10-14_trufill_dcs_orbit_galaxy-28_septembre_2010_2830_avis.pdf
HAS/2010-10-15_cadrage_chirurgie_cataracte.pdf
HAS/2010-10-15_rapport_chirurgie_cataracte.pdf
HAS/2010-10-15_synthese_chirurgie_cataracte.pdf
HAS/2010-10-15_texte_court_chirurgie_cataracte.pdf
HAS/2010-10-18_promus-12_octobre_2010_3009_avis.pdf
HAS/2010-10-18_promus_3009__3832__promus_element_3836__3932_synthese_davis.pdf
HAS/2010-10-19_arnicaboiron_-_ct-8822.pdf
HAS/2010-10-19_baypress_-_ct-8359.pdf
HAS/2010-10-19_carlin_-_ct_-_8962.pdf
HAS/2010-10-19_copegus_-_ct-8919.pdf
HAS/2010-10-19_ct-2792_diprolene.pdf
HAS/2010-10-19_ct-2792_diprosone.pdf
HAS/2010-10-19_ct-2792_diprostene_.pdf
HAS/2010-10-19_desogestrel_ethinylestradiol_elka_-_ct_-_8961.pdf
HAS/2010-10-19_desogestrel_ethinylestradiol_quill_-_c_-_8960.pdf
HAS/2010-10-19_edex_-_ct-8709.pdf
HAS/2010-10-19_femara_-_ct-7211.pdf
HAS/2010-10-19_mannitol_aguettant_-_ct-8685.pdf
HAS/2010-10-19_noxap_-_ct-8891.pdf
HAS/2010-10-19_oxeol_-_ct-8860.pdf
HAS/2010-10-19_promus_3009__3832__promus_element_3836__3932_synthese_davis.pdf
HAS/2010-10-19_promus_element-12_octobre_2010_3009_avis.pdf
HAS/2010-10-19_soluvit_-_ct-_8817.pdf
HAS/2010-10-19_vibraveineuse_-_ct-_8580.pdf
HAS/2010-10-19_zyloric_-_ct-8968.pdf
HAS/2010-10-20_dynexan_-_ct-8596.pdf
HAS/2010-10-20_nisis_-_ct-8991.pdf
HAS/2010-10-20_nisis_-_ct-9032.pdf
HAS/2010-10-20_nisis_ct_8991.pdf
HAS/2010-10-20_nisis_ct_9032.pdf
HAS/2010-10-20_synthese_davis_nisis-tareg-ct-9030.pdf
HAS/2010-10-20_synthese_nisis-tareg_-ct-8991-8529.pdf
HAS/2010-10-20_tareg_-_ct-8529.pdf
HAS/2010-10-20_tareg_-_ct-9030.pdf
HAS/2010-10-20_tareg_ct_8529.pdf
HAS/2010-10-20_tareg_ct_9030.pdf
HAS/2010-10-21_baha-12_octobre_2010_2744_avis.pdf
HAS/2010-10-21_heliogast-12_octobre_2010_2714_avis.pdf
HAS/2010-10-22_abstract_virtual_colonoscopy_meta-analysis_of_diagnostic_accuracy_indications_and_conditions_of_use_-_version_anglaise.pdf
HAS/2010-10-22_annexes_-_coloscopie_virtuelle.pdf
HAS/2010-10-22_avis_coloscopie_virtuelle.pdf
HAS/2010-10-22_fiche_de_bon_usage.pdf
HAS/2010-10-22_fresubin_bd_control-12_octobre_2010_3116_avis.pdf
HAS/2010-10-22_fresubin_db_control-12_octobre_2010_3116_synthese_davis.pdf
HAS/2010-10-22_midband-12_octobre_2010_2717_avis.pdf
HAS/2010-10-22_rapport_coloscopie_virtuelle.pdf
HAS/2010-10-22_summary_virtual_colonoscopy_meta-analysis_of_diagnostic_accuracy_indications_and_conditions_of_use_-_version_anglaise.pdf
HAS/2010-10-22_texte_court_coloscopie_virtuelle.pdf
HAS/2010-10-27_chlamydia_-_document_davis.pdf
HAS/2010-10-27_erylik_-_ct-8100.pdf
HAS/2010-10-27_synthese_chlamydia_trachomatis.pdf
HAS/2010-10-28_bioring-12_octobre_2010_2723_avis.pdf
HAS/2010-10-28_endeavor_resolute-12_octobre_2010_2806_avis.pdf
HAS/2010-10-28_restoresensor-12_octobre_2010_3004_avis.pdf
HAS/2010-11-02_arginine_veyron_-_ct-8995.pdf
HAS/2010-11-02_buprenorphine_arrow_-_ct-9057.pdf
HAS/2010-11-02_harmonet_minulet_tri_minulet_-_ct-9106.pdf
HAS/2010-11-02_lap-band-12_octobre_2010_2576_avis.pdf
HAS/2010-11-02_mini-sintrom_sintrom_-_ct-8343.pdf
HAS/2010-11-02_morphine_lavoisier_-_ct-9255.pdf
HAS/2010-11-02_perleane_-_ct-9133.pdf
HAS/2010-11-02_salbutamolmylan_-_ct-8997.pdf
HAS/2010-11-03_isentress_-_ct-8568.pdf
HAS/2010-11-03_isentress_ct_8568.pdf
HAS/2010-11-03_synthese_davis_isentress_-_ct-_8568.pdf
HAS/2010-11-03_synthese_davis_tyverb_-_ct-8653.pdf
HAS/2010-11-03_tyverb_-_ct-8653.pdf
HAS/2010-11-03_tyverb_ct_8653.pdf
HAS/2010-11-04_fragmine_-_ct-7974.pdf
HAS/2010-11-04_fragmine_ct_7974.pdf
HAS/2010-11-04_synthese_davis_fragmine_-_ct-7974_2010-11-04_10-56-40_115.pdf
HAS/2010-11-08_CEPP-3002_iBGSTAR-09_novembre_2010_(3002)_avis.pdf
HAS/2010-11-08_bgstar-09_novembre_2010_3001_avis.pdf
HAS/2010-11-09_biomatrix_flex-26_octobre_3006_avis.pdf
HAS/2010-11-09_consulta_crt-d_modele_d214trm-26_octobre_2010_3156.pdf
HAS/2010-11-09_heartware-26_octobre_2010_3007_avis.pdf
HAS/2010-11-09_secura_dr_modele_d214drm-26_octobre_2010_3157.pdf
HAS/2010-11-09_soft_gastric_band_premium-12_octobre_2010_2716_avis.pdf
HAS/2010-11-10_2020_2021_rapport_verticalisation_deambulateur_souleve_septembre_2010.pdf
HAS/2010-11-10_2020_2021_synthese_rapport_verticalisation_deambulateur_souleve_septembre_2010.pdf
HAS/2010-11-16_clarelux-_ct-_8902.pdf
HAS/2010-11-16_dextrocidine_-_ct-8651.pdf
HAS/2010-11-16_digaol_-_ct-8819.pdf
HAS/2010-11-16_equanil_-_ct-9087.pdf
HAS/2010-11-16_eryacne_-_ct8547.pdf
HAS/2010-11-16_haldol_-_ct-7978.pdf
HAS/2010-11-16_ikorel_-_ct-9297.pdf
HAS/2010-11-16_lacrinorm_liposic_-_ct-_8966.pdf
HAS/2010-11-16_lepticur_park_-_ct-7076.pdf
HAS/2010-11-16_lopril_-_ct-_9247.pdf
HAS/2010-11-16_monosept_-_ct-_8401.pdf
HAS/2010-11-16_myolastan_-_ct-_8712.pdf
HAS/2010-11-16_pentasa_-_ct-_9172.pdf
HAS/2010-11-16_quadrasa_-_ct_-_9026.pdf
HAS/2010-11-16_rapport_de_synthese_-_comparaisons_indirectes_methodes_et_validite_-_juillet_2009.pdf
HAS/2010-11-16_summary_report__indirect_comparisons_methods_and_validity_january_2011_2.pdf
HAS/2010-11-16_tahor_-_ct-_8969.pdf
HAS/2010-11-17_2020_2021_avis_verticalisation_deambulateur_soulevemalade_14092010.pdf
HAS/2010-11-17_2261_avis_general_ortheses_membre_superieur_26012010.pdf
HAS/2010-11-17_anaconda-26_octobre_2010_3052_avis.pdf
HAS/2010-11-17_c-band-09_novembre_2010_2745_avis.pdf
HAS/2010-11-17_excor-26_octobre_2010_1932_avis.pdf
HAS/2010-11-17_melody-25_janvier_2011_2720_avis_2012-03-08_16-03-54_303.pdf
HAS/2010-11-17_melody-26_octobre_2010_2720_synthese_davis.pdf
HAS/2010-11-17_melody_2720__english_version.pdf
HAS/2010-11-17_mepact-_ct-8306.pdf
HAS/2010-11-17_mepact_ct_8306.pdf
HAS/2010-11-17_minimizer-09_novembre_2010_2615_avis.pdf
HAS/2010-11-17_pacidol-09_novembre_2010_2851_synthese_davis_2011-03-08_10-44-40_386.pdf
HAS/2010-11-17_pacidol-_09_novembre_2010_2851_avis.pdf
HAS/2010-11-17_rapport_ortheses_membre_superieur.pdf
HAS/2010-11-17_sagb-09_novembre_2010_2462_avis.pdf
HAS/2010-11-17_synthese_davis_mepact_-_ct-_8306.pdf
HAS/2010-11-17_synthese_rapport_ortheses_membre_superieur_janvier_2010.pdf
HAS/2010-11-18_1310_avis_general_protheses_externes_membre_superieur_290610.pdf
HAS/2010-11-18_rapport_protheses_mb_sup_16_septembre_2010_v_finale_corrige_sl.pdf
HAS/2010-11-18_synthese_rapport_protheses_mb_sup_16_septembre_2010_v_finale.pdf
HAS/2010-11-22_paradym_rf_crt_9750-23_novembre_2010_3093_avis_2010-12-28_11-35-58_993.pdf
HAS/2010-11-22_paradym_rf_sonr_9770-23_novembre_2010_3094_avis.pdf
HAS/2010-11-22_paradym_rf_vr_9250-23_novembre_2010_3095_avis.pdf
HAS/2010-11-24_hyaneb-23_novembre_2010_2747_synthese_davis.pdf
HAS/2010-11-24_hyaneb_23_novembre_2010_2747_avis.pdf
HAS/2010-11-30_anzemet_-_ct-9250.pdf
HAS/2010-11-30_beclo_rhino_-_ct-_9173.pdf
HAS/2010-11-30_bicar_sodium_lavoisier_-_ct-8708.pdf
HAS/2010-11-30_bleomycine_-_ct-_8471.pdf
HAS/2010-11-30_euronac_-_ct8312.pdf
HAS/2010-11-30_geldene_feldene_-_ct-_8998.pdf
HAS/2010-11-30_gellarmes_-_ct-8538.pdf
HAS/2010-11-30_kapanol_-_ct-_9256.pdf
HAS/2010-11-30_mucomystendo_-_ct-9290.pdf
HAS/2010-11-30_oramorph_-_ct-9027.pdf
HAS/2010-11-30_septivon_-_ct-8815.pdf
HAS/2010-11-30_siccafluid_-_ct-8548.pdf
HAS/2010-11-30_somavert_-_ct-_6271.pdf
HAS/2010-12-01_ceplene_-_ct-8468.pdf
HAS/2010-12-01_ceplene_ct_8468.pdf
HAS/2010-12-01_menveo_-_ct-_8771.pdf
HAS/2010-12-01_menveo_ct_8771.pdf
HAS/2010-12-01_synthese_davis_ceplene_-_ct-9468.pdf
HAS/2010-12-01_synthese_davis_menveo_-_ct-8771.pdf
HAS/2010-12-01_synthese_davis_tronothane_-_ct-8705.pdf
HAS/2010-12-01_tronothane_-_ct-_8705.pdf
HAS/2010-12-01_tronothane_ct_8705.pdf
HAS/2010-12-03_abstract_cardiac_markers.pdf
HAS/2010-12-03_document_cadrage_marqueurs_cardiaques.pdf
HAS/2010-12-03_fbuts_marcoeurs_necrose.pdf
HAS/2010-12-03_fbuts_marqueurs_ic.pdf
HAS/2010-12-03_rapport_marqueurs_cardiaques.pdf
HAS/2010-12-03_texte_court_marqueurs_cardiaques.pdf
HAS/2010-12-05_omnispan_3178_pis.pdf
HAS/2010-12-13_advisa_dr_mri-23_novembre_2010_3008_synthese_davis.pdf
HAS/2010-12-13_advisa_mri_3008_23_11_2010.pdf
HAS/2010-12-13_cardiowest_2892_07_12_2010.pdf
HAS/2010-12-13_cotyle_rm_pressfit-07_decembre_2010_3030_synthese_davis.pdf
HAS/2010-12-13_exogen_4000-07_decembre_2010_2614_2639_synthese_davis.pdf
HAS/2010-12-13_exogen_4000_2639__2614.pdf
HAS/2010-12-13_inserts__selexys_vitamys_-09_novembre_2010_3264_synthese_davis.pdf
HAS/2010-12-13_respifor_2722_0712_2010.pdf
HAS/2010-12-13_vitamys_rm_pressfit_3030.pdf
HAS/2010-12-13_vitamys_selexys_3264.pdf
HAS/2010-12-14_ametycine_-_ct-_8424.pdf
HAS/2010-12-14_andractim_-_ct-5775.pdf
HAS/2010-12-14_antadys_-_ct-8622.pdf
HAS/2010-12-14_arthrocine_-_ct-8957.pdf
HAS/2010-12-14_asasantine_-_ct-9436.pdf
HAS/2010-12-14_cebutid_-_ct-_9221.pdf
HAS/2010-12-14_claradol_-_ct-_9211.pdf
HAS/2010-12-14_colchicine_-_ct-8592.pdf
HAS/2010-12-14_colchimax_-_ct9493.pdf
HAS/2010-12-14_combigan_-_ct-9257.pdf
HAS/2010-12-14_durogesic_-_ct-9222.pdf
HAS/2010-12-14_lescol_-_ct-9431.pdf
HAS/2010-12-14_picoprep_-_ct-9212.pdf
HAS/2010-12-14_twynsta_-_ct_9341.pdf
HAS/2010-12-15_celebrex_-_ct-8337.pdf
HAS/2010-12-15_celebrex_ct_8337.pdf
HAS/2010-12-15_qutenza_-_ct-8291.pdf
HAS/2010-12-15_qutenza_ct_8291.pdf
HAS/2010-12-15_synthese_davis_celebrex_-_ct-8337.pdf
HAS/2010-12-15_synthese_davis_qutenza_-_ct-8291.pdf
HAS/2010-12-17_ald_17_lap_fabry_vd.pdf
HAS/2010-12-17_ald_17_pnds_fabry_vd.pdf
HAS/2010-12-17_pnds_30_-_maladie_de_fabry_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2010-12-20_accu-chek_multiclix-23_novembre_2010_3240_avis.pdf
HAS/2010-12-20_accu-chek_performa-accu-chek_performa_nano-23_novembre_2010_3241_avis.pdf
HAS/2010-12-20_endurant-09_novembre_2010_2911_avis.pdf
HAS/2010-12-20_endurant-09_novembre_2010_2911_synthese_davis.pdf
HAS/2010-12-20_paradym_rf_dr_9550-23_novembre_2010_3092_avis_2010-12-28_11-34-52_924.pdf
HAS/2010-12-20_set_autosurveillance_de_la_glycemie-23_novembre_2010_3219_avis.pdf
HAS/2010-12-20_set_prelevement_de_sang_capillaire-23_novembre_2010_3218_avis.pdf
HAS/2010-12-25_argumentaire_recommandations_depistage_cancer_du_col_de_luterus.pdf
HAS/2010-12-25_fiche_de_synthese_recommandations_depistage_cancer_du_col_de_luterus.pdf
HAS/2010-12-25_note_de_cadrage_depistage_cancer_col_uterus_note_cadrage.pdf
HAS/2010-12-25_synthese_recommandations_depistage_cancer_du_col_de_luterus.pdf
HAS/2011-01-03_beconase_04012012_avis_ct11864.pdf
HAS/2011-01-04_alteisduo_-_ct-9555.pdf
HAS/2011-01-04_aricept_-_ct-9398.pdf
HAS/2011-01-04_calciprat_vitamined3_-_ct-_9466.pdf
HAS/2011-01-04_calcium_vitamine_sandoz_-_ct-9544.pdf
HAS/2011-01-04_coolmetec_-_ct9553.pdf
HAS/2011-01-04_decalogiflox-logiflox_-_ct-_8373.pdf
HAS/2011-01-04_dolgit_-_ct-_8649.pdf
HAS/2011-01-04_gestodene_ethinylestradiol_teva_-_ct-9525.pdf
HAS/2011-01-04_introna_-_ct-_9055.pdf
HAS/2011-01-04_loceryl_-_ct-_9293.pdf
HAS/2011-01-04_magnevist_-_ct-_9557.pdf
HAS/2011-01-04_molsidomine_mylan_-_ct-9550.pdf
HAS/2011-01-04_monuril_-_ct-8908.pdf
HAS/2011-01-04_nifluril_-_ct-8641.pdf
HAS/2011-01-04_orelox_-_ct-8949.pdf
HAS/2011-01-04_profenid_biprofenid_-_ct-9248.pdf
HAS/2011-01-04_rifater_-_ct-_9374.pdf
HAS/2011-01-04_somatuline_-_ct-9141.pdf
HAS/2011-01-04_tenordate_-_ct-_9649.pdf
HAS/2011-01-04_tenoretic_-_ct-_9648.pdf
HAS/2011-01-04_texodil_-_ct-_9295.pdf
HAS/2011-01-04_unalpha_-_ct-_9448.pdf
HAS/2011-01-04_voltarene_-_ct-_8918.pdf
HAS/2011-01-04_zinnat_-_ct-8913.pdf
HAS/2011-01-05_adcirca_-_ct-9769.pdf
HAS/2011-01-05_adcirca_ct_9769.pdf
HAS/2011-01-05_annexe_htap.pdf
HAS/2011-01-05_annexe_htap_2012-12-07_10-25-5_692.pdf
HAS/2011-01-05_annexe_htap_2012-12-07_10-29-49_359.pdf
HAS/2011-01-05_annexe_htap_2012-12-07_10-40-0_25.pdf
HAS/2011-01-05_annexe_htap_2012-12-07_10-43-59_870.pdf
HAS/2011-01-05_annexe_htap_2012-12-07_11-37-24_624.pdf
HAS/2011-01-05_annexe_htap_2012-12-07_11-50-46_65.pdf
HAS/2011-01-05_annexe_reevaluation_htap.pdf
HAS/2011-01-05_ceris_-_ct-8295.pdf
HAS/2011-01-05_ceris_ct_8295.pdf
HAS/2011-01-05_chloraminophene_-_ct-_9213.pdf
HAS/2011-01-05_cloraminophene_ct_9213.pdf
HAS/2011-01-05_flolan_-_ct-_6424.pdf
HAS/2011-01-05_flolan_ct_6424.pdf
HAS/2011-01-05_nexen_-_ct-7999.pdf
HAS/2011-01-05_nexen_ct_7999.pdf
HAS/2011-01-05_orencia_-_ct-_8640.pdf
HAS/2011-01-05_orencia_ct_8640.pdf
HAS/2011-01-05_remodulin_-_ct-_6327.pdf
HAS/2011-01-05_remodulin_ct_6327.pdf
HAS/2011-01-05_revatio_-_ct6330.pdf
HAS/2011-01-05_revatio_ct_6330.pdf
HAS/2011-01-05_synthese_davis_ceris_ct-8295.pdf
HAS/2011-01-05_synthese_davis_chloraminophene_ct-9213.pdf
HAS/2011-01-05_synthese_davis_nexen_-_ct-_7999.pdf
HAS/2011-01-05_synthese_davis_orencia_-_ct-8640.pdf
HAS/2011-01-05_synthese_davis_reevaluation_htap.pdf
HAS/2011-01-05_thelin_-_ct-_6458.pdf
HAS/2011-01-05_thelin_ct_6458.pdf
HAS/2011-01-05_tracleer_-_ct-_6316.pdf
HAS/2011-01-05_tracleer_ct_6316.pdf
HAS/2011-01-05_ventavis_-_ct-_6292.pdf
HAS/2011-01-05_ventavis_ct_6292.pdf
HAS/2011-01-05_volibris_-_ct-6314.pdf
HAS/2011-01-05_volibris_ct_6314.pdf
HAS/2011-01-06_activa-07_decembre_2010_3220_avis.pdf
HAS/2011-01-06_axeler_-_ct-6205.pdf
HAS/2011-01-06_axeler_ct_6205.pdf
HAS/2011-01-06_celebrex_-_ct-7107.pdf
HAS/2011-01-06_celebrex_ct_7107.pdf
HAS/2011-01-06_cnedimts-2132-interstim.pdf
HAS/2011-01-06_erbitux_-_ct-7363.pdf
HAS/2011-01-06_erbitux_ct_7363.pdf
HAS/2011-01-06_hylovis-07_decembre_2010_3051_avis.pdf
HAS/2011-01-06_hylovis_multi-07_decembre_2010_3072_avis.pdf
HAS/2011-01-06_interstim-23_novembre_2010_2783_avis.pdf
HAS/2011-01-06_neurocybernetic_prothesis_ncp_et_vns_bipolaire_-04_mai_2010_2380_avis.pdf
HAS/2011-01-06_optium_xceed-21_decembre_2010_3117_avis.pdf
HAS/2011-01-06_powerlink-07_decembre_2010_3096_avis.pdf
HAS/2011-01-06_sir_sphere-21_decembre_2010_2952_synthese-davis.pdf
HAS/2011-01-06_sir_spheres-21_decembre_2010_2952_avis.pdf
HAS/2011-01-06_sir_spheres_2952__english_version.pdf
HAS/2011-01-06_surgisis_afp-27_octobre_2010_2256_avis.pdf
HAS/2011-01-06_synthese_davis_axeler-sevikar_-_ct-6205-6175.pdf
HAS/2011-01-06_synthese_davis_erbitux_-_ct-7363.pdf
HAS/2011-01-06_synthese_davis_magnesium_associe_-_ct-5954-5987.pdf
HAS/2011-01-06_synthese_surgisis.pdf
HAS/2011-01-06_uvimag_-_ct-5987.pdf
HAS/2011-01-06_uvimag_b6_ct_5987.pdf
HAS/2011-01-06_vismed-07_decembre_2010_3053_avis.pdf
HAS/2011-01-06_vismed_multi-07_decembre_2010_3073_avis.pdf
HAS/2011-01-07_document_d_information_recommandations_de_bonne_pratique_2011-01-06_11-12-31_795.pdf
HAS/2011-01-07_fiche_consensus_formalise.pdf
HAS/2011-01-07_fiche_methodologique_audition_publique.pdf
HAS/2011-01-07_fiche_regles_de_cotation.pdf
HAS/2011-01-07_formal_consensus_rating_quick_methodology_guide_110531_2011-06-06_14-27-41_12.pdf
HAS/2011-01-07_good_practice_guidelines_fc_method.pdf
HAS/2011-01-07_guide_methodologique_audition_publique_2011-04-06_11-30-40_586.pdf
HAS/2011-01-07_guide_methodologique_consensus_formalise.pdf
HAS/2011-01-07_guideline_by_formal_consensus_quick_methodology_guide_110531.pdf
HAS/2011-01-10_annonce_dommage_associe_aux_soins_4_pages.pdf
HAS/2011-01-10_annonce_dommage_associe_aux_soins_affiche.pdf
HAS/2011-01-10_annonce_dommage_associe_aux_soins_guide.pdf
HAS/2011-01-11_ald_hors_liste_-_liste_des_actes_et_prestations_sur_la_dermatite_herpetiforme.pdf
HAS/2011-01-11_ald_hors_liste_-_liste_des_actes_et_prestations_sur_la_dermatose_a_iga_lineaire.pdf
HAS/2011-01-11_ald_hors_liste_-_liste_des_actes_et_prestations_sur_lepidermolyse_bulleuse_acquise.pdf
HAS/2011-01-11_synthese_medecin_traitant_sur_les_maladies_bulleuses_auto-immunes_2011-10-24_15-31-15_597.pdf
HAS/2011-01-11_synthese_medecin_traitant_sur_les_maladies_bulleuses_auto-immunes_2011-10-24_15-35-11_752.pdf
HAS/2011-01-11_synthese_medecin_traitant_sur_les_maladies_bulleuses_auto-immunes_2011-10-24_15-36-29_327.pdf
HAS/2011-01-11_synthese_medecin_traitant_sur_maladie_bulleuse_auto-immunes_-_dermatite_herpetiforme.pdf
HAS/2011-01-11_synthese_medecin_traitant_sur_maladie_bulleuse_auto-immunes_-_dermatose_a_iga_lineaire.pdf
HAS/2011-01-11_synthese_medecin_traitant_sur_maladie_bulleuse_auto-immunes_-_epidermolyse_bulleuse_acquise.pdf
HAS/2011-01-13_abraxane_-_ct-7088.pdf
HAS/2011-01-13_abraxane_ct_7088.pdf
HAS/2011-01-13_actilyse_-_ct-6722_2009-10-22_14-53-8_981.pdf
HAS/2011-01-13_actilyse_ct_6722.pdf
HAS/2011-01-13_adixone_-_ct-7144.pdf
HAS/2011-01-13_adixone_ct_7144.pdf
HAS/2011-01-13_cimzia_-_ct-7358.pdf
HAS/2011-01-13_cimzia_ct_7358.pdf
HAS/2011-01-13_ellaone_-_ct-7137.pdf
HAS/2011-01-13_ellaone_ct_7137.pdf
HAS/2011-01-13_mozobil_-_ct-7232.pdf
HAS/2011-01-13_mozobil_ct_7232.pdf
HAS/2011-01-13_removab_-_ct-6973.pdf
HAS/2011-01-13_removab_ct_6250.pdf
HAS/2011-01-13_roactemra_-_ct-6352.pdf
HAS/2011-01-13_roactemra_ct_6352.pdf
HAS/2011-01-13_synthese_davis_abraxane_-_ct-7088.pdf
HAS/2011-01-13_synthese_davis_actilyse_-_ct-6722.pdf
HAS/2011-01-13_synthese_davis_adixone_-_ct-7144.pdf
HAS/2011-01-13_synthese_davis_cimzia_-_ct-7358.pdf
HAS/2011-01-13_synthese_davis_ellaone_-_ct-7137.pdf
HAS/2011-01-13_synthese_davis_mozobil_-_ct-7232_2010-04-01_16-48-12_380.pdf
HAS/2011-01-13_synthese_davis_removab_-_ct-6973.pdf
HAS/2011-01-13_synthese_davis_roactemra_-_ct-6352.pdf
HAS/2011-01-13_synthese_davis_xolaire_-_ct-7237_2010-05-11_16-05-8_165.pdf
HAS/2011-01-13_theracap_-_ct-7184.pdf
HAS/2011-01-13_theracap_ct_7184.pdf
HAS/2011-01-13_xolair_-_ct-7237.pdf
HAS/2011-01-13_xolair_ct_7237.pdf
HAS/2011-01-17_1713_synthese_rapport_implants_mammaires.pdf
HAS/2011-01-17_breast_implants_synthesis.pdf
HAS/2011-01-17_rapport_implants_mammaires.pdf
HAS/2011-01-18_aequasyal-21_decembre_2010_3266_avis.pdf
HAS/2011-01-18_aracytine_-_ct-_8684.pdf
HAS/2011-01-18_chondro-gide-21_decembre_2010_2786_avis.pdf
HAS/2011-01-18_chondro-gide-21_decembre_2010_2786_synthese_davis.pdf
HAS/2011-01-18_chondro-gide_2786__english_version.pdf
HAS/2011-01-18_gadovist_-_ct-_8442.pdf
HAS/2011-01-18_gestodene_ethinylestradiol_ratiopharm_-_ct-9672.pdf
HAS/2011-01-18_glivec_-_ct-6837.pdf
HAS/2011-01-18_inspiration_elite-21_decembre_2010_3307_synthese_davis.pdf
HAS/2011-01-18_inspiration_elite-sidestream-21_decembre_2010_3307_avis.pdf
HAS/2011-01-18_resolute_integrity_21_decembre_2010_3352_avis.pdf
HAS/2011-01-18_tubulcus-11_janvier_2011_1410_avis.pdf
HAS/2011-01-19_ferrisat_-_ct-_9165.pdf
HAS/2011-01-19_ferrisat_ct_9165.pdf
HAS/2011-01-19_mexiletine_-_ct-9407.pdf
HAS/2011-01-19_mexiletine_ap-hp_ct_9407.pdf
HAS/2011-01-19_strattera_-_ct-_8904.pdf
HAS/2011-01-19_strattera_ct_8904.pdf
HAS/2011-01-19_synthese_davis_ferrisat-ct-9165.pdf
HAS/2011-01-19_synthese_davis_mexiletine_-_ct-9407.pdf
HAS/2011-01-19_synthese_davis_strattera_-_ct-8904.pdf
HAS/2011-01-19_synthese_davis_viread_-_ct-9449.pdf
HAS/2011-01-19_viread_-_ct9449.pdf
HAS/2011-01-19_viread_ct_9449.pdf
HAS/2011-01-21_asti3_rapport_final.pdf
HAS/2011-01-21_exemples_notices_explicatives_fiches_observance_rdebre.pdf
HAS/2011-01-21_realisations_enseignements_projets_fopim_2002_2010.pdf
HAS/2011-01-26_avis_genotypage_foetal.pdf
HAS/2011-01-26_cadrage_genotypage_foetal.pdf
HAS/2011-01-26_rapport_genotypage_foetal.pdf
HAS/2011-01-26_synthese_genotypage_foetal.pdf
HAS/2011-01-26_texte_court_genotypage_foetal.pdf
HAS/2011-01-28_abstract_hifu.pdf
HAS/2011-01-28_avis_hifu.pdf
HAS/2011-01-28_edwards_sapien_transcatheter_heart_valve-25_janvier_2011_2932_synthese_davis.pdf
HAS/2011-01-28_genesis-11_janvier_2011_3353_avis.pdf
HAS/2011-01-28_incepta_crt-d_p162__p163-11_janvier_2011_3331_avis.pdf
HAS/2011-01-28_incepta_crt-d_p165-11_janvier_2011_3417_avis.pdf
HAS/2011-01-28_incepta_dr_f162__f163_3330_avis.pdf
HAS/2011-01-28_incepta_vr_f160__f161-11_janvier_2011_3329_avis.pdf
HAS/2011-01-28_princi_b_ct_7121.pdf
HAS/2011-01-28_princib_-_ct-7121.pdf
HAS/2011-01-28_rapport_hifu.pdf
HAS/2011-01-28_sapien_systeme_retroflex_3-25_janvier_2011_2932_avis.pdf
HAS/2011-01-28_set_one_touch_verio_pro-11_janvier_2011_3404_avis.pdf
HAS/2011-01-28_spot-25_janvier_2011_3029_avis.pdf
HAS/2011-01-28_summary_hifu.pdf
HAS/2011-01-28_synthese_davis_viread_-_ct-6313.pdf
HAS/2011-01-28_tachosil_-_ct-6985.pdf
HAS/2011-01-28_tachosil_ct_6985.pdf
HAS/2011-01-28_texte_court_hifu.pdf
HAS/2011-01-28_topchair-s-11_janvier_2011_3005_avis.pdf
HAS/2011-01-28_topchair-s-11_janvier_2011_3005_synthese_davis.doc.pdf
HAS/2011-01-28_topchair-s_3005__english_version.pdf
HAS/2011-01-28_viread_-_ct-6313.pdf
HAS/2011-01-28_viread_ct_6313.pdf
HAS/2011-01-31_etude_sadm_actions_proposees.pdf
HAS/2011-01-31_etude_sadm_etat_des_lieux_1.pdf
HAS/2011-01-31_etude_sadm_etat_des_lieux_2.pdf
HAS/2011-01-31_etude_sadm_initiatives_us_et_europe.pdf
HAS/2011-01-31_etude_sadm_references.pdf
HAS/2011-01-31_etude_sadm_synthese.pdf
HAS/2011-02-01_apatos-25_janvier_2011_2995_avis.pdf
HAS/2011-02-01_apatos-25_janvier_2011_2995_synthese_davis.pdf
HAS/2011-02-01_betadine_-_ct-_8916.pdf
HAS/2011-02-01_briazide_-_ct-9546.pdf
HAS/2011-02-01_cibacene_-_ct-_9632.pdf
HAS/2011-02-01_diafusor_-_ct-9844.pdf
HAS/2011-02-01_emla_emlapatch_-_ct-_9561.pdf
HAS/2011-02-01_evolution-25_janvier_2011_2999_synthese_davis.pdf
HAS/2011-02-01_evolution-25_janvier_2999_avis.pdf
HAS/2011-02-01_fozitec_-_ct-_9755.pdf
HAS/2011-02-01_fractal_-_ct-9522.pdf
HAS/2011-02-01_gel_40-25_janvier_2011_2997_avis.pdf
HAS/2011-02-01_gel_40-25_janvier_2011_2997_synthese_davis.pdf
HAS/2011-02-01_gen-os-25_janvier_2011_2993_avis.pdf
HAS/2011-02-01_gen-os-25_janvier_2011_2993_synthese_davis.pdf
HAS/2011-02-01_infanrixtetra_-_ct-_8894.pdf
HAS/2011-02-01_lamina-25_janvier_2011_2998_avis.pdf
HAS/2011-02-01_lamina-25_janvier_2011_2998_synthese_davis.pdf
HAS/2011-02-01_lercan_-_ct-_9545.pdf
HAS/2011-02-01_monicor_-_ct-_9845.pdf
HAS/2011-02-01_mp3-25_janvier_2011_2994_avis.pdf
HAS/2011-02-01_mp3-25_janvier_2011_2994_synthese_davis.pdf
HAS/2011-02-01_natispray_-_ct-_9547.pdf
HAS/2011-02-01_paracetamolrpg_ranbaxy_-_ct-_9558.pdf
HAS/2011-02-01_pravadual_-_ct-_9681.pdf
HAS/2011-02-01_putty-25_janvier_2011_2996_avis.pdf
HAS/2011-02-01_putty-25_janvier_2011_2996_synthese_davis.pdf
HAS/2011-02-01_rifinah_-_ct-_9620.pdf
HAS/2011-02-01_special-25_janvier_2011_3000_avis.pdf
HAS/2011-02-01_special-25_janvier_2011_3000_synthese_davis.pdf
HAS/2011-02-01_tenormine_-_ct-_9796.pdf
HAS/2011-02-01_tenstaten_-_ct-_9599.pdf
HAS/2011-02-01_zestoretic_-_ct-_9795.pdf
HAS/2011-02-01_zocor_-_ct-_9709.pdf
HAS/2011-02-02_tasmar_-_ct-8249_et_ct-9252.pdf
HAS/2011-02-02_tasmar_ct_8249_9252.pdf
HAS/2011-02-07_impact_rapport_fermon_levy_diffusion_publique.pdf
HAS/2011-02-07_impact_synthese_imgeni_indicateurs.pdf
HAS/2011-02-07_impact_synthese_matrix_certification.pdf
HAS/2011-02-07_rapport-matrix.pdf
HAS/2011-02-08_fibrogammin_-_ct-7418.pdf
HAS/2011-02-08_fibrogammin_ct_7418.pdf
HAS/2011-02-08_firmagon_-_ct-6725.pdf
HAS/2011-02-08_firmagon_ct_6725.pdf
HAS/2011-02-08_quasym_-_ct-7544.pdf
HAS/2011-02-08_quasym__ct_7544.pdf
HAS/2011-02-08_synthese_davis_fibrogarmin_-_ct-7418.pdf
HAS/2011-02-08_synthese_davis_firmagon_-_ct-6725.pdf
HAS/2011-02-08_synthese_davis_quasym_-_ct-7544.pdf
HAS/2011-02-10_synthese_davis_torisel_-_ct-7303.pdf
HAS/2011-02-10_torisel_-_ct-7303.pdf
HAS/2011-02-10_torisel_ct_7303.pdf
HAS/2011-02-14_allogreffe_osseuse_traitee_par_procede_de_viro-inactivation_supercrit-25_janvier_2011_3262__3263_synthese_davis.pdf
HAS/2011-02-14_allogreffes_osseuses_supercrit-25_janvier_2011_3262-3263_avis.pdf
HAS/2011-02-14_zenith_spiral_z-08_fevrier_2011_3396_avis.pdf
HAS/2011-02-15_digoxine_hemidigoxine_-_ct-_9549.pdf
HAS/2011-02-15_farlutal_-_ct-_8710.pdf
HAS/2011-02-15_hytacand_-_ct-_9892.pdf
HAS/2011-02-15_nivestim_-_ct-9854.pdf
HAS/2011-02-15_serevent_serevent_diskus_-_ct-_8060.pdf
HAS/2011-02-15_tareg_-_ct-9947.pdf
HAS/2011-02-15_viskaldix_-_ct-9925.pdf
HAS/2011-02-15_zithromax_-_ct-8751.pdf
HAS/2011-02-16_bat_fiche_srh_pulmozyme.pdf
HAS/2011-02-16_fonzylane_-_ct-_10167.pdf
HAS/2011-02-16_fonzylane_ct_10167.pdf
HAS/2011-02-16_grazax_-_ct-_8469.pdf
HAS/2011-02-16_grazax_241109_fiche_bum.pdf
HAS/2011-02-16_grazax_ct_8469.pdf
HAS/2011-02-16_herceptin_-_ct-9411.pdf
HAS/2011-02-16_herceptin_ct_9411.pdf
HAS/2011-02-16_oralair_28032012_avis_ct11609.pdf
HAS/2011-02-16_pulmozyme_-_ct-_7639.pdf
HAS/2011-02-16_pulmozyme_ct_7639.pdf
HAS/2011-02-16_synthese_davis_fonzylane_-_ct-10167.pdf
HAS/2011-02-16_synthese_davis_grazax_-_ct-8469_2011-05-05_15-00-21_261.pdf
HAS/2011-02-16_synthese_davis_herceptin_-_ct-9411.pdf
HAS/2011-02-17_anaconda-08_fevrier_2011_3420_avis.pdf
HAS/2011-02-17_culture_de_securite_des_soins__du_concept_a_la_pratique.pdf
HAS/2011-02-18_pegasys_-_ct-7395.pdf
HAS/2011-02-18_pegasys_ct_7395.pdf
HAS/2011-02-18_solaraze_-_ct-8197.pdf
HAS/2011-02-18_solaraze_ct_6849.pdf
HAS/2011-02-18_synthese_davis_pegasys_-_ct-7395.pdf
HAS/2011-02-18_synthese_davis_solaraze_-_ct-6849.pdf
HAS/2011-02-18_synthese_davis_zavesca_-_ct-7042.pdf
HAS/2011-02-18_zavesca_-_ct-7042.pdf
HAS/2011-02-18_zavesca_ct_7042.pdf
HAS/2011-02-21_fast-fix_360-08_fevrier_2011_3003_avis.pdf
HAS/2011-02-21_fast-fix_360-08_fevrier_2011_3003_synthese_davis.pdf
HAS/2011-02-21_secura_d214vrm-08_fevrier_2011_3443_avis.pdf
HAS/2011-02-25_avis_autogreffe_chondrocytes.pdf
HAS/2011-02-25_note_cadrage_anneaux_valvulaires_conduits_valves2.pdf
HAS/2011-03-01_aptivus_adolescents_-_ct-7481.pdf
HAS/2011-03-01_aptivus_adultes_-_ct-6249.pdf
HAS/2011-03-01_aptivus_ct_6249.pdf
HAS/2011-03-01_aptivus_ct_7480.pdf
HAS/2011-03-01_aptivus_ct_7481.pdf
HAS/2011-03-01_aptivus_enfant_-_ct-7480.pdf
HAS/2011-03-01_ilaris_-_ct-7256.pdf
HAS/2011-03-01_ilaris_ct_7256.pdf
HAS/2011-03-01_synthese_davis_aptivus_capsules_-_ct-7481.pdf
HAS/2011-03-01_synthese_davis_aptivus_solution_-_ct-7480.pdf
HAS/2011-03-01_synthese_davis_ilaris_-_ct-7256.pdf
HAS/2011-03-04_argumentaire_-_depistage_de_la_retinopathie_diabetique_par_lecture_differee_de_photographies_du_fond_doeil.pdf
HAS/2011-03-04_fiche_de_synthese_retinopathie_vf.pdf
HAS/2011-03-04_pose_de_bioprothese_valvulaire_pulmonaire_par_voie_veineuse_transcutanee_-_document_d_avis.pdf
HAS/2011-03-04_synthese_et_recos_depistage_de_la_rd_vf_2011-03-02_15-09-1_169.pdf
HAS/2011-03-05_11_03_11_etude_anesm_v6_final_pour_pdf_10_05111.pdf
HAS/2011-03-08_activelle_kliogest_novofemme_trisequens_-_ct-9469.pdf
HAS/2011-03-08_adalate_chronoadalate_-_ct-_10057.pdf
HAS/2011-03-08_alodont_-_ct-9691.pdf
HAS/2011-03-08_artex_-_ct-10089.pdf
HAS/2011-03-08_augmentin_-_ct-9473.pdf
HAS/2011-03-08_cebemyxine_-_ct-_9373.pdf
HAS/2011-03-08_claramid_-_ct-_9760.pdf
HAS/2011-03-08_climaston_-_ct-_9253.pdf
HAS/2011-03-08_climene_-_ct-_9168.pdf
HAS/2011-03-08_co_tareg_-_ct-_9961.pdf
HAS/2011-03-08_cozaar_-_ct-_10061.pdf
HAS/2011-03-08_cromabak_cromadose_-_ct-_9499.pdf
HAS/2011-03-08_dakin_-_ct-_9693.pdf
HAS/2011-03-08_detensiel_-_ct-10164.pdf
HAS/2011-03-08_diaseptyl_-_ct-_9857.pdf
HAS/2011-03-08_entocort_-_ct-10190.pdf
HAS/2011-03-08_estraderm_vivelledot_-_ct-8394.pdf
HAS/2011-03-08_fonlipol_-_ct-9694.pdf
HAS/2011-03-08_fortzaar_hyzaar_-_ct-_10060.pdf
HAS/2011-03-08_givalex_-_ct-_9695.pdf
HAS/2011-03-08_glibenclamide_-_ct-9492.pdf
HAS/2011-03-08_glycothymoline_-_ct-9696.pdf
HAS/2011-03-08_hyperium_-_ct-_9950.pdf
HAS/2011-03-08_icaz_-_ct-9992.pdf
HAS/2011-03-08_iskedyl_iskedyl_fort_-_ct-_9846.pdf
HAS/2011-03-08_mag_2_sans_sucre_-_ct-_9794.pdf
HAS/2011-03-08_nisisco_-_ct-_10130.pdf
HAS/2011-03-08_oesclim_-_ct-_9314.pdf
HAS/2011-03-08_paroex_-_ct-_9754.pdf
HAS/2011-03-08_physiotens_-_ct-_10092.pdf
HAS/2011-03-08_prexidine_-_ct-_10234.pdf
HAS/2011-03-08_pulmicort_-_ct_-_7397.pdf
HAS/2011-03-08_refresh_-_ct-_8996.pdf
HAS/2011-03-08_rhinocort_-_ct-_10191.pdf
HAS/2011-03-08_sulfarlem_-_ct-_9368.pdf
HAS/2011-03-08_tobradex_-_ct_-_9446.pdf
HAS/2011-03-08_trasicor_-_ct_-_9955.pdf
HAS/2011-03-08_vibramycine_-_ct-_9631.pdf
HAS/2011-03-08_xylocaine_adrenaline_-_ct-_10187.pdf
HAS/2011-03-08_xylocaine_gamme_-_ct-_9621.pdf
HAS/2011-03-08_xylocaine_naphazoline_-_ct-_10189.pdf
HAS/2011-03-09_adartrel_-_ct-9292.pdf
HAS/2011-03-09_adartrel_annexe_1__resume_etude_postamm_chpm.pdf
HAS/2011-03-09_adartrel_annexe_2_donnees_egb.pdf
HAS/2011-03-09_adartrel_ct_9292.pdf
HAS/2011-03-09_albosure-22_fevrier_2011_3327_avis.pdf
HAS/2011-03-09_albosure-22_fevrier_2011_3327_synthese_davis_2011-04-28_10-27-52_69.pdf
HAS/2011-03-09_allogreffe_osseuse_phoenix-22_fevrier_20113285_avis.pdf
HAS/2011-03-09_chloraprep_colore_ct_9127.pdf
HAS/2011-03-09_chloraprepcolore_-_ct9127.pdf
HAS/2011-03-09_iasoflu_-_ct-_9190.pdf
HAS/2011-03-09_iasoflu_ct_9190.pdf
HAS/2011-03-09_reparation_meniscale__attache_ou_ancre__resorbables_ou_non-08_mars_2011_3548_avis.pdf
HAS/2011-03-09_riastap_-_ct-_9732.pdf
HAS/2011-03-09_riastap_ct_9732.pdf
HAS/2011-03-09_ruconest_-_ct-9842.pdf
HAS/2011-03-09_ruconest_ct_9842.pdf
HAS/2011-03-09_synthese_davis_adartrel_-_ct-9292.pdf
HAS/2011-03-09_synthese_davis_chloraprep_ct-9127.pdf
HAS/2011-03-09_synthese_davis_iasoflu_-_ct-9190.pdf
HAS/2011-03-09_synthese_davis_riastap_-_ct-9732.pdf
HAS/2011-03-09_synthese_davis_ruconest_-_ct-9842.pdf
HAS/2011-03-09_synthese_davis_tareg_-_ct-9679-9680.pdf
HAS/2011-03-09_synthese_davis_xeomin_-_ct-9626.pdf
HAS/2011-03-09_tareg_ct_9679.pdf
HAS/2011-03-09_tareg_ct_9680.pdf
HAS/2011-03-09_tareg_pediatrie-_ct-_9680.pdf
HAS/2011-03-09_tareg_solution_buvable_-_ct_-9679.pdf
HAS/2011-03-09_xeomin_-_ct_-_9626_2011-04-15_15-31-36_292.pdf
HAS/2011-03-09_xeomin_ct_9626.pdf
HAS/2011-03-11_CT-5999_REQUIP - CT- 5999.pdf
HAS/2011-03-11_argumentaire_gonocoque_vf.pdf
HAS/2011-03-11_avastin_-_ct-6250.pdf
HAS/2011-03-11_avastin_ct_6250.pdf
HAS/2011-03-11_coussins_de_serie_de_positionnement-08_mars_2011_2713_avis.pdf
HAS/2011-03-11_inexium_-_ct-7254.pdf
HAS/2011-03-11_inexium_ct_7254_2011-03-09_16-12-12_446.pdf
HAS/2011-03-11_mabthera_-_ct-7017.pdf
HAS/2011-03-11_mabthera_ct_7017.pdf
HAS/2011-03-11_nucleus_freedom_hybrid-09_juin_2009_1987_avis.pdf
HAS/2011-03-11_remicade_-_ct-_6220.pdf
HAS/2011-03-11_remicade_ct_6220.pdf
HAS/2011-03-11_requip_ct_5999x.pdf
HAS/2011-03-11_strategies_depistage_infection_neisseria_gonorrhoeae_note_cadrage.pdf
HAS/2011-03-11_synthese_davis_avastin_-_ct-6250.pdf
HAS/2011-03-11_synthese_davis_inexium_-_ct-7254.pdf
HAS/2011-03-11_synthese_davis_mabthera_-_ct-7017.pdf
HAS/2011-03-11_synthese_davis_remicade_-_ct-6220_2009-06-15_15-15-19_115.pdf
HAS/2011-03-11_synthese_davis_requip_-_ct-5999.pdf
HAS/2011-03-11_synthese_gonocoque_vf.pdf
HAS/2011-03-11_zenith_tx2__zenith_tx2_proform-22_fevrier_2011_2307_avis.pdf
HAS/2011-03-11_zenith_tx2_et_zenith_tx1-22_fevrier_2011_3589__avis_radiation.pdf
HAS/2011-03-14_CT-6086_MENCEVAX - CT- 6086.pdf
HAS/2011-03-14_ald_31_lap_dfm_web.pdf
HAS/2011-03-14_ald_31_pnds_dfm_web.pdf
HAS/2011-03-14_arixtra_-_ct-5418.pdf
HAS/2011-03-14_arixtra_-_ct-7044.pdf
HAS/2011-03-14_arixtra_avis_2_sca_st_-__5405.pdf
HAS/2011-03-14_arixtra_ct_5405.pdf
HAS/2011-03-14_arixtra_ct_5418.pdf
HAS/2011-03-14_arixtra_ct_7044.pdf
HAS/2011-03-14_cellosorb_ag_adhesive_3395_urgotul_trio_ag_3394-08_mars_2011_avis.pdf
HAS/2011-03-14_concerto__concerto_pin-08_mars_2011_3418_avis.pdf
HAS/2011-03-14_confirm-08_mars_2011_3328_synthese_davis.pdf
HAS/2011-03-14_confirm_modeles_dm2100_et_dm2102-08_mars_2011_3328_avis.pdf
HAS/2011-03-14_kanokad_-_ct-6278.pdf
HAS/2011-03-14_kanokad_ct_6278.pdf
HAS/2011-03-14_mencevax_ct_6086.pdf
HAS/2011-03-14_pnds_38_-_dysplasie_fibromusculaire_chez_ladulte_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2011-03-14_rapport_definition_environnements_techniques.pdf
HAS/2011-03-14_synthese_davis_arixtra_ct-7044.pdf
HAS/2011-03-14_synthese_davis_kanokad_-_ct-6278.pdf
HAS/2011-03-14_synthese_davis_mencevax_-_ct-6086.pdf
HAS/2011-03-14_synthese_davis_xamiol_-_ct-6219.pdf
HAS/2011-03-14_texte_court_definition_environnements_techniques.pdf
HAS/2011-03-14_xamiol_-_ct-6219.pdf
HAS/2011-03-14_xamiol_ct_6219.pdf
HAS/2011-03-22_allergodil_-_ct-_8850.pdf
HAS/2011-03-22_briem_-_ct-10194.pdf
HAS/2011-03-22_burinex_-_ct-_9447.pdf
HAS/2011-03-22_desferal_-_ct-9759.pdf
HAS/2011-03-22_excluder-08_mars_2011_3421_avis.pdf
HAS/2011-03-22_excluder-08_mars_2011_3422_avis.pdf
HAS/2011-03-22_excluder-08_mars_2011_3423_avis.pdf
HAS/2011-03-22_excluder_gore_c3-08_mars_2011_3421_synthese_davis.pdf
HAS/2011-03-22_invirase_-_ct-8732.pdf
HAS/2011-03-22_logimax_-_ct-10197.pdf
HAS/2011-03-22_monotildiem-bitildiem-tildiem-dilrne_-_ct-9733.pdf
HAS/2011-03-22_nisis_-_ct-_10131.pdf
HAS/2011-03-22_norvir_-_ct_-_9674.pdf
HAS/2011-03-22_octagam_-_ct-9860.pdf
HAS/2011-03-22_pariboy_sx__lc_sprint_star__lc_sprint_baby-08_mars_2011_3467_synthese_davis.pdf
HAS/2011-03-22_pariboy_sx__lc_sprint_star__lc_sprint_baby_3467-08_mars_2011_3467_avis.pdf
HAS/2011-03-22_takadol_-_ct-9891.pdf
HAS/2011-03-28_nucleus_ci_422-22_mars_2011_3593_avis.pdf
HAS/2011-03-28_nucleus_ci_551-22_mars_2011_3613_avis.pdf
HAS/2011-03-28_paigues_postoperatoires_suturees_non_infectees-22_mars_20113217_avis.pdf
HAS/2011-03-28_pcprofondes_cavitaires_humide_exsudative_bourgeonnemet__b2e-22_mars_2011_3514_avis.pdf
HAS/2011-03-28_pcprofondes_cavitaires_humide_exsudative_detersion_b1e-22_mars_2011_3512_avis.pdf
HAS/2011-03-28_pcprofondes_cavitaires_seches_peu_exsudative_detersion_b1s-22_mars_2011_3511_avis.pdf
HAS/2011-03-28_pcsupercifielles_humide_exsudative_bourgeonnement_a2e-22_mars_2011_3513_avis.pdf
HAS/2011-03-28_pcsupercifielles_humide_exsudative_detersion_a1e-22_mars_2011_3510_avis.pdf
HAS/2011-03-28_pcsupercifielles_seches_peu_exsudative_detersion_a1s-22_mars_2011_3177_avis.pdf
HAS/2011-03-31_ald_hors_liste_-_liste_des_actes_et_prestations_sur_la_pemphigoide_bulleuse.pdf
HAS/2011-04-04_sets_pansements-22_mars_2011_3701_autosaisine.pdf
HAS/2011-04-04_star-22_mars_2011_3354_avis.pdf
HAS/2011-04-04_xience_prime-23_mars_2011_3399_avis.pdf
HAS/2011-04-04_xience_v-23_mars_2011_3398_avis.pdf
HAS/2011-04-04_xience_v_3398_xience_prime_3399-22_mars_2011_synthese_davis_2011-05-11_14-19-51_597.pdf
HAS/2011-04-04_zenith_flex_aui_aaa-13_juillet_2010_3703_avis.pdf
HAS/2011-04-05_agrippal_-_ct-10530.pdf
HAS/2011-04-05_amycor_-_ct-_9858.pdf
HAS/2011-04-05_amycor_onychoset_-_ct-_9856.pdf
HAS/2011-04-05_celestamine_-_ct-9689.pdf
HAS/2011-04-05_chlorhydrate_de_mebeverine_mylan_-_ct-8825.pdf
HAS/2011-04-05_colopriv_-_ct-_10386.pdf
HAS/2011-04-05_colposeptine_-_ct-_9692.pdf
HAS/2011-04-05_dulcilarmes_-_ct-_10009.pdf
HAS/2011-04-05_eau_oxygenee_gilbert_-_ct-8646.pdf
HAS/2011-04-05_esidrex_-_ct-10259.pdf
HAS/2011-04-05_femsept_femseptcombi_femseptevo_-_ct-10314.pdf
HAS/2011-04-05_fluarix_-_ct-10531.pdf
HAS/2011-04-05_frakidex_-_ct-_9923.pdf
HAS/2011-04-05_immugrip_-_ct-10533.pdf
HAS/2011-04-05_influvac_-_ct-10534.pdf
HAS/2011-04-05_mebeverine_biogaran_-_ct-_9802.pdf
HAS/2011-04-05_mebeverine_eg_-_ct-10431_2011-07-28_14-42-13_478.pdf
HAS/2011-04-05_mebeverine_qualimed_-_ct-8824.pdf
HAS/2011-04-05_mebeverine_teva_-_ct-10432.pdf
HAS/2011-04-05_mebeverine_zydus_-_ct-9444.pdf
HAS/2011-04-05_mutagrip_-_ct-10535.pdf
HAS/2011-04-05_nalcron_-_ct-_9698.pdf
HAS/2011-04-05_oestrogel_oestrodose_thais_thaissept_-_ct-_8374_2011-04-19_10-29-36_770.pdf
HAS/2011-04-05_pannogel_-_ct-9429.pdf
HAS/2011-04-05_previgrip_-_ct-10536.pdf
HAS/2011-04-05_rebetol_-_ct-9625.pdf
HAS/2011-04-05_rhinotrophyl_-_ct-9702.pdf
HAS/2011-04-05_spasmopriv_-_ct-9214.pdf
HAS/2011-04-05_surgestone_-_ct-9430.pdf
HAS/2011-04-05_tetagrip_-_ct-10538.pdf
HAS/2011-04-05_trizivir_-_ct-7080.pdf
HAS/2011-04-05_vaxigrip_-_ct-10537.pdf
HAS/2011-04-05_visceralgine_-_ct-9798.pdf
HAS/2011-04-05_vitamine_a_dulcis_-_ct-_10282.pdf
HAS/2011-04-05_xalatan_-_ct-_9952.pdf
HAS/2011-04-06_abufene_-_ct_-_7419.pdf
HAS/2011-04-06_abufene_ct_7419.pdf
HAS/2011-04-06_copaxone_-_ct-9471.pdf
HAS/2011-04-06_copaxone_ct_9471.pdf
HAS/2011-04-06_debridat_-_ct-9409.pdf
HAS/2011-04-06_debridat_ct_9409.pdf
HAS/2011-04-06_dicetel_-_ct-_9797.pdf
HAS/2011-04-06_dicetel_ct_9797.pdf
HAS/2011-04-06_meteoxane_-_ct-9800.pdf
HAS/2011-04-06_meteoxane_ct_9800.pdf
HAS/2011-04-06_monazol_-_ct-_9888.pdf
HAS/2011-04-06_synthese_davis_abufene_-_ct-7419.pdf
HAS/2011-04-06_synthese_davis_copaxone_-_ct-9471.pdf
HAS/2011-04-06_synthese_davis_tasigna_-_ct-_9624.pdf
HAS/2011-04-06_tasigna_-_ct-9624.pdf
HAS/2011-04-06_tasigna_ct_9624.pdf
HAS/2011-04-08_avis_techniques_lipolyse.pdf
HAS/2011-04-12_autosurveillance_et_autotraitement-08_fevrier_2011_3286_avis.pdf
HAS/2011-04-14_angiox_-_ct-6275.pdf
HAS/2011-04-14_angiox_ct_6275.pdf
HAS/2011-04-14_annexe_prevenar_-_ct-7346.pdf
HAS/2011-04-14_autosurveillance_glycemique_diabete_type_2_fiche_de_bon_usage.pdf
HAS/2011-04-14_avis_compression_medicale_1276_23_11_2010.pdf
HAS/2011-04-14_compte_rendu_de_controle_de_la_refraction_2011-04-12_09-47-54_612.pdf
HAS/2011-04-14_encepur_-_ct-6457.pdf
HAS/2011-04-14_encepur_ct_6457.pdf
HAS/2011-04-14_exforge_hct-_ct-7151.pdf
HAS/2011-04-14_exforge_hct_ct_7151.pdf
HAS/2011-04-14_feldene_-_ct-6041.pdf
HAS/2011-04-14_feldene_ct_6041.pdf
HAS/2011-04-14_good_practice_-_self-monitoring_blood_glucose_type_2_diabetes.pdf
HAS/2011-04-14_javlor_-_ct-_7131.pdf
HAS/2011-04-14_javlor_ct_7131.pdf
HAS/2011-04-14_leeloo_-_ct-7389.pdf
HAS/2011-04-14_leeloo_ct_7389.pdf
HAS/2011-04-14_nevanac_-_ct-_8892.pdf
HAS/2011-04-14_nevanac_ct_8892.pdf
HAS/2011-04-14_note_de_cadrage_-_troubles_de_la_refraction_-_delivrance_de_verres_correcteurs_par_les_opticiens_dans_le_cadre_dun_renouvellement.pdf
HAS/2011-04-14_onglyza_-_ct-7111.pdf
HAS/2011-04-14_onglyza_ct_7111.pdf
HAS/2011-04-14_phosphosorb_-_ct-6727.pdf
HAS/2011-04-14_phosphosorb_ct_6727.pdf
HAS/2011-04-14_prevenar13_-_ct-7346.pdf
HAS/2011-04-14_prevenar_ct_7346.pdf
HAS/2011-04-14_reco2clics_troubles-de-la-refraction-renouvellement-des-lunettes.pdf
HAS/2011-04-14_renouveler_ses_lunettes_de_vue_-_mode_demploi_-_document_pour_les_usagers_-_format_a4_2011-04-11_18-25-40_931.pdf
HAS/2011-04-14_renouveler_ses_lunettes_de_vue_-_mode_demploi_-_document_pour_les_usagers_-_pour_impression_recto_verso.pdf
HAS/2011-04-14_rheo_knee-22_mars_2011_2370_avis.pdf
HAS/2011-04-14_rheo_knee-22_mars_2011_2370_synthese_davis.pdf
HAS/2011-04-14_salvacyl_-_ct-6221.pdf
HAS/2011-04-14_salvacyl_ct_6221.pdf
HAS/2011-04-14_synthese_davis_angiox_-_ct-6275.pdf
HAS/2011-04-14_synthese_davis_encepur_-_ct-6457.pdf
HAS/2011-04-14_synthese_davis_exforge_ct-7151.pdf
HAS/2011-04-14_synthese_davis_javlor_-_ct-7131.pdf
HAS/2011-04-14_synthese_davis_leeloo_-_ct-7389.pdf
HAS/2011-04-14_synthese_davis_nevanac-_ct-_8892.pdf
HAS/2011-04-14_synthese_davis_onglyza_-_ct-7111.pdf
HAS/2011-04-14_synthese_davis_phosphosorb_-_ct-6727.pdf
HAS/2011-04-14_synthese_davis_piroxicam_-_ct-5660-6214-6041-6027.pdf
HAS/2011-04-14_synthese_davis_prevenar_-_ct-7346.pdf
HAS/2011-04-14_synthese_davis_salvacyl_-_ct-6221.pdf
HAS/2011-04-14_synthese_davis_temerit_duo_-_ct-7110.pdf
HAS/2011-04-14_synthese_davis_vpriv_-_ct-_9171.pdf
HAS/2011-04-14_temerit_duo_-_ct-7110.pdf
HAS/2011-04-14_temerit_duo_ct_7110.pdf
HAS/2011-04-14_troubles_de_la_refraction_-_renouvellement_des_lunettes_-_argumentaire.pdf
HAS/2011-04-14_troubles_de_la_refraction_-_renouvellement_des_lunettes_-_recommandations.pdf
HAS/2011-04-14_troubles_de_la_refraction_-_renouvellement_des_lunettes_-_synthese.pdf
HAS/2011-04-14_vpriv_-_ct-_9171.pdf
HAS/2011-04-14_vpriv_ct_9171.pdf
HAS/2011-04-18_conserve_plus-05_avril_2011_3591_avis.pdf
HAS/2011-04-18_flexis-05_avril_2011_3444_avis.pdf
HAS/2011-04-18_flexis-05_avril_2011_3444_synthese_davis.pdf
HAS/2011-04-26_alfacalcidol_-_ct-_10379.pdf
HAS/2011-04-26_celance_-_ct-10635.pdf
HAS/2011-04-26_chibroproscar_-_ct-9766.pdf
HAS/2011-04-26_decapeptyl_-_ct-9628.pdf
HAS/2011-04-26_etidronate_mylan_-_ct-10632.pdf
HAS/2011-04-26_etidronate_sandoz_-_ct-10631.pdf
HAS/2011-04-26_glucose_lavoisier_-_ct-_8893.pdf
HAS/2011-04-26_jext_-_ct-10239.pdf
HAS/2011-04-26_kivexa_-_ct-7521.pdf
HAS/2011-04-26_megavix_-_ct-10682_2011-05-31_14-21-8_980.pdf
HAS/2011-04-26_mepronizine_-_ct-_8951.pdf
HAS/2011-04-26_moscontin_sevredol_-_ct-10374.pdf
HAS/2011-04-26_myolastan_-_ct-10616.pdf
HAS/2011-04-26_nimesulide_eg_-_ct-_10633.pdf
HAS/2011-04-26_nimesulide_teva_-_ct-10634.pdf
HAS/2011-04-26_osteocal_-_ct-10353.pdf
HAS/2011-04-26_panos_-_ct-9700.pdf
HAS/2011-04-26_tadenan_-_ct-10090.pdf
HAS/2011-04-26_tamoxifene_biogaran_-_ct-10381.pdf
HAS/2011-04-26_tetrazepam_almus_-_ct-10617.pdf
HAS/2011-04-26_tetrazepam_arrow_-_ct-10618.pdf
HAS/2011-04-26_tetrazepam_biogaran_-_ct-10619.pdf
HAS/2011-04-26_tetrazepam_cristers_-_ct-10620.pdf
HAS/2011-04-26_tetrazepam_eg_-_ct-10621.pdf
HAS/2011-04-26_tetrazepam_ggam_-_ct-10622.pdf
HAS/2011-04-26_tetrazepam_mylan_-_ct-10623.pdf
HAS/2011-04-26_tetrazepam_qualimed_-_ct-10624.pdf
HAS/2011-04-26_tetrazepam_ratiopharm_-_ct-10625.pdf
HAS/2011-04-26_tetrazepam_rpg_-_ct-10626.pdf
HAS/2011-04-26_tetrazepam_sandoz_-_ct-10627.pdf
HAS/2011-04-26_tetrazepam_teva_-_ct-10628.pdf
HAS/2011-04-26_tetrazepam_winthrop_-_ct-10629.pdf
HAS/2011-04-26_tetrazepam_zydus_-_ct-10630.pdf
HAS/2011-04-26_viramune_-_ct-9262.pdf
HAS/2011-04-26_zyrtec_-_ct-10373.pdf
HAS/2011-04-27_cortisal_-_ct-_8350.pdf
HAS/2011-04-27_dextrarine_phenylbutazone_-_ct-_8642.pdf
HAS/2011-04-27_effidia_plus-22_mars-2011_3464_avis.pdf
HAS/2011-04-27_effidia_plus-22_mars_2011_3464_synthese_davis.pdf
HAS/2011-04-27_fiche_de_bon_usage_-_compression_medicale_dans_le_traitement_de_la_maladie_thrombo-embolique_veineuse.pdf
HAS/2011-04-27_fiche_de_bon_usage_-_compression_medicale_dans_les_affections_veineuses_chroniques.pdf
HAS/2011-04-27_fiche_de_bon_usage_-_compression_medicale_dans_les_affections_veineuses_chroniques_2010-12-16_11-04-22_128.pdf
HAS/2011-04-27_fiche_de_bon_usage_-_compression_medicale_en_prevention_de_la_thrombose_veineuse.pdf
HAS/2011-04-27_glucovance_-_ct-7012.pdf
HAS/2011-04-27_glucovance_ct_7012.pdf
HAS/2011-04-27_hexaquine_-_ct-_8635.pdf
HAS/2011-04-27_hexaquine_ct_8635.pdf
HAS/2011-04-27_itrel_3-05_avril_2011_3594_avis.pdf
HAS/2011-04-27_mepronizine_-_ct-8952.pdf
HAS/2011-04-27_mepronizine_ct_8952.pdf
HAS/2011-04-27_percutalgine_-_ct-_8573.pdf
HAS/2011-04-27_quinine_vitamine_c_grand_ct_9701.pdf
HAS/2011-04-27_quinine_vitc_grand_-_ct-9701.pdf
HAS/2011-04-27_retacrit_-_ct-_9673.pdf
HAS/2011-04-27_synthese_davis_ains_topiques_-_ct-8350-_8373-_8642.pdf
HAS/2011-04-27_synthese_davis_glucovance_ct-_7012.pdf
HAS/2011-04-27_synthese_davis_mepronizine_-_ct-8952.pdf
HAS/2011-04-27_synthese_davis_quinine_-_ct-8635-10240-9701.pdf
HAS/2011-04-27_synthese_davis_retacrit_ct-9673.pdf
HAS/2011-04-29_synthese_davis_toctino_-_ct-6204.pdf
HAS/2011-04-29_synthese_davis_vidaza_-_ct-6362.pdf
HAS/2011-04-29_toctino_-_ct-6204.pdf
HAS/2011-04-29_toctino_ct_6204.pdf
HAS/2011-04-29_vidaza_-_ct-6362.pdf
HAS/2011-04-29_vidaza_ct_6362.pdf
HAS/2011-05-02_cycladol_-_ct-6214.pdf
HAS/2011-05-02_cycladol_ct_6214.pdf
HAS/2011-05-02_fiche_de_bon_usage_-_compression_medicale_dans_le_traitement_de_la_maladie_thrombo-embolique_veineuse.pdf
HAS/2011-05-02_fiche_de_bon_usage_-_compression_medicale_dans_les_affections_veineuses_chroniques.pdf
HAS/2011-05-02_fiche_de_bon_usage_-_compression_medicale_dans_les_affections_veineuses_chroniques_2010-12-16_11-04-22_128.pdf
HAS/2011-05-02_fiche_de_bon_usage_-_compression_medicale_en_prevention_de_la_thrombose_veineuse.pdf
HAS/2011-05-02_rapport_compression_medical_1276_vf.pdf
HAS/2011-05-02_synthese_davis_piroxicam_-_ct-5660-6214-6041-6027.pdf
HAS/2011-05-02_synthese_rapport_compression_medicale_vf.pdf
HAS/2011-05-03_anaconda-08_mars-2011-3509_avis.pdf
HAS/2011-05-05_hirobriz_breezhaler_-_ct-_8861.pdf
HAS/2011-05-05_hirobriz_breezhaler_ct_8861.pdf
HAS/2011-05-05_onbrez_breezhaler_-_ct_-_8861.pdf
HAS/2011-05-05_oslif_breezhaler_-_ct-_8861.pdf
HAS/2011-05-05_synthese_davis_onbrez_breezhaler-_ct-8861.pdf
HAS/2011-05-10_activa_sc-03_mai_2011_3507_avis.pdf
HAS/2011-05-10_acuitel_-_ct-10646.pdf
HAS/2011-05-10_alphagan_-_ct10508.pdf
HAS/2011-05-10_climara_-_ct-10529.pdf
HAS/2011-05-10_dermorelle_-_ct-10557.pdf
HAS/2011-05-10_duotrav_-_ct-10262.pdf
HAS/2011-05-10_flecaine_-_ct-10033.pdf
HAS/2011-05-10_flodil_-_ct-10196.pdf
HAS/2011-05-10_matri_bone-03_mai_2011_3397_avis.pdf
HAS/2011-05-10_matri_bone-03_mai_2011_3397_synthese_davis.pdf
HAS/2011-05-10_nexen_-_ct-10784.pdf
HAS/2011-05-10_provames_-_ct-10501.pdf
HAS/2011-05-10_sifrol_-_ct-7574.pdf
HAS/2011-05-10_timocomod_-_ct-10091.pdf
HAS/2011-05-10_timoptol_-_ct-10062.pdf
HAS/2011-05-10_tracitrans_-_ct-10563.pdf
HAS/2011-05-10_tracitrans_srh.pdf
HAS/2011-05-10_zorac_-_ct-10647.pdf
HAS/2011-05-12_optive-03_mai_2011_3568_avis.pdf
HAS/2011-05-12_optive-03_mai_2011_3568_synthese_davis.pdf
HAS/2011-05-16_alimta_-_ct-7892.pdf
HAS/2011-05-16_alimta_ct_7892.pdf
HAS/2011-05-16_brexin_-_ct-5660.pdf
HAS/2011-05-16_brexin_ct_5660.pdf
HAS/2011-05-16_combivir_-_ct-5974.pdf
HAS/2011-05-16_combivir_ct_5974.pdf
HAS/2011-05-16_enbrel_-_ct-6353.pdf
HAS/2011-05-16_enbrel_ct_6353.pdf
HAS/2011-05-16_erbitux_-_ct-6366.pdf
HAS/2011-05-16_erbitux_ct_6366.pdf
HAS/2011-05-16_fonlipol_-_ct-4683.pdf
HAS/2011-05-16_fonlipol_ct_4683.pdf
HAS/2011-05-16_gliolan__ct_7583.pdf
HAS/2011-05-16_gliolan_ct-7583.pdf
HAS/2011-05-16_glivec_-_ct-6889.pdf
HAS/2011-05-16_glivec_ct_6889.pdf
HAS/2011-05-16_synthese_davis_alimta_-_ct-7892.pdf
HAS/2011-05-16_synthese_davis_combivir_-_ct-5974.pdf
HAS/2011-05-16_synthese_davis_enbrel_pso_enfant_-_ct-6353.pdf
HAS/2011-05-16_synthese_davis_erbitux_-_ct-6366.pdf
HAS/2011-05-16_synthese_davis_gliolan_-_ct-7583.pdf
HAS/2011-05-16_synthese_davis_glivec_-_ct-6889.pdf
HAS/2011-05-16_synthese_davis_piroxicam_-_ct-5660-6214-6041-6027.pdf
HAS/2011-05-17_arcoxia_120_mg_-_ct-5948.pdf
HAS/2011-05-17_arcoxia_120_mg_ct_5948.pdf
HAS/2011-05-17_arcoxia_30_et_60_mg_-_ct-5948.pdf
HAS/2011-05-17_arcoxia_30_et_60_mg_ct_5948.pdf
HAS/2011-05-17_bat_fiche_navelbine.pdf
HAS/2011-05-17_bricanyl_-_ct-8591.pdf
HAS/2011-05-17_caelyx_-_ct-6273.pdf
HAS/2011-05-17_caelyx_ct_6273.pdf
HAS/2011-05-17_fiche_bon_usage_vesicare.pdf
HAS/2011-05-17_navelbine_-_ct-6287.pdf
HAS/2011-05-17_navelbine_-_ct-6288.pdf
HAS/2011-05-17_navelbine_ct_6287.pdf
HAS/2011-05-17_navelbine_ct_6288.pdf
HAS/2011-05-17_rm_classic__pressfit-03_mai_2011_3676_avis_2011-05-17_14-46-9_579.pdf
HAS/2011-05-17_synthese_davis_arcoxia_120_mg_-_ct-5948.pdf
HAS/2011-05-17_synthese_davis_arcoxia_30_et_60_mg_-_ct-5948.pdf
HAS/2011-05-17_synthese_davis_caelyx_-_ct-6273.pdf
HAS/2011-05-17_synthese_davis_navelbine_-_ct-6287.pdf
HAS/2011-05-17_synthese_davis_navelbine_-_ct-6288.pdf
HAS/2011-05-17_synthese_davis_tegeline_-_ct-7337.pdf
HAS/2011-05-17_synthese_davis_tracleer_-_ct-6026_2009-05-14_12-16-43_730.pdf
HAS/2011-05-17_synthese_davis_tracleer_-_ct-7227.pdf
HAS/2011-05-17_synthese_davis_vesicare_-_ct-6967.pdf
HAS/2011-05-17_synthese_davis_zypadhera_-_ct-5644.pdf
HAS/2011-05-17_tegeline_-_ct-7337.pdf
HAS/2011-05-17_tegeline_ct_7337.pdf
HAS/2011-05-17_tracleer_-_ct-6026.pdf
HAS/2011-05-17_tracleer_-_ct-7227.pdf
HAS/2011-05-17_tracleer_ct_6026.pdf
HAS/2011-05-17_tracleer_ct_7227.pdf
HAS/2011-05-17_vesicare_-_ct-6967.pdf
HAS/2011-05-17_vesicare_ct_6967.pdf
HAS/2011-05-17_zypadhera_-_ct-6663.pdf
HAS/2011-05-17_zypadhera_ct_6663.pdf
HAS/2011-05-24_alodont_-_ct-_10637.pdf
HAS/2011-05-24_azactam_-_ct-_10553.pdf
HAS/2011-05-24_bat_fiche_azactam.pdf
HAS/2011-05-24_ciflox_uniflox_-_ct-_9437.pdf
HAS/2011-05-24_kaleorid_-_ct-_10761.pdf
HAS/2011-05-24_morphine_chlorhydrate_aguettant_-_ct-_10336.pdf
HAS/2011-05-24_morphine_chlorhydrate_cooper_-_ct-10410.pdf
HAS/2011-05-24_nutrivisc_-_ct-10707.pdf
HAS/2011-05-24_proglicem_-_ct-_9791.pdf
HAS/2011-05-24_risperdalconsta_-_ct-7257.pdf
HAS/2011-05-24_risperdalconsta_lp_ct_7257.pdf
HAS/2011-05-24_singulair_4_mg_-_ct-6895.pdf
HAS/2011-05-24_singulair_ct_6895.pdf
HAS/2011-05-24_synthese_davis_singulair_-_ct-6895.pdf
HAS/2011-05-24_triatec_-_ct-10134.pdf
HAS/2011-05-24_triatec_-_ct-_10133_2011-06-15_10-44-2_12.pdf
HAS/2011-05-24_vitamine_-_ct-_10641.pdf
HAS/2011-05-24_ziagen_-_ct_6935.pdf
HAS/2011-05-25_avastin_-_ct_9954.pdf
HAS/2011-05-25_avastin_25-05-2011_synthese_ct9954.pdf
HAS/2011-05-25_avastin_ct_9954.pdf
HAS/2011-05-25_caryolysine_-_ct-_9861.pdf
HAS/2011-05-25_caryolysine_25-05-2011_synthese_9861.pdf
HAS/2011-05-25_edicis_-_ct-9991.pdf
HAS/2011-05-25_flixovate_-_ct-_9987.pdf
HAS/2011-05-25_flixovate_25-05-2011_synthese_111102.pdf
HAS/2011-05-25_flixovate_ct_9987.pdf
HAS/2011-05-25_lantus_-_ct-_9433.pdf
HAS/2011-05-25_lantus_annexe_1_note_dg_afssaps.pdf
HAS/2011-05-25_lantus_annexe_2_etudes_epidemio.pdf
HAS/2011-05-25_mabthera_-_ct-9841.pdf
HAS/2011-05-25_noctran_-_ct-_3151.pdf
HAS/2011-05-25_noctran_25-05-2011_synthese_3151.pdf
HAS/2011-05-25_peflacine_-_ct-8950.pdf
HAS/2011-05-25_protecta_xt_crt-d-03_mai_2011__3261_avis.pdf
HAS/2011-05-25_protecta_xt_dr-03_mai_20113287_avis.pdf
HAS/2011-05-25_protecta_xt_vr-03_mai_2011_3288_avis.pdf
HAS/2011-05-25_spiriva_-_ct-9435.pdf
HAS/2011-05-25_spiriva_ct_9435.pdf
HAS/2011-05-25_synthese_davis_edicis_-_ct-9991.pdf
HAS/2011-05-25_synthese_davis_lantus_ct-9433.pdf
HAS/2011-05-25_synthese_davis_peflacine_-_ct-8950.pdf
HAS/2011-05-25_synthese_davis_vagifem_ct-10309.pdf
HAS/2011-05-25_synthese_mabthera_ct-9841.pdf
HAS/2011-05-25_vagifem_avis1_ct10309.pdf
HAS/2011-05-25_zenith__zenith_flex-17_mai_2011_3704__3656_avis.pdf
HAS/2011-05-25_zenith__zenith_flex-17_mai_2011_3858_avis__radiation.pdf
HAS/2011-05-25_zenith_flex_aui-17_mai_2011_3678_3680_avis.pdf
HAS/2011-05-25_zenith_low_profile-17_mai_2011_3679_avis.pdf
HAS/2011-05-27_ald_hors_liste_-_liste_des_actes_et_prestations_sur_lhyperplasie_congenitale_des_surrenales.pdf
HAS/2011-05-27_ald_hors_liste_-_pnds_sur_lhyperplasie_congenitale_des_surrenales.pdf
HAS/2011-05-27_pnds_40_-_hyperplasie_congenitale_des_surrenales_par_deficit_en_21-hydroxylase_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2011-05-30_aldara_-_ct-8763.pdf
HAS/2011-05-30_aldara_ct_7369.pdf
HAS/2011-05-30_eucreas_-_ct-5439.pdf
HAS/2011-05-30_eucreas_ct_5439.pdf
HAS/2011-05-30_lucentis_pxe_art_56.pdf
HAS/2011-05-30_menjugatekit_-_ct-7081.pdf
HAS/2011-05-30_menjugatekit_ct_7081_2011-05-24_11-13-3_425.pdf
HAS/2011-05-30_plasmavolume_-_ct-6338.pdf
HAS/2011-05-30_plasmavolume_ct_6338.pdf
HAS/2011-05-30_synthese_davis_eucreas_-_ct-5439.pdf
HAS/2011-05-30_synthese_davis_menigitec_menjugate_neisvac_-_ct-7079-7081-7129.pdf
HAS/2011-05-30_synthese_davis_plasmavolume_-_ct-6338.pdf
HAS/2011-06-01_confidence-31_mai_2011_3614_synthese_davis.pdf
HAS/2011-06-01_confidence_spinal_cement_system-31_mai_2011_3614_avis.pdf
HAS/2011-06-01_developpement_de_la_prescription_de_therapeutiques_non_medicamenteuses_fiche_synthese.pdf
HAS/2011-06-01_developpement_de_la_prescription_de_therapeutiques_non_medicamenteuses_rapport.pdf
HAS/2011-06-01_developpement_de_la_prescription_de_therapeutiques_non_medicamenteuses_synthese.pdf
HAS/2011-06-01_prothese_externe_de_sein-31_mai_2011_3770_avis.pdf
HAS/2011-06-01_sentry-31_mai_2011_3466_synthese_davis.pdf
HAS/2011-06-01_sentry_1200-31_mai_2011_3466_avis.pdf
HAS/2011-06-01_therasphere-31_mai_2011_3508_avis.pdf
HAS/2011-06-01_therasphere-31_mai_2011_3508_synthese_davis_2011-07-26_10-15-58_383.pdf
HAS/2011-06-06_evicel_-_ct-_6940.pdf
HAS/2011-06-06_evicel_ct_6940.pdf
HAS/2011-06-06_neisvac_-ct-7129.pdf
HAS/2011-06-06_neisvac_ct_7129.pdf
HAS/2011-06-06_proxalyoc_-_ct-6027.pdf
HAS/2011-06-06_proxalyoc_ct_6027.pdf
HAS/2011-06-06_subcuvia_-_ct-6963.pdf
HAS/2011-06-06_subcuvia_ct_6963.pdf
HAS/2011-06-06_synthese_davis_menigitec_menjugate_neisvac_-_ct-7079-7081-7129.pdf
HAS/2011-06-06_synthese_davis_piroxicam_-_ct-5660-6214-6041-6027.pdf
HAS/2011-06-06_synthese_davis_subcuvia_-_ct-6963.pdf
HAS/2011-06-06_synthese_davis_vimpat_-_ct-6048.pdf
HAS/2011-06-06_vimpat_-_ct-6048.pdf
HAS/2011-06-06_vimpat_ct_6048.pdf
HAS/2011-06-07_betagan_-_ct-10857.pdf
HAS/2011-06-07_bilaska_-_ct-10679.pdf
HAS/2011-06-07_genac_-_ct-10765.pdf
HAS/2011-06-07_inorial_-_ct-10673.pdf
HAS/2011-06-07_justor_-_ct-10818.pdf
HAS/2011-06-07_proctolog_-_ct-10639.pdf
HAS/2011-06-07_ranexa_-_ct-_9838.pdf
HAS/2011-06-07_titanoreine_-_ct-10640.pdf
HAS/2011-06-07_xagrid_-_ct-_8853.pdf
HAS/2011-06-07_zymafluor_-_ct-10615.pdf
HAS/2011-06-08_reco2clics_regulation_medicale.pdf
HAS/2011-06-08_recommandation_regulation_medicale.pdf
HAS/2011-06-08_regulation_medicale__argumentaire.pdf
HAS/2011-06-08_regulation_medicale_fiche_de_synthese.pdf
HAS/2011-06-08_regulation_medicale_note_de_cadrage_2011-11-17_10-54-6_932.pdf
HAS/2011-06-09_prezista_-_ct-7149_-_ct-_7150.pdf
HAS/2011-06-09_prezista_ct_7149-7150.pdf
HAS/2011-06-09_synthese_davis_prezista_-_ct-7150_2010-03-04_14-17-44_943.pdf
HAS/2011-06-14_abstract_iron_metabolism_tests_in_iron_deficiency_2011-11-30_13-00-23_322.pdf
HAS/2011-06-14_fiche_buts_bilan_martial_carence_2011-11-09_17-07-51_399.pdf
HAS/2011-06-14_rapport_devaluation_bilan_martial_carence_2011-11-09_17-21-31_723.pdf
HAS/2011-06-14_summary_iron_metabolism_tests_in_iron_deficiency_2011-11-30_13-00-3_641.pdf
HAS/2011-06-14_texte_court__bilan_martial_carence_2011-11-09_17-22-2_135.pdf
HAS/2011-06-16_aridol_-_ct-7977.pdf
HAS/2011-06-16_aridol_ct_7977.pdf
HAS/2011-06-16_c-band-14_juin_2011_3635_avis.pdf
HAS/2011-06-16_carpenter_viscolux-31_mai_2011_3833_avis.pdf
HAS/2011-06-16_dermasilk-14_juin_2011_3590_avis.pdf
HAS/2011-06-16_dermasilk-14_juin_2011_3590_synthese_davis_2012-02-07_10-04-1_331.pdf
HAS/2011-06-16_profilair-14_juin_2011_3465_avis.pdf
HAS/2011-06-16_profilair-14_juin_2011_3465_synthese_davis_2011-10-18_10-40-9_37.pdf
HAS/2011-06-16_relay_nsb_plus-31_mai_2011_3791_avis.pdf
HAS/2011-06-16_relay_plus-31_mai_2011_3746_avis.pdf
HAS/2011-06-16_relay_plus___relay_plus_nbs-31_mai_2011_3746__3791_synthese_davis.pdf
HAS/2011-06-16_synthese_davis_aridol_-_ct-7977.pdf
HAS/2011-06-16_talent_lps-14_juin_2011_3595_3615_avis.pdf
HAS/2011-06-21_cokenzen_-_ct-10889.pdf
HAS/2011-06-21_iperten_-_ct-10882.pdf
HAS/2011-06-22_arixtra_-_ct-9676.pdf
HAS/2011-06-22_arixtra_22_06_2011_synthese_ct-9676.pdf
HAS/2011-06-22_arixtra_ct_9676.pdf
HAS/2011-06-22_differine_-_ct-10498.pdf
HAS/2011-06-22_efficort_-_ct-10823.pdf
HAS/2011-06-22_fucidine_-_ct-10762.pdf
HAS/2011-06-22_givalex_bainbouche_-_ct-10638.pdf
HAS/2011-06-22_givalex_collutoire_-_ct-10922.pdf
HAS/2011-06-22_increlex_-_ct-8906.pdf
HAS/2011-06-22_increlex_22-06-2011_synthese_ct-8906.pdf
HAS/2011-06-22_increlex_ct_8906.pdf
HAS/2011-06-22_locoid_-_ct-9370.pdf
HAS/2011-06-22_lumirelax_-_ct-_9697.pdf
HAS/2011-06-22_multaq_-_ct-_10281.pdf
HAS/2011-06-22_multaq_ct_10281.pdf
HAS/2011-06-22_octagam_-_ct-_10822.pdf
HAS/2011-06-22_octagam_ct_10822.pdf
HAS/2011-06-22_ossopan_-_ct-_9699.pdf
HAS/2011-06-22_sfasfon_-_ct-9243.pdf
HAS/2011-06-22_spasfon_ct_9243.pdf
HAS/2011-06-22_synthese_davis_multaq_ct-10281.pdf
HAS/2011-06-22_tarceva_-_ct-10255.pdf
HAS/2011-06-22_tarceva_22-06-2011_synthese_ct10255.pdf
HAS/2011-06-22_tarceva_ct_10255.pdf
HAS/2011-06-22_vectarion_-_ct-10088.pdf
HAS/2011-06-22_vectarion_ct_10088.pdf
HAS/2011-06-30_annexe_3_fiche_memo.pdf
HAS/2011-06-30_annexe_4_fiche_memo.pdf
HAS/2011-06-30_annexe_5_fiche_memo.pdf
HAS/2011-06-30_modele_de_fiche_de_demande_dadmission_en_had_du_post_partum.pdf
HAS/2011-06-30_modele_de_fiche_de_demande_dadmission_en_had_en_antepartum.pdf
HAS/2011-06-30_promus-14_juin_2011_3832_avis.pdf
HAS/2011-06-30_promus_element-14_juin_2011_3836_avis.pdf
HAS/2011-06-30_protocole_had_antepartum_-_antecedent_mfiu.pdf
HAS/2011-06-30_protocole_had_antepartum_-_cholestase_gravidique.pdf
HAS/2011-06-30_protocole_had_antepartum_-_diabete_gestationnel.pdf
HAS/2011-06-30_protocole_had_antepartum_-_diabete_preexistant.pdf
HAS/2011-06-30_protocole_had_antepartum_-_hta_chronique_moderee_gravidique.pdf
HAS/2011-06-30_protocole_had_antepartum_-_hta_chronique_moderee_preexistante.pdf
HAS/2011-06-30_protocole_had_antepartum_-_lupus_sapl_preexistant.pdf
HAS/2011-06-30_protocole_had_antepartum_-_map.pdf
HAS/2011-06-30_protocole_had_antepartum_-_placenta_praevia_en_situation_stable.pdf
HAS/2011-06-30_protocole_had_antepartum_-_rciu_modere.pdf
HAS/2011-06-30_protocole_had_antepartum_-_thrombophilie_genetique_preexistante.pdf
HAS/2011-06-30_protocole_had_postpartum_-_difficultes_allaitement.pdf
HAS/2011-06-30_protocole_had_postpartum_-_dpp.pdf
HAS/2011-06-30_protocole_had_postpartum_-_pathologies_non_specifiques_au_postpartum.pdf
HAS/2011-06-30_protocole_had_postpartum_-_soins_plaie_perineale.pdf
HAS/2011-06-30_protocole_had_postpartum_-_soins_post-cesarienne.pdf
HAS/2011-06-30_reco2clics_hospitalisation_domicile_post-partum.pdf
HAS/2011-06-30_recommandation_situations_pathologiques_pouvant_relever_de_lhospitalisation_a_domicile_au_cours_de_lante_et_post-partum.pdf
HAS/2011-06-30_situations_pathologiques_pouvant_relever_de_lhospitalisation_a_domicile_au_cours_de_lante_et_post-partum_-_argumentaire_-_90_pages.pdf
HAS/2011-06-30_situations_pathologiques_pouvant_relever_de_lhospitalisation_a_domicile_au_cours_de_lante_et_post-partum_-_fiche_de_synthese-_4_pages.pdf
HAS/2011-07-05_aspirine_protect_-_ct-10555.pdf
HAS/2011-07-05_beclospin_-_ct-10883.pdf
HAS/2011-07-05_codenfan_-_ct-9840.pdf
HAS/2011-07-05_densical_vitamine_d3_-_ct-10611.pdf
HAS/2011-07-05_indobiotic_-_ct8525.pdf
HAS/2011-07-05_indocollyre_-_ct-_7871.pdf
HAS/2011-07-05_lomusol_-_ct-10826.pdf
HAS/2011-07-05_meteospasmyl_-_ct9163.pdf
HAS/2011-07-05_modopar_-_ct-10789.pdf
HAS/2011-07-05_mosil_-_ct-10941.pdf
HAS/2011-07-05_nureflex_-_ct-10241.pdf
HAS/2011-07-05_ocufen_-_ct-10010.pdf
HAS/2011-07-05_paracetamol_codeine_almus_06-07-2011_avis_10957.pdf
HAS/2011-07-05_rocaltrol_-_ct-10858.pdf
HAS/2011-07-05_sumatriptan_-_ct-10790.pdf
HAS/2011-07-05_tanganil_-_ct-9859.pdf
HAS/2011-07-05_topalgic_-_ct-8392.pdf
HAS/2011-07-05_transilane_06-07-2011_avis_9089.pdf
HAS/2011-07-05_tussipax_-_ct-_10925.pdf
HAS/2011-07-06_competact_-_ct-10278.pdf
HAS/2011-07-06_competact_06-07-2011_synthese_ct10278.pdf
HAS/2011-07-06_competact_ct_10278.pdf
HAS/2011-07-06_paderyl_-_ct-10614.pdf
HAS/2011-07-06_trobalt-_ct10681.pdf
HAS/2011-07-06_trobalt_06-07-2011_synthese_ct-10681.pdf
HAS/2011-07-06_trobalt_ct_10681.pdf
HAS/2011-07-06_truvada_-_ct8304_ct8477.pdf
HAS/2011-07-06_truvada_ct_8304_8477.pdf
HAS/2011-07-08_ald_n15_-_liste_des_actes_et_prestations_sur_cadasil.pdf
HAS/2011-07-08_ald_n15_-_pnds_sur_cadasil.pdf
HAS/2011-07-08_pnds_41_-_cadasil_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2011-07-13_argu_depistage_neonatal_vf.pdf
HAS/2011-07-13_cadrage_spectro_msms_vf_2009-12-22_14-50-22_231.pdf
HAS/2011-07-13_fs_depistage_neonatal-en-v2.pdf
HAS/2011-07-13_fs_depistage_neonatal-fr-v3.pdf
HAS/2011-07-13_implants_dembolisation_arterielle-28_juin_2011_818_985_avis.pdf
HAS/2011-07-13_synthese_depistage_neonatal_vf.pdf
HAS/2011-07-19_gestodene_ethinylestradiol__arrow_-_ct_-_10306.pdf
HAS/2011-07-19_gestodene_ethinylestradiol_ranbaxy_-_ct-_10763.pdf
HAS/2011-07-19_gestodene_ethinylestradiol_winthrop_-_ct_-9889.pdf
HAS/2011-07-19_hizentra_-_ct10283.pdf
HAS/2011-07-19_previscan_-_ct10884.pdf
HAS/2011-07-19_surmontil_-_ct-10974.pdf
HAS/2011-07-19_tienam_-_ct-_10261.pdf
HAS/2011-07-19_tienam_srh.pdf
HAS/2011-07-19_tobi_-_ct-_8958.pdf
HAS/2011-07-19_tobi_srh.pdf
HAS/2011-07-19_verapamil_mylan_-_ct_10988_2011-08-01_14-38-46_502.pdf
HAS/2011-07-20_actos_-_ct-_10961.pdf
HAS/2011-07-20_actos_20-07-2011_synthese_ct10961.pdf
HAS/2011-07-20_actos_ct_10961.pdf
HAS/2011-07-20_artiss_-_ct-9244.pdf
HAS/2011-07-20_artiss_20-07-2011_synthese_ct-9244.pdf
HAS/2011-07-20_artiss_ct_9244.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_-_document_davis.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_-_texte_court_2011-08-10_14-55-5_339.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t1_temps_de_saignement_-_rapport_devaluation_2011-08-10_14-55-5_340.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t2_thrombine_-_rapport_devaluation_2011-08-10_14-55-5_342.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t3_tap_-_rapport_devaluation_2011-08-10_14-55-5_343.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t4_ac_anti-f4p_-_rapport_devaluation_2011-08-10_14-55-5_344.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t5_inhibiteurs_fah_-_rapport_devaluation_2011-08-10_14-55-5_345.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t6_al_-_rapport_devaluation_2011-08-10_14-55-5_347.pdf
HAS/2011-07-20_biologie_anomalie_hemostase_t7_mutations_fii_et_fv_-_rapport_devaluation_2011-08-10_14-55-5_348.pdf
HAS/2011-07-20_biologie_des_anomalies_de_lhemostase_-_note_de_cadrage_2011-09-02_14-44-6_306.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_methodology.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_1_2013-07-15_15-28-55_228.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_2_2013-07-15_15-29-55_431.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_3_2013-07-15_15-30-47_113.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_4_2013-07-15_15-33-54_243.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_5_2013-07-15_15-35-22_668.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_6_2013-07-15_15-36-52_803.pdf
HAS/2011-07-20_brief_inahta_-_biology_of_haemostasis_disorders_-_volume_7_2013-07-15_15-46-53_806.pdf
HAS/2011-07-20_chlorure_de_methylthioninium_proveblue_-_ct-_10943.pdf
HAS/2011-07-20_chlorure_de_methylthioninium_proveblue_ct_10943.pdf
HAS/2011-07-20_gilenya_-_ct-10252.pdf
HAS/2011-07-20_gilenya_20-07-2011_synthese_ct-10252.pdf
HAS/2011-07-20_gilenya_ct_10252.pdf
HAS/2011-07-20_halaven_-_ct10752.pdf
HAS/2011-07-20_halaven_20072011synthese_ct10752.pdf
HAS/2011-07-20_halaven_ct_10752.pdf
HAS/2011-07-20_summary_-_biology_of_haemostasis_disorders_2013-07-22_13-57-53_909.pdf
HAS/2011-07-25_fiche_buts_hemostatiques-v4.pdf
HAS/2011-07-25_good_practice_surgical_haemostatic_agents.pdf
HAS/2011-08-04_avis_reconstruction_du_sein_technique_diep_2011-08-02_16-31-44_124.pdf
HAS/2011-08-04_has_cadrage_diep.pdf
HAS/2011-08-04_highlander-12_juillet_2011_3708_avis.pdf
HAS/2011-08-04_libra-28_juin_2011_3726_avis.pdf
HAS/2011-08-04_libra-28_juin_2011_3726_synthese_davis.pdf
HAS/2011-08-04_pacifica_lp-12_juillet_2011_3705_avis.pdf
HAS/2011-08-04_rapport_reconstruction_du_sein_technique_diep_2011-08-02_16-19-12_793.pdf
HAS/2011-08-04_sierra-12_juillet_2011_3707_avis.pdf
HAS/2011-08-04_silhouette-12_juillet_2011_3706_avis.pdf
HAS/2011-08-04_texte_court_reconstruction_du_sein_technique_diep_2011-08-02_16-18-38_718.pdf
HAS/2011-08-08_fiche_buts_hemostatiques-v4.pdf
HAS/2011-08-08_rapport_hemostatiques_27052011_vd.pdf
HAS/2011-08-08_synthese_rapport_hemostatiques_vd.pdf
HAS/2011-08-09_diagnostic_biologique_de_la_leptospirose_-_document_davis_2011-08-05_12-37-23_101.pdf
HAS/2011-08-09_diagnostic_biologique_de_la_leptospirose_-_note_de_cadrage.pdf
HAS/2011-08-09_diagnostic_biologique_de_la_leptospirose_-_rapport_devaluation_2011-08-05_12-35-31_268.pdf
HAS/2011-08-09_diagnostic_biologique_de_la_leptospirose_-_texte_court_2011-08-05_12-35-31_267.pdf
HAS/2011-08-11_composition_du_gt.pdf
HAS/2011-08-11_implants_articulaires_de_coude_note_de_cadrage_pdf.pdf
HAS/2011-08-24_endeavor__resolute_3834__resolute_integrity_3835-12_juillet_2011_synthese_davis_2012-02-15_14-18-26_576.pdf
HAS/2011-08-24_endeavor_resolute-12_juillet_2011_3834_avis.pdf
HAS/2011-08-24_resolute_integrity-12_juillet_2011_3835_avis.pdf
HAS/2011-09-06_almide_-_ct10994.pdf
HAS/2011-09-06_boostrixtetra_-_ct7640.pdf
HAS/2011-09-06_carbidopa_levodopa_teva_-_ct10935.pdf
HAS/2011-09-06_celestene_diprostene_diprolene_diprosone_-_ct7408.pdf
HAS/2011-09-06_cepp_-_auto_saisine_de_reevaluation.7.02.07.pdf
HAS/2011-09-06_citrate_de_cafeine_-_ct-10135.pdf
HAS/2011-09-06_floxyfral_-_ct10944.pdf
HAS/2011-09-06_glucantime_-_ct10950.pdf
HAS/2011-09-06_icandra_-_ct9790.pdf
HAS/2011-09-06_infanrixquinta_-_ct8896.pdf
HAS/2011-09-06_jalra_-_ct9789.pdf
HAS/2011-09-06_lexomil_-_ct10613.pdf
HAS/2011-09-06_lioresal_-_ct8581.pdf
HAS/2011-09-06_lomusol_-_ct11198.pdf
HAS/2011-09-06_mesocaine_-_ct11040.pdf
HAS/2011-09-06_mestinon_-_ct-_11107.pdf
HAS/2011-09-06_mytelase_-_ct10976.pdf
HAS/2011-09-06_noctamide_-_ct9886.pdf
HAS/2011-09-06_nolvadex_-_ct8528.pdf
HAS/2011-09-06_nyogel_-_ct10970.pdf
HAS/2011-09-06_prostigmine_-_ct-11114.pdf
HAS/2011-09-06_pulmodexane_-_ct10591.pdf
HAS/2011-09-06_repevax_-_ct-6988.pdf
HAS/2011-09-06_rosiced_-_ct10969.pdf
HAS/2011-09-06_trileptal_-_ct9052.pdf
HAS/2011-09-06_valium_-_ct10612.pdf
HAS/2011-09-06_vectarion_-_ct11279.pdf
HAS/2011-09-06_virlix_-_ct-10304.pdf
HAS/2011-09-06_xeloda_-_ct7916.pdf
HAS/2011-09-06_zomig_zomigoro_-_ct9711.pdf
HAS/2011-09-07_zamudol_-_ct-10705.pdf
HAS/2011-09-08_auto_saisine_cepp_2007.pdf
HAS/2011-09-08_auto_saisine_cnedimts_2009.pdf
HAS/2011-09-08_auto_saisine_cnedimts_2010.pdf
HAS/2011-09-13_2ebat_fiche_succicaptal.pdf
HAS/2011-09-13_atacand_14-09-2011_avis_ct-10228.pdf
HAS/2011-09-13_importal_-_ct-10817.pdf
HAS/2011-09-13_kenzen_14-09-2011_avis_ct-10229.pdf
HAS/2011-09-13_neupogen_-_ct_9761.pdf
HAS/2011-09-13_neupogen_srh.pdf
HAS/2011-09-13_revaxis_-_ct_-_9853.pdf
HAS/2011-09-13_succicaptal_-_ct-_10238.pdf
HAS/2011-09-13_teralithe_-_ct8470.pdf
HAS/2011-09-13_zilver-09_novembre_2010_2807_avis.pdf
HAS/2011-09-14_gaviscon_-_ct-_10764.pdf
HAS/2011-09-14_gaviscon_ct_10764.pdf
HAS/2011-09-14_saflutan_-_ct-10571.pdf
HAS/2011-09-14_saflutan_06-07-2011_synthese_ct-10571.pdf
HAS/2011-09-14_saflutan_ct_10571.pdf
HAS/2011-09-16_actisorb_ag-13_septembre_2011_3904_synthese_davis_.doc.pdf
HAS/2011-09-16_actisorb_ag_13_septembre_2011_3904_avis.pdf
HAS/2011-09-16_butazolidine_-_ct-9053.pdf
HAS/2011-09-16_c-leg_compact-13_septembre_2011_3901_synthese_davis.pdf
HAS/2011-09-16_c-leg_compact_13_septembre_2011_3901_avis.pdf
HAS/2011-09-16_forfaits_relatifs_a_loxygenotherapie__a_long_terme-13_septembre_2011_3702_avis.pdf
HAS/2011-09-16_moviprep_-_ct-6888.pdf
HAS/2011-09-16_moviprep_ct_6888.pdf
HAS/2011-09-16_okimus_-_ct-10240.pdf
HAS/2011-09-16_okimus_ct_10240_2012-08-29_15-28-16_827.pdf
HAS/2011-09-16_siklos_-_ct-10560.pdf
HAS/2011-09-16_structum_-_ct-10059.pdf
HAS/2011-09-16_synthese_davis_butazolidine_-_ct-9053.pdf
HAS/2011-09-16_synthese_davis_moviprep_-_ct-6888.pdf
HAS/2011-09-16_synthese_davis_quinine_-_ct-8635-10240-9701.pdf
HAS/2011-09-16_synthese_davis_siklos_-_ct-10560.pdf
HAS/2011-09-16_synthese_davis_structum_-_ct-10059.pdf
HAS/2011-09-20_alkeran_-_ct-8907.pdf
HAS/2011-09-20_art_50__21-09-2011_avis_11088.pdf
HAS/2011-09-20_chondrosulf_21-09-2011_avis_11128.pdf
HAS/2011-09-20_depakote__21-09-2011_avis_9848.pdf
HAS/2011-09-20_deprenyl_-_ct-10335.pdf
HAS/2011-09-20_diacerine_actavis_21-09-2011_avis_11143.pdf
HAS/2011-09-20_diacerine_arrow_21-09-2011_avis_11144.pdf
HAS/2011-09-20_diacerine_biogaran_21-09-2011_avis_11145.pdf
HAS/2011-09-20_diacerine_cristers_21-09-2011_avis_11146.pdf
HAS/2011-09-20_diacerine_eg_21-09-2011_avis_11147.pdf
HAS/2011-09-20_diacerine_evolugen_21-09-2011_avis_11148.pdf
HAS/2011-09-20_diacerine_mylan_21-09-2011_avis_11149.pdf
HAS/2011-09-20_diacerine_negma_21-09-2011_avis_11151.pdf
HAS/2011-09-20_diacerine_pharma2000_21-09-2011_avis_11152.pdf
HAS/2011-09-20_diacerine_qualimed_21-09-2011_avis_11153.pdf
HAS/2011-09-20_diacerine_rambaxy_21-09-2011_avis_11154.pdf
HAS/2011-09-20_diacerine_ratiopharm_21-09-2011_avis_11155.pdf
HAS/2011-09-20_diacerine_sandoz_21-09-2011_avis_11156.pdf
HAS/2011-09-20_diacerine_teva_21-09-2011_avis_11157.pdf
HAS/2011-09-20_diacerine_winthrop_21-09-2011_avis_11158.pdf
HAS/2011-09-20_dipentum_-_ct-_11453.pdf
HAS/2011-09-20_distilbene_-_ct-_8823.pdf
HAS/2011-09-20_flexea_21-09-2011_avis_11170.pdf
HAS/2011-09-20_kardegic_-_ct-11417.pdf
HAS/2011-09-20_kayexalate_-_ct-_11268.pdf
HAS/2011-09-20_maxidrol_-_ct-11119.pdf
HAS/2011-09-20_mitosyl_irritations_-_ct-10888.pdf
HAS/2011-09-20_piascledine_21-09-2011_avis_11258.pdf
HAS/2011-09-20_sabril_21-09-2011_avis_10035.pdf
HAS/2011-09-20_yellox_-_ct-11382.pdf
HAS/2011-09-20_zondar_21-09-2011_avis_11259.pdf
HAS/2011-09-21_humira_21-09-2011_synthese_ct10820.pdf
HAS/2011-09-21_humira_crohn__pediatrique_-_ct10820.pdf
HAS/2011-09-21_humira_fit_14122012.pdf
HAS/2011-09-21_intanza_21-09-2011_avis_8577.pdf
HAS/2011-09-21_intanza_21092011synthese_ct8577.pdf
HAS/2011-09-21_intanza_ct_8577.pdf
HAS/2011-09-21_protelos_-_ct-8814.pdf
HAS/2011-09-21_protelos_ct_8814.pdf
HAS/2011-09-21_sutent_-_ct-10136.pdf
HAS/2011-09-21_sutent_21092011_synthese_ct10136.pdf
HAS/2011-09-21_sutent_ct_10136.pdf
HAS/2011-09-21_synthese_davis_protelos-_ct-8814.pdf
HAS/2011-09-22_etude_implantation_utilisation_cl_endoscopie_digestive.pdf
HAS/2011-09-23_invacare_venture_homefill_ii-13_septembre_2011_3934_avis.pdf
HAS/2011-09-23_promus_element_plus-13_septembre_2011_3932_avis.pdf
HAS/2011-09-23_synocrom_13_septembre_2011_3991_avis.pdf
HAS/2011-09-27_nucleus_abi541-13_septembre_2011_3979_avis.pdf
HAS/2011-09-27_promenade-13_septembre_2011_3987_avis.pdf
HAS/2011-09-27_senator-13_septembre_2011_3988_avis.pdf
HAS/2011-09-28_stratair-12_juillet_2011_2686_avis.pdf
HAS/2011-09-28_stratair-12_juillet_2011_2686_synthese_davis.pdf
HAS/2011-09-28_ultrafill-13_septembre_2011_3935_avis.pdf
HAS/2011-09-28_ultrafill-13_septembre_2011_3935_synthese_davis_2012-02-07_16-19-50_231.pdf
HAS/2011-09-29_bhr-27_septembre_2011_3267_avis.pdf
HAS/2011-09-29_re-flex-13_septembre_2011_3860_avis.pdf
HAS/2011-09-29_set_d_appareillage_incontinence_urinaire_masculine_avec_poche_de_jambe-27_septembre_2011_3861_avis.pdf
HAS/2011-09-29_set_d_appareillage_incontinence_urinaire_masculine_avec_poche_de_nuit_rns-27_septembre_2011_3862_avis.pdf
HAS/2011-09-29_set_d_appareillage_incontinence_urinaire_masculine_avec_poche_de_nuit_rs-27_septembre_2011_3863_avis.pdf
HAS/2011-09-29_set_de_poches_a_urine_de_jambe_avec_systeme_de_fixation_incontinence_urinaire_masculine-27_septembre_2011_3864_avis.pdf
HAS/2011-09-29_xience_prime-27-septembre_2011_3859_avis.pdf
HAS/2011-09-29_xience_v-27_septembre_2011_3857_avis.pdf
HAS/2011-09-29_xience_v_3857__xience_prime_3859-27_septembre-2011_synthese_davis.pdf
HAS/2011-10-03_bientraitance00-2._vdefpdf.pdf
HAS/2011-10-03_questionnaire_bientraitance_anesm_2010.pdf
HAS/2011-10-04_agyrax_5-10-2011_avis_11455.pdf
HAS/2011-10-04_antibio_synalar_-_ct-11342.pdf
HAS/2011-10-04_betaserc-serc_05_10_2011_avis_10375.pdf
HAS/2011-10-04_castor_equi_05-10-2011_avis_10859.pdf
HAS/2011-10-04_engerix_b_05-10-2011_avis_8752.pdf
HAS/2011-10-04_flucon_05-10-2011_avis_11125.pdf
HAS/2011-10-04_framyxone_-_ct-11338.pdf
HAS/2011-10-04_gaviscon__05-10-2011_avis_11173.pdf
HAS/2011-10-04_genac_-_ct-11175.pdf
HAS/2011-10-04_gestodene_ethinylestradiol_sandoz__05-10-2011_avis_11425.pdf
HAS/2011-10-04_helikit_-_ct-11446.pdf
HAS/2011-10-04_ipaqss_rapport-cdei_2010.pdf
HAS/2011-10-04_ipaqss_rapport-resultats-rcp_2010.pdf
HAS/2011-10-04_korec__05-10-2011_avis_11518.pdf
HAS/2011-10-04_laroxyl_-_ct-10985.pdf
HAS/2011-10-04_maxidex_05-10-2011_avis_11118.pdf
HAS/2011-10-04_oracilline_05-10-2011_avis_5709.pdf
HAS/2011-10-04_otofa_05-10-2011_avis_11036.pdf
HAS/2011-10-04_passiflora__05-10-2011_avis_10860_2011-10-28_12-03-38_286.pdf
HAS/2011-10-04_pentacarinat_05-10-2011_avis_10979.pdf
HAS/2011-10-04_sterdex_-_ct-11445.pdf
HAS/2011-10-04_tobrex_05-10-2011_avis_11124.pdf
HAS/2011-10-04_tofranil_05-10-2011_avis_11384.pdf
HAS/2011-10-04_tredemine_05-10-2011_avis_10973.pdf
HAS/2011-10-04_vaccin_bcg_05-10-2011_avis_7117.pdf
HAS/2011-10-04_vogalene05-10-2011_avis_ct-11494.pdf
HAS/2011-10-05_baraclude_05-10-2011_avis__10939.pdf
HAS/2011-10-05_baraclude_05-10-2011_synthese_ct10939.pdf
HAS/2011-10-05_baraclude_ct_10939.pdf
HAS/2011-10-05_protopic_05-10-2011_avis_8149.pdf
HAS/2011-10-05_protopic_ct_8149.pdf
HAS/2011-10-05_protopic_synthese_ct8149.pdf
HAS/2011-10-05_vastarel_-_ct-10934.pdf
HAS/2011-10-05_vastarel_05-10-2011_synthese_ct-10934.pdf
HAS/2011-10-05_vastarel_ct_10934.pdf
HAS/2011-10-06_caduet_-_ct-11438.pdf
HAS/2011-10-06_meprobamate_richard_-_ct-11205.pdf
HAS/2011-10-06_paralyoc_-_ct-_11123.pdf
HAS/2011-10-06_teveten_-_ct-11476.pdf
HAS/2011-10-06_transipeg_-_ct10207.pdf
HAS/2011-10-07_annexe_1_-_outils_daide_au_diagnostic_de_la_triade_autistique_chez_ladulte.pdf
HAS/2011-10-07_annexe_2_-_tests_classiques_pour_levaluation_du_niveau_intellectuel_et_de_ladaptation_sociale.pdf
HAS/2011-10-07_annexe_3_-_tests_elabores_pour_levaluation_du_fonctionnement_cognitif_et_socio-adaptatif.pdf
HAS/2011-10-07_annexe_4_-_echelles_specifiques_pour_levaluation_et_lobservation_des_comportements_dadultes_avec_autisme.pdf
HAS/2011-10-07_autism_and_other_pervasive_developmental_disorders_-_quick_reference_guide.pdf
HAS/2011-10-07_autisme_et_autres_ted_diagnostic_et_evaluation_chez_ladulte_-_argumentaire.pdf
HAS/2011-10-07_autisme_et_autres_ted_diagnostic_et_evaluation_chez_ladulte_-_recommandations.pdf
HAS/2011-10-07_autisme_et_autres_ted_diagnostic_et_evaluation_chez_ladulte_-_synthese.pdf
HAS/2011-10-07_note_de_cadrage_-_autisme_et_autres_troubles_envahissants_du_developpement_-_diagnostic_et_evaluation_chez_ladulte.pdf
HAS/2011-10-07_reco2clics_-_autisme_et_autre_ted_diagnostic_et_evaluation_chez_ladulte.pdf
HAS/2011-10-10_triton-27_septembre_2011_3993_avis.pdf
HAS/2011-10-12_anaconda-27_septembre-2011-3812_avis.pdf
HAS/2011-10-12_eurobone_2_sdt-11_octobre_2011_3902_synthese_davis.pdf
HAS/2011-10-12_eurobone_2_std-11_octobre_2011_3902_avis.pdf
HAS/2011-10-12_eurobone_2_sw-11_octobre_2011_3725_avis.pdf
HAS/2011-10-12_eurobone_2_sw-11_octobre_2011_3725_synthese_davis.pdf
HAS/2011-10-13_genou_plie_2.0_mpc-27_septembre_2011_3636_avis.pdf
HAS/2011-10-13_polydexa_-_ct-_11035.pdf
HAS/2011-10-18_alepsal_19-10-2011_avis_10966.pdf
HAS/2011-10-18_aparoxal_19-10-2011_avis_ct-11034.pdf
HAS/2011-10-18_atropine_alcon_19-10-2011_avis_ct-11121.pdf
HAS/2011-10-18_azantac_19-10-2011_avis_ct-11635.pdf
HAS/2011-10-18_celectol_19-10-2011_avis_11655.pdf
HAS/2011-10-18_chlorure_de_sodium_cooper_19-10-2011_avis_ct-11525.pdf
HAS/2011-10-18_cimetidines_generiques_19-10-2011_avis.pdf
HAS/2011-10-18_combantrin_19-10-2011_avis_ct11022.pdf
HAS/2011-10-18_cozaar_19-10-2011_avis_ct-11512.pdf
HAS/2011-10-18_cytotec_19-10-2011_avis_ct-11104_ct-11669.pdf
HAS/2011-10-18_depakine_micropakine_19-10-2011_avis_ct-8576.pdf
HAS/2011-10-18_elvorine_19-10-2011_avis_ct-11397.pdf
HAS/2011-10-18_elvorine_srh.pdf
HAS/2011-10-18_eucalcic_19_10_2011_avis_11601.pdf
HAS/2011-10-18_famotidine_generiques_19-10-2011_avis_ct.pdf
HAS/2011-10-18_fludex_19-10-2011_avis_ct-11661.pdf
HAS/2011-10-18_gardenal_19-10-2011_avis_10954.pdf
HAS/2011-10-18_helmintox_19-10-2011_avis_10996.pdf
HAS/2011-10-18_iomeron_-_ct-9140.pdf
HAS/2011-10-18_kaneuron_19-10-2011_avis_ct-11248.pdf
HAS/2011-10-18_lubentyl_19-10-2011_avis_ct-11199.pdf
HAS/2011-10-18_malocide_19-10-2011_avis_ct-11091.pdf
HAS/2011-10-18_nizaxid_09-10-2011_avis_ct-11219.pdf
HAS/2011-10-18_normacol_19-10-2011_avis_ct-11220.pdf
HAS/2011-10-18_pepdine_19-10-2011_avis_ct-11237_ct-9881.pdf
HAS/2011-10-18_raniplex_09-10-2011_avis_ct-11290.pdf
HAS/2011-10-18_ranitidine_generiques_19-10-2011_avis_ct.pdf
HAS/2011-10-18_rivotril_19-10-2011_avis_ct-11030.pdf
HAS/2011-10-18_tagamet_19-10-2011_avis_ct-11299.pdf
HAS/2011-10-18_virophta_19-10-2011i_avis_11043.pdf
HAS/2011-10-19_jevtana_19-10-2011_avis_ct-10702.pdf
HAS/2011-10-19_jevtana_19102011_synthese_ct_10702.pdf
HAS/2011-10-19_jevtana_ct_10702.pdf
HAS/2011-10-19_numetah_19-10-2011_avis_ct-11412.pdf
HAS/2011-10-19_numetah_19102011_synthese_ct11412.pdf
HAS/2011-10-19_numetah_ct_11412.pdf
HAS/2011-10-19_pediaven_19-10-2011_avis_10821.pdf
HAS/2011-10-19_pediaven_19-10-2011_avis_11420.pdf
HAS/2011-10-19_pediaven_19102011_synthese_ct10821.pdf
HAS/2011-10-19_pediaven_g15_g20_g25_ct_11420.pdf
HAS/2011-10-19_pediaven_nn_ct_10821.pdf
HAS/2011-10-20_synthese_davis__xeroquel_troubles_bipolaire_ct-9399.pdf
HAS/2011-10-20_synthese_davis_xeroquel_-_ct-9399.pdf
HAS/2011-10-20_urgotul_duo-27_septembre_2011_3925_avis.pdf
HAS/2011-10-20_xeroquel_-_ct-9399.pdf
HAS/2011-10-21_ech_heimomed-11_octobre_2011_3933_avis.pdf
HAS/2011-10-21_ech_heimomed-11_octobre_2011_3933_synthese_davis.pdf
HAS/2011-10-24_oha-11_octobre_2011_3749_avis.pdf
HAS/2011-10-26_exogen-25_octobre_2011_3923_syntheses_davis_2012-02-15_17-18-30_442.pdf
HAS/2011-10-26_exogen_4000_-25_octobre_2011_3923_avis.pdf
HAS/2011-10-26_urgotul_duo_fibers-25_octobre_2011_3793_avis.pdf
HAS/2011-10-26_urgotul_trio-25_octobre_2011_3926_avis.pdf
HAS/2011-10-31_respilene_enfant_16-11-2011_avis_ct-11356.pdf
HAS/2011-11-01_capergyl_02-11-2011_avis_ct-11262.pdf
HAS/2011-11-01_carlytene_02-11-2011_avis_ct-11263.pdf
HAS/2011-11-01_cervoxan_02-11-2011_avis_ct-11264.pdf
HAS/2011-11-01_equanil__02112011_avis_ct11729.pdf
HAS/2011-11-01_gabacet_02-11-2011_avis_ct-11265.pdf
HAS/2011-11-01_gestodene_ethinylestradiol_02-11-2011_avis_ct-11686.pdf
HAS/2011-11-01_hydergine_02-11-2011_avis_ct-11270.pdf
HAS/2011-11-01_nootropyl_02-11-2011_avis_ct-11289_11221_11668.pdf
HAS/2011-11-01_olmifon_02-11-2011_avis_ct-11293.pdf
HAS/2011-11-01_pentoflux_02-11-2011_avis_ct11295.pdf
HAS/2011-11-01_pentoxifylline_biogaran_02-11-2011_avis_ct-11298.pdf
HAS/2011-11-01_pentoxifylline_eg_02-11-2011_avis_ct11316.pdf
HAS/2011-11-01_pentoxifylline_mylan_02-11-2011_avis_ct-11319.pdf
HAS/2011-11-01_pentoxifylline_qualimed_02-11-2011_avis_ct-11322.pdf
HAS/2011-11-01_pentoxifylline_ratiopharm_02-11-2011_avis_ct11324.pdf
HAS/2011-11-01_pentoxifylline_rpg_02-11-2011_avis_ct-11325.pdf
HAS/2011-11-01_pentoxifylline_sandoz_02-11-2011_avis_ct11326.pdf
HAS/2011-11-01_pentoxifylline_teva_02-11-2011_avis_ct11327.pdf
HAS/2011-11-01_piracetam_arrow_02-11-2011_avis_ct-11329_11284.pdf
HAS/2011-11-01_piracetam_biogaran_02-11-2011_avis_ct-11330.pdf
HAS/2011-11-01_piracetam_eg_02-11-2011_avis_ct-11331.pdf
HAS/2011-11-01_piracetam_gnr_02-11-2011_avis_ct-11334.pdf
HAS/2011-11-01_piracetam_mylan_02-11-2011_avis_ct11389_11285.pdf
HAS/2011-11-01_piracetam_qualimed_02-11-2011_avis_ct-11335_11286.pdf
HAS/2011-11-01_piracetam_ratiopharm_02-11-2011_avis_ct-11336.pdf
HAS/2011-11-01_piracetam_rpg_02-11-2011_avis_ct-11337.pdf
HAS/2011-11-01_piracetam_sandoz_02-11-2011_avis_ct11287_11339.pdf
HAS/2011-11-01_piracetam_ucb_02-11-2011_avis_ct-11341.pdf
HAS/2011-11-01_piracetam_zydus_02-11-2011_avis_ct-11337.pdf
HAS/2011-11-01_rheobral_02-11-2011_avis_ct-11350.pdf
HAS/2011-11-01_torental_02-11-2011_avis_ct11353.pdf
HAS/2011-11-01_vasobral_02-11-2011_avis_ct-11390.pdf
HAS/2011-11-01_vinca_02-11-2011_avis_ct-11361.pdf
HAS/2011-11-01_vincarutine_02-11-2011_avis_ct-11363.pdf
HAS/2011-11-01_vitalogink_02-11-2011_ct-11366.pdf
HAS/2011-11-02_piracetam_teva_02-11-2011_avis_ct-11340_11288.pdf
HAS/2011-11-02_sycrest_2-11-2011_avis_ct-11050.pdf
HAS/2011-11-02_sycrest_ct_11050.pdf
HAS/2011-11-02_sycrest_synthese_ct11050.pdf
HAS/2011-11-02_tamiflu_02-11-2011_avis_ct-9677.pdf
HAS/2011-11-02_tamiflu_02112011_synthese_ct9677.pdf
HAS/2011-11-02_tamiflu_ct_9677.pdf
HAS/2011-11-07_odra-25_octobre_2011_3986_avis.pdf
HAS/2011-11-07_odra-25_octobre_2011_3986_synthese_davis.pdf
HAS/2011-11-15_aldactone_16-11-2011_avis_ct-10924.pdf
HAS/2011-11-15_alginates_de_sodium_bicarnoate_de_sodium_16-11-2011_avis.pdf
HAS/2011-11-15_clarityne_16-11-2011_avis_ct-11099.pdf
HAS/2011-11-15_dilatrane_16-11-2011_avis_ct-11764.pdf
HAS/2011-11-15_eductyl_16-11-2011_avis_ct-11161.pdf
HAS/2011-11-15_euphylline_16-11-2011_avis_ct-11019.pdf
HAS/2011-11-15_lodales_16-11-2011_avis_ct-11707.pdf
HAS/2011-11-15_mizollen_16-11-2011_avis_ct11093.pdf
HAS/2011-11-15_nasacort_16-11-2011_avis_ct-11456.pdf
HAS/2011-11-15_nasalide_16-11-2011_avis_ct-11501.pdf
HAS/2011-11-15_neo-codion_16-11-2011_avis_ct-11037.pdf
HAS/2011-11-15_paracetamol_grunenthal_16-11-2011_avis_ct-11457.pdf
HAS/2011-11-15_rafton_16-11-2011_avis_ct-11665.pdf
HAS/2011-11-15_subutex_16_11_2011_avis_ct11414.pdf
HAS/2011-11-15_tedralan_16-11-2011_avis_ct-11765.pdf
HAS/2011-11-15_theostat_16-11-2011_avis_ct-11039.pdf
HAS/2011-11-15_trentadil_16-11-2011_avis_ct-11058.pdf
HAS/2011-11-16_activa_non_rechargeable-15_novembre_2011_4065_avis.pdf
HAS/2011-11-16_arganova_16-11-2011_avis_ct-112225.pdf
HAS/2011-11-16_arganova_16112011_synthese_ct11225.pdf
HAS/2011-11-16_arganova_ct_11225.pdf
HAS/2011-11-16_pipeline-15_novembre_2011_3927_avis.pdf
HAS/2011-11-16_pipeline_15_novembre_2011_3927_synthese_davis.pdf
HAS/2011-11-16_revatio_16112011_avis_ct11475.pdf
HAS/2011-11-16_revatio_ct_11475.pdf
HAS/2011-11-16_revation_injectable_synthese_16112011.pdf
HAS/2011-11-16_zutectra_16-11-2011_avis_ct-10880.pdf
HAS/2011-11-16_zutectra_ct_10880.pdf
HAS/2011-11-16_zutectra_synthese_ct10880.pdf
HAS/2011-11-18_vph-13_septembre_2011_3242_avis.pdf
HAS/2011-11-22_activa_rc-15_novembre_2011_3978_synthese_davis.pdf
HAS/2011-11-22_activa_rc_15_novembre_2011_3978_avis.pdf
HAS/2011-11-22_pompes__insuline_25_octobre_2011_4050_avis.pdf
HAS/2011-11-24_invive_crt-p_w172-15_novembre_2011_4104_avis.pdf
HAS/2011-11-24_invive_crt-p_w173-15_novembre_2011_4048_avis.pdf
HAS/2011-11-24_produits_assistance_a_la_posture-15_novembre_2011_4026_avis.pdf
HAS/2011-11-24_xpert_pro-15_novembre_2011_4066_avis.pdf
HAS/2011-11-24_xpert_pro-15_novembre_2011_4066_synthese_davis.pdf
HAS/2011-11-28_certificat_medical_initial_concernant_une_personne_victime_de_violences_-_argumentaire.pdf
HAS/2011-11-28_certificat_medical_initial_concernant_une_personne_victime_de_violences_-_recommandations.pdf
HAS/2011-11-28_examen_medical_-_fiche_de_synthese.pdf
HAS/2011-11-28_info_patient_certificat_medical_6volets.pdf
HAS/2011-11-28_info_patient_certificat_medical_ecran.pdf
HAS/2011-11-28_modalites_de_saisine_du_medecin_signalement_contenu_et_remise_du_certificat_medical_initial_-_fiche_de_synthese.pdf
HAS/2011-11-28_reco2clics_certificat_medical_initial_personne_victime_violences.pdf
HAS/2011-11-29_aspegic_30-11-2011_avis_ct-11080.pdf
HAS/2011-11-29_caditar_30-11-2011_avis_ct-11109.pdf
HAS/2011-11-29_debridat_30-11-2011_avis_ct-11138.pdf
HAS/2011-11-29_eryfluid_30-11-2011_avis_ct-11162.pdf
HAS/2011-11-29_erythomycinebailleul_erythrogel_30-11-2011_avis_ct-11163.pdf
HAS/2011-11-29_euthyral_30-11-2011_avis_ct11165.pdf
HAS/2011-11-29_fongamil_30-11-2011_avis_ct-11171.pdf
HAS/2011-11-29_glucose_cooper_30-11-2011_avis_ct-11511.pdf
HAS/2011-11-29_indocid_chrono_indocid_30-11-2011_avis_ct-10936_2011-12-20_15-31-2_966.pdf
HAS/2011-11-29_paracetamol_mylan_30-11-2011_avis_ct10964.pdf
HAS/2011-11-29_paracetamol_teva_30-11-2011_avis_ct-11502.pdf
HAS/2011-11-29_polery_16-11-2011_avis_ct-11031.pdf
HAS/2011-11-29_proxalyoc_30-11-2011_avis_ct-10824.pdf
HAS/2011-11-29_stimycine_30-11-2011_avis_ct-11375.pdf
HAS/2011-11-29_trimebutine_generiques_30-11-2011_avis.pdf
HAS/2011-11-29_trimebutine_generiques_30-11-2011_avis_2011-12-20_17-16-14_2.pdf
HAS/2011-11-29_xenazine_30_11_2011_avis_ct9850.pdf
HAS/2011-11-29_zaditen__30-11-2011_avis_ct11280.pdf
HAS/2011-11-30_eon_c-29_novembre_2011_3977_avis.pdf
HAS/2011-11-30_eon_c-29_novembre_2011_3977_synthese_davis.pdf
HAS/2011-11-30_nulojix_30-11-2011_avis_ct11464.pdf
HAS/2011-11-30_nulojix_30112011synthese_ct11464.pdf
HAS/2011-11-30_nulojix_ct_11464.pdf
HAS/2011-11-30_tobi_podhaler_30-11-2011_avis_ct11466.pdf
HAS/2011-11-30_tobi_podhaler_ct_11466.pdf
HAS/2011-11-30_tobipodhaler_30112011_synthese_ct11466.pdf
HAS/2011-11-30_tygacil_30-11-2011_avis__ct_11250.pdf
HAS/2011-11-30_tygacil_ct_11250.pdf
HAS/2011-12-02_advance-29_novembre_2011_3592_avis.pdf
HAS/2011-12-02_advance-29_novembre_2011_3592_synthese_davis_2012-02-07_14-30-53_823.pdf
HAS/2011-12-02_aminotroph-29_novembre_2011_3903_avis.pdf
HAS/2011-12-02_implants_du_rachis-29_novembre_3998_avis.pdf
HAS/2011-12-02_mylife_omnipod-29_novembre_2011_3928_avis.pdf
HAS/2011-12-02_mylife_omnipod-29_novembre_2011_3928_synthese_davis.pdf
HAS/2011-12-02_physio-stim-29_novembre_2011_3976_avis.pdf
HAS/2011-12-02_physiostim-29_novembre_2011_3976_synthese_davis.pdf
HAS/2011-12-06_aloplastine_07-12-2011_avis_ct11086.pdf
HAS/2011-12-06_auxitrans_07-12-2011_avis_ct11103.pdf
HAS/2011-12-06_cadens_07-12-2011_avis_ct-10453_11108.pdf
HAS/2011-12-06_calcitonine_pharmy_ii_07-12-2011_avis_ct11629_11110.pdf
HAS/2011-12-06_calcitonine_sandoz_07-12-2011_avis_ct11111.pdf
HAS/2011-12-06_codoliprane_adulte_enfant_07-12-2011_avis_ct11078.pdf
HAS/2011-12-06_dexeryl_07_12_2011_avis_ct11142.pdf
HAS/2011-12-06_miacalcic_07_12_2011_avis_ct11208.pdf
HAS/2011-12-06_tanakan_tramisal_ginkogink_7_12_2011_avis_ct11267_ct11352_ct11355.pdf
HAS/2011-12-06_virgan_07-12-2011_avis_ct11862.pdf
HAS/2011-12-07_brilique_07-12-2011_avis_ct10968.pdf
HAS/2011-12-07_brilique_07122011_synthese_ct10968.pdf
HAS/2011-12-07_brilique_ct_10968.pdf
HAS/2011-12-07_genotonorm_07122011_avis_ct5437.pdf
HAS/2011-12-07_hormone_de_croissance_vecourt_post_college_vudoc_mise_en_ligne_2012-01-26_10-36-5_997.pdf
HAS/2011-12-07_hormone_de_croissance_velong_valide_college_vudoc_mise_en_ligne.pdf
HAS/2011-12-07_hormones_de_croissance_14122011_synthese_2012-05-25_14-39-0_547.pdf
HAS/2011-12-07_norditropine_07122011_avis_ct5343.pdf
HAS/2011-12-07_nutropinaq__07122011_avis_ct6430.pdf
HAS/2011-12-07_nutropinaq_ct_6430.pdf
HAS/2011-12-07_omnitrope_07122011_avis_ct10063.pdf
HAS/2011-12-07_saizen_07122011_avis__ct5421.pdf
HAS/2011-12-07_targinact_07122011_synthese_ct10871.pdf
HAS/2011-12-07_targinact_07_12_2011_avis_ct10861.pdf
HAS/2011-12-07_targinact_ct_10861.pdf
HAS/2011-12-07_umatrope_07122011_avis_ct6477.pdf
HAS/2011-12-07_zomacton_07122011_avis_ct6570.pdf
HAS/2011-12-09_10irp02_algo_obesite_enfant_adolescent_approches_et_moyens_therapeutiques.pdf
HAS/2011-12-09_10irp02_algo_obesite_enfant_adolescent_depistage_surpoids_et_obesite.pdf
HAS/2011-12-09_10irp02_algo_obesite_enfant_adolescent_niveaux_de_prise_en_charge.pdf
HAS/2011-12-09_10irp02_cons_pra_obesite_enfant_adolescent_accompagnement_dietetique.pdf
HAS/2011-12-09_10irp02_form_obesite_enfant_adolescent_certificat_d_inaptitude_partielle.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_evaluation_de_l_acitivte_physique.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_liste_des_etablissements_ssr.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_liste_reppop.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_modalites_de_prescription_de_l_activite_physique.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_recapitulatif_des_complications_comorbidites_du_surpoids_et_obesite.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_resume_donnees_evaluation_clinique.pdf
HAS/2011-12-09_10irp02_memo_obesite_enfant_adolescent_signes_evocateurs_d_une_obesite_secondaire.pdf
HAS/2011-12-09_obesite_enfant_et_adolescent_-_argumentaire.pdf
HAS/2011-12-09_obesite_enfant_et_adolescent_-_fiche_pratique_daccompagnement_dietetique.pdf
HAS/2011-12-09_obesite_enfant_et_adolescent_-_synthese.pdf
HAS/2011-12-09_overweight_and_obesity_in_children_and_adolescents_-_quick_reference_guide.pdf
HAS/2011-12-09_reco2clics_obesite_enfant_adolescent.pdf
HAS/2011-12-09_recommandation_obesite_enfant_et_adolescent.pdf
HAS/2011-12-12_taxus__element_3996-29_novembre_2011_synthese_davis.pdf
HAS/2011-12-12_taxus_element-29_novembre_2011_3996_avis.pdf
HAS/2011-12-13_algisedal_14-12-2011_avis_ct11101.pdf
HAS/2011-12-13_baseal_14_12_2011_avis_ct_11105.pdf
HAS/2011-12-13_biorgasept_14_12_2011_avis_ct_11106.pdf
HAS/2011-12-13_cibadrex_14-12-2011_avis_ct_11841.pdf
HAS/2011-12-13_contramal_14-12-2011_avis_ct11833.pdf
HAS/2011-12-13_cyteal_14_12_2011_avis_ct_11136.pdf
HAS/2011-12-13_dicodin_14-12-2011_avis_ct11498.pdf
HAS/2011-12-13_dimegan_14_12_2011_avis_ct11159_11016.pdf
HAS/2011-12-13_hexomedine__14_12_2011_avis_ct_11192.pdf
HAS/2011-12-13_hexomedine_generiques__14_12_2011_avis.pdf
HAS/2011-12-13_isimig_14_12_2011_avis_ct11810.pdf
HAS/2011-12-13_lindilane_14-12-2011_avis_ct11332.pdf
HAS/2011-12-13_mebeverine_14_12_2011_avis.pdf
HAS/2011-12-13_modiodal_14_12_2011_avis_ct10896.pdf
HAS/2011-12-13_mycoster__14_12_2011_avis_ct11790.pdf
HAS/2011-12-13_nicergoline_biogaran_14_12_2011_avis_ct11271.pdf
HAS/2011-12-13_nicergoline_eg_14122011_avis_ct11272.pdf
HAS/2011-12-13_nicergoline_mylan_14_12_2011_avis_ct11273.pdf
HAS/2011-12-13_nicergoline_qualimed_14_12_2011_avis_ct11275.pdf
HAS/2011-12-13_nicergoline_ranbaxy_14_12_2011_avis_ct11277.pdf
HAS/2011-12-13_nicergoline_teva_14_12_2011_avis_ct11278.pdf
HAS/2011-12-13_oxomemazine_toplexil_generiques_14_12_2011_avis.pdf
HAS/2011-12-13_phenergan_14_12_2011_avis_ct11603_11240.pdf
HAS/2011-12-13_septeal_14_12_2011_avis_ct_11312.pdf
HAS/2011-12-13_sermion_14-12-2011_avis_ct11854_2012-01-10_11-29-4_611.pdf
HAS/2011-12-13_skelid_14_12_2011_avis_ct11514.pdf
HAS/2011-12-13_stresam_14_12_2011_avis_ct11376_11442.pdf
HAS/2011-12-13_theralene_14_12_2011_avis_ct11321.pdf
HAS/2011-12-13_tigreat_14_12_2011_avis_ct11810.pdf
HAS/2011-12-13_toplexil_14_12_2011_avis_ct11358.pdf
HAS/2011-12-14_adreview_14122011_avis_ct8912.pdf
HAS/2011-12-14_adreview_14122011_synthese_ct8912.pdf
HAS/2011-12-14_adreview_ct_8912.pdf
HAS/2011-12-14_codman_enterprise-29_novembre_2011_4109_avis.pdf
HAS/2011-12-14_incivo_14122011_synthese_ct11500.pdf
HAS/2011-12-14_incivo_14_12_2011_avis_ct11500.pdf
HAS/2011-12-14_incivo_ct_11500.pdf
HAS/2011-12-14_ipaqss_rapport_dan_2011.pdf
HAS/2011-12-14_ipaqss_rapport_mco_2011.pdf
HAS/2011-12-14_ipaqss_rapport_ssr_2011.pdf
HAS/2011-12-14_ipaqss_synthese_rapport_mco_2011.pdf
HAS/2011-12-14_ipaqss_synthese_rapport_ssr_2011.pdf
HAS/2011-12-14_prezista_14-12-2011_avis_ct11428.pdf
HAS/2011-12-14_prezista_ct_11428.pdf
HAS/2011-12-14_prezista_synthese_ct11428.pdf
HAS/2011-12-14_prolia_14122011_avis_ct10890.pdf
HAS/2011-12-14_prolia_14122011_synthese_ct10890.pdf
HAS/2011-12-14_prolia_ct_10890.pdf
HAS/2011-12-14_tepadina_14_12_2011_avis_ct11752.pdf
HAS/2011-12-14_tepadina_ct_11752_2013-01-24_16-18-2_550.pdf
HAS/2011-12-14_victrelis_14122011_synthese_ct11493.pdf
HAS/2011-12-14_victrelis_14_12_2011_avis_ct11493.pdf
HAS/2011-12-14_victrelis_ct_11493.pdf
HAS/2011-12-14_yervoy_14122011_synthese_ct11462.pdf
HAS/2011-12-14_yervoy_14_12_2011_avis_ct_11462.pdf
HAS/2011-12-14_yervoy_ct_11462.pdf
HAS/2011-12-15_humira_crohn_-_ct-10819_9855.pdf
HAS/2011-12-15_humira_ct_10819_9855.pdf
HAS/2011-12-15_humira_fit_14122012.pdf
HAS/2011-12-16_erecaid-13_decembre_2011_3956_synthese_davis.pdf
HAS/2011-12-16_erecaid_esteem-13_decembre_2011_3956_avis.pdf
HAS/2011-12-16_implants_dembolisation_arterielle-28_juin_2011_818_985_avis.pdf
HAS/2011-12-16_prescription_psychotropes_sujet_age_version_courte_2007_11_07__19_34_38_576.pdf
HAS/2011-12-16_rapport_embolisation_hors_indications_craniocephaliques_vd_2012_2012-01-19_11-19-37_67.pdf
HAS/2011-12-16_rapport_psychotropes_version_longue_190208.pdf
HAS/2011-12-16_tableau_hors_indications_craniocephaliques_vd_2012.pdf
HAS/2011-12-16_texte_court_hors_indications_cranioencephaliques_vd_2012.pdf
HAS/2011-12-16_therabite-29_novembre_2011_4060_avis.pdf
HAS/2011-12-19_implants_dembolisation_arterielle-28_juin_2011_818_985_avis.pdf
HAS/2011-12-19_rapport_embolisation_indications_cranioencephalique_vd_2012_2012-01-19_11-16-59_366.pdf
HAS/2011-12-19_tableau_indic_cranioencephalique_vd_2012.pdf
HAS/2011-12-19_texte_court_indications_cranioencephaliques_vd_2012.pdf
HAS/2011-12-20_coaguchek_xs-12_juillet_2011_3528_avis.pdf
HAS/2011-12-20_conformable_tag-12_juillet_2011_3748_avis.pdf
HAS/2011-12-20_minipress_-_ct-9690.pdf
HAS/2011-12-20_paracetamol_biogaran_07-12-2011_avis_ct-11491.pdf
HAS/2011-12-20_tag_3747__conformable_tag_3748-12_juillet_2011_synthese_davis.pdf
HAS/2011-12-21_abstract_mri-guided_vacuum-assisted_breast_biopsy__vabb_.pdf
HAS/2011-12-21_avis_macrobiopsie_mammaire_irm.pdf
HAS/2011-12-21_concerto-concerto_pin-sonata_ti100-pulsar_ci100-29_novembre_2011_3997_avis.pdf
HAS/2011-12-21_concerto__pulsar__sonata_3997__digisonic_sp_3994-29_novembre_2011-nucleus_3980-10__24_janvier_2012_synthese_davis.pdf
HAS/2011-12-21_digisonic_sp-29_novembre_2011_3994_avis.pdf
HAS/2011-12-21_document_methodologique_levaluation_des_aspects_sociaux.pdf
HAS/2011-12-21_hta_summary_report_mri-guided_vacuum-assisted_breast_biopsy__vabb_.pdf
HAS/2011-12-21_jasouple-29_novembre_2011_4052_avis.pdf
HAS/2011-12-21_note_cadrage_macrobiopsie.pdf
HAS/2011-12-21_rapport_macrobiopsie_mammaire_irm.pdf
HAS/2011-12-21_set_disposet_urologie_poche_jambe-12_juillet_2011_3681_avis.pdf
HAS/2011-12-21_set_disposet_urologie_poche_nuit-12_juillet_2011_3682_avis.pdf
HAS/2011-12-21_synthese_levaluation_des_aspects_sociaux.pdf
HAS/2011-12-21_texte_court_macrobiopsie_mammaire_irm.pdf
HAS/2011-12-22_chir_ambu_note_d_orientation_2212_2011.pdf
HAS/2011-12-22_tag-12_juillet_2011_3747_avis.pdf
HAS/2011-12-22_tag_3747__conformable_tag_3748-12_juillet_2011_synthese_davis.pdf
HAS/2011-12-22_viabahn-12_juillet_2011_3677_avis.pdf
HAS/2011-12-22_viabahn-12_juillet_2011_3677_synthese_davis.pdf
HAS/2011-12-23_dangerosite_psychiatrique_-_synthese_bibliographique_-_vmel.pdf
HAS/2011-12-23_dangerosite_psychiatrique_-_textes_des_experts_-_v3mel.pdf
HAS/2011-12-23_declenchement_artificiel_du_travail-_synthese.pdf
HAS/2011-12-23_declenchement_artificiel_du_travail_-_argumentaire.pdf
HAS/2011-12-23_declenchement_artificiel_du_travail_-_diaporama.pdf
HAS/2011-12-23_declenchement_artificiel_du_travail_-_fiche_dinformation.pdf
HAS/2011-12-23_declenchement_artificiel_du_travail_-_phase_dadaptation_2008_06_04__10_08_37_615.pdf
HAS/2011-12-23_declenchement_artificiel_du_travail_-_recommandations.pdf
HAS/2011-12-23_evaluation_de_la_dangerosite_psychiatrique_-_rapport_dorientation.pdf
HAS/2011-12-23_evaluation_de_la_dangerosite_psychiatrique_-_recommandations_2011-07-06_15-48-9_213.pdf
HAS/2011-12-23_methode_audition_publique_10-09-10.pdf
HAS/2011-12-23_quelle_conduite_tenir_face_a_la_violence_emergente.pdf
HAS/2011-12-28_brief_inahta_albuminuria.pdf
HAS/2011-12-28_brief_inahta_creatinine.pdf
HAS/2011-12-28_creatinine_document_de_cadrage_2011-06-23_11-42-53_469.pdf
HAS/2011-12-28_evaluation_du_debit_de_filtration_glomerulaire_et_du_dosage_de_la_creatininemie_dans_le_diagnostic_de_la_maladie_renale_chronique_chez_ladulte_-_fiche_buts.pdf
HAS/2011-12-28_irradiation_intrcranienne_en_conditions_stereotaxiques_dans_le_traitement_des_pathologies_non_cancereuses_-_note_de_cadrage.pdf
HAS/2011-12-28_rapport__albuminurie_creatininurie_2011-12-27_14-57-31_440.pdf
HAS/2011-12-28_rapport__tome_i_radiotherapie_meningiomes.pdf
HAS/2011-12-28_rapport_dfg_creatininemie.pdf
HAS/2011-12-28_rapport_tome_ii__radiotherapie_adenomes_hypophysaires_2011-12-27_17-17-42_893.pdf
HAS/2011-12-28_rapport_tome_iii_radiotherapie_schwannomes_vestibulaires_2011-12-27_17-19-45_540.pdf
HAS/2011-12-28_rapport_tome_iv_radiotherapie_malformations_arterioveineuses_cerebrales_cm.pdf
HAS/2011-12-28_rapport_tome_v_radiotherapie__nevralgie_du_trijumeau.pdf
HAS/2011-12-28_rapport_tome_vi_radiotherapie_evaluation_medico_economique_2011-12-28_10-59-7_444.pdf
HAS/2011-12-28_summary_creatinine.pdf
HAS/2011-12-28_texte_court_dfg_creatininemie.pdf
HAS/2011-12-28_texte_court_tome_i_radiotherapie_meningiomes_2011-12-27_17-26-48_926.pdf
HAS/2011-12-28_texte_court_tome_ii_radiotherapie_adenomes_hypophysaires.pdf
HAS/2011-12-28_texte_court_tome_iii_radiotherapie_schwannomes_vestibulaires.pdf
HAS/2011-12-28_texte_court_tome_iv_radiotherapie_malformations_arterioveineuses_cerebrales.pdf
HAS/2011-12-28_texte_court_tome_v_radiotherapie__nevralgie_du_trijumeau.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_2.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_3.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_4_2011-12-19_17-01-43_457.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_5.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_6.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_7.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_8.pdf
HAS/2011-12-30_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_9.pdf
HAS/2011-12-30_reco2clics_maladie_d_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_2012-01-16_14-17-37_906.pdf
HAS/2011-12-30_recommandation_maladie_d_alzheimer_et_maladies_apparentees_diagnostic_et_prsie_en_charge.pdf
HAS/2011-12-30_s8_dispositif_annonce_du_diagnostic_et_accompagnement_revgg27042012.pdf
HAS/2012-01-03_aciclovir__04012012__avis.pdf
HAS/2012-01-03_alpha-13_decembre_2011_3999_avis.pdf
HAS/2012-01-03_alpha-13_decembre_2011_3999_synthese_davis.pdf
HAS/2012-01-03_ams_700_inhibizone-13_decembre_2011_4110_avis.pdf
HAS/2012-01-03_atrovent_nasal_04012012_avis_ct11089.pdf
HAS/2012-01-03_becotide_04012012_avis_ct11863.pdf
HAS/2012-01-03_dafalgan_codeine_04012012i_avis_ct11116.pdf
HAS/2012-01-03_diltiazem_biogaran_04012012_avis__ct11769.pdf
HAS/2012-01-03_firazyr__04012012_avis_ct11761.pdf
HAS/2012-01-03_flex_foot-29_novembre_2011_4057_avis.pdf
HAS/2012-01-03_longevity-13_decembre_2011_4058_avis.pdf
HAS/2012-01-03_meteoxane_04012012_avis_ct11206.pdf
HAS/2012-01-03_movicol__04012011_avis_ct_11888.pdf
HAS/2012-01-03_pentavac_04012012_avis_ct11392_2012-01-25_17-08-26_195.pdf
HAS/2012-01-03_zovirax_04012012__avis_ct11261.pdf
HAS/2012-01-03_zovirax_04012012_avis_ct11649.pdf
HAS/2012-01-04_2.analyse_documentaire_qdevie_ehpad_accueil_et_pp_version_site-2.pdf
HAS/2012-01-04_addendum_qdv_ehpad_volet_1_01_04_15.pdf
HAS/2012-01-04_analyse_documentaire_qdv2.pdf
HAS/2012-01-04_anesm_04_qdv2_ea.pdf
HAS/2012-01-04_anesm_06_qdv3_ea.pdf
HAS/2012-01-04_anesm_qdv4_ea.pdf
HAS/2012-01-04_anesm_qualite-de-vie_web_ea.pdf
HAS/2012-01-04_biblio_qualite_de_vie_ehpad_v1_anesm-3.pdf
HAS/2012-01-04_bibliographie_qdv4.pdf
HAS/2012-01-04_bibliographie_qualite_de_vie_en_ehpad__volet_3.pdf
HAS/2012-01-04_elements_de_cadrage_qdv-ehpad_03.10.pdf
HAS/2012-01-04_elements_de_contexte_9_nov_def_mis_en_page.pdf
HAS/2012-01-04_elements_de_contexte___qdv4.pdf
HAS/2012-01-04_lomudal_04012012_avis_ct10825.pdf
HAS/2012-01-04_lomudal_ct_10825.pdf
HAS/2012-01-04_qv1_ehpad_de_laccueil_de_la_personne_a_son_accompagnement_recommandations.pdf
HAS/2012-01-04_qv2_ehpad_organisation_du_cadre_de_vie_et_vie_quotidienne_recommandations.pdf
HAS/2012-01-04_qv3_ehpad_vie_sociale_des_residents_en_ehpad_recommandations.pdf
HAS/2012-01-04_qv4_ehpad_accompagnement_personnalise_de_la_sante_du_resident_recommandations.pdf
HAS/2012-01-04_rhinofluimucil_04012012_avis__ct8711.pdf
HAS/2012-01-04_rhinofluimucil_ct_8711.pdf
HAS/2012-01-04_site_addendum_qdv_ehpad_volet_2_01_04_15.pdf
HAS/2012-01-04_site_d2015-08_-_decision_portant_adoption_de_la_rbpp_qualite_de_vie_-_volet_n2_-_organisation_du_cadre_de_vie_et_de_la_cie_q.pdf
HAS/2012-01-04_site_decision_n_2015-07_-_decision_portant_adoption_de_la_rbpp_qualite_de_vie_-_volet_n1_-_de_l_accueil_de_la_personne_a_son.pdf
HAS/2012-01-04_site_decision_n_2015-09_-_decision_portant_adoption_de_la_rbpp_qualite_de_vie_-_volet_n3_-_la_vie_sociale_des_residents.pdf
HAS/2012-01-04_synthese_qualite_de_vie_2_v210911-2_2018-03-16_12-32-35_301.pdf
HAS/2012-01-04_synthese_qualite_de_vie_3-2_2018-03-16_12-32-35_305.pdf
HAS/2012-01-04_synthese_qualite_de_vie_4_novembre2012-2_2018-03-16_12-32-35_310.pdf
HAS/2012-01-04_synthese_reco_qualite_de_vie_ehpad_anesm-2_2018-03-16_12-32-35_297.pdf
HAS/2012-01-04_vasoconstricteurs_associes_synthese_05102011.pdf
HAS/2012-01-04_votubia_04012012_ct11628.pdf
HAS/2012-01-04_votubia_04012012_synthese__ct11628.pdf
HAS/2012-01-04_votubia_ct_11628.pdf
HAS/2012-01-05_assessment_of_tavi_-_summary_vdef.pdf
HAS/2012-01-05_avis_de_la_has_du_7_juin_2012.pdf
HAS/2012-01-05_avis_has_projet_arrete_21_12_2011_valves_2011_2012-01-04_15-50-49_591.pdf
HAS/2012-01-05_avis_has_sur_les_centres_2009.pdf
HAS/2012-01-05_avis_has_valves_aortiques_transcutanees_2011.pdf
HAS/2012-01-05_composition_gt_valves_aortiques_transcutanees.pdf
HAS/2012-01-05_rapport_has_valves_aortiques_transcutanees_2011_h2com.pdf
HAS/2012-01-05_texte_court_valves_aortiques_transcutanees_2011_h2com.pdf
HAS/2012-01-13_concerto__pulsar__sonata_3997__digisonic_sp_3994-29_novembre_2011-nucleus_3980-10__24_janvier_2012_synthese_davis.pdf
HAS/2012-01-13_nucleus-10_janvier_2012_3980_avis.pdf
HAS/2012-01-16_note_de_cadrage_-_algorithmes_de_depistage_des_hepatites_b_et_c.pdf
HAS/2012-01-16_strategies_de_depistage_biologique_des_hepatites_virales_b_et_c_-_argumentaire.pdf
HAS/2012-01-16_strategies_de_depistage_biologique_des_hepatites_virales_b_et_c_-_synthese.pdf
HAS/2012-01-17_beclojet_belcospray_18012012_avis_ct11328.pdf
HAS/2012-01-17_fostimon_18012012_avis_ct11682.pdf
HAS/2012-01-17_naftilux_18012012_avis_ct11217_ct11634.pdf
HAS/2012-01-17_retrovir_18012012_avis_ct8336.pdf
HAS/2012-01-17_telzir_18012012_avis_ct6892.pdf
HAS/2012-01-17_visceralgine_18012012_avis_ct11281.pdf
HAS/2012-01-18_arcoxia_18012012_avis_ct10706.pdf
HAS/2012-01-18_arcoxia_ct_10706.pdf
HAS/2012-01-18_celebrex_18012012_ct10645.pdf
HAS/2012-01-18_celebrex_ct_10645.pdf
HAS/2012-01-18_corevalve-10_janvier_2012_4087_avis.pdf
HAS/2012-01-18_corevalve-10_janvier_2012_4087_synthese_davis.pdf
HAS/2012-01-18_edwards_sapien_xt_mod_9300-10_janvier_2012_4088_avis.pdf
HAS/2012-01-18_edwards_sapien_xt_mod_9300-10_janvier_2012_4106_avis.pdf
HAS/2012-01-18_edwards_sapien_xt_mod_9300_-10_janvier_2012_4105_avis.pdf
HAS/2012-01-18_eliquis_18012012_avis_ct11097.pdf
HAS/2012-01-18_eliquis_18012012_synthese_ct11097.pdf
HAS/2012-01-18_eliquis_ct_11097.pdf
HAS/2012-01-18_heartmate_ii-10_janvier_2012_4001__4002_avis.pdf
HAS/2012-01-18_sapien_xt_ascendra_4106__ascendra_2_4105-10_janvier_2012_sytnhese_davis.pdf
HAS/2012-01-18_sapien_xt_novaflex-10_janvier_2012_4088_synthese_davis.pdf
HAS/2012-01-18_sequent-10_janvier_2012_4059_avis.pdf
HAS/2012-01-18_thoratec_pvad-10_janvier_2012_4047_avis.pdf
HAS/2012-01-20_medi_panthera_cf1-10_janvier_2012_4181_avis.pdf
HAS/2012-01-20_primeadvanced-10_janvier_2012_4186_avis.pdf
HAS/2012-01-20_restoreadvanced-10_janvier_2012_4189_avis.pdf
HAS/2012-01-20_restoresensor-10_janvier_2012_4188_avis.pdf
HAS/2012-01-25_somnodent-10_janvier_2012_4049_avis.pdf
HAS/2012-01-27_ponto-24_janvier_2012_4063_avis.pdf
HAS/2012-01-30_hormone_de_croissance_vecourt_post_college_vudoc_mise_en_ligne_2012-01-26_10-36-5_997.pdf
HAS/2012-01-30_hormone_de_croissance_velong_valide_college_vudoc_mise_en_ligne.pdf
HAS/2012-01-31_concerto__pulsar__sonata_3997__digisonic_sp_3994-29_novembre_2011-nucleus_3980-10__24_janvier_2012_synthese_davis.pdf
HAS/2012-01-31_flair_active_xtra-24_janvier_2012_3985_avis.pdf
HAS/2012-01-31_nucleus_ci24re-24_janvier_2012_4219_avis.pdf
HAS/2012-01-31_zomajet_vision_x__zomajet_2_vision-10_janvier_2012_4157_avis.pdf
HAS/2012-02-01_cervarix_01022012_avis_ct6893.pdf
HAS/2012-02-01_cervarix_ct_6893.pdf
HAS/2012-02-01_gardasil_01022012_avis_ct10759.pdf
HAS/2012-02-01_gardasil_cervarix_synthse.pdf
HAS/2012-02-01_gardasil_ct_10759.pdf
HAS/2012-02-01_xeplion_01022012_avis_ct11046.pdf
HAS/2012-02-01_xeplion_01022012_synthese_ct11046.pdf
HAS/2012-02-01_xeplion_ct_11046.pdf
HAS/2012-02-02_3c100_c-leg-24_janvier_2012_4212_avis.pdf
HAS/2012-02-02_accu-chek_mobile_kit_4004__cassette-24_janvier_2012_4005_avis.pdf
HAS/2012-02-02_accu-chek_mobile_kit_4004__cassette_4005-24_janvier_2012_synthese_davis.pdf
HAS/2012-02-02_perfusion__nutrition_parenterale_a_domicile_10_janvier_2012_3588_avis.pdf
HAS/2012-02-02_precision-24_janvier_2012_4215_avis.pdf
HAS/2012-02-02_proact-10_janvier_2012_4061_avis.pdf
HAS/2012-02-02_solo2-24_janvier_2012_3992_avis.pdf
HAS/2012-02-02_solo2-24_janvier_2012_3992_synthese_davis.pdf
HAS/2012-02-02_statine_-_fiche_bum.pdf
HAS/2012-02-02_xpo2-24_janvier_2012_4103_avis.pdf
HAS/2012-02-02_xpo2-24_janvier_2012_4103_synthese_davis.pdf
HAS/2012-02-03_argumentaire_-_participation_depistage_cancer_du_sein_2012-02-02_15-27-14_245.pdf
HAS/2012-02-03_fiche_de_synthese_-_4_pages_-_participation_depistage_cancer_du_sein_2012-02-03_09-41-16_837.pdf
HAS/2012-02-03_synthese_et_recommandations_participation_depistage_cancer_du_sein.pdf
HAS/2012-02-04_addendum_ei_ehpad.pdf
HAS/2012-02-04_alcimed_anesm_evaluation_interne_ehpad_vf.pdf
HAS/2012-02-04_anesm_evaluation_interne_web3.pdf
HAS/2012-02-04_bibliographie_ei_ehpad_version_finale.pdf
HAS/2012-02-04_consult_int_ehpad.pdf
HAS/2012-02-04_decision_n_2015-10_-_decision_portant_adoption_de_la_rbpp_evaluation_interne_ehpad.pdf
HAS/2012-02-04_erratump73.pdf
HAS/2012-02-04_lettre_de_cadrage_lm_ei_ehpad_val_cs_0709.pdf
HAS/2012-02-04_presentation_evaluation_interne.pdf
HAS/2012-02-04_rapport_appel_a_contribution_22_sept_2011.pdf
HAS/2012-02-04_rapport_test_faisabilite_isq_ehpad.pdf
HAS/2012-02-04_reco_citees_ei_ehpad.pdf
HAS/2012-02-04_references_juridiques_ei_ehpad.pdf
HAS/2012-02-08_fiche_bon_usage_implants_cochleaires.pdf
HAS/2012-02-08_medical_devices_for_home_infusion-summary.pdf
HAS/2012-02-08_perfusion_a_domicile_14_septembre_2010_1309_avis.pdf
HAS/2012-02-08_rapport_perfusion_a_domicile_2010_09_28_3588.pdf
HAS/2012-02-09_document_davis_bandelette_advance.pdf
HAS/2012-02-10_amiante_-_suivi_post-professionnel_-_rapport_dorientation.pdf
HAS/2012-02-10_amiante_-_suivi_post-professionnel_-_recommandations.pdf
HAS/2012-02-10_amiante_-_suivi_post-professionnel_-_texte_complet.pdf
HAS/2012-02-10_cepp-1333avisnutrition_parenteral_a_domicile.pdf
HAS/2012-02-10_rapport_nutrition_parenterale_a_domicile_2008-07-31_14-29-41_874.pdf
HAS/2012-02-10_suivi_post_professionnel__spp__des_personnes_exposees_a_lamiante.pdf
HAS/2012-02-14_cholurso_15022012_avis_ct11916.pdf
HAS/2012-02-14_larmabak_15022012_avis_ct11861.pdf
HAS/2012-02-14_moxydar_15022012_avis_ct11210.pdf
HAS/2012-02-15_eurartesim_15022012_avis__ct-11871.pdf
HAS/2012-02-15_eurartesim_ct_11871.pdf
HAS/2012-02-15_eurartesim_synthese_ct11871.pdf
HAS/2012-02-15_toviaz_15022012_avis_ct_10835.pdf
HAS/2012-02-15_toviaz_ct_10835.pdf
HAS/2012-02-15_toviaz_synthese_ct-10835.pdf
HAS/2012-02-16_ipaqss_rapport_idm-vf.pdf
HAS/2012-02-17_aotal_18012012_avis_ct11244.pdf
HAS/2012-02-17_chibro-cadron_04012012__avis_ct_10791.pdf
HAS/2012-02-17_crixivan_18012012_avis_ct8307.pdf
HAS/2012-02-17_diprosalic_18012012_avis_ct_11106.pdf
HAS/2012-02-17_esperal_18012012_avis_ct10948.pdf
HAS/2012-02-17_fosrenol_18012012_avis_ct11076.pdf
HAS/2012-02-17_fuzeon_18012012_avis_ct7016.pdf
HAS/2012-02-17_gingko_biogaran_02112012_avis_ct11521.pdf
HAS/2012-02-17_lectil_18012012_avis_ct11869.pdf
HAS/2012-02-17_nerisalic_18012012_avis_ct11218.pdf
HAS/2012-02-17_pethidine_renaudin_18012012_avis_ct11239.pdf
HAS/2012-02-17_pivalone_18012012_avis_ct11799.pdf
HAS/2012-02-17_sustiva_18012012_avis_ct9338.pdf
HAS/2012-02-17_unifluid_18012012_avis_ct11711.pdf
HAS/2012-02-24_coumadine_01022012_avis_ct10032.pdf
HAS/2012-02-24_forlax_01022012_avis_ct11610.pdf
HAS/2012-02-24_gabitril_01022012_avis_ct8335.pdf
HAS/2012-02-24_idarac_01022012_avis_ct11194_ct11098.pdf
HAS/2012-02-24_lariam_01022012_avis_ct11486_2012-02-23_16-00-8_400.pdf
HAS/2012-02-24_larmes_artificelles_martinet_15022012_avis_ct10993.pdf
HAS/2012-02-24_malarone_01022012_avis_ct11510.pdf
HAS/2012-02-24_mysoline_15022012_avis_ct11211.pdf
HAS/2012-02-24_parkinane_01022012_avis_ct11411.pdf
HAS/2012-02-24_paxeladine_01022012_avis_ct11223_ct11236.pdf
HAS/2012-02-24_phenylephrine_renaudin_15022012_avis_ct11666.pdf
HAS/2012-02-24_vidora_01022012_avis_ct11282_ct12031.pdf
HAS/2012-02-24_visken_18012012_avis_ct10667.pdf
HAS/2012-02-29_benlysta_29022012_avis_ct11779.pdf
HAS/2012-02-29_benlysta_ct_11779.pdf
HAS/2012-02-29_soluprick_controle_29022012_avis_ct11041.pdf
HAS/2012-02-29_soluprick_controle_ct_11041.pdf
HAS/2012-02-29_vantas_29022012_avis_ct11421.pdf
HAS/2012-02-29_vantas_ct_11421.pdf
HAS/2012-02-29_vantas_synthese_29022012.pdf
HAS/2012-02-29_xiapex_29022012_avis_ct10754.pdf
HAS/2012-02-29_xiapex__29022012_synthese_ct10754.pdf
HAS/2012-02-29_xiapex_ct_10754.pdf
HAS/2012-03-07_adrovance_15_02_2012_avis_ct-11850.pdf
HAS/2012-03-07_aerius_15_02_2012_avis_ct-11839.pdf
HAS/2012-03-07_aptivus_01022012_avis_ct10995.pdf
HAS/2012-03-07_artane_01022012_avis_ct10952.pdf
HAS/2012-03-08_09r18_autism_children_quick_reference_guide.pdf
HAS/2012-03-08_abelite_15022012_avis_ct11056_ct9671.pdf
HAS/2012-03-08_abelite_15022012_avis_ct11056_ct9671_2012-03-08_14-49-41_134.pdf
HAS/2012-03-08_argumentaire_autisme_ted_enfant_adolescent_interventions.pdf
HAS/2012-03-08_autisme_enfant_reco2clics_vd.pdf
HAS/2012-03-08_bactroban_15022012_avis_ct11658.pdf
HAS/2012-03-08_carbosymag_15022012_avis_ct11112.pdf
HAS/2012-03-08_fleetphosphosoda_15022012_avis_ct11251.pdf
HAS/2012-03-08_gastropulgite_15022012_avis_ct11172.pdf
HAS/2012-03-08_gelox_15022012_avis_ct11174.pdf
HAS/2012-03-08_imovax_polio_15022012_avis_ct11504.pdf
HAS/2012-03-08_isudrine_15022012_avis_ct11195.pdf
HAS/2012-03-08_keal_15022012_avis_ct11196.pdf
HAS/2012-03-08_recommandations_autisme_ted_enfant_adolescent_interventions.pdf
HAS/2012-03-08_rocgel_15022012_avis_ct11370.pdf
HAS/2012-03-08_synthese_autisme_ted_enfant_adolescent_interventions.pdf
HAS/2012-03-09_akineton_01022012_avis_ct11467.pdf
HAS/2012-03-09_contracide_15022012_avis_ct11135.pdf
HAS/2012-03-09_delursan_15022012_avis_ct11894.pdf
HAS/2012-03-09_fs_bum_naco_v5.pdf
HAS/2012-03-09_orbenine_15022012_avis_ct5725.pdf
HAS/2012-03-09_pradaxa_15022012_avis_ct10749.pdf
HAS/2012-03-09_pradaxa_ct_10749.pdf
HAS/2012-03-09_retacrit_29022012_avis_ct11849.pdf
HAS/2012-03-09_sucrafalte_15022012_avis_ct-11364.pdf
HAS/2012-03-09_topaal_15022012_avis_ct11313_ct9035.pdf
HAS/2012-03-12_phosphalugel_15022012_avis_ct11241.pdf
HAS/2012-03-12_scooters-21_fevrier_2012_4024_avis.pdf
HAS/2012-03-12_vph-13_septembre_2011_3242_avis.pdf
HAS/2012-03-14_annexe_10_-_fiche_suivi_hta_ppspr.pdf
HAS/2012-03-14_annexe_11-_fiche_suivi_avk_ppspr.pdf
HAS/2012-03-14_annexe_12_-_mise_au_format_informatique_ppspr.pdf
HAS/2012-03-14_annexe_2_-_gradation_messages_cles_2011-12-14_15-18-17_739.pdf
HAS/2012-03-14_annexe_3_-_recherche_documentaire_ppspr.pdf
HAS/2012-03-14_annexe_4_-_resume_1p_hta_ppspr.pdf
HAS/2012-03-14_annexe_5_-_resume_1p_avk_ppspr.pdf
HAS/2012-03-14_annexe_6_-_sources_erreur_prise_pa_ppspr.pdf
HAS/2012-03-14_annexe_7_-_algorithme_delais_intervention_medicale_hta_ppspr.pdf
HAS/2012-03-14_annexe_8_-_rappels_de_connaissances_hta_ppspr.pdf
HAS/2012-03-14_annexe_9_-_rappels_de_connaissances_avkppspr.pdf
HAS/2012-03-14_esbriet_14032012_avis_ct11398.pdf
HAS/2012-03-14_esbriet_14032012_synthese_ct11398.pdf
HAS/2012-03-14_esbriet_ct_11398.pdf
HAS/2012-03-14_freestyle_optium-21_fevrier_2012_4089_avis.pdf
HAS/2012-03-14_heartware-21_fevrier_2012_4226_avis.pdf
HAS/2012-03-14_powerlink-21_fevrier_2012_4159_avis.pdf
HAS/2012-03-14_powerlink-21_fevrier_2012_4160_avis.pdf
HAS/2012-03-14_ppspr-2clics_etapes_d_elaboration.pdf
HAS/2012-03-14_ppspr_2clics_annexe13_recherche_documentaire.pdf
HAS/2012-03-14_ppspr_2clics_annexe14_participants.pdf
HAS/2012-03-14_ppspr_2clics_annexe1_etapes.pdf
HAS/2012-03-14_ppspr_annexes__guide_pratique.pdf
HAS/2012-03-14_ppspr_exemple__avk.pdf
HAS/2012-03-14_ppspr_exemple__hta.pdf
HAS/2012-03-14_ppspr_guide_etapes_elaboration.pdf
HAS/2012-03-14_ppsrp_2clics_annexe15_fiche_descriptive.pdf
HAS/2012-03-14_ppsrp_2clics_principes_elaboration_4pages.pdf
HAS/2012-03-14_provox_1-21_fevrier_2012_4129_avis.pdf
HAS/2012-03-14_provox_2-21_fevrier_2012_4131_avis.pdf
HAS/2012-03-14_provox_activalve-21_fevrier_2012_4000_avis.pdf
HAS/2012-03-14_provox_vega_puncture_set-21_fevrier_2012_4132_avis.pdf
HAS/2012-03-14_provox_vega_smartinserter-21_fevrier_2012_4133_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4093_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4094_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4095_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4096_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4097_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4098_avis.pdf
HAS/2012-03-14_set_appareillage_stomie_digestive_21_fevrier_2012_4099_avis.pdf
HAS/2012-03-14_tableau_1_-_sources_messages_cles_hta_ppspr.pdf
HAS/2012-03-14_tableau_2_-_sources_messages_cles_avk.pdf
HAS/2012-03-14_xarelto_tvp_14032012_avis_ct11891.pdf
HAS/2012-03-14_xarelto_tvp_14032012_synthese_ct11891.pdf
HAS/2012-03-14_xarelto_tvp_ct_11891.pdf
HAS/2012-03-15_synthese_davis_visanne_-_ct-8792.pdf
HAS/2012-03-15_visanne_-_ct-8792.pdf
HAS/2012-03-15_visanne_ct_8792.pdf
HAS/2012-03-19_izilox_ct_8141.pdf
HAS/2012-03-19_izilox_iv_-_ct-8141.pdf
HAS/2012-03-19_powerlink-21_fevrier_2012_4134_avis.pdf
HAS/2012-03-19_set_appareillage_stomie_digestive_21_fevrier_2012_4100_avis.pdf
HAS/2012-03-19_synthese_davis_izilox_-_ct-8141.pdf
HAS/2012-03-20_ald_30__guide_ccr_web.pdf
HAS/2012-03-20_ald_30_gp_cancer_colorectal_web.pdf
HAS/2012-03-20_ald_30_gp_prostate_web_2010-09-28_10-51-52_20.pdf
HAS/2012-03-20_ald_30_guide__prostate_web.pdf
HAS/2012-03-20_lap_colon_version_web.pdf
HAS/2012-03-20_lap_kc_prostate_version_pour_web_validee_031208_cg.pdf
HAS/2012-03-20_paradigm_veo-21_decembre_2010_2711_avis.pdf
HAS/2012-03-20_paradigm_veo-21_decembre_2010_2711_synthese_davis.pdf
HAS/2012-03-20_paradigm_veo__2711__english_version.pdf
HAS/2012-03-20_relay-14_septembre_2010_2708_avis.pdf
HAS/2012-03-20_relay-14_septembre_2010_2708_synthese_davis.pdf
HAS/2012-03-20_relay__2708__english_version.pdf
HAS/2012-03-22_05c01_conf_consensus_infarctus_myocarde_recos_courtes.pdf
HAS/2012-03-22_rapport_epsilim_has_checklist.pdf
HAS/2012-03-26_aturgyl_05-10-2011_avis_ct-11266.pdf
HAS/2012-03-26_cetraxal_15022012_avis_ct11878.pdf
HAS/2012-03-26_cetraxal_15022012_synthese_ct11878.pdf
HAS/2012-03-26_derinox_02-11-2011_avis_ct-11095.pdf
HAS/2012-03-26_deturgylone_05-10-2011_avis_ct-11269.pdf
HAS/2012-03-26_helicidine_-_ct-8650.pdf
HAS/2012-03-26_helicidine_ct_8650.pdf
HAS/2012-03-26_pernazene_05-10-2011_avis_ct-9885.pdf
HAS/2012-03-26_rhinadvil_05-10-2011_avis_ct-11216.pdf
HAS/2012-03-26_rhinamide_05-10-2011_avis_ct-7568.pdf
HAS/2012-03-26_rhinureflex_05-10-2011_avis_ct-11029.pdf
HAS/2012-03-26_sudafed_05-10-2011_avis_ct-11458.pdf
HAS/2012-03-26_synthese_davis_helicidine_-_ct-8650.pdf
HAS/2012-03-26_vasoconstricteurs_associes_synthese_05102011.pdf
HAS/2012-03-26_vasoconstricteurs_non_associes_synthese_05102011.pdf
HAS/2012-03-27_fluvermal_29022012_avis__ct11214.pdf
HAS/2012-03-27_ganfort_29022012_avis_ct10497.pdf
HAS/2012-03-27_kiovig_29022012_avis_ct11883.pdf
HAS/2012-03-27_nabucox_29022012_avis_ct11656.pdf
HAS/2012-03-27_panotile_29022012_avis_ct_11527.pdf
HAS/2012-03-27_zentel_29022012_avis_ct11459.pdf
HAS/2012-03-28_afinitor_28032012_avis_ct11775.pdf
HAS/2012-03-28_afinitor_ct_11775.pdf
HAS/2012-03-28_afinitor_synthese_28032012.pdf
HAS/2012-03-28_afx-20_mars_2012_4238_avis.pdf
HAS/2012-03-28_caldine_29022012_avis_ct_11988.pdf
HAS/2012-03-28_exforge_hct_ct_11985.pdf
HAS/2012-03-28_exforge_hct_ins_2_avis2_ct11985.pdf
HAS/2012-03-28_exforge_hct_synthese_28032012.pdf
HAS/2012-03-28_hiresolution_bionic_ear-20_mars_2012_4255_avis.pdf
HAS/2012-03-28_nobori-21_fevrier_2012_4217_avis.pdf
HAS/2012-03-28_osvaren_28032012_avis_ct11951.pdf
HAS/2012-03-28_osvaren_28032012_synthese_ct11951.pdf
HAS/2012-03-28_osvaren_ct_11951_2013-01-23_14-24-31_39.pdf
HAS/2012-03-28_pam_2.0-06_mars_2012_4216_avis.pdf
HAS/2012-03-28_targretin_28032012_avis_ct118885.pdf
HAS/2012-03-28_targretin_28032012_synthese_ct18885.pdf
HAS/2012-03-28_targretin_ct_11885.pdf
HAS/2012-04-03_indications_cesarienne_programme_-_argumentaire.pdf
HAS/2012-04-03_indications_cesarienne_programmee_-_fiche_de_synthese_-_indications.pdf
HAS/2012-04-03_indications_cesarienne_programmee_-_fiche_de_synthese_-_information.pdf
HAS/2012-04-03_indications_cesarienne_programmee_-_recommandation_2012-03-12_14-44-28_679.pdf
HAS/2012-04-03_rapport_dorientation_-_cancer_de_la_prostate_2012-04-03_16-39-9_898.pdf
HAS/2012-04-03_reco2clics_indications-cesarienne.pdf
HAS/2012-04-05_simplygo-20_mars_2012_4230_avis.pdf
HAS/2012-04-05_urgostart-20_mars_2012_4107_avis.pdf
HAS/2012-04-05_urgostart_contact-20_mars_2012_4108_avis.pdf
HAS/2012-04-06_evaluation_medico-economique_des_endoprotheses_aortiques_abdominales.pdf
HAS/2012-04-10_cacit_vitamine_11042012_avis_ct11479.pdf
HAS/2012-04-11_2ebat_synthese_gdr-220312.pdf
HAS/2012-04-11_actions_thematiques_grand_format.pdf
HAS/2012-04-11_fampyra_11042012_avis_ct11904.pdf
HAS/2012-04-11_fampyra_11042012_avis_ct_11904.pdf
HAS/2012-04-11_fampyra_ct_11904.pdf
HAS/2012-04-11_fiche1.pdf
HAS/2012-04-11_fiche10.pdf
HAS/2012-04-11_fiche11.pdf
HAS/2012-04-11_fiche12.pdf
HAS/2012-04-11_fiche13.pdf
HAS/2012-04-11_fiche14.pdf
HAS/2012-04-11_fiche15.pdf
HAS/2012-04-11_fiche16.pdf
HAS/2012-04-11_fiche17.pdf
HAS/2012-04-11_fiche18.pdf
HAS/2012-04-11_fiche19.pdf
HAS/2012-04-11_fiche2.pdf
HAS/2012-04-11_fiche20.pdf
HAS/2012-04-11_fiche21.pdf
HAS/2012-04-11_fiche22.pdf
HAS/2012-04-11_fiche23.pdf
HAS/2012-04-11_fiche24.pdf
HAS/2012-04-11_fiche25.pdf
HAS/2012-04-11_fiche26.pdf
HAS/2012-04-11_fiche27.pdf
HAS/2012-04-11_fiche28.pdf
HAS/2012-04-11_fiche29.pdf
HAS/2012-04-11_fiche3.pdf
HAS/2012-04-11_fiche30.pdf
HAS/2012-04-11_fiche31.pdf
HAS/2012-04-11_fiche32.pdf
HAS/2012-04-11_fiche33.pdf
HAS/2012-04-11_fiche34.pdf
HAS/2012-04-11_fiche4.pdf
HAS/2012-04-11_fiche5.pdf
HAS/2012-04-11_fiche6.pdf
HAS/2012-04-11_fiche7.pdf
HAS/2012-04-11_fiche8.pdf
HAS/2012-04-11_fiche9.pdf
HAS/2012-04-11_format2clic_gestion_des_risques.pdf
HAS/2012-04-11_guide_gdr_pages1a64.pdf
HAS/2012-04-11_guide_gdr_pages65a220.pdf
HAS/2012-04-11_okbat_guide_gdr_03_04_12.pdf
HAS/2012-04-11_vyndaqel_11042012_ct11936.pdf
HAS/2012-04-11_vyndaqel_11042012_synthese_ct11936.pdf
HAS/2012-04-11_vyndaqel_ct_11936.pdf
HAS/2012-04-11_xgeva_11042012_avis_ct11892.pdf
HAS/2012-04-11_xgeva_ct_11892.pdf
HAS/2012-04-11_xgeva_synthese_11042012.pdf
HAS/2012-04-13_asmelor_novolizer_29022012_ct11713.pdf
HAS/2012-04-13_nalorex_29022012_avis_ct11925.pdf
HAS/2012-04-17_asmanex_twisthaler_29022012_avis_ct11679.pdf
HAS/2012-04-17_atimos_formoair_29022012_avis_ct9735_2012-04-16_10-50-36_843.pdf
HAS/2012-04-17_bionolyte_14032012_avis_ct10572.pdf
HAS/2012-04-17_bristopen_14032012_avis_ct_11939_2012-04-16_11-44-22_894.pdf
HAS/2012-04-17_foradil_29022012_avis_ct10378.pdf
HAS/2012-04-17_inexium_15022012_avis_ct11627.pdf
HAS/2012-04-17_izilox_14032012_avis_ct11809.pdf
HAS/2012-04-17_multihance_140320128_avis_ct11714.pdf
HAS/2012-04-17_naramig_14032012_avis_ct11023_2012-04-16_15-27-14_882.pdf
HAS/2012-04-17_nocertone_14032012_avis_ct10997.pdf
HAS/2012-04-17_viramune_29022012_avis_ct11944.pdf
HAS/2012-04-18_chlorhydrate_de_methadone_29022012_avis_ct11413.pdf
HAS/2012-04-18_epiduo_18012012_avis_ct11465.pdf
HAS/2012-04-18_epiduo_18012012_synthese_ct11465.pdf
HAS/2012-04-18_epiduo_ct_11465.pdf
HAS/2012-04-18_hexvix_29022012_avis_ct11859.pdf
HAS/2012-04-18_m-m-rvaxpro_29022012_avis_ct12087.pdf
HAS/2012-04-18_octegra_14032012_avis_ct_10703.pdf
HAS/2012-04-18_priorix_29022012_avis_ct12086.pdf
HAS/2012-04-18_sibelium_14032012_avis_ct11371.pdf
HAS/2012-04-18_stromectol_29022012__avis__ct11763.pdf
HAS/2012-04-18_tysabri_29022012_avis_ct_11948.pdf
HAS/2012-04-18_ventoline_15022012_ct11396.pdf
HAS/2012-04-20_2ebat_tazocilline.pdf
HAS/2012-04-20_bacicoline_bacitracine_28032012_avis_ct11051.pdf
HAS/2012-04-20_clamoxyl_14032012_avis_ct9472.pdf
HAS/2012-04-20_day_surgery_-_an_overview.pdf
HAS/2012-04-20_fraxodi-fraxiparine_28032012_avis_ct_10387.pdf
HAS/2012-04-20_ipaqss_rapport_psy-vf.pdf
HAS/2012-04-20_komboglyze_14032012_avis_ct11897.pdf
HAS/2012-04-20_la_chirurgie_ambulatoire_en_12_questions.pdf
HAS/2012-04-20_levonorgestrel_biogaran_28032012_avis_ct-11989.pdf
HAS/2012-04-20_minalfene_14032012_avis_ct11488.pdf
HAS/2012-04-20_modecate_28032012_avis_ct11079.pdf
HAS/2012-04-20_opticron_28032012_avis_ct11246.pdf
HAS/2012-04-20_rapport_-_socle_de_connaissances.pdf
HAS/2012-04-20_rifadine_28032012_avis_ct_11875.pdf
HAS/2012-04-20_rifamycine_chibret_28032012_avis_ct11049.pdf
HAS/2012-04-20_synthese_-_socle_de_connaissances.pdf
HAS/2012-04-20_tazocilline_29022012_avis_ct_10256.pdf
HAS/2012-04-20_vitamine_a_faure_14032012_avis_ct11048.pdf
HAS/2012-04-24_ipaqss_rapport_had-v4.pdf
HAS/2012-04-24_nutri-energie-17_avril_2012_4227_avis.pdf
HAS/2012-04-24_nutri-energie_-17_avril_2012_4247.pdf
HAS/2012-04-24_sanmigran_14032012_avis_ct11385.pdf
HAS/2012-04-24_stratos_lv_t-17_avril_2012_4249_avis.pdf
HAS/2012-04-26_athymil_11042012_avis_ct11117.pdf
HAS/2012-04-26_calcidose_11042012_avis_ct11873.pdf
HAS/2012-04-26_calcidose_vitamine_d_11042012_avis_ct11429.pdf
HAS/2012-04-26_calcium_vitd3_mylan_11042012_avis_ct10987.pdf
HAS/2012-04-26_composition_du_gt.pdf
HAS/2012-04-26_diamox_11042012_avis_ct11443.pdf
HAS/2012-04-26_dicloced_11042012_avis_ct11800.pdf
HAS/2012-04-26_exploration_osteo-articulaire_des_membres_par_irm_-_interet_diagnostique_des_equipements_a_champs_modere_et_des_equipements_dedies_-_rapport_devaluation_2012-04-25_13-10-14_533.pdf
HAS/2012-04-26_exploration_osteo-articulaire_des_membres_par_irm_-_interet_diagnostique_des_equipements_a_champs_modere_et_des_equipements_dedies_-_texte_court_2012-04-25_13-10-7_810.pdf
HAS/2012-04-26_has_cadrage_irm.pdf
HAS/2012-04-26_note_cadrage_rachis.pdf
HAS/2012-04-26_oxygenotherapie_a_domicile-17_avril_2012_avis.pdf
HAS/2012-04-26_oxygenotherapie_algie_vasculaire_de_la_face-17_avril_2012_avis.pdf
HAS/2012-04-26_ponto-17_avril_2012_4242_avis.pdf
HAS/2012-04-26_ponto-17_avril_2012_4242_synthese_davis.pdf
HAS/2012-04-26_rasilez_-_ct_6371.pdf
HAS/2012-04-26_rasilez_ct_6371.pdf
HAS/2012-04-26_synthese_davis_rasilez_-_ct-6371.pdf
HAS/2012-05-01_ald_hors_liste_-_liste_des_actes_et_prestations_sur_le_syndrome_de_prader-willi.pdf
HAS/2012-05-01_ald_hors_liste_-_pnds_sur_le_syndrome_de_prader-willi.pdf
HAS/2012-05-01_pnds_44_-_syndrome_de_prader-willi_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2012-05-02_accompagnement_etablissement_medico_social.pdf
HAS/2012-05-02_accueil_sequentiel_extrait.pdf
HAS/2012-05-02_alzheimer_-_actes_dergotherapie_et_de_psychomotricite_-_document_dinformation_2010-03-25_12-06-15_255.pdf
HAS/2012-05-02_alzheimer_annonce_accompa_diagnostic_diapo.pdf
HAS/2012-05-02_alzheimers_disease_and_related_conditions-disclosing_the_diagnosis_and_providing_support_-qrg-version_anglaise.pdf
HAS/2012-05-02_annexe2-projet_personnalise.pdf
HAS/2012-05-02_annexe_4_circulaire_dgos_du__20_oct.11.pdf
HAS/2012-05-02_annexe_5_circulaire_dgos_du__20_oct.11.pdf
HAS/2012-05-02_annexe_arrete_a_publier_dossier_unique.pdf
HAS/2012-05-02_dms-iv-tr.pdf
HAS/2012-05-02_gm_alzheimer_finale_web_juin2009.pdf
HAS/2012-05-02_guide_bonnes_pratiquescmrr.pdf
HAS/2012-05-02_indications_hospitalisation.pdf
HAS/2012-05-02_liste_des_ucc_ouvertes_pour_has_11_10_2012.pdf
HAS/2012-05-02_maladie_dalzheimer_-_annonce_et_accompagnement_du_diagnostic_-_argumentaire_2009-11-10_09-55-14_154.pdf
HAS/2012-05-02_maladie_dalzheimer_-_annonce_et_accompagnement_du_diagnostic_-_synthese_des_recommandations.pdf
HAS/2012-05-02_maladie_dalzheimer_-_synthese_-_septembre_2009.pdf
HAS/2012-05-02_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_3.pdf
HAS/2012-05-02_maladies_alzheimer_et_maladies_apparentees_diagnostic_et_prise_en_charge_annexe_5.pdf
HAS/2012-05-02_mmse.pdf
HAS/2012-05-02_place_hospitalisation.pdf
HAS/2012-05-02_planalzmesure_fichemedecin.pdf
HAS/2012-05-02_prepa_admission.pdf
HAS/2012-05-02_projet_personnalise.pdf
HAS/2012-05-02_reco2clics_alzheimer_accompagnement_annonce.pdf
HAS/2012-05-02_recommandation_maladie_alzheimer_annonce_et_accompagnement_du_diagnostic.pdf
HAS/2012-05-02_s8_dispositif_annonce_du_diagnostic_et_accompagnement_revgg27042012.pdf
HAS/2012-05-02_suivi_par_un_specialiste.pdf
HAS/2012-05-02_suivi_standardise_mg.pdf
HAS/2012-05-03_endurant_ii-09_octobre_2012_4360_avis_2012-10-12_10-13-45_244.pdf
HAS/2012-05-03_endurant_ii-17_avril_2012_4251_avis.pdf
HAS/2012-05-04_adenuric_11042012_avis_ct12188.pdf
HAS/2012-05-04_biocidan_11042012_avis_ct11067.pdf
HAS/2012-05-04_biovalsalva_biplex-17_avril_2012_4223_avis.pdf
HAS/2012-05-04_calcos_vitamine_11042012_avis_ct10937.pdf
HAS/2012-05-04_cayston_15022012_avis_ct8345.pdf
HAS/2012-05-04_cayston_15022012_synthese_ct8345.pdf
HAS/2012-05-04_cayston_ct_8345.pdf
HAS/2012-05-04_chup_enfant_mayzaud-17_avril_2012_4056_avis.pdf
HAS/2012-05-04_chup_pantortoze-17_avril_2012_4055_avis.pdf
HAS/2012-05-04_fixical_11042012_avis_ct11909.pdf
HAS/2012-05-04_gelseal-17_avril_2012_4231_avis.pdf
HAS/2012-05-04_gelsoft-17_avril_2012_4229_avis.pdf
HAS/2012-05-04_lamictal_lamicstart_-_ct-7616.pdf
HAS/2012-05-04_lamictal_lamicstart_ct_7616.pdf
HAS/2012-05-04_orocal_vitamine_d3_11042012_avis_ct11436.pdf
HAS/2012-05-04_piportil_11042012_avis_ct10951.pdf
HAS/2012-05-04_simponi_01022012_avis_ct11419.pdf
HAS/2012-05-04_simponi_01022012_synthse_ct11419.pdf
HAS/2012-05-04_simponi_ct_11419.pdf
HAS/2012-05-04_stelara_-_ct-6336.pdf
HAS/2012-05-04_stelara_ct_6336.pdf
HAS/2012-05-04_synthese_davis_lamictal_-_ct-7616.pdf
HAS/2012-05-04_synthese_davis_stelara_-_ct-6336_2009-09-17_15-04-19_149.pdf
HAS/2012-05-04_synthese_davis_yondelis_-_ct-7917.pdf
HAS/2012-05-04_ticlid_11042012_avis_ct11901.pdf
HAS/2012-05-04_ydralbum_11042012_avis_ct11969.pdf
HAS/2012-05-04_yondelis_-_ct-7917.pdf
HAS/2012-05-04_yondelis_ct_7917.pdf
HAS/2012-05-07_fixical_vitamine_d3_11042012_avis_ct11910.pdf
HAS/2012-05-07_ideos_11042012_avis_ct11490.pdf
HAS/2012-05-07_miorel_11042012_avis_ct11528.pdf
HAS/2012-05-09_anapen_23052012_avis_ct12049.pdf
HAS/2012-05-09_anapen_ct_12049.pdf
HAS/2012-05-09_edurant_09052012_avis_ct11993.pdf
HAS/2012-05-09_edurant_09052012_synthese.pdf
HAS/2012-05-09_edurant_ct_11993.pdf
HAS/2012-05-09_eviplera_09052012_avis__ct11958.pdf
HAS/2012-05-09_eviplera_09052012_synthese_ct11958.pdf
HAS/2012-05-09_eviplera_ct_11958.pdf
HAS/2012-05-09_roactemra_09052012_avis_ct-11877.pdf
HAS/2012-05-09_roactemra_aji_synthese_09052012.pdf
HAS/2012-05-09_roactemra_ct_11877.pdf
HAS/2012-05-16_08r13_form_maltraitance_sexuelles_fiche_signalement.pdf
HAS/2012-05-16_bat_fiche_uft_2007_11_08__15_23_15_26.pdf
HAS/2012-05-16_calciprat_11042012_avis_ct11164.pdf
HAS/2012-05-16_creon_11042012_avis_ct9470.pdf
HAS/2012-05-16_enbrel_11042012_avis_ct12025.pdf
HAS/2012-05-16_eurobiol_11042012_avis_ct8311.pdf
HAS/2012-05-16_josacine_11042012_avis_ct11977.pdf
HAS/2012-05-16_ketek_11042012_avis_ct11922.pdf
HAS/2012-05-16_maltraitance_sexuelle_argumentaire.pdf
HAS/2012-05-16_maltraitance_sexuelle_fiche_de_synthese.pdf
HAS/2012-05-16_maltraitance_sexuelle_fiche_de_synthese_version_anglaise.pdf
HAS/2012-05-16_maltraitance_sexuelle_recommandations_2011-06-30_11-12-0_519.pdf
HAS/2012-05-16_neoral_sandimmun_11042012_avis_ct12054.pdf
HAS/2012-05-16_norset_11042012_avis_ct12055.pdf
HAS/2012-05-16_note_de_cadrage_-_realisation_dune_grille_danalyse_de_la_pertinence_des_demandes_de_transfert_et_dadmission_en_ssr.pdf
HAS/2012-05-16_note_de_cadrage_-_violences_sexuelles_intrafamiliales_-_version_finale.pdf
HAS/2012-05-16_provox_hme-17_avril_2012_4158_avis.pdf
HAS/2012-05-16_provox_xtrahme-micron__trachphone-17_avril_2012_4179_avis.pdf
HAS/2012-05-16_reco2clics_reperage_et_signalement_inceste_par_les_medecins.pdf
HAS/2012-05-16_sporanox_11042012_avis_ct_12068.pdf
HAS/2012-05-16_taketiam_11042012_avis_ct12111.pdf
HAS/2012-05-16_tolexine_11042012_avis_ct11463.pdf
HAS/2012-05-16_uft_11042012_avis_ct10161.pdf
HAS/2012-05-16_vitabact_11042012_avis_ct11441.pdf
HAS/2012-05-21_alzheimer_19102011_synthese.pdf
HAS/2012-05-21_annexe_alzheimer_2013-01-28_15-08-14_845.pdf
HAS/2012-05-21_annexe_i_efficacite_alzheimer_19-10-2011.pdf
HAS/2012-05-21_annexe_ii_donnees_utilisation_20-10-2011.pdf
HAS/2012-05-21_annexe_iii_recherche_documentaire_has.pdf
HAS/2012-05-21_ebixa_19-10-2011_avis_10677.pdf
HAS/2012-05-21_ebixa_ct_10677.pdf
HAS/2012-05-21_questions_alzheimer_fiche_bum_mars_2012.pdf
HAS/2012-05-21_rapport_evaluation_mdc_alzheimer_19-10-2011.pdf
HAS/2012-05-23_dhe_migraine_synthese_23052012.pdf
HAS/2012-05-23_ikaran_23052012_avis_ct12075_11038.pdf
HAS/2012-05-23_ikaran_ct_12075_11038.pdf
HAS/2012-05-23_lamaline_23052012_avis_ct12019.pdf
HAS/2012-05-23_lamaline_ct_12019.pdf
HAS/2012-05-23_lamaline_synthese_23052012.pdf
HAS/2012-05-23_okimus_23052012_avis_ct12028.pdf
HAS/2012-05-23_okimus_ct_12028.pdf
HAS/2012-06-01_12irp06_reco_agents_antiplaquettaires.pdf
HAS/2012-06-01_antiscar-29_mai_2012_4220_avis.pdf
HAS/2012-06-01_argumentaire-aap_bon_usage_agents_antiplaquettaires.pdf
HAS/2012-06-01_brief_inahta_polysomnography_respiratory_polygraphy_in_sleep_disorders.pdf
HAS/2012-06-01_claventin_09052012_avis__ct_12117.pdf
HAS/2012-06-01_cre_8-15_mai_2012_4218_avis.pdf
HAS/2012-06-01_hiresolution_bionic_ear-15_mai_2012_4282_avis.pdf
HAS/2012-06-01_lithioderm_09052012_avis_ct11096.pdf
HAS/2012-06-01_locacid_09052012_avis_ct11245.pdf
HAS/2012-06-01_metoject_09052012_avis_ct11920.pdf
HAS/2012-06-01_monozeclar-_zeclar_09052012_avis_ct_12138.pdf
HAS/2012-06-01_orthovisc-15_mai_2012_4233_avis.pdf
HAS/2012-06-01_otipax_09052012_avis_ct10958.pdf
HAS/2012-06-01_place_et_conditions_de_realisation_de_la_polysomnographie_et_de_la_polygraphie_respiratoire_dans_les_troubles_du_sommeil_-_annexes_2012-06-01_11-50-18_892.pdf
HAS/2012-06-01_place_et_conditions_de_realisation_de_la_polysomnographie_et_de_la_polygraphie_respiratoire_dans_les_troubles_du_sommeil_-_note_de_cadrage.pdf
HAS/2012-06-01_place_et_conditions_de_realisation_de_la_polysomnographie_et_de_la_polygraphie_respiratoire_dans_les_troubles_du_sommeil_-_rapport_devaluation_2012-06-01_11-50-8_440.pdf
HAS/2012-06-01_place_et_conditions_de_realisation_de_la_polysomnographie_et_de_la_polygraphie_respiratoire_dans_les_troubles_du_sommeil_-_texte_court_2012-06-01_11-49-57_313.pdf
HAS/2012-06-01_procoralan_09052012_avis__ct12098.pdf
HAS/2012-06-01_rubozinc_09052012_avis_ct11893.pdf
HAS/2012-06-01_ticarpen_09052012_avis__ct_12113.pdf
HAS/2012-06-01_travatan_09052012_avis_ct11608.pdf
HAS/2012-06-01_viatorr_tips-15_mai_2012_4156_avis.pdf
HAS/2012-06-01_viatorr_tips-15_mai_2012_4232__radiation_.pdf
HAS/2012-06-04_acide_folique_09052012_avis_ct11675.pdf
HAS/2012-06-04_actonel_09052012_avis_ct9408.pdf
HAS/2012-06-04_adenuric_-_ct-6315.pdf
HAS/2012-06-04_adenuric_ct_6315.pdf
HAS/2012-06-04_atrovent_inhalation_09052012_avis_ct-11980.pdf
HAS/2012-06-04_atrovent_nasal_09052012_avis_ct-11980.pdf
HAS/2012-06-04_cardensiel_-_ct-6480.pdf
HAS/2012-06-04_cardensiel_ct_6480.pdf
HAS/2012-06-04_chlorure_de_sodium__macopharma_09052012_avis_ct_12166.pdf
HAS/2012-06-04_cisnaf_-_ct-8536.pdf
HAS/2012-06-04_cisnaf_ct_8536.pdf
HAS/2012-06-04_epipen_-_ct-6662.pdf
HAS/2012-06-04_epipen_ct_6662.pdf
HAS/2012-06-04_glucose__macopharma_09052012_avis_ct_12167.pdf
HAS/2012-06-04_mezavant_-_ct_8220.pdf
HAS/2012-06-04_mezavant_ct_8220.pdf
HAS/2012-06-04_mydriaticum_09052012_avis_ct11474.pdf
HAS/2012-06-04_neosynephrine_09052012_avis_ct11026.pdf
HAS/2012-06-04_nplate_-_ct-6579.pdf
HAS/2012-06-04_nplate_ct_6579.pdf
HAS/2012-06-04_synthese_davis_adenuric_-_ct-6315.pdf
HAS/2012-06-04_synthese_davis_cardensiel_-_cardiocor.pdf
HAS/2012-06-04_synthese_davis_cisnaf_-_ct-8536.pdf
HAS/2012-06-04_synthese_davis_epipen_-_ct-6662.pdf
HAS/2012-06-04_synthese_davis_mezavant_-_ct-8220_2011-01-27_15-14-2_771.pdf
HAS/2012-06-04_synthese_davis_nplate_-_ct-6579.pdf
HAS/2012-06-04_synthese_davis_varnoline_continu_-_ct-6507.pdf
HAS/2012-06-04_synthese_davis_velcade_-_ct-6647.pdf
HAS/2012-06-04_synthese_davis_votrient_ct-9713.pdf
HAS/2012-06-04_varnoline_continu_-_ct_-_6507.pdf
HAS/2012-06-04_varnoline_continu_ct_6507.pdf
HAS/2012-06-04_velcade_-_ct-6647.pdf
HAS/2012-06-04_velcade_ct_6647.pdf
HAS/2012-06-04_votrient_-_ct-_8713.pdf
HAS/2012-06-04_votrient_ct_8713.pdf
HAS/2012-06-05_methode_parcours_de_soins_web.pdf
HAS/2012-06-06_aetoxisclerol_06062012_avis_ct11773.pdf
HAS/2012-06-06_aetoxisclerol_ct_11773.pdf
HAS/2012-06-06_meteospasmyl_06062012_avis_ct11943.pdf
HAS/2012-06-06_meteospasmyl_ct_11943.pdf
HAS/2012-06-06_revlimid_06062012_avis__ct11991.pdf
HAS/2012-06-06_revlimid_ct_11991.pdf
HAS/2012-06-06_tarceva_06062012_avis_ct12040.pdf
HAS/2012-06-06_tarceva_06062012_synthese.pdf
HAS/2012-06-06_tarceva_ct_12040.pdf
HAS/2012-06-06_trombovar_06062012_avis_ct11391.pdf
HAS/2012-06-06_trombovar_ct_11391.pdf
HAS/2012-06-08_08r07_algo_maladie_alzheimer-troubles_comportement_traitement_2013-02-26_14-58-45_450.pdf
HAS/2012-06-08_08r07_algo_maladie_alzheimer_troubles_comportement_2013-02-26_14-58-35_12.pdf
HAS/2012-06-08_08r07_memo_maladie_alzheimer_troubles_comportement_equipe_soignante_npi-es_2013-02-26_14-58-55_901.pdf
HAS/2012-06-08_08r07_memo_maladie_alzheimer_troubles_comportement_npi_2013-02-26_14-59-5_931.pdf
HAS/2012-06-08_08r07_memo_maladie_alzheimer_troubles_comportement_npi_reduit_npi-r_2013-02-26_14-59-15_289.pdf
HAS/2012-06-08_alzheimer-prisencharge-reco2clics-v1.pdf
HAS/2012-06-08_alzheimer_troubles_comportement_perturbateurs_synthese.pdf
HAS/2012-06-08_alzheimers_disease-management_of_behavioural_disorders-quick_reference_guide_-_version_anglaise.pdf
HAS/2012-06-08_ferrisat_11042012_avis_ct11857.pdf
HAS/2012-06-08_granions_de_zinc_09052012_avis_ct11426.pdf
HAS/2012-06-08_intelence_11042012_avis_ct11902.pdf
HAS/2012-06-08_isudrine_23052012_avis_ct12171.pdf
HAS/2012-06-08_maladie_dalzheimer-troubles_du_comportement_perturbateurs-argumentaire.pdf
HAS/2012-06-08_maladie_dalzheimer-troubles_du_comportement_perturbateurs-recommandations.pdf
HAS/2012-06-08_mama_troubles_comportement___annexe_1.pdf
HAS/2012-06-08_mama_troubles_comportement___annexe_2.pdf
HAS/2012-06-08_mama_troubles_comportement_annexe_3.pdf
HAS/2012-06-08_mama_troubles_comportement_annexe_4.pdf
HAS/2012-06-08_mama_troubles_comportement_encadre_1_anxiolitiques.pdf
HAS/2012-06-08_mama_troubles_comportement_schema_1_arbre_decisionnel.pdf
HAS/2012-06-08_mama_troubles_comportement_tabl_1_types_de_symptomes.pdf
HAS/2012-06-08_modamide_23052012_avis_ct_12207.pdf
HAS/2012-06-08_moducren_23052012_avis_ct12204.pdf
HAS/2012-06-08_s8_dispositif_annonce_du_diagnostic_et_accompagnement_revgg27042012.pdf
HAS/2012-06-08_timacor_23052012_avis_1_ct12206.pdf
HAS/2012-06-11_lumax_740_dr-t-29_mai_2012_4185_avis.pdf
HAS/2012-06-11_lumax_740_vr-t-29_mai_2012_4184_avis.pdf
HAS/2012-06-11_simplygo-29_mai_2012_4278_avis.pdf
HAS/2012-06-11_simplygo_mode_pulse_nuit_desactive-29_mai_2012_4278_synthese_davis.pdf
HAS/2012-06-12_prostar_xl-29_mai_2012_4252_avis.pdf
HAS/2012-06-12_prostar_xl-29_mai_2012_4252_synthese_davis.pdf
HAS/2012-06-13_lamictal_lamicstart_-_ct-8271.pdf
HAS/2012-06-13_lamictal_lamicstart_ct_8271.pdf
HAS/2012-06-13_synthese_davis_lamictal_enfant_-_ct-8271.pdf
HAS/2012-06-14_Grossesse_tabac_court.pdf
HAS/2012-06-14_Grossesse_tabac_long.pdf
HAS/2012-06-14_Pregnancy-and-Smoking.pdf
HAS/2012-06-14_app_387_389_390_391_392_note_de_cadrage_maj_referentiel_certification_lap_coi_2020_02_13_v2_partie1.pdf
HAS/2012-06-14_combivir_23052012_avis_ct11953.pdf
HAS/2012-06-14_coteoula_23052012_avis_ct_12023.pdf
HAS/2012-06-14_essure-29_mai_2012_4062_avis.pdf
HAS/2012-06-14_eupantol_inipomp_09052012_avis_ct12088.pdf
HAS/2012-06-14_flixovate_23052012_avis_ct12041.pdf
HAS/2012-06-14_isocard_23052012_avis_ct_12205.pdf
HAS/2012-06-14_lamaline_23052012_avis_ct11613_ct11197.pdf
HAS/2012-06-14_precisions_sur_les_certifications_des_lap_et_des_lad_-_version_du_22_septembre_2016.pdf
HAS/2012-06-14_procedure_de_certification_par_essai_de_type_lap.pdf
HAS/2012-06-14_referentiel_certification_lap_hospitalier_juin12.pdf
HAS/2012-06-14_referentiel_lap_hospitaliers.pdf
HAS/2012-06-14_rovalcyte_09052012_avis_ct100291.pdf
HAS/2012-06-14_roze-12_juin_2012_4259_avis.pdf
HAS/2012-06-14_senza-12_juin_2012_4130_avis.pdf
HAS/2012-06-14_senza-12_juin_2012_4130_synthese_davis.pdf
HAS/2012-06-18_arava_-_ct8004.pdf
HAS/2012-06-18_arava_ct_8004.pdf
HAS/2012-06-18_arzerra_-_ct-8366.pdf
HAS/2012-06-18_arzerra_ct_8366.pdf
HAS/2012-06-18_avandia_avandamet_-_ct-9105.pdf
HAS/2012-06-18_avandia_avandamet_ct_9105.pdf
HAS/2012-06-18_cholestagel-_ct-8427.pdf
HAS/2012-06-18_cholestagel_ct_8427.pdf
HAS/2012-06-18_curacne_23052012_avis_ct11785.pdf
HAS/2012-06-18_depamide_23052012_avis_ct11087.pdf
HAS/2012-06-18_levact_-_ct-8297.pdf
HAS/2012-06-18_levact_ct_8297.pdf
HAS/2012-06-18_mobidisc-12_juin_2012_4241_avis.pdf
HAS/2012-06-18_procuta_23052012_avis_ct11911.pdf
HAS/2012-06-18_rhesonativ_-_ct-_8388.pdf
HAS/2012-06-18_rhesonativ_ct_8388.pdf
HAS/2012-06-18_smoflipid_-_ct-7826.pdf
HAS/2012-06-18_smoflipid_ct_7826.pdf
HAS/2012-06-18_synthese_davis__avandamet_-_ct-9105.pdf
HAS/2012-06-18_synthese_davis_arzerra_-_ct-8366.pdf
HAS/2012-06-18_synthese_davis_avandia_-_ct-9105.pdf
HAS/2012-06-18_synthese_davis_cholestagel_-_ct-8427.pdf
HAS/2012-06-18_synthese_davis_levact_llc-_ct-8297.pdf
HAS/2012-06-18_synthese_davis_levact_lnh_-_ct-8297.pdf
HAS/2012-06-18_synthese_davis_levact_mm_-_ct-8297.pdf
HAS/2012-06-18_synthese_davis_rhesonativ_-_ct-8388.pdf
HAS/2012-06-18_synthese_davis_tredaptive_-_ct-8054.pdf
HAS/2012-06-18_synthese_davis_versatis_-_ct-8107.pdf
HAS/2012-06-18_tredaptive_-_ct-_8054.pdf
HAS/2012-06-18_tredaptive_ct_8054.pdf
HAS/2012-06-18_versatis_-_ct-8107.pdf
HAS/2012-06-18_versatis_ct_8107.pdf
HAS/2012-06-18_zofenilduo_23052012_avis_ct_12052.pdf
HAS/2012-06-20_cinryze_20062012_avis_ct12045.pdf
HAS/2012-06-20_cinryze_20062012_synthese.pdf
HAS/2012-06-20_cinryze_ct_12045.pdf
HAS/2012-06-20_trajenta_20062012_avis_ct11905.pdf
HAS/2012-06-20_trajenta_ct_11905.pdf
HAS/2012-06-20_trajenta_synthese_20062012.pdf
HAS/2012-06-21_edwards_sapien_xt_mod_9300-12_juin_2012_4286_avis.pdf
HAS/2012-06-21_plaquette_maltraitance_v3.pdf
HAS/2012-06-21_rapport_ghadi_compagnon_2009.pdf
HAS/2012-06-21_rencontres08_presentationtr22_vghadi.pdf
HAS/2012-06-25_rapport_echographies_foetales_vde.pdf
HAS/2012-06-27_urgo_k2-15_mai_2012_4250_avis.pdf
HAS/2012-06-27_urgo_k2_4250__urgo_k2__latex_free_4274-15_mai_2012_synthese_davis.pdf
HAS/2012-06-27_urgo_k2_latex_free-15_mai_2012_4274_avis.pdf
HAS/2012-06-28_09r03_reco_delivrance_information_personne_etat_sante.pdf
HAS/2012-06-28_aclasta_ct_7083.pdf
HAS/2012-06-28_aclastaeitcortico_-_ct-7083.pdf
HAS/2012-06-28_amlor_06062012_avis_ct12184.pdf
HAS/2012-06-28_argumentaire_-_delivrance_de_linformation_a_la_personne_sur_son_etat_de_sante.pdf
HAS/2012-06-28_berinert_-_ct-6744.pdf
HAS/2012-06-28_berinert_ct_6744.pdf
HAS/2012-06-28_corgard_06062012_avis_ct_12010.pdf
HAS/2012-06-28_ct-5354_versatis__2008-06-23_17-02-20_768.pdf
HAS/2012-06-28_elonva_-_ct-_8390.pdf
HAS/2012-06-28_elonva_ct_8390.pdf
HAS/2012-06-28_gestodene_ethinylestradiol_ratiopharm_20062012_avis_ct12301.pdf
HAS/2012-06-28_gestodene_ethinylestradiol_teva_20062012_avis_ct12301.pdf
HAS/2012-06-28_gestodene_ethinylestradiol_teva_ct_12301.pdf
HAS/2012-06-28_lumigan_06062012_avis_ct12024.pdf
HAS/2012-06-28_menopur_06_06_2012_avis_ct11487.pdf
HAS/2012-06-28_moviprep_09052012_avis_ct10881.pdf
HAS/2012-06-28_navelbine06062012_avis_ct9085.pdf
HAS/2012-06-28_orgalutran_06_06_2012_avis_ct10704.pdf
HAS/2012-06-28_reco2clics_-_delivrance_de_linformation_a_la_personne_sur_son_etat_de_sante.pdf
HAS/2012-06-28_recommandations_-_delivrance_de_linformation_a_la_personne_sur_son_etat_de_sante.pdf
HAS/2012-06-28_seretide_diskus_-_ct-5503.pdf
HAS/2012-06-28_seretide_diskus_ct_5503.pdf
HAS/2012-06-28_synthese_davis_aclasta_-_ct-7083.pdf
HAS/2012-06-28_synthese_davis_berinert_-_ct-6744_2009-10-29_15-41-8_451.pdf
HAS/2012-06-28_synthese_davis_elonva_-_ct-8390.pdf
HAS/2012-06-28_synthese_davis_seretide_diskus_-_ct-5503.pdf
HAS/2012-06-28_synthese_davis_zebinix_-_ct-8152.pdf
HAS/2012-06-28_temgesic_09052012_avis_ct11606.pdf
HAS/2012-06-28_versatis_ct_5354.pdf
HAS/2012-06-28_zebinix_-_ct-8152.pdf
HAS/2012-06-28_zebinix_ct_8152.pdf
HAS/2012-06-28_zelitrex_06062012_avis__ct_11935_et_12183.pdf
HAS/2012-06-29_ipaqss_4pages_utilisation_psi_ocde.pdf
HAS/2012-07-03_12irp07_argu_transfusion_de_plasma.pdf
HAS/2012-07-03_12irp07_reco_transfusion_de_plasma.pdf
HAS/2012-07-03_viracept_04072012_avis__ct_12133.pdf
HAS/2012-07-04_abilify_-_ct-_8227.pdf
HAS/2012-07-04_abilify_ct_8227.pdf
HAS/2012-07-04_actilyse_04072012_avis_ct12124.pdf
HAS/2012-07-04_actilyse_ct_12124.pdf
HAS/2012-07-04_actonel_-_ct-_8349.pdf
HAS/2012-07-04_actonel_ct_8349.pdf
HAS/2012-07-04_actylise_synthese_04072012.pdf
HAS/2012-07-04_bonviva_-_ct-8848.pdf
HAS/2012-07-04_bonviva_ct_8848.pdf
HAS/2012-07-04_ipaqss_rapport_mco_v4.pdf
HAS/2012-07-04_synthese_davis_abilify_-_ct-_8096.pdf
HAS/2012-07-04_synthese_davis_bonviva_-_ct-8848.pdf
HAS/2012-07-06_acular_20062012_avis_ct12032.pdf
HAS/2012-07-06_annexe_reevaluation_inf_ag_-_sep.pdf
HAS/2012-07-06_annexe_reevaluation_inf_ag_-_sep_2010-07-30_15-37-39_686.pdf
HAS/2012-07-06_annexe_reevaluation_inf_ag_-_sep_2010-08-04_11-12-15_399.pdf
HAS/2012-07-06_annexe_reevaluation_inf_ag_-_sep_2012-07-05_11-53-6_33.pdf
HAS/2012-07-06_annexe_reevaluation_inf_ag_-_sep_2012-07-05_12-04-45_357.pdf
HAS/2012-07-06_avonex_-_ct-1863.pdf
HAS/2012-07-06_avonex_ct_1863.pdf
HAS/2012-07-06_betaferon_-_ct-4317.pdf
HAS/2012-07-06_betaferon_ct_4317.pdf
HAS/2012-07-06_bondronat_-_ct-_6817.pdf
HAS/2012-07-06_bondronat_ct_6817.pdf
HAS/2012-07-06_citrafleet_-_ct-7872.pdf
HAS/2012-07-06_citrafleet_ct_7872.pdf
HAS/2012-07-06_copaxone_-_ct-5615.pdf
HAS/2012-07-06_copaxone_ct_5615.pdf
HAS/2012-07-06_isopto_pilocarpine_20062012_avis_ct11120.pdf
HAS/2012-07-06_lacryvisc_20062012_avis_ct12036.pdf
HAS/2012-07-06_orm-26_juin_2012_4292_avis.pdf
HAS/2012-07-06_synthese_davis__sep_if_beta_copaxone.pdf
HAS/2012-07-06_synthese_davis_citrafleet_-_ct-7872.pdf
HAS/2012-07-06_vexol_20062012_avis_ct12042.pdf
HAS/2012-07-10_betoptic_20062012_avis_ct11122.pdf
HAS/2012-07-10_flixonase_20062012_ct12070.pdf
HAS/2012-07-10_ludiomil_20062012_avis_ct11379.pdf
HAS/2012-07-10_pritor_plus_20062012_avis_ct_12096.pdf
HAS/2012-07-11_cymbalta_-_ct-6356.pdf
HAS/2012-07-11_cymbalta_ct_6356.pdf
HAS/2012-07-11_prezista_-_ct-6571.pdf
HAS/2012-07-11_prezista_-_ct-6572.pdf
HAS/2012-07-11_prezista_ct_6571.pdf
HAS/2012-07-11_prezista_ct_6572_6833.pdf
HAS/2012-07-11_synthese_davis_cymbalta_-_ct-6356.pdf
HAS/2012-07-11_synthese_davis_prezista_-_ct-6572-6833.pdf
HAS/2012-07-11_synthese_davis_prezista_ct-6571.pdf
HAS/2012-07-11_zenith__zenith_flex-26_juin_2012_4271_avis.pdf
HAS/2012-07-13_fs_buts_oxygene_v_finale.pdf
HAS/2012-07-13_leo_plus__leo_plus_sur_mesure-10_juillet_2012_4262__4263_avis.pdf
HAS/2012-07-13_rapport_oxygenotherapie.pdf
HAS/2012-07-13_texte_court_rapport_oxygenotherapie_2012_06_08.pdf
HAS/2012-07-14_anesm_09_protection-juridique_cs4_web.pdf
HAS/2012-07-14_anesm_09_protection-juridique_ea.pdf
HAS/2012-07-14_bibliographie_participation_majeurs_proteges.pdf
HAS/2012-07-14_document_d_appui_ppp.pdf
HAS/2012-07-14_lettre_de_cadrage_definitive_v4_110330.pdf
HAS/2012-07-14_presentation_anesm.pdf
HAS/2012-07-14_rapport_eqr_-_anesm_18112011_-_appui_a_la_rbpp.pdf
HAS/2012-07-14_synthese_vdef.pdf
HAS/2012-07-16_lumax_740_vr-t_dx-10_juillet_2012_4200_avis.pdf
HAS/2012-07-17_alvesco_18072012_avis_ct12155.pdf
HAS/2012-07-17_celance_-_ct-8905.pdf
HAS/2012-07-17_celance_ct_8905.pdf
HAS/2012-07-17_synthese_davis_celance_-ct-8905.pdf
HAS/2012-07-18_botox_18072012_avis_ct12193.pdf
HAS/2012-07-18_botox_18072012_synthese.pdf
HAS/2012-07-18_botox_ct_12193.pdf
HAS/2012-07-19_brief_inahta_symmetrisation_breast_cancer_surgery.pdf
HAS/2012-07-19_cadrage_symetrisation_mammaire.pdf
HAS/2012-07-19_rapport_symetrisation_mammaire.pdf
HAS/2012-07-19_texte_court_symetrisation_mammaire.pdf
HAS/2012-07-20_ald30_gp_coluterin_web.pdf
HAS/2012-07-20_ald_30_gm_col_uterin_web_2010-02-12_09-57-34_599.pdf
HAS/2012-07-20_ald_30_gm_k_foie_web.pdf
HAS/2012-07-20_ald_30_gm_k_pancreas_web.pdf
HAS/2012-07-20_ald_30_gm_myelome_vf.pdf
HAS/2012-07-20_ald_30_gp__myelome_web.pdf
HAS/2012-07-20_ald_30_lap_col_uterin_web.pdf
HAS/2012-07-20_ald_30_lap_k_foie_web.pdf
HAS/2012-07-20_ald_30_lap_k_pancreas_web.pdf
HAS/2012-07-20_ald_30_lap_myelome_vf.pdf
HAS/2012-07-20_gp_ald_cardiopathie_valvulaire.pdf
HAS/2012-07-20_gp_ald_prothese_valvulaire.pdf
HAS/2012-07-20_gp_cancer_foie.pdf
HAS/2012-07-20_gp_cancer_pancreas.pdf
HAS/2012-07-20_grand_appareillage_orthopedique-10_juillet_2012_4237_avis.pdf
HAS/2012-07-20_guide_medecin_ald_5_valvulopathies.pdf
HAS/2012-07-20_guide_medecin_ald_5_valvulopathies_en_web.pdf
HAS/2012-07-20_lap_ald5_valvulopathies.pdf
HAS/2012-07-20_lumax_740_hf-t-10_juillet_2012_4289_avis.pdf
HAS/2012-07-20_oxygenotherapie_-_fiche_buts.pdf
HAS/2012-07-25_ipaqss_rapport_cdei_v4.pdf
HAS/2012-07-25_zenith_dissection-10_juillet_2012_4265_avis.pdf
HAS/2012-07-25_zenith_tx2_dissection_proform-10_juillet_2012_4264_avis.pdf
HAS/2012-07-26_airomir_04072012_avis_ct9526.pdf
HAS/2012-07-26_allergocomod_04072012_avis_ct12127.pdf
HAS/2012-07-26_baraclude_200620128avis_ct11680.pdf
HAS/2012-07-26_brexin_04072012_avis_ct8619.pdf
HAS/2012-07-26_calprimum_04072012_avis_ct10675.pdf
HAS/2012-07-26_cycladol_20062012_avis_ct12037.pdf
HAS/2012-07-26_fungizone_04072012_avis_ct_12176.pdf
HAS/2012-07-26_levemir_penfill_flexpen_innolet__20062012_avis_ct11896.pdf
HAS/2012-07-26_natulan_20062012_avis_ct10308.pdf
HAS/2012-07-26_otrasel_20062012_avis_ct11386.pdf
HAS/2012-07-26_perinutriflex_mednutriflex_reanutriflex_04072012_avis_ct11503.pdf
HAS/2012-07-26_quitaxon_20062012_avis_ct11808.pdf
HAS/2012-07-26_spagulax_04072012_avis_ct12135.pdf
HAS/2012-07-26_telfast_04072012_avis_ct11673.pdf
HAS/2012-07-26_toprec_04072012i_avis_ct10999.pdf
HAS/2012-07-26_urispas_20062012_avis_11283.pdf
HAS/2012-07-26_vitamine_e_nepalm_04072012_avis_ct11801.pdf
HAS/2012-07-27_paracetamol_arrow_18072012_avis_ct11973.pdf
HAS/2012-07-27_paracetamol_sandoz_18072012_avis_ct12069.pdf
HAS/2012-07-30_ald30_gp_kvessie_vf.pdf
HAS/2012-07-30_ald_30_gm_cancer_du_testicule__web.pdf
HAS/2012-07-30_ald_30_gm_vessie_inca_has_web.pdf
HAS/2012-07-30_ald_30_gp_cancer_testicule_web.pdf
HAS/2012-07-30_ald_30_lap_cancer_du_testicule_web.pdf
HAS/2012-07-30_ald_30_lap_vessie_inca_has_web.pdf
HAS/2012-07-30_gm_alzheimer_finale_web_juin2009.pdf
HAS/2012-07-30_lap_alzheimer_finale_web_juin2009.pdf
HAS/2012-07-30_seresta_18072012_avis_ct11562.pdf
HAS/2012-07-31_actrapid_insulatard_mixtard_18072012_avis_ct9258.pdf
HAS/2012-07-31_josir_mecir_18072012_avis_ct12131.pdf
HAS/2012-07-31_novorapid_novomix_18072012_avis_ct8375.pdf
HAS/2012-07-31_paracetamol_arrow_18072012_avis_ct11879.pdf
HAS/2012-07-31_potassium_richard_18072012_ct_12318.pdf
HAS/2012-07-31_temesta_18072012_avis_ct11563.pdf
HAS/2012-07-31_victan_18072012_avis_ct10955.pdf
HAS/2012-07-31_vitamine_a_nepalm_04072012_avis_ct11807.pdf
HAS/2012-07-31_zarontin_18072012_avis_ct12046.pdf
HAS/2012-08-03_clinimix_04072012_avis_ct12008.pdf
HAS/2012-08-03_comtan_18072012_avis_ct_11559.pdf
HAS/2012-08-03_hepsera_18072012_avis_ct6886.pdf
HAS/2012-08-03_lysanxia_18072012_avis_ct12027.pdf
HAS/2012-08-03_omix_omexel_18072012_avis_ct12128.pdf
HAS/2012-08-03_oravir_18072012_avis_ct11560.pdf
HAS/2012-08-03_roferon_a_18072012_avis_ct8225.pdf
HAS/2012-08-03_stalevo_18072012_avis_ct6580.pdf
HAS/2012-08-03_tranxene_18072012_avis_ct11000.pdf
HAS/2012-08-03_xanax_18072012_avis_c11986.pdf
HAS/2012-08-07_nasonex_18072012_avis_ct12208.pdf
HAS/2012-08-09_apokinon_20062012_avis_ct11537.pdf
HAS/2012-08-09_bard_vivexx-10_juin_2008_1471_avis.pdf
HAS/2012-08-22_ald_hors_liste_-_pnds_sur_le_syndrome_de_costello.pdf
HAS/2012-08-22_pnds_46_-_syndrome_de_costello_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2012-08-24_avis_general__pieds_a_restitution_denergie-12_juin_2012_4266_avis.pdf
HAS/2012-08-26_ald17_lap_hemochromatose_web.pdf
HAS/2012-08-26_ald30_gm_k_ovaire_vd_2010-02-11_15-00-56_15.pdf
HAS/2012-08-26_ald_30_gp_cancer_ovaire_web.pdf
HAS/2012-08-26_ald_30_gp_cancer_snc_edite_2011-04-08_09-38-48_889.pdf
HAS/2012-08-26_ald_30_gp_vads_2010-09-27_16-44-14_118.pdf
HAS/2012-08-26_ald_30_guide__k_snc_web.pdf
HAS/2012-08-26_ald_30_guide_vads_web.pdf
HAS/2012-08-26_ald_30_lap_k_ovaire_vd.pdf
HAS/2012-08-26_ald_30_lap_k_snc_has_web.pdf
HAS/2012-08-26_ald_30_lap_vads_web.pdf
HAS/2012-08-26_fiche_de_synth_350se_hfe-1_finale.pdf
HAS/2012-09-04_ipaqss_rapport_dan_v4.pdf
HAS/2012-09-06_ald_hors_liste_-_liste_dactes_et_de_prestations_sur_la_dysplasie_fibreuse_des_os.pdf
HAS/2012-09-06_ald_hors_liste_-_pnds_sur_la_dysplasie_fibreuse_des_os.pdf
HAS/2012-09-06_argu_irct_volet_greffe_vf.pdf
HAS/2012-09-06_didronel_-_ct-8007.pdf
HAS/2012-09-06_didronel_ct_8007.pdf
HAS/2012-09-06_neuroform_3__neuroform_3_ez-12_juin_2012_4248_avis.pdf
HAS/2012-09-06_note_cadrage_irct_vf.pdf
HAS/2012-09-06_pnds_47_-_dysplasie_fibreuse_des_os_et_syndrome_de_mccune-albright_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2012-09-06_synthese_davis_didronel_-_ct-8007.pdf
HAS/2012-09-06_synthese_irct_volet_greffe_vf.pdf
HAS/2012-09-10_alzheimers_disease_and_related_conditions-health_monitoring_for_family_carers-qrg-version_anglaise.pdf
HAS/2012-09-10_info_patient_consultation_aidant_6volets.pdf
HAS/2012-09-10_info_patient_consultation_aidant_ecran.pdf
HAS/2012-09-10_itrel_4-11_septembre_2012_4297_avis.pdf
HAS/2012-09-10_maladie_dalzheimer_-_suivi_medical_des_aidants_naturels_-_argumentaire_2010-03-31_15-38-54_749.pdf
HAS/2012-09-10_maladie_dalzheimer_-_suivi_medical_des_aidants_naturels_-_synthese.pdf
HAS/2012-09-10_reco2clics_alzheimer_suivi_medical.pdf
HAS/2012-09-10_recommandation_maladie_dalzheimer_-_suivi_medical_des_aidants_naturels.pdf
HAS/2012-09-10_s8_dispositif_annonce_du_diagnostic_et_accompagnement_revgg27042012.pdf
HAS/2012-09-12_demipulse__perrenia-11_septembre_2012_4256.pdf
HAS/2012-09-12_perigee__intepro_lite-11_septembre_2012_4187_avis.pdf
HAS/2012-09-17_actisorb-11_septembre_2012_4290_avis.pdf
HAS/2012-09-17_baha-11_septembre_2012_4281_avis.pdf
HAS/2012-09-17_baha_bp_110_power-11_septembre_2012_4269_avis.pdf
HAS/2012-09-17_zenith_fenestrated-09_octobre_2012_4359_avis.pdf
HAS/2012-09-17_zenith_fenestrated-11_septembre_2012_4291_avis.pdf
HAS/2012-09-17_zenith_low_profile-11_septembre_2012_4310_avis.pdf
HAS/2012-09-24_acidum_phosphoricum_compose_05092012_avis_ct12267.pdf
HAS/2012-09-24_betahistine_biogaran_05092012__avis_ct_12409.pdf
HAS/2012-09-24_calcium_sandoz_05092012_avis_ct9371.pdf
HAS/2012-09-24_captea_05092012_avis_ct_12386.pdf
HAS/2012-09-24_celluvisc_05092012_avis_ct11952.pdf
HAS/2012-09-24_corenitec_05092012_avis_ct_12363.pdf
HAS/2012-09-24_diastabol_05092012_avis_ct11852.pdf
HAS/2012-09-24_discotrine_05092012_avis_ct11999.pdf
HAS/2012-09-24_ecazide_05092012_avis_ct_12382.pdf
HAS/2012-09-24_eupressyl_05092012_avis_ct_12385.pdf
HAS/2012-09-24_extovyl_05092012_avis_ct12224.pdf
HAS/2012-09-24_gadovist_05092012_avis_ct_12279.pdf
HAS/2012-09-24_glucor_05092012_avis_ct11478.pdf
HAS/2012-09-24_ibuprofene__05092012_avis_ct12245.pdf
HAS/2012-09-24_isobar_05092012_avis_ct_12366.pdf
HAS/2012-09-24_jentadueto_05092012_avis_ct12491.pdf
HAS/2012-09-24_moduretic_05092012_avis_ct_12362.pdf
HAS/2012-09-24_prinivil_05092012_avis_ct_12401.pdf
HAS/2012-09-24_quinimax_05092012_avis_ct11781.pdf
HAS/2012-09-24_rebetol_05092012_avis_ct6939_et_12452.pdf
HAS/2012-09-24_stagid_05092012_avis_ct12419.pdf
HAS/2012-09-24_tienam_05092012_avis__ct_12289.pdf
HAS/2012-09-24_totamine_concentre_05092012_avis_ct_11377.pdf
HAS/2012-09-24_trusopt_05092012_avis_ct12106.pdf
HAS/2012-09-24_viraferonpeg_05092012_avis_ct12335.pdf
HAS/2012-09-24_zestril_05092012_avis_ct_12401.pdf
HAS/2012-09-25_breakyl_05092012_avis_ct12199.pdf
HAS/2012-09-25_minidiab_glibenese_05092012_avis_ct11917_ct11918_2012-09-24_11-50-32_119.pdf
HAS/2012-09-26_concerto-concerto_pin-11_septembre_2012_4288_avis.pdf
HAS/2012-09-26_concerto-concerto_pin_abi-11_septembre_2012_4287_avis.pdf
HAS/2012-09-27_04r23_algo_preparation_a_la_naissance_besoin_femme_couple.pdf
HAS/2012-09-27_04r23_algo_preparation_a_la_naissance_demarche_de_prevention.pdf
HAS/2012-09-27_04r23_algo_preparation_a_la_naissance_planification_de_la_preparation.pdf
HAS/2012-09-27_04r23_memo_preparation_a_la_naissance_liste_de_questions.pdf
HAS/2012-09-27_04r23_memo_preparation_a_la_naissance_objectifs_et_contenu_des_seances.pdf
HAS/2012-09-27_04r23_proto_preparation_a_la_naissance_guide_d_entretien.pdf
HAS/2012-09-27_criteres_qualite-pnp.pdf
HAS/2012-09-27_listes_des_criteres_qualite-pnp_-_pdf.pdf
HAS/2012-09-27_preparation_naissance_fiche.pdf
HAS/2012-09-27_preparation_naissance_rap.pdf
HAS/2012-09-27_preparation_naissance_recos.pdf
HAS/2012-09-27_preparing_birth_guidelines.pdf
HAS/2012-09-28_aquacel_ag-25_septembre_2012_4268_avis.pdf
HAS/2012-09-28_avis_general_implants_articulaires_de_coude-11_septembre_2012_2417_avis_2012-09-27_11-31-28_197.pdf
HAS/2012-09-28_composition_du_gt.pdf
HAS/2012-09-28_dtacp-25_septembre_2012_2763_avis.pdf
HAS/2012-09-28_note_cadrage_coude_vf_2012-09-27_11-41-53_644.pdf
HAS/2012-09-28_rapport_suite_cnedimts_pour_publication_2012-09-27_11-40-28_39.pdf
HAS/2012-09-28_texte_court_implants_articulaires_de_coude.pdf_2012-09-27_11-41-7_391.pdf
HAS/2012-09-28_texte_court_implants_du_coude_vu_ef.pdf
HAS/2012-10-02_avis_general_implants_articulaires_de_coude-11_septembre_2012_2417_avis.pdf
HAS/2012-10-02_avodart_chibro_proscar_combodart_synthese_ct9291_9896_11612_12202.pdf
HAS/2012-10-02_chibro-proscar_05092012_ct_11612.pdf
HAS/2012-10-02_flixotide18072012_avis_ct12079.pdf
HAS/2012-10-02_symbicort_18072012_avis_ct10285.pdf
HAS/2012-10-04_20120213_guide_pec_enfant_ado.pdf
HAS/2012-10-04_annexe_2_charte_europeenne_enfant_hospitalise.pdf
HAS/2012-10-04_format2clics_enfants_v3.pdf
HAS/2012-10-05_11igm02_consultation_publique_annexe_1.pdf
HAS/2012-10-05_11igm02_consultation_publique_annexe_2.pdf
HAS/2012-10-05_11igm02_consultation_publique_annexe_3.pdf
HAS/2012-10-05_11igm02_consultation_publique_annexe_4.pdf
HAS/2012-10-05_11igm02_consultation_publique_annexe_5.pdf
HAS/2012-10-05_11igm02_consultation_publique_annexe_6.pdf
HAS/2012-10-05_11igm02_consultation_publique_document_information_v2_liens_actifs.pdf
HAS/2012-10-05_11igm02_consultation_publique_format2clics.pdf
HAS/2012-10-05_11igm02_consultation_publique_guide_methodologique_v2_2012-10-18_14-16-44_998.pdf
HAS/2012-10-05_11igm02_consultation_publique_participants.pdf
HAS/2012-10-05_brief_inahta_canal_carpien.pdf
HAS/2012-10-05_chirurgie_du_syndrome_du_canal_carpien___approche_multidimensionnelle_pour_une_decision_pertinente_-_rapport_devaluation.pdf
HAS/2012-10-05_chirurgie_du_syndrome_du_canal_carpien___approche_multidimensionnelle_pour_une_decision_pertinente_-_texte_court.pdf
HAS/2012-10-05_consultation_publique_etat_des_lieux.pdf
HAS/2012-10-05_consultation_publique_etat_des_lieux_annexe_2.pdf
HAS/2012-10-05_format2clics_info-patient.pdf
HAS/2012-10-05_info_patient_biblio_participants.pdf
HAS/2012-10-05_info_patient_certificat_medical_6volets.pdf
HAS/2012-10-05_info_patient_certificat_medical_ecran.pdf
HAS/2012-10-05_info_patient_consultation_aidant_6volets.pdf
HAS/2012-10-05_info_patient_consultation_aidant_ecran.pdf
HAS/2012-10-05_info_patient_criteres_evaluation.pdf
HAS/2012-10-05_info_patient_diapo_pilotage_2012-10-11_10-27-28_501.pdf
HAS/2012-10-05_info_patient_diapo_test.pdf
HAS/2012-10-05_info_patient_etapes.pdf
HAS/2012-10-05_info_patient_fiche_descriptive.pdf
HAS/2012-10-05_info_patient_fiche_methodologique.pdf
HAS/2012-10-05_info_patient_guide_methodologique.pdf
HAS/2012-10-05_info_patient_test2_lettre__sollicitation.pdf
HAS/2012-10-05_info_patient_test_lettre_resultats.pdf
HAS/2012-10-05_info_patient_test_lettre_sollicitation.pdf
HAS/2012-10-05_info_patient_test_questionnaire.pdf
HAS/2012-10-05_note_de_cadrage_canal_carpien_2011-12-27_15-46-17_418.pdf
HAS/2012-10-09_methode_de_ssp_v15.pdf
HAS/2012-10-09_page_web_grille_evaluation_ssp_type_2.pdf
HAS/2012-10-10_annexes_rapport_compression_contention_2012_sed_vdef_2012-10-08_14-34-48_853.pdf
HAS/2012-10-10_avis_compression_contention_1277_120712.pdf
HAS/2012-10-10_rapport_compression_contention_2012_sed_vdef_3.pdf
HAS/2012-10-10_texte_court_compression_contention_2012_sed_vdef.pdf
HAS/2012-10-10_texte_court_compression_contention_en_vd.pdf
HAS/2012-10-12_carpenter_viscolux-25_septembre_2012_4324_avis.pdf
HAS/2012-10-12_edwards_sapien_xt_mod_9300_tfx_ascendra_-25_septembre_2012_4326_avis.pdf
HAS/2012-10-12_effidia-25_septembre_2012_4312_avis.pdf
HAS/2012-10-12_effidia-25_septembre_2012_4312_synthese_davis_2013-01-15_17-02-40_366.pdf
HAS/2012-10-12_ialuset_plus-25_septembre_2012_4303_avis.pdf
HAS/2012-10-12_ialuset_plus_25_septembre_2012_4303_synthese_davis_2013-01-14_12-09-4_593.pdf
HAS/2012-10-12_ostibone-25_septembre_2012_4304_avis.pdf
HAS/2012-10-12_zenith_branch-25_septembre_2012_4272_avis.pdf
HAS/2012-10-15_carlin_avis_ct11881.pdf
HAS/2012-10-15_desopharm_04072012_avis_ct11956.pdf
HAS/2012-10-15_gespharm_05092012_avis_ct11955_ins.pdf
HAS/2012-10-15_gestodene_ethinylestradiol_arrow_04072012_avis_ct12038.pdf
HAS/2012-10-15_optinesse_19092012_avis_ct11955.pdf
HAS/2012-10-16_aminomix_17102012_avis_ct12504.pdf
HAS/2012-10-16_aminomix_srh.pdf
HAS/2012-10-16_avis_general_compression_contention-10_juillet_2012_1277.pdf
HAS/2012-10-16_digisonic_sp_evo-09_octobre_2012_4343_avis.pdf
HAS/2012-10-16_eon_penta-11_septembre_2012_4295_avis.pdf
HAS/2012-10-16_flammazine_03102012_avis_ct11169.pdf
HAS/2012-10-18_calcidia_03102012_avis_ct12356.pdf
HAS/2012-10-18_corevalve_accutrak-25_septembre_2012_4332_avis.pdf
HAS/2012-10-18_corevalve_evolut_accutrak-25_septembre_4331_avis.pdf
HAS/2012-10-18_phosphalugel_03102012_avis_ct12357.pdf
HAS/2012-10-19_avlocardyl_03102012_avis__ct_12402.pdf
HAS/2012-10-19_clarelux_03102012_avis_ct12243.pdf
HAS/2012-10-19_evia_hf-t-09_octobre_2012_4283_avis.pdf
HAS/2012-10-19_intetrix_03102012_avis_ct_12414.pdf
HAS/2012-10-19_kabiven_03102012_avis1_ct11054.pdf
HAS/2012-10-19_langoran_lp_03102012_avis_ct_12328.pdf
HAS/2012-10-19_logroton_03102012_avis_ct_12354.pdf
HAS/2012-10-19_micardisplus_03102012_avis_ct12216.pdf
HAS/2012-10-19_perikabiven_03102012_avis_ct11055.pdf
HAS/2012-10-19_risordan_03102012_avis_ct_12324.pdf
HAS/2012-10-19_thiocolchicoside_biogaran_03102012_avis_ct12352.pdf
HAS/2012-10-22_acupan_03102012_avis_ct11224.pdf
HAS/2012-10-22_anausin_metoclopramide_03102012_avis_ct12376.pdf
HAS/2012-10-22_coaprovel_03102012_avis_ct12427.pdf
HAS/2012-10-22_colofoam_03102012_avis_ct_12375.pdf
HAS/2012-10-22_contracide_03102012_avis_ct12412.pdf
HAS/2012-10-22_dexef_03102012_avis_ct_12191.pdf
HAS/2012-10-22_fluarix_05092012_avis_ct12122.pdf
HAS/2012-10-22_gastropulgite_03102012_avis_ct12415.pdf
HAS/2012-10-22_gelox_03102012_avis_ct12416.pdf
HAS/2012-10-22_heparine_choay_03102012_avis_ct12390.pdf
HAS/2012-10-22_injection_de_toxine_botulique_dans_la_musculeuse_vesicale_par_uretrocystoscopie_-_etude_sur_les_actes_2012-10-22_10-00-30_558.pdf
HAS/2012-10-22_nalgesic_03102012_avis_ct11045.pdf
HAS/2012-10-22_nivaquine_03102012_avis_ct10972.pdf
HAS/2012-10-22_protamine_choay_03102012_avis_ct_12389.pdf
HAS/2012-10-22_tocopherol_teva_03102012_avis_ct12213.pdf
HAS/2012-10-22_vit_b12_delagrange_03102012_avis_ct12323_2012-10-19_15-28-17_748.pdf
HAS/2012-10-24_bientraitance_-_affiche.pdf
HAS/2012-10-24_bientraitance_-_cartographie.pdf
HAS/2012-10-24_bientraitance_-_charte_guide.pdf
HAS/2012-10-24_bientraitance_-_epp.pdf
HAS/2012-10-24_bientraitance_-_grille_ceppral.pdf
HAS/2012-10-24_bientraitance_-_guide_carto_risques.pdf
HAS/2012-10-24_bientraitance_-_guide_dutilisation-cahier_des_charges.pdf
HAS/2012-10-24_bientraitance_-_note-methodo.pdf
HAS/2012-10-24_bientraitance_-_outilccecqa.pdf
HAS/2012-10-24_bientraitance_-_protocole_grille_ceppral.pdf
HAS/2012-10-24_bientraitance_-_questionnaire_v1.pdf
HAS/2012-10-24_bientraitance_-_questionnaire_v2.pdf
HAS/2012-10-24_bientraitance_-_rapport.pdf
HAS/2012-10-24_bientraitance_-_support_de_presentation.pdf
HAS/2012-10-26_ald_30__gm_llc_web_2vf.pdf
HAS/2012-10-26_ald_30_gm_cancer__thyroide_web.pdf
HAS/2012-10-26_ald_30_gp_leucemie_lymphoide_web.pdf
HAS/2012-10-26_ald_30_gp_prostate_web_2010-09-28_10-55-8_471.pdf
HAS/2012-10-26_ald_30_lap_cancer_thyroide_web.pdf
HAS/2012-10-26_ald_30_lap_llc_web_2vf.pdf
HAS/2012-10-26_avis_perigee.pdf
HAS/2012-10-30_aesculus_compose_17102012_avis_ct12265.pdf
HAS/2012-10-30_cromoptic_17102012_avis_ct12082.pdf
HAS/2012-10-30_dexafree_17102012_avis_ct12278.pdf
HAS/2012-10-30_exocine_17102012_avis_ct11933.pdf
HAS/2012-10-30_hamamelis_compose_17102012_avis_ct12255.pdf
HAS/2012-10-30_isoptine_03102012_avis_ct_12425.pdf
HAS/2012-10-30_mononaxy-naxy_17102012_avis_ct12162.pdf
HAS/2012-10-30_rocephine_17102012_avis_ct11975.pdf
HAS/2012-10-31_anaconda_4315.pdf
HAS/2012-10-31_atomisor_pocket-4345.pdf
HAS/2012-10-31_heartware__09_octobre_2012_4347__avis.pdf
HAS/2012-10-31_vivexx_4276.pdf
HAS/2012-11-05_ipaqss-rapport-had-v4.pdf
HAS/2012-11-05_ipaqss-rapport-psy-v5.pdf
HAS/2012-11-05_ipaqss-rapport-ssr-v4.pdf
HAS/2012-11-09_4308_avis_cnedimts_ppc.pdf
HAS/2012-11-09_neurostimulateurs_rechargeables_4341_avis.pdf
HAS/2012-11-15_askina_carbosorb_4316.pdf
HAS/2012-11-16_birodogyl_rodogyl_17102012_avis_ct11783.pdf
HAS/2012-11-16_chibroxine_17102012_avis_ct11687.pdf
HAS/2012-11-16_daonil_hemidaonil_17102012_avis_ct12426.pdf
HAS/2012-11-16_diffu-k_17102012_avis_ct12377.pdf
HAS/2012-11-16_eludrilperio_17102012_avis_ct12338.pdf
HAS/2012-11-16_fiche_buts_ett_angor.pdf
HAS/2012-11-16_fiche_buts_ett_hta.pdf
HAS/2012-11-16_fiche_buts_ett_ia.pdf
HAS/2012-11-16_fiche_buts_ett_ic.pdf
HAS/2012-11-16_fiche_buts_ett_im.pdf
HAS/2012-11-16_fiche_buts_ett_ra.pdf
HAS/2012-11-16_fiche_buts_ett_rm.pdf
HAS/2012-11-16_fiche_buts_ett_sca.pdf
HAS/2012-11-16_fiche_buts_mediator_nov2012_vd_2012-11-16_09-46-5_303.pdf
HAS/2012-11-16_rapport_eval_ett_octobre_2012_vd.pdf
HAS/2012-11-16_texte_court_ett_octobre_2012_vd.pdf
HAS/2012-11-21_11irp01_argu_avc_methodes_de_reeducation.pdf
HAS/2012-11-21_11irp01_reco2clics_avc_methodes_de_reeducation.pdf
HAS/2012-11-21_11irp01_reco_avc_methodes_de_reeducation.pdf
HAS/2012-11-21_11irp01_synt_avc_methodes_de_reeducation.pdf
HAS/2012-11-23_enterprise_4296_avis.pdf
HAS/2012-11-23_ipaqss_rapport-avc-v5.pdf
HAS/2012-11-23_ipaqss_rapport_fermon_levy_nov2006_2012-11-21_17-48-14_160.pdf
HAS/2012-11-23_mepilex_ag_4301.pdf
HAS/2012-11-23_octenilin_4299.pdf
HAS/2012-11-23_physio-stim_4337.pdf
HAS/2012-11-23_roho_quadtro_select_4051.pdf
HAS/2012-11-23_ventilation_mecanique_a_domicile_dm_eval_11.pdf
HAS/2012-11-23_xenosure_4328.pdf
HAS/2012-11-26_CT-10502_TILCOTIL_ 17102012_AVIS_ CT10502_ 8590.pdf
HAS/2012-11-26_CT-11447_OGAST_07112012_AVIS_CT11447.pdf
HAS/2012-11-26_CT-11664_ALEVETABS_07112012_AVIS_CT11664.pdf
HAS/2012-11-26_CT-11758_AXEPIM_17102012_AVIS_CT11758.pdf
HAS/2012-11-26_CT-12011_TRACUTIL_17102012_AVIS_CT12011.pdf
HAS/2012-11-26_CT-12132_MEBEVERINE_ZENTIVA_07112012_AVIS_CT12132.pdf
HAS/2012-11-26_CT-12255_CHELIDONIUM_COMPOSE_17102012_AVIS_CT12255.pdf
HAS/2012-11-26_CT-12523_DESOGESTREL_ETHINYLESTRADIOL_ZENTIVA_07112012_AVIS_CT12523.pdf
HAS/2012-11-26_aprovel_03102012_avis_ct12428.pdf
HAS/2012-11-26_axepim_srh.pdf
HAS/2012-11-26_fortum_fortumset_17102012_avis_ct11561.pdf
HAS/2012-11-26_fortumset_srh_2008-08-08_11-31-23_194.pdf
HAS/2012-11-26_guide_methodologique_diffusion_indicateurs.pdf
HAS/2012-11-26_ipaqss_diaporama_diffusion_publique_indicateurs_internet.pdf
HAS/2012-11-26_lanzor_17102012_avis_ct11415.pdf
HAS/2012-11-26_pristam_500_mg_17102012_avis_ct_12487.pdf
HAS/2012-11-26_prothiaden_07112012_avis_ct11439.pdf
HAS/2012-11-26_pyostacine_17102012_avis_ct_12174.pdf
HAS/2012-11-26_synthese-diffusion-publique-v3.pdf
HAS/2012-11-26_synthese_guide_methodologique_diffusion_indicateurs.pdf
HAS/2012-12-04_contraceptis_oraux_3_g_fiche_bum.pdf
HAS/2012-12-06_ald_30__lap_k_oesophage_web.pdf
HAS/2012-12-06_ald_30_gm_k_estomac_web.pdf
HAS/2012-12-06_ald_30_gm_k_oesophage_web.pdf
HAS/2012-12-06_ald_30_lap_k_estomac_web.pdf
HAS/2012-12-11_CEPP-4318_PRODISC-L_4318_avis.pdf
HAS/2012-12-11_grossesses_a_risque_-_argumentaire.pdf
HAS/2012-12-11_grossesses_a_risque_-_fiche_de_synthese_-_criteres_2010-04-15_16-45-19_197.pdf
HAS/2012-12-11_grossesses_a_risque_-_fiche_de_synthese_-_informations.pdf
HAS/2012-12-11_grossesses_a_risque_-_recommandations.pdf
HAS/2012-12-12_ipaqss-rapport-hpp-v3.pdf
HAS/2012-12-13_CT-10956_NOZINAN_07112012_AVIS_CT10956.pdf
HAS/2012-12-13_CT-10975_NEULEPTIL_07112012_AVIS_CT10975.pdf
HAS/2012-12-13_CT-10977_LARGACTIL_07112012_AVIS_CT10977.pdf
HAS/2012-12-13_CT-10998_DOGMATIL_07112012_AVIS_CT10998.pdf
HAS/2012-12-13_CT-11100_LOXAPAC_07112012_AVIS_CT11100.pdf
HAS/2012-12-13_CT-11344_DIPIPERON_07112012_AVIS_CT11344.pdf
HAS/2012-12-13_CT-11676_CLOPIXOL_07112012_AVIS_CT11676.pdf
HAS/2012-12-13_CT-11762_FLUANXOL_07112012_AVIS_CT11762.pdf
HAS/2012-12-13_CT-12244_LOPRESSOR_21112012_AVIS_CT12244.pdf
HAS/2012-12-13_CT-12248_BUDESONIDE TEVA_17102012_AVIS_CT12248.pdf
HAS/2012-12-13_CT-12371_MOXYDAR_21112012_AVIS_CT12371.pdf
HAS/2012-12-13_CT-12395_TOPAAL_21112012_AVIS_CT12395.pdf
HAS/2012-12-13_CT-12400_SELOZOK_21112012_AVIS_CT12244.pdf
HAS/2012-12-13_CT-12584_PRESTOLE_21112012_CT12584.pdf
HAS/2012-12-13_seretidegamme_ri2012_avis_2_modifie_le_29_11_2012_ct8857.pdf
HAS/2012-12-14_08l55_guide_medecin_pnds_aplasies_utero_vaginales.pdf
HAS/2012-12-14_CT-11348_ORAP_07112012_AVIS_CT11348.pdf
HAS/2012-12-14_CT-11359_HALDOL_07112012_AVIS_CT11359.pdf
HAS/2012-12-14_CT-11984_KESTIN_KESTINLYO_17102012_AVIS_CT11984.pdf
HAS/2012-12-14_CT-12034_MIFLASONE_07112012_AVIS_CT12034.pdf
HAS/2012-12-14_CT-12399_SELOKEN_21112012_AVIS_CT12399.pdf
HAS/2012-12-14_CT-12411_FORTRANS_21112012_AVIS_CT12411.pdf
HAS/2012-12-14_CT-12459_ALOXI_21112012_AVIS_CT12459.pdf
HAS/2012-12-14_CT-12516_TAHOR_21112012_AVIS_CT12516.pdf
HAS/2012-12-14_CT-9434_CHLORAMINOPHENE_07112012_AVIS_CT9434.pdf
HAS/2012-12-14_fiche_de_bon_usage_-_angioplastie_coronarienne_interet_et_limites_des_stents_actifs.pdf
HAS/2012-12-14_gery_4323.pdf
HAS/2012-12-14_impact_enteral_4277.pdf
HAS/2012-12-14_inperia_advance_carbostent_4322.pdf
HAS/2012-12-14_merlin.net_4258.pdf
HAS/2012-12-14_merlin.net_4339.pdf
HAS/2012-12-14_merlin.net_4340_2012-12-04_10-45-46_712.pdf
HAS/2012-12-14_merlin.net_4355_2012-12-04_10-45-25_529.pdf
HAS/2012-12-14_merlin.net_4356_2012-12-04_10-42-16_852.pdf
HAS/2012-12-14_merlin.net_4357_2012-12-04_10-44-37_363.pdf
HAS/2012-12-14_oral_impact_4279.pdf
HAS/2012-12-14_pnds_49_-_aplasies_utero_vaginales_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2012-12-18_CT-11688_NAABAK-NAAXIA-NAAXIAFREE_05122012_Avis1_CT11688_RI_PIS.pdf
HAS/2012-12-18_CT-12305_PARIET_07112012_AVIS_CT12305.pdf
HAS/2012-12-18_CT-12321_DOLKO_PIS_AVIS1_CT12321.pdf
HAS/2012-12-18_CT-12332_SERECOR_RI_avis1_CT12332.pdf
HAS/2012-12-18_note_de_cadrage_appendicectomie_version_mise_en_ligne_vdef_22_02_12.pdf
HAS/2012-12-18_rapport_appendicectomie_vd_2012-12-17_16-14-27_74.pdf
HAS/2012-12-18_texte_court_appendicectomie_vd_2012-12-17_16-14-13_679.pdf
HAS/2012-12-18_zyprexa_11042012_avis_ct11921.pdf
HAS/2012-12-19_CT-11731_OMNISCAN_05122012 _AVIS_CT11731.pdf
HAS/2012-12-19_CT-12393_CORDARONE_RI_avis 2_CT12393 EC.pdf
HAS/2012-12-19_CT-12485_DIMETANE_05122012_AVIS_CT12485.pdf
HAS/2012-12-20_CT-11077_TERCIAN_07112012_AVIS_CT11921.pdf
HAS/2012-12-20_CT-12554_TARKA RI 2012_avis 2 CT 12554_VF.pdf
HAS/2012-12-20_a_2012_0047_avis_prothese_epiretinienne_2012-12-19_15-21-46_404.pdf
HAS/2012-12-20_a_2012_0048_avis_prothese_epiretinienne_argus_ii_2012-12-19_15-26-7_336.pdf
HAS/2012-12-20_avis_cnedimts_argus_ii.pdf
HAS/2012-12-20_brief_inahta_physiotherapeutic_treatment_of_lymphoedema.pdf
HAS/2012-12-20_composition_du_groupe_de_travail_evaluation_dun_implant_retinien_et_de_son_acte.pdf
HAS/2012-12-20_d_2012_0190_prothese_epiretinienne_2012-12-19_15-30-8_446.pdf
HAS/2012-12-20_prise_en_charge_masso-kinesitherapique_dun_lymphoedeme_et_dune_raideur_de_lepaule_apres_traitement_dun_cancer_du_sein_-_note_de_cadrage.pdf
HAS/2012-12-20_rapport_evaluation_dune_prothese_epiretinienne_et_de_son_acte_dimplantation.pdf
HAS/2012-12-20_rapport_lymphoedeme_2012-12-20_09-18-24_35.pdf
HAS/2012-12-20_summary_argus_ii.pdf
HAS/2012-12-20_texte_court_-_evaluation_dune_prothese_epiretinienne_et_de_son_acte_dimplantation.pdf
HAS/2012-12-20_texte_court_lymphoedeme.pdf
HAS/2012-12-21_avis_definitif_protheses_faciales.pdf
HAS/2012-12-26_10irp02_cons_pra_obeiste_adulte_conseils_pratiques_activites_physiques.pdf
HAS/2012-12-26_10irp02_cons_pra_obesite_adulte_conseils_pratiques_alimentation.pdf
HAS/2012-12-26_10irp02_fiche_memo_obesite_adulte_bilan_initial_d_un_exces_de_poids.pdf
HAS/2012-12-26_10irp02_fiche_memo_obesite_adulte_guide_d_entretien_initial.pdf
HAS/2012-12-26_10irp02_fiche_memo_obesite_adulte_prise_en_charge_de_l_obeiste.pdf
HAS/2012-12-26_10irp02_fiche_memo_obesite_adulte_prise_en_charge_du_surpoids.pdf
HAS/2012-12-26_10irp02_fiche_tech_obesite_adulte_table_d_indice_de_masse_corporelle.pdf
HAS/2012-12-26_2011_09_27_surpoids_obesite_adulte_v5_pao.pdf
HAS/2012-12-26_2011_09_30_obesite_adulte_argumentaire.pdf
HAS/2012-12-26_annexe_1_table_dindice_de_masse_corporelle.pdf
HAS/2012-12-26_annexe_2_fiche_de_support_a_lentretien_bilan_initial.pdf
HAS/2012-12-26_annexe_3_fiche_de_conseils_pour_lalimentation.pdf
HAS/2012-12-26_annexe_4_exemples_dactivites_physiques.pdf
HAS/2012-12-26_annexe_5_fiche_prise_en_charge_obesite.pdf
HAS/2012-12-26_avis_de_la_has_-_implants_articulaires_de_genou_-_6_novembre_2012_2012-12-21_11-41-59_361.pdf
HAS/2012-12-26_composition_du_groupe_de_travail.pdf
HAS/2012-12-26_elements_concourant_a_la_decision_darthroplastie_du_genou_et_du_choix_de_la_prothese.pdf
HAS/2012-12-26_overweight_and_obesity_in_adults_first_line_medical_management_version_anglaise.pdf
HAS/2012-12-26_rapport_devaluation_-_implants_articulaires_de_genou.pdf
HAS/2012-12-26_reco2clics_obesite_adulte_premiers_recours.pdf
HAS/2012-12-26_recommandation_obesite_adulte.pdf
HAS/2012-12-26_surpoids_et_obesite_de_ladulte_-_criteres_de_qualite_du_reperage.pdf
HAS/2012-12-26_surpoids_et_obesite_de_ladulte_-_criteres_de_qualite_du_suivi.pdf
HAS/2012-12-26_surpoids_et_obesite_de_ladulte_-_il_ny_a_pas_lieu_de.pdf
HAS/2012-12-26_tableau_bilan_initial_dun_exces_de_poids.pdf
HAS/2012-12-26_texte_court_-_implants_articulaires_de_genou.pdf
HAS/2012-12-27_comment_bien_prescrire_une_ventilation_mecanique_fiche_buts.pdf
HAS/2012-12-27_rapport_ventilation_cnedimts_2013.pdf
HAS/2012-12-27_texte_court_-_ventilation_mecanique_a_domicile.pdf
HAS/2013-01-03_ald_30_gm_cancer_rein_web.pdf
HAS/2013-01-03_ald_30_gp_cancer_du_rein_web.pdf
HAS/2013-01-03_ald_30_lap_cancer_rein_web.pdf
HAS/2013-01-07_eflow_rapid_4309.pdf
HAS/2013-01-07_gm_ald23_troubles_depressifs_webavril2009.pdf
HAS/2013-01-07_lap_ald23_troubles_depressifs_webavril2009.pdf
HAS/2013-01-07_opm4j_4101_avis.pdf
HAS/2013-01-07_prodisc-l_4318_avis.pdf
HAS/2013-01-07_troubles_depression_web.pdf
HAS/2013-01-10_carotid_wallstent_monorail_4270_avis.pdf
HAS/2013-01-10_lars_18_decembre_2012_4358_avis.pdf
HAS/2013-01-10_precise_pro_rx_4273_avis.pdf
HAS/2013-01-10_precision_18_decembre_2012_4349_avis.pdf
HAS/2013-01-10_protege_rx_4275_avis.pdf
HAS/2013-01-10_rx_acculink_4254_avis.pdf
HAS/2013-01-10_xact_4253_avis.pdf
HAS/2013-01-15_aorfix-25_septembre_2012_4261_avis.pdf
HAS/2013-01-15_aorfix_25_septcembre_2012_4261_synthese_davis.pdf
HAS/2013-01-15_coban_2_4280_avis.pdf
HAS/2013-01-15_coban_2_6_novembre_2012_4280_synthese_davis.pdf
HAS/2013-01-15_coban_2_lite_4284_avis.pdf
HAS/2013-01-15_coban_2_lite_6_novembre_2012_4284_synthese_davis.pdf
HAS/2013-01-15_resolute_integrity_18_decembre_2012_4319_avis.pdf
HAS/2013-01-15_xience_prime_18_decembre_2012_4260_avis.pdf
HAS/2013-01-15_xience_prime_18_decembre_2012_4364_avis.pdf
HAS/2013-01-15_xience_v_18_decembre_2012_4244_avis.pdf
HAS/2013-01-15_xience_v_18_decembre_2012_4263_avis.pdf
HAS/2013-01-15_xience_xpedition_18_decembre_2012_4410_avis.pdf
HAS/2013-01-15_xience_xpedition__18_decembre_2012__4354_avis.pdf
HAS/2013-01-18_CT-10007_ANDROCUR_Avis2_CT10007_RI_PIS.pdf
HAS/2013-01-18_CT-11333_LUVERIS_Avis2_CT11333_RI_PIS.pdf
HAS/2013-01-18_CT-11505_TETRAVAC_ACELLULAIRE_PIS_AVIS1_CT11505.pdf
HAS/2013-01-18_CT-11663_BIOCALYPTOL_RI_avis2_CT11663.pdf
HAS/2013-01-18_CT-11784_ANTARENE_RI_avis1_CT11784.pdf
HAS/2013-01-18_CT-11803_LHRH FERRING 100_Avis2_CT 11803_INS_ PIS.pdf
HAS/2013-01-18_CT-11895_CALSYN_reeval_avis2_CT11895.pdf
HAS/2013-01-18_CT-12249_BUPRENORPHINE_avis1_RI_CT12249.pdf
HAS/2013-01-18_CT-12326_RYTHMODAN_RI_avis2_CT12326.pdf
HAS/2013-01-18_CT-12381_SOTALEX_RI_avis2_CT12381.pdf
HAS/2013-01-18_CT-12383_QUESTRAN RI_avis 2_CT12383_revuAA.pdf
HAS/2013-01-18_CT-12410_CIPRALAN_RI_avis2_CT12410.pdf
HAS/2013-01-18_CT-12424_RYTHMOL_RI_avis2_CT12424.pdf
HAS/2013-01-18_CT-12429_LIPANOR_RI_avis 2 rectif indic _CT12429_revuAA.pdf
HAS/2013-01-18_CT-12454_PREZISTA Gamme_RI_P1_CT 12454.pdf
HAS/2013-01-18_CT-12463_AVASTIN Ovaire Ins_Avis2_CT12463.pdf
HAS/2013-01-18_avastin_synthese_05122012_ct12463_2013-03-25_16-10-0_630.pdf
HAS/2013-01-18_biatain_ag_15_janvier_2013_4306_avis.pdf
HAS/2013-01-18_homefill_ii_15_janvier_2013_4351_avis.pdf
HAS/2013-01-18_platinum9_15_janvier_2013_4350_avis.pdf
HAS/2013-01-22_CT-12711_TARDYFERON_80MG_23012013_CT12711_Avis1_PIS_RI.pdf
HAS/2013-01-24_annexe_reevaluation_inf_ag_-_sep.pdf
HAS/2013-01-24_annexe_reevaluation_inf_ag_-_sep_2012-07-05_12-08-23_905.pdf
HAS/2013-01-24_ct-4033_lucentis.pdf
HAS/2013-01-24_ct032416.pdf
HAS/2013-01-24_ct_2170_xolair_ang.pdf
HAS/2013-01-24_fiche_information_therapeutique_rebif_ct12060.pdf
HAS/2013-01-24_lucentis_-_ct-9548.pdf
HAS/2013-01-24_lucentis_18012012_avis_ct10898.pdf
HAS/2013-01-24_lucentis_18012012_synthese_10898.pdf
HAS/2013-01-24_lucentis_22-06-2011_synthese_ct-9548.pdf
HAS/2013-01-24_lucentis_ct_10898.pdf
HAS/2013-01-24_lucentis_ct_4033.pdf
HAS/2013-01-24_lucentis_ct_9548.pdf
HAS/2013-01-24_lucentis_fit_21112012.pdf
HAS/2013-01-24_ozurdex_-_ct-_8620.pdf
HAS/2013-01-24_ozurdex_ct_8620.pdf
HAS/2013-01-24_rebif_-_ct-_3166.pdf
HAS/2013-01-24_rebif_19-10-2011_avis_ct-11243.pdf
HAS/2013-01-24_rebif_20062012_avis_ct12060.pdf
HAS/2013-01-24_rebif_ct_3166.pdf
HAS/2013-01-24_rebif_rebismart_-_ct-7019.pdf
HAS/2013-01-24_stelara_-_ct-8633.pdf
HAS/2013-01-24_stelara_ct_8633.pdf
HAS/2013-01-24_stelara_fit_05122012.pdf
HAS/2013-01-24_synthese_davis__sep_if_beta_copaxone.pdf
HAS/2013-01-24_synthese_davis_ozurdex_-_ct-8620.pdf
HAS/2013-01-24_xolair_06062012_avis_ct10947_130712.pdf
HAS/2013-01-24_xolair_fit_05092012.pdf
HAS/2013-01-25_activa_pc__15_janvier_2013_4348_avis.pdf
HAS/2013-01-25_activa_rc_15_janvier_2013_4366_avis.pdf
HAS/2013-01-25_activa_sc_15_janvier_2013_4367_avis.pdf
HAS/2013-01-25_ascenda_15_janvier_2013_4374_avis.pdf
HAS/2013-01-25_excluder_15_janvier_2013_4385_avis.pdf
HAS/2013-01-25_hydrotul_15_janvier_2013_4307_avis.pdf
HAS/2013-01-25_kinetra_et_soletra_15_janvier_2013_4375_avis.pdf
HAS/2013-01-25_rapport_dorientation_facteurs_de_retard_au_diagnostic_du_melanome_cutane.pdf
HAS/2013-01-25_recommandation_actualisation_de_la_revue_de_la_litterature_dune_recommandation_en_sante_publique_sur_la_detection_precoce_du_melanome_cutane.pdf
HAS/2013-01-25_synthese_de_la_recommandation_actualisation_de_la_revue_de_la_litterature_dune_recommandation_en_sante_publique_sur_la_detection_precoce_du_melanome_cutane.pdf
HAS/2013-01-25_synthese_du_rapport_dorientation_facteurs_de_retard_au_diagnostic_du_melanome_cutane.pdf
HAS/2013-01-28_ct010611.pdf
HAS/2013-02-05_CT-12221_HUMALOG_RI_Avis1_CT12221.pdf
HAS/2013-02-05_CT-12394_CALCIPARINE_RI_PIS_Avis2_ CT12394.pdf
HAS/2013-02-05_CT-12550_SONOVUE_RI_Avis2_CT12550.pdf
HAS/2013-02-05_biatain_ibu_29_janvier_2013_4293_avis.pdf
HAS/2013-02-05_enquete_nationale_2012___eval_interne_fevier_2013.pdf
HAS/2013-02-05_flecaine_reeval_avis1_ct12461.pdf
HAS/2013-02-05_new_fill-25_septembre_2012_4321_avis.pdf
HAS/2013-02-05_physiotulle_29_janvier_2013_4300_avis.pdf
HAS/2013-02-05_speciafoldine_ri_avis2modifie_ct12322.pdf
HAS/2013-02-06_CT-11987_MOBIC_17102012_AVIS_CT11987_10499.pdf
HAS/2013-02-06_CT-12083_RITALINE_03102012_AVIS_CT12083.pdf
HAS/2013-02-06_CT-12439_CONCERTA_03102012_AVIS_CT12439.pdf
HAS/2013-02-06_annexe_methylphenidate.pdf
HAS/2013-02-06_annexe_methylphenidate_2013-04-25_16-29-41_161.pdf
HAS/2013-02-06_annexe_methylphenidate_2013-04-25_16-34-2_73.pdf
HAS/2013-02-06_aqua_foot_15_janvier_2013_4391_avis.pdf
HAS/2013-02-06_bat_web_fbum_circadin_cv_101109.pdf
HAS/2013-02-06_carlin_19092012_avis_ct12277.pdf
HAS/2013-02-06_carlin_ct_12277.pdf
HAS/2013-02-06_cilest_19092012_avis_ct12260.pdf
HAS/2013-02-06_cilest_ct_12260.pdf
HAS/2013-02-06_circadin_-_ct-5644.pdf
HAS/2013-02-06_circadin_ct_5644.pdf
HAS/2013-02-06_concerta_ct_12439.pdf
HAS/2013-02-06_desobel_19092012_avis_ct12274.pdf
HAS/2013-02-06_desobel_ct_12274.pdf
HAS/2013-02-06_desogestrel_ethinylestr_biogaran_19092012_avis_ct12297.pdf
HAS/2013-02-06_desogestrel_ethinylestradiol_biogaran_ct_12297.pdf
HAS/2013-02-06_efezial_20062012_avis_ct12306.pdf
HAS/2013-02-06_efezial_ct_12306.pdf
HAS/2013-02-06_fiche_bon_usage_vesicare.pdf
HAS/2013-02-06_fiche_bum_ranexa.pdf
HAS/2013-02-06_fiche_bum_valdoxan.pdf
HAS/2013-02-06_gest_ethinylestr_biogaran_perleane_19092012_avis_ct12295.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_actavis_20062012_avis_ct12307.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_actavis_ct_12307.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_arrow_20062012_avis_ct12303.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_arrow_ct_12303.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_biogaran_perleane_ct_12295.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_eg_20062012_avis_ct12300.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_eg_ct_12300.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_ranbaxy_20062012_avis_ct12298.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_ranbaxy_ct_12299.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_sandoz_20062012_avis_ct12296.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_sandoz_ct_12296.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_winthrop_20062012_avis_ct12298.pdf
HAS/2013-02-06_gestodene_ethinylestradiol_winthrop_ct_12298.pdf
HAS/2013-02-06_grazax_-_ct-_8469.pdf
HAS/2013-02-06_grazax_241109_fiche_bum.pdf
HAS/2013-02-06_harmonet_minesse_minulet_triminulet_20062012_avis__ct12280.pdf
HAS/2013-02-06_harmonet_minesse_minulet_triminulet_ct_12280.pdf
HAS/2013-02-06_meliane_moneva_phaeva_melodia_19092012_avis_ct12302.pdf
HAS/2013-02-06_meliane_moneva_phaeva_melodia_ct_12302.pdf
HAS/2013-02-06_methylphenidate_reeval_annexe.pdf
HAS/2013-02-06_mobic_ct_11987_10499.pdf
HAS/2013-02-06_quasym_03102012_avis_ct12435.pdf
HAS/2013-02-06_quasym_ct_12435.pdf
HAS/2013-02-06_ranexa_-_ct-6981.pdf
HAS/2013-02-06_restoreadvanced_29_janvier_2013_4334_avis.pdf
HAS/2013-02-06_restoresensor_29_janvier_2013_4333_avis.pdf
HAS/2013-02-06_restoreultra_29_janvier_2013_4377_avis.pdf
HAS/2013-02-06_ritaline_ct_12083.pdf
HAS/2013-02-06_synthese_davis_circadin_-_ct-5644.pdf
HAS/2013-02-06_synthese_davis_valdoxan_-_ct-6808.pdf
HAS/2013-02-06_tempur_challenger_15_janvier_2013_4338_avis.pdf
HAS/2013-02-06_valdoxan_-_ct-6808.pdf
HAS/2013-02-06_valdoxan_ct_6808_2011-01-26_12-31-52_729.pdf
HAS/2013-02-06_varnoline_continu_varnoline_mercilon_cycleane_ct_12268.pdf
HAS/2013-02-06_varnolinecontinu_varnoline_mercilon_cycleane_19092012_avis_ct12268.pdf
HAS/2013-02-06_vesicare_-_ct-6967.pdf
HAS/2013-02-08_rapport_chikungunya_vd.pdf
HAS/2013-02-08_rapport_dengue_vd.pdf
HAS/2013-02-08_texte_court_chikungunya_vd.pdf
HAS/2013-02-08_texte_court_dengue_vd.pdf
HAS/2013-02-12_inogen_one_g2_29_janvier_2013_4302_avis.pdf
HAS/2013-02-12_orencia_14032012_avis_ct10284.pdf
HAS/2013-02-12_orencia_ct_10284.pdf
HAS/2013-02-12_vari__flex_xc_29_janvier_2013_4394_avis.pdf
HAS/2013-02-14_CT-10940_TEGRETOL_avis2_RI_CT10940.pdf
HAS/2013-02-14_CT-11127_ALYOSTAL_VENIN_GUEPE_POLISTE_RI_avis2_CT11127.pdf
HAS/2013-02-14_CT-11139_ALBEY_VENINDEGUEPE_VESPULA_RI_avis2_CT11139.pdf
HAS/2013-02-14_CT-11914_DILUANT_PHYSIOLOGIQUE_RI_avis1_CT11914.pdf
HAS/2013-02-14_CT-11978_DAIVONEX_rad_PIC_avis2_CT11978.pdf
HAS/2013-02-14_albey_venin_dabeille_ri_avis2_ct11150.pdf
HAS/2013-02-14_alyostal_venin_guepe_vespula_ri_avis2_ct11126.pdf
HAS/2013-02-14_alyostal_venindab_apismellifera_ri_avis2_ct11131.pdf
HAS/2013-02-18_aaa_fiche_med_vfinale.pdf
HAS/2013-02-18_aaa_rapport_versfinale.pdf
HAS/2013-02-18_aaa_synthese_ou_4pages_vfinale.pdf
HAS/2013-02-18_endoprotheses_aortiques_abdominales_rapport.pdf
HAS/2013-02-18_evaluation_medico-economique_des_endoprotheses_aortiques_abdominales.pdf
HAS/2013-02-18_rapport_chir_vasc_coelio_vd.pdf
HAS/2013-02-20_2012-11-13_methodologie_utilisee_pour_la_redaction_des_bonnes_pratiques_en_genetique.pdf
HAS/2013-02-20_mabthera_18072012_synthese__ct12226.pdf
HAS/2013-02-20_mabthera_ct_12226.pdf
HAS/2013-02-20_mabthera_llc_18072012_avis_ct12226.pdf
HAS/2013-02-20_regles_de_bonne_pratique_en_genetique_constitutionnelle_a_des_fins_medicales.pdf
HAS/2013-02-22_eon_c_12_fevrier_2013_4408_avis.pdf
HAS/2013-02-28_CT-12380_DUPHALAC_RI_PIS_avis1_CT12380.pdf
HAS/2013-02-28_CT-12441_TRIVASTAL_RI_avis2_CT12441.pdf
HAS/2013-02-28_CT-12520_DOXY 50 et 100 mg_RI_Avis1_CT12520.pdf
HAS/2013-02-28_CT-12609_WELLVONE_RI_avis2_CT12609.pdf
HAS/2013-02-28_guide_medecin_thrombasthenie_de_glanzmann.pdf
HAS/2013-02-28_longevity_12_fevrier_2013_4362_avis_completant_2013-02-22_10-51-51_34.pdf
HAS/2013-02-28_orbit_galaxy_12_fevrier_2013_4314_avis.pdf
HAS/2013-02-28_pnds_50_-_thrombastenie_de_glanzmann_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2013-03-01_midband_12_fevrier_2013_4409_avis.pdf
HAS/2013-03-01_pnds_-_fievre_mediterraneenne_familiale.pdf
HAS/2013-03-01_pnds_51_-_fievre_mediterraneenne_familiale_-_fmf_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2013-03-05_CT-12222_UMULINE_RI_Avis1_CT12222.pdf
HAS/2013-03-05_CT-12325_FUMAFER_09012013_Avis1_CT12325_Avis1_PIS.pdf
HAS/2013-03-05_CT-12406_FERROSTRANE_09012013_CT12406_Avis1_RI.pdf
HAS/2013-03-05_CT-12407_FEROGRAD_VITC_09012013_Avis1_CT12407_RI_PIS.pdf
HAS/2013-03-05_CT-12685_THEINOL_avis1_RI_CT12685.pdf
HAS/2013-03-06_CT-12418_ASCOFER_09012013_Avis1_CT12418_RI_PIS.pdf
HAS/2013-03-06_CT-12497_BETNESOL_RI_Avis 2_CT12497.pdf
HAS/2013-03-06_CT-12558_IMODIUM_RI_Avis1_CT12558.pdf
HAS/2013-03-06_CT-12669_DERINOX_saisine_radiation_Audition23jan20113_avis1_CT11140.pdf
HAS/2013-03-06_cementek_26_fevrier_2013_4404_avis.pdf
HAS/2013-03-06_leo_plus__leo_plus_sur_mesure_12_fevrier_2013_4352_4353_avis.pdf
HAS/2013-03-06_rotateur_femoral_1k52_26_fevrier_2013_4025_avis.pdf
HAS/2013-03-07_cadrage_-_outils_et_recommandations_economiques.pdf
HAS/2013-03-07_evia_dr-t_12_fevrier_2013_4389_avis.pdf
HAS/2013-03-11_evia_sr-t_26_fevrier_2013_4386_avis.pdf
HAS/2013-03-12_radioprotection_du_patient_et_analyse_des_pratiques_dpc_et_certification_des_etablissements_de_sante_format2clics.pdf
HAS/2013-03-12_radioprotection_du_patient_et_analyse_des_pratiques_dpc_et_certification_des_etablissements_de_sante_guide.pdf
HAS/2013-03-14_CT-10558_MIRENA_Avis2_CT10558_RI.pdf
HAS/2013-03-14_disparites_ccarpien_alsace_2008_rapport_grille.pdf
HAS/2013-03-14_etude_dossier_ccarpien_alsace_2008.pdf
HAS/2013-03-14_glucofix_premium__b-ketone_sensor_26_fevrier_2013_4399_avis.pdf
HAS/2013-03-14_hybrid_1p360_12_mars_2013_4368_avis.pdf
HAS/2013-03-14_outils_6.10_audit.pdf
HAS/2013-03-14_outils_6.11_revur_morbidite.pdf
HAS/2013-03-14_outils_6.12_chemin_clinique.pdf
HAS/2013-03-14_outils_6.13_indicateurs.pdf
HAS/2013-03-14_outils_6.1_reco.pdf
HAS/2013-03-14_outils_6.2_consult.pdf
HAS/2013-03-14_outils_6.3_emg.pdf
HAS/2013-03-14_outils_6.4_activites.pdf
HAS/2013-03-14_outils_6.5_traitement_medical.pdf
HAS/2013-03-14_outils_6.6_chirurgie.pdf
HAS/2013-03-14_outils_6.7_persistance.pdf
HAS/2013-03-14_outils_6.8_opere.pdf
HAS/2013-03-14_outils_6.9_revue_pertinence.pdf
HAS/2013-03-14_pegasys_gamme_ri_avis2_ct12570.pdf
HAS/2013-03-14_points-cle_solution_-_pertience_cholecystectomie.pdf
HAS/2013-03-14_points-cle_solution_-_problematique_cholecystectomie.pdf
HAS/2013-03-14_points-cle_solution_-_qd_faire_cholecystectomie.pdf
HAS/2013-03-14_resultats_ccarpien_alsace_2008_diaporama_2013-06-27_17-44-24_752.pdf
HAS/2013-03-14_sebivo_ri_avis2_ct12566.pdf
HAS/2013-03-14_spiroctan_ri_avis1_ct12678_2013-03-07_16-32-12_751.pdf
HAS/2013-03-14_surgam_ri_avis2_ct12647.pdf
HAS/2013-03-14_syndrome_du_canal_carpien_optimiser_la_pertinence_du_parcours_patient.pdf
HAS/2013-03-19_abilify_14032012_avis_ct9034.pdf
HAS/2013-03-19_abilify_annexe_2_etude_star.pdf
HAS/2013-03-19_abilify_ct_9034.pdf
HAS/2013-03-19_alpress_18072012_avis_ct12020_ct12437.pdf
HAS/2013-03-19_alpress_ct_12020_12437.pdf
HAS/2013-03-19_annexe_reeval_antipsychotiques.pdf
HAS/2013-03-19_annexe_reeval_antipsychotiques_2013-03-01_11-50-53_861.pdf
HAS/2013-03-19_annexe_reeval_antipsychotiques_2013-03-01_11-55-53_763.pdf
HAS/2013-03-19_annexe_reeval_antipsychotiques_2013-03-01_12-03-24_615.pdf
HAS/2013-03-19_annexe_reeval_antipsychotiques_2013-03-01_12-06-37_965.pdf
HAS/2013-03-19_annexe_reeval_antipsychotiques_2013-03-01_12-11-6_974.pdf
HAS/2013-03-19_anti_psychotiques_rapport.pdf
HAS/2013-03-19_antipsychotiques_14032012_synthese.pdf
HAS/2013-03-19_avodart_chibro_proscar_combodart_synthese_ct9291_9896_11612_12202.pdf
HAS/2013-03-19_buccolam_18072012_avis_ct12074.pdf
HAS/2013-03-19_buccolam_ct_12074.pdf
HAS/2013-03-19_buccolam_synthese_18072012_ct12074.pdf
HAS/2013-03-19_caprelsa_20062012_avis_ct12099.pdf
HAS/2013-03-19_caprelsa_ct_12099.pdf
HAS/2013-03-19_caprelsa_synthese_20062012.pdf
HAS/2013-03-19_combodart_05092012_avis_ct9291.pdf
HAS/2013-03-19_combodart_ct_9291.pdf
HAS/2013-03-19_daxas_09052012_avis_ct11681.pdf
HAS/2013-03-19_daxas_ct_11681.pdf
HAS/2013-03-19_daxas_synthese_09052012.pdf
HAS/2013-03-19_desernil_23052012_avis_ct12062_11053.pdf
HAS/2013-03-19_desernil_ct_12062.pdf
HAS/2013-03-19_dhe_amdipharm_23052012_avis_ct12061.pdf
HAS/2013-03-19_dhe_amdipharm_ct_12061.pdf
HAS/2013-03-19_dhe_migraine_synthese_23052012.pdf
HAS/2013-03-19_fluenz_18072012_ct12345.pdf
HAS/2013-03-19_fluenz_ct_12345.pdf
HAS/2013-03-19_genotonorm_07122011_avis_ct5437.pdf
HAS/2013-03-19_globuline_fresenius_18072012_avis_ct12108.pdf
HAS/2013-03-19_globulines_antilymphocytaires_fresenius_ct_12108.pdf
HAS/2013-03-19_gynergene_cafeine_23052012_avis_ct12063_11052.pdf
HAS/2013-03-19_gynergene_cafeine_ct_12063_11052.pdf
HAS/2013-03-19_hormone_de_croissance_vecourt_post_college_vudoc_mise_en_ligne_2012-01-26_10-36-5_997.pdf
HAS/2013-03-19_hormone_de_croissance_velong_valide_college_vudoc_mise_en_ligne.pdf
HAS/2013-03-19_hormones_de_croissance_14122011_synthese_2012-05-25_14-39-0_547.pdf
HAS/2013-03-19_ikaran_23052012_avis_ct12075_11038.pdf
HAS/2013-03-19_januvia_janumet_18072012_avis_ct9807_ct9808_ct11768_ct11968.pdf
HAS/2013-03-19_januvia_janumet_ct_9807_9808_11768_11968.pdf
HAS/2013-03-19_januvia_janumet_xelevia_velmetia_18072012_synthese.pdf
HAS/2013-03-19_leponex_30112011_avis_ct8954.pdf
HAS/2013-03-19_leponex_ct_8954.pdf
HAS/2013-03-19_mabthera_18072012_avis_ct_12242.pdf
HAS/2013-03-19_mabthera_18072012_synthese_.pdf
HAS/2013-03-19_mabthera_ct_12242.pdf
HAS/2013-03-19_norditropine_07122011_avis_ct5343.pdf
HAS/2013-03-19_norditropine_ct_5343.pdf
HAS/2013-03-19_nutropinaq__07122011_avis_ct6430.pdf
HAS/2013-03-19_omnitrope_07122011_avis_ct10063.pdf
HAS/2013-03-19_omnitrope_ct_10063.pdf
HAS/2013-03-19_ozurdex_19092012_avis_ct12269.pdf
HAS/2013-03-19_ozurdex_ct_12269.pdf
HAS/2013-03-19_ozurdex_fit_19092012.pdf
HAS/2013-03-19_ozurdext_synthese_ct12269.pdf
HAS/2013-03-19_revatio_06062012_avis_ct12241.pdf
HAS/2013-03-19_revatio_ct_11431_12241.pdf
HAS/2013-03-19_revatio_oral_synthese_06062012.pdf
HAS/2013-03-19_risperdal_30112011_avis_ct9023.pdf
HAS/2013-03-19_risperdal_ct_9023.pdf
HAS/2013-03-19_saizen_07122011_avis__ct5421.pdf
HAS/2013-03-19_saizen_ct_5421.pdf
HAS/2013-03-19_seglor_23052012_avis_ct11066_12147.pdf
HAS/2013-03-19_seglor_ct_11066.pdf
HAS/2013-03-19_signifor_18072012_ct12258.pdf
HAS/2013-03-19_signifor_18072012_synthese.pdf
HAS/2013-03-19_signifor_ct_12258.pdf
HAS/2013-03-19_solian_30112011_avis_ct8948.pdf
HAS/2013-03-19_solian_ct_8948.pdf
HAS/2013-03-19_tamik_230520128avis_ct12044.pdf
HAS/2013-03-19_tamik_ct_12044.pdf
HAS/2013-03-19_umatrope_07122011_avis_ct6477.pdf
HAS/2013-03-19_umatrope_ct_6477.pdf
HAS/2013-03-19_xelevia_velmetia_18072012_avis_ct8855_ct8856.pdf
HAS/2013-03-19_xelevia_velmetia_ct_8855_8856.pdf
HAS/2013-03-19_xeomin_23052012_avis_ct11992.pdf
HAS/2013-03-19_xeomin_ct_11992.pdf
HAS/2013-03-19_xeomin_synthese_23052012.pdf
HAS/2013-03-19_xeroquel_30112011_avis_ct11064.pdf
HAS/2013-03-19_xeroquel_ct_11064.pdf
HAS/2013-03-19_zomacton_07122011_avis_ct6570.pdf
HAS/2013-03-19_zomacton_ct_6570.pdf
HAS/2013-03-19_zyprexa_30112011_avis_ct9128.pdf
HAS/2013-03-19_zyprexa_ct_9128.pdf
HAS/2013-03-26_CT-12341_LUBENTYL_RI_Avis2_CT12341.pdf
HAS/2013-03-26_CT-12398_EDUCTYL_Avis2_suite_audition_CT12398.pdf
HAS/2013-03-26_CT-12522_CONTRACNE_RI_PIS_Avis1_CT12522.pdf
HAS/2013-03-26_CT-12679_SPIROCTAZINE_RI_Avis1_CT12679.pdf
HAS/2013-03-26_CT-12688_CARTREX_100mg_RI_Avis2_CT12688.pdf
HAS/2013-03-26_CT-12710_ALDOMET_RI_Avis1_CT12710.pdf
HAS/2013-03-26_naprosyne_250_500_1000_ri_avis2_ct12697.pdf
HAS/2013-04-02_CT-10058_OPTRUMA_17102012_AVIS_CT10058.pdf
HAS/2013-04-02_CT-11855_OMNITROPE_03102012_AVIS_CT11855.pdf
HAS/2013-04-02_CT-12144_MEDIKINET_03102012_AVIS_CT12144.pdf
HAS/2013-04-02_CT-12194_SAIZEN_03102012_AVIS_CT12194.pdf
HAS/2013-04-02_CT-7155_GENOTONORM_03102012_AVIS_CT7155.pdf
HAS/2013-04-02_CT-7441_UMATROPE_03102012_AVIS_CT7441.pdf
HAS/2013-04-02_CT-7796_ZOMACTON_03102012_AVIS_CT7796.pdf
HAS/2013-04-02_CT-8909_NORDITROPINE_03102012_AVIS_CT8909.pdf
HAS/2013-04-02_CT-8965_VISUDYNE_17102012_AVIS_CT8965.pdf
HAS/2013-04-02_CT-9951_EVISTA_17102012_AVIS 2_RI_CT9951.pdf
HAS/2013-04-02_comprendre_la_promotion_pharmaceutique_et_y_repondre_-_un_manuel_pratique.pdf
HAS/2013-04-02_description_de_la_regulation_de_la_promotion_des_produits_de_sante_-_2013.pdf
HAS/2013-04-02_dysport_07112012_avis_ct12379.pdf
HAS/2013-04-02_dysport_ct_12379.pdf
HAS/2013-04-02_dysport_synthese_ct12379.pdf
HAS/2013-04-02_esmya_18072012_avis__ct12237.pdf
HAS/2013-04-02_esmya_18072012_synthese__ct12237.pdf
HAS/2013-04-02_esmya_ct_12237.pdf
HAS/2013-04-02_evista_ct_9951.pdf
HAS/2013-04-02_genotonorm_2013_fit.pdf
HAS/2013-04-02_genotonorm_ct_7155.pdf
HAS/2013-04-02_medikinet_ct_12144.pdf
HAS/2013-04-02_methylphenidate_reeval_annexe.pdf
HAS/2013-04-02_norditropine_ct_8909.pdf
HAS/2013-04-02_omnitrope_2013_fit.pdf
HAS/2013-04-02_omnitrope_ct_11855.pdf
HAS/2013-04-02_optruma_ct_10058.pdf
HAS/2013-04-02_oxycontin_oxynorm_oxynormoro_19092012_avis_ct11678_ct11677_ct8862.pdf
HAS/2013-04-02_oxycontin_oxynorm_oxynormoro_ct_8862_11677_11678.pdf
HAS/2013-04-02_saizen_2013_fit.pdf
HAS/2013-04-02_saizen_ct_12194.pdf
HAS/2013-04-02_synthese_oxycontin_norm_normo_synthese_ct8862-ct11677-ct11678.pdf
HAS/2013-04-02_umatrope_2013_fit.pdf
HAS/2013-04-02_umatrope_ct_7441.pdf
HAS/2013-04-02_visudyne_ct_8965.pdf
HAS/2013-04-02_zomacton_2013_fit.pdf
HAS/2013-04-02_zomacton_ct_7796.pdf
HAS/2013-04-03_pylera_03102012_avis_ct12234.pdf
HAS/2013-04-03_pylera_03102012_synthese_ct12234.pdf
HAS/2013-04-03_pylera_ct_12234.pdf
HAS/2013-04-03_soliris_19092012_avis_ct12290.pdf
HAS/2013-04-03_soliris_ct_12290.pdf
HAS/2013-04-03_soliris_synthese_19092012_ct12290.pdf
HAS/2013-04-04_10irp04_argu_diabete_type_2.pdf
HAS/2013-04-04_10irp04_reco_diabete_type_2.pdf
HAS/2013-04-04_10irp04_synth_diabete_type_2_objectif_glycemique_messages_cles.pdf
HAS/2013-04-04_12e_memo_algo-diabete_a3_080213.pdf
HAS/2013-04-04_argumentaire_atcd_cv_connu.pdf
HAS/2013-04-04_argumentaire_autosurveillance_glycemique.pdf
HAS/2013-04-04_argumentaire_correspondance_glycemie_hba1c.pdf
HAS/2013-04-04_argumentaire_epidemiologie.pdf
HAS/2013-04-04_argumentaire_gestion_ci.pdf
HAS/2013-04-04_argumentaire_insuffisance_renale.pdf
HAS/2013-04-04_argumentaire_methode_de_travail.pdf
HAS/2013-04-04_argumentaire_objectif_cible_cas_general.pdf
HAS/2013-04-04_argumentaire_participants.pdf
HAS/2013-04-04_argumentaire_patientes_enceintes.pdf
HAS/2013-04-04_argumentaire_patients_ages.pdf
HAS/2013-04-04_argumentaire_recherche_documentaire.pdf
HAS/2013-04-04_argumentaire_strat_med_atcd_cv.pdf
HAS/2013-04-04_argumentaire_strat_med_femmes_enceintes.pdf
HAS/2013-04-04_argumentaire_strat_med_irc.pdf
HAS/2013-04-04_argumentaire_strat_med_pat_ages.pdf
HAS/2013-04-04_argumentaire_strategie_medicamenteuse_cas_general.pdf
HAS/2013-04-04_argumentaire_strategie_medicamenteuse_efficacite_molecules.pdf
HAS/2013-04-04_diaporama_rbp_strat_medic_controle_glyce_diabete_t2.pdf
HAS/2013-04-04_dificlir_17102012_avis_ct_12235.pdf
HAS/2013-04-04_dificlir_ct_12235.pdf
HAS/2013-04-04_dificlir_synthse_17102012_ct12235.pdf
HAS/2013-04-04_fm_diabete_type_2_2013_lo_res_en_apr_16_hi-res_no_marks.pdf
HAS/2013-04-04_focus_diabete_bat_ok.pdf
HAS/2013-04-04_reco2clics__diabete_type_2.pdf
HAS/2013-04-08_CT-12090_ZOPHREN_RI_Avis1_CT12090.pdf
HAS/2013-04-08_CT-12104_IMMUGRIP_RI_Avis1_CT12104.pdf
HAS/2013-04-08_CT-12367_RANIPLEX_RI_Avis2_CT12367.pdf
HAS/2013-04-08_CT-12368_SPASMAG_INJECTABLE_RI_PIS_Avis1_CT12368.pdf
HAS/2013-04-08_CT-12475_PHOSPHONEUROS_RI_PIS_Avis2_CT12475.pdf
HAS/2013-04-08_CT-12709_TRANDATE_RI_Avis1_CT12709.pdf
HAS/2013-04-08_CT-6962_NUTROPINAQ_03102012_AVIS_CT6962.pdf
HAS/2013-04-08_affichea4_optimiser_cesar_12.pdf
HAS/2013-04-08_codes_ccam_cim10_accouchement_2011x.pdf
HAS/2013-04-08_donnees_epidemiologiques_generales_liees_a_la_grossesse.pdf
HAS/2013-04-08_heterogeneite_des_pratiques_de_la_cesarienne_en_france.pdf
HAS/2013-04-08_nutropinaq_2013_fit.pdf
HAS/2013-04-08_nutropinaq_ct_6962.pdf
HAS/2013-04-08_optimiser_pertinence_cesarienne_programmee_a_terme_2012.pdf
HAS/2013-04-08_outils_10_cesarienne.pdf
HAS/2013-04-08_outils_11_cesarienne.pdf
HAS/2013-04-08_outils_12_cesarienne.pdf
HAS/2013-04-08_outils_13_cesarienne.pdf
HAS/2013-04-08_outils_14_cesarienne.pdf
HAS/2013-04-08_outils_15_cesarienne.pdf
HAS/2013-04-08_outils_16_cesarienne.pdf
HAS/2013-04-08_outils_17_cesarienne.pdf
HAS/2013-04-08_outils_18_cesarienne.pdf
HAS/2013-04-08_outils_19_cesarienne.pdf
HAS/2013-04-08_outils_1_cesarienne.pdf
HAS/2013-04-08_outils_20_cesarienne.pdf
HAS/2013-04-08_outils_21_cesarienne.pdf
HAS/2013-04-08_outils_22_cesarienne.pdf
HAS/2013-04-08_outils_2_cesarienne.pdf
HAS/2013-04-08_outils_3_cesarienne.pdf
HAS/2013-04-08_outils_4_cesarienne.pdf
HAS/2013-04-08_outils_5_cesarienne.pdf
HAS/2013-04-08_outils_6_cesarienne.pdf
HAS/2013-04-08_outils_7_cesarienne.pdf
HAS/2013-04-08_outils_8_cesarienne.pdf
HAS/2013-04-08_outils_9_cesarienne.pdf
HAS/2013-04-08_pap-_upp_23-06-08.pdf
HAS/2013-04-08_priorix_ri_avis1_ct12189.pdf
HAS/2013-04-08_revue_pertinence_cesar_programmee_ccecqa.pdf
HAS/2013-04-08_rpc_uterus_cicatriciel_cngof_2012.pdf
HAS/2013-04-08_taux_cesar_terme_2011_2012-10-10_10-40-36_206.pdf
HAS/2013-04-11_CT-12430_VECTIBIX_17102012_AVIS_CT12430.pdf
HAS/2013-04-11_avis_de_la_cnedimts_implants_du_rachis_26_03_2013.pdf
HAS/2013-04-11_composition_du_gt.pdf
HAS/2013-04-11_januvia_19092012_avis_ct12239.pdf
HAS/2013-04-11_januvia_ct_12239.pdf
HAS/2013-04-11_januvia_janumet_xelevia_velmetia_19092012_synthese.pdf
HAS/2013-04-11_januvia_xelevia_synthese_ct12239_12257.pdf
HAS/2013-04-11_note_cadrage_rachis.pdf
HAS/2013-04-11_rapport_implants_du_rachis_dm_2_vd.pdf
HAS/2013-04-11_synthesis_spinal_implants_dm-eval_2.pdf
HAS/2013-04-11_texte_court_implants_du_rachis_dm_2_vd_2013-04-25_16-39-26_249.pdf
HAS/2013-04-11_teysuno__03102012_avis_ct12048.pdf
HAS/2013-04-11_teysuno_ct_12048.pdf
HAS/2013-04-11_teysuno_synthese_ct12048.pdf
HAS/2013-04-11_vectibix_annexe_ct12430.pdf
HAS/2013-04-11_vectibix_ct_12430.pdf
HAS/2013-04-11_vectibix_synthese_ct12430.pdf
HAS/2013-04-17_genotonorm_07122011_avis_ct5437.pdf
HAS/2013-04-17_genotonorm_ct_5437.pdf
HAS/2013-04-17_hormone_de_croissance_vecourt_post_college_vudoc_mise_en_ligne_2012-01-26_10-36-5_997.pdf
HAS/2013-04-17_hormone_de_croissance_velong_valide_college_vudoc_mise_en_ligne.pdf
HAS/2013-04-17_hormones_de_croissance_14122011_synthese_2012-05-25_14-39-0_547.pdf
HAS/2013-04-17_norditropine_07122011_avis_ct5343.pdf
HAS/2013-04-17_nutropinaq__07122011_avis_ct6430.pdf
HAS/2013-04-17_omnitrope_07122011_avis_ct10063.pdf
HAS/2013-04-17_roho_enhancer_09_avril_2013_4413_avis_2013-04-12_11-51-15_884.pdf
HAS/2013-04-17_roho_enhancer_20_novembre_2012_3929_avis_2013-04-12_11-50-21_386.pdf
HAS/2013-04-17_roho_monocompartiment_09_avril_2013_4412_avis_2013-04-12_11-44-54_749.pdf
HAS/2013-04-17_roho_monocompartiment_20_novembre_2012_3924_avis.pdf
HAS/2013-04-17_saizen_07122011_avis__ct5421.pdf
HAS/2013-04-17_umatrope_07122011_avis_ct6477.pdf
HAS/2013-04-17_zomacton_07122011_avis_ct6570.pdf
HAS/2013-04-18_neurx_dps_ra-4_09_avril_2013_4236_avis.pdf
HAS/2013-04-19_2012-10_-_ssp-_confusion_injectable-_rapport.pdf
HAS/2013-04-19_2012-10_rapport-ssp-erreur-site-chir-dermato.pdf
HAS/2013-04-19_confusion_antispetique_anesthesique_injectable_pcssp.pdf
HAS/2013-04-19_erreurs_site_exerese_lesions_cutanees.pdf
HAS/2013-04-19_how_to_avoid_confusion_between_antiseptic_and_injectable_anaesthetics.pdf
HAS/2013-04-19_how_to_reduce_wrong-site_skin_lesion_excision.pdf
HAS/2013-04-21_09r26__synt_tiu_synthese__organisation__et_information.pdf
HAS/2013-04-21_09r26_argu_transfert_en_urgence.pdf
HAS/2013-04-21_09r26_reco_transfert_en_urgence.pdf
HAS/2013-04-21_09r26_synt__criteres_indications_transfert__maternel.pdf
HAS/2013-04-21_09r26_synt__criteres_indications_transfert_pediatrique.pdf
HAS/2013-04-21_transfert-femmes-enc-reco2clics-v4.pdf
HAS/2013-04-22_08p03_argu_antiagregants_plaquettaires.pdf
HAS/2013-04-22_09r09_argu_dmla.pdf
HAS/2013-04-22_09r09_reco_dmla.pdf
HAS/2013-04-22_09r09_synth_dmla_fich__information_patient.pdf
HAS/2013-04-22_09r09_synth_dmla_fiche_diagnostique.pdf
HAS/2013-04-22_09r09_synth_dmla_fiche_reeduc_basse_vision.pdf
HAS/2013-04-22_09r09_synth_dmla_fiche_therapeutique.pdf
HAS/2013-04-22_echelle_edtrs.pdf
HAS/2013-04-22_effiprev_19092012_avis_ct12276.pdf
HAS/2013-04-22_effiprev_ct_12276.pdf
HAS/2013-04-22_fiche_de_synthese__antiagregant_plaquettaire__urologie.pdf
HAS/2013-04-22_fiche_de_synthese__antiagregant_plaquettaire_gastrologie.pdf
HAS/2013-04-22_fiche_de_synthese__antiagregant_plaquettaire_pneumologie.pdf
HAS/2013-04-22_fiche_de_synthese__antiagregant_plaquettaire_proctologie.pdf
HAS/2013-04-22_fiche_dinformation_sur_injection_intra_vitreenne.pdf
HAS/2013-04-22_fiche_dinformation_sur_langiographie_a_la_fluoresceine.pdf
HAS/2013-04-22_grille_damsler.pdf
HAS/2013-04-22_inliven_w274_cnedimts_09_avril_2013_4432_avis.pdf
HAS/2013-04-22_inliven_w275_cnedimts__09_avril_2013_4432_avis.pdf
HAS/2013-04-22_mise_au_point_de_lafssaps-ansm_2011_bp_injection_intra_vitreenne.pdf
HAS/2013-04-22_point_dinformation_afssaps-ansm_sur_utilisation_hors_amm_avastin_en_ophtalmologie.pdf
HAS/2013-04-22_principes_de_la_prise_en_charge_de_la_reeducation_de_la_basse_vision.pdf
HAS/2013-04-22_reco2clics_degenerescence_maculaire_liee_a_lage_prise_en_charge_diagnostique_et_therapeutique_2012-12-10_15-25-41_878.pdf
HAS/2013-04-22_recommandations_antiagregant_plaquettaire.pdf
HAS/2013-04-22_reveal_dx_26_mars_2103_4421_avis_2013-04-19_11-52-1_145.pdf
HAS/2013-04-22_reveal_xt_26_mars_2013_4420_avis_2013-04-19_12-02-50_323.pdf
HAS/2013-04-22_schema_de_loeil.pdf
HAS/2013-04-23_avis_ip_2013_04_23_2013-04-25_16-24-5_816.pdf
HAS/2013-04-23_implants_de_pontage___composition_du_groupe_de_travail.pdf
HAS/2013-04-23_note_cadrage_implants_de_pontage.pdf
HAS/2013-04-23_rapport_ep_implants_de_pontage_vd.pdf
HAS/2013-04-23_suivi_du_transplante_renal_-_grille_de_recueil_des_crieres.pdf
HAS/2013-04-23_suivi_du_transplante_renal_-_liste_des_criteres_de_qualite.pdf
HAS/2013-04-23_suivi_du_transplante_renal_-_serie_de_criteres_de_qualite_2009-12-30_12-18-57_827.pdf
HAS/2013-04-23_texte_court_implants_de_pontage.pdf
HAS/2013-04-23_texte_court_implants_de_pontage_version_anglaise.pdf
HAS/2013-04-25_CT-11919_ADVIL_PIS_avis1_CT11919.pdf
HAS/2013-04-25_CT-12329_URSOLVAN_RI_avis2_CT12329.pdf
HAS/2013-04-25_CT-12543_ZOFENIL-TEOULA RI et reeval IDM_avis 2_CT12022 12051 12543.pdf
HAS/2013-04-25_CT-12624_Act-HIB_RI_Avis1_CT12624.pdf
HAS/2013-04-25_CT-12644_DIVARIUS_avis2_RI_CT12644.pdf
HAS/2013-04-25_CT-8959_IMUREL_PISRI_avis1_CT8959.pdf
HAS/2013-04-25_anafranil_ri_avis2_ct12026.pdf
HAS/2013-04-25_caltrate_vitd_ri_pis_avis1_ct12211_2013-04-12_11-36-32_498.pdf
HAS/2013-04-25_deroxat_avis1_ri_ct10313_2013-04-22_11-21-7_690.pdf
HAS/2013-04-25_gutron_ri_avis1_ct12451.pdf
HAS/2013-04-25_immunoglobuline_hepatite_b_07112012_avis_ct12432.pdf
HAS/2013-04-25_immunoglobuline_humaine_de_l_hepatite_b_lfb_ct_12432.pdf
HAS/2013-04-25_remicade_03102012_avis_ct12225.pdf
HAS/2013-04-25_remicade_crohn_moderee_synthese_ct_12225.pdf
HAS/2013-04-25_remicade_ct_12225.pdf
HAS/2013-04-26_CT-12210_CALTRATE600_RI_PIS_avis1_CT12210.pdf
HAS/2013-04-26_CT-12608_ADVAGRAF_PROGRAF_PIS RI_avis1_CT12608.pdf
HAS/2013-04-26_CT-12751_TUSSIDANE_RI_avis2_CT12751.pdf
HAS/2013-04-26_osdremc_9_avril_2013_2719_avis.pdf
HAS/2013-04-26_prodisc-o_4392_avis.pdf
HAS/2013-04-29_carelink__d_9__avril_2013_4441_avis.pdf
HAS/2013-04-29_carelink_s_9_avril_2013_4383_avis.pdf
HAS/2013-04-29_carelink_t_9_avril_2013_4442_avis.pdf
HAS/2013-04-29_edwards_sapien_p-thv_23_avril_2013_4400_avis.pdf
HAS/2013-04-29_nutramigen_aa_26_mars_2013_4429_avis_2013-04-19_11-52-47_166.pdf
HAS/2013-04-29_pertinence_du_recours_a_lhospitalisation_pour_bronchiolite.pdf
HAS/2013-04-29_pertinence_du_recours_a_lhospitalisation_pour_bronchopneumopathie_chronique_surinfectee.pdf
HAS/2013-04-29_senza_23_avril_2013_4422_avis.pdf
HAS/2013-04-29_synergy_23_avril_2013_4378_avis_2013-04-26_15-53-21_552.pdf
HAS/2013-05-01_composition_experts_auditionnes_gt_reevaluation_des_protheses_de_hanche_metal-metal.pdf
HAS/2013-05-01_note_de_cadrage_protheses_totales_de_hanche_a_couple_de_frottement_metal-metal.pdf
HAS/2013-05-01_rapport_protheses_totales_de_hanche_metal-metal.pdf
HAS/2013-05-01_synthese_rapport_protheses_totales_de_hanche_metal-metal.pdf
HAS/2013-05-01_synthesis_metal_on_metal_hip_implants_dm-eval_54.pdf
HAS/2013-05-02_anesm-synthese-_travailhandi-esat.pdf
HAS/2013-05-02_anesm_rbpp_-handicapes-travailleurs_en_esat.pdf
HAS/2013-05-02_anesm_rbpp_-handicapes-travailleurs_en_esat_ea.pdf
HAS/2013-05-02_bibliographie_adaptation_de_l_accompagnement_aux_attentes_et_besoins_des_travailleurs_handicapes_en_esat__juin_2013.pdf
HAS/2013-05-02_contraception_durgence_-_argumentaire_2013-04-30_14-24-25_321.pdf
HAS/2013-05-02_contraception_durgence_-_fiche_de_synthese.pdf
HAS/2013-05-02_contraception_durgence_-_synthese_et_recommandations.pdf
HAS/2013-05-02_document_d_appui_rbpp_esat_juin_2013.pdf
HAS/2013-05-02_lettre_de_cadrage__esat_.pdf
HAS/2013-05-02_note_cadrage_cu_vf.pdf
HAS/2013-05-03_CT-12372_NORMACOL_avis2_CT12372.pdf
HAS/2013-05-14_CT-12814_CHLORUREDESODIUM_BBRAUN_RI_avis1_CT12814.pdf
HAS/2013-05-17_assessment_of_ethical_aspects.pdf
HAS/2013-05-17_levaluation_des_aspects_ethiques_a_la_has.pdf
HAS/2013-05-21_CT-11934_LUCENTIS_21112012_AVIS_CT11934.pdf
HAS/2013-05-21_CT-12080_IMIGRANE_RI_avis1_CT12080.pdf
HAS/2013-05-21_CT-12081_IMIJECT_RI_avis1_CT12081.pdf
HAS/2013-05-21_CT-12442_VECTARIONinjectable_saisine_Avis2_CT12442.pdf
HAS/2013-05-21_CT-12472_KALYDECO_Ins_avis 2_CT12474.pdf
HAS/2013-05-21_CT-12478_VOTRIENT Sarcomes_Avis2_CT12478.pdf
HAS/2013-05-21_CT-12490_RELPAX_RI_avis1_CT12490.pdf
HAS/2013-05-21_CT-12514_NIMENRIX_Insc_AVIS2_CT12514.pdf
HAS/2013-05-21_CT-12528_ALMOGRAN_RI_avis2_CT12528.pdf
HAS/2013-05-21_CT-12539_ZINFORO_Insc_Avis2_CT 12539.pdf
HAS/2013-05-21_CT-12556_INLYTA Ins Avis 2_CT 12556.pdf
HAS/2013-05-21_CT-12575_TETAGRIP_Saisine_nouvelles_populations_Avis2_CT12575.pdf
HAS/2013-05-21_CT-12577_AGRIPPAL_PREVIGRIP_Saisine_nouvelles_populations_Avis2_CT12577.pdf
HAS/2013-05-21_CT-12578_FLUARIX_Saisine_nouvelles_populations_Avis2_CT12578.pdf
HAS/2013-05-21_CT-12579_IMMUGRIP_Saisine_nouvelles_populations_Avis2_CT12579.pdf
HAS/2013-05-21_CT-12580_INFLUVAC_Saisine_nouvelles_populations_Avis2_CT12580.pdf
HAS/2013-05-21_CT-12598_MAXALT_RI_avis1_CT12598.pdf
HAS/2013-05-21_CT-12625_NEVANAC_OedemeMaculaire_avis2_CT12625.pdf
HAS/2013-05-21_CT-12650_VAXIGRIP_Saisine_nouvelles_populations_Avis2_CT12650.pdf
HAS/2013-05-21_CT-12683_BIORGASEPT_RI_avis1_CT12683.pdf
HAS/2013-05-21_CT-12701_SEBIPROX_RI_avis1_CT12701.pdf
HAS/2013-05-21_CT-12715_CERVARIX_RI_Avis2_CT 12715.pdf
HAS/2013-05-21_CT-12755_CERVARIX_Modif population cible_Avis2_CT 12755.pdf
HAS/2013-05-21_CT-12790_NATI-K_RI_Avis1_CT12790.pdf
HAS/2013-05-21_CT-6269_ACTIQ - CT- 6269.pdf
HAS/2013-05-21_CT-6575_ABSTRAL - CT- 6575.pdf
HAS/2013-05-21_CT-7400_ZOLOFT_PIC_avis1_CT7400.pdf
HAS/2013-05-21_acces_douloureux_paroxystiques_-_fiche_bum.pdf
HAS/2013-05-21_agrippal_previgrip_ct_12577.pdf
HAS/2013-05-21_alzheimer_19102011_synthese.pdf
HAS/2013-05-21_annexe_alzheimer.pdf
HAS/2013-05-21_annexe_alzheimer_2013-01-28_15-13-17_296.pdf
HAS/2013-05-21_annexe_alzheimer_2013-01-28_15-19-0_559.pdf
HAS/2013-05-21_annexe_i_efficacite_alzheimer_19-10-2011.pdf
HAS/2013-05-21_annexe_ii_donnees_utilisation_20-10-2011.pdf
HAS/2013-05-21_annexe_iii_recherche_documentaire_has.pdf
HAS/2013-05-21_aranesp_-_ct-7471.pdf
HAS/2013-05-21_aricept_19-10-2011_avis_10755.pdf
HAS/2013-05-21_aricept_ct_10755.pdf
HAS/2013-05-21_axorid_03102012_avis_ct_12309.pdf
HAS/2013-05-21_axorid_ct_12309.pdf
HAS/2013-05-21_axorid_synthese_ct12309.pdf
HAS/2013-05-21_betesil_17102012_avis_ct12218.pdf
HAS/2013-05-21_betesil_ct_12218.pdf
HAS/2013-05-21_betesil_synthese_ct12218.pdf
HAS/2013-05-21_bronchitol_19092012_avis_ct12350.pdf
HAS/2013-05-21_bronchitol_19092012_synthese_ct12350.pdf
HAS/2013-05-21_bronchitol_ct_12350.pdf
HAS/2013-05-21_cervarix_ct_12715.pdf
HAS/2013-05-21_cervarix_ct_12755.pdf
HAS/2013-05-21_ct-5111_mircera_.pdf
HAS/2013-05-21_dexdor_ct_12359.pdf
HAS/2013-05-21_dexdor_ins_avis2modifie_le21fevrier_ct12359.pdf
HAS/2013-05-21_dexdor_synthese_ct12359.pdf
HAS/2013-05-21_effentora_-_ct-6829.pdf
HAS/2013-05-21_effentora_ct_6829.pdf
HAS/2013-05-21_eporatio_-_ct-7413.pdf
HAS/2013-05-21_eporatio_comparateurs_annexe.pdf
HAS/2013-05-21_eprex_-_ct-7457.pdf
HAS/2013-05-21_exelon_19-10-2011_avis_10649.pdf
HAS/2013-05-21_exelon_ct_10649.pdf
HAS/2013-05-21_fiche_bum_jevtana_zytiga_xtandi_cv100414.pdf
HAS/2013-05-21_fiche_bum_ranexa.pdf
HAS/2013-05-21_fluarix_ct_12578.pdf
HAS/2013-05-21_fs_bum_epo_v5.pdf
HAS/2013-05-21_galvus_ct_12484.pdf
HAS/2013-05-21_galvus_ei_monotherapie_avis2_ct12484.pdf
HAS/2013-05-21_galvus_synthese_21112012_ct12484.pdf
HAS/2013-05-21_gardasil_ct_12747.pdf
HAS/2013-05-21_gardasil_modif_population_cible_avis2_ct_12747.pdf
HAS/2013-05-21_grazax_241109_fiche_bum.pdf
HAS/2013-05-21_herceptin_09012013_synthese_ct12365.pdf
HAS/2013-05-21_herceptin_ct_12365.pdf
HAS/2013-05-21_herceptin_neoadjuvant_avis2_ct12365.pdf
HAS/2013-05-21_humira_03102012_avis_ct12238.pdf
HAS/2013-05-21_humira_ct_12238.pdf
HAS/2013-05-21_humira_fit_14122012.pdf
HAS/2013-05-21_humira_synthese_03102012_ct12238.pdf
HAS/2013-05-21_immugrip_ct_12579.pdf
HAS/2013-05-21_influvac_ct_12580.pdf
HAS/2013-05-21_inlyta_ct_12556.pdf
HAS/2013-05-21_inlyta_synthese_09012013_ct12556.pdf
HAS/2013-05-21_instanyl_-_ct-7206.pdf
HAS/2013-05-21_instanyl_ct_7206.pdf
HAS/2013-05-21_jakavi_09032013_synthese_ct12530.pdf
HAS/2013-05-21_jakavi_ct_12530.pdf
HAS/2013-05-21_jakavi_ins__avis2_ct12530.pdf
HAS/2013-05-21_januvia_janumet_xelevia_velmetia_19092012_synthese.pdf
HAS/2013-05-21_januvia_xelevia_synthese_ct12239_12257.pdf
HAS/2013-05-21_jarvik_2000_14_mai_2013_4361-4373_avis.pdf
HAS/2013-05-21_jevtana_ct_12292.pdf
HAS/2013-05-21_jevtana_reeval_asmr_avis2_definitif__ct_12292_modif3_dec12.pdf
HAS/2013-05-21_kalydeco_ct_12474.pdf
HAS/2013-05-21_kalydeco_synthese_ct12474.pdf
HAS/2013-05-21_ketum_ct_11945.pdf
HAS/2013-05-21_ketum_gel_ri_avis_2_suite_audition_corrections_materielles_ct11945.pdf
HAS/2013-05-21_latitude_d_9_avril_2013_4438_avis.pdf
HAS/2013-05-21_latitude_s_9_avril_2013_4382_avis.pdf
HAS/2013-05-21_latitude_t_9_avril_2013_4439_avis.pdf
HAS/2013-05-21_lucentis_ct_11934.pdf
HAS/2013-05-21_lucentis_fit_21112012.pdf
HAS/2013-05-21_mircera_ct_5111.pdf
HAS/2013-05-21_myozyme_ct_12440.pdf
HAS/2013-05-21_myozyme_reeval_avis2correct_materiel_ct12440.pdf
HAS/2013-05-21_neorecormon_-_ct-7464.pdf
HAS/2013-05-21_nevanac_ct_12625.pdf
HAS/2013-05-21_nimenrix_05122012_synthese_ct_12514.pdf
HAS/2013-05-21_nimenrix_ct_12514.pdf
HAS/2013-05-21_nobori_23_avril_2013_4396_avis.pdf
HAS/2013-05-21_oralair_28032012_avis_ct11609.pdf
HAS/2013-05-21_oralair_ct_11609.pdf
HAS/2013-05-21_oralair_synthese_28032012.pdf
HAS/2013-05-21_pecfent_-_ct-_9366.pdf
HAS/2013-05-21_pecfent_ct_9366.pdf
HAS/2013-05-21_procoralan_09092012_synthese_ct12097.pdf
HAS/2013-05-21_procoralan_19092012_avis_ct12097.pdf
HAS/2013-05-21_procoralan_ct_12097.pdf
HAS/2013-05-21_questions_alzheimer_fiche_bum_mars_2012.pdf
HAS/2013-05-21_ranexa_-_ct-6981.pdf
HAS/2013-05-21_ranexa_ct_6981.pdf
HAS/2013-05-21_rapport_evaluation_mdc_alzheimer_19-10-2011.pdf
HAS/2013-05-21_reminyl_19-10-2011_avis_10676.pdf
HAS/2013-05-21_reminyl_ct_10676.pdf
HAS/2013-05-21_retacrit_-_ct-5687.pdf
HAS/2013-05-21_sifrol_ct_11252.pdf
HAS/2013-05-21_sifrol_reevalsmrasmr_ct11252_avis_2_16janv2013.pdf
HAS/2013-05-21_sifrol_synthese_2013_ct11227.pdf
HAS/2013-05-21_synthese_davis_effentora_-_ct-6829.pdf
HAS/2013-05-21_synthese_davis_instanyl_-_ct-7206.pdf
HAS/2013-05-21_synthese_davis_pecfent_-9366.pdf
HAS/2013-05-21_synthese_davis_ranexa_-_ct-6981.pdf
HAS/2013-05-21_synthese_myozyme_2_pdf_130412.pdf
HAS/2013-05-21_synthese_nevanac_pdf_130412.pdf
HAS/2013-05-21_synthese_votrient_sarcomes_pdf_130403.pdf
HAS/2013-05-21_tetagrip_ct_12575.pdf
HAS/2013-05-21_urgoclean_23_avril_2013_4431_avis_2013-05-13_14-33-50_320.pdf
HAS/2013-05-21_vaxigrip_ct_12650.pdf
HAS/2013-05-21_vectarion_ct_12442.pdf
HAS/2013-05-21_votrient_ct_12478.pdf
HAS/2013-05-21_xelevia_19092012_avis_ct12257.pdf
HAS/2013-05-21_xelevia_ct_12257.pdf
HAS/2013-05-21_zinforo_ct_12539.pdf
HAS/2013-05-21_zinforo_synthese_ct12539.pdf
HAS/2013-05-21_zoloft_ct_7400.pdf
HAS/2013-05-21_zytiga_29022012_ct11654.pdf
HAS/2013-05-21_zytiga_ct_11654.pdf
HAS/2013-05-21_zytiga_synthese_29022012.pdf
HAS/2013-05-22_amydalectomie_avec_ou_sans_adenoidectomie_chez_lenfant_ou_ladolescent_moins_de_18_ans_-_note_de_problematique.pdf
HAS/2013-05-23_rapport_evaluation_medicaments_antihypertenseurs.pdf
HAS/2013-05-23_rapport_technique_evaluation_de_la_persistance.pdf
HAS/2013-05-23_rapport_technique_evaluation_de_lefficience.pdf
HAS/2013-05-23_synthese.pdf
HAS/2013-05-24_impact_rapportvd.pdf
HAS/2013-05-24_synthese-impact-decisions-v3.pdf
HAS/2013-05-27_e_vita_thoracic_3g_14_mai_2013_4430_avis.pdf
HAS/2013-05-27_embogold_14_mai_2013_4447_avis.pdf
HAS/2013-05-27_embosphere_14_mai_2013_4448_avis.pdf
HAS/2013-05-27_hires_90k_advantage_14_mai_2013_4369_avis.pdf
HAS/2013-05-27_pnds_-_syndromes_periodiques_associes_a_la_cryopyrine_caps_2013-05-15_15-23-40_118.pdf
HAS/2013-05-27_pnds_52_-_syndromes_periodiques_associes_a_la_cryopyrine_caps_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2013-05-27_rondo_14_mai_2013_4452_avis.pdf
HAS/2013-05-27_swiss-trac_14_mai_2013_4365_avis.pdf
HAS/2013-05-28_CT-12547_HUMIRA_Spondyloarthrite_Axiale_Avis2_CT12547.pdf
HAS/2013-05-28_annexe_11_table_ronde_actes_2013-06-28_10-38-37_269.pdf
HAS/2013-05-28_annexe_11_table_ronde_diaporama.pdf
HAS/2013-05-28_fiches-techniques_v3.pdf
HAS/2013-05-28_guide-diag-externe_vd.pdf
HAS/2013-05-28_guide-gestion-projet_vd.pdf
HAS/2013-05-28_guide_securite_du_patient_en_chirurgie_ambulatoire.pdf
HAS/2013-05-28_humira_20022013_synthese_ct12547.pdf
HAS/2013-05-28_humira_ct_12547.pdf
HAS/2013-05-28_interdiag_vd.pdf
HAS/2013-05-28_methodologie-benchmark_vd.pdf
HAS/2013-05-28_note_de_cadrage_axe-3_v2.pdf
HAS/2013-05-28_recommandations_vd.pdf
HAS/2013-05-28_resultats_benchmark_annexe_12_1.pdf
HAS/2013-05-28_resultats_benchmark_annexe_12_2.pdf
HAS/2013-05-29_CT-12600_REMICADE RCH PEDIATRIQUE_avis2_CT_12600.pdf
HAS/2013-05-29_remicade_20022013_synthese_ct12600.pdf
HAS/2013-05-29_remicade_ct_12600.pdf
HAS/2013-05-30_bonnes_pratiques_et_criteres_de_qualite_des_revues_et_journaux_de_la_presse_medicale_francaise.pdf
HAS/2013-05-30_criteres_de_qualite_des_revues_et_journaux_de_la_presse_medicale_francaise_-_note_de_cadrage.pdf
HAS/2013-05-30_recommandation_icmje_version_aout_2013.pdf
HAS/2013-05-30_recommandations_icmje.pdf
HAS/2013-05-30_synthese_du_rapport__bonnes_pratiques_et_criteres_de_qualite_des_revues_et_journaux_de_la_presse_medicale_francaise_.pdf
HAS/2013-05-31_rapport_stent_intracranien.pdf
HAS/2013-05-31_rapport_stent_intracranien_texte_court.pdf
HAS/2013-06-03_contegra_14_mai_2013_4456_avis.pdf
HAS/2013-06-03_home_monitoring_double_chambre_28_mai_2013_4436_avis.pdf
HAS/2013-06-03_home_monitoring_simple_chambre_28_mai_2013_4387_avis.pdf
HAS/2013-06-03_home_monitoring_triple_chambre_28_mai_2013_4437_avis.pdf
HAS/2013-06-03_syncardia_tah-t_23_avril_2013_4393_avis_2013-05-27_16-44-33_78.pdf
HAS/2013-06-07_baha_28_mai_2013_4446_avis.pdf
HAS/2013-06-10_CT-12433_FAZOL_Avis1_RI_CT12433.pdf
HAS/2013-06-10_CT-12731_ONGLYZA_EI_Avis2_CT12731.pdf
HAS/2013-06-10_CT-12732_KOMBOGLYZE_EI_Avis2_CT12732.pdf
HAS/2013-06-10_CT-12736_MYCOHYDRALIN_Ins_Avis1_CT 12736_12745.pdf
HAS/2013-06-10_CT-12756_DEDROGYL_RI_Avis1_CT12756.pdf
HAS/2013-06-10_CT-12757_STEROGYL_RI_PIS_Avis1_CT12757.pdf
HAS/2013-06-10_CT-12800_CHLORUREDESODIUM_FRESENIUS_RI_avis2_CT12800.pdf
HAS/2013-06-10_CT-12813_GLUCOSE_CINQ_POUR_CENT_BBRAUN_RI_Avis1_CT12813.pdf
HAS/2013-06-10_CT-12890_UVEDOSE_RI_Avis1_CT12890.pdf
HAS/2013-06-10_komboglyze_ct_12732.pdf
HAS/2013-06-10_onglyza_ct_12731.pdf
HAS/2013-06-10_profilair_28_mai_2013_4451_avis.pdf
HAS/2013-06-10_promus_premier_14_mai_2013_4440_avis.pdf
HAS/2013-06-14_allogreffes_28_mai_2013_4435_avis.pdf
HAS/2013-06-14_excluder_28_mai_2013_4461_avis.pdf
HAS/2013-06-14_jelonet_plus_28_mai_2013_4376_avis.pdf
HAS/2013-06-14_jenavalve_tavi_11_juin_2013_4403_avis.pdf
HAS/2013-06-14_tryton_side_branch_11_juin_2013_4372_avis.pdf
HAS/2013-06-25_medi_panthera_cf2_11_juin_2013_4464_avis.pdf
HAS/2013-06-25_substituts_osseux_28_mai_2013_dm_eval3_avis.pdf
HAS/2013-06-28_CT-12753_ARTELAC_RI_PIS_Avis1_CT12753.pdf
HAS/2013-06-28_CT-9757_DOSTINEX_PISRI_avis1_CT9757.pdf
HAS/2013-06-28_annexe_methodo__rehospitalisations_evitables_vf.pdf
HAS/2013-06-28_annexe_methodologique__fragilite__vf.pdf
HAS/2013-06-28_fiche_parcours_fragilite_vf.pdf
HAS/2013-06-28_fiche_parcours_rehospitalisations_evitables_vf.pdf
HAS/2013-06-28_nanostim_11_juin_2013_4457_avis_2013-06-26_09-32-51_830.pdf
HAS/2013-06-28_softform_premier_25_juin_2013_4466_avis.pdf
HAS/2013-06-28_softform_premier_active_2_25_juin_2013_4325_avis.pdf
HAS/2013-07-01_analyse_litterature_juillet_2013.pdf
HAS/2013-07-01_anesm-rbpp-accompagnement_sante-ea.pdf
HAS/2013-07-01_anesm-rbpp-accompagnement_sante-juillet_2013.pdf
HAS/2013-07-01_anesm-synthese-accompagnement_personne_handicapee-juillet_2013.pdf
HAS/2013-07-01_bibliographie_accompagnement_sante_ph_juillet_2013.pdf
HAS/2013-07-01_lettre_de_cadrage_besoins_en_sante_des_personnes_handicapees_101011.pdf
HAS/2013-07-01_rapport_d_analyse_juillet_2013.pdf
HAS/2013-07-03_CT-12658_VOTUBIA_EIT angiomyolipome_avis 2_CT12659.pdf
HAS/2013-07-03_synthese_votubia_pdf_130627.pdf
HAS/2013-07-03_votubia_ct_12659.pdf
HAS/2013-07-04_bhr_28_mai_2013_4418_avis.pdf
HAS/2013-07-04_conserve_plus_28_mai_2013_4417_avis.pdf
HAS/2013-07-04_m2a_magnum_23_avril_2013_4414_avis.pdf
HAS/2013-07-04_metasul_26_mars_2013_4416_avis.pdf
HAS/2013-07-04_pinnacle_ultamet-20_mars_2012_4221_avis.pdf
HAS/2013-07-04_prothese_tmj_25_juin_2013_4267_avis.pdf
HAS/2013-07-04_recap_magnum_23_avril_2013_4415_avis.pdf
HAS/2013-07-08_ipaqss-rapport-cdei_campagne2012.pdf
HAS/2013-07-08_ipaqss-rapport-rcp.pdf
HAS/2013-07-09_CT-10946_PARLODEL_PIC_avis2_CT10946.pdf
HAS/2013-07-09_CT-10967_LOMEXIN_TERLOMEXIN_Avis2_RI_CT10967.pdf
HAS/2013-07-09_CT-11770_DOPERGINE_PISRI_avis2_CT11770.pdf
HAS/2013-07-09_CT-12006_TANATRIL_RI_avis 1_CT 12006 VF.pdf
HAS/2013-07-09_CT-12286_ZYMAD_PISRI_avis2_CT12286.pdf
HAS/2013-07-09_CT-12342_EXACYL_avis2_RI_reevalSMR_CT12342.pdf
HAS/2013-07-09_CT-12369_CALCIFORTE_VITD3_PISRI_avis1_CT12369.pdf
HAS/2013-07-09_CT-12464_INNOVAIR_FROMUDUAL_RI2012_avis2_CT12464.pdf
HAS/2013-07-09_CT-12476_VITAMINE D3 BON_PISRI_avis1_CT12476.pdf
HAS/2013-07-09_CT-12486_EPTAVIT_PISRI_avis1_CT12486.pdf
HAS/2013-07-09_CT-12684_TOPLEXIL_RI_Avis1_CT12684.pdf
HAS/2013-07-09_CT-12716_TRINITRINE SIMPLE LALEUF_PISRI_avis1_CT12716.pdf
HAS/2013-07-09_CT-12833_PARACETAMOL_RANBAXY_avis1_RI_CT12833.pdf
HAS/2013-07-09_CT-12839_LUMIGANunidose_PIS_Ins_avis2_CT12839.pdf
HAS/2013-07-09_CT-12852_OSMOTAN G5_RI_avis1_CT12852.pdf
HAS/2013-07-09_CT-12889_UVESTEROL_D_RI_avis2_CT12889.pdf
HAS/2013-07-09_CT-12900_OSTEOCAL_D3_RI_avis1_CT12900.pdf
HAS/2013-07-09_CT-12911_DEXAMBUTOL 500 mg_RI_Avis1_CT12911.pdf
HAS/2013-07-09_CT-12932_FLUIDABAK_RI_avis1_CT12932.pdf
HAS/2013-07-09_CT-12967_VAXIGRIP_Saisine_MCI_Avis2_CT12967.pdf
HAS/2013-07-09_CT-12968_AGRIPPAL_Saisine_MCI_Avis2_CT12968.pdf
HAS/2013-07-09_CT-12969_FLUARIX_Saisine_MCI_Avis2_CT12969.pdf
HAS/2013-07-09_CT-12970_IMMUGRIP_Saisine_MCI_Avis2_CT12970.pdf
HAS/2013-07-09_CT-12971_INFLUVAC_Saisine_MCI_Avis2_CT12971.pdf
HAS/2013-07-09_CT-8423_ANANDRON_RI_Avis2_CT8423.pdf
HAS/2013-07-09_rasilez_ct_12157.pdf
HAS/2013-07-09_rasilez_reeval_2012_avis_2_suite_audition_ct12157_corrections_materielles_03042013.pdf
HAS/2013-07-09_synthese_rasilez_2_pdf_130704.pdf
HAS/2013-07-09_xyzall_ri_avis1modifie14juin2013_ct12565.pdf
HAS/2013-07-10_CT-12594_DACOGEN Ins_Avis 2_CT12594.pdf
HAS/2013-07-10_CT-12639_PREZISTA_ins_sol_buv_EI_cp_avis_2_CT12639_12640.pdf
HAS/2013-07-10_CT-12648_XALKORI Ins_Avis2_CT12648.pdf
HAS/2013-07-10_CT-12649_BINOCRIT_RI2013_avis2_CT12649.pdf
HAS/2013-07-10_CT-12667_CLOROTEKAL_INS_avis2_CT12667.pdf
HAS/2013-07-10_binocrit_ri2013_radiation_fit2modifiee01juillet2013.pdf
HAS/2013-07-10_clorotekal_ct_12667.pdf
HAS/2013-07-10_clorotekal_synthese_ct12667.pdf
HAS/2013-07-10_dacogen_ct_12594.pdf
HAS/2013-07-10_dacogen_synthese_ct12530.pdf
HAS/2013-07-10_fs_bum_epo_v5.pdf
HAS/2013-07-10_prezista_ct_12639_12640.pdf
HAS/2013-07-10_prezista_synthese_ct12640.pdf
HAS/2013-07-10_synthese_xalcori_pdf_130627.pdf
HAS/2013-07-10_xalkori_ct_12648.pdf
HAS/2013-07-11_CT-13087_OSAFLEXAN_PIC_REEV_Avis3_CT13087.pdf
HAS/2013-07-11_CT-13088_STRUCTOFLEX_PIC_REEV_Avis3_CT13088.pdf
HAS/2013-07-11_CT-13094_FLEXEA_PIC_REEV_Avis3_CT13094.pdf
HAS/2013-07-11_CT-13097_VOTLTAFLEX_PIC_REEV_Avis2_CT13097.pdf
HAS/2013-07-11_CT-13107_DOLENIO_PIC_REEV_Avis3_CT13107.pdf
HAS/2013-07-11_art50_ri2012_avis2modifie17jan2013_ct12263.pdf
HAS/2013-07-11_chondrosulf_ri2012_avis2modifie17jan2013_ct9852.pdf
HAS/2013-07-11_fs_bum_aasal_v3.pdf
HAS/2013-07-11_piascledine_ri2012_avis2modifie17jan2013_ct9142.pdf
HAS/2013-07-11_zondar_ri2012_avis2modifie17jan2013_ct12262.pdf
HAS/2013-07-12_CT-12629_EFFALA_INS_Avis1_CT12629.pdf
HAS/2013-07-12_adcetris_ct_12643.pdf
HAS/2013-07-12_adcetris_ins_avis2_ct12643.pdf
HAS/2013-07-12_aprokam_ct_12564.pdf
HAS/2013-07-12_aprokam_ins_avis2modifie5avril2013_ct12564.pdf
HAS/2013-07-12_effala_ct_12629.pdf
HAS/2013-07-12_synthese_adcetris_pdf_130626.pdf
HAS/2013-07-12_synthese_aprokam_pdf_130627_2013-06-28_11-19-28_312.pdf
HAS/2013-07-12_synthese_effala_pdf_130627.pdf
HAS/2013-07-15_CEPP-4443_SPIROTEL_V2_25_juin_2013_(4443)_avis.pdf
HAS/2013-07-15_CEPP-4462_SOLITAIRE_AB_25_juin_2013_(4462)_avis.pdf
HAS/2013-07-15_CT-12645_SELEXID_Ins_Avis1_ CT 12645.pdf
HAS/2013-07-15_acurate_ta_25_juin_2013_4407_avis.pdf
HAS/2013-07-15_afinitor_ct_12583.pdf
HAS/2013-07-15_afinitor_ei_sein_avis2_post_commentaires_materiel_ct12583.pdf
HAS/2013-07-15_selexid_ct_12645.pdf
HAS/2013-07-15_synthese_afinitor_sein_pdf_130709.pdf
HAS/2013-07-15_synthese_selexid_cystite_pdf_130709.pdf
HAS/2013-07-15_zenith_tx2__zenith_pro-form_tx2_11_juin_2013_4380_avis_2013-06-26_14-37-31_563.pdf
HAS/2013-07-17_pied__a_restitution_denergie_09_juillet_2013_4490_autosaisine.pdf
HAS/2013-07-18_annexes_vf_2013-07-18_14-49-4_836.pdf
HAS/2013-07-18_cadrage_telemedecine_vf.pdf
HAS/2013-07-18_efficience_tlm_vf_2013-07-18_14-48-38_743.pdf
HAS/2013-07-18_guide_grille_de_pilotage_et_de_securite_d_un_projet_de_telemedecine_2013-07-18_13-34-47_545.pdf
HAS/2013-07-19_CT-12664_OPTAFLU_Ins_Avis2_17042013_CT12664.pdf
HAS/2013-07-19_composition_du_groupe_de_travail_substituts_osseux_-_cotation.pdf
HAS/2013-07-19_composition_du_groupe_de_travail_substituts_osseux_-_pilotage.pdf
HAS/2013-07-19_note_cadrage_substituts_osseux.pdf
HAS/2013-07-19_optaflu_ct_12664.pdf
HAS/2013-07-19_rapport_devaluation_des_substituts_osseux.pdf
HAS/2013-07-19_substituts_osseux_28_mai_2013_dm_eval3_avis.pdf
HAS/2013-07-19_synthese_optaflu_pdf_130712.pdf
HAS/2013-07-19_synthese_substituts_osseux_dm-eval_3.pdf
HAS/2013-07-19_synthesis_bones_substitutes.pdf
HAS/2013-07-24_CEPP-4225_PRESTATION_PM_09_juillet_2013_(4225)_avis.pdf
HAS/2013-07-24_CEPP-4445_HEARTMATE II_09_juillet_2013_(4445)_avis.pdf
HAS/2013-07-24_CEPP-4506_PRESTATION_DCI_09_juillet_2013_(4225)_avis.pdf
HAS/2013-07-25_CEPP-4474_RESOLUTE INTEGRITY_09_juillet_2013_(4474)_avis.pdf
HAS/2013-07-25_CT-12766_BECILAN_RI_avis1_CT12766.pdf
HAS/2013-07-25_CT-12767_BEVITINE_RI_avis1_CT12767.pdf
HAS/2013-07-25_CT-12857_GLUCOSE 5pCENT_MACOPHARMA_RI_avis1_CT12857.pdf
HAS/2013-07-25_antiarthrosique_09012013_synthese_2013-05-17_13-12-47_208.pdf
HAS/2013-07-25_art50_ct_12263.pdf
HAS/2013-07-25_art50_ri2012_avis2modifie17jan2013_ct12263.pdf
HAS/2013-07-25_chondrosulf_ct_9852.pdf
HAS/2013-07-25_chondrosulf_ri2012_avis2modifie17jan2013_ct9852.pdf
HAS/2013-07-25_fs_bum_aasal_v3.pdf
HAS/2013-07-25_piascledine_ct_9142.pdf
HAS/2013-07-25_piascledine_ri2012_avis2modifie17jan2013_ct9142.pdf
HAS/2013-07-25_zondar_ct_12262.pdf
HAS/2013-07-25_zondar_ri2012_avis2modifie17jan2013_ct12262.pdf
HAS/2013-07-30_CT-12212_CALCIUM_TEVA_500mg_RI_PIS_avis2_CT12212.pdf
HAS/2013-07-30_CT-12312_CACIT_500mg_1000mg_RI_PIS_avis1_CT12312.pdf
HAS/2013-07-30_CT-12370_CALCIFORTE_500mg_RI_PIS_avis1_CT12370.pdf
HAS/2013-07-30_CT-12421_OROCAL_500mg_RI_PIS_avis1_CT12421.pdf
HAS/2013-07-30_CT-12481_OSTRAM_RI_PIS_avis2_CT12481.pdf
HAS/2013-07-30_CT-12668_SOMAVERT_Avis3_CT12668.pdf
HAS/2013-07-30_fs_bum_naco_v5.pdf
HAS/2013-07-30_pradaxa_15022012_avis_ct10749.pdf
HAS/2013-07-30_pradaxa_ct_10749.pdf
HAS/2013-07-30_rapport_micro-stent_de_pontage_trabeculaire_2013-07-26_14-43-59_961.pdf
HAS/2013-07-30_synthese_somavert_pdf_130729.pdf
HAS/2013-07-30_xarelto_14032012_synthese_ct11771.pdf
HAS/2013-07-30_xarelto_avc_14032012_avis_ct11771.pdf
HAS/2013-07-30_xarelto_avc_ct_11771.pdf
HAS/2013-07-31_CT-12549_BRETARIS-GENUAIR_avis3_CT12549.pdf
HAS/2013-07-31_CT-12551_EKLIRA-GENUAIR_avis3_CT12551.pdf
HAS/2013-07-31_CT-12574_FLUTIFORM_IFFEZA_AFFERA_avis2_CT12574.pdf
HAS/2013-07-31_CT-12960_SOLIRIS_avis1_pop_cible_CT12960.pdf
HAS/2013-07-31_CT-9497_LAMISIL_RI_avis2_CT9497.pdf
HAS/2013-07-31_CT-9521_LAMISIL_topique_RI_Avis2_ CT9521.pdf
HAS/2013-07-31_bretaris_genuair_ct_12549.pdf
HAS/2013-07-31_eklira_genuair_ct_12551.pdf
HAS/2013-07-31_referentieleps_format2clic_kc_col_uterus_2013-30-08__vf_mel.pdf
HAS/2013-07-31_referentieleps_format2clic_kc_colon-vfinale_2013-08-30_vf_mel_2013-08-30_12-18-6_653.pdf
HAS/2013-07-31_synthese_bretaris_eklira_pdf_130712.pdf
HAS/2013-08-01_CT-12408_PSYLIA_RI_Avis2_CT12408.pdf
HAS/2013-08-01_CT-12627_VAXIGRIP_Avis2_10072013_CT12627_PIS_RI.pdf
HAS/2013-08-01_CT-12817_COPEGUS 200 400 mg_RI_Avis1_CT12817.pdf
HAS/2013-08-01_CT-12945_SAVARINE_RI_Avis1_CT12945.pdf
HAS/2013-08-01_CT-12946_PALUDRINE 100 mg_RI_Avis1_CT12946.pdf
HAS/2013-08-01_CT-12962_PARACETAMOL_CRISTERS_PISRI_avis1_CT12962.pdf
HAS/2013-08-12_CEPP-4335_iSTENT_09_juillet_2013_(4335)_avis.pdf
HAS/2013-08-20_CEPP-4454_ACTIFIT_23_juillet_2013_(4454)_avis.pdf
HAS/2013-08-20_CEPP-4465_XIENCE PRIME BTK_23_juillet_2013_(4465)_avis.pdf
HAS/2013-08-20_CEPP-4484_HOME MONITORING ILESTO 7 VR-T_23_juillet_2013_(4484)_avis.pdf
HAS/2013-08-20_CEPP-4485_HOME MONITORING ILESTO 7 DR-T_23_juillet_2013_(4485)_avis.pdf
HAS/2013-08-20_CEPP-4486_HOME MONITORING ILESTO 7 HF-T_23_juillet_2013_(4486)_avis.pdf
HAS/2013-08-20_CEPP-4492_MERLIN.NET_simple chambre_(4492)_avis.pdf
HAS/2013-08-20_CEPP-4493_MERLIN.NET_double chambre_(4493)_avis.pdf
HAS/2013-08-20_CEPP-4494_MERLIN.NET_resynchronisation_(4494)_avis.pdf
HAS/2013-08-20_CEPP-4497_BARD VIVEXX_23_juillet_2013_(4497)_avis.pdf
HAS/2013-08-30_CT-12029_STABLON_ReevalSMR_avis2_CT10411_CT12029.pdf
HAS/2013-08-30_fiche_bum_stablon.pdf
HAS/2013-08-30_stablon_ct_10411_12029.pdf
HAS/2013-08-30_synthese_stablon_pdf_130131.pdf
HAS/2013-09-03_CT-12964_OZIDIA_RI_Avis1_CT12964.pdf
HAS/2013-09-03_CT-8849_ELIGARD_gamme_RI_Avis2_CT8849.pdf
HAS/2013-09-03_duodopa_reeval_pop_cible_avis2_ct12680.pdf
HAS/2013-09-11_CT-12029_STABLON_ReevalSMR_avis2_CT10411_CT12029.pdf
HAS/2013-09-11_fiche_bum_stablon.pdf
HAS/2013-09-11_fm_troubles_causes_alcool_foetale_2013_en_hi-res_no_marks_2016-11-25_15-08-3_144.pdf
HAS/2013-09-11_troubles_causes_par_lalcoolisation_foetale_reperage-_rapport_delaboration.pdf
HAS/2013-09-11_troubles_causes_par_lalcoolisation_foetale_reperage_-_fiche_memo.pdf
HAS/2013-09-12_CT-12093_INFLUVAC_Avis2_10072013_CT12093_PIS_RI.pdf
HAS/2013-09-12_CT-12397_MAGINJECTABLE_RI_PIS_avis2_CT12397.pdf
HAS/2013-09-12_CT-12792_KEPPRA_avis1_RI_CT12789.pdf
HAS/2013-09-12_CT-12855_INOFER_RI_PIS_avis2_CT12855.pdf
HAS/2013-09-12_CT-12931_ALKONATREM_RI_avis 1_CT 12931.pdf
HAS/2013-09-12_CT-9260_CLARADOL_CAFEINE_avis1_RI_CT9260.pdf
HAS/2013-09-12_glucose_fresenius5_ri_avis_1_ct12816.pdf
HAS/2013-09-12_synthese_zelboraf_pdf_130121.pdf
HAS/2013-09-12_zelboraf_03102012_avis_ct12121.pdf
HAS/2013-09-12_zelboraf_ct_12121.pdf
HAS/2013-09-20_CEPP-4395_IFILL_03_septembre_2013_(4395)_avis.pdf
HAS/2013-09-20_CT-13090_TROSYD_RI_Avis1_CT13090.pdf
HAS/2013-09-20_confirm_modele_dm2100_23_juillet_2013_4476_avis.pdf
HAS/2013-09-20_note_de_cadrage_soins_palliatifs_web.pdf
HAS/2013-09-25_CEPP-4468_ECLIPSE_3_03_septembre_2013_(4468)_avis.pdf
HAS/2013-09-25_CEPP-4483_XIENCE XPEDITION_17_septembre_2013_(4483)_avis.pdf
HAS/2013-09-25_CT-12327_PLITICAN_PIS_RI_Avis1_CT12327.pdf
HAS/2013-09-25_CT-12649_BINOCRIT_RI2013_avis2_CT12649.pdf
HAS/2013-09-25_CT-12914_PERGOVERIS_PIS_RI_Avis2_CT12914.pdf
HAS/2013-09-25_ams_700_inhibizone_17_septembre_2013_4475_avis.pdf
HAS/2013-09-25_aranesp_-_ct-7471.pdf
HAS/2013-09-25_ct-5111_mircera_.pdf
HAS/2013-09-25_eporatio_-_ct-7413.pdf
HAS/2013-09-25_eprex_-_ct-7457.pdf
HAS/2013-09-25_fs_bum_epo_v5.pdf
HAS/2013-09-25_gore_propaten_03_septembre_2013_4460_avis.pdf
HAS/2013-09-25_macroplastique_17_septembre_2013_4455_avis.pdf
HAS/2013-09-25_neorecormon_-_ct-7464.pdf
HAS/2013-09-25_retacrit_-_ct-5687.pdf
HAS/2013-09-26_CEPP-4444_DEFLUX_17_septembre_2013_(4444)_avis.pdf
HAS/2013-09-26_CT-12662_RENAGEL_RI_Avis2_CT12662.pdf
HAS/2013-09-26_CT-13050_ERYFLUID_RI_Avis1_CT13050.pdf
HAS/2013-09-26_CT-13073_PANTESTONE_RI_Avis2_CT13073.pdf
HAS/2013-09-26_CT-13089_ANDROTARDYL_RI_Avis2_CT13089.pdf
HAS/2013-09-27_homefill_ii_17_septembre_2013__4523.pdf
HAS/2013-09-27_rapport_devaluation_des_vetements_compressifs_sur_mesure_pour_grands_brues_24_septembre_2013.pdf
HAS/2013-09-27_vetements_compressifs_avis_2013_dm_eval1.pdf
HAS/2013-09-30_day_surgery_tariffs_in_france_and_in_other_countries_current_situation_and_future_prospects.pdf
HAS/2013-09-30_rapport_dorientation_-_tarification_de_la_chirurgie_ambulatoire_en_france_et_a_letranger.pdf
HAS/2013-09-30_synthese_et_recommandations_tarification_de_la_chirurgie_ambulatoire_en_france_et_a_letranger.pdf
HAS/2013-10-04_CT-12719_MULTIHANCE_PIS_EI_Avis2_CT12719.pdf
HAS/2013-10-04_CT-12744_AVAMYS_RI2013_Avis2_CT12744.pdf
HAS/2013-10-04_CT-12907_ARTISIAL_RI_Avis2_CT12907.pdf
HAS/2013-10-04_CT-12978_RETACRIT_RI2013_PIS_Avis2_CT12978.pdf
HAS/2013-10-04_CT-13017_DIPROSALIC_PIS_RI_Avis2_CT13017.pdf
HAS/2013-10-04_CT-13019_NERISONE_PIS_RI_Avis1_CT13019.pdf
HAS/2013-10-04_CT-13020_TRIDESONIT_PIS_RI_Avis1_CT13020.pdf
HAS/2013-10-04_CT-13040_ANDRACTIM_RI_Avis1_CT13040.pdf
HAS/2013-10-04_CT-13057_SYNALAR_gamme_PIS_RI2013_Avis1_CT13057.pdf
HAS/2013-10-04_CT-13120_MEROPENEM_ACTAVIS_QDINS_Avis1_CT13123_13120.pdf
HAS/2013-10-04_CT-13122_ACIDE_ZOLEDRONIQUE_RESOLUTE_QDINS_Avis1_CT13122.pdf
HAS/2013-10-04_CT-13153_CISATRACURIUM_KABI_Avis2_CT13153.pdf
HAS/2013-10-04_CT-13158_SYNACTHENE_RI_Avis1_CT13158.pdf
HAS/2013-10-04_CT-13159_PROPRANOLOL_PIS_RI_Avis2_CT13159.pdf
HAS/2013-10-04_hintegra_17_septembre_2013_4501_avis.pdf
HAS/2013-10-04_meteospasmyl_avis1_ct11018_ins_qd.pdf
HAS/2013-10-04_note_de_cadrage_-_depistage_du_cancer_du_sein_chez_les_femmes_de_40-49_ans_et_70-79_ans.pdf
HAS/2013-10-05_anesm-rapport_d_enque_te_bientraitance.pdf
HAS/2013-10-05_anesm-rapport_d_enquete_bientraitance-synthese.pdf
HAS/2013-10-05_guide-questionnaire_final.pdf
HAS/2013-10-08_CT-13083_CISATRACURIUM_PFIZER_Avis2_CT13083.pdf
HAS/2013-10-08_CT-8964_DEPO-PRODASONE_REEVAL_SMR_Avis1_CT8964.pdf
HAS/2013-10-08_referentieleps_format2clic_kc_prostate_vfinale.pdf
HAS/2013-10-10_CEPP-4479_PRIMEADVANCED SURESCAN MRI_08_octobre_2013_(4479)_avis.pdf
HAS/2013-10-10_CEPP-4480_RESTOREADVANCED SURESCAN MRI_08_octobre_2013_(4480)_avis.pdf
HAS/2013-10-10_CEPP-4496_ONIRIS_08_octobre_2013_(4496)_avis.pdf
HAS/2013-10-10_CEPP-4502_PROFORE_17_septembre_2013_(4502)_avis.pdf
HAS/2013-10-10_crigler_najjar_08_octobre_2013_dm_eval_67_avis.pdf
HAS/2013-10-10_fit_restore_gamme_surescan_mri_2013-10-21_11-52-23_537.pdf
HAS/2013-10-11_CT-12330_KERLONE_PIS_RI_Avis1_CT12330.pdf
HAS/2013-10-11_CT-12374_DELURSAN_PIS_RI_Avis1_CT12374.pdf
HAS/2013-10-11_CT-12879_DODECAVIT_RI_PIS_Avis1_CT12879.pdf
HAS/2013-10-11_CT-13021_FLAMMAZINE_RI2013_Avis1_CT13021.pdf
HAS/2013-10-11_CT-13023_FORMICA_RUFA_COMPOSE_RI_PIS_Avis1_CT13023.pdf
HAS/2013-10-11_CT-13024_SCROFULARIA_COMPOSE_RI_PIS_Avis1_CT13024.pdf
HAS/2013-10-11_CT-13025_TABACUM_COMPOSE_RI_PIS_Avis1_CT13025.pdf
HAS/2013-10-11_CT-13027_CALENDULA_RI_PIS_Avis2_CT13027.pdf
HAS/2013-10-11_CT-13028_CALCAREA_COMPOSE_RI_PIS_Avis2_CT13028.pdf
HAS/2013-10-11_CT-13029_ACONITUM_COMPOSE_RI_PIS_Avis2_CT13029.pdf
HAS/2013-10-11_CT-13115_ATOVAQUONE-PROGUANIL_SIGMA-TAU_QDINS_Avis1_CT13115.pdf
HAS/2013-10-11_CT-13132_OXYGENE_MEDICINAL_MESSER_QDINS_Avis2_CT13132.pdf
HAS/2013-10-11_CT-13138_JAKAVI_QDINS_Avis1_CT13138.pdf
HAS/2013-10-11_CT-13171_CONFIDEX_QDINS_Avis2_CT13171.pdf
HAS/2013-10-14_algorithme_outil_daide_a_la_decision.pdf
HAS/2013-10-14_guide_k_bronchopulmonaires_finalweb__091013.pdf
HAS/2013-10-14_guide_lymphome_hodgkin_web.pdf
HAS/2013-10-14_guide_mesotheliome_pleural_malin_final_web_091013.pdf
HAS/2013-10-14_memo_k_broncho-pulmonaires_web.pdf
HAS/2013-10-14_memo_lymphome_hodgkin_web.pdf
HAS/2013-10-14_points_critiques_k_broncho-pulmonaires_web.pdf
HAS/2013-10-14_points_critiques_lymphome_hodgkin_web.pdf
HAS/2013-10-14_points_critiques_mesotheliome_web.pdf
HAS/2013-10-14_rapport_outil_daide_a_la_decision_pour_ladmission_des_patients_en_soins_de_suite_et_de_readaptation.pdf
HAS/2013-10-17_annexes_rapport_hpv.pdf
HAS/2013-10-17_brief_inahta_test_hpv_2014-01-14_14-30-58_104.pdf
HAS/2013-10-17_fiche_buts_adn_hpv_2014-05-23_12-10-11_339.pdf
HAS/2013-10-17_texte_court_hpv_2013-10-16_15-29-22_291.pdf
HAS/2013-10-17_texte_court_hpv_2013-10-16_15-29-26_79.pdf
HAS/2013-10-22_CT-12623_INOMAX_EI_Avis 2_CT12623.pdf
HAS/2013-10-22_inomax_ct12623.pdf
HAS/2013-10-22_synthese_inomax_pdf_130913.pdf
HAS/2013-10-23_CEPP-4499_KETO-DIASTIX_08_octobre_2013_(4499)_avis.pdf
HAS/2013-10-23_CEPP-4520_NUCLEUS CP910 et CP920_08_octobre_2013_(4520)_avis.pdf
HAS/2013-10-30_CEPP-4449_EON_03_septembre_2013_(4449)_avis.pdf
HAS/2013-10-30_CEPP-4450_EON _MINI_23_juillet_2013_(4450)_avis.pdf
HAS/2013-10-30_CEPP-4481_RESTOREULTRA SURESCAN MRI_08_octobre_2013_(4481)_avis.pdf
HAS/2013-10-30_CT-11926_SEROPRAM_RI_PIS_Avis1_CT11926.pdf
HAS/2013-10-30_CT-12053_EXFORGE_RI_PIS_Avis2_CT12053.pdf
HAS/2013-10-30_CT-12190_LAMICTAL_RI_PIS_Avis1_CT12190.pdf
HAS/2013-10-30_CT-12473_EFFEXOR_RI_PIS_Avis2_CT12473.pdf
HAS/2013-10-30_CT-12569_IXPRIM_ZALDIAR_PIS_RI_Avis1_CT12569.pdf
HAS/2013-10-30_CT-12703_PNEUMOVAX_RI_PIS_Avis2_CT12703.pdf
HAS/2013-10-30_CT-12738_THYROGEN_PIS_RCP_Avis1_CT12738.pdf
HAS/2013-10-30_CT-12843_RAPAMUNE_RI_PIS_Avis2_CT12843.pdf
HAS/2013-10-30_CT-12920_PONSTYL_PIS_RI_Avis1_CT12920.pdf
HAS/2013-10-30_CT-12929_ALKOSALEN_PIS_RI_Avis1_CT12929.pdf
HAS/2013-10-30_CT-12934_TRIFLUCAN_RI_PIS_Avis1_CT12934.pdf
HAS/2013-10-30_CT-12947_PROPOFOL_PANPHARMA_QDINS_Avis1_CT12947_CT13121_CT13165.pdf
HAS/2013-10-30_CT-12951_ISORYTHM_LP_PIS_RI_Avis1_CT12951.pdf
HAS/2013-10-30_CT-12983_MENOPUR_QDINS_Avis1_CT12983.pdf
HAS/2013-10-30_CT-12995_FONGAMIL_RI_PIS_Avis1_CT12995.pdf
HAS/2013-10-30_CT-13001_FLUCONAZOLE_MAJORELLE_Avis1_CT13001.pdf
HAS/2013-10-30_CT-13012_HYDROCORTISONE_ROUSSEL_PIS_RI_Avis1_CT13012.pdf
HAS/2013-10-30_CT-13018_SECNOL_RI_PIS_Avis1_CT13018.pdf
HAS/2013-10-30_CT-13022_GRAPHITES_RI_PIS_Avis2_CT13022.pdf
HAS/2013-10-30_CT-13026_TRIPHOSPHATES_RI_PIS_Avis2_CT13026.pdf
HAS/2013-10-30_CT-13044_ANCOTIL_PIS_RI_Avis1_CT13044.pdf
HAS/2013-10-30_CT-13054_LOCATOP_PIS_RI2013_Avis1_CT13054.pdf
HAS/2013-10-30_CT-13075_FONX_RI_Avis2_CT13075.pdf
HAS/2013-10-30_CT-13136_IMIPENEM-CILASTATINE_ACTAVIS_QDINS_Avis1_CT13136.pdf
HAS/2013-10-30_CT-13140_FLUCONAZOLE_KABI_QDINS_Avis2_CT13140.pdf
HAS/2013-10-30_CT-13145_HEXABRIX_QDINS_Avis1_CT13145.pdf
HAS/2013-10-30_CT-13162_FOSTIMONKIT_QDINS_Avis1_CT13362.pdf
HAS/2013-10-30_CT-13199_CISATRACURIUM_MYLAN_Avis1_CT13199.pdf
HAS/2013-10-30_CT-13214_CHLORAPREP_QDINS_Avis1_CT13214.pdf
HAS/2013-10-30_CT-13233_ATOSIBAN_SUN_QDINS_Avis2_CT13233.pdf
HAS/2013-10-30_CT-13284_PROGLICEM_QDINS_Avis1_CT13284.pdf
HAS/2013-10-30_clinical_utility_of_the_measurement_of_vitamin_d_-_brief_inahta.pdf
HAS/2013-10-30_codoliprane_qdins_avis1_ct13200_2013-10-30_10-36-25_618.pdf
HAS/2013-10-30_factane_qdins_avis1_ct13137.pdf
HAS/2013-10-30_fit_eon.pdf
HAS/2013-10-30_fit_eon_mini.pdf
HAS/2013-10-30_fit_restore_gamme_surescan_mri_2013-10-21_11-53-34_16.pdf
HAS/2013-10-30_locapred_pis_ri2013_avis1_ct13054.pdf
HAS/2013-10-30_opatanol_pis_ri_avis1_ct12672.pdf
HAS/2013-10-30_utilite_clinique_du_dosage_de_la_vitamine_d_-_annexes_du_rapport_devaluation.pdf
HAS/2013-10-30_utilite_clinique_du_dosage_de_la_vitamine_d_-_note_de_cadrage.pdf
HAS/2013-10-30_utilite_clinique_du_dosage_de_la_vitamine_d_-_rapport_devaluation.pdf
HAS/2013-10-30_utilite_clinique_du_dosage_de_la_vitamine_d_-_texte_court.pdf
HAS/2013-10-31_CT-12681_PNEUMO23_RI_PIS_Avis2_CT12681.pdf
HAS/2013-11-04_CT-12724_OPTISON_PIS_RI_Avis2_CT12724.pdf
HAS/2013-11-04_CT-12856_CHLORURE_DE_SODIUM_MACOPHARMA_RI_Avis1_CT12856.pdf
HAS/2013-11-04_CT-13170_PRIVIGEN_QDINS_Avis1_CT13170.pdf
HAS/2013-11-04_CT-13226_IMIPENEM_CILASTATINE_STRAVENCON_QDINS_Avis2_CT13226.pdf
HAS/2013-11-04_CT-13227_MEROPENEM_STRAVENCON_QDINS_Avis1_CT13227.pdf
HAS/2013-11-04_glucose_5_viaflo_qdins_avis2_ct13229.pdf
HAS/2013-11-06_CEPP-4470_METASUL_22_octobre_2013_(4470)_avis.pdf
HAS/2013-11-06_CEPP-4482_RESTORESENSOR SURESCAN MRI_08_octobre_2013_(4482)_avis.pdf
HAS/2013-11-06_CEPP-4524_TRITON LP_08_octobre_2013_(4524)_avis.pdf
HAS/2013-11-06_CEPP-4538_ALLURE - ALLURE RF_22_octobre_2013_(4538)_avis.pdf
HAS/2013-11-06_CT-12702_CERNEVIT_PIS_RI_Avis1_CT12702.pdf
HAS/2013-11-06_CT-12921_LEDERFOLINE_PIS_RI_Avis1_CT12921.pdf
HAS/2013-11-06_fit_restore_gamme_surescan_mri.pdf
HAS/2013-11-06_ultraflex.pdf
HAS/2013-11-07_12iex04_decision_medicale_partagee_mel_vd.pdf
HAS/2013-11-07_critere_de_qualite_format2clics.pdf
HAS/2013-11-07_criteres_de_qualite_-_bibliographie_et_participants.pdf
HAS/2013-11-07_criteres_de_qualite_-_guide_delaboration_et_de_mise_en_oeuvre_de_criteres_de_qualite.pdf
HAS/2013-11-07_criteres_de_qualite_-_guide_dutilisation_concernant_le_test_ou_la_mise_en_oeuvre.pdf
HAS/2013-11-07_criteres_de_qualite_-_pertinence_2013-10-10_15-53-51_455.pdf
HAS/2013-11-07_criteres_de_qualite_-_pilotage_-_courriel_de_sollicitation.pdf
HAS/2013-11-07_criteres_de_qualite_-_recherche_documentaire_2013-10-10_15-53-51_465.pdf
HAS/2013-11-07_criteres_de_qualite_-_test_-_compte_rendu_danalyse_2013-10-10_15-53-51_476.pdf
HAS/2013-11-07_criteres_de_qualite_-_test_-_courriel_de_sollicitation_2013-10-10_15-53-51_471.pdf
HAS/2013-11-07_elaboration_de_criteres_de_qualite_a_partir_de_recommandations_disponibles.pdf
HAS/2013-11-07_elaboration_de_criteres_de_qualite_au_decours_dune_rbp.pdf
HAS/2013-11-07_mise_en_oeuvre_de_criteres_de_qualite.pdf
HAS/2013-11-07_schema_-_etapes_de_mise_en_oeuvre_de_criteres_de_qualite.pdf
HAS/2013-11-07_schema_-_etapes_delaboration_a_partir_de_recommandations_disponibles.pdf
HAS/2013-11-07_schema_-_etapes_delaboration_au_decours_dune_recommandations_de_bonne_pratique.pdf
HAS/2013-11-07_synthese_avec_schema.pdf
HAS/2013-11-08_doc_trav_lch_mel.pdf
HAS/2013-11-08_luxation_hanche_v2_mel.pdf
HAS/2013-11-08_luxation_hanche_v3_dtp_apr_16_hi_res_no_marks.pdf
HAS/2013-11-12_CT-13225_PIPERACILLINE_TAZOBACTAM_STRAVENCON_QDINS_Avis1_CT13225.pdf
HAS/2013-11-13_ff7_note_de_cadrage_vf_2013_10_22.pdf
HAS/2013-11-13_web-composition_du_gt_ff7_2014-03-19_11-53-32_768.pdf
HAS/2013-11-15_13_07_10_note_problematique_endoscopies_vf.pdf
HAS/2013-11-15_argumentaire_coloscopie_post-polypectomie.pdf
HAS/2013-11-15_coloscopie-controle-v1.pdf
HAS/2013-11-15_protocole-surveillance-polypectomie_-_facteurs_patients.pdf
HAS/2013-11-15_protocole-surveillance-polypectomie_-_facteurs_techniques.pdf
HAS/2013-11-15_protocole-surveillance-polypectomie__facteurs_polypes.pdf
HAS/2013-11-15_protocole-surveillance-polypectomie_v8.pdf
HAS/2013-11-19_anaphylaxie_check_list.pdf
HAS/2013-11-19_anaphylaxie_document_de_travail_message__cles.pdf
HAS/2013-11-19_anaphylaxie_fiche_memo.pdf
HAS/2013-11-21_00_produits_iodes_reeval_synthese_avis3.pdf
HAS/2013-11-21_CEPP-4477_NARVAL ORM_05_novembre_2013_(4477)_avis.pdf
HAS/2013-11-21_CEPP-4498_XILOIAL_22_octobre_2013_(4498)_avis.pdf
HAS/2013-11-21_CEPP-4503_CALCIBON_22_octobre_2013_(4503)_avis.pdf
HAS/2013-11-21_CT-11024_OMNIPAQUE_RI_SMR_avis2_CT11024.pdf
HAS/2013-11-21_CT-11423_GASTROGRAFINE_RI_SMR_avis2 _CT11423.pdf
HAS/2013-11-21_CT-11535_RADIOSELECTAN_URINAIRE_RI_SMR_avis 2_CT12587.pdf
HAS/2013-11-21_CT-11536_ULTRAVIST 300_RI_SMR_avis2_CT11536.pdf
HAS/2013-11-21_CT-11811_HEXABRIX_RI_SMR_avis2_CT11811.pdf
HAS/2013-11-21_CT-11812_OPTIRAY_OPTIJECT_RI_SMR_avis2_CT_11812.pdf
HAS/2013-11-21_CT-11814_TELEBRIX_12_RI_SMR_avis2_CT11814.pdf
HAS/2013-11-21_CT-11860_XENETIX_RI_SMR_avis2_CT11860.pdf
HAS/2013-11-21_CT-12559_VISIPAQUE_RI_SMR_avis2_CT12559.pdf
HAS/2013-11-21_CT-12589_RADIOSELECTAN_URINAIRE_VASCU_RI_SMR_avis2_CT12589.pdf
HAS/2013-11-21_CT-12689_IOMERON_SMR_Avis2_CT12689.pdf
HAS/2013-11-21_CT-12690_IOPAMIRON_SMR_avis2_CT_12690.pdf
HAS/2013-11-21_CT-12691_TELEBRIX_30_meglubine_RI_SMR_avis3_CT12691.pdf
HAS/2013-11-21_CT-12692_TELEBRIX_35_RI_SMR_avis 3_CT12692.pdf
HAS/2013-11-21_CT-12693_TELEBRIX_GASTRO_RI_SMR_avis 2_CT11814.pdf
HAS/2013-11-21_CT-12694_TELEBRIX_HYSTERO_RI_SMR_avis1_CT11814.pdf
HAS/2013-11-21_inspra_ct12759.pdf
HAS/2013-11-21_inspra_eit_ic_avis3_ct12759.pdf
HAS/2013-11-21_synthese_inspra_ct12759.pdf
HAS/2013-11-21_synthese_produits_contraste_iodes_mai2013_2013-11-19_16-07-46_275.pdf
HAS/2013-11-21_xiloial_mono.pdf
HAS/2013-11-22_CT-10919_MEGACE_REEVAL_SMR_Avis2_CT10919.pdf
HAS/2013-11-22_CT-11115_MANTADIX_avis1_CT11115.pdf
HAS/2013-11-22_CT-12284_PREVENAR13_EI50 ans_avis2_CT12284.pdf
HAS/2013-11-22_CT-12333_ARIXTRA_2,5 mg_Reev_Prophylaxie_Avis3m_CT12333.pdf
HAS/2013-11-22_CT-12344_ARIXTRA 1,5mg_reev_Avis3m_CT12344.pdf
HAS/2013-11-22_CT-12417_SMECTA_RI_PIS_Avis2_CT12417.pdf
HAS/2013-11-22_CT-12537_ARIXTRA 2,5mg_Reev_SCA_Avis3m_CT12537.pdf
HAS/2013-11-22_CT-12555_CHONDROCELECT_Ins_AvisPostAud_CT12555.pdf
HAS/2013-11-22_CT-12557_EYLEA_Ins_avis3_CT12557_revuAA.pdf
HAS/2013-11-22_CT-12614_INFANRIX HEXA_RI_reevalASMR_avis2_CT12614.pdf
HAS/2013-11-22_CT-12646_PIXUVRI Ins _Avis3_CT12646.pdf
HAS/2013-11-22_CT-12666_ARIXTRA 2,5mg_reev_TVS_Avis3m_CT12666.pdf
HAS/2013-11-22_CT-12671_ELIQUIS_EI_AVC_Avis 3_CT12670_CT12671.pdf
HAS/2013-11-22_CT-12699_XARELTO_15_20mg_EI_CT12699_Avis POST OBS.pdf
HAS/2013-11-22_CT-12712_TOVIAZ_REEVAL_SMR_ASMR_ARGUMENTAIRE_Avis2_CT12712.pdf
HAS/2013-11-22_CT-12717_CERIS_REEVAL_SMR_ASMR_ARGUMENTAIRE_Avis2_CT12717.pdf
HAS/2013-11-22_CT-12748_MONOPROST_Ins_avis2_CT12748.pdf
HAS/2013-11-22_CT-12760_VESICARE_REEVAL_SMR_ASMR_ARGUMENTAIRE_Avis2_CT12760.pdf
HAS/2013-11-22_CT-12765_CILOXADEX 3 mg_Ins_Avis 2_CT 12765.pdf
HAS/2013-11-22_CT-12787_CERTICAN_EIT_Avis2_CT12787.pdf
HAS/2013-11-22_CT-12802_HUMIRA_EIT_CrohnSevEnfAdo_Avis2_CT12802.pdf
HAS/2013-11-22_CT-12826_ZYTIGA EI_Avis 2_CT12826.pdf
HAS/2013-11-22_CT-12897_PICATO_INS_Avis2_CT12897.pdf
HAS/2013-11-22_CT-12913_ZOCOR_EIT_enfant_Avis2_CT12913.pdf
HAS/2013-11-22_annexe_1_arixtra_resumes_epi_ct_17avril_2013.pdf
HAS/2013-11-22_annexe_2_arixtra_25__17avril_archimed_volet_ville.pdf
HAS/2013-11-22_annexe_3_arixtra__17avril_archimed_volet_hopital.pdf
HAS/2013-11-22_arixtra_ct_12333.pdf
HAS/2013-11-22_arixtra_ct_12344.pdf
HAS/2013-11-22_arixtra_ct_12537_2014-01-30_11-11-0_202.pdf
HAS/2013-11-22_arixtra_ct_12666.pdf
HAS/2013-11-22_ceris_ct12717.pdf
HAS/2013-11-22_certican_ct_12787.pdf
HAS/2013-11-22_chondrocelect_ct12555.pdf
HAS/2013-11-22_ciloxadex_ct_12765.pdf
HAS/2013-11-22_colobreathe_ct12840.pdf
HAS/2013-11-22_colobreathe_ins_pic_avis2_ct12840.pdf
HAS/2013-11-22_ditropan_ct12763.pdf
HAS/2013-11-22_ditropan_reeval_smr_asmr_argumentaire_avis2_ct12763.pdf
HAS/2013-11-22_eliquis_ct12671.pdf
HAS/2013-11-22_eylea_ct_12557.pdf
HAS/2013-11-22_fs_bum_naco_v5.pdf
HAS/2013-11-22_fycompa_ct12762.pdf
HAS/2013-11-22_fycompa_ins_avis2modifie_ct12762.pdf
HAS/2013-11-22_humira_ct12802.pdf
HAS/2013-11-22_humira_ct12804.pdf
HAS/2013-11-22_humira_eit_crohnmoderead_avis2_ct12804.pdf
HAS/2013-11-22_hydraperf_avis2_ct12737.pdf
HAS/2013-11-22_hydraperf_ct12737.pdf
HAS/2013-11-22_iluvien_avis2_ct12780.pdf
HAS/2013-11-22_iluvien_ct12780.pdf
HAS/2013-11-22_infanrix_hexa_ct12614.pdf
HAS/2013-11-22_mantadix_ct_11115.pdf
HAS/2013-11-22_megace_ct10919.pdf
HAS/2013-11-22_monoprost_ct12748.pdf
HAS/2013-11-22_picato_ct12897.pdf
HAS/2013-11-22_pixuvri_10072013_synthese_ct12646.pdf
HAS/2013-11-22_pixuvri__ct12646.pdf
HAS/2013-11-22_prevenar13_ct12284.pdf
HAS/2013-11-22_seroplex_avis1_r1_ct11853.pdf
HAS/2013-11-22_seroplex_ct11853.pdf
HAS/2013-11-22_smecta_ct12417.pdf
HAS/2013-11-22_synthese_anticholinergiques_pdf_131003_2013-10-09_10-22-14_543.pdf
HAS/2013-11-22_synthese_arixtra_reev_dosage_15__12344.pdf
HAS/2013-11-22_synthese_arixtra_reev_sca__12537.pdf
HAS/2013-11-22_synthese_arixtra_reev_thromboprophy__12333.pdf
HAS/2013-11-22_synthese_arixtra_reev_tvs__12666.pdf
HAS/2013-11-22_synthese_certican_pdf_130923.pdf
HAS/2013-11-22_synthese_choondrocelect_pdf_130925.pdf
HAS/2013-11-22_synthese_ciloxadex_pdf_130916.pdf
HAS/2013-11-22_synthese_colobreathe_ct12840.pdf
HAS/2013-11-22_synthese_eliquis_ac-fa_pdf_130913.pdf
HAS/2013-11-22_synthese_eylea_pdf_130712.pdf
HAS/2013-11-22_synthese_fycompa_pdf_130925.pdf
HAS/2013-11-22_synthese_humira_ct12802_2013-11-19_14-00-56_552.pdf
HAS/2013-11-22_synthese_humira_ct12804.pdf
HAS/2013-11-22_synthese_iluvien_pdf_131002.pdf
HAS/2013-11-22_synthese_infanrix_pdf_131108.pdf
HAS/2013-11-22_synthese_mantadix_pdf_130712.pdf
HAS/2013-11-22_synthese_monoprost_pdf_130916.pdf
HAS/2013-11-22_synthese_picato_pdf_131002.pdf
HAS/2013-11-22_synthese_seroplex_pdf_130912.pdf
HAS/2013-11-22_synthese_xarelto_embpulm_pdf_130926.pdf
HAS/2013-11-22_synthese_zocor_ct12913.pdf
HAS/2013-11-22_synthese_zytiga_ct12826.pdf
HAS/2013-11-22_toviaz_ct12712.pdf
HAS/2013-11-22_vesicare_ct12760.pdf
HAS/2013-11-22_votrient_26062013_synthese_rein_ct12477.pdf
HAS/2013-11-22_votrient_ct12477.pdf
HAS/2013-11-22_votrient_reeval_rein_avis3_ct12477.pdf
HAS/2013-11-22_xarelto_15_20mg_ct12699.pdf
HAS/2013-11-22_zocor_ct12913.pdf
HAS/2013-11-22_zytiga_ct12826.pdf
HAS/2013-11-25_CT-12927_SEEBRI BREEZHALER_Avis2_CT12927.pdf
HAS/2013-11-25_harmony.pdf
HAS/2013-11-25_seebri_ct12927.pdf
HAS/2013-11-25_synthese_seebri_ct12927.pdf
HAS/2013-11-28_CT-12958_ZOMETA_PIS_RI_Avis1_CT12958.pdf
HAS/2013-11-28_CT-12982_CLOBEX_PIS_RI_Avis1_CT12982.pdf
HAS/2013-11-28_CT-13168_PLASMALYTE_VIAFLO_QDINS_Avis1_CT13168.pdf
HAS/2013-11-28_CT-13174_FLUOREX_PIS_RI_Avis1_CT13174.pdf
HAS/2013-11-28_CT-13176_FLUORURE_DE_CALCIUM_CRINEX_PIS_RI_Avis1_CT13176.pdf
HAS/2013-11-28_CT-13186_URISPAS_PIS_RI_Avis1_CT13186.pdf
HAS/2013-12-02_CT-12548_KINERET_PIC_RI_Avis1_CT12548.pdf
HAS/2013-12-02_CT-12860_INTELENCE_PIC_EI_Pediatrie_Avis2_CT12860&12861.pdf
HAS/2013-12-04_CEPP-4510_CATIONORM_19_novembre_2013_(4510)_avis.pdf
HAS/2013-12-04_CT-13082_TEMOZOLOMIDE_MYLAN_QDINS_Avis1_CT13082.pdf
HAS/2013-12-04_CT-13164_CYTARABINE_ACCORD_QDINS_Avis1_CT13164.pdf
HAS/2013-12-04_CT-13175_FLUOSTEROL_PIS_RI_Avis1_CT13175.pdf
HAS/2013-12-04_CT-13228_CHLORURE_DE_SODIUM_VIAFLO_QDINS_Avis1_CT13228.pdf
HAS/2013-12-04_CT-13249_COVERSYL_PIS_RI_Avis2_CT13249.pdf
HAS/2013-12-06_CT-12749_VITAMINE_B12_GERDA_PIS_RI_Avis1_CT12749.pdf
HAS/2013-12-06_CT-12841_PURIVIST_PIS_RI_Avis1_CT12841.pdf
HAS/2013-12-06_CT-12973_CAYSTON_PIC_EI_Avis2_CT12973.pdf
HAS/2013-12-06_CT-13049_KENACORT_RETARD_PIS_RI_Avis2_CT13049.pdf
HAS/2013-12-06_argumentaire_antiagregants_plaquettaires_-_gestes_percutanes.pdf
HAS/2013-12-06_cayston_16102013_synthese_ct12973.pdf
HAS/2013-12-06_cayston_ct12973.pdf
HAS/2013-12-06_fiche_de_synthese_antiagregants_plaquettaires.pdf
HAS/2013-12-06_fiche_de_synthese_antiagregants_plaquettaires_-_gestes_percutanes.pdf
HAS/2013-12-06_recommandations_antiagregants_plaquettaires_-_gestes_percutanes.pdf
HAS/2013-12-09_CT-13099_CORTANCYL_PIS_RI_Avis2_CT13099.pdf
HAS/2013-12-09_CT-13113_HYDROCORTANCYL_PIS_RI_Avis2_CT13113.pdf
HAS/2013-12-09_CT-13256_ZANEXTRA_PIS_RI_Avis2_CT13256.pdf
HAS/2013-12-09_CT-13258_LERCAPRESS_PIS_RI_Avis2_CT13258.pdf
HAS/2013-12-09_walkaide.pdf
HAS/2013-12-12_freestyle_navigator_ii.pdf
HAS/2013-12-12_laser_treatment_of_lower_urinary_tract_symptoms_associated_with_benign_prostatic-brief_inahta.pdf
HAS/2013-12-12_rapport_devaluation_prostate_par_laser.pdf
HAS/2013-12-12_texte_court_prostate_par_laser.pdf
HAS/2013-12-16_CT-12896_CLEVIPREX_INSCOLL_Avis2_CT12896.pdf
HAS/2013-12-16_cleviprex_ct12896.pdf
HAS/2013-12-16_protonsan_wound_gel__gel_x.pdf
HAS/2013-12-16_synthese_cleviprex_pdf_131113.pdf
HAS/2013-12-16_valiant_avec__systeme_captiva_05_novembre_2013_4504_avis.pdf
HAS/2013-12-18_CT-11961_LORAMYC_PIS_RI_Avis2_CT11961.pdf
HAS/2013-12-18_CT-12095_PRITOR_PIC_RI_EIT_Avis2_CT12095.pdf
HAS/2013-12-18_CT-12126_SOPHIDONE_PIS_RI_Avis2_CT12126.pdf
HAS/2013-12-18_CT-12217_MICARDIS_PIC_RI_EIT_Avis2_CT12217.pdf
HAS/2013-12-18_CT-12597_INNOVAIR_FORMODUAL_NEXTHALER_PIC_INS_AvisPostAUD_CT12597&12465.pdf
HAS/2013-12-18_CT-12769_MEDROL_PIS_RI_Avis2_CT12769.pdf
HAS/2013-12-18_CT-12801_NOVATREX_PIS_RI_Avis1_CT12801.pdf
HAS/2013-12-18_CT-12861_INTELENCE_PIC_EI_Pediatrie_Avis2_CT12860&12861.pdf
HAS/2013-12-18_CT-12891_VIREAD_PIC_EI_Avis2_CT12891&12892.pdf
HAS/2013-12-18_CT-12892_VIREAD_PIC_EI_Avis2_CT12891&12892.pdf
HAS/2013-12-18_CT-12899_ISENTRESS_PIC_EI_Avis2_CT12898&12899.pdf
HAS/2013-12-18_isentress_pic_ei_avis2_ct1289812899.pdf
HAS/2013-12-18_micardis_ct12217.pdf
HAS/2013-12-18_pritor_en_ct12095_def.pdf
HAS/2013-12-19_composition_du_groupe_de_travail_.pdf
HAS/2013-12-19_guide_methodologique_17122013.pdf
HAS/2013-12-20_avis_radiofrequence_saphene_vd.pdf
HAS/2013-12-20_rapport_radiofreq_vd.pdf
HAS/2013-12-20_rapport_radiofrequence_saphene_vd.pdf
HAS/2013-12-20_synthese_radiofrequence_saphene_vd.pdf
HAS/2013-12-20_textcourt_radiofreq_vd.pdf
HAS/2013-12-27_inogen_one_g3.pdf
HAS/2013-12-27_onyx_les.pdf
HAS/2013-12-27_promus_element_plus_btk_monorail.pdf
HAS/2013-12-27_promus_element_plus_btk_over_the_wire.pdf
HAS/2013-12-27_stentys_bms.pdf
HAS/2014-01-02_CT-13169_DI-HYDAN_PIC_RI_Avis1_CT13169.pdf
HAS/2014-01-09_CEPP-4459_NUTRITION PARENTERALE A DOMICILE_4459_DMEVAL64_avis.pdf
HAS/2014-01-09_CEPP-4516_DURASUL Cotyle 4516_avis_VD.pdf
HAS/2014-01-09_CEPP-4519_XIENCE V_17_decembre_2013_(4519)_avis.pdf
HAS/2014-01-09_CEPP-4521_XIENCE PRIME_17_decembre_2013_(4521)_avis.pdf
HAS/2014-01-09_CEPP-4522_XIENCE XPEDITION_17_decembre_2013_(4522)_avis.pdf
HAS/2014-01-09_CEPP-4531_DURASUL Insert 4531_avis_VD.pdf
HAS/2014-01-09_CT-12979_STRIBILD_PIC_INS_Avis1_CT12979.pdf
HAS/2014-01-09_CT-13150_JAYDESS_PIC_INS_Avis2_CT13150.pdf
HAS/2014-01-09_biomatrix.pdf
HAS/2014-01-09_biomatrix_flex.pdf
HAS/2014-01-09_genesis.pdf
HAS/2014-01-09_interstim_i_et_ii.pdf
HAS/2014-01-09_jaydess_06112013_synthese_ct13150.pdf
HAS/2014-01-09_jaydess_ct1315.pdf
HAS/2014-01-09_omacor_02102013_synthese_ct12601.pdf
HAS/2014-01-09_omacor_ct12601_2014-02-28_12-44-44_793.pdf
HAS/2014-01-09_omacor_reeval_postidm_avis3_ct12601.pdf
HAS/2014-01-09_stribild_06112013_synthese_v2_ct12979.pdf
HAS/2014-01-09_stribild_ct12979.pdf
HAS/2014-01-09_tutopatch.pdf
HAS/2014-01-13_CT-11813_MICROPAQUE_PIS_RI_Avis1_CT11813.pdf
HAS/2014-01-13_CT-12447_METEOSPASMYL_PIS_RI_Avis1_CT12447.pdf
HAS/2014-01-13_CT-12637_LIPIODOL_REEV_SMR_EI_Avis1_CT12695_CT12637.pdf
HAS/2014-01-13_CT-12821_MELAXOSE_QD_INS_Avis1_CT12821.pdf
HAS/2014-01-13_CT-13051_SEPTEAL_PIS_RI_Avis1_CT13051.pdf
HAS/2014-01-13_CT-13052_CYTEAL_PIS_RI_Avis1_CT13052.pdf
HAS/2014-01-13_CT-13220_ROCGEL_PIS_RI_Avis1_CT13220.pdf
HAS/2014-01-13_CT-13316_BEFIZAL_PIS_RI_Avis1_CT13316.pdf
HAS/2014-01-13_CT-13317_CIMZIA_QD_INS_Avis1_CT13317.pdf
HAS/2014-01-13_CT-13351_ACTONELCOMBI_PIS_RI_Avis1_CT13351.pdf
HAS/2014-01-13_CT-13365_EXTRANEAL_QD_INS_Avis1_CT13365.pdf
HAS/2014-01-16_CT-10550_SANDOSTATINE_PIS_RI_Avis1_CT10550.pdf
HAS/2014-01-16_CT-12349_DOLENIO_QD_INS_Avis2_CT12349.pdf
HAS/2014-01-16_CT-12904_DOTAREM_PIC_REEV_ASMR_RI_Avis1_CT12904.pdf
HAS/2014-01-16_CT-12935_ENBREL_RI_PIS_Avis2_CT12935.pdf
HAS/2014-01-16_CT-12977_HUMIRA_EIT_Avis1_CT12977.pdf
HAS/2014-01-16_CT-12980_ROVALCYTE_PIS_RI_Avis2_CT12980.pdf
HAS/2014-01-16_CT-13288_NICOTINAMIDE_RENAUDIN_QD_INS_Avis1_CT13288.pdf
HAS/2014-01-16_CT-13309_ALEVETABS_QD_INS_Avis1_CT13309.pdf
HAS/2014-01-16_CT-13323_CEFUROXIME_PANPHARMA_QD_INS_Avis2_CT13323.pdf
HAS/2014-01-16_CT-13333_AXELER_PIS_RI_Avis2_CT13333.pdf
HAS/2014-01-16_CT-13334_SEVIKAR_PIS_RI_Avis2_CT13334.pdf
HAS/2014-01-16_CT-13366_LIDOCAINE_PRILOCAINE_AGUETTANT_QD_INS_Avis1_CT13366.pdf
HAS/2014-01-16_CT-13374_LEPONEX_QD_INS_Avis1_CT13374.pdf
HAS/2014-01-16_dotarem_ct1290412905.pdf
HAS/2014-01-16_fps_prise_en_charge_paf_ambulatoire.pdf
HAS/2014-01-16_humira_ct12977.pdf
HAS/2014-01-16_humiraenbrel__1809201316102013_synthese_ct1297712935.pdf
HAS/2014-01-16_note_methologique_fps_prise_en_charge_paf_ambulatoire.pdf
HAS/2014-01-16_radioselectan_urinaire_et_vasculaire_qdins_avis1_ct11753.pdf
HAS/2014-01-17_3ebat_guide_adm_reduit_261113.pdf
HAS/2014-01-17_administration_des_medicaments_en_hospitalisation_a_domicile_had_synthese.pdf
HAS/2014-01-17_guide_methode-champ_contenu_apald_web.pdf
HAS/2014-01-17_guide_outil_securisation_autoevaluation_administration_medicaments_partie3_boite_a_outils.pdf
HAS/2014-01-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie1_comprendre.pdf
HAS/2014-01-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie2_mettre_en_oeuvre.pdf
HAS/2014-01-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie4_pour_en_savoir_plus.pdf
HAS/2014-01-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie5_annexes.pdf
HAS/2014-01-23_CT-12788_GADOVIST_PIS_EI_Avis2_CT12788.pdf
HAS/2014-01-23_CT-12791_CARBOSYMAG_PIS_RI_Avis1_CT12791.pdf
HAS/2014-01-23_CT-12984_PLUREXID_PIS_RI_Avis2_CT12984.pdf
HAS/2014-01-23_CT-12997_HEXATRIONE_PIS_RI_Avis1_CT12997.pdf
HAS/2014-01-23_CT-13000_AZYTER_PIS_RI_Avis2_CT13000.pdf
HAS/2014-01-23_CT-13048_GYNO-TROSYD_PIS_RI_Avis1_CT13048.pdf
HAS/2014-01-23_CT-13221_NICOTINE_EG_MENTHE_QD_INS_Avis2_CT13221.pdf
HAS/2014-01-23_CT-13237_CLARITYNE_QD_INS_Avis1_CT13237.pdf
HAS/2014-01-23_CT-13289_RHINOMAXIL_PIS_RI_Avis2_CT13289.pdf
HAS/2014-01-23_CT-13292_EFFILEVO_EFFILEVOCONTINU_PIS_INS_Avis2_CT13292.pdf
HAS/2014-01-23_CT-13308_AFINITOR_PIC_REEV_POP_CIBLE_Avis3_CT13308.pdf
HAS/2014-01-23_CT-13326_DEXTROMETHORPHANE_PIS_INS_Avis2_CT13326.pdf
HAS/2014-01-23_CT-13377_EPIPEN_PIS_INS_Avis2_CT13377.pdf
HAS/2014-01-23_CT-13419_CUTACNYL_PIS_RI_Avis1_CT13419.pdf
HAS/2014-01-23_CT-13423_TETMODIS_QD_INS_Avis1_CT13423.pdf
HAS/2014-01-23_afinitor_en_ct13308_def.pdf
HAS/2014-01-27_CT-11558_LEVOCARNIL_RI_REEV_POP_CIBLE_Avis2_CT11558.pdf
HAS/2014-01-27_CT-12455_EFFEDERM_RI_PIC_Avis1_CT12455.pdf
HAS/2014-01-27_CT-12642_TRAJENTA_EI_Avis2_CT12642.pdf
HAS/2014-01-27_CT-12799_NEUPRO_EI_AvisPostAud_CT12798_12799.pdf
HAS/2014-01-27_CT-12991_GRISEFULINE_PIS_RI_Avis2_CT12991.pdf
HAS/2014-01-27_CT-13063_ORACILLINE_PIS_RI_Avis1_CT13063.pdf
HAS/2014-01-27_CT-13071_ORBENINE_PIS_RI_Avis1_CT13071.pdf
HAS/2014-01-27_CT-13076_MIACALCIC_PIS_RI_Avis2_CT13076.pdf
HAS/2014-01-27_CT-13081_ERYTHROCINE_PIS_RI_Avis1_CT13081.pdf
HAS/2014-01-27_CT-13091_FURADANTINE_PIS_RI_Avis2_CT13091.pdf
HAS/2014-01-27_CT-13189_ERY_NOURRISSON_PIS_RI_Avis2_CT13189.pdf
HAS/2014-01-27_CT-13203_OPTAFLU_QD_INS_Avis1_CT13203.pdf
HAS/2014-01-27_CT-13325_TARKA_LP_QD_INS_Avis2_CT13325.pdf
HAS/2014-01-27_CT-13344_PEVARYL_PIS_RI_Avis1_CT13344.pdf
HAS/2014-01-27_CT-13367_REMIFENTANIL_BBRAUN_QD_INS_Avis1_CT13367.pdf
HAS/2014-01-27_CT-13369_PARACETAMOL_GNR_QD_INS_Avis2_CT13369.pdf
HAS/2014-01-27_CT-13397_OXYTOCINE_MEDAC_QD_INS_Avis1_CT13397.pdf
HAS/2014-01-27_CT-13400_BENZATHINE_BENZYLPENICILLINE_PANPHARMA_QD_INS_Avis1_CT13400.pdf
HAS/2014-01-27_CT-13401_PHYSIONEAL_40_GLUCOSE_QD_INS_Avis2_CT13401.pdf
HAS/2014-01-27_CT-13410_INLYTA_QD_INS_Avis2_CT13410.pdf
HAS/2014-01-27_CT-13420_THIOCOLCHICOSIDE_ARROW_QD_INS_Avis1_CT13420.pdf
HAS/2014-01-27_CT-13425_PARACETAMOL_ARROW_QD_INS_Avis2_CT13425.pdf
HAS/2014-01-27_CT-13435_LIPUR_PIS_RI_Avis2_CT13435.pdf
HAS/2014-01-27_effederm_02102014_synthese_ct12455.pdf
HAS/2014-01-27_neupro_18092013_synthese_ct12799.pdf
HAS/2014-01-27_neupro_ct12799.pdf
HAS/2014-01-27_trajenta_ct_12642_2014-01-27_14-19-9_439.pdf
HAS/2014-01-31_CT-12536_ARIXTRA_Reev_curatif_Avis3m_CT12536.pdf
HAS/2014-01-31_annexe_1_arixtra_resumes_epi_ct_17avril_2013.pdf
HAS/2014-01-31_annexe_2_arixtra_25__17avril_archimed_volet_ville.pdf
HAS/2014-01-31_annexe_3_arixtra__17avril_archimed_volet_hopital.pdf
HAS/2014-01-31_arixtra_ct_12536_2014-01-30_11-09-26_272.pdf
HAS/2014-01-31_synthese_arixtra_reev_curatif__12536.pdf
HAS/2014-02-04_CT-13345_OCTREOTIDE_KABI_QD_INS_Avis1_CT13345.pdf
HAS/2014-02-04_CT-13364_FRAGMINE_PIS_RI_Avis1_CT13364.pdf
HAS/2014-02-06_CEPP-4405_GENESIS II_28 janvier 2014 (4405).pdf
HAS/2014-02-06_CEPP-4424_PROFIX OXINIUM_28 janvier 2014 (4424).pdf
HAS/2014-02-06_CEPP-4505_LEGION OXINIUM_28 janvier 2014 (4505).pdf
HAS/2014-02-06_CEPP-4532_SYNCHROMED II_28 janvier 2014 (4532).pdf
HAS/2014-02-06_CEPP-4550_CUSTOMBONE_28 janvier 2014 (4550).pdf
HAS/2014-02-06_CT-13007_KINOX_PIC_EI_Avis1_CT13007.pdf
HAS/2014-02-06_CT-13371_NEBILOX_PIS_RI_Avis2_CT13371.pdf
HAS/2014-02-06_kinox_04122013_synthese_ct13007_2014-02-06_09-09-58_723.pdf
HAS/2014-02-06_kinox_ct13007.pdf
HAS/2014-02-06_pnds_-_syndrome_de_williams-beuren.pdf
HAS/2014-02-06_pnds_53_-_syndrome_de_williams-beuren_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2014-02-06_tutoplast_28_janvier_2014_4336.pdf
HAS/2014-02-10_CT-13370_TEMERIT_PIS_RI_Avis2_CT13370.pdf
HAS/2014-02-10_CT-13451_LANTUS_PIC_EI_Avis2_CT13451.pdf
HAS/2014-02-10_lantus_ct13451.pdf
HAS/2014-02-17_CEPP-4336_TUTOPLAST_28 janvier 2014 (4336).pdf
HAS/2014-02-17_CEPP-4518_TOPCHAIR_28_janvier_2014_(4518)_avis.pdf
HAS/2014-02-17_CEPP-4529_INRatio2_28_janvier_2014_(4529)_avis.pdf
HAS/2014-02-17_CEPP-4545_FREESTYLE OPTIUM BETA CETONE_28_janvier_2014_(4545)_avis.pdf
HAS/2014-02-17_CEPP-4558_GLUCOFIX B-KETONE SENSOR_28_janvier_2014_(4558)_avis.pdf
HAS/2014-02-17_CT-13062_TOPSYNE_PIS_RI_Avis1_CT13062.pdf
HAS/2014-02-17_CT-13313_AMIKACINE_B_BRAUN_QD_INS_Avis1_CT13313.pdf
HAS/2014-02-17_CT-13332_OMNITROPE_QD_INS_Avis2_CT13332.pdf
HAS/2014-02-17_CT-13399_ESOMEPRAZOLE_SUN_QD_INS_Avis1_CT13399.pdf
HAS/2014-02-17_CT-13461_OMNISCAN_QD_INS_Avis1_CT13461.pdf
HAS/2014-02-17_CT-13471_ULTRAVIST_QD_INS_Avis2_CT13471.pdf
HAS/2014-02-21_CT-12903_ARTIREM_PIS_RI_Avis1_CT12903.pdf
HAS/2014-02-21_CT-12974_TROPHICREME_PIS_RI_Avis2_CT12974.pdf
HAS/2014-02-21_CT-13072_CONDYLINE_PIS_RI_Avis1_CT13072.pdf
HAS/2014-02-21_CT-13422_NORADRENALINE_RENAUDIN_QD_INS_Avis1_CT13422.pdf
HAS/2014-02-24_3efm_conseil_antibiotiques-2p_180214_hi-res_no_marks.pdf
HAS/2014-02-24_conseils_prescription_antibiotiques_rapport_d_elaboration.pdf
HAS/2014-02-24_fiche_memo_conseils_prescription_antibiotiques.pdf
HAS/2014-02-27_endoprothese_coronaire_-_problematique_pertinence.pdf
HAS/2014-02-28_CEPP-4508_LP ESP II_05_novembre_2013_(4508)_avis.pdf
HAS/2014-02-28_CEPP-4509_INTEGRA FLOWABLE WOUND MATRIX_28_janvier_2014_(4509)_avis.pdf
HAS/2014-02-28_CT-12955_KALETRA_PIS_RI_Avis2_CT12955.pdf
HAS/2014-02-28_CT-12986_ALTIM_PIC_RI_Avis2_CT12986.pdf
HAS/2014-02-28_CT-13315_TRINITRINE_MYLAN_PIS_RI_Avis1_CT13315.pdf
HAS/2014-02-28_CT-13342_FEGENOR_PIS_RI_Avis1_CT13342.pdf
HAS/2014-02-28_CT-13343_TRINIPATCH_PIS_RI_Avis1_CT13343.pdf
HAS/2014-02-28_CT-13406_BETA_ADALATE_PIS_RI_Avis1_CT13406.pdf
HAS/2014-02-28_CT-13497_LIDOCAINE_AGUETTANT_QD_INS_Avis1_CT13497.pdf
HAS/2014-02-28_altim_en_ct12986_def.pdf
HAS/2014-03-03_CT-12774_EXELON_PIC_INS_Avis3_CT12774.pdf
HAS/2014-03-03_CT-12905_DOTAREM_PIC_REEV_ASMR_RI_Avis1_CT12904&12905.pdf
HAS/2014-03-03_CT-12915_SELINCRO_PIC_INS_Avis3_CT12915.pdf
HAS/2014-03-03_CT-13106_RAPISCAN_PIC_INS_Avis1_CT13106.pdf
HAS/2014-03-03_dotarem_18122013_synthese_ct12904_2014-02-28_10-27-0_551.pdf
HAS/2014-03-03_exelon_18122013_synthese_ct12774.pdf
HAS/2014-03-03_exelon_ct12774.pdf
HAS/2014-03-03_orencia_0412013_synthese_ct12730.pdf
HAS/2014-03-03_orencia_ct12730.pdf
HAS/2014-03-03_orencia_pic_ins_avis2modifie16122013_ct12730.pdf
HAS/2014-03-03_rapiscan_20112013_synthese_ct3106.pdf
HAS/2014-03-03_rapiscan_ct13106.pdf
HAS/2014-03-03_selincro_04122013_synthese_ct12945_2014-02-28_12-00-18_162.pdf
HAS/2014-03-03_selincro_en_ct12915.pdf
HAS/2014-03-04_roactemra_04122013_synthese_ct12488-ct12918.pdf
HAS/2014-03-04_roactemra_ct1248812918.pdf
HAS/2014-03-04_roactemra_pic_reeval_asmr_avis2modifie06012014_ct1248812918.pdf
HAS/2014-03-05_CEPP-4593_BAHA 4_25_fevrier_2014_(4593)_avis.pdf
HAS/2014-03-05_CT-12941_PRIVIGEN_PIC_EI_polyradiculonevrite_Avis2_CT12941.pdf
HAS/2014-03-05_privigen_16102013_synthese_ct12941.pdf
HAS/2014-03-05_privigen_ct12941.pdf
HAS/2014-03-06_CEPP-4515_SAMI THE SEAL SIDESTREAM_28_janvier_2014_(4515)_avis.pdf
HAS/2014-03-06_CT-13297_TADIM_PIC_INS_AvisPostAud_CT13297.pdf
HAS/2014-03-06_tadim_21012014_synthese_ct13297.pdf
HAS/2014-03-06_tadim_en_ct13297_val.pdf
HAS/2014-03-07_evaluation_du_guidage_echographique_lors_de_la_realisation_dune_anesthesie_locoregionale_peripherique_-_rapport_devaluation.pdf
HAS/2014-03-07_ultrasound_guidance_for_peripheral_nerve_blockade_-_brief_inahta.pdf
HAS/2014-03-10_rapport_dorientation_depistage_neonatal_de_la_drepanocytose_en_france.pdf
HAS/2014-03-11_CEPP-4513_OVATION_11_fevrier_2014_(4513)_avis.pdf
HAS/2014-03-11_CEPP-4527_OVATION_PRIME_11_fevrier_2014_(4527)_avis.pdf
HAS/2014-03-12_CT-12922_ASPIRINE_PROTECT_QD_INS_Avis2_CT12922.pdf
HAS/2014-03-12_CT-13135_RIAMET_PIC_INS_Avis2_CT13135.pdf
HAS/2014-03-12_CT-13185_MIFLONIL_PIS_RI_Avis2_CT13185.pdf
HAS/2014-03-12_CT-13196_VACCIN_GENHEVAC_B_PASTEUR_PIS_RI_CT13196.pdf
HAS/2014-03-12_CT-13208_ZOLOFT_QD_INS_Avis1_CT13208.pdf
HAS/2014-03-12_CT-13311_SIMPONI_QD_INS_Avis2_CT13311.pdf
HAS/2014-03-12_CT-13330_DERMATRANS_PIS_RI_Avis1_CT13330.pdf
HAS/2014-03-12_CT-13375_EURARTESIM_PIC_INS_Avis2_CT13375.pdf
HAS/2014-03-12_CT-13450_INFLUVAC_ENFANT_QD_INS_Avis1_CT13450.pdf
HAS/2014-03-12_CT-13515_FLEXEA_PIC_RAD_Avis2_CT13515.pdf
HAS/2014-03-12_CT-13518_OSAFLEXAN_PIC_RAD_Avis2_CT13518.pdf
HAS/2014-03-12_CT-13519_DOLENIO_PIC_RAD_Avis2_CT13519.pdf
HAS/2014-03-12_artotec_en_ct13276_val.pdf
HAS/2014-03-12_artotec_pic_reeval_smr_avis1modifiele04032014_ct13276.pdf
HAS/2014-03-12_eurartesim_en_ct13375_val.pdf
HAS/2014-03-12_flector_voltarendolo_voltarene_05022014_synthese_ctval89.pdf
HAS/2014-03-12_riamet_ct13135.pdf
HAS/2014-03-13_argumentaire_scientifique_-_sortie_de_maternite_apres_accouchement.pdf
HAS/2014-03-13_compte-rendu_du_suivi_en_post-partum_immediat.pdf
HAS/2014-03-13_criteres_maternels_et_pediatriques_definissant_une_population_a_bas_risque_pour_une_sortie_de_la_maternite.pdf
HAS/2014-03-13_elements_de_chiffrage_et_analyses_des_donnees_du_pmsi.pdf
HAS/2014-03-13_fiche_de_liaison___maternite_suivi_en_post-partum_immediat.pdf
HAS/2014-03-13_fiche_de_synthese_-_sortie_de_maternite_apres_accouchement.pdf
HAS/2014-03-13_recommandations_-_sortie_de_maternite_apres_accouchement.pdf
HAS/2014-03-13_schema_du_parcours_de_soins_du_nouveau-ne_apres_sejour_72_-_96h.pdf
HAS/2014-03-13_schema_parcours_de_soins_du_nouveau-ne_apres_sortie_precoce.pdf
HAS/2014-03-13_v3-bat_reco2clics_sortie_de_maternite-120314.pdf
HAS/2014-03-18_CT-12998_ERYTHROMYCINE_BAILLEUL_ERYTHROGEL_RI_PIS_Avis1_CT12998.pdf
HAS/2014-03-18_CT-13043_BETADINE_DERMIQUE_PIC_RI_Avis2_CT13043.pdf
HAS/2014-03-18_CT-13445_REMIFENTANIL_PFIZER_QD_INS_Avis2_CT13445.pdf
HAS/2014-03-18_CT-13494_KETOPROFENE_MACOPHARMA_QD_INS_Avis1_CT13494.pdf
HAS/2014-03-18_CT-13496_IOMERON_QD_INS_Avis1_CT13496.pdf
HAS/2014-03-18_CT-13498_DUPHALAC_QD_INS_Avis1_CT13498.pdf
HAS/2014-03-18_CT-8499_BISEPTINE_PIC_RI_Avis2_CT8499.pdf
HAS/2014-03-18_CT-8629_VOLTARENE_EMULGEL_PIS_RI_Avis1_CT8629.pdf
HAS/2014-03-20_ciloxan_05102011_synthese_ct10831.pdf
HAS/2014-03-20_ciloxan_19-10-2011_avis_ct-10831.pdf
HAS/2014-03-20_ciloxan_ct_10831.pdf
HAS/2014-03-20_experimentation_rmm-ppa.pdf
HAS/2014-03-21_CEPP-4507_INTEGRA DERMAL REGENERATION TEMPLATE_28_janvir_2014_(4507)_avis.pdf
HAS/2014-03-21_CEPP-4539_ALLURE QUADRA - ALLURE QUADRA RF_25_fevrier_2014_(4539)_avis.pdf
HAS/2014-03-21_CEPP-4540_POWERLINK_11_fevrier_2014_(4540)_avis.pdf
HAS/2014-03-21_CEPP-4544_POWERLINK AFX_11_fevrier_2014_(4544)_avis.pdf
HAS/2014-03-21_CEPP-4560_ORSIRO_25_fevrier_2014_(4560)_avis.pdf
HAS/2014-03-21_anaconda_fenetree.pdf
HAS/2014-03-21_innospire_elegance_sidestream.pdf
HAS/2014-03-21_misoone_16102013_synthese_ct12961.pdf
HAS/2014-03-21_misoone_pic_ins_avis2modifie17122013_ct12961.pdf
HAS/2014-03-21_oxygenotherapie.pdf
HAS/2014-03-25_assessment_of_shoulder_joint_implants.pdf
HAS/2014-03-25_implants_articulaires_depaule_avis_du_25_mars_2014.pdf
HAS/2014-03-25_note_de_cadrage_implants_articulaires_depaule.pdf
HAS/2014-03-25_rapport_devaluation_des_implants_articulaires_depaule.pdf
HAS/2014-03-25_texte_court_du_rapport_devaluation_implants_articulaires_depaule.pdf
HAS/2014-03-26_CEPP-4525_AXIUM_25_fevrier_2014_(4525)_avis.pdf
HAS/2014-03-26_CT-12910_ANTIGONE_PIC_INS_Avis3_CT12910.pdf
HAS/2014-03-26_CT-12925_TENSIONORME_PIS_RI_Avis1_CT12925.pdf
HAS/2014-03-26_CT-12956_SUCCICAPTAL_PIC_INS_Avis3_CT12956.pdf
HAS/2014-03-26_CT-12957_AMYVID_PIC_INS_Avis3_CT12957.pdf
HAS/2014-03-26_CT-12990_DANATROL_PIS_RI_Avis2_CT12990.pdf
HAS/2014-03-26_CT-13013_CLOMID_PIS_RI_Avis2_CT13013.pdf
HAS/2014-03-26_CT-13105_DAKIN_COOPER_STABILISE_PIC_RI_Avis2_CT13105.pdf
HAS/2014-03-26_CT-13112_SYNCORTYL_PIS_RI_Avis2_CT13112.pdf
HAS/2014-03-26_CT-13271_MICROVAL_PIS_RI_Avis1_CT13271.pdf
HAS/2014-03-26_CT-13291_PARACETAMOL_ZYDUS_PIS_RI_Avis1_CT13291.pdf
HAS/2014-03-26_CT-13322_LEVOTONINE_PIS_RI_Avis1_CT13322.pdf
HAS/2014-03-26_CT-13337_PARACETAMOL_ISOMED_PIS_RI_Avis1_CT13337.pdf
HAS/2014-03-26_CT-13338_PARACETAMOL_RATIOPHARM_PIS_RI_Avis1_CT13338.pdf
HAS/2014-03-26_CT-13404_ADEPAL_MINIDRIL_TRINORDIOL_PIS_RI_Avis1_CT13404.pdf
HAS/2014-03-26_CT-13405_ZUMALGIC_PIS_RI_Avis1_CT13405.pdf
HAS/2014-03-26_CT-13433_DEXPANTHENOL_ARROW_QD_INS_Avis2_CT13433.pdf
HAS/2014-03-26_CT-13481_ATOVAQUONE-PROGUANIL_BIOGARAN_ENFANTS_QD_Avis1_CT13481.pdf
HAS/2014-03-26_CT-13484_TIROFIBAN_MEDAC_QD_INS_Avis1_CT13484.pdf
HAS/2014-03-26_CT-13490_COLOBREATHE_QD_INS_Avis1_CT13490.pdf
HAS/2014-03-26_amyvid_18122013_synthese_ct12957.pdf
HAS/2014-03-26_amyvid_en_ct12957_val.pdf
HAS/2014-03-26_antigone_en_ct12910_val.pdf
HAS/2014-03-26_succicaptal_18122013_synthese_ct12956.pdf
HAS/2014-03-27_CT-12607_PROTOPIC_PIC_RI_Avis3_CT12607.pdf
HAS/2014-03-27_CT-13116_ABILIFY_PIC_EI_Avis2_CT13116.pdf
HAS/2014-03-27_abilify_06112013_synthese_ct13116.pdf
HAS/2014-03-27_abilify_ct13116.pdf
HAS/2014-03-27_protopic_20112013_synthese_ct12607.pdf
HAS/2014-03-27_protopic_ct12607.pdf
HAS/2014-03-28_CEPP-4511_SALTO TALARIS_25_mars_2014_(4511)_avis.pdf
HAS/2014-03-28_CT-13056_RHINOTROPHYL_PIC_RI_Avis3_CT13056.pdf
HAS/2014-03-28_CT-13064_WYSTAMM_PIC_INS_Avis2_CT13064.pdf
HAS/2014-03-28_rhinotrophyl_08012014_synthese_ct13056.pdf
HAS/2014-03-28_rhinotrophyl_en_ct13056_def.pdf
HAS/2014-03-28_wystamm_08012104_synthese_ct13064.pdf
HAS/2014-03-28_wystamm_en_ct13064_val.pdf
HAS/2014-03-31_2e_version_format2clics-aa_patient_mc_300414.pdf
HAS/2014-03-31_guide_annonce_diagnostic_format_court_web.pdf
HAS/2014-03-31_guide_annonce_diagnostic_web.pdf
HAS/2014-04-01_CT-13087_OSAFLEXAN_PIC_REEV_Avis3_CT13087.pdf
HAS/2014-04-01_CT-13088_STRUCTOFLEX_PIC_REEV_Avis3_CT13088.pdf
HAS/2014-04-01_CT-13094_FLEXEA_PIC_REEV_Avis3_CT13094.pdf
HAS/2014-04-01_CT-13097_VOTLTAFLEX_PIC_REEV_Avis2_CT13097.pdf
HAS/2014-04-01_CT-13107_DOLENIO_PIC_REEV_Avis3_CT13107.pdf
HAS/2014-04-01_dolenio_ct13107.pdf
HAS/2014-04-01_flexea_ct13094.pdf
HAS/2014-04-01_osaflexan__voltaflex_dolenio_structoflex_voltaflex_20112013_synthese_ct13087.pdf
HAS/2014-04-01_osaflexan_ct13087.pdf
HAS/2014-04-01_structoflex_ct13088.pdf
HAS/2014-04-01_voltaflex_ct13097.pdf
HAS/2014-04-03_CEPP-4546_ICD16.5_25_mars_2014_(4546)_avis.pdf
HAS/2014-04-03_CEPP-4553_XIENCE XPEDITION_25_mars_2014_(4553)_avis.pdf
HAS/2014-04-03_CEPP-4580_HEARTMATE II_25_mars_2014_(4580)_avis.pdf
HAS/2014-04-03_CEPP-4583_XIENCE XPEDITION_25_mars_2014_(4583)_avis.pdf
HAS/2014-04-03_CT-12192_MYCOSTER_PIC_INS_Avis2_CT12192.pdf
HAS/2014-04-03_CT-12465_INNOVAIR_FORMODUAL_NEXTHALER_PIC_INS_AvisPostAUD_CT12597&12465.pdf
HAS/2014-04-03_CT-12633_MENVEO_PIC_EI_Avis2_CT12633.pdf
HAS/2014-04-03_CT-12695_LIPIODOL_REEV_SMR_EI_Avis1_CT12695_CT12637.pdf
HAS/2014-04-03_CT-12846_MACUGEN_PIC_RI_Avis1_CT12846.pdf
HAS/2014-04-03_CT-12847_ZALTRAP Ins_Avis2_ CT12847.pdf
HAS/2014-04-03_CT-12851_PERJETA INS_Avis2_CT12851.pdf
HAS/2014-04-03_CT-12912_JETREA_PIC_INS_Avis3_CT12912.pdf
HAS/2014-04-03_CT-12916_MIFFEE_PIC_INS_Avis1_CT12916.pdf
HAS/2014-04-03_CT-13086_ANTARENE_CODEINE_PIC_INS_Avis2_CT13086.pdf
HAS/2014-04-03_CT-13108_XTANDI_PIC_INS_Avis2_CT13108.pdf
HAS/2014-04-03_CT-13255_RASILEZ_HCT_PIC_REEV_RI_Avis2_CT13255.pdf
HAS/2014-04-03_antarene_codeine_20112013_synthese_ct13086.pdf
HAS/2014-04-03_antarene_codeine_ct13086.pdf
HAS/2014-04-03_formodual_innovair_20112013_synthese_ct1259712465.pdf
HAS/2014-04-03_jetrea_04122013_synthese_ct12912.pdf
HAS/2014-04-03_jetrea_ct12912.pdf
HAS/2014-04-03_lipiodol_18122013_synthese_ct12637.pdf
HAS/2014-04-03_lipiodol_en_ct12695_ct12637_def.pdf
HAS/2014-04-03_lucentis_04122013_synthese_ct13096.pdf
HAS/2014-04-03_lucentis_en_ct13096_val.pdf
HAS/2014-04-03_lucentis_pic_ei_myopieforte_avis2modifie14012014_ct13096.pdf
HAS/2014-04-03_macugen_04122013_synthese_ct12846.pdf
HAS/2014-04-03_macugen_ct1284.pdf
HAS/2014-04-03_menveo_08012014_synthese_ct12633.pdf
HAS/2014-04-03_menveo_ct12633.pdf
HAS/2014-04-03_miffee_18102013_synthese_ct12916.pdf
HAS/2014-04-03_miffee_ct12916.pdf
HAS/2014-04-03_mycoster_18122013_synthese_ct12192.pdf
HAS/2014-04-03_mycoster_en_ct12192_def.pdf
HAS/2014-04-03_perjeta_27042013_synthese_ct12851.pdf
HAS/2014-04-03_perjeta_ct12851.pdf
HAS/2014-04-03_rasilez_hct_04122013_synthese_ct13255.pdf
HAS/2014-04-03_rasilez_hct_en_ct13255_val.pdf
HAS/2014-04-03_xtandi_201120138_synthese_ct13108.pdf
HAS/2014-04-03_xtandi_ct13108.pdf
HAS/2014-04-03_zaltrap_24072013_synthese_ct12847_2014-04-02_13-16-29_124.pdf
HAS/2014-04-03_zaltrap_ct12847_2014-01-30_14-10-54_682.pdf
HAS/2014-04-07_companion_diagnostic_test_associated_with_a_targeted_therapy_-_definitions_and_assessment_method_2014-11-18_16-09-49_75.pdf
HAS/2014-04-07_companion_diagnostic_test_associated_with_a_targeted_therapy_-_scientific_appendix_2014-11-18_16-11-7_703.pdf
HAS/2014-04-07_guide_meth_court_test_cpagnon_vd.pdf
HAS/2014-04-07_guide_test_compagnon_annexe_scientifique_vd.pdf
HAS/2014-04-07_inahta_brief_companion_diagnostic_test.pdf
HAS/2014-04-08_information_patient-signes_dinfection_de_prothese_de_hanche_ou_genou.pdf
HAS/2014-04-08_rbp_argumentaire_prothese_infectees_vd_.pdf
HAS/2014-04-08_rbp_reco2clics_protheses_infectees.pdf
HAS/2014-04-08_rbp_recommandations_protheses_infectees_vd.pdf
HAS/2014-04-08_rbp_synthese_prothese_infectee.pdf
HAS/2014-04-11_CEPP-4491_ORTHESE PUL_08_avril_2014_(4491)_avis.pdf
HAS/2014-04-11_CEPP-4564_AXTAIR ONE_08_avril_2014_(4564)_avis.pdf
HAS/2014-04-11_CEPP-4588_PROMUS ELEMENT PLUS_25_mars_2014_(4588)_avis.pdf
HAS/2014-04-11_CEPP-4591_PROMUS PREMIER_25_mars_2014_(4591)_avis.pdf
HAS/2014-04-11_CEPP-4608_EXCLUDER (RADIATION)_25_mars_2014_(4608)_avis.pdf
HAS/2014-04-11_CT-12741_YERVOY_PIC_REEV_Avis3_CT12741.pdf
HAS/2014-04-11_yervoy_ct12741.pdf
HAS/2014-04-15_CEPP-4569_EXCLUDER_Conf_25_mars_2014_(4569)_avis.pdf
HAS/2014-04-15_CEPP-4592_ECHELON_08_avril_2014_(4592)_avis.pdf
HAS/2014-04-15_CT-12107_INSUMAN_PIS_RI_Avis1_CT12107&12331.pdf
HAS/2014-04-15_CT-12770_NALBUPHINE_SERB_PIC_REEVAL_SMR_Avis2_CT12770.pdf
HAS/2014-04-15_CT-12778_MOSCONTIN_SEVREDOL_PIC_REEVAL_SMR_Avis2_CT12778.pdf
HAS/2014-04-15_CT-12799_NEUPRO_EI_AvisPostAud_CT12798_12799.pdf
HAS/2014-04-15_CT-12818_METVIXIA_PIC_RI_AvisPostAud_CT12818.pdf
HAS/2014-04-15_CT-13198_ROUVAX_PIS_RI_Avis2_CT13198.pdf
HAS/2014-04-15_CT-13207_PEGASYS_PIS_INS_EI_Avis2_CT13206&13207.pdf
HAS/2014-04-15_CT-13238_CAVERJECT_PIS_RI_Avis2_CT13238.pdf
HAS/2014-04-15_CT-13294_SODIUM_CHLORURE_BIOLUZ_PIS_RI_Avis1_CT13294.pdf
HAS/2014-04-15_CT-13324_PARACETAMOL_PANPHARMA_QD_INS_Avis1_CT13324.pdf
HAS/2014-04-15_CT-13387_BETADINE_QD_INS_Avis2_CT13387.pdf
HAS/2014-04-15_CT-13402_APROKAM_PIS_INS_Avis1_CT13402.pdf
HAS/2014-04-15_CT-13453_KADCYLA_PIC_INS_Avis2_CT13453.pdf
HAS/2014-04-15_CT-13465_CRESTOR_PIS_RI_Avis2_CT13465.pdf
HAS/2014-04-15_CT-13492_PROFENID_QD_REEVAL_SMR_Avis2_CT13492.pdf
HAS/2014-04-15_CT-13504_MIKICORT_QD_INS_Avis1_CT13504.pdf
HAS/2014-04-15_CT-13517_ECOBEC_QD_INS_Avis1_CT13517.pdf
HAS/2014-04-15_CT-13526_BRILIVO_QD_INS_Avis1_CT13526.pdf
HAS/2014-04-15_CT-13533_NALBUPHINE_AGUETTANT_PIC_REEVAL_SMR_Avis2_CT13533.pdf
HAS/2014-04-15_CT-13534_MORPHINE_AGUETTANT_PIC_REEVAL_SMR_Avis2_CT13534.pdf
HAS/2014-04-15_CT-9340_EPITOMAX_PIS_RI_EI_Avis1_CT9340&12050.pdf
HAS/2014-04-15_actiskenan_skenan_en_ct12775_def.pdf
HAS/2014-04-15_actiskenan_skenan_pic_reeval_smr_avis1modifiele09042014_ct12775.pdf
HAS/2014-04-15_adartrel_-_ct-9292.pdf
HAS/2014-04-15_fiche_bum_sjsr_042014.pdf
HAS/2014-04-15_guide_bonnes_pratiques_simulation_sante_format2clics.pdf
HAS/2014-04-15_guide_qualite_securite_secteur_naissance.pdf
HAS/2014-04-15_kadcyla_11032014_avis_efficience.pdf
HAS/2014-04-15_kadcyla_19032014_synthese_ct13453.pdf
HAS/2014-04-15_kadcyla_en_ct13453_val.pdf
HAS/2014-04-15_metvixia_version_anglaise_ct12818.pdf
HAS/2014-04-15_morphine_aguettant_en_ct13534_val.pdf
HAS/2014-04-15_morphine_cooper_en_ct13531_val.pdf
HAS/2014-04-15_morphine_cooper_pic_reeval_smr_avis1modifiele09042014_ct13531.pdf
HAS/2014-04-15_morphine_lavoisier_en_ct12831_val.pdf
HAS/2014-04-15_morphine_lavoisier_pic_reeval_smr_avis1modifiele09042014_ct12831.pdf
HAS/2014-04-15_morphine_renaudin_en_ct12786_val.pdf
HAS/2014-04-15_morphine_renaudin_pic_reeval_smr_avis1modifiele09042014_ct12786.pdf
HAS/2014-04-15_moscontin_sevredol_en_ct12778_val_2014-10-14_11-31-33_123.pdf
HAS/2014-04-15_nalbuphine_aguettant_en_ct13533_val.pdf
HAS/2014-04-15_nalbuphine_mylan_en_ct13532_val.pdf
HAS/2014-04-15_nalbuphine_mylan_pic_reeval_smr_avis1modifiele09042014_ct13532.pdf
HAS/2014-04-15_nalbuphine_renaudin_en_ct12784_val.pdf
HAS/2014-04-15_nalbuphine_renaudin_pic_reeval_smr_avis1modifiele09042014_ct12784.pdf
HAS/2014-04-15_nalbuphine_serb_en_ct12770_val.pdf
HAS/2014-04-15_oramorph_en_ct12830_val.pdf
HAS/2014-04-15_oramorph_pic_reeval_smr_avis1modifiele09042014_ct12830.pdf
HAS/2014-04-15_pethidine_renaudin_en_ct12785_val.pdf
HAS/2014-04-15_pethidine_renaudin_pic_reeval_smr_avis1modifiele09042014_ct12785.pdf
HAS/2014-04-15_sifrol_reevalsmrasmr_ct11252_avis_2_16janv2013.pdf
HAS/2014-04-15_synthese_qualite_securite_secteur_naissance.pdf
HAS/2014-04-15_temgesic_en_ct12779_val.pdf
HAS/2014-04-15_temgesic_pic_reeval_smr_avis1modifiele09042014_ct12779.pdf
HAS/2014-04-16_CT-12110_LIPANTHYL-FENOFIBRATE_FOURNIER-SECALIP_PIC_RI_Avis3_CT12110.pdf
HAS/2014-04-16_CT-13211_RASILEZ_PIC_RI_Avis2_CT13211.pdf
HAS/2014-04-16_anesm-guide_daide_a_la_contractualisation-avril_2014.pdf
HAS/2014-04-16_lipanthyl-fenofibrate_fournier-secalip_ct12110.pdf
HAS/2014-04-16_lipanthyl_fenofibrate_fournier_secalip_22012014_synthese_ct12110.pdf
HAS/2014-04-16_rasilez_04122013_synthese_ct13211.pdf
HAS/2014-04-16_rasilez_en_ct13211_val_2014-06-11_09-42-57_646.pdf
HAS/2014-04-18_CEPP-4575_FREESTYLE OPTIUM NEO_08_avril_2014_(4575)_avis.pdf
HAS/2014-04-18_CT-13108_XTANDI_PIC_INS_Avis2_CT13108.pdf
HAS/2014-04-18_fiche_bum_jevtana_zytiga_xtandi_cv100414.pdf
HAS/2014-04-18_jevtana_reeval_asmr_avis2_definitif__ct_12292_modif3_dec12.pdf
HAS/2014-04-18_zytiga_29022012_ct11654.pdf
HAS/2014-04-23_ald8_guidemedecin_diabetetype1_revunp_vucd.pdf
HAS/2014-04-23_bd-07-057-diabete_1_mar_08.pdf
HAS/2014-04-23_lap_diab_actualis__3_juillet_07_2007_07_13__11_43_37_65.pdf
HAS/2014-04-23_yondelis_24072013_synthese_ct12733.pdf
HAS/2014-04-23_yondelis_ct12733.pdf
HAS/2014-04-23_yondelis_reeval_asmr_avis3definitif_ct12733.pdf
HAS/2014-04-24_CEPP-4601_PONTO_08_avril_2014_(4601)_avis.pdf
HAS/2014-04-24_ald8_guidemedecin_diabetepediatrie_revunp_vucd.pdf
HAS/2014-04-24_bd-07-058-diabete_enfant.pdf
HAS/2014-04-24_bd-07-059-diabete_2_mars_08.pdf
HAS/2014-04-24_guide_pds_diabete_t_3_web.pdf
HAS/2014-04-24_lap_diab_actualis__3_juillet_07_2007_07_13__11_43_37_65.pdf
HAS/2014-04-24_synthese_guide_pds_diabete_t_2_web.pdf
HAS/2014-04-25_CEPP-4559_TUBULCUS_08_avril_2014_(4559_avis.pdf
HAS/2014-04-25_CT-13339_ORPHACOL_PIC_INS_Avis2_CT13339.pdf
HAS/2014-04-25_CT-13341_PHEBURANE_PIC_INS_Avis1_CT13341.pdf
HAS/2014-04-25_orphacol_19022014_synthese_ct13339.pdf
HAS/2014-04-25_orphacol_ct13339.pdf
HAS/2014-04-25_pheburane_en_ct13341_def.pdf
HAS/2014-04-25_pherubane_synthese_22012014_ct13341.pdf
HAS/2014-04-30_CT-12524_METEOXANE_PIS_RI_Avis1_CT12524.pdf
HAS/2014-04-30_CT-12965_SCOBUREN_PIS_RI_Avis1_CT12965.pdf
HAS/2014-04-30_CT-13042_BETADINE_SCRUB_PIC_RI_Avis1_CT13042.pdf
HAS/2014-04-30_CT-13053_ECLARAN_PIS_RI_Avis1_CT13053.pdf
HAS/2014-04-30_CT-13128_DERMOVAL_RI_PIS_Avis1_CT13128.pdf
HAS/2014-04-30_CT-13195_VACCIN_TETANIQUE_PASTEUR_PIS_RI_Avis1_CT13195.pdf
HAS/2014-04-30_CT-13244_TETRALYSAL_PIS_RI_Avis2_CT13244.pdf
HAS/2014-04-30_CT-13427_COLPOTROPHINE_PIS_RI_Avis1_CT13427.pdf
HAS/2014-04-30_CT-13475_AGRIPPAL_PIS_RI_Avis1_CT13475.pdf
HAS/2014-04-30_CT-13495_MONOCRIXO_PIS_RI_Avis2_CT13495.pdf
HAS/2014-04-30_CT-13521_TILAVIST_PIS_RI_Avis1_CT13521.pdf
HAS/2014-04-30_CT-13529_VENLAFAXINE_ABBOTT_QD_INS_Avis1_CT13529.pdf
HAS/2014-04-30_CT-13540_BROMAZEPAM_ARROW_QD_INS_Avis2_CT13540.pdf
HAS/2014-04-30_betadine_scrub_en_ct13042_def.pdf
HAS/2014-04-30_glucose_bioluz_pis_ri_avis2_ct13290.pdf
HAS/2014-04-30_sapien_3_transapicale.pdf
HAS/2014-04-30_sapien_3_transfemorale.pdf
HAS/2014-05-02_analyse_de_la_litterature_rbpp_souffrance_psychique_pa_mai_2014.pdf
HAS/2014-05-02_ane-accompagnement_cada_annexe_1.pdf
HAS/2014-05-02_ane-accompagnement_cada_annexe_2.pdf
HAS/2014-05-02_ane-accompagnement_cada_annexe_3.pdf
HAS/2014-05-02_ane-accompagnement_cada_annexe_4.pdf
HAS/2014-05-02_ane-accompagnement_cada_chap_1pdf.pdf
HAS/2014-05-02_ane-accompagnement_cada_chap_2.pdf
HAS/2014-05-02_ane-accompagnement_cada_chap_3.pdf
HAS/2014-05-02_ane-accompagnement_cada_chap_4.pdf
HAS/2014-05-02_ane-accompagnement_cada_chap_5.pdf
HAS/2014-05-02_ane-accompagnement_cada_chap_6.pdf
HAS/2014-05-02_ane-accompagnement_cada_glossaire.pdf
HAS/2014-05-02_ane-accompagnement_cada_index.pdf
HAS/2014-05-02_ane-accompagnement_personnes_cada_pg1.pdf
HAS/2014-05-02_ane-affiche_souffrance_a4-basse_def.pdf
HAS/2014-05-02_ane-affiche_souffrance_a4-basse_def_2018-03-19_10-59-4_628.pdf
HAS/2014-05-02_ane-agees-souffrance_psychique_bat.pdf
HAS/2014-05-02_ane-agees-souffrance_psychique_bat_2018-03-19_10-59-4_630.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_annexe_1.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_annexe_2.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_annexe_3.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_annexe_4.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_annexe_5.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_annexe_6.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_chap_2.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_chap_5__cas_pratiques1.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_chapitre_1.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_chapitre_3.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_chapitre_4.pdf
HAS/2014-05-02_anesm-agees-souffrance_physique_presentation_generale.pdf
HAS/2014-05-02_anesm-rbpp_cada_mai_2014.pdf
HAS/2014-05-02_anesm-souffrance_psychique_de_la_personne_agee-mai_2014.pdf
HAS/2014-05-02_anesm-synthese_rbpp_cada_mai_2014.pdf
HAS/2014-05-02_bibliographie_cada_mai_2014.pdf
HAS/2014-05-02_bibliographie_souffrance_psychique_personnes_agees___mai_2014.pdf
HAS/2014-05-02_communique_du_directeur_de_l_anesm_090514.pdf
HAS/2014-05-02_lettre_cadrage_personnalisation_de_l_accompagnement_des_demandeurs_d_asile_accueillis_en_cada_mai_2013.pdf
HAS/2014-05-02_lettre_de_cadrage_prise_en_compte_de_la_souffrance_psychique_de_la_personne_agee.pdf
HAS/2014-05-06_CT-13061_FASIGYNE_PIS_RI_Avis1_CT13061.pdf
HAS/2014-05-06_CT-13241_ILARIS_CAPS_PIC_EI_Avis2_CT13241.pdf
HAS/2014-05-06_CT-13301_PEDIAZOLE_PIS_RI_Avis1_CT13301.pdf
HAS/2014-05-06_CT-13391_MOLSIDOMINE_MYLAN_PIS_RI_Avis1_CT13391.pdf
HAS/2014-05-06_CT-13516_STRUCTOFLEX_PIC_RAD_Avis1_CT13516.pdf
HAS/2014-05-06_CT-13547_ATROPINE_SULFATE_AGUETTANT_PIS_INS_Avis2_CT13547&13546.pdf
HAS/2014-05-06_CT-13571_ROZACREME_ROZAGEL_PIS_RI_Avis1_CT13571.pdf
HAS/2014-05-06_CT-13574_ONEZYP_QD_INS_Avis1_CT13574.pdf
HAS/2014-05-06_CT-13577_MESNA_EG_QD_INS_Avis1_CT13577.pdf
HAS/2014-05-06_CT-13588_TROMBOVAR_QD_INS_Avis1_CT13588.pdf
HAS/2014-05-06_ilaris_05022014_synthese_ct13241.pdf
HAS/2014-05-06_ilaris_caps_ct13241.pdf
HAS/2014-05-09_CT-13117_PHOSPHORE_ALKO_PIS_RI_Avis1_CT13117.pdf
HAS/2014-05-09_CT-13349_FORXIGA_PIC_INS_Avis2_CT13349.pdf
HAS/2014-05-09_CT-13538_ANAPEN_PIS_RI_Avis1_CT13538.pdf
HAS/2014-05-09_CT-13556_ZARZIO_PIS_RI_Avis2_CT13556.pdf
HAS/2014-05-09_CT-13590_LEVETIRACETAM_HOSPIRA_QD_INS_Avis2_CT13590.pdf
HAS/2014-05-09_forxiga_en_ct13349_prlabo.pdf
HAS/2014-05-13_CEPP-4541_LIFEVEST_4000_22_avril_2014_(4541)_avis.pdf
HAS/2014-05-13_CEPP-4570_CARELINK_CRT-D Triple_22_avril_2014_(4570)_avis.pdf
HAS/2014-05-13_CEPP-4574_URGOTUL Ag_06_mai_2014_(4574)_avis.pdf
HAS/2014-05-13_CEPP-4576_URGOTUL Ag LITE_06_mai_2014_(4576)_avis.pdf
HAS/2014-05-13_CEPP-4577_URGOTUL Ag LITE BORDER_06_mai_2014_(4577)_avis.pdf
HAS/2014-05-13_CEPP-4578_URGOCELL Ag_06_mai_2014_(4578)_avis.pdf
HAS/2014-05-13_CEPP-4579_URGOCELL Ag BORDER_06_mai_2014_(4579)_avis.pdf
HAS/2014-05-13_CEPP-4590_I LIMB ULTRA_08_avril_2014_(4590)_avis.pdf
HAS/2014-05-13_CEPP-4594_FLO TECH CONTOUR VISCO_22_avril_2014_(4594)_avis.pdf
HAS/2014-05-13_CEPP-4598_SMARTVIEW T_22_avril_2014_(4598)_avis.pdf
HAS/2014-05-13_CEPP-4599_SMARTVIEW S_22_avril_2014_(4599)_avis.pdf
HAS/2014-05-13_CEPP-4600_SMARTVIEW D_22_avril_2014_(4600)_avis.pdf
HAS/2014-05-13_CEPP-4605_COLLECTEUR EXPRESS_06_mai_2014_(4605)_avis.pdf
HAS/2014-05-13_CEPP-4606_ENDURANT II_08_avril_2014_(4606)_avis.pdf
HAS/2014-05-13_CEPP-4610_LATITUDE NXT S_22_avril_2014_(4610)_avis.pdf
HAS/2014-05-13_CEPP-4613_LATITUDE NXT D_22_avril_2014_(4613)_avis.pdf
HAS/2014-05-13_CEPP-4614_LATITUDE NXT T_22_avril_2014_(4614)_avis.pdf
HAS/2014-05-13_qvt_reco2clics.pdf
HAS/2014-05-14_CT-12963_XALUPRINE_PIC_INS_AvisPostAud_CT12963.pdf
HAS/2014-05-14_xaluprine_08012014_synthese_ct12963.pdf
HAS/2014-05-14_xaluprine_en_ct12963_def.pdf
HAS/2014-05-15_CT-12638_CARBAGLU_PIC_EI_Avis2_CT12638.pdf
HAS/2014-05-15_carbaglu_08012014_synthese_ct12638.pdf
HAS/2014-05-15_carbaglu_en_ct12638_val.pdf
HAS/2014-05-16_CT-13269_VOLTARENE_PIC_REEVAL_SMR_Avis2_CT13269.pdf
HAS/2014-05-16_flector_ct13353.pdf
HAS/2014-05-16_flector_pic_reeval_smr_avis1modifiele04032014_ct13353.pdf
HAS/2014-05-16_flector_voltarendolo_voltarene_05022014_synthese_ctval89.pdf
HAS/2014-05-16_voltarendolo_ct13254.pdf
HAS/2014-05-16_voltarendolo_pic_reeval_smr_avis1modifiele04032014_ct13254.pdf
HAS/2014-05-16_voltarene_ct13269.pdf
HAS/2014-05-19_depistage_du_cancer_du_sein_chez_les_femmes_a_haut_risque_synthese_vf.pdf
HAS/2014-05-19_depistage_du_cancer_du_sein_chez_les_femmes_a_haut_risque_volet_1_vf.pdf
HAS/2014-05-19_depistage_du_cancer_du_sein_chez_les_femmes_a_haut_risque_volet_2_vf.pdf
HAS/2014-05-19_note_de_cadrage_depistage_du_cancer_du_sein_-_identification_des_femmes_a_haut_risque_et_modalites_de_depistag.pdf
HAS/2014-05-21_CEPP-4589_SENTRY 1200_06_mai_2014_(4589)_avis.pdf
HAS/2014-05-22_guide_pds_fibrillation_atriale_vf.pdf
HAS/2014-05-22_synthese_guide_pds_fibrillation_atriale_vf.pdf
HAS/2014-05-23_CT-13310_SIMPONI_PIC_EI_Avis2_CT13310.pdf
HAS/2014-05-23_CT-13431_RECIVIT_PIS_INS_Avis2_CT13431.pdf
HAS/2014-05-23_CT-13457_FLUOCYNE_QD_INS_Avis1_CT13457.pdf
HAS/2014-05-23_CT-13524_NATRIXAM_PIC_INS_Avis2_CT13524.pdf
HAS/2014-05-23_CT-13557_XAMIOL_PIS_RI_Avis2_CT13557.pdf
HAS/2014-05-23_simponi_19022014_synthese_ct13310.pdf
HAS/2014-05-23_simponi_ct13310.pdf
HAS/2014-05-26_CT-12981_CELLCEPT_PIS_RI_Avis2_CT12981.pdf
HAS/2014-05-26_CT-13005_TECFIDERA_PIC_INS_Avis3_CT13005.pdf
HAS/2014-05-26_CT-13109_REMICADE_PIS_REEVAL_RCH_Avis2_CT13109.pdf
HAS/2014-05-26_CT-13131_BETNEVAL_PIS_RI_Avis2_CT13131.pdf
HAS/2014-05-26_CT-13354_BETAFERON_PIS_RI_Avis2_CT13354.pdf
HAS/2014-05-26_CT-13454_ABILIFY_MAINTENA_PIS_INS_Avis2_CT13454.pdf
HAS/2014-05-26_CT-13493_LINCOCINE_PIS_RI_Avis1_CT13493.pdf
HAS/2014-05-26_CT-13522_CABERGOLINE_SANDOZ_PIS_INS_Avis2_CT13522.pdf
HAS/2014-05-26_CT-13558_DAIVOBET_PIS_RI_Avis2_CT13558.pdf
HAS/2014-05-26_CT-13563_BARITEKAL_PIS_INS_Avis2_CT13563.pdf
HAS/2014-05-26_CT-9634_MIMPARA_PIC_RI_Avis2_CT9634.pdf
HAS/2014-05-26_mimpara_en_ct9634_def.pdf
HAS/2014-05-26_preterax-bipreterax_pis_ri_avis2modifiele16052014_ct13541.pdf
HAS/2014-05-26_tecfidera_24062014_avis_efficience.pdf
HAS/2014-05-26_tecfidera_en_ct13005_val.pdf
HAS/2014-05-26_tecfidera_sapub_ct13005.pdf
HAS/2014-05-27_CT-13593_ROCURONIUM_PFIZER_QD_INS_Avis1_CT13593.pdf
HAS/2014-05-27_CT-13613_MIKICORT_QD_INS_Avis1_CT13613.pdf
HAS/2014-05-27_fiche_de_bon_usage_neurostimulation_2014-04-03_10-38-24_855.pdf
HAS/2014-05-27_note_cadrage_neurostimulation_mise_en_ligne_2013-01-14_16-02-26_54.pdf
HAS/2014-05-27_place_des_trod_dans_la_strategie_de_depistage_de_vhc-_rapport.pdf
HAS/2014-05-27_place_des_trod_dans_la_strategie_de_depistage_du_vhc_-_note_de_cadrage.pdf
HAS/2014-05-27_rapport_neurostimulateurs.pdf
HAS/2014-05-27_short_text_spinal_cord_stimulation.pdf
HAS/2014-05-27_synthese_rapport_neurostimulateurs.pdf
HAS/2014-05-30_CEPP-4571_THORAFLEX HYBRID_06_mai_2014_(4571)_avis.pdf
HAS/2014-05-30_CT-10199_RISPERDAL_PIC_EI_Avis1_CT10199.pdf
HAS/2014-05-30_CT-13260_LOJUXTA_PIC_INS_Avis1_CT13260.pdf
HAS/2014-05-30_CT-13510_NOXAP_PIS_RI_Avis1_CT13510&13535.pdf
HAS/2014-05-30_CT-13535_NOXAP_PIS_RI_Avis1_CT13510&13535.pdf
HAS/2014-05-30_lojuxta_08012014_synthese_ct13260.pdf
HAS/2014-05-30_lojuxta_en_ct13260_val.pdf
HAS/2014-05-30_risperdal_ct10199.pdf
HAS/2014-05-30_risperdal_risperdaloro_19022014_synthese_ct10199.pdf
HAS/2014-06-04_pertinence_arthroscopie_autres_localisations.pdf
HAS/2014-06-06_CEPP-4517_HIRESOUTION BIONIC EAR_20_mai_2014_(4517)_avis.pdf
HAS/2014-06-06_CT-11042_EXJADE_PIC_RI_Avis 3_CT11042.pdf
HAS/2014-06-06_CT-12926_TENSIONORME_QD_INS_Avis1_CT12926.pdf
HAS/2014-06-06_CT-13381_SOMAVERT_PIC_RI_Avis1_CT13381.pdf
HAS/2014-06-06_CT-13432_PLENADREN_PIC_INS_Avis 2_CT13432.pdf
HAS/2014-06-06_exjade_en_ct11042_val.pdf
HAS/2014-06-06_plenadren_05032014_synthese_ct13432.pdf
HAS/2014-06-06_plenadren_version_anglaise_ct13432.pdf
HAS/2014-06-06_somavert_05032014_synthese_ct13381.pdf
HAS/2014-06-06_somavert_ct13381.pdf
HAS/2014-06-10_CT-13125_AUBAGIO_PIC_INS_Avis3_CT13125.pdf
HAS/2014-06-10_CT-13245_PREVENAR_PIS_EI_Avis2_CT13245.pdf
HAS/2014-06-10_CT-13305_CERUBIDINE_PIC_EI_Avis2_CT13305.pdf
HAS/2014-06-10_CT-13348_TROBALT_PIC_REEV_Avis2_CT13348.pdf
HAS/2014-06-10_aubagio_05032014_synthese_ct13125.pdf
HAS/2014-06-10_aubagio_version_anglaise_ct13125.pdf
HAS/2014-06-10_cerubidine_02042014_synthese_ct13305.pdf
HAS/2014-06-10_cerubidine_en_ct13305_val.pdf
HAS/2014-06-10_prevenar_13_18122013_synthese_ct13245.pdf
HAS/2014-06-10_trobalt_02042014_synthese_ct13348.pdf
HAS/2014-06-10_trobalt_en_ct13348_val_2014-10-01_09-26-14_358.pdf
HAS/2014-06-13_CEPP-4243_WATCHMAN_03_juin_2014_(4243)_avis.pdf
HAS/2014-06-13_CEPP-4607_DEMIPULSE (modele 103 et 104)_22_avril_2014_(4607)_avis.pdf
HAS/2014-06-13_CEPP-4609_LOTUS_03_juin_2014_(4609 )_avis.pdf
HAS/2014-06-13_CEPP-4651_PERENNIADURA & PERENNIFLEX (modele 303 & 304)_22_avril_2014_(4651)_avis.pdf
HAS/2014-06-19_arrete_du_2_aout_2010_relatif_au_cahier_des_charges_des_programmes__2012-03-26_17-10-1_195.pdf
HAS/2014-06-19_cadrage_tests_fibrose_vhb_vmel.pdf
HAS/2014-06-19_etp_-_comment_elaborer_un_programme_-_recommandations_juin_2007.pdf
HAS/2014-06-19_etp_-_comment_la_proposer_et_la_realiser_-_recommandations_juin_2007.pdf
HAS/2014-06-19_etp_-_decret_autorisation_programmes_etp.pdf
HAS/2014-06-19_etp_-_definition_finalites_-_recommandations_juin_2007.pdf
HAS/2014-06-19_etp_grille_aide_evaluation_autorisation_programme_ars_web.pdf
HAS/2014-06-19_etp_questions-reponses_2012-04-04_16-28-53_250.pdf
HAS/2014-06-19_evaluation_annuelle_maj_juin_2014.pdf
HAS/2014-06-19_evaluation_quadriennale_v2_2014-06-17_16-38-45_49.pdf
HAS/2014-06-19_inahta_brief_liver_fibrosis.pdf
HAS/2014-06-19_indicateurs_etp_v2.pdf
HAS/2014-06-19_rapport_fibrose_mel.pdf
HAS/2014-06-19_synthese_evaluation_etp_v2_2014-06-17_16-39-42_203.pdf
HAS/2014-06-19_tc_fibrose_mel.pdf
HAS/2014-06-23_CEPP-4528_NUCLEUS_03_juin_2014_(4528)_avis.pdf
HAS/2014-06-23_CEPP-4547_CONCERTO ABI & CONCERTO PIN ABI_03_juin_2014_(4547)_avis.pdf
HAS/2014-06-23_CEPP-4548_CONCERTO-CONCERTO PIN & OPUS 2 RONDO_03_juin_2014_(4548)_avis.pdf
HAS/2014-06-23_CEPP-4611_VALIANT CAPTIVIA_03_juin_2014_(4611)_avis.pdf
HAS/2014-06-23_CEPP-4656_BIOVALSALVA _03_juin_2014_(4656)_avis.pdf
HAS/2014-06-23_CEPP-4660_BIOVALSALVA BIPLEX_03_juin_2014_(4660)_avis.pdf
HAS/2014-06-23_CEPP-4665_ESPRIT_03_juin_2014_(4665)_avis.pdf
HAS/2014-06-23_CEPP-4666_ULTRA FAST FIX_03_juin_2014_(4666)_avis.pdf
HAS/2014-06-23_CT-12822_TRESIBA_PIC_INS_Avis3_CT12822.pdf
HAS/2014-06-23_CT-13363_HERCEPTIN_PIC_INS_Avis2_CT13363.pdf
HAS/2014-06-23_CT-13373_DIMETANE_RI_avis1_CT13373.pdf
HAS/2014-06-23_CT-13421_CALCIUMVITAMINED3__RI_avis1_CT13421.pdf
HAS/2014-06-23_CT-13431_RECIVIT_PIS_INS_Avis2_CT13431.pdf
HAS/2014-06-23_CT-13443_FLUOCARILBI FLUORE__RI_avis1_CT13443.pdf
HAS/2014-06-23_CT-13505_OMACOR_PIC_RAD_Avis 1_CT13505.pdf
HAS/2014-06-23_CT-13618_RHINOTROPHYL_PIC_RAD_Avis2_CT13618.pdf
HAS/2014-06-23_CT-13624_VERAPAMIL TEVA gamme RI_avis 2_CT13624.pdf
HAS/2014-06-23_CT-13637_OPTIMIZETTE_PIS_INS_Avis1_CT13637.pdf
HAS/2014-06-23_CT-6269_ACTIQ - CT- 6269.pdf
HAS/2014-06-23_CT-6575_ABSTRAL - CT- 6575.pdf
HAS/2014-06-23_berinert_en_ct13331_val.pdf
HAS/2014-06-23_berinert_pic_ei_prevention_intervention_avis2_ct13331.pdf
HAS/2014-06-23_effentora_-_ct-6829.pdf
HAS/2014-06-23_fbum_adp_maj_juillet2014.pdf
HAS/2014-06-23_herceptin_en_ct13363_val.pdf
HAS/2014-06-23_instanyl_-_ct-7206.pdf
HAS/2014-06-23_kyphon.pdf
HAS/2014-06-23_minimed_2007d.pdf
HAS/2014-06-23_pecfent_-_ct-_9366.pdf
HAS/2014-06-23_synthese_berinert_2014_pdf_140507.pdf
HAS/2014-06-23_synthese_herceptin_2014_pdf_140618.pdf
HAS/2014-06-23_synthese_tresiba_pdf_140619.pdf
HAS/2014-06-23_tresiba_en_ct12822_val.pdf
HAS/2014-06-23_vitamine_e_sandoz__ri_avis1_ct13295.pdf
HAS/2014-06-24_CT-13511_DROPERIDOL_QD_INS_AVIS2_CT13511.pdf
HAS/2014-06-24_CT-13579_NaF METATRACE_Ins_Avis2_CT13579.pdf
HAS/2014-06-24_CT-8018_LEVEMIR_PIC_RI_Avis1_CT8018.pdf
HAS/2014-06-24_formodual_innovair_traitsecours_avis2modifie06juin2014_ct13337.pdf
HAS/2014-06-24_levemir_en_ct8018_def.pdf
HAS/2014-06-25_protocole_examen_autopsique_foetal_neonatal_cd_20140528_vd.pdf
HAS/2014-06-25_protocole_examen_foetal_neonatal_rapport_elaboration_cd_20140528_vd.pdf
HAS/2014-06-26_CEPP-4620_HIRESOLUTION BIONIC EAR_03_juin_2014_(4620)_avis.pdf
HAS/2014-06-26_CT-13584_LONOTEN RI_avis 2_CT13584.pdf
HAS/2014-06-26_CT-13591_FERINJECT_PIC_REEV_Avis3_CT13591.pdf
HAS/2014-06-26_CT-13632_COVERAM_RI 2014_avis 2_CT 13632.pdf
HAS/2014-06-26_CT-13668_LEVONORGESTREL_ETHINYLESTRADIOL_ZENTIVA_PIS_INS_Avis1_CT13668.pdf
HAS/2014-07-01_CT-12247_DIACOMIT_PIS_INS_AVIS2_CT12247.pdf
HAS/2014-07-01_CT-13472_KINERET_PIC_RI_Avis2postaud_CT12548.pdf
HAS/2014-07-01_benlysta_en_ct13312_def.pdf
HAS/2014-07-01_benlysta_reevalasmr_avis2_ct13312.pdf
HAS/2014-07-02_fp_eligibilite_chir_ambu_vd.pdf
HAS/2014-07-02_inahta_brief_-_elements_to_evaluate_for_managing_a_patient_in_outpatient_surgery_2014-12-10_15-47-43_325.pdf
HAS/2014-07-02_note_de_cadrage_axe-2_v2_actualisee.pdf
HAS/2014-07-02_rapport_chir_ambu_axe2_vf.pdf
HAS/2014-07-02_tc_chir_ambu_axe2_vf.pdf
HAS/2014-07-02_triptyque_eligibilite_chir_ambu_vd.pdf
HAS/2014-07-03_exacerbations_bpco.pdf
HAS/2014-07-03_fps__exacerbations_bpco_vf2_latapy.pdf
HAS/2014-07-03_fps_bpco_rehabilitation_respiratoire_vf_latapy.pdf
HAS/2014-07-03_fps_bpco_rehabilitation_respiratoire_web_2014-06-02_17-33-40_489.pdf
HAS/2014-07-03_note_methodologique_bpco_rehabilitation_respiratoire_web.pdf
HAS/2014-07-03_note_methodologique_exacerbations_bpco_web.pdf
HAS/2014-07-08_CEPP-4565_MOBILE DREAM_17_juin_2014_(4565)_avis.pdf
HAS/2014-07-08_CT-13119_REMODULIN_IV_PIC_INS_Avis1_CT13119.pdf
HAS/2014-07-08_remodulin_ct13119_sapub.pdf
HAS/2014-07-08_remodulin_iv_en_ct13119_prlabo.pdf
HAS/2014-07-10_CEPP-4554_DIGISONIC SP & DIGISONIC SP EVO_17_juin_2014_(4554-4556)_avis.pdf
HAS/2014-07-10_CEPP-4556_DIGISONIC SP & DIGISONIC SP EVO_17_juin_2014_(4554-4556)_avis.pdf
HAS/2014-07-10_CEPP-4557_DIGISONIC SP ABI_14_juin_2014_(4557)_avis.pdf
HAS/2014-07-10_CT-13598_LASILIX SPECIAL QDINS_Avis1_CT13598.pdf
HAS/2014-07-10_CT-13642_MYLEUGYNE LP150mg_QDINS_avis2_CT13642.pdf
HAS/2014-07-10_CT-13657_NORPROLAC_RI_Avis2_CT13657.pdf
HAS/2014-07-11_radiologie_interventionnelle_v10_2014-07-08_16-46-50_792.pdf
HAS/2014-07-15_CEPP-4581_CARELINK_double_chambre_01_juillet_2014_(4581)_avis.pdf
HAS/2014-07-15_CEPP-4582_CARELINK_simple_chambre_01_juillet_2014_(4582)_avis.pdf
HAS/2014-07-15_CEPP-4595_HELISTENT TITAN 2_01_juillet_2014_(4595)_avis.pdf
HAS/2014-07-15_CEPP-4654_TITAN OPTIMAX_03_juin_2014_(4654)_avis.pdf
HAS/2014-07-15_CEPP-4672_LATITUDE NXT_triple_17_juin_2014_(4672)_avis.pdf
HAS/2014-07-16_CT-10932_DELIDOSE_PIC_REEVAL_SMR_Avis2_CT10932.pdf
HAS/2014-07-16_CT-10933_DIVINA_DUOVA_PIC_REEVAL_SMR_RI_Avis1_CT10933_CT12105I.pdf
HAS/2014-07-16_CT-11242_PHYSIOGINE_PIC_REEVAL_SMR_Avis1_CT11242.pdf
HAS/2014-07-16_CT-11492_ESTRADERM_VIVELLEDOT_PIC_REEVAL_SMR_Avis1_CT11526.pdf
HAS/2014-07-16_CT-11513_OESCLIM_OROMONE_PIC_REEVAL_SMR_RI_Avis2_CT11513_CT13663.pdf
HAS/2014-07-16_CT-11515_SURGESTONE_PIC_REEVAL_SMR_Avis2_CT11515.pdf
HAS/2014-07-16_CT-11516_PROVAMES_PIC_REEVAL_SMR_Avis1_CT11516.pdf
HAS/2014-07-16_CT-11517_LUTERAN_PIC_REEVAL_SMR_Avis1_CT11517.pdf
HAS/2014-07-16_CT-11524_COLPRONE_PIC_REEVAL_SMR_Avis1_CT11524.pdf
HAS/2014-07-16_CT-11526_ESTRADERM_VIVELLEDOT_PIC_REEVAL_SMR_Avis1_CT11526.pdf
HAS/2014-07-16_CT-11531_OESTROGEL_OESTRODOSE_THAIS_THAISSEPT_PIC_REEVAL_SMR_Avis1_CT11531.pdf
HAS/2014-07-16_CT-11585_DERMESTRIL_DERMESTRILSEPTEM_PIC_REEVAL_SMR_Avis1_CT11585.pdf
HAS/2014-07-16_CT-11754_LUTENYL_PIC_REEVAL_SMR_Avis1_CT11754.pdf
HAS/2014-07-16_CT-11755_NAEMIS_PIC_REEVAL_SMR_RI_Avis1_CT11755_CT12422.pdf
HAS/2014-07-16_CT-11756_MENAELLE_PIC_REEVAL_SMR_Avis1_CT11756.pdf
HAS/2014-07-16_CT-11757_FEMSEPTCOMBI_FEMSEPTEVO_PIC_REEVAL_SMR_Avis1_CT11757.pdf
HAS/2014-07-16_CT-12000_ACTIVELLE -PIC_REEVAL_SMR_Avis2_CT12000.pdf
HAS/2014-07-16_CT-12001_KLIOGEST_NOVOFEMME_TRISEQUENS_PIC_REEVAL_SMR_Avis1_CT12001.pdf
HAS/2014-07-16_CT-12002_CLIMARA -PIC_REEVAL_SMR_Avis2_CT12002.pdf
HAS/2014-07-16_CT-12003_CLIMENE -PIC_REEVAL_SMR_Avis1_CT12003.pdf
HAS/2014-07-16_CT-12012_UTROGESTAN_PIC_REEVAL_SMR_Avis2_CT12012.pdf
HAS/2014-07-16_CT-12015_CLIMASTON -PIC_REEVAL_SMR_Avis1_CT12015.pdf
HAS/2014-07-16_CT-12016_DUPHASTON_PIC_REEVAL_SMR_Avis1_CT12016.pdf
HAS/2014-07-16_CT-12018_ESTREVA_FEMSEPT_PIC_REEVA._SMR_RI_Avis2_CT12018_CT11651.pdf
HAS/2014-07-16_CT-12252_CLIMODIENE -PIC_REEVAL_SMR_RI_Avis1_CT12252_CT12004.pdf
HAS/2014-07-16_CT-12253_AVADENE -PIC_REEVAL_SMR_RI_Avis2_CT12253_CT122005.pdf
HAS/2014-07-16_CT-13059_LIVIAL_PIC_REEVAL_SMR_Avis1_CT13059.pdf
HAS/2014-07-16_CT-13440_CLIMASTON_PIC_INS_Avis1_CT13440.pdf
HAS/2014-07-16_activelle_version_anglaise_ct12000.pdf
HAS/2014-07-16_avadene_version_anglaise_ct12253_ct122005.pdf
HAS/2014-07-16_climara_version_anglaise_ct12002.pdf
HAS/2014-07-16_climaston_version_anglaise_ct12015.pdf
HAS/2014-07-16_climaston_version_anglaise_ct13440.pdf
HAS/2014-07-16_climene_version_anglaise_ct12003.pdf
HAS/2014-07-16_climodiene_version_anglaise_ct12252_ct12004.pdf
HAS/2014-07-16_colprone_version_anglaise_ct11524.pdf
HAS/2014-07-16_delidose_version_anglaise_ct10932.pdf
HAS/2014-07-16_dermestril_dermestrilseptem_version_anglaise_ct11585.pdf
HAS/2014-07-16_divina_duova_en_ct10933_ct12105.pdf
HAS/2014-07-16_duphaston_version_anglaise_ct12016.pdf
HAS/2014-07-16_estraderm_vivelledot_version_anglaise_ct11526.pdf
HAS/2014-07-16_estrapatch_version_anglaise_ct11492_ct10931_ct13004.pdf
HAS/2014-07-16_estreva_femsept_version_anglaise_ct12018_ct11651.pdf
HAS/2014-07-16_femseptcombi_femseptevo_version_anglaise_ct11757.pdf
HAS/2014-07-16_kliogest_novofemme_trisequens_version_anglaise_ct12001.pdf
HAS/2014-07-16_livial_version_anglaise_ct13059.pdf
HAS/2014-07-16_lutenyl_version_anglaise_ct11754.pdf
HAS/2014-07-16_luteran_version_anglaise_ct11517.pdf
HAS/2014-07-16_menaelle_version_anglaise_ct11756.pdf
HAS/2014-07-16_naemis_version_anglaise_ct11755_ct12422.pdf
HAS/2014-07-16_oesclim_oromone_version_anglaise_ct11513_ct13663.pdf
HAS/2014-07-16_oestrogel_oestrodose_thais_thaissept_version_anglaise_ct11531.pdf
HAS/2014-07-16_physiogine_version_anglaise_ct11242.pdf
HAS/2014-07-16_provames_version_anglaise_ct11516.pdf
HAS/2014-07-16_reeval_thm_rapport_devaluation_annexe.pdf
HAS/2014-07-16_reeval_thm_rapport_devaluation_annexe_version_anglaise.pdf
HAS/2014-07-16_surgestone_version_anglaise_ct11515.pdf
HAS/2014-07-16_utrogestan_version_anglaise_ct12012.pdf
HAS/2014-07-18_ultibro_breezhaler_ct13293.pdf
HAS/2014-07-18_ultibro_breezhaler_pic_ins_avis3modifiele07052014_ct13293.pdf
HAS/2014-07-18_ultirbro_breezhaler_sapub_ct13293.pdf
HAS/2014-07-22_brief_inahta__assessment_of_the_risks_associated_with_aesthetic_mesotherapy_practices.pdf
HAS/2014-07-22_rapport_mve_vd_mel.pdf
HAS/2014-07-23_CEPP-4657_CRE8_01_juillet_2014_(4657)_avis.pdf
HAS/2014-07-23_CEPP-4659_PARI MINI LC SPRINT_01_juillet_2014_(4659)_avis.pdf
HAS/2014-07-23_CEPP-4677_ROTATEUR 4R57_01_juillet_2014_(4677)_avis.pdf
HAS/2014-07-23_CT-13272_GIOTRIF_PIC_INS_Avis2_CT13272.pdf
HAS/2014-07-23_CT-13360_ILARIS_PIC_EI_AJI_Avis2_CT13360.pdf
HAS/2014-07-23_giotrif__sapub_ct13272.pdf
HAS/2014-07-23_giotrif_version_anglaise_ct13272.pdf
HAS/2014-07-23_ilaris_ajis_sapub_ct13360.pdf
HAS/2014-07-23_ilaris_en_ct13360_val.pdf
HAS/2014-07-23_ilaris_en_ct13361_val.pdf
HAS/2014-07-23_ilaris_goutte_sapub_ct13361.pdf
HAS/2014-07-23_ilaris_pic_ei_goutte_avis3_modifie_ct13361.pdf
HAS/2014-07-24_CT-13202_MOGADON_REEVAL_RI_Avis1_CT13202.pdf
HAS/2014-07-24_CT-13210_NOCTAMIDE_REEVAL_Avis1_CT13210.pdf
HAS/2014-07-24_CT-13222_ROHYPNOL_REEVAL_Avis1_CT13222.pdf
HAS/2014-07-24_CT-13418_NORMISON_REEVAL_RI_Avis1_CT13418_CT13597.pdf
HAS/2014-07-24_guide_parcours_de_soins_ic_web.pdf
HAS/2014-07-24_havlane_reeval_ri_avis1_ct10978_ct13218_2014-07-24_10-48-32_904.pdf
HAS/2014-07-24_havlane_version_anglaise_ct10978_ct13218.pdf
HAS/2014-07-24_mogadon_version_anglaise_ct13202.pdf
HAS/2014-07-24_noctamide_en_ct13210_val.pdf
HAS/2014-07-24_normison_version_anglaise_ct13418_ct13597.pdf
HAS/2014-07-24_parcours_de_soins_ic.pdf
HAS/2014-07-24_points_critiques_ic_web.pdf
HAS/2014-07-24_rohypnol_version_anglaise_ct13222.pdf
HAS/2014-07-29_evaluation_de_la_detection_du_genome_des_enterovirus_dans_le_liquide_cephalorachidien_par_amplification_genique_dans_les_meningites_-_rapport_devaluation.pdf
HAS/2014-07-29_evaluation_de_la_detection_du_genome_des_enterovirus_dans_le_liquide_cephalorachidien_par_amplification_genique_dans_les_suspicions_de_meningites_virales_-_note_de_cadrage.pdf
HAS/2014-07-29_inahta_brief_enterovirus_2015-06-12_17-15-30_978.pdf
HAS/2014-07-29_leustatine_reeval_liste_en_sus_avis1_ct13544.pdf
HAS/2014-07-29_nipent_reeval_liste_en_sus_avis2_ct13561.pdf
HAS/2014-07-30_CT-13246_RINOCLENIL_RI2014_Avis1_CT13246.pdf
HAS/2014-07-30_CT-13604_TAMIFLU_RI_Avis2_CT13604.pdf
HAS/2014-07-30_CT-13622_ULTRAVIST_QDINS_avis2_CT13622.pdf
HAS/2014-07-30_CT-13634_NOVORAPID_PUMPCART_QDIns_Avis2_CT13634.pdf
HAS/2014-07-30_CT-13689_PACLITAXEL_AHCL_QDINS_Avis1_ CT13689.pdf
HAS/2014-07-30_CT-13691_NICOTINELL FRUIT EXOTIQUE_QDINS_avis1_CT13691.pdf
HAS/2014-07-30_myleugyne1_qdins_avis1_ct13641.pdf
HAS/2014-08-06_CT-11047_NUCTALON_REEVAL_RI_Avis1_CT11047_CT13231.pdf
HAS/2014-08-06_CT-13355_IMOVANE_REEVAL_RI_Avis1_CT13218_CT13555.pdf
HAS/2014-08-06_nuctalon_version_anglaise_ct11047.pdf
HAS/2014-08-06_stilnox_reeval_ri_avis1_ct11444_ct13218.pdf
HAS/2014-08-06_stilnox_version_anglaise_ct11444_ct13218.pdf
HAS/2014-08-07_CT-11671_DAKTARIN_GYNODAKTARIN_gamme_23072014_CT11671_12567_RI_PIS_Avis1.pdf
HAS/2014-08-07_CT-12163_PROZAC_RI_avis2_CT12163_12152.pdf
HAS/2014-08-07_CT-12996_MICRODOINE_RI_avis1_CT12996.pdf
HAS/2014-08-07_CT-13307_WYSTAMM_RI2014_avis2_CT13307.pdf
HAS/2014-08-07_CT-13372_HELICOBACTER TEST INFAI_Avis2_PISRI_CT13372.pdf
HAS/2014-08-07_CT-13612_OXYGENE_MESSER_QD_INS_avis1_CT13612.pdf
HAS/2014-08-07_CT-13676_NICORETTE_QDINS_avis1_CT13676.pdf
HAS/2014-08-07_CT-13677_LACRIFLUID_LACRIGEL_RI2014_Avis 1_CT13677.pdf
HAS/2014-08-07_CT-13679_OLANZAPINE_SANDOZ _QDINS_Avis2_CT13679.pdf
HAS/2014-08-07_CT-13684_DROPERIDOL_PANPHARMA_QDIns_ Avis2_CT13684.pdf
HAS/2014-08-07_CT-13704_paracetamol actavis_QDINS_Avis1_CT13704.pdf
HAS/2014-08-07_CT-13723_AQUAREST_LACRINORM_LIPOSIC_PISRI_Avis1_CT13723.pdf
HAS/2014-08-07_daunoxome_pic_reevaluation_avis_2_ct_13536.pdf
HAS/2014-08-07_daunoxome_version_anglaise_ct13536.pdf
HAS/2014-08-07_muphoran__reeval_liste_en_sus_avis_2_ct13566_2014-07-31_16-43-7_943.pdf
HAS/2014-08-07_muphoran_en_ct13566_val.pdf
HAS/2014-08-07_photofrin_reeval_avis1_ct13559.pdf
HAS/2014-08-07_photofrin_version_anglaise_ct13559.pdf
HAS/2014-08-07_prozac_version_anglaise_ct12163_12152.pdf
HAS/2014-08-07_tomudex__en_ct13562_val.pdf
HAS/2014-08-07_tomudex__reeval_liste_en_sus_avis2_ct13562.pdf
HAS/2014-08-11_CT-13224_ASMASAL_RI2014_PIS_Avis1_CT13224.pdf
HAS/2014-08-11_CT-13340_XALACOM_RI2014_PIS_Avis1_CT13340.pdf
HAS/2014-08-11_normosang_en_ct_13572_val.pdf
HAS/2014-08-11_normosang_reevaluation_avis_2_ct_13572.pdf
HAS/2014-08-13_CEPP-4587_ZENITH ALPHA ABDOMINALE_22_avril_2014_(4587)_avis.pdf
HAS/2014-08-13_CEPP-4617_COROFLEX ISAR_01_juillet_2014_(4617)_avis.pdf
HAS/2014-08-13_CEPP-4658_EVITA_OPEN_PLUS_15_juillet_2014_(4658)_avis.pdf
HAS/2014-08-13_CEPP-4668_ELUNA 8 HF-T_(triple)_01_juillet_2014_(4668)_avis.pdf
HAS/2014-08-13_CEPP-4669_ELUNA 8 DR-T_(double)_01_juillet_2014_(4669)_avis.pdf
HAS/2014-08-13_CEPP-4670_ELUNA 8 SR-T_(Simple)_01_juillet_2014_(4670)_avis.pdf
HAS/2014-08-29_CEPP-4729_HIRESOLUTION BIONIC EAR_03_juin_2014_(4620)_avis de radiation.pdf
HAS/2014-08-29_CEPP-4730_NUCLEUS_03_juin_2014_(4730)_avis de radiation.pdf
HAS/2014-08-29_vercise.pdf
HAS/2014-09-01_anesm-enquetes-cvs-septembre_2014.pdf
HAS/2014-09-01_rapport_d_enquete_participation_des_usagers_septembre2014_.pdf
HAS/2014-09-05_ald_30_gp_melanome_web.pdf
HAS/2014-09-05_ald_30_guide_melanome_web.pdf
HAS/2014-09-05_lap_melanome_version_web.pdf
HAS/2014-09-09_1efiche_annexe_generiques_311012.pdf
HAS/2014-09-09_1efiche_indicateurs_generiques_311012.pdf
HAS/2014-09-09_CT-12445_M-M-RVAXPRO_PIS_RI_23072014_CT12445_Avis2.pdf
HAS/2014-09-09_CT-13234_VONCENTO_INS COLL_CT13234_Avis2_POST_Audition.pdf
HAS/2014-09-09_CT-13444_IXIARO_PIC_EI_enfants_Avis2_CT13444.pdf
HAS/2014-09-09_CT-13477_CARMYNE_PIC_INS_Avis2_CT13477.pdf
HAS/2014-09-09_CT-13491_TYBOST_PIC_INS_Avis2_CT13491.pdf
HAS/2014-09-09_CT-13607_VARILRIX_CT13607_23072014_PIS_Avis2.pdf
HAS/2014-09-09_CT-13711_CRESTOR QD_INS_Avis2_CT13711.pdf
HAS/2014-09-09_bilan_cooperation_ps_vd.pdf
HAS/2014-09-09_carmyne_en_ct13477_val.pdf
HAS/2014-09-09_carmyne_sapub_ct13477.pdf
HAS/2014-09-09_exemples_actes_derogatoires.pdf
HAS/2014-09-09_exemples_criteres_dinclusion.pdf
HAS/2014-09-09_exemples_remplissage_du_modele_type.pdf
HAS/2014-09-09_indicateurs_construction.pdf
HAS/2014-09-09_ixiaro_en_ct13444_val.pdf
HAS/2014-09-09_ixiaro_enfants_sapub_ct13444.pdf
HAS/2014-09-09_liste_prof_de_sante__coop_01092010_2010-09-03_14-05-35_125.pdf
HAS/2014-09-09_protocole_de_cooperation_-_doc_aide_professionnels_de_sante.pdf
HAS/2014-09-09_protocole_de_cooperation_-_fiche_formation.pdf
HAS/2014-09-09_protocole_de_cooperation_-_information_du_patient.pdf
HAS/2014-09-09_protocole_de_cooperation_-_lettre_formulaire_d_intention.pdf
HAS/2014-09-09_protocole_de_cooperation_-_mode_d_emploi.pdf
HAS/2014-09-09_protocole_de_cooperation_-_pei.pdf
HAS/2014-09-09_rapport_d-activite_article_51_2014_post-college_vf.pdf
HAS/2014-09-09_rapport_dactivite_2013_-_article_51.pdf
HAS/2014-09-09_tybost_en_ct13491_val.pdf
HAS/2014-09-09_tybost_sapub_ct13491.pdf
HAS/2014-09-09_voncento_en_ct13234_def.pdf
HAS/2014-09-09_voncento_sapub_ct13234.pdf
HAS/2014-09-10_CT-12919_BOSULIF_PIC_INS_Avis3_CT12919.pdf
HAS/2014-09-10_CT-13336_DYMISTA_PIC_INS_Avis2_CT13336.pdf
HAS/2014-09-10_CT-13434_ADASUVE_PIC_INS_Avis1_CT13434.pdf
HAS/2014-09-10_CT-13452_NOVOEIGHT_PIC_INS_Avis2_CT13452.pdf
HAS/2014-09-10_adasuve_en_ct13434_def.pdf
HAS/2014-09-10_adasuve_sapub_ct13434.pdf
HAS/2014-09-10_bosulif__sapub_ct12919.pdf
HAS/2014-09-10_bosulif_ct12919.pdf
HAS/2014-09-10_dymista_en_ct13336.pdf
HAS/2014-09-10_dymista_sapub_ct13336.pdf
HAS/2014-09-10_exjade_eit_sapub_ct13213.pdf
HAS/2014-09-10_exjade_en_ct13213_prlabo.pdf
HAS/2014-09-10_exjade_pic_ei_avis_2_ct13213.pdf
HAS/2014-09-10_inspra_en_ct13459_def.pdf
HAS/2014-09-10_inspra_reeval_ic_idm_2014_avis_2_ct13459.pdf
HAS/2014-09-10_inspra_sapub_ct13459.pdf
HAS/2014-09-10_novoeight_en_ct13452_val.pdf
HAS/2014-09-10_novoeight_sapub_ct13452.pdf
HAS/2014-09-11_CT-13392_SOVALDI_Insc_PIC_Avis 1_CT13392.pdf
HAS/2014-09-11_aad_avis_25052016_ct_25052016.pdf
HAS/2014-09-11_hepatite_c_prise_en_charge_anti_viraux_aad.pdf
HAS/2014-09-11_sovaldi_15042014_avis_efficience.pdf
HAS/2014-09-11_sovaldi_en_ct13392_prlabo.pdf
HAS/2014-09-11_sovaldi_sapub_ct13392.pdf
HAS/2014-09-12_CT-13166_ZONEGRAN EI_Avis2_CT13166.pdf
HAS/2014-09-15_CT-12976_LANTUS_PIC_REEVAL_RI_Avis3_PostAud_CT12976.pdf
HAS/2014-09-15_CT-13179_ERIVEDGE_PIC_INS_Avis2_CT13179.pdf
HAS/2014-09-15_CT-13259_VELCADE_PIC_EI_Avis2_CT13259.pdf
HAS/2014-09-15_CT-13417_MABELIO_INS_PIC_Avis2_CT13417.pdf
HAS/2014-09-15_CT-13456_PREZISTA_avis2_EI_adolescents_CT13456.pdf
HAS/2014-09-15_erivedge_ct13179_def.pdf
HAS/2014-09-15_erivedge_sapub_ct13179.pdf
HAS/2014-09-15_lantus_en_ct12976_prlabo_2015-01-15_15-59-39_372.pdf
HAS/2014-09-15_lantus_sapub_ct12976.pdf
HAS/2014-09-15_mabelio_en_ct13417_def.pdf
HAS/2014-09-15_mabelio_sapub_ct13417.pdf
HAS/2014-09-15_prezista_en_ct13456_pub.pdf
HAS/2014-09-15_prezista_sapub_ct13456.pdf
HAS/2014-09-15_velcade_ct13259.pdf
HAS/2014-09-15_velcade_sapub_ct13259.pdf
HAS/2014-09-16_CT-13215_IMNOVID_PIC_INS_Avis2_CT13215.pdf
HAS/2014-09-16_CT-13530_TIVICAY_PIC_Avis2_CT13530.pdf
HAS/2014-09-16_CT-13581_PALEXIA_PIC_Ins_Avis2_CT13581.pdf
HAS/2014-09-16_imnovid_en_ct13215_val.pdf
HAS/2014-09-16_imnovid_sapub_ct13215.pdf
HAS/2014-09-16_palexia_en_ct13581_pub.pdf
HAS/2014-09-16_palexia_sapub_ct13581.pdf
HAS/2014-09-16_tivicay_27052014_avis_efficience.pdf
HAS/2014-09-16_tivicay_en_ct13530_pub.pdf
HAS/2014-09-16_tivicay_sapub_ct13530.pdf
HAS/2014-09-18_CEPP-4243_WATCHMAN_03_juin_2014_(4243)_avis.pdf
HAS/2014-09-18_rapport_occlusion_transcutanee_aag_2014-09-18_11-44-33_990.pdf
HAS/2014-09-18_texte_court_occlusion_transcutanee_aag.pdf
HAS/2014-09-19_CEPP-4584_LEO PLUS & LEO PLUS SUR MESURE_09_septembre_2014_(4584-4585)_avis.pdf
HAS/2014-09-19_CEPP-4616_PK PAPYRUS_09_septembre_2014_(4616)_avis.pdf
HAS/2014-09-19_CEPP-4696_ENDURANT II_09_septembre_2014_(4696)_avis.pdf
HAS/2014-09-19_CT-13669_OXOMEMAZINE ZENTIVA LAB_QDINS_ Avis1-CT13699.pdf
HAS/2014-09-19_CT-13747_EUCREAS_QDINS_Avis1_CT13747.pdf
HAS/2014-09-24_cahier_charges_maisons_naissance_230914.pdf
HAS/2014-09-24_cahier_charges_rapport_elaboration_maisons_naissance_190914.pdf
HAS/2014-09-24_note_de_cadrage_maisons_de_naissance.pdf
HAS/2014-09-25_aide_decision_medecin.pdf
HAS/2014-09-25_aide_decision_patient.pdf
HAS/2014-09-25_annexe1_temoignage_quelles_decisions_prendre.pdf
HAS/2014-09-25_annexe2_temoignage_se_sentir_accueilli.pdf
HAS/2014-09-25_annexe3_temoignage_ce_qui_est_important.pdf
HAS/2014-09-25_annexe4_temoignage_quelle_information_echanger.pdf
HAS/2014-09-25_annexe5_temoignage_trouver_aide_et_soutien.pdf
HAS/2014-09-25_contraception_thrombophilie_en.pdf
HAS/2014-09-25_contraception_thrombophilie_fr.pdf
HAS/2014-09-25_rapport_elaboration.pdf
HAS/2014-09-25_recommandations_depistage_trombophilie_chc.pdf
HAS/2014-09-25_synthese_et_recommandations_depistage_trombophilie_chc.pdf
HAS/2014-09-25_temoignages_femmes_hommes.pdf
HAS/2014-09-26_adaptations_de_letp_chez_les_personnes_agees_en_risque_de_perte_dautonomie.pdf
HAS/2014-09-26_annexes_cadre_referentiel.pdf
HAS/2014-09-26_c_2014_0147_guide_methodo_efficacite_methodes_rbp_version_modifiee.pdf
HAS/2014-09-26_cadre_referentiel_etp_paerpa__chutes.pdf
HAS/2014-09-26_cadre_referentiel_etp_paerpa__depression.pdf
HAS/2014-09-26_cadre_referentiel_etp_paerpa__polypathologie.pdf
HAS/2014-09-26_cahier_des_charges_etp_paerpa__web.pdf
HAS/2014-09-26_efficacite_des_methodes_de_mise_en_oeuvre_des_recommandations_medicales.pdf
HAS/2014-09-26_fps_fonctions_appui_25_09_14.pdf
HAS/2014-09-26_fps_fonctions_appui_version_web_derozier.pdf
HAS/2014-09-26_fps_integration__25_09_2014.pdf
HAS/2014-09-26_fps_integration__25_09_2014_derozier.pdf
HAS/2014-09-26_indicateurs_etp_v2.pdf
HAS/2014-09-26_note_appui_coordo_25_09_14.pdf
HAS/2014-09-26_note_integration__25_09_2014.pdf
HAS/2014-09-26_note_methodo_cdc_etp_paerpa_web.pdf
HAS/2014-09-26_pipeline_flex.pdf
HAS/2014-09-26_pps-version_web_juillet2013.pdf
HAS/2014-09-26_questionnaire_pps_web.pdf
HAS/2014-09-30_CEPP-4695_AIRE DAX DOUAI_09_septembre_2014_(4695)_avis.pdf
HAS/2014-10-03_CEPP-4379_AMPLATZER CARDIAC PLUG_23_septembre_2014_(4379)_avis.pdf
HAS/2014-10-03_CT-10257_REYATAZ_avis2_EIT_CT10257.pdf
HAS/2014-10-03_CT-12373_SPASFON_RI_Avis2_CT12373.pdf
HAS/2014-10-03_CT-13074_MARSILID_Avis1_RI_CT13074.pdf
HAS/2014-10-03_CT-13750_LASILIX_QDINS_avis1_CT13750.pdf
HAS/2014-10-03_CT-13779_BROMAZEPAM_QD_INS_avis1_CT13779.pdf
HAS/2014-10-03_CT-13781_ZOPICLONE_QD_INS_avis1_CT13781.pdf
HAS/2014-10-03_CT-13805_RILUTEK_CT13805_17092014_PIS_RI_Avis1.pdf
HAS/2014-10-03_CT-9189_VARIVAX_CT9189_PIS_17092014_Avis1.pdf
HAS/2014-10-03_reyataz_en_ct10257_def.pdf
HAS/2014-10-03_reyataz_sapub_ados_ct10257.pdf
HAS/2014-10-03_tercian_qdins_avis2_ct13776.pdf
HAS/2014-10-06_CEPP-4586_ZENITH ALPHA THORACIQUE_09_septembre_2014_(4586)_avis.pdf
HAS/2014-10-06_CEPP-4723_PHARMA FORM ISKIO VISCO_23_septembre_2014_(4723)_avis.pdf
HAS/2014-10-06_CEPP-4724_PHARMA FORM KALLI VISCO_23_septembre_2014_(4724)_avis.pdf
HAS/2014-10-06_CEPP-4727_ALOVA GALBE_09_septembre_2014_(4727)_avis.pdf
HAS/2014-10-06_CEPP-4733_PHARMA FORM PRIMA_23_septembre_2014_(4733)_avis.pdf
HAS/2014-10-06_CEPP-4734_PHARMA FORM ISKIO BI MAT_23_septembre_2014_(4734)_avis.pdf
HAS/2014-10-06_CEPP-4735_PHARMA FORM PRIMA PLOT_23_septembre_2014_(4735)_avis.pdf
HAS/2014-10-06_CEPP-4741_SVPE_09_septembre_2014_(4741)_avis.pdf
HAS/2014-10-09_apathie_arbre_decisionnel.pdf
HAS/2014-10-09_apathie_argumentaire.pdf
HAS/2014-10-09_apathie_criteres_dsm-iv.pdf
HAS/2014-10-09_apathie_fiche_de_synthese_2014-10-07_16-36-45_104.pdf
HAS/2014-10-09_apathie_npi-es.pdf
HAS/2014-10-09_apathie_npi-r.pdf
HAS/2014-10-09_apathie_npi.pdf
HAS/2014-10-09_apathie_recommandations.pdf
HAS/2014-10-09_apathie_stimehpad.pdf
HAS/2014-10-09_bat-3v_reco2clicsapathie-alzheimer-071014.pdf
HAS/2014-10-10_CEPP-4691_PENUMBRA COIL 400_23_septembre_2014_(4691)_avis.pdf
HAS/2014-10-10_CEPP-4712_INNOSPIRE DELUXE SIDESTREAM_23_septembre_2014_(4712)_avis.pdf
HAS/2014-10-10_axtair_one_2014-10-07_10-41-24_597.pdf
HAS/2014-10-10_evaluation_de_lendomicroscopie_optique_dans_la_surveillance_de_lendo-brachy-oesophage_-_note_de_cadrage.pdf
HAS/2014-10-10_evaluation_de_lendomicroscopie_optique_realisee_lors_de_la_cartographie_dun_endo-brachy-oesophage_-_rapport_devaluation_2014-10-07_12-39-6_765.pdf
HAS/2014-10-10_evaluation_de_lendomicroscopie_optique_realisee_lors_de_la_cartographie_dun_endo-brachy-oesophage_-_texte_court_2014-10-07_12-39-6_770.pdf
HAS/2014-10-10_inahta_brief_endomicroscopy__barrett.pdf
HAS/2014-10-13_CEPP-4664_BAHA_23_septembre_2014_(4664)_avis.pdf
HAS/2014-10-13_CEPP-4686_ZENITH_FLEX_AUI_23_septembre_2014_(4686)_avis.pdf
HAS/2014-10-13_CEPP-4692_ZENITH_FLEX_23_septembre_2014_(4692)_avis.pdf
HAS/2014-10-13_CEPP-4693_ZENITH_SPIRAL_Z_23_septembre_2014_(4693)_avis.pdf
HAS/2014-10-13_CEPP-4694_ZENITH_LOW_PROFILE_23_septembre_2014_(4694)_avis.pdf
HAS/2014-10-13_CEPP-4722_RELAY PLUS_23_septembre_2014_(4722)_avis.pdf
HAS/2014-10-13_CEPP-4725_RELAY NBS PLUS_23_septembre_2014_(4725)_avis.pdf
HAS/2014-10-13_CT-13126_VICTRELIS_REEV_Avis2_CT13126.pdf
HAS/2014-10-13_CT-13383_DEFITELIO_PIC_INS_Avis3_CT13383.pdf
HAS/2014-10-13_CT-13507_CIMZIA 200 mg_ EI_SA_Avis 2_ CT13507.pdf
HAS/2014-10-13_CT-13609_FORSTEO_RI_Avis2_CT13609.pdf
HAS/2014-10-13_CT-13631_HYDROCORTANCYL_REEVAL_Avis1_CT.pdf
HAS/2014-10-13_CT-13633_ALTIM_REEVAL_Avis1_CT.pdf
HAS/2014-10-13_CT-13653_VEREGEN_Ins_PIC_avis2_CT13653.pdf
HAS/2014-10-13_CT-13690_GRASTOFIL_QDINS_avis2_CT13690.pdf
HAS/2014-10-13_CT-13753_GAMMANORM_QDINS_avis2_CT13753.pdf
HAS/2014-10-13_CT-13847_WILFACTIN_QDINS_avis1_CT13847.pdf
HAS/2014-10-13_altim_version_anglaise_ct13633_def.pdf
HAS/2014-10-13_cimzia_en_ct13507_val.pdf
HAS/2014-10-13_cimzia_spa__sapub_ct13507.pdf
HAS/2014-10-13_defitelio_18022014_avis_efficience.pdf
HAS/2014-10-13_defitelio_sapub_ct13383.pdf
HAS/2014-10-13_defitelio_version_anglaise_ct13383.pdf
HAS/2014-10-13_hydrocortancyl_version_anglaise_ct13631.pdf
HAS/2014-10-13_veregen_sapub_ct13653.pdf
HAS/2014-10-13_veregen_version_anglaise_ct13653.pdf
HAS/2014-10-13_victrelis_en_ct13126_def.pdf
HAS/2014-10-13_victrelis_sapub_ct13126.pdf
HAS/2014-10-14_CT-13270_BETMIGA_PIC_INS_Avispostaud_CT13270.pdf
HAS/2014-10-14_CT-13275_INCIVO_REEV_RCP_Avis2_CT13275.pdf
HAS/2014-10-14_betmiga_en_ct13270_val.pdf
HAS/2014-10-14_betmiga_sapub_ct13270.pdf
HAS/2014-10-14_incivo_en_ct13275_pub.pdf
HAS/2014-10-14_incivo_sapub_ct13275.pdf
HAS/2014-10-14_tyverb_pic_eit_avis2_ct13453.pdf
HAS/2014-10-14_tyverb_sapub_ct13610.pdf
HAS/2014-10-14_tyverb_version_anglaise_ct13453.pdf
HAS/2014-10-16_CEPP-4597_KETOCAL_07_octobre_2014_(4597)_avis.pdf
HAS/2014-10-16_CEPP-4653_PERISTEEN_07_octobre_2014_(4653)_avis.pdf
HAS/2014-10-16_CT-12525_GLIVEC_QDRCP et EPI_Avis 1_CT12525.pdf
HAS/2014-10-16_CT-13016_MUPIDERM_RI_avis1_CT13016.pdf
HAS/2014-10-16_CT-13623_MABTHERA SC_Ins_Avis2_CT13623.pdf
HAS/2014-10-16_CT-13851_CROMABAK_CROMADOSES_RI2014_avis1_CT13851.pdf
HAS/2014-10-16_CT-13859_XENETIX_QDINS_Avis2_CT13859.pdf
HAS/2014-10-20_CEPP-4667_URGOSTART CONTACT_07_octobre_2014_(4667)_avis.pdf
HAS/2014-10-21_ald_30_gp_kpoumon.pdf
HAS/2014-10-21_apald_lymphome_hodgkin_web.pdf
HAS/2014-10-21_guide_k_bronchopulmonaires_finalweb__091013.pdf
HAS/2014-10-21_guide_lymphome_hodgkin_web.pdf
HAS/2014-10-21_guide_mesotheliome_pleural_malin_final_web_091013.pdf
HAS/2014-10-21_lap_poumon_final_web_juillet2009.pdf
HAS/2014-10-23_CEPP-4573_HEARTWARE_07_octobre_2014_(4573)_avis 2 definitif.pdf
HAS/2014-10-23_CEPP-4709_ULTIMASTER_07_octobre_2014_(4709)_avis.pdf
HAS/2014-10-23_CEPP-4711_3C100 C-LEG_07_octobre_2014_(4711)_avis.pdf
HAS/2014-10-23_CEPP-4718_MELODY 20_07_octobre_2014_(4718)_avis.pdf
HAS/2014-10-23_pnds_-_spina_bifida_-_gestion_du_handicap_intestinal_has_juin_2014.pdf
HAS/2014-10-23_pnds_54_-_spina_bifida__gestion_du_handicap_intestinal_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2014-10-28_fpcs_prescription_web.pdf
HAS/2014-10-28_fpcs_taking_steps_to_prevent_the_drug-_problem-related_readmissions.pdf
HAS/2014-10-28_note_methodo_fpcs_prescription_web_2014-10-27_11-55-59_934.pdf
HAS/2014-10-29_CEPP-4683_COREVALVE EVOLUT AOA HR_21_octobre_2014_(4683)_Caviarde.pdf
HAS/2014-10-29_CT-13362_LONQUEX_PIC_INS_Avis post audition_CT133628MODIF.pdf
HAS/2014-10-29_lonquex_en_ct133628_def.pdf
HAS/2014-10-29_lonquex_sapub_ct13362.pdf
HAS/2014-11-03_CEPP-4687_MAVERICK_07_octobre_2014_(4687)_avis.pdf
HAS/2014-11-03_CEPP-4713_ZEBRA SP_21_octobre_2014_(4713)_avis.pdf
HAS/2014-11-03_CEPP-4719_SAPIEN XT TA_23_septembre_2014_(4719)_avis.pdf
HAS/2014-11-03_CEPP-4720_SAPIEN XT TF_23_septembre_2014_(4720)_avis.pdf
HAS/2014-11-03_CT-13508_BEXSERO _Ins_Avis2_CT13508.pdf
HAS/2014-11-03_bexsero_en_ct13508_val.pdf
HAS/2014-11-03_bexsero_sapub_ct13508.pdf
HAS/2014-11-03_matrice_de_maturite_-_guide_utilisation.pdf
HAS/2014-11-03_matrice_maturite.pdf
HAS/2014-11-03_matrices_de_maturite_en_soins_primaires_note_de_synthese.pdf
HAS/2014-11-03_noteproblematique_chirurgie_lombalgie_chronique_20140924_vd_2014-11-03_10-59-5_299.pdf
HAS/2014-11-03_rap_questionnaire.pdf
HAS/2014-11-03_rap_support_matrice_de_maturite.pdf
HAS/2014-11-05_CT-13543_EYLEA_OVCR_avis2_CT13543.pdf
HAS/2014-11-05_CT-13589_ROACTEMRA _AVlS 2_EITAJI_CT13589.pdf
HAS/2014-11-05_CT-13696_ROACTEMRA SC_Ins_Avis2_CT_13696.pdf
HAS/2014-11-05_eylea_en_ct13543_val.pdf
HAS/2014-11-05_eylea_occlusion_sapub_ct13543.pdf
HAS/2014-11-05_roactemra__en_ct13589_pub.pdf
HAS/2014-11-05_roactemra_iv_aji__sapub_ct13589.pdf
HAS/2014-11-05_roactemra_sapub_ct13696.pdf
HAS/2014-11-07_CEPP-4674_COREVALVE AOA ViV_21_octobre_2014_(4674)_Caviarde.pdf
HAS/2014-11-07_CEPP-4675_COREVALVE EVOLUT AOA ViV_21_octobre_2014_(4675)_Caviarde.pdf
HAS/2014-11-07_CEPP-4680_COREVALVEHR_21_octobre_2014_(4680)_Caviarde.pdf
HAS/2014-11-07_CEPP-4682_COREVALVE AOA HR_21_octobre_2014_(4682)_Caviarde.pdf
HAS/2014-11-07_CEPP-4752_FLOW COLLECTOR_21_octobre_2014_(4752)_avis.pdf
HAS/2014-11-07_CEPP-4756_URGOSTART BORDER_21_octobre_2014_(4756)_avis.pdf
HAS/2014-11-07_CEPP-4757_SAPIEN XT 20mm_21_octobre_2014_(4757)_avis.pdf
HAS/2014-11-07_CEPP-4762_TAG_21_octobre_2014_(4762)_avis_radiation.pdf
HAS/2014-11-07_conformable_tag.pdf
HAS/2014-11-12_CT-13014_CYNOMEL_RI_Avis1_CT13014.pdf
HAS/2014-11-12_CT-13527_QUADRAMET Reevalsus_ Avis 1_CT13527.pdf
HAS/2014-11-12_CT-13555_THYROZOL_PISRI_Avis1_CT13555.pdf
HAS/2014-11-12_CT-13683_FER_PANPHARMA_ins_QD_avis2_CT13683.pdf
HAS/2014-11-12_CT-13795_KETOPROFENE_MACOSOL_QD_INS_avis1_CT13795.pdf
HAS/2014-11-12_CT-13814_CREON_5000_Ins_Avis2_CT_13814.pdf
HAS/2014-11-12_CT-13831_ODRIK_RI2014_avis 2_CT 138231.pdf
HAS/2014-11-12_CT-13832_CREON_40000_Ins_Avis2_CT_13832.pdf
HAS/2014-11-12_CT-13837_NEOMERCAZOLE_PISRI_Avis2_CT13837.pdf
HAS/2014-11-12_CT-13853_HBVAXPRO_01102014_PIS_RI_Avis2_CT13853.pdf
HAS/2014-11-12_CT-13858_UVESTEROL_D_Ins_PIS_avis2_CT13858.pdf
HAS/2014-11-12_CT-13865_TAHOR_avis EPI 2014 avis 2_CT13865.pdf
HAS/2014-11-12_CT-13866_PARACETAMOL QD_INS_Avis1_CT13866.pdf
HAS/2014-11-12_CT-13874_FUROSEMIDE RENAUDIN QD_INS_Avis1_CT13874.pdf
HAS/2014-11-12_CT-13886_KETUM_CT-13886_ RECOURSRADIATION_R163-13.pdf
HAS/2014-11-12_chloruresodium_qdins_avis1_ct13695.pdf
HAS/2014-11-12_lits_medicaux_a_fonction_proclive-declive.pdf
HAS/2014-11-12_nulojix_reeval_pic_avis_post_audition_ct_13506_revuaa.pdf
HAS/2014-11-12_nulojix_sapub_ct13506.pdf
HAS/2014-11-12_quadramet_en_ct13527_val.pdf
HAS/2014-11-14_CT-13130_EUTHYRAL_RI_Avis2_CT13130.pdf
HAS/2014-11-14_CT-13188_BASDENE_RI_Avis2_CT13188.pdf
HAS/2014-11-14_CT-13569_METASTRON _Reeval sus_ Avis 1_CT13569.pdf
HAS/2014-11-14_CT-13670_DALACINE_RI_Avis1_CT13670.pdf
HAS/2014-11-14_CT-13673_A 313_PISRI_avis1_CT13673.pdf
HAS/2014-11-14_CT-13674_SALVACYL_RI_PIS_Avis1_CT13674.pdf
HAS/2014-11-14_CT-13793_OMACOR RI 2014 _ avis 2 _ CT 13793.pdf
HAS/2014-11-14_CT-13829_NIDREL_RI_avis 2_CT 13829.pdf
HAS/2014-11-14_CT-13830_CONEBILOX_RI 2014_avis 2_CT 13830.pdf
HAS/2014-11-14_feuille_de_route_2014-11-12_10-53-26_432.pdf
HAS/2014-11-14_metastron_version_anglaise_ct13569.pdf
HAS/2014-11-14_note_cadrage_generalites.pdf
HAS/2014-11-14_web-composition_du_gt_sieges-chassis_2014-11-12_10-54-16_424.pdf
HAS/2014-11-17_algorithme_depistage.pdf
HAS/2014-11-17_algorithme_ideal.pdf
HAS/2014-11-17_annexe_criteres_cim-10_abus_dependance.pdf
HAS/2014-11-17_annexe_criteres_cim-10_trouble_depressif_recidivant.pdf
HAS/2014-11-17_annexe_criteres_dsm-iv_abus_dependance_sevrage.pdf
HAS/2014-11-17_annexe_echelles_diveres_tabac.pdf
HAS/2014-11-17_annexe_fiche_nicomede.pdf
HAS/2014-11-17_annexe_methode_5a.pdf
HAS/2014-11-17_annexe_tableau_synthese_recommandations.pdf
HAS/2014-11-17_annexe_test_de_horn.pdf
HAS/2014-11-17_annexe_test_de_khimji_et_watts.pdf
HAS/2014-11-17_annexe_test_de_richmond.pdf
HAS/2014-11-17_annexe_test_qct2_de_gilliard.pdf
HAS/2014-11-17_argumentaire_scientifique-_arret_de_la_consommation_de_tabac.pdf
HAS/2014-11-17_check-list_deploiement_des_parcours.pdf
HAS/2014-11-17_outil__echelle_had.pdf
HAS/2014-11-17_outil_attitudes_stade_changement_patient.pdf
HAS/2014-11-17_outil_echelle_analogique_evaluation_motivation.pdf
HAS/2014-11-17_outil_evaluation_sentiment_efficacite.pdf
HAS/2014-11-17_outil_exemple_conseils_arret.pdf
HAS/2014-11-17_outil_fiche_soutien_psychologique.pdf
HAS/2014-11-17_outil_les_tns_en_pratique_2014-11-14_12-18-51_242.pdf
HAS/2014-11-17_outil_methode_entretien_motivationnel.pdf
HAS/2014-11-17_outil_modele_prochaska_et_diclemente.pdf
HAS/2014-11-17_outil_questionnaire_cage.pdf
HAS/2014-11-17_outil_questionnaire_cast.pdf
HAS/2014-11-17_outil_rechute_colonnes_de_beck.pdf
HAS/2014-11-17_outil_tests_fagerstrom.pdf
HAS/2014-11-17_recommandations_-_arret_de_la_consommation_de_tabac.pdf
HAS/2014-11-17_syst_am_p361_cl.pdf
HAS/2014-11-17_syst_am_p361_cv.pdf
HAS/2014-11-19_annexes_irct_vf.pdf
HAS/2014-11-19_argumentaire_irct_vf_2014-11-06_19-21-13_876.pdf
HAS/2014-11-19_fiche_de_sytnhese_vf.pdf
HAS/2014-11-19_focus_irct_-_article_webzine.pdf
HAS/2014-11-19_synthese_irct_vf.pdf
HAS/2014-11-20_CT-13068_GENTALLINE_RI_Avis1_CT 13068.pdf
HAS/2014-11-20_CT-13127_BYDUREON_INS_AVISpostaud3_CT13127.pdf
HAS/2014-11-20_CT-13184_MYAMBUTOL_RI_Avis 1_CT13184.pdf
HAS/2014-11-20_CT-13191_ADIAZINE_RI_Avis2_CT13191.pdf
HAS/2014-11-20_CT-13520_SATIVEX_Ins_Avis2post-audition_CT13520.pdf
HAS/2014-11-20_CT-13595_HEMANGIOL_Ins_avis 2_CT13595.pdf
HAS/2014-11-20_CT-13619_ABRAXANE_QDINS_Avis2_CT13619.pdf
HAS/2014-11-20_bydureon_en_sapub_ct13127_def.pdf
HAS/2014-11-20_hemangiol_sapub_ct13595.pdf
HAS/2014-11-20_hemangiol_version_anglaise_ct13595.pdf
HAS/2014-11-20_sativex_en_sapub_ct13520_val.pdf
HAS/2014-11-20_sativex_sapub_ct13520.pdf
HAS/2014-11-20_sativex_version_anglaise_ct13520.pdf
HAS/2014-11-24_CT-12942_ISENTRESS_ RI_Avis3_CT12942.pdf
HAS/2014-11-24_CT-13055_BACTRIM_RI_Avis 1_CT13055.pdf
HAS/2014-11-24_CT-13771_IZBA_Ins_PIS_avis2_CT13771.pdf
HAS/2014-11-24_CT-13780_DESLORATADINE_MYLAN_Ins_QD_avis2_CT13780.pdf
HAS/2014-11-24_CT-13824_COLOPEG_PIS_RI_Avis1_CT13824.pdf
HAS/2014-11-24_CT-13843_VANCOMYCINE MIP_QDInsc_ Avis 1_ CT 13843.pdf
HAS/2014-11-24_affiche_saed.pdf
HAS/2014-11-24_beromun_reeval_liste_en_sus_avis_2_ct13568.pdf
HAS/2014-11-24_beromun_version_anglaise_ct13568_def.pdf
HAS/2014-11-24_bloc_note_saed.pdf
HAS/2014-11-24_document_de_sortie_contenu_metier_23102014.pdf
HAS/2014-11-24_document_de_sortie_fiche_utilisation_23102014.pdf
HAS/2014-11-24_document_sortie_-_analyse_bibliographique.pdf
HAS/2014-11-24_proleukin_reeval_liste_en_sus_avis1_ct13702.pdf
HAS/2014-11-24_proleukin_version_anglaise_ct13702.pdf
HAS/2014-11-24_questionnaire_appelant.pdf
HAS/2014-11-24_questionnaire_appele.pdf
HAS/2014-11-24_questionnaire_eval_connaissances.pdf
HAS/2014-11-24_questionnaire_eval_formation.pdf
HAS/2014-11-24_questionnaire_satisfaction.pdf
HAS/2014-11-24_saed_guide_complet_2014-11-21_15-41-2_64.pdf
HAS/2014-11-27_CEPP-4679_TENOLIG_04_novembre_2014_(4679)_avis.pdf
HAS/2014-11-27_CEPP-4681_RM PRESSFIT VITAMYS_18_novembre_2014_(4681)_avis.pdf
HAS/2014-11-27_CEPP-4698_NEWCUP_04_novembre_2014_(4698)_avis.pdf
HAS/2014-11-27_CT-11884_DECAPEPTYL_PISRCP_Avis2_CT11884-CT13600.pdf
HAS/2014-11-27_CT-12728_GALVUS_JALRA__AVIS3postaud_CT12728.pdf
HAS/2014-11-27_CT-13180_NEBCINE_RI_Avis1_CT13180.pdf
HAS/2014-11-27_CT-13501_NOVOPULMON NOVOLIZER_RI2014_avis2_CT13501.pdf
HAS/2014-11-27_CT-13730_VITAMINE B12 LAVOISIER_QDINS_avis1_CT13730.pdf
HAS/2014-11-27_CT-13786_GONAL F_PISRI_Avis2_CT13786.pdf
HAS/2014-11-27_CT-13792_KALYDECO_EIT mutations_avis 2_CT13972.pdf
HAS/2014-11-27_CT-13822_GANFORT_unidose_QD_Ins_Avis1_CT13822.pdf
HAS/2014-11-27_CT-13828_DOTAREM_QDINS_Avis2_CT13828.pdf
HAS/2014-11-27_CT-13856_OPHTIM_TIMABAK_GELTIM_RI2014_avis2_CT13856.pdf
HAS/2014-11-27_CT-13864_DACARBAZINE MEDAC_QDins_Avis2_CT13864.pdf
HAS/2014-11-27_CT-13882_NATECAL VITAMINE D3_RI_Avis1_CT13882.pdf
HAS/2014-11-27_eucreas_icandra_avis3_modifiele13032015_ct13728.pdf
HAS/2014-11-27_eucreas_icandra_version_anglaise_ct13728.pdf
HAS/2014-11-27_galvus_jalra_version_anglaise_ct12728.pdf
HAS/2014-11-27_kalydeco_en_ct13972_val.pdf
HAS/2014-11-27_noxafil_qdins_avis_2_ct13757_modifie_le_21-11-2014.pdf
HAS/2014-11-27_rm_pressfit_vitamys.pdf
HAS/2014-12-01_analyse_de_la_litterature_mas-fam_volet_2_.pdf
HAS/2014-12-01_ane-handicapes-qualite_de_vie_en_mas-fam_volet_1_-ea.pdf
HAS/2014-12-01_ane-handicapes-qualite_de_vie_en_mas-fam_volet_1_-juillet_2013.pdf
HAS/2014-12-01_anesm-_ea_-_qualite_de_vie_en_mas-fam_volet_3_.pdf
HAS/2014-12-01_anesm-_qualite_de_vie_en_mas-fam_volet_2__decembre_2013.pdf
HAS/2014-12-01_anesm-_qualite_de_vie_en_mas-fam_volet_2__ea.pdf
HAS/2014-12-01_anesm-qualite_de_vie_en_mas-fam_volet_3_-pdf-interacti.pdf
HAS/2014-12-01_anesm-rbpp-protection_de_l_enfance-decembre_2014-interactif.pdf
HAS/2014-12-01_anesm-rbpp-protection_de_l_enfance-ea.pdf
HAS/2014-12-01_anesm-synthese-qualite_de_vie_en_mas-fam_volet_1_-juillet_2013.pdf
HAS/2014-12-01_anesm-synthese-qualite_de_vie_en_mas-fam_volet_2_.pdf
HAS/2014-12-01_anesm-synthese-qualite_de_vie_en_mas-fam_volet_3_-decembre2014.pdf
HAS/2014-12-01_anesm-synthese-rbppprotection_enfance_decembre_2014.pdf
HAS/2014-12-01_annexes.pdf
HAS/2014-12-01_bibliographie_rbpp_mas_fam_juillet_2013.pdf
HAS/2014-12-01_chapitre_1.pdf
HAS/2014-12-01_chapitre_2.pdf
HAS/2014-12-01_chapitre_3.pdf
HAS/2014-12-01_chapitre_4.pdf
HAS/2014-12-01_introduction.pdf
HAS/2014-12-01_lc_participation_en_pe_def.pdf
HAS/2014-12-01_lettre_de_cadrage_qualite_de_vie_mas-fam.pdf
HAS/2014-12-01_qdv_mas-fam__volet_1___recensement_outils_communication.pdf
HAS/2014-12-02_12irp09_argumentaire_011214.pdf
HAS/2014-12-02_12irp09_psychotropes_-_note_de_cadrage.pdf
HAS/2014-12-02_12irp09_synthese2_psychotropes_28-11-14.pdf
HAS/2014-12-02_12irp09_synthese_psychotropes_01-12-14.pdf
HAS/2014-12-02_12irp_recommandations_psychotrope_01-12-14.pdf
HAS/2014-12-02_CEPP-4549_JARVIK 2000_04_novembre_2014_(4549)_avis.pdf
HAS/2014-12-02_CEPP-4663_VIVA CRT-P_04_novembre_2014_(4663)_avis.pdf
HAS/2014-12-02_CEPP-4750_TUBULCUS_04_novembre_2014_(4750)_avis.pdf
HAS/2014-12-02_CEPP-4758_EXCLUDER_21_octobre_2014_(4758)_avis.pdf
HAS/2014-12-02_CT-13060_LTHYROXINE_SERB_RI_Avis2_CT-13060.pdf
HAS/2014-12-02_document_de_travail_-_analyse_du_groupe_de_lecture_-_comportements_perturbateurs.pdf
HAS/2014-12-02_schema_decisionnel_dorganisation_a_adopter_devant_un_trouble_du_comportement_persistant.pdf
HAS/2014-12-02_schema_decisionnel_dorganisation_a_adopter_devant_un_trouble_du_comportement_recent_tres_perturbateur.pdf
HAS/2014-12-03_avis_ceesp_sahos_27_mai_2014.pdf
HAS/2014-12-03_avis_cnedimts_sahos_15_juillet_2014.pdf
HAS/2014-12-03_composition_du_groupe_de_travail_sahos.pdf
HAS/2014-12-03_decision_college_2014_0146_sahos.pdf
HAS/2014-12-03_note_de_cadrage_sed_sahos_evaluation_clinique.pdf
HAS/2014-12-03_note_de_cadrage_seesp_sahos_evaluation_economique.pdf
HAS/2014-12-03_rapport_sahos_-_evaluation_clinique.pdf
HAS/2014-12-03_rapport_sahos_-_evaluation_economique.pdf
HAS/2014-12-03_sahos_-_fiche_de_bon_usage.pdf
HAS/2014-12-05_CEPP-4572_TRIDENT_X3_18_novembre_2014_(4572)_avis.pdf
HAS/2014-12-05_avis_aide_a_la_toux_-_forfait_7_2014-11-26_16-21-14_524.pdf
HAS/2014-12-05_ff7_note_de_cadrage_vf_2013_10_22.pdf
HAS/2014-12-05_rapport_aide_a_la_toux-forfait_7.pdf
HAS/2014-12-05_synthesis_of_intermittent_positive_pressure_breathing_and_mechanical_in-exsufflation_devices_weekly_fee.pdf
HAS/2014-12-05_texte_court_aide_a_la_toux-forfait_7.pdf
HAS/2014-12-05_web-composition_du_gt_ff7_2014-03-19_11-53-32_768.pdf
HAS/2014-12-08_CEPP-4661_PARADIGM_VEO_18_novembre_2014_(4661)_avis.pdf
HAS/2014-12-08_peristeen_obtal_18_novembre_2014_4745_avis.pdf
HAS/2014-12-08_protheses_hanche_dm_eval_65.pdf
HAS/2014-12-10_CT-13015_THIOPHENICOL_RI_avis2_CT13015.pdf
HAS/2014-12-10_CT-13286_HYALGAN_REEVAL_RI _CT13286_CT13796_Avis 3.pdf
HAS/2014-12-10_CT-13335_RELENZA_RI_PIS_avis2_CT13335.pdf
HAS/2014-12-10_CT-13596_CHOLIB_Ins_avis  3_CT 13596.pdf
HAS/2014-12-10_CT-13611_FOSFOCINE_QDINS_avis1_CT13611.pdf
HAS/2014-12-10_ethyol_en_ct13548_def.pdf
HAS/2014-12-10_ethyol_reevalasmr_avis2_ct13548.pdf
HAS/2014-12-10_hyalgan_en_ct13286_ct13796_val.pdf
HAS/2014-12-10_salbumol_ri2011_avis2_ct11460.pdf
HAS/2014-12-12_CEPP-4685_EXCOR_04_novembre_2014_(4685)_avis.pdf
HAS/2014-12-12_CT-13479_VELETRI ins_PIC_avis 2_CT 13479.pdf
HAS/2014-12-12_veletri_23072014_synthese_avis_ct13479.pdf
HAS/2014-12-12_veletri_en_ct13479_def.pdf
HAS/2014-12-15_annexe_1_propositions_de_definitions_des_manifestations_depressives.pdf
HAS/2014-12-15_annexe_2_classification_cftmea_des_manifestations_depressives_et_correspondance_diagnostique_avec_la_classification_cim.pdf
HAS/2014-12-15_annexe_3_definition_de_ledc_selon_la_cim-10.pdf
HAS/2014-12-15_annexe_4_definition_de_ledc_selon_le_dsm-5_proposition_de_traduction.pdf
HAS/2014-12-15_annexe_5_outils_daide_au_reperage_et_a_levaluation.pdf
HAS/2014-12-15_figure_1_strategie_de_prise_en_charge_therapeutique_des_manifestations_depressives_a_ladolescence.pdf
HAS/2014-12-15_manifestations_depressives_argumentaire_scientifique.pdf
HAS/2014-12-15_manifestations_depressives_fiche_de_synthese_prise_en_charge_therapeutique.pdf
HAS/2014-12-15_manifestations_depressives_fiche_de_synthese_reperage-diagnostic_et_strategie.pdf
HAS/2014-12-15_manifestations_depressives_recommandations.pdf
HAS/2014-12-16_CEPP-4566_AVANTAGE RELOAD_18_novembre_2014_(4566)_avis.pdf
HAS/2014-12-16_CEPP-4567_AVANTAGE a cimenter_18_novembre_2014_(4567)_avis.pdf
HAS/2014-12-16_CEPP-4689_PRODISC_L_02_decembre_2014_(4689)_avis.pdf
HAS/2014-12-16_CEPP-4690_PRODISC_O_02_decembre_2014_(4690)_avis.pdf
HAS/2014-12-16_CEPP-4746_NEOCATE_02_decembre_2014_(4746)_avis.pdf
HAS/2014-12-16_CEPP-4747_NEOCATE ADVANCE_02_decembre_2014_(4747)_avis.pdf
HAS/2014-12-16_CEPP-4749_NEOCATE ACTIVE_02_decembre_2014_(4749)_avis.pdf
HAS/2014-12-16_CEPP-4777_TRIDENT X3_18_novembre_2014_(Radiation 4777)_avis.pdf
HAS/2014-12-16_CEPP-4790_DURALITE_02_decembre_2014_(4790)_avis.pdf
HAS/2014-12-16_CEPP-4801_AVANTAGE 3P_18_novembre_2014_(4801)_avis.pdf
HAS/2014-12-16_CT-13542_CIMZIA 200 mg_ EI_RPso_Avis 3_CT13542.pdf
HAS/2014-12-16_CT-13616_ABRAXANE_Ins EI pancreas_Avis3mod281014_CT13616.pdf
HAS/2014-12-16_CT-13648_PROLIA_PIS_MCI_Avis1_CT13648.pdf
HAS/2014-12-16_CT-13658_OSTRAM_EG_RI_A1_CT13658.pdf
HAS/2014-12-16_CT-13772_STELARA_ EI_RPso_Avis2_ CT13772.pdf
HAS/2014-12-16_CT-13916_PROLIA_PIS_EI_NON_DEMANDEE_Avis1_CT13916.pdf
HAS/2014-12-16_CT-13951_DESOGESTREL_BIOGARAN_PIS_INS_Avis2_CT13951.pdf
HAS/2014-12-16_abraxane_15102014_synthese_ct13616.pdf
HAS/2014-12-16_abraxane_en_ct13616_val.pdf
HAS/2014-12-16_cimzia_01102014_synthese_avis_ct13542.pdf
HAS/2014-12-16_cimzia_en_ct13542_val.pdf
HAS/2014-12-16_peristeen_obtal.pdf
HAS/2014-12-16_stelara__version_anglaise_ct13772.pdf
HAS/2014-12-16_stelara_sapub_ct13772.pdf
HAS/2014-12-18_bat_rpc_cadrage_cv_050111.pdf
HAS/2014-12-18_document_d_information_recommandations_de_bonne_pratique_2011-01-06_11-12-31_795.pdf
HAS/2014-12-18_fiche_synthese_vf.pdf
HAS/2014-12-18_guide_methodologique_note_de_cadrage.pdf
HAS/2014-12-18_pnds_-_syndrome_nephrotique_idiopathique_de_ladulte.pdf
HAS/2014-12-18_pnds_55_-_syndrome_nephrotique_idiopathique_de_ladulte_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2014-12-18_valeurs_de_reference_vf.pdf
HAS/2014-12-19_CT-13643_CALCIUMVITAMINED3_EG_RI_Avis1_CT13643.pdf
HAS/2014-12-19_CT-13782_LATUDA_PIC_INS_avis2_CT13782.pdf
HAS/2014-12-19_CT-13826_METHOTREXATE SANDOZ_INS_Avis 1_CT13826.pdf
HAS/2014-12-19_CT-13949_IOPAMIRON-RI-PAVIS 2-CT 13949.pdf
HAS/2014-12-19_CT-13962_MOXIFLOXACINE_QDINS_A1_CT_13962.pdf
HAS/2014-12-19_argu_echo-endo_vd.pdf
HAS/2014-12-19_feuille_de_route_echo-endoscopie_bronchique.pdf
HAS/2014-12-19_fpcs_sotie_rehospit_pied_diabetique_web.pdf
HAS/2014-12-19_fpcs_taking_steps_to_prevent_diabetes_foot_ulcer_related_readmission_poutignat.pdf
HAS/2014-12-19_inahta_brief_transbronchial_needle_aspiration.pdf
HAS/2014-12-19_latuda_en_ct13782_val.pdf
HAS/2014-12-19_latuda_en_sapub_ct13782_val.pdf
HAS/2014-12-19_latuda_sapub_ct13782.pdf
HAS/2014-12-19_methodo_sortie_rehospit_pied_diabetique_web.pdf
HAS/2014-12-19_paracetamol_ahcl_qd_ins_a1_ct-13959.pdf
HAS/2014-12-19_vercyte_pic_ri_ct13812_avis2.pdf
HAS/2014-12-24_CEPP-4767_VISIONIST (U225)_02_decembre_2014_(4767)avis.pdf
HAS/2014-12-24_CEPP-4769_VISIONIST (U226)_02_decembre_2014_(4769)_avis.pdf
HAS/2014-12-24_CEPP-4770_VISIONIST (U228)_02_decembre_2014_(4770)_avis.pdf
HAS/2014-12-24_CEPP-4775_XPERT_18_novembre_2014_(4775)_avis.pdf
HAS/2014-12-24_CEPP-4776_XPERT PRO_18_novembre_2014_(4776)_avis.pdf
HAS/2014-12-24_CEPP-4780_ACTIVA Extensions_02_decembre_2014_(478)_avis_radiation.pdf
HAS/2014-12-24_naglazyme_reeval_avis_2_ct_13567_2014-11-07_10-04-50_789.pdf
HAS/2014-12-24_naglazyme_sapub_ct13567.pdf
HAS/2014-12-24_surescan_mri.pdf
HAS/2014-12-31_CT-11611_PHYSIOGYNE_PIS_Avis1_CT11611.pdf
HAS/2014-12-31_CT-13329_METOCALCIUM_EG_RI_A1_CT13329.pdf
HAS/2014-12-31_CT-13649_TOCTINO_RI2014_Avis 2_CT13649.pdf
HAS/2014-12-31_CT-13926_DESOPOP_75_PIS_INS_Avis2_CT13926.pdf
HAS/2014-12-31_clarealge_0075_pis_ins_avis2_ct13948.pdf
HAS/2014-12-31_toctino_sapub_ct13649.pdf
HAS/2015-01-05_CEPP-4701_XIENCE V_16_decembre_2014_(4701)_avis.pdf
HAS/2015-01-05_CEPP-4702_XIENCE PRIME_16_decembre_2014_(4702)_avis.pdf
HAS/2015-01-05_CEPP-4703_XIENCE XPEDITION_16_decembre_2014_(4703)_avis.pdf
HAS/2015-01-05_CT-13320_ROZEX_RI_PIS_avis1_CT13320.pdf
HAS/2015-01-05_CT-13514_SILKIS_RI_PIS_avis1_CT13514.pdf
HAS/2015-01-05_CT-13807_CISPLATINE_ACCORD_QDINS_Avis1_CT13807.pdf
HAS/2015-01-05_CT-13861_CALCIUM_VITAMINE_D3_SANDOZ_RI_Avis1_CT13861.pdf
HAS/2015-01-05_CT-13977_PHENYLEPHRINE RENAUDIN_QDINS_Avis1_CT 13977.pdf
HAS/2015-01-05_ane-rapport_d_enquete_bientraitance-syn-pa-bat.pdf
HAS/2015-01-05_ane-rapport_d_enquete_bientraitance-syn-ph-bat.pdf
HAS/2015-01-05_ane-trans-rbpp-soutien_aidants-interactif.pdf
HAS/2015-01-05_ane-trans-rbpp_l_accompagnement_des_enfants_en_camsp.pdf
HAS/2015-01-05_anesm-ea-rbpp-camsp.pdf
HAS/2015-01-05_anesm-synthese-rbpp_camsp.pdf
HAS/2015-01-05_anesm-synthese-soutien_aidants-vdef.pdf
HAS/2015-01-05_anesm__enquete_bientraitance_sad_synthese_volet_2_.pdf
HAS/2015-01-05_annexes2.pdf
HAS/2015-01-05_annexes3.pdf
HAS/2015-01-05_bibliographie_rbpp_camsp.pdf
HAS/2015-01-05_bibliographie_soutien_aux_aidants_non_professionnels.pdf
HAS/2015-01-05_cadrage_rbpp_accompagnement_des_aidants_non_professionnels_a_domicile.pdf
HAS/2015-01-05_chapitre1.pdf
HAS/2015-01-05_chapitre11.pdf
HAS/2015-01-05_chapitre_22.pdf
HAS/2015-01-05_chapitre_23.pdf
HAS/2015-01-05_chapitre_31.pdf
HAS/2015-01-05_chapitre_33.pdf
HAS/2015-01-05_chapitre_41.pdf
HAS/2015-01-05_chapitre_42.pdf
HAS/2015-01-05_chapitre_5.pdf
HAS/2015-01-05_doc_appui_aidants.pdf
HAS/2015-01-05_elements_d_appropriation_de_la_rbpp_aidants.pdf
HAS/2015-01-05_elements_de_cadrage_ippe__septembre_2013.pdf
HAS/2015-01-05_enquete_bientraitance_sad_volet_2.pdf
HAS/2015-01-05_guide_de_remplissage_et_de_correspondance_entre_le_questionnaire_et_l_evaluation_interne.pdf
HAS/2015-01-05_presentation_generale.pdf
HAS/2015-01-05_presentation_generale1.pdf
HAS/2015-01-05_rapport_bientraitance_sad_volet2.pdf
HAS/2015-01-05_rapport_qbt_sad_volet1_juin2014.pdf
HAS/2015-01-05_zymaduo_pisri_avis1_ct13913.pdf
HAS/2015-01-06_CEPP-4650_CONSERVE PLUS_16_decembre_2014_(4650)_avis.pdf
HAS/2015-01-06_CEPP-4728_MOBIDISC_02_decembre_2014_(4728)_avis.pdf
HAS/2015-01-06_CEPP-4751_RESTORATION ADM X3_16_decembre_2014_(4751)_avis.pdf
HAS/2015-01-13_guide_methodo_patient_traceur.pdf
HAS/2015-01-13_guide_patient_traceur.pdf
HAS/2015-01-13_rapport_experimentation_methode_patient_traceur.pdf
HAS/2015-01-19_CT-13466_ALOPLASTINE_RI_PIS_avis 2_CT1346.pdf
HAS/2015-01-19_CT-13849_MELAXOSE_RI_PIS_avis1_CT13849.pdf
HAS/2015-01-19_CT-13868_INOMAX_QDINS_Avis 2_CT13868_CT.pdf
HAS/2015-01-19_CT-13936_PHENYLEPHRINE AGUETTANT_PIS_Avis2_CT13936.pdf
HAS/2015-01-19_mozobil_reevaluation_2014_avis_2_ct_13869.pdf
HAS/2015-01-20_CEPP-4655_BHR _13_janvier_2015_(4655)_avis.pdf
HAS/2015-01-20_CEPP-4737_CONSERVE PLUS _16_decembre_2014_(4737)_avis_radiation.pdf
HAS/2015-01-20_CT-13551_KINERET_Ins_avis1_CT13551.pdf
HAS/2015-01-20_CT-13646_MULTIHANCE_Avis2_CT13646.pdf
HAS/2015-01-20_CT-13698_VIMIZIM_PIC_Ins_Avis2_CT13698.pdf
HAS/2015-01-20_CT-13729_BOTOX_PIC_CT13729_Avis 2.pdf
HAS/2015-01-20_CT-13765_IZINOVA_PIC_INS_Avis2_CT13765.pdf
HAS/2015-01-20_CT-13915_BYDUREON_QDINS_CT13915_Avis2.pdf
HAS/2015-01-20_alpress-minipress_en_sapub_ct13110_13124_val.pdf
HAS/2015-01-20_alpress-minipress_sapub_ct13110_13124.pdf
HAS/2015-01-20_alpress_en_ct13110_val.pdf
HAS/2015-01-20_alpress_reeval_2014_avis_2_ct13110.pdf
HAS/2015-01-20_botox_25112014_avis_efficience.pdf
HAS/2015-01-20_botox_ct13729_2015-04-16_11-52-56_290.pdf
HAS/2015-01-20_botox_sa_ct13729_en_def.pdf
HAS/2015-01-20_botox_sapub_ct13729.pdf
HAS/2015-01-20_bydureon_sapub_ct13127.pdf
HAS/2015-01-20_curosurf_en_sapub_ct13656_def.pdf
HAS/2015-01-20_curosurf_pic_reeval_avis_2_ct_13656_revuaa.pdf
HAS/2015-01-20_curosurf_sapub_ct13656.pdf
HAS/2015-01-20_evaluation_des_corsets-sieges_-_feuille_de_route.pdf
HAS/2015-01-20_izinova_en_ct13765_def.pdf
HAS/2015-01-20_izinova_en_sapub_ct13765_def.pdf
HAS/2015-01-20_izinova_sapub_ct13765.pdf
HAS/2015-01-20_kineret_en_ct13551.pdf
HAS/2015-01-20_kineret_en_sapub_ct13551.pdf
HAS/2015-01-20_kineret_sapub_ct13551.pdf
HAS/2015-01-20_minipress_reeval_2014_avis_2_ct13124.pdf
HAS/2015-01-20_minipress_version_anglaise_ct13124_2015-10-06_11-18-23_112.pdf
HAS/2015-01-20_multihance_en_ct13646_val.pdf
HAS/2015-01-20_multihance_en_sapub_ct13646_val.pdf
HAS/2015-01-20_multihance_sapub_ct13646.pdf
HAS/2015-01-20_note_cadrage_generalites.pdf
HAS/2015-01-20_vimizim_en_sapub_ct13698_val.pdf
HAS/2015-01-20_vimizim_sapub_ct13698.pdf
HAS/2015-01-20_vimizim_version_anglaise_ct13698.pdf
HAS/2015-01-20_web-composition_du_gt_corsets-sieges.pdf
HAS/2015-01-21_CT-13261_INNOHEP_CT 13261_EI_PIC_avis 2.pdf
HAS/2015-01-21_CT-13528_OPSUMIT ins_PIC_avis  3_CT 13479.pdf
HAS/2015-01-21_CT-13594_ADEMPAS_PIC_INS_avis2_CT13594.pdf
HAS/2015-01-21_CT-13608_YERVOY_PIC_Avis3_CT13608.pdf
HAS/2015-01-21_CT-13692_GRANUPAS_ins_avis3_CT16692.pdf
HAS/2015-01-21_adempas_14102014_avis_efficience.pdf
HAS/2015-01-21_adempas_en_ct13594.pdf
HAS/2015-01-21_adempas_en_sapub_ct13594.pdf
HAS/2015-01-21_adempas_sapub_ct13594.pdf
HAS/2015-01-21_granupas_en__sapub_ct13692.pdf
HAS/2015-01-21_granupas_en_ct13692_val.pdf
HAS/2015-01-21_granupas_sapub_ct13692.pdf
HAS/2015-01-21_innohep_en_ct13261.pdf
HAS/2015-01-21_innohep_sapub_ct13261.pdf
HAS/2015-01-21_innohep_sapub_ct13261_val.pdf
HAS/2015-01-21_opsumit_24062014_avis-efficience.pdf
HAS/2015-01-21_opsumit_en_sapub_ct13528.pdf
HAS/2015-01-21_opsumit_sapub_ct13528.pdf
HAS/2015-01-21_opsumit_version_anglaise_ct13479.pdf
HAS/2015-01-21_yervoy_en_ct13608_def.pdf
HAS/2015-01-21_yervoy_en_sapub_ct13608_def.pdf
HAS/2015-01-21_yervoy_sapub_ct13608.pdf
HAS/2015-01-22_CEPP-4708_PRIMEADVANCED SURESCAN MRI_02_decembre_2014_(4707-4708)_avis.pdf
HAS/2015-01-22_CEPP-4763_EXCOR_07_octobre_2014_(4763)_avis_radiation.pdf
HAS/2015-01-22_CEPP-4765_HEARTMATEII  LVAS_13_janvier_2015_(4765)_avis.pdf
HAS/2015-01-22_CT-13430_YTTRIGA_PIC_Avis1_CT13430.pdf
HAS/2015-01-22_CT-13709_OXYCONTIN_OXYNORM_OXYNORMORO_REEVAL_Avis2_CT13709.pdf
HAS/2015-01-22_oxycodone_en_sapub_ct13709_val.pdf
HAS/2015-01-22_oxycodone_sapub_ct13709.pdf
HAS/2015-01-22_oxycontin_oxynorm_oxynormoro_english_version_ct13709.pdf
HAS/2015-01-22_protelos_en_ct12966.pdf
HAS/2015-01-22_protelos_en_sapub_ct12966_val.pdf
HAS/2015-01-22_protelos_saisine_avis2_ct12966_modif.pdf
HAS/2015-01-22_protelos_sapub_ct12966.pdf
HAS/2015-01-22_yttriga__en_sapub_ct13430_val.pdf
HAS/2015-01-22_yttriga_ct13430.pdf
HAS/2015-01-22_yttriga_sapub_ct13430.pdf
HAS/2015-01-26_CEPP-4792_COREVALVE EVOULT R_13_janvier_2015_(4792)_avis.pdf
HAS/2015-01-26_CT-13190_PRADAXA_PIC_RI_REEV_Avis3_CT13190.pdf
HAS/2015-01-26_CT-13565_XARELTO_PIC_RI_REEV_Avis3_CT13565.pdf
HAS/2015-01-26_axe_la_garantie_des_droits.pdf
HAS/2015-01-26_axe_la_personnalisation_de_l_accompagnement.pdf
HAS/2015-01-26_axe_la_prevention_et_la_gestion_des_risques.pdf
HAS/2015-01-26_axe_la_prise_en_compte_de_l_interet_de_l_enfant.pdf
HAS/2015-01-26_bibliographie_ei_enfance_2015.pdf
HAS/2015-01-26_decision_n_2015-05-_decision_portant_adoption_de_la_rbpp_ei_mineurs-jeunes_majeurs_protection_de_l_enfance.pdf
HAS/2015-01-26_eliquis_pic_reev_avis3_modifiele16012015_ct13857.pdf
HAS/2015-01-26_lettre_de_cadrage_evaluation_interne_protection_enfance_.pdf
HAS/2015-01-26_rbpp_evalaution_interne_en_protection_de_l_enfance.pdf
HAS/2015-01-30_CT-13368_DEBRIDAT_PIS_RI_Avis2_CT13368.pdf
HAS/2015-01-30_CT-13644_JAVLOR_PIC_REEV_Avis3_CT13644.pdf
HAS/2015-01-30_CT-13710_OSSEANS_VITAMINE_D3_PIS_RI_Avis2_CT13710.pdf
HAS/2015-01-30_CT-13769_POVIDONE_IODEE_MYLAN_PIS_RI_Avis1_CT13769.pdf
HAS/2015-01-30_CT-13836_CALPEROS_D3_PIS_RI_Avis1_CT13836.pdf
HAS/2015-01-30_CT-13839_CALPEROS_PIS_RI_Avis2_CT13839.pdf
HAS/2015-01-30_CT-13964_OCTREOTIDE_KABI_QD_INS_Avis1_CT13964.pdf
HAS/2015-01-30_CT-13966_FOSAMAX_PIS_RI_Avis1_CT13966.pdf
HAS/2015-01-30_CT-14014_DULCILARMES_QD_INS_Avis2_CT14014.pdf
HAS/2015-01-30_CT-14016_DYSALFA_HYTRINE_PIS_RI_Avis1_CT14016.pdf
HAS/2015-01-30_CT-14042_BENZATHINE_BENZYLPENICILLINE_SANDOZ_QD_INS_Avis1_CT14042.pdf
HAS/2015-02-02_CT-12771_MIRCERA_PIC_RI_Avis2_CT12771.pdf
HAS/2015-02-02_CT-13744_RELVAR_ELLIPTA_PIC_INS_Asthme_Avis2_CT13744.pdf
HAS/2015-02-02_CT-13768_INNOVAIR_FORMODUAL_PIC_EI_BPCO_Avis2_CT13768.pdf
HAS/2015-02-02_relvar_ellipta_asthme_pic_ins_avis2_modifiele28012015_ct13744.pdf
HAS/2015-02-04_ald19_lap_nephropathie_juin_07.pdf
HAS/2015-02-04_guide__mrc.pdf
HAS/2015-02-10_CEPP-4671_MEDIHONEY_27_janvier_2015_(4671)_avis.pdf
HAS/2015-02-10_CEPP-4800_HOME MONITORING IPERIA 7 VR-T_27_janvier_2015_(4800)_avis.pdf
HAS/2015-02-10_CEPP-4804_HOME MONITORING IPERIA 7 DR-T_27_janvier_2015_(4804)_avis.pdf
HAS/2015-02-10_CEPP-4831_HOME MONITORING IPERIA 7 HF-T QP_27_janvier_2015_(4831)_avis.pdf
HAS/2015-02-10_CT-13142_SORIATANE_RI_avis2_CT13142.pdf
HAS/2015-02-10_soriatane_en_sapub_ct13142.pdf
HAS/2015-02-10_soriatane_sapub_ct13142.pdf
HAS/2015-02-10_winx.pdf
HAS/2015-02-12_tdah_argumentaire.pdf
HAS/2015-02-12_tdah_recommandations.pdf
HAS/2015-02-12_tdah_synthese.pdf
HAS/2015-02-13_7v_referentiel_2clics_diabete_060215.pdf
HAS/2015-02-13_CEPP-4771_INOGEN ONE G2_27_janvier_2015_(4771)_avis.pdf
HAS/2015-02-13_CEPP-4809_MENISCAL CINCH_13_janvier_2015_(4809)_avis.pdf
HAS/2015-02-13_CEPP-4834_PRECISION SPECTRA_27_janvier_2015_(4834)_caviarde.pdf
HAS/2015-02-13_fit_precision_spectra_4834.pdf
HAS/2015-02-16_guide_dpi.pdf
HAS/2015-02-16_methodes_has_exigences_communes.pdf
HAS/2015-02-20_argumentaire_coelio.pdf
HAS/2015-02-20_argumentaire_colectomies_vd.pdf
HAS/2015-02-20_feuille_de_route_coelioscopie_coi.pdf
HAS/2015-02-20_inahta_brief_laparoscopy_2015-07-28_11-34-29_304.pdf
HAS/2015-02-23_CT-12888_BYETTA_PICEIT_Avis2_CT12888.pdf
HAS/2015-02-23_CT-13080_DECTANCYL_PIS_RI_Avis2_CT13080.pdf
HAS/2015-02-23_CT-13098_DISULONE_PIS_RI_Avis2_CT13098.pdf
HAS/2015-02-23_CT-13403_EVICEL_EI_neurochir_avis3_CT13403.pdf
HAS/2015-02-23_CT-13478_ZOSTAVAX_PIC_Ins_Avis3_CT13478.pdf
HAS/2015-02-23_CT-13552_VIPIDIA_PIC_INS_Avis2mod28102014_CT13552.pdf
HAS/2015-02-23_CT-13553_VIPDOMET_PIC_INS_Avis2_CT13553.pdf
HAS/2015-02-23_CT-13801_LHRH_FERRING_PIS_RI_Avis2_CT13801.pdf
HAS/2015-02-23_CT-13801_LUTRELEF_PIS_RI_Avis2_CT13801.pdf
HAS/2015-02-23_CT-13938_TRANSLARNA_PIC_INS_Avis1_CT13938.pdf
HAS/2015-02-23_CT-13989_RIBAVOX_QD_INS_Avis1_CT13989.pdf
HAS/2015-02-23_CT-13997_FOZIRETIC_PIS_RI_Avis1_CT13997.pdf
HAS/2015-02-23_CT-14031_HUMALOG_KWIKPEN_QD_INS_Avis2_CT14031.pdf
HAS/2015-02-23_CT-14036_EPHEDRINE_RENAUDIN_QD_INS_Avis1_CT14036.pdf
HAS/2015-02-23_CT-14041_MORPHINE_CHLORHYDRATE_RENAUDIN_QD_INS_Avis1_CT14041.pdf
HAS/2015-02-23_CT-14050_CRESTOR_PIS_EI_enfant_Avis2_CT14050.pdf
HAS/2015-02-23_CT-14063_DOTAREM_QD_INS_Avis1_CT14063.pdf
HAS/2015-02-23_CT-14070_METRONIDAZOLE_MACOPHARMA_QD_INS_Avis1_CT14070.pdf
HAS/2015-02-23_CT-14102_DESOGESTREL_MYLAN_PIS_INS_Avis2_CT14102.pdf
HAS/2015-02-23_CT-14115_VENTAVIS_PIS_INS_Avis1_CT14115.pdf
HAS/2015-02-23_CT-14123_MICROVAL_PIS_INS_Avis2_CT14123.pdf
HAS/2015-02-23_byetta_en_ct12888_def.pdf
HAS/2015-02-23_byetta_en_sapub_ct12888_def.pdf
HAS/2015-02-23_byetta_sapub_ct12888.pdf
HAS/2015-02-23_evicel_en_sapub_ct13403_val.pdf
HAS/2015-02-23_evicel_sapub_ct13403.pdf
HAS/2015-02-23_fenofibrate_teva_pis_ri_avis2_ct14038.pdf
HAS/2015-02-23_lucentis_pic_reev_avis2_modifiele13022015_ct13967.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_anesthesie_reanimation_chirurgie_urgence_-_argumentaire.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_anesthesie_reanimation_chirurgie_urgence_-_fiche_de_synthese.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_hematologie_oncologie_-_argumentaire.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_hematologie_oncologie_-_fiche_de_synthese.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_neonatologie_-_argumentaire.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_neonatologie_-_fiche_de_synhtese.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_produits_et_examens_immuno-hematologiques_-_argumentaire.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_produits_et_examens_immuno-hematologiques_-_fiche_de_synhtese.pdf
HAS/2015-02-23_transfusion_de_globules_rouges_homologues_-_produits_indications_alternatives_-_recommandations.pdf
HAS/2015-02-23_translarna_21012015_synthese_ct13938.pdf
HAS/2015-02-23_translarna_summary_ct13938.pdf
HAS/2015-02-23_vipidia_version_anglaise_ct13552.pdf
HAS/2015-02-23_vipidia_vipdomet_en_sapub_ct13552_ct13553_20150108_val.pdf
HAS/2015-02-23_vipidia_vipdomet_sapub_ct13552_ct13553_20150108.pdf
HAS/2015-02-23_zostavax_avis_defficience_m.pdf
HAS/2015-02-23_zostavax_en_sapub_ct13478_val.pdf
HAS/2015-02-23_zostavax_sapub_ct13478.pdf
HAS/2015-02-23_zostavax_version_anglaise_ct13478.pdf
HAS/2015-02-24_CT-12729_EUCREAS_ICANDRA_AVIS3postaud_CT12729.pdf
HAS/2015-02-24_CT-13489_INSUMAN_IMPLANTABLE_PIC_INS_Avis2_CT13489.pdf
HAS/2015-02-24_CT-13727_GALVUS_JALRA_PIC_EITTriT_Avis2_CT13727.pdf
HAS/2015-02-24_eucreas_icandra_avis3_modifiele13032015_ct13728.pdf
HAS/2015-02-24_eucreas_icandra_version_anglaise_ct12729.pdf
HAS/2015-02-24_galvus_eucreas_trit_en_sapub_ct13727__13728_val.pdf
HAS/2015-02-24_galvus_eucreas_trit_sapub_ct13727__13728.pdf
HAS/2015-02-24_galvus_jalra_version_anglaise_ct13727.pdf
HAS/2015-02-24_hea_sapub_ct13550_ct13279_ct12815.pdf
HAS/2015-02-24_hea_summary_ct13550_ct13279_ct12815.pdf
HAS/2015-02-24_insuman_en_sapub_ct13489_val.pdf
HAS/2015-02-24_insuman_sapub_ct13489.pdf
HAS/2015-02-24_isovol6_en_ct12815_val.pdf
HAS/2015-02-24_isovol6_ins_avispostaudition_ct12815.pdf
HAS/2015-02-24_restorvol_en_ct13550_val.pdf
HAS/2015-02-24_restorvol_reeval_avispostaudition_ct13550.pdf
HAS/2015-02-24_voluven_en_ct13279_val.pdf
HAS/2015-02-24_voluven_reeval_avispostaudition_ct13279.pdf
HAS/2015-02-25_CT-10138_TROLOVOL_RI_Avis 1_CT10138.pdf
HAS/2015-02-25_CT-12849_KOMBOGLYZE_AVIS2postaud_CT12849.pdf
HAS/2015-02-25_CT-12959_IMUREL_PISRI_Avis 1_CT12959.pdf
HAS/2015-02-25_CT-12975_SALAZOPYRINE_Avis 1_RI_CT12975.pdf
HAS/2015-02-25_CT-13006_NEORAL_SANDIMMUN_RI_Avis 2_CT13006.pdf
HAS/2015-02-25_CT-13078_PLAQUENILRI_Avis 2_CT13078.pdf
HAS/2015-02-25_CT-13201_NIVAQUINE_RI_Avis 2_CT13201.pdf
HAS/2015-02-25_CT-13512_INVOKANA_PIC_INS_Avis2PostAudition_CT13512.pdf
HAS/2015-02-25_CT-13707_VOKANAMET_PIC_INS_Avis2post-audition_CT13707.pdf
HAS/2015-02-25_CT-13834_SIMBRINZA_Ins_avis2_CT13834.pdf
HAS/2015-02-25_CT-8421_ACADIONE_RI_Avis 2_CT8421.pdf
HAS/2015-02-25_CT-8572_ALLOCHRYSINE_PISRI_Avis 1_CT8572.pdf
HAS/2015-02-25_acadione_en_ct8421_def.pdf
HAS/2015-02-25_allochrysine_en_ct8572.pdf
HAS/2015-02-25_imurel_en_ct12959_def.pdf
HAS/2015-02-25_invokana_en_ct13512_def.pdf
HAS/2015-02-25_invokana_vokanamet_en_sapub_ct13512_ct13707_def.pdf
HAS/2015-02-25_invokana_vokanamet_sapub_ct13512_ct13707.pdf
HAS/2015-02-25_komboglyze_en_ct12849_val.pdf
HAS/2015-02-25_neoral_sandimmun_en_ct13006_def.pdf
HAS/2015-02-25_nivaquine_en_ct13201_def.pdf
HAS/2015-02-25_onglyza_komboglyze_en_sapub_ct12848_12849_def.pdf
HAS/2015-02-25_onglyza_komboglyze_sapub_ct12848_12849.pdf
HAS/2015-02-25_onglyza_pic_eittritherapie_avis2_ct12848_revuaa.pdf
HAS/2015-02-25_onglyza_version_anglaise_ct12848_def.pdf
HAS/2015-02-25_plaquenilri_en_ct13078_def.pdf
HAS/2015-02-25_salazopyrine_en_ct12975_pub.pdf
HAS/2015-02-25_simbrinza_en_sapub_ct13384_def.pdf
HAS/2015-02-25_simbrinza_sapub_ct13384.pdf
HAS/2015-02-25_traitements_fond_pr_sapub.pdf
HAS/2015-02-25_traitements_fond_pr_sapub_val.pdf
HAS/2015-02-25_trolovol_en_ct10138_def.pdf
HAS/2015-02-25_vokanamet_en_ct13707_def.pdf
HAS/2015-02-27_CEPP-4676_NUCLEUS CI512_01_juillet_2014_(4676)_avis.pdf
HAS/2015-02-27_CEPP-4710_NOBORI_27_janvier_2015_(4710)_avis.pdf
HAS/2015-02-27_CEPP-4714_PROMUS PREMIER_27_janvier_2015_(4714)_avis_caviarde.pdf
HAS/2015-02-27_CEPP-4717_RESOLUTE INTEGRITY_13janvier_2015_(4717)_avis_caviarde.pdf
HAS/2015-02-27_CEPP-4744_PROMUS ELEMENT PLUS_27_janvier_2015_(4744)_avis caviarde.pdf
HAS/2015-02-27_CEPP-4774_RESOLUTE ONYX_27_janvier_2015_(4774)_avis.pdf
HAS/2015-02-27_CEPP-4781_ENGAGER_13_janvier_2015_4781_avis_caviarde.pdf
HAS/2015-02-27_CEPP-4815_SYSTANE ULTRA_27_janvier_2015_(4815)_avis.pdf
HAS/2015-02-27_CEPP-4816_SYSTANE ULTRA UD_27_janvier_2015_(4816)_avis.pdf
HAS/2015-02-27_CEPP-4819_AMPLATZER AMULET_13_janvier_2015_(4819)_avis.pdf
HAS/2015-02-27_CEPP-4835_XIENCE ALPINE_27_janvier_2015_(4835)_avis.pdf
HAS/2015-02-27_CT-13662_MISODEL_PIC_INS_AvisPostAud_CT13662.pdf
HAS/2015-02-27_amplatzer_pof_17122019_avis_efficience.pdf
HAS/2015-02-27_misodel_en_sapub_ct13662_val.pdf
HAS/2015-02-27_misodel_sapub_ct13662.pdf
HAS/2015-02-27_revlimid_ei_ins_myelodysplasie_avis2_ct13681_ct13682.pdf
HAS/2015-02-27_revlimid_en_sapub_ct13681_13682_def.pdf
HAS/2015-02-27_revlimid_sapub_ct13681_13682.pdf
HAS/2015-03-02_CEPP-4585_LEO PLUS & LEO PLUS SUR MESURE_09_septembre_2014_(4584-4585)_avis.pdf
HAS/2015-03-02_CEPP-4618_ANACONDA_09_septembre_2014_(4618_4640)_avis.pdf
HAS/2015-03-02_CEPP-4705_PRIMEADVANCED_02_decembre_2014_(4705-4706)_avis.pdf
HAS/2015-03-02_CEPP-4715_ENDEAVOR RESOLUTE_27_janvier_2015_(4715)_avis caviarde.pdf
HAS/2015-03-02_CEPP-4716_RESOLUTE INTEGRITY_27_janvier_2015_(4716)_avis caviarde.pdf
HAS/2015-03-02_CEPP-4738_ACTIVA SC_10_fevrier_2015_(4738) _avis caviarde.pdf
HAS/2015-03-02_CEPP-4739_ACTIVA PC_10_fevrier_2015_(4739)_avis caviarde.pdf
HAS/2015-03-02_CEPP-4740_ACTIVA RC_10_fevrier_2015_4740_avis caviarde.pdf
HAS/2015-03-02_CEPP-4779_ZENITH FENESTRATED_10_fevrier_2015_(4779)_avis.pdf
HAS/2015-03-02_CEPP-4782_ALBER TWION_27_janvier_2015_(4782)_avis.pdf
HAS/2015-03-02_CEPP-4783_CARPENTER VISCOLUX TECHNIQUE_13_janvier_2015_(4783)_avis.pdf
HAS/2015-03-02_CEPP-4828_PARIBOY MOBILE S_LC SPRINT_10_fevrier_2015_(4828)_avis.pdf
HAS/2015-03-02_CT-12336_CATAPRESSAN_PIS_RI_Avis2_CT12336.pdf
HAS/2015-03-02_CT-13436_NATULAN_PIS_EI_Avis2_CT13436.pdf
HAS/2015-03-02_CT-13627_NPLATE_PIC_REEV_RI_Avis2_CT13627.pdf
HAS/2015-03-02_CT-13716_WYTENS_PIS_RI_Avis1_CT13716.pdf
HAS/2015-03-02_CT-13811_FIRMAGON_PIC_REEV_RI_Avis2_CT13811.pdf
HAS/2015-03-02_CT-13947_EUROBIOL_PIS_RI_Avis1_CT13947.pdf
HAS/2015-03-02_CT-13988_REVOLADE_PIC_REEV_Avis2_CT13988.pdf
HAS/2015-03-02_CT-14071_CLOXACILLINE_PANPHARMA_QD_INS_Avis2_CT14071.pdf
HAS/2015-03-02_dexpanthenol_sandoz_conseil_qd_ins_avis2_ct14022.pdf
HAS/2015-03-02_nplate_03022015_avis_efficience.pdf
HAS/2015-03-03_ane-zoom-enque_te_bientraitance_2015-mars2016.pdf
HAS/2015-03-03_anesm_guide-questionnaire-bientraitance_avril_2015.pdf
HAS/2015-03-03_enquete_bientraitancepa_2015_web_mars2017_vdef.pdf
HAS/2015-03-03_erratum_p.6.pdf
HAS/2015-03-03_instruction_dgcs_03032015_.pdf
HAS/2015-03-04_CT-13754_JARDIANCE_PIC_INS_Avis2_CT13754.pdf
HAS/2015-03-04_jardiance_en_ct13754_val.pdf
HAS/2015-03-04_jardiance_sapub_ct13754.pdf
HAS/2015-03-04_jardiance_summary_ct13754.pdf
HAS/2015-03-05_CEPP-4786_SALTO_24_fevrier_2015_(4786)_avis.pdf
HAS/2015-03-05_CEPP-4839_SYNCHRONY et  SYNCHRONY PIN_24_fevrier_2015_(4839)_avis.pdf
HAS/2015-03-06_CT-13651_OLYSIO_PIC_INS_Avis3_CT13651.pdf
HAS/2015-03-06_CT-13788_BEMFOLA_PIS_Avis1_CT13788.pdf
HAS/2015-03-06_aad_avis_25052016_ct_25052016.pdf
HAS/2015-03-06_bemfola_03122014_synthese_ct13788.pdf
HAS/2015-03-06_bemfola_summary_ct13788.pdf
HAS/2015-03-06_daklinza_-_avis_defficience_m.pdf
HAS/2015-03-06_daklinza_17122014_synthese_ct13899.pdf
HAS/2015-03-06_daklinza_pic_ins_avis2_modifiele22012015_ct13899.pdf
HAS/2015-03-06_daklinza_summary_ct13899.pdf
HAS/2015-03-06_olysio_-_avis_defficience_masque.pdf
HAS/2015-03-06_olysio_17122014_synthese_ct13651.pdf
HAS/2015-03-06_olysio_summary_ct13651.pdf
HAS/2015-03-08_addendum_sad_01_04_15_d2015-14.pdf
HAS/2015-03-08_anesm_eval_internesad_web.pdf
HAS/2015-03-08_bibliographie_generale_de_la_recommandation.pdf
HAS/2015-03-08_etude_anesm_saad_rapport_final_axes_1_a_3_complet.pdf
HAS/2015-03-08_lettre_de_cadrage_conduite_de_l_evaluation_interne_v1.pdf
HAS/2015-03-08_liens_recommandations.pdf
HAS/2015-03-08_liens_references_juridiques.pdf
HAS/2015-03-08_presentation_evaluation_interne-2.pdf
HAS/2015-03-08_site_decision_n_2015-14_-_decision_portant_adoption_de_la_rbpp_ei_-_repere_pour_les_services_a_domicile_au_benefice_des_publ.pdf
HAS/2015-03-09_anesm_sessad4_web.pdf
HAS/2015-03-09_anesm_sessad_ea.pdf
HAS/2015-03-09_bibliographie_sessad.pdf
HAS/2015-03-09_lettre_de_cadrage_sessad_anesm.pdf
HAS/2015-03-09_site_decision_n_2015-13_-_decision_portant_adoption_de_la_rbpp_accompagnement_des_jeuens_en_situation_de_handicap_par_les_se.pdf
HAS/2015-03-09_synthese__sessad_v210911.pdf
HAS/2015-03-12_CEPP-4704_HYDROCLEAN_24 fevrier_2015_(4704)_avis.pdf
HAS/2015-03-12_CEPP-4755_MYLIFE OMPNIPOD_24_fevrier_2015_(4755)_avis.pdf
HAS/2015-03-12_CEPP-4832_OSTEOPURE_10_fevrier_2015_(4832)_avis.pdf
HAS/2015-03-12_CT-13813_PROHANCE_PIC_REEV_RI_AvisPostAudition_CT13813.pdf
HAS/2015-03-12_CT-13895_TECTASIM_PIS_INS_Avis2_CT13895.pdf
HAS/2015-03-12_CT-14110_GALANTAMINE_BIOGARAN_LP_QD_INS_Avis1_CT14110.pdf
HAS/2015-03-12_CT-14125_LASILIX_PIS_RI_Avis2_CT14125.pdf
HAS/2015-03-12_addendum_accompagner_l_acces_aux_droits.pdf
HAS/2015-03-12_anesm_reco08_acces-droits_ea.pdf
HAS/2015-03-12_anesm_reco08_acces-droits_web_2.pdf
HAS/2015-03-12_bibliographie_acces_aux_droits.pdf
HAS/2015-03-12_doc_d_appui_accompagner_l_acces_aux_droits.pdf
HAS/2015-03-12_lettre_de_cadrage_v8_validee_cos10022011.pdf
HAS/2015-03-12_site_decision_n_2015-20_-_decision_portant_adoption_de_la_rbpp_acces_aux_droits.pdf
HAS/2015-03-12_synthese_accomppagner_l_acces_aux_droits.pdf
HAS/2015-03-14_anesm-rbpp-adaptation_personnes_handicapees_vieillissantes-interactif.pdf
HAS/2015-03-14_anesm-rbpp_synthese-adaptation_personnes_handicapees_vieillissantes-mars_2015.pdf
HAS/2015-03-14_annexes_phv.pdf
HAS/2015-03-14_bibliographie_pour_la_recommandation_phv2015.pdf
HAS/2015-03-14_chapitre4_phv.pdf
HAS/2015-03-14_chapitre_1_phv.pdf
HAS/2015-03-14_chapitre_2_phv.pdf
HAS/2015-03-14_chapitre_3_phv.pdf
HAS/2015-03-14_chapitre_5_phv.pdf
HAS/2015-03-14_decision_n_2014-29_-_decision_portant_adoption_de_la_rbpp_phv.pdf
HAS/2015-03-14_ea_phv.pdf
HAS/2015-03-14_personnes_handicapees_vieillissantes_lettre_de_cadrage.pdf
HAS/2015-03-14_presentation_generale_phv.pdf
HAS/2015-03-14_revue_litterature_cisame-anesm.pdf
HAS/2015-03-16_chimiotherapie_en_had_-_monographie_de_lhad_de_la_mspb_bagatelle.pdf
HAS/2015-03-16_chimiotherapie_en_had_-_monographie_de_lhad_de_laphp.pdf
HAS/2015-03-16_chimiotherapie_en_had_-_monographie_de_lhad_du_centre_leon_berard.pdf
HAS/2015-03-16_chimiotherapie_en_had_-_monographie_de_sante_service.pdf
HAS/2015-03-16_chimiotherapie_en_hospitalisation_a_domicile_-_note_de_cadrage.pdf
HAS/2015-03-16_chimiotherapie_injectable_en_had_-_monographie_des_had_du_limousin_dans_le_cadre_du_reseau_dhematologie_du_limousin_hematolim_via_le_dispositif_escadhem.pdf
HAS/2015-03-16_conditions_du_developpement_de_la_chimiotherapie_en_hospitalisation_a_domicile_-_rapport.pdf
HAS/2015-03-16_conditions_du_developpement_de_la_chimiotherapie_en_hospitalisation_a_domicile_-_synthese_et_recommandations.pdf
HAS/2015-03-17_action_when_finding_moisture_in_boxes_of_sterile_instruments_after_patient_incision.pdf
HAS/2015-03-17_doc_complementaire_ssp_boites_mouillees.pdf
HAS/2015-03-17_fiche_ssp_boites_mouillees.pdf
HAS/2015-03-17_inahta_brief_imrt_cervical_cancer.pdf
HAS/2015-03-17_note_de_cadrage_rcmi.pdf
HAS/2015-03-17_rapport_rcmi_col_uterus_vd_2015-03-09_10-26-53_423.pdf
HAS/2015-03-17_ssp_boites_mouillees-rapport.pdf
HAS/2015-03-17_tc_rcmi_col_uterus_vd_2015-03-09_10-26-33_857.pdf
HAS/2015-03-20_CEPP-4652_DYNADAPT_10_mars_2015_(4652)_avis.pdf
HAS/2015-03-20_CEPP-4743_PEPTAMEN JUNIOR _10_mars_2015_(4743)_avis.pdf
HAS/2015-03-20_CEPP-4787_SALTO TALARIS_24_fevrier_2015_(4787)_avis.pdf
HAS/2015-03-20_CEPP-4822_BAHA ATTRACT_10_mars_2015_(4822)_avis.pdf
HAS/2015-03-23_CT-13240_STIVARGA_PIC_INS_Avis 3_CT13240.pdf
HAS/2015-03-23_CT-13242_TAFINLAR_PIC_INS_Avis3_CT13242.pdf
HAS/2015-03-23_CT-13799_VOTUBIA_PIC_EI_SEGA_3_ans_Avis2_CT13799.pdf
HAS/2015-03-23_CT-13932_OCTAGAM_PIC_EI_PIDC_Avis2_CT13932.pdf
HAS/2015-03-23_octagam_04022015_synthese_ct13932.pdf
HAS/2015-03-23_octagam_summary_ct13932.pdf
HAS/2015-03-23_stivarga_14052014_synthese_ct13240.pdf
HAS/2015-03-23_stivarga_en_ct13240_prlabo.pdf
HAS/2015-03-23_stivarga_summary_ct13240.pdf
HAS/2015-03-23_tafinlar_22102014_synthese_ct13242.pdf
HAS/2015-03-23_tafinlar_en_ct13242_prlabo.pdf
HAS/2015-03-23_tafinlar_summary_ct13242.pdf
HAS/2015-03-23_votubia_17122014_synthese_ct13799.pdf
HAS/2015-03-23_votubia_summary_ct13799_ct13800_2015-09-22_15-56-8_605.pdf
HAS/2015-03-24_protheses_hanche_dm_eval_65.pdf
HAS/2015-03-24_rapport_phasecontradictoire_protheseshanche.pdf
HAS/2015-03-24_summary_hip_implants_consultation_phase.pdf
HAS/2015-03-24_texte-court-rapport_phasecontradictoire_protheseshanche_novembre2014.pdf
HAS/2015-03-25_CEPP-4785_HAPPYVISC_10_mars_2015_(4785)_avis.pdf
HAS/2015-03-25_epr_cnce_erreur_identitev3.pdf
HAS/2015-03-25_epr_cnce_erreur_solute_v4.pdf
HAS/2015-03-26_CEPP-4811_ZENITH ALPHA SPIRAL Z_24_fevrier_2015_(4811)_avis.pdf
HAS/2015-03-26_CEPP-4829_SYNERGY_10_mars_2015_(4829)_avis.pdf
HAS/2015-03-26_CEPP-4842_SYST AM P361C_10_fevrier_2015_(4842)_avis.pdf
HAS/2015-03-26_CEPP-4843_SYST AM P361CP_10_fevrier_2015_(4843)_avis.pdf
HAS/2015-03-26_CEPP-4844_SYST AM P361CA_10_fevrier_2015_(4844)_avis.pdf
HAS/2015-03-26_CEPP-4845_ULTIMASTER_24_fevrier_2015_(4845)_avis.pdf
HAS/2015-03-26_CEPP-4849_QUADRA ALLURE MP RF_10_mars_2015_(4849)_avis.pdf
HAS/2015-03-26_CEPP-4852_ENDURANT IIs_24_fevrier_2015_(4852)_avis.pdf
HAS/2015-03-26_CEPP-4860_ALOVA GALBE_10_mars_2015_(4860)_avis.pdf
HAS/2015-03-26_CEPP-4861_ALOVA GALBE_10_mars_2015_(4861)_avis.pdf
HAS/2015-03-30_grille_controle_interne_chir_ambu.pdf
HAS/2015-03-30_grille_patient_traceur_chir_ambu.pdf
HAS/2015-03-30_methodes_et_outils_construction_dun_outil_de_micro-costing_en_chirurgie_ambulatoire.pdf
HAS/2015-04-01_CT-12065_TRANSULOSE_PIS_RI_Avis1_CT12065.pdf
HAS/2015-04-01_CT-13671_PRINZIDE_PIS_RI_Avis2_CT13671.pdf
HAS/2015-04-01_CT-13821_TEMERITDUO_PIS_RI_Avis1_CT13821.pdf
HAS/2015-04-01_CT-13881_TRIPLIXAM_PIC_INS_AvisPostAud_CT13881.pdf
HAS/2015-04-01_CT-13927_INSTANYL_PIS_RI_Avis2_CT13927.pdf
HAS/2015-04-01_CT-13961_ADVATE_QD_INS_Avis2_CT13961.pdf
HAS/2015-04-01_CT-13969_EPORATIO_PIS_RI_Avis2_CT13969.pdf
HAS/2015-04-01_CT-13984_NOVONORM_PIS_RI_Avis1_CT13984.pdf
HAS/2015-04-01_CT-14009_BEAGYNE_QD_INS_Avis1_CT14009.pdf
HAS/2015-04-01_CT-14035_TOCOPHEROL_TEVA_PIS_RI_Avis1_CT14035.pdf
HAS/2015-04-01_CT-14064_CALSYN_PIS_RI_Avis1_CT14064.pdf
HAS/2015-04-01_CT-14073_HYDROCORTISONE_UPJOHN_PIS_RI_Avis2_CT14073.pdf
HAS/2015-04-01_CT-14079_MYCOHYDRALIN_PIS_INS_Avis1_CT14079.pdf
HAS/2015-04-01_CT-14081_ATROPINE_SULFATE_RENAUDIN_QD_INS_Avis1_CT14081.pdf
HAS/2015-04-01_CT-14108_LANSOPRAZOLE_BIOGARAN_QD_INS_Avis2_CT14108.pdf
HAS/2015-04-01_CT-14113_MILRINONE_PANPHARMA_QD_INS_Avis2_CT14113.pdf
HAS/2015-04-01_CT-14114_METFORMINE_ARROW_LAB_QD_INS_Avis2_CT14114.pdf
HAS/2015-04-01_CT-14128_FLUARIX_QD_INS_Avis2_CT14128.pdf
HAS/2015-04-01_CT-14139_LEVEMIR_PIS_RI_Avis1_CT14139.pdf
HAS/2015-04-01_CT-14144_TACROLIMUS_EG_QD_INS_Avis2_CT14144.pdf
HAS/2015-04-01_CT-14151_CONTRAMAL_QD_INS_Avis2_CT14151.pdf
HAS/2015-04-01_CT-14159_DESOGESTREL_EG_PIS_INS_Avis1_CT14159.pdf
HAS/2015-04-01_CT-14220_TAVANIC_PIS_EI_NON_DEMANDEE_Avis1_CT14220.pdf
HAS/2015-04-03_CT-13513_EPTAVIT_PIS_RI_Avis2_CT13513.pdf
HAS/2015-04-03_CT-13635_FERINJECT_PIC_REEV_Avis3_CT13635.pdf
HAS/2015-04-03_CT-13720_LODOZ_PIS_RI_Avis2_CT13720.pdf
HAS/2015-04-03_CT-13756_KALYDECO_QD_INS_Avis1_CT13756.pdf
HAS/2015-04-03_CT-13775_PERMIXON_PIS_RI_Avis1_CT13775.pdf
HAS/2015-04-03_CT-13918_SYNAREL_PIS_RI_Avis2_CT13918.pdf
HAS/2015-04-03_CT-13928_ENVARSUS_PIS_INS_Avis2_CT13928.pdf
HAS/2015-04-03_CT-14170_PARACETAMOL_ARROW_QD_INS_Avis1_CT14170.pdf
HAS/2015-04-03_CT-14180_EZETROL_QD_INS_Avis2_CT14180.pdf
HAS/2015-04-03_prunier_dafrique_mylan_pis_ri_avis1_ct14149.pdf
HAS/2015-04-09_CEPP-4305_ALBER E-MOTION M15_24_mars_2015_(4305)_avis.pdf
HAS/2015-04-09_CEPP-4825_SIR-SPHERES_24_mars_2015_(4825)_avis.pdf
HAS/2015-04-09_CEPP-4838_SYNCHRONY ABI SYNCHRONY PIN ABI_24_fevrier_2015_(4838)_avis.pdf
HAS/2015-04-09_CEPP-4840_CEMENTEK_24_mars_2015_(4840)_avis.pdf
HAS/2015-04-09_CEPP-4841_MYOBOCK_24_mars_2015_(4841)_avis.pdf
HAS/2015-04-09_CEPP-4869_BIOBANK_24_mars_2015_(4869).pdf
HAS/2015-04-09_CEPP-4883_TERION_24_mars_2015_(4883)_avis.pdf
HAS/2015-04-09_CEPP-4895_ALBER E-MOTION M12_24_mars_2015_(4895)_avis.pdf
HAS/2015-04-09_CT-13688_TOPISCAB_PIC_INS_Avis2_CT13688.pdf
HAS/2015-04-09_CT-13862_NUTROPINAQ_RI_EPI_Avis2_CT13862.pdf
HAS/2015-04-09_CT-13963_GAVISCONPRO_MENTHE_PIS_INS_Avis1_CT13963.pdf
HAS/2015-04-09_cementek.pdf
HAS/2015-04-09_evaluation_des_postiches_-_avis_du_24_mars_2015_2015-03-26_16-59-52_928.pdf
HAS/2015-04-09_feuille_de_route_postiches_2014_10_03_2014-11-12_10-43-4_674.pdf
HAS/2015-04-09_note_cadrage_generalites.pdf
HAS/2015-04-09_topiscab_21012105_synthese_ct13688_2015-04-07_11-51-19_818.pdf
HAS/2015-04-09_topiscab_summary_ct13688.pdf
HAS/2015-04-09_web-composition_du_gt_postiches_2014-11-12_10-43-56_590.pdf
HAS/2015-04-10_CT-12863_OLICLINOMEL_N4550E_PIS_RI_Avis1_CT12863.pdf
HAS/2015-04-10_CT-13278_PENICILLINE_G_PANPHARMA_PIS_RI_Avis1_CT13278.pdf
HAS/2015-04-10_CT-13712_SECTRAL_PIS_RI_Avis2_CT13712.pdf
HAS/2015-04-10_CT-14205_ATOVAQUONE-PROGUANIL_SANDOZ_QD_INS_Avis1_CT14205.pdf
HAS/2015-04-10_document_dinformation_bloc_certification_2015-04-07_14-43-14_24.pdf
HAS/2015-04-10_refces_k_du_sein_vf.pdf
HAS/2015-04-16_CEPP-4806_SAPIEN 3 Commander_10_mars_2015_(4806)_avis.pdf
HAS/2015-04-16_CEPP-4866_COREVALVE EVOLUT R_10_mars_2015_(4866)_avis.pdf
HAS/2015-04-16_CT-10949_TIAPRIDAL_PIS_RI_Avis1_CT10949.pdf
HAS/2015-04-16_CT-13699_ZONEGRAN_PIC_EI_Avis2_CT13699.pdf
HAS/2015-04-16_CT-13904_MABTHERA_PIC_EI_vascularite_Avis2_CT13904.pdf
HAS/2015-04-16_CT-14053_OROKEN_PIS_RI_Avis1_CT14053.pdf
HAS/2015-04-16_CT-14202_TOPALGIC_QD_INS_Avis1_CT14202.pdf
HAS/2015-04-16_advih_qr__201503_2015-04-07_12-20-12_604.pdf
HAS/2015-04-16_argumentaire_advih_201503.pdf
HAS/2015-04-16_argumentaire_mesure_no_vd.pdf
HAS/2015-04-16_fdr_mesure_no_vd.pdf
HAS/2015-04-16_inahta_brief_no.pdf
HAS/2015-04-16_mabthera_04022015_synthese_ct13904.pdf
HAS/2015-04-16_mabthera_summary_ct13904.pdf
HAS/2015-04-16_note_de_cadrage_autotests_vih.pdf
HAS/2015-04-16_zonegran_17122014_synthese_ct13699.pdf
HAS/2015-04-16_zonegran_summary_ct13699.pdf
HAS/2015-04-17_CT-13560_ROTATEQ_PIC_INS_Avis3_CT13560.pdf
HAS/2015-04-17_rotarix_rotateq_sapub_ct13564.pdf
HAS/2015-04-17_rotarix_rotateq_summary_ct13564.pdf
HAS/2015-04-17_rotateq_-_avis_masque.pdf
HAS/2015-04-22_CEPP-4688_MITRACLIP_24_mars_2015_(4688)_avis.pdf
HAS/2015-04-22_CEPP-4784_SURPASS_24_mars_2015_(4784)_avis.pdf
HAS/2015-04-22_CEPP-4808_SURPASS STREAMLINE_24_mars_2015_(4808)_avis.pdf
HAS/2015-04-22_CEPP-4837_ECLIPSE 5_10_mars_2015_(4837)_avis.pdf
HAS/2015-04-22_CEPP-4858_ZILVER PTX_07_avril_2015_(4858)_avis.pdf
HAS/2015-04-22_CEPP-4891_POWERLINK AFX_07_avril_2015_(4891)_avis.pdf
HAS/2015-04-22_CEPP-4897_HOME MONITORING IPERIA 7 HF-T_07_avril_2015_(4897)_avis.pdf
HAS/2015-04-22_CEPP-4899_ZILVER PTX_07_avril_2015_(4858)_radiation_avis.pdf
HAS/2015-04-22_CT-13890_IASOCHOLINE_PIC_INS_Avis1_CT13890.pdf
HAS/2015-04-22_CT-13905_PROPOFOL_LIPURO_PIC_EI_Avis2_CT13905&13919&13889.pdf
HAS/2015-04-22_ald_30_gm_leucemies_aigues_adulte_web.pdf
HAS/2015-04-22_ald_30_gp_lymphomes_web.pdf
HAS/2015-04-22_ald_30_guide_lnh_final_web_2012-06-11_13-25-17_16.pdf
HAS/2015-04-22_ald_30_lap_la_final.web.pdf
HAS/2015-04-22_ald_30_lap_lnh_web.pdf
HAS/2015-04-22_alova_galbe_standard_entre_38_cm_et_45_cm.pdf
HAS/2015-04-22_argumentaire_ffr_vd.pdf
HAS/2015-04-22_feuille_de_route_ffr.pdf
HAS/2015-04-22_iasocholine_04022015_synthese_ct13890.pdf
HAS/2015-04-22_iasocholine_summary_ct13890.pdf
HAS/2015-04-22_inahta_brief_ffr.pdf
HAS/2015-04-22_mitraclip_avis_efficience_20150407.pdf
HAS/2015-04-22_propofol_lipuro_04022015_synthese_ct13905.pdf
HAS/2015-04-22_propofol_lipuro_summary_ct13905.pdf
HAS/2015-04-24_inahta_brief_shortage_of_technetium.pdf
HAS/2015-04-24_rapport_technetium_vd.pdf
HAS/2015-04-27_CEPP-4742_NEXGEN_24_mars_2015_(4742)_avis.pdf
HAS/2015-04-27_CEPP-4798_HELIX-7E9_21_avril_2015_(4798)_avis.pdf
HAS/2015-04-27_CEPP-4826_HELIX-7E10_21_avril_2015_(4826)_avis.pdf
HAS/2015-04-27_CEPP-4876_URGOTUL_07_avril_2015_(4876)_avis.pdf
HAS/2015-04-27_CEPP-4880_URGOTUL DUO_07_avril_2015_(4880)_avis.pdf
HAS/2015-04-27_CEPP-4892_NUCLEUS CI522_21_avril_2015_(4892)_avis.pdf
HAS/2015-04-27_CEPP-4893_OSTEOPURE_07_avril_2015_(4893)_avis.pdf
HAS/2015-04-27_CT-13277_VICTOZA_PIC_REEV_RI_RCP_Avis2_CT13277&13956&14141.pdf
HAS/2015-04-27_CT-13645_ROWASA_PIS_RI_Avis1_CT13645.pdf
HAS/2015-04-27_CT-13735_QUININE_CHLORHYDRATE_LAFRAN-QUININE_SULFATE_LAFRAN_PIS_RI_Avis1_CT13735.pdf
HAS/2015-04-27_CT-13852_ARCOXIA_PIS_RI_Avis2_CT13852.pdf
HAS/2015-04-27_CT-13877_FOLINORAL_PIS_RI_Avis1_CT13877.pdf
HAS/2015-04-27_CT-13958_CLOMIPRAMINE_MYLAN_PIS_RI_Avis2_CT13958.pdf
HAS/2015-04-27_CT-13975_LEELOO_PIS_RI_Avis1_CT13975.pdf
HAS/2015-04-27_CT-14032_DUORESP_SPIROMAX_PIS_INS_Avis2_CT14032.pdf
HAS/2015-04-27_CT-14095_RESIKALI_PIS_RI_Avis1_CT14095.pdf
HAS/2015-04-27_CT-14157_PRAVASTATINE_ARROW_QD_INS_Avis2_CT14157.pdf
HAS/2015-04-27_CT-14161_EFFIZINC_PIS_RI_Avis1_CT14161.pdf
HAS/2015-04-27_CT-14167_NUTRYELT_QD_INS_Avis1_CT14167.pdf
HAS/2015-04-27_CT-14182_LUCENTIS_PIS_INS_Avis2_CT14182.pdf
HAS/2015-04-27_CT-14203_CHLORURE_DE_SODIUM_HYPERTONIQUE_LAVOISIER_QD_INS_Avis2_CT14203.pdf
HAS/2015-04-27_CT-14207_CHLORURE_DE_SODIUM_LAVOISIER_QD_INS_Avis2_CT14207.pdf
HAS/2015-04-27_CT-14229_ACCOFIL_QD_INS_Avis1_CT14229.pdf
HAS/2015-04-27_CT-14231_CHLORURE_DE_SODIUM_BAXTER_QD_INS_Avis1_CT14231.pdf
HAS/2015-04-27_CT-14268_LEVONORGESTREL_ETHINYLESTRADIOL_CLEXNI_PIS_INS_Avis1_CT14268.pdf
HAS/2015-04-27_CT-14300_RENITEC_PIS_RI_Avis2_CT14300.pdf
HAS/2015-04-27_CT-14315_MINIPRESS_PIC_RECOURS_R163-13_Avis1_CT14315.pdf
HAS/2015-04-27_arthrum_2_pourcent_1_seringue.pdf
HAS/2015-04-27_arthrum_2_pourcent_3_seringues.pdf
HAS/2015-04-27_evaluation_de_la_securite_et_des_conditions_de_realisation_de_lautogreffe_de_tissu_adipeux_dans_la_chirurgie_reconstructrice_reparatrice_et_esthetique_du_sein_-_note_de_cadrage.pdf
HAS/2015-04-27_evaluation_de_la_securite_et_des_conditions_de_realisation_de_lautogreffe_de_tissu_adipeux_dans_la_chirurgie_reconstructrice_reparatrice_et_esthetique_du_sein_-_rapport_devaluation_2015-02-20_11-52-13_659.pdf
HAS/2015-04-27_evaluation_de_la_securite_et_des_conditions_de_realisation_de_lautogreffe_de_tissu_adipeux_dans_la_chirurgie_reconstructrice_reparatrice_et_esthetique_du_sein_-_texte_court_2015-02-20_11-52-34_501.pdf
HAS/2015-04-27_inahta_brief_autologous_fat_grafting.pdf
HAS/2015-04-27_monoxyde_dazote_messer_qd_ins_avis1_ct14171.pdf
HAS/2015-04-29_assessment_of_mitraclip_-_summary.pdf
HAS/2015-04-29_mitraclip_24_mars_2015_4688_avis_2015-04-22_16-18-44_127.pdf
HAS/2015-04-29_rapport_devaluation_mitraclip.pdf
HAS/2015-04-29_texte_court_du_rapport_devaluation_mitraclip.pdf
HAS/2015-05-04_fpcs_protocoles_pluri-pro_web2.pdf
HAS/2015-05-04_fpcs_protocoles_pluri-pro_web_3_derozier.pdf
HAS/2015-05-04_guide_methode_fiches_points_cles_solutions.pdf
HAS/2015-05-04_note_methodo_protocoles_pluri-pro_web.pdf
HAS/2015-05-07_CEPP-4542_SYNVISCONE_21_avril_2015_(4542)_avis.pdf
HAS/2015-05-07_CEPP-4788_OSTENIL_21_avril_2015_(4788)_avis.pdf
HAS/2015-05-07_CEPP-4817_STAR_21_avril_2015_(4817)_avis_renouvellement.pdf
HAS/2015-05-07_CEPP-4846_STAR_21_avril_2015_(4846)_avis_inscription.pdf
HAS/2015-05-07_CEPP-4847_STAR_21_avril_2015_(4847)_avis_radiation.pdf
HAS/2015-05-07_CEPP-4890_ADJUST_21_avril_2015_(4890)_avis.pdf
HAS/2015-05-07_CT-10962_BETADINE_PIS_INS_EI_REEV_Avis2_CT10962&14152&14156.pdf
HAS/2015-05-07_CT-12172_ZONEGRAN_PIS_RI_Avis2_CT12172.pdf
HAS/2015-05-07_CT-12448_TACROLIMUS_SANDOZ_03102012_AVIS_CT12448.pdf
HAS/2015-05-07_CT-13230_BRUFEN_PIS_RI_Avis1_CT13230.pdf
HAS/2015-05-07_CT-13770_VENTILASTIN_NOVOLIZER_PIS_RI_Avis1_CT13770.pdf
HAS/2015-05-07_CT-13909_LEVOPHTA_LEVOFREE_PIS_RI_Avis1_CT13909.pdf
HAS/2015-05-07_CT-13931_FIVASA_PIS_RI_Avis2_CT13931.pdf
HAS/2015-05-07_CT-13968_DAFALGAN-EFFERALGAN_PIS_RI_Avis2_CT13968.pdf
HAS/2015-05-07_CT-13998_REVIA_PIS_RI_Avis1_CT13998.pdf
HAS/2015-05-07_CT-14040_DOLIPRANE-GELUPRANE-PARACETAMOL_ZENTIVA_PIS_RI_Avis1_CT14040.pdf
HAS/2015-05-07_CT-14046_LEVIDCEN_PIS_INS_Avis2_CT14046.pdf
HAS/2015-05-07_CT-14090_NAPROSYNE_PIS_RI_Avis1_CT14090.pdf
HAS/2015-05-07_CT-14107_CROMOGLICATE_DE_SODIUM_MYLAN_QD_INS_Avis2_CT14107.pdf
HAS/2015-05-07_CT-14122_MIANSERINE_MYLAN_QD_INS_Avis2_CT14122.pdf
HAS/2015-05-07_CT-14137_PRAXILENE_PIS_RI_Avis1_CT14137.pdf
HAS/2015-05-07_CT-14140_IMETH_QD_INS_Avis2_CT14140.pdf
HAS/2015-05-07_CT-14178_DUALKOPT_PIS_INS_Avis2_CT14178.pdf
HAS/2015-05-07_CT-14188_TACHOSIL_QD_INS_Avis2_CT14188.pdf
HAS/2015-05-07_CT-14190_ACUILIX_PIS_RI_Avis2_CT14190.pdf
HAS/2015-05-07_CT-14191_ALDACTAZINE_PIS_RI_Avis2_CT14191.pdf
HAS/2015-05-07_CT-14222_LOXEN_PIS_RI_Avis 2_CT14222.pdf
HAS/2015-05-07_grille_auto-evaluation_rs_29_04_2015.pdf
HAS/2015-05-07_grille_auto-evaluation_rs_guide_utilisation__29_04_2015.pdf
HAS/2015-05-07_grille_auto-evaluation_rs_support_pdf_29_04_2015.pdf
HAS/2015-05-07_note_de_cadrage_coordination_mg_psy.pdf
HAS/2015-05-07_pnds_57_-_prise_en_charge_en_medecine_physique_et_readaptation_du_patient_atteint_de_spina_bifida_-_synthese_a_destination_d.pdf
HAS/2015-05-07_pnds_mpr_has_spina_bifida_04_2015.pdf
HAS/2015-05-11_CEPP-4814_ADAPTIC TOUCH_21_avril_2015_(4814)_avis.pdf
HAS/2015-05-11_sondes_de_defibrillation_cardiaque_2015_02_17a_feuille_de_route.pdf
HAS/2015-05-19_CT-14121_FENOFIBRATE_MYLAN_QD_INS_Avis1_CT14121.pdf
HAS/2015-05-19_CT-14206_PHENYLEPHRINE_AGUETTANT_QD_INS_Avis1_CT14206.pdf
HAS/2015-05-19_CT-14236_CALCIUM_MYLAN_PIS_RI_Avis1_CT14236.pdf
HAS/2015-05-19_CT-14282_ROCURONIUM_B_BRAUN_QD_INS_Avis1_CT14282.pdf
HAS/2015-05-22_CT-13664_DEXERYL_PIC_REEV_Avis1_CT13664.pdf
HAS/2015-05-22_check-list_sortie_hospitalisation_web.pdf
HAS/2015-05-22_dexeryl_sapub_ct13664.pdf
HAS/2015-05-22_dexeryl_summary_ct13664.pdf
HAS/2015-05-22_guide_utilisation_check-list_sortie-dhospitalisation_web.pdf
HAS/2015-05-22_note_documentaire_check-list_sortie_hospitalisation_web.pdf
HAS/2015-05-26_4_pages_rmm_juin_09.pdf
HAS/2015-05-26_aide_pour_lanalyse_dun_cas.pdf
HAS/2015-05-26_alarm_supplement_jam14.pdf
HAS/2015-05-26_analyse_systemique_2009-06-11_11-45-32_961.pdf
HAS/2015-05-26_check-list_des_actions_a_realiser_pour_mettre_en_oeuvre_une_rmm.pdf
HAS/2015-05-26_criteres_de_qualite_dune_rmm.pdf
HAS/2015-05-26_fiche_de_suivi_daction.pdf
HAS/2015-05-26_guide_rmm_juin_09.pdf
HAS/2015-05-26_modele_de_procedure_rmm.pdf
HAS/2015-05-26_rex_comprendre_mettre_en_oeuvre.pdf
HAS/2015-05-26_rmm_et_mg_4_pages_11_02_2010.pdf
HAS/2015-05-27_CT-13721_MYCOSTATINE_PIS_RI_Avis2_CT13721.pdf
HAS/2015-05-27_CT-13763_FAMPYRA_PIC_REEV_Avis3_CT13763.pdf
HAS/2015-05-27_CT-13764_EFIENT_PI_RI_REEV_Avis2_CT13764.pdf
HAS/2015-05-27_CT-14054_OFLOCET_MONOFLOCET_PIS_RI_Avis2_CT14054.pdf
HAS/2015-05-27_CT-14058_XATRAL_PIS_RI_Avis1_CT14058.pdf
HAS/2015-05-27_CT-14154_AMOXICILLINE_ACIDE_CLAVULANIQUE_PANPHARMA_QD_INS_Avis2_CT14154.pdf
HAS/2015-05-27_CT-14242_VELCADE_PIS_EPI_Avis1_CT14242.pdf
HAS/2015-05-27_CT-14264_STEOVESS_PIS_INS_Avis2_CT14264.pdf
HAS/2015-05-27_setofilm_ge_pic_ei_avis2_ct14106.pdf
HAS/2015-06-01_CT-13382_TAXOTERE_PIC_EI_Avis1_CT13382.pdf
HAS/2015-06-01_CT-14138_ROTOP-NanoHSA_PIC_INS_Avis1_CT14138.pdf
HAS/2015-06-01_rotopnanohsa_sapub_ct14138.pdf
HAS/2015-06-01_rotopnanohsa_summary_ct14138.pdf
HAS/2015-06-01_taxotere_sapub_ct13382.pdf
HAS/2015-06-01_taxotere_summary_ct13382.pdf
HAS/2015-06-02_CEPP-4789_SINOVIAL_05_mai_2015_(4789)_avis.pdf
HAS/2015-06-02_CEPP-4791_EUFLEXXA_05_mai_2015_(4791)_avis.pdf
HAS/2015-06-02_CEPP-4851_HYDROSIL_19_mai_2015_(4851)_avis.pdf
HAS/2015-06-02_CEPP-4853_NUTRAMIGEN PURAMINO_05_mai_2015_(4853)_avis.pdf
HAS/2015-06-02_CEPP-4854_YUKON CHOICE PC_21_avril_2015_(4854)_avis.pdf
HAS/2015-06-02_CEPP-4856_TUTOBONE_05_mai_2015_(4856)_avis.pdf
HAS/2015-06-02_CEPP-4863_ORSIRO_21_avril_2015_(4863)_avis caviarde.pdf
HAS/2015-06-02_CEPP-4886_AMS 800_05_mai_2015_(4886)_avis.pdf
HAS/2015-06-02_CEPP-4894_ZENITH RENU_05_mai_2015_(4894)_avis.pdf
HAS/2015-06-02_CT-13092_PERGOTIME_PIS_RI_Avis1_CT13092.pdf
HAS/2015-06-02_CT-13787_PROFENID_BIPROFENID_PROFEMIGR_TOPREC_PIS_RI_Avis2_CT13787.pdf
HAS/2015-06-02_CT-13982_FAZOL_PIS_RI_Avis1_CT13982.pdf
HAS/2015-06-02_CT-14132_NEGABAN_PIC_INS_Avis2_CT14132.pdf
HAS/2015-06-02_CT-14266_EAU_PPI_KABI_QD_INS_Avis1_CT14266.pdf
HAS/2015-06-02_CT-14267_CHLORURE_DE_POTASSIUM_KABI_QD_INS_Avis2_CT14267.pdf
HAS/2015-06-02_CT-14283_BUSULFAN_FRESENIUS_KABI_QD_INS_Avis2_CT14283.pdf
HAS/2015-06-02_CT-14325_DEXPANTHENOL_BIOGARAN_CONSEIL_QD_INS_Avis1_CT14325.pdf
HAS/2015-06-02_CT-14329_DIOSMECTITE_MYLAN_QD_INS_Avis1_CT14329.pdf
HAS/2015-06-02_argumentaire_syphilis_vd.pdf
HAS/2015-06-02_cadrage_sialendoscopie.pdf
HAS/2015-06-02_fdr_syphilis_vd.pdf
HAS/2015-06-02_glivec_ei_lal_pediatrie_avis1_ct13248_2014-06-23_15-31-56_818.pdf
HAS/2015-06-02_glivec_en_ct13248_pub.pdf
HAS/2015-06-02_glivec_sapub_ct13248.pdf
HAS/2015-06-02_glivec_summary_ct13248.pdf
HAS/2015-06-02_inahta_brief_sialendoscopy.pdf
HAS/2015-06-02_inahta_brief_syphilis.pdf
HAS/2015-06-02_rapport_devaluation_ventilation_auto-asservie.pdf
HAS/2015-06-02_rapport_sialendoscopie.pdf
HAS/2015-06-02_revestive_pic_ins_avis2_ct13835.pdf
HAS/2015-06-02_revestive_sapub_ct13835.pdf
HAS/2015-06-02_revestive_summary_ct13835.pdf
HAS/2015-06-02_texte_court_sialendoscopie.pdf
HAS/2015-06-03_CT-13500_VITAROS_PIC_INS_AvisPostAud_CT13500.pdf
HAS/2015-06-03_CT-13841_BRINAVESS_PIC_INS_Avis3_CT13841.pdf
HAS/2015-06-03_CT-13885_SYLVANT_PIC_INS_AvisPostAud_CT13885.pdf
HAS/2015-06-03_brinavess_sapub_ct13841.pdf
HAS/2015-06-03_brinavess_summary_avis_ct13841.pdf
HAS/2015-06-03_place_de_la_strategie_couplant_les_dosages_de_la_tir_et_de_la_pap_dans_le_depistage_systematique_de_la_mucoviscidose_en_france.pdf
HAS/2015-06-03_sylvant_sapub_ct13885.pdf
HAS/2015-06-03_sylvant_summary_ct13885.pdf
HAS/2015-06-03_vitaros_sapub_ct13500.pdf
HAS/2015-06-03_vitaros_summary_ct13500.pdf
HAS/2015-06-04_asip_sante_has_synthese_medicale.pdf
HAS/2015-06-04_cadre_referentiel_etp_paerpa__polypathologie.pdf
HAS/2015-06-04_epp_pmsa_aide3.pdf
HAS/2015-06-04_fiche_parcours_polypathologie_du_sujet_age.pdf
HAS/2015-06-04_fiche_parcours_polypathologie_du_sujet_age_corbillon.pdf
HAS/2015-06-04_fpcs_prescription_web.pdf
HAS/2015-06-04_fps_prise_en_charge_paf_ambulatoire.pdf
HAS/2015-06-04_justificatif_pmsa_et_cheminements_cliniques_080708.pdf
HAS/2015-06-04_note_methodologique_polypathologie_de_la_personne_agee.pdf
HAS/2015-06-04_pmsa_remplissage_hospitalier_2015_03_16.pdf
HAS/2015-06-04_pmsa_revision_en_soins_primaires_2015_03_17.pdf
HAS/2015-06-04_pps-version_web_juillet2013.pdf
HAS/2015-06-04_questionnaire_pps_web.pdf
HAS/2015-06-08_CEPP-4793_GO-ON_02_juin_2015_(4793)_avis.pdf
HAS/2015-06-08_CT-13564_ROTARIX_PIC_INS_Avis3_CT13564.pdf
HAS/2015-06-08_CT-13848_COMETRIQ_PIC_INS_Avis2_CT13848.pdf
HAS/2015-06-08_brintellix_pic_ins_avis3modifiele31032015_ct13896.pdf
HAS/2015-06-08_brintellix_sapub_ct13896.pdf
HAS/2015-06-08_brintellix_summary_ct13896.pdf
HAS/2015-06-08_cometriq_sapub_ct13848.pdf
HAS/2015-06-08_cometriq_summary_ct13848.pdf
HAS/2015-06-08_rotarix_-_avis_masque.pdf
HAS/2015-06-08_rotarix_rotateq_sapub_ct13564.pdf
HAS/2015-06-08_rotarix_rotateq_summary_ct13564_2015-11-10_10-47-36_926.pdf
HAS/2015-06-12_thoratec_pvad.pdf
HAS/2015-06-15_CEPP-4874_ACTIVA_SOLETRA_ACTIVA_KINETRA_Radiations_(4874)_avis.pdf
HAS/2015-06-15_CEPP-4905_WALLSTENT_02_juin_2015_(4905)_caviarde.pdf
HAS/2015-06-15_CT-12568_BYETTA_PIS_RI_Avis1_CT12568.pdf
HAS/2015-06-15_CT-12948_SPIFEN_PIS_RI_Avis1_CT12948.pdf
HAS/2015-06-15_CT-13267_GALVUS-JALRA_PIS_RI_Avis2_CT13267.pdf
HAS/2015-06-15_CT-13661_BONDRONAT_PIS_RI_Avis1_CT13661.pdf
HAS/2015-06-15_CT-13725_EUCREAS-ICANDRA_PIS_RI_Avis1_CT13725.pdf
HAS/2015-06-15_CT-13818_LEPTICUR_PIS_RI_Avis1_CT13818.pdf
HAS/2015-06-15_CT-13888_INOVELON_PIS_RI_Avis2_CT13888.pdf
HAS/2015-06-15_CT-13983_REQUIP_PIS_RI_Avis2_CT13983.pdf
HAS/2015-06-15_CT-13993_LEVOFLOXACINE_B_BRAUN_QD_INS_Avis2_CT13993.pdf
HAS/2015-06-15_CT-14078_ABILIFY_PIC_RI_REEV_Avis2_CT14078.pdf
HAS/2015-06-15_CT-14223_GLUCOPHAGE_PIS_RI_Avis2_CT14223.pdf
HAS/2015-06-15_CT-14254_IZALGI_QD_INS_Avis2_CT14254.pdf
HAS/2015-06-15_CT-14293_AMINOPLASMAL_QD_INS_Avis2_CT14293.pdf
HAS/2015-06-15_CT-14307_NEFOPAM_MEDISOL_QD_INS_Avis1_CT14307.pdf
HAS/2015-06-15_CT-14328_SIFROL_PIS_RI_Avis2_CT14328.pdf
HAS/2015-06-15_CT-14353_PARACETAMOL_B_BRAUN_QD_INS_Avis2_CT14353.pdf
HAS/2015-06-15_fdr_implants_mammaires_vd.pdf
HAS/2015-06-15_rapport_implants_mammaires_vd.pdf
HAS/2015-06-19_CEPP-4848_TUTOPLAST_02_juin_2015_(4848)_avis.pdf
HAS/2015-06-24_CT-13147_GYNO_PEVARYL_PIS_RI_Avis1_CT13147.pdf
HAS/2015-06-24_CT-13407_STEDIRIL_PIC_RI_REEV_Avis2_CT13407&14290.pdf
HAS/2015-06-24_CT-13446_DEPO_PROVERA_PIS_RI_Avis1_CT13446.pdf
HAS/2015-06-24_CT-13654_NORLEVO_PIS_RI_Avis1_CT13654.pdf
HAS/2015-06-24_CT-13680_ADENURIC_PIS_RI_Avis1_CT13680.pdf
HAS/2015-06-24_CT-13737_EGERY_PIS_RI_Avis1_CT13737.pdf
HAS/2015-06-24_CT-13773_XOLAIR_PIC_EI_Avis2_CT13773.pdf
HAS/2015-06-24_CT-13816_NEISVAC_PIS_RI_Avis1_CT13816.pdf
HAS/2015-06-24_CT-13870_DERMESTRIL-DERMESTRIL_SEPTEM_PIS_RI_Avis1_CT13870.pdf
HAS/2015-06-24_CT-13878_ACTISKENAN-SKENAN_PIS_RI_Avis1_CT13878.pdf
HAS/2015-06-24_CT-13900_MENJUGATEKIT_PIS_RI_Avis2_CT13900.pdf
HAS/2015-06-24_CT-14027_ARANESP_PIS_RI_Avis2_CT14027.pdf
HAS/2015-06-24_CT-14043_IXEL_PIS_RI_Avis2_CT14043.pdf
HAS/2015-06-24_CT-14133_SINEMET_PIS_RI_Avis2_CT14133.pdf
HAS/2015-06-24_CT-14153_ILARIS_PIS_RI_Avis2_CT14153.pdf
HAS/2015-06-24_CT-14177_SPIRIVA_RESPIMAT_PIC_EI_Avis2_CT14177.pdf
HAS/2015-06-24_CT-14192_ARTOTEC_PIS_RI_Avis1_CT14192.pdf
HAS/2015-06-24_CT-14197_ARAVA_PIS_RI_Avis2_CT14197.pdf
HAS/2015-06-24_CT-14285_DAIVOBET_PIS_INS_Avis2_CT14285.pdf
HAS/2015-06-24_CT-14310_CEFTRIAXONE_GERDA_QD_INS_Avis1_CT14310.pdf
HAS/2015-06-24_CT-14322_DEXPANTHENOL_MYLAN_QD_INS_Avis1_CT14322.pdf
HAS/2015-06-24_CT-14350_GADOVIST_QD_INS_Avis2_CT14350.pdf
HAS/2015-06-24_CT-14351_VERAPAMIL_BIOGARAN_LP_PIS_RI_Avis1_CT14351.pdf
HAS/2015-06-24_CT-14352_TOBRAMYCINE_MYLAN_QD_INS_Avis1_CT14352.pdf
HAS/2015-06-24_CT-14367_NIQUITINMINIS_ORANGE_QD_INS_Avis1_CT14367.pdf
HAS/2015-06-24_CT-14369_INSPRA_PIS_RI_Avis2_CT14369.pdf
HAS/2015-06-24_CT-14404_CELEBREX_PIS_RI_Avis2_CT14404.pdf
HAS/2015-06-24_stediril_sapub_ct13290.pdf
HAS/2015-06-24_stediril_summary_ct14290.pdf
HAS/2015-06-24_xolair_25112014_avis_efficience.pdf
HAS/2015-06-24_xolair_sapub_ct13773.pdf
HAS/2015-06-24_xolair_summary_ct13773.pdf
HAS/2015-06-25_cadrage_prestations_derogatoires_reseaux.pdf
HAS/2015-06-25_demarche_centree_patient_web.pdf
HAS/2015-06-25_fiche_1_information.pdf
HAS/2015-06-25_fiche_2_etp.pdf
HAS/2015-06-25_fiche_3_soutien_suivi.pdf
HAS/2015-06-25_tableau_de_bord_des_indicateurs_de_suivi_reseaux.pdf
HAS/2015-06-26_CEPP-4795_SYNOCROM_16_juin_2015_(4795)_avis.pdf
HAS/2015-06-26_CEPP-4796_STRUCTOVIAL_16_juin_2015_(4796)_avis.pdf
HAS/2015-06-26_CEPP-4803_HOME MONITORING IPERIA 7 VR-T DX_02_juin_2015_(4803)_avis.pdf
HAS/2015-06-26_CEPP-4924_BIO 1 QUICK SET_16_juin_2015_(4294)_avis.pdf
HAS/2015-06-26_CT-13785_STRIVERDI_RESPIMAT_PIC_INS_Avis2_CT13785.pdf
HAS/2015-06-26_CT-13850_ESBRIET_PIC_REEV_Avis3_CT13850.pdf
HAS/2015-06-26_CT-13935_VELPHORO_PIC_INS_Avis2_CT13935.pdf
HAS/2015-06-26_CT-13953_HARVONI_PIC_INS_Avis2_CT 13953.pdf
HAS/2015-06-26_CT-14030_EYLEA_PIC_EI_Avis2_CT14030.pdf
HAS/2015-06-26_CT-14069_VIEKIRAX_EXVIERA_PIC_INS_Avis3_CT14068_CT14069.pdf
HAS/2015-06-26_aad_avis_25052016_ct_25052016.pdf
HAS/2015-06-26_esbriet_20150203_avis_efficience.pdf
HAS/2015-06-26_esbriet_sapub_ct13850.pdf
HAS/2015-06-26_esbriet_summary_ct13850.pdf
HAS/2015-06-26_exviera_-_avis_defficience_m_-_vf.pdf
HAS/2015-06-26_eylea_sapub_ct14030.pdf
HAS/2015-06-26_eylea_summary_ct14030.pdf
HAS/2015-06-26_fpc_i_ns_cardiaque_web.pdf
HAS/2015-06-26_harvoni_-_avis_defficience_m.pdf
HAS/2015-06-26_harvoni_sapub_ct_13953.pdf
HAS/2015-06-26_harvoni_summary_ct_13953.pdf
HAS/2015-06-26_note_cadrage_imagerie_cardio.pdf
HAS/2015-06-26_note_methodo_synthese_documentaire_ic_web.pdf
HAS/2015-06-26_rapport_sca_vd.pdf
HAS/2015-06-26_striverdi_respimat_sapub_ct13785.pdf
HAS/2015-06-26_striverdi_respimat_summary_ct13785.pdf
HAS/2015-06-26_tc_sca_vd.pdf
HAS/2015-06-26_velphoro_sapub_ct13935.pdf
HAS/2015-06-26_velphoro_summary_ct13935.pdf
HAS/2015-06-26_viekirax_-_avis_defficience_m_-_vf.pdf
HAS/2015-06-26_viekirax_exviera_summary_ct_14068_ct14069.pdf
HAS/2015-06-29_CEPP-4764_SALITOL_16_juin_2015_(4764)_avis.pdf
HAS/2015-06-29_CEPP-4836_ABSORB_02_juin_2015_(4836)_avis caviarde.pdf
HAS/2015-06-29_CT-13736_ENTYVIO_PIC_INS_Avis3_CT13736.pdf
HAS/2015-06-29_CT-14136_NORDAZ_PIC_REEVAL_RI_Avis2_CT14136.pdf
HAS/2015-06-29_CT-14158_LYSANXIA_PIC_REEVAL_Avis2_CT14158.pdf
HAS/2015-06-29_CT-14176_XANAX_PIC_REEVAL_Avis2_CT14176.pdf
HAS/2015-06-29_CT-14195_VERATRAN_PIC_REEVAL_RI_Avis2_CT14195.pdf
HAS/2015-06-29_CT-14196_SERESTA_PIC_REEVAL_Avis2_CT14196.pdf
HAS/2015-06-29_CT-14198_TRANXENE_PIC_REEVAL_Avis2_CT14198.pdf
HAS/2015-06-29_CT-14199_LEXOMIL_PIC_REEVAL_Avis2_CT14199.pdf
HAS/2015-06-29_CT-14200_VALIUM_PIC_REEVAL_Avis2_CT14200.pdf
HAS/2015-06-29_CT-14201_TEMESTA_PIC_REEVAL_Avis2_CT14201.pdf
HAS/2015-06-29_CT-14213_URBANYL_PIC_REEVAL_Avis2_CT14213.pdf
HAS/2015-06-29_CT-14214_VICTAN_PIC_REEVAL_Avis2_CT14214.pdf
HAS/2015-06-29_argumentaire_hsv_vzv_vd_2015-06-29_12-06-3_178.pdf
HAS/2015-06-29_argumentaire_igra_vd_2015-06-29_11-57-54_758.pdf
HAS/2015-06-29_entyvio_07012015_synthese_ct13736.pdf
HAS/2015-06-29_entyvio_25112014_avis_efficience.pdf
HAS/2015-06-29_entyvio_summary_ct13507.pdf
HAS/2015-06-29_fdr_hsv_vzv_vd.pdf
HAS/2015-06-29_fdr_igra_vd.pdf
HAS/2015-06-29_fiche_memo_arret_benzodiazepines_pour_mel_2015_06_16.pdf
HAS/2015-06-29_fiche_memo_arret_benzodiazepines_pour_mel_2015_06_16_en.pdf
HAS/2015-06-29_fiche_memo_rapport_elaboration_arret_benzodiazepines__2015_06_17.pdf
HAS/2015-06-29_fm_-_agenda_sommeil-eveil_2015-06-12_09-40-51_769.pdf
HAS/2015-06-29_fm_-_calendrier_de_suivi.pdf
HAS/2015-06-29_fm_-_courrier_dinformation.pdf
HAS/2015-06-29_fm_-_echelle_ecab.pdf
HAS/2015-06-29_fm_-_echelle_ecab_-_document_patient.pdf
HAS/2015-06-29_fm_-_signes_a_larret_des_benzodiazepines.pdf
HAS/2015-06-29_fm_has_-_agenda_sommeil_-_eveil.pdf
HAS/2015-06-29_fm_has_-_calendrier_de_suivi.pdf
HAS/2015-06-29_inahta_brief_hsv_vzh.pdf
HAS/2015-06-29_interferon_gamma_inahta_brief.pdf
HAS/2015-07-03_cadrage_keratocone.pdf
HAS/2015-07-03_inahta_brief_corneal_ectasia.pdf
HAS/2015-07-03_rapport_keratocone.pdf
HAS/2015-07-03_ventilation_assistee.pdf
HAS/2015-07-07_CT-13687_KYTRIL_PIS_RI_Avis2_CT13687.pdf
HAS/2015-07-07_CT-13774_MENINGITEC_PIS_RI_Avis2_CT13774.pdf
HAS/2015-07-07_CT-13817_DIERGOSPRAY-DIHYDROERGOTAMINE_AMDIPHARM_PIS_RI_Avis2_CT13817.pdf
HAS/2015-07-07_CT-13884_DELIDOSE_PIS_RI_Avis2_CT13884.pdf
HAS/2015-07-07_CT-13893_NEOSYNEPHRINE_FAURE_PIC_INS_Avis2_CT13893.pdf
HAS/2015-07-07_CT-14011_SEROPLEX_PIS_RI_Avis2_CT14011.pdf
HAS/2015-07-07_CT-14126_ZYTIGA_PIC_REEV_AvisPostObs_CT14126.pdf
HAS/2015-07-07_CT-14279_GYDRELLE_PIS_RI_Avis2_CT14279.pdf
HAS/2015-07-07_CT-14299_REMSIMA_QD_INS_Avis1_CT14299.pdf
HAS/2015-07-07_CT-14303_PEDIAVEN_AP-HP_NOUVEAU_NE_QD_INS_Avis2_CT14303.pdf
HAS/2015-07-07_CT-14311_LERCAPRESS_PIS_RI_Avis2_CT14311.pdf
HAS/2015-07-07_CT-14321_SELOZOK_LP_PIS_EI_Avis2_CT14321.pdf
HAS/2015-07-07_CT-14348_GLUCOSE_LAVOISIER_QD_INS_Avis2_CT14348.pdf
HAS/2015-07-07_CT-14361_SURGAM_PIS_RI_Avis1_CT14361.pdf
HAS/2015-07-07_CT-14433_LUCENTIS_PIS_ETUDE_LUEUR_Avis1_CT14433.pdf
HAS/2015-07-07_CT-14441_DESOGESTREL_MITHRA_QD_INS_Avis1_CT14441.pdf
HAS/2015-07-08_anesm-inlusion_sociale-axe-droit-et-libertes-2016.pdf
HAS/2015-07-08_anesm-inlusion_sociale-axe-personnalisation-accompagnement-2016-.pdf
HAS/2015-07-08_anesm-inlusion_sociale-axe-protection-prevention-2016.pdf
HAS/2015-07-08_anesm-inlusion_sociale-axe_promotion_autonomie-2016.pdf
HAS/2015-07-08_anesm-inlusion_sociale-doc_principal-2016.pdf
HAS/2015-07-08_bibliographie_evaluation_interne_inclusion.pdf
HAS/2015-07-08_decision_n_2015-44_-_decision_portant_adoption_de_la_rbpp_ei_reperes_inclusion_sociale.pdf
HAS/2015-07-08_lettre_de_cadrage_ei_reperes_pour_les_es_de_l_inclusion_sociale_version_definitive_121001.pdf
HAS/2015-07-09_ane-rbpp-reperage_et_accompagnement_en_chrs-interactif.pdf
HAS/2015-07-09_anesm-rbpp_l_accompagnement_des_enfants_civiles_penales.pdf
HAS/2015-07-09_anesm-synthe_se-rbpp-articulations_pe_pjj.pdf
HAS/2015-07-09_anesm-synthe_se-reperage_et_accompagnement_en_chrs.pdf
HAS/2015-07-09_annexe_1_elements_d_appropriation_de_la_rbpp_civile_penale.pdf
HAS/2015-07-09_annexe_1_elements_dappropriation_de_la_rbpp_civile_penale.pdf
HAS/2015-07-09_annexe_2_glossaire_des_sigles_civile_penale.pdf
HAS/2015-07-09_annexe_3_les_dispositifs_de_protection_de_lenfance_et_de_la_justice_penale_des_mineurs.pdf
HAS/2015-07-09_annexe_4_civile_penale__les_aides_et_les_mesures.pdf
HAS/2015-07-09_annexe_5_civile_penale__elaboration_de_la_rbpp.pdf
HAS/2015-07-09_annexe_6_civile_penale_anesm.pdf
HAS/2015-07-09_bibliographie_rbpp_reperage_et_accompagnement_des_situations_de_ruptures.pdf
HAS/2015-07-09_chrs_chap1_dimension_relationnelle.pdf
HAS/2015-07-09_chrs_chap1_lessentiel.pdf
HAS/2015-07-09_chrs_chap2_dimension_sante.pdf
HAS/2015-07-09_chrs_chap2_lessentiel.pdf
HAS/2015-07-09_chrs_chap3_dimension_spatiale_et_sociale.pdf
HAS/2015-07-09_chrs_chap3_lessentiel.pdf
HAS/2015-07-09_chrs_chap4_dimension_economique.pdf
HAS/2015-07-09_chrs_chap4_lessentiel.pdf
HAS/2015-07-09_chrs_glossaire.pdf
HAS/2015-07-09_chrs_index_des_thematiques_evaluatives.pdf
HAS/2015-07-09_chrs_presentation_generale.pdf
HAS/2015-07-09_decision_n_2015-42_-_decision_portant_adoption_de_la_rbpp_mesures_civiles_et_penales_pour_le_mineur_et_le_jeune_majeur.pdf
HAS/2015-07-09_decision_n_2015-43_-_decision_portant_adoption_de_la_rbpp_reperage_et_accompagnement_chrs.pdf
HAS/2015-07-09_deuxieme_part_chap1_civile_penale.pdf
HAS/2015-07-09_deuxieme_part_chap2_civile_penale1.pdf
HAS/2015-07-09_elements_d_appropriation_des_rbpp.pdf
HAS/2015-07-09_introduction_civile_penale.pdf
HAS/2015-07-09_lettre_de_cadrage_situations_de_ruptures_dans_les_parcours_personnalises.pdf
HAS/2015-07-09_lettre_de_cadrage_v_21_09_2012.pdf
HAS/2015-07-09_premiere_partie_civile_penale.pdf
HAS/2015-07-10_CEPP-4732_FLAMINAL Hydro_19_mai_2015_(4732)_avis.pdf
HAS/2015-07-10_CEPP-4754_FLAMINAL Forte_19_mai_2015_(4754)_avis.pdf
HAS/2015-07-10_CEPP-4799_REVEAL LINQ_16_juin_2015_(4799)_avis.pdf
HAS/2015-07-10_CEPP-4805_REVEAL XT_16_juin_2015_(4805)_avis.pdf
HAS/2015-07-10_CEPP-4850_ACTIVA RC_16_juin_2015_(4850)_avis_caviarde.pdf
HAS/2015-07-10_CT-12590_TAVANIC_PIC_EI_Avis2_CT12590.pdf
HAS/2015-07-10_CT-13894_TRIUMEQ_PIC_INS_Avis2_CT13894.pdf
HAS/2015-07-10_CT-14013_KETOSTERIL_PIC_INS_Avis2_CT14013.pdf
HAS/2015-07-10_ketosteril_sapub_ct14013.pdf
HAS/2015-07-10_ketosteril_summary_ct14013.pdf
HAS/2015-07-10_pnds_-_deficit_en_mevalonate_kinase_mkd.pdf
HAS/2015-07-10_pnds_58_-_deficit_en_mevalonate_kinase_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2015-07-10_tavanic_sapub_ct12590.pdf
HAS/2015-07-10_tavanic_summary_ct12590.pdf
HAS/2015-07-10_triumeq_sapub_ct13894.pdf
HAS/2015-07-10_triumeq_summary_ct13894.pdf
HAS/2015-07-15_CT-13139_INDUCTOS_PIC_REEV_Avis3_CT13139.pdf
HAS/2015-07-15_inductos_ct13139_sapub.pdf
HAS/2015-07-15_inductos_summary_ct13139.pdf
HAS/2015-07-16_CEPP-4794_DUROLANE 4794.pdf
HAS/2015-07-16_CEPP-4797_ADANT 4797.pdf
HAS/2015-07-16_allogreffe_de_veine_saphene_conservee_16_juin_2015_4896_avis.pdf
HAS/2015-07-16_allogreffes_osseuses_massives_cryoconservees_30_juin_2015_4919_avis.pdf
HAS/2015-07-16_fresubin_db_control_30_juin_2015_4910_avis.pdf
HAS/2015-07-17_CT-10680_ZAVEDOS_PIS_RI_Avis2_CT10680.pdf
HAS/2015-07-17_CT-12882_AVODART_PIS_RI_Avis2_CT12882.pdf
HAS/2015-07-17_CT-13067_GONADOTROPHINE_CHORIONIQUE_ENDO_PIC_RI_Avis2_CT13067.pdf
HAS/2015-07-17_CT-13111_RIMACTAN_PIS_RI_Avis1_CT13111.pdf
HAS/2015-07-17_CT-13146_TRIELLA_PIS_RI_Avis1_CT13146.pdf
HAS/2015-07-17_CT-13149_PIRILENE_PIS_RI_Avis2_CT13149.pdf
HAS/2015-07-17_CT-13455_CONCERTA_LP_Avis2_PIS_RI_CT13455.pdf
HAS/2015-07-17_CT-13586_SOLUMEDROL_PIS_RI_Avis1_CT13586.pdf
HAS/2015-07-17_CT-13628_INTELENCE_PIS_RI_Avis2_CT13628.pdf
HAS/2015-07-17_CT-13784_TEXODIL_PIS_RI_Avis1_CT13784.pdf
HAS/2015-07-17_CT-13794_ZIAGEN_PIS_RI_Avis2_CT13794.pdf
HAS/2015-07-17_CT-13806_TRIZIVIR_PIS_RI_Avis2_CT13806.pdf
HAS/2015-07-17_CT-13880_NORMACOL_PIS_RI_Avis2_CT13880.pdf
HAS/2015-07-17_CT-13906_ARESTAL_PIS_RI_Avis1_CT13906.pdf
HAS/2015-07-17_CT-13987_VITALIPIDE_ADULTES_PIS_RI_Avis2_CT13987.pdf
HAS/2015-07-17_CT-14019_VITAMINE_E_MYLAN_PIS_RI_Avis1_CT14019.pdf
HAS/2015-07-17_CT-14052_SUPREFACT_PIS_RI_Avis1_CT14052.pdf
HAS/2015-07-17_CT-14061_ASPIRINE_UPSA_PIS_RI_Avis2_CT14061.pdf
HAS/2015-07-17_CT-14072_ACNETRAIT_PIS_RI_Avis1_CT14072.pdf
HAS/2015-07-17_CT-14089_UN-ALFA_PIS_RI_Avis2_CT14089.pdf
HAS/2015-07-17_CT-14211_ELIGARD_PIS_EI_Avis2_CT14211.pdf
HAS/2015-07-17_CT-14238_NEUPRO_PIS_RI_Avis2_CT14238.pdf
HAS/2015-07-17_CT-14278_AMAREL_PIS_RI_Avis2_CT14278.pdf
HAS/2015-07-17_CT-14298_ZANEXTRA_PIS_INS_Avis2_CT14298.pdf
HAS/2015-07-17_CT-14370_NOVORAPID-NOVOMIX_PIS_RI_Avis2_CT14370.pdf
HAS/2015-07-17_CT-14411_LEVOBUPIVACAINE_KABI_QD_INS_Avis2_CT14411.pdf
HAS/2015-07-17_CT-14419_ROCURONIUM_HOSPIRA_QD_INS_Avis2_CT14419.pdf
HAS/2015-07-17_CT-14425_MENJUGATE_QD_INS_Avis2_CT14425.pdf
HAS/2015-07-17_CT-14457_EUROBIOL_QD_INS_Avis1_CT14457.pdf
HAS/2015-07-17_fludara_pis_ri_avis2_ct12582.pdf
HAS/2015-07-17_gonadotrophine_chorionique_endo_sapub_ct13067.pdf
HAS/2015-07-17_gonadotrophine_chorionique_endo_summary_ct13067.pdf
HAS/2015-07-17_janumet_pis_ri_avis2_ct13263_modifie.pdf
HAS/2015-07-17_rapport_art70_2014_05_22_collegefinal_sdc.pdf
HAS/2015-07-17_rapport_evaluation_art_70_perte_autonomie_2015-07-16_12-17-35_601.pdf
HAS/2015-07-17_velmetia_pis_ri_avis2_ct132658_modifie.pdf
HAS/2015-07-24_08-096_gp_insuf-cardia.pdf
HAS/2015-07-24_guide_parcours_de_soins_ic_web.pdf
HAS/2015-07-24_liste_ald_5_fibrillation_auriculaire.pdf
HAS/2015-07-24_liste_ald_insuf_card_systolique.pdf
HAS/2015-07-24_liste_ald_insuf_cardaique_diastolique.pdf
HAS/2015-07-24_pnds_-_figures_myasthenie_autoimmune.pdf
HAS/2015-07-24_pnds_-_myasthenie_autoimmune.pdf
HAS/2015-07-24_pnds_59_-_myasthenie_auto-immune_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2015-07-27_dlu_doc_liaison_web.pdf
HAS/2015-07-27_dlu_fiche_liaison_urgence.pdf
HAS/2015-07-27_dlu_note_methodologique.pdf
HAS/2015-07-27_fpc_reduire_hospit_residents_ehpad.pdf
HAS/2015-07-27_fpc_v3_vf_uk_reduire_hospit_residents_ehpad_en_vuas_en.pdf
HAS/2015-07-27_guide_utilisation_dlu.pdf
HAS/2015-07-27_note_methodo_reduire_hospit_residents_ehpad.pdf
HAS/2015-07-30_CT-10953_URBANYL_PIS_RI_Avis2_CT10953.pdf
HAS/2015-07-30_CT-13929_UMATROPE_PIS_RI_EPI_Avis2_CT13929.pdf
HAS/2015-07-30_CT-13946_LOJUXTA_PIC_REEV_Avis3_CT13946.pdf
HAS/2015-07-30_CT-13992_ELAPRASE_PIC_REEV_Avis3_CT13992.pdf
HAS/2015-07-30_CT-14057_SOLUPRED_PIS_RI_Avis2_CT14057.pdf
HAS/2015-07-30_CT-14333_LOPERAMIDE_LYOC_PIS_RI_Avis1_CT14333.pdf
HAS/2015-07-30_CT-14432_KEPPRA_QD_INS_Avis1_CT14432.pdf
HAS/2015-07-30_elaprase_summary_ct13992.pdf
HAS/2015-07-30_elaprase_synthese_ct13992.pdf
HAS/2015-07-31_CT-13733_PHYSIOMYCINE_PIS_RI_Avis1_CT13733.pdf
HAS/2015-07-31_CT-14407_DEFANYL_PIS_RI_Avis1_CT14407.pdf
HAS/2015-07-31_CT-14459_DROPERIDOL_PANPHARMA_QD_INS_Avis2_CT14459.pdf
HAS/2015-07-31_CT-14464_PROHANCE_QD_INS_Avis1_CT14464.pdf
HAS/2015-07-31_ald_20_guide_paraplegie__20_septembre_2007.pdf
HAS/2015-07-31_ald_20_lap_paraplegie_septembre_2007.pdf
HAS/2015-08-04_argumentaire_cmv_vd.pdf
HAS/2015-08-04_fdr_cmv_vd.pdf
HAS/2015-08-04_inahta_brief_cytomegalovirus.pdf
HAS/2015-08-05_inahta_brief_imrt_anal_canal_cancer.pdf
HAS/2015-08-05_note_de_cadrage_rcmi.pdf
HAS/2015-08-05_rapport_rcmi_canal_anal.pdf
HAS/2015-08-06_CT-13066_LYSOCLINE_PIS_RI_Avis1_CT13066.pdf
HAS/2015-08-06_CT-13079_PIPRAM_FORT_PIS_RI_Avis1_CT13079.pdf
HAS/2015-08-06_CT-13177_ROVAMYCINE_PIS_RI_Avis1_CT13177.pdf
HAS/2015-08-06_CT-14010_ORDIPHA_PIS_RI_Avis1_CT14010.pdf
HAS/2015-08-06_CT-14059_BIGONIST_PIS_RI_Avis1_CT14059.pdf
HAS/2015-08-06_CT-14160_ZOMACTON_PIS_RI_Avis2_CT14160.pdf
HAS/2015-08-06_CT-14302_FLECTOR_PIS_RI_Avis1_CT14302.pdf
HAS/2015-08-06_CT-14403_BICARBONATE_DE_SODIUM_COOPER_PIS_RI_Avis2_CT14403.pdf
HAS/2015-08-06_CT-14465_EURELIX_PIS_RI_Avis1_CT14465.pdf
HAS/2015-08-06_CT-14474_CEBUTID_PIS_RI_Avis2_CT14474.pdf
HAS/2015-08-06_CT-14493_ADOPORT_QD_INS_Avis2_CT14493.pdf
HAS/2015-08-06_CT-14496_EPORATIO_QD_INS_Avis2_CT14496.pdf
HAS/2015-08-06_fdr_implants_mammaires_vd.pdf
HAS/2015-08-06_rapport_implants_mammaires_vd.pdf
HAS/2015-08-13_CEPP-4906_MUTARS 21 07 2015 (4906) avis.pdf
HAS/2015-08-13_algosteril_16_juin_2015_4879_avis.pdf
HAS/2015-08-13_coalgan_30_juin_2015_4878_avis.pdf
HAS/2015-08-13_ialuset_30_juin_2015_4875_avis.pdf
HAS/2015-08-14_CEPP-4830_iSTENT INJECT 21 07 2015 (4830) avis.pdf
HAS/2015-08-14_CEPP-4907_ATOMISOR DJINN NL9M_21 juillet 2015_4907_Avis.pdf
HAS/2015-08-14_thealose_21_juillet_2015_4921_avis.pdf
HAS/2015-08-19_baha_5_21_juillet_2015_4932_pilier_avis_completant_du_7_octobre_2014.pdf
HAS/2015-08-19_baha_5_21_juillet_2015_4932_processeur_de_son_avis.pdf
HAS/2015-08-24_CT-11607_KIDROLASE_PIS_RI_Avis1_CT11607.pdf
HAS/2015-08-24_CT-13129_UNACIM_INJECTABLE_PIS_RI_Avis1_CT13129.pdf
HAS/2015-08-24_CT-13815_STALEVO_PIS_RI_Avis1_CT13815.pdf
HAS/2015-08-24_CT-13955_VICTOZA_PIC_EI_Avis2_CT13955.pdf
HAS/2015-08-24_CT-14093_PLEGRIDY_PIS_INS_Avis2_CT14093.pdf
HAS/2015-08-24_CT-14193_GONAPEPTYL_PIS_RI_Avis2_CT14193.pdf
HAS/2015-08-24_CT-14257_MOCLAMINE_PIS_RI_Avis1_CT14257.pdf
HAS/2015-08-24_CT-14357_RETACRIT_QD_INS_Avis2_CT14357.pdf
HAS/2015-08-24_CT-14476_VOLTARENE_PIS_RI_Avis1_CT14476.pdf
HAS/2015-08-24_CT-14484_NATULAN_QD_INS_Avis1_CT14484.pdf
HAS/2015-08-24_plegridy_sapub_ct14093.pdf
HAS/2015-08-24_plegridy_summary_ct14093.pdf
HAS/2015-08-24_victoza_sapub_ct13955.pdf
HAS/2015-08-24_victoza_summary_ct13955.pdf
HAS/2015-08-25_CT-13863_ONGLYZA_PIS_RI_Avis1_CT13863&14241.pdf
HAS/2015-08-25_CT-14219_CLOPIXOL_PIS_RI_Avis1_CT14219.pdf
HAS/2015-08-25_CT-14439_CARDENSIEL_PIS_RI_Avis1_CT14439.pdf
HAS/2015-08-27_implants_mammaires_30_juin_2015_dm_eval_102.pdf
HAS/2015-08-27_solutes_rehydratation_orale_21_juillet_2015_dm_eval_74.pdf
HAS/2015-09-02_CT-12118_ENANTONE_LP_PIS_RI_Avis2_CT12118.pdf
HAS/2015-09-02_CT-12164_ENANTONE_LP_PIS_RCP_Avis2_CT12164.pdf
HAS/2015-09-02_CT-13685_BUPRENORPHINE_SANDOZ_PIS_RI_Avis2_CT13685.pdf
HAS/2015-09-02_CT-13783_REBETOL_PIS_RI_Avis2_CT13783.pdf
HAS/2015-09-02_CT-13941_LITAK_PIC_RI_REEV_Avis1_CT13941.pdf
HAS/2015-09-02_CT-13943_TROBICINE_PIS_RI_Avis2_CT13943.pdf
HAS/2015-09-02_CT-14355_DIAMICRON_PIS_RI_Avis2_CT14355.pdf
HAS/2015-09-02_CT-14364_JEXT_QD_INS_Avis2_CT14364.pdf
HAS/2015-09-02_CT-14431_CARDIOCOR_PIS_RI_Avis2_CT14431.pdf
HAS/2015-09-02_CT-14480_COTRIATEC_PIS_RI_Avis2_CT14480.pdf
HAS/2015-09-02_CT-14486_AFINITOR_QD_INS_Avis1_CT14486.pdf
HAS/2015-09-02_CT-14508_BURINEX_PIS_RI_Avis2_CT14508.pdf
HAS/2015-09-04_CT-14166_NEXAVAR_PIC_EI_Avis2_CT14166.pdf
HAS/2015-09-04_nexavar_sapub_ct14166.pdf
HAS/2015-09-04_nexavar_summary_ct14166.pdf
HAS/2015-09-07_CT-13502_RATIOGRASTIM-TEVAGRASTIM_PIS_RI_Avis2_CT13502.pdf
HAS/2015-09-07_CT-13617_SIRTURO_PIC_INS_Avis2_CT13617.pdf
HAS/2015-09-07_CT-13767_AZILECT_PIS_RI_Avis2_CT13767.pdf
HAS/2015-09-07_CT-14163_GENOTONORM_PIS_RI_Avis2_CT14163.pdf
HAS/2015-09-07_CT-14423_OESTROGEL_OESTRODOSE_THAIS_THAISSEPT_PIS_RI_Avis2_CT14423.pdf
HAS/2015-09-07_sirturo_summary_ct13617.pdf
HAS/2015-09-07_sirturo_synthese_ct13617.pdf
HAS/2015-09-10_CEPP-4957_POWERLINK AFX 4957.pdf
HAS/2015-09-10_CT-12832_TARDYFERON_B9_PIC_RI_AvisPostAud_CT12396&12832.pdf
HAS/2015-09-10_CT-13468_ATRIPLA_PIC_RI_Avis2_CT13468.pdf
HAS/2015-09-10_CT-13675_SUBOXONE_PIC_RI_Avis3_CT13675.pdf
HAS/2015-09-10_CT-13838_AFINITOR_PIC_REEV_Avis2_CT13838.pdf
HAS/2015-09-10_CT-14037_SIGNIFOR_PIC_INS_Avis2_CT14037.pdf
HAS/2015-09-10_CT-14083_TARGINACT_PIC_REEV_Avis3_CT14083.pdf
HAS/2015-09-10_CT-14147_OZURDEX_PIC_EI_Avis2_CT14147.pdf
HAS/2015-09-10_CT-14162_OFEV_PIC_INS_Avis2_CT14162.pdf
HAS/2015-09-10_CT-14187_FLUARIXTETRA_PIC_INS_Avis2_CT14187.pdf
HAS/2015-09-10_afinitor_sapub_ct13838.pdf
HAS/2015-09-10_afinitor_summary_ct13838.pdf
HAS/2015-09-10_atripla_sapub_ct13468.pdf
HAS/2015-09-10_atripla_summary_ct13468.pdf
HAS/2015-09-10_fluarixtetra_sapub_ct14187.pdf
HAS/2015-09-10_fluarixtetra_summary_ct14187.pdf
HAS/2015-09-10_guide_representantsusagers_certification.pdf
HAS/2015-09-10_ofev_sapub_ct14162.pdf
HAS/2015-09-10_ofev_summary_ct14162.pdf
HAS/2015-09-10_ozurdex_sapub_ct14147.pdf
HAS/2015-09-10_ozurdex_summary_ct14147.pdf
HAS/2015-09-10_signifor_sapub_ct14037.pdf
HAS/2015-09-10_signifor_summary_ct14037.pdf
HAS/2015-09-10_suboxone_sapub_ct13675.pdf
HAS/2015-09-10_suboxone_summary_ct13675.pdf
HAS/2015-09-10_tardyferon_b9_sapub_ct12396.pdf
HAS/2015-09-10_tardyferon_b9_summary_ct12396.pdf
HAS/2015-09-10_targinact_sapub_ct14083.pdf
HAS/2015-09-10_targinact_summary_ct14083.pdf
HAS/2015-09-14_CT-13429_XOFIGO Ins_Avis 2_CT13429.pdf
HAS/2015-09-14_CT-13901_ELIQUIS_PIC_EI_Avis2_CT13901.pdf
HAS/2015-09-14_CT-13911_ALTEIS_PIC_REEV_Avis3_CT13911&13667.pdf
HAS/2015-09-14_CT-13912_OLMETEC_PIC_REEV_Avis3_CT13912&13659.pdf
HAS/2015-09-14_CT-13913_ALTEIS_PIC_REEV_Avis3_CT13913&13667.pdf
HAS/2015-09-14_CT-13914_ALTEISDUO_PIC_REEV_Avis3_CT13914.pdf
HAS/2015-09-14_CT-14094_AXELER_PIC_REEV_Avis3_CT14094.pdf
HAS/2015-09-14_CT-14096_SEVIKAR_PIC_REEV_Avis3_CT14096.pdf
HAS/2015-09-14_CT-14173_NIMENRIX_PIC_INS_Avis2_CT14173.pdf
HAS/2015-09-14_CT-14185_MENVEO_PIC_INS_Avis2_CT14185.pdf
HAS/2015-09-14_eliquis_sapub_ct1390.pdf
HAS/2015-09-14_eliquis_summary_ct1390.pdf
HAS/2015-09-14_menveo_nimenrix_sapub_ct14185_ct14173.pdf
HAS/2015-09-14_menveo_nimenrix_summary_ct14185_ct14173.pdf
HAS/2015-09-14_menveo_nimenrix_summary_ct14185_ct14173_2016-01-12_16-21-2_106.pdf
HAS/2015-09-14_olmesartan_reevaluation__sapub.pdf
HAS/2015-09-14_olmesartan_summary.pdf
HAS/2015-09-14_xofigo_-_avis_defficience_masque.pdf
HAS/2015-09-14_xofigo_en_ct13429_val.pdf
HAS/2015-09-14_xofigo_sapub_ct13429.pdf
HAS/2015-09-14_xofigo_summary_ct13429.pdf
HAS/2015-09-15_CEPP-4827_TUTOMESH 4827postAudition.pdf
HAS/2015-09-15_CT-13910_PROCORALAN_PIC_REEV_Avis3_CT13910.pdf
HAS/2015-09-15_CT-14104_KETOCONAZOLE_HRA_PIC_INS_Avis2_CT14104.pdf
HAS/2015-09-15_ketoconazole_sapub_ct14104.pdf
HAS/2015-09-15_ketoconazole_summary_ct14104.pdf
HAS/2015-09-15_procoralan_sapub_ct13910.pdf
HAS/2015-09-15_procoralan_summary_ct13910.pdf
HAS/2015-09-17_CT-13920_FLUENZ_TETRA_PIC_INS_Avis3_CT13920.pdf
HAS/2015-09-17_CT-14099_TRULICITY_PIC_INS_Avis2_CT14099.pdf
HAS/2015-09-17_fluenz_tetra_20150609_avis_efficience.pdf
HAS/2015-09-17_fluenztetra_summary_ct13920.pdf
HAS/2015-09-17_fluenztetra_synthese_ct13920.pdf
HAS/2015-09-17_trulicity_sapub_ct14099.pdf
HAS/2015-09-17_trulicity_summary_ct14099.pdf
HAS/2015-09-21_1e_partie_guide_e-learning.pdf
HAS/2015-09-21_2e_partie_guide_e-learning.pdf
HAS/2015-09-21_3e_partie_guide_e-learning.pdf
HAS/2015-09-21_4e_partie_guide_e-learning.pdf
HAS/2015-09-21_5e_partie_guide_e-learning.pdf
HAS/2015-09-21_guide_e-learning_rapport_complet.pdf
HAS/2015-09-24_CEPP-4855_PRO-KINETIC ENERGY 4855.pdf
HAS/2015-09-24_CEPP-4911_PRECISION_NOVI_08 Septembre 2015_(4911)_avis.pdf
HAS/2015-09-28_CEPP-4873_KENEVO 4873.pdf
HAS/2015-09-28_CEPP-4989_VERCISE PARKINSON_08 Septembre 2015_(4989)_avis.pdf
HAS/2015-09-28_corsets_sieges_8_septembre_2015_dm_eval_73.pdf
HAS/2015-09-28_evaluation_des_corsets-sieges_-_feuille_de_route.pdf
HAS/2015-09-28_feuille_de_route_2014-11-12_10-53-26_432.pdf
HAS/2015-09-28_note_cadrage_generalites.pdf
HAS/2015-09-28_pansements_06_octobre_2015_dm_eval_105_avis.pdf
HAS/2015-09-28_sieges_coquilles_de_serie_08_septembre_2015_dm_eval_38.pdf
HAS/2015-09-28_sieges_de_serie_modulables_et_evolutifs_08_septembre_2015_dm_eval_38.pdf
HAS/2015-09-28_web-composition_du_gt_corsets-sieges.pdf
HAS/2015-09-28_web-composition_du_gt_sieges-chassis_2014-11-12_10-54-16_424.pdf
HAS/2015-10-01_CEPP-4857_IGO  22 septembre 2015  4857.pdf
HAS/2015-10-01_CEPP-4867_BIOMATRIX NEOFLEX_08 Septembre 2015 (4867)_avis.pdf
HAS/2015-10-01_CEPP-4908_BIOMATRIX_08 Septembre 2015_(4908)_Avis.pdf
HAS/2015-10-01_CEPP-4912_BIOMATRIX FLEX_08 Septembre 2015_(4912)_Avis.pdf
HAS/2015-10-01_CEPP-4913_NEUROFORM 3 et NEUROFORM3EZ_08 Septembre 2015_(4898)_(4913)_Avis.pdf
HAS/2015-10-01_CEPP-4931_XIENCE PRIME BTK_08 Septembre 2015_(4931)_Avis.pdf
HAS/2015-10-01_CEPP-4947_AERIS SOLUTION_22 septembre 2015_4947.pdf
HAS/2015-10-01_CEPP-4958_PROMUS_PREMIER_MONORAIL_BTK_08 SEPTEMBRE 2015_4958_caviarde.pdf
HAS/2015-10-01_CEPP-4959_PROMUS_PREMIER_Over_The_Wire_BTK_08 septembre 2015_4959_caviarde.pdf
HAS/2015-10-01_CEPP-4961_ANACONDA_08 Septembre 2015_(4961)_avis.pdf
HAS/2015-10-01_argumentaire_sivb.pdf
HAS/2015-10-01_fdr_sivb_vd.pdf
HAS/2015-10-01_lg_dai_16_juin_2015_avis_intraghs_dm_95.pdf
HAS/2015-10-01_rapport_devaluation_des_defibrillateurs_cardiaques_implantables_avec_sondes_endocavitaires_2015-09-29_17-26-44_810.pdf
HAS/2015-10-01_texte_court_defibrillateurs_cardiaques_implantables_avec_sondes_endocavitaires_2015-09-29_17-26-44_817.pdf
HAS/2015-10-02_CT-12987_FLAGYL_PIS_RI_Avis1_CT12987.pdf
HAS/2015-10-02_CT-13416_PROGESTERONE_RETARD_PHARLON_PIC_RI_Avis1_CT13416.pdf
HAS/2015-10-02_CT-13438_ABSTRAL_PIS_RI_Avis1_CT13438.pdf
HAS/2015-10-02_CT-13488_ACTIQ_EFFENTORA_PIS_RI_Avis2_CT13488.pdf
HAS/2015-10-02_CT-13606_VIMPAT_PIS_RI_Avis2_CT13606.pdf
HAS/2015-10-02_CT-13897_COLOKIT_PIS_RI_Avis2_CT13897.pdf
HAS/2015-10-02_CT-13970_RHINOCORT_PIS_RI_Avis1_CT13970.pdf
HAS/2015-10-02_CT-13981_GLUCAGEN_PIS_RI_Avis2_CT13981.pdf
HAS/2015-10-02_CT-14066_KIVEXA_PIS_RI_Avis2_CT14066.pdf
HAS/2015-10-02_CT-14215_XGEVA_PIC_EI_Avis2_CT14215.pdf
HAS/2015-10-02_CT-14221_IMOVANE_PIS_RI_Avis1_CT14221.pdf
HAS/2015-10-02_CT-14225_ENTOCORT_PIS_RI_Avis2_CT14225.pdf
HAS/2015-10-02_CT-14246_PULMICORT_PIS_RI_Avis2_CT14246.pdf
HAS/2015-10-02_CT-14284_MOPRAL_ZOLTUM_PIS_RI_Avis2_CT14284.pdf
HAS/2015-10-02_CT-14312_HYQVIA_PIC_INS_Avis3_CT14312.pdf
HAS/2015-10-02_CT-14330_HEXYON_PIC_INS_Avis2_CT14330.pdf
HAS/2015-10-02_CT-14406_AMIPED_QD_INS_Avis1_CT14406.pdf
HAS/2015-10-02_CT-14416_MINI-SINTROM_SINTROM_PIS_RI_Avis2_CT14416.pdf
HAS/2015-10-02_CT-14440_TEGLUTIK_PIS_INS_Avis2_CT14440.pdf
HAS/2015-10-02_CT-14447_VFEND_QD_INS_Avis2_CT14447.pdf
HAS/2015-10-02_CT-14453_RIXUBIS_PIS_INS_Avis2_CT14453.pdf
HAS/2015-10-02_CT-14462_FENOFIBRATE_BIOGARAN_PIS_RI_Avis2_CT14462.pdf
HAS/2015-10-02_CT-14472_LOVAVULO_PIS_RI_Avis1_CT14472.pdf
HAS/2015-10-02_CT-14478_VFEND_QD_INS_Avis1_CT14478.pdf
HAS/2015-10-02_CT-14479_BCG-MEDAC_QD_INS_Avis2_CT14479.pdf
HAS/2015-10-02_CT-14487_INDOBIOTIC_PIS_RI_Avis1_CT14487.pdf
HAS/2015-10-02_CT-14495_LODINE_PIS_RI_Avis1_CT14495.pdf
HAS/2015-10-02_CT-14512_BREXIN_PIS_RI_Avis2_CT14512.pdf
HAS/2015-10-02_CT-14536_JANUVIA_QD_INS_Avis1_CT14536.pdf
HAS/2015-10-02_CT-14546_VELMETIA_QD_INS_Avis2_CT14546.pdf
HAS/2015-10-02_CT-14547_PANNOGEL_PIS_RI_Avis1_CT14547.pdf
HAS/2015-10-02_CT-14551_TIMOCOMOD_PIS_RI_Avis2_CT14551.pdf
HAS/2015-10-02_CT-14554_NITRIDERM_PIS_RI_Avis2_CT14554.pdf
HAS/2015-10-02_CT-14559_CARTEOL_PIS_RI_Avis1_CT14559.pdf
HAS/2015-10-02_CT-14560_TOCOPA_PIS_RI_Avis1_CT14560.pdf
HAS/2015-10-02_CT-14561_ONDANSETRON_ACCORD_QD_INS_Avis1_CT14561.pdf
HAS/2015-10-02_CT-14613_JANUMET_QD_INS_Avis1_CT14613.pdf
HAS/2015-10-02_CT-14637_ZOLTUM_QD_INS_Avis2_CT14637.pdf
HAS/2015-10-02_CT-14638_MOPRAL_QD_INS_Avis2_CT14638.pdf
HAS/2015-10-02_CT-14717_XELEVIA_QD_INS_Avis2_CT14717.pdf
HAS/2015-10-02_emblem_s-icd_3401__22_septembre_2015_4535.pdf
HAS/2015-10-02_emblem_s-icd_a209_21_juillet_2015_4900_intra_ghs.pdf
HAS/2015-10-02_hexyon_sapub_ct14330.pdf
HAS/2015-10-02_hexyon_summary_ct14330.pdf
HAS/2015-10-02_hyqvia_summary_ct14312.pdf
HAS/2015-10-02_hyqvia_synthese_ct14312.pdf
HAS/2015-10-02_progesterone_retard_pharlon_summary_ct13416.pdf
HAS/2015-10-02_progesterone_retard_pharlon_synthese_ct13416.pdf
HAS/2015-10-02_xgeva_synthese_ct14215.pdf
HAS/2015-10-05_2015-09-01-sfctcv-eias-3.pdf
HAS/2015-10-05_CT-10237_TARCEVA_PIS_RI_Avis2_CT10237.pdf
HAS/2015-10-05_CT-13944_TOCOLION_PIS_RI_Avis1_CT13944.pdf
HAS/2015-10-05_CT-14020_PUREGON_PIS_RI_Avis2_CT14020.pdf
HAS/2015-10-05_CT-14422_EUPHON_PIS_RI_Avis1_CT14422.pdf
HAS/2015-10-05_CT-14539_ZALERG_PIS_RI_Avis2_CT14539.pdf
HAS/2015-10-05_CT-14574_ALLERGODIL_PIS_RI_Avis2_CT14574.pdf
HAS/2015-10-05_CT-14632_LINEZOLIDE_SANDOZ_QD_INS_Avis1_CT14632.pdf
HAS/2015-10-06_annex_5_situations_durgence.pdf
HAS/2015-10-06_annexe_4_associations.pdf
HAS/2015-10-06_fiche_memo_rapport_elaboration_trouble_bipolaire_mel.pdf
HAS/2015-10-06_fiche_memo_trouble_bipolaire_vd.pdf
HAS/2015-10-06_troubles_bipolaires_reperage_et_diagnostic_en_premier_recours_-_note_de_cadrage_2014-06-13_10-53-16_714.pdf
HAS/2015-10-07_2015-09-01-orthorisq-eias-3.pdf
HAS/2015-10-07_CT-14088_HUMIRA_PIC_EI_Avis2_CT14088.pdf
HAS/2015-10-07_humira_enbrel__aji_ct14088_ct14261_sadef.pdf
HAS/2015-10-09_anesm-rbpp-enf-sante_mineurs-jeunes_majeurs-interactif.pdf
HAS/2015-10-09_anesm-synthe_se-rbpp-enf-sante_mineurs-jeunes_majeurs.pdf
HAS/2015-10-09_annexes_rbpp_sante_mineurs_jeunes_majeurs.pdf
HAS/2015-10-09_chap2_rbpp_sante_mineurs_jeunes_majeurs.pdf
HAS/2015-10-09_chap3_rbpp_sante_mineurs_jeunes_majeurs.pdf
HAS/2015-10-09_chap_1___rbpp_sante_mineurs_jeunes_majeurs.pdf
HAS/2015-10-09_chap_4___rbpp_sante_mineurs_jeunes_majeurs.pdf
HAS/2015-10-09_decision_n_2015-66_-_decision_portant_adoption_de_la_rbpp_mesures_educatives_ase-pjj.pdf
HAS/2015-10-09_lettre_de_cadrage_sante_protection_de_l_enfance_octobre_2014_.pdf
HAS/2015-10-09_presentation_generale_rbpp_sante_mineurs_jeunes_majeurs.pdf
HAS/2015-10-12_2015-09-01-cfar-eias-_3.pdf
HAS/2015-10-12_2015-09-01-eias-neuro3.pdf
HAS/2015-10-12_perfusion_a_domicile_22_septembre_2015_dm_eval_106_avis.pdf
HAS/2015-10-12_prothse_mammaire_externe_06_octobre_2015_dm_eval_103_avis.pdf
HAS/2015-10-15_CEPP-4933_DYNAMIQUE 1D10_22 Septembre 2015_(4933)_Avis.pdf
HAS/2015-10-15_CEPP-4934_DYNAMIC MOTION 1D35_22 Septembre 2015_(4934)_Avis.pdf
HAS/2015-10-15_CEPP-4935_TRITON 1C60_22 Septembre 2015_(4935)_Avis.pdf
HAS/2015-10-15_CEPP-4936_TRIAS 1C30_22 Septembre 2015_(4936)_Avis.pdf
HAS/2015-10-15_CEPP-4937_GREISSINGER 1A30_22 Septembre 2015_(4937)_Avis.pdf
HAS/2015-10-15_lits_medicaux_06_octobre_2015_dm_eval_110_avis.pdf
HAS/2015-10-16_CEPP-4938_LO_RIDER_06 Octobre 2015_(4938)_avis.pdf
HAS/2015-10-16_CEPP-4939_CHOPART_06 Octobre 2015_(4939)_avis.pdf
HAS/2015-10-16_CEPP-4940_UNIVERSAL_06 Octobre 2015_(4940)_avis.pdf
HAS/2015-10-16_CEPP-4941_PROSYMES_06 Octobre 2015_(4941)_avis.pdf
HAS/2015-10-21_CT-13155_CELSENTRI_PIS_RI_Avis1_CT13155.pdf
HAS/2015-10-21_CT-13742_FUZEON_PIS_RI_Avis2_CT13742.pdf
HAS/2015-10-21_CT-13798_EMTRIVA_PIS_RI_Avis2_CT13798.pdf
HAS/2015-10-21_CT-13809_IRESSA_PIS_RI_Avis2_CT13809.pdf
HAS/2015-10-21_CT-13875_IRINOTECAN_SEACROSS_QD_INS_Avis1_CT13875.pdf
HAS/2015-10-21_CT-13907_APSOR_PIS_RI_Avis1_CT13907.pdf
HAS/2015-10-21_CT-13999_EFFEDERM_PIS_RI_Avis1_CT13999.pdf
HAS/2015-10-21_CT-14024_CETROTIDE_PIS_RI_Avis1_CT14024.pdf
HAS/2015-10-21_CT-14033_TIMOLOL_ALCON_PIS_RI_Avis2_CT14033.pdf
HAS/2015-10-21_CT-14060_AZOPT_PIS_RI_Avis2_CT14060.pdf
HAS/2015-10-21_CT-14120_PERNAZENE_PIS_RI_Avis1_CT14120.pdf
HAS/2015-10-21_CT-14129_LEVOTHYROX_PIS_RI_Avis2_CT14129.pdf
HAS/2015-10-21_CT-14135_PULMOZYME_PIS_RI_Avis2_CT14135.pdf
HAS/2015-10-21_CT-14169_DOSISEPTINE_PIS_RI_Avis1_CT14169.pdf
HAS/2015-10-21_CT-14174_INDOCOLLYRE_PIS_RI_Avis1_CT14174.pdf
HAS/2015-10-21_CT-14228_CROMEDIL_PIS_RI_Avis1_CT14228.pdf
HAS/2015-10-21_CT-14240_REYATAZ_PIS_RI_Avis2_CT14240.pdf
HAS/2015-10-21_CT-14280_NEXPLANON_PIS_RI_Avis2_CT14280.pdf
HAS/2015-10-21_CT-14291_EURONAC_PIS_RI_Avis2_CT14291.pdf
HAS/2015-10-21_CT-14358_IMETH_PIS_RI_Avis1_CT14358.pdf
HAS/2015-10-21_CT-14388_EPIVIR_PIS_RI_Avis2_CT14388.pdf
HAS/2015-10-21_CT-14399_INVIRASE_PIS_RI_Avis1_CT14399.pdf
HAS/2015-10-21_CT-14434_VIVELLEDOT_PIS_RI_Avis2_CT14434.pdf
HAS/2015-10-21_CT-14456_VIDEX_PIS_RI_Avis2_CT14456.pdf
HAS/2015-10-21_CT-14482_IMETH_PIS_INS_Avis1_CT14482.pdf
HAS/2015-10-21_CT-14489_NUTRYELT_QD_INS_Avis1_CT14489.pdf
HAS/2015-10-21_CT-14503_SUPPLIVEN_QD_INS_Avis2_CT14503.pdf
HAS/2015-10-21_CT-14507_BENEMIDE_PIS_RI_Avis1_CT14507.pdf
HAS/2015-10-21_CT-14518_CORVASAL_PIS_RI_Avis1_CT14518.pdf
HAS/2015-10-21_CT-14525_MOEX_PIS_RI_Avis2_CT14525.pdf
HAS/2015-10-21_CT-14538_IMUREL_PIS_RI_Avis2_CT14538.pdf
HAS/2015-10-21_CT-14550_AIROMIR_AUTOHALER-SALBUTAMOL_TEVA_PIS_RI_Avis2_CT14550.pdf
HAS/2015-10-21_CT-14552_MONURIL_PIS_RI_Avis2_CT14552.pdf
HAS/2015-10-21_CT-14584_VASTEN_PIS_RI_Avis1_CT14584.pdf
HAS/2015-10-21_CT-14587_MULTICROM_PIS_RI_Avis2_CT14587.pdf
HAS/2015-10-21_CT-14593_CIPROFLOXACINE_KABI_QD_INS_Avis2_CT14593.pdf
HAS/2015-10-21_CT-14595_JETREA_QD_INS_Avis1_CT14595.pdf
HAS/2015-10-21_CT-14607_NIFLURIL_NIFLUGEL_PIS_RI_Avis1_CT14607.pdf
HAS/2015-10-21_CT-14612_SCOPOLAMINE_COOPER_PIS_RI_Avis1_CT14612.pdf
HAS/2015-10-21_CT-14619_ICAZ_PIS_RI_Avis2_CT14619.pdf
HAS/2015-10-21_CT-14624_TICOVAC_QD_INS_Avis2_CT14624.pdf
HAS/2015-10-21_CT-14626_ELISOR_PIS_RI_Avis2_CT14626.pdf
HAS/2015-10-21_CT-14628_NICOPASS_QD_INS_Avis2_CT14628.pdf
HAS/2015-10-21_CT-14631_AMOXILLICINE_ARROW_LAB_QD_INS_Avis1_CT14631.pdf
HAS/2015-10-21_CT-14658_LINEZOLIDE_PANPHARMA_QD_INS_Avis2_CT14658.pdf
HAS/2015-10-21_CT-14716_NIFLURIL_ENFANT-NIFLURIL_ADULTE_PIS_RI_Avis1_CT14716.pdf
HAS/2015-10-21_c_2015_0148_rbp_acne.pdf
HAS/2015-10-21_nexplanon_15092015_avis_efficience.pdf
HAS/2015-10-22_CEPP-4885_ATOPICLAIR_06 Octobre 2015_(4885)_avis.pdf
HAS/2015-10-22_corevalve_accutrak_22_septembre_2015_4984_radiation.pdf
HAS/2015-10-22_silk_22_septembre_2015_4877_avis.pdf
HAS/2015-10-22_watchman_flx_06_octobre_2015_4983_avis.pdf
HAS/2015-10-23_CT-12994_HYCAMTIN_PIS_RI_Avis1_CT12994.pdf
HAS/2015-10-23_CT-13464_ARIMIDEX_PIS_RI_Avis2_CT13464.pdf
HAS/2015-10-23_CT-14243_SEREVENT_PIS_RI_Avis1_CT14243.pdf
HAS/2015-10-23_CT-14483_PRODINAN_PIS_RI_Avis1_CT14483.pdf
HAS/2015-10-23_CT-14527_EFUDIX_PIS_RI_Avis2_CT14527.pdf
HAS/2015-10-23_CT-14528_BLEOMYCINE_BELLON_PIS_RI_Avis2_CT14528.pdf
HAS/2015-10-23_CT-14634_DESOGESTREL_ZENTIVA_QD_INS_Avis1_CT14634.pdf
HAS/2015-10-23_uridoz_adultes_pis_ri_avis1_modifiele21102015_ct14648.pdf
HAS/2015-11-02_CT-13193_TUBERTEST_PIS_RI_Avis2_CT13193.pdf
HAS/2015-11-02_CT-13650_HEXOMEDINE_PIS_RI_Avis1_CT13650.pdf
HAS/2015-11-02_CT-14044_NEORECORMON_PIS_RI_Avis2_CT14044.pdf
HAS/2015-11-02_CT-14314_ELLAONE_PIS_RI_Avis1_CT14314.pdf
HAS/2015-11-02_CT-14400_DUOPLAVIN_PIC_REEV_EPI_Avis2_CT14400.pdf
HAS/2015-11-02_CT-14435_URION_PIS_RI_Avis2_CT14435.pdf
HAS/2015-11-02_CT-14438_LANSOPRAZOLE_MYLAN_PHARMA_QD_INS_Avis1_CT14438.pdf
HAS/2015-11-02_CT-14452_TOUJEO_PIC_INS_Avis2_CT14452.pdf
HAS/2015-11-02_CT-14466_BISEPTINE_PIS_RI_Avis1_CT14466.pdf
HAS/2015-11-02_CT-14500_ABILIFY_MAINTENA_QD_INS_Avis1_CT14500.pdf
HAS/2015-11-02_CT-14540_GLUCOSE_LAVOISIER_PIS_RI_Avis1_CT14540.pdf
HAS/2015-11-02_CT-14562_TEMOZOLOMIDE_ACCORD_QD_INS_Avis1_CT14562.pdf
HAS/2015-11-02_CT-14565_DEXTROCIDINE_PIS_RI_Avis1_CT14565.pdf
HAS/2015-11-02_CT-14566_HELICIDINE_PIS_RI_Avis2_CT14566.pdf
HAS/2015-11-02_CT-14568_ASCABIOL_PIS_INS_Avis2_CT14568.pdf
HAS/2015-11-02_CT-14570_VARIQUEL_QD_INS_Avis2_CT14570.pdf
HAS/2015-11-02_CT-14616_COSOPT_PIS_RI_Avis1_CT14616.pdf
HAS/2015-11-02_CT-14629_CLIMENE_PIS_RI_Avis2_CT14629.pdf
HAS/2015-11-02_CT-14652_PANTOPRAZOLE_ACTAVIS_QD_INS_Avis1_CT14652.pdf
HAS/2015-11-02_CT-14656_PARACETAMOL_MYLAN_QD_INS_Avis2_CT14656.pdf
HAS/2015-11-02_CT-14661_PARACETAMOL_EVOLUGEN_QD_INS_Avis1_CT14661.pdf
HAS/2015-11-02_CT-14692_CYCLOPHOSPHAMIDE_SANDOZ_QD_INS_Avis1_CT14692.pdf
HAS/2015-11-06_CEPP-4929_VIBRANT SOUNDBRIDGE_20 Octobre 2015_(4929)_avis.pdf
HAS/2015-11-06_CEPP-4942_LOW-PROFIL_06 Octobre 2015_(4942)_avis.pdf
HAS/2015-11-06_CT-14408_ABASAGLAR_PIS_INS_Avis2_CT14408.pdf
HAS/2015-11-06_CT-14409_SILODYX_PIS_RI_Avis2_CT14409.pdf
HAS/2015-11-06_CT-14410_UROREC_PIS_RI_Avis2_CT14410.pdf
HAS/2015-11-06_CT-14504_GLUCOSE_BIOLUZ_PIS_RI_Avis2_CT14504.pdf
HAS/2015-11-09_CEPP-4944_HANCOCK_20_octobre_2015_(4944)_avis.pdf
HAS/2015-11-09_CEPP-4980_ITREL 4_20_octobre_2015_(4980)_avis_caviarde.pdf
HAS/2015-11-09_CEPP-4985_SAPIEN_XT ASCENDRA_ASCENDRA 2_22 Septembre 2015_(4985)_avis.pdf
HAS/2015-11-09_sapien_xt_ascendraplus.pdf
HAS/2015-11-12_CT-13118_ICLUSIG_PIC_INS_Avis2_CT13118.pdf
HAS/2015-11-12_CT-13629_ESMYA_PIC_INS_Avis3_CT13629.pdf
HAS/2015-11-12_CT-13872_GAZYVARO_PIC_INS_Avis2_CT13872.pdf
HAS/2015-11-12_CT-14012_IMBRUVICA_PIC_INS_Avis3_CT14012.pdf
HAS/2015-11-12_CT-14217_ENBREL_PIC_EI_Avis2_CT14217.pdf
HAS/2015-11-12_enbrel_summary_ct14217.pdf
HAS/2015-11-12_enbrel_synthese_avis_ct14217.pdf
HAS/2015-11-12_esmya_summary_ct13629.pdf
HAS/2015-11-12_esmya_synthese_avis_ct13629.pdf
HAS/2015-11-12_gazyvaro_03022015_avis_efficience.pdf
HAS/2015-11-12_gazyvaro__summary_ct13872.pdf
HAS/2015-11-12_gazyvaro__synthese_avis_ct13872.pdf
HAS/2015-11-12_gazyvaro_llc_13022018_avis_efficience.pdf
HAS/2015-11-12_iclusig_summary__ct13118.pdf
HAS/2015-11-12_iclusig_synthese_avis__ct13118.pdf
HAS/2015-11-12_imbruvica_14062016_avis_efficience.pdf
HAS/2015-11-12_imbruvica_dans_la_lcm__07042015_avis_defficience.pdf
HAS/2015-11-12_imbruvica_dans_la_llc_07042015_avis_defficience.pdf
HAS/2015-11-12_imbruvica_summary_ct14012.pdf
HAS/2015-11-12_imbruvica_synthese_avis_ct14012.pdf
HAS/2015-11-13_CEPP-4925_MUTARS HANCHE_06 Octobre 2015_(4925)_avis.pdf
HAS/2015-11-13_CEPP-4926_VERCISE DYSTONIE_03_novembre_2015_(4926)_avis.pdf
HAS/2015-11-13_CEPP-4952_MUTARS EPAULE_06 Octobre 2015_(4952)_avis.pdf
HAS/2015-11-16_CEPP-4697_BST-CARGEL_06 octobre 2015_ 4697_Avis.pdf
HAS/2015-11-16_CEPP-4887_PIPELINE_4887.pdf
HAS/2015-11-16_CEPP-4888_PIPELINE_FLEX_4888.pdf
HAS/2015-11-16_CEPP-4902_COREVALVE_AOA_ACCUTRAK 4902_Caviardé.pdf
HAS/2015-11-16_CEPP-4903_COREVALVE_EVOLUT_AOA_ACCUTRAK 4903_Caviardé.pdf
HAS/2015-11-16_CEPP-4904_COREVALVE_EVOLUT_R_ENVEOR 4904_Caviardé.pdf
HAS/2015-11-16_CEPP-4960_PARI SINUS_LC SPRINT SINUS_06 Octobre 2015_(4960)_avis.pdf
HAS/2015-11-16_CEPP-4990_PROCLAIM_03_novembre_2015_(4990)_avis.pdf
HAS/2015-11-16_CEPP-4999_HYLOVIS_MULTI_03_novembre_2015_(4999)_avis.pdf
HAS/2015-11-16_CT-13715_INNOHEP_PIS_RI_Avis1_CT13715.pdf
HAS/2015-11-16_CT-13803_LOVENOX_PIS_RI_Avis2_CT13803.pdf
HAS/2015-11-16_CT-14481_ADRIGYL_PIS_RI_Avis1_CT14481.pdf
HAS/2015-11-16_CT-14582_RESITUNE_PIS_INS_Avis1_CT14582.pdf
HAS/2015-11-16_CT-14608_PRADAXA_PIS_EI_non_demandée_Avis1_CT14608.pdf
HAS/2015-11-16_CT-14673_CHLORURE_DE_CALCIUM_RENAUDIN_QD_INS_Avis1_CT14673.pdf
HAS/2015-11-16_CT-14680_ADANCOR_PIS_RI_Avis1_CT14680.pdf
HAS/2015-11-16_CT-14683_CLARADOL_PIS_RI_Avis1_CT14683.pdf
HAS/2015-11-16_CT-14696_ALFACALCIDOL_TEVA_PIS_RI_Avis2_CT14696.pdf
HAS/2015-11-16_CT-14701_SOMAVERT_QD_INS_Avis1_CT14701.pdf
HAS/2015-11-16_CT-14744_TWYNSTA_PIS_RI_Avis 2_CT14744.pdf
HAS/2015-11-16_corevalve_13092016_avis_efficience_.pdf
HAS/2015-11-16_corevalve_13102015_avis_efficience.pdf
HAS/2015-11-16_fiche_memo_uretrites_cervicites_durees_antibiotherapies_.pdf
HAS/2015-11-16_itrel_3plus.pdf
HAS/2015-11-16_rapport_elaboration__durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2015-11-16_reco360_synthese_durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2015-11-16_traitement_des_uretrites_et_cervicites_non_compliquees_-_note_de_cadrage.pdf
HAS/2015-11-18_CEPP-4820_iSTENT_20 Octobre 2015_(4820)_avis.pdf
HAS/2015-11-18_CEPP-4914_BALANCE FOOT_06 Octobre 2015_(4914)_avis.pdf
HAS/2015-11-18_CEPP-4953_SMARTVIEW_20 Octobre 2015_(4953)_avis.pdf
HAS/2015-11-18_CEPP-4954_SMARTVIEW_20 Octobre 2015_(4954)_avis.pdf
HAS/2015-11-18_CEPP-4955_SMARTVIEW_20 Octobre 2015_(4955)_avis.pdf
HAS/2015-11-18_CT-12758_NEULASTA_PIS_RI_Avis2_CT12758.pdf
HAS/2015-11-18_CT-13197_IMMUNOGLOBULINE_EQUINE_TETANIQUE_PASTEUR_PIS_RI_Avis2_CT13197.pdf
HAS/2015-11-18_CT-13409_THERALENE_PIS_RI_Avis1_CT13409.pdf
HAS/2015-11-18_CT-13957_AZADOSE-ZITHROMAX_PIS_RI_Avis2_CT13957.pdf
HAS/2015-11-18_CT-14534_DECAPEPTYL_LP_PIS_RI_Avis2_CT14534.pdf
HAS/2015-11-18_CT-14557_CIVIGEL_PIS_RI_Avis2_CT14557.pdf
HAS/2015-11-18_CT-14567_GEL_LARMES-SICCAFLUID_PIS_RI_Avis2_CT14567&14601.pdf
HAS/2015-11-18_CT-14635_BERINERT_QD_INS_Avis2_CT14635.pdf
HAS/2015-11-18_argumentaire_-_transfusions_de_plaquettes.pdf
HAS/2015-11-18_fiche_de_synthese_-_transfusion_de_plaquettes_dans_le_contexte_perioperatoire.pdf
HAS/2015-11-18_fiche_de_synthese_-_transfusion_de_plaquettes_en_medecine_hematologie-oncologie.pdf
HAS/2015-11-18_fiche_de_synthese_-_transfusion_de_plaquettes_en_neonatologie.pdf
HAS/2015-11-18_pnds-sclerose_laterale_amyotrophique_sla.pdf
HAS/2015-11-18_pnds_61_-_sclerose_laterale_amyotrophique_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2015-11-18_rapport_des_avis_du_groupe_de_lecture_-_transfusion_de_plaquettes.pdf
HAS/2015-11-18_recommandation_trisomie_21.pdf
HAS/2015-11-18_recommandations_-_transfusion_de_plaquettes.pdf
HAS/2015-11-19_argumentaire_cmv_me_vd.pdf
HAS/2015-11-19_inahta_brief_cmv.pdf
HAS/2015-11-20_argumentaire_ebv.pdf
HAS/2015-11-20_inahta_brief_epstein_barr_virus.pdf
HAS/2015-11-24_4pages_idm_2015_vd.pdf
HAS/2015-11-24_4pages_sca_2015_vd.pdf
HAS/2015-11-24_ipaqss_analyse_descriptive_mco.pdf
HAS/2015-11-24_ipaqss_analyse_descriptive_ssr.pdf
HAS/2015-11-24_ipaqss_rapport_idm-vf.pdf
HAS/2015-11-24_plaquette_idm_sca_vf.pdf
HAS/2015-11-24_plaquette_idm_vf.pdf
HAS/2015-11-24_rapport-idm_vf_2014-07-16_17-47-37_160.pdf
HAS/2015-11-24_rapport_long_idm_2015_vd.pdf
HAS/2015-11-24_synthese_idm_2015_vd.pdf
HAS/2015-11-25_CT-14142_ZEFFIX_PIS_RI_Avis2_CT14142.pdf
HAS/2015-11-25_CT-14511_RETROVIR_PIS_RI_Avis2_CT14511.pdf
HAS/2015-11-25_CT-14524_QUADRASA_PIS_RI_Avis1_CT14524.pdf
HAS/2015-11-25_CT-14572_LOCERYL_PIS_RI_Avis1_CT14572.pdf
HAS/2015-11-25_CT-14579_RULID_PIS_RI_Avis2_CT14579.pdf
HAS/2015-11-25_CT-14665_SIROCTID_PIS_RI_Avis2_CT14665.pdf
HAS/2015-11-25_CT-14684_CLARADOL_CAFEINE_PIS_RI_Avis1_CT14684.pdf
HAS/2015-11-25_CT-14693_IKOREL_PIS_RI_Avis2_CT14693.pdf
HAS/2015-11-25_CT-14711_BECLO-RHINO_PIS_RI_Avis1_CT14711.pdf
HAS/2015-11-26_CEPP-4946_ALOVA_20 Octobre 2015_(4946)_avis.pdf
HAS/2015-11-26_CEPP-4951_INCRAFT_06 Octobre 2015_(4951)_avis.pdf
HAS/2015-11-26_CEPP-4993_VISMED_03_novembre_2015_(4993)_avis.pdf
HAS/2015-11-26_CEPP-4997_VISMED MULTI_03_novembre_2015_(4997)_avis.pdf
HAS/2015-11-27_pnds_-_atrophie_mutisystematisee.pdf
HAS/2015-11-27_pnds_62_-_atrophie_multi-systematisee_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2015-12-02_c_2015_0229_rbp_transplantation_renale.pdf
HAS/2015-12-02_cpg_kidney_transplantation_access_to_waiting_list.pdf
HAS/2015-12-02_cpg_kidney_transplantation_patient_information_before_access_to_waiting_list.pdf
HAS/2015-12-02_note_cadrage_greffe_renale_mel.pdf
HAS/2015-12-02_rbp_argumentaire_greffe_renale_vd_mel.pdf
HAS/2015-12-02_rbp_greffe_renal_fiche_synthese_criteres_v1_pao.pdf
HAS/2015-12-02_rbp_greffe_renal_fiche_synthese_informations_v1_pao.pdf
HAS/2015-12-02_rbp_greffe_renale_resultats_gl_anonyme_mel.pdf
HAS/2015-12-02_rbp_recommandations_greffe_renale_vd_mel.pdf
HAS/2015-12-03_CEPP-4979_PHOENIX_03_novembre_2015_(4979)_avis.pdf
HAS/2015-12-03_CEPP-5012_SPRINGLITE ADVANTAGE_03_novembre_2015_(5012)_avis_radiation.pdf
HAS/2015-12-04_CEPP-4956_NEUROFORM ATLAS_03_novembre_2015_(4956)_avis.pdf
HAS/2015-12-04_ald_27_gm_spondylarthrite_web.pdf
HAS/2015-12-04_ald_27_gp_spondylarthrite_web.pdf
HAS/2015-12-04_ald_27_lap_spondylarthrite_web.pdf
HAS/2015-12-04_fdr_gonocoque_vd.pdf
HAS/2015-12-04_gm_polyarthrite_web.pdf
HAS/2015-12-04_gp_ald_polyarthrite_.pdf
HAS/2015-12-04_inahta_brief_neisseria_gonorrhoeae_2016-04-28_14-04-47_742.pdf
HAS/2015-12-04_lap_polyarthrite_web.pdf
HAS/2015-12-04_sorin_newliving.pdf
HAS/2015-12-04_taan_gonocoques_argumentaire.pdf
HAS/2015-12-07_bilharziose_final_lap_janvier_2008.pdf
HAS/2015-12-07_guide_bilharziose_final_web.pdf
HAS/2015-12-08_CEPP-4889_DEXCOM_17_novembre_2015_(4889)_avis.pdf
HAS/2015-12-08_CEPP-4917_ASPIRE SR106_17_novembre_2015_(4917)_avis.pdf
HAS/2015-12-10_CEPP-4818_HINTEGRA_03_novembre_2015(4818_avis.pdf
HAS/2015-12-10_CT-13976_ALDARA_PIS_RI_EPI_Avis2_CT13976.pdf
HAS/2015-12-10_CT-13991_ANSATIPINE_PIS_RI_Avis2_CT13991.pdf
HAS/2015-12-10_CT-14086_CARTREX_PIS_REEV_Avis2_CT14086.pdf
HAS/2015-12-10_CT-14271_KETODERM_PIS_RI_Avis1_CT14271.pdf
HAS/2015-12-10_CT-14366_IOPIDINE_PIS_RI_Avis2_CT14366.pdf
HAS/2015-12-10_CT-14418_TARGAXAN_PIC_INS_Avis3_CT14418.pdf
HAS/2015-12-10_CT-14437_ZONTIVITY_PIC_INS_AvisPostAud_CT14437.pdf
HAS/2015-12-10_CT-14463_MONOSEPT_PIS_RI_Avis1_CT14463.pdf
HAS/2015-12-10_CT-14581_PICOPREP_PIS_RI_Avis1_CT14581.pdf
HAS/2015-12-10_composition_gt_valves_aortiques_transcutanees.pdf
HAS/2015-12-10_rapport_eval_encadrement_des_centres_cavfinale.pdf
HAS/2015-12-10_zontivity_-_avis_defficience_masque.pdf
HAS/2015-12-10_zontivity_sapub_ct14437.pdf
HAS/2015-12-10_zontivity_summary_ct14437.pdf
HAS/2015-12-11_CEPP-4820_iSTENT_20 Octobre 2015_(4820)_avis.pdf
HAS/2015-12-11_CEPP-4830_iSTENT INJECT 21 07 2015 (4830) avis.pdf
HAS/2015-12-11_pnds_-_maladie_de_gaucher.pdf
HAS/2015-12-11_pnds_63_-_maladie_de_gaucher_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2015-12-11_rapport_evaluation_micro-stents_de_pontage_trabeculaire.pdf
HAS/2015-12-14_CT-13247_GLIVEC_PIS_RI_Avis1_CT13247.pdf
HAS/2015-12-14_CT-13873_CHLORHYDRATE_DE_METOCLOPRAMIDE_RENAUDIN_QD_INS_Avis1_CT13873.pdf
HAS/2015-12-14_CT-13903_EZETROL_PIS_RI_Avis2_CT13903.pdf
HAS/2015-12-14_CT-14492_ARNICA_BOIRON_PIS_RI_Avis2_CT14492.pdf
HAS/2015-12-14_CT-14529_INEGY_PIS_RI_Avis2_CT14529.pdf
HAS/2015-12-14_CT-14722_OESCLIM_PIS_RI_Avis2_CT14722.pdf
HAS/2015-12-14_CT-14727_CLIMASTON_PIS_RI_Avis2_CT14727.pdf
HAS/2015-12-14_CT-14761_SIMVASTATINE_ARROW_LAB_QD_INS_Avis2_CT14761.pdf
HAS/2015-12-14_CT-14788_OLMETEC_PIC_RECOURS_R163-13_Avis3_CT14788.pdf
HAS/2015-12-14_CT-14789_COOLMETEC_PIC_RECOURS_R163-13_Avis3_CT14789.pdf
HAS/2015-12-14_CT-14790_SEVIKAR_PIC_RECOURS_R163-13_Avis3_CT14790.pdf
HAS/2015-12-14_CT-14791_ALTEIS_PIC_RECOURS_R163-13_Avis3_CT14791.pdf
HAS/2015-12-14_CT-14792_ALTEISDUO_PIC_RECOURS_R163-13_Avis3_CT14792.pdf
HAS/2015-12-14_CT-14793_AXELER_PIC_RECOURS_R163-13_Avis3_CT14793.pdf
HAS/2015-12-17_CT-14260_CITRAFLEET_PIS_RI_Avis3_CT14260.pdf
HAS/2015-12-17_CT-14618_OVALEAP_PIS_INS_Avis2_CT14618.pdf
HAS/2015-12-17_CT-14633_SEEBRI_BREEZHALER_QD_INS_Avis1_CT14633.pdf
HAS/2015-12-17_CT-14675_PEFLACINE_PIS_RI_Avis1_CT14675.pdf
HAS/2015-12-17_CT-14715_VORICONAZOLE_ACCORD_QD_INS_Avis1_CT14715.pdf
HAS/2015-12-17_CT-14720_LEVONORGESTREL-ETHINYLESTRADIOL_MEDIPHA_SANTE_QD_INS_Avis1_CT14720.pdf
HAS/2015-12-17_CT-14747_ESMOCARD_QD_INS_Avis1_CT14747.pdf
HAS/2015-12-17_CT-14762_REVESTIVE_QD_INS_Avis1_CT14762.pdf
HAS/2015-12-17_CT-14769_NORADRENALINE_TARTRATE_AGUETTANT_QD_INS_Avis2_CT14769.pdf
HAS/2015-12-17_CT-14804_HEPARINE_CHOAY_QD_INS_Avis1_CT14804.pdf
HAS/2015-12-17_anesm-rbpp-prise_en_compte_de_la_sante_en_chrs-ea.pdf
HAS/2015-12-17_anesm-rbpp-prise_en_compte_de_la_sante_en_chrs-pdf_interactif.pdf
HAS/2015-12-17_anesm-synthe_se-prise_en_compte_de_la_sante_en_chrs.pdf
HAS/2015-12-17_bibliographie_rbpp_sante_chrs.pdf
HAS/2015-12-17_decision_n_2015-67_-_decision_portant_adoption_de_la_rbpp_prise_en_compte_de_la_sante_physique_et_psychique_chrs.pdf
HAS/2015-12-17_lettre_de_cadrage_sante_inclusion.pdf
HAS/2015-12-18_CEPP-4923_MODULEN IBD_01_decembre_2015_(4923)_avis.pdf
HAS/2015-12-18_CEPP-4965_NEURO ZTI_01_décembre_2015_(4965)_avis.pdf
HAS/2015-12-18_anesm-handicap_psychique_participants__erratum_.pdf
HAS/2015-12-18_anesm-synthese-hand-handicap_psychique-mai2016.pdf
HAS/2015-12-18_anesm_1__rbpp_accompagnement_adultes_handicapes_psychiques_2016.pdf
HAS/2015-12-18_bibliographie_handicap_psychique.pdf
HAS/2015-12-18_decision_n_2015-68_-_decision_portant_adoption_de_la_rbpp_adultes_handicapes_psychiques_l312-1.pdf
HAS/2015-12-18_lettre_de_cadrage_handicap_psychique_octobre_2014.pdf
HAS/2015-12-21_app_387_389_390_391_392_note_de_cadrage_maj_referentiel_certification_lap_coi_2020_02_13_v2_partie1.pdf
HAS/2015-12-21_bilan_a_6_mois__plan_personnalise_sante__vf_web.pdf
HAS/2015-12-21_exemple_de_pps_complete_a_partir_de_vignettes_cliniques_web.pdf
HAS/2015-12-21_experimentation_d_hotels_pour_patients_-_feuille_de_route.pdf
HAS/2015-12-21_lap_htap_novembre_2007.pdf
HAS/2015-12-21_pnds_8_-_hypertension_arterielle_pulmonaire_htap_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2015-12-21_pnds_htap_decembre_2007_vu_doc.pdf
HAS/2015-12-21_pps-version_web_juillet2013.pdf
HAS/2015-12-21_precisions_sur_les_certifications_des_lap_et_des_lad_-_version_du_22_septembre_2016.pdf
HAS/2015-12-21_procedure_lad_version_2022.pdf
HAS/2015-12-21_questionnaire_pps_web.pdf
HAS/2015-12-21_rapport_dorientation_-_criteres_deligibilite_des_patients_a_un_hebergement_a_proximite_dun_etablissement_de_sante.pdf
HAS/2015-12-21_referentiel_lad_officine_2018_12_20.pdf
HAS/2015-12-21_synthese_mode_d-emploi_du_pps_web.pdf
HAS/2015-12-22_CT-14362_FEMARA_PIS_RI_Avis1_CT14362.pdf
HAS/2015-12-22_CT-14424_FEMARA_PIC_EI_Avis1_CT14424.pdf
HAS/2015-12-22_CT-14745_LINEZOLIDE_KABI_QD_INS_Avis2_CT14745.pdf
HAS/2015-12-22_CT-14768_LEVOCARNIL_PIS_RI_Avis1_CT14768.pdf
HAS/2015-12-22_femara_summary_ct14424.pdf
HAS/2015-12-22_femara_synthese_ct14424.pdf
HAS/2015-12-22_nouvelles_durees_dinscription_30_juin_2015_saisine_dgs_dss.pdf
HAS/2015-12-23_CEPP-4949_ENTERPRISE_17_novembre_2015_(4949)_avis_caviarde.pdf
HAS/2015-12-23_CEPP-4950_ENTERPRISE 2_17_novembre_2015_(4950)_avis.pdf
HAS/2015-12-23_CEPP-4964_REPLY CRT P_03_novembre_2015_(4964)_avis.pdf
HAS/2015-12-23_CEPP-4968_SIMPLYGO MINI_01_decembre_2015_(4968)_avis.pdf
HAS/2015-12-23_CEPP-5010_OPTIVE FUSION_15_decembre_2015_(5010)_avis.pdf
HAS/2015-12-23_systeme_stimulation_cerebrale_profonde_20_octobre_2015_5011.pdf
HAS/2016-01-05_CT-13580_KOGENATE_BAYER_PIC_REEV_Avis2_CT13580.pdf
HAS/2016-01-05_CT-13636_ARIXTRA_PIS_RI_Avis2_CT13414&13636.pdf
HAS/2016-01-05_CT-13917_HELIXATE_NEXGEN_PIC_REEV_Avis2_CT13917.pdf
HAS/2016-01-05_CT-14143_NUWIQ_PIC_INS_Avis2_CT14143.pdf
HAS/2016-01-05_CT-14226_CILOXAN_PIS_RI_Avis2_CT14226.pdf
HAS/2016-01-05_CT-14443_DERMOBACTER_PIS_RI_Avis1_CT14443.pdf
HAS/2016-01-05_CT-14672_CHLORHYDRATE_DE_LIDOCAINE_RENAUDIN_QD_INS_Avis1_CT14672.pdf
HAS/2016-01-05_CT-14674_MITOXANTRONE_ACCORD_QD_INS_Avis1_CT14674.pdf
HAS/2016-01-05_CT-14757_OCTANATE_LV_QD_INS_Avis2_CT14757.pdf
HAS/2016-01-05_CT-14784_TADENAN_QD_INS_Avis1_CT14784.pdf
HAS/2016-01-05_CT-14794_MANNITOL_LAVOISIER_QD_INS_Avis1_CT14794.pdf
HAS/2016-01-05_CT-14809_MEBEVERINE_ZYDUS_PIS_RI_Avis1_CT14809.pdf
HAS/2016-01-05_CT-14813_FINASTERIDE_ARROW_LAB_QD_INS_Avis1_CT14813.pdf
HAS/2016-01-05_CT-14867_LUCENTIS_PIC_EPI_Avis2_CT14867.pdf
HAS/2016-01-05_helixate_kogenate_sapub_ct13580_ct13917.pdf
HAS/2016-01-05_helixate_kogenate_summary_ct13580_ct13917.pdf
HAS/2016-01-05_nuwiq_sapub_ct14143.pdf
HAS/2016-01-05_nuwiq_summary_ct14143.pdf
HAS/2016-01-08_CT-13156_SUTENT_PIS_RI_Avis2_CT13156.pdf
HAS/2016-01-08_CT-13934_ARZERRA_PIC_EI_Avis2_CT13934.pdf
HAS/2016-01-08_CT-14075_ORAVIR_PIS_RI_Avis2_CT14075.pdf
HAS/2016-01-08_CT-14100_ERBITUX_PIC_REEV_Avis3_CT14100.pdf
HAS/2016-01-08_CT-14127_NEXOBRID_PIC_INS_AvisPostAud_CT14127.pdf
HAS/2016-01-08_CT-14227_STRUCTOCAL_VITAMINE_D3_PIS_INS_Avis1_CT14227.pdf
HAS/2016-01-08_CT-14237_PROCYSBI_PIC_INS_AvisPostAud_CT14237.pdf
HAS/2016-01-08_CT-14708_SOMATULINE_PIS_RI_Avis2_CT14708.pdf
HAS/2016-01-08_CT-14729_SALMESON_PIS_INS_AvisPostObs_CT14729.pdf
HAS/2016-01-08_CT-14742_KUVAN_PIS_EI_Avis2_CT14742.pdf
HAS/2016-01-08_CT-14764_CEFAZOLINE_HOSPIRA_QD_INS_Avis2_CT14764.pdf
HAS/2016-01-08_CT-14800_LOPRIL_PIS_RI_Avis2_CT14800.pdf
HAS/2016-01-08_arzerra_sapub_ct13934.pdf
HAS/2016-01-08_arzerra_summary_ct13934.pdf
HAS/2016-01-08_nexobrid_summary_ct14127.pdf
HAS/2016-01-08_nexobrid_synthese_ct14127.pdf
HAS/2016-01-08_procysbi_sapub_ct14237.pdf
HAS/2016-01-08_procysbi_summary_ct14237.pdf
HAS/2016-01-13_CEPP-4969_3C100 C-LEG _01_decembre_2015_(4969)_avis.pdf
HAS/2016-01-13_CEPP-4974_HELIX-3D-7E10_01_decembre_2015_(4974)_avis.pdf
HAS/2016-01-13_CEPP-5014_SPOT_15_decembre_2015_(5014)avis.pdf
HAS/2016-01-13_CEPP-5022_PIED AERIS K2_15_decembre_2015_(5022)_avis.pdf
HAS/2016-01-13_CT-14098_LYNPARZA_PIC_INS_Avis2_CT14098.pdf
HAS/2016-01-13_cooperation_between_anaesthetists-_resuscitation_specialists_and_surgeons.pdf
HAS/2016-01-13_fiche_15_points-cles_pour_une_pratique_efficace_-cooperation_anesthesistes-reanimateurs_chirurgiens.pdf
HAS/2016-01-13_fiche_action_cooperation_entre_anesthesistes-reanimateurs_et_chirugiens.pdf
HAS/2016-01-13_fiche_synthese_de_levaluation__cooperation_entre_anesthesistes-reanimateurs_et_chirurgiens.pdf
HAS/2016-01-13_lynparza_sapub2_ct14098.pdf
HAS/2016-01-13_lynparza_summary_ct14098.pdf
HAS/2016-01-13_nucleus_ci532.pdf
HAS/2016-01-13_points_cles_et_solutions_-_cooperation_entre_anesthesistes-reanimateurs_et_chirurgiens.pdf
HAS/2016-01-13_rapport_delaboration_-_ssp_cooperation_entre_anesthesistes-reanimateurs_et_chirurgiens.pdf
HAS/2016-01-13_speedcinch.pdf
HAS/2016-01-14_CEPP-4821_AQUALEG_17_novembre_2015_(4821)_avis.pdf
HAS/2016-01-14_CEPP-4948_RM PRESSFIT VITAMYS_12_janvier_2016_(4948)_avis.pdf
HAS/2016-01-14_CT-14686_ZINNAT_PIS_RI_Avis2_CT14686.pdf
HAS/2016-01-14_CT-14805_ALPRAZOLAM_MYLAN_QD_INS_Avis1_CT14805.pdf
HAS/2016-01-14_CT-14829_ADENOSINE_MEDAC_QD_INS_Avis1_CT14829.pdf
HAS/2016-01-14_plasmafit_vitelene_avis.pdf
HAS/2016-01-14_vibrant_soundbridge_indication_des_surdites_neurosensorielles.pdf
HAS/2016-01-15_CEPP-4943_WINGSPAN_01_decembre_2015_(4943)_avis_caviarde.pdf
HAS/2016-01-15_CEPP-4972_MEPITEL_15_decembre_2015_(4972)_avis.pdf
HAS/2016-01-15_CEPP-4973_MEPITEL ONE_15_decembre_2015_(4973)_avis.pdf
HAS/2016-01-18_CT-13469_EVIPLERA_PIC_MCI_Avis3_CT13469.pdf
HAS/2016-01-18_CT-13638_STRIBILD_PIC_MCI_Avis3_CT13638.pdf
HAS/2016-01-18_CT-13974_AVASTIN_PIC_EI_Avis2_CT13974.pdf
HAS/2016-01-18_CT-14208_CERDELGA_PIC_INS_Avis3_CT14208.pdf
HAS/2016-01-18_CT-14209_KEAL_PIS_RI_AvisPostAud_CT14209.pdf
HAS/2016-01-18_CT-14395_SIVEXTRO_PIC_INS_AvisPostObs_CT14395.pdf
HAS/2016-01-18_CT-14451_RAPLIXA_PIC_INS_Avis2_CT14451.pdf
HAS/2016-01-18_CT-14548_ORBACTIV_PIC_INS_Avis2_CT14548.pdf
HAS/2016-01-18_CT-14620_TOBI-TOBI_PODHALER_PIS_RI_Avis1_CT14620.pdf
HAS/2016-01-18_CT-14666_ORELOX_PIS_RI_Avis1_CT14666.pdf
HAS/2016-01-18_CT-14778_ARACYTINE_PIS_RI_Avis2_CT14778.pdf
HAS/2016-01-18_CT-14831_SOLUDACTONE_QD_INS_Avis2_CT14831.pdf
HAS/2016-01-18_CT-14833_ACUITEL_PIS_RI_Avis2_CT14833.pdf
HAS/2016-01-18_CT-14853_NORVIR_QD_INS_Avis1_CT14853.pdf
HAS/2016-01-18_CT-14869_FLIXOVATE_PIC_EPI_Avis2_CT14869.pdf
HAS/2016-01-18_avastin_ovaire_summary_ct13974.pdf
HAS/2016-01-18_avastin_ovaire_synthese_ct13974.pdf
HAS/2016-01-18_cerdelga_summary_ct14208.pdf
HAS/2016-01-18_cerdelga_synthese_ct14208.pdf
HAS/2016-01-18_eviplera_summary_ct13469.pdf
HAS/2016-01-18_eviplera_synthese_ct13469.pdf
HAS/2016-01-18_keal_summary_ct14209.pdf
HAS/2016-01-18_keal_synthese_ct14209.pdf
HAS/2016-01-18_orbactiv_summary_ct14548.pdf
HAS/2016-01-18_orbactiv_synthese_ct14548.pdf
HAS/2016-01-18_raplixa_summary_ct14319.pdf
HAS/2016-01-18_raplixa_synthese_ct14319.pdf
HAS/2016-01-18_sivextro_summary_ct14395.pdf
HAS/2016-01-18_sivextro_synthese_ct14395.pdf
HAS/2016-01-18_stribild_synthese_ct13638.pdf
HAS/2016-01-21_CEPP-4810_REPLY 200 DR_12_janvier_2016_(4810)_avis.pdf
HAS/2016-01-21_CEPP-4812_KORA 100 DR_12_janvier_2016_(4812)_avis.pdf
HAS/2016-01-21_CT-13352_AZARGA_PIS_RI_Avis2_CT13352.pdf
HAS/2016-01-21_CT-14349_AFINITOR_PIS_RI_Avis1_CT14349.pdf
HAS/2016-01-21_CT-14627_TRUVADA_PIS_RI_Avis1_CT14627.pdf
HAS/2016-01-21_CT-14704_PENTASA_PIS_RI_Avis2_CT14704.pdf
HAS/2016-01-21_CT-14740_CIFLOX-UNIFLOX_PIS_RI_Avis2_CT14740.pdf
HAS/2016-01-21_CT-14811_BRIAZIDE-CIBADREX_PIS_RI_Avis2_CT14811.pdf
HAS/2016-01-21_CT-14812_BRIEM-CIBACENE_PIS_RI_Avis2_CT14812.pdf
HAS/2016-01-21_CT-14839_ZANIDIP_PIS_RI_Avis2_CT14839.pdf
HAS/2016-01-21_CT-14844_LERCAN_PIS_RI_Avis2_CT14844.pdf
HAS/2016-01-21_CT-14859_BAYPRESS_PIS_RI_Avis2_CT14859.pdf
HAS/2016-01-22_07-042-traceur_liste-adl-avc.pdf
HAS/2016-01-22_07-042_traceur_guide-adl-avc.pdf
HAS/2016-01-22_08-097_gp_acv.pdf
HAS/2016-01-25_CT-14682_EYLEA_PIC_EI_OBVR_Avis2_CT14682.pdf
HAS/2016-01-25_CT-14822_ZOCOR_PIS_RI_Avis2_CT14822.pdf
HAS/2016-01-25_eylea_obvr_summary_ct14682.pdf
HAS/2016-01-25_eylea_obvr_synthese_ct14682.pdf
HAS/2016-01-28_CEPP-4922_MICHELANGELO_12_janvier_2016_(4922)_avis.pdf
HAS/2016-01-28_CT-14039_CETORNAN_PIC_RI_Avis3_CT14039.pdf
HAS/2016-01-28_CT-14224_GLYBERA_PIC_INS_Avis3_CT14224.pdf
HAS/2016-01-28_CT-14397_ERWINASE_PIC_INS_Avis2_CT14397.pdf
HAS/2016-01-28_CT-14807_TENSTATEN_PIS_RI_Avis2_CT14807.pdf
HAS/2016-01-28_CT-14905_ATOSIBAN_PANPHARMA_QD_INS_Avis2_CT14905.pdf
HAS/2016-01-28_cadrage_thermoplastie_bronchique.pdf
HAS/2016-01-28_cetornan_summary_ct14506.pdf
HAS/2016-01-28_cetornan_synthese_ct14039.pdf
HAS/2016-01-28_erwinase_summary_ct14397.pdf
HAS/2016-01-28_erwinase_synthese_ct14397.pdf
HAS/2016-01-28_glybera_summary_ct14224.pdf
HAS/2016-01-28_glybera_synthese_ct14224.pdf
HAS/2016-01-28_inahta_brief_thermoplasty.pdf
HAS/2016-01-28_rapport_thermo_bronch.pdf
HAS/2016-01-29_CEPP-4909_UROLIFT_26_janvier_2016_(4909)_avis.pdf
HAS/2016-01-29_CT-13077_KEFORAL_PIS_RI_Avis1_CT13077.pdf
HAS/2016-01-29_CT-14218_ANAUSIN_METOCLOPRAMIDE_PIC_REEV_Avis2_CT14218.pdf
HAS/2016-01-29_CT-14253_PRIMPERAN_PIC_RI_REEV_Avis2_CT12392&14253.pdf
HAS/2016-01-29_CT-14442_GABITRIL_PIS_RI_Avis1_CT14442.pdf
HAS/2016-01-29_CT-14455_ZYKADIA_PIC_INS_Avis2_CT14455.pdf
HAS/2016-01-29_CT-14510_LENVIMA_PIC_INS_Avis3_CT14510.pdf
HAS/2016-01-29_CT-14516_ALFATIL_PIS_RI_Avis1_CT14516.pdf
HAS/2016-01-29_CT-14586_NORDITROPINE_PIS_RI_EPI_Avis2_CT14558&14586.pdf
HAS/2016-01-29_CT-14594_MENOTROPHINE_LG_PIC_INS_Avis2_CT14594.pdf
HAS/2016-01-29_CT-14728_FORMOTEROL_MYLAN_PIS_INS_Avis1_CT14728.pdf
HAS/2016-01-29_CT-14752_BILTRICIDE_PIS_RI_Avis1_CT14752.pdf
HAS/2016-01-29_argumentaire_herpesviridae_popge.pdf
HAS/2016-01-29_argumentaire_herpesviridae_vih.docx.pdf
HAS/2016-01-29_inahta_brief_herpeveridae_popge.pdf
HAS/2016-01-29_inahta_brief_herpeveridae_vih.pdf
HAS/2016-01-29_lenvima_summary_ct14510.pdf
HAS/2016-01-29_lenvima_synthese_ct14510.pdf
HAS/2016-01-29_menotrophine_lg_summary_ct14594.pdf
HAS/2016-01-29_menotrophine_lg_synthese_ct14594.pdf
HAS/2016-01-29_metoclopramide_reevaluation__summary.pdf
HAS/2016-01-29_metoclopramide_reevaluation__synthese.pdf
HAS/2016-01-29_zykadia__summary__ct14455.pdf
HAS/2016-01-29_zykadia__synthese__ct14455.pdf
HAS/2016-02-01_CEPP-4881_SAPIEN_3_CERTITUDE_22 Septembre 2015_(4881)_avis.pdf
HAS/2016-02-01_CEPP-5008_ABSORB_12_janvier_2016_(5008)_avis_caviarde.pdf
HAS/2016-02-01_CEPP-5009_ABSORB GT1_12_janvier_2016_(5009)_avis_caviarde.pdf
HAS/2016-02-01_CT-12384_PROKINYL_LP_PIC_REEV_Avis2_CT12384.pdf
HAS/2016-02-01_bioprotheses_valvulaires_cardiaques_-_referentiel.pdf
HAS/2016-02-01_metoclopramide_reevaluation__summary.pdf
HAS/2016-02-01_metoclopramide_reevaluation__synthese.pdf
HAS/2016-02-01_pnds_-_deletion_22q11_2.pdf
HAS/2016-02-01_pnds_64_-_deletion_22q11_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-02-01_sapien_3_avis_efficience_20151013_2017-02-16_14-53-41_15.pdf
HAS/2016-02-03_CEPP-4870_SAPIEN_3_COMMANDER_22 Septembre 2015_(4870)_avis.pdf
HAS/2016-02-03_CEPP-5056_COREVALVE_EVOLUT_R_12_janvier_2016_(5056)_avis_(QD_Erreur ref).pdf
HAS/2016-02-03_CT-13937_VOTRIENT_PIC_REEV_AvisPostAud_CT13937.pdf
HAS/2016-02-03_CT-14263_XIGDUO_PIC_INS_Avis2_CT14263.pdf
HAS/2016-02-03_CT-14270_FORXIGA_PIC_EI_Avis2_CT14273&14270.pdf
HAS/2016-02-03_forxiga_sapub_ct14273_14270.pdf
HAS/2016-02-03_sapien_3_avis_efficience_20151013_2017-02-16_14-53-41_15.pdf
HAS/2016-02-03_votrient_rein__sapub__ct13937.pdf
HAS/2016-02-03_votrient_rein__summary__ct13937.pdf
HAS/2016-02-03_xigduo_sapub_ct14263.pdf
HAS/2016-02-03_xigduo_summary_ct14263.pdf
HAS/2016-02-05_CT-13714_HAXIFAL_PIS_RI_Avis1_CT13714.pdf
HAS/2016-02-05_CT-14084_VESICARE_PIS_RI_Avis2_CT14084.pdf
HAS/2016-02-05_CT-14131_BOOSTRIXTETRA_PIS_RI_Avis2_CT14131.pdf
HAS/2016-02-05_CT-14517_DANTRIUM_PIS_RI_Avis2_CT14517.pdf
HAS/2016-02-05_CT-14576_INFANRIXTETRA_PIS_RI_Avis2_CT14576.pdf
HAS/2016-02-05_CT-14577_INFANRIXQUINTA_PIS_RI_Avis2_CT14577.pdf
HAS/2016-02-05_CT-14719_VARIVAX_PIS_RI_Avis1_CT14719.pdf
HAS/2016-02-05_CT-14830_CARBIDOPA_LEVODOPA_TEVA_PIS_RI_Avis1_CT14830.pdf
HAS/2016-02-08_CT-13740_HEPSERA_PIS_RI_Avis1_CT13740.pdf
HAS/2016-02-08_CT-13762_TELZIR_PIS_RI_Avis2_CT13762.pdf
HAS/2016-02-08_CT-14556_VERSATIS_PIS_RI_Avis2_CT14556.pdf
HAS/2016-02-08_CT-14654_TRILEPTAL_PIS_RI_Avis2_CT14654.pdf
HAS/2016-02-08_CT-14723_TASMAR_PIS_RI_Avis2_CT14723.pdf
HAS/2016-02-08_CT-14782_INCRUSE_PIS_INS_Avis2_CT14782.pdf
HAS/2016-02-10_CEPP-4971_ROSIDAL K_26_janvier_2016_(4971)_avis.pdf
HAS/2016-02-10_CEPP-4988_ROSIDAL SYS_26_janvier_2016_(4988)_avis.pdf
HAS/2016-02-11_CT-11887_NEURONTIN_PIS_RI_Avis2_CT11887.pdf
HAS/2016-02-11_CT-13573_REPEVAX_PIS_RI_Avis2_CT13573.pdf
HAS/2016-02-11_CT-13854_VACCIN_BCG_SSI_PIS_RI_Avis2_CT13854.pdf
HAS/2016-02-11_CT-14590_MESTINON_LP_PIS_INS_Avis3_CT14590.pdf
HAS/2016-02-11_CT-14681_GRAZAX_PIC_RI_REEV_SMR_Avis2_CT14681.pdf
HAS/2016-02-11_CT-14896_MIGLUSTAT_BLUEFISH_QD_INS_Avis1_CT14896.pdf
HAS/2016-02-12_CEPP-4981_SYSTANE BALANCE_09_fevrier_2016_(4981)_avis.pdf
HAS/2016-02-12_CT-13065_COLPRONE_PIS_RI_Avis1_CT13065.pdf
HAS/2016-02-12_CT-13134_GLUCONATE_DE_CALCIUM_LAVOISIER_PIS_RI_Avis2_CT13134.pdf
HAS/2016-02-12_CT-14085_ZOXAN_PIS_RI_Avis2_CT14085.pdf
HAS/2016-02-12_CT-14130_ONYTEC_PIS_RI_Avis2_CT14130.pdf
HAS/2016-02-12_CT-14522_TILCOTIL_PIS_RI_Avis2_CT14522.pdf
HAS/2016-02-12_CT-14575_ACTRAPID_INSULATARD_MIXTARD_PIS_RI_Avis1_CT14575.pdf
HAS/2016-02-12_CT-14816_CALCIPRAT_VITAMINE_D3_PIS_RI_Avis2_CT14816.pdf
HAS/2016-02-12_CT-14832_AMIKACINE_MYLAN_QD_INS_Avis2_CT14832.pdf
HAS/2016-02-12_CT-14840_SPIRIVA_PIS_RI_Avis1_CT14840.pdf
HAS/2016-02-12_CT-14852_CIPROFLOXACINE_KABI_QD_INS_Avis2_CT14852.pdf
HAS/2016-02-12_CT-14862_ESMOCARD_QD_INS_Avis1_CT14862.pdf
HAS/2016-02-12_CT-14898_LINEZOLIDE_KABI_QD_INS_Avis2_CT14898.pdf
HAS/2016-02-12_CT-15010_JAKAVI_QD_INS_Avis1_CT15010.pdf
HAS/2016-02-12_thoraflex_hybrid.pdf
HAS/2016-02-15_CT-14776_HYDROCORTISONE_BIOCODEX_PIS_RI_Avis1_CT14776.pdf
HAS/2016-02-15_ane-rbpp_reperage_des_risques_personnes_agees-ehpad-pdf_interactif.pdf
HAS/2016-02-15_anesm-rbpp_reperage_des_risques_personnes_agees_a5-bat_-_pdf_interactif.pdf
HAS/2016-02-15_decision_no_2016-07_-_decision_portant_adoption_de_la_rbpp_reperage_des_risques_de_perte_d_autonomie_-_volet_a_domicile.pdf
HAS/2016-02-15_decision_no_2016-08_-_decision_portant_adoption_de_la_rbpp_reperage_des_risques_de_perte_d_autonomie_-_volet_ehpad.pdf
HAS/2016-02-15_fiche_repere_chutes_volet_resi_aut_decembre_2016_pdf.pdf
HAS/2016-02-15_fiche_repere_mauvaise_nutritiondenutrition_et_deshydratation__volet_resi_aut_decembre_2016_pdf.pdf
HAS/2016-02-15_fiche_repere_prise_de_medicaments_volet_resi_aut_decembre_2016_pdf.pdf
HAS/2016-02-15_fiche_repere_souffrance_physique_volet_resi_aut_decembre_2016.pdf
HAS/2016-02-15_fiche_repere_souffrance_psychique_volet_resi_aut_decembre_2016.pdf
HAS/2016-02-15_fiche_repere_troubles_du_comportement_volet_resi_aut_decembre_2016.pdf
HAS/2016-02-15_fiche_reperes_aidants_volet_resi_aut_decembre_2016.pdf
HAS/2016-02-15_grille_de_lecture_volet_resi_aut_decembre_2016.pdf
HAS/2016-02-16_cadrage_capsulecolique_vd.pdf
HAS/2016-02-16_fiche_de_bon_usage_traitement_des_plaies_par_pression_negative.pdf
HAS/2016-02-16_rapport_capsule_colique_vd.pdf
HAS/2016-02-16_rapport_devaluation_actes_de_prise_en_charge_de_palies_complexes_a_laide_dun_appareil_de_traitement_par_pression_negative.pdf
HAS/2016-02-16_rapport_devaluation_des_traitements_de_plaies_par_pression_negative_tpn.pdf
HAS/2016-02-16_texte_court_capsule_colique_vd.pdf
HAS/2016-02-19_CEPP-5044_OMNISPAN_09_fevrier_2016_(5044)_avis.pdf
HAS/2016-02-19_CT-13069_DUPHASTON_PIS_RI_Avis2_CT13069.pdf
HAS/2016-02-19_CT-13384_MERONEM_PIS_RI_Avis1_CT13384.pdf
HAS/2016-02-19_CT-13385_MERONEM_PIS_EI_Avis2_CT13385.pdf
HAS/2016-02-19_CT-13487_LUTENYL_PIS_RI_Avis2_CT13487.pdf
HAS/2016-02-19_CT-13545_EMEND_PIS_RI_Avis2_CT13545.pdf
HAS/2016-02-19_CT-13789_OROCAL_VIT_D3-CALCIUM_VIT_D3_TEVA-RATIOPHARM_PIS_RI_Avis2_CT13789.pdf
HAS/2016-02-19_CT-14067_RHOPHYLAC_PIS_RI_Avis1_CT14067.pdf
HAS/2016-02-19_CT-14526_APRANAX_PIS_RI_Avis2_CT14526.pdf
HAS/2016-02-19_CT-14549_ANTADYS_PIS_RI_Avis1_CT14549.pdf
HAS/2016-02-19_CT-14553_ACADIONE_PIS_RI_Avis1_CT14553.pdf
HAS/2016-02-19_CT-14564_ENGERIX_B_PIS_RI_Avis2_CT14564.pdf
HAS/2016-02-19_CT-14589_SEPTIVON_PIS_RI_Avis1_CT14589.pdf
HAS/2016-02-19_CT-14799_SURGESTONE_PIS_RI_Avis2_CT14799.pdf
HAS/2016-02-19_CT-14825_DOSTINEX_PIS_RI_Avis2_CT14825.pdf
HAS/2016-02-19_CT-14827_APIDRA_PIS_RI_Avis1_CT14827.pdf
HAS/2016-02-19_CT-14837_VIRAMUNE_PIS_RI_Avis2_CT14837.pdf
HAS/2016-02-19_CT-14887_TENORETIC_PIS_RI_Avis2_CT14887.pdf
HAS/2016-02-19_CT-14888_TENORDATE_PIS_RI_Avis2_CT14888.pdf
HAS/2016-02-19_CT-14892_CEFUROXIME_BGR_QD_INS_Avis1_CT14892.pdf
HAS/2016-02-19_CT-14897_ULTIBRO_BREEZHALER_QD_INS_Avis1_CT14897.pdf
HAS/2016-02-19_CT-14922_ZESTORETIC_PIS_RI_Avis2_CT14922.pdf
HAS/2016-02-19_CT-14924_ARTEX_PIS_RI_Avis2_CT14924.pdf
HAS/2016-02-19_CT-14925_HYPERIUM_PIS_RI_Avis2_CT14925.pdf
HAS/2016-02-21_ald_5_gm_troubles_du_rythme_web.pdf
HAS/2016-02-21_ald_5_gp_trv_web.pdf
HAS/2016-02-21_ald_5_lap_troubles_du_rythme_web.pdf
HAS/2016-02-22_CEPP-5039_CARELINK VR VISIA_09_fevrier_2016_(5039)_avis.pdf
HAS/2016-02-22_CEPP-5060_HOMEFILL II_09_fevrier_2016_(5060)_avis.pdf
HAS/2016-02-22_argumentaire_implants_mammaires.pdf
HAS/2016-02-25_CEPP-5015_AEQUASYAL_09_fevrier_2016_(5015)_avis.pdf
HAS/2016-02-25_prise_en_charge_de_la_douleur_chez_lenfant_-_alternatives_au_palier_2_-_note_de_cadrage.pdf
HAS/2016-02-25_prise_en_charge_medicamenteuse_de_la_douleur_chez_lenfant_alternatives_a_la_codeine_-_fiche_memo.pdf
HAS/2016-02-25_prise_en_charge_medicamenteuse_de_la_douleur_chez_lenfant_alternatives_a_la_codeine_-_rapport_delaboration.pdf
HAS/2016-02-29_CEPP-4916_IMPACT ENTERAL_09_fevrier_2016_(4916)_avis.pdf
HAS/2016-02-29_CEPP-4976_TIGE APTA_24_fevrier_2016_(4976)_avis.pdf
HAS/2016-02-29_CEPP-4977_PROTIBIS_23_fevrier_2016_(4977)_avis.pdf
HAS/2016-02-29_CEPP-4992_VERCISE PC_09_fevrier_2016_(4992)_avis_caviarde.pdf
HAS/2016-02-29_CEPP-5004_TIGE HYDRA_23_fevrier_2016_(5004)_avis.pdf
HAS/2016-02-29_CEPP-5005_TIGE RECTA_24_fevrier_2016_(5005)_avis.pdf
HAS/2016-02-29_CT-13930_ZYDELIG_PIC_INS_Avis3_CT13930.pdf
HAS/2016-02-29_CT-14103_LIPTRUZET_PIC_INS_Avis2_CT14103.pdf
HAS/2016-02-29_CT-14134_CYRAMZA_PIC_INS_Avis3_CT14134.pdf
HAS/2016-02-29_CT-14155_GENAC_PIS_RI_Avis1_CT14155.pdf
HAS/2016-02-29_CT-14287_VFEND_PIC_EIT_Avis2_CT14287.pdf
HAS/2016-02-29_CT-14318_JAKAVI_PIC_EI_Avis3_CT14318.pdf
HAS/2016-02-29_CT-14697_FLOLAN_PIS_EInondemandee_Avis1_CT14697.pdf
HAS/2016-02-29_CT-14883_RIFATER_PIS_RI_Avis1_CT14883.pdf
HAS/2016-02-29_CT-14912_NEUPOGEN_PIS_RI_Avis2_CT14912.pdf
HAS/2016-02-29_CT-14940_NIMOTOP_PIS_RI_Avis2_CT14940.pdf
HAS/2016-02-29_CT-14941_KOGENATE_BAYER_QD_INS_Avis1_CT14941.pdf
HAS/2016-02-29_CT-14954_NICOTINE_EG_FRUIT_SANS_SUCRE_QD_INS_Avis1_CT14954.pdf
HAS/2016-02-29_CT-14959_FOZITEC_PIS_RI_Avis2_CT14959.pdf
HAS/2016-02-29_CT-14986_VORICONAZOLE_ACCORD_QD_INS_Avis2_CT14986.pdf
HAS/2016-02-29_CT-15011_TRAMADOL_PARACETAMOL_MYLAN_QD_INS_Avis2_CT15011.pdf
HAS/2016-02-29_cyramza_summary_ct14134.pdf
HAS/2016-02-29_cyramza_synthese_ct14134.pdf
HAS/2016-02-29_helixate_kogenate_sapub_ct13580_ct13917.pdf
HAS/2016-02-29_helixate_kogenate_summary_ct13580_ct13917.pdf
HAS/2016-02-29_jakavi_summary_ct14318.pdf
HAS/2016-02-29_jakavi_synthese_ct14318.pdf
HAS/2016-02-29_januvia_pic_ri_avis2_ct12571_modifie.pdf
HAS/2016-02-29_januvia_summary_ct12571_ct12572_en.pdf
HAS/2016-02-29_januvia_synthese_ct12571_ct12572.pdf
HAS/2016-02-29_liptruzet_summary_ct14103.pdf
HAS/2016-02-29_liptruzet_synthese_ct14103.pdf
HAS/2016-02-29_vfend_summary_ct14287.pdf
HAS/2016-02-29_vfend_synthese_ct14287.pdf
HAS/2016-02-29_xelevia_pic_ri_avis2_ct125728_modifie.pdf
HAS/2016-02-29_zydelig_07042015_avis__efficience.pdf
HAS/2016-02-29_zydelig_16052017_avis_efficience.pdf
HAS/2016-02-29_zydelig_summary_ct13930.pdf
HAS/2016-02-29_zydelig_synthese_ct13930.pdf
HAS/2016-03-02_CT-14051_LUTERAN_PIS_RI_Avis2_CT14051.pdf
HAS/2016-03-02_CT-14933_INNOVAIR-FORMODUAL_NEXTHALER_PIS_EI_BPCO_Avis2_CT14933.pdf
HAS/2016-03-02_argumentaire_zika.pdf
HAS/2016-03-02_inahta_brief_zika.pdf
HAS/2016-03-04_CT-14700_NATULAN_PIS_RI_Avis2_CT14700.pdf
HAS/2016-03-04_CT-14786_REFRESH_PIS_RI_Avis1_CT14786.pdf
HAS/2016-03-04_CT-14894_NEFOPAM_BIOCODEX_QD_INS_Avis1_CT14894.pdf
HAS/2016-03-04_CT-14923_TENORMINE_PIS_RI_Avis2_CT14923.pdf
HAS/2016-03-04_CT-14972_MONICOR_PIS_RI_Avis1_CT14972.pdf
HAS/2016-03-04_CT-14973_DIAFUSOR_PIS_RI_Avis1_CT14973.pdf
HAS/2016-03-08_asip_sante_has_synthese_medicale.pdf
HAS/2016-03-08_synthese_medicale_quel_contenu_analyse_bibliographique.pdf
HAS/2016-03-09_oral_impact.pdf
HAS/2016-03-11_07-024_sclerose-guide_sans_lap.pdf
HAS/2016-03-11_08-093_gp_sep.pdf
HAS/2016-03-11_CT-10750_STERIDOSE_PIC_RI_Avis1_CT10750.pdf
HAS/2016-03-11_CT-10788_DACUDOSES_PIC_RI_Avis1_CT10788.pdf
HAS/2016-03-11_CT-11213_DACRYOSERUM_PIC_RI_Avis2_CT11213.pdf
HAS/2016-03-11_CT-13755_SINGULAIR_PIC_RI_Avis2_CT13755.pdf
HAS/2016-03-11_CT-14048_VARGATEF_PIC_INS_Avis3_CT14048.pdf
HAS/2016-03-11_ald_30_gm_endometre_inca_has_web.pdf
HAS/2016-03-11_ald_30_gp_k_endometre_final_web.pdf
HAS/2016-03-11_ald__30_lap_endometre_inca_has_web_2011-02-01_14-33-20_782.pdf
HAS/2016-03-11_dacryoserum_dacudose_steridose_summary_ct107888_10750_11213.pdf
HAS/2016-03-11_dacryoserum_dacudose_steridose_synthese_ct107888_10750_11213.pdf
HAS/2016-03-11_lap_ald_25_sep_actualisation.pdf
HAS/2016-03-11_singulair_ri_summary_ct13755.pdf
HAS/2016-03-11_singulair_ri_synthese_ct13755.pdf
HAS/2016-03-11_vargatef__summary_ct14048.pdf
HAS/2016-03-11_vargatef__synthese_ct14048.pdf
HAS/2016-03-14_CT-14262_CYTOTEC_PIC_REEVAL_RI_Avis2_CT13694_CT14262.pdf
HAS/2016-03-14_CT-14294_TIXTAR_PIC_INS_Avis3_CT14294.pdf
HAS/2016-03-14_CT-14506_MOVENTIG_PIC_INS_Avis2_CT14506.pdf
HAS/2016-03-14_cytotec_summary_ct13694_14262.pdf
HAS/2016-03-14_cytotec_synthese_ct13694_14262.pdf
HAS/2016-03-14_moventig_summary_ct14506.pdf
HAS/2016-03-14_moventig_synthese_ct14506.pdf
HAS/2016-03-14_tixtar_synthese_ct14418_14494.pdf
HAS/2016-03-15_CEPP-4918_COAGUCHEK XS_08_mars_2016_(4918)_avis.pdf
HAS/2016-03-15_CEPP-5036_I-DIGITS_08_mars_2016_(5036)_avis.pdf
HAS/2016-03-16_arg_pertinence_chir-lombalgie.pdf
HAS/2016-03-16_fs_pertinence_chir-lombalgie.pdf
HAS/2016-03-17_2019_08_05_elements_princeps_4_pages_it.pdf
HAS/2016-03-17_2019_10_09__supports_daccompagnement_it_vd.pdf
HAS/2016-03-17_guide_it_140316vf.pdf
HAS/2016-03-17_guide_outil_securisation_autoevaluation_administration_medicaments_partie3_boite_a_outils.pdf
HAS/2016-03-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie1_comprendre.pdf
HAS/2016-03-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie2_mettre_en_oeuvre.pdf
HAS/2016-03-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie4_pour_en_savoir_plus.pdf
HAS/2016-03-17_guide_outils_securisation_autoevaluation_administration_medicaments_partie5_annexes.pdf
HAS/2016-03-17_resultat_enquete_guide_administration_des_medicaments_mai_2013.pdf
HAS/2016-03-17_schema___le_processus_du_circuit_du_medicament.pdf
HAS/2016-03-18_CEPP-5043_VENOTRAIN ULCERTEC 39_08_mars_2015_(5043)_avis.pdf
HAS/2016-03-18_CEPP-5046_VENOTRAIN ULCERTEC 46_08_mars_2016_(5046)_avis.pdf
HAS/2016-03-18_CEPP-5061_NOVA FORM_23_fevrier_2016_(5061)_avis.pdf
HAS/2016-03-18_CEPP-5062_VITA FORM 4_23_fevrier_2016_(5062)_avis.pdf
HAS/2016-03-18_CT-14488_AMELUZ_PIC_INS_Avis3_CT14488.pdf
HAS/2016-03-18_CT-14705_MEKINIST_PIC_INS_Avis3_CT14705.pdf
HAS/2016-03-18_ameluz_sapub_ct14488.pdf
HAS/2016-03-18_ameluz_summary_ct14488.pdf
HAS/2016-03-18_mekinist_-_avis_defficience.pdf
HAS/2016-03-18_mekinist_summary_ct14705.pdf
HAS/2016-03-18_mekinist_synthese_ct14705.pdf
HAS/2016-03-21_CEPP-5037_CYRANOSE GLOBAL SYSTEM_09_fevrier_2016_(5037)_avis.pdf
HAS/2016-03-21_CT-12136_MOTILIUM_PIC_REEV_RI_Avis1_CT12136.pdf
HAS/2016-03-21_CT-14065_MIGPRIV_PIC_RI_Avis2_CT14065&14335.pdf
HAS/2016-03-21_CT-14097_PHOSPHOSORB_PIS_RI_Avis2_CT14097.pdf
HAS/2016-03-21_CT-14277_PERIDYS-OROPERIDYS_PIC_REEV_RI_Avis2_CT12388&14277&14281.pdf
HAS/2016-03-21_CT-14319_TISSEEL_PIC_INS_Avis2_CT14319.pdf
HAS/2016-03-21_CT-14332_KLEAN_PREP_PIS_RI_Avis2_CT14332.pdf
HAS/2016-03-21_CT-14569_TERALITHE_PIS_RI_Avis1_CT14569.pdf
HAS/2016-03-21_CT-14621_VISUDYNE_PIS_RI_Avis2_CT14621.pdf
HAS/2016-03-21_CT-14775_SUSTIVA_PIS_RI_Avis2_CT14775.pdf
HAS/2016-03-21_CT-14780_TAHOR_PIS_RI_Avis2_CT14780.pdf
HAS/2016-03-21_CT-14826_COMBIGAN_PIS_RI_Avis1_CT14826.pdf
HAS/2016-03-21_CT-14903_TAZOCILLINE_PIS_RI_Avis2_CT14903.pdf
HAS/2016-03-21_CT-14920_PAROEX_PIS_RI_Avis2_CT14920.pdf
HAS/2016-03-21_CT-14934_EPIRUBICINE_ALTISO_QD_INS_Avis1_CT14934.pdf
HAS/2016-03-21_CT-14938_CHLORURE_DE_SODIUM_AGUETTANT_QD_INS_Avis1_CT14938.pdf
HAS/2016-03-21_CT-14955_OMEPRAZOLE_EG_QD_INS_Avis1_CT14955.pdf
HAS/2016-03-21_CT-14964_ALDACTONE_PIS_RI_Avis2_CT14964.pdf
HAS/2016-03-21_CT-14989_HEPARINE_SODIQUE_PANPHARMA_QD_INS_Avis1_CT14989.pdf
HAS/2016-03-21_CT-14991_TRIMEBUTINE_ARROW_QD_INS_Avis2_CT14991.pdf
HAS/2016-03-21_CT-15012_EPTIFIBATIDE_ACCORD_QD_INS_Avis2_CT15012.pdf
HAS/2016-03-21_CT-15016_BEFIZAL_QD_INS_Avis1_CT15016.pdf
HAS/2016-03-21_CT-15020_LEVONORGESTREL_ETHINYLESTRADIOL_MYLAN_QD_INS_Avis1_CT15020.pdf
HAS/2016-03-21_CT-15039_PARACETAMOL_EVOLUGEN_QD_INS_Avis1_CT15039.pdf
HAS/2016-03-21_domperidone_reevaluation__summary.pdf
HAS/2016-03-21_domperidone_reevaluation__synthese.pdf
HAS/2016-03-21_peptamen_23_fevrier_2016_5024_avis.pdf
HAS/2016-03-21_peptamen_hn_23_fevrier_2016_5025_avis.pdf
HAS/2016-03-21_tisseel_summary_ct14319.pdf
HAS/2016-03-21_tisseel_synthese_ct14319.pdf
HAS/2016-03-23_CT-14874_FLUOROCHOLINE_CIS_BIO_INTERNATIONAL_PIS_INS_Avis2_CT14874.pdf
HAS/2016-03-24_CT-14490_ROACTEMRA_PIS_EI_Avis1_CT14490.pdf
HAS/2016-03-24_roactemra_summary_ct14490.pdf
HAS/2016-03-24_roactemra_synthese_ct14490.pdf
HAS/2016-03-30_CT-12334_CYMBALTA_PIC_RI_Avis2_CT12334.pdf
HAS/2016-03-30_CT-14875_CAELYX_MM_PIC_REEV_Avis2_CT14875.pdf
HAS/2016-03-30_CT-14882_DECAPEPTYL_PIS_RI_Avis2_CT14882.pdf
HAS/2016-03-30_CT-14908_TILDIEM_BI-TILDIEM_MONOTILDIEM_PIS_RI_Avis1_CT14908.pdf
HAS/2016-03-30_CT-14956_DEPAKOTE_PIS_RI_Avis2_CT14956.pdf
HAS/2016-03-30_CT-14957_ADENOSINE_PANPHARMA_QD_INS_Avis1_CT14957.pdf
HAS/2016-03-30_CT-14997_FORTZAAR-HYZAAR_PIS_RI_Avis2_CT14997.pdf
HAS/2016-03-30_CT-15002_RISPERDAL-RISPERDALCONSTA_PIS_RI_Avis1_CT15002.pdf
HAS/2016-03-30_CT-15014_OPTRUMA_PIS_RI_Avis2_CT15014.pdf
HAS/2016-03-30_CT-15018_OXYGENE_MEDICINAL_LIQUIDE_AIR_PRODUCTS_MEDICAL_QD_INS_Avis1_CT15018.pdf
HAS/2016-03-30_CT-15025_MONO-TILDIEM_LP_QD_INS_Avis1_CT15025.pdf
HAS/2016-03-30_CT-15071_KIDROLASE_PIS_RI_Avis2_CT15071.pdf
HAS/2016-03-30_CT-15076_METOJECT_QD_INS_Avis2_CT15076.pdf
HAS/2016-03-30_definition_des_criteres_de_realisation_des_interventions_de_chirurgie_bariatrique_chez_les_moins_de_18_ans_-_note_de_cadrage.pdf
HAS/2016-03-30_fm_chirurgie_bariatrique__v3_2.pdf
HAS/2016-03-30_fm_rapport_elaboration_chirurgie_bariatrique_ado_cd_20160120_vd.pdf
HAS/2016-03-30_xylocaine_pis_ri_avis2_ct14886.pdf
HAS/2016-03-31_1_synthese_patient_traceur.pdf
HAS/2016-03-31_2_guide_methodologique.pdf
HAS/2016-03-31_3_rapport_experimentation.pdf
HAS/2016-03-31_4_exemples_d_analyses_de_parcours.pdf
HAS/2016-03-31_diaporama__de__presentation__patient__traceur___en__ville.pdf
HAS/2016-03-31_le_patient_traceur_demarche_danalyse_en_equipe_du_parcours_du_patient_-_outil_1.pdf
HAS/2016-03-31_le_patient_traceur_demarche_danalyse_en_equipe_du_parcours_du_patient_-_outil_2.pdf
HAS/2016-03-31_le_patient_traceur_demarche_danalyse_en_equipe_du_parcours_du_patient_-_outil_3.pdf
HAS/2016-03-31_le_patient_traceur_demarche_danalyse_en_equipe_du_parcours_du_patient_-_outil_4.pdf
HAS/2016-04-04_CT-14497_OPSUMIT_PIC_INS_Avis3_CT14497.pdf
HAS/2016-04-04_CT-14533_BRICANYL_PIS_RI_Avis2_CT14533.pdf
HAS/2016-04-04_CT-14597_PREZISTA_PIS_MCI_Avis2_CT14597.pdf
HAS/2016-04-04_CT-14625_DUAKLIR_GENUAIR_PIC_INS_Avis2_CT14625.pdf
HAS/2016-04-04_CT-14743_URSOLVAN_PIS_EI_Avis1_CT14743.pdf
HAS/2016-04-04_CT-14751_NAVELBINE_PIS_RI_Avis2_CT14751.pdf
HAS/2016-04-04_CT-14848_REGIOCIT_QD_INS_Avis1_CT14848.pdf
HAS/2016-04-04_CT-14851_DAKLINZA_PIC_REEV_Avis2_CT14851.pdf
HAS/2016-04-04_aad_avis_25052016_ct_25052016.pdf
HAS/2016-04-04_alimta_cbnpc_pic_reev_avis2modifie_ct14873.pdf
HAS/2016-04-04_alimta_cbnpc_summary_ct14873.pdf
HAS/2016-04-04_alimta_cbnpc_synthese_ct14873.pdf
HAS/2016-04-04_opsumit_summary_ct_14497.pdf
HAS/2016-04-04_opsumit_synthese_ct_14497.pdf
HAS/2016-04-06_CEPP-5027_NOVALAC AMINA_22_mars_2016_(5027)_avis.pdf
HAS/2016-04-06_CEPP-5065_CALCIBON INJECT_22_mars_2016_(5065)_avis.pdf
HAS/2016-04-06_CT-14295_COSENTYX_PIC_INS_Avis3_CT14295.pdf
HAS/2016-04-06_CT-14430_REZOLSTA_PIC_INS_Avis3_CT14430.pdf
HAS/2016-04-06_CT-14555_JINARC_PIC_INS_Avis2_CT14555.pdf
HAS/2016-04-06_CT-14667_VELCADE_PIC_EI_Avis3_CT14667.pdf
HAS/2016-04-06_CT-14718_BLINCYTO_PIC_INS_Avis3_CT14718.pdf
HAS/2016-04-06_CT-14726_DELTYBA_PIC_INS_Avis2_CT14726.pdf
HAS/2016-04-06_CT-14771_ACLASTA_PIS_RI_Avis1_CT14771.pdf
HAS/2016-04-06_CT-14952_ACTILYSE_PIS_EPI_Avis2_CT14952.pdf
HAS/2016-04-06_CT-15017_ADALATE-CHRONADALATE_PIS_RI_Avis2_CT15017.pdf
HAS/2016-04-06_affiche_fairedire_avril2016.pdf
HAS/2016-04-06_affiche_fairedire_communiquer_avec_son_patient.pdf
HAS/2016-04-06_blincyto_summary_ct14718.pdf
HAS/2016-04-06_blincyto_synthese_ct14718.pdf
HAS/2016-04-06_brochure_fairedire_avril2016.pdf
HAS/2016-04-06_brochure_fairedire_communiquer_avec_son_patient.pdf
HAS/2016-04-06_cosentyx_-_avis_defficience_m.pdf
HAS/2016-04-06_cosentyx_summary_ct14295.pdf
HAS/2016-04-06_cosentyx_synthese_ct14295.pdf
HAS/2016-04-06_deltyba_summary_ct14726.pdf
HAS/2016-04-06_deltyba_synthese_ct14726.pdf
HAS/2016-04-06_faire_dire_references_bibliographiques.pdf
HAS/2016-04-06_jinarc_summary_ct14555.pdf
HAS/2016-04-06_jinarc_synthese_ct14555.pdf
HAS/2016-04-06_rezolsta_summary_ct14430.pdf
HAS/2016-04-06_rezolsta_synthese_ct14430.pdf
HAS/2016-04-06_velcade_summary_ct14667_2016-10-19_12-41-19_124.pdf
HAS/2016-04-06_velcade_synthese_ct14667.pdf
HAS/2016-04-07_CT-14365_IKERVIS_PIC_INS_Avis3_CT14365.pdf
HAS/2016-04-07_CT-14421_CIMZIA_PIC_REEV_Avis2_CT14421.pdf
HAS/2016-04-07_cimzia_rpso__summary_ct14421.pdf
HAS/2016-04-07_cimzia_rpso__synthese_ct14421.pdf
HAS/2016-04-07_ikervis_summary_ct14365.pdf
HAS/2016-04-07_ikervis_synthese_ct14365.pdf
HAS/2016-04-08_CEPP-5042_SPEEDICATH_22_mars_2016_(5042)_avis.pdf
HAS/2016-04-08_CEPP-5094_MITRACLIP_22_mars_2016_(5094)_avis.pdf
HAS/2016-04-08_inahta_brief_technetium_pulmonary_embolism.pdf
HAS/2016-04-08_rapport_tc99.pdf
HAS/2016-04-11_rapport_etat_de_sante_des_personnes_en_situation_de_prostitution_et_des_travailleurs_du_sexe_vf.pdf
HAS/2016-04-12_calendrier_rp_medicaments_-_timelines_ed_medicinal_products.pdf
HAS/2016-04-12_early_dialogue_for_a_medicinal_product_in_clinical_development.pdf
HAS/2016-04-13_CEPP-4884_NEURX_05_avril_2016_(4884)_avis.pdf
HAS/2016-04-13_CEPP-5006_TIGE PULCHRA_12_janvier_2016_(5006)_avis.pdf
HAS/2016-04-13_CEPP-5007_TIGE PARVA_12_janvier_2016_(5007)_avis.pdf
HAS/2016-04-13_CEPP-5052_METS tibia_22_mars_2016_(5052)_avis.pdf
HAS/2016-04-13_CEPP-5080_SONNET_22_mars_2016_(5080)_avis.pdf
HAS/2016-04-13_CEPP-5081_METS fémur_22_mars_2016_(5081)_avis.pdf
HAS/2016-04-13_CEPP-5095_SURPASS STREAMLINE_05_avril_2016_(5095)_avis.pdf
HAS/2016-04-13_mets_femur_2016-04-12_11-09-26_450.pdf
HAS/2016-04-14_CT-12750_AURICULARUM_PIC_RI_REEV_Avis2_CT12750&14297.pdf
HAS/2016-04-14_CT-14458_ISENTRESS_PIC_EI_Avis2_CT14458.pdf
HAS/2016-04-14_CT-14622_AIRFLUSAL_FORSPIRO_PIS_INS_Avis2_CT14622.pdf
HAS/2016-04-14_CT-14750_DOPACEPTIN_QD_INS_Avis2_CT14750.pdf
HAS/2016-04-14_CT-14819_AUGMENTIN_PIS_RI_Avis2_CT14819.pdf
HAS/2016-04-14_CT-14820_CLAMOXYL_PIS_RI_Avis1_CT14820.pdf
HAS/2016-04-14_CT-14821_CLAMOXYL_QD_INS_Avis1_CT14821.pdf
HAS/2016-04-14_CT-14842_ALOXI_PIC_EI_Avis2_CT14842.pdf
HAS/2016-04-14_CT-14893_DOPAVIEW_PIS_INS_Avis1_CT14893.pdf
HAS/2016-04-14_CT-14913_FLUOROCHOL_PIS_INS_Avis2_CT14913.pdf
HAS/2016-04-14_CT-15070_BENDAMUSTINE_ACCORD_QD_INS_Avis1_CT15070.pdf
HAS/2016-04-14_CT-15077_OXYCODONE_AGUETTANT_QD_INS_Avis2_CT15077.pdf
HAS/2016-04-14_CT-15098_ICLUSIG_QD_INS_Avis1_CT15098.pdf
HAS/2016-04-14_airflusal_forspiro_summary_ct14622_2016-10-12_13-52-1_865.pdf
HAS/2016-04-14_airflusal_forspiro_synthese_ct14622.pdf
HAS/2016-04-14_aloxi_enfant_summary_ct14842.pdf
HAS/2016-04-14_aloxi_enfant_synthese_ct14842.pdf
HAS/2016-04-14_auricularum_summary_ct14297.pdf
HAS/2016-04-14_auricularum_synthese_ct14297.pdf
HAS/2016-04-14_isentress_susp_buv_summary_ct14458.pdf
HAS/2016-04-14_isentress_susp_buv_synthese_ct14458.pdf
HAS/2016-04-15_08-092-ald_guide_patient_epilepsie.pdf
HAS/2016-04-15_CT-14449_XULTOPHY_PIC_INS_AvisPostAud_CT14449.pdf
HAS/2016-04-15_CT-14573_ZYCLARA_PIC_INS_Avis1_CT14573.pdf
HAS/2016-04-15_CT-14591_OTEZLA_PIC_INS_Pso_Avis2_CT14591.pdf
HAS/2016-04-15_ald_9__epilepsies_guide_medecin.pdf
HAS/2016-04-15_cadrage_bridges_dentaires_vd.pdf
HAS/2016-04-15_cdc_ivg_vd.pdf
HAS/2016-04-15_feuille_de_route_ivg.pdf
HAS/2016-04-15_inahta_brief_abortions.pdf
HAS/2016-04-15_inahta_brief_multi_unit_prostheses.pdf
HAS/2016-04-15_lap_ald9_epilepsie_juillet_07.pdf
HAS/2016-04-15_otezla_pic_ins_rpso_avis2_ct14591.pdf
HAS/2016-04-15_otezla_pso_summary_ct14591.pdf
HAS/2016-04-15_otezla_pso_synthese_ct14591.pdf
HAS/2016-04-15_rapport_bridges_dentaires_vd.pdf
HAS/2016-04-15_rapport_ivg_vd.pdf
HAS/2016-04-15_xultophy_summary_ct14449.pdf
HAS/2016-04-15_xultophy_synthese_ct14449.pdf
HAS/2016-04-15_zyclara_summary_ct14573.pdf
HAS/2016-04-15_zyclara_synthese_ct14573.pdf
HAS/2016-04-18_CT-14029_VALDOXAN_PIC_REEV_RI_EPI_Avis3_CT14029.pdf
HAS/2016-04-18_CT-14371_XADAGO_PIC_INS_Avis2_CT14371.pdf
HAS/2016-04-18_CT-14428_STIVARGA_PIC_EI_Avis2_CT14428.pdf
HAS/2016-04-18_stivarga_summary_ct14428.pdf
HAS/2016-04-18_stivarga_synthese_ct14428.pdf
HAS/2016-04-18_valdoxan_summary_ct14029.pdf
HAS/2016-04-18_valdoxan_synthese_ct14029.pdf
HAS/2016-04-18_xadago_summary_ct14371.pdf
HAS/2016-04-18_xadago_synthese_ct14371.pdf
HAS/2016-04-20_annexe_1_fiche_dengagement_simulation.pdf
HAS/2016-04-20_annexe_2_presentation_de_linfrasture_simulation.pdf
HAS/2016-04-20_annexe_3_programme_de_simulation.pdf
HAS/2016-04-20_annexe_4_document_daide_a_la_gestion_du_projet_dautoevaluation_simulation.pdf
HAS/2016-04-20_annexe_5_autoevaluation_simulation.pdf
HAS/2016-04-20_annexe_6_rapport_dauto-evaluation_simulation.pdf
HAS/2016-04-20_annexe_7_fiche_action_simulation.pdf
HAS/2016-04-20_guide_bonnes_pratiques_simulation_sante_guide.pdf
HAS/2016-04-20_guide_for_the_assessment_of_healthcare_simulation_infrastructures.pdf
HAS/2016-04-20_guide_pour_levaluation_des_infrastrures_de_simulation_en_sante_2015-07-21_11-26-51_939.pdf
HAS/2016-04-21_CT-13039_TROPHIGIL_PIS_RI_Avis1_CT13039.pdf
HAS/2016-04-21_CT-14239_DENSICAL_PIS_RI_Avis2_CT14239.pdf
HAS/2016-04-21_CT-14630_METHOTREXATE_BIODIM-LEDERTREXATE_PIS_RI_Avis2_CT14630&10279.pdf
HAS/2016-04-21_CT-15047_DETENSIEL_PIS_RI_Avis1_CT15047.pdf
HAS/2016-04-21_CT-15057_SULFATE_DE_MAGNESIUM_RENAUDIN_QD_INS_Avis1_CT15057.pdf
HAS/2016-04-25_CT-13749_FLORGYNAL_PIS_RI_Avis2_CT13749.pdf
HAS/2016-04-25_CT-14092_EPREX_PIS_EI_Avis2_CT14092.pdf
HAS/2016-04-25_CT-14210_HEXVIX_PIC_REEV_Avis3_CT14210.pdf
HAS/2016-04-25_CT-14502_FELDENE_PIS_RI_Avis2_CT14502.pdf
HAS/2016-04-25_CT-14664_OZURDEX_PIS_RI_Avis2_CT14664.pdf
HAS/2016-04-25_CT-14734_MORPHINE_LAVOISIER_PIS_RI_Avis1_CT14734.pdf
HAS/2016-04-25_CT-14756_ZALVISO_PIC_INS_Avis2_CT14756.pdf
HAS/2016-04-25_CT-14796_RESPREEZA_PIC_INS_Avis1_CT14796.pdf
HAS/2016-04-25_CT-14857_NIVESTIM_PIS_RI_Avis2_CT14857.pdf
HAS/2016-04-25_CT-14890_FLUMAZENIL_INTSEL_CHIMOS_QD_INS_Avis1_CT14890.pdf
HAS/2016-04-25_CT-14899_ROZEX_QD_INS_Avis1_CT14899.pdf
HAS/2016-04-25_CT-14993_LESCOL_PIS_RI_Avis2_CT14993.pdf
HAS/2016-04-25_CT-15046_PHYSIOTENS_PIS_RI_Avis2_CT15046.pdf
HAS/2016-04-25_CT-15055_FLODIL_PIS_RI_Avis2_CT15055.pdf
HAS/2016-04-25_CT-15069_COTAREG_PIS_RI_Avis2_CT15069.pdf
HAS/2016-04-25_CT-15074_ATACAND_PIS_RI _Avis2_CT15074.pdf
HAS/2016-04-25_CT-15080_DOLIPRANELIQUIZ_QD_INS_Avis2_CT15080.pdf
HAS/2016-04-25_CT-15092_DESFERAL_PIS_RI_Avis2_CT15092.pdf
HAS/2016-04-25_accelerated_guidelines_methodological_guide_has_2016.pdf
HAS/2016-04-25_evarrest_pic_ins_avis2_ct14248_pour_publication.pdf
HAS/2016-04-25_evarrest_summary_ct14248.pdf
HAS/2016-04-25_evarrest_synthese_ct14248.pdf
HAS/2016-04-25_geldene_pis_ri_avis2_ct14502.pdf
HAS/2016-04-25_guide_methodologique_fiche_memo_fiche_pertinence.pdf
HAS/2016-04-25_hexvix_summary_ct14210.pdf
HAS/2016-04-25_hexvix_synthese_ct14210.pdf
HAS/2016-04-25_respreeza_summary_ct14796.pdf
HAS/2016-04-25_respreeza_synthese_ct14796.pdf
HAS/2016-04-25_zalviso_summary_ct14756.pdf
HAS/2016-04-25_zalviso_synthese_ct14756.pdf
HAS/2016-04-26_CT-15066_TAREG_PIS_RI_Avis2_CT15066.pdf
HAS/2016-04-26_fdr_cancer_cavum_vd.pdf
HAS/2016-04-26_note_problematique_cancer_cavum__2016-04-22_16-56-47_995.pdf
HAS/2016-04-27_CEPP-4927_PE TRIANON_19_avril_2016_(4927)_avis.pdf
HAS/2016-04-27_CEPP-5017_Cotyle POLYMAX_23_fevrier_2016_(5017)_avis.pdf
HAS/2016-04-27_CEPP-5047_Insert POLYMAX_23_fevrier_2016_(5047)_avis.pdf
HAS/2016-04-28_CT-14087_EPREX_PIS_RI_Avis2_CT14087.pdf
HAS/2016-04-28_CT-14994_OCUFEN_PIS_RI_Avis1_CT14994.pdf
HAS/2016-04-29_CEPP-5092_Naida CIQ90_19_avril_2016_(5092)_avis.pdf
HAS/2016-04-29_CT-14327_CARBOSYMAG_PIS_RI_Avis1_CT14327.pdf
HAS/2016-04-29_CT-14884_SPINAFOL_PIS_INS_Avis1_CT14884.pdf
HAS/2016-04-29_CT-14951_PARACETAMOL_MYLAN_QD_INS_Avis1_CT14951.pdf
HAS/2016-04-29_CT-15041_MORPHINE_CHLORHYDRATE_COOPER_PIS_RI_Avis2_CT15041.pdf
HAS/2016-04-29_CT-15062_NIZAXID_PIS_RI_Avis2_CT15062.pdf
HAS/2016-04-29_CT-15063_ROFERON-A_QD_INS_Avis2_CT15063.pdf
HAS/2016-04-29_CT-15086_ACTIVELLE-NOVOFEMME-TRISEQUENS-KLIOGEST_PIS_RI_Avis1_CT15086.pdf
HAS/2016-04-29_CT-15108_ENDOXAN_PIS_RI_Avis1_CT15108&9245.pdf
HAS/2016-04-29_CT-15118_PARACETAMOL_BIOGARAN_QD_INS_Avis2_CT15118.pdf
HAS/2016-04-29_CT-15126_PARACETAMOL_BIOGARAN_QD_INS_Avis2_CT15126.pdf
HAS/2016-04-29_CT-15151_VITAMINE_PP_AGUETTANT_QD_INS_Avis1_CT15151.pdf
HAS/2016-04-29_CT-15152_DOMPERIDONE_ARROW_QD_REEV_Avis1_CT15152.pdf
HAS/2016-04-29_CT-15154_DOMPERIDONE_BIOGARAN_QD_REEV_Avis1_CT15154.pdf
HAS/2016-04-29_CT-15155_DOMPERIDONE_CRISTERS_QD_REEV_Avis1_CT15155.pdf
HAS/2016-04-29_CT-15156_DOMPERIDONE_EG_QD_REEV_Avis1_CT15156.pdf
HAS/2016-04-29_CT-15157_DOMPERIDONE_MYLAN_QD_REEV_Avis1_CT15157.pdf
HAS/2016-04-29_CT-15158_DOMPERIDONE_RATIOPHARM-TEVA_QD_REEV_Avis1_CT15158.pdf
HAS/2016-04-29_CT-15159_DOMPERIDONE_SANDOZ_QD_REEV_Avis1_CT15159.pdf
HAS/2016-04-29_CT-15160_DOMPERIDONE_ZENTIVA_QD_REEV_Avis1_CT15160.pdf
HAS/2016-04-29_CT-15219_ZYDELIG_PIS_RCP_Avis2_CT15219.pdf
HAS/2016-04-29_extavia_pis_ri_avis1_ct13447.pdf
HAS/2016-04-29_pnds_-_syndrome_nephrotique_idiopatique_de_lenfant_2016-04-29_15-02-42_382.pdf
HAS/2016-04-29_pnds_65_-_syndrome_nephrotique_idiopathique_de_lenfant_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-05-03_CEPP-4962_MEPILEX BORDER Plaies_12_janvier_2016_(4962)_avis.pdf
HAS/2016-05-03_CEPP-5054_ATROSTIM_05_avril_2016_(5054)_avis.pdf
HAS/2016-05-03_CEPP-5059_MEPILEX BORDER Prevt Escarre_08_mars_2016_(5059)_avis.pdf
HAS/2016-05-04_CEPP-4768_BIOPORE_19_avril_2016_(4768)_avis.pdf
HAS/2016-05-04_CT-14610_STIMU-ACTH_PIS_RI_Avis2_CT14610.pdf
HAS/2016-05-04_CT-14937_INNOVAIR-FORMODUAL_NEXTHALER_PIS_INS_Avis2_CT14937.pdf
HAS/2016-05-04_CT-14965_EZETROL_PIC_EI_Avis2_CT14965.pdf
HAS/2016-05-04_CT-15048_CHOLIB_PIC_NE_Avis2_CT15048.pdf
HAS/2016-05-04_CT-15072_TIENAM_PIS_RI_Avis2_CT15072.pdf
HAS/2016-05-04_CT-15110_ALPHAGAN_PIS_RI_Avis1_CT15110.pdf
HAS/2016-05-04_cholib_summary_ct_15048.pdf
HAS/2016-05-04_cholib_synthese_ct_15048.pdf
HAS/2016-05-04_ezetrol_eitpediarique_summary_ct14965.pdf
HAS/2016-05-04_ezetrol_eitpediarique_synthese_ct14965.pdf
HAS/2016-05-10_fiche_bum_bpco_2016.pdf
HAS/2016-05-11_CT-14891_OLANZAPINE_BIOGARAN_QD_INS_Avis2_CT14891.pdf
HAS/2016-05-11_CT-14902_LEVETIRACETAM_ARROW_LAB_QD_INS_Avis2_CT14902.pdf
HAS/2016-05-11_CT-15124_REPAGLINIDE_ARROW_LAB_QD_INS_Avis1_CT15124.pdf
HAS/2016-05-12_CT-14798_YONDELIS_PIC_REEV_Avis3_CT14798.pdf
HAS/2016-05-12_CT-15056_LOGIMAX_PIS_RI_Avis2_CT15056.pdf
HAS/2016-05-13_CT-14921_DISTILBENE_PIC_REEV_Avis2_CT14921.pdf
HAS/2016-05-13_distilbene_summary_ct14921.pdf
HAS/2016-05-13_distilbene_synthese_ct14921.pdf
HAS/2016-05-18_06-072_hepat-c_internet_sans_liste.pdf
HAS/2016-05-18_07-007_hepatite_b_internet_sans_liste.pdf
HAS/2016-05-18_cadrage_rtpo.pdf
HAS/2016-05-18_guide_patient_vhb.pdf
HAS/2016-05-18_inahta_brief_iort.pdf
HAS/2016-05-18_lap_ald_6_final_juillet_2007.pdf
HAS/2016-05-18_rapport_rtpo.pdf
HAS/2016-05-18_to_vhb_web.pdf
HAS/2016-05-19_note_de_cadrage_cancer_du_poumon.pdf
HAS/2016-05-19_rapport_depistage_cbp_.pdf
HAS/2016-05-23_CEPP-5064_MINIMED 640G_03_mai_2016_(5064)_avis.pdf
HAS/2016-05-23_CEPP-5070_INFINITY_19_avril_2016_(5070)_avis_caviarde.pdf
HAS/2016-05-23_CEPP-5079_VELOX_03_mai_2016_(5079)_avis.pdf
HAS/2016-05-23_CT-14962_XALATAN_PIS_RI_Avis2_CT14962.pdf
HAS/2016-05-23_CT-14990_FRAKIDEX_PIS_RI_Avis1_CT14990.pdf
HAS/2016-05-23_CT-15189_SULFATE_DE_MAGNESIUM_RENAUDIN_QD_INS_Avis1_CT15189.pdf
HAS/2016-05-23_CT-15194_ESIDREX_PIS_RI_Avis2_CT15194.pdf
HAS/2016-05-23_CT-15217_LINEZOLIDE_OHRE_PHARMA_QD_INS_Avis1_CT15217.pdf
HAS/2016-05-23_phosphoneuros_qd_ins_avis1_modifiele26042016_ct15168.pdf
HAS/2016-05-25_CT-14817_ELOCTA_PIC_INS_Avis2_CT14817.pdf
HAS/2016-05-25_CT-14849_CRESEMBA_PIC_INS_Avis2_CT14849.pdf
HAS/2016-05-25_CT-14929_COTELLIC_PIC_INS_Avis2_CT14929.pdf
HAS/2016-05-25_argu_meningites_bact_vd.pdf
HAS/2016-05-25_cotellic_14062016_avis_efficience.pdf
HAS/2016-05-25_cotellic_summary_ct14929.pdf
HAS/2016-05-25_cotellic_synthese_ct14929.pdf
HAS/2016-05-25_cresemba_summary_ct14849.pdf
HAS/2016-05-25_cresemba_synthese_ct14849.pdf
HAS/2016-05-25_elocta_summary_ct14817.pdf
HAS/2016-05-25_elocta_synthese_ct14817.pdf
HAS/2016-05-25_fdr_mening_bact_vd.pdf
HAS/2016-05-25_inahta_brief_hsv_vzv.pdf
HAS/2016-05-25_inahta_brief_tests_diagnosis_meningitis.pdf
HAS/2016-05-25_rapport_hvzv_me_vd.pdf
HAS/2016-05-26_05r08_fiche_tech_suivi_des_femmes_enceintes_type_de_suivi_recommande.pdf
HAS/2016-05-26_CT-12246_SPRYCEL_PIS_RI_Avis2_CT12246.pdf
HAS/2016-05-26_CT-14062_DICETEL_PIS_RI_Avis2_CT14062.pdf
HAS/2016-05-26_CT-14753_HUMIRA_PIC_EI_Verneuil_AvisPostAud_CT14753.pdf
HAS/2016-05-26_CT-14810_GENVOYA_PIC_INS_Avis2_CT14810.pdf
HAS/2016-05-26_genvoya_12042016_avis_efficience.pdf
HAS/2016-05-26_genvoya_summary_ct14810.pdf
HAS/2016-05-26_genvoya_synthese_ct14810.pdf
HAS/2016-05-26_humira_summary_ct14753.pdf
HAS/2016-05-26_humira_synthese_ct14753.pdf
HAS/2016-05-26_progestogel-utrogestan_pis_ri_avis1_modifiele12052016_ct1417514194.pdf
HAS/2016-05-26_suivi_des_femmes_enceintes_-_argumentaire_maj.pdf
HAS/2016-05-26_suivi_des_femmes_enceintes_-_recommandations_23-04-2008.pdf
HAS/2016-05-26_suivi_et_orientation_des_femmes_enceintes_en_fonction_des_situations_a_risque_identifiees_-_argumentaire.pdf
HAS/2016-05-26_suivi_orientation_femmes_enceintes_synthese.pdf
HAS/2016-05-27_CEPP-4978_Cotyle XLPE_08_mars_2016_(4978)_avis_caviarde.pdf
HAS/2016-05-27_CEPP-4996_Insert XLPE_03_mai_2016_(4996)_avis_caviarde.pdf
HAS/2016-05-27_rapport_elaboration_ssp_pneumoperitoine_2014_0164.pdf
HAS/2016-05-27_ssp_comment_reduire_les_risques_associes_a_la_creation_dun_pneumoperitoine_en_chirurgie_digestive_-_annexes.pdf
HAS/2016-05-27_ssp_pneumo_maj_mai2016.pdf
HAS/2016-05-27_ssp_pneumo_version_anglaise.pdf
HAS/2016-05-31_CEPP-4823_AMO_17_avril_2016_(4823)_avis.pdf
HAS/2016-05-31_oxinium.pdf
HAS/2016-06-01_CT-15207_OCTAPLEX_QD_INS_Avis1_CT15207.pdf
HAS/2016-06-01_CT-15208_GLUSOSE_VIAFLO_QD_INS_Avis1_CT15208.pdf
HAS/2016-06-03_CEPP-5050_ACTINICA_03_mai_2016_(5050)_avis.pdf
HAS/2016-06-03_CEPP-5063_GORE IBE_17_mai_2016_(5063)_avis_caviarde.pdf
HAS/2016-06-03_CEPP-5067_IN PACT Admiral_03_mai_2016_(5067)_avis_caviarde..pdf
HAS/2016-06-03_CEPP-5071_PACIFICA LP_17_mai_2016_(5071)_avis.pdf
HAS/2016-06-03_CEPP-5088_HYDRIAL UNIDOSE_17_mai_2016_(5088)_avis.pdf
HAS/2016-06-03_CEPP-5090_HYDRIAL MULTIDOSE_17_mai_2016_(5090)_avis.pdf
HAS/2016-06-03_CEPP-5093_CARELINK TRIPLE CHAMBRE AMPLIA CLARIA_03_mai_2016_(5093)_avis.pdf
HAS/2016-06-03_CEPP-5098_FAST-FIX 360_19_avril_2016_(5098)_avis.pdf
HAS/2016-06-03_CEPP-5107_PRIMEADVANCED SPECIFY SURESCAN MRI_17_mai_2016_(5107)_avis.pdf
HAS/2016-06-03_CEPP-5109_FLEXIFORM_17_mai_2016_(5109)_avis.pdf
HAS/2016-06-03_CT-13306_TIMOFEROL_PIS_RI_Avis1_CT13306.pdf
HAS/2016-06-03_CT-14347_ASCOFER_QD_INS_Avis1_CT14347.pdf
HAS/2016-06-03_CT-14363_TIMOFEROL_QD_INS_Avis2_CT14363.pdf
HAS/2016-06-03_CT-14731_MULTIHANCE_QD_INS_Avis2_CT14731.pdf
HAS/2016-06-03_CT-14983_ROACTEMRA_AJI_PIC_REEV_Avis2_CT14983.pdf
HAS/2016-06-03_CT-14984_ROACTEMRA_PR_PIC_REEV_Avis2_CT14984.pdf
HAS/2016-06-03_CT-15153_ABASAGLAR_QD_INS_Avis1_CT15153.pdf
HAS/2016-06-03_CT-15166_POLARAMINE_QD_INS_Avis1_CT15166.pdf
HAS/2016-06-03_CT-15174_EAU_PPI_BBRAUN_QD_INS_Avis2_CT15174.pdf
HAS/2016-06-03_CT-15183_OXYGENE_MEDICINAL_LINDE_HEALTHCARE_QD_INS_Avis2_CT15183.pdf
HAS/2016-06-03_CT-15195_INOFER_Sachets_QD_INS_Avis1_CT15195.pdf
HAS/2016-06-03_CT-15220_CEFOTAXIME_PANPHARMA_QD_INS_Avis1_CT15220.pdf
HAS/2016-06-03_CT-15248_LACTINETTE_QD_INS_Avis1_CT15248.pdf
HAS/2016-06-03_chlorure_de_potassium_b._braun_qd_ins_avis2_ct15179.pdf
HAS/2016-06-03_chlorure_de_sodium_b._braun_qd_ins_avis1_ct15182.pdf
HAS/2016-06-03_gluconate_de_calcium_b._braun_qd_ins_avis1_ct15180.pdf
HAS/2016-06-03_onyx.pdf
HAS/2016-06-03_sapien_xt_modele_9300_tfx_transfemorale.pdf
HAS/2016-06-03_simplygo_mini.pdf
HAS/2016-06-06_CEPP-5073_SIERRA_17_mai_2016_(5073)_avis.pdf
HAS/2016-06-06_CEPP-5119_RESTOREADVANCED SURESCAN MRI_17_mai_2016_(5119)_avis_caviarde.pdf
HAS/2016-06-06_CEPP-5120_RESTOREULTRA SURESCAN MRI_17_mai_2016_(5120)_avis_caviarde.pdf
HAS/2016-06-06_CEPP-5121_RESTORESENSOR SURESCAN MRI_17_mai_2016_(5121)_avis_caviarde.pdf
HAS/2016-06-06_guide_depistage_combine_trisomie_21.pdf
HAS/2016-06-06_pnds_-_dermatite_herpetiforme_dh.pdf
HAS/2016-06-06_pnds_-_dermatose_a_iga_lineaire.pdf
HAS/2016-06-06_pnds_-_epidermolyse_bulleuse_acquise_eba.pdf
HAS/2016-06-06_pnds_-_pemphigoide_cicatricielle_pc.pdf
HAS/2016-06-06_pnds_-_pemphigoide_de_la_grossesse.pdf
HAS/2016-06-06_pnds_66_-_maladies_bulleuses_auto-immunes_epidermolyse_bulleuse_acquise_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-06-06_pnds_68_-_maladies_bulleuses_auto-immunes_dermatite_herpetiforme_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-06-06_pnds_69_-_maladies_bulleuses_auto-immunes_dermatose_a_iga_lineaire_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-06-06_pnds_70_-_maladies_bulleuses_auto-immunes_pemphigoide_cicatricielle_pc_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-06-06_pnds_72_-_maladies_bulleuses_auto-immunes_pemphigoide_de_la_grossesse_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-06-07_senator.pdf
HAS/2016-06-08_CT-13973_XTANDI_PIC_EI_Avis2_CT13973.pdf
HAS/2016-06-08_referentiel_tabac.pdf
HAS/2016-06-08_xtandi_-_avis_defficience_m.pdf
HAS/2016-06-08_xtandi_04032015_synthese_ct13973.pdf
HAS/2016-06-08_xtandi_summary_ct13973.pdf
HAS/2016-06-09_CEPP-5089_ALAIR_17_mai_2016_(5089)_avis_caviarde.pdf
HAS/2016-06-09_CEPP-5096_POWERLINK_AFX 2_17_mai_2016_(5096)_avis.pdf
HAS/2016-06-09_CT-14614_BRIMICA_GENUAIR_PIC_INS_Avis2_CT14614.pdf
HAS/2016-06-09_CT-14864_STRENSIQ_PIC_INS_Avis3_CT14864.pdf
HAS/2016-06-09_CT-14900_BENEPALI_PIS_INS_Avis2_CT14900.pdf
HAS/2016-06-09_CT-15089_BIPHOZYL_PIS_INS_Avis1_CT15089.pdf
HAS/2016-06-09_CT-15112_XALATAN_PIC_EI_Avis2_CT15112.pdf
HAS/2016-06-09_CT-15249_MALOCIDE_PIS_RI_Avis1_CT15249.pdf
HAS/2016-06-09_alimta_mesotheliome_pic_reev_avis2_ct15033.pdf
HAS/2016-06-09_alimtamesotheliome_summary_ct15033.pdf
HAS/2016-06-09_alimtamesotheliome_synthese_ct15033.pdf
HAS/2016-06-09_benepali_summary_ct14900.pdf
HAS/2016-06-09_benepali_synthese_ct14900.pdf
HAS/2016-06-09_brimica_duaklir_genuair_summary_ct14614.pdf
HAS/2016-06-09_brimica_duaklir_genuair_synthese_ct14614.pdf
HAS/2016-06-09_strensiq_10052016_avis_efficience.pdf
HAS/2016-06-09_strensiq_summary_ct14864.pdf
HAS/2016-06-09_strensiq_synthese_ct14864.pdf
HAS/2016-06-09_xalatan_summary_ct15112.pdf
HAS/2016-06-09_xalatan_synthese_ct15112.pdf
HAS/2016-06-10_CT-14772_SOMATULINE_LP_PIC_EI_AvisPostAud_CT14772.pdf
HAS/2016-06-10_CT-14774_CEBEMYXINE_PIS_RI_Avis1_CT14774.pdf
HAS/2016-06-10_CT-15061_CAELYX_sarcome_de_Kaposi_PIC_REEV_Avis2_CT15061.pdf
HAS/2016-06-10_caelyx_kaposi_reeval_liste_en_sus_summary_ct15061.pdf
HAS/2016-06-10_caelyx_kaposi_reeval_liste_en_sus_synthese_ct15061.pdf
HAS/2016-06-10_somatuline_summary_ct14772.pdf
HAS/2016-06-10_somatuline_synthese_ct14772.pdf
HAS/2016-06-14_CT-13760_PRIMALAN_PIS_RI_Avis2_CT13760&14678.pdf
HAS/2016-06-14_CT-14733_LOCOID_PIS_RI_Avis2_CT14733.pdf
HAS/2016-06-14_CT-14787_CURACNE_PIS_RI_Avis2_CT14787.pdf
HAS/2016-06-14_CT-15029_DIASEPTYL_PIS_RI_Avis2_CT15029.pdf
HAS/2016-06-14_CT-15185_ARMISARTE_QD_INS_Avis2_CT15185.pdf
HAS/2016-06-14_CT-15203_VASTEN_QD_INS_Avis2_CT15203.pdf
HAS/2016-06-15_CT-14906_DIFFERINE_PIS_RI_Avis2_CT14906.pdf
HAS/2016-06-17_CT-13745_GILENYA_PIS_EPI_RCP_Avis2_CT13745&14870.pdf
HAS/2016-06-17_avis_college_keytruda_masque.pdf
HAS/2016-06-17_avis_college_melanome_masque_def.pdf
HAS/2016-06-17_fiche_pertinence_angioplastie.pdf
HAS/2016-06-17_keytrudamelanome_summary_ct14660.pdf
HAS/2016-06-17_keytrudamelanome_synthese_ct14660.pdf
HAS/2016-06-17_la_recommandation_prise_en_charge_du_melanome_par_les_nouvelles_immunotherapies_anti-pd1_opdivo_et_keytruda.pdf
HAS/2016-06-17_opdivomelanome_summary_ct14578.pdf
HAS/2016-06-17_opdivomelanome_synthese_ct14578.pdf
HAS/2016-06-17_rapport_elaboration_fiche_pertinence_angioplastie.pdf
HAS/2016-06-20_CEPP-5048_DIRECT FLOW MEDICAL_14_juin_2016_(5048)_avis.pdf
HAS/2016-06-20_CEPP-5110_INOGEN ONE G3_31_mai_2016_(5110)_avis.pdf
HAS/2016-06-22_bum_olmesartan_21_juin.pdf
HAS/2016-06-23_CT-14749_RAXONE_PIC_INS_Avis3_CT14749.pdf
HAS/2016-06-23_CT-14877_HERCEPTIN_PIC_REEV_Avis2_CT14877.pdf
HAS/2016-06-23_CT-14879_AVASTIN_sein_PIC_REEV_Avis3_CT14879.pdf
HAS/2016-06-23_avastin_sein_summary_ct14879.pdf
HAS/2016-06-23_avastin_sein_synthese_ct14879.pdf
HAS/2016-06-23_herceptin_1ere_ligne_summary_ct14877.pdf
HAS/2016-06-23_herceptin_1ere_ligne_synthese_ct14877.pdf
HAS/2016-06-23_herceptin_3eme_ligne_summary_ct14877.pdf
HAS/2016-06-23_herceptin_3eme_ligne_synthese_ct14877.pdf
HAS/2016-06-23_raxone_summary_ct14749.pdf
HAS/2016-06-23_raxone_synthese_ct14749.pdf
HAS/2016-06-24_CEPP-5029_HEARTMATE 3_22_mars_2016_(5029)_avis.pdf
HAS/2016-06-24_lotus_2016-06-22_16-51-4_663.pdf
HAS/2016-06-24_myairvo2.pdf
HAS/2016-06-27_CEPP-4982_WEB_22_mars_2016_(4982)_avis.pdf
HAS/2016-06-27_CEPP-5002_ONYSTER_12_janvier_2016_(5002)_avis.pdf
HAS/2016-06-27_CEPP-5122_OPTIVE_14_juin_2016_(5122)_avis.pdf
HAS/2016-06-27_CT-14878_AVASTIN_rein_PIC_REEV_Avis2_CT14878.pdf
HAS/2016-06-27_avastin_rein_summary_ct14878.pdf
HAS/2016-06-27_avastin_rein_synthese_ct14878.pdf
HAS/2016-06-29_CT-13791_AROLAC_PIS_RI_Avis1_CT13791.pdf
HAS/2016-06-29_CT-14583_DEPAKINE-MICROPAKINE_PIS_RI_Avis2_CT14583.pdf
HAS/2016-06-29_CT-14865_ZIMINO_PIC_INS_Avis3_CT14865.pdf
HAS/2016-06-29_CT-15034_GIOTRIF_PIC_REEV_Avis2_CT15034.pdf
HAS/2016-06-29_zimino_summary_ct14865.pdf
HAS/2016-06-29_zimino_synthese_ct14865.pdf
HAS/2016-07-04_CT-14259_TIORFAN-TIORFANOR_PIS_RI_Avis1_CT14259.pdf
HAS/2016-07-04_CT-14981_MIANSERINE_MYLAN_QD_INS_Avis1_CT14981.pdf
HAS/2016-07-04_CT-15068_CISATRACURIUM_ACCORD_QD_INS_Avis2_CT15068.pdf
HAS/2016-07-04_CT-15127_FRAXODI-FRAXIPARINE_PIS_RI_Avis1_CT15127.pdf
HAS/2016-07-04_CT-15129_FRAXIPARINE_QD_INS_Avis1_CT15129.pdf
HAS/2016-07-04_CT-15186_VORICONAZOLE_SANDOZ_QD_INS_Avis_CT15186.pdf
HAS/2016-07-04_CT-15209_CHLORURE_DE_SODIUM_VIAFLO_QD_INS_Avis1_CT15209.pdf
HAS/2016-07-04_CT-15215_BIONOLYTE_G5_PIS_RI_Avis1_CT15215.pdf
HAS/2016-07-04_CT-15229_BETADINE_ALCOOLIQUE_QD_INS_Avis1_CT15229.pdf
HAS/2016-07-04_CT-15258_VORICONAZOLE_ARROW_QD_INS_Avis1_CT15258.pdf
HAS/2016-07-04_CT-15285_VORICONAZOLE_OHRE_PHARMA_QD_INS_Avis1_CT15285.pdf
HAS/2016-07-05_maladie_de_parkinson_et_syndromes_apparentes_-_fiche_memo.pdf
HAS/2016-07-05_maladie_de_parkinson_et_syndromes_apparentes_-_rapport_delaboration.pdf
HAS/2016-07-06_CT-13902_HUMIRA_PIS_RI_Avis2_CT13902.pdf
HAS/2016-07-06_CT-13990_STELARA_PIS_RI_Avis2_CT13990.pdf
HAS/2016-07-06_CT-14105_ORENCIA_PIS_NE_AvisPostObs_CT14105.pdf
HAS/2016-07-06_CT-14261_ENBREL_PIC_EI_AJI_Enth_Pso_Oligo_Avis2_CT14261.pdf
HAS/2016-07-06_CT-14401_CIMZIA_PIS_RI_Avis2_CT14401.pdf
HAS/2016-07-06_CT-14588_ORENCIA_QD_INS_Avis2_CT14588.pdf
HAS/2016-07-06_CT-14724_ROACTEMRA_PIS_NE_Avis1_CT14724.pdf
HAS/2016-07-06_CT-14846_STELARA_PIC_EI_PsoAdos_Avis2_CT14846.pdf
HAS/2016-07-06_CT-15008_HUMIRA_QD_INS_Avis2_CT15008.pdf
HAS/2016-07-06_fpc__sp_sortiehopital__web.pdf
HAS/2016-07-06_fpc_sp_a_domicile__web.pdf
HAS/2016-07-06_humira_enbrel__aji_ct14088_ct14261_sadef.pdf
HAS/2016-07-06_humira_enbrel__aji_ct14088_ct14261_summary.pdf
HAS/2016-07-06_note_methodologique_soins-palliatifs_web.pdf
HAS/2016-07-06_recommandatin_place_des_tests_rapides_dorientation_diagnostique_trod_dans_la_strategie_de_depistage_de_lhepatite_b.pdf
HAS/2016-07-06_stelara_psoado_summary_ct14846.pdf
HAS/2016-07-06_stelara_psoado_synthese_ct14846.pdf
HAS/2016-07-06_synthese_place_of_point-of-care_tests_pocts_in_hepatitis_b_screening_strategy.pdf
HAS/2016-07-06_synthese_recommandation__place_des_tests_rapides_dorientation_diagnostique_trod_hepatite_b_2016-07-21_13-56-32_782.pdf
HAS/2016-07-06_v5-bat_fiche_organisation_parcours-sortie_hopital_web.pdf
HAS/2016-07-06_v5-bat_fiche_organisation_parcours-sp_a_domicile_web.pdf
HAS/2016-07-11_CEPP-4615_LIFECHOICE ACTIVOX_01_juillet_2014_(4615)_avis.pdf
HAS/2016-07-12_avis_du_22_mars_2016_implant_endovasculaire_dit_stent_aortique_renal_iliaque_ou_femoral.pdf
HAS/2016-07-12_avis_modifiant_implant_endovasculaire_dm_eval-8.pdf
HAS/2016-07-12_composition_du_groupe_de_travail_implant_endovasculaire_dit_stent_aortique_renal_iliaque_ou_femoral.pdf
HAS/2016-07-12_note_de_cadrage_implant_endovasculaire_dit_stent_aortique_renal_iliaque_ou_femoral.pdf
HAS/2016-07-12_rapport_devaluation_implant_endovasculaire_dit_stent_aortique_renal_iliaque_ou_femoral.pdf
HAS/2016-07-12_texte_court_implant_endovasculaire_dit_stent_aortique_renal_iliaque_ou_femoral_2016-07-07_16-59-46_138.pdf
HAS/2016-07-13_CEPP-4824_INSPIRE_28_juin_2016_(4824)_avis.pdf
HAS/2016-07-13_c_2015_0016_inspire.pdf
HAS/2016-07-18_decision_n_d2016-30_-_rbpp_prevention_et_reponses_aux_comportements_problemes_ph_-_volet_1_et_2.pdf
HAS/2016-07-18_guide_des_problemes_somatiques.pdf
HAS/2016-07-18_guide_medecin_rch_web.pdf
HAS/2016-07-18_guide_patient_rch_ald24_1dec.pdf
HAS/2016-07-18_lap_rch_web.pdf
HAS/2016-07-18_lettre_de_cadrage_rbpp_comportements_pbl.pdf
HAS/2016-07-18_rbpp_comportements_problemes_volets_1_et_2.pdf
HAS/2016-07-18_rbpp_les_espaces_de_calme_retrait.pdf
HAS/2016-07-18_web_anesm_synthese-outils_rbpp-2.pdf
HAS/2016-07-20_CEPP-5082_LVIS_14_juin_2016_(5082)_avis_caviarde.pdf
HAS/2016-07-20_CEPP-5100_LVIS JUNIOR_14_juin_2016_(5100)_avis_caviarde.pdf
HAS/2016-07-20_CEPP-5104_HYLO CONFORT PLUS_12_juillet_2016_(5104)_avis.pdf
HAS/2016-07-20_CEPP-5105_CHEETAH XPLORE_12_juillet_2016_(5105)_avis.pdf
HAS/2016-07-20_CEPP-5127_KANSO CP950_28_juin_2016_(5127)_avis.pdf
HAS/2016-07-20_CT-13925_MYFORTIC_PIS_RI_Avis3_CT13925.pdf
HAS/2016-07-20_CT-14387_CRIXIVAN_PIS_RI_Avis2_CT14387.pdf
HAS/2016-07-20_CT-14402_FOSAVANCE_PIS_RI_Avis3_CT14402.pdf
HAS/2016-07-20_CT-14420_ZERIT_PIS_RI_Avis1_CT14420.pdf
HAS/2016-07-20_CT-14477_LIORESAL_PIS_RI_Avis1_CT14477.pdf
HAS/2016-07-20_CT-14513_ESTRACYT_PIS_RI_Avis2_CT8623&14513.pdf
HAS/2016-07-20_CT-14519_METHOTREXATE_BELLON_PIS_RI_Avis1_CT14519.pdf
HAS/2016-07-20_CT-14530_COLCHICINE_OPOCALCIUM-COLCHIMAX_PIS_RI_Avis1_CT14530.pdf
HAS/2016-07-20_CT-14543_ZYLORIC_PIS_RI_Avis2_CT14543.pdf
HAS/2016-07-20_CT-14617_ELIGARD_PIS_RI_Avis1_CT14617.pdf
HAS/2016-07-20_CT-14651_ANDROCUR_PIS_RI_Avis2_CT14651.pdf
HAS/2016-07-20_CT-14662_ARGININE_VEYRON_PIS_RI_Avis1_CT14662.pdf
HAS/2016-07-20_CT-14694_IOMERON_PIS_RI_Avis1_CT14694.pdf
HAS/2016-07-20_CT-14707_SOLUVIT_PIS_RI_Avis1_CT14707.pdf
HAS/2016-07-20_CT-14876_MIMPARA_PIS_RI_Avis1_CT14876.pdf
HAS/2016-07-20_CT-14901_CETORNAN_PIS_REEV_Avis2_CT14901.pdf
HAS/2016-07-20_CT-14992_LAMISIL_PIS_RI_Avis1_CT14992.pdf
HAS/2016-07-20_CT-14996_COZAAR_PIS_RI_Avis1_CT14996.pdf
HAS/2016-07-20_CT-15022_FLUDESOXYGLUCOSE-(F18)_CYCLOPHARMA_PIS_INS_Avis2_CT15022.pdf
HAS/2016-07-20_CT-15027_NUREFLEX-NUROFENPRO_PIS_RI_Avis2_CT15027.pdf
HAS/2016-07-20_CT-15088_SUCCICAPTAL_PIS_RI_Avis2_CT15088.pdf
HAS/2016-07-20_CT-15095_TRANSIPEG_PIS_RI_Avis1_CT15095.pdf
HAS/2016-07-20_CT-15116_GADOVIST_QD_INS_Avis2_CT15116.pdf
HAS/2016-07-20_CT-15117_TRIATEC_PIS_RI_Avis2_CT15117.pdf
HAS/2016-07-20_CT-15131_SKUDEXUM_PIC_INS_Avis2_CT15131.pdf
HAS/2016-07-20_CT-15143_ZYMAFLUOR_PIS_RI_Avis2_CT15143.pdf
HAS/2016-07-20_CT-15184_DOMPERIDONE_MYLAN_QD_INS_Avis1_CT15184.pdf
HAS/2016-07-20_CT-15204_MYTELASE_PIS_RI_Avis1_CT15204.pdf
HAS/2016-07-20_CT-15206_DERMORELLE_PIS_RI_Avis1_CT15206.pdf
HAS/2016-07-20_CT-15230_BETADINE_DERMIQUE_QD_INS_Avis2_CT15230.pdf
HAS/2016-07-20_CT-15232_EMERADE_QD_INS_Avis2_CT15232.pdf
HAS/2016-07-20_CT-15233_ZAVEDOS_PIS_RI_Avis1_CT15233.pdf
HAS/2016-07-20_CT-15234_IMPORTAL_PIS_RI_Avis2_CT15234.pdf
HAS/2016-07-20_CT-15239_GAVISCON_PIS_RI_Avis2_CT15239.pdf
HAS/2016-07-20_CT-15242_COLCHIMAX-COLCHICINE_OPOCALCIUM_QD_INS_Avis2_CT15242.pdf
HAS/2016-07-20_CT-15253_VISKEN_PIS_RI_Avis1_CT15253.pdf
HAS/2016-07-20_CT-15254_DACUDOSES_PIS_RI_Avis1_CT15254.pdf
HAS/2016-07-20_CT-15257_TRANXENE_PIS_RI_Avis2_CT15257.pdf
HAS/2016-07-20_CT-15259_DOMPERIDONE_ARROW_QD_INS_Avis2_CT15259.pdf
HAS/2016-07-20_CT-15270_VORICONAZOLE_XELLIA_QD_INS_Avis2_CT15270.pdf
HAS/2016-07-20_CT-15273_GEMCITABINE_KABI_QD_INS_Avis1_CT15273.pdf
HAS/2016-07-20_CT-15284_PARACETAMOL_ACCORD_QD_INS_Avis1_CT15284.pdf
HAS/2016-07-20_CT-15295_OPTICRON_PIS_RI_Avis1_CT15295.pdf
HAS/2016-07-20_CT-15299_IPERTEN_PIS_RI_Avis2_CT15299.pdf
HAS/2016-07-20_CT-15313_DOMPERIDONE_ARROW_QD_INS_Avis2_CT15313.pdf
HAS/2016-07-20_CT-15346_VIROPHTA_PIS_RI_Avis1_CT15346.pdf
HAS/2016-07-20_electrostimulateurs_neuromusculaires_urogenitaux_feuille_de_route.pdf
HAS/2016-07-20_evaluation_des_dispositifs_medicaux_devacuation_et_de_recueil_des_urines_et_des_selles_-_feuille_de_route.pdf
HAS/2016-07-20_skudexum_summary_ct15131.pdf
HAS/2016-07-20_skudexum_synthese_ct15131.pdf
HAS/2016-07-27_CEPP-5084_INVACARE LEO_12_juillet_2016_(5084)_avis_caviarde.pdf
HAS/2016-07-27_CEPP-5091_DIABEO_12_juillet_2016_(5091)_avis.pdf
HAS/2016-07-27_CEPP-5102_SEQUENT PLEASE NEO_28_juin_2016_(5102)_avis_caviarde.pdf
HAS/2016-07-27_CEPP-5103_SEQUENT PLEASE_28_juin_2016_(5103)_avis_caviarde.pdf
HAS/2016-07-27_CEPP-5108_SYNERGY_12_juillet_2016_(5108)_avis.pdf
HAS/2016-07-27_CEPP-5112_UTTCAL_12_juillet_2016_(5112)_avis.pdf
HAS/2016-07-27_CEPP-5113_FREESTYLE LIBRE_12_juillet_2016_(5113)_avis.pdf
HAS/2016-07-27_CEPP-5126_NEUROFORM ATLAS_12_juillet_2016_(5126)_avis_caviarde.pdf
HAS/2016-07-27_CEPP-5131_Cotyle RM CLASSIC_12_juillet_2016_(5131)_avis.pdf
HAS/2016-07-27_cotyle_rm_pressfit_12_juillet_2016_5132_avis.pdf
HAS/2016-07-28_argumentaire_clostridium.pdf
HAS/2016-07-28_inahta_brief_clostridium.pdf
HAS/2016-08-01_CT-14966_ZADITEN_PIS_RI_Avis1_CT14966.pdf
HAS/2016-08-01_CT-15081_XENETIX_PIS_RI_Avis1_CT15081.pdf
HAS/2016-08-01_CT-15324_DOMPERIDONE_BIOGARAN_QD_INS_Avis1_CT15324.pdf
HAS/2016-08-01_CT-15330_BACTRIM_QD_INS_Avis1_CT15330.pdf
HAS/2016-08-02_CT-13700_MINIRIN-MINIRINMELT-OCTIM_PIS_RI_Avis2_CT13700.pdf
HAS/2016-08-02_CT-14216_KREDEX_PIS_RI_Avis2_CT14216.pdf
HAS/2016-08-02_CT-14341_VITAMINE_K1_ROCHE_PIS_RI_Avis2_CT14341.pdf
HAS/2016-08-02_CT-14521_BICARBONATE_DE_SODIUM_LAVOISIER_PIS_RI_Avis1_CT14521.pdf
HAS/2016-08-02_CT-14544_PURINETHOL_PIS_RI_Avis2_CT8911&14544.pdf
HAS/2016-08-02_CT-14545_ALKERAN_PIS_RI_Avis2_CT14545.pdf
HAS/2016-08-02_CT-14592_CHLORURE_DE_SODIUM_LAVOISIER_PIS_RI_Avis1_CT14592.pdf
HAS/2016-08-02_CT-14604_EDEX_PIS_RI_Avis2_CT14604.pdf
HAS/2016-08-02_CT-14623_HYDREA_PIS_RI_Avis1_CT8630&14623.pdf
HAS/2016-08-02_CT-14759_APURONE_PIS_REEV_Avis1_CT14759.pdf
HAS/2016-08-02_CT-14802_COOLMETEC_PIS_RI_Avis3_CT14802.pdf
HAS/2016-08-02_CT-14806_ALTEISDUO_PIS_RI_Avis 3_CT14806.pdf
HAS/2016-08-02_CT-14856_LAMISIL-LAMISIL_DERMGEL_PIS_RI_Avis1_CT14856.pdf
HAS/2016-08-02_CT-14889_EMLA-EMLAPATCH_PIS_RI_Avis2_CT14889.pdf
HAS/2016-08-02_CT-15004_TADENAN_PIS_RI_Avis2_CT15004.pdf
HAS/2016-08-02_CT-15042_VITAMINE_K1_ROCHE_QD_INS_Avis2_CT15042.pdf
HAS/2016-08-02_CT-15104_DUOTRAV_PIS_RI_Avis2_CT15104.pdf
HAS/2016-08-02_CT-15119_PREXIDINE_PIS_RI_Avis1_CT15119.pdf
HAS/2016-08-02_CT-15138_VOTUBIA_PIS_RI_Avis 2_CT14359&15138.pdf
HAS/2016-08-02_CT-15223_SURMONTIL_PIS_RI_Avis2_CT15223.pdf
HAS/2016-08-02_CT-15260_BILASKA_PIS_RI_Avis2_CT15260.pdf
HAS/2016-08-02_CT-15263_INORIAL_PIS_RI_Avis2_CT15263.pdf
HAS/2016-08-02_CT-15268_STERIDOSE_PIS_RI2016_Avis2_CT15268.pdf
HAS/2016-08-02_CT-15297_LAROXYL_PIS_RI_Avis1_CT15297.pdf
HAS/2016-08-02_CT-15309_PROTHIADEN_PIS_RI_Avis2_CT15309.pdf
HAS/2016-08-02_gp_ald_cirrhose_.pdf
HAS/2016-08-02_guide_medecin_cirrhoses_final_web_novembre_2008.pdf
HAS/2016-08-02_lap_ald_6_cirrhoses_final.pdf
HAS/2016-08-03_4_pages_fiche_briefing_vd_2016-07-26_17-23-25_586.pdf
HAS/2016-08-03_4_pages_fiche_debriefing_vd_2016-07-26_17-23-25_588.pdf
HAS/2016-08-03_CT-13722_COPAXONE_PIS_RI_Avis2_CT13722.pdf
HAS/2016-08-03_CT-13965_ORACEFAL_PIS_RI_Avis2_CT13965.pdf
HAS/2016-08-03_CT-15044_COPAXONE_PIC_INS_Avis2_CT15044.pdf
HAS/2016-08-03_CT-15050_VICTAN_QD_INS_Avis1_CT15050.pdf
HAS/2016-08-03_CT-15075_HYTACAND_PIS_RI_Avis 2_CT15075.pdf
HAS/2016-08-03_CT-15091_CALCIUM_VITAMINE_D3_ZYDUS_PIS_RI_Avis1_CT15091.pdf
HAS/2016-08-03_CT-15164_KENZEN_PIS_RI_EI_Avis 2_CT15164&15165.pdf
HAS/2016-08-03_CT-15169_NISIS_PIS_RI_Avis 2_CT15169.pdf
HAS/2016-08-03_CT-15252_ADRENALINE_AGUETTANT_SANS_SULFITE_QD_INS_Avis2_CT15252.pdf
HAS/2016-08-03_CT-15306_COKENZEN_PIS_RI_Avis 2_CT15306.pdf
HAS/2016-08-03_CT-15307_INEXIUM_QD_INS_Avis1_CT15307.pdf
HAS/2016-08-03_CT-15312_TUSSIPAX_PIS_RI_Avis1_CT15312.pdf
HAS/2016-08-03_CT-15314_HALDOL_QD_INS_Avis1_CT15314.pdf
HAS/2016-08-03_CT-15360_PALONOSETRON_ACCORD_QD_INS_Avis2_CT15360.pdf
HAS/2016-08-03_CT-15366_CHLORURE_DE_POTASSIUM-CHLORURE_DE_SODIUM_KABI_QD_INS_Avis1_CT15366.pdf
HAS/2016-08-03_CT-15379_DOMPERIDONE_ZENTIVA_QD_INS_Avis1_CT15379.pdf
HAS/2016-08-03_CT-15398_BETADINE_TULLE_QD_INS_Avis1_CT15398.pdf
HAS/2016-08-03_boite_a_outils_vd.pdf
HAS/2016-08-03_fiche_de_tracabilite.pdf
HAS/2016-08-03_memo_briefing.pdf
HAS/2016-08-03_memo_debriefing.pdf
HAS/2016-08-03_satisfaction_briefing.pdf
HAS/2016-08-03_satisfaction_debriefing.pdf
HAS/2016-08-08_pnds_-_maladie_de_pompe.pdf
HAS/2016-08-08_pnds_-_mucopolysaccharidoses.pdf
HAS/2016-08-08_pnds_74_-_maladie_de_pompe_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-08-08_pnds_75_-_mucopolysaccharidoses_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-08-08_utilisation_des_endoprotheses-stents-coronaires_en_france_en_2014_etude_a_partir_des_donnees_du_sniiram.pdf
HAS/2016-08-11_pnds_-_maladie_et_syndrome_de_moyamoya_de_lenfant_et_de_ladulte_2016-08-11_11-35-20_513.pdf
HAS/2016-08-11_pnds_76_-_maladie_et_syndrome_de_moyamoya_de_lenfant_et_de_ladulte_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-08-12_CEPP-5057_ONYX LES 5057_05_avril_2016_(5057)_avis_caviarde.pdf
HAS/2016-08-18_zenith_dissection_tx2_proform.pdf
HAS/2016-08-23_CT-14710_FARYDAK_PIC_INS_Avis3_CT14710.pdf
HAS/2016-08-23_CT-14777_PRALUENT_PIC_INS_Avis3_CT14777.pdf
HAS/2016-08-23_CT-14978_COSENTYX_RP_PIC_EI_Avis2_CT14978.pdf
HAS/2016-08-23_CT-14979_COSENTYX_SA_PIC_INS_Avis2_CT14979.pdf
HAS/2016-08-23_CT-15054_NOXAFIL_PIC_INS_Avis2_CT15054.pdf
HAS/2016-08-23_CT-15101_SANDOSTATINE_PIS_RI_Avis2_CT15101.pdf
HAS/2016-08-23_CT-15372_DIAMOX_PIS_RI_Avis2_CT15372.pdf
HAS/2016-08-23_cosentyx__rpso_summary_ct14978.pdf
HAS/2016-08-23_cosentyx__rpso_synthese_ct14978.pdf
HAS/2016-08-23_cosentyx_summary_ct14979.pdf
HAS/2016-08-23_cosentyx_synthese_ct14979.pdf
HAS/2016-08-23_extencilline_qd_ins_avis1_modifiele03082016_ct15373.pdf
HAS/2016-08-23_farydak_summary_ct14710.pdf
HAS/2016-08-23_farydak_synthese_ct14710.pdf
HAS/2016-08-23_noxafil_sapub_ct15054_summary.pdf
HAS/2016-08-23_noxafil_synthese_ct15054.pdf
HAS/2016-08-23_praluent_12042016_avis_efficience.pdf
HAS/2016-08-23_praluent_summary_ct14777.pdf
HAS/2016-08-23_praluent_synthese_ct14777.pdf
HAS/2016-08-23_velcade_mm_non_pretraite_pic_reev_avis2_ct15114.pdf
HAS/2016-08-23_velcade_mm_pretraite_pic_reev_avis2_ct14872.pdf
HAS/2016-08-23_velcade_saynthese_pretraite_ct14872.pdf
HAS/2016-08-23_velcade_summary_non_pretraite_ct15114.pdf
HAS/2016-08-23_velcade_summary_pretraite_ct14872.pdf
HAS/2016-08-23_velcade_synthese_non_pretraite_ct15114.pdf
HAS/2016-08-26_CT-14286_RENVELA_PIS_RI_Avis1_CT14286.pdf
HAS/2016-08-26_CT-14861_RIFINAH_PIS_RI_Avis2_CT14861.pdf
HAS/2016-08-26_CT-14977_ASPIRINE_PROTECT_PIS_RI_Avis1_CT14977.pdf
HAS/2016-08-29_CT-14783_VIBRAMYCINE_N_PIS_RI_Avis1_CT14783.pdf
HAS/2016-08-29_CT-14885_ZOMIG-ZOMIGORO_PIS_RI_Avis2_CT14885.pdf
HAS/2016-08-29_CT-15111_DAIVONEX_PIS_INS_Avis1_CT15111.pdf
HAS/2016-08-29_CT-15197_NISISCO_PIS_RI_Avis 2_CT15197.pdf
HAS/2016-08-29_CT-15319_PADERYL_PIS_RI_Avis1_CT15319.pdf
HAS/2016-08-29_CT-15327_MOSIL_PIS_RI_Avis1_CT15327.pdf
HAS/2016-08-29_CT-15336_QUITAXON_PIS_RI_Avis1_CT15336.pdf
HAS/2016-09-01_CT-15279_CALCIUM_SANDOZ_PIS_RI_Avis1_CT15279.pdf
HAS/2016-09-05_CT-14930_SIMPONI_SPA_non_radiographique_PIC_EI_Avis2_CT14930.pdf
HAS/2016-09-05_simponi_summary_spanr_ct14930.pdf
HAS/2016-09-05_simponi_synthese_spanr_ct14930.pdf
HAS/2016-09-08_CT-13697_INFLECTRA_INS_PIS_Avis2_CT136978.pdf
HAS/2016-09-08_CT-15060_CAELYX_cancer_du_sein_PIC_REEV_Avis2_CT15060.pdf
HAS/2016-09-08_CT-15264_FLIXABI_PIS_INS_Avis2_CT15264.pdf
HAS/2016-09-08_caelyx_synthese_ct15060.pdf
HAS/2016-09-08_inflectra_remsima_sapub_ct136978_ct13747.pdf
HAS/2016-09-08_inflectra_summary_ct15264_2017-01-03_15-03-8_258.pdf
HAS/2016-09-09_CT-13741_REMSIMA_INS_PIS_Avis 2_CT13741.pdf
HAS/2016-09-09_CT-14498_TARGINACT_PIC_EI_AvisPostAud_CT14498.pdf
HAS/2016-09-09_CT-14841_KENGREXAL_PIC_INS_Avis1_CT14841.pdf
HAS/2016-09-09_CT-14963_VFEND_PIC_REEV_Avis2_CT14963.pdf
HAS/2016-09-09_inflectra_remsima_sapub_ct136978_ct13747.pdf
HAS/2016-09-09_inflectra_summary_ct15264_2017-01-03_15-03-8_258.pdf
HAS/2016-09-09_kengrexal_summary__ct14841.pdf
HAS/2016-09-09_kengrexal_synthese__ct14841.pdf
HAS/2016-09-09_targinact_ei_summary_ct14498.pdf
HAS/2016-09-09_targinact_ei_synthese_ct14498.pdf
HAS/2016-09-09_vfend_summary_ct14963.pdf
HAS/2016-09-09_vfend_synthese_ct14963.pdf
HAS/2016-09-13_CEPP-5040_DYNASPORT 1A920_6_septembre_2016_(5040)_avis.pdf
HAS/2016-09-13_CEPP-5041_DYNASPORT 1A900_6_septembre_2016_(5041)_avis.pdf
HAS/2016-09-19_pnds_-_dermatomyosite_de_lenfant_et_de_ladulte.pdf
HAS/2016-09-19_pnds_77_-_dermatomyosite_de_lenfant_et_de_ladulte_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-09-27_CEPP-5026_CORDIVA_6 septembre_2016_(5026)_avis.pdf
HAS/2016-09-27_CEPP-5129_PONTO BHX_6_septembre_2016_(5129)_avis.pdf
HAS/2016-09-27_CEPP-5137_PONTO pilier 14 mm_6_septembre_2016_(5137)_avis.pdf
HAS/2016-09-27_CEPP-5142_BAHA 5 POWER_6_septembre_2016_(5142)_avis.pdf
HAS/2016-09-27_CT-14931_LYXUMIA_PIC_INS_Avis3_CT14931.pdf
HAS/2016-09-27_exemple_regles_es_vm.pdf
HAS/2016-09-27_guide_es_vm.pdf
HAS/2016-09-27_litterature_es_vm.pdf
HAS/2016-09-27_lyxumia_summary_ct14931.pdf
HAS/2016-09-27_lyxumia_synthese_ct14931.pdf
HAS/2016-09-27_tegeline_pic_ei_myasthenie_avis1_ct15243.pdf
HAS/2016-09-27_tegeline_summary_ct15243.pdf
HAS/2016-09-27_tegeline_synthese_ct15243.pdf
HAS/2016-09-28_CT-15036_HERCEPTIN_Estomac_PIC_REEV_Avis2_CT15036.pdf
HAS/2016-09-28_casodex_pic_ri_ei_monotherapie_localement_avance_avis1_ct148459627.pdf
HAS/2016-09-28_casodex_summary_ct14845_9627.pdf
HAS/2016-09-28_casodex_synthese_ct14845_9627.pdf
HAS/2016-09-28_herceptin_estomac_summary_ct15036.pdf
HAS/2016-09-28_herceptin_estomac_summary_ct15036_2017-01-03_15-30-56_41.pdf
HAS/2016-09-28_herceptin_estomac_synthese_ct15036.pdf
HAS/2016-09-28_herceptin_sein_precoce_pic_reev_avis2_ct15035.pdf
HAS/2016-09-28_herceptin_sein_precoce_synthese_ct15035.pdf
HAS/2016-09-30_CT-14773_CALPRIMUM_PIS_RI_Avis1_CT14773.pdf
HAS/2016-09-30_CT-14779_CLASTOBAN_PIS_RI_Avis1_CT14779.pdf
HAS/2016-09-30_CT-14836_CREON_PISRI_avis2_CT14836.pdf
HAS/2016-09-30_CT-14953_CITRATE_DE_CAFEINE_PIS_RI_Avis2_CT14953.pdf
HAS/2016-09-30_CT-14985_FLECAINE_PIS_RI_Avis2_CT14985.pdf
HAS/2016-09-30_CT-14995_DULCILARMES_PIS_RI_Avis1_CT14995.pdf
HAS/2016-09-30_CT-15007_TIMOPTOL_PIS_RI_Avis1_CT15007.pdf
HAS/2016-09-30_CT-15296_ABRAXANE_PIS_EI_NON_DEMANDEE_Avis1_CT15296.pdf
HAS/2016-09-30_CT-15302_XANAX_PIS_RI_Avis2_CT15302.pdf
HAS/2016-09-30_CT-15303_ELVORINE_PIS_RI_Avis1_CT15303.pdf
HAS/2016-09-30_CT-15310_FLUCORTAC_PISRI_avis1_CT15310.pdf
HAS/2016-09-30_CT-15322_MESOCAINE_PISRI_Avis1_CT15322.pdf
HAS/2016-09-30_CT-15344_CALCOS_VITAMINE_D3_PIS_RI_Avis1_CT15344.pdf
HAS/2016-09-30_CT-15345_NOCTAMIDE_PIS_RI_Avis2_CT15345.pdf
HAS/2016-09-30_CT-15378_NIVAQUINE_PIS_RI_Avis2_CT15378.pdf
HAS/2016-09-30_CT-15382_COMBANTRIN_PIS_RI_Avis1_CT15382.pdf
HAS/2016-09-30_CT-15389_TEMESTA_PIS_RI_Avis2_CT15389.pdf
HAS/2016-09-30_CT-15444_URBANYL_PIS_RI_avis2_CT15444.pdf
HAS/2016-09-30_CT-15448_LEXOMIL_PIS_RI_avis2_CT15448.pdf
HAS/2016-09-30_CT-15517_VORICONAZOLE MYLAN_QD_INS_AVIS1_CT-15517.pdf
HAS/2016-09-30_CT-15519_VORICONAZOLE_FRESENIUS_KABI_QD_INS_Avis1_CT15519.pdf
HAS/2016-09-30_CT-15638_VORICONAZOLE OHRE PHARMA_QD_INS_avis1_CT-15638.pdf
HAS/2016-09-30_lysanxia_pis_ri_avis1_modifiele16092016_ct15361.pdf
HAS/2016-09-30_seresta_pis_ri_avis2_ct15390.pdf
HAS/2016-09-30_victan_pis_ri_avis1_modifiele16092016_ct15331.pdf
HAS/2016-10-03_CT-14649_ACTONEL_PIS_RI_AvisPostObs_CT14649.pdf
HAS/2016-10-03_CT-15137_MOSCONTIN_SEVREDOL_PIS_RI_Avis2_CT15137.pdf
HAS/2016-10-03_CT-15291_TOCTINO_PIS_EPI_Avis2_CT15291.pdf
HAS/2016-10-03_CT-15364_CLINIMIX_QD_INS_avis1_CT15364.pdf
HAS/2016-10-03_CT-15365_HOSPASOL CT15365 QD Avis 1.pdf
HAS/2016-10-03_CT-15384_VASCULOCIS_PIS_INS_Avis 1_CT15384.pdf
HAS/2016-10-03_CT-15518_AMINOPHYLLINE-QD_INS_AVIS1_CT15518.pdf
HAS/2016-10-03_CT-15543_VICTOZA_EIT_MONO_PIS_Avis2_CT15543.pdf
HAS/2016-10-03_CT-15588_LINEZOLIDE_ARROW_QD_INS_Avis1_CT15588.pdf
HAS/2016-10-03_annexe_raac.pdf
HAS/2016-10-03_note_de_cadrage__programme_rehabilitation_rapide.pdf
HAS/2016-10-03_raac_annexe_avis_parties_prenantes__2016.pdf
HAS/2016-10-03_rapport_orientation_raac.pdf
HAS/2016-10-03_synthese_raac_2016-09-01_15-49-32_230.pdf
HAS/2016-10-03_xylocaine_naphazoline-adrenaline_pis_ri_avis2_ct15308.pdf
HAS/2016-10-04_guide_parcours_de_soins_parkinson.pdf
HAS/2016-10-04_parcours_de_soins_parkinson.pdf
HAS/2016-10-04_points_critiques_parcours_de_soins_parkinson_web.pdf
HAS/2016-10-06_CT-14164_FARESTON_PIS_RI_Avis2_CT14164.pdf
HAS/2016-10-06_CT-14535_ZOLADEX_PIS_RI_Avis2_CT8595&14535.pdf
HAS/2016-10-06_CT-15097_MORPHINE_CHLORHYDRATE_AGUETTANT_PIS_RI_Avis2_CT15097.pdf
HAS/2016-10-06_CT-15187_TROLOVOL_PIS_RI_Avis2_CT15187.pdf
HAS/2016-10-06_CT-15241_PROVAMES_PIS_RI_Avis2_CT15241.pdf
HAS/2016-10-06_CT-15438_SPREGAL_PIS_INS_Avis2_CT15438.pdf
HAS/2016-10-06_guide_mcs_web_2014-09-09_21-25-19_719.pdf
HAS/2016-10-06_synthese_mcs_web.pdf
HAS/2016-10-10_CEPP-5045_Y-STRUT_20 septembre_2016_(5045)_Caviardé.pdf
HAS/2016-10-10_inahta_brief_rtsx.pdf
HAS/2016-10-10_obe_plaquette_2014_vf.pdf
HAS/2016-10-10_obe_plaquette_vf.pdf
HAS/2016-10-10_obe_rapport_2014_vf.pdf
HAS/2016-10-10_obe_rapport_vf.pdf
HAS/2016-10-10_rapport_radiotherapie_stereo_vd.pdf
HAS/2016-10-11_CEPP-5140_EMBLEM S-ICD A219_6_septembre_2016_(5140)_avis.pdf
HAS/2016-10-11_CEPP-5148_VERCISE CARTESIA_20 septembre_2016_(5148)_avis.pdf
HAS/2016-10-11_CEPP-5160_PRECISION MONTAGE MRI_20_septembre_avis_5160_occulté.pdf
HAS/2016-10-12_CT-12343_PLAVIX_PIS_RI_EPI_Avis2_CT12343.pdf
HAS/2016-10-12_CT-14881_AVASTIN_Colorectal_2ligne_PIC_REEV_Avis3_CT14881.pdf
HAS/2016-10-12_CT-14895_NUCALA_PIC_INS_Avis3_CT14895.pdf
HAS/2016-10-12_CT-14918_PRAXBIND_PIC_INS_Avis3_CT14918.pdf
HAS/2016-10-12_CT-14927_ORKAMBI_PIC_INS_Avis3_CT14927.pdf
HAS/2016-10-12_CT-15030_VONCENTO_PIC_EI_Avis2_CT15030.pdf
HAS/2016-10-12_avastin_11102016_avis_efficience.pdf
HAS/2016-10-12_avastin__2emelignecolorectal_summary_ct14881.pdf
HAS/2016-10-12_avastin__2emelignecolorectal_synthese_ct14881.pdf
HAS/2016-10-12_avastin_col_uterus_pic_ei_avispostaud_ct15038.pdf
HAS/2016-10-12_avastin_summary_ct15038_col_uterus.pdf
HAS/2016-10-12_avastin_synthese_ct15038_col_uterus.pdf
HAS/2016-10-12_fiche_memo_-_prise_en_charge_de_la_fievre_chez_lenfant.pdf
HAS/2016-10-12_guidance_leaflet_management_of_fever_in_children.pdf
HAS/2016-10-12_note_de_cadrage_prise_en_charge_de_la_fievre_chez_lenfant.pdf
HAS/2016-10-12_nucala_summary_ct14895.pdf
HAS/2016-10-12_nucala_synthese_ct14895.pdf
HAS/2016-10-12_orkambi_10052016_avis_efficience.pdf
HAS/2016-10-12_orkambi_summary_ct14927.pdf
HAS/2016-10-12_orkambi_synthese_ct14927.pdf
HAS/2016-10-12_plavix_summary_ct12343.pdf
HAS/2016-10-12_plavix_synthese_ct12343.pdf
HAS/2016-10-12_praxbind_summary_ct14918.pdf
HAS/2016-10-12_praxbind_synthese_ct14918.pdf
HAS/2016-10-12_rapport_delaboration_-_prise_en_charge_de_la_fievre_chez_lenfant.pdf
HAS/2016-10-12_tygacil_pic_ei_pediatrie_avis2_ct15084.pdf
HAS/2016-10-12_tygacil_summary_ct15084.pdf
HAS/2016-10-12_tygacil_synthese_ct15084.pdf
HAS/2016-10-12_voncento_summary_ct15030.pdf
HAS/2016-10-12_voncento_synthese_ct15030.pdf
HAS/2016-10-13_CEPP-5086_IALURIL PREFILL_04_octobre_2016_(5086)_avis.pdf
HAS/2016-10-13_CEPP-5123_THORAFLEX HYBRID_20 septembre_2016_(5123)_avis.pdf
HAS/2016-10-13_CEPP-5130_RM PRESSFIT VITAMYS_6 septembre_2016_(5130)_avis.pdf
HAS/2016-10-13_CEPP-5146_PROFLEX XC_20_septembre_2016_(5146)_avis.pdf
HAS/2016-10-13_CEPP-5168_NeuRx DPS RA4_20_septembre_2016_ (5168)_avis.pdf
HAS/2016-10-13_CT-13148_DELPRIM_PIC_INS_Avis1_CT13148.pdf
HAS/2016-10-13_CT-14863_KALYDECO_PIC_INS_Avis2_CT14863.pdf
HAS/2016-10-13_CT-14871_CAELYX_cancer_ovarien_PIC_REEV_Avis2_CT14871.pdf
HAS/2016-10-13_CT-14880_AVASTIN_poumon_PIC_REEV_Avis3_CT14880.pdf
HAS/2016-10-13_CT-15037_AVASTIN_ovaire_PIC_REEV_AvisPostAud_CT15037.pdf
HAS/2016-10-13_CT-15065_ONCASPAR_PIC_INS_AvisPostObs_CT15065.pdf
HAS/2016-10-13_CT-15073_ILTRIA_PIC_INS_AvisPostAud_CT15073.pdf
HAS/2016-10-13_avastin_summary_ct15037.pdf
HAS/2016-10-13_avastin_synthese_ct15037_ovaire.pdf
HAS/2016-10-13_avastinpoumon_summary_ct14880.pdf
HAS/2016-10-13_avastinpoumon_synthese_ct14880.pdf
HAS/2016-10-13_caelyx_synthese_ct14871.pdf
HAS/2016-10-13_compresses_cotons_05_04_2016_dm_eval_128_4.pdf
HAS/2016-10-13_delprim_ct13148_summary.pdf
HAS/2016-10-13_delprim_ct13148_synthese.pdf
HAS/2016-10-13_iltria_summary_ct15073.pdf
HAS/2016-10-13_iltria_synthese_ct15073.pdf
HAS/2016-10-13_kalydeco_pedia_summary_ct14863.pdf
HAS/2016-10-13_kalydeco_pedia_synthese_ct14863.pdf
HAS/2016-10-13_oncaspar_summary_ct15065.pdf
HAS/2016-10-13_oncaspar_synthese_ct15065.pdf
HAS/2016-10-13_orthese_davancee_mandibulaire_12_juillet_2016dm129_avis_phase_cotradictoire_jo.pdf
HAS/2016-10-13_pompes_a_insuline_03_mai_2016_dm_eval_123_avis.pdf
HAS/2016-10-14_CT-13212_PARACETAMOL_CODEINE_CRISTERS_PIS_RI_Avis2_CT13212.pdf
HAS/2016-10-14_CT-13303_PARACETAMOL_CODEINE_BIOGARAN-PARACETAMOL_CODEINE_REF_PIS_RI_Avis2_CT13303.pdf
HAS/2016-10-14_CT-13350_PARACETAMOL_CODEINE_TEVA_PIS_RI_Avis2_CT13350.pdf
HAS/2016-10-14_CT-13408_PARACETAMOL_CODEINE_MYLAN_PIS_RI_Avis2_CT13408.pdf
HAS/2016-10-14_CT-13441_PARACETAMOL_CODEINE_EG_PIS_RI_Avis2_CT13441.pdf
HAS/2016-10-14_CT-13759_KLIPAL_CODEINE_PIS_RI_Avis2_CT13759.pdf
HAS/2016-10-14_CT-13986_BEMEDREX_EASYHALER_PIS_RI_Avis2_CT13986.pdf
HAS/2016-10-14_CT-14429_BUSILVEX_PIC_REEV_AvisPostAud_CT15040&14429.pdf
HAS/2016-10-14_CT-14663_AVASTIN_Colorectal_1ligne_PIC_REEV_Avis3_CT14663.pdf
HAS/2016-10-14_CT-14970_WAKIX_PIC_INS_Avis3_CT14970.pdf
HAS/2016-10-14_CT-15064_SPIOLTO_RESPIMAT_PIC_INS_Avis3_CT15064.pdf
HAS/2016-10-14_CT-15224_ZORAC_PIS_RI_Avis2_CT15224.pdf
HAS/2016-10-14_CT-15236_LOMUSOL_PIS_RI_Avis2_CT15236.pdf
HAS/2016-10-14_CT-15269_COSIMPREL_PIS_INS_Avis2_CT15269.pdf
HAS/2016-10-14_CT-15271_ROZEX_QD_INS_Avis1_CT15271.pdf
HAS/2016-10-14_CT-15272_FUCITHALMIC_PIS_RI_Avis2_CT15272.pdf
HAS/2016-10-14_CT-15332_XEROQUEL_PIS_RI_Avis2_CT15332.pdf
HAS/2016-10-14_CT-15340_BETAGAN_PIS_RI_Avis1_CT15340.pdf
HAS/2016-10-14_CT-15350_DEXPANTHENOL_EG_LABO_CONSEIL_QD_INS_Avis1_CT15350.pdf
HAS/2016-10-14_CT-15356_PIVALONE_PIS_RI_Avis2_CT15356.pdf
HAS/2016-10-14_CT-15358_FLEETPHOSPHOSODA_PIS_RI_Avis2_CT15358.pdf
HAS/2016-10-14_CT-15391_LINDILANE_PIS_RI_Avis2_CT15391.pdf
HAS/2016-10-14_CT-15399_ALGISEDAL_PIS_RI_Avis2_CT15399.pdf
HAS/2016-10-14_CT-15407_ATROPINE_ALCON_PIS_RI_Avis2_CT15407.pdf
HAS/2016-10-14_CT-15426_POLERY_PIS_RI_Avis2_CT15426.pdf
HAS/2016-10-14_CT-15446_CADUET_PIS_RI_Avis2_CT15446.pdf
HAS/2016-10-14_CT-15447_DAFALGAN_CODEINE_PIS_RI_Avis2_CT15447.pdf
HAS/2016-10-14_CT-15472_CLARADOL_CODEINE_PIS_RI_Avis2_CT15472.pdf
HAS/2016-10-14_CT-15483_HAVLANE_PIS_RI_Avis1_CT15483.pdf
HAS/2016-10-14_CT-15485_CODOLIPRANE_PIS_RI_Avis2_CT15485.pdf
HAS/2016-10-14_CT-15600_LINEZOLIDE_MYLAN_QD_INS_Avis1_CT15600.pdf
HAS/2016-10-14_avastin__1erelignecolorectal_synthese_ct14663.pdf
HAS/2016-10-14_avastin__summary_ct14663.pdf
HAS/2016-10-14_busilvex_summary_ct15040_14429.pdf
HAS/2016-10-14_busilvex_synthese_ct15040_14429.pdf
HAS/2016-10-14_cesariennes_programmees_a_terme_rapport_court_2016-10-13_10-54-47_923.pdf
HAS/2016-10-14_cesariennes_programmees_a_terme_rapport_long.pdf
HAS/2016-10-14_experimentation_cesarienne__taux_2011_a_2013_2014-09-16_17-11-16_366.pdf
HAS/2016-10-14_spiolto_summary_ct15064.pdf
HAS/2016-10-14_spiolto_synthese_ct15064.pdf
HAS/2016-10-14_wakix_summary_ct14970.pdf
HAS/2016-10-14_wakix_synthese_ct14970.pdf
HAS/2016-10-24_CEPP-5106_KENEVO_20 septembre_2016_(5106)_avis.pdf
HAS/2016-10-24_pnds_-_syndrome_gilles_de_la_tourette.pdf
HAS/2016-10-24_pnds_78_-_syndrome_gilles_de_la_tourette_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-10-27_algorithme_hta_mel.pdf
HAS/2016-10-27_fiche_memo_hta__mel.pdf
HAS/2016-10-27_fiche_memo_note_de_cadrage_hta_cd_20150723_vd.pdf
HAS/2016-10-27_fiche_memo_rapport_elaboration_hta_mel.pdf
HAS/2016-10-28_CEPP-5003_PULLUP_20_septembre_2016_(5003)_avis.pdf
HAS/2016-11-02_CT-13777_BECLOMETASONE_TEVA-ECOBEC-QVARSPRAY-QVAR_AUTOHALER_PIS_RI_Avis2_CT13777.pdf
HAS/2016-11-02_CT-14461_NOCERTONE_PIC_REEV_RI_Avis2_CT14461&15484.pdf
HAS/2016-11-02_CT-14932_TAKADOL_PIS_RI_Avis2_CT14932.pdf
HAS/2016-11-02_CT-15300_TOPALGIC-MONOALGIC_PIS_RI_Avis2_CT15300.pdf
HAS/2016-11-02_CT-15342_CONTRAMAL-MONOTRAMAL_PIS_RI_Avis2_CT15342.pdf
HAS/2016-11-02_CT-15353_CYRAMZA_cancer_bronchique_avancé_PIS_EI_non_demandée_Avis2_CT15353.pdf
HAS/2016-11-02_CT-15380_TERCIAN_PIS_RI_Avis1_CT15380.pdf
HAS/2016-11-02_CT-15395_FLOXYFRAL_PIS_RI_Avis2_CT15395.pdf
HAS/2016-11-02_CT-15414_LOMEXIN-TERLOMEXIN_PIS_RI_Avis2_CT15414.pdf
HAS/2016-11-02_CT-15476_ESMYA_PIS_EPI_Avis2_CT15476.pdf
HAS/2016-11-02_CT-15500_EMERADE_QD_INS_Avis1_CT15500.pdf
HAS/2016-11-02_CT-15505_DOXY_PIS_RI_Avis1_CT15505.pdf
HAS/2016-11-02_CT-15511_BEPANTHEN_QD_INS_Avis1_CT15511.pdf
HAS/2016-11-02_CT-15622_CHLORURE_DE_MAGNESIUM_LAVOISIER_QD_INS_Avis1_CT15622.pdf
HAS/2016-11-02_CT-15656_ORDIPHA_QD_REEV_Avis1_CT15656.pdf
HAS/2016-11-02_CT-15660_CARTREX_QD_REEV_Avis1_CT15660.pdf
HAS/2016-11-03_CT-14460_COLTRAMYL_PIC_REEV_RI_Avis2_CT13761&14460.pdf
HAS/2016-11-03_CT-14470_AVONEX_PIS_RI_Avis2_CT14470.pdf
HAS/2016-11-03_CT-14858_KYPROLIS_PIC_INS_AvisPostAud_CT14858.pdf
HAS/2016-11-03_CT-14904_MEDROL_PIS_RI_Avis2_CT14904.pdf
HAS/2016-11-03_CT-14969_BARACLUDE_PIC_EI_pédiatrie_Avis2_CT14969.pdf
HAS/2016-11-03_CT-14998_ARTHROCINE_PIS_RI_Avis1_CT14998.pdf
HAS/2016-11-03_CT-15015_SABRIL_PIS_RI_Avis1_CT15015.pdf
HAS/2016-11-03_CT-15130_IASOGLIO_PIC_INS_Avis1_CT15130.pdf
HAS/2016-11-03_CT-15196_XENAZINE_PIS_RI_Avis1_CT15196.pdf
HAS/2016-11-03_CT-15221_ZAMUDOL_LP_PIS_RI_Avis2_CT15221.pdf
HAS/2016-11-03_CT-15318_NALGESIC_PIS_RI_Avis1_CT15318.pdf
HAS/2016-11-03_CT-15329_ARTANE_PIS_RI_Avis1_CT15329.pdf
HAS/2016-11-03_CT-15343_AKINETON_PIS_RI_Avis1_CT15343.pdf
HAS/2016-11-03_CT-15347_MODECATE_PIS_RI_Avis1_CT15347.pdf
HAS/2016-11-03_CT-15420_CHLORURE_DE_SODIUM_COOPER_PIS_RI_Avis1_CT15420.pdf
HAS/2016-11-03_CT-15422_LAMALINE_PIS_RI_Avis2_CT15422.pdf
HAS/2016-11-03_CT-15429_DOLKO_PIS_RI_Avis1_CT15429.pdf
HAS/2016-11-03_CT-15437_PARKINANE_LP_PIS_RI_Avis2_CT15437.pdf
HAS/2016-11-03_CT-15450_ROCALTROL_PIS_RI_Avis1_CT15450.pdf
HAS/2016-11-03_CT-15453_MODOPAR_PIS_RI_Avis2_CT15453.pdf
HAS/2016-11-03_CT-15459_NEO-CODION_PIS_RI_Avis2_CT15459.pdf
HAS/2016-11-03_CT-15482_NASACORT_PIS_RI_Avis2_CT15482.pdf
HAS/2016-11-03_CT-15487_KAYEXALATE_PIS_RI_Avis2_CT15487.pdf
HAS/2016-11-03_CT-15508_EXTOVYL_PIS_RI_Avis1_CT15508.pdf
HAS/2016-11-03_CT-15509_ANTARENE_PIS_RI_Avis1_CT15509.pdf
HAS/2016-11-03_CT-15526_KINOX_QD_INS_Avis1_CT15526.pdf
HAS/2016-11-03_CT-15534_TEMESTA_QD_INS_Avis2_CT15534.pdf
HAS/2016-11-03_CT-15556_DOMPERIDONE_MYLAN_QD_INS_Avis1_CT15556.pdf
HAS/2016-11-03_CT-15559_DICODIN_LP_PIS_RI_Avis2_CT15559.pdf
HAS/2016-11-03_CT-15586_PEMETREXED_FRESENIUS_KABI_QD_INS_Avis2_CT15586.pdf
HAS/2016-11-03_CT-15589_PERIDYS-OROPERIDYS_QD_INS_Avis2_CT15589.pdf
HAS/2016-11-03_CT-15591_TEVETEN_PIS_RI_Avis2_CT15591.pdf
HAS/2016-11-03_CT-15592_OGAST-OGASTORO_PIS_RI_Avis1_CT15592.pdf
HAS/2016-11-03_CT-15597_MINALFENE_PIS_RI_Avis1_CT15597.pdf
HAS/2016-11-03_CT-15603_XEOMIN_QD_INS_Avis1_CT15603.pdf
HAS/2016-11-03_CT-15610_DOCETAXEL_SEACROSS_QD_INS_Avis1_CT15610.pdf
HAS/2016-11-03_CT-15619_NOVATREX_QD_INS_Avis2_CT15619.pdf
HAS/2016-11-03_CT-15626_LEVONORGESTREL_ETHINYLESTRADIOL_SANDOZ_QD_INS_Avis1_CT15626.pdf
HAS/2016-11-03_CT-15639_MILRINONE_CARINOPHARM_QD_INS_Avis1_CT15639.pdf
HAS/2016-11-03_baraclude_summary_ct14969.pdf
HAS/2016-11-03_baraclude_synthese_ct14969.pdf
HAS/2016-11-03_cimzia_pic_ei_prnaifs_avis2_ct15321.pdf
HAS/2016-11-03_cimzia_summary_ct15321.pdf
HAS/2016-11-03_cimzia_synthese_ct15321.pdf
HAS/2016-11-03_coltramyl_summary_ct_13761_ct_14460.pdf
HAS/2016-11-03_coltramyl_synthes_ct_13761_ct_14460.pdf
HAS/2016-11-03_humira_pic_ei_psoenfant_avis1_modifiele14032016_ct14596.pdf
HAS/2016-11-03_humira_psoenfant_synthese_ct14596.pdf
HAS/2016-11-03_iasoglio_summary_ct15130.pdf
HAS/2016-11-03_iasoglio_synthese_ct15130.pdf
HAS/2016-11-03_kyprolis_10052016_avis_efficience.pdf
HAS/2016-11-03_kyprolis_summary_ct14858.pdf
HAS/2016-11-03_kyprolis_synthese_ct14858.pdf
HAS/2016-11-03_tachosil_neurochirurgie_pis_ei_non_demandee_avis1_modifiele131102016_ct15539.pdf
HAS/2016-11-04_CT-14850_ZERBAXA_PIC_INS_Avis3_CT14850.pdf
HAS/2016-11-04_CT-14980_METYRAPONE_HRA_PHARMA_PIC_INS_Avis2_CT14980.pdf
HAS/2016-11-04_CT-15334_NUMETAH_PIC_INS_Avis2_CT15334.pdf
HAS/2016-11-04_metyrapone_summary_ct14980.pdf
HAS/2016-11-04_metyrapone_synthese_ct14980.pdf
HAS/2016-11-04_numetah_prematures_sulmmary_ct15334.pdf
HAS/2016-11-04_numetah_prematures_synthese_ct15334.pdf
HAS/2016-11-04_zerbaxa_summary_ct14850.pdf
HAS/2016-11-04_zerbaxa_synthese_ct14850.pdf
HAS/2016-11-07_CEPP-4991_CHONDRO-GIDE_4_octobre_2016_(4991)_avis.pdf
HAS/2016-11-07_CEPP-5077_MICRA_avis_du_18_octobre_2016_ 5077_occulte.pdf
HAS/2016-11-07_CEPP-5101_ZILVER_PTX_(5101)_4_octobre_2016_occulte.pdf
HAS/2016-11-07_CEPP-5136_NUTRAMIGEN PURAMINO_18_octobre_2016_(5136)_avis.pdf
HAS/2016-11-07_CEPP-5183_HYLO CONFORT_18_octobre_2016_(5183)_avis.pdf
HAS/2016-11-07_CT-14541_CHRONO-INDOCID_INDOCID_PIS_RI_Avis2_CT14541.pdf
HAS/2016-11-07_CT-15226_ORGALUTRAN_PIS_RI_Avis2_CT15226.pdf
HAS/2016-11-07_CT-15335_ESTRAPATCH_PIS_RI_Avis1_CT15335.pdf
HAS/2016-11-07_CT-15424_FLUVERMAL_PIS_RI_Avis1_CT15424.pdf
HAS/2016-11-07_CT-15433_ASPEGIC_PIS_RI_Avis2_CT15433.pdf
HAS/2016-11-07_CT-15442_MESTINON_PIS_RI_Avis1_CT15442.pdf
HAS/2016-11-07_CT-15443_PROSTIGMINE_PIS_RI_Avis2_CT15443.pdf
HAS/2016-11-07_CT-15480_METOCALCIUM_PIS_RI_Avis2_CT15480.pdf
HAS/2016-11-07_CT-15488_GLUCANTIME_PIS_RI_Avis1_CT15488.pdf
HAS/2016-11-07_CT-15496_LOCACID_PIS_RI_Avis2_CT15496.pdf
HAS/2016-11-07_CT-15501_RIFAMYCINE_CHIBRET_PIS_RI_Avis2_CT15501.pdf
HAS/2016-11-07_CT-15520_SMOFKABIVEN_PIS_RI_Avis2_CT14960&15520.pdf
HAS/2016-11-07_CT-15602_PANZYGA_PIS_INS_Avis1_CT15602.pdf
HAS/2016-11-07_CT-15636_NORCHOLESTEROL_IODE_PIS_INS_Avis2_CT15636.pdf
HAS/2016-11-07_CT-15653_BENEMIDE_QD_REEV_Avis1_CT15653.pdf
HAS/2016-11-07_CT-15654_IMMUNOGLOBULINE_EQUINE_TETANIQUE_PASTEUR_QD_REEV_Avis1_CT15654.pdf
HAS/2016-11-07_CT-15658_RULID_QD_REEV_Avis1_CT15658.pdf
HAS/2016-11-07_assessment_of_apps_in_the_mobile_health_mhealth_sector._overview_and_quality_criteria_of_medical_content.pdf
HAS/2016-11-07_benepali_prnaifs_pis_reev_avis1_ct15671.pdf
HAS/2016-11-07_criteres_de_qualite_du_contenu_medical_referencement_mhealth_ens_2021-06-30_10-58-28_773.pdf
HAS/2016-11-07_flixabi_prnaifs_pis_reev_avis1_ct15670.pdf
HAS/2016-11-07_good_practice_guidelines_on_health_apps_and_smart_devices_mobile_health_or_mhealth.pdf
HAS/2016-11-07_has_ref_apps_oc.pdf
HAS/2016-11-07_inflectra_prnaifs_pis_reev_avis2_ct15673.pdf
HAS/2016-11-07_remsima_prnaifs_pis_reev_avis1_ct15672.pdf
HAS/2016-11-08_CT-15276_PROCYSBI_PIC_REEV_Avis 2_CT15276.pdf
HAS/2016-11-08_CT-15367_FEMSEPT-FEMSEPTEVO-FEMSEPTCOMBI-ESTREVA_PIS_RI_Avis2_CT15367.pdf
HAS/2016-11-08_CT-15648_PIPRAM_FORT_QD_REEV_Avis1_CT15648.pdf
HAS/2016-11-08_CT-15650_ULCAR_QD_REEV_Avis1_CT15650.pdf
HAS/2016-11-08_CT-15655_AZADOSE-ZITHROMAX_QD_REEV_Avis2_CT15655.pdf
HAS/2016-11-08_CT-15657_ALDARA_QD_REEV_Avis2_CT15657.pdf
HAS/2016-11-08_app_387_389_390_391_392_note_de_cadrage_maj_referentiel_certification_lap_coi_2020_02_13_v2_partie1.pdf
HAS/2016-11-08_app_387_referentiel_lapv_cd_2021_03_25_v1.pdf
HAS/2016-11-08_precisions_sur_les_certifications_des_lap_et_des_lad_-_version_du_22_septembre_2016.pdf
HAS/2016-11-08_procedure_de_certification_par_essai_de_type_lap.pdf
HAS/2016-11-08_procysbi_summary_ct15276.pdf
HAS/2016-11-08_procysbi_synthese_ct15276.pdf
HAS/2016-11-08_referentiel_certif_lap_2016-09-26_15-20-40_629.pdf
HAS/2016-11-09_CT-14017_CELESTENE_DIPROSTENE_PIS_RI_Avis2_CT14017.pdf
HAS/2016-11-09_da_formulaire_v2_maj.pdf
HAS/2016-11-09_da_personne_confiance_v9.pdf
HAS/2016-11-09_da_professionnels_v11_actualisation.pdf
HAS/2016-11-09_diprolene_diprosone_pis_ri_avis2_ct14017.pdf
HAS/2016-11-09_directives_anticipees_concernant_les_situations_de_fin_de_vie_v16.pdf
HAS/2016-11-09_modele_de_redaction_des_directives_anticipees.pdf
HAS/2016-11-09_note_methodo_da_version_web.pdf
HAS/2016-11-10_CT-14514_VOLTARENE_EMULGEL-VOLTARENDOLO_PIS_RI_Avis2_CT14514.pdf
HAS/2016-11-10_CT-14847_MIKICORT_PIC_EI_Avis1_CT14847.pdf
HAS/2016-11-10_CT-14907_EFFICORT_PIS_RI_Avis1_CT14907.pdf
HAS/2016-11-10_CT-15079_MYDRANE_PIC_INS_Avis2_CT15079.pdf
HAS/2016-11-10_CT-15411_LITHIODERM_PIS_RI_Avis1_CT15411.pdf
HAS/2016-11-10_CT-15649_KEAL_QD_REEV_Avis1_CT15649.pdf
HAS/2016-11-10_CT-15651_THERALENE_QD_REEV_Avis1_CT15651.pdf
HAS/2016-11-10_CT-15652_EFFEDERM_QD_REEV_Avis1_CT15652.pdf
HAS/2016-11-10_mikicort_summary_ct14847.pdf
HAS/2016-11-10_mydrane_summary_ct15079.pdf
HAS/2016-11-10_revolade_ams_pic_ei_avispostobs_modifiele19092016_ct15134.pdf
HAS/2016-11-10_revolade_summary_ct15134.pdf
HAS/2016-11-14_CEPP-5156_HIRES ULTRA HIFOCUS MS_18_octobre_2016_(5156)_avis.pdf
HAS/2016-11-14_CEPP-5170_NUCLEUS ABI_18_octobre_2016_(5170)_avis.pdf
HAS/2016-11-14_CT-14360_CERTICAN_PIS_RI_Avis2_CT14360.pdf
HAS/2016-11-14_CT-15149_AUBAGIO_PIS_RCP_Avis2_CT15149.pdf
HAS/2016-11-14_enquete_point_de_vue_des_usagers_certif.pdf
HAS/2016-11-14_enquete_point_de_vue_des_usagers_certif_-_synthese.pdf
HAS/2016-11-15_CEPP-4963_AKILE_31_mai_2016_(4963)_avis.pdf
HAS/2016-11-15_CEPP-5114_HOME MONITORING ILIVIA 7 VR-T_04_octobre_2016_( 5114)_avis.pdf
HAS/2016-11-15_CEPP-5115_HOME MONITORING ILIVIA 7 DR-T_04_octobre_2016_(5115)_avis.pdf
HAS/2016-11-15_CEPP-5116_HOME MONITORING ILIVIA 7HF-T et ILIVIA 7 HF-T QP_04_octobre_2016_( 5116)_avis.pdf
HAS/2016-11-15_CEPP-5152_URGOCLEAN AG_04_octobre_2016_( 5152)_avis.pdf
HAS/2016-11-17_CEPP-4920_NESS_L300_31_mai_2016_(4920)_avis.pdf
HAS/2016-11-17_CEPP-5069_TREVO_PROVUE 5069_4_octobre_2016_occulte.pdf
HAS/2016-11-17_CEPP-5078_SOLITAIRE_2_4_octobre_2016_5078_occulte.pdf
HAS/2016-11-17_CEPP-5083_TREVO_XP_PROVUE 5083_4_octobre_2016_occulte.pdf
HAS/2016-11-17_CEPP-5085_PIED_BREEZE_14_juin_2016_(5085)_avis.pdf
HAS/2016-11-17_CT-14091_INOFER_Cp_QD_INS_Avis1_CT14091.pdf
HAS/2016-11-17_CT-14974_TARDYFERON_PIS_INS_Avis2_CT14974.pdf
HAS/2016-11-17_CT-15298_BECLOSPIN_PIS_RI_Avis1_CT15298.pdf
HAS/2016-11-17_CT-15371_CUBICIN_QD_ADM_Avis1_CT15371.pdf
HAS/2016-11-17_CT-15681_MYSILDECARD_QD_INS_Avis1_CT15681.pdf
HAS/2016-11-17_CT-15706_FLOLAN_QD_INS_Avis1_CT15706.pdf
HAS/2016-11-17_d2016-56_-_decision_portant_adoption_du_guide_essms.pdf
HAS/2016-11-17_fer_summary.pdf
HAS/2016-11-17_fer_synthese_avis.pdf
HAS/2016-11-17_fer_synthese_avis_2016-11-16_10-37-33_532.pdf
HAS/2016-11-17_web_guide_evaluation_suite_a5_091216.pdf
HAS/2016-11-18_CEPP-5202_LOTUS_EDGE_8_novembre_2016_(5202)_occulte.pdf
HAS/2016-11-18_fiche_memo_cystite_durees_antibiotherapies_.pdf
HAS/2016-11-18_fiche_memo_femme_enceinte_durees_antibiotherapies_.pdf
HAS/2016-11-18_fiche_memo_oma_purulente_adulte_durees_antibiotherapies.pdf
HAS/2016-11-18_fiche_memo_oma_purulente_enfant_durees_antibiotherapies.pdf
HAS/2016-11-18_fiche_memo_pyelonephrite_durees_antibiotherapies_.pdf
HAS/2016-11-18_fiche_memo_rhinopharyngite_angine_adulte_durees_antibiotherapies.pdf
HAS/2016-11-18_fiche_memo_rhinopharyngite_angine_enfant_durees_antibiotherapies.pdf
HAS/2016-11-18_fiche_memo_sinusite_adulte_durees_antibiotherapies.pdf
HAS/2016-11-18_fiche_memo_sinusite_enfant_durees_antibiotherapies.pdf
HAS/2016-11-18_rapport_elaboration__durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2016-11-18_reco360_synthese_durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2016-11-21_CT-15125_FORMOAIR_PIS_RI_Avis2_CT15125.pdf
HAS/2016-11-21_CT-15362_VESANOID_PIS_REEV_Avis2_CT15362.pdf
HAS/2016-11-21_CT-15393_VENTOLINE_PIS_RI_Avis2_CT15393.pdf
HAS/2016-11-22_14_outils_violence_en_hospi_psy.pdf
HAS/2016-11-22_15_programmes_violence_hospi_psy_cd21092016_v0.pdf
HAS/2016-11-22_CEPP-5051_NAVINA CLASSIC_08_11_2016_(5051)_avis.pdf
HAS/2016-11-22_CEPP-5111_NAVINA SMART_08_11_2016_(5111)_avis.pdf
HAS/2016-11-22_cadre_general_devaluation_des_demarches_danalyse_des_eias_-_novembre_2016.pdf
HAS/2016-11-22_guide_methodo_violence_hospi_psy.pdf
HAS/2016-11-22_moments_violence_psychiatrie_cadrage_2014-01-14_14-33-44_590.pdf
HAS/2016-11-22_outil_01_projet_therapeutique_individualise.pdf
HAS/2016-11-22_outil_02_recueil_donnees_parcours_patient.pdf
HAS/2016-11-22_outil_03_plan_prevention.pdf
HAS/2016-11-22_outil_04_circuit_information.pdf
HAS/2016-11-22_outil_05_desamorcage.pdf
HAS/2016-11-22_outil_06_espace_apaisement.pdf
HAS/2016-11-22_outil_07_appel_renforts.pdf
HAS/2016-11-22_outil_08_apres_etat_agitation.pdf
HAS/2016-11-22_outil_09_post_incident.pdf
HAS/2016-11-22_outil_10_gestion_post_incident.pdf
HAS/2016-11-22_outil_11_exemple_rmm.pdf
HAS/2016-11-22_outil_12_guide_elaboration_projet_equipe.pdf
HAS/2016-11-22_outil_13_organiser_promouvoir.pdf
HAS/2016-11-22_outil_14_renforcement_connaissances_competences.pdf
HAS/2016-11-22_programme_01_apprehender_realite_phenomenes_violence_psy.pdf
HAS/2016-11-22_programme_02_evaluer_patient_accueil_violence_hospi.pdf
HAS/2016-11-22_programme_03_impliquer_ameliorer_accueil_patient.pdf
HAS/2016-11-22_programme_04_accueillir_famille_entourage.pdf
HAS/2016-11-22_programme_05_ameliorer_collecte_donnees_patient_circuit_information.pdf
HAS/2016-11-22_programme_06_prevenir_gerer_crise.pdf
HAS/2016-11-22_programme_07_reprendre_incident_avec_patients.pdf
HAS/2016-11-22_programme_08_reprendre_incident_equipe.pdf
HAS/2016-11-22_programme_09_gerer_suites_incident_niveau_institutionnel.pdf
HAS/2016-11-22_programme_10_mettre_place_gestion_risques.pdf
HAS/2016-11-22_programme_11_construire_dynamique_equipe.pdf
HAS/2016-11-22_programme_12_organiser_promouvoir_prevention_violence_en_etablissement.pdf
HAS/2016-11-22_programme_13_promouvoir_droits_patients_demarches_ethiques_bientraitance.pdf
HAS/2016-11-22_programme_14_prevenir_prendre_en_charge_violence_hospi_longue_duree.pdf
HAS/2016-11-22_programme_15_actualiser_renforcer_connaissances_competences_fondamentales_des_professionnels.pdf
HAS/2016-11-22_rapport_biblio_violence_hospi_psy_en_attente.pdf
HAS/2016-11-22_referentiel_generique_d_evaluation_demarches_d_analyse_eias.pdf
HAS/2016-11-23_CEPP-5124_VISMED_LIPO_8_novembre_2016_(5124)_occulte.pdf
HAS/2016-11-23_CEPP-5125_VISMED_LIPO_MULTI_8_novembre_2016_(5125)_occulte.pdf
HAS/2016-11-23_CEPP-5162_POLARCUP_sans_ciment_8_novembre_2016_(5162)_occulte.pdf
HAS/2016-11-23_CT-15552_VIEKIRAX_EXVIERA_PIC_REEV_AAD_Avis2_CT15552.pdf
HAS/2016-11-23_inahta_brief_thrombectomy.pdf
HAS/2016-11-23_polarcup_cimentee_8_novembre_2016_5133_occulte.pdf
HAS/2016-11-23_rapport_thrombectomie.pdf
HAS/2016-11-24_CEPP-5174_STRUCTOVIAL_22_novembre_2016_(5174)_avis.pdf
HAS/2016-11-24_arthrum_h_2_22_novembre_2016_5176_avis.pdf
HAS/2016-11-25_CT-14961_TANGANIL-TANGANILPRO_PIS_RI_Avis1_CT14961.pdf
HAS/2016-11-25_CT-15199_FORADIL_PIS_RI_Avis2_CT15199.pdf
HAS/2016-11-25_CT-15490_ACUPAN_PIS_RI_Avis2_CT15490.pdf
HAS/2016-11-25_CT-15535_AMLOR_PIS_RI_Avis2_CT15535.pdf
HAS/2016-11-25_CT-15545_ALPRESS_PIS_RI_Avis2_CT15545.pdf
HAS/2016-11-25_CT-15558_SKELID_PIS_RI_Avis1_CT15558.pdf
HAS/2016-11-25_CT-15606_PARACETAMOL_BIOGARAN_PIS_RI_Avis2_CT15606.pdf
HAS/2016-11-25_ibuprofene_rpg_pis_ri_avis1_modifiele18112016_ct15416.pdf
HAS/2016-11-25_sieges_coquilles_de_serie_22_novembre_2016_dm_eval_135_avis_2016-11-24_15-36-3_502.pdf
HAS/2016-11-25_simponi_prnaifs_pis_reev_avis1_ct15691.pdf
HAS/2016-11-28_08-098_gp_maladie_corona_2008-06-16_14-30-47_587.pdf
HAS/2016-11-28_ald3_aomi_guide_cardiovasc_post_corrlemire_revuenp28avril__205.pdf
HAS/2016-11-28_liste_actes_presta_aomi_ald3.pdf
HAS/2016-11-29_CEPP-5128_TERION_K2_22_novembre_2016_(5128)_avis.pdf
HAS/2016-11-30_CEPP-4966_REPNEU_22_novembre_2016_(4966)_avis.pdf
HAS/2016-11-30_CEPP-5157_ZEN-O RS-00500_8_novembre_2016_(5157)_avis.pdf
HAS/2016-11-30_biomatrix_alpha_22_novembre_2016_5159_occulte.pdf
HAS/2016-12-01_d2016-31_-_decision_d_adoption_rbpp_reperage_des_risques_autonomie_-_volet_ra.pdf
HAS/2016-12-01_fiche_repere_chutes_volet_resi_aut_decembre_2016_pdf.pdf
HAS/2016-12-01_fiche_repere_mauvaise_nutritiondenutrition_et_deshydratation__volet_resi_aut_decembre_2016_pdf.pdf
HAS/2016-12-01_fiche_repere_prise_de_medicaments_volet_resi_aut_decembre_2016_pdf.pdf
HAS/2016-12-01_fiche_repere_souffrance_physique_volet_resi_aut_decembre_2016.pdf
HAS/2016-12-01_fiche_repere_souffrance_psychique_volet_resi_aut_decembre_2016.pdf
HAS/2016-12-01_fiche_repere_troubles_du_comportement_volet_resi_aut_decembre_2016.pdf
HAS/2016-12-01_fiche_reperes_aidants_volet_resi_aut_decembre_2016.pdf
HAS/2016-12-01_grille_de_lecture_volet_resi_aut_decembre_2016.pdf
HAS/2016-12-01_perte_autonomie_volet_resi_aut_decembre_2016.pdf
HAS/2016-12-01_sandostatine_pic_ei_avispostobs_modifiele19092016_ct15290.pdf
HAS/2016-12-01_sandostatine_summary_ct15290.pdf
HAS/2016-12-01_sandostatine_synthese_ct15290.pdf
HAS/2016-12-02_CEPP-5134_REXPOL_EP_FIT PLUS_8_novembre_2016_(5134)_occulte.pdf
HAS/2016-12-02_inahta_brief_cardiac_imaging.pdf
HAS/2016-12-02_rapport_imagerie_cardiaque.pdf
HAS/2016-12-05_CT-15205_BRONCHODUAL_PIS_RI_Avis2_CT15205.pdf
HAS/2016-12-05_CT-15351_PARLODEL_PIS_RI_AvisPostObs_CT15351.pdf
HAS/2016-12-05_CT-15722_MORPHINE_CHLORHYDRATE_RENAUDIN_QD_INS_Avis1_CT15722.pdf
HAS/2016-12-06_aad_avis_25052016_ct_25052016.pdf
HAS/2016-12-06_rapport_actualisation_strat_aad_2017_avis2_06122017_cteval318.pdf
HAS/2016-12-06_rapport_reev_aad_avis2_19102016.pdf
HAS/2016-12-08_bum_plasma.pdf
HAS/2016-12-12_CEPP-5206_CHAUSSURE THERAPEUTIQUE DE SERIE A USAGE PROLONGE POUR ENFANT_22_novembre_2016_(5206)_avis.pdf
HAS/2016-12-12_CEPP-5207_PANTORZOTE CHAUSSURE THERMOFORMABLE_22_novembre_2016_(5207)_avis.pdf
HAS/2016-12-12_CT-15341_TREVICTA_PIC_INS_Avis1_CT15341.pdf
HAS/2016-12-12_CT-15394_IDEOS_PIS_RI_Avis1_CT15394.pdf
HAS/2016-12-12_CT-15413_VITAMINE_A_FAURE_PIS_RI_Avis1_CT15413.pdf
HAS/2016-12-12_CT-15451_DACRYOSERUM_PIS_RI_Avis1_CT15451.pdf
HAS/2016-12-12_CT-15455_OMNIPAQUE_PIS_RI_Avis1_CT15455.pdf
HAS/2016-12-12_CT-15493_MICROPAQUE_SCANNER_PIS_RI_Avis1_CT15493.pdf
HAS/2016-12-12_CT-15506_VITABACT_PIS_RI_Avis1_CT15506.pdf
HAS/2016-12-12_CT-15549_CALCIDOSE_VITAMINE_D3_PIS_RI_Avis1_CT15549.pdf
HAS/2016-12-12_CT-15644_MAGNESIUM_CHLORURE_RENAUDIN_QD_INS_Avis1_CT15644.pdf
HAS/2016-12-12_CT-15690_SIMPONI_PIS_EI_NON_DEMANDEE_AvisPostObs_CT15690.pdf
HAS/2016-12-12_CT-15707_DOMPERIDONE_ZENTIVA_QD_INS_Avis1_CT15707.pdf
HAS/2016-12-12_CT-15719_DOMPERIDONE_SANDOZ_QD_INS_Avis1_CT15719.pdf
HAS/2016-12-12_CT-15721_BROMHYDRATE_DE_SCOPOLAMINE_RENAUDIN_QD_INS_Avis1_CT15721.pdf
HAS/2016-12-12_argumentaire_paludisme.pdf
HAS/2016-12-12_enbrel_humira_remicade_summary_ct15200_ct15191_ct15202.pdf
HAS/2016-12-12_enbrel_humira_remicade_synthese_ct15200_ct15191_ct15202.pdf
HAS/2016-12-12_enbrel_prnaifs_pis_reev_avis2_ct15200.pdf
HAS/2016-12-12_humira_pic_reev_prnaifs_avis2_modifiele26092016_ct15202.pdf
HAS/2016-12-12_inahta_brief_plasmodium_infections.pdf
HAS/2016-12-12_pnds_-_syringomyelie.pdf
HAS/2016-12-12_pnds_80_-_syringomyelie_les_fentes_intramedullaires_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2016-12-12_remicade_prnaifs_pis_reev_avis2_ct15191.pdf
HAS/2016-12-12_trevicta_summary_ct15341.pdf
HAS/2016-12-12_trevicta_synthese_ct15341.pdf
HAS/2016-12-13_anesm_troubles_comportement_1-2.pdf
HAS/2016-12-13_anesm_troubles_comportement_1.pdf
HAS/2016-12-13_anesm_troubles_comportement_2-2.pdf
HAS/2016-12-13_anesm_troubles_comportement_2.pdf
HAS/2016-12-13_cp_rbpp_pasa_comm.pdf
HAS/2016-12-13_cp_rbpp_uhr_comm.pdf
HAS/2016-12-13_d2016-32_-_decision_adoption_deficiences_sensorielles_-_ehpad_et_ra.pdf
HAS/2016-12-13_decision_adoption_pasa-2.pdf
HAS/2016-12-13_decision_adoption_uhr.pdf
HAS/2016-12-13_deficience_auditive_ephad.pdf
HAS/2016-12-13_deficience_gustative_ephad.pdf
HAS/2016-12-13_deficience_olfactive_ephad.pdf
HAS/2016-12-13_deficience_resi_aut_230117.pdf
HAS/2016-12-13_deficience_sesf_auditive_ephad.pdf
HAS/2016-12-13_deficience_sesf_gustative_olfactive_ephad.pdf
HAS/2016-12-13_deficience_sesf_memento_ephad.pdf
HAS/2016-12-13_deficience_sesf_visuelle_ephad.pdf
HAS/2016-12-13_deficience_tactile_ephad.pdf
HAS/2016-12-13_deficience_vestibulaire_ephad.pdf
HAS/2016-12-13_deficience_visuelle_volet_ephad.pdf
HAS/2016-12-13_enquete_nationale_uhr.pdf
HAS/2016-12-13_lc_pasa-uhr_vf-2.pdf
HAS/2016-12-13_lc_pasa-uhr_vf-3.pdf
HAS/2016-12-13_lettre_de_cadrage_deficiences_sensorielles.pdf
HAS/2016-12-13_rbpp_sesf_deficience_tactile_ephad.pdf
HAS/2016-12-13_rbpp_sesf_deficience_vestibulaire_ephad.pdf
HAS/2016-12-13_revue_de_litterature_deficiences_sensorielles_livrable1.pdf
HAS/2016-12-13_revue_de_litterature_deficiences_sensorielles_livrable_2.pdf
HAS/2016-12-13_web_rbpp_deficience_volet_ephad.pdf
HAS/2016-12-13_web_rbpp_pasa_16x24.pdf
HAS/2016-12-13_web_rbpp_uhr_16x24.pdf
HAS/2016-12-13_web_synthese_pasa.pdf
HAS/2016-12-13_web_synthese_uhr.pdf
HAS/2016-12-14_guide_methodologique__choix_methodologiques_pour_lanalyse_de_limpact_budgetaire_a_la_has_.pdf
HAS/2016-12-15_CT-14766_ECALTA_PIC_EI_Avis2_CT14766.pdf
HAS/2016-12-15_CT-15386_MAXIDEX_PIS_RI_Avis1_CT15386.pdf
HAS/2016-12-15_CT-15402_BIOCIDAN_PIS_RI_Avis2_CT15402.pdf
HAS/2016-12-15_CT-15460_BETOPTIC_PIS_RI_Avis1_CT15460.pdf
HAS/2016-12-15_CT-15473_ISOPTO_PILOCARPINE_PIS_RI_Avis1_CT15473.pdf
HAS/2016-12-15_CT-15507_BRICANYL_QD_INS_Avis1_CT15507.pdf
HAS/2016-12-15_CT-15538_CHIBROXINE_PIS_RI_Avis2_CT15538.pdf
HAS/2016-12-15_CT-15580_RADIOSELECTAN_URINAIRE_PIS_RI_Avis2_CT15580.pdf
HAS/2016-12-15_CT-15581_GASTROGRAFINE_PIS_RI_Avis2_CT15581.pdf
HAS/2016-12-15_CT-15604_CALCIUM_VITAMINE_D3_MYLAN_PIS_RI_Avis1_CT15604.pdf
HAS/2016-12-15_CT-15662_MALARONE_PIS_RI_Avis2_CT15662.pdf
HAS/2016-12-15_CT-15664_MODOPAR_QD_INS_Avis1_CT15664.pdf
HAS/2016-12-15_CT-15684_CHLORURE_DE_SODIUM_MACOPHARMA_QD_INS_Avis1_CT15684.pdf
HAS/2016-12-15_CT-15695_FEGENOR_PIS_RI_Avis1_CT15695.pdf
HAS/2016-12-15_CT-15708_ELAVIL_PIS_RI_Avis1_CT15708.pdf
HAS/2016-12-15_CT-15723_SULFATE_DE_MAGNESIUM_LAVOISIER_QD_INS_Avis1_CT15723.pdf
HAS/2016-12-15_CT-15730_PECFENT_QD_INS_Avis1_CT15730.pdf
HAS/2016-12-15_CT-15735_NORDIMET_QD_INS_Avis1_CT15735.pdf
HAS/2016-12-15_CT-15737_DILTIAZEM_BIOGARAN_LP_PIS_RI_Avis2_CT15737.pdf
HAS/2016-12-15_CT-15744_LEDERFOLINE_PIS_RI_Avis2_CT15744.pdf
HAS/2016-12-15_CT-15758_CASPOFUNGINE_ACCORD_QD_INS_Avis1_CT15758.pdf
HAS/2016-12-15_CT-15759_LINEZOLIDE_ACCORD_QD_INS_Avis1_CT15759.pdf
HAS/2016-12-15_CT-15765_LINEZOLIDE_MYLAN_PHARMA_QD_INS_Avis1_CT15765.pdf
HAS/2016-12-15_CT-15770_ZOLPIDEM_MYLAN_QD_INS_Avis2_CT15770.pdf
HAS/2016-12-15_CT-15799_ZYDELIG_QD_RCP_Avis2_CT15774&15799.pdf
HAS/2016-12-15_buspirone_mylan_qd_ins_avis2_modifiele20122016_ct15584.pdf
HAS/2016-12-15_ecalta_summary_ct14766.pdf
HAS/2016-12-15_ecalta_synthese_ct14766.pdf
HAS/2016-12-15_ipaqss-rapport-psy-v5.pdf
HAS/2016-12-15_ipaqss_rapport_psy-vf.pdf
HAS/2016-12-15_plaquette_psy_vf.pdf
HAS/2016-12-15_psy_plaquette_2014_vf.pdf
HAS/2016-12-15_psy_rapport_2014_vf.pdf
HAS/2016-12-15_rapport_2016_dpa_psy_vf.pdf
HAS/2016-12-15_rapport_complementaire_vf.pdf
HAS/2016-12-19_CEPP-5226_CLASSIC VISCO_06_decembre_2016_(5226)_avis.pdf
HAS/2016-12-19_mc_247_lessentiel_demarche_palliative_coi_2016_12_07_v0.pdf
HAS/2016-12-19_mc_247_note_methodo_demarche_palliative_web.pdf
HAS/2016-12-19_mc_247_synthese_demarche_palliative_web.pdf
HAS/2016-12-19_organisation_of_pathways_-_essentials_of_the_palliative_approach.pdf
HAS/2016-12-21_CEPP-4970_MUTARS LUMIC_06_decembre_2016_(4970)_avis.pdf
HAS/2016-12-21_CEPP-5175_EUFLEXXA_06_decembre_2016_(5175)_avis.pdf
HAS/2016-12-21_CEPP-5178_DUROLANE_06_decembre_2016_(5178)_avis.pdf
HAS/2016-12-21_CT-15193_GARDENAL_PIS_RI_Avis1_CT15193.pdf
HAS/2016-12-21_CT-15250_AZACTAM_PIS_RI_Avis2_CT15250.pdf
HAS/2016-12-21_CT-15289_FOSRENOL_PIS_RI_Avis2_CT15289.pdf
HAS/2016-12-21_CT-15381_KANEURON_PIS_RI_Avis1_CT15381.pdf
HAS/2016-12-21_CT-15383_FLUCON_PIS_RI_Avis1_CT15383.pdf
HAS/2016-12-21_CT-15387_LARMES_ARTIFICIELLES_MARTINET_PIS_RI_Avis1_CT15387.pdf
HAS/2016-12-21_CT-15388_TOBREX_PIS_RI_Avis2_CT15388.pdf
HAS/2016-12-21_CT-15396_SYMBICORT_RAPIHALER_PIS_INS_Avis2_CT15396.pdf
HAS/2016-12-21_CT-15410_ALEPSAL_PIS_RI_Avis1_CT15410.pdf
HAS/2016-12-21_CT-15465_LUDIOMIL_PIS_RI_Avis1_CT15465.pdf
HAS/2016-12-21_CT-15585_TAFINLAR_QD_ADM_Avis2_CT15585.pdf
HAS/2016-12-21_CT-15668_CELECTOL_PIS_RI_Avis1_CT15668.pdf
HAS/2016-12-21_CT-15676_FLUDEX_PIS_RI_Avis2_CT15676.pdf
HAS/2016-12-21_CT-15720_DIAZEPAM_RENAUDIN_QD_INS_Avis1_CT15720.pdf
HAS/2016-12-21_CT-15733_ROACTEMRA_SC_EI_NON_DEMANDEE_Avis1_CT15733.pdf
HAS/2016-12-21_argumentaire_cryoablation_vd.pdf
HAS/2016-12-21_avis_laser_saphene_vd.pdf
HAS/2016-12-21_inahta_brief_cryotherapy.pdf
HAS/2016-12-21_rapport_laser_endoveineux_vd.pdf
HAS/2016-12-21_rapport_laser_saphene_vd_2008-07-29_10-34-45_555.pdf
HAS/2016-12-21_synthese_laser_saphene_vd.pdf
HAS/2016-12-22_CT-15665_RABIPUR_QD_INS_Avis1_CT15665.pdf
HAS/2016-12-22_CT-15703_LIPTRUZET_PIS_EI_Prevention_NON_DEMANDEE_Avis2_CT15703.pdf
HAS/2016-12-22_CT-15704_INEGY_PIS_EI_Prevention_NON_DEMANDEE_Avis2_CT15704.pdf
HAS/2016-12-22_CT-15739_IBUPROFENE_ZENTIVA_QD_INS_Avis1_CT15739.pdf
HAS/2016-12-22_CT-15754_DILUANT_PHYSIOLOGIQUE_PHENOLE_PIS_RI_Avis2_CT15754.pdf
HAS/2016-12-22_CT-15762_FERTIFOL_400_QD_INS_Avis2_CT15762.pdf
HAS/2016-12-22_CT-15821_LEVONORGESTREL_ETHINYLESTRADIOL_CRISTERS_QD_INS_Avis2_CT15821.pdf
HAS/2016-12-22_inahta_brief_robot_assisted_surgery_radical_prostatectomy.pdf
HAS/2016-12-22_rapport_robot_vd.pdf
HAS/2016-12-27_CT-14725_INTRONA_PIS_RI_Avis1_CT14725.pdf
HAS/2016-12-27_CT-15274_KOVALTRY_PIS_INS_Avis2_CT15274.pdf
HAS/2016-12-27_CT-15392_MYSOLINE_PIS_RI_Avis2_CT15392.pdf
HAS/2016-12-27_CT-15464_TOFRANIL_PIS_RI_Avis2_CT15464.pdf
HAS/2016-12-27_CT-15510_IBLIAS_PIS_INS_Avis2_CT15510.pdf
HAS/2016-12-27_CT-15595_IMOVAX_POLIO_PIS_RI_Avis1_CT15595.pdf
HAS/2016-12-27_CT-15599_TETRAVAC-ACELLULAIRE_QD_INS_Avis1_CT15599.pdf
HAS/2017-01-02_dataset_-_contenu_metier_hypertension_arterielle.pdf
HAS/2017-01-02_dataset__contenu_metier_bpco.pdf
HAS/2017-01-02_dataset__contenu_metier_diabete_type_2.pdf
HAS/2017-01-02_dataset__contenu_metier_infections_respiratoires_hautes.pdf
HAS/2017-01-03_CEPP-5181_SATURNE sans ciment_20_decembre_2016_(5181)_avis.pdf
HAS/2017-01-03_CEPP-5191_PROVOX FLEXIVOICE_06_decembre_2016_(5191)_avis.pdf
HAS/2017-01-03_CEPP-5194_SATURNE cimentee_20_decembre_2016_(5194)_avis.pdf
HAS/2017-01-03_CEPP-5218_PAIN G-NUTRITION_20_decembre_2016_(5218)_avis.pdf
HAS/2017-01-03_CT-14615_QUASYM_LP_PIC_REEV_RI_Avis2_CT14615.pdf
HAS/2017-01-03_CT-15177_FYCOMPA_PIS_INS_Avis2_CT15177.pdf
HAS/2017-01-03_fycompa_summary_ct15177.pdf
HAS/2017-01-03_fycompa_synthese_ct15177.pdf
HAS/2017-01-03_quasymlp_summary_ct14615.pdf
HAS/2017-01-03_quasymlp_synthese_ct14615.pdf
HAS/2017-01-04_CT-14342_ROFERON-A_PIS_RI_Avis1_CT14342.pdf
HAS/2017-01-04_CT-15594_PENTAVAC_PIS_RI_Avis2_CT15594.pdf
HAS/2017-01-04_CT-15692_SOLIAN_PIS_RI_Avis2_CT15692.pdf
HAS/2017-01-04_CT-15736_LOPRESSOR_PIS_RI_Avis2_CT15736.pdf
HAS/2017-01-04_pnds_-_osteogenese_imparfaite.pdf
HAS/2017-01-04_pnds_82_-_osteogenese_imparfaite_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-01-06_CEPP-5177_OSTENIL_20_decembre_2016_(5177)_avis.pdf
HAS/2017-01-06_CEPP-5180_SINOVIAL_20_decembre_2016_(5180)_avis.pdf
HAS/2017-01-06_CEPP-5195_SYNOCROM_20_decembre_2016_(5195)_avis.pdf
HAS/2017-01-06_CT-14958_AMYCOR_ONYCHOSET_PIS_RI_Avis2_CT14958.pdf
HAS/2017-01-06_CT-14967_AMYCOR_PIS_RI_Avis2_CT14967.pdf
HAS/2017-01-06_CT-15596_TETRAVAC-ACELLULAIRE_PIS_RI_Avis1_CT15596.pdf
HAS/2017-01-06_CT-15635_MISODEL_PIC_INS_Avis2_CT15635.pdf
HAS/2017-01-09_CEPP-5151_ALBER_VIAMOBIL_V25_5151_cavardie.pdf
HAS/2017-01-10_CT-14398_PRADAXA_PIC_REEV_Avis3_CT14398.pdf
HAS/2017-01-10_CT-15598_ORFADIN_QD_INS_Avis1_CT15598.pdf
HAS/2017-01-12_CT-14982_CHAMPIX_PIC_INS_Avis3_CT14982.pdf
HAS/2017-01-12_CT-15170_BRIVIACT_PIC_INS_Avis2_CT15170.pdf
HAS/2017-01-12_CT-15171_JARDIANCE_PIC_REEV_Avis3_CT15171.pdf
HAS/2017-01-12_briviact_summary_ct15170_en_ucb.pdf
HAS/2017-01-12_briviact_synthese_ct15170.pdf
HAS/2017-01-12_champix_summary_ct14982.pdf
HAS/2017-01-12_champix_synthese_ct14982.pdf
HAS/2017-01-12_jardiance_13092016_avis_efficience_2019-05-10_12-15-16_315.pdf
HAS/2017-01-12_jardiance_summary_ct15171.pdf
HAS/2017-01-12_jardiance_synthese_ct15171.pdf
HAS/2017-01-13_CEPP-5166_E-MAG ACTIVE_10_janvier_2017_(5166)_avis.pdf
HAS/2017-01-13_CEPP-5222_COAGUCHEK INRANGE_10_janvier_2017_(5222)_avis.pdf
HAS/2017-01-13_CT-14698_XARELTO_PIS_REEV_Avis2_CT14698.pdf
HAS/2017-01-13_CT-15006_LIXIANA_AVC_FANV_PIC_INS_Avis2_CT15006.pdf
HAS/2017-01-13_CT-15100_LIKOZAM_PIC_INS_Avis3_CT15100.pdf
HAS/2017-01-13_CT-15403_DIMEGAN_PIS RI_Avis1_CT15403.pdf
HAS/2017-01-13_CT-15406_LIXIANA_MTEV_PIC_INS_Avis2_CT15406.pdf
HAS/2017-01-13_CT-15478_PIXUVRI_PIC_REEV_Avis2_CT15478.pdf
HAS/2017-01-13_CT-15860_PARACETAMOL_MYLAN_PHARMA_QD_INS_Avis1_CT15860.pdf
HAS/2017-01-13_likozam_summary_ct15100_agitation.pdf
HAS/2017-01-13_likozam_summary_ct15100_anxiete_.pdf
HAS/2017-01-13_likozam_summary_ct15100_epilepsie.pdf
HAS/2017-01-13_likozam_synthese_ct15100_agitation.pdf
HAS/2017-01-13_likozam_synthese_ct15100_anxiete_2017-01-12_15-06-23_412.pdf
HAS/2017-01-13_likozam_synthese_ct15100_epilepsie.pdf
HAS/2017-01-13_lixiana_fnav_ct15006_summary.pdf
HAS/2017-01-13_lixiana_fnav_ct15006_synthese.pdf
HAS/2017-01-13_lixiana_mtev_ct15406_summary.pdf
HAS/2017-01-13_lixiana_mtev_ct15406_synthese.pdf
HAS/2017-01-13_pixuvri_summary_ct15478.pdf
HAS/2017-01-13_pixuvri_synthese_ct15478.pdf
HAS/2017-01-13_xarelto_ct14698_summary.pdf
HAS/2017-01-13_xarelto_ct14698_synthese.pdf
HAS/2017-01-16_argumentaire_hepatites-b-c-d_vd.pdf
HAS/2017-01-16_inahta_brief_hepatitis_b_c_d.pdf
HAS/2017-01-17_CT-15190_HOLOCLAR_PIC_INS_Avis2_CT15190.pdf
HAS/2017-01-17_holoclar_summary_ct15190.pdf
HAS/2017-01-17_holoclar_synthese_ct15190.pdf
HAS/2017-01-18_CEPP-5138_ICD_20_decembre_2016_(5138)_avis.pdf
HAS/2017-01-18_CEPP-5158_BIOFREEDOM_5158_avis_du_20_decembre_2016_caviarde.pdf
HAS/2017-01-18_CEPP-5179_ADANT_10_janvier_2017_(5179)_avis.pdf
HAS/2017-01-18_CEPP-5182_GO ON_10_janvier_2017_(5182)_avis.pdf
HAS/2017-01-18_CEPP-5187_SYNVISC ONE_10_janvier_2017_(5187)_avis.pdf
HAS/2017-01-18_CEPP-5229_PLATINUM MOBILE_10_janvier_2017_(5229)_avis.pdf
HAS/2017-01-20_CT-15562_TOLEXINE_PIS_RI_Avis1_CT15562.pdf
HAS/2017-01-20_CT-15727_IBUFETUM_PIS_RI_Avis1_CT15727.pdf
HAS/2017-01-20_CT-15745_DOMPERIDONE_BIOGARAN_10mg_QD_INS_CT15745.pdf
HAS/2017-01-24_CT-15522_OROCAL-CALCIUM_TEVA_PIS_RI_Avis1_CT15522.pdf
HAS/2017-01-24_CT-15572_CACIT_VITAMINE_D3_PIS_RI_Avis1_CT15572.pdf
HAS/2017-01-24_CT-15624_APOKINON_PIS_RI_Avis2_CT15624.pdf
HAS/2017-01-24_argumentaire_schistosomose_vd.pdf
HAS/2017-01-24_brief_inahta_bilharzia.pdf
HAS/2017-01-24_ssp-_grossesses_de_localisation_inhabituelle_-_rapport_delaboration.pdf
HAS/2017-01-24_ssp_-_difficulte_dablation_du_materiel_dosteosynthese_-_rapport_delaboration.pdf
HAS/2017-01-24_ssp_-_difficulte_dablation_du_materiel_dosteosynthese_fiche.pdf
HAS/2017-01-24_ssp_-_grossesses_de_localisation_inhabituelle.pdf
HAS/2017-01-24_ssp_-_surpoids_maternel_et_echographie_foetale.pdf
HAS/2017-01-24_ssp_-_surpoids_maternel_et_echographie_foetale_-_rapport_delaboration.pdf
HAS/2017-01-25_CT-15435_ANAFRANIL_PIS_RI_AvisPostObs_CT15435.pdf
HAS/2017-01-25_CT-15470_MIZOLLEN_PIS_RI_Avis1_CT15470.pdf
HAS/2017-01-25_CT-15575_ENTRESTO_PIC_REEV_AvisPostAud_CT15575.pdf
HAS/2017-01-25_CT-15640_SECNOL_PIS_INS_AvisPostObs_CT15640.pdf
HAS/2017-01-25_CT-15646_BIOCALYPTOL_PIS_RI_Avis2_CT15646.pdf
HAS/2017-01-25_CT-15749_DOMPERIDONE_ZYDUS_10mg_QD_INS_CT15749.pdf
HAS/2017-01-25_CT-15776_DOMPERIDONE_TEVA_10mg_QD_INS_CT15776.pdf
HAS/2017-01-25_CT-15803_BOSENTAN_MYLAN_QD_INS_Avis2_CT15803.pdf
HAS/2017-01-25_CT-15805_ATACAND_PIS_EI_pédiatrie_Avis2_CT15805.pdf
HAS/2017-01-25_CT-15812_BOSENTAN_ACCORD_QD_INS_Avis2_CT15812.pdf
HAS/2017-01-25_CT-15813_BOSENTAN_TEVA_QD_INS_Avis2_CT15813.pdf
HAS/2017-01-25_CT-15858_MIKICORT_9mg_QD_INS_Avis1_CT15858.pdf
HAS/2017-01-25_annexe_-_rapport_devaluation_des_medicaments.pdf
HAS/2017-01-25_aricept_exelon_reminyl_ebixa_summary.pdf
HAS/2017-01-25_aricept_exelon_reminyl_ebixa_synthese.pdf
HAS/2017-01-25_aricept_exelon_reminyl_ebixa_synthese_2017-01-25_11-36-40_933.pdf
HAS/2017-01-25_aricept_pic_reev_ri_avispostaud_ct15053.pdf
HAS/2017-01-25_ebixa_19-10-2016_avis_ct-12743__ct-15059.pdf
HAS/2017-01-25_exelon_19-10-2016_avis_ct-15067.pdf
HAS/2017-01-25_reminyl_19-10-2016_avis_ct-15049.pdf
HAS/2017-01-26_CT-15227_EYLEA_Myopie_PIC_EI_Avis2_CT15227.pdf
HAS/2017-01-26_CT-15479_TALTZ_PIS_INS_Avis2_CT15479.pdf
HAS/2017-01-26_eylea_myopie_summary_ct15227.pdf
HAS/2017-01-26_eylea_myopie_synthese_ct15227.pdf
HAS/2017-01-26_taltz_summary_ct15479.pdf
HAS/2017-01-26_taltz_synthese_ct15479.pdf
HAS/2017-01-27_cotyles_a_double_mobilite_et_des_tiges_a_col_modulaire_avis_de_la_cnedimts_du_24_janvier_2017__dm_eval_137.pdf
HAS/2017-01-27_implants_pour_plastie_endocanalaire_avis_de_la_cnedimts_du_24_janvier_2017_dm_eval_138.pdf
HAS/2017-01-30_CEPP-5139_CAROTID WALLSTENT MONORAIL_24_janvier_2017_(5139)_avis_occultations.pdf
HAS/2017-01-30_CEPP-5220_MITRACLIP_NT_10_janvuer_2017_5220_occulte.pdf
HAS/2017-01-30_CT-15261_OPDIVO_non_epidermoide_PIC_INS_Avis3_CT15261.pdf
HAS/2017-01-30_CT-15349_VITAMINE_A_DULCIS_PIS_RI_Avis1_CT15349.pdf
HAS/2017-01-30_CT-15427_REBIF_PIS_RI_Avis2_CT15427.pdf
HAS/2017-01-30_CT-15514_KARDEGIC_PIS_RI_Avis2_CT15514.pdf
HAS/2017-01-30_CT-15566_LANZOR_PIS_RI_Avis2_CT15566.pdf
HAS/2017-01-30_CT-15772_POTASSIUM_H2_PHARMA_QD_INS_Avis1_CT15772.pdf
HAS/2017-01-30_CT-15786_STROMECTOL_PIS_RI_Avis2_CT15786.pdf
HAS/2017-01-30_CT-15792_CIMZIA_QD_INS_Avis1_CT15792.pdf
HAS/2017-01-30_decision_d2016-62_-_rbpp_espace_calme_retrait.pdf
HAS/2017-01-30_fiche_memo_eps__v2.pdf
HAS/2017-01-30_mitraclip_nt_14032017_avis_efficience.pdf
HAS/2017-01-30_opdivo_11102016_avis_efficience.pdf
HAS/2017-01-30_quand_prescrire_une_electrophorese_des_proteines_seriques_eps_et_conduite_a_tenir_en_cas_dune_immunoglobuline_monoclonale.pdf
HAS/2017-01-30_rapport_experimentations_telemedecine.pdf
HAS/2017-01-30_rbpp_les_espaces_de_calme_retrait.pdf
HAS/2017-01-30_resultats_appel_contribution_espaces_calme-retrait-2.pdf
HAS/2017-01-30_web_anesm_synthese-outils_rbpp.pdf
HAS/2017-02-02_CT-15247_IONSYS_PIC_INS_AvisPostAud_CT15247.pdf
HAS/2017-02-02_CT-15326_PENTHROX_PIC_INS_Avis2_CT15326.pdf
HAS/2017-02-02_CT-15418_CASTOR_EQUI_BOIRON_PIS_RI_Avis2_CT15418.pdf
HAS/2017-02-02_CT-15530_GRANIONS_DE_ZINC_PIS_RI_Avis1_CT15530.pdf
HAS/2017-02-02_CT-15578_HALDOL_PIS_RI_Avis1_CT15578.pdf
HAS/2017-02-02_CT-15613_DERMOVAL_15g_QD_INS_Avis1_CT15613.pdf
HAS/2017-02-02_CT-15782_PARACETAMOL_CODEINE_SANDOZ_PIS_RI_Avis2_CT15782.pdf
HAS/2017-02-02_CT-15859_PANTOPRAZOLE_MYLAN_PHARMA_QD_INS_Avis1_CT15859.pdf
HAS/2017-02-02_CT-15879_HEPARINE_CALCIQUE_PANPHARMA_25000_QD_INS_Avis2_CT15879.pdf
HAS/2017-02-02_CT-15886_CLINDAMYCINE_MIP_QD_INS_Avis1_CT15886.pdf
HAS/2017-02-02_CT-15939_ATOSIBAN_ACCORD_QD_INS_Avis2_CT15939.pdf
HAS/2017-02-02_app_150_fiche_pertinence_chirurgie_fractures_femur_vweb.pdf
HAS/2017-02-02_ionsys_summary_ct15247.pdf
HAS/2017-02-02_ionsys_synthese_ct15247.pdf
HAS/2017-02-02_penthrox_summary_ct15326.pdf
HAS/2017-02-02_penthrox_synthese_ct15326.pdf
HAS/2017-02-02_recommandation_app_150_chirurgie_fractures_extremite_proximale_femur_vweb.pdf
HAS/2017-02-03_CT-15265_TRAVATAN_PIC_EI_Avis2_CT15265.pdf
HAS/2017-02-03_CT-15531_ZAVICETFA_PIC_INS_Avis2_CT15531.pdf
HAS/2017-02-03_travatan_summary_ct15265.pdf
HAS/2017-02-03_travatan_synthese_ct15265.pdf
HAS/2017-02-03_zavicefta_summary_ct15531.pdf
HAS/2017-02-03_zavicefta_synthese_ct15531.pdf
HAS/2017-02-06_CT-15419_PASSIFLORA_COMPOSE_BOIRON_PIS_RI_Avis2_CT15419.pdf
HAS/2017-02-06_CT-15834_XYREM_QD_INS_Avis2_CT15834.pdf
HAS/2017-02-07_CEPP-5143_PROTEGE_RX 5143_occultations.pdf
HAS/2017-02-07_CEPP-5147_PRECISE PRO RX_24 janvier 2017_5147_occultations.pdf
HAS/2017-02-07_CEPP-5149_RX_ACCULINK_5149_24_janvier_2017_occultations.pdf
HAS/2017-02-07_CEPP-5150_XACT_5150_24_janvier_2017_occultations.pdf
HAS/2017-02-08_CEPP-5189_STELLAREX_24_janvier_2017_5189_occultations.pdf
HAS/2017-02-09_CT-15293_KALEORID_PIS_RI_Avis1_CT15293.pdf
HAS/2017-02-09_CT-15449_LARGACTIL_PIS_RI_Avis2_CT15449.pdf
HAS/2017-02-09_CT-15495_LUVERIS_PIS_RI_Avis1_CT15495.pdf
HAS/2017-02-09_CT-15524_AGYRAX_PIS_RI_Avis1_CT15524.pdf
HAS/2017-02-09_CT-15568_NOVATREX_PIS_RI_Avis1_CT15568.pdf
HAS/2017-02-09_CT-15853_OXALIPLATINE_SUN_QD_INS_Avis1_CT15853.pdf
HAS/2017-02-09_ciments_pour_arthroplastie_avec_ou_sans_antibiotiques_dm_eval-75.pdf
HAS/2017-02-09_composition_du_gt_ciments_2016-06-10_15-08-27_451.pdf
HAS/2017-02-09_evaluation_des_ciments_-_feuille_de_route.pdf
HAS/2017-02-09_rapport_ciment_vf.pdf
HAS/2017-02-09_texte_court_ciment_vf.pdf
HAS/2017-02-10_CEPP-5154_PRESSUREWIRE_CERTUS_AERIS_X_24_janvier_2017_5154_occultations.pdf
HAS/2017-02-13_argumentaire_toxoplasmose_me_to.pdf
HAS/2017-02-13_inahta_brief__toxoplasmosis.pdf
HAS/2017-02-16_CEPP-5188_VLIFT_24_janvier_2017_(5188)_avis.pdf
HAS/2017-02-21_CT-14331_LIPIODOL_ULTRA_FLUIDE_PIC_EI_AvisPostObs_CT14331.pdf
HAS/2017-02-21_CT-14781_DUROGESIC_PIS_RI_Avis1_CT14781.pdf
HAS/2017-02-21_CT-15210_ONBREZ_BREEZHALER_PIS_RI_Avis1_CT15210.pdf
HAS/2017-02-21_CT-15262_GALAFOLD_PIC_INS_Avis3_CT15262.pdf
HAS/2017-02-21_CT-15421_FLUANXOL_PIS_RI_Avis2_CT15421.pdf
HAS/2017-02-21_CT-15471_CLARITYNE_PIS_RI_Avis1_CT15471.pdf
HAS/2017-02-21_CT-15486_MENOPUR_PIS_RI_Avis2_CT15486.pdf
HAS/2017-02-21_CT-15489_IASOCHOLINE_PIS_REEV_Avis2_CT15489.pdf
HAS/2017-02-21_CT-15492_EXJADE_90_180_360_PIS_INS_Avis2_CT15492.pdf
HAS/2017-02-21_CT-15499_OVITRELLE_PIS_RI_Avis2_CT15499.pdf
HAS/2017-02-21_CT-15678_FUCIDINE_PIS_RI_Avis2_CT15678.pdf
HAS/2017-02-21_CT-15840_VORICONAZOLE_TEVA_QD_INS_Avis1_CT15840.pdf
HAS/2017-02-21_CT-15854_BECLOJET-BECLOSPRAY_PIS_RI_Avis1_CT15854.pdf
HAS/2017-02-21_CT-15866_PROSTATEP_PIS_INS_Avis2_CT15866.pdf
HAS/2017-02-21_CT-15882_CHLORURE_DE_SODIUM_HYPERTONIQUE_FRESENIUS_QD_INS_Avis1_CT15882.pdf
HAS/2017-02-21_CT-15899_LINEZOLIDE_DR_REDDYS_QD_INS_Avis1_CT15899.pdf
HAS/2017-02-21_CT-15900_VORICONAZOLE_DR_REDDYS_QD_INS_Avis1_CT15900.pdf
HAS/2017-02-21_CT-15907_GRANPIDAM_QD_INS_Avis1_CT15907.pdf
HAS/2017-02-21_CT-15956_CYTARABINE_ACCORD_QD_INS_Avis1_CT15956.pdf
HAS/2017-02-21_galafold_sapub_ct15262.pdf
HAS/2017-02-21_galafold_summary_ct15262.pdf
HAS/2017-02-21_lipiodol_summary_ct14331.pdf
HAS/2017-02-21_lipiodol_synthese_ct14331.pdf
HAS/2017-02-24_CT-14475_LOGIFLOX-DECALOGIFLOX_PIS_RI_Avis2_CT14475.pdf
HAS/2017-02-24_CT-15103_ZYRTEC_PIS_RI_Avis2_CT15103.pdf
HAS/2017-02-24_CT-15139_MIRENA_PIC_REEV_Avis3_CT15139.pdf
HAS/2017-02-24_CT-15146_VIRLIX_PIS_RI_Avis1_CT15146.pdf
HAS/2017-02-24_CT-15377_DEPAMIDE_PIS_RI_Avis2_CT15377.pdf
HAS/2017-02-24_CT-15717_ASMELOR_NOVOLIZER_PIS_RI_Avis1_CT15717.pdf
HAS/2017-02-24_CT-15810_BECOTIDE_PIS_RI_Avis1_CT15810.pdf
HAS/2017-02-24_CT-15811_BECONASE_PIS_RI_Avis1_CT15811.pdf
HAS/2017-02-24_CT-15865_NASONEX_QD_INS_Avis2_CT15865.pdf
HAS/2017-02-24_CT-15874_AERIUS_PIS_RI_Avis1_CT15874.pdf
HAS/2017-03-01_CEPP-5141_OPTIMIZER_IVs__21_fevrier_2017_(5141)_avis.pdf
HAS/2017-03-01_CEPP-5163_RUSH LOPRO_21_fevrier_2017_(5163)_avis.pdf
HAS/2017-03-01_CEPP-5164_RUSH HIPRO_21_fevrier_2017_(5164)_avis.pdf
HAS/2017-03-01_CT-15940_BOSENTAN_ARROW_QD_INS_Avis1_CT15940.pdf
HAS/2017-03-01_CT-15954_PROPOFOL_FRESENIUS_QD_INS_Avis2_CT15954.pdf
HAS/2017-03-01_abstract_assessment_of_cardiac_defibrillator_leads.pdf
HAS/2017-03-01_avis_sondes_de_defibrillation_cardiaque.pdf
HAS/2017-03-01_optimizer_11042017_avis_efficience.pdf
HAS/2017-03-01_pnds_83_-_anemie_hemolytique_auto-immune_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-03-01_pnds_ahai_version_actualisee_2017.pdf
HAS/2017-03-01_rapport_devaluation_des_sondes_de_defibrillation_cardiaque_01_02_2017_2017-02-10_15-56-47_299.pdf
HAS/2017-03-01_sondes_de_defibrillation_cardiaque_2015_02_17a_feuille_de_route.pdf
HAS/2017-03-01_texte_court_sondes_de_defibrillation_cardiaque.pdf
HAS/2017-03-02_CT-15747_SIBELIUM_PIS_RI_ Avis1_CT15747.pdf
HAS/2017-03-02_CT-15998_TRINORDIOL_QD_INS_Avis1_CT15998.pdf
HAS/2017-03-03_CT-14599_REVOLADE_PIC_RI_EI_VHC_Avis2_CT14599.pdf
HAS/2017-03-03_CT-14644_SALBUTAMOL_MYLAN_PIS_RI_Avis1_CT14644.pdf
HAS/2017-03-03_CT-15093_DEROXAT_PIS_RI_Avis1_CT15093.pdf
HAS/2017-03-03_CT-15107_DEPRENYL_PIS_RI_Avis2_CT15107.pdf
HAS/2017-03-03_CT-15145_LEVEMIR_PIC_EI_Avis2_CT15145.pdf
HAS/2017-03-03_CT-15228_ESMYA_PIC_EI_Avis3_CT15228.pdf
HAS/2017-03-03_CT-15354_EPCLUSA_PIC_INS_Avis2_CT15354.pdf
HAS/2017-03-03_CT-15354_EPCLUSA_PIC_REEV_AAD_Avis2_CT15354.pdf
HAS/2017-03-03_CT-15375_REVOLADE_75mgcp_25mgsuspensionbuvable_PIC_INS_Avis1_CT14834&15375.pdf
HAS/2017-03-03_CT-15536_METHADONE-CHLORHYDRATE_DE_METHADONE_PIS_RI_Avis2_CT15536&15456.pdf
HAS/2017-03-03_CT-15564_STILNOX_PIS_RI_Avis2_CT15564.pdf
HAS/2017-03-03_CT-15725_FORTUM-FORTUMSET_PIS_RI_Avis2_CT15725.pdf
HAS/2017-03-03_CT-15845_OXYNOX_PIS_RCP_Avis1_CT15845.pdf
HAS/2017-03-03_CT-15896_UNACIM_PIS_RI_Avis2_CT15896.pdf
HAS/2017-03-03_CT-15908_XENAZINE_PIS_RCP_Avis2_CT15908.pdf
HAS/2017-03-03_CT-15938_SANDOSTATINE_LP_QD_INS_Avis1_CT15938.pdf
HAS/2017-03-03_CT-15983_LEVONORGESTREL-ETHINYLESTRADIOL_BIOGARAN_QD_INS_Avis2_CT15983.pdf
HAS/2017-03-03_CT-16002_PAROXETINE_MYLAN_QD_INS_Avis1_CT16002.pdf
HAS/2017-03-03_CT-16004_ARZERRA_PIS_EI_non_demandée_Avis1_CT16004.pdf
HAS/2017-03-03_epclusa_summary_ct15354.pdf
HAS/2017-03-03_epclusa_synthese_ct15354.pdf
HAS/2017-03-03_esmya_summary_ct15228.pdf
HAS/2017-03-03_esmya_synthese_ct15228.pdf
HAS/2017-03-03_levemir_summary_ct15145.pdf
HAS/2017-03-03_levemir_synthese_ct15145.pdf
HAS/2017-03-06_CT-15121_NULOJIX_PIC_REEV_AvisPostAud_CT15121.pdf
HAS/2017-03-06_nulojix_summary_ct15121.pdf
HAS/2017-03-06_nulojix_synthese_ct15121.pdf
HAS/2017-03-08_CT-15280_DOGMATIL_PIS_RI_Avis1_CT15280.pdf
HAS/2017-03-08_CT-15412_NEULEPTIL_PIS_RI_Avis1_CT15412.pdf
HAS/2017-03-08_CT-15930_BECLOMETASONE_CHIESI_QD_INS_Avis1_CT15930.pdf
HAS/2017-03-09_CEPP-5171_EDORA 8 SR-T_21_fevrier_2017_(5171)_avis.pdf
HAS/2017-03-09_CEPP-5172_EDORA 8 DR-T_21_fevrier_2017_(5172)_avis.pdf
HAS/2017-03-09_CEPP-5231_ZOMAJET VISION X & ZOMAJET 2 VISION_21_février_2017_(5231)_avis.pdf
HAS/2017-03-09_CT-15021_LEPONEX_PIS_RI_Avis2_CT15021.pdf
HAS/2017-03-09_CT-15305_LOXAPAC_PIS_RI_Avis1_CT15305.pdf
HAS/2017-03-09_CT-15409_NOZINAN_PIS_RI_Avis2_CT15409.pdf
HAS/2017-03-09_CT-15481_APTIVUS_PIS_RI_Avis2_CT15481.pdf
HAS/2017-03-09_CT-15590_LARIAM_PIS_RI_Avis2_CT15590.pdf
HAS/2017-03-09_CT-15995_BOSENTAN_EG_QD_INS_Avis1_CT15995.pdf
HAS/2017-03-09_argumentaire_toxocarose_vd.pdf
HAS/2017-03-09_articles_pour_pansements_21_fevrier_2017_dm_eval_144_avis.pdf
HAS/2017-03-09_inahta_brief_toxocariasis.docx.pdf
HAS/2017-03-09_lits_medicaux_07_mars_2017_dm_eval-145_avis.pdf
HAS/2017-03-10_CEPP-5215_DEMIPULSE_21_fevrier_2017_(5215)_avis_caviarde.pdf
HAS/2017-03-10_CEPP-5216_PERENNIADURA & PERENNIAFLEX_21_fevrier_2017_(5216)_avis.pdf
HAS/2017-03-10_CT-15024_ANORO_PIC_INS_Avis3_CT15024.pdf
HAS/2017-03-10_CT-15286_ALPROLIX_PIC_INS_Avis2_CT15286.pdf
HAS/2017-03-10_CT-15738_CABOMETYX_PIC_INS_AvisPostObs_CT15738.pdf
HAS/2017-03-10_alprolix_idelvion_summary_ct15286_ct15251.pdf
HAS/2017-03-10_alprolix_idelvion_synthese_ct15286_ct15251.pdf
HAS/2017-03-10_anoro_summary_ct15024.pdf
HAS/2017-03-10_anoro_synthese_ct15024.pdf
HAS/2017-03-10_cabometyx_11072017_avis_efficience.pdf
HAS/2017-03-10_cabometyx_summary_ct15738.pdf
HAS/2017-03-10_cabometyx_synthese_ct15738.pdf
HAS/2017-03-13_CEPP-5018_DYNA-C 1A400_07_mars_2017_(5018)_avis.pdf
HAS/2017-03-13_CEPP-5019_DYNA-J 1A410_07_mars_2017_(5019)_avis.pdf
HAS/2017-03-13_CEPP-5020_DYNASTAR 1A500_07_mars_2017_(5020)_avis.pdf
HAS/2017-03-13_CT-15251_IDELVION_PIC_INS_Avis2_CT15251.pdf
HAS/2017-03-13_CT-15275_HELMINTOX_PIS_RI_Avis1_modifiele07032017_CT15275.pdf
HAS/2017-03-13_CT-15357_ZEPATIER_PIC_INS_Avis2_CT15357.pdf
HAS/2017-03-13_CT-15357_ZEPATIER_PIC_REEV_AAD_Avis2_CT15357.pdf
HAS/2017-03-13_CT-15547_ZINBRYTA_PIC_INS_Avis3_CT15547.pdf
HAS/2017-03-13_CT-15609_RASILEZ_PIC_REEV_Avis1_CT15609.pdf
HAS/2017-03-13_CT-15617_ZEBINIX_PIS_RI_Avis2_CT15617.pdf
HAS/2017-03-13_alprolix_idelvion_summary_ct15286_ct15251.pdf
HAS/2017-03-13_alprolix_idelvion_synthese_ct15286_ct15251.pdf
HAS/2017-03-13_rasilez_summary_ct15609.pdf
HAS/2017-03-13_rasilez_synthese_ct15609.pdf
HAS/2017-03-13_zepatier_summary_ct15357.pdf
HAS/2017-03-13_zepatier_synthese_ct15357.pdf
HAS/2017-03-13_zinbryta_summary_ct15547.pdf
HAS/2017-03-13_zinbryta_synthese_ct15547.pdf
HAS/2017-03-14_CEPP-5242_INLIVEN CRT-P radiation_07_mars_2017_(5242)_avis.pdf
HAS/2017-03-14_CEPP-5243_INVIVE CRT-P radiation_07_mars_2017_(5243)_avis.pdf
HAS/2017-03-20_CEPP-5272_TRUESPAN_07_mars_2017_(5272)_avis.pdf
HAS/2017-03-20_contention_synthese_v3_actualisee.pdf
HAS/2017-03-20_guidance_leaflet_-_mechanical_restraint_in_general_psychiatry.pdf
HAS/2017-03-20_guidance_leaflet_-_seclusion_in_general_psychiatry.pdf
HAS/2017-03-20_isolement_et_contention_en_psychiatrie_generale_-_argumentaire_2_2017-03-15_10-33-36_53.pdf
HAS/2017-03-20_isolement_et_contention_en_psychiatrie_generale_-_recommandations_2017-03-13_10-13-59_378.pdf
HAS/2017-03-20_isolement_synthese_v3.pdf
HAS/2017-03-20_place_de_la_contention_et_de_la_chambre_disolement_en_psychiatrie_-_note_de_cadrage.pdf
HAS/2017-03-21_pnds_-_embryo-foetopathie_au_valproate.pdf
HAS/2017-03-21_pnds_-_embryo-foetopathie_au_valproate_-_argumentaire.pdf
HAS/2017-03-21_pnds_-_lupus_systemique.pdf
HAS/2017-03-21_pnds_84_-_lupus_erythemateux_systemique_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-03-21_pnds_85_-_embryo-foetopathie_au_valproate_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-03-22_CEPP-5245_LUMENO FLEX 5245_occultations.pdf
HAS/2017-03-22_CEPP-5246_LUMENO FREE 5246_occultations.pdf
HAS/2017-03-22_CEPP-5247_LUMENO ALPHA 5247_occultations.pdf
HAS/2017-03-23_CEPP-5239_THORAFLEX HYBRID PLEXUS_07_mars_2017_(5239)_avis.pdf
HAS/2017-03-23_CEPP-5259_BIATAIN SILICONE ANATOMIQUE_07_mars_2017_(5259)_avis.pdf
HAS/2017-03-23_CEPP-5265_THORAFLEX HYBRID ANTE-FLO_07_mars_2017_(5265)_avis.pdf
HAS/2017-03-23_CT-14509_VECTIBIX_PIS_RCP_Avis1_CT14509.pdf
HAS/2017-03-23_CT-14606_OXEOL_PIS_RI_Avis2_CT14606.pdf
HAS/2017-03-23_CT-14611_SERETIDE-SERETIDE_DISKUS_PIS_RI_Avis2_CT14611.pdf
HAS/2017-03-23_CT-15679_BACTROBAN_PIS_RI_Avis1_CT15679.pdf
HAS/2017-03-23_CT-15751_MIANSERINE_BIOGARAN_PIS_RI_Avis1_CT15751.pdf
HAS/2017-03-23_CT-15878_JOSACINE_PIS_RI_Avis2_CT15878.pdf
HAS/2017-03-23_CT-15928_DOMPERIDONE_ALMUS_10MG_QD_INS_CT15928.pdf
HAS/2017-03-23_CT-15945_APROKAM_QD_INS_Avis1_CT15945.pdf
HAS/2017-03-23_CT-15982_DULCILARMES_QD_INS_Avis2_CT15982.pdf
HAS/2017-03-23_CT-16020_CODOLIPRANE_QD_INS_Avis1_CT16020.pdf
HAS/2017-03-23_fit_thoraflex_hybrid_anteflo_6210.pdf
HAS/2017-03-23_fit_thoraflex_hybrid_plexus_6211.pdf
HAS/2017-03-24_feuille_de_route_vih_201503_2015-03-31_17-41-14_255.pdf
HAS/2017-03-24_reevaluation_de_la_strategie_depistage_vih_-_recommandation.pdf
HAS/2017-03-24_reevaluation_de_la_strategie_depistage_vih_-_synthese_conclusions_reco.pdf
HAS/2017-03-24_reevaluation_de_la_strategie_depistage_vih_-_synthese_reco.pdf
HAS/2017-03-27_CT-15663_TRUVADA_PIC_INS_AvisPostAud_CT15663.pdf
HAS/2017-03-28_CEPP-5021_DYNASTEP 1A101_21_mars_2017_(5021)_avis.pdf
HAS/2017-03-28_CEPP-5237_DYNATREK 1A600_21_mars_2017_(5237)_avis.pdf
HAS/2017-03-28_CEPP-5256_NEOCATE SPOON_21_mars_2017_(5256)_avis.pdf
HAS/2017-03-28_argumentaire_syphilis.pdf
HAS/2017-03-28_inahtabrief_syphilis.pdf
HAS/2017-03-29_CT-13442_QUTENZA_PIC_REEV_Avis3_CT13442.pdf
HAS/2017-03-29_CT-14706_XOFIGO_PIC_REEV_AvisPostAud_CT14706.pdf
HAS/2017-03-29_CT-15113_TAGRISSO_PIC_INS_Avis3_CT15113.pdf
HAS/2017-03-29_CT-15135_SYMBICORT_TURBUHALER_PIS_RI_Avis1_CT15135&15136.pdf
HAS/2017-03-29_CT-15491_TREDEMINE_PIS_RI_Avis2_CT15491.pdf
HAS/2017-03-29_CT-15546_ODEFSEY_PIC_INS_AvisPostObs_CT15546.pdf
HAS/2017-03-29_CT-15571_COMBODART_PIC_RI_REEV_Avis2_CT15571.pdf
HAS/2017-03-29_CT-15615_XYDALBA_PIC_INS_Avis1_CT15615.pdf
HAS/2017-03-29_CT-15647_CHIBRO-PROSCAR_PIS_RI_Avis1_CT15647.pdf
HAS/2017-03-29_CT-15726_CORTIMENT_PIC_INS_Avis1_CT15726.pdf
HAS/2017-03-29_CT-15848_REVESTIVE_QD_INS_Avis1_CT15848.pdf
HAS/2017-03-29_CT-15947_DAIVONEX_PIS_RI_Avis1_CT15947.pdf
HAS/2017-03-29_CT-16080_ISOSORBIDE_MEDISOL_QD_INS_Avis1_CT16080.pdf
HAS/2017-03-29_combodart_ct15571_summary.pdf
HAS/2017-03-29_combodart_ct15571_synthese.pdf
HAS/2017-03-29_cortiment_summary_ct15726-1.pdf
HAS/2017-03-29_cortiment_synthese_ct15726-1.pdf
HAS/2017-03-29_cyramza_cancer_colorectal_adulte_metastatique_pic_ei_avis2_ct15311.pdf
HAS/2017-03-29_cyramza_sapub_ct15311-1.pdf
HAS/2017-03-29_cyramza_summary_ct15311.pdf
HAS/2017-03-29_odefsey_summary_ct15546.pdf
HAS/2017-03-29_odefsey_synthese_ct15546.pdf
HAS/2017-03-29_qutenza_summary_ct13442.pdf
HAS/2017-03-29_qutenza_synthese_ct13442.pdf
HAS/2017-03-29_tagrisso_summary_ct15113.pdf
HAS/2017-03-29_tagrisso_synthese_ct15113.pdf
HAS/2017-03-29_xofigo_summary_ct14706.pdf
HAS/2017-03-29_xofigo_synthese_ct14706.pdf
HAS/2017-03-29_xydalba_summary_ct15615.pdf
HAS/2017-03-29_xydalba_synthese_ct15615.pdf
HAS/2017-03-31_CEPP-5192_THERABITE_07_mars_2017_(5192)_avis.pdf
HAS/2017-03-31_CEPP-5227_MAGMARIS_21_mars_2017_(5227)_avis.pdf
HAS/2017-04-03_app-17_fiche_pertinence_att_cd_2017_03_22_vfinale.pdf
HAS/2017-04-03_points-cle_solution_-_pertience_cholecystectomie.pdf
HAS/2017-04-03_points-cle_solution_-_problematique_cholecystectomie.pdf
HAS/2017-04-03_points-cle_solution_-_qd_faire_cholecystectomie.pdf
HAS/2017-04-03_rapport_app-17_fiche_pertinence_att_cd_2017_03_22_vfinale.pdf
HAS/2017-04-04_CT-15868_PROCUTA_PIS_RI_Avis2_CT15868.pdf
HAS/2017-04-04_CT-15977_OCTAGAM_QD_EI_Avis2_CT15977.pdf
HAS/2017-04-04_CT-16015_REVINTY_ELLIPTA_QD_INS_Avis2_CT16015.pdf
HAS/2017-04-04_CT-16016_LAVENTAIR_QD_INS_Avis2_CT16016.pdf
HAS/2017-04-04_CT-16051_MILRINONE_STRAGEN_QD_INS_Avis1_CT16051.pdf
HAS/2017-04-04_CT-16064_LEVOTHYROX_QD_INS_Avis2_CT16064.pdf
HAS/2017-04-05_CEPP-5173_EDORA 8 HF-T QP_21_mars_2017_(5173)_avis.pdf
HAS/2017-04-05_CEPP-5234_VERRATA_VERRATA_PLUS_5234_occultations.pdf
HAS/2017-04-05_CEPP-5288_EDORA 8 HF-T_21_mars_2017_(5288)_avis.pdf
HAS/2017-04-07_CT-14603_XAGRID_PIS_RI_Avis2_CT14603.pdf
HAS/2017-04-07_CT-15827_ZELBORAF_PIS_NE_EPI_Avis2_CT15827.pdf
HAS/2017-04-07_CT-15842_ZYTIGA_QD_INS_Avis2_CT15842.pdf
HAS/2017-04-07_CT-15864_LECTIL_PIS_RI_Avis1_CT15864.pdf
HAS/2017-04-07_CT-15892_ZYTIGA_PIS_RI_Avis2_CT15892.pdf
HAS/2017-04-07_CT-15980_DISCOTRINE_PIS_RI_Avis2_CT15980.pdf
HAS/2017-04-07_CT-16022_MABTHERA_PIS_EPI_AIRPR_Avis2_CT16022.pdf
HAS/2017-04-11_CT-15553_GILENYA_PIS_RI_Avis2_CT15553.pdf
HAS/2017-04-11_CT-15740_ALBEY_VENIN_DE_GUEPE_PIS_RI_Avis1_CT15740.pdf
HAS/2017-04-11_CT-15741_ALYOSTAL_VENIN_DE_GUEPE_VESPULA_PIS_RI_Avis1_CT15741.pdf
HAS/2017-04-11_CT-15742_ALBEY_VENIN_DABEILLE_PIS_RI_Avis1_CT15742.pdf
HAS/2017-04-11_CT-15743_ALYOSTAL_VENIN_DE_GUEPE_POLISTES_PIS_RI_Avis1_CT15743.pdf
HAS/2017-04-11_CT-15750_ALYOSTAL_VENIN_DABEILLE_APIS_MELLIFERA_PIS_RI_Avis1_CT15750.pdf
HAS/2017-04-11_CT-16079_EMEND_ADULTES_PIS_EI_Avis2_CT16079.pdf
HAS/2017-04-14_CT-15709_EZETROL_PIC_EI_prévention_Avis3_CT15709.pdf
HAS/2017-04-14_CT-16029_TRACLEER_QD_INS_Avis1_CT16029.pdf
HAS/2017-04-14_CT-16062_GEMCITABINE_SUN_QD_INS_Avis2_CT16062.pdf
HAS/2017-04-14_CT-16082_DALACINE_QD_INS_Avis1_CT16082.pdf
HAS/2017-04-14_CT-16085_BETADINE_ALCOOLIQUE_QD_INS_Avis1_CT16085.pdf
HAS/2017-04-14_bzd_insomnie_v2.pdf
HAS/2017-04-18_CT-15881_ZOFENIL_TEOULA_PIS_RI_Avis2_CT15881.pdf
HAS/2017-04-18_CT-15884_SYNAGIS_QD_INS_Avis2_CT15884.pdf
HAS/2017-04-18_CT-15888_ZOFENILDUO_COTEOULA_PIS_RI_Avis1_CT15888.pdf
HAS/2017-04-18_CT-16060_ZAWEK_QD_INS_Avis2_CT16060.pdf
HAS/2017-04-18_CT-16077_ATOSIBAN_EVER_PHARMA_QD_INS_Avis1_CT16077.pdf
HAS/2017-04-19_CEPP-5165_OVALE_21_mars_2017_(5165)_avis.pdf
HAS/2017-04-21_CT-14702_FIRDAPSE_PIC_RI_Avis2_CT14702.pdf
HAS/2017-04-21_CT-16110_PARACETAMOL_NEPENTHES_QD_INS_Avis1_CT16110.pdf
HAS/2017-04-25_CEPP-5261_PONTO 3 PONTO 3 POWER PONTO 3 SUPER POWER_18_avril_2017_(5261)_avis.pdf
HAS/2017-04-25_CEPP-5302_BIOBANK_18_avril_2017_(5302)_avis.pdf
HAS/2017-04-25_argumentaire_anguillulose_vd.pdf
HAS/2017-04-25_inahta_brief_strongyloidiasis.pdf
HAS/2017-04-26_CT-15683_GLUCOSE_MACOPHARMA_QD_INS_Avis1_CT15683.pdf
HAS/2017-04-26_CT-16005_DOMPERIDONE_EG_10MG_QD_INS_Avis1_CT16005.pdf
HAS/2017-04-26_CT-16134_CASPOFUNGINE_OHRE_PHARMA_QD_INS_Avis1_CT16134.pdf
HAS/2017-04-27_CT-16021_ESOMEPRAZOLE_ACCORD_40MG_QD_INS_Avis1_CT16021.pdf
HAS/2017-05-02_CEPP-5241_COROFLEX_ISAR_5241_21_mars_2017_occultations.pdf
HAS/2017-05-02_CEPP-5268_BASKO-SPL_18_avril_2017_(5268)_avis.pdf
HAS/2017-05-02_CEPP-5282_AIR PLUG_18_avril_2017_(5282)_avis.pdf
HAS/2017-05-02_CT-15705_FOSTIMONKIT_PIS_RI_Avis1_CT15705.pdf
HAS/2017-05-02_CT-15802_MIKICORT_PIS_RI_Avis1_CT15802.pdf
HAS/2017-05-02_CT-15911_PRALUENT_PIC_INS_heterozygotes_Avis2_CT15911.pdf
HAS/2017-05-02_CT-16096_TRUXIMA_PIS_INS_Avis2_CT16096.pdf
HAS/2017-05-03_pnds_-_neuropathie_amyloide_familiale_-_argumentaire.pdf
HAS/2017-05-03_pnds_-_neuropathies_amyloides_familiales.pdf
HAS/2017-05-03_pnds_-_syndromes_de_rett_et_apparentes_2017-05-03_14-15-56_224.pdf
HAS/2017-05-03_pnds_86_-_neuropathie_amyloide_familiale_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-05-03_pnds_87_-_syndromes_de_rett_et_apparentes_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-05-03_pnds_syndromes_de_rett_et_apparentes_-_argumentaire.pdf
HAS/2017-05-05_feuille_de_route_hyperplastie_congenitale_des_surrenales_aux_nouveaux-nes.pdf
HAS/2017-05-05_pertinence_depistage_hyperplasie_congenitale_nouveau-nes_32sa.pdf
HAS/2017-05-09_CEPP-5230_VIATORR TIPS 5230_occultations.pdf
HAS/2017-05-09_CEPP-5293_PERCEPTA CRT-P MRI SURESCAN_18_avril_2017_(5293)_avis.pdf
HAS/2017-05-09_CEPP-5294_PERCEPTA QUAD CRT-P MRI SURESCAN_18_avril_2017_(5294)_avis.pdf
HAS/2017-05-10_CT-15123_MYLERAN_PIS_RI_Avis1_CT15123.pdf
HAS/2017-05-10_CT-15338_GLUCOSE_COOPER_PIC_RI_Avis2_CT15338.pdf
HAS/2017-05-10_CT-15348_METVIXIA_PIC_EI_Avis1_CT15348.pdf
HAS/2017-05-10_CT-15425_MIFFEE_PIC_REEV_Avis3_CT15425.pdf
HAS/2017-05-10_CT-15804_CETINOR_PIC_INS_Avis2_CT15804.pdf
HAS/2017-05-10_cetinor_summary_ct15804.pdf
HAS/2017-05-10_cetinor_synthese_ct15804.pdf
HAS/2017-05-10_glucose_5_cooper_ct15338_summary.pdf
HAS/2017-05-10_glucose_5_cooper_synthese_ct15338.pdf
HAS/2017-05-10_jakavi_15102019_avis_efficience.pdf
HAS/2017-05-10_jakavi_pic_ne_avis2_ct14600.pdf
HAS/2017-05-10_jakavi_summary_ct14600.pdf
HAS/2017-05-10_jakavi_synthese_ct14600.pdf
HAS/2017-05-10_metvixia_summary_ct15348.pdf
HAS/2017-05-10_metvixia_synthese_ct15348.pdf
HAS/2017-05-10_miffee_summary_ct15425.pdf
HAS/2017-05-10_miffee_synthese_ct15425.pdf
HAS/2017-05-10_myleran_summary_ct10209.pdf
HAS/2017-05-10_myleran_synthese_ct10209.pdf
HAS/2017-05-11_CEPP-5240_BT_5240.pdf
HAS/2017-05-11_CEPP-5248_BT_5248.pdf
HAS/2017-05-11_CEPP-5249_BT_5249.pdf
HAS/2017-05-11_CEPP-5263_BT_5263.pdf
HAS/2017-05-11_CT-14737_TRASYLOL_PIC_REEV_AvisPostObs_CT14737.pdf
HAS/2017-05-11_CT-14801_PERJETA_PIC_INS_AvisPostAud_CT14801.pdf
HAS/2017-05-11_CT-15294_IMBRUVICA_Waldenstrom_PIC_INS_Avis2_CT15294.pdf
HAS/2017-05-11_CT-15529_STRESAM_PIS_RI_Avis2_CT15529.pdf
HAS/2017-05-11_CT-15532_VIZAMYL_PIC_INS_AvisPostAud_CT15532.pdf
HAS/2017-05-11_CT-15541_PARACETAMOL_ISOMED-TEVA-TEVA_SANTE-PARALYOC_PIS_RI_Avis2_CT15541.pdf
HAS/2017-05-11_CT-15601_ZAVEDOS_PIC_EI_LAM_pediatrie_Avis2_CT15601.pdf
HAS/2017-05-11_CT-15633_IMBRUVICA_PIC_EI_AvisPostAud_CT15633.pdf
HAS/2017-05-11_CT-15642_FORLAX_PIS_RI_Avis2_CT15642.pdf
HAS/2017-05-11_CT-15680_NABUCOX_PIS_RI_Avis2_CT15680.pdf
HAS/2017-05-11_CT-15763_REVLIMID_PIC_EI_myelome_multiple_Avis2_CT15763.pdf
HAS/2017-05-11_CT-15795_MYCOSTER_PIS_RI_Avis2_CT15795.pdf
HAS/2017-05-11_CT-15829_MOVICOL_PIS_RI_Avis2_CT15829.pdf
HAS/2017-05-11_CT-15844_PARACETAMOL_MYLAN_PIS_RI_Avis1_CT15844.pdf
HAS/2017-05-11_CT-15846_NOOTROPYL_PIS_RI_Avis2_CT15846.pdf
HAS/2017-05-11_CT-15851_ROVALCYTE_PIS_EI_pediatrie_Avis2_CT15851.pdf
HAS/2017-05-11_CT-15873_IBRANCE_PIC_INS_Avis3_CT15873.pdf
HAS/2017-05-11_CT-15916_OPTILOVA-OPTIDRIL_PIS_RI_Avis1_CT15916.pdf
HAS/2017-05-11_CT-15966_LEVONORGESTREL_BIOGARAN_PIS_RI_Avis2_CT15966.pdf
HAS/2017-05-11_CT-16036_MOBIC_PIS_RI_Avis2_CT16036.pdf
HAS/2017-05-11_CT-16107_CLAVENTIN_PIS_RI_Avis 1_CT16107.pdf
HAS/2017-05-11_CT-16145_GRANPIDAM_QD_INS_Avis1_CT16145.pdf
HAS/2017-05-11_CT-16160_CASPOFUNGINE_TEVA_QD_INS_Avis1_CT16160.pdf
HAS/2017-05-11_ibrance_11072017_avis_efficience.pdf
HAS/2017-05-11_ibrance_synthese_ct15873.pdf
HAS/2017-05-11_imbruvica_summary_ct15633.pdf
HAS/2017-05-11_imbruvica_synthese_ct15633_2017-05-10_11-10-50_950.pdf
HAS/2017-05-11_imbruvica_waldenstrom_synthese_ct15294.pdf
HAS/2017-05-11_perjeta_summary_ct14801.pdf
HAS/2017-05-11_perjeta_synthese_ct14801.pdf
HAS/2017-05-11_revlimid_synthese_ct15763.pdf
HAS/2017-05-11_trasylol_summary_ct14737.pdf
HAS/2017-05-11_trasylol_synthese_ct14737.pdf
HAS/2017-05-11_vizamyl_summary_ct15532.pdf
HAS/2017-05-11_vizamyl_synthese_ct15532.pdf
HAS/2017-05-11_zavedos_summary_ct15601.pdf
HAS/2017-05-11_zavedos_synthese_ct15601.pdf
HAS/2017-05-12_CT-15838_PEVARYL_PIS_RI_Avis2_CT15838.pdf
HAS/2017-05-12_CT-16031_PARACETAMOL_GNR_SANDOZ_PIS_RI_Avis1_CT16031.pdf
HAS/2017-05-12_cp_guide_problemes_somatiques_comm.pdf
HAS/2017-05-12_decision_d_adoption_du_guide.pdf
HAS/2017-05-12_guide_des_problemes_somatiques.pdf
HAS/2017-05-12_resultats_appel_contribution_guide_pb_somatiques-2.pdf
HAS/2017-05-15_CT-16092_NOVORAPID_PIS_EI_Avis1_CT16092.pdf
HAS/2017-05-16_CEPP-5270_COREVALVE_EVOLUT_R_34mm_5270_occultations.pdf
HAS/2017-05-16_CEPP-5299_SOLO2_11_avril_2017_(5299)_avis.pdf
HAS/2017-05-17_note_cadrage_place_des_tests_dadn_libre_circulant_dans_le_sang_maternel_dans_la_strategie_de_depistage_de_la_trisomie_foetal.pdf
HAS/2017-05-17_recommandation_en_sante_publique__place_des_tests_adn_libre_circulant_dans_le_sang_maternel_dans_le_depistage_de_la_trisomie.pdf
HAS/2017-05-17_summary_of_rationale_and_recomendations_role_of_maternal_blood_cell-free_dna_tests_in_foetal_trisomy_21_screening_english_ve.pdf
HAS/2017-05-17_synthese_et_recommandations__place_des_tests_adn_libre_circulant_dans_le_sang_maternel_dans_le_depistage_de_la_trisomie_21_f.pdf
HAS/2017-05-18_CEPP-5184_PRODIGY MRI 5184_occultations.pdf
HAS/2017-05-18_CEPP-5185_PROCLAIM ELITE 5185_occultations.pdf
HAS/2017-05-18_CT-15439_ZENTEL_PIS_RI_Avis2_CT15439.pdf
HAS/2017-05-18_CT-15513_PENTACARINAT_PIS_RI_Avis2_CT15513.pdf
HAS/2017-05-18_CT-15835_CALCIDOSE_PIS_RI_Avis1_CT15835.pdf
HAS/2017-05-18_CT-15991_TRANSULOSE_PIS_RI_Avis2_CT15991.pdf
HAS/2017-05-18_CT-16009_CAVERJECT_PIS_RI_Avis2_CT16009.pdf
HAS/2017-05-18_CT-16108_NEISVAC_PIS_MCI_Avis2_CT16108.pdf
HAS/2017-05-18_CT-16114_FUROSEMIDE_ARROW_QD_INS_Avis1_CT16114.pdf
HAS/2017-05-18_CT-16120_SPAGULAX_PIS_RI_Avis2_CT16120.pdf
HAS/2017-05-18_CT-16142_INSUMAN_INFUSAT_PIS_RI_Avis2_CT16142.pdf
HAS/2017-05-18_CT-16159_CASPOFUNGINE_EG_QD_INS_Avis1_CT16159.pdf
HAS/2017-05-19_CEPP-5244_XTEND FOOT H100 5244_2_mai_2017_(5244)_avis.pdf
HAS/2017-05-19_CEPP-5255_RESORB X et SONICPINS RX_2_mai_2017_(5255)_avis.pdf
HAS/2017-05-22_CT-15627_COMTAN_PIS_RI_Avis2_CT15627.pdf
HAS/2017-05-22_CT-15895_BINOCRIT_PIS_RCP_Avis2_CT15895.pdf
HAS/2017-05-22_CT-15992_DEBRIDAT_PIS_RI_Avis2_CT15992.pdf
HAS/2017-05-22_CT-16041_XALKORI_PIC_EI_CPNPC_ALK_1ere_ligne_Avis2_CT16041.pdf
HAS/2017-05-22_CT-16103_AERIVIO_SPIROMAX_PIS_INS_Avis2_CT16103.pdf
HAS/2017-05-22_fiche_memo_burnout.pdf
HAS/2017-05-22_rapport_elaboration_burnout.pdf
HAS/2017-05-22_xalkori_cbnpc_alk_sapub_ct16041.pdf
HAS/2017-05-22_xalkori_cbnpc_alk_summary_ct16041.pdf
HAS/2017-05-23_CEPP-5291_CHALLENGER 1E95_16_mai_2017_(5291)_avis.pdf
HAS/2017-05-23_CT-15423_ALDURAZYME_PIC_REEV_Avis2_CT15423.pdf
HAS/2017-05-23_CT-15849_STELARA_PIC_EI_CROHN_Avis1_CT15849&15850.pdf
HAS/2017-05-23_CT-15883_RELISTOR_PIC_RI_EI_non_palliatif_Avis2_CT15883.pdf
HAS/2017-05-23_aldurazyme_summary_ct15423.pdf
HAS/2017-05-23_aldurazyme_synthese_ct15423.pdf
HAS/2017-05-23_relistor_summary_ct15883.pdf
HAS/2017-05-23_relistor_synthese_ct15883.pdf
HAS/2017-05-23_stelara_mc_summary_ct15850.pdf
HAS/2017-05-23_stelara_mc_synthese_ct15850.pdf
HAS/2017-05-24_CEPP-5145_ATROSTIM_2_mai_2017_(5145)_avis.pdf
HAS/2017-05-24_CEPP-5236_RM PRESSFIT VITAMYS_16_mai_2017_(5236)_avis.pdf
HAS/2017-05-24_CEPP-5310_CLASSIC VISCO_2_mai_2017_(5310)_avis.pdf
HAS/2017-05-24_CEPP-5321_MYLIFE OMNIPOD_16_mai_2017_(5321)_avis.pdf
HAS/2017-05-29_CT-14815_DETICENE-DACARBAZINE_LIPOMED-MEDAC_PIC_REEV_Avis2_CT14390&14815&14256.pdf
HAS/2017-05-29_CT-15385_SANMIGRAN_PIS_RI_Avis1_CT15385.pdf
HAS/2017-05-29_CT-16081_MIFLASONE_PIS_RI_Avis2_CT16081.pdf
HAS/2017-05-29_CT-16137_ZELITREX_PIS_RI_Avis2_CT16137.pdf
HAS/2017-05-29_CT-16151_TISSEEL_QD_INS_Avis1_CT16151.pdf
HAS/2017-05-29_argumentaire_toxoplasmose_id.pdf
HAS/2017-05-29_inahta_brief_toxoplasmosis.pdf
HAS/2017-05-30_CT-15408_GYNERGENE_CAFEINE_PIS_RI_Avis2_CT15408.pdf
HAS/2017-05-30_CT-15904_TELFAST_PIS_RI_Avis1_CT15904.pdf
HAS/2017-05-30_CT-16147_UMULINE_PIS_RI_Avis2_CT16147.pdf
HAS/2017-05-30_CT-16154_MEBEVERINE_ZENTIVA_PIS_RI_Avis1_CT16154.pdf
HAS/2017-05-30_CT-16163_LUBENTYL_PIS_RI_Avis1_CT16163.pdf
HAS/2017-06-01_CT-15083_LYRICA_PIS_RI_Avis2_CT9953&15083.pdf
HAS/2017-06-01_CT-15370_NARAMIG_PIS_RI_Avis2_CT15370.pdf
HAS/2017-06-01_CT-15570_MONOVER_PIC_INS_Avis2_CT15570.pdf
HAS/2017-06-01_CT-15852_ALFALASTIN_PIC_REEV_Avis1_CT15852.pdf
HAS/2017-06-01_CT-16164_MONOPROST_QD_INS_Avis1_CT16164.pdf
HAS/2017-06-01_CT-16178_BENEFIX_1500UI_QD_INS_Avis1_CT16178.pdf
HAS/2017-06-01_alfalastin_summary_ct15852.pdf
HAS/2017-06-01_alfalastin_synthese_ct15852.pdf
HAS/2017-06-01_monover_summary_ct15570.pdf
HAS/2017-06-01_monover_synthese_ct15570.pdf
HAS/2017-06-02_CEPP-5238_Courriers_dépôt_HAS_CEPS.pdf
HAS/2017-06-02_CT-15925_RUBOZINC_PIS_RI_Avis1_CT15925.pdf
HAS/2017-06-02_CT-16186_XARELTO_Kit_init_QD_INS_Avis2_CT16186.pdf
HAS/2017-06-08_20140520_grille_generique_investigation.pdf
HAS/2017-06-08_20150113_brochure_cq_v2014_2015-01-15_12-23-17_976.pdf
HAS/2017-06-08_CT-16019_LEPTOPROL_PIS_INS_Avis2_CT16019.pdf
HAS/2017-06-08_diapo_3_audit_processus_vd.pdf
HAS/2017-06-08_suivi_evolution_guide_methodo_cq_v2014.pdf
HAS/2017-06-09_CT-15576_HUMIRA_PIC_EI_uveite_Avis2_CT15576.pdf
HAS/2017-06-09_CT-16205_FRAXIPARINE_QD_INS_Avis1_CT16205.pdf
HAS/2017-06-09_argumentaire_aspergillose.pdf
HAS/2017-06-09_humira_summary_ct15576.pdf
HAS/2017-06-09_humira_uveites_synthese_ct15576.pdf
HAS/2017-06-09_inahta_brief_aspergillus.pdf
HAS/2017-06-09_pnds-_purpura_thrombopenique_immunologique.pdf
HAS/2017-06-09_pnds_25_-_purpura_thrombopenique_immunologique_de_lenfant_et_de_ladulte_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2017-06-13_CEPP-5303_UROLIFT_30_mai_2017_(5303)_avis.pdf
HAS/2017-06-14_CT-16161_CEFAZOLINE_MYLAN_QD_INS_Avis1_CT16161.pdf
HAS/2017-06-14_CT-16166_BOSENTAN_BIOGARAN_QD_INS_Avis1_CT16166.pdf
HAS/2017-06-14_CT-16167_PARACETAMOL_BIOGARAN_QD_INS_Avis2_CT16167.pdf
HAS/2017-06-14_CT-16184_BOSENTAN_MYLAN_QD_EI_Avis1_CT16184.pdf
HAS/2017-06-14_CT-16191_ACETATE_DE_TERLIPRESSINE_EVER_PHARMA_QD_INS_Avis1_CT16191.pdf
HAS/2017-06-15_CEPP-5267_BIOSS LIM C_16_mai_2017_(5267)_avis.pdf
HAS/2017-06-15_CEPP-5325_ZEN-O RS-00500_16_mai_2017_(5325)_avis.pdf
HAS/2017-06-15_CT-15325_ACARIZAX_PIC_INS_Avis3_CT15325.pdf
HAS/2017-06-15_CT-15806_IASOTOC_PIC_INS_Avis2_CT15806.pdf
HAS/2017-06-15_CT-15915_CHLORURE_DE_SODIUM_FRESENIUS_PIS_RI_Avis2_CT15915.pdf
HAS/2017-06-15_CT-15958_MONOKETO_PIS_RI_Avis1_CT15958.pdf
HAS/2017-06-15_CT-15965_SPORANOX_PIS_RI_Avis2_CT15965.pdf
HAS/2017-06-15_CT-16221_ROLUFTA_QD_INS_Avis1_CT16221.pdf
HAS/2017-06-15_CT-16223_BOSENTAN_TEVA_QD_INS_Avis1_CT16223.pdf
HAS/2017-06-15_acarizax_summary_ct15325.pdf
HAS/2017-06-15_acarizax_synthese_ct15325.pdf
HAS/2017-06-15_iasotoc_summary_ct15806.pdf
HAS/2017-06-15_iasotoc_synthese_ct15806.pdf
HAS/2017-06-16_CT-15830_TRIFLUCAN_PIS_RI_Avis2_CT15830.pdf
HAS/2017-06-16_CT-15901_TRULICITY_PIS_RCP_Avis1_CT15901.pdf
HAS/2017-06-16_CT-15963_LORAMYC_PIS_RI_Avis1_CT15963.pdf
HAS/2017-06-16_questions_reponses_certification_ip.pdf
HAS/2017-06-16_questions_reponses_certification_ip_mars_2016.pdf
HAS/2017-06-16_rapport_d_elaboration_du_referentiel_ip_mars_2017.pdf
HAS/2017-06-16_referentiel_de_certification_ip_mars_2016.pdf
HAS/2017-06-16_referentiel_de_certification_ip_mars_2017.pdf
HAS/2017-06-19_07-029_tuberculose-guide_edite_sans_lap.pdf
HAS/2017-06-19_actualisationlap_tuberculose__web_.pdf
HAS/2017-06-19_ald_guide_patient_tuberculose.pdf
HAS/2017-06-19_decision_2012_0141_apald_ald_29_cancer_tuberculose.pdf
HAS/2017-06-19_gm_tuberculoseen_web.pdf
HAS/2017-06-20_CEPP-5153_AXIUM_5153_occultations.pdf
HAS/2017-06-20_CEPP-5232_REPLENS_30_mai_2017_(5232)_avis.pdf
HAS/2017-06-20_CEPP-5266_RESOLUTE ONYX 5266_30_mai_2017occultations.pdf
HAS/2017-06-20_CEPP-5311_OPTIVE FUSION UD_30_mai_2017_(5311)_avis.pdf
HAS/2017-06-20_CEPP-5330_POMPES A INSULINE_30_mai_2017_(5330)_avis.pdf
HAS/2017-06-20_CT-15955_DEXAFREE_PIS_RI_Avis2_CT15955.pdf
HAS/2017-06-20_CT-16152_FUNGIZONE_PIS_RI_Avis2_CT16152.pdf
HAS/2017-06-20_fiche_memo_ccr.pdf
HAS/2017-06-20_reco248_rapport_elaboration_cancer__colorectal.pdf
HAS/2017-06-21_dc_2017_0068_helicobacter_cd_2017_05_31.pdf
HAS/2017-06-21_helicobacter_analyse_bases_de_donnees.pdf
HAS/2017-06-21_helicobacter_courrier_hge_gastroscopie.pdf
HAS/2017-06-21_helicobacter_courrier_hge_serologie.pdf
HAS/2017-06-21_helicobacter_courrier_mg_information_gastroscopie.pdf
HAS/2017-06-21_helicobacter_courrier_mg_ttt_guide.pdf
HAS/2017-06-21_helicobacter_courrier_mg_ttt_probabiliste.pdf
HAS/2017-06-21_helicobacter_fiche_pertinence_diagnostic.pdf
HAS/2017-06-21_helicobacter_fiche_pertinence_traitement.pdf
HAS/2017-06-21_helicobacter_pylori_-_tool_for_appropriate_diagnosis.pdf
HAS/2017-06-21_helicobacter_pylori_-_tool_for_appropriate_treatment.pdf
HAS/2017-06-21_helicobacter_rapport_elaboration.pdf
HAS/2017-06-21_screening_for_helicobacter_pylori.pdf
HAS/2017-06-21_treating_helicobacter_pylori.pdf
HAS/2017-06-22_fiche_pertinence_traitements_interventionnels_premiere_intention_calculs_urinaires.pdf
HAS/2017-06-22_pnds_-_maladie_de_kennedy.pdf
HAS/2017-06-22_pnds_89_-_maladie_de_kennedy.pdf
HAS/2017-06-22_pnds_maladie_de_kennedy_-_argumentaire.pdf
HAS/2017-06-22_rapport_traitements_interventionnels_premiere_intention_calculs_urinaires.pdf
HAS/2017-06-23_CT-15631_DAKTARIN_GYNO-DAKTARIN_PIS_RI_Avis1_CT15631.pdf
HAS/2017-06-23_CT-15857_ATARAX_PIS_RI_Avis2_CT11057&15857.pdf
HAS/2017-06-23_CT-16119_JOSIR_MECIR_PIS_RI_Avis2_CT16119.pdf
HAS/2017-06-23_CT-16153_VIEKIRAX_EXVIERA_PIS_RCP_Avis1_CT16153.pdf
HAS/2017-06-23_CT-16157_LINEZOLIDE_EG_QD_INS_Avis1_CT16157.pdf
HAS/2017-06-23_CT-16211_HEXVIX_QD_INS_Avis2_CT16211.pdf
HAS/2017-06-23_avis_sur_les_dispositifs_de_drainage_et_de_recueil_des_urines_et_des_selles.pdf
HAS/2017-06-23_evaluation_des_dispositifs_medicaux_devacuation_et_de_recueil_des_urines_et_des_selles_-_feuille_de_route.pdf
HAS/2017-06-23_fiche_action.pdf
HAS/2017-06-23_fiche_points_cles_pour_une_pratique_efficace_-.pdf
HAS/2017-06-23_grille_evaluation_circuit_des_prelevements.pdf
HAS/2017-06-23_points_cles_et_solutions_-_comment_securiser_le.pdf
HAS/2017-06-23_rapport_delaboration_-_ssp.pdf
HAS/2017-06-23_rapport_devaluation_des_dispositifs_de_drainage_et_de_recueil_des_urines_et_des_selles.pdf
HAS/2017-06-23_securing_the_circuit_of_a_sample_collected_in_the_operating_room.pdf
HAS/2017-06-23_texte_court_evaluation_des_dispositifs_de_drainage_et_de_recueil_des_urines_et_des_selles.pdf
HAS/2017-06-26_CEPP-5339_XPO2_13_juin_2017_(5339)_avis.pdf
HAS/2017-06-26_CT-16209_BENDAMUSTINE_MEDAC_QD_INS_Avis1_CT16209.pdf
HAS/2017-06-26_CT-16228_BENDAMUSTINE_DR_REDDYS_QD_INS_Avis1_CT16228.pdf
HAS/2017-06-26_CT-16231_BENDAMUSTINE_MYLAN_QD_INS_Avis1_CT16231.pdf
HAS/2017-06-26_CT-16251_GANCICLOVIR_MYLAN_QD_INS_Avis1_CT16251.pdf
HAS/2017-06-28_CT-15032_LEVACT_PIC_REEV_Avis3_CT15032.pdf
HAS/2017-06-28_CT-15376_REVOLADE_PIC_EI_PTI_non_splenectomise_enfants_RI_PTI_Avis3_CT15376.pdf
HAS/2017-06-28_CT-15502_NPLATE_PIC_EI_PTI_non_splenectomise_Avis3_CT15502.pdf
HAS/2017-06-28_CT-15521_OBIZUR_PIC_INS_Avis2_CT15521.pdf
HAS/2017-06-28_CT-15912_REKOVELLE_PIC_INS_Avis2_CT15912.pdf
HAS/2017-06-28_levact_summary_ct15032.pdf
HAS/2017-06-28_levact_synthese_ct15032.pdf
HAS/2017-06-28_nplate_revolade_summary_ct15376.pdf
HAS/2017-06-28_nplate_revolade_synthese_ct15376_15502.pdf
HAS/2017-06-28_obizur_summary_ct15521.pdf
HAS/2017-06-28_obizur_synthese_ct15521.pdf
HAS/2017-06-28_rekovelle_summary_ct15912.pdf
HAS/2017-06-28_rekovelle_synthese_ct15912.pdf
HAS/2017-06-28_revolade_summary_ct15376.pdf
HAS/2017-06-28_revolade_synthese_ct15376.pdf
HAS/2017-06-29_CT-15551_XULTOPHY_PIC_EI_Avis3_CT15551.pdf
HAS/2017-06-29_CT-15797_REVESTIVE_PIC_EI_Avis2_CT15797.pdf
HAS/2017-06-29_CT-15809_COMBIVIR_PIS_RI_Avis1_CT15809.pdf
HAS/2017-06-29_revestive_summary_ct15797.pdf
HAS/2017-06-29_revestive_synthese_ct15797.pdf
HAS/2017-06-29_xultophy_summary_ct15551.pdf
HAS/2017-06-29_xultophy_synthese_ct15551.pdf
HAS/2017-06-30_CEPP-5217_MAGNEZIX CS_13_juin_2017_(5217)_avis.pdf
HAS/2017-06-30_CEPP-5284_HEARTMATE 3 5284_occultations.pdf
HAS/2017-06-30_CEPP-5317_ORION PRO_13_juin_2017_(5317)_avis.pdf
HAS/2017-07-01_hospital_mortality_indicators_report.pdf
HAS/2017-07-01_rapport_mortalite_2017.pdf
HAS/2017-07-05_CEPP-5233_PLIE 3.0_27_juin_2017_(5233)_avis.pdf
HAS/2017-07-05_CEPP-5262_QUADRA ALLURE MP PM3562_13_juin_2017_(5262)_avis.pdf
HAS/2017-07-05_CEPP-5346_ALBER TWION_27_juin_2017_(5346)_avis.pdf
HAS/2017-07-05_CEPP-5351_SIMPLYGO_27_juin_2017_(5351)_avis.pdf
HAS/2017-07-05_CEPP-5352_ALBER E-MOTION M15_27_juin_2017_(5352)_avis.pdf
HAS/2017-07-05_CT-15218_NEOFORDEX_PIC_INS_AvisPostAud_CT15218.pdf
HAS/2017-07-05_CT-15909_ALBUMINE_HUMAINE_IODEE_PIC_INS_Avis2_CT15909.pdf
HAS/2017-07-05_CT-16125_EFFEXOR_LP_PIS_RI_Avis2_CT16125.pdf
HAS/2017-07-05_CT-16201_PRITORPLUS_PIS_RI_Avis2_CT16201.pdf
HAS/2017-07-05_CT-16218_MICARDISPLUS_PIS_RI_Avis2_CT16218.pdf
HAS/2017-07-05_albumine_humaine_iodee_summary_ct15909.pdf
HAS/2017-07-05_albumine_humaine_iodee_synthese_ct15909.pdf
HAS/2017-07-05_neofordex_summary_ct15218.pdf
HAS/2017-07-05_neofordex_synthese_ct15218.pdf
HAS/2017-07-05_sapien_xt_avec_catheter_dinsertion_novaflex__30_mai_2017_5221_avis.pdf
HAS/2017-07-07_CT-15527_SEROPRAM_PIS_RI_Avis2_CT15527.pdf
HAS/2017-07-07_CT-15985_EXFORGE_PIS_RI_Avis2_CT15985.pdf
HAS/2017-07-07_CT-16014_NORSET_PIS_RI_Avis1_CT16014.pdf
HAS/2017-07-07_CT-16024_NEORAL_PIS_RI_Avis2_CT16024.pdf
HAS/2017-07-07_CT-16095_CYCLADOL_PIS_RI_Avis1_CT16095.pdf
HAS/2017-07-07_CT-16104_ISOPEDIA_PIC_INS_Avis2_CT16104.pdf
HAS/2017-07-07_CT-16245_NICOTINE_EG_QD_INS_Avis_CT16245.pdf
HAS/2017-07-07_isopedia_summary_ct16104.pdf
HAS/2017-07-07_isopedia_synthese_ct16104.pdf
HAS/2017-07-11_CEPP-5320_PRO-FLEX LP_27_juin_2017_(5320)_avis.pdf
HAS/2017-07-11_CT-15990_IMBRUVICA_LCM_PIC_REEV_Avis3_CT15990.pdf
HAS/2017-07-11_imbruvica_lcm_summary_ct15990.pdf
HAS/2017-07-11_imbruvica_lcm_synthese_ct15990.pdf
HAS/2017-07-12_CT-14814_ODOMZO_PIC_INS_Avis3_CT14814.pdf
HAS/2017-07-12_CT-16046_DESCOVY_PIC_INS_Avis2_CT16046.pdf
HAS/2017-07-12_descovy_summary_ct16046.pdf
HAS/2017-07-12_descovy_synthese_ct16046.pdf
HAS/2017-07-12_odomzo_summary_ct14814.pdf
HAS/2017-07-12_odomzo_synthese_ct14814.pdf
HAS/2017-07-17_avis_no_2016-109_-_cs_du_12_12_2016_-_fiche_repere_-_prise_en_charge_med....pdf
HAS/2017-07-17_avis_no_2016-114_-_cos_du_9_12_2016_-_fiche_repere_-_prise_en_charge_med....pdf
HAS/2017-07-17_cp_fiche-repere_medicaments.pdf
HAS/2017-07-17_fr_medicament_vdef_crea.pdf
HAS/2017-07-18_CT-13394_TYSABRI_PIS_NE_Avis2_CT15688&13394.pdf
HAS/2017-07-18_CT-15452_RIVOTRIL_PIS_RI_Avis1_CT15452.pdf
HAS/2017-07-18_CT-15877_FIXICAL_PIS_RI_Avis2_CT15877.pdf
HAS/2017-07-18_CT-15988_NINLARO_PIC_INS_Avis3_CT15988.pdf
HAS/2017-07-18_CT-16183_KEYTRUDA_QD_INS_Avis1_CT16183.pdf
HAS/2017-07-18_CT-16206_EPIRUBICINE_MEDIPHA_SANTE_QD_INS_Avis1_CT16206.pdf
HAS/2017-07-18_CT-16246_ZYMAD_PIS_RI_Avis1_CT16246.pdf
HAS/2017-07-18_ninlaro_pic_ins_avis3_ct16714.pdf
HAS/2017-07-18_ninlaro_summary_ct16714.pdf
HAS/2017-07-18_ninlaro_synthese_ct16714.pdf
HAS/2017-07-19_CT-14815_DETICENE-DACARBAZINE_LIPOMED-MEDAC_PIC_REEV_Avis2_CT14390&14815&14256.pdf
HAS/2017-07-19_CT-16169_DETICENE_LNH_PIC_REEV_Avis1_CT16169.pdf
HAS/2017-07-19_dacarbazine_summary_ct14390_14815_14256.pdf
HAS/2017-07-19_dacarbazine_synthese_ct14390_14815_14256.pdf
HAS/2017-07-20_CEPP-5364_VERCISE GEVIA 5364_occultations.pdf
HAS/2017-07-24_06-072_hepat-c_internet_sans_liste.pdf
HAS/2017-07-24_CEPP-5307_PE TRIANON_27_juin_2017_(5307)_avis.pdf
HAS/2017-07-24_CEPP-5336_ACCU-CHEK MOBILE KIT ET CASSETTE_27_juin_2017_(5336)_avis.pdf
HAS/2017-07-24_alber_scalamobil_s35_5257_occultations.pdf
HAS/2017-07-24_has_06-017_vhc_pdf_15decembre.pdf
HAS/2017-07-24_hepatite_c_traduit_anglais.pdf
HAS/2017-07-24_lap_ald_6_vhc__actualisation_dec_2007_.pdf
HAS/2017-07-25_argumentaire_echinococcoses.pdf
HAS/2017-07-25_argumentaire_hepatite_e_.pdf
HAS/2017-07-25_argumentaire_leishmaniose.pdf
HAS/2017-07-25_inahta_brief_echinococcosis.pdf
HAS/2017-07-25_inahta_brief_hepatisis_e.pdf
HAS/2017-07-25_inahta_brief_leishmaniasis.pdf
HAS/2017-07-26_argumentaire_t560_amh.pdf
HAS/2017-07-26_argumentaire_vitrification.pdf
HAS/2017-07-26_inahta_brief__vitrification.pdf
HAS/2017-07-26_inahta_brief_amh.pdf
HAS/2017-08-02_CT-14417_ATRICAN_PIS_RI_Avis1_CT14417.pdf
HAS/2017-08-02_CT-15301_ZARONTIN_PIS_RI_Avis1_CT15301.pdf
HAS/2017-08-02_CT-15503_XOLAIR_PIS_RI_Avis2_modifiele21072017_CT15503.pdf
HAS/2017-08-02_CT-15793_NOCDURNA_PIC_INS_Avis3_modifiele25072017_CT15793.pdf
HAS/2017-08-02_CT-15952_CORGARD_PIS_RI_Avis2_CT15952.pdf
HAS/2017-08-02_CT-15964_KANUMA_PIC_INS_Avis3_CT15964.pdf
HAS/2017-08-02_CT-15976_KESTIN_KESTINLYO_PIS_RI_Avis2_CT15976.pdf
HAS/2017-08-02_CT-16035_AFSTYLA_PIS_INS_Avis2_modifiele24072017_CT16035.pdf
HAS/2017-08-02_CT-16059_FIASP_PIS_INS_Avis2_CT16059.pdf
HAS/2017-08-02_CT-16097_TROLOVOL_PIC_EI_intox_plomb_Avis2_CT16097.pdf
HAS/2017-08-02_CT-16189_ICLUSIG_PIS_RCP_Avis2_CT16189.pdf
HAS/2017-08-02_CT-16195_PRITOR_PIS_RI_Avis2_CT16195.pdf
HAS/2017-08-02_CT-16197_GANCICLOVIR_SANDOZ_QD_INS_Avis1_CT16197.pdf
HAS/2017-08-02_CT-16207_GLYCEROL-VASELINE-PARAFINE_CRISTERS_QD_INS_Avis2_CT16207.pdf
HAS/2017-08-02_CT-16217_MICARDIS_PIS_RI_Avis2_CT16217.pdf
HAS/2017-08-02_CT-16225_DAPTOMYCINE_HOSPIRA_QD_INS_Avis2_CT16225.pdf
HAS/2017-08-02_CT-16226_PEMETREXED_HOSPIRA_QD_INS_Avis2_CT16226.pdf
HAS/2017-08-02_CT-16256_BENDAMUSTINE_FRESENIUS_QD_INS_Avis1_CT16256.pdf
HAS/2017-08-02_CT-16265_BOSENTAN_SANDOZ_QD_INS_Avis1_CT16265.pdf
HAS/2017-08-02_CT-16298_IBUPROFENE_ACCORD_QD_INS_Avis1_CT16298.pdf
HAS/2017-08-02_CT-16302_ATOSIBAN_STRAGEN_QD_INS_Avis1_CT16302.pdf
HAS/2017-08-02_CT-16307_IMIPENEM_CILASTATINE_VILLERTON_QD_INS_Avis1_CT16307.pdf
HAS/2017-08-02_CT-16314_AMIKACINE_BBRAUN_QD_INS_Avis2_CT16314.pdf
HAS/2017-08-02_CT-16317_DESOGESTREL_CRISTERS_QD_INS_Avis1_CT16317.pdf
HAS/2017-08-02_CT-16333_CASPOFUNGINE_DR_REDDYS_QD_INS_Avis1_CT16333.pdf
HAS/2017-08-02_CT-16372_TRUXIMA_100_mg_QD_INS_Avis2_CT16372.pdf
HAS/2017-08-02_nocdurna_summary_ct15793.pdf
HAS/2017-08-02_nocdurna_synthese_ct15793.pdf
HAS/2017-08-02_trolovol_saturnisme_summary_ct16097.pdf
HAS/2017-08-02_trolovol_saturnisme_synthese_ct16097.pdf
HAS/2017-08-04_CT-16247_CHLORURE_DE_SODIUM_VIAFLO_QD_INS_Avis1_CT16247.pdf
HAS/2017-08-07_CEPP-5199_HOME MONITORING DAI simple chambre_11_juillet_2017_(5199)_avis.pdf
HAS/2017-08-07_CEPP-5200_HOME MONITORING DAI double chambre_11_juillet_2017_(5200)_avis.pdf
HAS/2017-08-07_CEPP-5201_HOME MONITORING DAI triple chambre_11_juillet_2017_(5201)_avis.pdf
HAS/2017-08-07_CEPP-5203_MERLIN NET DAI simple 5203_avis 11 07 2017_occultations.pdf
HAS/2017-08-07_CEPP-5204_MERLIN NET DAI double 5204_avis 11 07 2017_occultations.pdf
HAS/2017-08-07_CEPP-5205_MERLIN NET DAI triple 5205_avis 11 07 2017_occultations.pdf
HAS/2017-08-09_CEPP-5196_CARELINK DAI triple chambre_11_juillet_2017_(5196)_avis.pdf
HAS/2017-08-09_CEPP-5197_CARELINK DAI simple chambre_11_juillet_2017_(5197)_avis.pdf
HAS/2017-08-09_CEPP-5198_CARELINK DAI double chambre_11_juillet_2017_(5198)_avis.pdf
HAS/2017-08-09_CEPP-5271_SOLITAIRE PLATINIUM 5271_avis du 2 mai 2017_occultations.pdf
HAS/2017-08-09_CEPP-5319_COMET 5319_occultations.pdf
HAS/2017-08-09_CEPP-5326_COROFLEX ISAR NEO 5326_avis du 13 juin 2017_occultations.pdf
HAS/2017-08-09_CT-16075_INFLUVAC_PIS_RI_Avis2_CT16075.pdf
HAS/2017-08-10_CEPP-5212_SMARTVIEW DAI simple chambre_11_juillet_2017_(5212)_avis.pdf
HAS/2017-08-10_CEPP-5213_SMARTVIEW DAI double chambre_11_juillet_2017_(5213)_avis.pdf
HAS/2017-08-10_CEPP-5214_SMARTVIEW DAI triple chambre_11_juillet_2017_(5214)_avis.pdf
HAS/2017-08-24_CEPP-5219_LUTONIX 035_2_mai_2017_(5219)_avis.pdf
HAS/2017-08-24_CEPP-5269_PANTERA LUX 5269_avis du 27 juin 2017_occultations.pdf
HAS/2017-08-24_CEPP-5292_ECLIPSE 5_13_juin_2017_(5292)_avis.pdf
HAS/2017-08-24_CEPP-5300_GORE VIABAHN 5300_avis du 11 07 2017_occultations.pdf
HAS/2017-08-24_pnds_-_arterite_a_cellules_geantes.pdf
HAS/2017-08-24_pnds_90_-_arterite_a_cellules_geantes_horton.pdf
HAS/2017-08-24_pnds_hypoparathyroidie_vf.pdf
HAS/2017-08-25_rapport_systemes_de_telesurveillance_pour_defibrillateurs_cardiaques_automatiques_implantables_07_2017_annexes.pdf
HAS/2017-08-25_rapport_systemes_de_telesurveillance_pour_defibrillateurs_cardiaques_automatiques_implantables_07_20_2017-08-28_10-11-32_428.pdf
HAS/2017-08-25_texte_court_systemes_de_telesurveillance_pour_defibrillateurs_cardiaques_automatiques.pdf
HAS/2017-08-28_CEPP-5209_LATITUDE NXT DAI simple chambre_11_juillet_2017_(5209)_avis.pdf
HAS/2017-08-28_CEPP-5210_LATITUDE NXT DAI double chambre_11_juillet_2017_(5210)_avis.pdf
HAS/2017-08-28_CEPP-5211_LATITUDE NXT DAI triple chambre_11_juillet_2017_(5211)_avis.pdf
HAS/2017-08-28_CEPP-5235_PENUMBRA SYSTEM 5235_V2_occultations.pdf
HAS/2017-08-28_CEPP-5251_SEPARATEUR 3D PENUMBRA_11_juillet_2017_(5251)_avis.pdf
HAS/2017-08-28_CEPP-5297_VENOTRAIN Ulcertec 46_11_juillet_2017_(5297)_avis.pdf
HAS/2017-08-28_CEPP-5298_VENOTRAIN Ulcertec 39_11_juillet_2017_(5298)_avis.pdf
HAS/2017-08-28_CEPP-5380_KETO DIASTIX_11_juillet_2017_(5380)_avis.pdf
HAS/2017-08-28_CT-15105_VOLIBRIS_PIC_EI_AvisPostAud_CT15105.pdf
HAS/2017-08-28_CT-15256_BRILIQUE_PIC_INS_Avis3_CT15256.pdf
HAS/2017-08-28_CT-15304_LONSURF_PIC_INS_Avis3_CT15304.pdf
HAS/2017-08-28_CT-16240_MYDRIATICUM_PIS_RI_Avis1_CT16240.pdf
HAS/2017-08-28_CT-16332_CASPOFUNGINE_SUN_QD_INS_Avis1_CT16332.pdf
HAS/2017-08-28_brilique_60mg_summary_ct15256.pdf
HAS/2017-08-28_brilique_60mg_synthese_ct15256.pdf
HAS/2017-08-28_implant_endovaculaire_dit_stent_aortique_renal_iliaque_ou_femoral_avis_du_11_07_2017_dm-eval_157.pdf
HAS/2017-08-28_lonsurf_summary_ct15311.pdf
HAS/2017-08-28_lonsurf_synthese_ct15311.pdf
HAS/2017-08-28_volibris_summary_ct15105.pdf
HAS/2017-08-28_volibris_synthese_ct15105.pdf
HAS/2017-09-01_CT-15839_CINQAERO_PIC_INS_Avis2_CT15839.pdf
HAS/2017-09-06_CT-15477_GAZYVARO_PIC_EI_AvisPostAud_CT15477.pdf
HAS/2017-09-06_CT-15734_REVLIMID_PIC_EI_LCM_AvisPostObs_CT15734.pdf
HAS/2017-09-06_CT-15891_OPDIVO_PIC_EI_LHC_Avis3_CT15891.pdf
HAS/2017-09-06_CT-15913_ZINFORO_PIS_EI_Avis2_CT15913.pdf
HAS/2017-09-06_CT-16073_IMMUGRIP_PIS_RI_Avis2_CT16073.pdf
HAS/2017-09-06_CT-16149_HUMALOG_HUMALOG_MIX_PIS_RI_Avis2_CT16149.pdf
HAS/2017-09-06_CT-16193_DIACOMIT_PIS_RI_Avis2_CT16193.pdf
HAS/2017-09-06_CT-16215_ERELZI_PIS_INS_Avis2_CT16215.pdf
HAS/2017-09-06_CT-16235_PROCORALAN_PIS_RI_Avis2_CT16235&16315.pdf
HAS/2017-09-06_CT-16243_TROLOVOL_PIC_EI_cystinurie_Avis1_CT16243.pdf
HAS/2017-09-06_CT-16252_BENEPALI_50mg_PIS_EI_Pédiatrie_Avis2_CT16252.pdf
HAS/2017-09-06_CT-16253_BENEPALI_QD_INS_Avis2_CT16253.pdf
HAS/2017-09-06_CT-16303_BOSENTAN_SUN_QD_INS_Avis2_CT16303.pdf
HAS/2017-09-06_chlorure_sodium_macopharma_pis_ri_avis2_ct16130.pdf
HAS/2017-09-06_gazyvaro_lf_16052017_avis_efficience.pdf
HAS/2017-09-06_gazyvaro_summary_ct15477.pdf
HAS/2017-09-06_gazyvaro_synthese_ct15477.pdf
HAS/2017-09-06_opdivo_summary_ct15891.pdf
HAS/2017-09-06_opdivo_synthese_ct15891.pdf
HAS/2017-09-06_revlimid_lcm_summary_ct15734.pdf
HAS/2017-09-06_revlimid_lcm_synthese_ct15734.pdf
HAS/2017-09-06_trolovol_cystinurie_summary_ct16243.pdf
HAS/2017-09-06_trolovol_cystinurie_synthese_ct16243.pdf
HAS/2017-09-06_zinforo_summary_ct15913.pdf
HAS/2017-09-06_zinforo_sythese_ct15913.pdf
HAS/2017-09-07_CT-16139_ZINPLAVA_PIC_INS_Avis2_CT16139.pdf
HAS/2017-09-07_communique_de_presse_recommandations_caarud.pdf
HAS/2017-09-07_d2017-45_-_adoption_rbpp_caarud.pdf
HAS/2017-09-07_lettre_de_cadrage_programme_addictions-2.pdf
HAS/2017-09-07_recommandations_caarud_web.pdf
HAS/2017-09-07_zinplava_summary_ct16139.pdf
HAS/2017-09-07_zinplava_synthese_ct16139.pdf
HAS/2017-09-11_CEPP-5223_MELODY ENSEMBLE II 5223_occultations.pdf
HAS/2017-09-11_CEPP-5264_MELODY ENSEMBLE 5264_occultations.pdf
HAS/2017-09-11_CEPP-5283_EPIC MITRALE 5283_occultations.pdf
HAS/2017-09-11_CEPP-5285_EPIC 5285_occultations.pdf
HAS/2017-09-11_CEPP-5286_TRIFECTA 5286_occultations.pdf
HAS/2017-09-11_CEPP-5289_EPIC SUPRA 5289_occultations.pdf
HAS/2017-09-11_CEPP-5290_TRIFECTA GT 5290_occultations.pdf
HAS/2017-09-11_CEPP-5295_SOLO SMART 5295_occultations.pdf
HAS/2017-09-11_CEPP-5296_CROWN PRT 5296_occultations.pdf
HAS/2017-09-11_CEPP-5304_PERICARBON MORE MITRAL 5304_occultations.pdf
HAS/2017-09-11_gore_tigris_5305_avis_du_30_mai_2017_occultations.pdf
HAS/2017-09-11_ranger_5169_avis_du_2_mai_2017_occultations.pdf
HAS/2017-09-11_zilver_ptx_5371_11_juillet_2017_occultations.pdf
HAS/2017-09-12_CT-15997_ZONEGRAN_PIS_RI_Avis2_CT15997.pdf
HAS/2017-09-12_CT-16292_PNEUMOVAX_QD_INS_Avis1_CT16292.pdf
HAS/2017-09-15_CT-16115_TRISENOX_PIC_EI_Avis2_CT16115.pdf
HAS/2017-09-15_trisenox_sapub_ct16115.pdf
HAS/2017-09-15_trisenox_summaru_ct16115.pdf
HAS/2017-09-19_CEPP-5186_PROPHYLAXE Ref 96100 96101 96103_12_septembre_2017_(5186)_avis.pdf
HAS/2017-09-19_CEPP-5224_FINN ORTHO_12_septembre_2017_(5224)_avis.pdf
HAS/2017-09-19_CEPP-5382_PROPHYLAXE Ref 97307 97308_12_septembre_2017_(5382)_avis.pdf
HAS/2017-09-19_CEPP-5383_PROPHYLAXE Ref 96519 96522_12_septembre_2017_(5383)_avis.pdf
HAS/2017-09-19_CEPP-5384_PROPHYLAXE Ref 96524 96525_12_septembre_2017_(5384)_avis.pdf
HAS/2017-09-19_pnds_2017_vf1.pdf
HAS/2017-09-19_pnds_91_-_mucoviscidose.pdf
HAS/2017-09-19_pnds_92_-_syndrome_de_rubinstein-taybi.pdf
HAS/2017-09-19_pnds_syndrome_de_rubinstein-taybi.pdf
HAS/2017-09-20_CEPP-5161_NEXGEN LPS 5161_12_septembre_2017_occultations.pdf
HAS/2017-09-20_CEPP-5276_LONGEVITY 5276_12_septembre_2017_occultations.pdf
HAS/2017-09-20_CEPP-5279_XPOSITION S_12_septembre_2017_(5279)_avis.pdf
HAS/2017-09-20_CT-14118_MEGACE_PIS_RI_Avis1_CT14118.pdf
HAS/2017-09-20_CT-16098_HELICOBACTER_TEST_INFAI_PIS_RI_Avis1_CT16098.pdf
HAS/2017-09-20_CT-16182_AMINOMIX_PIS_RI_Avis2_CT16182.pdf
HAS/2017-09-20_CT-16268_OMNIPAQUE_QD_INS_Avis1_CT16268.pdf
HAS/2017-09-20_CT-16344_UCEDANE_QD_INS_Avis1_CT16344.pdf
HAS/2017-09-21_c_2015_0115_check-list_mrc.pdf
HAS/2017-09-21_check-list_parcours_mrc_pre-suppleance_web.pdf
HAS/2017-09-21_dispositif_annonce_suppleance_web.pdf
HAS/2017-09-21_dispositif_inclusion_experimentation_vf.pdf
HAS/2017-09-21_informations_pour_les_professionnels_de_sante_et_les_equipes_de_soins.pdf
HAS/2017-09-21_methode_decider_ensemble_mode_de_suppleance_renale_argumentaire.pdf
HAS/2017-09-21_note_methodologique__parcours_pre-suppleance_web.pdf
HAS/2017-09-21_schema_experimentation_irct_vf.pdf
HAS/2017-09-21_tableau_comparatif_modes_suppleance_renale.pdf
HAS/2017-09-21_v22-decider_ensemble-080317-relecture-lien.pdf
HAS/2017-09-22_CT-15023_MONAZOL_PIS_RI_Avis1_CT15023.pdf
HAS/2017-09-22_CT-16403_IMBRUVICA_PIS_EI_NON_DEMANDEE_Avis1_CT16403.pdf
HAS/2017-09-25_CT-15823_PALEXIA_LP_PIC_REEV_Avis3_CT15823.pdf
HAS/2017-09-25_bilan_experimentation_contributions.pdf
HAS/2017-09-25_contribution_asso_patients_guide_v3.pdf
HAS/2017-09-25_palexia_lp_summary_ct15823.pdf
HAS/2017-09-25_palexia_lp_synthese_ct15823.pdf
HAS/2017-09-27_CT-15560_DESLORATADINE_MYLAN_PIS_RI_Avis2_CT15560.pdf
HAS/2017-09-27_CT-15910_KOLBAM_PIC_INS_Avis3_CT15910.pdf
HAS/2017-09-27_CT-16188_NANDIKTOR_PIS_INS_Avis1_CT16188.pdf
HAS/2017-09-27_CT-16264_ERYTHROMYCINE_PANPHARMA_QD_INS_Avis1_CT16264.pdf
HAS/2017-09-27_kolbam_summary_ct15910.pdf
HAS/2017-09-27_kolbam_synthse_ct15910.pdf
HAS/2017-09-28_CEPP-4901_TITAN OPTIMAX_12_septembre_2017_(4901)_avis.pdf
HAS/2017-09-29_2015_12_04_fiche_memo_maltraitance_enfant_en.pdf
HAS/2017-09-29_fiche_memo_maltraitance_enfant.pdf
HAS/2017-09-29_fs_1_bebe_secoue.pdf
HAS/2017-09-29_fs_2_bebe_secoue.pdf
HAS/2017-09-29_fs_3_bebe_secoue.pdf
HAS/2017-09-29_maltraitance_enfant_rapport_d_elaboration.pdf
HAS/2017-09-29_modele_de_certificat_sur_demande_spontanee_format_pdf.pdf
HAS/2017-09-29_modele_type_de_signalement_format_pdf.pdf
HAS/2017-09-29_outil_interactif_reperage_maltraitance_enfants.pdf
HAS/2017-09-29_reco239_argumentaire_syndrome_bebe_secoue.pdf
HAS/2017-09-29_reco239_recommandations_syndrome_bebe_secoue.pdf
HAS/2017-09-29_shaken_baby_syndrome.pdf
HAS/2017-09-29_syndrome_du_bebe_secoue_-_rapport_dorientation_de_la_commission_daudition.pdf
HAS/2017-10-02_CEPP-5343_ONYX LES 5343_11_juillet_2017_occultations.pdf
HAS/2017-10-02_CEPP-5398_TREVO XP PROVUE RETRIEVER_12_septembre_2017_(5398)_avis.pdf
HAS/2017-10-02_CEPP-5417_ASKINA CARBOSORB_12_septembre_2017_(5417)_avis.pdf
HAS/2017-10-04_CEPP-5392_OSTIBONE_12_septembre_2017_(5392)_avis.pdf
HAS/2017-10-04_CT-14709_INCRELEX_PIC_RI_REEV_Avis3_CT14709.pdf
HAS/2017-10-04_CT-14838_AKYNZEO_PIC_INS_Avis2_CT14838.pdf
HAS/2017-10-04_CT-15148_BETASERC_SERC_PIS_RI_Avis2_CT15148.pdf
HAS/2017-10-04_CT-15466_TEGRETOL_PIS_RI_Avis1_CT15466.pdf
HAS/2017-10-04_CT-15550_HELIKIT_PIS_RI_Avis1_CT15550.pdf
HAS/2017-10-04_CT-15700_VIDAZA_PIC_EI_LAM_Avis3_CT15700.pdf
HAS/2017-10-04_CT-15731_EMEND_PIC_EI_Avis2_CT15731&15732.pdf
HAS/2017-10-04_CT-15789_ARIXTRA_1,5_PIC_INS_AvisPostObs_CT15789.pdf
HAS/2017-10-04_CT-15794_ONIVYDE_PIC_INS_Avis3_CT15794.pdf
HAS/2017-10-04_CT-15820_TRANSLARNA_PIC_REEV_Avis3_CT15820.pdf
HAS/2017-10-04_CT-15943_OCALIVA_PIC_INS_Avis3_CT15943.pdf
HAS/2017-10-04_CT-15974_INTUNIV_PIC_INS_Avis3_CT15974.pdf
HAS/2017-10-04_CT-15986_CALDINE_PIS_RI_Avis2_CT15986.pdf
HAS/2017-10-04_CT-16012_FEMADEXIL_PIC_INS_Avis1_CT16012.pdf
HAS/2017-10-04_CT-16116_OLUMIANT_PIC_INS_Avis 2_CT16116.pdf
HAS/2017-10-04_CT-16175_LEDAGA_PIC_INS_Avis3_CT16175.pdf
HAS/2017-10-04_akynzeo_ct14838_summary.pdf
HAS/2017-10-04_akynzeo_ct14838_synthese.pdf
HAS/2017-10-04_arixtra_1.5mg_summary_ct15789.pdf
HAS/2017-10-04_arixtra_1.5mg_synthese_ct15789.pdf
HAS/2017-10-04_emend_summary_ct15731_et_ct15732.pdf
HAS/2017-10-04_emend_synthese_ct15731_et_ct15732.pdf
HAS/2017-10-04_femadexil_summary_ct16012.pdf
HAS/2017-10-04_femadexil_synthese_ct16012.pdf
HAS/2017-10-04_increlex_summary_ct14709.pdf
HAS/2017-10-04_increlex_synthese_ct14709.pdf
HAS/2017-10-04_intuniv_summary_ct15974.pdf
HAS/2017-10-04_intuniv_synthese_ct15974.pdf
HAS/2017-10-04_ledaga_summary_ct16175.pdf
HAS/2017-10-04_ledaga_synthese_ct16175.pdf
HAS/2017-10-04_ocaliva_12092017_avis_efficience.pdf
HAS/2017-10-04_ocaliva_summary_ct15943.pdf
HAS/2017-10-04_ocaliva_synthese_ct15943.pdf
HAS/2017-10-04_olumiant_summary_ct16116.pdf
HAS/2017-10-04_olumiant_synthese_ct16116.pdf
HAS/2017-10-04_onivyde_summary_ct15794.pdf
HAS/2017-10-04_onivyde_synthese_ct15794.pdf
HAS/2017-10-04_translarna_summary_ct15820.pdf
HAS/2017-10-04_translarna_synthese_ct15820.pdf
HAS/2017-10-04_vidaza_summary_ct15700.pdf
HAS/2017-10-04_vidaza_synthese_ct15700.pdf
HAS/2017-10-05_CEPP-5253_SAPIEN 3 modèle 9600 TFX transapicale 5253_12 septembre 2017_occultations.pdf
HAS/2017-10-05_CEPP-5254_SAPIEN 3 modèle 9600 TFX transfémorale 5254_-12 septembre 2017_occultations.pdf
HAS/2017-10-06_CT-15620_VITAMINE_A_NEPALM_PIS_RI_Avis1_CT15620.pdf
HAS/2017-10-06_CT-15621_VITAMINE_E_NEPALM_PIS_RI_Avis1_CT15621.pdf
HAS/2017-10-06_CT-16155_EPITOMAX_PIS_RI_Avis1_CT16155.pdf
HAS/2017-10-06_CT-16194_IBUPROFENE_MYLAN_PIS_RI_Avis2_CT16194.pdf
HAS/2017-10-06_CT-16286_VITAMINE_B12_DELAGRANGE_PIS_RI_Avis2_CT16286.pdf
HAS/2017-10-06_CT-16329_POVIDONE_IODEE_CHAUVIN_PIS_INS_Avis1_CT16329.pdf
HAS/2017-10-06_CT-16404_LEVONORGESTREL_ETHINYLESTRADIOL_BIOGARANCONTINU_QD_INS_Avis1_CT16404.pdf
HAS/2017-10-06_CT-16416_HYDROCORTISONE_PANPHARMA_QD_INS_Avis1_CT16416.pdf
HAS/2017-10-06_CT-16476_XENETIX_QD_INS_Avis1_CT16476.pdf
HAS/2017-10-06_CT-16496_REKOVELLE_QD_INS_Avis2_CT16496.pdf
HAS/2017-10-06_implants_pour_plastie_endocanalaire_stents_dm_eval_162_avis_du_26_septembre_2017.pdf
HAS/2017-10-09_CEPP-5228_ULTRAFILL_12_septembre_2017_(5228)_avis.pdf
HAS/2017-10-09_avis_de_la_cnedimts_du_12_septembre_2017_aspirateurs_tracheaux_forfait_8.pdf
HAS/2017-10-09_composition_du_gt_aspirateurs_tracheaux.pdf
HAS/2017-10-09_evaluation_des_aspirateurs_tracheaux_-_feuille_de_route.pdf
HAS/2017-10-09_rapport_devaluation_aspirateurs_tracheaux_forfati_8.pdf
HAS/2017-10-09_synthesis_of_tracheal_vacuum_suctioning_systems_weekly_fee.pdf
HAS/2017-10-09_texte_court_aspirateurs_tracheaux_forfait_8.pdf
HAS/2017-10-13_CT-15278_TIAPRIDAL_PIS_RI_Avis1_CT15278.pdf
HAS/2017-10-13_CT-16331_SPASFON_PIS_RI_Avis1_CT16331.pdf
HAS/2017-10-13_CT-16408_PERGOVERIS_QD_INS_Avis2_CT16408.pdf
HAS/2017-10-13_CT-16423_BETASERC_QD_INS_Avis1_CT16423.pdf
HAS/2017-10-13_CT-16452_DOCETAXEL_AMRING_QD_INS_Avis2_CT16452.pdf
HAS/2017-10-13_lomexin_qd_ins_avis_ct16399.pdf
HAS/2017-10-18_CEPP-5032_FLEX FOOT BALANCE_10_octobre_2017_(5032)_avis.pdf
HAS/2017-10-18_CEPP-5329_MULTIFLEX_26_septembre_2017_(5329)_avis.pdf
HAS/2017-10-18_CEPP-5409_NEWFILL_12_septembre_2017_(5409)_avis.pdf
HAS/2017-10-18_CEPP-5420_FLEX FOOT ASSURE_12_septembre_2017_(5420)_avis.pdf
HAS/2017-10-18_CEPP-5445_DYNACITY 1A510_26_septembre_2017_(5445)_avis.pdf
HAS/2017-10-18_CT-15569_MYOZYME_PIC_REEV_AvisPostAud_CT15569.pdf
HAS/2017-10-18_CT-15641_ESTROTEP_PIC_INS_Avis3_CT15641.pdf
HAS/2017-10-18_CT-16112_JUNIMIN_PIC_INS_Avis2_modifiele20072017_CT16112.pdf
HAS/2017-10-18_argumentaire_candidoses_invasives.pdf
HAS/2017-10-18_argumentaire_pneumocystose.pdf
HAS/2017-10-18_estrotep_summary_ct15641.pdf
HAS/2017-10-18_estrotep_synthese_ct15641.pdf
HAS/2017-10-18_inahta_brief_candidiasis.pdf
HAS/2017-10-18_inahta_brief_pneumocystis_pneumonia.pdf
HAS/2017-10-18_junimin_summary_ct16112.pdf
HAS/2017-10-18_junimin_synthese_ct16112.pdf
HAS/2017-10-18_myozyme_summary_ct15569.pdf
HAS/2017-10-18_myozyme_synthese_ct15569.pdf
HAS/2017-10-19_CT-15837_TRACUTIL_PIS_RI_Avis2_CT15837.pdf
HAS/2017-10-19_CT-16124_DOTAREM_QD_INS_Avis1_CT16124.pdf
HAS/2017-10-19_CT-16436_IRINOTECAN_MEDAC_QD_INS_Avis1_CT16436.pdf
HAS/2017-10-19_CT-16441_SRIVASSO_QD_INS_Avis2_CT16441.pdf
HAS/2017-10-19_CT-16482_CASPOFUNGINE_PANPHARMA_QD_INS_Avis1_CT16482.pdf
HAS/2017-10-19_CT-16497_FUROSEMIDE_ACCORD_QD_INS_Avis1_CT16497.pdf
HAS/2017-10-19_CT-16504_EZETIMIBE_ACCORD_QD_INS_Avis1_CT16504.pdf
HAS/2017-10-19_deficit_en_g6pd_-_argumentaire.pdf
HAS/2017-10-19_deficit_en_g6pd_-_pnds.pdf
HAS/2017-10-19_pnds_93_-_deficit_en_g6pd.pdf
HAS/2017-10-20_CEPP-5252_LATITUDE NXT EMBLEM S-ICD_12_septembre_2017_(5252)_avis.pdf
HAS/2017-10-20_CT-14473_DEPO-PRODASONE_PIS_RI_Avis2_CT14473.pdf
HAS/2017-10-20_CT-15533_PONSTYL_PIS_RI_Avis2_CT15533.pdf
HAS/2017-10-20_CT-15587_MEDNUTRIFLEX-REANUTRIFLEX_OMEGA_PIS_RI_Avis2_CT15587.pdf
HAS/2017-10-20_CT-16199_CIMZIA_PIS_PR_EXXELERATE_Avis2_CT16199.pdf
HAS/2017-10-20_CT-16216_RIXATHON_PIS_INS_Avis2_CT16216.pdf
HAS/2017-10-20_CT-16453_OXYCODONE_MEDAC_QD_INS_Avis2_CT16453.pdf
HAS/2017-10-20_CT-16510_THIOCOLCHICOSIDE_ALMUS_RECOURS_R163-13_CT16510.pdf
HAS/2017-10-20_CT-16514_MIOREL_RECOURS_R163-13_CT16514.pdf
HAS/2017-10-20_CT-16515_THIOCOLCHICOSIDE_BIOGARAN_RECOURS_R163-13_CT16515.pdf
HAS/2017-10-20_CT-16523_ACICLOVIR_HIKMA_QD_INS_Avis1_CT16523.pdf
HAS/2017-10-23_syndrome_apnees-hypopnees_obstructives_du_sommeil_sahos_avis_du_10_octobre_2017.pdf
HAS/2017-10-25_CEPP-5459_LUTONIX 035_10_octobre_2017_(5459)_avis.pdf
HAS/2017-10-25_CT-15555_PERINUTRIFLEX-MEDNUTRIFLEX-REANUTRIFLEX_LIPIDE_PIS_RI_Avis2_CT15555.pdf
HAS/2017-10-25_CT-16200_DMLA_PIC_REEV_Avis3_CT16200&16091&16196.pdf
HAS/2017-10-25_CT-16278_ADEPAL_MINIDRIL_TRINORDIOL_PIS_RCP_Avis1_CT16278.pdf
HAS/2017-10-25_CT-16326_SELEXID_PIC_REEV_Avis2_CT16326.pdf
HAS/2017-10-25_CT-16448_BRILIQUE_90mg_QD_INS_Avis1_CT16448.pdf
HAS/2017-10-25_CT-16450_ACTONEL_35mg_gastroresistants_QD_INS_Avis1_CT16450.pdf
HAS/2017-10-25_CT-16498_DAFALGAN_PEDIATRIQUE_QD_INS_Avis1_CT16498.pdf
HAS/2017-10-25_selexid_summary_ct16326.pdf
HAS/2017-10-25_selexid_synthese_ct16326.pdf
HAS/2017-10-26_interpretariat_dans_le_domaine_de_la_sante_-_referentiel_de_competences....pdf
HAS/2017-10-26_la_mediation_en_sante_pour_les_personnes_eloignees_des_systemes_de_preve....pdf
HAS/2017-10-26_recommandation_vaccinale_utilisation_du_vaccin_contre_la_grippe_saisonniere_vaxigrip_tetra.pdf
HAS/2017-10-27_orthogeriatrie_et_fracture_de_la_hanche_-_fiche_points_cles.pdf
HAS/2017-10-27_orthogeriatrie_et_fracture_de_la_hanche_-_note_methodologique.pdf
HAS/2017-10-27_prevenir_la_dependance_iatrogene_liee_a_lhospitalisation_chez_les_personnes_agees_-_fiche_points_cles.pdf
HAS/2017-10-27_prevenir_la_dependance_iatrogene_liee_a_lhospitalisation_chez_les_personnes_agees_-_note_methodologique.pdf
HAS/2017-10-30_pnds_-_arthrites_juveniles_idiopathiques.pdf
HAS/2017-11-03_pnds_94_-_pneumopathies_interstitielles_diffuses_de_lenfant.pdf
HAS/2017-11-03_pneumopathies_interstitielles_diffuses_de_lenfant_-_argumentaire.pdf
HAS/2017-11-03_pneumopathies_interstitielles_diffuses_de_lenfant_-_pnds.pdf
HAS/2017-11-08_CEPP-5312_XLMOB à cimenter_10_octobre_2017_(5312)_avis.pdf
HAS/2017-11-08_CEPP-5313_XLMOB sans ciment_10_octobre_2017_(5313)_avis.pdf
HAS/2017-11-08_CEPP-5342_TWIN CUP CIMENTE_10_octobre_2017_(5342)_avis.pdf
HAS/2017-11-08_CEPP-5401_AIR_24_octobre_2017_(5401)_avis.pdf
HAS/2017-11-08_depression_adulte_argumentaire_diagnostic.pdf
HAS/2017-11-08_depression_adulte_argumentaire_pec.pdf
HAS/2017-11-08_depression_adulte_fiche_de_synthese_diagnostic.pdf
HAS/2017-11-08_depression_adulte_fiche_de_synthese_pec.pdf
HAS/2017-11-08_depression_adulte_recommandations_version_mel.pdf
HAS/2017-11-08_rapport_des_avis_du_groupe_de_lecture.pdf
HAS/2017-11-09_CT-16057_ENSTILAR_PIC_INS_Avis3_CT16057.pdf
HAS/2017-11-09_CT-16259_TALMANCO_20mg_QD_INS_Avis1_CT16259.pdf
HAS/2017-11-09_CT-16277_PALMIER_DE_FLORIDE_BIOGARAN_capsule_QD_INS_Avis2_CT16277.pdf
HAS/2017-11-09_CT-16368_TRIVASTAL_PIS_RI_Avis2_CT16368.pdf
HAS/2017-11-09_CT-16392_ACIDUM_PHOSPHORICUM_COMPOSE_BOIRON_PIS_RI_Avis1_CT16392.pdf
HAS/2017-11-09_CT-16406_MODAMIDE_PIS_RI_Avis1_CT16406.pdf
HAS/2017-11-09_CT-16435_NIQUITIN_MENTHE_GLACIALE_QD_INS_Avis2_CT16435.pdf
HAS/2017-11-09_CT-16459_ATOSIBAN_EVER_PHARMA_75_QD_INS_Avis1_CT16459.pdf
HAS/2017-11-09_CT-16495_ESBRIET_QD_INS_Avis2_CT16495.pdf
HAS/2017-11-09_CT-16501_AVASTIN_PIS_EI_NON_DEMANDEE_Avis2_CT16501.pdf
HAS/2017-11-09_CT-16505_CINQAERO_QD_INS_Avis1_CT16505.pdf
HAS/2017-11-09_enstilar_summary_ct16057.pdf
HAS/2017-11-09_enstilar_synthese_ct16057.pdf
HAS/2017-11-10_CEPP-5454_SATURNE II_7_novembre_2017_(5454)_avis.pdf
HAS/2017-11-13_CEPP-5118_LIFECHOICE ACTIVOX 4L_31_mai_2016_(5118)_avis.pdf
HAS/2017-11-13_CEPP-5338_PROCIZE EZ VIEW_24_octobre_2017_(5338)_avis.pdf
HAS/2017-11-13_CEPP-5341_EVAC_24_octobre_2017_ (5341)_avis.pdf
HAS/2017-11-13_CEPP-5391_ALLEVYN GENTLE BORDER HEEL_10_octobre_2017_(5391)_avis.pdf
HAS/2017-11-13_CEPP-5418_URGO K2_24_octobre_2017_(5418)_avis.pdf
HAS/2017-11-13_CEPP-5419_URGO K2 LATEX FREE_24_octobre_2017_(5419)_avis.pdf
HAS/2017-11-13_CEPP-5463_LUTONIX 035 GeoAlign_24_octobre_2017_(5463)_avis.pdf
HAS/2017-11-13_CT-16042_ICECA_PIS_INS_Avis2_CT16042.pdf
HAS/2017-11-13_CT-16462_ACTYNOX_QD_INS_Avis1_CT16462.pdf
HAS/2017-11-13_argumentaire_bcr-abl_vd.pdf
HAS/2017-11-13_hemiarthroplastie_ou_prothese_inversee_dans_les_fractures_complexes_de_lext._sup._de_lhumerus_de_sujet_age._rapport_delabora.pdf
HAS/2017-11-13_hemiarthroplastie_ou_prothese_inversee_dans_les_fractures_complexes_de_lext._sup._de_lhumerus_du_sujet_age._fiche_pertinence.pdf
HAS/2017-11-13_inahta_brief_bcr_abl.docx.pdf
HAS/2017-11-14_CEPP-5350_RANGER 5350_ occultations_validées par HG_20 10 2017.pdf
HAS/2017-11-15_CT-15861_TAMIFLU_PIC_EI_Avis2_CT15861.pdf
HAS/2017-11-15_CT-16023_TEKTROTYD_PIC_INS_Avis2_CT16023.pdf
HAS/2017-11-15_CT-16063_SOMAKIT_TOC_PIC_INS_Avis1_CT16063.pdf
HAS/2017-11-15_somakit_summary_ct16063.pdf
HAS/2017-11-15_somakit_synthese_ct16063.pdf
HAS/2017-11-15_tamiflu_summary_ct15861.pdf
HAS/2017-11-15_tamiflu_synthese_ct15861.pdf
HAS/2017-11-15_tektrotyd_summary_ct16023.pdf
HAS/2017-11-15_tektrotyd_synthese_ct16023.pdf
HAS/2017-11-16_CEPP-5449_DYNAMIC CARBON FOOT 1H04Y_24_octobre_2017_(5449)_avis.pdf
HAS/2017-11-20_CT-15826_LEMTRADA_PIC_REEV_Avis3_CT15826.pdf
HAS/2017-11-20_CT-16056_PARACETAMOL_CODEINE_ARROW_PIS_RI_Avis1_CT16056.pdf
HAS/2017-11-20_CT-16321_PHOSPHALUGEL_PIS_RI_Avis2_CT16321.pdf
HAS/2017-11-20_CT-16489_COLISTIMETHATE_SODIQUE_PANPHARMA_QD_INS_Avis1_CT16489.pdf
HAS/2017-11-20_CT-16494_LEVETIRACETAM_STRAGEN_QD_INS_Avis2_CT16494.pdf
HAS/2017-11-20_CT-16508_DOPACEPTIN_inj_QD_INS_Avis2_CT16508.pdf
HAS/2017-11-20_fluorocholine_siemens_healthcare_pis_ins_avis1_ct16438.pdf
HAS/2017-11-22_CEPP-5455_HIRES ULTRA HIFOCUS SLIM J_7_novembre_2017_(5455)_avis.pdf
HAS/2017-11-22_CT-16146_PROZAC_PIS_RI_Avis1_CT16146.pdf
HAS/2017-11-22_CT-16174_ILARIS_QD_INS_Avis2_CT16174.pdf
HAS/2017-11-22_CT-16208_DIVINA_DUOVA_PIS_RI_Avis2_CT16208.pdf
HAS/2017-11-22_CT-16232_IKERVIS_PIC_REEV_Avis3_CT16232.pdf
HAS/2017-11-22_CT-16463_URIDOZ_PIS_EI_Avis1_CT16463.pdf
HAS/2017-11-22_CT-16540_DAPTOMYCINE_ACCORD_QD_INS_Avis2_CT16540.pdf
HAS/2017-11-23_CEPP-5281_ABSORB 5281_occultations acceptées par HG le 25 10 2017.pdf
HAS/2017-11-23_CEPP-5340_ABSORB GT1 5340_occultations acceptées par HG le 25 10 2017.pdf
HAS/2017-11-24_references_contraception_liste_methodes.pdf
HAS/2017-11-24_synthese_methodes_contraceptives_format2clics.pdf
HAS/2017-11-27_08-098_gp_maladie_corona.pdf
HAS/2017-11-27_CT-15028_EVISTA_PIS_RI_Avis2_CT15028.pdf
HAS/2017-11-27_CT-16260_CLIMODIENE_PIS_RI_Avis2_CT16260.pdf
HAS/2017-11-27_CT-16560_REVESTIVE_QD_INS_Avis2_CT16560.pdf
HAS/2017-11-27_gp_parkinson_10818_001_008.pdf
HAS/2017-11-27_guide_parcours_de_soins_parkinson.pdf
HAS/2017-11-27_liste_ald_maladie_coronarienne.pdf
HAS/2017-11-27_syndromes_parkinsoniens_liste_actes_presta.pdf
HAS/2017-11-28_recommandation_vaccinale_utilisation_du_vaccin_hexavalent_vaxelis.pdf
HAS/2017-11-29_CEPP-5072_HIGHLANDER_7_novembre_2017_(5072)_avis.pdf
HAS/2017-11-29_CEPP-5074_SILHOUETTE_7_novembre_2017_(5074)_avis.pdf
HAS/2017-11-29_CEPP-5076_PROMENADE_7_novembre_2017_(5076)_avis.pdf
HAS/2017-11-29_CEPP-5389_ALBER VIAMOBIL ECO V14_21_novembre_2017_(5389)_avis.pdf
HAS/2017-11-29_CEPP-5475_ESSURE_7_novembre_2017_(5475)_avis.pdf
HAS/2017-11-29_argumentaire_pnds_cohen.pdf
HAS/2017-11-29_pnds_syndrome_de_cohen.pdf
HAS/2017-11-29_synthese_mg_syndrome_de_cohen.pdf
HAS/2017-12-01_CT-14119_FASLODEX_PIS_RI_Avis2_CT14119.pdf
HAS/2017-12-01_CT-14444_AROMASINE_PIS_RI_Avis2_CT11489&14444.pdf
HAS/2017-12-01_CT-16272_GIBITER_EASYHALER_PIS_INS_Avis2_CT16272.pdf
HAS/2017-12-01_CT-16293_SPASMAG_INJECTABLE_PIS_RI_Avis2_CT16293.pdf
HAS/2017-12-01_CT-16576_TRESIBA_QD_INS_Avis1_CT16576.pdf
HAS/2017-12-04_bum_medicaments_biosimilaires_v1.pdf
HAS/2017-12-05_CT-16377_MAGINJECTABLE_PIS_RI_Avis1_CT16377.pdf
HAS/2017-12-05_chir_ambu_axe_5_-_indicateurs_suivi_et_evaluation.pdf
HAS/2017-12-05_communique_presse_recommandations_fin_de_vie.pdf
HAS/2017-12-05_d2016-61_-_decision_adoption_rbpp_accompagner_la_fin_de_vie_des_pa_a_domicile_-_mention_signe.pdf
HAS/2017-12-05_document_d_appui_17_12_07.pdf
HAS/2017-12-05_lettre_de_cadrage_fin_de_vie_vf-2.pdf
HAS/2017-12-05_rapport_exp_indicateurs_chirurgie_ambulatoire_2017.pdf
HAS/2017-12-05_synthese_indicateurs_retenus_chir_ambu_juillet2017.pdf
HAS/2017-12-05_web_rbpp_findevie_domicile.pdf
HAS/2017-12-05_web_synthese_findevie_domicile.pdf
HAS/2017-12-07_CT-14274_HALAVEN_PIC_EI_REEV_Avis3_CT14274&14276.pdf
HAS/2017-12-07_CT-14394_LEMTRADA_PIC_INS_Avis3_CT14394.pdf
HAS/2017-12-07_CT-14598_REPATHA_PIC_INS_Avis3_CT14598.pdf
HAS/2017-12-07_CT-15085_OCTAPLASLG_PIC_INS_Avis2_CT15085.pdf
HAS/2017-12-07_CT-15616_HALAVEN_PIC_EI_Avis3_CT15616.pdf
HAS/2017-12-07_halaven_14032017_avis_efficience.pdf
HAS/2017-12-07_halaven_21072015_avis_efficience.pdf
HAS/2017-12-07_halaven_ei_summary_ct15891.pdf
HAS/2017-12-07_halaven_ei_synthese_ct15616.pdf
HAS/2017-12-07_halaven_sapub_ct14274_14276.pdf
HAS/2017-12-07_halaven_summary_ct14274_14276.pdf
HAS/2017-12-07_lemtrada_15092015_avis_efficience.pdf
HAS/2017-12-07_lemtrada_summary_ct14394.pdf
HAS/2017-12-07_lemtrada_synthese_ct14394.pdf
HAS/2017-12-07_octaplaslg_08112016_avis_efficience.pdf
HAS/2017-12-07_octaplaslg_en_summary_ct15085.pdf
HAS/2017-12-07_octaplaslg_synthese_ct15085.pdf
HAS/2017-12-07_repatha_08122015_avis_efficience.pdf
HAS/2017-12-07_repatha_summary_ct14598.pdf
HAS/2017-12-07_repatha_synthese_ct14598.pdf
HAS/2017-12-07_vectibix_03092014_synthese_avis_ct13386_2014-12-11_15-58-1_143.pdf
HAS/2017-12-07_vectibix_27052014_avis_efficience.pdf
HAS/2017-12-07_vectibix_en_ct13386.pdf
HAS/2017-12-07_vectibix_mci_avispostaudition_ct13386.pdf
HAS/2017-12-08_CT-15724_KYPROLIS_QD_INS_Avis1_CT15724.pdf
HAS/2017-12-08_CT-16288_GLATIRAMER_MYLAN_QD_INS_Avis2_CT16288.pdf
HAS/2017-12-08_CT-16330_METEOSPASMYL_PIS_RI_Avis1_CT16330.pdf
HAS/2017-12-08_CT-16358_RISORDAN_PIS_RI_Avis1_CT16358.pdf
HAS/2017-12-08_CT-16370_METEOXANE_PIS_RI_Avis2_CT16370.pdf
HAS/2017-12-08_CT-16552_ALMOGRAN_PIS_RI_Avis2_CT16552.pdf
HAS/2017-12-08_CT-16587_NINLARO_QD_INS_Avis1_CT16587.pdf
HAS/2017-12-11_CEPP-5258_GLIDELIGHT_21_novembre_2017_(5258)_avis.pdf
HAS/2017-12-11_CEPP-5377_TWICARE_21_novembre_2017_(5377)_avis.pdf
HAS/2017-12-11_CEPP-5412_PROVOX XtraHME MICRON et TRACHPHONE_24_octobre_2017_(5412)_avis.pdf
HAS/2017-12-11_CEPP-5416_TALI_21_novembre_2017_(5416)_avis.pdf
HAS/2017-12-11_CEPP-5424_COREVALVE EVOLUT PRO_24_octobre_2017_(5424)_occultations acceptées par HG le 13 11 2017.pdf
HAS/2017-12-11_CEPP-5434_HOMEFILL II_21_novembre_2017_(5434)_avis.pdf
HAS/2017-12-11_CEPP-5435_JARVIK 2000_10_octobre_2017_(5435)_avis.pdf
HAS/2017-12-11_CEPP-5464_PHYSIOTULLE_21_novembre_2017_(5464)_avis.pdf
HAS/2017-12-11_CT-16565_COLISTIMETHATE_SODIQUE_PANPHARMA_QD_INS_Avis1_CT16565.pdf
HAS/2017-12-12_fs_diverticulite_v5.pdf
HAS/2017-12-12_prise_en_charge_medicale_et_chirurgicale_-_argumentaire.pdf
HAS/2017-12-12_prise_en_charge_medicale_et_chirurgicale_-_recommandations.pdf
HAS/2017-12-13_CEPP-5385_BLOM SINGER_24_octobre_2017_(5385)_avis.pdf
HAS/2017-12-13_CEPP-5436_PROVOX HME_24_octobre_2017_(5436)_avis.pdf
HAS/2017-12-14_CEPP-5344_ACRYSOF IQ TORIC_7_novembre_2017_(5344)_avis.pdf
HAS/2017-12-14_CEPP-5414_EFFIDIA_24_octobre_2017_(5414)_avis.pdf
HAS/2017-12-14_CEPP-5466_PROVOX HME_24_octobre_2017_(5466)_avis.pdf
HAS/2017-12-19_4_pages__avc_2015_vd.pdf
HAS/2017-12-19_4_pages_dia_2015_vd.pdf
HAS/2017-12-19_4pages_hpp_2015_vd.pdf
HAS/2017-12-19_ipaqss-rapport-hpp-v3.pdf
HAS/2017-12-19_ipaqss_rapport-avc-v5.pdf
HAS/2017-12-19_obe_plaquette_2014_vf.pdf
HAS/2017-12-19_obe_plaquette_vf.pdf
HAS/2017-12-19_obe_rapport_2014_vf.pdf
HAS/2017-12-19_obe_rapport_vf.pdf
HAS/2017-12-19_plaquette_avc.pdf
HAS/2017-12-19_plaquette_avc_2017.pdf
HAS/2017-12-19_plaquette_dialyse.pdf
HAS/2017-12-19_plaquette_dialyse_2017.pdf
HAS/2017-12-19_plaquette_hpp_vf.pdf
HAS/2017-12-19_plaquette_obesite_2015.pdf
HAS/2017-12-19_plaquette_obesite_2017_vf.pdf
HAS/2017-12-19_plaquette_pphpp_2017.pdf
HAS/2017-12-19_plaquette_pphpp_2017_2017-12-18_16-39-23_486.pdf
HAS/2017-12-19_rapport-dialyse.pdf
HAS/2017-12-19_rapport-hpp_vf_2014-07-16_17-47-29_928.pdf
HAS/2017-12-19_rapport_avc.pdf
HAS/2017-12-19_rapport_avc_2017.pdf
HAS/2017-12-19_rapport_dialyse_2017.pdf
HAS/2017-12-19_rapport_hpp_mco_2015_vd.pdf
HAS/2017-12-19_rapport_long_avc_2015_vd.pdf
HAS/2017-12-19_rapport_long_dia_2015_vd.pdf
HAS/2017-12-19_rapport_obesite_2015.pdf
HAS/2017-12-19_rapport_obesite_2017.pdf
HAS/2017-12-19_rapport_pphpp_2017.pdf
HAS/2017-12-19_rapport_pphpp_2017_2017-12-18_16-39-23_488.pdf
HAS/2017-12-19_synthese_avc_2015_vd.pdf
HAS/2017-12-19_synthese_dia_2015_vd.pdf
HAS/2017-12-19_synthese_hpp_mco_2015_vd.pdf
HAS/2017-12-20_cp_recommandations_findevie_ehpad.pdf
HAS/2017-12-20_d2016-60_-_decision_adoption_rbpp_accompagner_la_fin_de_vie_des_pa_en_ehpad_-_mention_signe.pdf
HAS/2017-12-20_document_d_appui.pdf
HAS/2017-12-20_lettre_de_cadrage_fin_de_vie.pdf
HAS/2017-12-20_web_rbpp_findevie_ehpad.pdf
HAS/2017-12-20_web_synthese_findevie_ehpad.pdf
HAS/2017-12-21_CT-14655_OPDIVO_PIC_INS_Avis3_CT14655.pdf
HAS/2017-12-21_CT-14835_ENTRESTO_PIC_INS_Avis3_CT14835.pdf
HAS/2017-12-21_cp_recommandations_socialisation.pdf
HAS/2017-12-21_d2017-23_-_decision_adoption_rbpp_processus_de_socialisation_mention_signee.pdf
HAS/2017-12-21_entresto_12042016_avis_efficience.pdf
HAS/2017-12-21_entresto_summary_ct14835.pdf
HAS/2017-12-21_entresto_synthese_ct14835.pdf
HAS/2017-12-21_lettre_de_cadrage_processus_de_socialisation-2.pdf
HAS/2017-12-21_opdivo_08122015_avis_efficience.pdf
HAS/2017-12-21_opdivo_poumon_summary_ct14655.pdf
HAS/2017-12-21_opdivo_poumon_synthese_ct14655.pdf
HAS/2017-12-21_web_rbpp_socialisation.pdf
HAS/2017-12-28_procedure_selection_demandes_evaluation_actes_prof.pdf
HAS/2018-01-03_CT-15757_EXOCINE_PIS_RI_Avis1_CT15757.pdf
HAS/2018-01-03_CT-16068_EDURANT_PIS_RI_Avis2_CT16068.pdf
HAS/2018-01-03_CT-16258_EVIPLERA_PIS_RI_Avis2_CT16258.pdf
HAS/2018-01-03_CT-16281_DEDROGYL_PIS_RI_Avis2_CT16281.pdf
HAS/2018-01-03_CT-16284_STEROGYL_PIS_RI_Avis2_CT16284.pdf
HAS/2018-01-03_CT-16558_GEMCITABINE_SUN_QD_INS_Avis1_CT16558.pdf
HAS/2018-01-03_CT-16562_GALLIAPHARM_PIS_INS_Avis1_CT16562.pdf
HAS/2018-01-03_CT-16585_THIOPENTAL_PANPHARMA_QD_INS_Avis1_CT16585.pdf
HAS/2018-01-03_CT-16588_CIMZIA_QD_INS_Avis1_CT16588.pdf
HAS/2018-01-03_CT-16596_IRINOTECAN_ACCORD_QD_INS_Avis1_CT16596.pdf
HAS/2018-01-03_CT-16624_ERTAPENEM_FRESENIUS_KABI_QD_INS_Avis2_CT16624.pdf
HAS/2018-01-03_CT-16643_BOSENTAN_ZENTIVA_QD_INS_Avis1_CT16643.pdf
HAS/2018-01-03_CT-16657_MYCOPHENOLATE_MOFETIL_ACCORD_QD_INS_Avis1_CT16657.pdf
HAS/2018-01-03_CT-16664_VISIPAQUE_QD_INS_Avis1_CT16664.pdf
HAS/2018-01-03_penurie_vaccin_pneumococcique_23-valent_pneumovax_-_recommandation_vaccinale.pdf
HAS/2018-01-04_CT-16093_QUINOFREE_PIS_RI_Avis1_CT16093.pdf
HAS/2018-01-04_CT-16386_COLIMYCINE_PIS_RI_Avis2_CT16386.pdf
HAS/2018-01-04_CT-16431_DEPAKOTE-DEPAMIDE_PIS_RCP_Avis2_CT16431.pdf
HAS/2018-01-04_CT-16443_VOSEVI_PIC_INS_Avis2_CT16443.pdf
HAS/2018-01-04_CT-16524_ISENTRESS_600mg_PIS_INS_Avis2_CT16524.pdf
HAS/2018-01-04_CT-16559_BUCCOLAM_PIS_RI_Avis2_CT16559.pdf
HAS/2018-01-04_CT-16573_MAXALT-MAXALTLYO_PIS_RI_Avis2_CT16573.pdf
HAS/2018-01-04_vosevi_sapub_ct16443.pdf
HAS/2018-01-04_vosevi_summary_ct16443.pdf
HAS/2018-01-05_reco_vaccinale_necessite_des_rappels_vaccinaux_chez_lenfant_exigibilite_des_vaccinations_en_collectiv_2017-12-26_18-37-41_83.pdf
HAS/2018-01-08_utilisation_du_vaccin_contre_la_grippe_saisonniere_influvac_tetra_-_recommandation_vaccinale.pdf
HAS/2018-01-09_CEPP-5273_MOBILITY sans ciment_19_décembre_2017_(5273)_avis.pdf
HAS/2018-01-09_CEPP-5274_MOBILITY à cimenter_19_décembre_2017_(5274)_avis.pdf
HAS/2018-01-09_CEPP-5287_XCUP MOB sans ciment_19_décembre_2017_(5287)_avis.pdf
HAS/2018-01-09_CEPP-5394_C-LEG 3C100_19_décembre_2017_(5394)_avis.pdf
HAS/2018-01-09_CEPP-5451_MERCURY à cimenter_19_décembre_2018_(5451)_avis.pdf
HAS/2018-01-09_CEPP-5452_MERCURY PRESSFIT et MERCUPRY PLUS PRESSFIT_19_décembre_2017_(5452)_avis.pdf
HAS/2018-01-09_CEPP-5469_ENDOBON_5_décembre_2017_(5469)_avis.pdf
HAS/2018-01-09_CEPP-5471_NUCLEUS 7_19_dcembre_2017_(5471)_avis.pdf
HAS/2018-01-09_hot_axios_5_decembre_2017_5318_avis.pdf
HAS/2018-01-09_ifuse_5_decembre_2017_5386_avis.pdf
HAS/2018-01-09_perfusion_a_domicile_avis_du_19_decembre_2017.pdf
HAS/2018-01-10_CEPP-5355_HANCOCK II ULTRA_21_novembre_2017_(5355)_avis.pdf
HAS/2018-01-10_CEPP-5356_MOSAIC AORTIQUE_21_novembre_2017_(5356)_avis.pdf
HAS/2018-01-10_CEPP-5357_FREESTYLE modèle 995_21_novembre_2017_(5357)_avis.pdf
HAS/2018-01-10_CEPP-5358_CARPENTIER-EDWARDS PERIMOUNT 2900_21_novembre_2017_(5358)_avis.pdf
HAS/2018-01-10_CEPP-5359_CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE 3300TFX_21_novembre_2017_(5359)_avis.pdf
HAS/2018-01-10_CEPP-5360_INSPIRIS RESILIA 11500A_21_novembre_2017_(5360)_avis.pdf
HAS/2018-01-10_CEPP-5361_CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE 7300TFX_21_novembre_2017_(5361)_avis.pdf
HAS/2018-01-10_CEPP-5362_CARPENTIER-EDWARDS PERIMOUNT PLUS 6900P Mitral_21_novembre_2017_(5362)_avis.pdf
HAS/2018-01-10_CEPP-5367_OVATION iX_7_novembre_2017_(5367)_occultations acceptées HG le 01 12 2017.pdf
HAS/2018-01-10_CEPP-5372_HANCOCK II AORTIQUE modèle T505C_21_novembre_2017_(5372)_avis.pdf
HAS/2018-01-10_CEPP-5373_HANCOCK II MITRALE_21_novembre_2017_(5373)_avis.pdf
HAS/2018-01-10_CEPP-5374_MOSAIC MITRALE_21_novembre_2017_(5374)_avis.pdf
HAS/2018-01-10_CEPP-5375_MOSAIC ULTRA_21_novembre_2017_(5375)_avis.pdf
HAS/2018-01-10_CEPP-5376_PRESTYLED FREESTYLE_21_novembre_2017_(5376)_avis.pdf
HAS/2018-01-10_CEPP-5393_MEPILEX BORDER_10_octobre_2017_(5393)_avis.pdf
HAS/2018-01-10_CEPP-5410_ROHO QUADTRO SELECT_19_décembre_2017_(5410)_avis.pdf
HAS/2018-01-10_CEPP-5411_ROHO MONOCOMPARTIMENT_19_décembre_2017_(5411)_avis.pdf
HAS/2018-01-10_CEPP-5426_SOMNODENT_21_novembre_2017_(5426)_avis.pdf
HAS/2018-01-10_CEPP-5433_PLATINUM 9_21_novembre_2017_(5433)_avis.pdf
HAS/2018-01-10_CEPP-5439_AVALUS_21_novembre_2017_(5439)_avis.pdf
HAS/2018-01-10_CEPP-5446_ALFAMINO_21_novembre_2017_(5446)_avis.pdf
HAS/2018-01-10_CEPP-5456_VISMED MULTI_5_décembre_2017_(5456)_avis.pdf
HAS/2018-01-10_CEPP-5465_HYLOVIS MULTI_5_décembre_2017_(5465)_avis.pdf
HAS/2018-01-10_CEPP-5468_CARPENTIER-EDWARDS PERIMOUNT PLUS 6900PTFX Mitral_21_novembre_2017_(5468)_avis.pdf
HAS/2018-01-10_CEPP-5504_RANGER_5_décembre_2017_(5504)_avis.pdf
HAS/2018-01-10_CEPP-5511_SOLO SMART_5_décembre_2017_(5511)_avis.pdf
HAS/2018-01-10_CEPP-5580_TRUFILL DCS  et TRUFILL DCS ORBIT_19-décembre_2017_(5580)_avis.pdf
HAS/2018-01-10_CT-15893_PARSABIV_PIC_INS_Avis2_CT15893.pdf
HAS/2018-01-10_parsabiv_summary_ct15893.pdf
HAS/2018-01-10_parsabiv_synthese_ct15893.pdf
HAS/2018-01-10_pnds_ais_version_finale.pdf
HAS/2018-01-10_synthese_mg_insensibilites_aux_androgenes.pdf
HAS/2018-01-10_systemes_de_nebulisation_pari_avis_du_19_decembre_2017.pdf
HAS/2018-01-11_maladie_de_rendu-osler_-_pnds.pdf
HAS/2018-01-11_synthese_mg_maladie_de_rendu_osler.pdf
HAS/2018-01-12_CT-16591_ENBREL_QD_INS_Avis1_CT16591.pdf
HAS/2018-01-12_CT-16604_LEVOTHYROX_QD_INS_Avis2_CT16604.pdf
HAS/2018-01-12_CT-16656_ARGATROBAN_ACCORD_QD_INS_Avis1_CT16656.pdf
HAS/2018-01-12_argumentaire_pnds-dcp_20171124_2.pdf
HAS/2018-01-12_pnds-dcp_texte_version_2017_12_05.pdf
HAS/2018-01-12_synthese_mg_dyskinesies_ciliaires_primitives.pdf
HAS/2018-01-15_08-090_gp_schizophenie_2008-06-16_14-36-31_927.pdf
HAS/2018-01-15_08-091_tag.pdf
HAS/2018-01-15_CT-16126_SORIATANE_PIS_RI_Avis2_CT16126.pdf
HAS/2018-01-15_CT-16229_ASMANEX_TWISTHALER_PIS_RI_Avis2_CT16229.pdf
HAS/2018-01-15_CT-16535_ZYMAD_QD_INS_Avis1_CT16535.pdf
HAS/2018-01-15_ald_23__lap_troubles_bipolaires_web.pdf
HAS/2018-01-15_ald_23_gp_troublebipolaire_web.pdf
HAS/2018-01-15_guide_ald23_schizophr_juin_07.pdf
HAS/2018-01-15_guide_medecin_troubles_anxieux.pdf
HAS/2018-01-15_lap_ald23_schizophr_juin_07.pdf
HAS/2018-01-15_liste_ald_troubles_anxieux.pdf
HAS/2018-01-15_mg_tag_web.pdf
HAS/2018-01-17_pris_en_charge_de_lendometriose_-_argumentaire.pdf
HAS/2018-01-17_prise_en_charge_de_lendiometriose_-_demarche_diagnostique_et_traitement_medical_-_fiche_de_synthese.pdf
HAS/2018-01-17_prise_en_charge_de_lendiometriose_-_messages_cles_destines_au_medecin_generaliste.pdf
HAS/2018-01-17_prise_en_charge_de_lendiometriose_-_traitement_chirurgical_et_fertilite_-_fiche_de_synthese.pdf
HAS/2018-01-17_prise_en_charge_de_lendometriose_-_recommandations.pdf
HAS/2018-01-18_CT-16198_XELJANZ_PIC_INS_Avis2_CT16198.pdf
HAS/2018-01-18_CT-16219_VARUBY_PIC_INS_Avis3_CT16219.pdf
HAS/2018-01-18_CT-16237_TIVICAY_PIC_EI_Avis2_CT16237&16238.pdf
HAS/2018-01-18_CT-16299_VAXELIS_PIC_INS_Avis2_CT16299.pdf
HAS/2018-01-18_CT-16609_BEVITINE_QD_INS_Avis1_CT16609.pdf
HAS/2018-01-18_CT-16615_TRIMEBUTINE_MEDISOL_QD_INS_Avis1_CT16615.pdf
HAS/2018-01-18_CT-16653_IMETH_PIS_EI_NON_DEMANDEE_Avis1_CT16653.pdf
HAS/2018-01-18_CT-16679_HUMALOG_QD_INS_Avis1_CT16679.pdf
HAS/2018-01-18_tivicay_summary_ct16237.pdf
HAS/2018-01-18_tivicay_synthese_ct16237_16238.pdf
HAS/2018-01-18_varuby_summary_ct16219.pdf
HAS/2018-01-18_vaxelis_summary_ct16299.pdf
HAS/2018-01-18_vaxelis_synthese_ct16299.pdf
HAS/2018-01-18_xeljanz_summary_ct16198.pdf
HAS/2018-01-18_xeljanz_synthese_ct16198.pdf
HAS/2018-01-19_CEPP-5031_TALUX_19_décembre_2017_(5031)_avis.pdf
HAS/2018-01-19_CEPP-5397_ORBIT GALAXY_19_décembre_2017_(5397)_avis.pdf
HAS/2018-01-19_CEPP-5448_PONTO_09_janvier_2018_(5448)_avis.pdf
HAS/2018-01-19_CEPP-5484_CEMSTOP_09_janvier_2018_(5484)_avis.pdf
HAS/2018-01-22_CEPP-5322_PASSEO 18 LUX 5322_occultations validées par HG le 26 12 2017.pdf
HAS/2018-01-22_CEPP-5387_EMBOSPHERE_5_décembre_2017_(5387)_occultations validées par HG le 09 01 2017.pdf
HAS/2018-01-22_CEPP-5388_EMBOGOLD_5_décembre_2017_(5388)_occultations validées par HG le 09 01 2017.pdf
HAS/2018-01-22_CEPP-5390_EMBLEM MRI S-ICD 5390_occultations validées par HG le 22 12 2017.pdf
HAS/2018-01-22_CEPP-5415_CONFORMABLE TAG 5415_occultations acceptées par HG le 15 12 2017.pdf
HAS/2018-01-22_CEPP-5489_CAIRFLOW PM100A EVO_09_janvier_2018_(5489)_avis.pdf
HAS/2018-01-22_CEPP-5503_XIENCE SIERRA_09_janvier_2018_(5503)_avis.pdf
HAS/2018-01-22_CEPP-5581_ZILVER PTX_09_janvier_2018_(5581)_avis.pdf
HAS/2018-01-22_CT-16617_DAPTOMYCINE_REDDY_QD_INS_Avis2_CT16617.pdf
HAS/2018-01-22_vertiges_positionnels_paroxystiques_benins_-_manoeuvres_diagnostiques_et_therapeutiques_-_argumentaire.pdf
HAS/2018-01-22_vertiges_positionnels_paroxystiques_benins_-_manoeuvres_diagnostiques_et_therapeutiques_-_recommandations.pdf
HAS/2018-01-22_vertiges_positionnels_paroxystiques_benins_-_manoeuvres_diagnostiques_et_therapeutiques_-_synthese.pdf
HAS/2018-01-24_CEPP-5396_ANACONDA FENETREE_7_novembre_2017_(5396)_avis.pdf
HAS/2018-01-25_CT-16118_ALECENSA_PIC_INS_Avis2_CT16118.pdf
HAS/2018-01-25_CT-16213_SUBUTEX_PIS_RI_Avis2_CT16213.pdf
HAS/2018-01-25_CT-16323_VITAMINE_B12_GERDA_PIS_RI_Avis1_CT16323.pdf
HAS/2018-01-25_CT-16379_PHOSPHONEUROS_PIS_RI_Avis2_CT16379.pdf
HAS/2018-01-25_CT-16383_PRIMPERAN_PIS_RI_Avis2_CT16383.pdf
HAS/2018-01-25_CT-16451_TEMGESIC_PIS_RI_Avis1_CT16451.pdf
HAS/2018-01-25_CT-16474_ERTAPENEM_PANPHARMA_QD_INS_Avis1_CT16474.pdf
HAS/2018-01-25_CT-16670_BENDAMUSTINE_REDDY_QD_INS_Avis2_CT16670.pdf
HAS/2018-01-25_CT-16711_CASPOFUNGINE_FRESENIUS_KABI_QD_INS_Avis2_CT16711.pdf
HAS/2018-01-25_accouchement_normal_-_argumentaire.pdf
HAS/2018-01-25_accouchement_normal_-_recommandations.pdf
HAS/2018-01-25_fiche_memo_nouveau_ne_v3.pdf
HAS/2018-01-25_fs_accouchement_v3.pdf
HAS/2018-01-25_initial_care_of_neonates_in_the_delivery_room_-_memo_sheet.pdf
HAS/2018-01-25_normal_childbirth_-_physiologic_labour_support_and_medical_procedures_-_summary_of_practice_guideline.pdf
HAS/2018-01-26_CT-15686_FEIBA_PIS_RCP_Avis2_CT15686.pdf
HAS/2018-01-26_CT-16285_ADOPORT_PIS_RI_Avis2_CT16285.pdf
HAS/2018-01-29_CT-16348_GASTROPULGITE_PIS_RI_Avis1_CT16348.pdf
HAS/2018-01-29_CT-16360_NORMACOL_LAVEMENT_PIS_RI_Avis2_CT16360.pdf
HAS/2018-01-29_CT-16647_BENDAMUSTINE_EG_QD_INS_Avis1_CT16647.pdf
HAS/2018-01-31_figure_1._profils_de_situations.pdf
HAS/2018-01-31_figure_2._vue_densemble_du_parcours.pdf
HAS/2018-01-31_guide_tsla_vf.pdf
HAS/2018-01-31_role_enseignant_vf.pdf
HAS/2018-01-31_role_medecin_enfant_vf.pdf
HAS/2018-01-31_signes_alerte_v2.pdf
HAS/2018-01-31_synthese_troubles_dys_v4.pdf
HAS/2018-02-01_CT-16113_HYQVIA_PIC_EI_Avis3_CT16113.pdf
HAS/2018-02-01_CT-16625_HEPARINE_CALCIQUE_PANPHARMA_25000_QD_EI_Avis1_CT16625.pdf
HAS/2018-02-01_CT-16708_PERINDOPRIL-INDAPAMIDE_ARROW_LAB_QD_INS_Avis1_CT16708.pdf
HAS/2018-02-01_CT-16709_PERINDOPRIL_ARROW_GENERIQUES_QD_INS_Avis1_CT16709.pdf
HAS/2018-02-01_hyqvia_summary_ct16113.pdf
HAS/2018-02-01_hyqvia_summary_ct16113bis.pdf
HAS/2018-02-01_hyqvia_synthese_ct16113.pdf
HAS/2018-02-01_hyqvia_synthese_ct16113bis.pdf
HAS/2018-02-01_pompes_a_insuline_23_janvier_2018_dm_eval_179_avis.pdf
HAS/2018-02-02_CT-15917_GLIBENESE_MINIDIAB_PIS_RI_Avis1_CT15917.pdf
HAS/2018-02-02_CT-16557_HEPARINE_CALCIQUE_PANPHARMA_25000_QD_INS_Avis2_CT16557&16630.pdf
HAS/2018-02-02_CT-16571_CEFOTAXIME_MYLAN_QD_INS_Avis1_CT16571.pdf
HAS/2018-02-02_CT-16667_CLARITYNE_QD_INS_Avis1_CT16667.pdf
HAS/2018-02-02_CT-16735_METHOTREXATE_ACCORD_25_100_QD_INS_Avis1_CT16735.pdf
HAS/2018-02-05_CEPP-5430_TREGOR - TREGOR PLUS_23_janvier_2018_(5430)_avis.pdf
HAS/2018-02-05_CEPP-5432_TREGOR MEDIAL CUP_23_janvier_2018_(5432)_avis.pdf
HAS/2018-02-05_CEPP-5501_NOVAE_23_janvier_2018_(5501)_avis.pdf
HAS/2018-02-05_CEPP-5502_NOVAE STICK_23_janvier_2018_(5502)_avis.pdf
HAS/2018-02-05_CEPP-5568_NOVALAC AMINA_23_janvier_2018_(5568)_avis.pdf
HAS/2018-02-05_CT-15240_NUTRIVISC_PIS_RI_Avis1_CT15240.pdf
HAS/2018-02-05_CT-15677_TRAVATAN_PIS_RI_Avis2_CT15677.pdf
HAS/2018-02-05_CT-15816_OZIDIA_PIS_RI_Avis2_CT15816.pdf
HAS/2018-02-05_CT-16694_NICORETTESKIN_QD_INS_Avis2_CT16694.pdf
HAS/2018-02-05_CT-16713_METHOTREXATE_ACCORD_50_QD_INS_Avis2_CT16713.pdf
HAS/2018-02-08_CEPP-5309_OMNIPORE STANDARD_23_janvier_2018_(5309)_avis.pdf
HAS/2018-02-08_CEPP-5404_FIXA DUPLEX_23_janvier_2018_(5404)_avis.pdf
HAS/2018-02-08_CEPP-5427_INTEGRA_19_décembre_2017_(5427)_occultations.pdf
HAS/2018-02-08_CEPP-5428_QUATTRO HAP_19_décembre_2017_(5428)_occultations.pdf
HAS/2018-02-08_CEPP-5429_QUATTRO CIM_19_décembre_2017_(5429)_occultations.pdf
HAS/2018-02-08_CEPP-5467_OMNIPORE SUR MESURE_23_janvier_2018_(5467)_avis.pdf
HAS/2018-02-08_cp_rbpp_mna.pdf
HAS/2018-02-08_d2017-44_-_adoption_rbpp_mna.pdf
HAS/2018-02-08_rbpp_mna_argumentaire.pdf
HAS/2018-02-08_rbpp_mna_web.pdf
HAS/2018-02-09_CEPP-5353_LIBERTY AC_23_janvier_2018_(5353)_avis.pdf
HAS/2018-02-09_CEPP-5354_LIBERTY SC-LIBERTY T_23_janvier_2018_(5354)_avis.pdf
HAS/2018-02-09_CEPP-5403_FIXA 3P DUPLEX_23_janvier_2018_(5403)_avis.pdf
HAS/2018-02-09_CEPP-5521_EDORA 8 DR-T_23_janvier_2018_(5521)_avis.pdf
HAS/2018-02-09_CEPP-5522_EDORA 8 SR-T_23_janvier_2018_(5522)_avis.pdf
HAS/2018-02-09_coumadine_pic_reev_avis3_ct16065.pdf
HAS/2018-02-09_eliquis_avis_ct1569916066.pdf
HAS/2018-02-09_lixiana_avis_ct15785.pdf
HAS/2018-02-09_pradaxa_13032018_avis_efficience.pdf
HAS/2018-02-09_pradaxa_avis_ct15697.pdf
HAS/2018-02-09_previscan_avis_ct16109.pdf
HAS/2018-02-09_rapport_reev_aco_cteval234.pdf
HAS/2018-02-09_rapport_reev_aco_cteval234_2018-02-09_15-38-37_999.pdf
HAS/2018-02-09_sintrom_minisintrom_avis_ct16069.pdf
HAS/2018-02-09_xarelto_avis_ct157101571215713.pdf
HAS/2018-02-13_CEPP-5450_ALBER VIAPLUS V12_06_février_2018_(5450)_avis.pdf
HAS/2018-02-13_CEPP-5587_RONDO 2_06_février_2018_(5587)_avis.pdf
HAS/2018-02-13_CEPP-5602_PONTO_06_février_2018_(5602)_avis.pdf
HAS/2018-02-14_CEPP-5034_RE-FLEX_09_janvier_2018_(5034)_avis.pdf
HAS/2018-02-14_CEPP-5405_FIXA_DUPLEX_23_janvier_2018_(5405)_avis.pdf
HAS/2018-02-14_CEPP-5473_ADES - ADES PLUS_06_février_2018_(5473)_avis.pdf
HAS/2018-02-14_CEPP-5478_ADES a cimenter_06_février_2018_(5478)_avis.pdf
HAS/2018-02-14_CEPP-5494_COLIBRI_06_février_2018_(5494)_avis.pdf
HAS/2018-02-14_gyros_23_janvier_2018_5495_avis_2018-02-14_12-38-48_108.pdf
HAS/2018-02-16_CT-15769_DYNEXAN_PIS_RI_Avis2_CT15769.pdf
HAS/2018-02-16_CT-15775_QUINIMAX_PIS_RI_Avis1_CT15775.pdf
HAS/2018-02-16_CT-15790_ROCEPHINE_PIS_RI_Avis1_CT15790.pdf
HAS/2018-02-16_CT-15890_BRISTOPEN_PIS_RI_Avis1_CT15890.pdf
HAS/2018-02-16_CT-16465_ZINBRYTA_PIS_RCP_Avis1_CT16465.pdf
HAS/2018-02-16_CT-16598_ORENCIA_PIS_EI_NON_DEMANDEE_Avis2_CT16598.pdf
HAS/2018-02-16_CT-16641_KEYTRUDA_PIS_EI_NON_DEMANDEE_Avis2_CT16641.pdf
HAS/2018-02-16_CT-16644_EDUCTYL_PIS_RI_Avis 1_CT16644.pdf
HAS/2018-02-16_CT-16666_ESOMEPRAZOLE_SUN_PHARMA_QD_INS_Avis1_CT16666.pdf
HAS/2018-02-16_CT-16672_ACIDE_FOLIQUE_CCD_0,4mg_PIS_RI_Avis1_CT16672.pdf
HAS/2018-02-16_CT-16720_PSYLIA PISRI_Avis 1_CT16720.pdf
HAS/2018-02-16_CT-16726_ACIDE_FOLIQUE_CCD_0.4mg_QD_INS_Avis2_CT16726.pdf
HAS/2018-02-16_CT-16730_TRH_FERRING_200_QD_INS_Avis2_CT16730.pdf
HAS/2018-02-16_CT-16737_ADRENALINE_AGUETTANT_QD_INS_Avis1_CT16737.pdf
HAS/2018-02-16_CT-16753_TAXOTERE_QD_EI_Avis1_CT16753.pdf
HAS/2018-02-16_CT-16777_OPTICRON_UNIDOSE_QD_INS_Avis1_CT16777.pdf
HAS/2018-02-16_CT-16778_CRINESAL_QD_INS_Avis1_CT16778.pdf
HAS/2018-02-16_CT-16800_TRAMADOL_ARROW_QD_INS_Avis1_CT16800.pdf
HAS/2018-02-19_CEPP-5400_LARYVOX FAHL_24_octobre_2017_(5400)_avis.pdf
HAS/2018-02-19_CEPP-5481_CARBOSEAL_23_janvier_2018_(5481)_avis.pdf
HAS/2018-02-19_CEPP-5507_CARBOSEAL VALSALVA_23_janvier_2018_(5507)_avis.pdf
HAS/2018-02-19_CT-15987_ATROVENT_PIS_RI_Avis1_CT15987.pdf
HAS/2018-02-19_CT-16440_KABIVEN_PERIKABIVEN_PIS_RI_Avis2_CT16440.pdf
HAS/2018-02-19_CT-16512_NALSCUE_PIC_INS_Avis3_CT16512.pdf
HAS/2018-02-19_CT-16618_SOFTACORT_PIS_INS_Avis2_CT16618.pdf
HAS/2018-02-19_CT-16671_CERIS_PIS_RI_Avis2_CT16671.pdf
HAS/2018-02-19_CT-16733_MITOMYCINE_ACCORD_QD_INS_Avis1_CT16733.pdf
HAS/2018-02-19_CT-16734_BLEOMYCINE_ACCORD_QD_INS_Avis1_CT16734.pdf
HAS/2018-02-19_CT-16769_ATROVENT_NASAL_PIS_RI_Avis2_CT16769.pdf
HAS/2018-02-19_avis_des_parties_prenantes_tsa.pdf
HAS/2018-02-19_cpg_asd_diagnostic_assessment_child_teenager_2018.pdf
HAS/2018-02-19_trouble_du_spectre_de_lautisme_de_lenfant_et_ladolescent_-_argumentaire.pdf
HAS/2018-02-19_trouble_du_spectre_de_lautisme_de_lenfant_et_ladolescent__recommandations.pdf
HAS/2018-02-19_tsa_-_annonce_du_diagnostic_et_information_des_familles_-_synthese.pdf
HAS/2018-02-19_tsa_-_des_signes_dalerte_a_la_consultation_dediee_en_soins_primaires_1er_ligne_-_synthese.pdf
HAS/2018-02-19_tsa_-_diagnostic_et_evaluation_chez_lenfant_et_ladolescent_2e_ligne_-_synthese.pdf
HAS/2018-02-20_annexe_2_fiche_de_recueil_des_informations_par_source_pour_concilier.pdf
HAS/2018-02-20_annexe_3_guide_dentretien_du_patient_a_ladmission_en_etablissement_de_sante_pour_lobtention.pdf
HAS/2018-02-20_annexe_4_fiche_de_conciliation_des_traitements_a_ladmission_fct.pdf
HAS/2018-02-20_evaluation_de_l_implementation_ctm.pdf
HAS/2018-02-20_exemple_daffiche_high_5s_soyez_acteur_de_votre_sante.pdf
HAS/2018-02-20_exemple_de_courrier_de_conciliation__des_traitements_medicamenteux_de_sortie.pdf
HAS/2018-02-20_exemple_de_fiche_de_liaison_du_traitement_personnel_du_patient_avant_consultation_danesthesie.pdf
HAS/2018-02-20_exemple_de_fiche_dinformation_patient.pdf
HAS/2018-02-20_exemple_de_plan_de_posologie_des_medicaments_en_sortie_dhopsitalisation_omedit_aquitaine.pdf
HAS/2018-02-20_exemple_de_support_de_formation_a_la_conciliation.pdf
HAS/2018-02-20_guide_conciliation_des_traitements_medicamenteux_en_etablissement_de_sante.pdf
HAS/2018-02-20_rapport_dexperimentation_sur_la_mise_en_oeuvre_conciliation_des_traitements_medicamenteux_par_9_es.pdf
HAS/2018-02-20_tableau_des_4_sequences_de_la_ctm.pdf
HAS/2018-02-20_volet_medicamenteux_de_la_lettre_de_liaison_a_la_sortie.pdf
HAS/2018-02-21_CT-15611_DIPENTUM_PIS_RI_Avis2_CT15611.pdf
HAS/2018-02-21_CT-16692_GLYCEROL-VASELINE-PARAFFINE_TEVA_QD_INS_Avis2_CT16692.pdf
HAS/2018-02-21_feuille_de_route_stents_coronaires.pdf
HAS/2018-02-21_risques_ischemiques_et_hemorragiques_lies_aux_gammes_dendoprotheses_stents_coronaires_en_france_2018-02-21_11-01-10_880.pdf
HAS/2018-02-21_syndrome_dondine_-_argumentaire.pdf
HAS/2018-02-21_syndrome_dondine_-_pnds.pdf
HAS/2018-02-21_synthese_mg_syndrome_d_ondine.pdf
HAS/2018-03-05_CEPP-5597_POWERLINK AFX_20_février_2018_(5597)_avis.pdf
HAS/2018-03-05_CT-15431_THEOSTAT_LP_PIS_RI_Avis1_CT15431.pdf
HAS/2018-03-05_CT-16340_COLOFOAM_PIS_RI_Avis2_CT16340.pdf
HAS/2018-03-05_CT-16341_ANAUSIN_METOCLOPRAMIDE_PIS_RI_Avis2_CT16341.pdf
HAS/2018-03-05_CT-16349_SMECTA_OrangeVanille_PIS_RI_Avis2_CT16349.pdf
HAS/2018-03-05_CT-16569_SMOFKABIVEN_PROTEINE_QD_INS_Avis2_CT16569.pdf
HAS/2018-03-05_CT-16623_BETESIL_PIS_RI_Avis1_CT16623.pdf
HAS/2018-03-05_CT-16746_TERLIPRESSINE_SUN_QD_INS_Avis1_CT16746.pdf
HAS/2018-03-05_CT-16747_ENANTONE_LP_QD_INS_Avis2_CT16747.pdf
HAS/2018-03-05_CT-16794_CHLORURE_DE_SODIUM_FRESENIUS_QD_INS_Avis1_CT16794.pdf
HAS/2018-03-05_CT-16799_CLOFARABINE_MYLAN_QD_INS_Avis1_CT16799.pdf
HAS/2018-03-06_CEPP-5378_ELITE_06_février_2018_(5378)_avis.pdf
HAS/2018-03-06_CEPP-5422_HAPPYVISC_20_février_2018_(5422)_avis.pdf
HAS/2018-03-06_CT-16220_ILARIS_PIC_EI_Avis3_CT16220.pdf
HAS/2018-03-06_fiche_pertinence_chirurgie_pediatrique.pdf
HAS/2018-03-06_fs_allergie_immuno.pdf
HAS/2018-03-06_grand_appareillage_orthopedique_20_fevrier_2018_dm_eval_180_avis.pdf
HAS/2018-03-06_ilaris_12122017_avis_efficience_2020-02-24_12-38-1_104.pdf
HAS/2018-03-06_ilaris_summary_ct16220.pdf
HAS/2018-03-06_ilaris_synthese_ct16220.pdf
HAS/2018-03-06_rapport_fiche_pertinence_allergologie-immunologie.pdf
HAS/2018-03-06_rapport_fiche_pertinence_chirurgie_pediatrique.pdf
HAS/2018-03-08_CEPP-5030_VARI-FLEX MODULAR_20_février_2018_(5030)_avis.pdf
HAS/2018-03-08_CEPP-5035_VARI-FLEX_20_février_2018_(5035)_avis.pdf
HAS/2018-03-08_CEPP-5476_THERASPHERE_20_février_2018_(5476)_avis.pdf
HAS/2018-03-08_CEPP-5493_SERENITY_06_mars_2018_(5493)_avis.pdf
HAS/2018-03-08_therasphere_fiche_dinformation_therapeutique.pdf
HAS/2018-03-09_CEPP-5560_2M_20_février_2018_(5560)_avis.pdf
HAS/2018-03-09_CEPP-5583_VARI FLEX XC_06_février_2018_(5583)_avis.pdf
HAS/2018-03-09_CEPP-5604_SURE-FLEX et FLEX-WALK_06_février_2018_(5604)_avis.pdf
HAS/2018-03-09_CT-16422_GUTRON_2,5mg_PIS_RI_Avis1_CT16422.pdf
HAS/2018-03-09_CT-16680_DIVARIUS_PIS_RI_Avis2_CT16680.pdf
HAS/2018-03-09_CT-16690_KALETRA_Sol_buv_PIS_EI_pédiatrie_moins_de_2ans_Avis2_CT16690.pdf
HAS/2018-03-12_CEPP-5399_AXTAIR ONE_06_février_2018_(5399)_avis.pdf
HAS/2018-03-12_CEPP-5402_AXTAIR ONE PLUS_06_février_2018_(5402)_avis.pdf
HAS/2018-03-12_CEPP-5485_INOGEN ONE G4_20_février_2018_(5485)_avis.pdf
HAS/2018-03-12_CEPP-5520_ULTIMASTER_06_février_2018_(5520)_avis.pdf
HAS/2018-03-12_CEPP-5592_HYLOVIS MULTI_23_janvier_2018_(5592)_avis.pdf
HAS/2018-03-12_CEPP-5595_VISMED MULTI_23_janvier_2018_(5595)_avis.pdf
HAS/2018-03-12_CEPP-5608_THEALOSE UD_20_février_2018_(5608)_avis.pdf
HAS/2018-03-12_CT-15415_EUPHYLLINE_L.A._PIS_RI_Avis1_CT15415.pdf
HAS/2018-03-12_CT-16043_LUCENTIS_PIC_EI_Avis3_CT16043.pdf
HAS/2018-03-12_CT-16106_TICARPEN_PIS_RI_Avis1_CT16106.pdf
HAS/2018-03-12_CT-16325_DAONIL_HEMI-DAONIL_PIS_RI_Avis2_CT16325.pdf
HAS/2018-03-12_CT-16373_PROPYLEX_PIS_RI_Avis1_CT16373.pdf
HAS/2018-03-12_CT-16378_VITAMINE_D3_BON_PIS_RI_Avis1_CT16378.pdf
HAS/2018-03-12_CT-16439_SKUDEXUM_PIC_REEV_Avis3_CT16439.pdf
HAS/2018-03-12_CT-16556_STAGID_PIS_RI_Avis2_CT16556.pdf
HAS/2018-03-12_CT-16575_IMODIUM_ENFANTS_QD_INS_Avis1_CT16575.pdf
HAS/2018-03-12_CT-16589_XYBILUN_QD_INS_Avis1_CT16589.pdf
HAS/2018-03-12_CT-16616_KETAMINE_RENAUDIN_QD_INS_Avis1_CT16616.pdf
HAS/2018-03-12_CT-16791_MOBIC_QD_INS_Avis2_CT16791.pdf
HAS/2018-03-12_CT-16792_RISPERIDONE_ARROW_QD_INS_Avis2_CT16792.pdf
HAS/2018-03-12_CT-16823_SILDENAFIL_EG_QD_INS_Avis1_CT16823.pdf
HAS/2018-03-13_has_methode_generale_actes_08_03_2018.pdf
HAS/2018-03-13_has_procedure_evaluation_rapide_actes_v1.pdf
HAS/2018-03-13_has_rdv_predepot_actes.pdf
HAS/2018-03-16_CEPP-5548_CORIN à cimenter_06_mars_2018_(5548)_avis.pdf
HAS/2018-03-16_CEPP-5549_CORIN sans ciment_06_mars_2018_(5549)_avis.pdf
HAS/2018-03-16_CEPP-5571_BIS DUAL MOBILITY_06_mars_2018_(5571)_avis.pdf
HAS/2018-03-16_CEPP-5578_BAHA 5 SUPER POWER_06_mars_2018_(5578)_avis.pdf
HAS/2018-03-16_CT-16739_ATROPINE_ALCON_QD_INS_Avis3_CT16739.pdf
HAS/2018-03-16_CT-16786_MEDNUTRIFLEX_OMEGA_E_QD_INS_Avis2_CT16786.pdf
HAS/2018-03-16_CT-16787_REANUTRIFLEX_OMEGA_QD_INS_Avis2_CT16787.pdf
HAS/2018-03-16_CT-16790_PERINUTRIFLEX_OMEGA_E_QD_INS_Avis2_CT16790.pdf
HAS/2018-03-16_CT-16835_LINEZOLIDE_FRESENIUS_KABI_QD_INS_Avis1_CT16835.pdf
HAS/2018-03-16_app_194_rapport_elaboration_cardiologie__coi_2018_02_22_vfinale.pdf
HAS/2018-03-16_fs_cardio_insuff_cardiaque_v3.pdf
HAS/2018-03-16_fs_cardio_maladie_coronarienne_v3.pdf
HAS/2018-03-16_fs_cardio_troubles_rythmes_v3.pdf
HAS/2018-03-16_fs_cardio_valvulopathie_v3.pdf
HAS/2018-03-19_CT-14448_PRIALT_PIC_REEV_Avis1_CT14448.pdf
HAS/2018-03-19_CT-15328_DILATRANE_TEDRALAN_PIS_RI_Avis1_CT15328.pdf
HAS/2018-03-19_CT-16444_SKUDEXUM_QD_INS_Avis1_CT16444.pdf
HAS/2018-03-19_CT-16478_TADIM_PIS_REEV_Avis2_CT16478.pdf
HAS/2018-03-19_CT-16531_AETOXISCLEROL_PIS_RI_Avis1_CT16531.pdf
HAS/2018-03-19_CT-16774_CEFOXITINE_PANPHARMA_QD_INS_Avis1_CT16774.pdf
HAS/2018-03-19_CT-16789_REANUTRIFLEX_OMEGA_E_QD_INS_Avis2_CT16789.pdf
HAS/2018-03-19_CT-16793_TERLIPRESSINE_REDDY_QD_INS_Avis2_CT16793.pdf
HAS/2018-03-19_CT-16802_HUMIRA_QD_INS_Avis2_CT16802.pdf
HAS/2018-03-19_CT-16809_L-THYROXIN_HENNING_PIS_INS_Avis2_CT16809.pdf
HAS/2018-03-19_pnds_syndrome_de_marfan_et_apparente_mars_2018_def.pdf
HAS/2018-03-19_skudexum_sapub_ct16439.pdf
HAS/2018-03-19_skudexum_summary_ct16439.pdf
HAS/2018-03-19_synthese_mg_syndrome_de_marfan_et_apparentes.pdf
HAS/2018-03-23_CEPP-5447_SEQUENT PLEASE OTW_20_février_2018_(5447)_occultation.pdf
HAS/2018-03-26_20180213_argumentaire_autisme_adulte_vdef.pdf
HAS/2018-03-26_20180213_recommandations_vdef.pdf
HAS/2018-03-26_CEPP-5492_ZENITH TX2 et ZENITH PRO-FORM TX2_06_mars_2018_(5492)_occultation.pdf
HAS/2018-03-26_autisme_adulte_guide_appropriation_fevrier_2018.pdf
HAS/2018-03-26_coordination_presentation_ppt.pdf
HAS/2018-03-26_coordination_synthese_et_outils.pdf
HAS/2018-03-26_cp_pratiques_de_cooperation.pdf
HAS/2018-03-26_decision_rbpp_pratiques_de_cooperation.pdf
HAS/2018-03-26_web_rbpp_coordination.pdf
HAS/2018-03-28_CT-16541_BUSULFAN_MYLAN_QD_INS_Avis2_CT16541.pdf
HAS/2018-03-29_CT-14653_POLYGYNAX_PIC_REEV_RI_Avis3_CT13070&14653.pdf
HAS/2018-03-29_CT-14767_TERGYNAN_PIC_REEV_RI_Avis3_CT13192&14767.pdf
HAS/2018-03-29_CT-15132_YERVOY_PIC_REEV_Avis3_CT15132&15764.pdf
HAS/2018-03-29_CT-15701_ADCETRIS_PIC_EI_Avis3_modifiele09052017_CT15701.pdf
HAS/2018-03-29_CT-15867_GARDASIL_9_PIC_INS_Avis3_CT15867.pdf
HAS/2018-03-29_CT-16034_BETMIGA_PIC_REEV_Avis1_CT16034.pdf
HAS/2018-03-29_CT-16045_CYSTADROPS_PIC_INS_Avis3_CT16045.pdf
HAS/2018-03-29_CT-16132_ULTIBRO_BREEZHALER_PIC_REEV_Avis3_CT16132.pdf
HAS/2018-03-29_CT-16287_CINRYZE_PIC_EI_Avis2_CT16287.pdf
HAS/2018-03-29_CT-16367_DINUTUXIMAB_BETA_EUSA_PIC_INS_Avis3_CT16367.pdf
HAS/2018-03-29_CT-16456_OXERVATE_PIC_INS_Avis3_CT16456.pdf
HAS/2018-03-29_CT-16477_XULTOPHY_PIC_REEV_Avis2_CT16477.pdf
HAS/2018-03-29_CT-16483_ENTYVIO_PIC_REEV_Avis2_CT16483.pdf
HAS/2018-03-29_CT-16502_CLAIRYG_PIC_EI_Avis1_CT16502.pdf
HAS/2018-03-29_CT-16570_KOVALTRY_QD_INS_Avis1_CT16570.pdf
HAS/2018-03-29_adcetris_summary_ct15701.pdf
HAS/2018-03-29_adcetris_synthese_ct15701.pdf
HAS/2018-03-29_betmiga_summary_ct16034.pdf
HAS/2018-03-29_betmiga_synthese_ct16034.pdf
HAS/2018-03-29_cinryze_summary_ct16287.pdf
HAS/2018-03-29_cinryze_synthese_ct16287.pdf
HAS/2018-03-29_clairyg_summary_ct16502.pdf
HAS/2018-03-29_clairyg_synthese_ct16502.pdf
HAS/2018-03-29_cystadrops_summary_ct16045.pdf
HAS/2018-03-29_cystadrops_synthese_ct16045.pdf
HAS/2018-03-29_dc_2017_0070_impact_significatif_eco_effi_gardasil9_cd_2017_05_31_vd.pdf
HAS/2018-03-29_dinutuximab_summary_ct16367.pdf
HAS/2018-03-29_dinutuximab_synthese_ct16367.pdf
HAS/2018-03-29_entyvio_summary_ct16483.pdf
HAS/2018-03-29_entyvio_synthese_ctct16483.pdf
HAS/2018-03-29_gardasil9_12092017_avis_efficience.pdf
HAS/2018-03-29_gardasil9_summary_ct15867.pdf
HAS/2018-03-29_gardasil9_synthese_ct15867.pdf
HAS/2018-03-29_kovaltry_summary_ct15274.pdf
HAS/2018-03-29_kovaltry_synthese_ct15274.pdf
HAS/2018-03-29_oxervate_summary_ct16456.pdf
HAS/2018-03-29_oxervate_synthese_ct16456.pdf
HAS/2018-03-29_polygynax_tergynan_summary_ct13070_15653_14767.pdf
HAS/2018-03-29_polygynax_tergynan_summary_ct13070_15653_14767_2019-01-17_15-50-58_428.pdf
HAS/2018-03-29_polygynax_tergynan_synthese_ct13070_15653_14767.pdf
HAS/2018-03-29_ultibro_breezhaler_summary_ct16132.pdf
HAS/2018-03-29_ultibro_breezhaler_synthese_ct16132.pdf
HAS/2018-03-29_xultophy_summary_ct16477.pdf
HAS/2018-03-29_xultophy_synthese_ct16477.pdf
HAS/2018-03-29_yervoy_13092016_avis_efficience.pdf
HAS/2018-03-29_yervoy_summary_ct15132_15764.pdf
HAS/2018-03-29_yervoy_synthese_ct15132_15764.pdf
HAS/2018-03-30_CT-15440_OTIPAX_PIS_RI_Avis2_CT15440.pdf
HAS/2018-03-30_CT-15582_GLUCOR_PIS_RI_Avis1_CT15582.pdf
HAS/2018-03-30_CT-16415_NOYADA_PIC_INS_Avis2_CT16415.pdf
HAS/2018-03-30_CT-16628_DECAPEPTYL_LP_225_PIS_EI_Avis2_CT16628.pdf
HAS/2018-03-30_CT-16698_FLUARIXTETRA_QD_INS_Avis2_CT16698.pdf
HAS/2018-03-30_CT-16725_ACIDE_TRANEXAMIQUE_AGUETTANT_QD_INS_Avis2_CT16725.pdf
HAS/2018-03-30_CT-16816_TIGECYCLINE_MYLAN_QD_INS_Avis1_CT16816.pdf
HAS/2018-03-30_CT-16817_HEPARINE_CHOAY_QD_INS_Avis2_CT16817.pdf
HAS/2018-03-30_CT-16844_BOSENTAN_OHRE_PHARMA_QD_INS_Avis1_CT16844.pdf
HAS/2018-03-30_CT-16849_CASPOFUNGINE_TEVA_SANTE_QD_INS_Avis1_CT16849.pdf
HAS/2018-03-30_CT-16852_LINEZOLIDE_B_BRAUN_QD_INS_Avis2_CT16852.pdf
HAS/2018-03-30_CT-16877_SILDENAFIL_OHRE_PHARMA_QD_INS_Avis1_CT16877.pdf
HAS/2018-03-30_noyada_sapub_ct16415.pdf
HAS/2018-03-30_noyada_summary_ct16415.pdf
HAS/2018-04-02_decision_no_2016-09_-_decision_portant_adoption_de_l_outil_de_reperage_des_risques_de_perte_d_autonomie_-_domicile.pdf
HAS/2018-04-02_fiche-notice_outil_reperage_perte_autonomie.pdf
HAS/2018-04-02_fiche-outil_reperage_perte_autonomie.pdf
HAS/2018-04-03_CT-16597_SIGNIFOR_PIS_EI_INS_Avis3_CT16597&16603.pdf
HAS/2018-04-03_preset.pdf
HAS/2018-04-03_preset_lite.pdf
HAS/2018-04-04_ald_31_pnds_sjs_lyell_web.pdf
HAS/2018-04-04_pnds_19_-_sclerodermie_systemique_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2018-04-04_pnds_32_-_necrolyse_epidermique_toxique_syndromes_de_stevens-johnson_et_de_lyell_-_synthese_a_destination_du_medecin_traitan.pdf
HAS/2018-04-04_pnds__sclerodermie_web.pdf
HAS/2018-04-05_CEPP-5472_SYMBOL CUP DM CEM_20_mars_2018_(5472)_avis.pdf
HAS/2018-04-05_CEPP-5474_SYMBOL CUP DM HA et DMR HA_20_mars_2018_(5474)_avis.pdf
HAS/2018-04-05_CEPP-5477_DS EVOLUTION_20_mars_2018_(5477)_avis.pdf
HAS/2018-04-05_CEPP-5479_DS EVOLUTION_20_mars_2018_(5479)_avis.pdf
HAS/2018-04-05_CEPP-5528_GYRACUP E CEM_20_mars_2018_(5528)_avis.pdf
HAS/2018-04-05_CEPP-5529_GYRACUP E_20_mars_2018_(5529)_avis.pdf
HAS/2018-04-05_CEPP-5605_AQUA FOOT_20_mars_2018_(5605)_avis.pdf
HAS/2018-04-05_CT-15729_CALCIPRAT_PIS_RI_Avis2_CT15729.pdf
HAS/2018-04-06_brochure_projet_des_usagers.pdf
HAS/2018-04-06_elaborer_une_aide_a_la_prise_de_decision_partagee_mel.pdf
HAS/2018-04-09_CT-16655_NORFLOXACINE_PIS_REEV_Avis3.pdf
HAS/2018-04-09_CT-16727_CERTICAN_QD_INS_Avis1_CT16727.pdf
HAS/2018-04-12_CEPP-5628_PRIMEADVANCED - RESTOREADVANCED - RESTOREULTRA - RESTOREULTRA SURESCAN MRI_20_mars_2018_(5628)_avis.pdf
HAS/2018-04-12_CEPP-5631_HEIMOMED_03_avril_2018_(5631)_avis.pdf
HAS/2018-04-12_CT-15788_RADIOGARDASE_PIC_INS_Avis2_CT15788.pdf
HAS/2018-04-12_CT-15989_QUTENZA_PIC_EI_Avis2_ CT15989.pdf
HAS/2018-04-12_CT-15996_TAGRISSO_PIC_REEV_Avis3_CT15996.pdf
HAS/2018-04-12_CT-16185_UPTRAVI_PIC_INS_Avis3_CT16185.pdf
HAS/2018-04-12_CT-16248_HYDROCORTANCYL_PIC_REEV_Avis2_CT16248.pdf
HAS/2018-04-12_CT-16322_ISOCARD_PIS_RI_Avis1_CT16322.pdf
HAS/2018-04-12_CT-16337_VAXIGRIPTETRA_PIC_INS_Avis2_CT16337.pdf
HAS/2018-04-12_CT-16468_KEVZARA_PIC_INS_Avis2_CT16468.pdf
HAS/2018-04-12_CT-16706_EXJADE_90_180_360_QD_INS_Avis1_CT16706.pdf
HAS/2018-04-12_CT-16842_SILDENAFIL_ARROW_QD_INS_Avis1_CT16842.pdf
HAS/2018-04-12_hydrocortancyl_summary_ct16248.pdf
HAS/2018-04-12_hydrocortancyl_synthese_ct16248.pdf
HAS/2018-04-12_kevzara_summary_ct16468.pdf
HAS/2018-04-12_kevzara_syntehse_ct16468.pdf
HAS/2018-04-12_qutenza_summary_ct15989.pdf
HAS/2018-04-12_qutenza_synthese_ct15989.pdf
HAS/2018-04-12_radiogardase_summary_ct15788.pdf
HAS/2018-04-12_radiogardase_synthese_ct15788.pdf
HAS/2018-04-12_tagrisso_12092017_avis_efficicience.pdf
HAS/2018-04-12_tagrisso_summary_ct15996.pdf
HAS/2018-04-12_tagrisso_synthese_ct15996.pdf
HAS/2018-04-12_uptravi_summary_ct16185.pdf
HAS/2018-04-12_uptravi_synthese_ct16185.pdf
HAS/2018-04-12_vaxigriptetra_summary_ct16337.pdf
HAS/2018-04-12_vaxigriptetra_synthese_ct16337.pdf
HAS/2018-04-13_CEPP-5533_PROFEMUR R_03_avril_2018_(5533)_avis.pdf
HAS/2018-04-13_CEPP-5537_PROFEMUR Z_03_avril_2018_(5537)_avis.pdf
HAS/2018-04-13_CEPP-5545_PROFEMUR AM_03_avril_2018_(5545)_avis.pdf
HAS/2018-04-13_CEPP-5573_OPTIMUM_20_mars_2018_(5573)_avis.pdf
HAS/2018-04-13_CEPP-5574_PARVUM_20_mars_2018_(5574)_avis.pdf
HAS/2018-04-13_CEPP-5598_LOFRIC_20_mars_2018_(5598)_avis.pdf
HAS/2018-04-13_CEPP-5634_MOBILITY sans ciment_03_avril_2018_(5634)_avis.pdf
HAS/2018-04-13_CEPP-5635_MOBILITY à cimenter_03_avril_2018_(5635)_avis.pdf
HAS/2018-04-13_CEPP-5636_XCUP MOB_03_avril_2018_(5636)_avis.pdf
HAS/2018-04-13_fiche_memo_-_aide_a_la_redaction_des_certificats_et_avis_medicaux_dans_le_cadre_des_soins_psychiatriques_sans_consente.pdf
HAS/2018-04-13_rapport_delaboration_-_aide_a_la_redaction_des_certificats_et_avis_medicaux_dans_le_cadre_des_soins_psychiatriques_sans_cons.pdf
HAS/2018-04-13_recommandation___vaccination_contre_la_rougeole_avant_lage_de_12_mois_suite_a_larret_de_commercialisation_du_vaccin_monovale.pdf
HAS/2018-04-16_CT-16526_WELLVONE_PIS_RI_Avis2_CT16526.pdf
HAS/2018-04-16_argumentaire_filarioses.pdf
HAS/2018-04-16_inahta_brief_filariasis.pdf
HAS/2018-04-19_recommandation_vaccinale_place_de_synflorix_dans_la_strategie_vaccinale_contre_les_infections_a_pneumocoques_chez_lenfant_ag.pdf
HAS/2018-04-19_summary_english_synflorix_022018.pdf
HAS/2018-04-19_synthese_place_de_synflorix_dans_la_strategie_vaccinale_contre_les_infections_a_pneumocoques_chez_lenfant_age_de_moins_de_5_.pdf
HAS/2018-04-20_fiche_memo_qualite_et_securite_des_actes_de_teleconsultation_et_de_teleexpertise_avril_2018_2018-04-20_11-05-33_441.pdf
HAS/2018-04-20_points-cle_solution_-_pertience_cholecystectomie.pdf
HAS/2018-04-20_points-cle_solution_-_problematique_cholecystectomie.pdf
HAS/2018-04-20_points-cle_solution_-_qd_faire_cholecystectomie.pdf
HAS/2018-04-20_rapport_delaboration_de_la_fiche_memo_teleconsultation_teleexpertise_avril_2018_2018-04-20_11-04-50_363.pdf
HAS/2018-04-27_CEPP-5593_MELODY ENSEMBLE_17_avril_2018_(5593)_avis.pdf
HAS/2018-04-27_CEPP-5594_ONYX-LES_17_avril_2018_(5594)_avis_occultation.pdf
HAS/2018-04-27_CEPP-5599_MELODY ENSEMBLE II_17_avril_2018_(5599)_avis.pdf
HAS/2018-04-27_precision_montage_mri.pdf
HAS/2018-04-27_precision_spectra.pdf
HAS/2018-05-02_CT-15818_BARACLUDE_PIS_RI_Avis1_CT15818.pdf
HAS/2018-05-02_CT-15889_RIFADINE_PIS_RI_Avis2_CT15889.pdf
HAS/2018-05-02_CT-16181_PRIORIX_PIS_RI_Avis2_CT16181.pdf
HAS/2018-05-02_CT-16369_ARTISIAL_PIS_RI_Avis1_CT16369.pdf
HAS/2018-05-02_CT-16536_CAYSTON_PIS_RI_Avis2_CT16536.pdf
HAS/2018-05-02_CT-16831_NICOPATCHLIB_QD_INS_Avis2_CT16831.pdf
HAS/2018-05-02_CT-16874_OXYTOCINE_EVER_PHARMA_QD_INS_Avis1_CT16874.pdf
HAS/2018-05-04_CT-15458_OTOFA_PIS_RI_Avis2_CT15458.pdf
HAS/2018-05-04_CT-15567_NEURONTIN_PIS_AVIS2_CT15567.pdf
HAS/2018-05-04_CT-15814_RELPAX_PIS_RI_AVIS2_CT15814.pdf
HAS/2018-05-04_CT-15841_AUGMENTIN 1 g200 mg_QD_INS_AVIS1_CT15841.pdf
HAS/2018-05-04_CT-15922_CLINIMIX_PIS_RI_AVIS2_CT15922.pdf
HAS/2018-05-04_CT-15962_KOMBOGLYZE_PIS_RI_Avis2_CT15962.pdf
HAS/2018-05-04_CT-16013_CHOLURSO_PIS_RI_AVIS1_CT16013.pdf
HAS/2018-05-04_CT-16202_CALTRATE VIT D3_PISRI_AVIS2_CT16202.pdf
HAS/2018-05-04_CT-16204_CALTRATE 600mg_PISRI_AVIS2_CT16204.pdf
HAS/2018-05-04_CT-16324_QUESTRAN_PIS_RI_AVIS2_CT16324.pdf
HAS/2018-05-04_CT-16455_GAZYVARO_PIC_EI_Avis3_CT14555.pdf
HAS/2018-05-04_CT-16595_PYLERA_PIS_RI_Avis2_CT16595.pdf
HAS/2018-05-04_CT-16768_DECAPEPTYL_LP_QD_RCP_Avis2_CT16768.pdf
HAS/2018-05-04_CT-16857_ONCASPAR_poudre_QD_INS_Avis2_CT16857.pdf
HAS/2018-05-04_CT-16900_CYSTADROPS_QD_INS_AVIS1_CT16900.pdf
HAS/2018-05-04_CT-16910_NICOPASS MENTHE CITRON SS SUCRE_QD_INS_AVIS2_CT16910.pdf
HAS/2018-05-04_CT-16913_CEFEPIME GERDA_Insc_AVIS1_CT16913.pdf
HAS/2018-05-07_CT-15632_ZOVIRAX_PISRI_Avis 1_CT15632.pdf
HAS/2018-05-07_CT-16838_COLCHICINE_PIS_EI_NON_DEMANDEE_AVIS1_CT16838.pdf
HAS/2018-05-07_CT-16962_COLCHIMAX_PIS_EI_NON_DEMANDEE_AVIS1_CT16962.pdf
HAS/2018-05-07_transilane_pisri_avis1_ct14679.pdf
HAS/2018-05-09_CT-15807_JETREA_PIC_REEV_Avis3_CT15807.pdf
HAS/2018-05-09_CT-16732_BENLYSTA_200mg_SC_PIS_INS_Avis2_CT16732.pdf
HAS/2018-05-09_CT-16883_LANTUS_TOUJEO_PIS_RI_AVIS2_CT16883.pdf
HAS/2018-05-09_jetrea_synthese_ct15807.pdf
HAS/2018-05-14_hypophosphatemies_hereditaires_a_fgf23_eleve_dont_hypophosphatemies_liees_a_lx_-_pnds.pdf
HAS/2018-05-14_synthese_mg_hypophosphatemies_hereditaires_a_fgf23_eleve.pdf
HAS/2018-05-15_recommandations_rattrapage_vaccinal_mayotte_mars_2018_2018-05-14_15-34-27_506.pdf
HAS/2018-05-15_recommandations_vaccination_coqueluche_femme_enceinte_mayotte_mars2018_2018-05-15_11-36-37_267.pdf
HAS/2018-05-16_CEPP-5615_ROSIDAL SYS_03_avril_2018_(5615)_avis.pdf
HAS/2018-05-16_CT-16749_SEVOFLURANE_BAXTER_QD_INS_Avis1_CT16749.pdf
HAS/2018-05-17_CEPP-5487_A2T_15_mai_2018_(5487)_avis.pdf
HAS/2018-05-17_CEPP-5508_OSTENIL PLUS_17_avril_2018_(5508)_avis.pdf
HAS/2018-05-17_CEPP-5514_XLMOB sans ciment_15_mai_2018_(5514)_avis.pdf
HAS/2018-05-17_CEPP-5515_XLMOB à cimenter_15_mai_2018_(5515)_avis.pdf
HAS/2018-05-17_CEPP-5539_EVORA - EVORA SP - EVORA LIS - EVORA GRIP - EVORA GRIP 3P_03_avril_2018_(5539)_avis.pdf
HAS/2018-05-17_CEPP-5546_STRATOS_03_avril_2018_(5546)_avis.pdf
HAS/2018-05-18_CEPP-5423_TADIMDILUANT 3ML_17_avril_2018_(5423)_avis.pdf
HAS/2018-05-18_CEPP-5603_TADIMDILUANT 1ML_17_avril_2018_(5603)_avis.pdf
HAS/2018-05-18_CEPP-5621_PROCLAIM DRG_17_avril_2018_(5621)_avis_occultation.pdf
HAS/2018-05-23_CEPP-5408_SOFTFORM PREMIER_15_mai_2018_(5408)_avis.pdf
HAS/2018-05-23_CEPP-5586_DEFLUX_03_avril_2018_(5586)_avis.pdf
HAS/2018-05-23_CEPP-5626_COMET ULTRA_03_avril_2018_(5626)_avis.pdf
HAS/2018-05-23_avis_du_15_mai_2018_endoprotheses_coronaires_couvertes__stents_couvertes_de_ptfe.pdf
HAS/2018-05-23_avis_du_15_mai_2018_endoprotheses_coronaires_metalliques_nues_non_resorbables__stents_nus.pdf
HAS/2018-05-23_feuille_de_route_stents_coronaires.pdf
HAS/2018-05-23_rapports_devaluation_endoprotheses_stents_coronaires_2018-05-18_16-37-11_73.pdf
HAS/2018-05-23_utilisation_des_endoprotheses-stents-coronaires_en_france_en_2014_etude_a_partir_des_donnees_du_sniiram.pdf
HAS/2018-05-25_CT-16342_ELMIRON_PIC_INS_Avis3_CT16342.pdf
HAS/2018-05-25_CT-16361_EPREX_PIC_EI_SMD_Avis3_CT16361.pdf
HAS/2018-05-25_CT-16544_INFLUVAC_TETRA_PIC_INS_Avis2_CT16544.pdf
HAS/2018-05-25_app_180_synthese_alzheimer_vf.pdf
HAS/2018-05-25_aricept_eisai_recours_r163-13_ct16767.pdf
HAS/2018-05-25_donepezil_biogaran_recours_r163-13_ct16755.pdf
HAS/2018-05-25_ebixa_recours_r163-13_ct16754_audition.pdf
HAS/2018-05-25_elmiron_sapub_ct16342.pdf
HAS/2018-05-25_elmiron_summary_ct16342.pdf
HAS/2018-05-25_eprex_smd_sapub_ct16361.pdf
HAS/2018-05-25_eprex_smd_summary_ct16361.pdf
HAS/2018-05-25_exelon_novartis_recours_r163-13_ct16759.pdf
HAS/2018-05-25_fiche_10_acceder_recherche_innovation.pdf
HAS/2018-05-25_fiche_11_comprendre_handicap_ma.pdf
HAS/2018-05-25_fiche_12_tnm_preserver_autonomie_cognitivo-fonctionnelle.pdf
HAS/2018-05-25_fiche_13_prevenir_troubles_comportement.pdf
HAS/2018-05-25_fiche_14_communiquer_troubles_memoire_langage.pdf
HAS/2018-05-25_fiche_15_vivre_le_quotidien.pdf
HAS/2018-05-25_fiche_16_mesure_protection_juridique.pdf
HAS/2018-05-25_fiche_17_situations_de__rupture.pdf
HAS/2018-05-25_fiche_18_soins_stade_ultime.pdf
HAS/2018-05-25_fiche_19_soins_qualite_de_vie.pdf
HAS/2018-05-25_fiche_1_troubles_cognitifs_et_trouble_neurocognitifs.pdf
HAS/2018-05-25_fiche_2_maladies_apparentees_differentes.pdf
HAS/2018-05-25_fiche_3_ma_avant_65_ans_2018-05-24_11-36-42_498.pdf
HAS/2018-05-25_fiche_4_demarche_diagnostique_trouble_cognitif_mg.pdf
HAS/2018-05-25_fiche_5_tests_reperage_mg.pdf
HAS/2018-05-25_fiche_6_situations_diagnostiques_complexes.pdf
HAS/2018-05-25_fiche_7_droit_savoir_decider-revue.pdf
HAS/2018-05-25_fiche_8_optimiser_consultations_memoire.pdf
HAS/2018-05-25_fiche_9_etiologie_tnc_consultations_memoire.pdf
HAS/2018-05-25_galantamine_biogaran_recours_r163-13_ct16756.pdf
HAS/2018-05-25_influvactetra_sapub_ct16544.pdf
HAS/2018-05-25_influvactetra_summary_ct16544.pdf
HAS/2018-05-25_memantine_biogaran_recours_r163-13_ct16758.pdf
HAS/2018-05-25_parcours_de_soins_alzheimer.pdf
HAS/2018-05-25_rivastigmine_biogaran_recours_r163-13_ct16757.pdf
HAS/2018-05-29_17_04_2018_matrice_maturite_pacte_4pages.pdf
HAS/2018-05-29_17_04_2018_mevpc_vd.pdf
HAS/2018-05-29_17_04_2018_mm_boite_outils__vd.pdf
HAS/2018-05-29_1_cs__grille_de_recueil.pdf
HAS/2018-05-29_2_cs__mode_emploi_questionnaire.pdf
HAS/2018-05-29_CEPP-5627_FLO-TECH LITE VISCO_20_mars_2018_(5627)_avis.pdf
HAS/2018-05-29_CT-15607_VOGALENE_PIC_RI_Avis2_CT15607.pdf
HAS/2018-05-29_CT-15693_ISIMIG_PIS_RI_AVIS1_CT15693.pdf
HAS/2018-05-29_CT-15694_TIGREAT_PIS_RI_AVIS1_CT15694.pdf
HAS/2018-05-29_CT-15760_AXEPIM_PISRI_AVIS1_CT15760_14052018.pdf
HAS/2018-05-29_CT-16269_TRANDATE_PIS_RI_AVIS1_CT16269.pdf
HAS/2018-05-29_CT-16280_BEVITINE_PIS_RI_AVIS1_CT16280.pdf
HAS/2018-05-29_CT-16282_BECILAN_PIS_RI_AVIS1_CT16282.pdf
HAS/2018-05-29_CT-16290_BRILIQUE_60_PIC_INS_Avis3_CT16290.pdf
HAS/2018-05-29_CT-16294_ISORYTHM_PIS_RI_AVIS1_CT16294.pdf
HAS/2018-05-29_CT-16365_CALCIDIA_PIS_RI_AVIS1_CT16365.pdf
HAS/2018-05-29_CT-16371_BETNESOL_PISRI_AVIS1_CT16371.pdf
HAS/2018-05-29_CT-16461_CACIT 500 - 1000 mg_PIS_RI_Avis2_CT-16461.pdf
HAS/2018-05-29_CT-16695_COSIMPREL_PIS_INS_AVIS1_CT16695.pdf
HAS/2018-05-29_CT-16905_DOXYCYCLINE_BIOGARAN_QD_INS_AVIS1_CT16905.pdf
HAS/2018-05-29_CT-16950_NICORETTE FRUITS NICORETTE SPRAY FRUITS ROUGES_QD_INS_AVIS1_CT16950.pdf
HAS/2018-05-29_crm_sante.pdf
HAS/2018-05-29_dc_2018_0071_pacte_cd_2018_05_16_vd.pdf
HAS/2018-05-29_fiche_action_analyse_de_processus.pdf
HAS/2018-05-29_fiche_synthetique.pdf
HAS/2018-05-29_guide_animateur_outil_leadershipe.pdf
HAS/2018-05-29_mode_operatoire_analyse_de_processus.pdf
HAS/2018-05-29_module_leadership_4p.pdf
HAS/2018-05-29_questionnaire_culture_securite_ahrq_traduit_et_valide_par_le_ccecqa.pdf
HAS/2018-05-29_spa_123_guide_culture_securite_cd_2019_05_29_v1.pdf
HAS/2018-05-30_05_2018_biblio_les_essentiels_pacte.pdf
HAS/2018-05-30_05_2018_outils_pacte_vd.pdf
HAS/2018-05-30_05_2018_pacte_les_essentiels_vd.pdf
HAS/2018-05-30_18_04_2018__pacte_bo_facilitateur.pdf
HAS/2018-05-30_dc_2018_0071_pacte_cd_2018_05_16_vd.pdf
HAS/2018-06-01_CT-16026_FLIXOVATE_Avis1_PIS_RI_CT16026.pdf
HAS/2018-06-01_CT-16037_FLIXONASE_Avis1_PIS_RI_CT16037.pdf
HAS/2018-06-01_CT-16049_IMIGRANE_IMIJECT_PIS_RI_Avis2_CT16048_16049.pdf
HAS/2018-06-01_CT-16354_ISOPTINE_PIS_RI_Avis2_CT16354.pdf
HAS/2018-06-01_CT-16827_YONDELIS_sarcomes_PIC_REEV_Avis2_CT16827.pdf
HAS/2018-06-01_fiche_bon_usage_anticoagulants_oraux.pdf
HAS/2018-06-01_flixotide_avis1_pis_ri_ct16038.pdf
HAS/2018-06-01_glucose_b_braun_pisri_avis_2_ct16870.pdf
HAS/2018-06-01_glucose_fresenius__pisri_avis_2_ct15914.pdf
HAS/2018-06-01_glucose_lavoisier_qdins_avis1_ct16828.pdf
HAS/2018-06-01_glucose_macopharma_pisri_avis_2_ct16129.pdf
HAS/2018-06-01_glucose_viaflo_qdins_avis1_ct16776.pdf
HAS/2018-06-01_projet_etablissement_-_accompagnement_personnes_agees.pdf
HAS/2018-06-01_yondelis_summary_ct16827.pdf
HAS/2018-06-01_yondelis_synthese_ct16827.pdf
HAS/2018-06-04_fdr_laser_femtoseconde_vd.pdf
HAS/2018-06-04_phenylcetonurie_-_pnds.pdf
HAS/2018-06-04_synthese_mg_la_phenylcetonurie.pdf
HAS/2018-06-06_2017-alarm-commente.pdf
HAS/2018-06-06_25_04_2018_fiche_gdr_6pages_vd.pdf
HAS/2018-06-06_CT-15969_SOPHIDONE_PISRI_AVIS1_CT15969.pdf
HAS/2018-06-06_CT-16177_RIMIFON_RI_AVIS1_CT16177.pdf
HAS/2018-06-06_CT-16261_ALDOMET_PIS_RI_AVIS1_CT16261.pdf
HAS/2018-06-06_CT-16276_SIKLOS_PIS_RI_Avis3_CT16276.pdf
HAS/2018-06-06_CT-16417_BREAKYL_RI_AVIS2_CT16417.pdf
HAS/2018-06-06_CT-16845_MEMANTINE OHRE PHARMA 10mg_QDINS_AVIS1_CT16845.pdf
HAS/2018-06-06_CT-16897_LATANOPROST-NORIDEM_INS_PIS_AVIS1_CT16897.pdf
HAS/2018-06-06_CT-16906_MORPHINERENAUDIN_QD_INS_AVIS1_CT 16906.pdf
HAS/2018-06-06_CT-16909_VENLAFAXINE ARROW GENERIQUES LP_QD_INS_AVIS1_CT16909 (2).pdf
HAS/2018-06-06_CT-16946_OXSYNIA_QD_INS_AVIS1_CT16946.pdf
HAS/2018-06-06_CT-16957_DOXORUBICINEACCORD_QD_INS_AVIS1_CT16957_TD.pdf
HAS/2018-06-06_fiche_dpc__gdr_equipe_2014-06-24_11-13-56_822.pdf
HAS/2018-06-06_grille_alarm_v2.pdf
HAS/2018-06-07_CEPP-5316_ISIS II_17_avril_2018_(5316)_avis.pdf
HAS/2018-06-07_CEPP-5490_AVANTAGE 3P PLASMA TiHA-AVANTAGE REVISION_15_mai_2018_(5490)_avis.pdf
HAS/2018-06-07_CEPP-5547_GALILEA_29_mai_2018_(5547)_avis.pdf
HAS/2018-06-07_CEPP-5618_NEURO 2_17_avril_2018_(5618)_avis.pdf
HAS/2018-06-08_CEPP-5337_BARRX_15_mai_2018_(5337)_avis_occultation.pdf
HAS/2018-06-08_CEPP-5480_PERENNIADURA 303 et PERENNIAFLEX 304_29_mai_2018_(5480)_avis.pdf
HAS/2018-06-08_CEPP-5482_DEMIPULSE 103 et DEMIPULSE 104_29_mai_2018_(5482)_avis.pdf
HAS/2018-06-08_CEPP-5588_AZURE XT SR_15_mai_2018_(5588)_avis.pdf
HAS/2018-06-08_CEPP-5589_AZURE XT DR_15_mai_2018_(5589)_avis.pdf
HAS/2018-06-08_CEPP-5590_PERCEPTA CRT-P_15_mai_2018_(5590)_avis.pdf
HAS/2018-06-08_CEPP-5591_PERCEPTA QUAD CRT-P_15_mai_2018_(5591)_avis.pdf
HAS/2018-06-08_CEPP-5613_ACTISORB_29_mai_2018_(5613)_avis.pdf
HAS/2018-06-08_CEPP-5623_PROFORE_15_mai_2018_(5623)_avis.pdf
HAS/2018-06-08_CEPP-5653_SEQUENT_29_mai_2018_(5653)_avis.pdf
HAS/2018-06-08_CEPP-5656_NANOSTIM_29_mai_2018_(5656)_avis.pdf
HAS/2018-06-08_CEPP-5660_GLASSBONE_29_mai_2018_(5660)_avis.pdf
HAS/2018-06-08_CEPP-5667_TRES_29_mai_2018_(5667)_avis.pdf
HAS/2018-06-08_CEPP-5684_SEQUENT_29_mai_2018_(5684)_avis.pdf
HAS/2018-06-08_argumentaire_vitamine_c_vd.pdf
HAS/2018-06-08_fiche_bon_usage_vitamine_c_vd.pdf
HAS/2018-06-08_inahta_brief_vitamin_c.pdf
HAS/2018-06-08_lutonix_035.pdf
HAS/2018-06-08_ranger.pdf
HAS/2018-06-11_pemphigus_-_argumentaire.pdf
HAS/2018-06-11_pnds_-_pemphigus.pdf
HAS/2018-06-11_pnds_71_-_maladies_bulleuses_auto-immunes_pemphigus_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2018-06-11_pnds_argumentaire_syndromefoxg1-foxg1plus-11062018.pdf
HAS/2018-06-11_pnds_texte_syndromefoxg1-foxg1plus_11062018.pdf
HAS/2018-06-11_synthese_mg_syndromes_foxg1_foxg1_plus.pdf
HAS/2018-06-13_CT-15467_TELEBRIX_GASTRO_Avis2_PIS_RI_CT15674.pdf
HAS/2018-06-13_CT-15469_TELEBRIX_12_SODIUM_Avis2_PIS_RI_CT15649.pdf
HAS/2018-06-13_CT-15752_ULTRAVIST_Avis2_PIS_RI_CT15752.pdf
HAS/2018-06-13_CT-16347_INTETRIX_PIS_RI_Avis1_CT16347.pdf
HAS/2018-06-13_CT-16803_FOLINATE DE CALCIUM EBEWE inj_QDINS_AVIS1_CT16803.pdf
HAS/2018-06-13_CT-16812_CASPOFUNGINE_MYLAN_QD_INS_AVIS1_CT16812.pdf
HAS/2018-06-13_CT-16856_LIDOCAINE_ACCORD_QD_INS_AVIS1_CT16856.pdf
HAS/2018-06-13_CT-16963_NICOPATCH_QD_INS_AVIS1_CT16963.pdf
HAS/2018-06-13_CT-16973_NICOPASS_QD_INS_Avis2_CT16973.pdf
HAS/2018-06-13_CT-16975_NICOPATCHLIB_QD_INS_AVIS1_CT16975.pdf
HAS/2018-06-13_avc_annexe_1.pdf
HAS/2018-06-13_avc_annexe_2.pdf
HAS/2018-06-13_avc_annexe_3.pdf
HAS/2018-06-13_avc_argumentaire.pdf
HAS/2018-06-13_avc_recommandation_2014-09-25_13-08-18_537.pdf
HAS/2018-06-13_avc_synthese_des_recommandations.pdf
HAS/2018-06-13_evaluation_des_ortheses_plantaires_et_coques_talonnieres_-_feuille_de_route.pdf
HAS/2018-06-13_evaluation_des_ortheses_plantaires_et_des_coques_talonnieres_rapport_devaluation.pdf
HAS/2018-06-13_glatiramer_mylan_qd_ins_avis2_ct_16822.pdf
HAS/2018-06-13_ortheses_plantaires_et_coques_talonnieres_avis_2018-06-12_12-42-25_904.pdf
HAS/2018-06-13_ortheses_plantaires_et_coques_talonnieres_composition_du_groupe_de_travail.pdf
HAS/2018-06-15_CEPP-5637_CONTEGRA_29_mai_2018_(5637)_avis_occultation.pdf
HAS/2018-06-15_CEPP-5647_E-VITA OPEN PLUS_29_mai_2018_(5647)_avis.pdf
HAS/2018-06-20_CEPP-5345_ZEPHYR_12_juin_2018_(5345)_avis.pdf
HAS/2018-06-20_CT-15320_IRESSA_PIS_ EPI_CT15320_Avis 2.pdf
HAS/2018-06-20_CT-15374_DENSICAL_VITAMINE_D3_PISRI_Avis1_CT15374.pdf
HAS/2018-06-20_CT-15637_BIRODOGYL_RODOGYL_PISRI_AVIS2_CT15637.pdf
HAS/2018-06-20_CT-15784_MYOCET_PIC_INS_Avis2_CT15784.pdf
HAS/2018-06-20_CT-15817_IZILOX_PIS_RI_Avis2_CT158178.pdf
HAS/2018-06-20_CT-15836_ZINNAT 750 mg_QD_INS_AVIS1_CT15836.pdf
HAS/2018-06-20_CT-15929_ADVILMED_PISRI_AVIS2_CT15929_03052018.pdf
HAS/2018-06-20_CT-15936_KETEK_RI_AVIS2_CT 15936.pdf
HAS/2018-06-20_CT-16028_FIXORINOX_Avis1_PIS_RI_CT16028.pdf
HAS/2018-06-20_CT-16044_OMIX OMEXEL_PISRI_AVIS1_CT_CT16044.pdf
HAS/2018-06-20_CT-16105_TRUSOPT_PIS_RI_AVIS1_CT16105.pdf
HAS/2018-06-20_CT-16122_ZECLAR_MONOZECLAR_PISRI_AVIS2_CT16122.pdf
HAS/2018-06-20_CT-16320_URSOLVAN_PISRI_Avis1_CT16320.pdf
HAS/2018-06-20_CT-16336_EUPRESSYL_MEDIATENSYL_PIS_RI_AVIS2_CT16336.pdf
HAS/2018-06-20_CT-16409_ISOBAR_PIS_RI_AVIS1_CT16409.pdf
HAS/2018-06-20_CT-16419_MODUCREN_PIS_RI_AVIS1_CT16419.pdf
HAS/2018-06-20_CT-16457_TECENTRIQ_CBNPC_PIC_INS_Avis2_CT16457.pdf
HAS/2018-06-20_CT-16533_TARKA LP_PIS_RI_AVIS1_CT16533.pdf
HAS/2018-06-20_CT-16549_SONOVUE_PIS_Avis1_RI_CT16549.pdf
HAS/2018-06-20_CT-16567_SEBIVO_PIS_RI_Avis2_CT16567.pdf
HAS/2018-06-20_CT-16652_DALACINE_PIS_RI_AVIS2_CT16652.pdf
HAS/2018-06-20_CT-16661_M-M-RVAXPRO_PIS_RI_Avis2_CT16661.pdf
HAS/2018-06-20_CT-16752_ZESTRIL_PIS_RI_Avis2_CT16752.pdf
HAS/2018-06-20_CT-16811_MORPHINE_CHLORHYDRATE_RENAUDIN_PIS_RI_AVIS1_CT16811.pdf
HAS/2018-06-20_CT-16813_SELEXID_PIS_RI_AVIS2_CT16813.pdf
HAS/2018-06-20_CT-16818_TUBERTEST_PIS_RI_Avis2_CT16818.pdf
HAS/2018-06-20_CT-16850_PEDIAZOLE_RI_AVIS1_CT16850.pdf
HAS/2018-06-20_CT-16855_OROCAL VIT D3 500mg_400UI_QDINS_AVIS2_CT16855.pdf
HAS/2018-06-20_CT-16879_MIGLUSTAT_GEN.ORPH_QD_INS_Avis1_CT16879.pdf
HAS/2018-06-20_CT-16881_BETADINE_ALCOOLIQUE_MYLAN_QD_INS_AVIS1_CT16881.pdf
HAS/2018-06-20_CT-16893_INSTANYLDoseGuard_QD_Ins_AVIS2_CT16893.pdf
HAS/2018-06-20_CT-16898_ARZERRA_PIC_REEV_Avis 2_CT16898.pdf
HAS/2018-06-20_CT-16908_MIANSERINE BIOGARAN_QD_INS_Avis2_CT16908.pdf
HAS/2018-06-20_CT-16925_LONOTEN_PIS_RI_AVIS2_CT16925.pdf
HAS/2018-06-20_CT-16943_BORTEZOMIB_MEDAC_QD_INS_AVIS1_CT16943.pdf
HAS/2018-06-20_chaussures_therapeutiques_a_usage_temporaire_et_prolonge_12_juin_2018_dm_eval_183_avis.pdf
HAS/2018-06-20_fiche_rbp_1_prevention_des_mvt-v1-180618.pdf
HAS/2018-06-20_fiche_rbp_2_borreliose_de_lyme-v1-180618.pdf
HAS/2018-06-20_fiche_rbp_3_autres_maladies_vectorielles_a_tiques-v1-180618.pdf
HAS/2018-06-20_fiche_rbp_4_sppt-v1-180618.pdf
HAS/2018-06-20_fs-rbp_performances_des_tests_diagnostiques_recommandes-190618-v5.pdf
HAS/2018-06-20_fs_rbp_borreliose_de_lyme_adulte-180618-v1.pdf
HAS/2018-06-20_reco266_rbp_borreliose_de_lyme_cd_2018_06_13__recommandations.pdf
HAS/2018-06-20_reco266_rbp_borreliose_de_lyme_cd_2018_06_13_argumentaire.pdf
HAS/2018-06-20_tecentriq_13032018_avis_efficience.pdf
HAS/2018-06-20_tecentriq_13122018_avis_efficience.pdf
HAS/2018-06-21_CT-16775_CETIRIZINE ARROW LAB_QD_INS_AVIS1_CT16775.pdf
HAS/2018-06-21_CT-16928_PHENYLEPHRINE MEDAC sol inj_QDINS_AVIS1_CT16928.pdf
HAS/2018-06-21_CT-16974_PANTOPRAZOLE ARROW GENERIQUES 20_40mg_QD_INS_AVIS1_CT16974.pdf
HAS/2018-06-21_CT-16976_ACIDE_CARGLUMIQUE_WAYMADE_QD_INS_AVIS1_CT16976.pdf
HAS/2018-06-21_CT-16999_CLOFARABINE_TILLOMED_QD_INS_AVIS1_CT16999.pdf
HAS/2018-06-25_CEPP-5519_EDEN_12_juin_2018_(5519)_avis.pdf
HAS/2018-06-25_CEPP-5527_HIPNGO sans ciment_12_juin_2018_(5527)_avis.pdf
HAS/2018-06-25_CEPP-5530_HIPNGO à cimenter_12_juin_2018_(5530)_avis.pdf
HAS/2018-06-25_CEPP-5531_PROFEMUR PRESERVE_03_avril_2018_(5531)_avis.pdf
HAS/2018-06-25_CEPP-5532_PROFEMUR L et L REVISION_03_avril_2018_(5532)_avis.pdf
HAS/2018-06-25_CEPP-5534_PROFEMUR GLADIATOR sans ciment_03_avril_2018_(5534)_avis.pdf
HAS/2018-06-25_CEPP-5538_PROFEMUR GLADIATOR à cimenter_03_avril_2018_(5538)_avis.pdf
HAS/2018-06-25_CEPP-5562_APTA sans ciment_12_juin_2018_(5562)_avis.pdf
HAS/2018-06-25_CEPP-5563_HYDRA sans ciment_12_juin_2018_(5563)_avis.pdf
HAS/2018-06-25_CEPP-5564_RECTA_12_juin_2018_(5564)_avis.pdf
HAS/2018-06-25_CEPP-5569_ACUTA_12_juin_2018_(5569)_avis.pdf
HAS/2018-06-25_CEPP-5600_APTA avec ciment_12_juin_2018_(5600)_avis.pdf
HAS/2018-06-25_CEPP-5601_HYDRA avec ciment_12_juin_2018_(5601)_avis.pdf
HAS/2018-06-25_CEPP-5646_MACROPLASTIQUE_12_juin_2018_(5646)_avis.pdf
HAS/2018-06-25_CEPP-5659_SERENITY_12_juin_2018_(5659)_avis.pdf
HAS/2018-06-25_CT-15593_AFINITOR_PIC_EI_TNE_Avis3_CT15593.pdf
HAS/2018-06-25_CT-15689_OXYCONTIN_OXYNORM_OXYNORMORO_PISRI_AVIS1_CT15689.pdf
HAS/2018-06-25_CT-16470_VAXIGRIP_PIS_RI_Avis1_CT16470.pdf
HAS/2018-06-25_CT-16984_BETADINE_SCRUB_QD_INS_AVIS2_CT16984.pdf
HAS/2018-06-25_CT-16998_BUSULFAN_TILLOMED_QD_INS_AVIS2_CT16998.pdf
HAS/2018-06-25_afinitor_sapub_ct15593_en_def.pdf
HAS/2018-06-25_afinitor_synthese_ct15593.pdf
HAS/2018-06-27_CT-16074_BLINCYTO_PIC_REEV_Avis3_CT16074.pdf
HAS/2018-06-27_CT-16353_DUPHALAC RI_reev SMR_PIC_Avis 2_CT16353.pdf
HAS/2018-06-27_CT-16460_BESPONSA_PIC_INS_Avis3_CT16460.pdf
HAS/2018-06-27_CT-16554_DACOGEN_PIC_REEV_MCI_Avis2_CT15856&16554.pdf
HAS/2018-06-27_CT-16683_AURICULARUM_Péri-opératoire_PIC_REEV_Avis2_CT16683.pdf
HAS/2018-06-27_auricularum_summary_ct16683.pdf
HAS/2018-06-27_auricularum_synthese_ct16683.pdf
HAS/2018-06-27_besponsa_summary_ct16460.pdf
HAS/2018-06-27_besponsa_synthese_ct16460.pdf
HAS/2018-06-27_blincyto_summary_ct16074.pdf
HAS/2018-06-27_blincyto_synthese_ct16074.pdf
HAS/2018-06-27_ciloxadex_otorrhees_sur_att_07032018_avis_ct16682.pdf
HAS/2018-06-27_ciloxadex_summary_ct16682.pdf
HAS/2018-06-27_ciloxadex_synthese_ct16682.pdf
HAS/2018-06-27_dacogen_summary_ct16554.pdf
HAS/2018-06-27_dacogen_synthese_ct16554.pdf
HAS/2018-06-27_duphalac_summary_ct16350.pdf
HAS/2018-06-27_duphalac_synthese_ct16350.pdf
HAS/2018-07-02_argu_np_neonat_2018-06-28_11-18-23_280.pdf
HAS/2018-07-02_argu_np_neonat_2018-06-28_11-20-17_917.pdf
HAS/2018-07-02_rapport_analyse_prospective_2018.pdf
HAS/2018-07-05_CEPP-5526_NAOS_26_juin_2018_(5526)_avis_occultation.pdf
HAS/2018-07-05_CEPP-5570_ATHELIA II à cimenter_12_juin_2018_(5570)_avis.pdf
HAS/2018-07-05_CEPP-5572_ATHELIA non cimenté_12_juin_2018_(5572)_avis.pdf
HAS/2018-07-05_CEPP-5643_LINK BI MOBILE sans ciment_12_juin_2018_(5643)_avis.pdf
HAS/2018-07-05_CEPP-5644_LINK BI MOBILE à cimenter_12_juin_2018_(5644)_avis.pdf
HAS/2018-07-05_CEPP-5666_COLIBRI OUTDOOR_26_juin_2018_(5666)_avis.pdf
HAS/2018-07-05_CEPP-5669_BAHA_12_juin_2018_(5669)_avis.pdf
HAS/2018-07-05_CEPP-5673_OPEN PIVOT_12_juin_2018_(5673)_avis.pdf
HAS/2018-07-05_CT-15819_ADROVANCE_PISRI_AVIS2_CT15819.pdf
HAS/2018-07-05_CT-15920_HEXVIX_PIC_RI_REEVAL_Avis3_CT15920.pdf
HAS/2018-07-05_CT-16173_NASONEX_RI_PIS_avis2_CT16173.pdf
HAS/2018-07-05_CT-16433_ACTONELCOMBI_PISRI_AVIS1_CT16433.pdf
HAS/2018-07-05_CT-16740_VESANOID_PIS_EIassociation_Avis1_CT16740.pdf
HAS/2018-07-05_CT-16882_HERZUMA_PIS_INS_AVIS2_CT16882.pdf
HAS/2018-07-05_CT-16907_NITISINONE_MDK_QD_INS_AVIS1_CT16907.pdf
HAS/2018-07-05_CT-16930_BUSULFAN_ACCORD_QD_INS_AVIS1_CT16930.pdf
HAS/2018-07-05_CT-17024_EFFERALGANMED_PEDIATRIQUE_QD_INS_AVIS1_CT 17024_sk.pdf
HAS/2018-07-05_argumentaire_cysticercose.pdf
HAS/2018-07-05_argumentaire_distomatose.pdf
HAS/2018-07-05_argumentaire_trichinellose.pdf
HAS/2018-07-05_inahta_brief_cysticercosis.pdf
HAS/2018-07-05_inahta_brief_fasciolosis.pdf
HAS/2018-07-05_inahta_brief_trichinellosis.pdf
HAS/2018-07-05_inhixa_pis_ins_avis1_ct16797.pdf
HAS/2018-07-05_pnds_-_traps_tumor_necrosis_factor-receptor-associated_periodic_syndrome_ou_syndrome_de_fievre_recurrente_lie_au_recepteur_d.pdf
HAS/2018-07-05_synthese_mg_traps_tumor_necrosis_factor_receptor_associated_periodic_syndrome.pdf
HAS/2018-07-06_CT-15316_ANTIBIO_SYNALAR_PIC_REEV_Avis2_CT15316.pdf
HAS/2018-07-06_CT-15333_FRAMYXONE_PIC_REEV_Avis2_CT15333.pdf
HAS/2018-07-06_CT-15401_PANOTILE_PIC_REEV_Avis2_CT15401.pdf
HAS/2018-07-06_CT-15457_POLYDEXA_PIC_REEV_Avis2_CT15457&16255.pdf
HAS/2018-07-06_CT-15950_KISPLYX_PIC_INS_Avis2_CT15950.pdf
HAS/2018-07-06_CT-15973_ZYDELIG_PIC_REEV_Avis3_CT15973.pdf
HAS/2018-07-06_CT-16190_AURICULARUM_PIC_REEV_Avis2_CT16190.pdf
HAS/2018-07-06_CT-16233_CILOXADEX_PIC_REEV_Avis2_CT16233.pdf
HAS/2018-07-06_CT-16362_SPINRAZA_PIC_INS_Avis3_CT16362.pdf
HAS/2018-07-06_CT-16410_TRUVADA_PIC_EI_pediatrie12ans_Avis2_CT16410.pdf
HAS/2018-07-06_CT-16434_MAVIRET_PIC_INS_Avis2_CT16434.pdf
HAS/2018-07-06_CT-16471_KISQALI_PIC_INS_Avis2_CT16471.pdf
HAS/2018-07-06_gouttes_auriculaires_summary.pdf
HAS/2018-07-06_gouttes_auriculaires_synthese.pdf
HAS/2018-07-06_kisplyx_summary_ct15950.pdf
HAS/2018-07-06_kisplyx_synthese_ct15950.pdf
HAS/2018-07-06_kisqali_22052018_avis_efficience.pdf
HAS/2018-07-06_kisqali_summary_ct16471.pdf
HAS/2018-07-06_kisqali_synthese_ct16471.pdf
HAS/2018-07-06_maviret_summary_ct16434.pdf
HAS/2018-07-06_maviret_synthese_ct16434.pdf
HAS/2018-07-06_rapport_reev_gouttes_auriculaires_avis2_cteval302.pdf
HAS/2018-07-06_spinraza_12122017_avis_efficience.pdf
HAS/2018-07-06_spinraza_summary_ct16362.pdf
HAS/2018-07-06_spinraza_synthese_ct16362.pdf
HAS/2018-07-06_trimbow_pic_ins_avis3_ct16518.pdf
HAS/2018-07-06_trimbow_summary_ct16518.pdf
HAS/2018-07-06_trimbow_synthese_ct16518.pdf
HAS/2018-07-06_truvada_summary_ct16410.pdf
HAS/2018-07-06_truvada_synthese_ct16410.pdf
HAS/2018-07-06_zydelig_summary_ct15973.pdf
HAS/2018-07-06_zydelig_synthese_ct15973.pdf
HAS/2018-07-09_CT-16829_ANGUSTA_PIC_INS_Avis2_CT16829.pdf
HAS/2018-07-09_angusta_summary_ct168291.pdf
HAS/2018-07-09_angusta_synthese_ct168291.pdf
HAS/2018-07-10_CT-16058_ZOPHREN PISRI_Avis 2_CT16058.pdf
HAS/2018-07-10_CT-16295_PRESTOLE_PIS_RI_Avis2_CT16295.pdf
HAS/2018-07-10_CT-16335_EPINITRIL_PIS_RI_Avis1_CT16335.pdf
HAS/2018-07-10_CT-16467_CATAPRESSAN_PIS_RI_Avis2_CT116467.pdf
HAS/2018-07-10_CT-16977_CRUSIA_PIS_INS_Avis2_CT16977.pdf
HAS/2018-07-10_CT-16991_BIVALIRUDINE_QD_INS_AVIS1_CT16991.pdf
HAS/2018-07-10_CT-17012_NICOTINELL MENTHE_QD_INS_AVIS1_CT17012.pdf
HAS/2018-07-10_CT-17025_NICORETTE_QD_INS_AVIS1_CT17025.pdf
HAS/2018-07-10_CT-17027_ADENOSINE ACCORD_QD_INS_AVIS1_CT17027.pdf
HAS/2018-07-10_CT-17032_DACARBAZINELIPOMED_500_1000_QD_AVIS2_CT17032.pdf
HAS/2018-07-16_CEPP-5381_IALUSET PLUS_15_mai_2018_(5381)_avis_occultation.pdf
HAS/2018-07-16_CEPP-5607_PRO KINETIC ENERGY_26_juin_2018_(5607)_avis_occultation.pdf
HAS/2018-07-16_CEPP-5620_INFINITY_26_juin_2018_(5620)_avis_occultation.pdf
HAS/2018-07-16_CEPP-5629_iSTENT INJECT_12_juin_2018_(5629)_avis_occultation.pdf
HAS/2018-07-16_CEPP-5678_CAVGJ 514 00_26_juin_2018_(5678)_avis_occultation.pdf
HAS/2018-07-16_CEPP-5679_VAVGJ 515_26_juin_2018_(5679_avis_occultation.pdf
HAS/2018-07-17_CEPP-5512_ATLANTIS MODULAR_26_juin_2018_(5512)_avis.pdf
HAS/2018-07-17_CEPP-5670_MEPILEX BORDER PROTECT_10_juillet_2018_(5670)_avis.pdf
HAS/2018-07-17_CT-16390_HAMAMELIS COMPOSE_PIS_RI_AVIS1_CT16390.pdf
HAS/2018-07-17_CT-16391_CHELIDONIUM COMPOSE_PIS_RI_AVIS1_CT16391.pdf
HAS/2018-07-17_CT-16394_AESCULUS COMPOSE BOIRON_PIS_RI_AVIS1_CT16394.pdf
HAS/2018-07-17_CT-16685_RENAGEL_PIS_RI_Avis2_CT16685.pdf
HAS/2018-07-17_CT-16868_RELVAR_PIS_INS_Avis2_CT16868.pdf
HAS/2018-07-17_CT-16875_LOCERYL_QD_INS_AVIS1_CT16875.pdf
HAS/2018-07-17_CT-16914_LOLISTREL_CONTINU_QD_INS_AVIS1_CT16914.pdf
HAS/2018-07-17_CT-16917_LIPOROSA_PIS_INS_Avis2_CT16917.pdf
HAS/2018-07-17_CT-16964_OXYNORM_QD_INS_AVIS2_CT16964.pdf
HAS/2018-07-17_CT-16966_HELICOBACTER TEST INFAI 75 mg _QD_INS_AVIS1_CT16966.pdf
HAS/2018-07-17_CT-16968_NUWIQ_QD_INS_AVIS2_CT16968.pdf
HAS/2018-07-17_CT-16970_IRINOTECAN_HIKMA_QD_INS_AVIS1_CT16970.pdf
HAS/2018-07-17_CT-16978_KANJINTI_PIS_INS_Avis2_CT16978.pdf
HAS/2018-07-17_CT-16987_FLAGYL0.5POURCENT_QDINS_AVIS1_CT16987.pdf
HAS/2018-07-17_CT-16995_DROPERIDOL HIKMA 2,5 mg_mL_QDColl_AVIS1_CT16995.pdf
HAS/2018-07-17_CT-17005_DOMPERIDONE MYLAN 10 mg_QDIns_AVIS1_CT17005.pdf
HAS/2018-07-17_CT-17046_FEIBA_Ins_QD_AVIS2_CT17046.pdf
HAS/2018-07-17_CT-17062_LEVOFLOXACINEKABI_QD_INS_AVIS1_CT17062_TD.pdf
HAS/2018-07-17_CT-17094_TADALAFILQUIVER_QD_INS_AVIS2_CT17094.pdf
HAS/2018-07-17_fiche_bum_benzodiazepines_anxiete_cd_27062018.pdf
HAS/2018-07-18_CT-15718_XALKORI_PIC_EI_ROS1_AvisPostAud_CT15718.pdf
HAS/2018-07-18_CT-16117_FLUCORTAC_PIC_EI_Avis2_CT16117.pdf
HAS/2018-07-18_CT-16563_CELSENTRI_EI pédiatrie 2 ans et plus_AVIS2_CT 16563 et CT 16564.pdf
HAS/2018-07-18_CT-16717_HARVONI_EI pédiatrie_Avis2_CT16717.pdf
HAS/2018-07-18_CT-16743_SOVALDI_EI pédiatrie_Avis2_CT16743.pdf
HAS/2018-07-18_celsentri_summary_ct16654.pdf
HAS/2018-07-18_celsentri_synthese_ct16654.pdf
HAS/2018-07-18_flucortac_summary_ct16117.pdf
HAS/2018-07-18_flucortac_synthese_ct16117.pdf
HAS/2018-07-18_harvoni_summary_ct16717.pdf
HAS/2018-07-18_harvoni_synthese_ct16717.pdf
HAS/2018-07-18_sovaldi_summary_ct16743.pdf
HAS/2018-07-18_sovaldi_synthese_ct16743.pdf
HAS/2018-07-18_xalkori_summary_ros_ct15718.pdf
HAS/2018-07-18_xalkori_synthese_ros_ct15718.pdf
HAS/2018-07-19_CEPP-5616_BLUEPRO_17_juillet_2018_(5616)_avis.pdf
HAS/2018-07-19_CEPP-5681_PRECISION SPECTRA_10_juillet_2018_(5681)_avis.pdf
HAS/2018-07-19_CEPP-5705_PRECISION NOVI_10_juillet_2018_(5705)_avis.pdf
HAS/2018-07-19_CEPP-5706_PRECISION MONTAGE MRI_10_juillet_2018_(5706)_avis.pdf
HAS/2018-07-19_CT-15277_OPDIVO_cancer_rein_PIC_INS_Avis2_CT15277.pdf
HAS/2018-07-19_CT-15561_OPDIVO_PIC_EI_association_Yervoy_melanome_Avis2_CT15561.pdf
HAS/2018-07-19_CT-15634_KEYTRUDA_PIC_EI_poumon_Avis3_modifiele03052017_CT15634.pdf
HAS/2018-07-19_CT-15825_KEYTRUDA_PIC_REEV_Melanome_Avis1_CT15825.pdf
HAS/2018-07-19_CT-16249_VIMPAT_PIC_EI_Avis2_CT16249.pdf
HAS/2018-07-19_CT-16334_TAFINLAR_MEKINIST_PIC_EI_Avis3_CT16334.pdf
HAS/2018-07-19_CT-16375_SELOKEN_100_LP200_PIS_RI_Avis 1_CT16375.pdf
HAS/2018-07-19_CT-16405_TIMACOR_PIS_RI_Avis1_CT16405.pdf
HAS/2018-07-19_CT-16413_FLUCONAZOLESANDOZ_QD_INS_AVIS1_CT16413.pdf
HAS/2018-07-19_CT-16530_KEYTRUDA_carcinome_urothelial_PIC_EI_Avis3_CT16530.pdf
HAS/2018-07-19_CT-16594_AVASTIN_PIS_EI_NON_DEMANDEE_en asso à erlotinib_Avis1_CT16594.pdf
HAS/2018-07-19_CT-16707_KYNTHEUM_PIS_INS_Avis3_CT16707.pdf
HAS/2018-07-19_CT-17011_VENLAFAXINE ARROW LP 150 mg_QD_INS_AVIS1_CT17011.pdf
HAS/2018-07-19_CT-17043_ARGANOVA_QDINS_AVIS2_CT17043.pdf
HAS/2018-07-19_CT-17078_PARACETAMOL CRISTERS 1G_QD_EIT_CT17078.pdf
HAS/2018-07-19_CT-17085_FERRIPROX_PIS_EI_NON_DEMANDEE_Avis1_CT17085.pdf
HAS/2018-07-19_inahta_brief_cryolipolysis.pdf
HAS/2018-07-19_keytruda_10072018_avis_efficience.pdf
HAS/2018-07-19_keytruda_cbnpc_2ligne_summary_ct15941_modif14082018_en_def.pdf
HAS/2018-07-19_keytruda_cbnpc_2ligne_synthese_ct15634.pdf
HAS/2018-07-19_keytruda_cbnpc_ltt2_17012017_avis_efficience.pdf
HAS/2018-07-19_keytruda_melanome_sapub_ct15825_en_def.pdf
HAS/2018-07-19_keytruda_melanome_synthese_ct15825.pdf
HAS/2018-07-19_keytruda_urothelial_summary_ct16530.pdf
HAS/2018-07-19_keytruda_urothelial_synthese_ct16530.pdf
HAS/2018-07-19_kyntheum_summary_ct16707.pdf
HAS/2018-07-19_kyntheum_synthese_ct16707.pdf
HAS/2018-07-19_opdivo_melanome_asso_summary_ct15561.pdf
HAS/2018-07-19_opdivo_melanome_asso_synthese_ct15561.pdf
HAS/2018-07-19_opdivo_rein_-_avis_defficience_m.pdf
HAS/2018-07-19_opdivo_rein_summary_ct15277.pdf
HAS/2018-07-19_opdivo_rein_synthese_ct15277.pdf
HAS/2018-07-19_rapport_cryolipolyse.pdf
HAS/2018-07-19_recueil_reponses_questionnaire_cryolipolyse_consultation_publique.pdf
HAS/2018-07-19_tafinlar_mekinist_summary_ct16334.pdf
HAS/2018-07-19_tafinlar_mekinist_synthese_ct16334.pdf
HAS/2018-07-19_trinitrine_mylan_pis_ri_avis1_ct16953.pdf
HAS/2018-07-19_vimpat_summary_ct16249.pdf
HAS/2018-07-19_vimpat_synthese_ct16249.pdf
HAS/2018-07-25_CEPP-5674_COMET ALPINE_10_juillet_2018_(5674)_avis.pdf
HAS/2018-07-26_CEPP-5190_IMPELLA 5_06_mars_2018_(5190)_avis_occultation.pdf
HAS/2018-07-26_CEPP-5193_IMPELLA CP_06_mars_2018_(5193)_avis.pdf
HAS/2018-07-26_CEPP-5645_RESOLUTE ONYX 5645_10_juillet_2018_(5645)_avis_occultation.pdf
HAS/2018-07-26_CEPP-5688_ULTRAFILL_17_juillet_2018_(5688)_avis.pdf
HAS/2018-07-26_annexe_rapport_thrombectomie_vd.pdf
HAS/2018-07-26_appendix_assessment_report_thrombectomy_2019-08-02_13-14-0_907.pdf
HAS/2018-07-26_assessment_report_summary_thrombectomy.pdf
HAS/2018-07-26_assessment_report_thrombectomy.pdf
HAS/2018-07-26_cadrage_thrombectomie_organisation.pdf
HAS/2018-07-26_rapport_thrombectomie_vd.pdf
HAS/2018-07-26_texte_court_thrombectomie_vd.pdf
HAS/2018-07-27_feuille_de_route_statut_vaccinal_inconnu_has_spilf.pdf
HAS/2018-08-01_feuille_de_route_evaluation_a_priori_de_lextension_du_depistage_neonatal_au_deficit_immunitaire_combine_severe_dics.pdf
HAS/2018-08-02_CEPP-5275_GLACE_26_juillet_2018_(5275)_avis.pdf
HAS/2018-08-02_CEPP-5565_XO sans ciment_26_juillet_2018_(5565)_avis.pdf
HAS/2018-08-02_CEPP-5566_XO à cimenter_26_juillet_2018_(5566)_avis.pdf
HAS/2018-08-02_CEPP-5567_LOUXOR_26_juillet_2018_(5567)_avis.pdf
HAS/2018-08-02_CEPP-5577_BAHA_26_juillet_2018_(5577)_avis.pdf
HAS/2018-08-02_CEPP-5680_BIOSEM II_17_juillet_2018_(5680)_avis.pdf
HAS/2018-08-08_recommandation_vaccinale__extension_des_competences_des_professionnels_de_sante_en_matiere_de_vaccin_2018-08-08_14-46-16_310.pdf
HAS/2018-08-10_argumentaire_pnds_cystinose_26072018.pdf
HAS/2018-08-10_pnds_cystinose_-_26072018.pdf
HAS/2018-08-10_pnds_still_de_ladulte_vfinale_2.pdf
HAS/2018-08-10_synthese_mg_cystinose.pdf
HAS/2018-08-10_synthese_mg_maladie_de_still.pdf
HAS/2018-08-16_recommandations_fluarix_tetra_ped_juin_2018.pdf
HAS/2018-08-16_recommandations_vaxigrip_tetra_ped_juin_2018.pdf
HAS/2018-08-27_CEPP-5609_URGOSTART_26_juillet_2018_(5609)_avis_occultation.pdf
HAS/2018-08-27_CEPP-5610_URGOSTART INTERFACE_26_juillet_2018_(5610)_avis_occultation.pdf
HAS/2018-08-27_CEPP-5611_URGOSTART PLUS COMPRESSE_26_juillet_2018_(5611)_avis.pdf
HAS/2018-08-27_CEPP-5648_URGOSTART PLUS BORDER_26_juillet_2018_(5648)_avis.pdf
HAS/2018-08-27_CEPP-5649_URGOSTART BORDER_26_juillet_2018_(5649)_avis_occultation.pdf
HAS/2018-08-27_CT-15941_KEYTRUDA_PIC_EI_poumon_1ere_ligne_Avis2_CT15941.pdf
HAS/2018-08-27_CT-16176_KYPROLIS_dexa_PIC_EI_Avis3_CT16176.pdf
HAS/2018-08-27_CT-16445_KYPROLIS_PIC_REEV_Avis3_CT16445.pdf
HAS/2018-08-27_CT-16729_ZYTIGA_PIC_EI_avis2_CT16729.pdf
HAS/2018-08-27_keytruda_cbnpc_1ligne_summary_ct15941_en_def.pdf
HAS/2018-08-27_keytruda_cbnpc_1ligne_synthese_ct15941.pdf
HAS/2018-08-27_keytruda_cbnpc_ltt1_16052017_avis_efficience.pdf
HAS/2018-08-27_kyprolis_bitherapie_summary_ct16716.pdf
HAS/2018-08-27_kyprolis_bitherapie_synthese_ct16716.pdf
HAS/2018-08-27_kyprolis_tritherapie_summary_ct16445.pdf
HAS/2018-08-27_kyprolis_tritherapie_synthese_ct16445.pdf
HAS/2018-08-27_urgo_upd_13112018_avis_efficience.pdf
HAS/2018-08-27_urgo_uvj_13112018_avis_efficience.pdf
HAS/2018-08-27_zytiga_10072018_avis_efficience.pdf
HAS/2018-08-27_zytiga_summary_ct16729.pdf
HAS/2018-08-27_zytiga_synthese_ct16729.pdf
HAS/2018-08-28_CT-15932_VENCLYXTO_PIC_INS_avispostAUD_CT15932_.pdf
HAS/2018-08-28_CT-16979_AMGEVITA_PIS_INS_Avis2_CT16979.pdf
HAS/2018-08-28_CT-17068_IMRALDI_PIS_INS_Avis2_CT17068.pdf
HAS/2018-08-28_CT-17093_LINEZOLIDE ARROW GENERIQUES 2mg_QD_INS_Avis2_CT17093.pdf
HAS/2018-08-28_aides_auditives_avis.pdf
HAS/2018-08-28_ceftriaxone_gerda_qd_ins_avis2_ct17086.pdf
HAS/2018-08-28_composition_du_groupe_de_travail_-_aides_auditives.pdf
HAS/2018-08-28_cuvitru_pis_ins_avis2_ct16949.pdf
HAS/2018-08-28_dc_2017_0004_impact_significatif_produit_venclyxto_cd_2017_01_25_vd.pdf
HAS/2018-08-28_fludarabine_accord_qd_ins_avis1_ct17026.pdf
HAS/2018-08-28_fulvestrant_teva_qd_ins_avis1_ct17097.pdf
HAS/2018-08-28_mepivacaine_accord_qd_ins_avis1_ct16992.pdf
HAS/2018-08-28_optique_medicale_avis.pdf
HAS/2018-08-28_optique_medicale_composition_du_groupe_de_travail.pdf
HAS/2018-08-28_venclyxto_20170613_avis_efficience.pdf
HAS/2018-08-28_venclyxto_summary_ct15932.pdf
HAS/2018-08-28_venclyxto_synthese_ct15932.pdf
HAS/2018-08-29_CT-16061_HUMIRA_PIS_EI NON DEMANDEE_avis2_CT16061.pdf
HAS/2018-08-29_CT-16486_BIOCADEXTRO_PIS_RI_Avis1_CT16486.pdf
HAS/2018-08-29_CT-16520_POTASSIUM RICHARD_PIS_RI_Avis1_CT16520.pdf
HAS/2018-08-29_CT-16640_SULIQUA_PIC_INS_Avis2_CT16640.pdf
HAS/2018-08-29_CT-16806_PEGASYS_PIS_RI_Avis1_modifiele27072018_CT16806.pdf
HAS/2018-08-29_CT-16878_OCREVUS_PICins_SEP-R_avis2_CT16878_def.pdf
HAS/2018-08-29_CT-16911_ACIDE_TRANEXAMIQUE_MYLAN_QD_INS_AVIS1_CT16911_vuCT.pdf
HAS/2018-08-29_CT-17031_ERTAPENEM_HIKMA_QD_INS_Avis1_CT17031.pdf
HAS/2018-08-29_CT-17049_KIPOS 100 000 UI_QDINS_AVIS1_CT17049.pdf
HAS/2018-08-29_CT-17057_PROCYSBI_Ins_QD_AVIS2_CT17057.pdf
HAS/2018-08-29_CT-17076_LEVETIRACETAM_ARROW_LAB_QD_INS_Avis1_CT17076.pdf
HAS/2018-08-29_CT-17092_MYDRIATICUM_BTE20_INS_QD_AVIS2_CT17092.pdf
HAS/2018-08-29_CT-17148_XTANDI_QD_INS_Avis1_CT17148.pdf
HAS/2018-08-29_dexambutol500mg_ri_avis1_ct_17055.pdf
HAS/2018-08-29_ocrevus_aib__20122018_avis_efficience.pdf
HAS/2018-08-29_ocrevus_sep-r_20122018_avis_efficience.pdf
HAS/2018-08-29_oxycodone_delbert_ex-pharmadyne_qd_ins_avis2_ct17030.pdf
HAS/2018-08-29_salbumol_pic_ri_avis1_ct15445.pdf
HAS/2018-08-29_salbumol_sapub_ct15445.pdf
HAS/2018-08-29_salbumol_sapub_ct15445_en_val.pdf
HAS/2018-08-29_suliqua_sapub_ct16640.pdf
HAS/2018-08-29_suliqua_summary_ct16640_en_def.pdf
HAS/2018-08-29_venlafaxine_biphar_lp_150_mg_et_225_mg_qd_ins_avis2_ct16948.pdf
HAS/2018-08-30_zenith_branch.pdf
HAS/2018-08-31_CEPP-5557_H MAX M_26_juillet_2018_(5557)_avis.pdf
HAS/2018-08-31_CEPP-5558_SAM FIT_26_juillet_2018_(5558)_avis.pdf
HAS/2018-08-31_CEPP-5559_MINIMA M_26_juillet_2018_(5559)_avis.pdf
HAS/2018-08-31_CT-17103_SPASMAG_INJECTABLE_QD_INS_Avis1_CT17103.pdf
HAS/2018-08-31_pradaxa_reeval_ao_recours_r163_13_avis1.pdf
HAS/2018-08-31_vitamine_k1_cheplapharm_qd_ins_avis1_ct17039.pdf
HAS/2018-08-31_yervoy_ei_nivolumab_pis_avis1_ct17018.pdf
HAS/2018-09-05_CT-16675_TASIGNA_PIC_EI pédiatrie_Avis2_CT16675.pdf
HAS/2018-09-05_tasigna_eiped_synthese_ct16675.pdf
HAS/2018-09-05_tasignaeipedsapubct16675_en_def.pdf
HAS/2018-09-07_CT-16649_LARTRUVO_INS_PIC_Avis2_CT16649.pdf
HAS/2018-09-07_CT-16704_SOLIRIS_Myasténie_PIS_avis2_CT16704.pdf
HAS/2018-09-07_CT-16832_YERVOY_EI_adolescents_Avis2_CT16832.pdf
HAS/2018-09-07_CT-17040_HIZENTRA_PIS_EI_Avis2_CT17040.pdf
HAS/2018-09-07_CT-17071_NICORETTESKIN_B7_QD_INS_Avis2_CT17071.pdf
HAS/2018-09-07_lartruvo_summary_ct16649.pdf
HAS/2018-09-07_lartruvo_synthese_ct_16649.pdf
HAS/2018-09-07_niquitin_gamme_qd_ins_avis2_ct17059_17060_17063_17064_17065.pdf
HAS/2018-09-07_yervoy_adolescents_summary_ct16832.pdf
HAS/2018-09-07_yervoy_adolescents_synthese_ct16832.pdf
HAS/2018-09-10_corevalve_08012019_avis_efficience.pdf
HAS/2018-09-10_corevalve_aoa.pdf
HAS/2018-09-10_corevalve_evolut_aoa.pdf
HAS/2018-09-10_corevalve_evolut_pro.pdf
HAS/2018-09-10_corevalve_evolut_r.pdf
HAS/2018-09-10_dc_2017_0214_eco_effi_corevalve_cd_2017_12_20_vd.pdf
HAS/2018-09-11_CT-16715_PREVYMIS_PIC_INS_Avis3_CT16715.pdf
HAS/2018-09-11_CT-16859_DECAPEPTYL_EI_PIS_Avis2_CT16859.pdf
HAS/2018-09-11_CT-16902_FIRAZYR_Avis2_EI_CT16902.pdf
HAS/2018-09-11_CT-16985_BALCOGA_QD_INS_AVIS1_CT16985.pdf
HAS/2018-09-11_CT-17038_ONTRUZANT_PIS_INS_Avis1_CT17038.pdf
HAS/2018-09-11_CT-17073_HUMIRA_PIS_MODIF RCP_AVIS 2_CT17073.pdf
HAS/2018-09-11_prevymis_sapub_ct16715.pdf
HAS/2018-09-11_prevymis_summary_ct16715.pdf
HAS/2018-09-12_CT-16027_VOTUBIA_PIC_INS_Avis2_CT16027.pdf
HAS/2018-09-12_CT-16810_XARELTO_10mg_EI_Avis2_CT16810.pdf
HAS/2018-09-12_votubia_synthese_ct16027.pdf
HAS/2018-09-12_votubiasapubct16027en_def.pdf
HAS/2018-09-12_xarelto_10mg_summary_ct16810.pdf
HAS/2018-09-12_xarelto_10mg_synthese_ct16810.pdf
HAS/2018-09-14_CEPP-5694_ALBER E-MOTION M25_04_septembre_2018_(5694)_avis.pdf
HAS/2018-09-14_CEPP-5725_SOLEUS_04_septembre_2018_(5725)_avis.pdf
HAS/2018-09-14_harmony.pdf
HAS/2018-09-18_CT-16847_OPDIVO_PIS_RCP_Avis1_CT16847.pdf
HAS/2018-09-18_CT-16915_VAXIGRIPTETRA_PIC_EI_Avis3_CT16915.pdf
HAS/2018-09-18_CT-16996_RISPERIDONE MYLAN_QD_INS_AVIS1_CT16996.pdf
HAS/2018-09-18_CT-17016_CELSENTRI_PIS_RI_Avis1_modifié_CT17016.pdf
HAS/2018-09-18_CT-17091_PREXATE _INS_AVIS2_CT17091.pdf
HAS/2018-09-18_CT-17220_HALDOL_PIS_EI_Avis1_CT17220.pdf
HAS/2018-09-18_CT-17241_METRONIDAZOLEL0.5POURCENTBAXTER_QDINS_AVIS2_CT17241.pdf
HAS/2018-09-19_CEPP-5517_ECOFIT 2M à cimenter_11_septembre_2018_(5517)_avis.pdf
HAS/2018-09-19_CEPP-5518_ECOFIT 2M sans ciment_11_septembre_2018_(5518)_avis.pdf
HAS/2018-09-19_CEPP-5624_MINIMED 2007D_11_septembre_2018_(5624)_avis.pdf
HAS/2018-09-19_CEPP-5677_HARMONY_04_septembre_2018_(5677)_avis_occultation.pdf
HAS/2018-09-21_CEPP-5721_CONFORMABLE TAG 5721_11_septembre_2018_avis_occultation.pdf
HAS/2018-09-25_CEPP-5661_SOLITAIRE 2_17_juillet_2018_(5661)_avis_occultation.pdf
HAS/2018-09-25_CEPP-5663_MITRACLIP XTR_04_septembre_2018_(5663)_avis_occultation.pdf
HAS/2018-09-25_CEPP-5664_MITRACLIP NTR_04_septembre_2018_(5664)_avis_occultation.pdf
HAS/2018-09-25_caprelsa_pic_ei_avis2_ct16613.pdf
HAS/2018-09-25_solitaire_platinum.pdf
HAS/2018-09-28_d2017-61_-_rbpp_chrs_violence.pdf
HAS/2018-09-28_violences_chrs_recommandations.pdf
HAS/2018-10-01_CEPP-5208_LEGION OXINIUM_17_juillet_2018_(5208)_avis_occultation.pdf
HAS/2018-10-01_CEPP-5625_ODRA_25_septembre_2018_(5625)_avis.pdf
HAS/2018-10-01_decision_n_d2017-62_portant_adoption_de_la_fiche-repere_securite_alimentaire_convivialite_et_qualite_de_vie_les_champs_du_po.pdf
HAS/2018-10-01_decision_n_d2018-02_portant_adoption_de_la_fiche-repere_la_commission_de_coordination_geriatrique.pdf
HAS/2018-10-01_fiche-repere-projet_personnalise_ehpad.pdf
HAS/2018-10-01_fiche-repere_commission_coordination_geriatrique.pdf
HAS/2018-10-01_fiche-repere_haccp.pdf
HAS/2018-10-01_fiche-repere_jetu.pdf
HAS/2018-10-01_flyer_ccg.pdf
HAS/2018-10-02_CT-14505_NOLVADEX_PIS_RI_AVIS1_CT14505.pdf
HAS/2018-10-02_CT-16751_ELUDRILPERIO_PIS_RI_AVIS1_CT16751.pdf
HAS/2018-10-02_CT-16903_COPEGUS_PIS_RI_Avis2_CT16903.pdf
HAS/2018-10-02_CT-16927_FASENRA_INS_PIC_Avis2_CT16927.pdf
HAS/2018-10-02_CT-17008_GAMMANORM_PIS_EI_AVIS1_CT-17008.pdf
HAS/2018-10-02_CT-17014_BIKTARVY_PIC_AVIS2_CT17014.pdf
HAS/2018-10-02_CT-17084_CEFOXITINE GERDA_QD Ins_AVIS1_CT 17084.pdf
HAS/2018-10-02_CT-17101_SELINCRO_QD_AVIS1_CT17101.pdf
HAS/2018-10-02_CT-17141_ANCOTIL_PIS_RI_AVIS2_CT17141.pdf
HAS/2018-10-02_CT-17194_ERYFLUID_PIS_RI_AVIS1_CT_17194.pdf
HAS/2018-10-02_CT-17221_IOPAMIRON_QD_INS_AVIS2_CT17221.pdf
HAS/2018-10-02_CT-17260_TRAZIMERA_PIS_INS_AVIS2_CT17260.pdf
HAS/2018-10-02_biktarvy_sapub_ct17014.pdf
HAS/2018-10-02_biktarvy_summary_ct17014.pdf
HAS/2018-10-03_recommandations_vaccination_contre_la_rage_en_prophylaxie_post-exposition.pdf
HAS/2018-10-04_CEPP-5167_RHEO KNEE_11_septembre_2018_(5167)_avis.pdf
HAS/2018-10-05_CEPP-5652_URGOCLEAN_11_septembre_2018_(5652)_avis_occultation.pdf
HAS/2018-10-05_CEPP-5701_COREVALVE EVOLUT R_04_septembre_2018_(5701)_avis_occultation.pdf
HAS/2018-10-05_CEPP-5702_COREVALVE EVOLUT PRO_04_septembre_2018_(5702)_avis_occultation.pdf
HAS/2018-10-05_CEPP-5769_CARBONART AVP-BOVIN_25_septembre_2018_(5769)_avis.pdf
HAS/2018-10-05_corevalve_08012019_avis_efficience.pdf
HAS/2018-10-08_CT-16420_PROTAMINE_CHOAY_PIS_RI_Avis2_CT16420.pdf
HAS/2018-10-08_CT-17184_HYRIMOZ_INS_Avis2_CT17184.pdf
HAS/2018-10-09_CT-15951_PYOSTACINE_PIS_AVIS2_RI_CT15951.pdf
HAS/2018-10-09_CT-16006_LUCENTIS_RI2017_PIS-AVIS2_CT16006.pdf
HAS/2018-10-09_CT-16397_PREZISTA_PIS_RI_AVIS1_CT16397.pdf
HAS/2018-10-09_CT-16447_MODURETIC_PIS_RI_AVIS1_CT16447.pdf
HAS/2018-10-09_CT-16798_ZEBINIX_PIS_EI_AVIS2_CT16798.pdf
HAS/2018-10-09_CT-16804_SETOFILM_PIS_RI_AVIS2_CT16804.pdf
HAS/2018-10-09_CT-16986_PIRILENE_PIS_RI_AVIS2_CT16986.pdf
HAS/2018-10-09_CT-17167_RUCONEST_Avis3_EI_CT17167.pdf
HAS/2018-10-09_CT-17240_MOVENTIG comp_QDINS_AVIS1_CT17240.pdf
HAS/2018-10-09_CT-17245_CASPOFUNGINE_ALTAN_QD_INS_AVIS1_CT17245.pdf
HAS/2018-10-09_CT-17305_ATRACURIUM_KALCEKS_QD_INS_Avis1_CT17305.pdf
HAS/2018-10-09_guide_coordination_mg_psy.pdf
HAS/2018-10-09_note_de_cadrage_coordination_mg_psy.pdf
HAS/2018-10-09_rapport_coordination_mg_psy.pdf
HAS/2018-10-09_synthese_coordination_mg_psy.pdf
HAS/2018-10-11_CT-15867_GARDASIL_9_PIC_INS_Avis3_CT15867.pdf
HAS/2018-10-11_dc_2018_0167_pvvih_cd_2018_10_03_vd.pdf
HAS/2018-10-11_doc_ru_2018_09_26.pdf
HAS/2018-10-11_fiche-contraception-urgence.pdf
HAS/2018-10-11_fiche_organisation_parcours_pvvih__v2-091018.pdf
HAS/2018-10-11_guide_handicap_etablissement.pdf
HAS/2018-10-11_infographie_vih_consultation_de_suivi_medecine_generale_pour_impression_a4.pdf
HAS/2018-10-11_note_explicative_cd_2018_09_26.pdf
HAS/2018-10-11_note_methodo_pvvih_vf.pdf
HAS/2018-10-11_parcours_pvvih_vf.pdf
HAS/2018-10-11_reco2clics_obesite_adulte_premiers_recours.pdf
HAS/2018-10-11_synthese_guide_handicap.pdf
HAS/2018-10-12_CEPP-5727_PINNACLE ULTAMET_25_septembre_2018_(5727)_avis.pdf
HAS/2018-10-15_CEPP-5687_AMOENA_25_septembre_2018_(5687)_avis.pdf
HAS/2018-10-15_CEPP-5768_NEUROCYBERNETIC PROTHESIS SYSTEMES 102 & 102R_25_septembre_2018_(5768)_avis.pdf
HAS/2018-10-16_produits_pour_complementation_nutritionnelle_orale_destines_aux_adultes_25_septembre_2018_dm_eval_20_2018-10-16_14-26-49_138.pdf
HAS/2018-10-17_CEPP-5506_RL_09_octobre_2018_(5506)_avis.pdf
HAS/2018-10-17_CEPP-5726_NATRELLE 168_NATRELLE 468_25_septembre_2018_(5726)_avis.pdf
HAS/2018-10-17_CEPP-5770_PHOENIX_25_septembre_2018_(5770)_avis.pdf
HAS/2018-10-17_CEPP-5771_EDEN_09_octobre_2018_(5771)_avis.pdf
HAS/2018-10-17_app_244_ref_aps_icc_vf.pdf
HAS/2018-10-17_app_247_ref_aps_cancers_cd_vf.pdf
HAS/2018-10-17_app_248_ref_aps_pa_vf.pdf
HAS/2018-10-17_app_249_ref_aps_depression_vf.pdf
HAS/2018-10-17_app_329_ref_aps_grossesse_vf.pdf
HAS/2018-10-17_guide_aps_annexes.pdf
HAS/2018-10-17_guide_aps_chapitre_1_connaissances_generales.pdf
HAS/2018-10-17_guide_aps_chapitre_2_evaluation_du_niveau_de_risque_cardiovasculaire.pdf
HAS/2018-10-17_guide_aps_chapitre_3_reperage_en_population_generale.pdf
HAS/2018-10-17_guide_aps_chapitre_4_evaluation_medicale_minimale.pdf
HAS/2018-10-17_guide_aps_chapitre_5_recommandations_pour_la_consultation_et_les_examens_complementaires.pdf
HAS/2018-10-17_guide_aps_chapitre_6_la_consultation_medicale_ap.pdf
HAS/2018-10-17_guide_aps_vf.pdf
HAS/2018-10-17_note_methodo_aps_vf.pdf
HAS/2018-10-17_ref_aps_avc_vf.pdf
HAS/2018-10-17_ref_aps_bpco_vf.pdf
HAS/2018-10-17_ref_aps_dt2_vf.pdf
HAS/2018-10-17_ref_aps_hta_vf.pdf
HAS/2018-10-17_ref_aps_ic_vf.pdf
HAS/2018-10-17_ref_aps_surpoids_obesite_vf.pdf
HAS/2018-10-18_CEPP-5606_KIT BIFLEX_11_septembre_2018_(5606)_avis_occultation.pdf
HAS/2018-10-18_CEPP-5683_PROVOX LUNA_25_septembre_2018_(5683)_avis.pdf
HAS/2018-10-18_CEPP-5795_SENTRY 1200_09_octobre_2018_(5795)_avis.pdf
HAS/2018-10-22_CEPP-5734_NEOVIS TOTAL_09_octobre_2018_(5734)_avis.pdf
HAS/2018-10-22_CEPP-5735_NEOVIS TOTAL MULTI_09_octobre_2018_(5735)_avis.pdf
HAS/2018-10-22_CEPP-5746_HYLOVIS LIPO_09_octobre_2018_(5746)_avis.pdf
HAS/2018-10-22_CEPP-5747_HYLOVIS LIPO MULTI_09_octobre_2018_(5747)_avis.pdf
HAS/2018-10-23_feuille_de_route_strategie_de_depistage_des_infections_a_chlamydia_trachomatis.pdf
HAS/2018-10-23_recommandation_en_sante_publique__reevaluation_de_la_strategie_de_depistage_des_infection_a_chlamydia_trachomatis_vf.pdf
HAS/2018-10-23_synthese_reevaluation_de_la_strategie_de_depistage_des_infections_a_chlamydia_trachomatis.pdf
HAS/2018-10-24_CT-16067_FERRIPROX_PIC_EI_Avis3_CT16067.pdf
HAS/2018-10-24_CT-16359_BRINEURA_PIC_INS_Avis3_CT16359.pdf
HAS/2018-10-24_CT-16449_VEMLIDY_PIC_INS_Avis_post_aud_CT16449.pdf
HAS/2018-10-24_CT-16458_KEYTRUDA_LHc_PIC_EI_Avis3_CT16458.pdf
HAS/2018-10-24_CT-16479_KYLEENA_PIS_INS_Avis3_CT16479.pdf
HAS/2018-10-24_CT-16513_STIVARGA_CHC_PIC_EI_Avis3_CT16513.pdf
HAS/2018-10-24_CT-16527_ENTOCORT_PIC_EI_Avis3_CT16527.pdf
HAS/2018-10-24_CT-16546_DELURSAN_EIT_RI_Avis2_CT16545_16546.pdf
HAS/2018-10-24_CT-16547_RAVICTI_PIC_INS_Avis2_CT16547.pdf
HAS/2018-10-24_CT-16642_ZURAMPIC_PIC_INS_Avis2_CT16642.pdf
HAS/2018-10-24_CT-16665_SONOVUE_PIC_Avis2_EI_CT16665.pdf
HAS/2018-10-24_CT-16676_AXUMIN_PIC_INS_Avis1_CT16676.pdf
HAS/2018-10-24_CT-16718_ELEBRATO-TREGELY_ELLIPTA_PIC_INS_Avis2_CT16718.pdf
HAS/2018-10-24_CT-16853_XIMEPEG_Ins_Avis 2_CT16853.pdf
HAS/2018-10-24_axumin_sapub_ct16676.pdf
HAS/2018-10-24_axumin_summary_ct16676.pdf
HAS/2018-10-24_brineura_sapub_ct16359.pdf
HAS/2018-10-24_brineura_summary_ct16359.pdf
HAS/2018-10-24_dc_2018_0023_eco_effi_ocrevus_sep-pp_cd_2018_02_21-vd.pdf
HAS/2018-10-24_delursan_sapub_ct16545_16546.pdf
HAS/2018-10-24_delursan_summary_ct16545_16546.pdf
HAS/2018-10-24_entocort_sadef_ct16527_revubm.pdf
HAS/2018-10-24_entocort_summary_ct16527.pdf
HAS/2018-10-24_ferriprox_sapub_ct16067.pdf
HAS/2018-10-24_ferriprox_summary_ct16067.pdf
HAS/2018-10-24_keytruda_lhc_sapub_ct16458.pdf
HAS/2018-10-24_keytruda_lhc_summary_ct16458.pdf
HAS/2018-10-24_kyleena_sapub_ct16479.pdf
HAS/2018-10-24_kyleena_summary_ct16479.pdf
HAS/2018-10-24_ocrevus_aib__20122018_avis_efficience.pdf
HAS/2018-10-24_ocrevus_pic_ins_avis_3_ct16833.pdf
HAS/2018-10-24_ocrevus_sep-pp_20122018_avis_efficience.pdf
HAS/2018-10-24_ocrevus_summary_ct16833_en_def.pdf
HAS/2018-10-24_ocrevus_synthese_ct16833.pdf
HAS/2018-10-24_ravicti_sapub_ct16547.pdf
HAS/2018-10-24_ravicti_summary_ct16547.pdf
HAS/2018-10-24_sonovue_sapub_ct16665.pdf
HAS/2018-10-24_sonovue_summary_ct16665.pdf
HAS/2018-10-24_stivarga_chc_sapub_ct16513.pdf
HAS/2018-10-24_stivarga_chc_summary_ct16513.pdf
HAS/2018-10-24_trelegy_elebrato_sapub_ct16718.pdf
HAS/2018-10-24_trelegy_elebrato_summary_ct16718.pdf
HAS/2018-10-24_vemlidy_sapub_ct16449.pdf
HAS/2018-10-24_vemlidy_sapub_ct16449_en_def.pdf
HAS/2018-10-24_ximepeg_ct16853_sapub.pdf
HAS/2018-10-24_ximepeg_ct16853_summary.pdf
HAS/2018-10-24_zurampic_sapub_ct16642.pdf
HAS/2018-10-24_zurampic_summary_ct16642.pdf
HAS/2018-10-25_CT-15863_ACULAR_PIS_RI_AVIS1_CT15863.pdf
HAS/2018-10-25_CT-16607_MAVENCLAD_PICins_avis3_CT16607.pdf
HAS/2018-10-25_CT-16840_ARTELAC_PIS_RI_AVIS1_CT16840.pdf
HAS/2018-10-25_CT-16922_ELSEP_PICrééval_avis3_CT16922.pdf
HAS/2018-10-25_CT-16923_GILENYA_PICrééval_avis3_CT16923.pdf
HAS/2018-10-25_CT-16924_LEMTRADA_PICrééval_avis3_CT16924 (2).pdf
HAS/2018-10-25_CT-16983_TRESIBA_PIC_EI_Avis2_CT16983.pdf
HAS/2018-10-25_CT-17149_CONDYLINE_PIS_RI_Avis2_CT17149.pdf
HAS/2018-10-25_CT-17337_BETAHISTINE_ARROW_QD_INS_AVIS1_CT17337.pdf
HAS/2018-10-25_tresiba_summary_ct16983.pdf
HAS/2018-10-25_tresiba_synthese_ct16983.pdf
HAS/2018-10-25_tysabri_picreeval_avis3_ct16918.pdf
HAS/2018-10-26_CT-13257_VIREAD_PIS_RI_AVIS1_CT13257.pdf
HAS/2018-10-26_CT-14165_XELODA_PIS_RI_AVIS1_CT14165.pdf
HAS/2018-10-26_CT-15831_VIRGAN_PIS_RI_AVIS2_CT15831.pdf
HAS/2018-10-26_CT-16308_REVAXIS_PIS_RI_Avis1_CT16308.pdf
HAS/2018-10-26_CT-16446_CORENITEC_PIS_RI_Avis1_CT16446.pdf
HAS/2018-10-26_CT-16719_CERNEVIT_PIS_RI_Avis1_CT16719.pdf
HAS/2018-10-26_CT-16807_GRANIONS_DE_ZINC_EI_acrodermatite_Avis1_CT16807.pdf
HAS/2018-10-26_CT-16871_CHLORURE DE SODIUM B BRAUN_PIS_RI_AVIS2_CT16871.pdf
HAS/2018-10-26_CT-16895_FLUIDABAK_PIS_RI_AVIS2_CT16895.pdf
HAS/2018-10-26_CT-16896_GAMMATETANOS_PIS_RI_Avis1_CT16896.pdf
HAS/2018-10-26_CT-16938_TUSSIDANE_PIS_RI_AVIS1_CT16938.pdf
HAS/2018-10-26_CT-17087_MESNA_QD_INS_AVIS1_CT17087.pdf
HAS/2018-10-26_CT-17090_IMIPENEM_CILASTATINE_GERDA_QD_INS_AVIS1_CT17090.pdf
HAS/2018-10-26_CT-17100_LEVOFREE_SansConservateur_INS_PIS_AVIS1_CT17100.pdf
HAS/2018-10-26_CT-17104_MEROPENEM BRADEX_QD_INS_avis2_CT17104.pdf
HAS/2018-10-26_CT-17129_SOLUMEDROL_PIS_RI_Avis2_CT17129.pdf
HAS/2018-10-26_CT-17145_ALOPLASTINE_PIS_RI_Avis2_CT17145.pdf
HAS/2018-10-26_CT-17153_CASPOFUNGINE_HIKMA_QD_INS_AVIS1_CT17153.pdf
HAS/2018-10-26_CT-17211_DESOGESTREL_SANDOZ_QD_INS_AVIS1_CT17211.pdf
HAS/2018-10-26_CT-17216_IZALGI_QD_INS_AVIS2_CT17216.pdf
HAS/2018-10-26_CT-17217_MAGINJECTABLE_QD_INS_Avis1_CT17217.pdf
HAS/2018-10-26_CT-17239_FLECTOR_QD_INS_AVIS1_CT17239.pdf
HAS/2018-10-26_CT-17244_RYDAPT_QD_INS_AVIS1_CT17244.pdf
HAS/2018-10-26_CT-17306_VANCOMYCINE HIKMA_QDInsc_avis2_CT17306.pdf
HAS/2018-10-26_CT-17330_CASPOFUNGINE_NORIDEM_QD_INS_avis2_CT17330.pdf
HAS/2018-10-26_CT-17343_REPATHA_420mg_QD_INS_AVIS2_CT17343.pdf
HAS/2018-10-26_roactemra_sc_eit_ajip_avis2_modifie_le05112018_ct_17189.pdf
HAS/2018-11-06_CT-16566_INFANRIX_HEXA_PIS_RI_Avis2_CT16566.pdf
HAS/2018-11-08_CEPP-5638_ACURATE NEO_23_octobre_2018_(5638)_avis.pdf
HAS/2018-11-08_CEPP-5707_ALOVA_22_octobre_2018_(5707)_avis.pdf
HAS/2018-11-08_CEPP-5774_SPIROTEL V2_22_octobre_2018_(5774)_avis.pdf
HAS/2018-11-09_CEPP-5617_LUTONIX 035_25_septembre_2018_(5617)_avis_occultation.pdf
HAS/2018-11-09_CEPP-5741_ARTISAN MRI_25_septembre_2018_(5741)_avis_occultation.pdf
HAS/2018-11-09_silk_.pdf
HAS/2018-11-12_CEPP-5651_TREGOR MEDIAL CUP_06_novembre_2018_(5651)_avis.pdf
HAS/2018-11-12_CEPP-5698_NOVAE E TH et COPTOS TH_23_octobre_2018_(5698)_avis.pdf
HAS/2018-11-12_CEPP-5709_SYMBOL CUP_GYRACUP_DS EVOLUTION sans ciment_09_octobre_2018_(5709)_avis_occultation.pdf
HAS/2018-11-12_CEPP-5711_SYMBOLCUP_GYRACUP_DS EVOLUTION à cimenter_09_octobre_2018_(5711)_avis_occultation.pdf
HAS/2018-11-12_CEPP-5748_HOT AXIOS_09_octobre_2018_(5748)_avis_occultation.pdf
HAS/2018-11-12_CEPP-5773_PROFEMUR L_06_novembre_2018_(5773)_avis.pdf
HAS/2018-11-12_CEPP-5790_PROFEMUR GLADIATOR à cimenter_06_novembre_2018_(5790)_avis.pdf
HAS/2018-11-12_CEPP-5791_PROFEMUR GLADIATOR sans ciment_06_novembre_2018_(5791)_avis.pdf
HAS/2018-11-12_CEPP-5808_CERAVER OSTEAL_22_octobre_2018_(5808)_avis.pdf
HAS/2018-11-12_guide_methodo_vf.pdf
HAS/2018-11-12_note_de_synthese_place_de_la_qualite_de_vie.pdf
HAS/2018-11-12_principes_devaluation_de_la_cnedimts-v4-161117.pdf
HAS/2018-11-13_CT-15870_ZYPREXA_PIS_RI_Avis2_CT15870.pdf
HAS/2018-11-13_CT-15918_ZYPADHERA_PIS_EPI_Avis2_CT15918.pdf
HAS/2018-11-13_CT-16517_GLIVEC_PIS_RI_AVIS1_CT16517.pdf
HAS/2018-11-13_CT-17019_ROVAMYCINE_PIS_RI_Avis2_CT17019.pdf
HAS/2018-11-13_CT-17136_COLPOTROPHINE_PIS_RI_AVIS1_CT17136.pdf
HAS/2018-11-13_CT-17146_ROVALCYTE_PIS_RI_AVIS2_CT17146.pdf
HAS/2018-11-13_CT-17150_FONX_PIS_RI_AVIS2_CT17150.pdf
HAS/2018-11-13_CT-17173_ERYTHROMYCINE BAILLEUL_ERYTHROGEL_PISRI_AVIS2_CT17173.pdf
HAS/2018-11-13_CT-17230_ENOXAPARINE_BECAT_PIS_INS_AVIS1_CT17230.pdf
HAS/2018-11-13_CT-17295_LIDOCAINE_AGUETTANT_QD_INS_AVIS1_CT17295.pdf
HAS/2018-11-13_CT-17329_ERTAPENEM ARROW 1 g_QD_INS_AVIS1_CT17329.pdf
HAS/2018-11-13_CT-17387_ULTIBRO_BREEZHALER_Obs_BaisseDeTaux_Avis3_CT17387.pdf
HAS/2018-11-14_CEPP-5658_INTELLIS_06_novembre_2018_(5658)_avis.pdf
HAS/2018-11-14_CEPP-5691_PROMUS PREMIER_23_octobre_2018_(5691)_avis_occultation.pdf
HAS/2018-11-14_CEPP-5692_PROMUS ELITE_23_octobre_2018_(5692)_avis_occultation.pdf
HAS/2018-11-14_CEPP-5695_CICA CARE_06_novembre_2018_(5695)_avis.pdf
HAS/2018-11-14_CEPP-5713_ULTIMASTER TANSEI_06_novembre_2018_(5713)_avis_occultation.pdf
HAS/2018-11-14_CT-14436_METHERGIN_PIC_RI_Avis 1_CT14436.pdf
HAS/2018-11-14_CT-16242_OPDIVO_ORL_PIC_EI_ Avis3_CT16242.pdf
HAS/2018-11-14_CT-16500_ZYKADIA_PIC_EI_1ere_ligne_Avis2_CT16500.pdf
HAS/2018-11-14_CT-16605_DUPIXENT_PIC_INS_avis3_CT16605.pdf
HAS/2018-11-14_CT-16722_ZEJULA_PIC_ Ins_Avis 2_CT16722.pdf
HAS/2018-11-14_CT-16745_EQWILATE_PIC_INS_Avis3_CT16745.pdf
HAS/2018-11-14_CT-16771_ALECENSA_1ere Ligne_Avis 2_CT16771.pdf
HAS/2018-11-14_alecensa_11102018_avis_efficience.pdf
HAS/2018-11-14_alecensa_poumon_1ligne_sapub_ct16771.pdf
HAS/2018-11-14_alecensa_poumon_1ligne_sapub_ct16771_en_val.pdf
HAS/2018-11-14_dupixent_22052018_avis_efficience_2020-02-12_11-37-56_458.pdf
HAS/2018-11-14_dupixent_summary_ct16005.pdf
HAS/2018-11-14_dupixent_synthese_ct16005.pdf
HAS/2018-11-14_eqwilate_summary_ct16745.pdf
HAS/2018-11-14_eqwilate_synthese_ct16745.pdf
HAS/2018-11-14_intellis_fiche_dinformation_therapeutique.pdf
HAS/2018-11-14_juluca_ins_avis2_modifie_07092018_ct16942.pdf
HAS/2018-11-14_juluca_summary_ct16942.pdf
HAS/2018-11-14_juluca_synthese_ct16942.pdf
HAS/2018-11-14_methergin_summary_ct14436.pdf
HAS/2018-11-14_methergin_synthese_ct14436.pdf
HAS/2018-11-14_opdivo_20171107_avis_efficience.pdf
HAS/2018-11-14_opdivo_summary_ct16242_en_def.pdf
HAS/2018-11-14_opdivo_synthese_ct16242.pdf
HAS/2018-11-14_synergy_.pdf
HAS/2018-11-14_zejula_12102018_avis_efficience.pdf
HAS/2018-11-14_zejula_summary_ct16722.pdf
HAS/2018-11-14_zejula_synthese_ct16722.pdf
HAS/2018-11-14_zykadia_poumon_1ligne_sapub_ct16500_en_def.pdf
HAS/2018-11-14_zykadia_poumon_1ligne_synthese_ct16500.pdf
HAS/2018-11-20_CEPP-5766_PROTHESE TMJ_06_novembre_2018_(5766)_avis.pdf
HAS/2018-11-20_ald_28_lap_suite_transplantation_web.pdf
HAS/2018-11-20_guidem_scoliose_web.pdf
HAS/2018-11-20_guidem_syndrome_myelo_version_web_2008_05_20__8_32_46_696.pdf
HAS/2018-11-20_lap_scoliose_web.pdf
HAS/2018-11-20_lap_syndrome_myelo_version_web.pdf
HAS/2018-11-20_mai_08_guidem_syndrome_myelo_version_web_en_revu_ec_mg.pdf
HAS/2018-11-20_suivi_du_transplante_renal_-_synthese_des_recommandations.pdf
HAS/2018-11-23_10__ssp_be__fiche_evaluation.pdf
HAS/2018-11-23_11_ssp_be_fiche_action.pdf
HAS/2018-11-23_1_ssp_be.pdf
HAS/2018-11-23_2__ssp_be_fiche_feu_bo.pdf
HAS/2018-11-23_3__ssp_be_fiche_cfar_stim_card.pdf
HAS/2018-11-23_4__ssp_be_fcvd.pdf
HAS/2018-11-23_5__ssp_be_oa_chirped.pdf
HAS/2018-11-23_6_ssp_be_orthorisq.pdf
HAS/2018-11-23_7_ssp_be_cefa_hge.pdf
HAS/2018-11-23_8_ssp_be_gynerisq.pdf
HAS/2018-11-23_9_ssp_be_points_cles.pdf
HAS/2018-11-23_CEPP-5612_PODIABETES CORTINA & PODIABETES COURMAYEUR_20_novembre_2018_(5612)_avis.pdf
HAS/2018-11-23_CEPP-5703_TREGOR PLUS_06_novembre_2018_(5703)_avis.pdf
HAS/2018-11-23_CEPP-5712_PK PAPYRUS_06_novembre_2018_(5712)_avis_occultation.pdf
HAS/2018-11-23_CEPP-5809_GERY_06_novembre_2018_(5809)_avis.pdf
HAS/2018-11-23_algorithme_daide_a_la_decision_dorientation_des_patients_en_hospitalisation_a_domicile_had_a_destination_des_medecins_prescr.pdf
HAS/2018-11-23_feuille_de_route_-_algorithme_daide_a_la_decision_dorientation_des_patients_en_hospitalisation_a_domicile_had_a_destination_.pdf
HAS/2018-11-23_flyer_adop-had.pdf
HAS/2018-11-23_itrel_4.pdf
HAS/2018-11-23_managing_the_risks_associated_with_an_electrosurgical_device.pdf
HAS/2018-11-23_primeadanced_surescan_mri.pdf
HAS/2018-11-23_restoreadvanced_surescan_mri-restoresensor_surescan_mri_fiche_dinformation_therapeutique.pdf
HAS/2018-11-23_restoreadvanced_surescan_mri-restoresensor_surescan_mri_fiche_dinformation_therapeutique_2018-11-30_12-18-21_169.pdf
HAS/2018-11-23_restoreadvanced_surescan_mri.pdf
HAS/2018-11-23_restoresensor.pdf
HAS/2018-11-23_restoresensor_fiche_dinformation_therapeutique.pdf
HAS/2018-11-23_restoresensor_surescan_mri.pdf
HAS/2018-11-27_CT-16834_STRIBILD_PIC_EI_pédiatrie_Avis2_CT16834.pdf
HAS/2018-11-27_CT-16929_GENVOYA_PIC_EI_pédiatrie_Avis2_CT16929.pdf
HAS/2018-11-27_genvoya_sapub_ct16929.pdf
HAS/2018-11-27_genvoya_summary_ct16929.pdf
HAS/2018-11-27_prolia_opm_reeval_ct16525_avis_3.pdf
HAS/2018-11-27_prolia_sapub_ct16525.pdf
HAS/2018-11-27_prolia_summary_ct16525.pdf
HAS/2018-11-27_stribild_sapub_ct16834.pdf
HAS/2018-11-27_stribild_summary_ct16834_en_val.pdf
HAS/2018-11-27_symtuza_pic_ins_avis_post_audition_ct16608.pdf
HAS/2018-11-27_symtuza_sapub_ct16608_2018-11-26_15-11-47_650.pdf
HAS/2018-11-27_symtuza_summary_ct16608.pdf
HAS/2018-11-28_CT-16384_CHENODEOXYCHOLIC_ACID_LEADIANT_PIC_INS_Avis2_CT16384.pdf
HAS/2018-11-28_CT-16400_REFIXIA_PIC_INS_Avis3_CT16400.pdf
HAS/2018-11-28_CT-16427_REPATHA_REEVAL_PIC_AVIS3_CT16427.pdf
HAS/2018-11-28_CT-16606_LUTATHERA_PIC_INS_Avis3_CT16606.pdf
HAS/2018-11-28_CT-16723_MIMPARA_PIC_EI_Avis3_CT16723.pdf
HAS/2018-11-28_chenodeoxycholic_acid_sapub_ct16384.pdf
HAS/2018-11-28_chenodeoxycholic_acid_sapub_ct16384_en_val.pdf
HAS/2018-11-28_lutathera_22052018_avis_efficience_2020-02-12_11-34-19_105.pdf
HAS/2018-11-28_lutathera_sapub_ct16606.pdf
HAS/2018-11-28_lutathera_summary_ct16606.pdf
HAS/2018-11-28_mimpara_sapub_ct16723.pdf
HAS/2018-11-28_mimpara_summary_ct16723.pdf
HAS/2018-11-28_pegasys_13062018_avis_ct16805.pdf
HAS/2018-11-28_pegasys_sapub_ct16805.pdf
HAS/2018-11-28_pegasys_summary_ct16805.pdf
HAS/2018-11-28_refixia_sapub_ct16400.pdf
HAS/2018-11-28_refixia_summary_ct16400.pdf
HAS/2018-11-28_repatha_sapub_ct16427.pdf
HAS/2018-11-28_repatha_summary_ct16427.pdf
HAS/2018-11-29_1._ssp_no_go.pdf
HAS/2018-11-29_2._ssp_no_go_points_cles.pdf
HAS/2018-11-29_2010_cl_endoscopie_digestive_sfed_has.pdf
HAS/2018-11-29_3._outil_pour_decider.pdf
HAS/2018-11-29_4._ssp_no_go__fiche_evaluation.pdf
HAS/2018-11-29_5._ssp_no_go_fiche_action.pdf
HAS/2018-11-29_check-list_english_version.pdf
HAS/2018-11-29_check-list_interactive_securite.pdf
HAS/2018-11-29_etude_implantation_utilisation_cl_endoscopie_digestive.pdf
HAS/2018-11-29_la_check-list_comment_ca_marche.pdf
HAS/2018-11-29_mc_238_actualisation_litterature_etp_vf.pdf
HAS/2018-11-29_mc_238_synthese_litterature_etp_vf.pdf
HAS/2018-11-29_mode_demploi_de_la_version_2016_de_la_check-list_securite_du_patient_au_bloc_operatoire.pdf
HAS/2018-11-29_mode_demploi_et_version_2016_de_la_check-list_securite_du_patient_au_bloc_operatoire.pdf
HAS/2018-11-29_no_go_in_the_operating_room.pdf
HAS/2018-11-29_orientations_etp_v4_191118_vf.pdf
HAS/2018-11-29_points_cles_et_solutions.pdf
HAS/2018-11-29_rapport_elaboration_ssp_cl_1911.pdf
HAS/2018-11-29_version_2016_de_la_check-list_securite_du_patient_au_bloc_operatoire.pdf
HAS/2018-11-30_CT-16187_SPRYCEL_PIS_RI_AVIS2_CT16187.pdf
HAS/2018-11-30_CT-16645_CLARELUX_RI2018_PIS_AVIS2_CT16645.pdf
HAS/2018-11-30_CT-16742_VIMPAT_PIC_EI_Avis3_CT16742.pdf
HAS/2018-11-30_CT-16825_AVAMYS_PISRI_AVIS1_CT16825.pdf
HAS/2018-11-30_CT-16860_IKERVIS_PIC_REEV_Avis postaudition_CT16860.pdf
HAS/2018-11-30_CT-16951_HALAVEN_Rééval2_Liste en sus_Avis postaudition_CT16951.pdf
HAS/2018-11-30_CT-16994_PERGOVERIS_PIS_RI_AVIS2_CT16994.pdf
HAS/2018-11-30_CT-17079_FLAGYL_PIS_RI_AVIS2_CT17079.pdf
HAS/2018-11-30_CT-17081_CORTIMENT_PIC_REEV_Avis 1_CT17081.pdf
HAS/2018-11-30_CT-17082_MICROVAL_PIS_RI_AVIS2_CT17082.pdf
HAS/2018-11-30_CT-17108_PANTESTONE_PIS_RI_AVIS1_CT17108.pdf
HAS/2018-11-30_CT-17155_AFFERA_PISRI_AVIS2_CT17155.pdf
HAS/2018-11-30_CT-17193_SELEXID_QD_INS_AVIS1_CT17193.pdf
HAS/2018-11-30_CT-17212_TROPHICREME_PIS_RI_AVIS1_CT17212.pdf
HAS/2018-11-30_CT-17213_SYNACTHENE_PIS_RI_AVIS1_CT17213.pdf
HAS/2018-11-30_CT-17263_STREPTOZOCINE_KEOCYT_INS_AVIS2_CT17263.pdf
HAS/2018-11-30_CT-17279_RIFATER_PIS_RCP_AVIS1_CT17279.pdf
HAS/2018-11-30_CT-17292_RIFINAH_PIS_RCP_AVIS1_CT17292.pdf
HAS/2018-11-30_CT-17333_ACICLOVIR BIOGARAN _intention de radier_17333.pdf
HAS/2018-11-30_CT-17335_PROPRANOLOL_ACETLAB_5mg5ml_QD_INS_AVIS1_CT17335.pdf
HAS/2018-11-30_CT-17342_CEFEPIME_NORIDEM_QD_INS_Avis2_CT17342.pdf
HAS/2018-11-30_CT-17344_KEYTRUDA_PIS_RCP_AVIS2_CT17344.pdf
HAS/2018-11-30_CT-17364_CASPOFUNGINE_B_BRAUN_QD_INS_Avis2_CT17364.pdf
HAS/2018-11-30_CT-17368_FEBUXOSTAT_TEVA_SANTE_QD_INS_AVIS2_CT17368.pdf
HAS/2018-11-30_CT-17376_DACARBAZINE_MEDAC_QD_INS_AVIS1_CT17376.pdf
HAS/2018-11-30_CT-17400_MERONEM_PIS_RI_AVIS2_CT17400.pdf
HAS/2018-11-30_CT-17425_BICARBONATE DE SODIUM_RENAUDIN_QD_INS_AVIS1_CT17425.pdf
HAS/2018-11-30_aciclovir_eg_2112018_avis_ct17334.pdf
HAS/2018-11-30_bimaprost_timolol_chauvin_qd_ins_avis1_ct16971.pdf
HAS/2018-11-30_halaven_summary_ct_16951.pdf
HAS/2018-11-30_halaven_synthese_ct_16951.pdf
HAS/2018-11-30_ikervis_synthese_ct16232_16860.pdf
HAS/2018-12-03_CEPP-5810_EDEN_20_novembre_2018_(5810)_avis.pdf
HAS/2018-12-03_CEPP-5818_SPECTRA WAVEWRITER_20_novembre_2018_(5818)_avis_occultation.pdf
HAS/2018-12-03_spectra_wavewriter_fiche_dinformation_therapeutique.pdf
HAS/2018-12-04_CT-16795_NANOCOLL_PIS_EI_Avis1_CT16795.pdf
HAS/2018-12-04_crt_8000.pdf
HAS/2018-12-04_synchromed_ii.pdf
HAS/2018-12-05_CT-15876_FIXICAL_VITAMINE_D3_PIS_Avis2_CT15876.pdf
HAS/2018-12-05_CT-16989_VERAPAMIL_MYLAN_LP_120_PIS_RI_AVIS1_CT16491_CT16989.pdf
HAS/2018-12-05_CT-17006_SAVARINE_PISRI_AVIS2_CT17006.pdf
HAS/2018-12-05_CT-17099_ORACILLINE_PISRI_AVIS2_CT17099.pdf
HAS/2018-12-05_CT-17105_OFLOXACINE MACO PHARMA_QD_INS_AVIS2_CT17105.pdf
HAS/2018-12-05_CT-17124_CYTEAL_PIS_RI_AVIS1_CT17124.pdf
HAS/2018-12-05_CT-17132_LOCAPRED_LOCATOP_PIS_RI_avis1_CT17132.pdf
HAS/2018-12-05_CT-17218_GRISEFULINE_RI_PIS_AVIS2_EDEPOT_CT17218.pdf
HAS/2018-12-05_CT-17256_SECNOL_RI_AVIS1-CT17256.pdf
HAS/2018-12-05_CT-17269_ZYKADIA_150mg_QD_INS_AVIS1_CT17269.pdf
HAS/2018-12-05_CT-17369_GALLIAD_PIS_INS_AVIS1_CT17369.pdf
HAS/2018-12-05_CT-17401_NICOTINELL_QD_INS_AVIS2_CT17401.pdf
HAS/2018-12-05_potassium_liberty_pharma_qd_ins_avis1_ct17262.pdf
HAS/2018-12-05_rifadine_pis_rcp_avis1_ct17278.pdf
HAS/2018-12-06_07-008_insuf-asthm-guide_sans_lap.pdf
HAS/2018-12-06_bpco_sans_lap.pdf
HAS/2018-12-06_gm_anglais_asthme_web.pdf
HAS/2018-12-06_guide_patient-asthme.pdf
HAS/2018-12-06_guide_patient-bcpo.pdf
HAS/2018-12-06_lap_irc_asthme_actualisee_ald_14_web.pdf
HAS/2018-12-07_argumentairemrc.16082018.pdf
HAS/2018-12-07_pndsmrchas30112018.pdf
HAS/2018-12-07_synthese_mg_maladie_renale_chronique_de_l_enfant.pdf
HAS/2018-12-10_dan_plaquette_vf.pdf
HAS/2018-12-10_dan_rapport_2014_vf_2014-12-17_14-39-26_406.pdf
HAS/2018-12-10_dc_2018_iqss81_rapport_des_campagnes_des_iqss_2018_cd_2018_12_05.pdf
HAS/2018-12-10_ipaqss-rapport-rcp.pdf
HAS/2018-12-10_ipaqss_analyse_descriptive_mco.pdf
HAS/2018-12-10_ipaqss_rapport-resultats-rcp_2010.pdf
HAS/2018-12-10_ipaqss_rapport_dan_2011.pdf
HAS/2018-12-10_ipaqss_rapport_dan_v4.pdf
HAS/2018-12-10_plaquette_dan_vf.pdf
HAS/2018-12-10_plaquette_rcp_vf.pdf
HAS/2018-12-10_rapport-facteurs-associes-v2.pdf
HAS/2018-12-10_rapport_2016_dan_mco_vf.pdf
HAS/2018-12-10_rapport_2016_rcp_vf.pdf
HAS/2018-12-10_rapport_dan_2018.pdf
HAS/2018-12-10_rapport_iqss_2018.pdf
HAS/2018-12-10_rapport_rcp_2018.pdf
HAS/2018-12-10_rapport_rcp_vf.pdf
HAS/2018-12-10_rcp_plaquette_vf.pdf
HAS/2018-12-11_CEPP-5655_INPACT ADMIRAL_06_novembre_2018_(5655)_avis_occultation.pdf
HAS/2018-12-11_CEPP-5672_SENTRY 1200 ST_04_décembre_2018_(5672)_avis.pdf
HAS/2018-12-11_CT-15682_UNIFLUID_PIS_RI_AVIS2_CT15682.pdf
HAS/2018-12-11_CT-16090_LARMABAK_RI2018_PIS_AVIS2_CT16090.pdf
HAS/2018-12-11_CT-16203_PARIET_PISRI_AVIS1_CT16203.pdf
HAS/2018-12-11_CT-16539_ALVESCO_PISRI_AVIS1_CT16539.pdf
HAS/2018-12-11_CT-17002_TRUVADA_PrEP_Ado_PIC_Avis 2_CT17002.pdf
HAS/2018-12-11_CT-17007_PALUDRINE_PISRI_AVIS1_CT17007.pdf
HAS/2018-12-11_CT-17095_CORTANCYL_PIS_RI_avis1_CT17095.pdf
HAS/2018-12-11_CT-17118_CIPROFLOXACINE_MACOPHARMA_QD_INS_AVIS2_CT17118.pdf
HAS/2018-12-11_CT-17119_FLUCONAZOLE_MACOPHARMA_QD_INS_AVIS1_CT17119.pdf
HAS/2018-12-11_CT-17270_ZYKADIA_150mg_PIS_Modif de RCP_Avis1_CT17270.pdf
HAS/2018-12-11_CT-17273_ROCURONIUM_MYLAN_QD_INS_AVIS2_CT17273.pdf
HAS/2018-12-11_CT-17324_PELGRAZ_PIS_INS_Avis1_CT17324.pdf
HAS/2018-12-11_CT-17353_MIFEGYNE_QD_INS_AVIS2_CT17353.pdf
HAS/2018-12-11_CT-17371_COLISTIMETHATE_MEDAC_QD_INS__AVIS1_CT17371.pdf
HAS/2018-12-11_CT-17377_BORTEZOMIB_REDDY_PHARMA_QD_AVIS2_CT17377.pdf
HAS/2018-12-11_CT-17391_PLEGISOL_QD_INS_AVIS1_CT17391.pdf
HAS/2018-12-11_CT-17420_BUPRENORPHINE_NALOXONE_ARROW_QD_INS_AVIS1_CT17420.pdf
HAS/2018-12-12_CEPP-5737_GLASSBONE PUTTY_04_décembre_2018_(5737)_avis.pdf
HAS/2018-12-12_CT-15614_NAABAK-NAAXIA-NAAXIAFREE_RI2018_PIS_AVIS2_CT15614.pdf
HAS/2018-12-12_CT-15768_VOLTARENOPHTABAK_RI2018_PIS_avis2_CT15768.pdf
HAS/2018-12-12_CT-16677_LEVETIRACETAM_HIKMA_QD_INS_Avis1_CT16677.pdf
HAS/2018-12-12_CT-17243_LIDOCAINE_KABI_QD_INS_AVIS1_CT17243.pdf
HAS/2018-12-12_CT-17336_RESPREEZA_QDINS_AVIS2_CT17336.pdf
HAS/2018-12-12_CT-17415_HULIO_PIS_INS_AVIS2_CT17415.pdf
HAS/2018-12-12_alber_e-pilot.pdf
HAS/2018-12-12_cisatracurium_mylan_qdins_avis2_ct17272.pdf
HAS/2018-12-12_neosynephrine-faure-revalsmr_ri_avis2_ct15005.pdf
HAS/2018-12-12_tasigna_pis_ri_avis2_ct15574.pdf
HAS/2018-12-13_CT-15931_LACRYVISC_PISRI_AVIS1_CT15931.pdf
HAS/2018-12-13_CT-17459_MIGLUSTAT_ACCORD_QD_INS_AVIS1_CT17459.pdf
HAS/2018-12-13_app_239_rapport_ssr_bpco_cd_2018_12_05_vfinale.pdf
HAS/2018-12-13_decision_d2018-19_rbpp_qualite_vie_en_residences_autonomie.pdf
HAS/2018-12-13_fiche_bum_glucose.pdf
HAS/2018-12-13_qualite_de_vie_en_residences_autonomie-argumentaire.pdf
HAS/2018-12-13_qualite_de_vie_en_residences_autonomie-enquete.pdf
HAS/2018-12-13_qualite_de_vie_en_residences_autonomie-fr_pp_ra.pdf
HAS/2018-12-13_qualite_de_vie_en_residences_autonomie-recommandations.pdf
HAS/2018-12-13_qualite_de_vie_en_residences_autonomie-synthese.pdf
HAS/2018-12-14_rapport_eval_encadrement_des_centres_tavi_2018.pdf
HAS/2018-12-17_20181212_pnds_atresie_de_loesophage__argumentaire_scientifique_dec_2018_vf_charte_2018-12-14_15-47-39_463.pdf
HAS/2018-12-17_20181212_pnds_atresie_de_loesophage_dec_2018_vf_charte.pdf
HAS/2018-12-17_brochure_rencontres_securite_un_partenariat_entre_les_equipes_et_la_gouvernance_novembre_2018.pdf
HAS/2018-12-17_guide_methodologique_et_outils__rencontres_securite_un_partenariat_entre_les_equipes_et_la_gouvernance_novembre_2018.pdf
HAS/2018-12-17_illustration_experimentation_rencontres_securite_novembre_2018.pdf
HAS/2018-12-17_outil_2_support_pedagogiue_rencontres_securite_novembre_2018.pdf
HAS/2018-12-17_outil_6_fiche_memo_rencontres_securite_novembre_2018.pdf
HAS/2018-12-17_pnds_18_-_atresie_de_loesophage_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2018-12-17_rapport_dexperimentation_rencontres_securite_un_partenariat_entre_les_equipes_et_la_gouvernance_novembre_2018.pdf
HAS/2018-12-17_vue_synthetique_et_outils_rencontres_securite_novembre_2018.pdf
HAS/2018-12-18_CT-16401_PRAXBIND_PIC_REEV_Avis3_CT16401.pdf
HAS/2018-12-18_CT-16820_HUMIRA_EIT_uveiteEnfant_Avis2_CT16820.pdf
HAS/2018-12-18_CT-16841_BYDUREON_PIC_EI_Avis2_CT16841.pdf
HAS/2018-12-18_CT-16886_SAMSCA_PIC_CT16886_Avis3.pdf
HAS/2018-12-18_CT-16891_FLUARIXTETRA_PIC_EI_Avis3_CT16891.pdf
HAS/2018-12-18_CT-16892_TREMFYA_INS_PIS_avis3_CT16892.pdf
HAS/2018-12-18_CT-16916_SIALANAR_INS_ Avis 1_CT16916.pdf
HAS/2018-12-18_bydureon_sapub_ct16841.pdf
HAS/2018-12-18_bydureon_summary_ct16841.pdf
HAS/2018-12-18_fiche_info_patients_dpd_5_fu.pdf
HAS/2018-12-18_fluarixtetra_summary_ct16891.pdf
HAS/2018-12-18_fluarixtetra_synthese_ct16891.pdf
HAS/2018-12-18_humira_uveite_enfant_sapub_ct16820.pdf
HAS/2018-12-18_humira_uveite_enfant_synthese_ct16820.pdf
HAS/2018-12-18_inahta_brief_dpd_5fu.pdf
HAS/2018-12-18_praxbind_sapub_ct16401_en_val.pdf
HAS/2018-12-18_praxbind_synthese_ct16401.pdf
HAS/2018-12-18_recherche_dun_deficit_en_dihydropyrimidine_deshydrogenase_visant_a_prevenir_certaines_toxicites_severes_associees_aux_traite.pdf
HAS/2018-12-18_samsca_sapub_ct16886_en_val.pdf
HAS/2018-12-18_samsca_synthese_ct16886.pdf
HAS/2018-12-18_sialanar_sadef_ct16916_en_val.pdf
HAS/2018-12-18_sialanar_synthese_ct16916.pdf
HAS/2018-12-18_tremfya_sapub_ct16892_en_val.pdf
HAS/2018-12-18_tremfya_synthese_ct16892.pdf
HAS/2018-12-20_CEPP-5693_SIR_SPHERE_5693_avis_6_novembre_2018_occultation_accord_MJ.pdf
HAS/2018-12-20_CEPP-5798_IALUSET PLUS_04_décembre_2018_(5798)_avis.pdf
HAS/2018-12-20_argumentaire_pied_diabetique_vd.pdf
HAS/2018-12-20_fm_valproate_epilepsie_maj_oct2018.pdf
HAS/2018-12-20_fm_valproate_trouble_bi_maj_oct2018.pdf
HAS/2018-12-20_inahta_brief_diabetic_foot.pdf
HAS/2018-12-20_rapport_d_elaboration_alternatives_acide_valproique_2015-12-08_15-24-53_180.pdf
HAS/2018-12-20_sir-spheres_11122018_avis_efficience.pdf
HAS/2018-12-21_ac_2018_0062_assainissement_parodontal_cd_2018_12_19_vd.pdf
HAS/2018-12-21_annexe_rapport_t632_assainissement_parodontal.pdf
HAS/2018-12-21_annexes_dsm_estomac_vd.pdf
HAS/2018-12-21_annexes_dsm_oesophage_vd.pdf
HAS/2018-12-21_inahta_brief_oesophageal_cancer.pdf
HAS/2018-12-21_inahta_brief_periodontal_disease.pdf
HAS/2018-12-21_inahta_brief_stomach_cancer.pdf
HAS/2018-12-21_rapport_dsm_estomac_vd.pdf
HAS/2018-12-21_rapport_dsm_oesophage_vd.pdf
HAS/2018-12-26_pnds_hpe-_texte_pnds-_decembre_2018.pdf
HAS/2018-12-26_pnds_hpe_-_argumentaire_so-_decembre_2018.pdf
HAS/2018-12-26_synthese_mg_holoprosencephalie_hpe_et_formes_apparentees.pdf
HAS/2018-12-27_CT-15946_YELLOX_PIS_RI_Avis1_CT15946.pdf
HAS/2018-12-27_CT-16473_MOVIPREP_Avis2_PIS_RI_CT16473.pdf
HAS/2018-12-27_CT-16858_ARTIREM_PIS_RI_Avis1_CT16858.pdf
HAS/2018-12-27_CT-16899_VIZITRAV_QD_INS_Avis3_CT16899.pdf
HAS/2018-12-27_CT-16941_KIVIZIDIALE_QD_INS_Avis3_CT16941.pdf
HAS/2018-12-27_CT-17000_OROFLUCO_PIS_RI_Avis1_CT17000.pdf
HAS/2018-12-27_CT-17003_SPIFEN_PIS_RI_Avis2_CT17003.pdf
HAS/2018-12-27_CT-17056_TOPSYNE_PIS_RI_Avis1_CT17056.pdf
HAS/2018-12-27_CT-17075_LYNPARZA_comp_PIS_INS_Avis3_CT17075.pdf
HAS/2018-12-27_CT-17089_MEDIKINET_PIS_RI_Avis2_CT17089.pdf
HAS/2018-12-27_CT-17143_KEYTRUDA_PIC_REEV_Avis3_CT17143.pdf
HAS/2018-12-27_CT-17179_INSULINE_LISPRO_SANOFI_PIS_INS_Avis1_CT17179.pdf
HAS/2018-12-27_CT-17207_ERY_NOURRISSONS_PIS_RI_Avis1_CT17207.pdf
HAS/2018-12-27_CT-17242_NICOTINELL_QD_INS_AVIS1_CT17242.pdf
HAS/2018-12-27_CT-17281_VEYVONDI_PIS_INS_Avis2_CT17281.pdf
HAS/2018-12-27_CT-17293_DEFERIPRONE_ARROW_QD_INS_Avis2_CT17293.pdf
HAS/2018-12-27_CT-17340_TREPROSTINIL_REDDY_PHARMA_QD_INS_Avis2_CT17340.pdf
HAS/2018-12-27_CT-17399_ZIEXTENZO_PIS_INS_Avis2_CT17399.pdf
HAS/2018-12-27_CT-17405_LEVOTHYROX_PIC_INS_Avis1_CT17405.pdf
HAS/2018-12-27_CT-17427_PEMETREXED_MYLAN_PIS_INS_Avis2_CT17427.pdf
HAS/2018-12-27_CT-17434_ZESSLY_PIS_INS_Avis2_CT17434.pdf
HAS/2018-12-27_CT-17435_BRICANYL_TURBUHALER_QD_INS_Avis1_CT17435.pdf
HAS/2018-12-27_CT-17436_BINOCRIT_PIS_EI_Avis2_CT17436.pdf
HAS/2018-12-27_CT-17447_SPASFON_PIS_INS_CG_Avis 1_CT17447.pdf
HAS/2018-12-27_CT-17460_IDARUBICINE_ACCORD_QD_INS_Avis1_CT17460.pdf
HAS/2018-12-27_CT-17475_BEVITINE_PIS_CDT_Avis1_CT17475.pdf
HAS/2018-12-27_CT-17476_OXYCODONE_DELBERT_PIS_INS_AVIS1_CT17476.pdf
HAS/2018-12-27_protheses_capillaires_dm_eval_206.pdf
HAS/2019-01-10_CEPP-5457_VISCO_18_décembre_2018_(5457)_avis.pdf
HAS/2019-01-10_CEPP-5640_LARS_04_décembre_2018_(5640)_avis.pdf
HAS/2019-01-10_CEPP-5671_SONALTO_18_décembre_2018_(5671)_avis.pdf
HAS/2019-01-10_CEPP-5696_AXTAIR AUTOMORPHO PLUS_18_décembre_2018_(5696)_avis.pdf
HAS/2019-01-10_CEPP-5720_SNAP THERAPY SYSTEM_18_décembre_2018_(5720)_avis.pdf
HAS/2019-01-10_CEPP-5815_ERIS_18_décembre_2018_(5815)_avis.pdf
HAS/2019-01-10_CEPP-5834_SORTEZ COUVERTS_18_décembre_2018_(5834)_avis.pdf
HAS/2019-01-10_CT-15984_ORALAIR_PIC_RI_REEV_EPI_Avis2_CT15984&16411.pdf
HAS/2019-01-10_durasul_insert__cotyle.pdf
HAS/2019-01-11_CT-15428_OPTIJECT_OPTIRAY_PIS_RI_Avis2_CT15428.pdf
HAS/2019-01-11_CT-16100_ENANTONE_LP_RI_PIS_Avis2_CT16100.pdf
HAS/2019-01-11_CT-16345_FORTRANS_PIS_RI_Avis1_CT16345.pdf
HAS/2019-01-11_CT-16584_BAVENCIO_PIC_INS_Avis3_CT16584.pdf
HAS/2019-01-11_CT-16660_METOJECT_PIS_RI_Avis1_CT16660.pdf
HAS/2019-01-11_CT-16702_XYZALL_PIS_RI_Avis2_CT16702.pdf
HAS/2019-01-11_CT-16721_MUPIDERM_PIS_RI_Avis2_CT16721.pdf
HAS/2019-01-11_CT-16770_ROACTEMRA_SC_PIC_EI_Avis3_CT16770.pdf
HAS/2019-01-11_CT-16944_PHOCYTAN_PIS_RI_Avis2_CT16944.pdf
HAS/2019-01-11_CT-16959_MULTIHANCE_PIC_Avis2_EI_CT16959.pdf
HAS/2019-01-11_CT-16981_CLOBEX_PIS_RI_Avis1_CT16981.pdf
HAS/2019-01-11_CT-17106_NATPAR_INS_Avis2_CT17108.pdf
HAS/2019-01-11_CT-17114_OPDIVO_QD_INS_Avis1_CT17114.pdf
HAS/2019-01-11_CT-17188_XELJANZ_PIC_EIT_RP_Avis2_CT17188.pdf
HAS/2019-01-11_CT-17200_IMODIUM_gamme_PIS_RI_Avis1_CT17200.pdf
HAS/2019-01-11_CT-17208_ERYTHROCINE_PIS_RI_Avis2_CT17208.pdf
HAS/2019-01-11_CT-17253_VICTOZA_PIC_REEV_Avis2_CT17253.pdf
HAS/2019-01-11_CT-17277_OROCAL_VITAMINE_D3_QD_INS_Avis2_CT17277.pdf
HAS/2019-01-11_CT-17346_PEMETREXED_ZENTIVA_QD_INS_Avis_CT17346.pdf
HAS/2019-01-11_CT-17366_KALETRA_PIS_RI_Avis2_CT17366.pdf
HAS/2019-01-11_CT-17378_HERZUMA_QD_INS_AVIS2_CT17378.pdf
HAS/2019-01-11_CT-17397_RINOCLENIL_PIS_RI_Avis1_CT17397.pdf
HAS/2019-01-11_bavencio_05092018_ct165848_transcription.pdf
HAS/2019-01-11_bavencio_19092018_ct16584_transcription.pdf
HAS/2019-01-11_bavencio_21032018_ct16584_transcription.pdf
HAS/2019-01-11_bavencio_sapub_ct16584.pdf
HAS/2019-01-11_bavencio_sapub_ct16584_en_val.pdf
HAS/2019-01-11_evolutions_guide_methodo_pour_etablissements_de_sante__certification_v2014.pdf
HAS/2019-01-11_guide_methodologique_v2014.pdf
HAS/2019-01-11_informations_pratiques_pour_preparer_la_demarche_conjointe_de_certification_des_ght.pdf
HAS/2019-01-11_multihance_sapub_ct16959.pdf
HAS/2019-01-11_multihance_sapub_ct16959_en_val.pdf
HAS/2019-01-11_natpar_sapub_ct17108.pdf
HAS/2019-01-11_natpar_sapub_ct17108_en_val.pdf
HAS/2019-01-11_roactemra_sapub_ct16770.pdf
HAS/2019-01-11_roactemra_summary_ct16770.pdf
HAS/2019-01-11_schemas_guide_methodo_pour_etablissements_de_sante__certification.pdf
HAS/2019-01-11_victoza_15012019_avis_efficience.pdf
HAS/2019-01-11_xeljanz_summary_ct17188.pdf
HAS/2019-01-11_xeljanz_synthese_ct17188.pdf
HAS/2019-01-14_CEPP-5722_ELUVIA_18_décembre_2018_(5722)_avis_occultation.pdf
HAS/2019-01-14_CT-15875_RITALINE_PIS_RI_Avis2_CT15875.pdf
HAS/2019-01-14_CT-16945_ACARIZAX_PIC_EIT_adolescent_Avis3_CT16945.pdf
HAS/2019-01-14_CT-17088_EPITOPIC_PIS_RI_Avis1_CT17088.pdf
HAS/2019-01-14_CT-17112_JEVTANA_PIS_EPI_Avis2_CT17112.pdf
HAS/2019-01-14_CT-17116_OPDIVO_QD_RCP_Avis2_CT17116.pdf
HAS/2019-01-14_CT-17467_BYDUREON_PIS_CDT_Avis2_CT17467.pdf
HAS/2019-01-14_acarizax_eit_summary_ct16945.pdf
HAS/2019-01-14_acarizax_eit_synthese_ct16945.pdf
HAS/2019-01-14_zenith_fenestrated.pdf
HAS/2019-01-15_CEPP-5470_REVEAL LINQ_18_décembre_2018_(5470)_avis_occultation.pdf
HAS/2019-01-17_CT-14738_DOTAREM_PIC_Avis2_CT14738.pdf
HAS/2019-01-17_CT-14739_PROHANCE_PIC_Avis2_CT14739.pdf
HAS/2019-01-17_CT-14741_GADOVIST_PIC_Avis2_CT14741.pdf
HAS/2019-01-17_CT-15173_ESPERAL_REEVAL_RI_Avis2_CT15173.pdf
HAS/2019-01-17_CT-15430_AOTAL_PIC_REEVAL_RI_Avis2_CT16128.pdf
HAS/2019-01-17_CT-15715_MULTIHANCE_PIC_Avis2_CT14732_CT15715.pdf
HAS/2019-01-17_CT-15783_SKIACOL_PIC_INS_Avis3_CT15783.pdf
HAS/2019-01-17_CT-16140_REVIA_REEVAL_Avis2_CT16140.pdf
HAS/2019-01-17_CT-16222_GADOVIST_PIC_Avis2_EI_CT16222.pdf
HAS/2019-01-17_CT-17017_VESICARE 1 mg_mL_CT17017_INS_avis 2.pdf
HAS/2019-01-17_aotal_esperal_revia_synthese_ct15430_15173_16140.pdf
HAS/2019-01-17_aotal_esperal_revia_synthese_ct15430_15173_16140_2019-01-17_11-11-35_4.pdf
HAS/2019-01-17_aotalesperalreviasapubct154301517316140anglais.pdf
HAS/2019-01-17_gadolinium_pic_ri_reeval_rapport_annexe.pdf
HAS/2019-01-17_gadolinium_summary.pdf
HAS/2019-01-17_gadolinium_summary_2019-05-28_11-46-21_777.pdf
HAS/2019-01-17_gadolinium_summary_2019-05-28_11-52-12_857.pdf
HAS/2019-01-17_gadolinium_summary_2019-05-28_11-55-44_393.pdf
HAS/2019-01-17_gadolinium_synthese_ct14741.pdf
HAS/2019-01-17_gadovist_summary_ct16222.pdf
HAS/2019-01-17_gadovist_synthese_ct16222.pdf
HAS/2019-01-17_skiacol_summary_ct15783.pdf
HAS/2019-01-17_skiacol_synthese_ct15783.pdf
HAS/2019-01-17_vesicare_summary_ct17017.pdf
HAS/2019-01-17_vesicare_synthese_ct17017.pdf
HAS/2019-01-21_dexliq_qd_ins_avis3_ct17083.pdf
HAS/2019-01-21_diprosalic_pis_ri_avis1_ct17126.pdf
HAS/2019-01-21_lincocine_pis_ri_avis2_ct17131.pdf
HAS/2019-01-21_trydonis_qd_ins_avis2_ct17219.pdf
HAS/2019-01-23_allergocomod_pis_ri_avis2_ct15919.pdf
HAS/2019-01-23_disulone_pis_ri_avis2_ct17172.pdf
HAS/2019-01-23_scoburen_inj_pis_ri_avis2_ct17098.pdf
HAS/2019-01-25_CEPP-5596_EXEM FOAM KIT FK05_18_décembre_2018_(5596)_avis.pdf
HAS/2019-01-25_CEPP-5693_SIR SPHERE_06_novembre_2018_(5693)_avis_occultation.pdf
HAS/2019-01-25_CEPP-5797_FREESTYLE OPTIUM BETA CETONE_18_décembre_2018_(5797)_avis.pdf
HAS/2019-01-25_CT-16854_TALTZ_PIC_INS_Avis 2_CT16854.pdf
HAS/2019-01-25_durasul_cotyle.pdf
HAS/2019-01-25_durasul_insert.pdf
HAS/2019-01-25_fiche_dinformation_therapeutique_sir-spheres.pdf
HAS/2019-01-25_mobiderm_standard.pdf
HAS/2019-01-25_taltz_summary_ct16854.pdf
HAS/2019-01-25_taltz_synthese_ct16854.pdf
HAS/2019-01-25_yukon_choice_pc.pdf
HAS/2019-01-28_CT-16582_RYDAPT_LAM_PIC_INS_Avis3 _CT16582.pdf
HAS/2019-01-28_guide_methodologique_pnds.pdf
HAS/2019-01-28_optikinzy_pic_ins_avis3_ct16826.pdf
HAS/2019-01-28_optikinzy_sa2_ct16826.pdf
HAS/2019-01-28_optikinzy_summary_ct16826.pdf
HAS/2019-01-28_rydapt-lam_22052018_avis_efficience.pdf
HAS/2019-01-28_rydapt__lam_sa1_ct16582.pdf
HAS/2019-01-28_rydaptlam_summary_ct16582.pdf
HAS/2019-01-29_CT-17035_ROACTEMRA_SC_QD_INS_avis1_CT17035.pdf
HAS/2019-01-29_amoxicilline_arrow_lab_pis_ins_ge_avis1_ct17504.pdf
HAS/2019-01-29_celluvisc_pis_ri_avis1_ct15885.pdf
HAS/2019-01-29_crysvita_pic_ins_avis3_ct16912.pdf
HAS/2019-01-29_crysvita_summary_ct16912.pdf
HAS/2019-01-29_crysvita_synthese_ct16912.pdf
HAS/2019-01-29_cutacnyl_pis_ri_avis1_ct17347.pdf
HAS/2019-01-29_dodecavit_pis_ri_avis1_ct17187.pdf
HAS/2019-01-29_ellaone_pis_ins_cg_avis1_ct17502.pdf
HAS/2019-01-29_innohep_pis_ei_non_demandee_avis2_ct17450.pdf
HAS/2019-01-29_pelmeg_pis_ins_avis2_ct17498.pdf
HAS/2019-01-29_tridesonit_pis_ri_avis1_ct17259.pdf
HAS/2019-01-31_CT-15400_DARZALEX_monotherapie_PIC_INS_Avis3_CT15400.pdf
HAS/2019-01-31_CT-16172_DARZALEX_en_association_PIC_INS_Avis3_CT16172.pdf
HAS/2019-01-31_abenox_pis_ins_avis2_ct17429.pdf
HAS/2019-01-31_bioprotheses_valvulaires_aortiques_implantees_par_voie_transcatheter_tavi_-_referentiel_2019-01-31_10-29-32_136.pdf
HAS/2019-01-31_darzalex_12122017_avis_efficience.pdf
HAS/2019-01-31_darzalex_association_sapub_ct15400.pdf
HAS/2019-01-31_darzalex_association_summary_ct15400.pdf
HAS/2019-01-31_darzalex_monotherapie_summary_ct15400.pdf
HAS/2019-01-31_darzalex_monotherapie_synthese_ct15400.pdf
HAS/2019-01-31_extraneal_pis_ins_cg_avis2_ct17423.pdf
HAS/2019-01-31_nilevar_pis_ri_avis2_ct16033.pdf
HAS/2019-01-31_omeprazole_cristers_pharma_pis_ins_ge_avis2_ct17452.pdf
HAS/2019-01-31_transcatheter_aortic_valve_implantation_tavi_devices_clinical_data_requirements.pdf
HAS/2019-01-31_verapamil_teva_pis_ri_avis2_ct17414.pdf
HAS/2019-01-31_wystamm_pis_ri_avis1_ct17441.pdf
HAS/2019-01-31_xenetix_pis_ins_cg_avis2_ct17513.pdf
HAS/2019-02-01_cromoptic_pis_ri_avis1_ct16086.pdf
HAS/2019-02-01_tire-lait_15_janvier_2019_dm_eval_203.pdf
HAS/2019-02-04_airsoft_duo.pdf
HAS/2019-02-04_axonics_snm.pdf
HAS/2019-02-04_custombone.pdf
HAS/2019-02-04_dispositifs_medicaux_utilises_pour_le_recueil_ou_le_drainage_des_urines_et_des_selles.pdf
HAS/2019-02-04_dizg.pdf
HAS/2019-02-04_elunir.pdf
HAS/2019-02-04_embotrap_ii.pdf
HAS/2019-02-04_episil.pdf
HAS/2019-02-04_gore_viabahn.pdf
HAS/2019-02-04_inogen_g3.pdf
HAS/2019-02-04_lvis.pdf
HAS/2019-02-04_mpact_dm.pdf
HAS/2019-02-04_precision.pdf
HAS/2019-02-04_versacem.pdf
HAS/2019-02-04_versafitcup_dm.pdf
HAS/2019-02-04_yukon_chrome_pc.pdf
HAS/2019-02-04_zen-o_lite_rs-00608-g.pdf
HAS/2019-02-05_inogen_g2.pdf
HAS/2019-02-05_mobiderm_autofit.pdf
HAS/2019-02-05_mobiderm_sur_mesure.pdf
HAS/2019-02-06_CT-16876_FOTIVDA_PIC_INS_ Avis postaudition_CT_16876.pdf
HAS/2019-02-06_CT-16921_HEMLIBRA_PIC_Ins_Avis2_CT16921.pdf
HAS/2019-02-06_CT-17072_SIMPONI_PIC_EIT_AJIp_Avis2_CT17072.pdf
HAS/2019-02-06_fotivda_summary_ct16876.pdf
HAS/2019-02-06_fotivda_synthese_ct16876.pdf
HAS/2019-02-06_hemlibra_13122018_avis_efficience.pdf
HAS/2019-02-06_hemlibra_summary_ct16921.pdf
HAS/2019-02-06_hemlibra_synthese_ct16921.pdf
HAS/2019-02-06_nutramigen_puramino_junior.pdf
HAS/2019-02-06_simponi_summary_ct17072.pdf
HAS/2019-02-06_simponi_synthese_ct17072.pdf
HAS/2019-02-06_vaccin_dengvaxia_dans_la_strategie_de_lutte_contre_la_dengue_dans_les_departements_francais_doutre-mer_lile_de_la_reunion.pdf
HAS/2019-02-08_CT-16952_BERINERT_PIC_REEVAL_Avis3_CT16952.pdf
HAS/2019-02-08_CT-16954_RUCONEST_PIC_REEVAL_Avis3_CT16954.pdf
HAS/2019-02-08_CT-16955_FIRAZYR_PIC_REEVAL_Avis2_CT16955.pdf
HAS/2019-02-08_CT-16956_CINRYZE_PIC_REEVAL_Avis2_CT16956.pdf
HAS/2019-02-08_inhc1esterase_sapub_en_val.pdf
HAS/2019-02-08_inhc1esterase_synthese.pdf
HAS/2019-02-08_rapport_evaluation_aoh_annexe_avis3_cteval381.pdf
HAS/2019-02-08_rebel_reliever.pdf
HAS/2019-02-10_annexes_signatures_genomiques.pdf
HAS/2019-02-10_inahta_brief_genomic_signatures_2019-03-22_14-57-13_608.pdf
HAS/2019-02-10_rapport_signatures_genomiques.pdf
HAS/2019-02-12_11_02_2019_enquete_bt_pe_version_com_pour_pdf.pdf
HAS/2019-02-12_11_02_2019_fiche_synthese_bientraitance_vf.pdf
HAS/2019-02-12_bortezomib_accord_pis_ins_ge_avis1_ct17422.pdf
HAS/2019-02-12_bortezomib_sandoz_pis_ins_ge_avis1_ct17433.pdf
HAS/2019-02-12_bortezomib_tillomed_pis_ins_ge_avis1_ct17437.pdf
HAS/2019-02-12_cotyle_double_mobilite_cimente.pdf
HAS/2019-02-12_cotyle_double_mobilite_hac.pdf
HAS/2019-02-12_enquete_bientraitance_pe_2016_volet_1.pdf
HAS/2019-02-12_guide_de_remplissage__mai_2016.pdf
HAS/2019-02-12_infographie_prevention_violence_entre_mineurs_2019-03-25_15-56-56_658.pdf
HAS/2019-02-12_lettre_cadrage_rbpp_violences_corrigeempmb.pdf
HAS/2019-02-12_opatanol_pis_ri_avis1_ct16662.pdf
HAS/2019-02-12_prevention_violence_entre_mineurs__adolescents__etablissements_accueil-recommandations.pdf
HAS/2019-02-12_purivist_pis_ri_avis1_ct17013.pdf
HAS/2019-02-12_ultra_fast_fix.pdf
HAS/2019-02-13_annexes_dsm_colon_vd.pdf
HAS/2019-02-13_inahta_esd_colon_cancer.pdf
HAS/2019-02-13_rapport_dsm_colon_vd.pdf
HAS/2019-02-13_reco_vaccinale_vaccination_contre_les_infections_invasives_a_meningocoques_de_serogroupe_w.pdf
HAS/2019-02-14_CT-16583_MUPHORAN_REEVAL_MELANOME_Avis2_CT16583.pdf
HAS/2019-02-14_CT-16772_LYMPHOSEEK_INS_Avis3_CT16772.pdf
HAS/2019-02-14_argumentaire_pnds_lymphoedeme_primaire_final_has.pdf
HAS/2019-02-14_dexmedetomidine_mylan_pis_ins_ge_avis2_ct17448.pdf
HAS/2019-02-14_lymphoseek_summary_ct16772.pdf
HAS/2019-02-14_lymphoseek_synthese_ct16772.pdf
HAS/2019-02-14_muphoran_summary_ct16583.pdf
HAS/2019-02-14_muphoran_synthese_ct16583.pdf
HAS/2019-02-14_pnds_lymphoedeme_primaire_final_has.pdf
HAS/2019-02-14_reagila_pic_ins_avis3_ct16931.pdf
HAS/2019-02-14_reagila_synthese_ct16931.pdf
HAS/2019-02-14_synthese_mg_lymphoedemes_primaires.pdf
HAS/2019-02-14_vizilatan_pis_ins_avis2_ct17547.pdf
HAS/2019-02-14_web.pdf
HAS/2019-02-15_frakidex_flacon_pis_ins_avis1_ct17523.pdf
HAS/2019-02-15_fs_sante_maintien_emploi_v1.pdf
HAS/2019-02-15_reco271_argumentaire_maintien_en_emploi_v1.pdf
HAS/2019-02-15_reco271_recommandations_maintien_en_emploi_v1.pdf
HAS/2019-02-18_izilox_pis_ins_cg_avis1_ct17525.pdf
HAS/2019-02-19_composition_du_gt_dm_eval-181.pdf
HAS/2019-02-19_guide_sur_les_specificites_devaluation_clinique_dun_dmc_en_vue_de_son_acces_au_remboursement.pdf
HAS/2019-02-19_guide_to_the_specific_features_of_clinical_evaluation_of_cmd_in_view_of_its_application_for_reimbursement.pdf
HAS/2019-02-19_rapport_dmc_2019_english_vd.pdf
HAS/2019-02-19_rapport_methodologiques_devaluation_clinique_dun_dmc.pdf
HAS/2019-02-19_travaux_sur_les_specificites_methodologiques_devaluation_clinique_des_dispositifs_medicaux_connectes_feuille_de_route.pdf
HAS/2019-02-20_CT-16532_FAMPYRA_PIC_REEVAL_Avis2_CT16532.pdf
HAS/2019-02-20_CT-16663_DECAPEPTYL_LP_3mg_PIC_EI_cancer du sein_Avis 3_CT16663.pdf
HAS/2019-02-20_CT-16972_LAMZEDE_PIC_INS_Avis3_CT16972.pdf
HAS/2019-02-20_decapeptyl_summary_ct16663.pdf
HAS/2019-02-20_decapeptyl_synthese_ct16663.pdf
HAS/2019-02-20_fampyra_summary_ct16532.pdf
HAS/2019-02-20_fampyra_synthese_ct16532.pdf
HAS/2019-02-20_lamzede_sapub_ct16972_en_val.pdf
HAS/2019-02-20_lamzede_synthese_ct16972.pdf
HAS/2019-02-21_CT-17468_DIMETANE_SANS_SUCRE_PIS_RI_Avis1_CT17468.pdf
HAS/2019-02-22_CT-16542_RAPIBLOC_PIC_INS_Avis2_CT16542.pdf
HAS/2019-02-22_CT-16648_RYDAPT_mastocytose_INS_Avis3_ CT16648.pdf
HAS/2019-02-22_CT-16731_OROBUPRE_PIC_Ins_Avis2_CT16731.pdf
HAS/2019-02-22_CT-16982_TARCEVA_PIC_RCP_Avis3_CT16982.pdf
HAS/2019-02-22_CT-17070_ORKAMBI_PIC_EI_Avis3_CT17070.pdf
HAS/2019-02-22_CT-17190_MONOPROST_PIS_RI_Avis2_CT17190.pdf
HAS/2019-02-22_CT-17462_ROACTEMRA_PIC_EI_SRC_Avis3_CT17462.pdf
HAS/2019-02-22_CT-17469_ELUDRILPERIO_PIS_INS_CG_Avis1_CT17469.pdf
HAS/2019-02-22_CT-17497_RUCONEST_PIS_INS_Avis1_CT17497.pdf
HAS/2019-02-22_CT-17555_IMRALDI_PIS_INS_CG_Avis1_CT17555.pdf
HAS/2019-02-22_guide_bonnes_pratiques_simulation_sante_guide.pdf
HAS/2019-02-22_guide_methodologique_simulation_en_sante_et_gestion_des_risques.pdf
HAS/2019-02-22_guide_pour_levaluation_des_infrastrures_de_simulation_en_sante_2015-07-21_11-26-51_939.pdf
HAS/2019-02-22_kymriah_lal_15012019_avis_efficience.pdf
HAS/2019-02-22_kymriah_lal_pic_ins_avis3_ct17202.pdf
HAS/2019-02-22_kymriah_lal_summary_ct17202.pdf
HAS/2019-02-22_kymriah_lal_synthese_ct17202.pdf
HAS/2019-02-22_kymriah_ldgcb_15012019_avis_efficience.pdf
HAS/2019-02-22_kymriah_ldgcb_pic_ins_avis3_ct17238.pdf
HAS/2019-02-22_kymriah_ldgcb_summary_ct17238.pdf
HAS/2019-02-22_kymriah_ldgcb_synthese_ct17238.pdf
HAS/2019-02-22_okbat_guide_gdr_03_04_12.pdf
HAS/2019-02-22_orkambi_summary_ct17070.pdf
HAS/2019-02-22_orkambi_synthese_ct17070.pdf
HAS/2019-02-22_orobupre_summary_ct16731.pdf
HAS/2019-02-22_orobupre_synthese_ct16731.pdf
HAS/2019-02-22_outil_10_simulation_et_gdr__de_ville_.pdf
HAS/2019-02-22_outil_11_debriefing_en_simulation.pdf
HAS/2019-02-22_outil_12_ecoute_active.pdf
HAS/2019-02-22_outil_13_encadrement_de_patients_simules.pdf
HAS/2019-02-22_outil_14_outil__saed_.pdf
HAS/2019-02-22_outil_15_outil__faire_dire_.pdf
HAS/2019-02-22_outil_16_donnees_a_recueillir_pour_lanalyse_approfondie_dun_eias.pdf
HAS/2019-02-22_outil_1_procedure_training.pdf
HAS/2019-02-22_outil_2_test_dun_environnement_de_travail.pdf
HAS/2019-02-22_outil_3_competences_non_techniques_et_travail_en_equipe.pdf
HAS/2019-02-22_outil_4_rmm_simulee.pdf
HAS/2019-02-22_outil_5_chambre_des_erreurs.pdf
HAS/2019-02-22_outil_6_analyse_de_scenario_clinique_deias_simule.pdf
HAS/2019-02-22_outil_7_annonce_dun_dommage_associe_aux_soins.pdf
HAS/2019-02-22_outil_8_carte_conceptuelle.pdf
HAS/2019-02-22_outil_9_communication_en_situation_de_crise.pdf
HAS/2019-02-22_outils_du_guide_methodo_simulation_en_sante_et_gestion_des_risques.pdf
HAS/2019-02-22_rapibloc_summary_ct16452.pdf
HAS/2019-02-22_rapibloc_synthese_ct16452.pdf
HAS/2019-02-22_roactemra_ei_src_summary_ct17462.pdf
HAS/2019-02-22_roactemra_ei_src_synthese_ct17462.pdf
HAS/2019-02-22_rydapt-msa_10042018_avis_efficience.pdf
HAS/2019-02-22_rydapt_mastocytose_summary_ct16648.pdf
HAS/2019-02-22_rydapt_mastocytose_synthese_ct16648.pdf
HAS/2019-02-22_tarceva_summary_ct16982.pdf
HAS/2019-02-22_tarceva_synthese_ct16982.pdf
HAS/2019-02-22_yescarta_20190225_avis_efficience.pdf
HAS/2019-02-22_yescarta_pic_ins_avis3_ct17214.pdf
HAS/2019-02-22_yescarta_synthese_ct17214.pdf
HAS/2019-02-22_zalmoxis_pic_ins_avis3_modifiele15012019_ct16901.pdf
HAS/2019-02-22_zalmoxis_summary_ct16901.pdf
HAS/2019-02-22_zalmoxis_synthese_ct16901.pdf
HAS/2019-02-25_CT-17540_CEBESINE_PIS_INS_Avis1_CT17540.pdf
HAS/2019-02-25_CT-17565_OGIVRI_PIS_INS_Avis1_CT17565.pdf
HAS/2019-02-25_CT-17568_LEVOBUPIVACAINE_ALTAN_PIS_INS_GE_Avis1_CT17568.pdf
HAS/2019-02-25_CT-17575_MOVYMIA_PIS_INS_Avis1_CT17575.pdf
HAS/2019-02-25_relay_nbs_pro.pdf
HAS/2019-02-25_relay_pro.pdf
HAS/2019-02-26_endurant_ii_endurant_iis.pdf
HAS/2019-02-26_endurant_ii_endurant_iis_2019-02-25_15-58-8_420.pdf
HAS/2019-02-27_CNEDIMTS-5676_COLLAPAT II_12_février_2019_(5676)_avis.pdf
HAS/2019-02-27_smartdrive_mx2.pdf
HAS/2019-02-27_stratos.pdf
HAS/2019-02-28_eluna_8_sr-t_et_hf-t.pdf
HAS/2019-03-04_3d-cut_12_fevrier_2019_5775_avis.pdf
HAS/2019-03-04_CNEDIMTS-5829_C-WALK 1C40_26_février_2019_(5829)_avis.pdf
HAS/2019-03-04_ctba_allotec.pdf
HAS/2019-03-04_triton_lp.pdf
HAS/2019-03-07_1h11y_pied_dynamique_en_carbone_et_talon_en_polyurethane_2019-02-18_15-36-22_425.pdf
HAS/2019-03-07_hires_ultra_3d.pdf
HAS/2019-03-07_inahta_brief_placement_interim_crown.pdf
HAS/2019-03-07_qualite_de_vie_en_residences_autonomie-fr_pp_ra.pdf
HAS/2019-03-07_rapport_couronne_dentoportee.pdf
HAS/2019-03-11_app_151_fiche_pertinence__rapport_cataracte_vf.pdf
HAS/2019-03-11_app_151_rapport_elaboration_cataracte_vf_2019-02-26_15-03-47_723.pdf
HAS/2019-03-11_fm_contraception_patientestransplantees_maj_fev19.pdf
HAS/2019-03-11_reco274_rap_elaborat_contraception_transplant__cd_2019_02_06_v0_pour_mise_en_ligne.pdf
HAS/2019-03-12_CNEDIMTS-5719_VALIANT_15_janvier_2019_(5719)_avis_occultation.pdf
HAS/2019-03-12_CNEDIMTS-5811_ZEPHYR_26_février_2019_(5811)_avis.pdf
HAS/2019-03-12_CT-15369_MODIODAL_PIS_RI_Avis1_CT15369.pdf
HAS/2019-03-12_CT-15781_MYNOCINE_PIS_RI_Avis2_CT15781.pdf
HAS/2019-03-12_CT-15787_CHLORAMINOPHENE_PIC_RI_REEV_LLC_LH_LNH_Avis3_CT15266_15787.pdf
HAS/2019-03-12_CT-16047_XALACOM_PIS_RI_Avis2_CT16047.pdf
HAS/2019-03-12_CT-16561_IXPRIM_ZALDIAR_PIS_RI_Avis2_CT16561.pdf
HAS/2019-03-12_CT-16691_SIGNIFOR_PIS_RI_Avis2_CT16691.pdf
HAS/2019-03-12_CT-17197_HYDROCORTISONE_ROUSSEL_PIS_RI_Avis2_CT17197.pdf
HAS/2019-03-12_CT-17234_CIMZIA_PIS_NE_Avis2_CT17234.pdf
HAS/2019-03-12_CT-17254_CIMZIA_psoriasis_PIS_EI_Avis2_CT17254.pdf
HAS/2019-03-12_CT-17266_BLINCYTO_PIC_REEV_Avis3_CT17266.pdf
HAS/2019-03-12_CT-17286_TEVAGRASTIM_RATIOGRASTIM_PIS_RI_Avis2_CT17286.pdf
HAS/2019-03-12_CT-17470_RELISTOR_PIS_RI_Avis1_CT17470.pdf
HAS/2019-03-12_CT-17485_TREMFYA_PIS_INS_CG_Avis1_CT17485.pdf
HAS/2019-03-12_CT-17492_CASPOFUNGINE_NORIDEM_PIS_INS_GE_Avis2_CT17492.pdf
HAS/2019-03-12_CT-17527_CHLORHEXIDINE_MYLAN_PIS_INS_Avis2_CT17527.pdf
HAS/2019-03-12_CT-17528_GLUCOSE_VIAFLO_PIS_INS_CG_Avis2_CT17528.pdf
HAS/2019-03-12_CT-17529_CHLORHEXIDINE_ARROW_PIS_INS_Avis1_CT17529.pdf
HAS/2019-03-12_CT-17531_CHLORHEXIDINE_BIOGARAN_PIS_INS_Avis1_CT17531.pdf
HAS/2019-03-12_CT-17537_NITISINONE_DIPHARMA_PIS_GE_INS_Avis1_CT17537.pdf
HAS/2019-03-12_mistent.pdf
HAS/2019-03-14_CT-15282_PREVISCAN_PIC_RI_Avis2_CT15282.pdf
HAS/2019-03-14_previscan_summary_ct15282.pdf
HAS/2019-03-14_previscan_synthese_ct15282.pdf
HAS/2019-03-15_pnds_bbs_texte_mars19.pdf
HAS/2019-03-15_pnds_syndrome_alstrom_texte_mars19.pdf
HAS/2019-03-15_synthese_mg_syndrome_d_alstrom.pdf
HAS/2019-03-15_synthese_mg_syndrome_de_bardet_biedl.pdf
HAS/2019-03-18_CNEDIMTS-5668_DE17L_26_février_2019_(5668)_avis.pdf
HAS/2019-03-18_CNEDIMTS-5779_NAIDA CI 70_12_mars_2019_(5779)_avis.pdf
HAS/2019-03-19_CNEDIMTS-5483_ACOR sans ciment_26_février_2019_(5483)_avis.pdf
HAS/2019-03-19_CNEDIMTS-5488_ACOR à cimenter_26_février_2019_(5488)_avis.pdf
HAS/2019-03-19_CNEDIMTS-5510_OPTIMAL_26_février_2019_(5510)_avis.pdf
HAS/2019-03-19_CNEDIMTS-5921_CONCERTO_(5921-5932)_OPUS2_(5933)_ SONNET_(5934)_12_mars_2018_avis.pdf
HAS/2019-03-19_CNEDIMTS-5932_CONCERTO_(5921-5932)_OPUS2_(5933)_ SONNET_(5934)_12_mars_2018_avis.pdf
HAS/2019-03-19_CNEDIMTS-5933_CONCERTO_(5921-5932)_OPUS2_(5933)_ SONNET_(5934)_12_mars_2018_avis.pdf
HAS/2019-03-19_CNEDIMTS-5934_CONCERTO_(5921-5932)_OPUS2_(5933)_ SONNET_(5934)_12_mars_2018_avis.pdf
HAS/2019-03-19_fiche_pertinence_hypothyroidie_vf.pdf
HAS/2019-03-19_rapport_pertinence_hypothyroidie_vf.pdf
HAS/2019-03-20_CNEDIMTS-5708_SYNERGO RITE_12_mars_2019_(5708)_avis.pdf
HAS/2019-03-20_CNEDIMTS-5866_INOGEN ONE G4_26_février_2019_(5866)_avis.pdf
HAS/2019-03-20_CNEDIMTS-5883_XIENCE XPEDITION_12_mars_2019_(5883)_avis.pdf
HAS/2019-03-20_CNEDIMTS-5884_XIENCE ALPINE_12_mars_2019_(5884)_avis.pdf
HAS/2019-03-20_CNEDIMTS-5885_XIENCE SIERRA_12_mars_2019_(5885)_avis.pdf
HAS/2019-03-20_CNEDIMTS-5928_GORE EXCLUDER_12_mars_2019_(5928)_avis.pdf
HAS/2019-03-20_CNEDIMTS-5936_SOLITAIRE AB_12_mars_2019_(5936)_avis.pdf
HAS/2019-03-20_firehawk.pdf
HAS/2019-03-22_CNEDIMTS-5792_MERCI _12_février_2019_(5792)_avis_occultation.pdf
HAS/2019-03-22_CNEDIMTS-5793_FLOWGATE 2_12_février_2019_(5793)_avis_occultation.pdf
HAS/2019-03-22_alofisel_pic_ins_avis3_ct17069.pdf
HAS/2019-03-22_alofisel_synthese_ct17069.pdf
HAS/2019-03-22_cotyles_a_simple_et_double_mobilite.pdf
HAS/2019-03-22_xermelo_pic_ins_avis3_ct16851.pdf
HAS/2019-03-22_xermelo_summary_ct_16851.pdf
HAS/2019-03-22_xermelo_synthese_ct_16851.pdf
HAS/2019-03-25_CT-16612_CAPRELSA_PIC_RI_Avis2_CT16612.pdf
HAS/2019-03-25_CT-17195_KINERET_PIC_EIT_Avis2_CT17195.pdf
HAS/2019-03-25_CT-17367_VYXEOS_PIC_INS_Avis3_CT17367.pdf
HAS/2019-03-25_kineret_20032019_transcription_ct17195.pdf
HAS/2019-03-25_kineret_summary_ct17195.pdf
HAS/2019-03-25_kineret_synthese_ct17195.pdf
HAS/2019-03-26_CNEDIMTS-5850_LAMBRE_12_mars_2019_(5850)_avis.pdf
HAS/2019-03-26_CT-17121_DIPHANTE_PIC_INS_Avis3_CT17121.pdf
HAS/2019-03-26_CT-17446_CRESTOR_PIS_RI_Avis1_CT17446.pdf
HAS/2019-03-26_CT-17465_BORTEZOMIB_EG_PIS_INS_HYB_Avis1_CT17465.pdf
HAS/2019-03-26_CT-17642_APREPITANT_ARROW_PIS_INS_GE_Avis1_CT17642.pdf
HAS/2019-03-26_CT-17657_ROPIVACAINE_ALTAN_PIS_INS_Avis1_CT17657.pdf
HAS/2019-03-26_diphante_20032019_transcription_ct17121.pdf
HAS/2019-03-26_diphante_synthese_ct17121.pdf
HAS/2019-03-26_recommandations_dengvaxia_mayotte_et_dans_les_territoires_damerique.pdf
HAS/2019-03-27_CT-15862_LUMIGAN_PIS_RI_Avis2_CT15862.pdf
HAS/2019-03-27_CT-17532_BICAVERA_GLUCOSE_PIS_INS_CG_Avis2_CT17532.pdf
HAS/2019-03-27_CT-17687_COSOPT_PIS_INS_CG_Avis2_CT17687.pdf
HAS/2019-03-28_inahta_brief_pulp_capping.pdf
HAS/2019-03-28_rapport_coiffage_pulpaire.pdf
HAS/2019-03-29_CNEDIMTS-5812_RESOLUTE INTEGRITY_26_février_2019_(5812)_avis_occulation.pdf
HAS/2019-03-29_CNEDIMTS-5813_RESOLUTE ONYX_26_février_2019_(5813)_avis_occultation.pdf
HAS/2019-04-01_CT-17543_CHLORURE_DE_SODIUM_VIAFLO_PIS_INS_CG_Avis2_CT17543.pdf
HAS/2019-04-01_fiche_de_synthese_infections_cutanees_mel.pdf
HAS/2019-04-01_prise_en_charge_des_infections_cutanees_bacteriennes_courantes_argumentaire.pdf
HAS/2019-04-01_prise_en_charge_des_infections_cutanees_bacteriennes_courantes_recommandations.pdf
HAS/2019-04-02_CNEDIMTS-5863_DUALIS SANS CIMENT_26_mars_2019_(5863)_avis.pdf
HAS/2019-04-02_CNEDIMTS-5864_DUALIS A CIMENTER_26_mars_2019_(5864)_avis.pdf
HAS/2019-04-02_CNEDIMTS-5886_XLMOB SANS CIMENT_26_mars_2019_(5886)_avis.pdf
HAS/2019-04-02_CNEDIMTS-5937_NUCLEUS Ci551_(5937)_NUCLEUS FRREDOM HYBRID_(5938)_12_mars_2019.pdf
HAS/2019-04-02_nucleus_frredom_hybrid.pdf
HAS/2019-04-04_CNEDIMTS-5897_URGOTUL AG_26_février_2019_(5897)_avis_occultation.pdf
HAS/2019-04-04_CNEDIMTS-5898_URGOTUL AG LITE_26_février_2019_(5898)_avis_occultation.pdf
HAS/2019-04-04_CNEDIMTS-5899_URGOTUL AG LITE BORDER_26_février_2019_(5899)_avis_occultation.pdf
HAS/2019-04-04_CNEDIMTS-5900_URGOCELL AG_26_février_2019_(5900)_avis_occultation.pdf
HAS/2019-04-04_CNEDIMTS-5901_URGOCELL AG BORDER_26_février_2019_(5901)_avis_occultation.pdf
HAS/2019-04-04_arg_pertinence_chir-lombalgie.pdf
HAS/2019-04-04_fm_lombalgie_v2_2.pdf
HAS/2019-04-04_reco271_recommandations_maintien_en_emploi_v1.pdf
HAS/2019-04-04_reco315_arbre_decisionnel_cd_2019_03_28vd.pdf
HAS/2019-04-04_reco315_rapport_lombalgie_2019_04_02.pdf
HAS/2019-04-08_CNEDIMTS-5738_COROFLEX ISAR_12_mars_2019_(5738)_avis_occultation.pdf
HAS/2019-04-08_CNEDIMTS-5739_COROFLEX ISAR NEO_12_mars_2019_(5739)_avis_occultation.pdf
HAS/2019-04-08_CNEDIMTS-5767_HEARTWARE_26_mars_2019_(5767)_avis.pdf
HAS/2019-04-08_CNEDIMTS-5858_BLINK INTENSIVE TEARS multidoses_12_mars_2019_(5858)_avis_occultation.pdf
HAS/2019-04-08_CNEDIMTS-5859_BLINK INTENSIVE TEARS unidoses_12_mars_2019_(5859)_avis_occultation.pdf
HAS/2019-04-08_CNEDIMTS-5860_BLINK INTENSIVE TEARS PLUS multidoses_12_mars_2019_(5860)_avis_occultation.pdf
HAS/2019-04-08_CNEDIMTS-5879_TREVO PROVUE_26_mars_2019_(5879)_avis.pdf
HAS/2019-04-08_CT-16279_BUPRENORPHINE_MYLAN_PIS_RI_Avis2_CT16279.pdf
HAS/2019-04-08_CT-16343_DIFFU_K_PIS_RI_Avis2_CT16343.pdf
HAS/2019-04-08_CT-16346_GELOX_PIS_RI_Avis2_CT16346.pdf
HAS/2019-04-08_CT-16385_MOXYDAR_PIS_RI_Avis2_CT16385.pdf
HAS/2019-04-08_CT-16681_PNEUMOVAX_PIS_RI_Avis2_CT16681.pdf
HAS/2019-04-08_CT-17481_TETRALYSAL_PIS_RI_Avis1_CT17481.pdf
HAS/2019-04-08_CT-17534_BORTEZOMIB_TEVA_PIS_INS_CG_Avis2_CT17534.pdf
HAS/2019-04-08_CT-17567_ACIDE_FOLIQUE_CDD_PIS_INS_CG_Avis1_CT17567.pdf
HAS/2019-04-08_CT-17582_EURARTESIM_PIS_RI_Avis1_CT17582.pdf
HAS/2019-04-08_alair.pdf
HAS/2019-04-09_CNEDIMTS-5917_EVORA GRIP-EVORA GRIP 3P_26_mars_2019_(5917)_avis.pdf
HAS/2019-04-09_CNEDIMTS-5918_ORION METRO_26_mars_2019_(5918)_avis_occultation.pdf
HAS/2019-04-09_CNEDIMTS-5929_ROTATEUR FEMORAL 1K52_26_mars_2019_(5929)_avis.pdf
HAS/2019-04-09_CNEDIMTS-5939_HYBRID 1P360_26_mars_2019_(5939)_avis.pdf
HAS/2019-04-09_CNEDIMTS-5961_ROTATEUR FEMORAL 1K52_26_mars_2019_(5961)_avis.pdf
HAS/2019-04-09_grand_appareillage_orthopedique.pdf
HAS/2019-04-10_CNEDIMTS-5855_DURAFIBER_26_mars_2019_(5855)_avis.pdf
HAS/2019-04-10_CT-16947_ADCETRIS_PIC_EI_Avis3_CT16947.pdf
HAS/2019-04-10_CT-17023_MYLOTARG_PIC_INS_Avis3_CT17023.pdf
HAS/2019-04-10_CT-17464_SEEBRI_BREEZHALER_PIS_RI_Avis2_CT17464.pdf
HAS/2019-04-10_CT-17487_FLUOGEL_PIS_RI_Avis2_CT17487.pdf
HAS/2019-04-10_CT-17615_ATRACURIUM_HIKMA_PIS_INS_GE_Avis1_CT17615.pdf
HAS/2019-04-10_CT-17643_PARACETAMOL_ACCORD_QD_INS_CG_Avis1_CT17643.pdf
HAS/2019-04-10_CT-17652_TRANXENE_PIS_INS_Avis1_CT17652.pdf
HAS/2019-04-10_CT-17653_MYCOHYDRALIN_PIS_INS_Avis1_CT17653.pdf
HAS/2019-04-10_CT-17659_APREPITANT_REDDY_PHARMA_PIS_INS_Avis1_CT17659.pdf
HAS/2019-04-10_CT-17661_ROCURONIUM_KALCEKS_PIS_INS_Avis1_CT17661.pdf
HAS/2019-04-10_pnds_aniridie_texte_avril_2019.pdf
HAS/2019-04-10_pnds_sep_enfant_texte_version_2_finale.pdf
HAS/2019-04-10_synthese_mg_aniridie.pdf
HAS/2019-04-10_synthese_mg_sclerose_en_plaque_de_l_enfant.pdf
HAS/2019-04-11_amglidia_pic_ins_avis3_ct17120.pdf
HAS/2019-04-11_amglidia_summary_ct17120.pdf
HAS/2019-04-11_amglidia_synthese_ct17120.pdf
HAS/2019-04-11_ongentys_pic_ins_avis2_ct17186.pdf
HAS/2019-04-11_ongentys_synthese_ct17186.pdf
HAS/2019-04-12_CNEDIMTS-5682_MOOVCARE POUMON_09_avril_2019_(5682)_avis_occultation.pdf
HAS/2019-04-12_CNEDIMTS-5849_AXON HOOK_09_avril_2019_(5849)_avis.pdf
HAS/2019-04-12_CNEDIMTS-5857_POLARCUP CIMENTE_26_mars_2019_(5857)_avis.pdf
HAS/2019-04-12_CNEDIMTS-5927_NEOCATE JUNIOR_09_avril_2019_(5927)_avis.pdf
HAS/2019-04-15_CNEDIMTS-5835_PROMOGRAN_09_avril_2019_(5835)_avis.pdf
HAS/2019-04-18_ctm_a_la_retrocession_institut_bergonie.pdf
HAS/2019-04-18_ctm_a_ladmission_en_hopital_de_semaine_centre_paul_strauss.pdf
HAS/2019-04-18_ctm_a_ladmission_en_oncogeriatrie_avec_consultation_chu_de_nimes.pdf
HAS/2019-04-18_ctm_a_ladmission_institut_gustave_roussy.pdf
HAS/2019-04-18_ctm_admission_et_ou_sortie_patient_sous_chimio_orale_h_europeen_marseille.pdf
HAS/2019-04-18_ctm_admission_et_sortie_en_oncologie_hospitalisation_complete_hp_antony.pdf
HAS/2019-04-18_ctm_consultation_primo_prescription_anticancereux_oral_gh_sud_hcl.pdf
HAS/2019-04-18_ctm_hospitalisation_de_jour_en_oncogeriatrie_institut_bergonie.pdf
HAS/2019-04-18_ctm_initiation_therapie_anticancereuse_per_os_centre_paul_strauss.pdf
HAS/2019-04-18_ctm_lors_de_linclusion_des_patients_en_essais_cliniques_institut_bergonie.pdf
HAS/2019-04-18_ctm_par_le_pharmacien_dofficine_picto_region_grand_est.pdf
HAS/2019-04-18_ctm_patient_atteint_de_cancer_prenant_des_tc_institut_sainte_catherine.pdf
HAS/2019-04-18_ctm_patients_allogreffes_sortie_et_suivi_du_patient_gh_sud_hcl.pdf
HAS/2019-04-18_ctm_suivi_patient_atteint_de_cancer_sous_anticancereux_oraux_gh_sud_hcl.pdf
HAS/2019-04-18_ctm_therapie_anticancereuse_orale_per_os_pour_glioblastome_clcc_f._leclerc.pdf
HAS/2019-04-18_guide_conciliation_des_traitements_medicamenteux_en_cancerologie.pdf
HAS/2019-04-18_guide_conciliation_des_traitements_medicamenteux_en_etablissement_de_sante.pdf
HAS/2019-04-18_rapport_dexperimentation_sur_la_mise_en_oeuvre_conciliation_des_traitements_medicamenteux_par_9_es.pdf
HAS/2019-04-24_CNEDIMTS-5749_ASSURITY MRI VR MERLIN_09_avril_2019_(5749)_avis_occultation.pdf
HAS/2019-04-24_CNEDIMTS-5752_ASSURITY MRI DR MERLIN_09_avril_2019_(5752)_avis_occultation.pdf
HAS/2019-04-24_CNEDIMTS-5755_ALLURE RF MERLIN_09_avril_2019_(5755)_avis_occultation.pdf
HAS/2019-04-24_CNEDIMTS-5758_QUADRA ALLURE MP MERLIN CRTP_09_avril_2019_(5758)_avis_occultation.pdf
HAS/2019-04-24_CNEDIMTS-5923_PLATINUM MOBILE_09_avril_2019_(5923)_avis.pdf
HAS/2019-04-24_CNEDIMTS-5945_MEPILEX BORDER PROTECT SACRUM_09_avril_2019_(5945)_avis.pdf
HAS/2019-04-24_CT-17392_SPRYCEL_Pediatrie_PIC_EI_Avis2_CT17392&17393.pdf
HAS/2019-04-25_CT-14265_TAVANIC_PIS_RI_Avis2_CT14265.pdf
HAS/2019-04-25_CT-16697_FASLODEX_PIC_EI_Avis2_CT16697.pdf
HAS/2019-04-25_CT-17010_IBRANCE_PIC_REEV_Avis2_CT17010.pdf
HAS/2019-04-25_CT-17389_CABLIVI_PIC_INS_Avis3_CT17389.pdf
HAS/2019-04-25_CT-17561_ROCURONIUM_HIKMA_PIS_INS_Avis1_CT17561.pdf
HAS/2019-04-25_CT-17576_TIROFIBAN_FARMAGES_PIS_INS_Avis1_CT17576.pdf
HAS/2019-04-25_CT-17631_ROACTEMRA_SC_PIS_EI_AJIs_Avis1_CT17631.pdf
HAS/2019-04-25_CT-17660_CHOLECALCIFEROL_LABORATOIRE_XO_PIS_INS_Avis1_CT17660.pdf
HAS/2019-04-25_cablivi_summary_ct17389.pdf
HAS/2019-04-25_faslodex_en_ass_ibrance_partie2_20032019_transcription_ct16697.pdf
HAS/2019-04-25_faslodex_partie1_20032019_transcription_ct16697.pdf
HAS/2019-04-25_ibrance_20032019_transcription_ct17010.pdf
HAS/2019-04-25_ibrance__synthese_ct17010_2019-09-09_15-06-53_263.pdf
HAS/2019-04-25_ibrance_asso_letrozole_summary_ct17010.pdf
HAS/2019-04-25_ibrance_asso_letrozole_synthese_ct17010_2019-09-09_15-06-53_282.pdf
HAS/2019-04-25_ibrance_summary_ct17010.pdf
HAS/2019-04-26_annexes_rapport_helicobacter_pylori_vd.pdf
HAS/2019-04-26_rapport_helicobacter_pylori_vd.pdf
HAS/2019-05-07_CT-17372_TECENTRIQ_PIS_RCP_Avis1_CT17372.pdf
HAS/2019-05-07_CT-17570_DEXMEDETOMIDINE_EVER_PHARMA_PIS_INS_Avis1_CT17570.pdf
HAS/2019-05-07_CT-17583_EPIPEN_PIS_RI_Avis2_CT17583.pdf
HAS/2019-05-07_CT-17625_ISENTRESS_PIS_INS_Avis1_CT17625.pdf
HAS/2019-05-07_CT-17634_CEFTRIAXONE_PANPHARMA_PIS_INS_CG_Avis2_CT17634.pdf
HAS/2019-05-07_CT-17647_DEMECLOCYCLINE_ACETLAB_150mg_PIS_INS_GE_Avis1_CT17647.pdf
HAS/2019-05-07_CT-17713_APREPITANT_ACCORD_PIS_INS_Avis1_CT17713.pdf
HAS/2019-05-07_CT-17727_LEVETIRACETAM_ALTAN_PIS_INS_GE_Avis1_CT17727.pdf
HAS/2019-05-13_CT-17133_RIMACTAN_PIS_RI_Avis1_CT17133.pdf
HAS/2019-05-13_CT-17169_MIFFEE_PIC_REEV_SMR_Avis1_CT17169.pdf
HAS/2019-05-13_CT-17232_RETACRIT_PIS_RI_EI_Avis1_CT17232&17443.pdf
HAS/2019-05-13_CT-17488_RIAMET_PIS_RI_Avis1_CT17488.pdf
HAS/2019-05-13_CT-17597_OLIMEL_PIS_RI_Avis2_CT17597.pdf
HAS/2019-05-13_miffee_summary_ct17169.pdf
HAS/2019-05-13_miffee_synthese_ct17169.pdf
HAS/2019-05-14_CT-17053_ISENTRESS_PIS_RI_Avis1_CT17053.pdf
HAS/2019-05-14_CT-17113_POLYGYNAX_PIS_RI_Avis1_CT17113.pdf
HAS/2019-05-14_CT-17482_IBUPROFENE_B_BRAUN_PIC_INS_Avis1_CT17482.pdf
HAS/2019-05-14_CT-17514_OXYCODONE_RENAUDIN_PIS_INS_Avis1_modifiele30042019_CT17514.pdf
HAS/2019-05-14_CT-17602_TADIM_PIS_RI_Avis1_CT17602.pdf
HAS/2019-05-14_CT-17606_TAFINLAR_PIS_RI_Avis2_CT17606.pdf
HAS/2019-05-14_CT-17619_CROMOFREE_PIS_RI_Avis1_CT17619.pdf
HAS/2019-05-14_CT-17621_STRIVERDI_RESPIMAT_PIS_INS_Avis2_CT17621.pdf
HAS/2019-05-14_CT-17627_SPIRIVA_RESPIMAT_PIS_INS_Avis2_CT17627.pdf
HAS/2019-05-14_CT-17641_INNOHEP_PIS_INS_CG_Avis1_CT17641.pdf
HAS/2019-05-14_CT-17644_ATOSIBAN_ACCORD_PIS_INS_Avis1_CT17644.pdf
HAS/2019-05-14_CT-17650_METRONIDAZOLE_NORIDEM_PIS_INS_Avis2_CT17650.pdf
HAS/2019-05-14_CT-17730_DESFLURANE_PIRAMAL_PIS_INS_Avis1_CT17730.pdf
HAS/2019-05-14_ibuprofene_bbraun_summary_ct17482.pdf
HAS/2019-05-15_bum_osteoporose_maj_avril2019.pdf
HAS/2019-05-16_annexes_evaluation_medico-economique_polyarthrite_rhumatoide_2019-05-07_11-29-1_646.pdf
HAS/2019-05-16_feuille_de_route_-_prise_en_charge_de_la_polyarthrite_rhumatoide.pdf
HAS/2019-05-16_rapport_evaluation_medico-economique_polyarthrite_rhumatoide.pdf
HAS/2019-05-17_CNEDIMTS-5894_ORSIRO_23_avril_2019_(5894)_avis_occultation.pdf
HAS/2019-05-17_CT-16651_SALAZOPYRINE_PIC_RI_Avis2_CT16651.pdf
HAS/2019-05-17_CT-16716_FERINJECT_PIC_REEV_ASMR_Avis3_CT16716.pdf
HAS/2019-05-17_CT-16890_VELTASSA_PIC_INS_Avis3_CT16890.pdf
HAS/2019-05-17_CT-17283_ESMYA_PIC_REEV_SMR_RI_Avis3_CT17283&17284.pdf
HAS/2019-05-17_CT-17339_MEPSEVII_PIC_INS_Avis3_CT17339.pdf
HAS/2019-05-17_esmya_summary_ct17283.pdf
HAS/2019-05-17_esmya_synthese_ct17283.pdf
HAS/2019-05-17_ferinject_summary_ct16716.pdf
HAS/2019-05-17_ferinject_synthese_ct16716.pdf
HAS/2019-05-17_jardiance_pic_reev_avis3_ct17144.pdf
HAS/2019-05-17_jardiance_sapub_ct14177_en_val.pdf
HAS/2019-05-17_jardiance_synthese_ct14177.pdf
HAS/2019-05-17_mepsevii_summary_ct17339.pdf
HAS/2019-05-17_mepsevii_synthese_ct17339.pdf
HAS/2019-05-17_naftilux_pis_ri_avis3_ct16271.pdf
HAS/2019-05-17_naftilux_summary_ct16271.pdf
HAS/2019-05-17_naftilux_synthese_ct16271.pdf
HAS/2019-05-17_neuraceq_pic_ins_avis3_ct16710.pdf
HAS/2019-05-17_neuraceq_summary_ct16710.pdf
HAS/2019-05-17_neuraceq_synthese_ct16710.pdf
HAS/2019-05-17_salazopyrine_summary_ct16651.pdf
HAS/2019-05-17_salazopyrine_synthese_ct16651.pdf
HAS/2019-05-17_veltassa_summary_ct16890.pdf
HAS/2019-05-17_veltassa_synthese_ct16890.pdf
HAS/2019-05-21_CNEDIMTS-5723_LEVEEN_23_avril_2019_(5723)_avis_occultation.pdf
HAS/2019-05-21_CNEDIMTS-5796_SOLOIST_23_avril_2019_(5723)_avis_occultation.pdf
HAS/2019-05-21_CNEDIMTS-5914_ORFEO D_23_avril_2019_(5914)_avis.pdf
HAS/2019-05-21_CNEDIMTS-5915_VALENTINA D_23_avril_2019_(5915)_avis.pdf
HAS/2019-05-21_CNEDIMTS-5943_COLLECTEUR EXPRESS_23_avril_2019_(5943)_avis.pdf
HAS/2019-05-21_CNEDIMTS-5948_VENEZIA D_23_avril_2019_(5948)_avis.pdf
HAS/2019-05-21_CNEDIMTS-5949_VANDA D_23_avril_2019_(5949)_avis.pdf
HAS/2019-05-21_CNEDIMTS-5950_VELINA D_23_avril_2019_(5950)_avis.pdf
HAS/2019-05-21_CNEDIMTS-5951_OCTAVIO D_23_avril_2019_(5951)_avis.pdf
HAS/2019-05-22_CT-17505_ZOPICLONE_ARROW_LAB_3,75mg_PIS_INS_Avis1_CT17505.pdf
HAS/2019-05-22_CT-17571_THIOPENTAL_MEDIPHA_PIS_INS_Avis1_CT17571.pdf
HAS/2019-05-22_CT-17620_SPIOLTO_RESPIMAT_PIS_INS_Avis2_CT17620.pdf
HAS/2019-05-22_CT-17646_FLUMAZENIL_HIKMA_PIS_INS_Avis2_CT17646.pdf
HAS/2019-05-22_CT-17696_PARACETAMOL_CODEINE_TEVA_PIS_INS_Avis2_CT17696.pdf
HAS/2019-05-22_CT-17697_BORTEZOMIB_MYLAN_PIS_INS_Avis1_CT17697.pdf
HAS/2019-05-22_CT-17706_ZOPICLONE_ARROW_LAB_7,5mg_PIS_INS_Avis1_CT17706.pdf
HAS/2019-05-22_CT-17732_ILARIS_PIS_EI_NON_DEMANDEE_Avis1_CT17732.pdf
HAS/2019-05-24_CNEDIMTS-5788_DIGISONIC SP ABI_23_avril_2019_(5788)_avis.pdf
HAS/2019-05-24_CNEDIMTS-5833_FIXA_DUPLEX sans ciment_07_mai_2019_(5833)_avis.pdf
HAS/2019-05-24_CNEDIMTS-5909_Mi1200 SYNCHRONY ABI-Mi1200 SYNCHRONY PIN ABI_23_avril_2019_(5909)_avis.pdf
HAS/2019-05-24_CNEDIMTS-5946_INTERSTIM I_09_avril_2019_(5946)_avis.pdf
HAS/2019-05-24_CNEDIMTS-5989_INVACARE COLIBRI OUTDOOR 4 ROUES_21_mai_2019_(5989)_avis.pdf
HAS/2019-05-24_CNEDIMTS-5992_FREESTYLE OPTIUM NEO_21_mai_2019_(5992)_avis.pdf
HAS/2019-05-24_fixa_duplex_a_cimenter.pdf
HAS/2019-05-27_CNEDIMTS-5854_ONIRIS PRO_21_mai_2019_(5854)_avis.pdf
HAS/2019-05-27_CNEDIMTS-5983_CATIONORM unidoses_21_mai_2019_(5983)_avis.pdf
HAS/2019-05-27_CNEDIMTS-5987_CATIONORM multidoses_21_mai_2019_(5987)_avis.pdf
HAS/2019-05-27_CT-17494_DELSTRIGO_PIC_INS_Avis2_CT17494.pdf
HAS/2019-05-27_CT-17535_LUXTURNA_PIC_INS_Avis2_CT17535.pdf
HAS/2019-05-27_cteval376_fiche_bum_antinauseeux_cd_10042019_2019-05-13_14-40-46_22.pdf
HAS/2019-05-27_delstrigo_summary_ct17494.pdf
HAS/2019-05-27_delstrigo_synthese_ct17494.pdf
HAS/2019-05-27_luxturna_14052019_avis_efficience.pdf
HAS/2019-05-27_luxturna_20032019_ct17535_transcription.pdf
HAS/2019-05-27_luxturna_adoption_03042019_ct17535_transcription.pdf
HAS/2019-05-27_luxturna_summary_ct17535.pdf
HAS/2019-05-27_luxturna_synthese_ct17535.pdf
HAS/2019-05-27_pifeltro_delstrigo_20032019_transcription_ct1749517494.pdf
HAS/2019-05-28_CNEDIMTS-5827_AVANTGARDE CHRONO CARBOSTENT_07_mai_2019_(5827)_avis.pdf
HAS/2019-05-29_CNEDIMTS-5853_ARGUS II_07_mai_2019_(5853)_avis_occultation.pdf
HAS/2019-05-29_CNEDIMTS-5952_MENISCAL CINCH II_07_mai_2019_(5952)_avis.pdf
HAS/2019-05-29_CNEDIMTS-5956_DIGI SP_DIGI SPK_DIGISONIC BTE ZEBRA_ 23_avril_2019_(5956)_avis.pdf
HAS/2019-05-29_CNEDIMTS-5999_ELUNIR_21_mai_2019_(5999)_avis.pdf
HAS/2019-06-04_argumentaire_infections_enterobacteries.pdf
HAS/2019-06-04_fiche_outil_anact_jeu_de_cartes_2018.pdf
HAS/2019-06-04_fiche_outil_anact_vis_mon_travail_2018.pdf
HAS/2019-06-04_guide_demarche_qvt_2017.pdf
HAS/2019-06-04_jeu_de_cartes_fichiers_questions_has_vf.pdf
HAS/2019-06-04_jeu_de_cartes_matrice_daide_animateur_has.pdf
HAS/2019-06-04_lettre_appel_volontariat_-vmt.pdf
HAS/2019-06-04_plateauqvt_jeu_de_cartes.pdf
HAS/2019-06-04_qvt_fiche_outil_boussole.pdf
HAS/2019-06-04_qvt_fiche_outil_edd.pdf
HAS/2019-06-04_qvt_fiche_outil_reportagephotos.pdf
HAS/2019-06-04_rapport_detonnement_vmt.pdf
HAS/2019-06-04_recommandations_infections_enterobacteries.pdf
HAS/2019-06-04_synthese_infections_enterobacteries.pdf
HAS/2019-06-04_synthese_infections_enterobacteries_en_vf_mel.pdf
HAS/2019-06-05_2019_05_19_rapport_transversal_evaluation_clusters_qvt.pdf
HAS/2019-06-05_CT-16425_MIANSERINE_MYLAN_PIS_RI_Avis2_CT16425.pdf
HAS/2019-06-05_CT-16610_ADVAGRAF_MODIGRAF_PROGRAF_PIS_RI_Avis1_CT16610.pdf
HAS/2019-06-05_CT-16611_CARTREX_PIS_RI_Avis2_CT16611.pdf
HAS/2019-06-05_CT-17096_FASIGYNE_PIS_RI_Avis1_CT17096.pdf
HAS/2019-06-05_CT-17151_TROPHIGIL_PIS_RI_Avis1_CT17151.pdf
HAS/2019-06-05_CT-17175_TROSYD-GYNO_TROSYD_PIS_RI_Avis1_CT17175.pdf
HAS/2019-06-05_CT-17206_TERGYNAN_PIS_RI_Avis1_CT17206.pdf
HAS/2019-06-05_CT-17267_RULID_PIS_RCP_Avis1_CT17267.pdf
HAS/2019-06-05_CT-17477_ICLUSIG_PIS_REEV_POP_CIB_Avis2_CT17477.pdf
HAS/2019-06-05_CT-17493_VISIPAQUE_PIS_RI_Avis1_CT17493.pdf
HAS/2019-06-05_CT-17637_CLAIRYG_PIS_EI_Avis1_CT17637.pdf
HAS/2019-06-05_CT-17698_NEODIOP_TravoprostTimololHorusPharma_PIS_INS_Avis1_CT17698.pdf
HAS/2019-06-05_CT-17731_ONTRUZANT_PIS_INS_Avis1_CT17731.pdf
HAS/2019-06-05_rapport_virus_nil_occidental.pdf
HAS/2019-06-05_synthese_rapport_evaluation_des_clusters_sociaux_2018.pdf
HAS/2019-06-07_CNEDIMTS-5781_NUCLEUS_23_avril_2019_(5780)_(5781)_(5782)_(5783)_(5840)_(5841)_avis.pdf
HAS/2019-06-07_CNEDIMTS-5887_XLMOB A CIMENTER_23_avril_2019_(5887)_avis.pdf
HAS/2019-06-07_CT-16658_PROTOPIC_PIS_RI_Avis2_CT16658.pdf
HAS/2019-06-07_CT-17130_TROBICINE_PIS_RI_Avis2_CT17130.pdf
HAS/2019-06-07_CT-17171_FONGAMIL_PIS_RI_Avis2_CT17171.pdf
HAS/2019-06-07_CT-17322_MYALEPTA_PIC_INS_Avis2_CT17322&17457.pdf
HAS/2019-06-07_CT-17490_FYCOMPA_PIS_RI_Avis2_CT17490.pdf
HAS/2019-06-07_CT-17522_DEPAKINE_MICROPAKINE_PIS_RCP_Avis2_CT17522.pdf
HAS/2019-06-07_CT-17564_TWICOR_PIS_INS_Avis2_CT17564.pdf
HAS/2019-06-07_CT-17600_INTELENCE_PIS_RI_Avis1_CT17600.pdf
HAS/2019-06-07_CT-17616_TIMOFEROL_PIS_RI_Avis1_CT17616.pdf
HAS/2019-06-07_CT-17704_FOSOMEL_FOSOMELPERI_QD_INS_Avis2_CT17704.pdf
HAS/2019-06-07_CT-17705_IBUPROFENE_ARROW_QD_INS_Avis1_CT17705.pdf
HAS/2019-06-07_CT-17778_NIMOTOP_PIS_INS_Avis1_CT17778.pdf
HAS/2019-06-07_digisonic_sp-digisonic_sp_evo_5786_neuro_zti_cla-neuro_zti_evo_5787_saphyr_sp-saphyr_cx_5789_neuro_one-neuro_2_5837_23_avril.pdf
HAS/2019-06-07_hires_90k_advantage-hires_90k_advantage_hifocus_ms_5776_neptune_5838_auria_harmony_5839_23_avril_2019_avis.pdf
HAS/2019-06-07_myalepta_summary_ct17457.pdf
HAS/2019-06-07_myalepta_synthese_ct17457.pdf
HAS/2019-06-07_venaseal_23_avril_2019_5761_avis_occultation.pdf
HAS/2019-06-11_CT-15109_GANFORT_PIC_RI_REEV_Avis1_CT15109.pdf
HAS/2019-06-11_CT-17037_HIZENTRA_PIC_EI_Avis3_CT17037.pdf
HAS/2019-06-11_CT-17224_CABOMETYX_PIC_EI_Avis3_CT17224.pdf
HAS/2019-06-11_CT-17264_CUPRIOR_150mg_PIC_INS_Avis3_CT17264.pdf
HAS/2019-06-11_CT-17325_INDUCTOS_PIC_EI_Avis2_CT17325.pdf
HAS/2019-06-11_CT-17542_GILENYA_PIC_EI_Avis2_CT17345&17542.pdf
HAS/2019-06-11_app_260_note_de_problematique_ssr_avc_cd_2019_05_22_vfinale.pdf
HAS/2019-06-11_cabometyx_summary_ct17224.pdf
HAS/2019-06-11_cabometyx_synthese_ct17224_2019-06-11_14-23-59_646.pdf
HAS/2019-06-11_cuprior__summary_ct17264.pdf
HAS/2019-06-11_cuprior__synthese_ct17264.pdf
HAS/2019-06-11_ganfort_summary_ct15109.pdf
HAS/2019-06-11_ganfort_synthese_ct15109.pdf
HAS/2019-06-11_gilenya_summary_ct17345_ct17542.pdf
HAS/2019-06-11_gilenya_synthese_ct17345_ct17542.pdf
HAS/2019-06-11_guide_medecin_crohn_web.pdf
HAS/2019-06-11_guide_patient_mcrohn_ald24_1_dec.pdf
HAS/2019-06-11_hizentra_summary_ct17037.pdf
HAS/2019-06-11_hizentra_synthese_ct17037.pdf
HAS/2019-06-11_inductos_20032019_transcription_ct17325.pdf
HAS/2019-06-11_inductos_summary_ct17325.pdf
HAS/2019-06-11_inductos_synthese_ct17325.pdf
HAS/2019-06-11_lap_crohn_web.pdf
HAS/2019-06-12_CT-14028_PREVENAR_13_PIS_RI_Avis2_CT14028.pdf
HAS/2019-06-12_CT-16267_PREVENAR_13_PIC_EI_pneumonieAD_Avis3_CT16267.pdf
HAS/2019-06-12_CT-17406_MEKINIST_TAFINLAR_MelanomeAdjuv_PIC_EI_Avis2_CT17406.pdf
HAS/2019-06-12_CT-17546_TAKHZYRO_PIC_INS_Avis3_CT17546.pdf
HAS/2019-06-12_prevenar13_ei_pneumoniead_synthese_ct16267.pdf
HAS/2019-06-12_prevenar_13_05062019_transcription_ct16267.pdf
HAS/2019-06-12_prevenar_13_20032019_transcription_ct16267.pdf
HAS/2019-06-12_prevenar_13_summary_ct16267.pdf
HAS/2019-06-12_tafilnlar_mekinist_summary_ct17406.pdf
HAS/2019-06-12_tafilnlar_mekinist_synthese_ct17406.pdf
HAS/2019-06-12_tafinlar_mekinist_14052019_avis_efficience.pdf
HAS/2019-06-12_takhzyro_05062019_transcription_ct17546.pdf
HAS/2019-06-12_takhzyro_15102019_avis_efficience_2020-01-15_10-52-6_990.pdf
HAS/2019-06-12_takhzyro_17042019_transcription_ct17546.pdf
HAS/2019-06-12_takhzyro_adoption_15052019_transcription_ct17546.pdf
HAS/2019-06-12_takhzyro_synthese_ct17546.pdf
HAS/2019-06-17_CT-17185_REVERPLEG_PIC_INS_Avis3_CT17185.pdf
HAS/2019-06-17_CT-17311_TCAPS_PIC_INS_Avis3_CT17311.pdf
HAS/2019-06-17_argumentaire_pnds_mcardle.pdf
HAS/2019-06-17_pnds_argumentaire_epilepsie_myoclonique_nourrisson_mai_2019.pdf
HAS/2019-06-17_pnds_texte__epilepsie_myoclonique_nourrisson_mai_2019.pdf
HAS/2019-06-17_reverpleg_summary_ct17185_2019-10-17_15-29-16_396.pdf
HAS/2019-06-17_reverpleg_synthese_ct17185.pdf
HAS/2019-06-17_synthese_mg_glycogenose_de_type_v_maladie_de_mcardle.pdf
HAS/2019-06-17_synthese_mg_traps_epilepsie_myoclonique_du_nourrisson.pdf
HAS/2019-06-17_tcaps_summary_ct17311.pdf
HAS/2019-06-17_tcaps_synthese_ct17311.pdf
HAS/2019-06-17_texte_pnds_mcardle.pdf
HAS/2019-06-20_fiche_memo_teleconsultation_et_teleexpertise_mise_en_oeuvre.pdf
HAS/2019-06-20_fiche_memo_teleimagerie.pdf
HAS/2019-06-20_grille_devaluation_methode_du_patient_traceur_teleconsultation_et_teleexpertise.pdf
HAS/2019-06-20_guide_teleconsultation_et_teleexpertise.pdf
HAS/2019-06-20_guide_teleimagerie.pdf
HAS/2019-06-20_has_fiche_teleconsultation-telesoin.pdf
HAS/2019-06-20_points-cle_solution_-_pertience_cholecystectomie.pdf
HAS/2019-06-20_points-cle_solution_-_problematique_cholecystectomie.pdf
HAS/2019-06-20_points-cle_solution_-_qd_faire_cholecystectomie.pdf
HAS/2019-06-20_rapport_delaboration_teleconsultation_et_teleexpertise.pdf
HAS/2019-06-21_CT-16988_ADYNOVI_PIC_INS_Avis3_CT16988.pdf
HAS/2019-06-21_CT-17416_PERJETA_Adjuv_PIC_EI_INS_Avis3_CT17416.pdf
HAS/2019-06-21_CT-17466_RYLIGENCY_PIS_INS_Avis2_CT17466.pdf
HAS/2019-06-21_CT-17714_BUPIVACAINE_ACCORD_PIS_INS_Avis1_CT17714.pdf
HAS/2019-06-21_adynovi_summary_ct16988.pdf
HAS/2019-06-21_adynovi_synthese_ct16988.pdf
HAS/2019-06-21_perjeta_05062019_transcription_ct17416.pdf
HAS/2019-06-21_perjeta_17042019_transcription_ct17416.pdf
HAS/2019-06-26_pnds_vns.pdf
HAS/2019-06-26_synthese_mg_vascularites_necrosantes_systemiques_periarterite_noueuse_et_vascularites_associees_aux_anca.pdf
HAS/2019-07-01_rapport_rougeole.pdf
HAS/2019-07-02_rapport_analyse_prospective_20191.pdf
HAS/2019-07-09_CNEDIMTS-5496_CAPITOLE EVIDENCE sans ciment_21_mai_2019_(5496)_(5497)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5499_CAPTIV DM EVIDENCE TiHAC_21_mai_2019_(5498)_(5499)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5697_SORBACT compresse_04_juin_2019_(5697)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5794_SYNCHROMED II_(5794)_(5913)_04_juin_2019_occultation_avis.pdf
HAS/2019-07-09_CNEDIMTS-5852_FIXA 3P DUPLEX_18_juin_2019_(5852)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5889_SORBACT pansement_04_juin_2019_(5889)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5890_VALIANT NAVION_09_avril_2019_(5890)_avis_occultion.pdf
HAS/2019-07-09_CNEDIMTS-5893_TMARS_21_mai_2019_(5893)_avis_occultation.pdf
HAS/2019-07-09_CNEDIMTS-5940_NEB 200_04_juin_2019_(5940)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5942_NEB 400_04_juin_2019_(5942)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5958_XIENCE ALPINE_21_mai_2019_(5958)_avis_occultation.pdf
HAS/2019-07-09_CNEDIMTS-5959_XIENCE SIERRA_21_mai_2019_(5959)_avis_occultation.pdf
HAS/2019-07-09_CNEDIMTS-5960_XIENCE XPEDITION_21_mai_2019_(5960)_avis_occultation.pdf
HAS/2019-07-09_CNEDIMTS-5962_1025KS_18_juin_2019_(5962)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5963_OSSDSIGN CRANIAL PSI_04_juin_2019_(5963)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5985_GALILEA_04_juin_2019_(5985)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5991_POWERLINK et POWERLINK AFX_21_mai_2019_(5991)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5994_LP ESP II_04_juin_2019_(5994)_avis.pdf
HAS/2019-07-09_CNEDIMTS-5995_JARVIK 2000_21_mai_2019_(5995)_avis.pdf
HAS/2019-07-09_CNEDIMTS-6004_CELSUS_18_juin_2019_(6004)_avis.pdf
HAS/2019-07-09_CNEDIMTS-6005_VELOCITY_18_juin_2019_(6005)_avis.pdf
HAS/2019-07-09_CNEDIMTS-6012_THEALOSE_18_juin_2019_(6012)_avis.pdf
HAS/2019-07-09_CNEDIMTS-6014_ACTIVA_18_juin_2019_(6014)_avis.pdf
HAS/2019-07-09_CT-17021_DANATROL_PIS_RI_Avis1_CT17021.pdf
HAS/2019-07-09_CT-17107_CLOMID_PIS_RI_Avis2_CT17107.pdf
HAS/2019-07-09_CT-17115_OPDIVO_LH_PIC_REEV_Avis3_CT17115.pdf
HAS/2019-07-09_CT-17135_FURADANTINE_PIS_RI_Avis2_CT17135.pdf
HAS/2019-07-09_CT-17180_THIOPHENICOL_PIS_RI_Avis2_CT17180.pdf
HAS/2019-07-09_CT-17720_DAPTOMYCINE_MEDAC_PIS INS_Avis1_CT17720.pdf
HAS/2019-07-09_CT-17762_CALCITONINE_SANDOZ_PIC_REEV_Avis1_CT17762.pdf
HAS/2019-07-09_CT-17806_ELOCTA_PIS_INS_Avis2_CT17806.pdf
HAS/2019-07-09_CT-17837_OLANZAPINE_ARROW_PIS_INS_Avis1_CT17837.pdf
HAS/2019-07-09_calcitonine_summary_ct_17428_ct15979_ct_17762_2020-01-14_16-34-25_534.pdf
HAS/2019-07-09_calcitonine_synthese_ct_17428_ct15979_ct_17762.pdf
HAS/2019-07-09_capitole_evidence_a_cimenter.pdf
HAS/2019-07-09_opdivo_03042019_ct17115_transcription.pdf
HAS/2019-07-09_opdivo_05062019_transcription_ct17115.pdf
HAS/2019-07-09_perfusion_a_domicile_et_prestations.pdf
HAS/2019-07-09_proact.pdf
HAS/2019-07-09_reevaluation_calcitonine_22052019_transcription_ct159791742817762.pdf
HAS/2019-07-09_sieges_coquilles_de_serie.pdf
HAS/2019-07-10_CNEDIMTS-5877_TREVO XP PROVUE_23_avril_2019_(5877)_avis.pdf
HAS/2019-07-10_CNEDIMTS-5908_AXS CATALYST_23_avril_2019_(5908)_avis_occultation.pdf
HAS/2019-07-10_CNEDIMTS-5972_SURPASS_21_mai_2019_(5972)_avis.pdf
HAS/2019-07-10_CNEDIMTS-5978_PIPELINE_21_mai_2019_(5978)_avis.pdf
HAS/2019-07-11_evaluation_de_la_recherche_des_hpv_en_depistage_primaire_des_lesions_precancereuses_et_cancereuses_du_col_de_luterus_-_feuil.pdf
HAS/2019-07-11_fm_ponction_lombaire.pdf
HAS/2019-07-11_infographie_ponction_lombaire.pdf
HAS/2019-07-11_rapport_elaboration_ponction_lombaire_06-2019.pdf
HAS/2019-07-11_rapport_hpv_2019-09-09_14-20-44_251.pdf
HAS/2019-07-11_synthese_anglais_hpv.pdf
HAS/2019-07-11_synthese_et_recommandations_hpv.pdf
HAS/2019-07-11_synthese_hpv.pdf
HAS/2019-07-12_sorbact_meche.pdf
HAS/2019-07-18_rapport_fluoroscopie.pdf
HAS/2019-07-22_CT-17388_ONPATTRO_PIC_INS_Avis3_CT17388.pdf
HAS/2019-07-22_CT-17530_BICAVERA_GLUCOSE_PIS_INS_Avis1_CT17530.pdf
HAS/2019-07-22_CT-17538_KEYTRUDA_PIS_EI_NON_DEMANDEE_Avis2_CT17538.pdf
HAS/2019-07-22_CT-17640_ERLEADA_PIC_INS_Avis2_CT17640.pdf
HAS/2019-07-22_CT-17917_ENBREL_adulte_PIS_RI_Avis2_CT17917.pdf
HAS/2019-07-22_erleada_17092019_avis_efficience.pdf
HAS/2019-07-22_erleada_22052019_transcription_ct17640.pdf
HAS/2019-07-22_erleada_synthese_ct17640.pdf
HAS/2019-07-22_onpattro_11062019_avis_efficience.pdf
HAS/2019-07-22_onpattro_20032019_transcription_ct17388.pdf
HAS/2019-07-22_onpattro_summary_ct17388.pdf
HAS/2019-07-22_onpattro_synthese_ct17388.pdf
HAS/2019-07-23_cteval395_bum_fasenra_nucala_cd4072019.pdf
HAS/2019-07-23_xtandi_16072019_avis_efficience.pdf
HAS/2019-07-23_xtandi_19032019_avis_efficience.pdf
HAS/2019-07-24_reussite_scolaire_et_educative_-_note_de_cadrage.pdf
HAS/2019-07-25_tire-lait_dm_eval_233.pdf
HAS/2019-07-26_recommandation_vaccinale_contre_la_coqueluche_chez_la_femme_enceinte_feuille_de_route.pdf
HAS/2019-07-26_recommandations_influvac_tetra_ped_juillet_2019_2019-07-26_17-18-39_642.pdf
HAS/2019-07-30_avulsion_des_3es_molaire_indications_techniques_et_modalites_-_argumentaire.pdf
HAS/2019-07-30_avulsion_des_3es_molaires_indications_techniques_et_modalites_-_fiche_de_synthese.pdf
HAS/2019-07-30_avulsion_des_3es_molaires_indications_techniques_et_modalites_-_recommandations.pdf
HAS/2019-07-30_note_problematique_3ememolaire_10_12_2014_vd.pdf
HAS/2019-08-01_CNEDIMTS-5976_GLUCOFIX PREMIUM_23_avril_2019_(5976)_avis.pdf
HAS/2019-08-01_CNEDIMTS-5982_PIED RUSH KID PROTEOR_04_juin_2019_(5982)_avis.pdf
HAS/2019-08-01_CT-17509_PRALUENT_PIC_EI_Avis3_CT17509.pdf
HAS/2019-08-01_praluent_15052019_transcription_ct17509.pdf
HAS/2019-08-01_praluent_17072019_transcription_ct17509.pdf
HAS/2019-08-01_praluent_adoption_05062019_transcription_ct17509.pdf
HAS/2019-08-01_praluent_summary_ct17509.pdf
HAS/2019-08-01_praluent_synthese_ct17509.pdf
HAS/2019-08-06_CT-17134_KEFORAL_PIS_RI_Avis1_CT17134.pdf
HAS/2019-08-06_CT-17681_INFLUVAC_TETRA_PIC_EI_Avis2_CT17681.pdf
HAS/2019-08-06_CT-17751_OLIMEL_PIS_INS_CG_Avis2_CT17751.pdf
HAS/2019-08-06_CT-17759_NIVESTIM_PIS_INS_BIO_Avis2_CT17759.pdf
HAS/2019-08-06_CT-17766_IDACIO_PIS_INS_Avis2_CT17766.pdf
HAS/2019-08-06_CT-17788_BORTEZOMIB_ZENTIVA_PIS_INS_Avis1_CT17788.pdf
HAS/2019-08-06_CT-17789_NICORETTE_MICROTAB_PIS_INS_CG_Avis1_CT17789.pdf
HAS/2019-08-06_CT-17821_POSACONAZOLE_MYLAN_PIS_INS_Avis2_CT17821.pdf
HAS/2019-08-06_CT-17868_NORDITROPINE_FLEXPRO_PIS_INS_Avis1_CT17868.pdf
HAS/2019-08-06_CT-17897_PARACETAMOL_ALMUS_PHARMA_500mg_PIS_INS_Avis2_CT17897.pdf
HAS/2019-08-06_CT-17899_PARACETAMOL_ALMUS_PHARMA_1000mg_PIS_INS_Avis2_CT17899.pdf
HAS/2019-08-06_CT-17911_GADOVISTMANUEL_PIS_INS_Avis2_CT17911.pdf
HAS/2019-08-06_influvac_tetra_10072019_transcription_ct17681.pdf
HAS/2019-08-08_pnds_pfapa_vf_050819_2.pdf
HAS/2019-08-08_synthese_mg_pfapa_fievre_periodique_stomatite_pharyngite_adenopathie.pdf
HAS/2019-08-20_CNEDIMTS-5421_I NEB AAD_16_juillet_2019_(5421)_avis.pdf
HAS/2019-08-20_CNEDIMTS-5728_VISIONIST_18_juin_2019_(5728)_(5729)_(5730)_avis_occultation.pdf
HAS/2019-08-20_CNEDIMTS-5729_VISIONIST_18_juin_2019_(5728)_(5729)_(5730)_avis_occultation.pdf
HAS/2019-08-20_CNEDIMTS-5730_VISIONIST_18_juin_2019_(5728)_(5729)_(5730)_avis_occultation.pdf
HAS/2019-08-20_CNEDIMTS-5731_ACCOLADE SR_18_juin_2019_(5731)_avis_occultation.pdf
HAS/2019-08-20_CNEDIMTS-5732_ACCOLADE DR_18_juin_2019_(5732)_avis_occultation.pdf
HAS/2019-08-20_CNEDIMTS-5733_ACCOLADE DR EL_18_juin_2019_(5733)_avis_occultation.pdf
HAS/2019-08-20_CNEDIMTS-5891_LP ESP II_18_juin_2019_(5891)_avis.pdf
HAS/2019-08-20_CNEDIMTS-5947_INVACARE G-TRAC_25_juillet_2019_(5947)_avis.pdf
HAS/2019-08-20_CNEDIMTS-5975_PEEK_02_juillet_2019_(5975)_avis.pdf
HAS/2019-08-20_CNEDIMTS-5993_PONTO 4_02_juillet_2019_(5993)_avis.pdf
HAS/2019-08-20_CNEDIMTS-6038_PIED RUSH ROVER PROTEOR_16_juillet_2019_(6038)_avis.pdf
HAS/2019-08-21_CT-17850_SIMPONI_PIS_EI_NON_DEMANDEE_Avis2_CT17850.pdf
HAS/2019-08-21_aplasie_medullaire_pnds__20190813.pdf
HAS/2019-08-21_argumentaire_scientifique.pdf
HAS/2019-08-21_pnds_crmr_caen_2019_2.pdf
HAS/2019-08-21_synthese_mg_aplasies_medullaires_acquises_et_constitutionnelles.pdf
HAS/2019-08-21_synthese_mg_microdeletion_2q37.pdf
HAS/2019-08-27_mi1200_synchrony-mi1200_synchrony_pin_5874_opus2_5910_sonnet-sonnet_eas_5911_rondo-rondo2_5912_23_avril_2019_avis.pdf
HAS/2019-08-29_CNEDIMTS-6002_DC BEAD_16_juillet_2019_(6002)_avis.pdf
HAS/2019-08-29_cteval460_bum_xolair_maj_cd_04072019.pdf
HAS/2019-08-30_CNEDIMTS-5740_ZENITH FENETREE MULTIBRANCHE_25_JUILLET_2019_(5740)_avis_occultation.pdf
HAS/2019-08-30_CNEDIMTS-5819_ZENITH FENESTRATED_04_juin_2019_(5819)_avis_occultation.pdf
HAS/2019-08-30_CNEDIMTS-5867_FRED_(5867)_FRED Jr_(5868)_04_juin_2019_avis_occultations.pdf
HAS/2019-08-30_CNEDIMTS-5881_SURPASS STREAMLINE_04_juin_2019_(5881)_avis_occultations.pdf
HAS/2019-08-30_CNEDIMTS-5920_STELLAREX_16_juillet_2019_(5920)_avis_occultations.pdf
HAS/2019-08-30_CNEDIMTS-5935_PIPELINE FLEX AVEC SHIELD TECHNOLOGY_16_juillet_2019_(5935)_avis_occultations.pdf
HAS/2019-08-30_CNEDIMTS-5971_SURPASS EVOLVE_04_juin_2019_(5971)_avis_occultation.pdf
HAS/2019-08-30_CNEDIMTS-5996_RELAY PLUS_16_juillet_2019_(5996)_avis_occultation.pdf
HAS/2019-08-30_CNEDIMTS-5997_RELAY NBS PLUS_16_juillet_2019_(5997)_avis_occultation.pdf
HAS/2019-09-03_CNEDIMTS-6008_NUCLEUS CI612 622 et 632_16_juillet_2019_(6008)_avis.pdf
HAS/2019-09-03_CNEDIMTS-6009_CHORUS_16_juillet 2019_(6009)_avis.pdf
HAS/2019-09-03_annexe_cadrage_megeeg_hr.pdf
HAS/2019-09-03_cadrage_megeeg_hr.pdf
HAS/2019-09-05_CNEDIMTS-5724_POUSSEUR2 PREMIUM_16_juillet_2019_(5724)_avis.pdf
HAS/2019-09-05_CNEDIMTS-5878_iVASCULAR LUMINOR 35_16_juillet_2019_(5878)_avis_occultation.pdf
HAS/2019-09-05_CT-15923_CELLTOP_PIS_RI_Avis2_CT15923.pdf
HAS/2019-09-05_CT-15924_BRILIQUE_90_PIC_RI_EPI_Avis2_CT15924.pdf
HAS/2019-09-05_CT-16136_LAMICTAL_PIS_RI_Avis2_CT16136.pdf
HAS/2019-09-05_CT-16935_DITROPAN_PIC_RI_Avis2_CT16935.pdf
HAS/2019-09-05_CT-17050_STEGLATRO_PIC_INS_Avis3_CT17050.pdf
HAS/2019-09-05_CT-17052_STEGLUJAN_PIC_INS_Avis3_CT17052.pdf
HAS/2019-09-05_CT-17147_ORBENINE_PIS_RI_Avis2_CT17147.pdf
HAS/2019-09-05_CT-17176_OZEMPIC_PIC_INS_Avis3_CT17176.pdf
HAS/2019-09-05_CT-17192_GYNO_PEVARYL_PIS_RI_Avis1_CT17192.pdf
HAS/2019-09-05_CT-17196_EUTHYRAL_PIS_RI_Avis2_CT17196.pdf
HAS/2019-09-05_CT-17203_BASDENE_RI_PIS_Avis2_CT17203.pdf
HAS/2019-09-05_CT-17226_OPDIVO_melanome_adjuvant_PIC_EI_Avis2_CT17226.pdf
HAS/2019-09-05_CT-17229_XELJANZ_RCH_PIC_INS_Avis3_CT17198&17229.pdf
HAS/2019-09-05_CT-17248_BOSULIF_400mg_PIS_INS_Avis2_CT17248.pdf
HAS/2019-09-05_CT-17249_BOSULIF_PIC_EI_Avis3_modifiele20082019_CT17249.pdf
HAS/2019-09-05_CT-17265_TRESIBA_PIC_REEV_Avis2_CT17265.pdf
HAS/2019-09-05_CT-17274_L-THYROXINE_SERB_PIS_RI_Avis1_CT17274.pdf
HAS/2019-09-05_CT-17390_PRENOXAD_PIC_INS_Avis1_CT17390.pdf
HAS/2019-09-05_CT-17431_BRAFTOVI-MEKTOVI_PIC_INS_Avis3_CT17431.pdf
HAS/2019-09-05_CT-17495_PIFELTRO_PIC_INS_Avis2_CT17495.pdf
HAS/2019-09-05_CT-17553_CELSIOR_PIC_INS_Avis1_CT17553.pdf
HAS/2019-09-05_CT-17630_BECLOMETASONE_TEVA-ECOBEC-QVARSPRAY-QVARAUTOHALER_PIS_RI_Avis2_CT17630.pdf
HAS/2019-09-05_CT-17682_THYROZOL_PIS_RI_Avis2_CT17682.pdf
HAS/2019-09-05_CT-17684_TRUSOPT_PIS_INS_Avis2_CT17684.pdf
HAS/2019-09-05_CT-17707_DEPAKINE_400mg_4ml_IV_PIS_INS_Avis2_CT17707.pdf
HAS/2019-09-05_CT-17725_RAVICTI_PIS_EI_Avis2_CT17725.pdf
HAS/2019-09-05_CT-17738_NICORETTE_PIS_INS_CG_Avis1_CT17738.pdf
HAS/2019-09-05_CT-17752_CRYSVITA_PIS_INS_Avis1_CT17752.pdf
HAS/2019-09-05_CT-17826_VITAMINE_B6_ARROW_PIS_INS_Avis1_CT17826.pdf
HAS/2019-09-05_bosulif_10072019_transcription_ct17249.pdf
HAS/2019-09-05_bosulif_22052019_transcription_ct17249.pdf
HAS/2019-09-05_braftovi-mektovi_20032019_transcription_ct17431.pdf
HAS/2019-09-05_braftovi_mektovi_05062019_transcription_ct17431.pdf
HAS/2019-09-05_braftovi_mektovi_12062019_transcription_ct17431.pdf
HAS/2019-09-05_braftovi_mektovi_summary_ct17431.pdf
HAS/2019-09-05_braftovi_mektovi_synthese_ct17431.pdf
HAS/2019-09-05_brilique_22052019_transcription_ct15924.pdf
HAS/2019-09-05_celsior_15052019_ct17553_transcription.pdf
HAS/2019-09-05_celsior_synthese_ct17553.pdf
HAS/2019-09-05_ditropan__summary_ct16935.pdf
HAS/2019-09-05_ditropan__synthese_ct16935.pdf
HAS/2019-09-05_fraxiparine_pic_ei_avis2_ct16700.pdf
HAS/2019-09-05_fraxiparine_summary_ct16700.pdf
HAS/2019-09-05_fraxiparine_synthese_ct16700.pdf
HAS/2019-09-05_ivascular_luminor_18_16_juillet_2019_5878_avis_occultation.pdf
HAS/2019-09-05_opdivo_16042019_avis_efficience_2019-07-29_15-55-38_800.pdf
HAS/2019-09-05_opdivo_melanadjuv_summary_ct17226.pdf
HAS/2019-09-05_opdivo_melanadjuv_synthese_ct17226.pdf
HAS/2019-09-05_ozempic_summary_ct17176.pdf
HAS/2019-09-05_ozempic_synthese_ct17176.pdf
HAS/2019-09-05_pifeltro_delstrigo_20032019_transcription_ct1749517494.pdf
HAS/2019-09-05_pifeltro_summary_ct17495.pdf
HAS/2019-09-05_pifeltro_synthese_ct17495.pdf
HAS/2019-09-05_prenoxad_summary_ct17390.pdf
HAS/2019-09-05_prenoxad_synthese_ct17390.pdf
HAS/2019-09-05_steglatro_steglujan_20032019_transcription_ct1705017052.pdf
HAS/2019-09-05_steglatro_steglujan_summary_ct17050_ct17052.pdf
HAS/2019-09-05_steglatro_steglujan_synthese_ct17050_ct17052.pdf
HAS/2019-09-05_tegsedi_09012019_ct17282_transcription.pdf
HAS/2019-09-05_tegsedi_14052019_avis_efficience.pdf
HAS/2019-09-05_tegsedi_17042019_transcription_ct17282.pdf
HAS/2019-09-05_tegsedi_20032019_transcription_ct17282.pdf
HAS/2019-09-05_tegsedi_27022019_ct17282_transcription.pdf
HAS/2019-09-05_tegsedi_pic_ins_avis3_ct17282.pdf
HAS/2019-09-05_tegsedi_summary_ct17282.pdf
HAS/2019-09-05_tegsedi_synthese_ct17282.pdf
HAS/2019-09-05_tresiba_summary_ct17265.pdf
HAS/2019-09-05_tresiba_synthese_ct17265.pdf
HAS/2019-09-05_xeljanz_rch_20032019_transcription_ct17229.pdf
HAS/2019-09-05_xeljanz_rch_ct1719817229_sa2.pdf
HAS/2019-09-05_xeljanz_rch_ct1719817229_summary.pdf
HAS/2019-09-06_CNEDIMTS-5824_COMBO STENT_02_juillet_2019_(5824)_avis.pdf
HAS/2019-09-06_CNEDIMTS-5825_COMBO PLUS STENT_02_juillet_2019_(5825)_avis.pdf
HAS/2019-09-06_CNEDIMTS-5924_BIOMONITOR 2AF_02_juillet_2019_(5924)_avis_occultation.pdf
HAS/2019-09-06_CT-16961_ADEPAL_MINIDRIL_TRINORDIOL_PIC_RI_REEV_Avis1_CT16961.pdf
HAS/2019-09-06_CT-17454_XOFIGO_PIC_REEV_Avis3_CT17454.pdf
HAS/2019-09-06_CT-17512_NUCALA_PIC_EI_Avis3_CT17512.pdf
HAS/2019-09-06_CT-17578_CADDERA_PIC_INS_Avis1_CT17578.pdf
HAS/2019-09-06_CT-17743_VARILRIX_PIS_RI_Avis2_CT17743.pdf
HAS/2019-09-06_CT-17750_ATRIPLA_PIS_RI_Avis2_CT17750.pdf
HAS/2019-09-06_CT-17758_TIMOPTOL-TIMOPTOL_LP_PIS_INS_Avis2_CT17688&17758.pdf
HAS/2019-09-06_CT-17792_PARACETAMOL_CRISTERS_1000mg_PIS_INS_CG_Avis2_CT17792.pdf
HAS/2019-09-06_CT-17794_MYDRANE_PIS_INS_Avis2_CT17794.pdf
HAS/2019-09-06_CT-17801_PARACETAMOL_CRISTERS_500mg_PIS_INS_CG_Avis2_CT17801.pdf
HAS/2019-09-06_CT-17822_MIGLUSTAT_DIPHARMA_PIS_INS_GE_Avis1_CT17822.pdf
HAS/2019-09-06_CT-17824_MEROPENEM_ARROW_LAB_PIS_INS_Avis1_CT17824.pdf
HAS/2019-09-06_CT-17852_ETOPOSIDE_ACCORD_PIS_INS_Avis1_CT17852.pdf
HAS/2019-09-06_CT-17873_REANUTRIFLEX_PERINUTRIFLEX_MEDNUTRIFLEX_PIS_INS_Avis2_CT17870&17871&17872&17873.pdf
HAS/2019-09-06_CT-17875_FENTICONAZOLE_BAILLEUL_PIS_INS_Avis2_CT17875.pdf
HAS/2019-09-06_CT-17891_BONASOL_PIS_INS_Avis2_CT17891.pdf
HAS/2019-09-06_adepal_minidril_trinordiol_12062019_transcription_ct16961.pdf
HAS/2019-09-06_caddera_26062019_transcription_ct17578.pdf
HAS/2019-09-06_caddera_summary_ct17578.pdf
HAS/2019-09-06_caddera_synthese_ct17578.pdf
HAS/2019-09-06_nucala_15052019_transcription_ct17512.pdf
HAS/2019-09-06_nucala_17072019_transcription_ct17512.pdf
HAS/2019-09-06_xofigo_17072019_transcription_ct17454.pdf
HAS/2019-09-06_xofigo_22052019_transcription_ct17454.pdf
HAS/2019-09-07_CT-17572_CONTRIBUTIONS_HOMEO.pdf
HAS/2019-09-07_homeopathie_12062019_transcription_cteval415.pdf
HAS/2019-09-07_homeopathie_17042019_transcription_cteval415.pdf
HAS/2019-09-07_homeopathie_26062019_transcription_cteval415.pdf
HAS/2019-09-07_homeopathie_adoption_15052019_transcription_cteval415.pdf
HAS/2019-09-07_homeopathie_pic_avis3_cteval415.pdf
HAS/2019-09-07_homeopathie_synthese_anglaise_18102019.pdf
HAS/2019-09-09_CT-17432_IMFINZI_PIC_INS_Avis2_CT17432.pdf
HAS/2019-09-09_imfinzi_14052019_avis_efficience.pdf
HAS/2019-09-09_imfinzi_summary_ct17432_val.pdf
HAS/2019-09-09_imfinzi_synthese_ct17432.pdf
HAS/2019-09-10_CNEDIMTS-5973_TOOKAD_03_septembre_2019_(5973)_avis.pdf
HAS/2019-09-10_CT-17449_PALMIER_DE_FLORIDE_MYLAN_PIS_INS_Avis1_CT17449.pdf
HAS/2019-09-10_CT-17683_TOOKAD_PIC_INS_Avisdéfinitif_CT17683.pdf
HAS/2019-09-10_CT-17774_GADOVISTAUTO_PIS_INS_Avis2_CT17774.pdf
HAS/2019-09-11_CT-17733_GLICLAZIDE_SANDOZ_PIS_INS_Avis1_CT17733.pdf
HAS/2019-09-11_CT-17811_TOUJEO_DOUBLESTAR_PIS_INS_Avis2_CT17811.pdf
HAS/2019-09-11_inahta_brief_nephrectomy.pdf
HAS/2019-09-11_lyric3.pdf
HAS/2019-09-11_rapport_robot_nephrectomie.pdf
HAS/2019-09-11_reco294_protocole_maj_tdm_amiante.pdf
HAS/2019-09-11_reco294_rapport_maj_tdm_amiante_cd_2019_08_28_v1.pdf
HAS/2019-09-12_CNEDIMTS-5323_LIFEVEST 4000_16_juillet_2019_(5323)_(5820)_(5848)_avis.pdf
HAS/2019-09-12_CNEDIMTS-5806_CONFIRM RX_16_juillet_2019_(5806)_avis_occultation.pdf
HAS/2019-09-12_CT-16291_BORTEZOMIB_TEVA_QD_INS_Avis2_CT16291.pdf
HAS/2019-09-12_CT-16608_SYMTUZA_PIC_INS_Avis Post Audition_CT16608.pdf
HAS/2019-09-12_CT-16738_ENBREL_PIC_RI_REEV_enfant_Avis1_CT16738.pdf
HAS/2019-09-12_CT-17607_STRIBILD_PIS_RI_Avis2_CT17607.pdf
HAS/2019-09-12_CT-17636_VOTUBIA_PIC_REEV_Avis2_CT17636.pdf
HAS/2019-09-12_CT-17664_COSENTYX_RP_Pso_PIS_MCI_Avis2_CT17664.pdf
HAS/2019-09-12_CT-17756_VOLTARENE_EMULGEL_PIS_INS_Avis1_CT17756.pdf
HAS/2019-09-12_CT-17814_TRAZIMERA_PIS_INS_Avis1_CT17814.pdf
HAS/2019-09-12_boulimie_et_hyperphagie_boulimique_-_argumentaire.pdf
HAS/2019-09-12_boulimie_et_hyperphagie_boulimique_-_recommandations.pdf
HAS/2019-09-12_coordinated_multidisciplinary_care_-_toolkit_5.pdf
HAS/2019-09-12_detection_and_management_of_dental_problems_by_dentists_-_toolkit_7.pdf
HAS/2019-09-12_emergency_situations_and_eating_disorders_-_toolkit_8.pdf
HAS/2019-09-12_enbrel_26062019_transcription_ct16738.pdf
HAS/2019-09-12_fs_boulimie_aspects_gynecologiques_v1.pdf
HAS/2019-09-12_fs_boulimie_commentenparler_v2.pdf
HAS/2019-09-12_fs_boulimie_complications_somatiques_v1.pdf
HAS/2019-09-12_fs_boulimie_evaluation_initiation_v2.pdf
HAS/2019-09-12_fs_boulimie_prise_en_charge_dentaire_v2.pdf
HAS/2019-09-12_fs_boulimie_prise_en_charge_pluri_v2.pdf
HAS/2019-09-12_fs_boulimie_reperage_v1.pdf
HAS/2019-09-12_fs_boulimie_urgences_v3.pdf
HAS/2019-09-12_gynaecological_and_obstetric_aspect_-_toolkit_6.pdf
HAS/2019-09-12_how_to_talk_about_it_-_toolkit_2.pdf
HAS/2019-09-12_identification_and_screening_-_toolkit_1.pdf
HAS/2019-09-12_initial_assessment_and_initiation_of_treatment_-_toolkit_3.pdf
HAS/2019-09-12_rbp_cadrage_boulimie_mel.pdf
HAS/2019-09-12_reco_anorexie_mentale.pdf
HAS/2019-09-12_somatic_complications_and_their_management_-_toolkit_4.pdf
HAS/2019-09-12_symtuza_sapub_ct16608.pdf
HAS/2019-09-12_votubia_12062019_transcription_ct17636.pdf
HAS/2019-09-12_votubia_summary_ct17636.pdf
HAS/2019-09-12_votubia_synthese_ct17636.pdf
HAS/2019-09-13_CT-17601_KISQALI_IA_chez_femme_non_ménopausée_PIC_EI_Avis3_CT17601.pdf
HAS/2019-09-13_kisqali_04092019_transcription_ct17601.pdf
HAS/2019-09-13_kisqali_26062019_transcription_ct1756617601.pdf
HAS/2019-09-17_13e_version_contraception_cardiop1-220713.pdf
HAS/2019-09-17_1e_maj-contraception-post-partum-060215.pdf
HAS/2019-09-17_1e_maj_contraception-post-ivg-060215.pdf
HAS/2019-09-17_1e_maj_contraception_prescription-conseil-femmes-060215.pdf
HAS/2019-09-17_1e_maj_contraceptionfadulte-procreer-060215.pdf
HAS/2019-09-17_CT-17613_PEVARYL_PIS_ADM_RCP_Avis1_CT17613.pdf
HAS/2019-09-17_CT-17880_HYDROCHLOROTHIAZIDE_ARROW_PIS_INS_Avis1_CT17880.pdf
HAS/2019-09-17_CT-17944_CYTARABINE_ACCORD_PIS_INS_Avis1_CT17944.pdf
HAS/2019-09-17_CT-17998_YARGESA_PIS_INS_GE_Avis1_CT17998.pdf
HAS/2019-09-17_contraception_chez_la_femme_a_risque_cardiovasculaire_-_annexe.pdf
HAS/2019-09-17_contraception_fiches_memo_rapport_delaboration.pdf
HAS/2019-09-17_contraception_hormonale__maj_janv2015.pdf
HAS/2019-09-17_contraception_transdermique_v3.pdf
HAS/2019-09-17_contraception_urgence_officine_maj_juillet2015.pdf
HAS/2019-09-17_fiche-contraception-homme.pdf
HAS/2019-09-17_fiche-contraception-sterilisation.pdf
HAS/2019-09-17_fiche-contraception-urgence.pdf
HAS/2019-09-17_fiche_memo_sur_la_contraception_en_officine_-_rapport_delaboration.pdf
HAS/2019-09-17_liste_groupe_relecture_externe.pdf
HAS/2019-09-18_neurostimulation_electrique_transcutanee_dm_eval_225.pdf
HAS/2019-09-23_annexe_cadrage_bypass_omega_vd.pdf
HAS/2019-09-23_cadrage_bypass_omega_vd.pdf
HAS/2019-09-23_gastric_bypass_technological_assessment_report.pdf
HAS/2019-09-23_rapport_bypass_gastrique_en_omega_vd.pdf
HAS/2019-09-24_CNEDIMTS-5916_BIOMIME_16_juillet_2019_(5916)_avis.pdf
HAS/2019-09-24_CNEDIMTS-5941_DAC_10_septembre_2019_(5941)_avis.pdf
HAS/2019-09-24_CNEDIMTS-5969_INFASOURCE_03_septembre_2019_(5969)_avis.pdf
HAS/2019-09-24_CNEDIMTS-6034_TOPCHAIR-S_10_septembre_2019_(6034)_avis.pdf
HAS/2019-09-24_CNEDIMTS-6050_PERISTEEN OBTAL_03_septembre_2019_(6050)_avis.pdf
HAS/2019-09-24_dac_12112019_avis_efficience.pdf
HAS/2019-09-25_evaluation_economique_evaluation_des_strategies_de_depistage_des_personnes_infectees_par_le_vhc_volet_1.pdf
HAS/2019-09-25_feuille_de_route_evaluation_strategies_depistage_vhc_vf_2018-11-28_15-43-5_301.pdf
HAS/2019-09-25_hepatite_c_prise_en_charge_anti_viraux_aad.pdf
HAS/2019-09-27_fdr_puce_adn_vd.pdf
HAS/2019-09-27_rapport_acpa_onco_vd.pdf
HAS/2019-09-30_CT-16741_SEBIPROX_PIS_RI_Avis1_CT16741.pdf
HAS/2019-09-30_CT-17036_CELLCEPT_PIS_RI_Avis1_CT17036.pdf
HAS/2019-09-30_CT-17426_CERESTAB_CERETEC_PIS_EI_RCP_Avis2_CT17426.pdf
HAS/2019-09-30_CT-17438_VENCLYXTO_PIC_REEV_Avis2_CT17438.pdf
HAS/2019-09-30_CT-17611_TRIPLIXAM_PIC_INS_Avis2_CT17611.pdf
HAS/2019-09-30_CT-17726_SMECTA_PIS_RCP_Avis1_CT17726.pdf
HAS/2019-09-30_CT-17734_GAMUNEX_PIS_INS_Avis2_CT17734.pdf
HAS/2019-09-30_CT-17753_FYCOMPA_PIS_INS_Avis2_CT17753.pdf
HAS/2019-09-30_CT-17768_SUVREZA_PIS_INS_Avis2_CT17768.pdf
HAS/2019-09-30_CT-17816_BONDRONAT_PIS_RI_Avis2_CT17816.pdf
HAS/2019-09-30_CT-17823_VITAMINE_B1_ARROW_CONSEIL_PIS_INS_Avis1_CT17823.pdf
HAS/2019-09-30_CT-17827_NICOPASS_PIS_INS_Avis2_CT17827.pdf
HAS/2019-09-30_CT-17847_OXYGENE_MEDICINAL_AIR_PRODUCTS_MEDICAL_QD_INS_CG_Avis1_CT17847.pdf
HAS/2019-09-30_CT-17861_ROPIVACAINE_READYFUSOR_PIS_INS_HYB_Avis1_CT17861.pdf
HAS/2019-09-30_CT-17878_KIOVIG_PIS_EI_Avis1_CT17878.pdf
HAS/2019-09-30_CT-17884_FULPHILA_PIS_INS_BIO_Avis2_CT17884.pdf
HAS/2019-09-30_CT-17914_SALFLUAIR_EASYHALER_PIS_INS_HYB_Avis1_CT17914.pdf
HAS/2019-09-30_CT-17936_TEGSEDI_PIS_INS_Avis1_CT17936.pdf
HAS/2019-09-30_CT-17955_OGIVRI_PIS_INS_BIO_Avis2_CT17955.pdf
HAS/2019-09-30_triplixam_10072019_transcription_ct17611.pdf
HAS/2019-09-30_venclyxto_14052019_avis_efficience.pdf
HAS/2019-09-30_venclyxto_reev_10072019_transcription_ct17438.pdf
HAS/2019-10-02_app_282_cas_pratiques_ppcs_web.pdf
HAS/2019-10-02_app_282_glossaire_ppcs_web.pdf
HAS/2019-10-02_app_282_mode_emploi_ppcs_web.pdf
HAS/2019-10-02_app_282_modele_ppcs_web.pdf
HAS/2019-10-03_CT-17313_GENOTONORM_NORDITROPINE_NUTROPINAQ_UMATROPE_PIS_EPI_Avis1_CT17313&17110&17312&17314.pdf
HAS/2019-10-03_CT-17323_PARACETAMOL_CODEINE_CRISTERS_PIS_RI_Avis2_CT17323.pdf
HAS/2019-10-03_CT-17341_PARACETAMOL_CODEINE_BIOGARAN_PIS_RI_Avis2_CT17341.pdf
HAS/2019-10-03_CT-17458_PARACETAMOL_CODEINE_SANDOZ_PIS_RI_Avis2_CT17458.pdf
HAS/2019-10-03_CT-17585_PARACETAMOL_CODEINE_EG_PIS_RI_Avis2_CT17585.pdf
HAS/2019-10-03_CT-17735_CYMEVAN_PIC_EI_Avis1_CT17735.pdf
HAS/2019-10-03_CT-17969_AIMOVIG_PIS_INS_Avis2_CT17969.pdf
HAS/2019-10-03_cymevan_04092019_transcription_ct17735.pdf
HAS/2019-10-04_CNEDIMTS-5821_NAVVUS_16_juillet_2019_(5821)_avis_occultation.pdf
HAS/2019-10-04_CNEDIMTS-5876_ZENITH UNIVERSAL DISTAL BODY_10_septembre_2019_(5876)_avis_occultation.pdf
HAS/2019-10-04_CNEDIMTS-6021_ROTATEUR 4R57_03_septembre_2019_(6021)_avis.pdf
HAS/2019-10-04_CNEDIMTS-6022_ROTATEUR 4R57WR_24_septembre_2019_(6022)_avis.pdf
HAS/2019-10-04_CNEDIMTS-6089_FRED_03_septembre_2019_(6089)_avis.pdf
HAS/2019-10-04_CT-17326_VERZENIOS_PIC_INS_Avis2_CT17326.pdf
HAS/2019-10-04_CT-17473_KIGABEQ_PIC_INS_Avis3_CT17473.pdf
HAS/2019-10-04_CT-17491_JINARC_PIC_EI_Avis3_CT17491.pdf
HAS/2019-10-04_CT-17516_DARZALEX_1ereligne_PIC_EI_Avis2_CT17516.pdf
HAS/2019-10-04_CT-17554_CABOMETYX_PIC_EI_Avis3_CT17554.pdf
HAS/2019-10-04_cabometyx_12062019_transcription_ct17554.pdf
HAS/2019-10-04_cabometyx_17072019_transcription_ct17554.pdf
HAS/2019-10-04_cabometyx_ei_synthes_ct17554.pdf
HAS/2019-10-04_darzalex_03042019_ct17516_transcription.pdf
HAS/2019-10-04_darzalex_ei_1ligne_synthese_ct17516.pdf
HAS/2019-10-04_jinarc_10072019_transcription_ct17491.pdf
HAS/2019-10-04_jinarc_22052019_transcription_ct17491.pdf
HAS/2019-10-04_jinarc_synthese_ct17491.pdf
HAS/2019-10-04_kigabeq_03042019_transcription_ct17473.pdf
HAS/2019-10-04_kigabeq_05062019_transcription_ct17473.pdf
HAS/2019-10-04_kigabeq_synthese_ct17473.pdf
HAS/2019-10-04_verzenios_synthese_ct17326.pdf
HAS/2019-10-08_CT-15354_EPCLUSA_PIC_REEV_AAD_Avis2_CT15354.pdf
HAS/2019-10-08_CT-16434_MAVIRET_PIC_INS_Avis2_CT16434.pdf
HAS/2019-10-08_dc_2019_0198_fiche_memo_hepatite_c_cd_2019_09_18_vd.pdf
HAS/2019-10-08_fiche_bum_-_medicaments_utilises_dans_les_formes_tres_actives_de_sclerose_en_plaques_recurrente.pdf
HAS/2019-10-08_fiche_memo_hepatite_c.pdf
HAS/2019-10-08_rapport_elaboration_hepatite_c.pdf
HAS/2019-10-09_CT-17701_TRIMBOW_PIC_EI_Avis2_CT17701.pdf
HAS/2019-10-09_CT-17879_PARACETAMOL_CODEINE_MYLAN_PIS_RI_Avis2_CT17879.pdf
HAS/2019-10-09_trimbow_04092019_transcription_ct1770118101.pdf
HAS/2019-10-11_CNEDIMTS-5689_MINIMED 640G_10_septembre_2019_(5689)_avis.pdf
HAS/2019-10-11_CNEDIMTS-5762_NATPAR PEN_16_juillet_2019_(5762)_avis.pdf
HAS/2019-10-11_CNEDIMTS-5954_PERISTEEN IRRIGATION TRANSANALE_10_septembre_2019_(5954)_avis.pdf
HAS/2019-10-11_CNEDIMTS-6047_GLUCOFIX TECH 2K_24_septembre_2019_(6047)_avis.pdf
HAS/2019-10-11_CNEDIMTS-6069_SAPIEN 3 COMMANDER_24_septembre_2019_(6069)_avis.pdf
HAS/2019-10-11_CNEDIMTS-6070_SAPIEN 3 CERTITUDE_24_septembre_2019_(6070)_avis.pdf
HAS/2019-10-11_CNEDIMTS-6085_GREISSINGER_24_septembre_2019_(6085)_avis.pdf
HAS/2019-10-11_CNEDIMTS-6086_UNIVERSAL_24_septembre_2019_(6086)_avis.pdf
HAS/2019-10-11_CT-17015_PLUREXID_PIS_RI_Avis1_CT17015.pdf
HAS/2019-10-11_CT-17479_DAIVOBET_XAMIOL_PIS_RI_Avis2_CT17479.pdf
HAS/2019-10-11_CT-17609_SUBSOL_PIS_INS_Avis2_CT17608&17609.pdf
HAS/2019-10-11_CT-17638_GIOTRIF_PIS_RI_Avis2_CT17638.pdf
HAS/2019-10-11_CT-17702_SPECTRILA_PIC_INS_Avis2_CT17702.pdf
HAS/2019-10-11_CT-17760_PRAXILENE_PIC_REEV_Avis2_CT17760.pdf
HAS/2019-10-11_CT-17883_RESIKALI_PIS_RI_Avis3_CT17883.pdf
HAS/2019-10-11_CT-17932_PAZENIR_PIS_INS_GE_Avis1_CT17932.pdf
HAS/2019-10-11_CT-17999_PROPOFOL_KABI_PIS_INS_Avis2_CT17999.pdf
HAS/2019-10-11_pnds_argumentaire_ip_06032019.chbbon_001.pdf
HAS/2019-10-11_pnds_argumentaire_syndrome_daicardi_17sept2019.pdf
HAS/2019-10-11_pnds_fragilites_osseuses-27-09-2019.pdf
HAS/2019-10-11_pnds_ip_24_fevrier2019.chbbon.pdf
HAS/2019-10-11_pnds_texte_syndrome_daicardi_17sept2019.pdf
HAS/2019-10-11_praxilene_18092019_synthese_ct17760.pdf
HAS/2019-10-11_praxilene_18092019_transcription_ct17760.pdf
HAS/2019-10-11_praxilene_summary_ct17760.pdf
HAS/2019-10-11_spectrila_04092019_transcription_ct17702.pdf
HAS/2019-10-11_synthese_mg_fragilites_osseuses_secondaires_de_lenfant.pdf
HAS/2019-10-11_synthese_mg_incontinentia_pigmenti.pdf
HAS/2019-10-11_synthese_mg_syndrome_d_aicardi.pdf
HAS/2019-10-11_zenith-t_branch.pdf
HAS/2019-10-14_CT-17668_GRANOCYTE_PIS_RI_Avis2_CT13554&17668.pdf
HAS/2019-10-14_argumentaire_albinisme_2019-10-11_16-18-32_89.pdf
HAS/2019-10-14_pnds_albinisme14juillet_2019-10-11_16-18-32_87.pdf
HAS/2019-10-14_synthese_mg_albinisme_2019-10-11_16-18-32_90.pdf
HAS/2019-10-16_CNEDIMTS-5974_NINO ONE_08_octobre_2019_(5974)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6003_ALBER E-PILOT_08_octobre_2019_(6003)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6006_TENOLIG_10_septembre_2019_(6006)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6013_AXONICS_24_septembre_2019_( 6013)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6015_OPUR_08_octobre_2019_(6015)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6024_CAPTIV DM_EVIDENCE Ti HAC_25_juillet_2019_(6024)_(6033)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6025_CAPITOLE I_CAPITOLE R_EVIDENCE Ti HAC REVISION_25_juillet_2019_(6025)_(6027)_(6031)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6026_CAPITOLE U_25_juillet_2019_(6026)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6028_CAPITOLE_EVIDENCE A CIMENTER_25_juillet_2019_(6028)_(6032)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6051_BIOBANK_03_septembre_2019_(6051)_(6052)_avis.pdf
HAS/2019-10-16_CNEDIMTS-6054_Mi 1250 SYNCHRONY 2_Mi 1250 SYNCHRONY 2 PIN_SONNET 2_SONNET 2 EAS_24_septembre_2019_(6054)_avis.pdf
HAS/2019-10-16_CT-14754_MUCOMYSTENDO_PIC_RI_REEV_Avis3_CT14754.pdf
HAS/2019-10-16_CT-17223_AIMOVIG_PIC_INS_Avis3_CT17223.pdf
HAS/2019-10-16_CT-17250_ZUBSOLV_PIC_INS_Avis2_CT17250.pdf
HAS/2019-10-16_CT-17439_TRELEGY_ELLIPTA_PIC_EI_Avis3_CT17439.pdf
HAS/2019-10-16_CT-17552_SKILARENCE_PIC_INS_Avis3_CT17552.pdf
HAS/2019-10-16_CT-17559_JIVI_PIC_INS_Avis3_CT17559.pdf
HAS/2019-10-16_CT-17569_POTELIGEO_PIC_INS_Avis3_CT17569.pdf
HAS/2019-10-16_CT-17670_KALYDECO_PIC_EI_Avis2_CT17670.pdf
HAS/2019-10-16_CT-17710_TRELEGY_ELLIPTA_PIC_REEV_Avis3_CT17710.pdf
HAS/2019-10-16_aimovig_12022019_avis_efficience_2019-05-10_13-50-54_656.pdf
HAS/2019-10-16_aimovig_synthese_ct17223.pdf
HAS/2019-10-16_elebrato_ellipta_trelegy_ellipta_transcription_20032019_ct17710.pdf
HAS/2019-10-16_jivi_05062019_transcription_ct17559.pdf
HAS/2019-10-16_jivi_10042019_transcription_ct17559.pdf
HAS/2019-10-16_jivi_synthese_ct17559.pdf
HAS/2019-10-16_kalydeco_10072019_transcription_ct1762817633.pdf
HAS/2019-10-16_kalydeco_synthese_ct17670.pdf
HAS/2019-10-16_mucomystendo_03042019_transcription_ct14754.pdf
HAS/2019-10-16_mucomystendo_05062019_transcription_ct14754.pdf
HAS/2019-10-16_mucomystendo_synthese_ct14754.pdf
HAS/2019-10-16_poteligeo_15052019_transcription_ct17569.pdf
HAS/2019-10-16_poteligeo_17072019_transcription_ct17569.pdf
HAS/2019-10-16_poteligeo_adoption_05062019_transcription_ct17569.pdf
HAS/2019-10-16_poteligeo_synthese_ct17569.pdf
HAS/2019-10-16_skilarence_15052019_transcription_ct17552.pdf
HAS/2019-10-16_skilarence_17072019_transcription_ct17552.pdf
HAS/2019-10-16_skilarence_synthese_ct17552.pdf
HAS/2019-10-16_trelegy_elebrato_synthese_ct17439-17710.pdf
HAS/2019-10-16_zubsolv_synthese_ct17250.pdf
HAS/2019-10-18_CT-17228_DITROPAN_PIC_EI_Avis1_CT17228.pdf
HAS/2019-10-18_CT-17767_FIXAPOST_PIC_INS_Avis3_CT17767.pdf
HAS/2019-10-18_argumentaire_vdef_30_9_19.pdf
HAS/2019-10-18_chloraprep_pic_reev_avis3_ct15625.pdf
HAS/2019-10-18_chloraprep_sapub_ct15325.pdf
HAS/2019-10-18_chloraprep_summary_ct15625.pdf
HAS/2019-10-18_ditropan_20032019_transcription_ct17228.pdf
HAS/2019-10-18_ditropan_ct17228_enuresie_summary.pdf
HAS/2019-10-18_ditropan_ct17228_enuresie_synthese.pdf
HAS/2019-10-18_fixapost_09102019_synthese_ct17767.pdf
HAS/2019-10-18_fixapost_09102019_transcription_ct17767.pdf
HAS/2019-10-18_fixapost_18092019_transcription_ct17767.pdf
HAS/2019-10-18_fixapost_summary_ct17767.pdf
HAS/2019-10-18_pnds_deash24.pdf
HAS/2019-10-18_synthese_mg_dysplasie_ectodermique_anhidrotique.pdf
HAS/2019-10-18_synthese_mg_syndrome_de_wolfram.pdf
HAS/2019-10-18_texte_pndsv_def_27_9_19-jl.pdf
HAS/2019-10-21_pnds_hemophilie_argumentaire_10.10.19.pdf
HAS/2019-10-21_synthese_mg_hemophilie.pdf
HAS/2019-10-24_CNEDIMTS-5842_AZURE XT SR_08_octobre_2019_(5842)_avis_occultation.pdf
HAS/2019-10-24_CNEDIMTS-5843_AZURE XT DR_08_octobre_2019_(5843)_avis_occultation.pdf
HAS/2019-10-24_CNEDIMTS-5844_PERCEPTA CRT-P_08_octobre_2019_(5844)_avis_occultation.pdf
HAS/2019-10-24_CNEDIMTS-5845_PERCEPTA QUAD CRT-P_08_octobre_2019_(5845)_avis_occultation.pdf
HAS/2019-10-24_iqss_2019_aide_utilisation_proms_eds.pdf
HAS/2019-10-28_CT-16980_SPIRIVA_RESPIMAT_PIS_EI_Avis3_CT16980.pdf
HAS/2019-10-28_CT-17463_XARELTO_2,5_PIC_INS_Avis3_CT17463.pdf
HAS/2019-10-28_CT-17765_HEMLIBRA_PIC_EI_Avis2_CT17765_EPI653.pdf
HAS/2019-10-28_CT-17971_MAVIRET_PIS_RCP_Avis2_CT17971.pdf
HAS/2019-10-28_argumentaire_pnds_cystinurie.pdf
HAS/2019-10-28_hemlibra_18092019_transcription_ct17765.pdf
HAS/2019-10-28_hemlibra_summary_ct17765.pdf
HAS/2019-10-28_hemlibra_synthese_02102019_ct17765.pdf
HAS/2019-10-28_maviret_02102019_transcription_ct17744.pdf
HAS/2019-10-28_maviret_pic_ei_avis3_modifiele29112019_ct17744.pdf
HAS/2019-10-28_maviret_summary_ct17744.pdf
HAS/2019-10-28_maviret_synthese_02102019_ct17744.pdf
HAS/2019-10-28_pndscystinurie.pdf
HAS/2019-10-28_spiriva_synthese_ct16980.pdf
HAS/2019-10-28_synthese_mg_la_cystinurie.pdf
HAS/2019-10-28_xarelto_09102019_transcription_ct17463.pdf
HAS/2019-10-28_xarelto_26062019_transcription_ct17463.pdf
HAS/2019-11-04_CNEDIMTS-6093_JUGGERSTITCH_08_octobre_2019_(6093)_avis.pdf
HAS/2019-11-04_CNEDIMTS-6094_TALEO_08_octobre_2019_(6094)_avis.pdf
HAS/2019-11-04_CNEDIMTS-6095_EXABONE PUTTY_08_octobre_2019_(6095)_avis.pdf
HAS/2019-11-04_CNEDIMTS-6096_EXABONE PASTE_08_octobre_2019_(6096)_avis.pdf
HAS/2019-11-04_CT-17550_URIVESC_PIC_INS_Avis3_CT17550.pdf
HAS/2019-11-04_CT-17622_VYNDAQEL_PIC_RI_REEV_Avis3_CT17622&17699.pdf
HAS/2019-11-04_CT-17916_ARSENIC_TRIOXYDE_ARROW_PIS_INS_Avis1_CT17916.pdf
HAS/2019-11-04_CT-17941_EPCLUSA_PIS_RCP_Avis2_CT17941.pdf
HAS/2019-11-04_CT-17988_ORENCIA_PIS_INS_Avis2_CT17988.pdf
HAS/2019-11-04_CT-18037_PARACETAMOL_KRKA_PIS_INS_Avis1_CT18037.pdf
HAS/2019-11-04_urivesc_18092019_transcription_ct17550.pdf
HAS/2019-11-04_urivesc_23102019_synthese_ct17550.pdf
HAS/2019-11-04_urivesc_23102019_transcription_ct17550.pdf
HAS/2019-11-04_urivesc_summary_ct17550.pdf
HAS/2019-11-04_vyndaqel_18092019_transcription_ct1762217699.pdf
HAS/2019-11-04_vyndaqel_23102019_synthese_ct1762217699.pdf
HAS/2019-11-04_vyndaqel_23102019_transcription_ct1762217699.pdf
HAS/2019-11-04_vyndaqel_sa_ct1762217699_en.pdf
HAS/2019-11-05_CNEDIMTS-6007_PROMUS PREMIER BTK_08_octobre_2019_(6007)_avis.pdf
HAS/2019-11-05_CNEDIMTS-6060_INNOSPIRE GO_08_octobre_2019_(6060)_avis.pdf
HAS/2019-11-05_CNEDIMTS-6068_AEROLIGHT_22_octobre_2019_(6068)_avis.pdf
HAS/2019-11-05_CNEDIMTS-6077_ZILVER PTX_24_septembre_2019_(6077)_avis.pdf
HAS/2019-11-05_ellipsys_03_septembre_2019_5905_avis_occultation.pdf
HAS/2019-11-05_wallstent_uni_6016.pdf
HAS/2019-11-07_CT-17815_AUBAGIO_PIS_RI_Avis2_CT17815.pdf
HAS/2019-11-07_CT-17832_PREMINOR_PIS_INS_Avis2_CT17832.pdf
HAS/2019-11-07_CT-17862_KEYTRUDA_PIS_RCP_Avis1_CT17862.pdf
HAS/2019-11-07_CT-18016_DEXMEDETOMIDINE_ALTAN_PIS_INS_HYB_Avis1_CT18016.pdf
HAS/2019-11-07_CT-18084_OPTIJECT_PIS_INS_Avis2_CT18084.pdf
HAS/2019-11-07_CT-18095_BORTEZOMIB_OHRE_PHARMA_PIS_INS_Avis1_CT18095.pdf
HAS/2019-11-08_CNEDIMTS-6019_NARVAL ORM_05_novembre_2019_(6019)_avis.pdf
HAS/2019-11-08_CNEDIMTS-6074_PROMUS ELEMENT OVER THE WIRE BTK_24_septembre_2019_(6074)_avis.pdf
HAS/2019-11-08_CNEDIMTS-6075_PROMUS EPLEMENT PLUS MONORAIL BTK_24_septembre_2019_(6075)_avis.pdf
HAS/2019-11-08_CNEDIMTS-6118_iSTENT INJECT_05_novembre_2019_(6118)_avis.pdf
HAS/2019-11-08_CT-18069_STRIASCAN_PIS_INS_Avis2_CT18069.pdf
HAS/2019-11-08_CT-18077_PROPRANOLOL_ARROW_PIS_INS_Avis1_CT18077.pdf
HAS/2019-11-08_CT-18136_PROPOFOL_BAXTER_PIS_INS_Avis2_CT18136.pdf
HAS/2019-11-12_CT-17927_CACIT_VITAMINE_D3_PIS_INS_Avis3_CT17927.pdf
HAS/2019-11-12_CT-18062_ZOXAN_LP_PIS_RI_Avis1_CT18062.pdf
HAS/2019-11-12_CT-18090_POSACONAZOLE_ACCORD_PIS_INS_Avis2_CT18090.pdf
HAS/2019-11-12_CT-18114_CLOFARABINE_ACCORD_PIS_INS_Avis1_CT18114.pdf
HAS/2019-11-12_CT-18121_POSACONAZOLE_OHRE_PHARMA_PIS_INS_Avis2_CT18121.pdf
HAS/2019-11-12_skyrizi_06112019_synthese_ct17924.pdf
HAS/2019-11-12_skyrizi_06112019_transcription_ct17924.pdf
HAS/2019-11-12_skyrizi_23102019_transcription_ct17924.pdf
HAS/2019-11-12_skyrizi_pic_ins_avis3_ct17924.pdf
HAS/2019-11-12_skyrizi_summary_ct17924.pdf
HAS/2019-11-13_CT-18056_POSACONAZOLE_AHCL_PIS_INS_Avis2_CT18056.pdf
HAS/2019-11-13_hascnpp__bronchiolite_argumentaire_2019_vd.pdf
HAS/2019-11-13_hascnpp_bronchiolite_fiche_outil_conseils_surveillance_parents_2019.pdf
HAS/2019-11-13_hascnpp_bronchiolite_fiche_outil_pec_bronchiolite_coi_2019_10_10_vd.pdf
HAS/2019-11-13_hascnpp_bronchiolite_rapport_analyse_groupe_lecture_juin__2019.pdf
HAS/2019-11-13_hascnpp_bronchiolite_texte_recommandations_2019.pdf
HAS/2019-11-18_CT-17628_OPDIVO_YERVOY_PIC_EI_CCR_Avis2_CT17633&CT17628.pdf
HAS/2019-11-18_CT-17722_TRANSLARNA_PIC_EI_Avis1_CT17722.pdf
HAS/2019-11-18_CT-17749_DUODOPA_PIS_REEV_POP_CIBLE_Avis2_CT17749.pdf
HAS/2019-11-18_CT-17793_CORTIMENT_PIC_REEV_Avis2_CT17793.pdf
HAS/2019-11-18_CT-17945_TRISENOX_PIS_INS_Avis2_CT17945.pdf
HAS/2019-11-18_CT-17956_OZALIN_PIC_INS_Avis1_CT17956.pdf
HAS/2019-11-18_CT-18004_CARMUSTINE_OBVIUS_PIS_INS_Avis1_CT18004.pdf
HAS/2019-11-18_CT-18070_VISIPAQUE_PIS_INS_Avis2_CT18070.pdf
HAS/2019-11-18_CT-18072_OMNIPAQUE_PIS_INS_Avis2_CT18072.pdf
HAS/2019-11-18_CT-18081_URAPIDIL_STRAGEN_PIS_INS_Avis1_CT18081.pdf
HAS/2019-11-18_CT-18089_FLEBOGAMMA_DIF_PIS_EI_Avis2_CT18089.pdf
HAS/2019-11-18_CT-18099_CROMOPTIC_PIS_INS_Avis1_CT18099.pdf
HAS/2019-11-18_CT-18127_MITOMYCINE_SUBSTIPHARM_PIS_INS_Avis2_CT18127.pdf
HAS/2019-11-18_cortiment_02102019_transcription_ct17793.pdf
HAS/2019-11-18_cortiment_23102019_synthese_ct17793.pdf
HAS/2019-11-18_cortiment_summary_ct17793.pdf
HAS/2019-11-18_opdivo_15102019_avis_efficience.pdf
HAS/2019-11-18_opdivo_yervoy_10072019_transcription_ct1762817633.pdf
HAS/2019-11-18_opdivo_yervoy_sapub.pdf
HAS/2019-11-18_ozalin_23102019_synthese_ct17956.pdf
HAS/2019-11-18_ozalin_23102019_transcription_ct17956.pdf
HAS/2019-11-18_ozalin_summary_ct17956.pdf
HAS/2019-11-18_translarna_02102019_transcription_ct17722.pdf
HAS/2019-11-18_translarna_23102019_synthese_ct17722.pdf
HAS/2019-11-18_translarna_summary_ct17722.pdf
HAS/2019-11-20_CNEDIMTS-6056_CARPO 2 SE_22_octobre_2019_(6056)_avis.pdf
HAS/2019-11-20_conserve_plus.pdf
HAS/2019-11-20_interstim_ii.pdf
HAS/2019-11-22_CT-17549_SLENYTO_PIC_INS_Avis2_CT17549.pdf
HAS/2019-11-22_fiche_outil_diagnostic_denutrition.pdf
HAS/2019-11-22_reco277_argumentaire_rbp_denutrition__cd_2019_11_13_v0.pdf
HAS/2019-11-22_reco277_recommandations_rbp_denutrition_cd_2019_11_13_v0.pdf
HAS/2019-11-22_slenyto_12062019_transcription_ct17549.pdf
HAS/2019-11-22_slenyto_summary_ct17549.pdf
HAS/2019-11-22_slenyto_synthese_ct17549.pdf
HAS/2019-11-25_CNEDIMTS-5641_UNLOADER ONE SMARTDOSING_05_novembre_2019_(5641)_avis.pdf
HAS/2019-11-25_CNEDIMTS-6042_MITRACLIP NTR_19_novembre_2019_(6042)_avis.pdf
HAS/2019-11-25_CNEDIMTS-6055_MITRACLIP XTR_19_novembre_2019_(6055)_avis.pdf
HAS/2019-11-25_CNEDIMTS-6092_NEOCATE_05_novembre_2019_(6092)_avis.pdf
HAS/2019-11-25_CNEDIMTS-6107_NEOCATE ACTIVE_08_octobre_2019_(6107)_avis.pdf
HAS/2019-11-25_CNEDIMTS-6132_LOTUS_19_novembre_2019_(6132)_avis.pdf
HAS/2019-11-25_CT-10897_NEXAVAR_PIS_RI_thyroide_CHC_Avis2_CT10897.pdf
HAS/2019-11-25_CT-17042_VOTRIENT_PIS_RI_Avis2_CT17042.pdf
HAS/2019-11-25_CT-17577_ALUNBRIG_PIC_INS_Avis2_CT17577.pdf
HAS/2019-11-25_CT-17755_INOVELON_PIC_EI_Avis2_CT17755.pdf
HAS/2019-11-25_CT-17866_VIZIMPRO_PIC_INS_Avis2_CT17866.pdf
HAS/2019-11-25_CT-18082_CHLORURE_DE_SODIUM_BAXTER_PIS_RCP_Avis2_CT18082.pdf
HAS/2019-11-25_CT-18123_GLIVEC_PIS_INS_Avis2_CT18123.pdf
HAS/2019-11-25_alunbrig_02102019_transcription_ct17577.pdf
HAS/2019-11-25_alunbrig_23102019_synthese_ct17577.pdf
HAS/2019-11-25_alunbrig_summary_ct17577.pdf
HAS/2019-11-25_inovelon_06112019_synthese_ct17755.pdf
HAS/2019-11-25_inovelon_23102019_transcription_ct17755.pdf
HAS/2019-11-25_inovelon_summary_ct17755.pdf
HAS/2019-11-25_mitraclip_ntr_et_xtr_21012020_avis_efficience.pdf
HAS/2019-11-25_thalidomide_celgene_reco_rtu__autosaisine_has_sem_cteval480.pdf
HAS/2019-11-25_vehicules_destines_au_transport_passif_des_personnes_handicapees_19_novembre_2019_dm_eval_243_avis.pdf
HAS/2019-11-25_vizimpro_23102019_synthese_ct17866.pdf
HAS/2019-11-25_vizimpro_23102019_transcription_ct17866.pdf
HAS/2019-11-25_vizimpro_sapub_ct17866_en.pdf
HAS/2019-11-27_CT-17533_DELTYBA_PIC_REEV_Avis2_CT17533.pdf
HAS/2019-11-27_CT-17737_HEMLIBRA_PIS_RCP_Avis2_CT17737.pdf
HAS/2019-11-27_CT-17889_LIDOCAINE_AGUETTANT_PIC_EI_Avis3_CT17889.pdf
HAS/2019-11-27_CT-18085_PRISMASOL_POTASSIUM_PIS_RCP_Avis2_CT18085.pdf
HAS/2019-11-27_CT-18093_PEMETREXED_OHRE_PHARMA_PIS_INS_HYB_Avis1_CT18093.pdf
HAS/2019-11-27_CT-18141_CISATRACURIUM_KALCEKS_PIS_INS_Avis1_CT18141.pdf
HAS/2019-11-27_CT-18158_TECENTRIQ_PIS_EI_NON_DEMANDEE_Avis1_CT18158.pdf
HAS/2019-11-27_annexes_rapport_tomosynthese.pdf
HAS/2019-11-27_deficit_synthese_abp_argumentaire.pdf
HAS/2019-11-27_deficit_synthese_abp_pnds.pdf
HAS/2019-11-27_deltyba_06112019_synthese_ct17533.pdf
HAS/2019-11-27_deltyba_06112019_transcription_ct17533.pdf
HAS/2019-11-27_deltyba_15052019_transcription_ct17533.pdf
HAS/2019-11-27_feuille_de_route_tomosynthese_mai_2018.pdf
HAS/2019-11-27_fiche_synthese_tomosynthese.pdf
HAS/2019-11-27_lidocaine_aguettant_20112019_synthese_ct17889.pdf
HAS/2019-11-27_lidocaine_aguettant_20112019_transcription_ct17889.pdf
HAS/2019-11-27_lidocaine_aguettant_23102019_transcription_ct17889.pdf
HAS/2019-11-27_lidocaine_aguettant_summary_ct17889.pdf
HAS/2019-11-27_pnds_castleman_2019.pdf
HAS/2019-11-27_pnds_duchenne_raccourci_18_pages_final_nov_2019_.pdf
HAS/2019-11-27_pnds_duchenne_vlongue_final_20_nov_2019_.pdf
HAS/2019-11-27_rapport_tomosynthese.pdf
HAS/2019-11-27_synthese_mg_deficits_de_synthese_des_acides_biliaires_primaires.pdf
HAS/2019-11-27_synthese_mg_dystrophie_musculaire_de_duchenne.pdf
HAS/2019-11-27_synthese_mg_maladie_de_castleman.pdf
HAS/2019-11-28_guide_methodologique_pnds.pdf
HAS/2019-12-02_figure_3_-_conduite_a_tenir_devant_tout_patient_suspecte_de_poliomyelite_ou_tout_isolement_de_poliovirus.pdf
HAS/2019-12-02_recommandation_strategie_vaccinale_autour_dun_cas_de_poliomyelite_ou_en_cas_de_detection_environnementale_de_poliovirus.pdf
HAS/2019-12-06_CT-17579_METOJECT_PIC_EI_Avis2_CT17579.pdf
HAS/2019-12-06_CT-17908_NUCALA_PIS_INS_Avis2_CT17908.pdf
HAS/2019-12-06_CT-17958_VOTRIENT_PIC_REEV_sarcome_Avis3_CT17958.pdf
HAS/2019-12-06_metoject_06112019_synthese_ct17579.pdf
HAS/2019-12-06_metoject_23102019_transcription_ct17579.pdf
HAS/2019-12-06_metoject_summary_ct17579.pdf
HAS/2019-12-06_recommandation_flucelvax_tetra_octobre_2019.pdf
HAS/2019-12-06_votrient_04092019_transcription_ct17958.pdf
HAS/2019-12-06_votrient_10072019_transcription_ct17958.pdf
HAS/2019-12-06_votrient_sarcome_synthese_ct17958.pdf
HAS/2019-12-09_CT-17709_REPEVAX_PIS_RI_Avis2_CT17709.pdf
HAS/2019-12-09_CT-17943_EZETROL_PIS_RI_Avis1_CT17943.pdf
HAS/2019-12-09_CT-18036_COLOBREATHE_PIS_RI_Avis1_CT18036.pdf
HAS/2019-12-09_CT-18067_MIGLUSTAT_ACCORD_PIS_EI_Avis1_CT18067.pdf
HAS/2019-12-09_CT-18131_GLICLAZIDE_ARROW_LAB_PIS_INS_Avis1_CT18131.pdf
HAS/2019-12-10_CT-18083_FOSCAVIR_PIC_REEV_Avis2_CT18083.pdf
HAS/2019-12-10_foscavir_06112019_transcription_ct18083.pdf
HAS/2019-12-10_foscavir_20112019_synthese_ct18083.pdf
HAS/2019-12-10_foscavir_summary_ct18083.pdf
HAS/2019-12-11_CNEDIMTS-6010_FRESSTYLE COMFORT_05_novembre_2019_(6010)_avis.pdf
HAS/2019-12-11_CNEDIMTS-6078_ANGIOLITE_22_octobre_2019_(6078)_avis.pdf
HAS/2019-12-11_CT-17548_PLENVU_PIC_INS_Avis3_CT17548.pdf
HAS/2019-12-11_baclocur_06112019_transcription_ct17817.pdf
HAS/2019-12-11_baclocur_20112019_synthese_ct17817.pdf
HAS/2019-12-11_baclocur_20112019_transcription_ct17817.pdf
HAS/2019-12-11_baclocur_pic_ins_avis2_ct17817_epi655.pdf
HAS/2019-12-11_baclocur_summary_ct17817_epi655.pdf
HAS/2019-12-11_plenvu_09102019_transcription_ct17548.pdf
HAS/2019-12-11_plenvu_10072019_transcription_ct17548.pdf
HAS/2019-12-11_plenvu_summary_ct17545.pdf
HAS/2019-12-11_plenvu_synthese_ct17548.pdf
HAS/2019-12-12_CT-17679_LONQUEX_PIC_INS_Avis2_CT17679.pdf
HAS/2019-12-12_CT-17846_ORKAMBI_PIC_INS_Avis2_CT17846.pdf
HAS/2019-12-12_lonquex_04092019_transcription_ct17679.pdf
HAS/2019-12-12_lonquex_summary_ct17679.pdf
HAS/2019-12-12_lonquex_synthese_ct17679.pdf
HAS/2019-12-12_orkambi_04092019_transcription_ct17846.pdf
HAS/2019-12-12_orkambi_summary_ct17846.pdf
HAS/2019-12-12_orkambi_synthese_ct17846.pdf
HAS/2019-12-13_dc_2018_iqss81_rapport_des_campagnes_des_iqss_2018_cd_2018_12_05.pdf
HAS/2019-12-13_had_plaquette_2014_vf.pdf
HAS/2019-12-13_had_rapport_2014_vf.pdf
HAS/2019-12-13_infographie_-_820_eigs_analyses_pour_lannee_2018.pdf
HAS/2019-12-13_ipaqss-rapport-had-v4.pdf
HAS/2019-12-13_ipaqss-rapport-ssr-v4.pdf
HAS/2019-12-13_ipaqss_analyse_descriptive_mco.pdf
HAS/2019-12-13_ipaqss_analyse_descriptive_ssr.pdf
HAS/2019-12-13_ipaqss_rapport_had-v4.pdf
HAS/2019-12-13_ipaqss_rapport_mco_2011.pdf
HAS/2019-12-13_ipaqss_rapport_mco_v4.pdf
HAS/2019-12-13_ipaqss_rapport_ssr_2011.pdf
HAS/2019-12-13_ipaqss_synthese_rapport_mco_2011.pdf
HAS/2019-12-13_ipaqss_synthese_rapport_ssr_2011.pdf
HAS/2019-12-13_iqss_rapport_ca_qls_2019.pdf
HAS/2019-12-13_iqss_rapport_complet_2019.pdf
HAS/2019-12-13_iqss_rapport_had_coord_2019.pdf
HAS/2019-12-13_iqss_rapport_had_dtn_2019.pdf
HAS/2019-12-13_iqss_rapport_had_tdp_2019.pdf
HAS/2019-12-13_iqss_rapport_had_tre_2019.pdf
HAS/2019-12-13_iqss_rapport_mco_pcd_2019.pdf
HAS/2019-12-13_iqss_rapport_mco_qls_2019.pdf
HAS/2019-12-13_iqss_rapport_ssr_pcd_2019.pdf
HAS/2019-12-13_iqss_rapport_ssr_pspv_2019.pdf
HAS/2019-12-13_iqss_rapport_ssr_qls_2019.pdf
HAS/2019-12-13_mco_plaquette_2014_vf.pdf
HAS/2019-12-13_mco_rapport_2014_vf.pdf
HAS/2019-12-13_plaquette_dpa_mco_vf.pdf
HAS/2019-12-13_plaquette_had_vf.pdf
HAS/2019-12-13_plaquette_ssr_vf.pdf
HAS/2019-12-13_rapport-facteurs-associes-v2.pdf
HAS/2019-12-13_rapport_2016_dpa_had_vf.pdf
HAS/2019-12-13_rapport_2016_dpa_mco_vf.pdf
HAS/2019-12-13_rapport_2016_dpa_ssr_vf.pdf
HAS/2019-12-13_rapport_annuel_eigs_2018_vd-avecinfo.pdf
HAS/2019-12-13_rapport_ca_2018.pdf
HAS/2019-12-13_rapport_complementaire_vf.pdf
HAS/2019-12-13_rapport_dpamco_2018.pdf
HAS/2019-12-13_rapport_had_2018.pdf
HAS/2019-12-13_rapport_iqss_2018.pdf
HAS/2019-12-13_rapport_ssr_2018.pdf
HAS/2019-12-13_retour_dexperience_sur_les_evenements_indesirables_graves_associes_a_des_soins_eigs._rapport_annuel_2017.pdf
HAS/2019-12-13_ssr_plaquette_2014_vf.pdf
HAS/2019-12-13_ssr_rapport_2014_vf.pdf
HAS/2019-12-16_CNEDIMTS-6057_ROTALINK PLUS_03_décembre_2019_(6057)_avis.pdf
HAS/2019-12-16_CNEDIMTS-6071_ROTAPRO_03_décembre_2019_(6071)_avis.pdf
HAS/2019-12-16_fiche_synthese_de_la_recommandation_vaccinale_vaccination_contre_les_papillomavirus_chez_les_garcons.pdf
HAS/2019-12-16_overview_of_vaccination_guidelines_papillomavirus_vaccination_in_boys.pdf
HAS/2019-12-16_recommandation_vaccinale_elargissement_de_la_vaccination_contre_les_papillomavirus_aux_garcons.pdf
HAS/2019-12-19_CT-17949_MABTHERA_PIC_EI_Avis2_CT17949.pdf
HAS/2019-12-19_CT-18164_COLIMYCINE_PIS_INS_Avis1_CT18164.pdf
HAS/2019-12-19_CT-18175_ARSENIC_TRIOXIDE_ACCORD_PIS_INS_Avis2_CT18175.pdf
HAS/2019-12-19_CT-18182_IVOZALL_PIS_INS_Avis1_CT18182.pdf
HAS/2019-12-19_CT-18186_ACIDE_ACETYLSALICYLIQUE_MYLAN_100mg_GR_PIS_INS_Avis2_CT18186.pdf
HAS/2019-12-19_CT-18213_HEMLIBRA_PIS_INS_Avis1_CT18213.pdf
HAS/2019-12-19_CT-18249_BEAGYNE_PIS_EI_Avis2_CT17918&18249.pdf
HAS/2019-12-19_mabthera_20112019_synthese_ct17949.pdf
HAS/2019-12-19_mabthera_20112019_transcription_ct17949.pdf
HAS/2019-12-19_mabthera_summary_ct17949.pdf
HAS/2019-12-20_CNEDIMTS-6043_PORTICO_03_décembre_2019_(6043)_avis.pdf
HAS/2019-12-20_CT-17803_ROZACREME_ROZAGEL_PIS_RI_Avis2_CT17803.pdf
HAS/2019-12-20_CT-17909_DUPIXENT_PIC_EI_Avis3_CT17909&17925_EPI654.pdf
HAS/2019-12-20_CT-17980_FLUCELVAX_TETRA_PIC_INS_Avis3_CT17980.pdf
HAS/2019-12-20_CT-18049_DEXAMETHASONE_RAFARM_PIS_INS_Avis1_CT18049.pdf
HAS/2019-12-20_CT-18064_PANTOPRAZOLE_HIKMA_PIS_INS_Avis1_CT18064.pdf
HAS/2019-12-20_CT-18078_PELGRAZ_PIS_INS_Avis2_CT18078.pdf
HAS/2019-12-20_CT-18107_NICORETTESPRAY-NICORETTESPRAY_FRUITS_ROUGES_PIS_INS_Avis2_CT18107.pdf
HAS/2019-12-20_CT-18112_XYLONOR_PIS_INS_Avis1_CT18112.pdf
HAS/2019-12-20_CT-18147_VANCOMYCINE_HIKMA_PIS_INS_Avis1_CT18147.pdf
HAS/2019-12-20_CT-18165_AMBRISENTAN_ACCORD_PIS_INS_Avis1_CT18165.pdf
HAS/2019-12-20_CT-18177_LEVOTHYROX_PIS_INS_Avis2_CT18177.pdf
HAS/2019-12-20_CT-18203_PEMETREXED_REDDY_PHARMA_PIS_INS_Avis1_CT18203.pdf
HAS/2019-12-20_CT-18216_BENDAMUSTINE_HIKMA_PIS_INS_Avis1_CT18216.pdf
HAS/2019-12-20_CT-18221_PANTOPRAZOLE_SUNPHARMA_PIS_INS_Avis2_CT18221.pdf
HAS/2019-12-20_CT-18265_FLEBOGAMMA_DIF_PIS_RCP_Avis1_CT18265.pdf
HAS/2019-12-20_dupixent_06112019_transcription_ct1790917925.pdf
HAS/2019-12-20_dupixent_11122019_synthese_ct1790917925.pdf
HAS/2019-12-20_dupixent_11122019_transcription_ct1790917925.pdf
HAS/2019-12-20_dupixent_summary_ct1790917925_epi654.pdf
HAS/2019-12-20_flucelvax_tetra_11122019_synthese_ct17980.pdf
HAS/2019-12-20_flucelvax_tetra_11122019_transcription_ct17980.pdf
HAS/2019-12-20_flucelvax_tetra_23102019_transcription_ct17980.pdf
HAS/2019-12-20_flucelvax_tetra_summary_ct17980.pdf
HAS/2019-12-24_CT-15979_CALCITONINE_PHARMY_II_PIC_REEV_Avis1_CT15979.pdf
HAS/2019-12-24_CT-17237_BOTOX_HVI_PIS_NE_EPIBoreal_Avis2_modifiele09052019_CT17237.pdf
HAS/2019-12-24_CT-17428_CALSYN_PIC_REEV_Avis1_CT17428.pdf
HAS/2019-12-24_CT-17544_INVICORP_PIC_INS_Avis3_CT17544.pdf
HAS/2019-12-24_CT-17656_BOTOX_HDN_EPI_PIC_EI_Avis1_CT17656.pdf
HAS/2019-12-24_CT-17795_NAMUSCLA_PIC_INS_Avis3_CT17795.pdf
HAS/2019-12-24_CT-17858_TRYDONIS_PIS_INS_Avis3_CT17858.pdf
HAS/2019-12-24_CT-17974_LYNPARZA_sein_PIC_EI_Avis3_CT17974.pdf
HAS/2019-12-24_CT-17989_ILOMEDINE_PIC_INS_Avis3_CT17989.pdf
HAS/2019-12-24_CT-17990_LYNPARZA_ovaire_PIC_EI_Avis3_CT17990.pdf
HAS/2019-12-24_CT-18008_TALZENNA_PIC_INS_Avis3_CT18008.pdf
HAS/2019-12-24_CT-18032_FASENRA_PIS_INS_Avis2_CT18032.pdf
HAS/2019-12-24_CT-18105_PROTOXYDE_AZOTE_MEDICINAL_MESSER_FRANCE_PIS_INS_Avis1_CT18105.pdf
HAS/2019-12-24_CT-18153_PROTOXYDE_AZOTE_LINDE_HEALTHCARE_PIS_INS_Avis1_CT18153.pdf
HAS/2019-12-24_botox_hdn_22052019_transcription_ct17656.pdf
HAS/2019-12-24_botox_synthese_hdn_ct17656.docx.pdf
HAS/2019-12-24_botox_synthese_hvi_ct17237.pdf
HAS/2019-12-24_calcitonine_summary_ct_17428_ct15979_ct_17762_2020-01-14_16-34-25_534.pdf
HAS/2019-12-24_calcitonine_synthese_ct_17428_ct15979_ct_17762.pdf
HAS/2019-12-24_ilomedine_02102019_transcription_ct17989.pdf
HAS/2019-12-24_ilomedine_11122019_synthese_ct17989.pdf
HAS/2019-12-24_ilomedine_11122019_transcription_ct17989.pdf
HAS/2019-12-24_ilomedine_summary_ct17989.pdf
HAS/2019-12-24_invicorp_04092019_transcription_ct17544.pdf
HAS/2019-12-24_invicorp_17072019_transcription_ct17544.pdf
HAS/2019-12-24_invicorp_22052019_transcription_ct17544.pdf
HAS/2019-12-24_invicorp_synthese_ct17544.pdf
HAS/2019-12-24_lynparza_21042020_avis_efficience.pdf
HAS/2019-12-24_lynparza_ovaire_11122019_synthese_ct17990.pdf
HAS/2019-12-24_lynparza_ovaire_11122019_transcription_ct17990.pdf
HAS/2019-12-24_lynparza_ovaire_23102019_transcription_ct17990.pdf
HAS/2019-12-24_lynparza_ovaire_summary_ct17990.pdf
HAS/2019-12-24_lynparza_sein_11122019_synthese_ct17974.pdf
HAS/2019-12-24_lynparza_sein_talzenna_20112019_transcription_ct1794718008.pdf
HAS/2019-12-24_lynparza_talzenna_11122019_transcription_ct1797418008.pdf
HAS/2019-12-24_namuscla_06112019_transcription_ct17795.pdf
HAS/2019-12-24_namuscla_11122019_synthese_ct17795.pdf
HAS/2019-12-24_namuscla_11122019_transcription_ct17795.pdf
HAS/2019-12-24_namuscla_summary_ct17795.pdf
HAS/2019-12-24_reevaluation_calcitonine_22052019_transcription_ct159791742817762.pdf
HAS/2019-12-24_talzenna_11122019_synthese_ct18008.pdf
HAS/2019-12-24_talzenna_sa_ct18008.pdf
HAS/2019-12-27_inahta_brief_cancer_somatic_gene_testing.pdf
HAS/2019-12-27_inahta_brief_haemorrhoidal_artery_ligation.pdf
HAS/2019-12-27_rapport_analyse_gen_somatique.pdf
HAS/2019-12-27_rapport_arteres_hemorroidaires.pdf
HAS/2020-01-02_CNEDIMTS-6048_CRE8_05_novembre_2019_(6048)_avis.pdf
HAS/2020-01-02_CNEDIMTS-6053_NEURX DPS RA-4_03_décembre_2019_(6053)_avis.pdf
HAS/2020-01-03_CT-17904_HUMIRA_PIS_INS_AvisDef_CT17904.pdf
HAS/2020-01-03_CT-18031_PULMICORT_PIS_EI_AvisDef_CT18031.pdf
HAS/2020-01-06_CT-17348_ANAGRELIDE_AOP_PIC_INS_AvisDef_CT17348.pdf
HAS/2020-01-06_CT-17954_MABTHERA_pemphigus_PIC_EI_AvisDef_CT17954.pdf
HAS/2020-01-06_CT-17996_IMRALDI_PIS_EI_AvisDef_CT17996.pdf
HAS/2020-01-06_CT-18059_LAMISIL_PIS_INS_AvisDef_CT18059.pdf
HAS/2020-01-06_CT-18116_NUREFLEX_PIS_INS_AvisDef_CT18116.pdf
HAS/2020-01-06_CT-18188_DAFALGAN_PIS_INS_Avis1_CT18188.pdf
HAS/2020-01-06_CT-18230_DAFALGAN_500_PIS_INS_AvisDef_CT18230.pdf
HAS/2020-01-06_CT-18231_DAFALGAN_1000_PIS_INS_AvisDef_CT18231.pdf
HAS/2020-01-06_anagrelide_04122019_transcription_ct17348.pdf
HAS/2020-01-06_anagrelide_aop_summary_ct17348.pdf
HAS/2020-01-06_anagrelide_synthese_11122019_ct17348.pdf
HAS/2020-01-06_mabthera_04122019_transcription_ct17954.pdf
HAS/2020-01-06_mabthera_pemphigus_11122019_synthese_ct17954.pdf
HAS/2020-01-06_mabthera_pemphigus_summary_ct17954.pdf
HAS/2020-01-07_CT-18228_CLINIMIX_PIS_INS_AvisDef_CT18228.pdf
HAS/2020-01-13_CNEDIMTS-5763_TRANSTIBIAL LIGHT COVER_03_décembre_2019_(5763)_avis.pdf
HAS/2020-01-13_CNEDIMTS-6104_SIFLOKI_19_novembre_2019_(6104)_avis.pdf
HAS/2020-01-13_implants_du_rachis_17_decembre_2019__dm_eval_204_avis.pdf
HAS/2020-01-15_pression_positive_continue_03_decembre_2019_dm_eval_248_avis.pdf
HAS/2020-01-16_CNEDIMTS-5977_ZILVER PTX_24_septembre_2019_(5977)_avis_occultation.pdf
HAS/2020-01-16_CNEDIMTS-6018_PROLAFIX-V_17_décembre_2019_(6018)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6020_ANTERIOR SWIFT_17_décembre_2019_(6020)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6037_E-LIAC_17_décembre_2019_(6037)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6041_MEPILEX BORDER_19_novembre_2019_(6041)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6049_CRE8 EVO_17_décembre_2019_(6049)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6058_BHR_17_décembre_2019_(6058)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6066_CLINUTREN THICKENUP CLEAR_17_décembre_2019_(6066)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6101_SOLITAIRE X_05_novembre_2019_(6101)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6102_AXS CATALYST_05_novembre_2019_(6102)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6110_PIED RUSH CHOPART PROTEOR_17_décembre_2019_(6110)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6116_PENUMBRA SYSTEM ACE 68-ACE 60_19_novembre_2019_(6116)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6125_PEEK_03_décembre_2019_(6125)_avis.pdf
HAS/2020-01-16_CNEDIMTS-6138_PENUMBRA SYSTEM JET7-JETD_19_novembre_2019_(6138)_(6139)_avis.pdf
HAS/2020-01-20_CNEDIMTS-6084_SUPRAFLEX_17_décembre_2019_(6084)_avis.pdf
HAS/2020-01-20_CNEDIMTS-6135_SUPRAFLEX CRUZ_17_décembre_2019_(6135)_avis.pdf
HAS/2020-01-20_CT-17703_RAGWIZAX_PIC_INS_Avis3_CT17703.pdf
HAS/2020-01-20_CT-17745_TAFINLAR_MEKINIST_PIC_REEV_CBNPC_AvisDef_CT17745_EPI657.pdf
HAS/2020-01-20_CT-17807_BLINCYTO_PIC_EI_pediatrie_AvisDef_CT17807.pdf
HAS/2020-01-20_CT-17812_SPRYCEL_PIC_EI_LAL_pediatrie_AvisDef_CT17812.pdf
HAS/2020-01-20_CT-17834_PALEXIA_PIC_INS_AvisDef_CT17834.pdf
HAS/2020-01-20_CT-17863_ILOPROST_TEVA_PIS_INS_AvisDef_CT17863.pdf
HAS/2020-01-20_CT-17907_LORVIQUA_PIC_INS_AvisDef_CT17907&18168_EPI656.pdf
HAS/2020-01-20_CT-18170_OXYBATE_DE_SODIUM_KALCEKS_PIS_INS_AvisDef_CT18170.pdf
HAS/2020-01-20_CT-18233_BORAX_ACIDE_BORIQUE_MYLAN_PIS_INS_AvisDef_CT18233.pdf
HAS/2020-01-20_CT-18246_FOLINATE_DE_CALCIUM_HIKMA_PIS_INS_AvisDef_CT18246.pdf
HAS/2020-01-20_CT-18271_LEVETIRACETAM_TILLOMED_PIS_INS_AvisDef_CT18271.pdf
HAS/2020-01-20_CT-18296_POSACONAZOLE_EG_PIS_INS_AvisDef_CT18296.pdf
HAS/2020-01-20_CT-18298_GLICLAZIDE_KRKA_PIS_INS_AvisDef_CT18298.pdf
HAS/2020-01-20_blincyto_08012020_synthese_ct17807.pdf
HAS/2020-01-20_blincyto_08012020_transcription_ct17807.pdf
HAS/2020-01-20_blincyto_20112019_transcription_ct17807.pdf
HAS/2020-01-20_blincyto_summary_ct17807.pdf
HAS/2020-01-20_lorviqua_06112019_transcription_ct17907.pdf
HAS/2020-01-20_lorviqua_080120220_synthese_ct1790718168.pdf
HAS/2020-01-20_lorviqua_11122019_transcription_ct17907.pdf
HAS/2020-01-20_lorviqua_summary_ct1790718168_epi656.pdf
HAS/2020-01-20_palexia_04122019_transcription_ct17834.pdf
HAS/2020-01-20_palexia_11122019_synthese_ct17834.pdf
HAS/2020-01-20_palexia_summary_ct17834.pdf
HAS/2020-01-20_ragwizax_04092019_transcription_ct17703.pdf
HAS/2020-01-20_ragwizax_23102019_transcription_ct17703.pdf
HAS/2020-01-20_ragwizax_summary_ct17703.pdf
HAS/2020-01-20_ragwizax_synthese_ct17703.pdf
HAS/2020-01-20_sprycel_08012020_synthese_ct17812.pdf
HAS/2020-01-20_sprycel_08012020_transcription_ct17812.pdf
HAS/2020-01-20_sprycel_20112019_transcription_ct17812.pdf
HAS/2020-01-20_sprycel_pic_ei_lal_pediatrie_summary_ct17812.pdf
HAS/2020-01-20_tafinlar-mekinist_06112019_transcription_ct17745.pdf
HAS/2020-01-20_tafinlar_mekinist_08012020_synthese_ct17745.pdf
HAS/2020-01-20_tafinlar_mekinist_11122019_transcription_ct17745.pdf
HAS/2020-01-20_tafinlar_mekinist_summary_ct17745_epi657.pdf
HAS/2020-01-22_CT-17921_AQUAREST_LACRINORM_LIPOSIC_PIS_RI_AvisDef_CT17921.pdf
HAS/2020-01-22_CT-18019_DOVATO_PIC_INS_AvisDef_CT18019.pdf
HAS/2020-01-22_CT-18239_CEBEMYXINE_PIS_INS_AvisDef_CT18239.pdf
HAS/2020-01-22_CT-18250_ONPATTRO_PIS_INS_AvisDef_CT18250.pdf
HAS/2020-01-22_dovato_08012020_synthese_ct18019.pdf
HAS/2020-01-22_dovato_08012020_transcription_ct18019.pdf
HAS/2020-01-22_dovato_summary_ct18019.pdf
HAS/2020-01-22_rapport_laser_femtoseconde.pdf
HAS/2020-01-27_CNEDIMTS-5944_ORION3_03_janvier_2020_(5944)_avis.pdf
HAS/2020-01-27_CNEDIMTS-6155_PHARMA FORM KALLI VISCO_14_janvier_2020_(6155)_avis.pdf
HAS/2020-01-27_CNEDIMTS-6176_PHARMA PRIMA_14_janvier_2020_(6176)_avis.pdf
HAS/2020-01-27_CNEDIMTS-6182_PHARMA ISKIO_14_janvier_2020_(6182)_avis.pdf
HAS/2020-01-27_CNEDIMTS-6185_PHARMA FORM PRIMA PLOT_14_janvier_2020_(6185)_avis.pdf
HAS/2020-01-27_CT-18179_ALFENTANIL_KALCEKS_PIS_INS_AvisDef_CT18179.pdf
HAS/2020-01-27_CT-18225_OXYBATE_DE_SODIUM_REIG_JOFRE_PIS_INS_AvisDef_CT18225.pdf
HAS/2020-01-27_CT-18399_POSACONAZOLE_MYLAN_PIS_INS_AvisDef_CT18399.pdf
HAS/2020-01-27_argumentaire_pnds_dup7q11.23-dec2019.pdf
HAS/2020-01-27_inahta_brief_autologous_breast_reconstruction_methods.pdf
HAS/2020-01-27_la_prevention_des_addictions_et_la_reduction_des_risques_et_des_dommages_par_les_csapa-_recommandations.pdf
HAS/2020-01-27_lettre_de_cadrage_programme_addictions.pdf
HAS/2020-01-27_pnds_argumentaire_syndrome_duplication_gene_mecp2_dec_2019.pdf
HAS/2020-01-27_pnds_behcet_vf_171219.pdf
HAS/2020-01-27_pnds_dup7q11_23_dec2019.pdf
HAS/2020-01-27_pnds_texte_syndrome_duplication_gene_mecp2_dec_2019.pdf
HAS/2020-01-27_rapport__reconstruction_mammaire.pdf
HAS/2020-01-27_synthese_mg_maladie_de_behcet.pdf
HAS/2020-01-27_synthese_mg_syndrome_de_duplication_du_gene_mecp2.pdf
HAS/2020-01-27_synthese_mg_syndrome_de_microduplication_7q11.23.pdf
HAS/2020-01-27_synthese_mg_thrombasthenie_de_glanzmann_et_pathologies_plaquettaires_apparentees.pdf
HAS/2020-01-27_v4_pnds_argumentaire_ea.pdf
HAS/2020-01-27_v5_pnds_texte_court_ea.pdf
HAS/2020-01-28_feuille_de_route_tomosynthese_mai_2018.pdf
HAS/2020-01-28_note_de_cadrage_evaluation_de_la_performance_et_de_la_place_de_la_mammographie_par_tomosynthese_vole_2020-01-27_10-00-20_527.pdf
HAS/2020-01-28_pnds_becker_argumentaire_vdef.pdf
HAS/2020-01-28_pnds_becker_def.pdf
HAS/2020-01-28_synthese_mg_dystrophie_musculaire_de_becker.pdf
HAS/2020-01-29_CNEDIMTS-6023_MATRX_14_janvier_2020_(6023)_avis.pdf
HAS/2020-01-29_CNEDIMTS-6097_FLOW COLLECTOR_03_décembre_2019_(6097)_avis.pdf
HAS/2020-01-29_CNEDIMTS-6123_VERCISE_17_décembre_2019_(6123)_avis.pdf
HAS/2020-01-29_CNEDIMTS-6134_DOMUS 4 AUTO_14_janvier_2020_(6134)_avis.pdf
HAS/2020-01-29_CNEDIMTS-6179_FIREHAWK_14_janvier_2020_(6179)_avis.pdf
HAS/2020-01-29_allotec_ctba.pdf
HAS/2020-01-29_argumentaire_pnds_trisomie_21.pdf
HAS/2020-01-29_catch-up_vaccination_in_practice_unknown_incomplete_or_incompletely_known_immunisation_status_in_the_general_popula.pdf
HAS/2020-01-29_examples_in_case_of_unknown_incomplete_or_incompletely_known_immunisation_status.docx.pdf
HAS/2020-01-29_fiche_synthese_exemples_rattrapage_migrants_vf.pdf
HAS/2020-01-29_fiche_synthese_exemples_rattrapage_vaccinal_en_pratique-vf.pdf
HAS/2020-01-29_fiche_synthese_rattrapage_vaccinal_migrants_primo_arrivants.pdf
HAS/2020-01-29_fiche_synthese_rattrapage_vaccinal_population_generale_vf.pdf
HAS/2020-01-29_in_the_event_of_unknown_incomplete_or_incompletely_known_immunisation_status.pdf
HAS/2020-01-29_neofordex_pec_temporaire_alternative_cteval488.pdf
HAS/2020-01-29_pnds_trisomie_21.pdf
HAS/2020-01-29_recommandation_vaccinale_statut_vaccinal_inconnu.pdf
HAS/2020-01-29_synthese_mg_trisomie_21.pdf
HAS/2020-01-29_unknown_incomplete_or_incompletely_known_immunisation_status.pdf
HAS/2020-01-30_CT-18176_LAMICTAL_PIS_INS_AvisDef_CT18176.pdf
HAS/2020-01-30_CT-18251_MEROPENEM_GERDA_PIS_INS_AvisDef_CT18251.pdf
HAS/2020-01-30_app_323_guide_bpco_actu_2019_vf.pdf
HAS/2020-01-30_app_323_points_critiques_bpco_vf.pdf
HAS/2020-01-30_app_361_fiche_pertinence_bpco_vf.pdf
HAS/2020-01-30_app_361_rapport_pertinence_bpco_cd_2019_11_20_v0.pdf
HAS/2020-01-30_rapport_bpco_iqss_parcours.pdf
HAS/2020-01-31_CT-18039_ADCETRIS_PIC_EI_AvisDef_CT18039.pdf
HAS/2020-01-31_CT-18334_ZYNTEGLO_PECT_AvisDef_CT18334.pdf
HAS/2020-01-31_adcetris_04122019_transcription_ct18039.pdf
HAS/2020-01-31_adcetris_22012020_synthese_ct18039.pdf
HAS/2020-01-31_adcetris_22012020_transcription_ct18039.pdf
HAS/2020-01-31_adcetris_summary_ct18039.pdf
HAS/2020-01-31_good_practice_guidelines_cpg_method.pdf
HAS/2020-01-31_reco363_gm_rbp_maj_janv_2020_cd_2020_01_22_v0.pdf
HAS/2020-02-03_CNEDIMTS-6100_CONFORMABLE TAG_14_janvier_2020_(6100)_avis.pdf
HAS/2020-02-03_CT-16688_BINOCRIT_PIS_RI_AvisDef_CT16688.pdf
HAS/2020-02-03_CT-16808_POLERY_PIS_RCP_AvisDef_CT16808.pdf
HAS/2020-02-03_CT-17833_UN-ALFA_PIS_RI_AvisDef_CT17833.pdf
HAS/2020-02-03_CT-17836_CHLORURE_DE_SODIUM_BBRAUN_PIS_RCP_AvisDef_CT17836.pdf
HAS/2020-02-03_CT-17940_DEFERIPRONE_LIPOMED_PIS_INS_AvisDef_CT17940.pdf
HAS/2020-02-03_CT-17963_ROZEX_PIS_RI_AvisDef_CT17963.pdf
HAS/2020-02-03_CT-17965_SILKIS_PIS_RI_AvisDef_CT17965.pdf
HAS/2020-02-03_feuille_de_route_evaluation_a_priori_de_l_extension_du_depistage_neonatal_a_une_ou_plusieurs_erreurs_innees_du_metabolisme_p.pdf
HAS/2020-02-03_rapport_dnn_eim.pdf
HAS/2020-02-03_synthese_dnn_eim.pdf
HAS/2020-02-06_CNEDIMTS-6011_UROLIFT_05_novembre_2019_(6011)_avis.pdf
HAS/2020-02-06_CNEDIMTS-6177_MAVERICK_14_janvier_2020_(6177)_avis.pdf
HAS/2020-02-06_how_to_assess_risk_-_toolkit_guide_1.pdf
HAS/2020-02-06_how_to_broach_the_subject_with_parents_-_toolkit_guide_3.pdf
HAS/2020-02-06_how_to_detect_and_broach_the_issue_-_toolkit_guide_2.pdf
HAS/2020-02-06_how_to_protect_a_minor_patient_-_toolkit_guide_4.pdf
HAS/2020-02-06_how_to_protect_an_adult_patient_-_toolkit_guide_6.pdf
HAS/2020-02-06_in_cases_of_mutilation_in_a_minor_-toolkit_guide_5.pdf
HAS/2020-02-06_management_of_female_genital_mutilation_by_primary_healthcare_professionals_-_best_practice_guideline.pdf
HAS/2020-02-06_mutilations_sexuelles_feminines_arbre_decisionnel.pdf
HAS/2020-02-06_reco307__recommandations_mutilations_sexuelles_feminines.pdf
HAS/2020-02-06_reco307_argumentaire_mutilations_sexuelles_feminines.pdf
HAS/2020-02-06_reco307_fiche_4__comment_proteger_mineures.pdf
HAS/2020-02-06_reco307_fiche__1__evaluer__les__risques.pdf
HAS/2020-02-06_reco307_fiche__2_reperer_aborder_la_question.pdf
HAS/2020-02-06_reco307_fiche__3_aborder_le__sujet_avec_parents.pdf
HAS/2020-02-06_reco307_fiche__5_en__cas_de__msf_chez_une__mineure_cat.pdf
HAS/2020-02-06_reco307_fiche__6__protection__patiente__majeure.pdf
HAS/2020-02-07_CNEDIMTS-5998_DBLG1 5998_occultation.pdf
HAS/2020-02-07_avis_bandes_allongement_long_dm_eval_244.pdf
HAS/2020-02-07_dispositifs_medicaux_de_compression_de_type_bandes_seches_-_feuille_de_route.pdf
HAS/2020-02-07_rapport_bandes_a_allongement_long_dm-eval_244.pdf
HAS/2020-02-09_analyse_gl__soins_palliatifs_final.pdf
HAS/2020-02-09_argu_fin_vie_med.pdf
HAS/2020-02-09_fiche_antalgie_mg.pdf
HAS/2020-02-09_fiche_sedation_mg.pdf
HAS/2020-02-09_reco_fin_vie_med.pdf
HAS/2020-02-09_retour_institutionnels_061119.pdf
HAS/2020-02-11_app_164_guide_pds_sedation_web.pdf
HAS/2020-02-11_app_164_rapport_biblio_pds_sedation_vf.pdf
HAS/2020-02-11_app_164_synthese_pds_sedation_web.pdf
HAS/2020-02-11_care_pathway_guide_how_to_implement_continuous_deep_sedation_until_death.pdf
HAS/2020-02-11_care_pathway_quick_reference_guide_how_to_implement_continuous_deep_sedation_until_death.pdf
HAS/2020-02-11_difference_entre_sedation_et_euthanasie_web.pdf
HAS/2020-02-21_CT-17982_VERKAZIA_PIC_INS_AvisDef_CT17982.pdf
HAS/2020-02-21_CT-17994_THERASOLV_PIC_INS_AvisDef_CT17994.pdf
HAS/2020-02-21_CT-18120_VABOREM_PIC_INS_AvisDef_CT18120.pdf
HAS/2020-02-21_CT-18198_ZAVICETFA_PIC_REEV_AvisDef_CT18198.pdf
HAS/2020-02-21_CT-18211_ZERBAXA_PIC_REEV_EI_AvisDef_CT18211.pdf
HAS/2020-02-21_therasolv_05022020_synthese_ct17994.pdf
HAS/2020-02-21_therasolv_22012020_transcription_ct17994.pdf
HAS/2020-02-21_therasolv_summary_ct17994.pdf
HAS/2020-02-21_vaborem_08012020_transcription_ct18120.pdf
HAS/2020-02-21_vaborem_22012020_synthese_ct18120.pdf
HAS/2020-02-21_vaborem_summary_ct18120.pdf
HAS/2020-02-21_verkazia_20112019_transcription_ct17982.pdf
HAS/2020-02-21_verkazia_22012020_synthese_ct17982.pdf
HAS/2020-02-21_verkazia_22012020_transcription_ct17982.pdf
HAS/2020-02-21_verkazia_summary_ct17982.pdf
HAS/2020-02-21_zavicefta_08012020_transcription_ct18198.pdf
HAS/2020-02-21_zavicefta_summary_ct18198.pdf
HAS/2020-02-21_zavicetfa_22012020_synthese_ct18198.pdf
HAS/2020-02-21_zerbaxa_08012020_transcription_ct18211.pdf
HAS/2020-02-21_zerbaxa_22012020_synthese_ct18211.pdf
HAS/2020-02-21_zerbaxa_summary_ct18211.pdf
HAS/2020-02-26_18rbp321_rpc_cadrage_reeduc_avc_29-10-19.pdf
HAS/2020-02-26_300120_reco329__note_cadrage_rbp_prolapsus_mel.pdf
HAS/2020-03-02_ct-18117_plan_d_acces_25112015.pdf
HAS/2020-03-02_ervebo_05022020_transcription_ct18117.pdf
HAS/2020-03-02_ervebo_19022020_synthese_ct18117.pdf
HAS/2020-03-02_ervebo_22012020_transcription_ct18117.pdf
HAS/2020-03-02_ervebo_summary_ct18117.pdf
HAS/2020-03-02_recommandation_vaccinale_utilisation_du_vaccin_contre_la_maladie_a_virus_ebola_ervebo.pdf
HAS/2020-03-04_CT-15288_HAVRIX_PIS_RI_AvisDef_CT15288.pdf
HAS/2020-03-04_CT-15623_NEXAVAR_PIC_REEV_rein_Avis2_CT15623.pdf
HAS/2020-03-04_CT-16516_AVAXIM_PIS_RI_AvisDef_CT16516.pdf
HAS/2020-03-04_CT-16578_XELEVIA_PIC_RI_REEV_Avis2_CT16578.pdf
HAS/2020-03-04_CT-16580_JANUVIA_PIC_RI_REEV_Avis2_CT16580.pdf
HAS/2020-03-04_CT-16821_MIRCERA_PIS_RI_AvisDef_CT16821.pdf
HAS/2020-03-04_CT-17610_VENCLYXTO_PIC_EI_Avis2_CT17610.pdf
HAS/2020-03-04_CT-17654_RUBRACA_PIC_INS_Avis3_CT17654.pdf
HAS/2020-03-04_CT-17655_TECENTRIQ_PIC_EI_Avis3_CT17655.pdf
HAS/2020-03-04_CT-17813_REVOLADE_PIC_RCP_AvisDef_CT17813.pdf
HAS/2020-03-04_CT-17840_ADENURIC_PIS_RI_AvisDef_CT17840.pdf
HAS/2020-03-04_CT-17857_MELPHALAN_SUN_PIS_INS_AvisDef_CT17857.pdf
HAS/2020-03-04_CT-17865_KYTRIL_PIS_RI_AvisDef_CT17865.pdf
HAS/2020-03-04_CT-17922_OLANZAPINE_ARROW_PIS_INS_AvisDef_CT17922.pdf
HAS/2020-03-04_CT-17939_MIFLONIL_BREEZHALER_PIS_INS_CG_AvisDef_CT17939.pdf
HAS/2020-03-04_CT-18017_SANTURIL_PIS_INS_AvisDef_CT18017.pdf
HAS/2020-03-04_CT-18023_NPLATE_PIC_INS_AvisDef_CT18023.pdf
HAS/2020-03-04_CT-18209_SAWIS_PIS_INS_GE_AvisDef_CT18209.pdf
HAS/2020-03-04_CT-18264_POSACONAZOLE_ZENTIVA_PIS_INS_AvisDef_CT18264.pdf
HAS/2020-03-04_CT-18295_OROFLUCO_PIS_INS_AvisDef_CT18295.pdf
HAS/2020-03-04_CT-18333_HARVONI_PIS_RCP_AvisDef_CT18333.pdf
HAS/2020-03-04_CT-18336_BORTEZOMIB_MEDAC_PIS_INS_HYB_AvisDef_CT18336.pdf
HAS/2020-03-04_CT-18338_SOVALDI_PIS_RCP_AvisDef_CT18338.pdf
HAS/2020-03-04_CT-18339_EPCLUSA_PIS_RCP_AvisDef_CT18339.pdf
HAS/2020-03-04_CT-18393_CLOXACILLINE_PANPHARMA_PIS_INS_AvisDef_CT18393.pdf
HAS/2020-03-04_januvia_xelevia_synthese_ct16580_16578.pdf
HAS/2020-03-04_nexavar_02102019_transcription_ct15623.pdf
HAS/2020-03-04_nexavar_23102019_synthese_ct15623.pdf
HAS/2020-03-04_nexavar_summary_rein_ct15623_en.pdf
HAS/2020-03-04_nplate_05022020_synthese_ct18023.pdf
HAS/2020-03-04_nplate_05022020_transcription_ct18023.pdf
HAS/2020-03-04_nplate_20112019_transcription_ct18023.pdf
HAS/2020-03-04_nplate_summary_ct18023.pdf
HAS/2020-03-04_prevention_of_positional_skull_deformities_and_sudden_infant_death_syndrome_-_memo.pdf
HAS/2020-03-04_reco276_fiche_memo_deformatons_craniennes_min_cd_2020_02_05_v11_fev.pdf
HAS/2020-03-04_reco276_rapport_elaboration_fm__deformations_craniennes_min_cd_2020_02_05_v0.pdf
HAS/2020-03-04_revolade_05022020_synthese_ct17813.pdf
HAS/2020-03-04_revolade_05022020_transcription_ct17813.pdf
HAS/2020-03-04_revolade_08012020_transcription_ct17813.pdf
HAS/2020-03-04_revolade_20112019_transcription_ct17813.pdf
HAS/2020-03-04_revolade_summary_ct17813.pdf
HAS/2020-03-04_rubraca_04092019_transcription_ct17654.pdf
HAS/2020-03-04_rubraca_09102019_transcription_ct17654.pdf
HAS/2020-03-04_rubraca_summary_ct17654.pdf
HAS/2020-03-04_rubraca_synthese_ct17654.pdf
HAS/2020-03-04_tecentriq_09102019_transcription_ct17655.pdf
HAS/2020-03-04_tecentriq_16072019_avis_defenitif.pdf
HAS/2020-03-04_tecentriq_26062019_transcription_ct17655.pdf
HAS/2020-03-04_tecentriq_summary_ct17655.pdf
HAS/2020-03-04_tecentriq_synthese_ct17655.pdf
HAS/2020-03-04_venclyxto_ei_10072019_transcription_ct17610.pdf
HAS/2020-03-04_venclyxto_ei_synthese.pdf
HAS/2020-03-05_CT-17461_GARDASIL9_PIC_REEV_AvisDef_CT17461&17456.pdf
HAS/2020-03-05_CT-18044_METOJECT_psoriasis_PIC_EI_AvisDef_CT18044.pdf
HAS/2020-03-05_CT-18055_LEPTOPROL_PIS_INS_AvisDef_CT18055.pdf
HAS/2020-03-05_CT-18261_AZITHROMYCINE_ARROW_LAB_PIS_INS_AvisDef_CT18261.pdf
HAS/2020-03-05_gardasil9_19022020_synthese_ct1746117456.pdf
HAS/2020-03-05_gardasil9_summary_ct1746117456.pdf
HAS/2020-03-05_gardasil_9_05022020_transcription_ct17461.pdf
HAS/2020-03-05_metoject_05022020_synthese_ct18044.pdf
HAS/2020-03-05_metoject_psoriasis_05022020_transcription_ct18044.pdf
HAS/2020-03-05_metoject_summary_ct18044.pdf
HAS/2020-03-06_CT-17898_NASACORT_enfant_PIC_EI_AvisDef_CT17898.pdf
HAS/2020-03-06_CT-17938_TILLHEPO_PIS_INS_AvisDef_CT17938.pdf
HAS/2020-03-06_CT-18199_VORICONAZOLE_ARROW_PIS_INS_AvisDef_CT18199.pdf
HAS/2020-03-06_CT-18234_OPDIVO_PIS_RCP_AvisDef_CT18234.pdf
HAS/2020-03-06_CT-18238_NYXOID_PIC_INS_AvisDef_CT18238.pdf
HAS/2020-03-06_CT-18266_XENETIX_PIS_INS_AvisDef_CT18266.pdf
HAS/2020-03-06_CT-18291_TRAMADOL_MYLAN_PHARMA_LP_PIS_INS_AvisDef_CT18291.pdf
HAS/2020-03-06_CT-18337_VOSEVI_PIS_RCP_AvisDef_CT18337.pdf
HAS/2020-03-06_nasacort_05022020_synthese_ct17898.pdf
HAS/2020-03-06_nasacort_22012020_transcription_ct17898.pdf
HAS/2020-03-06_nasacort_enfant_summary_ct17898.pdf
HAS/2020-03-06_nyxoid_05022020_synthese_ct18238.pdf
HAS/2020-03-06_nyxoid_05022020_transcription_ct18238.pdf
HAS/2020-03-06_nyxoid_summary_ct18238.pdf
HAS/2020-03-09_analyse_gl_arsenic.pdf
HAS/2020-03-09_annexe_1-fiche_renseignements.pdf
HAS/2020-03-09_annexe_2-logigramme_strategie_de_depistage.pdf
HAS/2020-03-09_annexe_3-logigramme_strategie_de_diagnostic.pdf
HAS/2020-03-09_annexe_4-logigramme_strategie_de_surveillance_medicale.pdf
HAS/2020-03-09_argu_arsenic.pdf
HAS/2020-03-09_reco_arsenic.pdf
HAS/2020-03-09_retour_institutionnels_final.pdf
HAS/2020-03-11_CNEDIMTS-6045_ACTIVA RC_28_janvier_2020_(6045)_avis.pdf
HAS/2020-03-11_CNEDIMTS-6065_AMPLATZER PFO OCCLUDER_28_janvier_2020_(6065)_avis.pdf
HAS/2020-03-11_CNEDIMTS-6072_ACTIVA PC_28_anvier_2020_(6072)_avis.pdf
HAS/2020-03-11_CNEDIMTS-6073_ACTIVA SC_28_janvier_2020_(6073)_avis.pdf
HAS/2020-03-11_CNEDIMTS-6184_TELECOMMANDE PATIENT ACTIVA SC_11_février_2020_(6184)_avis.pdf
HAS/2020-03-11_CNEDIMTS-6204_TELECOMMANDE PATIENT ACTIVA PC_11_février_2020_(6204)_avis.pdf
HAS/2020-03-11_sofia_sofia_plus_17_decembre_2019_6076_6131_avis.pdf
HAS/2020-03-12_CNEDIMTS-6109_PEPTAMEN JUNIOR_28_février_2020_(6109)_avis.pdf
HAS/2020-03-12_CNEDIMTS-6142_BRAVA SUPPORT PLUS_11_février_2020_(6142)_avis.pdf
HAS/2020-03-12_CNEDIMTS-6143_MERCURY CIMENTE_11_février_2020_(6143)_avis.pdf
HAS/2020-03-12_CT-16814_CERVARIX_PIS_RI_EI_NON_DEMANDEE_AvisDef_CT16814&15897.pdf
HAS/2020-03-12_CT-17373_RENVELA_PIC_EI_AvisDef_CT17373.pdf
HAS/2020-03-12_CT-17694_NOVOPULMON_NOVOLIZER_PIS_RI_AvisDef_CT17694.pdf
HAS/2020-03-12_CT-17912_WAYLIVRA_PIC_INS_AvisDef_CT17912_EPI658.pdf
HAS/2020-03-12_CT-17937_METHOTREXATE_ACCORD_PIS_INS_AvisDef_CT17937.pdf
HAS/2020-03-12_CT-17948_IMNOVID_PIC_EI_AvisDef_CT17948&17968.pdf
HAS/2020-03-12_CT-17991_ZIRABEV_PIS_INS_AvisDef_CT17991.pdf
HAS/2020-03-12_CT-18003_AMLODIPINE_CEVIDRA_PIS_INS_HYB_AvisDef_CT18003.pdf
HAS/2020-03-12_CT-18010_ESTROTEP_PIC_REEV_AvisDef_CT18010.pdf
HAS/2020-03-12_CT-18054_TREMFYA_PIC_REEV_AvisDef_CT18054.pdf
HAS/2020-03-12_CT-18094_CIFLOX_UNIFLOX_PIS_INS_AvisDef_CT18094.pdf
HAS/2020-03-12_CT-18135_MOVYMIA_PIS_INS_CG_AvisDef_CT18135.pdf
HAS/2020-03-12_CT-18152_IMNOVID_PIC_REEV_AvisDef_CT18152.pdf
HAS/2020-03-12_CT-18178_TOBRAMYCINE_ALTAN_PIS_INS_HYB_AvisDef_CT18178.pdf
HAS/2020-03-12_CT-18258_MITOMYCINE_MEDAC_PIS_INS_AvisDef_CT18258.pdf
HAS/2020-03-12_CT-18263_NICOTINE_EG_PIS_INS_GE_AvisDef_CT18263.pdf
HAS/2020-03-12_CT-18341_IMIPENEM_CILASTATINE_HIKMA_PIS_INS_AvisDef_CT18341.pdf
HAS/2020-03-12_CT-18345_MEROPENEM_HIKMA_PIS_INS_AvisDef_CT18345.pdf
HAS/2020-03-12_CT-18394_AZACITIDINE_ACCORD_PIS_INS_AvisDef_CT18394.pdf
HAS/2020-03-12_CT-18407_AMBRISENTAN_EG_PIS_INS_AvisDef_CT18407.pdf
HAS/2020-03-12_CT-18429_LEELOO_CONTINU_PIS_INS_AvisDef_CT18429.pdf
HAS/2020-03-12_CT-18436_ACIDE_ACETYLSALICYLIQUE_EG_LABO_CONSEIL_PIS_INS_AvisDef_CT18436.pdf
HAS/2020-03-12_CT-18444_GADOVISTAUTO_PIS_INS_AvisDef_CT18444.pdf
HAS/2020-03-12_CT-18445_CLOXACILLINE_STRAGEN_PIS_INS_AvisDef_CT18445.pdf
HAS/2020-03-12_estrotep_05022020_transcription_ct18010.pdf
HAS/2020-03-12_estrotep_18022020_synthese_ct18010.pdf
HAS/2020-03-12_estrotep_summary_ct18010.pdf
HAS/2020-03-12_imnovid_05022020_transcription_ct17948.pdf
HAS/2020-03-12_imnovid_05022020_transcription_ct18152.pdf
HAS/2020-03-12_imnovid_19022020_synthese_ct1794817968.pdf
HAS/2020-03-12_imnovid_19022020_synthese_ct18152.pdf
HAS/2020-03-12_imnovid_summary_ct1794817968.pdf
HAS/2020-03-12_imnovid_summary_ct18152.pdf
HAS/2020-03-12_renvela_04032020_synthese_ct17373.pdf
HAS/2020-03-12_renvela_04032020_transcription_ct17373.pdf
HAS/2020-03-12_renvela_08012020_transcription_ct17373.pdf
HAS/2020-03-12_renvela_summary_ct17373.pdf
HAS/2020-03-12_sofia_sofia_plus_17_decembre_2019_6076_6131_avis.pdf
HAS/2020-03-12_tremfya_04032020_synthese_ct18054.pdf
HAS/2020-03-12_tremfya_19022020_transcription_ct18054.pdf
HAS/2020-03-12_tremfya_summary_ct18054.pdf
HAS/2020-03-12_waylivra_08012020_transcription_ct17912.pdf
HAS/2020-03-12_waylivra_19022020_synthese_ct17912.pdf
HAS/2020-03-12_waylivra_19022020_transcription_ct17912.pdf
HAS/2020-03-12_waylivra_summary_ct17912_epi658.pdf
HAS/2020-03-16_utilisation_du_vaccin_antityphoidique_vivotif_chez_les_adultes_et_les_enfants_ages_de_5_ans_et_plus.pdf
HAS/2020-03-17_diagramme_du_parcours_dun_enfant-0-7ans_a_risque_de_tnd.pdf
HAS/2020-03-17_fiche_de_synthese_troubles_du_neurodeveloppement_en_relmd_modif_acceptees.pdf
HAS/2020-03-17_fs_tnd_fiche_v2.pdf
HAS/2020-03-17_fs_tnd_synthese_v2.pdf
HAS/2020-03-17_reco299_argumentaire_reperage_tnd_mel_v2.pdf
HAS/2020-03-17_reco299_recommandations_reperage_tnd_mel_v2.pdf
HAS/2020-03-17_respifil_pnds_phs_2020.pdf
HAS/2020-03-17_respifil_pnds_phs_as_2020.pdf
HAS/2020-03-17_synthese_mg_pneumopathie_d_hypersensibilite_de_l_enfant.pdf
HAS/2020-03-17_troubles_du_neurodeveloppement_reperage_et_orientation_des_enfants_a_risque_-_avis_du_groupe_de_lecture_sur_la_version_initi.pdf
HAS/2020-03-18_CT-17440_RHINOMAXIL_PIS_RI_AvisDef_CT17440.pdf
HAS/2020-03-18_CT-18022_MOZOBIL_PIC_INS_Avisdef_CT18022.pdf
HAS/2020-03-18_CT-18086_CUFENCE_PIC_INS_Avisdef_CT18086.pdf
HAS/2020-03-18_CT-18223_OXYCODONE_RENAUDIN_PIS_INS_AvisDef_CT18223.pdf
HAS/2020-03-18_CT-18430_RENVELA_PIS_INS_AvisDef_CT18430.pdf
HAS/2020-03-18_CT-18458_ARGANOVA_PIS_INS_AvisDef_CT18458.pdf
HAS/2020-03-18_creon_05022020_transcription_ct17809.pdf
HAS/2020-03-18_creon_11032020_synthese_ct17809.pdf
HAS/2020-03-18_creon_11032020_transcription_ct17809.pdf
HAS/2020-03-18_creon_pic_ins_avisdef_ct17809.pdf
HAS/2020-03-18_creon_summary_ct17809.pdf
HAS/2020-03-18_cufence_04032020_synthese_ct18086.pdf
HAS/2020-03-18_cufence_19022020_transcription_ct18086.pdf
HAS/2020-03-18_cufence_summary_ct18086.pdf
HAS/2020-03-18_guide_it_anesthesie_vd.pdf
HAS/2020-03-18_mozobil_04032020_synthese_ct18022.pdf
HAS/2020-03-18_mozobil_19022020_transcription_ct18022.pdf
HAS/2020-03-18_mozobil_summary_ct18022.pdf
HAS/2020-03-19_CT-17563_TECHNESCAN_DTPA_PIS_INS_Avisdef_CT17563.pdf
HAS/2020-03-19_CT-18155_ETOPOSIDE_TEVA_PIS_RCP_AvisDef_CT18155.pdf
HAS/2020-03-19_CT-18194_ETOPOPHOS_PIS_RCP_AvisDef_CT18194.pdf
HAS/2020-03-19_CT-18351_THYROFIX_PIS_INS_GE_AvisDef_CT18351.pdf
HAS/2020-03-19_CT-18466_PARACETAMOL_ACCORD_PIS_INS_AvisDef_CT18466.pdf
HAS/2020-03-20_CNEDIMTS-5965_MOVYMIA PEN_11_février_2020_(5965)_avis.pdf
HAS/2020-03-20_CNEDIMTS-6061_DEXCOM G6_25_février_2020_(6061)_avis.pdf
HAS/2020-03-20_CNEDIMTS-6115_OMNIPOD DASH INSULIN MANAGEMENT SYSTEM_28_janvier_2020_(6115)_avis.pdf
HAS/2020-03-20_CNEDIMTS-6122_GLASSBONE PUTTY_10_mars_2020_(6122)_avis.pdf
HAS/2020-03-20_cello_08_octobre_2019_6000_avis_occultation.pdf
HAS/2020-03-23_reco347_cadrage_rbp_pile_bouton__coi_2020_03_19_vpost_coi.pdf
HAS/2020-03-23_vehicules_destines_au_transport_passif_des_personnes_handicapees_avis_de_la_cnedimts_du_11_fevrier_2020.pdf
HAS/2020-03-24_CNEDIMTS-5990_PROCLAIM_11_février_2020_(5990)_avis.pdf
HAS/2020-03-24_CNEDIMTS-6111_URGOSTART PLUS_11_février_2020_(6111)_avis.pdf
HAS/2020-03-24_CT-17280_KEYTRUDA_PIC_EI_poumon_avec_pemetrexed_Avis3_CT17280.pdf
HAS/2020-03-24_CT-17321_LENVIMA_PIC_EI_Avis3_CT17321.pdf
HAS/2020-03-24_CT-17551_XTANDI_PIC_EI_Avis2_CT17551.pdf
HAS/2020-03-24_CT-17558_KEYTRUDA_mélanoAdjuv_PIC_EI_Avis2_CT17558.pdf
HAS/2020-03-24_CT-17786_ZORYON_PIC_INS_Avis2_CT17786.pdf
HAS/2020-03-24_argumentaire_pnds_urologie_v3_1.pdf
HAS/2020-03-24_keytruda_12022019_avis_efficience.pdf
HAS/2020-03-24_keytruda_12062019_transcription_ct17558.pdf
HAS/2020-03-24_keytruda_16072019_avis_efficience.pdf
HAS/2020-03-24_keytruda_synthese_ct17280.pdf
HAS/2020-03-24_keytruda_synthese_ct17558.pdf
HAS/2020-03-24_lenvima_09102019_transcription_ct17321.pdf
HAS/2020-03-24_lenvima_10072019_transcription_ct17321.pdf
HAS/2020-03-24_lenvima_summary_ct17321.pdf
HAS/2020-03-24_lenvima_synthese_ct17321.pdf
HAS/2020-03-24_pnds_urologie_v7.pdf
HAS/2020-03-24_xtandi_12062019_transcription_ct17551.pdf
HAS/2020-03-24_xtandi_16072019_avis_efficience.pdf
HAS/2020-03-24_xtandi_synthese_ct17551.pdf
HAS/2020-03-24_zoryon_04092019_transcription_ct17786.pdf
HAS/2020-03-24_zoryon_summary_ct17786.pdf
HAS/2020-03-24_zoryon_synthese_ct17786.pdf
HAS/2020-03-26_CT-18061_ZYNTEGLO_PIC_INS_AvisDef_CT18061_EPI659.pdf
HAS/2020-03-26_CT-18068_ENTYVIO_RCH_PIC_REEV_AvisDef_CT18068.pdf
HAS/2020-03-26_CT-18145_IMBRUVICA_PIS_INS_AvisDef_CT18145.pdf
HAS/2020-03-26_entyvio_18032020_synthese_ct18068.pdf
HAS/2020-03-26_entyvio_18032020_transcription_ct18068.pdf
HAS/2020-03-26_entyvio_22012020_transcription_ct18068.pdf
HAS/2020-03-26_entyvio_rch_summary_ct18068.pdf
HAS/2020-03-26_zynteglo_11022020_avis_efficience.pdf
HAS/2020-03-26_zynteglo_18032020_synthese_ct18061.pdf
HAS/2020-03-26_zynteglo_18032020_transcription_ct18061.pdf
HAS/2020-03-26_zynteglo_22012020_transcription_ct18061.pdf
HAS/2020-03-27_CT-18297_MAINTELYTE_PIS_INS_AvisDef_CT18297.pdf
HAS/2020-03-27_CT-18342_THYROFIX_PIS_INS_HYB_AvisDef_CT18342.pdf
HAS/2020-03-27_CT-18343_TIORFAN_PIS_INS_AvisDef_CT18343.pdf
HAS/2020-03-27_CT-18409_ESOMEPRAZOLE_TILLOMED_PIS_INS_AvisDef_CT18409.pdf
HAS/2020-03-27_CT-18414_TRIMBOW_RECOURS_R163-13_AvisDef_CT18414.pdf
HAS/2020-03-27_libtayo_08012020_transcription_ct18038.pdf
HAS/2020-03-27_libtayo_18032020_synthese_ct18038.pdf
HAS/2020-03-27_libtayo_18032020_transcription_ct18038.pdf
HAS/2020-03-27_libtayo_pic_ins_avisdef_ct18038.pdf
HAS/2020-03-27_libtayo_summary_ct18038.pdf
HAS/2020-03-27_trimbow_18032020_synthese_ct18414.pdf
HAS/2020-03-27_trimbow_18032020_transcription_ct18414.pdf
HAS/2020-03-30_CNEDIMTS-5861_IMPELLA CP_11_mars_2020_(5861)_avis.pdf
HAS/2020-03-30_CNEDIMTS-5865_IMPELLA 5 0_24_mars_2020_(5865)_avis.pdf
HAS/2020-03-30_CNEDIMTS-6059_BIOMONITOR III_25_février_2020_(6059)_avis.pdf
HAS/2020-03-30_CNEDIMTS-6130_SILK_25_février_2020_(6130)_avis.pdf
HAS/2020-03-30_CNEDIMTS-6207_VISMED GEL MULTI_10_mars_2020_(6207)_avis.pdf
HAS/2020-03-30_CNEDIMTS-6212_HYLOVIS GEL MULTI_10_mars_2020_(6212)_avis.pdf
HAS/2020-03-30_CNEDIMTS-6232_COREVALVE AOA_10_mars_2020_(6232)_avis.pdf
HAS/2020-03-30_CNEDIMTS-6233_COREVALVE EVOLUT AOA_10_mars_2020_(6233)_avis.pdf
HAS/2020-03-31_CT-17777_REVLIMID_PIC_EI_AvisDef_CT17777.pdf
HAS/2020-03-31_CT-17860_ORGARAN_PIS_RCP_AvisDef_CT17860.pdf
HAS/2020-03-31_CT-18132_LYSAKARE_PIC_INS_AvisDef_CT18132.pdf
HAS/2020-03-31_CT-18206_TECENTRIQ_840_PIC_INS_AvisDef_CT18206&18149.pdf
HAS/2020-03-31_CT-18365_DEXMEDETOMIDINE_ALTAN_PIS_INS_AvisDef_CT18365.pdf
HAS/2020-03-31_CT-18478_IBUPROFENE_EVOLUGEN_PHARMA_PIS_INS_AvisDef_CT18478.pdf
HAS/2020-03-31_CT-18488_MVASI_PIS_INS_AvisDef_CT18488.pdf
HAS/2020-03-31_lysakare_11032020_synthese_ct18132.pdf
HAS/2020-03-31_lysakare_11032020_transcription_ct18132.pdf
HAS/2020-03-31_lysakare_summary_ct18132.pdf
HAS/2020-03-31_revlimid_05022020_transcription_ct17777.pdf
HAS/2020-03-31_revlimid_18032020_synthese_ct17777.pdf
HAS/2020-03-31_revlimid_18032020_transcription_ct17777.pdf
HAS/2020-03-31_revlimid_summary_ct17777_2020-07-24_14-56-37_684.pdf
HAS/2020-03-31_tecentriq_04032020_transcription_ct1820618149.pdf
HAS/2020-03-31_tecentriq_11032020_avis_efficience_2020-05-20_17-48-30_554.pdf
HAS/2020-03-31_tecentriq_20032020_synthese_ct1820618149.pdf
HAS/2020-03-31_tecentriq_840_summary_ct1820618149.pdf
HAS/2020-04-01_CNEDIMTS-6099_SURELIFT CPS_11_février_2020_(6099)_avis.pdf
HAS/2020-04-01_CNEDIMTS-6230_PHOENIX_10_mars_2020_(6230)_avis.pdf
HAS/2020-04-02_374_rr_covid19_prenatal_maj_deconfinement_mel.pdf
HAS/2020-04-02_375_rr_covid19_postnatal_maj_deconfinement_mel-.pdf
HAS/2020-04-02_CNEDIMTS-6091_WELLION GALILEO GLUKET et WELLION GALILEO KET_24_mars_2020_(6091)_avis.pdf
HAS/2020-04-02_CT-17445_CRESTOR_PIC_EI_Avis2_CT17445.pdf
HAS/2020-04-02_arrete_du_14_avril_2020_completant_larrete_du_23_mars_2020.pdf
HAS/2020-04-02_covid_19_methode_reponses_rapides.pdf
HAS/2020-04-02_crestor_synthese_ct17445.pdf
HAS/2020-04-02_fiche_memo_teleconsultation_et_teleexpertise_mise_en_oeuvre.pdf
HAS/2020-04-02_has_fiche_teleconsultation_7_mai_2020.pdf
HAS/2020-04-02_modifications_des_modalites_dinscription_des_articles_pansements_dm_eval_267.pdf
HAS/2020-04-02_reponse_rapide_covid-19_psychiatrie_confinement.pdf
HAS/2020-04-02_reponse_rapide_covid19_malchron.pdf
HAS/2020-04-02_reponse_rapide_covid19_methode_vd_en.pdf
HAS/2020-04-02_reponses_rapides_dans_le_cadre_du_covid-19_-teleconsultation_et_telesoin.pdf
HAS/2020-04-03_CT-17471_RAPAMUNE_PIC_EI_Avis2_CT17471.pdf
HAS/2020-04-03_CT-18101_TRIMBOW_PIC_REEV_Avis1_CT18101.pdf
HAS/2020-04-03_CT-18138_DUPIXENT_EIT_DAadolescent_PIC_AvisDef_CT18138.pdf
HAS/2020-04-03_CT-18143_IMBRUVICA_PIC_REEV_AvisDef_CT18143.pdf
HAS/2020-04-03_CT-18190_VIREAD_PIC_INS_AvisDef_CT18190.pdf
HAS/2020-04-03_CT-18212_IMBRUVICA_LLC_en_association_PIC_EI_AvisDef_CT18212.pdf
HAS/2020-04-03_CT-18220_TAGRISSO_PIC_EI_AvisDef_CT18220.pdf
HAS/2020-04-03_CT-18408_CHLORAPREP_PIS_INS_AvisDef_CT18408.pdf
HAS/2020-04-03_CT-18443_TRYDONIS_PIS_SAISINE_AvisDef_CT18443.pdf
HAS/2020-04-03_dupixent_11022020_avis_efficience.pdf
HAS/2020-04-03_dupixent_11032020_synthese_ct18138.pdf
HAS/2020-04-03_dupixent_11032020_transcription_ct18138.pdf
HAS/2020-04-03_dupixent_summary_ct18138.pdf
HAS/2020-04-03_imbruvica_04032020_transcription_ct18143.pdf
HAS/2020-04-03_imbruvica_04032020_transcription_ct18212.pdf
HAS/2020-04-03_imbruvica_20032020_synthese_ct18143.pdf
HAS/2020-04-03_imbruvica_llc_en_association_20032020_synthese_ct18212.pdf
HAS/2020-04-03_imbruvica_summary_ct18143.pdf
HAS/2020-04-03_imbruvica_summary_ct18212.pdf
HAS/2020-04-03_rapamune_20032019_transcription_ct17471.pdf
HAS/2020-04-03_rapamune_synthese_ct17471.pdf
HAS/2020-04-03_tagrisso_11032020_transcription_ct18220.pdf
HAS/2020-04-03_tagrisso_20032020_synthese_ct18220.pdf
HAS/2020-04-03_tagrisso_summary_ct18220.pdf
HAS/2020-04-03_trimbow_04092019_transcription_ct1770118101.pdf
HAS/2020-04-03_trimbow_summary_ct17701ct18101.pdf
HAS/2020-04-03_trimbow_synthese_ct17701ct18101.pdf
HAS/2020-04-03_viread_11032020_transcription_ct18190.pdf
HAS/2020-04-03_viread_20032020_synthese_ct18190.pdf
HAS/2020-04-03_viread_summary_ct18190.pdf
HAS/2020-04-07_CNEDIMTS-6039_SPACEOAR_10_mars_2020_(6039)_avis.pdf
HAS/2020-04-07_CNEDIMTS-6114_MEDPOR CCI_24_mars_2020_(6114)_avis.pdf
HAS/2020-04-07_argumentaire_pndshnf1b.pdf
HAS/2020-04-07_pnds_hnf1b.18032020.pdf
HAS/2020-04-07_reco330_cadrage_syndrome_nez_vide_vd_1.pdf
HAS/2020-04-07_reco350__note_cadrage_rbp_glaucome_coi_2019_11_14_v0_-_mel.pdf
HAS/2020-04-07_respifil_pnds_htap_2020.pdf
HAS/2020-04-07_respifil_pnds_htap_as_2020.pdf
HAS/2020-04-07_respifil_pnds_htap_mt_2020.pdf
HAS/2020-04-08_CNEDIMTS-5980_INFINITY_10_mars_2020_(5980)_avis.pdf
HAS/2020-04-08_CNEDIMTS-6079_SPYSCOPE DSII_25_février_2020_(6079)_avis.pdf
HAS/2020-04-08_CNEDIMTS-6080_SPYSCOPE DS_25_février_2020_(6080)_avis.pdf
HAS/2020-04-08_CNEDIMTS-6239_DIZG_10_mars_2020_(6239)_avis.pdf
HAS/2020-04-08_CT-18207_BAVENCIO_PIC_REEV_EPI_RCP_AvisDef_CT18207&18303.pdf
HAS/2020-04-08_CT-18276_EFFERALGANMED_PIS_INS_AvisDef_CT18276.pdf
HAS/2020-04-08_CT-18502_AMBRISENTAN_REDDY_PHARMA_PIS_INS_AvisDef_CT18502.pdf
HAS/2020-04-08_bavencio_18032020_synthese_ct1820718303.pdf
HAS/2020-04-08_bavencio_18032020_transcription_ct18207.pdf
HAS/2020-04-08_bavencio_22012020_transcription_ct18207.pdf
HAS/2020-04-08_bavencio_summary_ct18207.pdf
HAS/2020-04-08_dimetrum_pis_ins_avisdef_ct18503.pdf
HAS/2020-04-09_CNEDIMTS-6030_OPTIMIZER SMART_25_février_2020_(6030)_avis.pdf
HAS/2020-04-09_CNEDIMTS-6120_SYNERGY MEGATRON_28_janvier_2020_(6120)_avis.pdf
HAS/2020-04-09_CNEDIMTS-6124_XIENCE PRIME BTK_28_janvier_2020_(6124)_avis.pdf
HAS/2020-04-09_CNEDIMTS-6192_CARPENTIER EDWARDS PERIMOUNT RSR 2800TFX_10_mars_2020_(6192)_avis.pdf
HAS/2020-04-09_CNEDIMTS-6205_TELECOMMANDE PATIENT ACTIVA RC_11_février_2020_(6205)_avis.pdf
HAS/2020-04-09_CNEDIMTS-6214_AXTAIR AUTOMORPHO PLUS_24_mars_2020_(6214)_avis.pdf
HAS/2020-04-09_CT-18539_DUPIXENT_PIS_INS_CG_AvisDef_CT18539.pdf
HAS/2020-04-09_optimizer_smart_11022020_avis_efficience.pdf
HAS/2020-04-10_analyse_descriptive_contributions.pdf
HAS/2020-04-10_continuite_du_suivi_des_personnes_vivant_avec_le_vih_et_de_loffre_de_soins_en_sante_sexuelle_-_reponses_rapides.pdf
HAS/2020-04-10_p_2020_0088_reco383_rr_covid19.pdf
HAS/2020-04-10_reco380_rr_hepatites_v5_valideecollege.pdf
HAS/2020-04-10_reponse_rapide_codid-19_indication_tdm_mel2.pdf
HAS/2020-04-10_reponse_rapide_covid19_epilepsie_maj_25_05_2020_mel_2020-06-03_16-01-19_785.pdf
HAS/2020-04-10_reponse_rapide_covid19_maladies_respiratoires_chroniques_mel3.pdf
HAS/2020-04-10_reponse_rapide_covid19_tuberculose_mel3.pdf
HAS/2020-04-10_reponse_rapide_ivg__09_04_2020_coiv8.pdf
HAS/2020-04-10_reponses_rapides_covid19._insuffisance_cardiaque.pdf
HAS/2020-04-10_reponses_rapides_covid19_mrc_decembre_2020_mel.pdf
HAS/2020-04-10_reponses_rapides_covid19_suivi_des_patients_atteints_de_maladie_de_parkinson.pdf
HAS/2020-04-10_reponses_rapides_covid19_suivi_des_patients_atteints_de_syndrome_coronarien_chronique.pdf
HAS/2020-04-14_CT-18411_INNNOVAIR_NEXTHALER_FORMODUAL_NEXTHALER_PIS_INS_AvisDef_CT18411.pdf
HAS/2020-04-14_CT-18556_MELPHALAN_TILLOMED_PIS_INS_AvisDef_CT18556.pdf
HAS/2020-04-16_cadrage_tests_serologiques_covid-19_vf.pdf
HAS/2020-04-16_cahier_des_charges_test_serologique_covid19.pdf
HAS/2020-04-16_has_serological_tests_covid19_specifications.pdf
HAS/2020-04-16_rapport_indications_tests_serologiques_covid-19.pdf
HAS/2020-04-16_rapport_tests_serologiques_rapides_covid-19_vd.pdf
HAS/2020-04-17_373_reponse_rapide_covid19_mk_15-04-20_v4_vmssr.pdf
HAS/2020-04-17_378_rr_covid19_dt1dt2_20_04_16_mel_v11.pdf
HAS/2020-04-17_386_reponse_rapide_covid19_nutrition_mel.pdf
HAS/2020-04-17_388_reponse_rapide_covid19__mpr_srr_03-05-20_anglaise_2020-05-05_14-50-42_202.pdf
HAS/2020-04-17_388_reponse_rapide_covid19__mpr_srr_mel.pdf
HAS/2020-04-20_CT-18523_BECLOSPIN_PIS_RCP_AvisDef_CT18523.pdf
HAS/2020-04-20_argumentaire-pnds-cmt.pdf
HAS/2020-04-20_pnds-cmt-sa-v2-converti.pdf
HAS/2020-04-20_synthese_a_destination_du_medecin_traitant.pdf
HAS/2020-04-23_CT-17997_REVLIMID_PIC_EI_AvisDef_CT17997.pdf
HAS/2020-04-23_CT-18113_XOGEL_PIC_INS_AvisDef_CT18113.pdf
HAS/2020-04-23_CT-18172_OPHTESIC_PIC_INS_AvisDef_CT18172.pdf
HAS/2020-04-23_CT-18293_THALIDOMIDE_ACCORD_PIS_INS_AvisDef_CT18293.pdf
HAS/2020-04-23_CT-18354_CYRAMZA_PIC_EI_AvisDef_CT18354.pdf
HAS/2020-04-23_CT-18507_ACIDE_GADOTERIQUE_GUERBET_PIS_INS_GE_AvisDef_CT18507.pdf
HAS/2020-04-23_CT-18571_PALMIER_DE_FLORIDE_PHARMATOKA_PIS_INS_AvisDef_CT18571.pdf
HAS/2020-04-23_cymraza_summary_ct18534.pdf
HAS/2020-04-23_cyramza_01042020_synthese_ct18354.pdf
HAS/2020-04-23_cyramza_11032020_transcription_ct18354.pdf
HAS/2020-04-23_ophtesic_15042020_synthese_ct18172.pdf
HAS/2020-04-23_ophtesic_15042020_transcription_ct18172.pdf
HAS/2020-04-23_ophtesic_19022020_transcription_ct18172.pdf
HAS/2020-04-23_pnds_takayasu_fair_-_favamulti.pdf
HAS/2020-04-23_revlimid_01042020_synthese_ct17997.pdf
HAS/2020-04-23_revlimid_11032020_transcription_ct17997.pdf
HAS/2020-04-23_revlimid_summary_ct17997.pdf
HAS/2020-04-23_synthese_mg_arterite_de_takayasu.pdf
HAS/2020-04-23_xogel_15042020_synthese_ct18113.pdf
HAS/2020-04-23_xogel_15042020_transcription_ct18113.pdf
HAS/2020-04-23_xogel_enfant_adulte_11032020_transcription_ct18113.pdf
HAS/2020-04-23_xogel_summary_ct18113.pdf
HAS/2020-04-24_2020_04_21_contribution_csms_covid19.pdf
HAS/2020-04-24_CT-17901_DECTOVA_PIC_INS_AvisDef_CT17901.pdf
HAS/2020-04-24_CT-18144_IMBRUVICA_PIC_EI_AvisDef_CT18144.pdf
HAS/2020-04-24_CT-18197_LUCENTIS_RDP_PIC_EI_INS_AvisDef_CT18197.pdf
HAS/2020-04-24_CT-18505_FIVASA_PIS_INS_AvisDef_CT18505.pdf
HAS/2020-04-24_CT-18512_RIXATHON_PIS_EI_AvisDef_CT18512.pdf
HAS/2020-04-24_CT-18519_APOKINON_PIS_INS_AvisDef_CT18519.pdf
HAS/2020-04-24_CT-18525_ERYTHROMYCINE_STRAGEN_PIS_INS_AvisDef_CT18525.pdf
HAS/2020-04-24_CT-18537_PENTASA_1gpour100ml_Bte7_PIS_INS_AvisDef_CT18537.pdf
HAS/2020-04-24_CT-18538_PENTASA_1gSuppo_Bte14_PIS_INS_AvisDef_CT18538.pdf
HAS/2020-04-24_CT-18563_LOVENOX_PIS_INS_AvisDef_CT18563.pdf
HAS/2020-04-24_CT-18581_TEICOPLANINE_HIKMA_PIS_INS_AvisDef_CT18581.pdf
HAS/2020-04-24_CT-18601_RESINSODIUM_PIS_INS_AvisDef_CT18601.pdf
HAS/2020-04-24_dectova_01042020_synthese_ct17901.pdf
HAS/2020-04-24_dectova_11032020_transcription_ct17901.pdf
HAS/2020-04-24_dectova_summary_ct17901.pdf
HAS/2020-04-24_imbruvica_22042020_synthese_ct18144.pdf
HAS/2020-04-24_imbruvica_22042020_synthese_ct18144_2020-04-23_17-32-28_647.pdf
HAS/2020-04-24_imbruvica_22042020_transcription_ct18144.pdf
HAS/2020-04-24_imbruvica_summary_ct18144_2020-07-10_11-07-15_4.pdf
HAS/2020-04-24_lucentis_rdp_08012020_transcription_ct18197.pdf
HAS/2020-04-24_lucentis_rdp_15042020_transcription_ct18197.pdf
HAS/2020-04-24_lucentis_rdp_18032020_synthese_ct18197.pdf
HAS/2020-04-24_lucentis_rdp_18032020_transcription_ct18197.pdf
HAS/2020-04-24_lucentis_rdp_summary_ct18197.pdf
HAS/2020-04-27_ovitrelle_rtu_reco_autosaisine_has_sem_cteval498.pdf
HAS/2020-04-27_remicade_rtu_reco_autosaisine_has_sem_cteval499.pdf
HAS/2020-04-27_xalkori_rtu_reco_autosaisine_has_sem_cteval494.pdf
HAS/2020-05-05_conseil_pour_lengagement_des_usagers_-_compte_rendu_de_la_seance_du_16_avril_2020.pdf
HAS/2020-05-05_epidemie_du_covid-19_-_avis_n1_2020_du_conseil_pour_lengagement_des_usagers.pdf
HAS/2020-05-05_rr385_mpr_rea_30042020_mel.pdf
HAS/2020-05-05_rr385_mpr_rea_30042020_mel_anglaise.pdf
HAS/2020-05-05_rr_pratiques_palliatives_epargne_midazolam_mel.pdf
HAS/2020-05-07_CT-18015_REVLIMID_PIS_INS_AvisDef_CT18015.pdf
HAS/2020-05-07_CT-18063_TODEXAL_PIS_INS_AvisDef_CT18063.pdf
HAS/2020-05-07_CT-18181_RINVOQ_PIC_INS_AvisDef_CT18181.pdf
HAS/2020-05-07_CT-18184_XOLAIR_PIS_RCP_AvisDef_CT18184.pdf
HAS/2020-05-07_CT-18275_ROPIVACAINE_BBRAUN_PIS_INS_AvisDef_CT18275.pdf
HAS/2020-05-07_CT-18386_TAREG_PIC_EI_AvisDef_CT18386.pdf
HAS/2020-05-07_CT-18476_CEGFILA_PIS_INS_AvisDef_CT18476.pdf
HAS/2020-05-07_CT-18477_TERROSA_PIS_INS_AvisDef_CT18477.pdf
HAS/2020-05-07_CT-18485_BLINCYTO_PIS_EI_non_demandee_AvisDef_CT18485.pdf
HAS/2020-05-07_CT-18518_ZYMAD_PIS_INS_CG_AvisDef_CT18518.pdf
HAS/2020-05-07_CT-18532_ESKAZOLE_PIS_INS_AvisDef_CT18532.pdf
HAS/2020-05-07_CT-18535_AZACITIDINE_MYLAN_PIS_INS_AvisDef_CT18535.pdf
HAS/2020-05-07_CT-18553_POSACONAZOLE_FRESENIUS_KABI_PIS_INS_AvisDef_CT18553.pdf
HAS/2020-05-07_CT-18568_ETOPOSIDE_MYLAN_PIS_RCP_AvisDef_CT18568.pdf
HAS/2020-05-07_CT-18576_CYAMEMAZINE_MYLAN_PIS_INS_Avisdef_CT18576.pdf
HAS/2020-05-07_CT-18577_EPIRUBICINE_HIKMA_PIS_INS_AvisDef_CT18577.pdf
HAS/2020-05-07_CT-18587_ENCEPUR_PIS_INS_AvisDef_CT18587.pdf
HAS/2020-05-07_CT-18591_SUXAMETHONIUM_AGUETTANT_PIS_INS_AvisDef_CT18591.pdf
HAS/2020-05-07_CT-18592_PEMETREXED_SANDOZ_PIS_INS_AvisDef_CT18592.pdf
HAS/2020-05-07_CT-18599_ENOXAPARINE_VENIPHARM_PIS_INS_AvisDef_CT18599.pdf
HAS/2020-05-07_CT-18613_ATRIANCE_PIS_INS_AvisDef_CT18613.pdf
HAS/2020-05-07_CT-18620_PHENYLEPHRINE_ALTAN_PIS_INS_AvisDef_CT18620.pdf
HAS/2020-05-07_CT-18622_DEXMEDETOMIDINE_ACCORD_PIS_INS_AvisDef_CT18622.pdf
HAS/2020-05-07_CT-18639_FULVESTRANT_MYLAN_PIS_INS_AvisDef_CT18639.pdf
HAS/2020-05-07_endovela_pis_ins_avisdef_ct18566.pdf
HAS/2020-05-07_prise_en_charge_des_patients_covid-19_sans_indication_dhospitalisation_isoles_et_surveilles_a_domicile.pdf
HAS/2020-05-07_rinvoq_11032020_transcription_ct18181.pdf
HAS/2020-05-07_rinvoq_22042020_synthese_ct18181.pdf
HAS/2020-05-07_rinvoq_22042020_transcription_ct18181.pdf
HAS/2020-05-07_rinvoq_summary_ct18181.pdf
HAS/2020-05-07_tareg_22042020_synthese_ct18386.pdf
HAS/2020-05-07_tareg_22042020_transcription_ct18386.pdf
HAS/2020-05-07_tareg_summary_ct18386.pdf
HAS/2020-05-07_xeljanz_pis_ins_avisdef_ct18604.pdf
HAS/2020-05-09_2020_05_07_fin_de_vie_-covid19.pdf
HAS/2020-05-09_2020_05_07_mesures_barrieres.pdf
HAS/2020-05-09_covic_19_methode_rapide_delaboration__champ_social_et_medico-social.pdf
HAS/2020-05-09_protection_autonomie_covid19_maj_post_publication_maj_07072020_2020-07-20_13-27-2_470.pdf
HAS/2020-05-12_241120_reco_392_reponse_rapide_codid-19_suivi_hta_maj.pdf
HAS/2020-05-12_rr_souffrance_des_professionnels_du_monde_la_sante_version_cd_vdef_dlg_mel.pdf
HAS/2020-05-14_CT-17673_KEYTRUDA_CBNPC_épidermoïde_PIC_EI_Avis3_CT17673.pdf
HAS/2020-05-14_CT-18301_DARZALEX_1eL_non_eligibles_PIC_INS_AvisDef_CT18301.pdf
HAS/2020-05-14_CT-18404_DARZALEX_1eL_non_eligibles_PIC_REEV_AvisDef_CT18404.pdf
HAS/2020-05-14_CT-18461_DARZALEX_1eL_eligibles_PIC_INS_AvisDef_CT18461.pdf
HAS/2020-05-14_CT-18527_CALCIDOSE_VITAMINE_D3_PIS_INS_CG_AvisDef_CT18527.pdf
HAS/2020-05-14_darzalex_22042020_summary_ct18301.pdf
HAS/2020-05-14_darzalex_22042020_summary_ct18404.pdf
HAS/2020-05-14_darzalex_22042020_summary_ct18461.pdf
HAS/2020-05-14_darzalex_22042020_synthese_ct18301.pdf
HAS/2020-05-14_darzalex_22042020_synthese_ct18404.pdf
HAS/2020-05-14_darzalex_22042020_synthese_ct18461.pdf
HAS/2020-05-14_darzalex_22042020_transcription_ct183011840418461.pdf
HAS/2020-05-14_keytruda_09102019_transcription_ct17673.pdf
HAS/2020-05-14_keytruda_15102019_avis_efficience_2020-02-28_13-58-43_28.pdf
HAS/2020-05-14_keytruda_26062019_transcription_ct17673.pdf
HAS/2020-05-14_keytruda_summary_ct17673.pdf
HAS/2020-05-14_keytruda_synthese_ct17673.pdf
HAS/2020-05-18_CT-18154_KEYTRUDA_PIC_EI_AvisDef_CT18154.pdf
HAS/2020-05-18_CT-18189_EPIDYOLEX_PIC_INS_AvisDef_CT18189.pdf
HAS/2020-05-18_CT-18200_TROGARZO_PIC_INS_AvisDef_CT18200.pdf
HAS/2020-05-18_CT-18280_SYMKEVI_KALYDECO_PIC_INS_AvisDef_CT18280&18279.pdf
HAS/2020-05-18_CT-18294_ANAPEN_PIS_INS_AvisDef_CT18294.pdf
HAS/2020-05-18_CT-18302_BAVENCIO_PIC_EI_AvisDef_CT18302.pdf
HAS/2020-05-18_CT-18614_AMBRISENTAN_MYLAN_PIS_INS_AvisDef_CT18614.pdf
HAS/2020-05-18_CT-18626_TOBRAMYCINE_SUN_PIS_INS_AvisDef_CT18626.pdf
HAS/2020-05-18_CT-18635_ACICLOVIR_AGEPHA_PIS_INS_AvisDef_CT18635.pdf
HAS/2020-05-18_CT-18651_MIDAZOLAM_KALCEKS_PIS_INS_AvisDef_CT18651.pdf
HAS/2020-05-18_CT-18663_KETAMINE_AGUETTANT_PIS_INS_AvisDef_CT18663.pdf
HAS/2020-05-18_bavencio_13052020_synthese_ct18302.pdf
HAS/2020-05-18_bavencio_150420202_transcription_ct18302.pdf
HAS/2020-05-18_bavencio_rein_13052020_transcription_ct18302.pdf
HAS/2020-05-18_bavencio_summary_ct18302_en.pdf
HAS/2020-05-18_epidyolex_05022020_transcription_ct18189.pdf
HAS/2020-05-18_epidyolex_13052020_summary_ct18189.pdf
HAS/2020-05-18_epidyolex_13052020_synthese_ct18189.pdf
HAS/2020-05-18_epidyolex_13052020_transcription_ct18189.pdf
HAS/2020-05-18_epidyolex_21042020_avis_efficience.pdf
HAS/2020-05-18_keytruda_10032020_avis_efficience.pdf
HAS/2020-05-18_keytruda_13052020_synthese_ct18154.pdf
HAS/2020-05-18_keytruda_15042020_transcription_ct18154.pdf
HAS/2020-05-18_keytruda_cancer_du_rein_13052020_transcription_ct18154.pdf
HAS/2020-05-18_keytruda_rcc_13052020_summary_ct18154.pdf
HAS/2020-05-18_rr_391_soins_bucco-dentaires_apres_le_deconfinement_14_05_20_mel.pdf
HAS/2020-05-18_symkevi_16062020_avis_economique.pdf
HAS/2020-05-18_symkevi_kalydeco_13052020_synthese_ct1828018279.pdf
HAS/2020-05-18_symkevi_kalydeco_15042020_transcription_ct1827918280.pdf
HAS/2020-05-18_symkevi_summary_ct18280_18279.pdf
HAS/2020-05-18_trogarzo_13052020_synthese_ct18200.pdf
HAS/2020-05-18_trogarzo_13052020_transcription_ct18200.pdf
HAS/2020-05-18_trogarzo_19022020_transcription_ct18200.pdf
HAS/2020-05-18_trogarzo_summary_ct18200.pdf
HAS/2020-05-19_CNEDIMTS-6189_SAPIEN 3 MODÈLE 9600 TFX_7_avril_2020_(6189)_avis.pdf
HAS/2020-05-19_CNEDIMTS-6201_LVIS EVO_7_avril_2020_(6201)_avis.pdf
HAS/2020-05-19_CNEDIMTS-6213_DERIVO_DERIVO mini_7_avril_2020_(6140)_(6213)_avis.pdf
HAS/2020-05-20_CNEDIMTS-6119_SUPRASORB P SENSITIVE SACRUM_7_avril_2020_(6119)_avis.pdf
HAS/2020-05-20_CNEDIMTS-6140_DERIVO_DERIVO mini_7_avril_2020_(6140)_(6213)_avis.pdf
HAS/2020-05-20_CNEDIMTS-6151_MEPITEL FILM_7_avril_2020_(6151)_avis.pdf
HAS/2020-05-20_CNEDIMTS-6167_SUPRASORB P SENSITIVE HEEL_7_avril_2020_(6167)_avis.pdf
HAS/2020-05-20_CT-18042_XALKORI_ROS1_PIC_REEV_AvisDef_CT18042.pdf
HAS/2020-05-20_CT-18047_CUBICIN_PIS_EI_AvisDef_CT18047.pdf
HAS/2020-05-20_CT-18159_TECENTRIQ_PIC_EI_CBPC_AvisDef_CT18159.pdf
HAS/2020-05-20_CT-18582_AMBRISENTAN_TEVA_PIS_INS_AvisDef_CT18582.pdf
HAS/2020-05-20_CT-18585_NICOTINELL_MENTHE_FRAICHEUR_FRUIT_SANS_SUCRE_PIS_INS_CG_AvisDef_CT18585.pdf
HAS/2020-05-20_CT-18607_CIPROFLOXACINE_MYLAN_PHARMA_PIS_RCP_AvisDef_CT18607.pdf
HAS/2020-05-20_CT-18621_PAZENIR_PIS_EI_AvisDef_CT18621.pdf
HAS/2020-05-20_CT-18625_IRINOTECAN_ACCORD_PIS_INS_AvisDef_CT18625.pdf
HAS/2020-05-20_CT-18628_CASPOFUNGINE_LORIEN_PIS_INS_AvisDef_CT18628.pdf
HAS/2020-05-20_CT-18633_MIGLUSTAT_DIPHARMA_PIS_INS_AvisDef_CT18633.pdf
HAS/2020-05-20_rr_pediatrie_levee_confinement_mel_004.pdf
HAS/2020-05-20_supporting_children_and_adolescents_including_those_with_a_chronic_disease_during_lockdown_exit.pdf
HAS/2020-05-20_tecentriq_04032020_transcription_ct18159.pdf
HAS/2020-05-20_tecentriq_cbpc_13052020_synthese_ct18159.pdf
HAS/2020-05-20_tecentriq_cbpc_13052020_transcription_ct18159.pdf
HAS/2020-05-20_tecentriq_cpbc_11032020_avis_efficience.pdf
HAS/2020-05-20_tecentriq_es-sclc_13052020_summary_ct18159.pdf
HAS/2020-05-20_vaccination_dans_le_contexte_du_covid-19_-_les_actions_de_la_has.pdf
HAS/2020-05-20_xalkori_11032020_transcription_ct18042.pdf
HAS/2020-05-20_xalkori_13052020_transcription_ct18042.pdf
HAS/2020-05-20_xalkori_ros1_13052020_summary_ct18042.pdf
HAS/2020-05-20_xalkori_ros1_13052020_synthese_ct18042.pdf
HAS/2020-05-27_reco_place_du_vaccin_quadrivalent_haute_dose_efluelda_dans_la_strategie_de_vaccination.pdf
HAS/2020-05-28_CNEDIMTS-6152_KIT DE NAVIGATION NAVIKIT_21_avril_2020_(6152)_avis.pdf
HAS/2020-05-29_20rr418_maladie_rhumatologique_chronique_mel.pdf
HAS/2020-05-29_CT-18007_OCALIVA_PIC_REEV_AvisDef_CT18007.pdf
HAS/2020-05-29_CT-18046_MAVENCLAD_PIC_INS_AvisDef_CT18046.pdf
HAS/2020-05-29_CT-18359_CYRAMZA_PIS_EI_NON_DEMANDEE_AvisDef_CT18359.pdf
HAS/2020-05-29_CT-18554_UNACIM_INJECTABLE_PIS_INS_AvisDef_CT18554.pdf
HAS/2020-05-29_CT-18600_DOTAREM_PIS_INS_AvisDef_CT18600.pdf
HAS/2020-05-29_CT-18641_SOJOURN_PIS_INS_AvisDef_CT18641.pdf
HAS/2020-05-29_CT-18644_ARSENIC_TRIOXYDE_MYLAN_PIS_INS_AvisDef_CT18644.pdf
HAS/2020-05-29_mavenclad_13052020_transcription_ct18046.pdf
HAS/2020-05-29_mavenclad_19022020_transcription_ct18046.pdf
HAS/2020-05-29_mavenclad_27052020_synthese_ct18046.pdf
HAS/2020-05-29_mavenclad_summary_ct18046.pdf
HAS/2020-05-29_ocaliva_13052020_transcription_ct18007.pdf
HAS/2020-05-29_ocaliva_19022020_transcription_ct18007.pdf
HAS/2020-05-29_ocaliva_27052020_summary_ct18007.pdf
HAS/2020-05-29_ocaliva_27052020_synthese_ct18007.pdf
HAS/2020-06-03_CT-18448_METOPROLOL_ARROW_LAB_PIS_INS_AvisDef_CT18448.pdf
HAS/2020-06-03_CT-18624_DUPIXENT_PIS_EI_AvisDef_CT18624.pdf
HAS/2020-06-03_note_de_cadrage_notification_aux_partenaires.pdf
HAS/2020-06-04_CNEDIMTS-6180_PRODISC_L_5_mai_2020_(6180)_avis.pdf
HAS/2020-06-04_CNEDIMTS-6225_PRODISC_O_5_mai_2020_(6225)_avis.pdf
HAS/2020-06-04_CNEDIMTS-6264_OSTEOPURE_5_mai_2020_(6264)_avis.pdf
HAS/2020-06-04_inahta_brief_anaesthesia_techniques_lens_surgery.pdf
HAS/2020-06-04_rapport_anesthesie_cataracte_vd.pdf
HAS/2020-06-05_CNEDIMTS-6067_XPRESS_5_mai_2020_(6067)_avis.pdf
HAS/2020-06-05_CNEDIMTS-6117_ASPIRESR_7_avril_2020_(6117)_avis.pdf
HAS/2020-06-05_CNEDIMTS-6218_IALUSET_5_mai_2020_(6218)_avis.pdf
HAS/2020-06-05_CNEDIMTS-6277_DOMUS_5_05_2020_(6277)_avis.pdf
HAS/2020-06-05_CT-18654_RUXIENCE_PIS_INS_AvisDef_CT18654.pdf
HAS/2020-06-05_argumentaire_oscar_pnds_sed_nv_vdef_2020jlv2.pdf
HAS/2020-06-05_argumentaire_pemphigoide_bulleuse_avril_2020_2020-05-28_19-23-51_75.pdf
HAS/2020-06-05_oscar_pnds_sed_nv_vdef_2020jlv2.pdf
HAS/2020-06-05_pnds_pemphigoide_bulleuse_avril_2020_final_2020-05-28_19-23-51_71.pdf
HAS/2020-06-05_pnds_ucni.pdf
HAS/2020-06-05_reco_420_rr_covid-19_psy_ambulatoire_maj_mel.pdf
HAS/2020-06-05_rr_parcours_covid_parcours_de_readaptation_du_patient_covid_-_domicile_mel.pdf
HAS/2020-06-05_sahd_mct8_argumentaire.pdf
HAS/2020-06-05_sahd_mct8_texte_pnds.pdf
HAS/2020-06-05_synthese_mg_pemphigoide_bulleuse.pdf
HAS/2020-06-05_synthese_mg_syndrome_d_ehlers_danlos_non_vasculaire_.pdf
HAS/2020-06-05_synthese_mg_syndrome_de_allan_herndon_dudley.pdf
HAS/2020-06-05_synthese_mg_uveites_chroniques_non_infectieuses_de_l_enfant__et_de__l_adulte.pdf
HAS/2020-06-08_CT-17566_KISQALI_fulvestrant_PIC_EI_Avis2_CT17566.pdf
HAS/2020-06-08_CT-17586_AFINITOR_BOLERO_6_PIC_REEV_Avis2_CT17586.pdf
HAS/2020-06-08_afinitor_26062019_transcription_ct17586.pdf
HAS/2020-06-08_afinitor_synthese_ct17586.pdf
HAS/2020-06-08_kisqali_26062019_transcription_ct1756617601.pdf
HAS/2020-06-08_kisqali_asso_fulv_ei_synthese_ct17566.pdf
HAS/2020-06-10_CNEDIMTS-6175_MOBIDISC_5_mai_2020_(6175)_avis.pdf
HAS/2020-06-10_CNEDIMTS-6206_MEDPOR CRANIAL HEMISPHERE_24_mars_2020_(6206)_avis.pdf
HAS/2020-06-10_CNEDIMTS-6281_MOBIDISC_5_mai_2020_(6281)_avis.pdf
HAS/2020-06-11_rapport_calprotectine_rechute_maladie_inflammatoire.pdf
HAS/2020-06-11_rapport_calprotectine_troubles_digestifs.pdf
HAS/2020-06-12_CT-18229_PABAL_PIC_EI_AvisDef_CT18229.pdf
HAS/2020-06-12_CT-18278_LOPERAMIDE_ARROW_LAB_PIS_INS_AvisDef_CT18278.pdf
HAS/2020-06-12_CT-18346_KADCYLA_adjuvant_PIC_EI_AvisDef_CT18346.pdf
HAS/2020-06-12_CT-18454_FLUCLOXACILLINE_ARROW_PIS_INS_AvisDef_CT18454.pdf
HAS/2020-06-12_CT-18590_GIOTRIF_PIS_RCP_AvisDef_CT18590.pdf
HAS/2020-06-12_CT-18667_ACICLOVIR_ACCORD_PIS_INS_AvisDef_CT18667.pdf
HAS/2020-06-12_CT-18672_UVEDOSE_PIS_INS_AvisDef_CT18672.pdf
HAS/2020-06-12_kadcyla_12052020_avis_efficience_biffe.pdf
HAS/2020-06-12_kadcyla_27052020_summary_ct18346.pdf
HAS/2020-06-12_kadcyla_27052020_transcription_ct18346.pdf
HAS/2020-06-12_kadcyla_adjuvant_27052020_synthese_ct18346.pdf
HAS/2020-06-12_pabal_27052020_synthese_ct18229.pdf
HAS/2020-06-12_pabal_27052020_transcription_ct18229.pdf
HAS/2020-06-12_pabal_summary_ct18229.pdf
HAS/2020-06-15_CT-18262_KRONALIS_PIS_INS_AvisDef_CT18262.pdf
HAS/2020-06-15_CT-18640_IBUPROFENE_ARROW_PIS_EI_AvisDef_CT18640.pdf
HAS/2020-06-15_CT-18655_DOTAREM_PIS_INS_AvisDef_CT18655.pdf
HAS/2020-06-15_CT-18668_ULTRAVIST_PIS_INS_AvisDef_CT18668.pdf
HAS/2020-06-15_pnds_amylose_aa_1.pdf
HAS/2020-06-15_rr_396__pedicurie_podologies_mel.pdf
HAS/2020-06-15_synthese_mg_amylosse_aa.pdf
HAS/2020-06-18_CT-17455_STRESAM_PIC_REEV_AvisDef_CT17455.pdf
HAS/2020-06-18_CT-18257_KEYTRUDA_PIC_EI_AvisDef_CT18257&18289.pdf
HAS/2020-06-18_CT-18474_LYUMJEV_PIC_INS_AvisDef_CT18474.pdf
HAS/2020-06-18_CT-18557_ILUMETRI_PIC_INS_AvisDef_CT18557.pdf
HAS/2020-06-18_CT-18589_LEVOTHYROXINE_HELM_AG_PIS_INS_AvisDef_CT18589.pdf
HAS/2020-06-18_cteval_500_procedure_fiche_bum_cd_2020_06_04_v0.pdf
HAS/2020-06-18_ilumetri_03062020_synthese_ct18557.pdf
HAS/2020-06-18_ilumetri_03062020_transcription_ct18557.pdf
HAS/2020-06-18_keytruda_27052020_transcription_ct18257.pdf
HAS/2020-06-18_keytruda_cetec_03062020_synthese_ct1825718289.pdf
HAS/2020-06-18_keytruda_cetec_16072020_avis_economique_2020-11-26_14-39-27_291.pdf
HAS/2020-06-18_keytruda_summary_ct18257_18289.pdf
HAS/2020-06-18_lyumjev_03062020_transcription_ct18474.pdf
HAS/2020-06-18_lyumjev_10062020_summary_ct18474.pdf
HAS/2020-06-18_lyumjev_10062020_synthese_ct18474.pdf
HAS/2020-06-18_lyumjev_27052020_transcription_ct18474.pdf
HAS/2020-06-18_stresam_03062020_summary_ct17455.pdf
HAS/2020-06-18_stresam_03062020_synthese_ct17455.pdf
HAS/2020-06-18_stresam_27052020_transcription_ct17455.pdf
HAS/2020-06-23_CNEDIMTS-6238_AIR PLUS_24_mars_2020_(6238)_avis.pdf
HAS/2020-06-23_perfusion_a_domicile_et_prestations_associees_avis_du_21_avril_2020.pdf
HAS/2020-06-24_11_mai_2020_argumentaire__pnds_generique_polyhandicap_1.pdf
HAS/2020-06-24_11_mai_2020_texte_pnds_generique_polyhandicap.pdf
HAS/2020-06-24_CNEDIMTS-6269_AIR PLUS_5_mai_2020_(6269)_avis.pdf
HAS/2020-06-24_generique_polyhandicap_-_pnds_version_anglaise.pdf
HAS/2020-06-24_strategie_therapeutique_du_diabete_du_type_2_-_fiche_memo_et_parcours_de_soins_integres_-_note_de_cadrage.pdf
HAS/2020-06-24_synthese_mg_generique_polyhandicap.pdf
HAS/2020-06-26_reco453_rr_covid_19_premier_recours_mel.pdf
HAS/2020-06-29_CT-18169_LONSURF_gastrique_PIC_EI_AvisDef_CT18169.pdf
HAS/2020-06-29_CT-18347_BENLYSTA_enfant_PIC_EI_Avisdef_CT18347.pdf
HAS/2020-06-29_CT-18378_EMGALITY_PIC_INS_AvisDef_CT18378.pdf
HAS/2020-06-29_CT-18406_MISOONE_PIC_INS_AvisDef_CT18406.pdf
HAS/2020-06-29_CT-18423_KALYDECO_PIC_INS_EI_AvisDef_CT18423&18428.pdf
HAS/2020-06-29_CT-18680_AMBRISENTAN_OHRE_MYLAN_PIS_INS_AvisDef_CT18680.pdf
HAS/2020-06-29_CT-18707_BENDAMUSTINE_HIKMA_PIS_INS_AvisDef_CT18707.pdf
HAS/2020-06-29_CT-18710_BENDAMUSTINE_BAXTER_PIS_INS_AvisDef_CT18710.pdf
HAS/2020-06-29_benlysta_03062020_transcritpion_ct18347.pdf
HAS/2020-06-29_benlysta_10062020_summary_ct18347.pdf
HAS/2020-06-29_benlysta_enfant_10062020_synthese_ct18347.pdf
HAS/2020-06-29_emgality_03062020_transcription_ct18378.pdf
HAS/2020-06-29_emgality_24062020_summary_ct18378.pdf
HAS/2020-06-29_emgality_24062020_synthese_ct18378.pdf
HAS/2020-06-29_emgality_24062020_transcription_ct18378.pdf
HAS/2020-06-29_kalydeco_03062020_summary_ct18423.pdf
HAS/2020-06-29_kalydeco_03062020_synthese_ct1842318428.pdf
HAS/2020-06-29_kalydeco_03062020_transcription_ct18423.pdf
HAS/2020-06-29_lonsurf_22042020_transcription_ct18169.pdf
HAS/2020-06-29_lonsurf_24062020_transcription_ct18169.pdf
HAS/2020-06-29_lonsurf_gastrique_24062020_synthese_ct18169.pdf
HAS/2020-06-29_lonsurf_summary_ct18169.pdf
HAS/2020-06-29_misoone_10062020_synthese_ct18406.pdf
HAS/2020-06-29_misoone_10062020_transcription_ct18406.pdf
HAS/2020-06-29_misoone_summary_ct18406.pdf
HAS/2020-06-29_reco365_cadrage_psychotropes_vd_1.pdf
HAS/2020-07-01_CNEDIMTS-6292_ASSANIS_30_juin_2020_(6292)_avis.pdf
HAS/2020-07-01_CT-17302_RELENZA_PIC_RI_AvisDef_CT17302.pdf
HAS/2020-07-01_CT-17831_TAMIFLU_PIC_RI_AvisDef_CT17831.pdf
HAS/2020-07-01_CT-18142_RAPISCAN_PIC_EI_AvisDef_CT18142.pdf
HAS/2020-07-01_CT-18299_MEPSEVII_PIC_INS_AvisDef_CT18299.pdf
HAS/2020-07-01_CT-18366_NERLYNX_PIC_INS_AvisDef_CT18366.pdf
HAS/2020-07-01_CT-18416_TAXOTERE_prostate_PIC_EI_AvisDef_CT18416.pdf
HAS/2020-07-01_CT-18482_ERLEADA_PIC_EI_AvisDef_CT18482.pdf
HAS/2020-07-01_CT-18616_EFLUELDA_PIC_INS_AvisDef_CT18616.pdf
HAS/2020-07-01_CT-18642_RELVAR_ELLIPTA_PIS_INS_CG_AvisDef_CT18642.pdf
HAS/2020-07-01_CT-18646_REVINTY_ELLIPTA_PIS_INS_CG_AvisDef_CT18646.pdf
HAS/2020-07-01_CT-18648_LAVENTAIR_ELLIPTA_PIS_INS_CG_AvisDef_CT18648.pdf
HAS/2020-07-01_CT-18649_ANORO_ELLIPTA_PIS_INS_CG_AvisDef_CT18649.pdf
HAS/2020-07-01_CT-18684_GAMUNEX_PIS_INS_AvisDef_CT18684.pdf
HAS/2020-07-01_CT-18690_NUCALA_PIS_RCP_AvisDef_CT18690.pdf
HAS/2020-07-01_CT-18712_GRASUSTEK_PIS_INS_AvisDef_CT18712.pdf
HAS/2020-07-01_efluelda_13052020_transcription_ct18616.pdf
HAS/2020-07-01_efluelda_24062020_summary_ct18616.pdf
HAS/2020-07-01_efluelda_24062020_synthese_ct18616.pdf
HAS/2020-07-01_efluelda_24062020_transcription_ct18616.pdf
HAS/2020-07-01_efluelda_25062020_avis_efficience_v3.pdf
HAS/2020-07-01_erleada_10062020_summary_ct18482.pdf
HAS/2020-07-01_erleada_10062020_synthese_ct18482.pdf
HAS/2020-07-01_erleada_10062020_transcription_ct18482.pdf
HAS/2020-07-01_erleada__16072020_avis_economique_2.pdf
HAS/2020-07-01_mepsevii_15042020_transcription_ct18299_1.pdf
HAS/2020-07-01_mepsevii_24062020_summary_ct18299.pdf
HAS/2020-07-01_mepsevii_24062020_synthese_ct18299.pdf
HAS/2020-07-01_mepsevii_24062020_transcription_ct18299.pdf
HAS/2020-07-01_nerlynx_24062020_summary_ct18366.pdf
HAS/2020-07-01_nerlynx_24062020_synthese_ct18366.pdf
HAS/2020-07-01_nerlynx_24062020_transcription_ct18366.pdf
HAS/2020-07-01_nerlynx_27052020_transcription_ct18366.pdf
HAS/2020-07-01_rapiscan_03062020_transcription_ct18142.pdf
HAS/2020-07-01_rapiscan_24062020_summary_ct18142.pdf
HAS/2020-07-01_rapiscan_24062020_synthese_ct18142.pdf
HAS/2020-07-01_rapiscan_24062020_transcription_ct18142.pdf
HAS/2020-07-01_relenza_11032020_transcription_ct17302.pdf
HAS/2020-07-01_relenza_24062020_synthese_ct17302.pdf
HAS/2020-07-01_relenza_summary_ct17302.pdf
HAS/2020-07-01_tamiflu_11032020_transcription_ct17831.pdf
HAS/2020-07-01_tamiflu_24062020_summary_ct17831.pdf
HAS/2020-07-01_tamiflu_24062020_synthese_ct17831.pdf
HAS/2020-07-01_tamiflu_relenza_24062020_transcription_ct1783117302.pdf
HAS/2020-07-01_taxotere_10062020_transcription_ct18416.pdf
HAS/2020-07-01_taxotere_prostate_10062020_synthese_ct18416.pdf
HAS/2020-07-01_taxotere_summary_ct18146.pdf
HAS/2020-07-02_CT-18270_XOSPATA_PIC_INS_AvisDef_CT18270.pdf
HAS/2020-07-02_CT-18433_REMSIMA_SC_PIC_INS_AvisDef_CT18433.pdf
HAS/2020-07-02_CT-18515_CYNOMEL_PIS_RCP_AvisDef_CT18515.pdf
HAS/2020-07-02_CT-18608_GIVLAARI_PIC_INS_avisDef_CT18608.pdf
HAS/2020-07-02_givlaari_15092020_avis_economique_3.pdf
HAS/2020-07-02_givlaari_24062020_summary_ct18608.pdf
HAS/2020-07-02_givlaari_24062020_synthese_ct18608.pdf
HAS/2020-07-02_givlaari_24062020_transcription_ct18608.pdf
HAS/2020-07-02_givlaari_27052020_transcription_ct18608.pdf
HAS/2020-07-02_remsima_13052020_transcription_ct18433.pdf
HAS/2020-07-02_remsima_24062020_transcription_ct18433.pdf
HAS/2020-07-02_remsima_sc_24062020_synthese_ct18433.pdf
HAS/2020-07-02_remsima_summary_ct18433.pdf
HAS/2020-07-02_xospata_16062020_avis_efficience.pdf
HAS/2020-07-02_xospata_22042020_transcription_ct18270.pdf
HAS/2020-07-02_xospata_24062020_synthese_ct18270.pdf
HAS/2020-07-02_xospata_24062020_transcription_ct18270.pdf
HAS/2020-07-02_xospata_summary_ct18270.pdf
HAS/2020-07-03_CNEDIMTS-6246_AIRE_19_mai_2020_(6246)_avis.pdf
HAS/2020-07-03_CNEDIMTS-6248_DOUAI_19_mai_2020_(6248)_avis.pdf
HAS/2020-07-03_rr_401_prise_en_charge_des_patients_post-covid-19_en_orthophonie_02-07-20_mel.pdf
HAS/2020-07-07_CT-18432_SPRAVATO_PIC_INS_AvisDef_CT18432_EPI673.pdf
HAS/2020-07-07_spravato_24062020_synthese_ct18432.pdf
HAS/2020-07-07_spravato_24062020_transcription_ct18432.pdf
HAS/2020-07-07_spravato_27052020_transcription_ct18432.pdf
HAS/2020-07-07_spravatoo_summary_ct18432_epi673.pdf
HAS/2020-07-08_20200703_pnds_ao_version_final_002.pdf
HAS/2020-07-08_CNEDIMTS-6196_AVANTAGE 3P PLASMA TIHA_2_juin_2020_(6196)_avis.pdf
HAS/2020-07-08_CT-17920_AGRASTAT_PIC_EI_AvisDef_CT17920.pdf
HAS/2020-07-08_CT-18242_EKLIRA_GENUAIR_PIC_INS_AvisDef_CT18242.pdf
HAS/2020-07-08_CT-18252_DUAKLIR_GENUAIR_PIC_INS_AvisDef_CT18252.pdf
HAS/2020-07-08_CT-18490_SUNOSI_PIC_INS_AvisDef_CT18490_EPI675.pdf
HAS/2020-07-08_accompagnement_personnes_maladie_neuro-degeneratives_lc.pdf
HAS/2020-07-08_agrastat_10062020_transcription_ct17920.pdf
HAS/2020-07-08_agrastat_24062020_summary_ct17920.pdf
HAS/2020-07-08_agrastat_24062020_synthese_ct17920.pdf
HAS/2020-07-08_diqasm_guide_mnd_projetpersonnalise.pdf
HAS/2020-07-08_diqasm_guidemnd_pratiquesdaccompagnement_vf_publi.pdf
HAS/2020-07-08_diqasm_guidemnd_projetdeservice_publi.pdf
HAS/2020-07-08_diqasm_guidemnd_tableaux_vf_publi.pdf
HAS/2020-07-08_diqasm_sr_guide_medicament_dom_publi.pdf
HAS/2020-07-08_duaklir_genuair_16062020_summary_ct18252.pdf
HAS/2020-07-08_duaklir_genuair_16062020_synthese_ct18252.pdf
HAS/2020-07-08_eklira_genuair_10062020_transcription_ct18242.pdf
HAS/2020-07-08_eklira_genuair_16062020_summary_ct18242.pdf
HAS/2020-07-08_eklira_genuair_16062020_synthese_ct18242.pdf
HAS/2020-07-08_sunosi_10062020_transcription_ct18490.pdf
HAS/2020-07-08_sunosi_24062020_synthese_ct18490.pdf
HAS/2020-07-08_sunosi_summary_ct18490_epi675.pdf
HAS/2020-07-08_synthese_mg_aciduries_organiques.pdf
HAS/2020-07-09_CT-18126_SPHEROX_PIC_INS_AvisDef_CT18126.pdf
HAS/2020-07-09_spherox_05022020_transcription_ct18126.pdf
HAS/2020-07-09_spherox_30062020_summary_ct18126.pdf
HAS/2020-07-09_spherox_30062020_synthese_ct18126.pdf
HAS/2020-07-09_spherox_30062020_transcription_ct18126.pdf
HAS/2020-07-10_CT-18180_VITRAKVI_PIC_INS_AvisDef_CT18180.pdf
HAS/2020-07-10_CT-18653_ROACTEMRA_PIS_EI_AvisDef_CT18653.pdf
HAS/2020-07-10_CT-18701_COMTAN_PIS_INS_AvisDef_CT18701.pdf
HAS/2020-07-10_CT-18725_AZACITIDINE_BETAPHARM_PIS_INS_AvisDef_CT18725.pdf
HAS/2020-07-10_CT-18736_ALBUREX_PIS_INS_AvisDef_CT18736.pdf
HAS/2020-07-10_CT-18746_VINORELBINE_ACCORD_PIS_INS_AvisDef_CT18746.pdf
HAS/2020-07-10_vitrakvi_04032020_transcription_ct18180.pdf
HAS/2020-07-10_vitrakvi_09072020_summary_ct18180.pdf
HAS/2020-07-10_vitrakvi_09072020_synthese_ct18180.pdf
HAS/2020-07-10_vitrakvi_09072020_transcription_ct18180.pdf
HAS/2020-07-10_vitrakvi_15042020_transcription_ct18180.pdf
HAS/2020-07-10_vitrakvi_24062020_transcription_ct18180.pdf
HAS/2020-07-15_CNEDIMTS-6178_PERCEVAL PLUS_2_juin_2020_(6178)_avis.pdf
HAS/2020-07-15_CNEDIMTS-6282_COREVALVE EVOLUT R_19_mai_2020_(6282)_avis.pdf
HAS/2020-07-15_CNEDIMTS-6283_COREVALVE EVOLUT PRO_19_mai_2020_(6283)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6154_SAFIRE  SWIFT SLING  SMILE_16_juin_2020_(6154)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6158_ARIS_16_juin_2020_(6158)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6159_CYRENE_16_juin_2020_(6159)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6160_UNITAPE T PLUS_7_juillet_2020_(6160)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6162_UNITAPE VS_16_juin_2020_(6162)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6173_ORSIRO_16_juin_2020_(6173)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6191_ORSIRO MISSION_16_juin_2020_(6191)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6199_CAIRFLOW PM100A EVO DIGITAL_16_juin_2020_(6199)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6240_AQUACEL FOAM PRO talon_16_juin_2020_(6240)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6247_DAX_19_mai_2020_(6247)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6254_ENERGY FOOT_16_juin_2020_(6254)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6278_AQUACEL FOAM PRO sacrum_16_juin_2020_(6278)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6284_AIRE V2_16_juin_2020_(6284)_avis.pdf
HAS/2020-07-16_CNEDIMTS-6286_WATCHMAN_30_juin_2020_(6286)_avis.pdf
HAS/2020-07-17_CNEDIMTS-6161_OPHIRA_30_juin_2020_(6161)_avis.pdf
HAS/2020-07-17_CNEDIMTS-6208_IRYFIX_5_mai_2020_(6208)_avis.pdf
HAS/2020-07-17_CT-18679_AZACITIDINE_SANDOZ_PIS_INS_AvisDef_CT18679.pdf
HAS/2020-07-17_CT-18681_AZACITIDINE_ZENTIVA_PIS_INS_AvisDef_CT18681.pdf
HAS/2020-07-17_CT-18706_FOSCARNET_KABI_PIS_INS_AvisDef_CT18706.pdf
HAS/2020-07-17_CT-18727_LIDOCAINE_ARROW_SANS_CONSERVATEUR_PIS_INS_AvisDef_CT18727.pdf
HAS/2020-07-17_CT-18737_INCRELEX_PIS_RCP_AvisDef_CT18737.pdf
HAS/2020-07-20_CT-18415_TOUJEO_PIC_EI_AvisDef_CT18415.pdf
HAS/2020-07-20_CT-18498_TROPHICREME_PIS_RCP_AvisDef_CT18498.pdf
HAS/2020-07-20_inahta_brief_pancreatic_islet_transplantation.pdf
HAS/2020-07-20_toujeo_10062020_summary_ct18415.pdf
HAS/2020-07-20_toujeo_10062020_synthese_ct18415.pdf
HAS/2020-07-20_toujeo_10062020_transcription_ct184151.pdf
HAS/2020-07-20_transplantion_ilots_pancreatiques.pdf
HAS/2020-07-22_CT-18741_PREVENAR_13_PIS_MCI_AvisDef_CT18741.pdf
HAS/2020-07-23_guide_rmm_juin_09.pdf
HAS/2020-07-23_has_64_avis_ceu_retex_2020-07-20_11-22-24_830.pdf
HAS/2020-07-23_rapport_analyse_prospective_20191.pdf
HAS/2020-07-24_CNEDIMTS-6121_F PHOENIX DBM_16_juin_2020_(6121)_avis.pdf
HAS/2020-07-24_CNEDIMTS-6146_OBTRYX_OBTRYX II_7_juillet_2020_(6147_6146)_avis.pdf
HAS/2020-07-24_CNEDIMTS-6147_OBTRYX_OBTRYX II_7_juillet_2020_(6147_6146)_avis.pdf
HAS/2020-07-24_CNEDIMTS-6190_ALBER SMOOV ONE O10_5_mai_2020_(6190)_avis.pdf
HAS/2020-07-24_CNEDIMTS-6285_ACRYSOF IQ TORIC_30_juin_2020_(6285)_avis.pdf
HAS/2020-07-24_CT-17800_HEMANGIOL_PIS_REEV_AvisDef_CT17800.pdf
HAS/2020-07-24_CT-18134_STELARA_RCH_PIC_EI_AvisDef_CT18134.pdf
HAS/2020-07-24_CT-18208_TRECONDI_PIC_INS_AvisDef_CT18208.pdf
HAS/2020-07-24_CT-18437_PROLASTIN_PIC_INS_AvisDef_CT18437.pdf
HAS/2020-07-24_CT-18468_MAYZENT_PIC_INS_AvisDef_CT18468.pdf
HAS/2020-07-24_CT-18611_ALPRAZOLAM_ARROW_LAB_PIS_INS_AvisDef_CT18611.pdf
HAS/2020-07-24_CT-18747_ASPIRINE_ARROW_PIS_INS_AvisDef_CT18747.pdf
HAS/2020-07-24_CT-18748_BUDESONIDE_MYLAN_PIS_INS_AvisDef_CT18748.pdf
HAS/2020-07-24_CT-18753_CABAZITAXEL_REDDY_PHARMA_PIS_INS_AvisDef_CT18753.pdf
HAS/2020-07-24_CT-18765_TIGECYCLINE_ACCORD_PIS_INS_AvisDef_CT18765.pdf
HAS/2020-07-24_CT-18768_MICAFUNGINE_MYLAN_PIS_INS_AvisDef_CT18768.pdf
HAS/2020-07-24_hemangiol_09072020_synthese_ct17800.pdf
HAS/2020-07-24_hemangiol_09072020_transcription_ct17111.pdf
HAS/2020-07-24_mayzent_10062020_transcription_ct18468.pdf
HAS/2020-07-24_mayzent_22072020_summary_ct18468.pdf
HAS/2020-07-24_mayzent_22072020_synthese_ct18468.pdf
HAS/2020-07-24_mayzent_22072020_transcription_ct18468.pdf
HAS/2020-07-24_prolastin_08072020_summary_ct18437.pdf
HAS/2020-07-24_prolastin_08072020_synthese_ct18437.pdf
HAS/2020-07-24_prolastin_08072020_transcription_ct18437.pdf
HAS/2020-07-24_stelara_03062020_transcription_ct18134.pdf
HAS/2020-07-24_stelara_22072020_transcription_ct18134.pdf
HAS/2020-07-24_stelara_rch_22072020_synthese_ct18134.pdf
HAS/2020-07-24_trecondi_03062020_transcription_ct18208.pdf
HAS/2020-07-24_trecondi_22072020_summary_ct18208.pdf
HAS/2020-07-24_trecondi_22072020_synthese_ct18208.pdf
HAS/2020-07-24_trecondi_22072020_transcription_ct18208.pdf
HAS/2020-07-27_CNEDIMTS-6223_COREVALVE EVOLUT R_21_juillet_2020_(6223)_avis.pdf
HAS/2020-07-27_CNEDIMTS-6224_COREVALVE EVOLUT PRO_21_juillet_2020_(6224)_avis.pdf
HAS/2020-07-27_CT-18492_POLIVY_PIC_INS_AvisDef_CT18492.pdf
HAS/2020-07-27_polivy_03062020_transcription_ct184921.pdf
HAS/2020-07-27_polivy_10062020_synthese_ct18492.pdf
HAS/2020-07-27_polivy_16072020_avis_economique.pdf
HAS/2020-07-27_polivy_pic_ins_avisdef_ct18492_en.pdf
HAS/2020-07-28_annexe_a_consultation_publique_vf.pdf
HAS/2020-07-28_annexe_b_actualisation_guide_ces.pdf
HAS/2020-07-28_choices_in_methods_for_economic_evaluation_-_2011.pdf
HAS/2020-07-28_choix_methodologiques_evaluation_economique_reponses_a_la_consultation_publique.pdf
HAS/2020-07-28_guide_methodo_vf.pdf
HAS/2020-07-28_guide_methodologique_evaluation_economique_has_2020_vf.pdf
HAS/2020-07-28_methodological_guidance_2020_-choices_in_methods_for_economic_evaluation.pdf
HAS/2020-07-28_note_de_cadrage_strategie_vaccinale_contre_la_covid_19.pdf
HAS/2020-07-28_rapport_strategie_vaccination_covid_19_vf.pdf
HAS/2020-07-31_CT-17051_SEGLUROMET_PIC_INS_AvisDef_CT17051.pdf
HAS/2020-07-31_CT-18235_ARIPIPRAZOLE_ARROW_PIS_INS_AvisDef_CT18235.pdf
HAS/2020-07-31_CT-18375_FIASP_PIC_EI_AvisDef_CT18375.pdf
HAS/2020-07-31_CT-18720_NITISINONE_DIPHARMA_PIS_INS_AvisDef_CT18720.pdf
HAS/2020-07-31_CT-18784_OXOMEMAZINE_CRISTERS_SANS_SUCRE_PIS_INS_AvisDef_CT18784.pdf
HAS/2020-07-31_fiasp_08072020_summary_ct18375.pdf
HAS/2020-07-31_fiasp_08072020_synthese_ct18375.pdf
HAS/2020-07-31_fiasp_08072020_transcription_ct18375.pdf
HAS/2020-07-31_mylotarg_rtu_reco_autosaisine_has_sem_cteval504.pdf
HAS/2020-07-31_steglatro_steglujan_segluromet_03102018_ct170501705217051_transcription.pdf
HAS/2020-08-12_pnds_syndrome_de_fraser_argumentaire_juillet_2020.pdf
HAS/2020-08-12_pnds_syndrome_de_fraser_texte_pnds_juillet_2020.pdf
HAS/2020-08-12_reco367_note_cadrage_gestion_capital_sanguin_coi_2020_07_01.pdf
HAS/2020-08-12_syndrome_de_fraser_-_synthese_a_destination_du_medecin_traitant.pdf
HAS/2020-08-17_niquitin_pis_rad_avisdef_ct18219_1.pdf
HAS/2020-08-21_CNEDIMTS-6082_THERASPHERE_28_janvier_2020_(6082)_avis.pdf
HAS/2020-08-21_CNEDIMTS-6133_CARTIVA_21_juillet_2020_(6133)_avis.pdf
HAS/2020-08-21_CNEDIMTS-6290_TRITON_21_juillet_2020_(6290)_avis.pdf
HAS/2020-08-21_CNEDIMTS-6291_DYNAMIQUE 1D10_21_juillet_2020_(6291)_avis.pdf
HAS/2020-08-21_therasphere_25_fevrier_2020_6216_fit.pdf
HAS/2020-08-27_CT-18685_INDUCTOS_PIS_INS_AvisDef_CT18685.pdf
HAS/2020-09-01_CT-18245_ELIQUIS_PIS_EPI_AvisDef_CT18245.pdf
HAS/2020-09-01_CT-18350_KISQALI_IA_chez_femme_non_menopausee_PIC_REEV_AvisDef_CT18350.pdf
HAS/2020-09-01_CT-18533_ADONTEX_PIC_Avisdef_CT18533.pdf
HAS/2020-09-01_adontex_22072020_summary_ct18533.pdf
HAS/2020-09-01_adontex_22072020_synthese_ct18533.pdf
HAS/2020-09-01_adontex_22072020_transcription_ct18533.pdf
HAS/2020-09-01_kisqali_09072020_transcription_ct18350.pdf
HAS/2020-09-01_kisqali_13102020_avis_economique2.pdf
HAS/2020-09-01_kisqali_22072020_synthese_ct18350.pdf
HAS/2020-09-02_CNEDIMTS-6174_WHEELDRIVE_21_juillet_2020_(6174)_avis.pdf
HAS/2020-09-02_CNEDIMTS-6181_AMS 800_21_juillet_2020_(6181)_avis.pdf
HAS/2020-09-02_CNEDIMTS-6293_TRIAS 1C30_21_juillet_2020_(6293)_avis.pdf
HAS/2020-09-02_CT-17022_PRADAXA_PIC_REEV_AvisDef_CT17022.pdf
HAS/2020-09-02_CT-18244_SPINRAZA_PIC_NE_AvisDef_CT18244.pdf
HAS/2020-09-02_contribution_france_avc_37_pradaxa_ct17022.pdf
HAS/2020-09-02_pradaxa_08072020_transcription_ct17022.pdf
HAS/2020-09-02_pradaxa_22072020_summary_ct17022.pdf
HAS/2020-09-02_pradaxa_22072020_synthese_ct17022.pdf
HAS/2020-09-02_spinraza_09072020_transcription_ct18244.pdf
HAS/2020-09-02_spinraza_22072020_summary_ct18244.pdf
HAS/2020-09-02_spinraza_22072020_synthese_ct18244.pdf
HAS/2020-09-03_CNEDIMTS-6260_PENUMBRA SYSTEM incluant le cathéter de reperfusion PENUMBRA JET 7_30_juin_2020_(6260)_avis.pdf
HAS/2020-09-03_CNEDIMTS-6261_PENUMBRA SYSTEM incluant le cathéter de reperfusion PENUMBRA JET D_30_juin_2020_(6261)_avis.pdf
HAS/2020-09-03_CNEDIMTS-6296_MEDITRADE_(6296)_Avis du 21 juillet 2020.pdf
HAS/2020-09-07_CNEDIMTS-6136_PANTHERA D-SAD_7_juillet_2020_(6136)_avis.pdf
HAS/2020-09-07_CNEDIMTS-6172_INPACT PACIFIC_10_mars_2020_(6172)_avis.pdf
HAS/2020-09-07_CNEDIMTS-6259_PENUMBRA SYSTEM incluant le cathéter de reperfusion PENUMBRA ACE 68_PENUMBRA SYSTEM incluant le cathéter de reperfusion PENUMBRA ACE 60_30_juillet_2020_(6259)_avis.pdf
HAS/2020-09-08_fiche_parcours_de_reeducation_readaptation_des_patients_apres_la_phase_initiale_de_lavc.pdf
HAS/2020-09-08_rapport_parcours_de_reeducation_readaptation_des_patients_apres_la_phase_initiale_de_lavc.pdf
HAS/2020-09-09_CNEDIMTS-6145_SOLYX SIS SYSTEM & SOLYX BLUE SIS SYSTEM_21_juillet_2020_(6145)_avis.pdf
HAS/2020-09-09_CNEDIMTS-6258_BRUMAN PULMAN BR3071_21_juillet_2020_(6258)_avis.pdf
HAS/2020-09-09_CNEDIMTS-6302_FIBERSTITCH_30_juin_2020_(6302)_avis.pdf
HAS/2020-09-10_CNEDIMTS-5650_TITAN OPTIMAX_21_juillet_2020_(5650)_avis.pdf
HAS/2020-09-10_CNEDIMTS-6148_ADVANTAGE_(6148) _ADVANTAGE FIT_(6149)_30_juin_2020_avis.pdf
HAS/2020-09-10_CNEDIMTS-6149_ADVANTAGE_(6148) _ADVANTAGE FIT_(6149)_30_juin_2020_avis.pdf
HAS/2020-09-10_CNEDIMTS-6197_ERIC_5_mai_2020_(6197)_avis.pdf
HAS/2020-09-10_CNEDIMTS-6288_SYNERGY XD_21_juillet_2020_(6288)_avis.pdf
HAS/2020-09-10_CNEDIMTS-6314_SYSTANE ULTRA_21_juillet_2020_(6314)_avis.pdf
HAS/2020-09-10_CNEDIMTS-6321_SYSTANE ULTRA UD_21_juillet_2020_(6321)_avis.pdf
HAS/2020-09-10_CNEDIMTS-6340_PERCEVAL S_21_juillet_2020_(6340)_avis.pdf
HAS/2020-09-11_CNEDIMTS-6289_POLYFLEX_1_septembre_2020_(6289)_avis.pdf
HAS/2020-09-11_CNEDIMTS-6334_ADJUST 1M10_1_septembre_2020_(6334)_avis.pdf
HAS/2020-09-11_CNEDIMTS-6335_CHOPART_1_septembre_2020_(6335)_avis.pdf
HAS/2020-09-11_CNEDIMTS-6337_LOW PROFIL AXTION 1E56_1_septembre_2020_(6337)_avis.pdf
HAS/2020-09-11_CNEDIMTS-6338_DYNAMIC MOTION 1D35_1_septembre_2020_(6338)_avis.pdf
HAS/2020-09-11_CNEDIMTS-6369_CHOPART 1E80 et 1E82_1_septembre_2020_(6369)_avis.pdf
HAS/2020-09-11_app_362_fiche_telesoin_criteres_eligibilite_cd_2020_09_03_v0.pdf
HAS/2020-09-15_CNEDIMTS-6195_REACT_19_mai_2020_(6195)_avis.pdf
HAS/2020-09-15_CT-18594_ALUNBRIG_1L_PIC_EI_AvisDef_CT18594.pdf
HAS/2020-09-15_CT-18673_DARZALEX_PIC_INS_AvisDef_CT18673.pdf
HAS/2020-09-15_CT-18757_JORVEZA_PIC_INS_AvisDef_CT18757&18588.pdf
HAS/2020-09-15_CT-18814_FULVESTRANT_ACCORD_PIS_INS_AvisDef_CT18814.pdf
HAS/2020-09-15_alunbrig_09092020_summary_ct18594.pdf
HAS/2020-09-15_alunbrig_09092020_transcription_ct18594.pdf
HAS/2020-09-15_alunbrig_1l_09092020_synthese_ct18594.pdf
HAS/2020-09-15_alunbrig_22072020_transcription_ct18594.pdf
HAS/2020-09-15_darzalex_22072020_summary_ct18673.pdf
HAS/2020-09-15_darzalex_22072020_synthese_ct18673.pdf
HAS/2020-09-15_darzalex_22072020_transcription_ct18673.pdf
HAS/2020-09-15_jorveza_08072020_transcription_ct18588.pdf
HAS/2020-09-15_jorveza_09092020_summary_ct18757_18588.pdf
HAS/2020-09-15_jorveza_09092020_synthese_ct1875718588.pdf
HAS/2020-09-15_jorveza_09092020_transcription_ct18757.pdf
HAS/2020-09-16_CT-18381_NINLARO_PIC_REEV_AvisDef_CT18381.pdf
HAS/2020-09-16_CT-18603_STELARA_enfant_PIC_EI_AvisDef_CT18603.pdf
HAS/2020-09-16_CT-18676_MINALFENE_PIS_RCP_AvisDef_CT18676.pdf
HAS/2020-09-16_CT-18742_TAKHZYRO_PIS_INS_AvisDef_CT18742.pdf
HAS/2020-09-16_CT-18833_FIASP_PUMPCART_PIS_INS_AvisDef_CT18833.pdf
HAS/2020-09-16_CT-18844_HUMALOG_PIS_INS_AvisDef_CT18844.pdf
HAS/2020-09-16_inahta_brief_no_nasal.pdf
HAS/2020-09-16_ninlaro_09072020_transcription_ct18381.pdf
HAS/2020-09-16_ninlaro_09092020_summary_ct18381.pdf
HAS/2020-09-16_ninlaro_09092020_synthese_ct18381.pdf
HAS/2020-09-16_ninlaro_09092020_transcription_ct18381.pdf
HAS/2020-09-16_rapport_mesure_no_dpc.pdf
HAS/2020-09-16_stelara_08072020_transcription_ct18603.pdf
HAS/2020-09-16_stelara_09092020_summary_ct18603.pdf
HAS/2020-09-16_stelara_09092020_transcription_ct18603.pdf
HAS/2020-09-16_stelara_enfant_09092020_synthese_ct18603.pdf
HAS/2020-09-21_methotrexate_rtu_reco_autosaisine_has_sem_cteval510_2020-09-18_16-13-55_171.pdf
HAS/2020-09-22_has_49_argumentaire_engagement_usagers.pdf
HAS/2020-09-22_has_49_guide_glossaire_engagement_usagers.pdf
HAS/2020-09-22_has_49_rapport_enquete_pratique.pdf
HAS/2020-09-22_has_49_rapport_groupe_lecture_engagement_usagers.pdf
HAS/2020-09-22_has_49_reco_engagement_usagers.pdf
HAS/2020-09-22_has_49_reco_engagement_usagers_anglais_vdef.pdf
HAS/2020-09-23_CT-18516_SIRTURO_PIC_EI_AvisDef_CT18516.pdf
HAS/2020-09-23_CT-18522_DYSPORT_PIC_INS_AvisDef_CT18522.pdf
HAS/2020-09-23_CT-18526_AJOVY_PIC_INS_AvisDef_CT18526.pdf
HAS/2020-09-23_CT-18580_ULTOMIRIS_PIC_INS_AvisDef_CT18580.pdf
HAS/2020-09-23_CT-18606_ENTYVIO_SC_PIC_INS_AvisDef_CT18606.pdf
HAS/2020-09-23_CT-18643_SOLIRIS_NMOSD_PIC_EI_AvisDef_CT18643_EPI678.pdf
HAS/2020-09-23_CT-18721_ADCETRIS_PIC_INS_AvisDef_CT18721.pdf
HAS/2020-09-23_CT-18817_BRIMAZED_PIS_INS_AvisDef_CT18817.pdf
HAS/2020-09-23_CT-18818_GEMCITABINE_HIKMA_PIS_INS_AvisDef_CT18818.pdf
HAS/2020-09-23_CT-18822_ORATORIA_PIS_INS_AvisDef_CT18822.pdf
HAS/2020-09-23_CT-18834_PEMETREXED_FRESENIUS_KABI_PIS_INS_AvisDef_CT18834.pdf
HAS/2020-09-23_adcetris_09092020_summary_ct18721.pdf
HAS/2020-09-23_adcetris_09092020_synthese_ct18721.pdf
HAS/2020-09-23_adcetris_09092020_transcription_ct18721.pdf
HAS/2020-09-23_ajovy_08072020_transcription_ct18526.pdf
HAS/2020-09-23_ajovy_16092020_synthese_ct18526.pdf
HAS/2020-09-23_ajovy_16092020_transcription_ct18526.pdf
HAS/2020-09-23_ajovy__summary_ct18526.pdf
HAS/2020-09-23_dysport_08072020_transcription_ct18522.pdf
HAS/2020-09-23_dysport_16092020_summary_ct18522.pdf
HAS/2020-09-23_dysport_16092020_synthese_ct18522.pdf
HAS/2020-09-23_dysport_16092020_transcription_ct18522.pdf
HAS/2020-09-23_entyvio_08072020_transcription_ct18606.pdf
HAS/2020-09-23_entyvio_09092020_transcription_ct18606.pdf
HAS/2020-09-23_entyvio_16092020_summary_ct18606.pdf
HAS/2020-09-23_entyvio_16092020_synthese_ct18606.pdf
HAS/2020-09-23_sirturo_09092020__summary_ct18516.pdf
HAS/2020-09-23_sirturo_09092020_synthese_ct18516.pdf
HAS/2020-09-23_sirturo_09092020_transcription_ct18516.pdf
HAS/2020-09-23_soliris_13102020_avis_economique.pdf
HAS/2020-09-23_soliris_16092020_transcription_ct18643.pdf
HAS/2020-09-23_soliris_22072020_transcription_ct18643.pdf
HAS/2020-09-23_soliris_nmosd_16092020_summary_ct18643.pdf
HAS/2020-09-23_soliris_nmosd_16092020_synthese_ct18643.pdf
HAS/2020-09-23_ultomiris_09072020_transcription_ct18580.pdf
HAS/2020-09-23_ultomiris_16092020__summary_ct18580.pdf
HAS/2020-09-23_ultomiris_16092020_synthese_ct18580.pdf
HAS/2020-09-23_ultomiris_16092020_transcription_ct18580.pdf
HAS/2020-09-24_CNEDIMTS-6249_I-STOP_1_septembre_2020_(6249)_avis.pdf
HAS/2020-09-24_CNEDIMTS-6270_LIFT_1_septembre_2020_(6270)_avis.pdf
HAS/2020-09-24_CNEDIMTS-6287_FRESUBIN DB CONTROL_1_septembre_2020_(6287)_avis.pdf
HAS/2020-09-25_adcetris_rtu_reco_saisinehas_cteval507_2020-09-25_15-00-35_799.pdf
HAS/2020-09-28_CNEDIMTS-6029_NEBUSAL_21_juillet_2020_(6029)_avis.pdf
HAS/2020-09-28_CNEDIMTS-6187_SPINEJACK_22_septembre_2020_(6187)_avis.pdf
HAS/2020-09-28_CNEDIMTS-6279_PASSEO 18 LUX_1_septembre_2020_(6279)_avis.pdf
HAS/2020-09-28_pnds_syndrome_oro-facio-digital_de_type_i-ofdi_argumentaire_2020.pdf
HAS/2020-09-28_pnds_syndrome_oro-facio-digital_de_type_i__ofdi_2020.pdf
HAS/2020-09-28_synthese_mg_syndrome_oro_facio_digital_de_type_i.pdf
HAS/2020-09-30_CNEDIMTS-6272_ALLOGREFFON VEINEUX SAPHENE_22_septembre_2020_(6272)_avis.pdf
HAS/2020-09-30_CT-18471_CONCERTA_PIC_REEV_RI_AvisDef_CT18471.pdf
HAS/2020-09-30_CT-18473_MEDIKINET_PIC_REEV_AvisDef_CT18473.pdf
HAS/2020-09-30_CT-18479_QUASYM_PIC_REEV_RI_AvisDef_CT18479.pdf
HAS/2020-09-30_CT-18481_RITALINE_RITALINE_LP_PIC_REEV_AvisDef_CT18481.pdf
HAS/2020-09-30_CT-18821_BECILAN_PIS_INS_AvisDef_CT18821.pdf
HAS/2020-09-30_concerta_24062020_summary_ct18471.pdf
HAS/2020-09-30_concerta_24062020_synthese_ct18471.pdf
HAS/2020-09-30_medikinet_24062020_summary_ct18473.pdf
HAS/2020-09-30_medikinet_24062020_synthese_ct18473.pdf
HAS/2020-09-30_quasym_24062020_summary_ct18479.pdf
HAS/2020-09-30_quasym_24062020_synthese_ct18479.pdf
HAS/2020-09-30_rapport_reevaluation_methylphenidate_avisdef_cteval485.pdf
HAS/2020-09-30_reevaluation_methylphenidate_10062020_transcription_cteval485.pdf
HAS/2020-09-30_ritaline_24062020_synthese_ct18481.pdf
HAS/2020-09-30_ritaline_lp_24062020_summary_ct18481.pdf
HAS/2020-10-01_CT-18369_SCENESSE_PIC_INS_AvisDef_modifiele30092020_CT18369.pdf
HAS/2020-10-01_CT-18551_ZINFORO_pediatrie_PIC_EI_AvisDef_CT18551.pdf
HAS/2020-10-01_scenesse_24062020_summary_ct18369.pdf
HAS/2020-10-01_scenesse_24062020_synthese_ct18369.pdf
HAS/2020-10-01_scenesse_24062020_transcription_ct18369.pdf
HAS/2020-10-01_scenesse_27052020_transcription_ct18369.pdf
HAS/2020-10-01_zinforo_09092020_summary_ct18551.pdf
HAS/2020-10-01_zinforo_09092020_transcription_ct18551.pdf
HAS/2020-10-01_zinforo_pediatrie_09092020_synthese_ct18551.pdf
HAS/2020-10-02_CT-16919_PROLIA_OPM_PIC_RI_EPI_AvisDef_CT16919&17783.pdf
HAS/2020-10-02_CT-17780_EXACOR_PIC_REEV_AvisDef_CT17780.pdf
HAS/2020-10-02_CT-17946_ADEMPAS_POPCIBLE_EPI_PIS_AvisDef_CT17946&17935.pdf
HAS/2020-10-02_CT-18305_ISORYTHM_PIC_REEV_AvisDef_CT18305.pdf
HAS/2020-10-02_CT-18329_SYLVANT_PIC_REEV_AvisDef_CT18329.pdf
HAS/2020-10-02_CT-18389_CORDARONE_PIC_REEV_AvisDef_CT16356&18389.pdf
HAS/2020-10-02_CT-18390_RYTHMOL_PIC_REEV_AvisDef_CT16355&18390_EPI677.pdf
HAS/2020-10-02_CT-18413_SERECOR_PIC_REEV_AvisDef_CT16357&18413.pdf
HAS/2020-10-02_CT-18420_RYTHMODAN_PIC_REEV_AvisDef_CT16311&18420.pdf
HAS/2020-10-02_CT-18438_DUPIXENT_PNS_PIC_EI_AvisDef_CT18438_EPI698.pdf
HAS/2020-10-02_CT-18475_SOTALEX_PIC_REEV_AvisDef_CT16396&18475.pdf
HAS/2020-10-02_CT-18480_FLECAINE_PIC_REEV_AvisDef_CT18480_EPI676.pdf
HAS/2020-10-02_CT-18659_LUCENTIS_PIS_EI_nondemandee_AvisDef_CT18659.pdf
HAS/2020-10-02_CT-18661_MIACALCIC_PIC_REEV_AvisDef_CT18661.pdf
HAS/2020-10-02_CT-18860_CABAZITAXEL_EVER_PHARMA_PIS_INS_AvisDef_CT18860.pdf
HAS/2020-10-02_CT-18866_CABAZITAXEL_TEVA_SANTE_PIS_INS_AvisDef_CT18866.pdf
HAS/2020-10-02_cordarone_16092020_summary_ct16356_18389.pdf
HAS/2020-10-02_cordarone_16092020_synthese_ct1635618389.pdf
HAS/2020-10-02_dupixent_08072020_transcription_ct18438.pdf
HAS/2020-10-02_dupixent_16092020_summary_ct18438.pdf
HAS/2020-10-02_dupixent_16092020_transcription_ct18438.pdf
HAS/2020-10-02_dupixent_pns_16062020_avis_economique_biffe.pdf
HAS/2020-10-02_dupixent_pns_16092020_synthese_ct18438.pdf
HAS/2020-10-02_exacor_16092020_synthese_ct17780.pdf
HAS/2020-10-02_exacor_16092020_transcription_ct17780.pdf
HAS/2020-10-02_flecaine_16092020_summary_ct18480.pdf
HAS/2020-10-02_flecaine_16092020_synthese_ct18480.pdf
HAS/2020-10-02_flecaine_16092020_transcription_ct18480.pdf
HAS/2020-10-02_inspire_iv_21_juillet_2020_6200_avis.pdf
HAS/2020-10-02_isorythm_16092020_summary_ct18305.pdf
HAS/2020-10-02_isorythm_16092020_synthese_ct18305.pdf
HAS/2020-10-02_miacalcic_09092020_summary_ct18661.pdf
HAS/2020-10-02_miacalcic_09092020_synthese_ct18661.pdf
HAS/2020-10-02_miacalcic_09092020_transcription_ct18661.pdf
HAS/2020-10-02_prolia_16092020_transcription_ct16919.pdf
HAS/2020-10-02_prolia_22072020_transcription_ct16919.pdf
HAS/2020-10-02_prolia_opm_16092020_summary_ct16919_17783_v2.pdf
HAS/2020-10-02_prolia_opm_16092020_synthese_ct1691917783.pdf
HAS/2020-10-02_rapport_reevaluation_antiarythmiques_avisdef_cteval486.pdf
HAS/2020-10-02_reevaluation_antiarythmiques_09072020_transcription_cteval486.pdf
HAS/2020-10-02_rythmodan_16092020_summary_ct16311_18420.pdf
HAS/2020-10-02_rythmodan_16092020_synthese_ct1631118420.pdf
HAS/2020-10-02_rythmol_16092020_summary_ct16355_18390.pdf
HAS/2020-10-02_rythmol_16092020_synthese_ct1635518390.pdf
HAS/2020-10-02_serecor_16092020_summary_ct16357_18413.pdf
HAS/2020-10-02_serecor_16092020_synthese_ct1635718413.pdf
HAS/2020-10-02_sotalex_16092020_summary_ct16396_18475.pdf
HAS/2020-10-02_sotalex_16092020_synthese_ct1639618475.pdf
HAS/2020-10-02_sylvant_08072020_transcription_ct18329.pdf
HAS/2020-10-02_sylvant_16092020_summary_ct18329.pdf
HAS/2020-10-02_sylvant_16092020_synthese_ct18329.pdf
HAS/2020-10-02_sylvant_16092020_transcription_ct18329.pdf
HAS/2020-10-05_CNEDIMTS-6262_PEPTAMEN JUNIOR ADVANCE_1_septembre_2020_(6262)_avis.pdf
HAS/2020-10-05_CNEDIMTS-6280_SWING-BAND SB3 et SB4_22_septembre_2020_(6280)_avis.pdf
HAS/2020-10-05_CNEDIMTS-6327_OMNIPOD_1_septembre_2020_(6327)_avis.pdf
HAS/2020-10-06_cadrage_information_rm.pdf
HAS/2020-10-06_reponses_pp_quaire_information_rm.pdf
HAS/2020-10-07_CT-18662_TALTZ_SpA_PIC_EI_AvisDef_CT18662.pdf
HAS/2020-10-07_CT-18716_COSENTYX_SpAnr_PIC_EI_AvisDef_CT18716.pdf
HAS/2020-10-07_CT-18849_FLUCONAZOLE_ARROW_LAB_PIS_INS_AvisDef_CT18849.pdf
HAS/2020-10-07_cosentyx_09092020_transcription_ct18716.pdf
HAS/2020-10-07_cosentyx_16092020_summary_ct18716.pdf
HAS/2020-10-07_cosentyx_spanr_16092020_synthese_ct18716.pdf
HAS/2020-10-07_taltz_09092020_transcription_ct18662.pdf
HAS/2020-10-07_taltz_16092020_summary_ct18662.pdf
HAS/2020-10-07_taltz_spa_16092020_synthese_ct18662.pdf
HAS/2020-10-08_CNEDIMTS-6209_DANIS STENT_8_septembre_2020_(6205)_avis.pdf
HAS/2020-10-08_CNEDIMTS-6231_AMOENA BALANCE NATURA et NATURA_1_septembre_2020_(6231)_avis.pdf
HAS/2020-10-08_CNEDIMTS-6310_FIREHAWK LIBERTY_1_septembre_2020_(6310)_avis.pdf
HAS/2020-10-08_CT-18726_RECARBRIO_PIC_INS_AvisDef_CT18726.pdf
HAS/2020-10-08_cadrage_smtr.pdf
HAS/2020-10-08_recarbrio_23092020_summary_ct18726.pdf
HAS/2020-10-08_recarbrio_23092020_synthese_ct18726.pdf
HAS/2020-10-08_recarbrio_23092020_transcription_ct18726.pdf
HAS/2020-10-09_guide_pathway_of_medical_devices_in_france.pdf
HAS/2020-10-09_guide_pratique_dm.pdf
HAS/2020-10-09_parcours_du_dispositif_medical_en_france_guide_pratique_actualisation_juillet_2021.pdf
HAS/2020-10-13_CNEDIMTS-6141_TYRX_1_juillet_2020_(6141)_avis.pdf
HAS/2020-10-13_CT-18631_NUBEQA_PIC_INS_AvisDef_CT18631.pdf
HAS/2020-10-13_CT-18819_CABAZITAXEL_ACCORD_PIS_INS_AvisDef_CT18819.pdf
HAS/2020-10-13_CT-18870_FOMICYT_PIS_INS_AvisDef_CT18870.pdf
HAS/2020-10-13_nubeqa_23092020_summary_ct18631.pdf
HAS/2020-10-13_nubeqa_23092020_synthese_ct18631.pdf
HAS/2020-10-13_nubeqa_23092020_transcription_ct18631.pdf
HAS/2020-10-14_note_de_cadrage_-_pertinence_echographie_thyroidienne.pdf
HAS/2020-10-15_CT-18713_ZELBORAF_PIC_REEV_AvisDef_CT18713.pdf
HAS/2020-10-15_guide_methodologique_qualite_samu.pdf
HAS/2020-10-15_inahta_brief_bariatric_surgery_.pdf
HAS/2020-10-15_spa-120_rapport_etat_lieux_eigs_samu-smur_cd_v3.pdf
HAS/2020-10-15_synthese_guide_qualite_samu.pdf
HAS/2020-10-15_synthese_nouvelles_techniques_chirurgie_bariatrique_vd.pdf
HAS/2020-10-15_zelboraf_23092020_summary_ct18713.pdf
HAS/2020-10-15_zelboraf_23092020_synthese_ct18713.pdf
HAS/2020-10-15_zelboraf_23092020_transcription_ct18713.pdf
HAS/2020-10-16_CT-17626_XARELTO_PIC_RI_AvisDef_CT17626.pdf
HAS/2020-10-16_CT-18570_REVLIMID_PIC_EI_AvisDef_CT18570.pdf
HAS/2020-10-16_CT-18579_VYNDAQEL_PIC_INS_AvisDef_CT18579.pdf
HAS/2020-10-16_revlimid_09092020_transcription_ct18570.pdf
HAS/2020-10-16_revlimid_23092020__summary_ct18570.pdf
HAS/2020-10-16_revlimid_23092020_synthese_ct18570.pdf
HAS/2020-10-16_tao_366_vyndaqel_ceesp_17112020.pdf
HAS/2020-10-16_vyndaqel_09092020_transcription_ct18579.pdf
HAS/2020-10-16_vyndaqel_17112020_avis_economique.pdf
HAS/2020-10-16_vyndaqel_23092020__summary_ct18579.pdf
HAS/2020-10-16_vyndaqel_23092020_synthese_ct18579.pdf
HAS/2020-10-16_xarelto_08072020_summary_ct17626.pdf
HAS/2020-10-16_xarelto_08072020_synthese_ct17626.pdf
HAS/2020-10-16_xarelto_08072020_transcription_ct17626.pdf
HAS/2020-10-19_20200813_pnds_hi_final_v6.pdf
HAS/2020-10-19_CT-18658_ITULAZAX_PIC_INS_AvisDef_CT18658.pdf
HAS/2020-10-19_itulazax_07102020_summary_ct18658.pdf
HAS/2020-10-19_itulazax_07102020_synthese_ct18658.pdf
HAS/2020-10-19_itulazax_23092020_transcription_ct18658.pdf
HAS/2020-10-19_pnds_hi_argumentaire.pdf
HAS/2020-10-19_synthese_mg_hyperinsulinisme_congenital.pdf
HAS/2020-10-19_synthese_tests_antigeniques_vd.pdf
HAS/2020-10-20_CNEDIMTS-6198_CUSTOMFLEX ARTIFICIALIRIS_6_octobre_2020_(6198)_avis.pdf
HAS/2020-10-22_CT-18759_ANDROCUR_PIC_REEV_AvisDef_CT18759.pdf
HAS/2020-10-22_CT-18854_REMSIMA_MC_Pso_Rhu_PIC_EI_AvisDef_modifiele20102020_CT18854.pdf
HAS/2020-10-22_androcur_07102020_summary_ct18759.pdf
HAS/2020-10-22_androcur_07102020_synthese_ct18759.pdf
HAS/2020-10-22_androcur_09092020_transcription_ct18759.pdf
HAS/2020-10-22_remsima_07102020_transcription_ct18854.pdf
HAS/2020-10-22_remsima_mc_07102020_ct18854_v2.pdf
HAS/2020-10-22_remsima_mc_pso_rhu_07102020_synthese_ct18854.pdf
HAS/2020-10-23_veklury_08072020_transcription_ct18745.pdf
HAS/2020-10-23_veklury_16072020_avis_economique.pdf
HAS/2020-10-23_veklury_16092020_avis_ct18745.pdf
HAS/2020-10-23_veklury_16092020_synthese_ct18745.pdf
HAS/2020-10-23_veklury_16092020_transcription_ct18745.pdf
HAS/2020-10-23_veklury_pic_ins_avisdef_ct18745_en.pdf
HAS/2020-10-27_argumentaire_pnds-hcd_sept2020.pdf
HAS/2020-10-27_pnds_hdc_septembre_2020.pdf
HAS/2020-10-27_synthese_mg_hernie_de_coupole_diaphragmatique.pdf
HAS/2020-10-29_CNEDIMTS-6163_SYSTEME GYNECARE TVT_22_septembre_2020_(6163)_avis.pdf
HAS/2020-10-29_CNEDIMTS-6166_SYSTEME GYNECARE TVT EXACT_22_septembre_2020_(6166)_avis.pdf
HAS/2020-10-29_CNEDIMTS-6332_MODULEN IBD_22_septembre_2020_(6332)_avis.pdf
HAS/2020-10-29_CNEDIMTS-6366_DIZG_22_septembre_2020_(6366)_avis.pdf
HAS/2020-11-02_CNEDIMTS-6164_SYSTEME GYNECARE TVT OBTURATEUR_22_septembre_2020_(6164)_avis.pdf
HAS/2020-11-03_CT-18460_TECENTRIQ_PIC_REEV_AvisDef_CT18460.pdf
HAS/2020-11-03_CT-18596_TOLAK_PIC_INS_AvisDef_CT18596.pdf
HAS/2020-11-03_CT-18671_DIFICLIR_PIC_EI_AvisDef_CT18670&18671.pdf
HAS/2020-11-03_CT-18683_NORDITROPINE_PIC_EI_AvisDef_CT18683_EPI699.pdf
HAS/2020-11-03_CT-18864_PARACETAMOL_ARROW_LAB_PIS_INS_AvisDef_CT18864.pdf
HAS/2020-11-03_annexes_rapport_dsm_rectum.pdf
HAS/2020-11-03_dificlir_07102020_summary_ct18670_18671.pdf
HAS/2020-11-03_dificlir_07102020_synthese_ct18671.pdf
HAS/2020-11-03_dificlir_07102020_transcription_ct18671.pdf
HAS/2020-11-03_inahta_brief_endoscopic_submucosal_dissection_.pdf
HAS/2020-11-03_label_-_surveillance_medico-professionnelle_des_travailleurs_exposes_ou_ayant_ete_exposes_a_la_silice_cristalline_-_argument.pdf
HAS/2020-11-03_label_-_surveillance_medico-professionnelle_des_travailleurs_exposes_ou_ayant_ete_exposes_a_la_silice_cristalline_-_recomman.pdf
HAS/2020-11-03_label_-_surveillance_medico-professionnelle_des_travailleurs_exposes_ou_ayant_ete_exposes_a_la_silice_cristalline_-_synthese.pdf
HAS/2020-11-03_lettre_cadrage_polyhandicap_vdef_sitehas.pdf
HAS/2020-11-03_norditropine_07102020_summary_ct18683.pdf
HAS/2020-11-03_norditropine_21102020_synthese_ct18683.pdf
HAS/2020-11-03_norditropine_21102020_transcription_ct18683.pdf
HAS/2020-11-03_norditropine_23092020_transcription_ct18683.pdf
HAS/2020-11-03_pnds-polyhandicap_2020.pdf
HAS/2020-11-03_polyhandicap_1_participation.pdf
HAS/2020-11-03_polyhandicap_2_dimensions_fonct.pdf
HAS/2020-11-03_polyhandicap_3_sante.pdf
HAS/2020-11-03_polyhandicap_4_quotidien.pdf
HAS/2020-11-03_polyhandicap_5_transitions.pdf
HAS/2020-11-03_polyhandicap_6_prof_familles.pdf
HAS/2020-11-03_polyhandicap_argumentaire_vdef.pdf
HAS/2020-11-03_polyhandicap_preambule.pdf
HAS/2020-11-03_polyhandicap_synthese_vdef.pdf
HAS/2020-11-03_rapport_dsm_rectum.pdf
HAS/2020-11-03_reco332_cadrage_opioides_2019_11_07_vd.pdf
HAS/2020-11-03_tecentriq_09092020_transcription_ct18460.pdf
HAS/2020-11-03_tecentriq_21102020_summary_ct18460.pdf
HAS/2020-11-03_tecentriq_21102020_synthese_ct18460.pdf
HAS/2020-11-03_tecentriq_21102020_transcription_ct18460.pdf
HAS/2020-11-03_tolak_09092020_transcription_ct18596.pdf
HAS/2020-11-03_tolak_21102020_summary_ct18596.pdf
HAS/2020-11-03_tolak_21102020_synthese_ct18596.pdf
HAS/2020-11-03_tolak_21102020_transcription_ct18596.pdf
HAS/2020-11-04_CT-18717_APREXEVO_PIS_INS_AvisDef_CT18717.pdf
HAS/2020-11-04_CT-18810_PARACETAMOL_CODEINE_TEVA_PIS_INS_AvisDef_CT18810.pdf
HAS/2020-11-04_CT-18865_PARACETAMOL_ARROW_LAB_pdr_PIS_INS_AvisDef_CT18865.pdf
HAS/2020-11-04_CT-18890_SYMBICORT_RAPIHALER_PIS_INS_CG_AvisDef_CT18890.pdf
HAS/2020-11-04_CT-18899_ENERZAIR_BREEZHALER_PIS_INS_AvisDef_CT18899.pdf
HAS/2020-11-04_CT-18907_KALETRA_PIS_INS_AvisDef_CT18907.pdf
HAS/2020-11-04_CT-18938_DIMETRUM_PIS_INS_AvisDef_CT18938.pdf
HAS/2020-11-04_CT-18949_VAQTA_PIS_MCI_AvisDef_CT18949.pdf
HAS/2020-11-06_CT-18682_COSTEC_PIC_INS_AvisDef_CT18682.pdf
HAS/2020-11-06_cadrage_ecus_nodule_cirrhose_mel_novembre2020_vdef.pdf
HAS/2020-11-06_cadrage_ecus_nodule_fortuit_mel_novembre2020_vdef.pdf
HAS/2020-11-06_prise_en_charge_des_dysthyroidies_chez_ladulte_-_note_de_cadrage.pdf
HAS/2020-11-06_reco318_cadrage_radionucleides_mel_v2.pdf
HAS/2020-11-06_reco_310__note_cadrage_evaluation_et_prise_en_charge_des_syndromes_psychotraumatiques_mel.pdf
HAS/2020-11-09_20rr415_covid_19_oxygenotherapie_mel_vf.pdf
HAS/2020-11-09_CNEDIMTS-6301_INOGEN ONE G5_22_septembre_2020_(6301)_avis.pdf
HAS/2020-11-09_CNEDIMTS-6333_CONFIRM RX_6_octobre_2020_(6333)_avis.pdf
HAS/2020-11-09_has_66_avis_ceu_strategie_vaccinale_covid_2020_11_05_mel_2020-11-09_10-30-53_177.pdf
HAS/2020-11-10_CNEDIMTS-6251_PERCPEPT PC_6_octobre_2020_(6251)_avis.pdf
HAS/2020-11-10_CNEDIMTS-6308_DIZG_21_juillet_2020_(6308)_avis.pdf
HAS/2020-11-10_CNEDIMTS-6309_HIGHCROSS_20_octobre_2020_(6309)_avis.pdf
HAS/2020-11-10_CNEDIMTS-6331_EVITA OPEN PLUS_20_septembre_2020_(6331)_avis.pdf
HAS/2020-11-10_CNEDIMTS-6372_RONDO 3_20_octobre_2020_(6372)_avis.pdf
HAS/2020-11-10_CT-18904_BUVIDAL_PECT_AvisDef_CT18904.pdf
HAS/2020-11-10_argumentaire_tests_multiplex_grippe_covid-19_vd.pdf
HAS/2020-11-10_fit_evita_open_plus_6331.pdf
HAS/2020-11-12_CT-18253_PARIET_PIC_REEV_AvisDef_CT18253.pdf
HAS/2020-11-12_CT-18277_LANZOR_PIC_REEV_AvisDef_CT18277.pdf
HAS/2020-11-12_CT-18370_OGAST_OGASTORO_PIC_REEV_AvisDef_CT18370.pdf
HAS/2020-11-12_CT-18373_INIPOMP_EUPANTOL_PIC_REEV_AvisDef_CT18373.pdf
HAS/2020-11-12_CT-18380_INEXIUM_PIC_REEV_AvisDef_CT18380.pdf
HAS/2020-11-12_CT-18382_MOPRAL_ZOLTUM_PIC_REEV_AvisDef_CT18382.pdf
HAS/2020-11-12_CT-18392_OMEPRAZOLE_ARROW_PIC_REEV_AvisDef_CT18392.pdf
HAS/2020-11-12_CT-18424_OMEPRAZOLE_MYLAN_PIC_REEV_AvisDef_CT18424.pdf
HAS/2020-11-12_eupantol_inipomp_16092020_summary_ct18373.pdf
HAS/2020-11-12_eupantol_inipomp_16092020_synthese_ct18373.pdf
HAS/2020-11-12_inexium_16092020_summary_ct18380.pdf
HAS/2020-11-12_inexium_16092020_synthese_ct18380.pdf
HAS/2020-11-12_lanzor_16092020_summary_ct18277.pdf
HAS/2020-11-12_lanzor_16092020_synthese_ct18277.pdf
HAS/2020-11-12_mopral_zoltum_09092020_summary_ct18382.pdf
HAS/2020-11-12_mopral_zoltum_16092020_synthese_ct18382.pdf
HAS/2020-11-12_ogast_ogastoro_16092020_summary_ct18370.pdf
HAS/2020-11-12_ogast_ogastoro_16092020_synthese_ct18370.pdf
HAS/2020-11-12_omeprazole_arrow_16092020_summary_ct18392.pdf
HAS/2020-11-12_omeprazole_arrow_16092020_synthese_ct18392.pdf
HAS/2020-11-12_omeprazole_mylan_16092020_summary__ct18424_2021-03-22_10-44-47_912.pdf
HAS/2020-11-12_omeprazole_mylan_16092020_synthese_ct18424.pdf
HAS/2020-11-12_pariet_16092020_summary_ct18253.pdf
HAS/2020-11-12_pariet_16092020_synthese_ct18253.pdf
HAS/2020-11-12_rapport_reevaluation_ipp_avisdef_cteval493.pdf
HAS/2020-11-12_reevaluation_ipp_09072020_transcription_cteval493.pdf
HAS/2020-11-16_CNEDIMTS-6263_Mi1250 SYNCHRONY_6_octobre_2020_(6263)_avis.pdf
HAS/2020-11-16_CNEDIMTS-6375_AMOENA BALANCE CONTACT_20_octobre_2020_(6375)_avis.pdf
HAS/2020-11-16_CT-18664_METHYLPREDNISOLONE_HIKMA_PIS_INS_AvisDef_modifiele12112020_CT18664.pdf
HAS/2020-11-16_CT-18887_RESELIP_PIS_INS_AvisDef_CT18887.pdf
HAS/2020-11-16_CT-18917_DEPAMIDE_PIS_INS_AvisDef_CT18917.pdf
HAS/2020-11-16_CT-18919_SPACYR_PIS_INS_AvisDef_CT18919.pdf
HAS/2020-11-17_CNEDIMTS-6271_MERLIN.NET DAI simple_20_octobre_2020_(6271)_avis.pdf
HAS/2020-11-17_CNEDIMTS-6435_MERLIN.NET DAI double_20_octobre_2020_(6435)_avis.pdf
HAS/2020-11-17_CNEDIMTS-6436_MERLIN.NET DAI triple_20_octobre_2020_(6236)_avis.pdf
HAS/2020-11-18_CNEDIMTS-6108_DEKAS ESSENTIAL LIQUIDE_22_septembre_2020_(6108)_avis.pdf
HAS/2020-11-18_CNEDIMTS-6316_BIOSTOP G_6_octobre_2020_(6316)_avis.pdf
HAS/2020-11-18_CNEDIMTS-6368_SAMBA 2_6_octobre_2020_(6368)_avis.pdf
HAS/2020-11-18_rapport_tavis.pdf
HAS/2020-11-19_CT-18766_INTELENCE_pediatrie_PIC_EI_AvisDef_CT18766.pdf
HAS/2020-11-19_intelence_04112020_transcription_ct18766.pdf
HAS/2020-11-19_intelence_pediatrie_04112020_synthese_ct18766.pdf
HAS/2020-11-20_CNEDIMTS-6106_DEKAS AQUA-E LIQUIDE_22_septembre_2020_(6106)_avis.pdf
HAS/2020-11-20_CNEDIMTS-6255_HIRESOLUTION_6_octobre_2020_(6255)_avis.pdf
HAS/2020-11-20_CNEDIMTS-6256_NUCLEUS_6_octobre_2020_(6256)_avis.pdf
HAS/2020-11-20_CNEDIMTS-6257_NEURO ZTI_6_octobre_2020_(6257)_avis.pdf
HAS/2020-11-20_CNEDIMTS-6341_HYLO LIPID_3_novembre_2020_(6341)_avis.pdf
HAS/2020-11-20_CNEDIMTS-6386_PORTICO FLEXNAV _3_novembre_2020_(6386)_avis.pdf
HAS/2020-11-20_CT-18875_DEXAMETHASONE_KRKA_PIS_INS_AvisDef_CT18875.pdf
HAS/2020-11-20_CT-18979_DEXAMETHASONE_PANPHARMA_PIS_INS_AvisDef_CT18977&18979.pdf
HAS/2020-11-20_note_de_cadrage_validee_addictions.pdf
HAS/2020-11-24_20spa198_covid19_mesures__prevention_transmission_sars-cov2_pec_patients_milieu_soins_mel.pdf
HAS/2020-11-24_CT-18857_METHOTREXATE_ACCORD_Crohn_PIS_EI_AvisDef_CT18857.pdf
HAS/2020-11-24_CT-18927_PHENERGAN_PIS_INS_CG_AvisDef_CT18927.pdf
HAS/2020-11-24_CT-18941_IDELVION_PIS_INS_CG_AvisDef_CT18941.pdf
HAS/2020-11-24_app_253_cadrage_douleur_post_coi_2019_11_13_v0.pdf
HAS/2020-11-26_epilepsies_particularites_de_la_prise_en_charge_des_filles_et_des_femmes_en_age_de_procreer_-_synthese.pdf
HAS/2020-11-26_epilepsies_prise_en_charge_chez_lenfant_et_ladulte_-_avis_du_groupe_de_lecture.pdf
HAS/2020-11-26_reco308_argumentaire_epilepsies_preparation_mel.pdf
HAS/2020-11-26_reco308_recommandations_epilepsies_preparation_mel.pdf
HAS/2020-11-26_syndrome_nail-patela_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2020-11-26_syndrome_nail_patella_-_argumentaire.pdf
HAS/2020-11-26_syndrome_nail_patella_-_pnds.pdf
HAS/2020-11-27_CNEDIMTS-6266_FREESTYLE LIBRE 2_20_octobre_2020_(6266)_avis.pdf
HAS/2020-11-27_CNEDIMTS-6387_PHOENIX_3_novembre_2020_(6387)_avis.pdf
HAS/2020-11-27_CT-18933_L-THYROXIN_HENNING_PIS_INS_AvisDef_CT18933.pdf
HAS/2020-11-27_synthese_actualisation_tests_antigeniques_vd.pdf
HAS/2020-11-30_CEPP-4994_HYLOVIS_03_novembre_2015_(4994)_avis.pdf
HAS/2020-11-30_CNEDIMTS-6243_COALGAN_3_novembre_2020_(6243)_avis.pdf
HAS/2020-11-30_CNEDIMTS-6298_LAMITRODE TRIPOLE PENTA_30_juin_2020_(6298)_avis.pdf
HAS/2020-11-30_CNEDIMTS-6299_QUATTRODE OCTRODE LAMITRODE S SERIES_30_juin_2020_(6299)_avis.pdf
HAS/2020-11-30_endoprotheses_vasculaires_peripheriques_dm-eval_269_avis_2020-11-27_18-00-15_393.pdf
HAS/2020-11-30_note_de_cadrage_strategie_vaccinale_contre_la_covid_19.pdf
HAS/2020-11-30_strategie_de_vaccination_contre_le_sars-cov-2_2020-11-30_10-40-59_242.pdf
HAS/2020-12-01_immunological_and_virological_aspects_of_sars-cov-2_-_genetic_variability_immune_responses_vaccine_platforms_and_animal_mode.pdf
HAS/2020-12-01_rapport_-_immunite_au_cours_de_linfection_par_le_sars-cov-2_2020-11-30_17-25-10_860.pdf
HAS/2020-12-02_CT-16631_CLOTTAFACT_PIS_MCI_AvisDef_CT16631.pdf
HAS/2020-12-02_CT-18731_PALYNZIQ_PIC_INS_AvisDef_CT18731_EPI705.pdf
HAS/2020-12-02_CT-18838_KINERET_FMF_PIC_EI_AvisDef_CT18838.pdf
HAS/2020-12-02_cr-gl-tracheotomie.pdf
HAS/2020-12-02_kineret_18112020_transcription_ct18838.pdf
HAS/2020-12-02_kineret_181120_summary_ct18838.pdf
HAS/2020-12-02_kineret_fmf_18112020_synthese_ct18838.pdf
HAS/2020-12-02_palynziq_04112020_transcription_ct18731.pdf
HAS/2020-12-02_palynziq_18112020_synthese_ct18731.pdf
HAS/2020-12-02_palynziq_181121_summary_ct18731.pdf
HAS/2020-12-02_reco291_argumentaire_rbp_tracheotomie_cd_2020_11_mel.pdf
HAS/2020-12-02_reco291_recommandations_rbp_tracheotomie_11_2020_mel.pdf
HAS/2020-12-04_CT-18785_MABTHERA_PIC_EI_AvisDef_CT18785.pdf
HAS/2020-12-04_mabthera_02122020_synthese_ct18785.pdf
HAS/2020-12-04_mabthera_02122020_transcription_ct18785.pdf
HAS/2020-12-04_mabthera_021220_summary_ct18785.pdf
HAS/2020-12-04_mabthera_04112020_transcription_ct18785.pdf
HAS/2020-12-04_reco425_reponse_prevention_cd_2020_12_03_v1_2_mel.pdf
HAS/2020-12-04_synthese_rt-lamp_salivaire_sars-cov-2.pdf
HAS/2020-12-04_synthese_rt-pcr_salivaire_sars-cov-2.pdf
HAS/2020-12-08_00_reco265_pied_personnes_agees__recommandations_-_relecture_et_post_cd_30_11_2020-mel.pdf
HAS/2020-12-08_CT-18836_ILARIS_MSA_PIC_EI_AvisDef_CT18836.pdf
HAS/2020-12-08_CT-18962_ADEMPAS_PIS_INS_CG_AvisDef_CT18962.pdf
HAS/2020-12-08_analysedesquestions_du_gl_pied_age_09_11_2018_version_pour_le_gt.pdf
HAS/2020-12-08_ilaris_18112020_synthese_ct18836.pdf
HAS/2020-12-08_ilaris_18112020_transcription_ct18836.pdf
HAS/2020-12-08_ilaris_181120_summary_ct18836.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n10_medecin_de_premier_recours__orienter_pedicure_podologue.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n11_medecins_evaluationstraitementspodologiques_diabete.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n12_medecin_premier_recours_evaluations_traitements_podologiques_risques_chutes.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n1_evaluations_du_pied_dun_patient_diabetique.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n2_traitement_podologique_pied_patient_diabetique.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n3_patient_a_risque_de_chutes.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n4_effets_secondaires_traitements_anti-cancereux.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n5_modification_de_la_masse_corporelle.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n6_evaluation_de_la_douleur.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n7_examen_fonctionnel_du_pied_et_appareil_locomoteur.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n8_conseils_pour_chaussures_de_series.pdf
HAS/2020-12-08_pied_de_la_personne_agee_-_fiche_outil_n9_conseils_pour_lhygiene_et_les_soins_des_pieds.pdf
HAS/2020-12-08_reco265_pied__personnes_agees_argumentaire__post_cdet_post_relecture_jfb___2020_12-01_mel.pdf
HAS/2020-12-09_CT-18812_KAFTRIO_KALYDECO_PIC_INS_EI_AvisDef_CT18812&18878.pdf
HAS/2020-12-09_CT-18945_LATAZED_PIS_INS_AvisDef_CT18945.pdf
HAS/2020-12-09_app_356_fiche_pertinence_imagerie_cervicalgie_non_trauma_mel.pdf
HAS/2020-12-09_app_356_fiche_pertinence_imagerie_cervicalgie_post_trauma_mel.pdf
HAS/2020-12-09_app_356_rapport_pertinence_imagerie_cervicalgie_mel.pdf
HAS/2020-12-09_contribution_vaincre_la_mucoviscidose_kaftrio_ct18812.pdf
HAS/2020-12-09_kaftrio_09022021_avis_economique.pdf
HAS/2020-12-09_kaftrio_09022021_avis_economique_transcription_ceesp.pdf
HAS/2020-12-09_kaftrio_09022021_avis_economique_transcription_ceesp_2021-04-21_10-19-12_29.pdf
HAS/2020-12-09_kaftrio_12012021_avis_economique_transcription_ceesp.pdf
HAS/2020-12-09_kaftrio_kalydeco_18112020_summary_ct18812_18878_2021-03-05_12-43-44_587.pdf
HAS/2020-12-09_kaftrio_kalydeco_18112020_synthese_ct18812.pdf
HAS/2020-12-09_kaftrio_kalydeco_18112020_transcription_ct18812.pdf
HAS/2020-12-09_note_de_cadrage_actes_dimagerie_cervicale_en_cas_de_cervicalgie_chez_ladulte.pdf
HAS/2020-12-09_regles_prediction_pertinence_imagerie_cervicalgie_mel.pdf
HAS/2020-12-10_CT-17304_PARACETAMOL_SANDOZ_PIS_RCP_AvisDef_CT17304.pdf
HAS/2020-12-10_CT-18942_LIDOCAINE_CHLORHYDRATE_RENAUDIN_PIS_INS_AvisDef_CT18942.pdf
HAS/2020-12-11_170919_reperage_des_femmes_victimes_de_violences_au_sein_du_couple_argumentaire.pdf
HAS/2020-12-11_170919_reperage_des_femmes_victimes_de_violences_au_sein_du_couple_texte_recommandations.pdf
HAS/2020-12-11_CNEDIMTS-6165_GYNECARE TVT ABBREVO_3_novembre_2020_(6165)_avis.pdf
HAS/2020-12-11_CNEDIMTS-6217_SALTO_TALARIS_17_novembre_2020_(6217)_avis.pdf
HAS/2020-12-11_CNEDIMTS-6268_JUST SWING SVS_20_octobre_2020_(6268)_avis.pdf
HAS/2020-12-11_fs_femmes_violence_agir_092019.pdf
HAS/2020-12-11_fs_femmes_violence_reperer_092019.pdf
HAS/2020-12-14_CNEDIMTS-6087_BRIO_1er_décembre_2020_(6087)_avis.pdf
HAS/2020-12-14_CNEDIMTS-6349_EMBOTRAP III_6_octobre_2020_(6349)_avis.pdf
HAS/2020-12-14_CNEDIMTS-6367_TREVO NXT_6_octobre_2020_(6367)_avis.pdf
HAS/2020-12-14_has_prospective_analysis_report_2020_sex_gender_health.pdf
HAS/2020-12-14_rapport_analyse_prospective_2020.pdf
HAS/2020-12-14_rapport_analyse_prospective_2020_synthese.pdf
HAS/2020-12-15_note_de_cadrage_strategie_vaccinale_contre_la_covid_19.pdf
HAS/2020-12-15_resultat_de_la_consultation_publique_relative_au_projet_de_recommandations_intermediaires_sur_les_modalites_de_mise_en_oeuvr.pdf
HAS/2020-12-15_strategie_de_vaccination_contre_le_sars-cov-2_-_recommandations_intermediaires_sur_les_modalites_de_mise_en_oeuvre_de_la_vac.pdf
HAS/2020-12-16_CT-18344_INVOKANA_PIC_REEV_AvisDef_CT18344_EPI706.pdf
HAS/2020-12-16_CT-18623_JARDIANCE_PIC_REEV_INS_AvisDef_CT18623_EPI706.pdf
HAS/2020-12-16_CT-18678_SYNJARDY_PIC_REEV_INS_AvisDef_CT18678_EPI706.pdf
HAS/2020-12-16_CT-18813_XIGDUO_PIC_REEV_AvisDef_CT18813_EPI706.pdf
HAS/2020-12-16_CT-18815_FORXIGA_PIC_REEV_AvisDef_CT18815_EPI706.pdf
HAS/2020-12-16_contribution_alliance_du_coeur_jardiance_ct18623.pdf
HAS/2020-12-16_forxiga_18112020_summary_ct18815.pdf
HAS/2020-12-16_forxiga_18112020_synthese_ct18815.pdf
HAS/2020-12-16_forxiga_xigduo_18112020_transcription_ct1881518813.pdf
HAS/2020-12-16_invokana_21102020_summary_ct18344.pdf
HAS/2020-12-16_invokana_21102020_synthese_ct18344.pdf
HAS/2020-12-16_jardiance_21102020_summary_ct18623.pdf
HAS/2020-12-16_jardiance_21102020_synthese_ct18623.pdf
HAS/2020-12-16_rapport_reevaluation_gliflozines_avisdef_cteval506_epi706.pdf
HAS/2020-12-16_reevaluation_glifozines_07102020_transcription_cteval506.pdf
HAS/2020-12-16_synjardy_21102020_summary_ct18678.pdf
HAS/2020-12-16_synjardy_21102020_synthese_ct18678.pdf
HAS/2020-12-16_xigduo_18112020_ct18813.pdf
HAS/2020-12-16_xigduo_18112020_synthese_ct18813.pdf
HAS/2020-12-17_CT-18795_EUCREAS_PIS_INS_CG_AvisDef_CT18795.pdf
HAS/2020-12-17_CT-18889_HARVONI_PIC_EI_AvisDef_CT18889&18894.pdf
HAS/2020-12-17_CT-18900_SOVALDI_PIC_EI_AvisDef_CT18900&18901.pdf
HAS/2020-12-17_CT-18915_SMOFLIPID_PIS_INS_AvisDef_CT18915.pdf
HAS/2020-12-17_CT-18991_EPCLUSA_PIC_EI_AvisDef_CT18990&18991.pdf
HAS/2020-12-17_epclusa_02122020_synthese_ct18991.pdf
HAS/2020-12-17_epclusa_harvoni_sovaldi_02122020_transcription_ct1899118889189001.pdf
HAS/2020-12-17_harvoni_02122020_synthese_ct18889.pdf
HAS/2020-12-17_harvoni_021220_summary_ct1888918894.pdf
HAS/2020-12-17_sovaldi_02122020_synthese_ct18900.pdf
HAS/2020-12-17_sovaldi_021220_summary_ct1890018901.pdf
HAS/2020-12-18_CT-18376_BEOVU_PIC_INS_AvisDef_CT18376.pdf
HAS/2020-12-18_CT-18630_AKYNZEO_PIC_REEV_AvisDef_CT18630.pdf
HAS/2020-12-18_CT-18652_MAVIRET_PIS_RCP_AvisDef_CT18652.pdf
HAS/2020-12-18_CT-18688_QUOFENIX_PIC_INS_AvisDef_CT18688.pdf
HAS/2020-12-18_CT-18696_NOVOTHIRTEEN_PIC_INS_AvisDef_CT18696.pdf
HAS/2020-12-18_CT-18743_ZOLGENSMA_PIC_INS_AvisDef_CT18743.pdf
HAS/2020-12-18_CT-18835_BLENREP_PIC_INS_AvisDef_CT18835.pdf
HAS/2020-12-18_CT-18845_PRIMOVIST_PIC_INS_AvisDef_CT18845.pdf
HAS/2020-12-18_CT-18877_HEPCLUDEX_PIC_INS_AvisDef_CT18877.pdf
HAS/2020-12-18_akynzeo_07102020_transcription_ct18630.pdf
HAS/2020-12-18_akynzeo_16122020_synthese_ct18630.pdf
HAS/2020-12-18_akynzeo_16122020_transcription_ct18630.pdf
HAS/2020-12-18_akynzeo_161220_summary_ct18630.pdf
HAS/2020-12-18_beovu_07102020_transcription_ct18376.pdf
HAS/2020-12-18_beovu_16122020_synthese_ct18376.pdf
HAS/2020-12-18_beovu_16122020_transcription_ct18376.pdf
HAS/2020-12-18_beovu_161220_summary_ct18376_2021-11-10_17-50-34_432.pdf
HAS/2020-12-18_blenrep_16122020_synthese_ct18835.pdf
HAS/2020-12-18_blenrep_16122020_transcription_ct18835.pdf
HAS/2020-12-18_blenrep_21102020_transcription_ct18835.pdf
HAS/2020-12-18_contribution_af3m_blenrep_ct18835.pdf
HAS/2020-12-18_contribution_afh_novothirteen_ct18636.pdf
HAS/2020-12-18_contribution_afm_telethon_zolgensma_ct18743.pdf
HAS/2020-12-18_contribution_dmla_beovu_ct18376.pdf
HAS/2020-12-18_contribution_eclas_zolgensma_ct18743.pdf
HAS/2020-12-18_contribution_sos_hepatites_hepcludex_ct18877.pdf
HAS/2020-12-18_contribution_trt_5_hepcludex_ct18877.pdf
HAS/2020-12-18_hepcludex_04112020_transcription_ct18877.pdf
HAS/2020-12-18_hepcludex_12012021_avis_economique.pdf.pdf
HAS/2020-12-18_hepcludex_16122020_synthese_ct18877.pdf
HAS/2020-12-18_hepcludex_16122020_transcription_ct18877.pdf
HAS/2020-12-18_hepcludex_161220_summary_ct18877.pdf
HAS/2020-12-18_hepcludex_19.02.2020_avis_eco_transcription_ceesp.pdf
HAS/2020-12-18_novothirteen_07102020_transcription_ct18696.pdf
HAS/2020-12-18_novothirteen_16122020_synthese_ct18696.pdf
HAS/2020-12-18_novothirteen_16122020_transcription_ct18696.pdf
HAS/2020-12-18_novothirteen_161220_summary_ct18696.pdf
HAS/2020-12-18_pancreatite_chronique_hereditaire_-_argumentaire.pdf
HAS/2020-12-18_pancreatite_chronique_hereditaire_-_pnds.pdf
HAS/2020-12-18_pancreatite_chronique_hereditaire_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2020-12-18_primovist_16122020_synthese_ct18845.pdf
HAS/2020-12-18_primovist_16122020_transcription_ct18845.pdf
HAS/2020-12-18_primovist_161220_summary_ct18845.pdf
HAS/2020-12-18_primovist_18112020_transcription_ct18845.pdf
HAS/2020-12-18_quofenix_16122020_synthese_ct18688.pdf
HAS/2020-12-18_quofenix_16122020_transcription_ct18688.pdf
HAS/2020-12-18_quofenix_161220_summary_ct18688.pdf
HAS/2020-12-18_quofenix_23092020_transcription_ct18688.pdf
HAS/2020-12-18_zolgensma_07102020_transcription_ct18743.pdf
HAS/2020-12-18_zolgensma_15122020_avis_eco_transcription_ceesp.pdf
HAS/2020-12-18_zolgensma_15122020_avis_economique.pdf
HAS/2020-12-18_zolgensma_16122020_synthese_ct18743.pdf
HAS/2020-12-18_zolgensma_16122020_transcription_ct18743.pdf
HAS/2020-12-18_zolgensma_161220_summary_ct18743.pdf
HAS/2020-12-18_zolgensma_17112020_avis_eco_transcription_ceesp.pdf
HAS/2020-12-18_zolgensma_23092020_transcription_ct18743.pdf
HAS/2020-12-22_argumentaire_pnds_pros_hors_mcap-dec_2020.pdf
HAS/2020-12-22_pnds_kbg-dec2020.pdf
HAS/2020-12-22_pnds_kbg_argumentaire-dec2020.pdf
HAS/2020-12-22_pnds_kbg_synthese_mt_dec2020.pdf
HAS/2020-12-22_pnds_pros_hors_mcap_dec2020_1.pdf
HAS/2020-12-22_synthese_mg_syndromes_hypertrophiques_lies_au_gene_pik3ca_pros.pdf
HAS/2020-12-23_CNEDIMTS-6137_LOTUS EDGE_1_décembre_2020_(6137)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6171_PERCEVAL S_30_juin_2020_(6171)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6250_ALGOSTERIL_15_décembre_2020_(6250)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6274_SYSTÈME METS SANS REVÊTEMENT D’HYDROXYAPATITE_22_septembre_2020_(6274)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6276_SYSTÈME METS AGLUNA_20_octobre_2020_(6276).pdf
HAS/2020-12-23_CNEDIMTS-6300_INFATRINI PEPTISORB_3_novembre_2020_(6300)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6303_TRIDENT X3_6_octobre_2020_(6303 & 6307)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6304_ORAL IMPACT_3_novembre_2020_(6304)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6305_IMPACT ENTERAL_3_novembre_2020_(6305)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6336_KANSO 2_1_décembre_2020_(6336)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6343_BPM CONNECT_1_avril_2020_(6343)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6347_SILK VISTA  6347  SILK VISTA BABY 6384_6_octobre_2020_avis_occultations.pdf
HAS/2020-12-23_CNEDIMTS-6355_COPTOS TH 6355_17_novembre_2020_(6355)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6356_FREESTYLE OPTIUM BÉTA-CÉTONE et OPTIUM NEO_1er_décembre_2020_(6356)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6359_PROVOX MICRON HME_1er_décembre_2020_(6359)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6362_WAVEWRITER ALPHA SYSTEM_1_décembre_2020_(6362)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6363_WAVEWRITER ALPHA SYSTEM PRIME_1_décembre_2020_(6363)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6384_SILK VISTA  6347  SILK VISTA BABY 6384_6_octobre_2020_avis_occultations.pdf
HAS/2020-12-23_CNEDIMTS-6392_AMOENA BALANCE ESSENTIAL et ESSENTIAL LIGHT_20_octobre_2020_(6392)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6394_SYSTÈME METS SANS REVÊTEMENT D’HYDROXYAPATITE_22_septembre_2020_(6394)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6402_E-VITAOPEN PLUS_20_octobre_2020_(6402)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6418_SYSTANE ULTRA_1_décembre_2020_(6418)_avis.pdf
HAS/2020-12-23_CNEDIMTS-6432_LO RIDER_1_décembre_2020_(6432)_avis.pdf
HAS/2020-12-23_CT-18769_BESREMI_PIC_INS_AvisDef_CT18769.pdf
HAS/2020-12-23_CT-18782_BRAFTOVI_PIC_EI_AvisDef_CT18782.pdf
HAS/2020-12-23_CT-18846_LYNPARZA_pancreas_PIC_EI_AvisDef_CT18846.pdf
HAS/2020-12-23_CT-18903_MOVENTIG_PIS_REEV_AvisDef_CT18903.pdf
HAS/2020-12-23_besremi_04112020_transcription_ct18769.pdf
HAS/2020-12-23_besremi_16122020_synthese_ct18769.pdf
HAS/2020-12-23_besremi_16122020_transcription_ct18769.pdf
HAS/2020-12-23_besremi_161220_summary_ct18769.pdf
HAS/2020-12-23_braftovi_07102020_transcription_ct18782.pdf
HAS/2020-12-23_braftovi_0902021_avis_eco_transcription_ceesp.pdf
HAS/2020-12-23_braftovi_09022021_avis_economique_vf.pdf
HAS/2020-12-23_braftovi_15122020_avis_eco_transcription_ceesp.pdf
HAS/2020-12-23_braftovi_16122020_synthese_ct18782.pdf
HAS/2020-12-23_braftovi_16122020_transcription_ct18782.pdf
HAS/2020-12-23_braftovi_161220_summary_ct18782.pdf
HAS/2020-12-23_lynparza_04112020_transcription_ct18846.pdf
HAS/2020-12-23_lynparza_16122020_transcription_ct18846.pdf
HAS/2020-12-23_lynparza_161220_summary_ct18846.pdf
HAS/2020-12-23_lynparza_contribution_apch_ct18846.pdf
HAS/2020-12-23_lynparza_pancreas_16122020_synthese_ct18846.pdf
HAS/2020-12-24_place_vaccin_a_arnm_comirnaty_bnt162b2_synthese.pdf
HAS/2020-12-24_reponses_rapides_dans_le_cadre_de_la_covid-19_-_demarche_medicale_pour_la_vaccination_contre_la_covid-19.pdf
HAS/2020-12-24_strategie_vaccination_covid_19_place_vaccin_a_arnm_comirnaty_bnt162b2.pdf
HAS/2020-12-29_CT-18722_TAVLESSE_PIC_INS_AvisDef_CT18722_EPI709.pdf
HAS/2020-12-29_CT-18787_RYBELSUS_PIC_INS_AvisDef_CT18787.pdf
HAS/2020-12-29_CT-18799_ZEPOSIA_PIC_INS_AvisDef_CT18799.pdf
HAS/2020-12-29_CT-18831_TRULICITY_PIC_REEV_INS_AvisDef_CT18831&18943.pdf
HAS/2020-12-29_bon_usage_des_inhibiteurs_de_la_pompe_a_protons_note_de_cadrage_2020-12-02_12-01-0_843.pdf
HAS/2020-12-29_rybelsus_04112020_transcription_ct18787.pdf
HAS/2020-12-29_rybelsus_16122020_synthese_ct18787.pdf
HAS/2020-12-29_rybelsus_16122020_transcription_ct18787.pdf
HAS/2020-12-29_rybelsus_161220_summary_ct18787.pdf
HAS/2020-12-29_tavlesse_16122020_synthese_ct18722.pdf
HAS/2020-12-29_tavlesse_16122020_transcription_ct18722.pdf
HAS/2020-12-29_tavlesse_161220__summary_ct18722.pdf
HAS/2020-12-29_tavlesse_21102020_transcription_ct18722.pdf
HAS/2020-12-29_trulicity_021220_summary_ct1883118943.pdf
HAS/2020-12-29_trulicity_16122020_synthese_ct18831.pdf
HAS/2020-12-29_trulicity_18112020_transcription_ct1883118943.pdf
HAS/2020-12-29_zeposia_02122020_synthese_ct18799.pdf
HAS/2020-12-29_zeposia_02122020_transcription_ct18799.pdf
HAS/2020-12-29_zeposia_021220_summary_ct18799.pdf
HAS/2020-12-29_zeposia_contribution_lfsep_ct18799.pdf
HAS/2020-12-30_feuille_de_route_evaluation_de_la_telesurveillance_pour_eclairer_la_decision_publique_2019-02-07_16-26-4_102.pdf
HAS/2020-12-30_rapport_evaluation_telesurveillance.pdf
HAS/2020-12-31_feuille_de_route_guide_methodologique_impacts_organisationnels_dans_levaluation_des_technologies_de_sante.pdf
HAS/2020-12-31_guide_methodologique_impacts_organisationnels.pdf
HAS/2020-12-31_organisational_impact_map_for_health_technology_assessment.pdf
HAS/2021-01-05_CNEDIMTS-6307_TRIDENT X3_6_octobre_2020_(6303 & 6307)_avis.pdf
HAS/2021-01-07_CT-18842_ATECTURA_BREEZHALER_PIS_INS_AvisDef_CT18842.pdf
HAS/2021-01-07_guide_rbpp_sms_2021-01-07_10-47-37_949.pdf
HAS/2021-01-08_CT-18724_KISQALI_PIC_REEV_AvisDef_CT18724.pdf
HAS/2021-01-08_CT-18786_MABTHERA_PIC_EI_AvisDef_CT18786.pdf
HAS/2021-01-08_CT-18793_MITOMYCINE_SUBSTIPHARM_PIS_EI_AvisDef_CT18793.pdf
HAS/2021-01-08_CT-19022_ASTERLUNA_CONTINU_PIS_INS_AvisDef_CT19022.pdf
HAS/2021-01-08_CT-19023_ASTERLUNA_PIS_INS_AvisDef_CT19023.pdf
HAS/2021-01-08_kisqali_02122020_synthese_ct18724.pdf
HAS/2021-01-08_kisqali_02122020_transcription_ct18724.pdf
HAS/2021-01-08_kisqali_021220_summary_ct18724.pdf
HAS/2021-01-08_kisqali_contribution_patients_en_reseau_ct18724.pdf
HAS/2021-01-08_mabthera_02122020_transcription_ct18786.pdf
HAS/2021-01-08_mabthera_06012021_synthese_ct18786.pdf
HAS/2021-01-08_mabthera_06012021_transcription_ct18786.pdf
HAS/2021-01-08_mabthera_060121_summary_ct18786.pdf
HAS/2021-01-08_strategie_de_vaccination_contre_la_covid-19_place_du_vaccin_moderna_covid-19_mrna_nucleoside_modifie_2021-02-26_17-55-48_757.pdf
HAS/2021-01-08_synthese_strategie_de_vaccination_contre_la_covid-19_-_place_du_vaccin_moderna_covid-19_mrna_nucleoside_modified_dans_la_str.pdf
HAS/2021-01-12_CT-19016_PEMETREXED_EVER_PHARMA_PIS_INS_AvisDef_CT19016.pdf
HAS/2021-01-14_argumentaire_lhss_lam_act_08122020.pdf
HAS/2021-01-14_la_coordination_des_parcours_des_personnes_confrontees_a_des_difficultes_specifiques._la_place_des_lhss-des_lam_et_des_act-n.pdf
HAS/2021-01-14_recommandation_lhss_lam_act_08122020.pdf
HAS/2021-01-14_synthese_lhss_lam_act___08122020.pdf
HAS/2021-01-14_tab_dispositifs_soins_12_janv_maj_2021-01-13_08-37-54_588.pdf
HAS/2021-01-15_CT-18779_SARCLISA_PIC_INS_AvisDef_CT18779.pdf
HAS/2021-01-15_guide_methodologique_esatis_2019.pdf
HAS/2021-01-15_has_esatis_methodological_guide.pdf
HAS/2021-01-15_piqray_pec_temporaire_alternative_avis_1_cteval515.pdf
HAS/2021-01-15_sarclisa_15122020_avis_eco_transcription_ceesp.pdf
HAS/2021-01-15_sarclisa_15122020_avis_economique.pdf
HAS/2021-01-15_sarclisa_18112020_synthese_ct18779.pdf
HAS/2021-01-15_sarclisa_18112020_transcription_ct18779.pdf
HAS/2021-01-15_sarclisa_181120_summary_ct18779.pdf
HAS/2021-01-15_sarclisa_contribution_af3m_ct18779.pdf
HAS/2021-01-20_CT-18732_XYLOCARD_PIC_EI_AvisDef_CT18732.pdf
HAS/2021-01-20_CT-18828_GAMUNEX_PIS_EI_AvisDef_CT18828.pdf
HAS/2021-01-20_cadre_national_de_reference_-_livret_1.pdf
HAS/2021-01-20_cadre_national_de_reference_-_livret_2.pdf
HAS/2021-01-20_cadre_national_de_reference_-_livret_3.pdf
HAS/2021-01-20_cadre_national_de_reference_-_preambule.pdf
HAS/2021-01-20_cadre_national_de_reference_-_synthese.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_1-trame_pour_le_recueil_des_informations_preoccupantes.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_2-informations_pour_les_parents.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_3-modele_journal_de_bord.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_4-conseils_entretien_parents.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_5-conseils_entretien_enfant.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_6-trame_de_rapport_evaluation.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_7-presentation_des_acteurs.pdf
HAS/2021-01-20_cadre_nationale_de_reference_-_boite_outils_8-presentation_structures_pe.pdf
HAS/2021-01-20_gamunex_contribution_afm_telethon_ct18828.pdf
HAS/2021-01-20_xylocard_06012021_synthese_ct18732.pdf
HAS/2021-01-20_xylocard_06012021_transcription_ct18732.pdf
HAS/2021-01-20_xylocard_060121_summary_ct18732.pdf
HAS/2021-01-21_CT-18841_COSENTYX_enfant_PIC_EI_AvisDef_CT18841&18848.pdf
HAS/2021-01-21_CT-18960_ATROPINE_SULFATE_ACCORD_PIS_INS_AvisDef_CT18960.pdf
HAS/2021-01-21_cosentyx_02122020_transcription_ct18841.pdf
HAS/2021-01-21_cosentyx_20012021_transcription_ct18841.pdf
HAS/2021-01-21_cosentyx_200121_summary_ct1884118848.pdf
HAS/2021-01-21_cosentyx_contribution_france_psoriasis_ct18841.pdf
HAS/2021-01-21_cosentyx_enfant_20012021_synthese_ct18841.pdf
HAS/2021-01-21_monoxyde_d_azote_sol_france_pis_ins_avisdef_ct19050.pdf
HAS/2021-01-22_CNEDIMTS-5869_ACORN PRIMARY_16_juin_2020_(5869)_avis.pdf
HAS/2021-01-22_CNEDIMTS-5870_ACORN cimenté_16_juin_2020_(5870)_avis.pdf
HAS/2021-01-22_CNEDIMTS-6371_RM PRESSFIT VITAMYS_15_décembre_2020_(6371)_avis (1).pdf
HAS/2021-01-22_CT-18839_OFEV_PID_ScS_PIC_INS_AvisDef_CT18839_EPI701.pdf
HAS/2021-01-22_CT-18840_OFEV_PID_FP_PIC_INS_AvisDef_CT18840_EPI702.pdf
HAS/2021-01-22_CT-18871_PIQRAY_PIC_INS_AvisDef_CT18871.pdf
HAS/2021-01-22_ofev_04112020_transcription_ct1883918840.pdf
HAS/2021-01-22_ofev_16122020_transcription_ct1883918840.pdf
HAS/2021-01-22_ofev_contribution_andar_ct18840.pdf
HAS/2021-01-22_ofev_contribution_asso_sclerodermiques_france_ct18839.pdf
HAS/2021-01-22_ofev_pid_fp_16122020_synthese_ct18840.pdf
HAS/2021-01-22_ofev_pid_fp_161220_summary_ct18840.pdf
HAS/2021-01-22_ofev_pid_scs_16122020_synthese_ct18839.pdf
HAS/2021-01-22_ofev_pid_scs_161220_summary_ct18839.pdf
HAS/2021-01-22_piqray_02122020_transcription_ct18871.pdf
HAS/2021-01-22_piqray_20012021_synthese_ct18871.pdf
HAS/2021-01-22_piqray_20012021_transcription_ct18871.pdf
HAS/2021-01-22_piqray_200121_summary_ct18871.pdf
HAS/2021-01-23_modification_du_schema_vaccinal_contre_le_sarscov-2_dans_le_nouveau_contexte_epidemique-synthese.pdf
HAS/2021-01-25_CNEDIMTS-6241_URGOTUL_15_décembre_2020_(6241)_avis.pdf
HAS/2021-01-25_CNEDIMTS-6242_URGOTUL DUO_15 décembre_2020_(6242)_avis.pdf
HAS/2021-01-25_CNEDIMTS-6344_3D REVASCULARISATION DEVICE_15_décembre_2020_(6344)_avis.pdf
HAS/2021-01-25_CNEDIMTS-6346_COMET _20_octobre_2020_(6346)_avis.pdf
HAS/2021-01-25_CNEDIMTS-6348_COMET II _20_octobre_2020_(6348)_avis.pdf
HAS/2021-01-25_CNEDIMTS-6395_ZENITH FENETREE MULTIBRANCHE_3_novembre_2020_(6395)_avis.pdf
HAS/2021-01-26_CT-18811_DOPTELET_PIC_INS_AvisDef_CT18811.pdf
HAS/2021-01-26_CT-18908_FETCROJA_PIC_INS_AvisDef_CT18908.pdf
HAS/2021-01-26_CT-18955_OXYGENE_MEDICINAL_AIR_LIQUIDE_SANTE_FRANCE_PIS_INS_AvisDef_CT18955.pdf
HAS/2021-01-26_CT-19019_GIBITER_EASYHALER_PIS_INS_AvisDef_CT19019.pdf
HAS/2021-01-26_doptelet_02122020_transcription_ct18811.pdf
HAS/2021-01-26_doptelet_20012021_synthese_ct18811.pdf
HAS/2021-01-26_doptelet_20012021_transcription_ct18811.pdf
HAS/2021-01-26_doptelet_200121_summary_ct18811.pdf
HAS/2021-01-26_fetcroja_02122020_transcription_ct18908.pdf
HAS/2021-01-26_fetcroja_20012021_synthese_ct18908.pdf
HAS/2021-01-26_fetcroja_20012021_transcription_ct18908.pdf
HAS/2021-01-26_fetcroja_200121_summary_ct18908.pdf
HAS/2021-01-28_2020-12-10-rapport-annuel-eigs_vd.pdf
HAS/2021-01-28_infographie_rapport_eigs2019_sansintro.pdf
HAS/2021-01-28_infographie_rapport_em_2019_v0.pdf
HAS/2021-01-28_iqss_83_note_cadrage_mesures_complications_2021_01_07_vd.pdf
HAS/2021-01-28_iqss_83_rapport_eias_complications_post_ope_2020_12_19_vd.pdf
HAS/2021-01-28_iqss_has_methode_developpement_ir_2019.3.pdf
HAS/2021-01-28_rapport_eigs_medicament.pdf
HAS/2021-01-29_reco349__note_cadrage_rbp_troubles_psychiques_perinatals__mel.pdf
HAS/2021-02-02_210121_reco364__note_cadrage_rbp__partenariat_us__melv1.pdf
HAS/2021-02-02_strategie_de_vaccination_contre_la_covid-19_-_place_du_covid-19_vaccine_astrazeneca_recommandations.pdf
HAS/2021-02-02_strategie_de_vaccination_contre_la_covid-19_-_place_du_covid-19_vaccine_astrazeneca_synthese.pdf
HAS/2021-02-08_CT-19084_PEMETREXED_REDDY_PHARMA_PIS_INS_AvisDef_CT19084.pdf
HAS/2021-02-08_CT-19088_PEMETREXED_ACCORD_PIS_INS_AvisDef_CT19088.pdf
HAS/2021-02-08_rapport_fiches_dinformation_a_destination_des_familles_et_des_professionnels_de_sante_dans_le_cadre_de_lajout_du_deficit_en_.pdf
HAS/2021-02-09_CT-18985_DESOGESTREL_MYLAN_PHARMA_PIS_INS_AvisDef_CT18985.pdf
HAS/2021-02-09_CT-19031_PEMETREXED_EG_PIS_INS_AvisDef_CT19031.pdf
HAS/2021-02-09_crysvita_pect_avisdef_ct19065.pdf
HAS/2021-02-10_CNEDIMTS-6422_PROSYMES 1C20_15_décembre_2020_(6422)_avis.pdf
HAS/2021-02-11_CNEDIMTS-6328_HYDROSOFT3D_(6329)_HYDROSOFT HELICOIDAL_(6328)_HYDROFILL_(6481)_HYDROFRAME_(6480)_15_décembre_2020_avis.pdf
HAS/2021-02-11_CNEDIMTS-6329_HYDROSOFT3D_(6329)_HYDROSOFT HELICOIDAL_(6328)_HYDROFILL_(6481)_HYDROFRAME_(6480)_15_décembre_2020_avis.pdf
HAS/2021-02-11_CNEDIMTS-6345_AEQUASYAL_5_janvier_2021_(6345)_avis.pdf
HAS/2021-02-11_CNEDIMTS-6480_HYDROSOFT3D_(6329)_HYDROSOFT HELICOIDAL_(6328)_HYDROFILL_(6481)_HYDROFRAME_(6480)_15_décembre_2020_avis.pdf
HAS/2021-02-11_CNEDIMTS-6481_HYDROSOFT3D_(6329)_HYDROSOFT HELICOIDAL_(6328)_HYDROFILL_(6481)_HYDROFRAME_(6480)_15_décembre_2020_avis.pdf
HAS/2021-02-11_CT-18912_OLUMIANT_PIC_EI_DA_AvisDef_CT18912.pdf
HAS/2021-02-11_meta-analyse_rt-pcr_salive_vd.pdf
HAS/2021-02-11_olumiant_03022021_synthese_ct18912.pdf
HAS/2021-02-11_olumiant_03022021_transcription_ct18912.pdf
HAS/2021-02-11_olumiant_contribution_association_francaise_eczema_ct18912.pdf
HAS/2021-02-12_CNEDIMTS-6323_SAPIEN 3 MODÈLE 9600 TFX AVEC SYSTEME DE MISE EN PLACE CERTITUDE_5_janvier_2021_(6323)_avis.pdf
HAS/2021-02-12_CT-18971_VERZENIOS_PIC_REEV_AvisDef_CT18971.pdf
HAS/2021-02-12_fiche_douleurs.pdf
HAS/2021-02-12_fiche_douleurs_thoraciques.pdf
HAS/2021-02-12_fiche_dyspnee.pdf
HAS/2021-02-12_fiche_fatigue.pdf
HAS/2021-02-12_fiche_kinesitherapie_re_entrainement_a_l_effort.pdf
HAS/2021-02-12_fiche_kinesitherapie_syndrome_hyperventilation.pdf
HAS/2021-02-12_fiche_manifestations_neurologiques.pdf
HAS/2021-02-12_fiche_signes_cutanes_2021-11-18_22-40-4_204.pdf
HAS/2021-02-12_fiche_signes_oculaires_2021-11-18_22-39-40_963.pdf
HAS/2021-02-12_fiche_symptomes_digestifs_2021-11-18_22-40-32_267.pdf
HAS/2021-02-12_fiche_symptomes_dysautonomiques.pdf
HAS/2021-02-12_fiche_troubles_du_gout_et_de_l_odorat.pdf
HAS/2021-02-12_fiche_troubles_somatiques_fonctionnels.pdf
HAS/2021-02-12_reco403_fiche_outil_2021_alcool_cannabis_tabac_cd_2021_02_11_v0.pdf
HAS/2021-02-12_reco403_rapport_elaboration_2014_maj2021_alcool_cannabis_tabac_cd_2021_02_05.pdf
HAS/2021-02-12_reperage_precoce_et_intervention_breve_en_alcoologie_en_premier_recours_-_note_de_cadrage.pdf
HAS/2021-02-12_strategie_de_vaccination_contre_le_sars-cov-2___vaccination_des_personnes_ayant_un_antecedent_de_covid-19_-_synthese.pdf
HAS/2021-02-12_symptomes_prolonges_a_la_suite_d_une_covid_19_de_l_adulte_diagnostic_et_prise_en_charge.pdf
HAS/2021-02-12_verzenios_03022021_synthese_ct18971.pdf
HAS/2021-02-12_verzenios_03022021_transcription_ct18971.pdf
HAS/2021-02-12_verzenios_030221_summary_ct18971.pdf
HAS/2021-02-12_webinaire_symptomes_prolonges_de_la_covid-19_chez_ladulte_-_diaporama.pdf
HAS/2021-02-15_diqasm_nc_tdi_csms_validee.pdf
HAS/2021-02-16_glycogenose_de_type_iii_-_argumentaire.pdf
HAS/2021-02-16_glycogenose_de_type_iii_-_pnds.pdf
HAS/2021-02-16_guide_methodologique_pnds.pdf
HAS/2021-02-16_syndrome_lipodystrophique_de_dunnigan_-_argumentaire.pdf
HAS/2021-02-16_syndrome_lipodystrophique_de_dunnigan_-_argumentaire_2021-02-10_13-00-54_572.pdf
HAS/2021-02-16_syndrome_lipodystrophique_de_dunnigan_-_pnds.pdf
HAS/2021-02-16_syndrome_lipodystrophique_de_dunnigan_-_pnds_2021-02-10_13-00-54_570.pdf
HAS/2021-02-16_synthese_mg__syndrome_hemolytique_et_uremique.pdf
HAS/2021-02-16_synthese_mg_glycogenose_de_type_iii.pdf
HAS/2021-02-16_synthese_mg_syndrome_lipodystrophique_de_dunnigan.pdf
HAS/2021-02-17_CT-17961_FUCIDINE_PIS_RAD_AvisDef_CT17961.pdf
HAS/2021-02-17_CT-19015_DEXAMETHASONE_MYLAN_PIC_INS_AvisDef_CT19015.pdf
HAS/2021-02-17_CT-19068_DEXAMETHASONE_KRKA_PIC_INS_AvisDef_CT19068.pdf
HAS/2021-02-17_CT-19076_PRALUENT_PIS_INS_AvisDef_CT19076.pdf
HAS/2021-02-17_classification_fonctionnelle_selon_leur_finalite_dusage_des_solutions_numeriques_utilisees_dans_le_cadre_de_soins_medicaux_o.pdf
HAS/2021-02-17_dexamethasone_20012021_transcription_ct1901519068.pdf
HAS/2021-02-17_dexamethasone_krka_20012021_synthese_ct19068.pdf
HAS/2021-02-17_dexamethasone_krka_200121_summary_ct19068.pdf
HAS/2021-02-17_dexamethasone_mylan_20012021_synthese_ct19015.pdf
HAS/2021-02-17_dexamethasone_mylan_200121_summary_ct19015.pdf
HAS/2021-02-17_dm_eval_270_proposition_classification.pdf
HAS/2021-02-25_imfinzi_rtu_reco_autosaisine_has_sem_cteval516.pdf
HAS/2021-02-25_veille_covid_fevrier_2021.pdf
HAS/2021-02-25_veille_des_etudes_cliniques_publiees_pour_certains_medicaments_du_covid-19.pdf
HAS/2021-02-25_veille_des_etudes_cliniques_publiees_pour_certains_medicaments_du_covid19_-_20_octobre_2020.pdf
HAS/2021-02-25_veille_des_etudes_cliniques_publiees_pour_certains_medicaments_du_covid19_-_23_novembre_2020.pdf
HAS/2021-02-25_veille_des_etudes_cliniques_publiees_pour_certains_medicaments_du_covid19_23092020.pdf
HAS/2021-02-26_prise_en_charge_de_la_main_bote_radiale_-_argumentaire.pdf
HAS/2021-02-26_prise_en_charge_de_la_main_bote_radiale_-_pnds.pdf
HAS/2021-02-26_prise_en_charge_de_la_main_bote_radiale_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2021-03-02_CNEDIMTS-6421_COREVALVE_EVOLUT_R_02_février_2021_(6421)_avis.pdf
HAS/2021-03-02_CNEDIMTS-6423_COREVALVE_EVOLUT_PRO_02_février_2021_(6423)_avis.pdf
HAS/2021-03-02_actualisation_des_facteurs_de_risque_de_formes_graves_de_la_covid-19_et_des_reco_sur_la_strategie_de_priorisation_des_popula.pdf
HAS/2021-03-02_annexes__actualisation_des_facteurs_de_risque_de_formes_graves_de_la_covid-19_et_des_recommandations_sur_la_strategie_de_pri.pdf
HAS/2021-03-02_corevalve_evolut_r_evolut_pro_11052021_avis_economique.pdf
HAS/2021-03-02_corevalve_evolut_r_evolut_pro_11052021_transcription_ceesp_2021-07-09_15-11-11_604.pdf
HAS/2021-03-02_strategie_de_vaccination_contre_le_sars-cov-2__extension_des_competences_vaccinales_des_professionnels_de_sante.pdf
HAS/2021-03-03_CT-18869_COSENTYX_PIS_RCP_AvisDef_CT18869.pdf
HAS/2021-03-03_CT-18924_IMBRUVICA_PIC_EI_AvisDef_CT18924.pdf
HAS/2021-03-03_imbruvica_03022021_synthese_ct18924.pdf
HAS/2021-03-03_imbruvica_030221_summary_ct18924.pdf
HAS/2021-03-03_imbruvica_20012021_transcription_ct18924.pdf
HAS/2021-03-04_CT-18914_RYDAPT_PIC_REEV_AvisDef_modifiele02032021_CT18914.pdf
HAS/2021-03-04_CT-18959_CARBETOCINE_AGUETTANT_PIS_INS_AvisDef_CT18959.pdf
HAS/2021-03-04_CT-19001_TECENTRIQ_PIC_EI_AvisDef_CT19001.pdf
HAS/2021-03-04_CT-19020_CUTAQUIG_PIS_INS_AvisDef_CT19020.pdf
HAS/2021-03-04_CT-19021_COSENTYX_300mg_PIS_INS_AvisDef_CT19021.pdf
HAS/2021-03-04_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2021-03-04_rydapt_03022021_transcription_ct18914.pdf
HAS/2021-03-04_rydapt_17022021_synthese_ct18914.pdf
HAS/2021-03-04_tecentriq_03022021_synthese_ct19001.pdf
HAS/2021-03-04_tecentriq_03022021_transcription_ct19001.pdf
HAS/2021-03-04_tecentriq_030221_summary_ct19001.pdf
HAS/2021-03-04_tecentriq_13042021_avis_eco_transcription_ceesp.pdf
HAS/2021-03-04_tecentriq_13042021_avis_economique.pdf
HAS/2021-03-05_CT-19055_LYNPARZA_PECT_AvisDef_CT19055.pdf
HAS/2021-03-09_maladie_de_willebrand_-_argumentaire.pdf
HAS/2021-03-09_maladie_de_willebrand_-_pnds.pdf
HAS/2021-03-09_malformations_lymphatiques_kystiques_-_argumentaire.pdf
HAS/2021-03-09_malformations_lymphatiques_kystiques_-_pnds.pdf
HAS/2021-03-09_malformations_lymphatiques_kystiques_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2021-03-09_synthese_mg_maladie_de_willebrand.pdf
HAS/2021-03-11_CT-18045_FIRMAGON_PIC_REEV_AvisDef_CT18045.pdf
HAS/2021-03-11_CT-18650_AMELGEN_PIC_INS_AvisDef_CT18650.pdf
HAS/2021-03-11_CT-18824_ESPEROCT_PIC_INS_AvisDef_CT18824.pdf
HAS/2021-03-11_CT-18920_IMFINZI_PIC_EI_AvisDef_CT18920.pdf
HAS/2021-03-11_CT-18953_AYVAKYT_PIC_INS_AvisDef_CT18953_EPI711.pdf
HAS/2021-03-11_amelgen_06012021_transcription_ct18650.pdf
HAS/2021-03-11_amelgen_10032021_synthese_ct18650.pdf
HAS/2021-03-11_amelgen_10032021_transcription_ct18650.pdf
HAS/2021-03-11_amelgen_100321_summary_ct_18650.pdf
HAS/2021-03-11_ayvakyt_10032021_synthese_ct18953.pdf
HAS/2021-03-11_ayvakyt_10032021_transcription_ct18953.pdf
HAS/2021-03-11_ayvakyt_100321_summary_ct18953.pdf
HAS/2021-03-11_ayvakyt_20012021_transcription_ct18953.pdf
HAS/2021-03-11_esperoct_10032021_synthese_ct18824.pdf
HAS/2021-03-11_esperoct_10032021_transcription_ct18824.pdf
HAS/2021-03-11_esperoct_100321_summary_ct18824.pdf
HAS/2021-03-11_esperoct_20012021_transcription_ct18824.pdf
HAS/2021-03-11_esperoct_contribution_afh_ct18824.pdf
HAS/2021-03-11_firmagon_17022021_synthese_ct18045.pdf
HAS/2021-03-11_firmagon_17022021_transcription_ct18045.pdf
HAS/2021-03-11_firmagon_170221_summary_ct18045.pdf
HAS/2021-03-11_imfinzi_03022021_transcription_ct18920.pdf
HAS/2021-03-11_imfinzi_10032021_synthese_ct18920.pdf
HAS/2021-03-11_imfinzi_10032021_transcription_ct18920.pdf
HAS/2021-03-11_imfinzi_100321_summary_ct18920.pdf
HAS/2021-03-12_CT-18583_VECTARION_PIC_REEV_AvisDef_CT18583&17729.pdf
HAS/2021-03-12_CT-18829_JYSELECA_PIC_INS_AvisDef_CT18829.pdf
HAS/2021-03-12_CT-18988_TRIXEO_AEROSPHERE_PIC_INS_AvisDef_CT18988.pdf
HAS/2021-03-12_CT-19035_CARMUSTINE_OBVIUS_PIS_EI_AvisDef_CT19035.pdf
HAS/2021-03-12_carmustine_obvius_030321_summary_ct19035_2021-12-07_11-34-54_415.pdf
HAS/2021-03-12_jyseleca_06012021_transcription_ct18829.pdf
HAS/2021-03-12_jyseleca_10032021_synthese_ct18829.pdf
HAS/2021-03-12_jyseleca_10032021_transcription_ct18829.pdf
HAS/2021-03-12_jyseleca_100321_summary_ct18829_def.pdf
HAS/2021-03-12_jyseleca_contribution_andar_ct18929.pdf
HAS/2021-03-12_strategie_de_vaccination_contre_la_covid-19-place_du_vaccin_covid-19_janssen_recommandation_2021-03-12_20-15-41_476.pdf
HAS/2021-03-12_strategie_de_vaccination_contre_la_covid-19-place_du_vaccin_covid-19_janssen_synthese.pdf
HAS/2021-03-12_trixeo_aerosphere_03022021_transcription_ct18988.pdf
HAS/2021-03-12_trixeo_aerosphere_10032021_synthese_ct18988.pdf
HAS/2021-03-12_trixeo_aerosphere_10032021_transcription_ct18988.pdf
HAS/2021-03-12_vectarion_03022021_transcription_ct18583.pdf
HAS/2021-03-12_vectarion_17022021_synthese_ct18583.pdf
HAS/2021-03-12_vectarion_170221_summary_ct1858317729.pdf
HAS/2021-03-15_CNEDIMTS-6088_LIBRA_15_décembre_2020_(6088)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6090_INFINITY_15_décembre_2020_(6090)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6317_EXUFIBER_19_janvier_2021_(6317)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6352_HYLOVIS MULTI_15_décembre_2020_(6352)_(6393)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6353_HYLOVIS_15_décembre_2020_(6353)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6354_VISMED_15_décembre_2020_(6354)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6377_PROCLAIM XR_5_janvier_2021_(6377)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6379_PRESSUREWIRE CERTUS AERIS X_19_janvier_2021_ (6379)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6382_VISMED MULTI_15_décmbre_2020_(6382)_(6399)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6393_HYLOVIS MULTI_15_décembre_2020_(6352)_(6393)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6397_FIGULLA FLEX II PFO_19_ janvier_ 2021_(6397)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6399_VISMED MULTI_15_décmbre_2020_(6382)_(6399)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6401_ON-X ASCENDING AORTIC PROSTHESIS_5_janvier_2021_(6401)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6439_ENTERPRISE_5_janvier_2021_(6439)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6445_MITRACLIP G4-XT_19_janvier_2021_(6445)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6447_MITRACLIP G4-NT_19_janvier_2021_(6447)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6488_REVEAL XT_16_février_2021_6488_avis.pdf
HAS/2021-03-15_CNEDIMTS-6496_LUMENO FLEX_2_février_2021_(6496)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6497_LUMENO ALPHA_2_février_2021_( 6497)_avis.pdf
HAS/2021-03-15_CNEDIMTS-6498_LUMENO FREE_02_février_2021_(6498)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6105_MOBILE DREAM_19_janvier_2021_(6105)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6357_DBLG1_15_décembre_2020_(6357)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6364_KETOCAL 4 1_19_ janvier_2021_ (6364)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6419_YOMPER_2_février_2021_(6419)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6424_MINIMX4_1_décembre_2020_(6424)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6438_NUCLEUS CI522_02_février_2021_(6438)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6450_TRUESPAN_15_décembre_2020_(6450)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6463_BALANCE FOOT S_5_janvier_2021_ (6463)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6487_TALEO LP_02_février_2021_(6487)_avis.pdf
HAS/2021-03-16_CNEDIMTS-6493_MENTOR_02_février_2021_(6493)_avis.pdf
HAS/2021-03-16_CT-18796_OTEZLA_PIC_EI_AvisDef_CT18796.pdf
HAS/2021-03-16_CT-18913_VERASEAL_PIC_INS_AvisDef_CT18913.pdf
HAS/2021-03-16_CT-18956_ZEJULA_PIC_EI_Entretien_1ere_ligne_AvisDef_CT18956.pdf
HAS/2021-03-16_CT-19030_ENERZAIR_BREEZHALER_PIC_INS_AvisDef_CT19030.pdf
HAS/2021-03-16_CT-19087_PLEGRIDY_PIS_INS_AvisDef_CT19087.pdf
HAS/2021-03-16_enerzair_breezhaler_10032021_synthese_ct19030.pdf
HAS/2021-03-16_enerzair_breezhaler_10032021_transcription_ct19030.pdf
HAS/2021-03-16_enerzair_breezhaler_100321_summary_ct19030.pdf
HAS/2021-03-16_enerzair_breezhaler_20012021_transcription_ct19030.pdf
HAS/2021-03-16_inahta_brief_rm_implantable_loop_recorder.pdf
HAS/2021-03-16_otezla_06012021_transcription_ct18796.pdf
HAS/2021-03-16_otezla_10032021_synthese_ct18796.pdf
HAS/2021-03-16_otezla_10032021_transcription_ct18796.pdf
HAS/2021-03-16_otezla_100321_summary_ct18796.pdf
HAS/2021-03-16_rapport_ts_mci_vd.pdf
HAS/2021-03-16_veraseal_06012021_transcription_ct18913.pdf
HAS/2021-03-16_veraseal_10032021_synthese_ct18913.pdf
HAS/2021-03-16_veraseal_10032021_transcription_ct18913.pdf
HAS/2021-03-16_zejula_03032021_synthese_ct18956.pdf
HAS/2021-03-16_zejula_030321_summary_ct18956.pdf
HAS/2021-03-16_zejula_17022021_transcription_ct18956.pdf
HAS/2021-03-18_CT-17784_TOBRADEX_PIC_REEV_AvisDef_CT17784.pdf
HAS/2021-03-18_CT-17785_MAXIDROL_PIC_REEV_AvisDef_CT17785.pdf
HAS/2021-03-18_CT-17851_STERDEX_PIC_REEV_AvisDef_CT17851.pdf
HAS/2021-03-18_CT-17853_CHIBRO-CADRON_PIC_REEV_AvisDef_CT17853.pdf
HAS/2021-03-18_CT-17962_FRAKIDEX_PIC_REEV_AvisDef_CT17962.pdf
HAS/2021-03-18_CT-18929_EVENITY_PIC_INS_AvisDef_CT18929_EPI712.pdf
HAS/2021-03-18_CT-18984_BAVENCIO_PIC_EI_AvisDef_CT18984.pdf
HAS/2021-03-18_bavencio_03032021_synthese_ct18984.pdf
HAS/2021-03-18_bavencio_03032021_transcription_ct18984.pdf
HAS/2021-03-18_bavencio_030321_summary_ct18984.pdf
HAS/2021-03-18_bavencio_26102021_avis_eco_transcription_ceesp.pdf
HAS/2021-03-18_bavencio_26102021_avis_economique.pdf
HAS/2021-03-18_bavencio_28092021_avis_eco_transcription_ceesp.pdf
HAS/2021-03-18_bavencio_contribution_association_cancer_vessie_france_ct18984.pdf
HAS/2021-03-18_chibro-cadron_17022021_synthese_ct17853.pdf
HAS/2021-03-18_chibro-cadron_170221_summary_ct17853.pdf
HAS/2021-03-18_evenity_03022021_transcription_ct18929.pdf
HAS/2021-03-18_evenity_10032021_synthese_ct18929.pdf
HAS/2021-03-18_evenity_10032021_transcription_ct18929.pdf
HAS/2021-03-18_evenity_100321_summary_ct18929.pdf
HAS/2021-03-18_evenity_contribution_aflar_ct18929.pdf
HAS/2021-03-18_fiche_telesoin_bonnes_pratiques_2021-03-12_11-33-56_248.pdf
HAS/2021-03-18_frakidex_17022021_synthese_ct17962.pdf
HAS/2021-03-18_frakidex_170221_summary_ct17962.pdf
HAS/2021-03-18_has_fiche_teleconsultation-telesoin.pdf
HAS/2021-03-18_maxidrol_17022021_synthese_ct17785.pdf
HAS/2021-03-18_qualite_et_securite_du_telesoin_-_criteres_deligibilite_et_bonnes_pratiques_pour_la_mise_en_oeuvre_-_rapport_delaboration.pdf
HAS/2021-03-18_rapport_reevaluation_collyres_atb_corticoides_avisdef_cteval503.pdf
HAS/2021-03-18_reevaluation_collyres_17022021_transcription_cteval503.pdf
HAS/2021-03-18_reevaluation_collyres_21102020_transcription_cteval503.pdf
HAS/2021-03-18_sterdex_17022021_synthese_ct17851.pdf
HAS/2021-03-18_sterdex_170221_summary_ct17851.pdf
HAS/2021-03-18_tobradex_17022021_synthese_ct17784.pdf
HAS/2021-03-18_tobradex_170221_summary_ct17784.pdf
HAS/2021-03-19_rapport_endoprothese_aortique_abdominale_dm-eval_235.pdf
HAS/2021-03-22_CNEDIMTS-5986_ZENITH LOW PROFILE_1_décembre_2020_(5986)_avis.pdf
HAS/2021-03-22_CNEDIMTS-6193_MYOBOCK_19_janvier_2021_(6193)_avis.pdf
HAS/2021-03-22_CNEDIMTS-6405_BIOMONITOR IIIm_02_février_2021_(6405)_avis.pdf
HAS/2021-03-22_CNEDIMTS-6464_ANACONDA_15_décembre_2020_(6464)_avis.pdf
HAS/2021-03-22_CNEDIMTS-6465_SPOT_2_février_2021_(6465)_avis.pdf
HAS/2021-03-22_CNEDIMTS-6469_ZENITH FLEX AUI_15_décembre_2020_(6469)_avis.pdf
HAS/2021-03-22_CNEDIMTS-6501_MYOBOCK_19_janvier_2021_(6501)_avis.pdf
HAS/2021-03-22_CT-18876_HUMIRA_hidrosadenite_PIC_REEV_AvisDef_CT18876.pdf
HAS/2021-03-22_CT-18922_BUVIDAL_PIC_INS_AvisDef_CT18922.pdf
HAS/2021-03-22_CT-19130_ZYKADIA_PIC_REEV_AvisDef_CT19130.pdf
HAS/2021-03-22_brief_inahta_vitamine_b1.pdf
HAS/2021-03-22_buvidal_06012021_transcription_ct18922.pdf
HAS/2021-03-22_buvidal_10032021_synthese_ct18922.pdf
HAS/2021-03-22_buvidal_10032021_transcription_ct18922.pdf
HAS/2021-03-22_buvidal_100321_summary_ct18922.pdf
HAS/2021-03-22_buvidal_contribution_asud_ct18922.pdf
HAS/2021-03-22_buvidal_contribution_fpea_ct18922.pdf
HAS/2021-03-22_buvidal_contribution_safe_ct18922.pdf
HAS/2021-03-22_humira_03032021_synthese_ct18876.pdf
HAS/2021-03-22_humira_030321_summary_ct18876.pdf
HAS/2021-03-22_humira_17022021_transcription_ct18876.pdf
HAS/2021-03-22_rapport_dosage_vitamine_b1_vd.pdf
HAS/2021-03-22_systeme_myobock.pdf
HAS/2021-03-22_zykadia_03032021_synthese_ct19130.pdf
HAS/2021-03-22_zykadia_03032021_transcription_ct19130.pdf
HAS/2021-03-22_zykadia_030321_summary_ct19130.pdf
HAS/2021-03-25_19fm328_pic_pollution_cadrage__mel.pdf
HAS/2021-03-25_amyotrophie_spinale_infantile_-_argumentaire.pdf
HAS/2021-03-25_amyotrophie_spinale_infantile_-_pnds.pdf
HAS/2021-03-25_les_maladies_du_spectre_de_la_neuromyelite_optique_-_argumentaire.pdf
HAS/2021-03-25_les_maladies_du_spectre_de_la_neuromyelite_optique_-_pnds.pdf
HAS/2021-03-25_syndromes_myastheniques_congenitaux_-_argumentaire.pdf
HAS/2021-03-25_syndromes_myastheniques_congenitaux_-_pnds.pdf
HAS/2021-03-25_syndromes_myastheniques_congenitaux_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2021-03-25_synthese_mg_amyotrophie_spinale_infantile.pdf
HAS/2021-03-25_synthese_mg_les_maladies_du_spectre_de_la_neuromyelite_optique.pdf
HAS/2021-03-26_CT-17354_KEYTRUDA_PIC_REEV_AvisDef_CT17354.pdf
HAS/2021-03-26_argumentaire_du_dossier_de_liaison_durgence_domicile_dlu-dom.pdf
HAS/2021-03-26_document_de_liaison_dugence_a_domicile.pdf
HAS/2021-03-26_dossier_de_liaison_durgence_domicile_dlu_dom_note_de_cadrage.pdf
HAS/2021-03-26_fiche_de_liaison_durgence.pdf
HAS/2021-03-26_guide_dutilisation_du_dossier_de_liaison_durgence_domicile_dlu-dom.pdf
HAS/2021-03-26_keytruda_03032021_transcription_ct17354.pdf
HAS/2021-03-26_keytruda_030321_summary_ct17354.pdf
HAS/2021-03-26_keytruda_cbnpc_2eme_ligne_03032021_synthese_ct17354.pdf
HAS/2021-03-26_talzenna_pec_temporaire_alternative_avisdef_cteval521.pdf
HAS/2021-03-29_CT-19128_TARDYFERON_PIS_INS_AvisDef_CT19128.pdf
HAS/2021-03-29_namuscla_rtu_reco_autosaisine_has_sem_cteval517.pdf
HAS/2021-03-30_argumentaire_pnds_pendred.pdf
HAS/2021-03-30_recommandation_vaccinale_contre_les_meningocoques_des_serogroupes_a_c_w_et_y_2021-03-30_11-41-37_392.pdf
HAS/2021-03-30_reommandation_vaccinale_contre_les_meningocoques_des_serogroupes_a_c_w_et_y_synthese.pdf
HAS/2021-03-30_syndrome_de_pendred_pnds.pdf
HAS/2021-03-30_synthese_mg_syndrome_de_pendred.pdf
HAS/2021-03-31_CNEDIMTS-6294_EDWARDS_SAPIEN3_16_03_2021_(6294)_avis.pdf
HAS/2021-03-31_CNEDIMTS-6339_ADHEAR_9_mars_2021_(6339)_avis.pdf
HAS/2021-03-31_CNEDIMTS-6443_BR 7000_9_mars_2021_( 6443)_avis.pdf
HAS/2021-03-31_CT-18957_RUCONEST_PIC_EI_REEV_AvisDef_CT18957.pdf
HAS/2021-03-31_ruconest_03032021_transcription_ct18957.pdf
HAS/2021-03-31_ruconest_10032021_synthese_ct18957.pdf
HAS/2021-03-31_ruconest_100321_summary_ct18957.pdf
HAS/2021-03-31_ruconest_contribution_amsao_ct18957.pdf
HAS/2021-03-31_sapien3_09022021_avis_eco_transcription_ceesp_vf.pdf
HAS/2021-03-31_sapien3_09032021_avis_eco_transcription_ceesp_vf.pdf
HAS/2021-03-31_sapien3_9022021_avis_economique_vf2.pdf
HAS/2021-04-01_CT-19059_BACLOFENE_ZENTIVA_PIC_EI_AvisDef_CT19059_EPI715.pdf
HAS/2021-04-01_CT-19110_GIVLAARI_PIS_INS_AvisDef_CT19110.pdf
HAS/2021-04-01_baclofene_zentiva_03032021_transcription_ct18760.pdf
HAS/2021-04-01_baclofene_zentiva_24032021_synthese_ct19059.pdf
HAS/2021-04-01_baclofene_zentiva_240321_summary_ct_19059.pdf
HAS/2021-04-01_baclofene_zentiva_contribution_association_baclofene_ct19059.pdf
HAS/2021-04-01_baclofene_zentiva_contribution_collectif_baclohelp_ct19059.pdf
HAS/2021-04-02_CT-19166_XENETIX_PIS_INS_AvisDef_CT19166.pdf
HAS/2021-04-02_note_de_cadrage_integration_de_la_cartograhie_relative_a_limpact_organisationnel_dans_les_criteres_devaluation_cnedimts.pdf
HAS/2021-04-07_CT-19124_FOLINATE_DE_CALCIUM_ALTAN_PIS_INS_AvisDef_CT19124.pdf
HAS/2021-04-07_evaluation_des_evolutions_incrementales_des_dispositifs_medicaux_par_la_cnedimts_-_note_de_cadrage.pdf
HAS/2021-04-07_guide_evolutions_incrementales.pdf
HAS/2021-04-08_CT-18760_SELINCRO_PIC_REEV_EPI_AvisDef_CT18760.pdf
HAS/2021-04-08_CT-19053_RECARBRIO_PIS_RCP_AvisDef_CT19053.pdf
HAS/2021-04-08_CT-19122_PHESGO_PIC_INS_AvisDef_CT19122.pdf
HAS/2021-04-08_CT-19140_BACTRIM_PIS_INS_AvisDef_CT19140.pdf
HAS/2021-04-08_phesgo_24032021_synthese_ct19122.pdf
HAS/2021-04-08_phesgo_24032021_transcription_ct19122.pdf
HAS/2021-04-08_phesgo_240321_summary_ct19122.pdf
HAS/2021-04-08_selincro_03032021_transcription_ct18760.pdf
HAS/2021-04-08_selincro_24032021_synthese_ct18760.pdf
HAS/2021-04-08_selincro_240321_summary_ct18760.pdf
HAS/2021-04-08_selincro_contribution_fnas_ct18760.pdf
HAS/2021-04-09_CT-18961_SINETRAV_PIS_INS_AvisDef_CT18961.pdf
HAS/2021-04-09_CT-18963_BAQSIMI_PIC_INS_AvisDef_CT18963.pdf
HAS/2021-04-09_CT-18992_SMOFKABIVEN_E_PROTEINE_PIS_INS_AvisDef_CT18992.pdf
HAS/2021-04-09_CT-19017_XROMI_PIC_INS_AvisDef_CT19017.pdf
HAS/2021-04-09_CT-19028_SELENIUM_PANPHARMA_PIS_INS_AvisDef_CT19028.pdf
HAS/2021-04-09_CT-19090_DUPHALAC_PIS_INS_AvisDef_CT19090.pdf
HAS/2021-04-09_baqsimi_03032021_transcription_ct18963.pdf
HAS/2021-04-09_baqsimi_24032021_summary_ct18963.pdf
HAS/2021-04-09_baqsimi_24032021_synthese_ct18963.pdf
HAS/2021-04-09_baqsimi_24032021_transcription_ct18963.pdf
HAS/2021-04-09_baqsimi_contribution_aide_jeunes_diabetiques_ct18963.pdf
HAS/2021-04-09_baqsimi_contribution_federation_francaise_des_diabetiques_ct18963.pdf
HAS/2021-04-09_strategie_vaccinale_contre_la_covid-19___impact_potentiel_de_la_circulation_des_variants_du_sars-cov-2_sur_la_strategie_synt.pdf
HAS/2021-04-09_xromi_24032021_synthese_ct19017.pdf
HAS/2021-04-09_xromi_24032021_transcription_ct19017.pdf
HAS/2021-04-09_xromi_contribution_federation_fmdt_sos_globi_ct19017.pdf
HAS/2021-04-12_reco406_argumentaire_ivg_medicamenteuse_mel.pdf
HAS/2021-04-12_reco406_recommandations_ivg_medicamenteuse_mel.pdf
HAS/2021-04-13_CNEDIMTS-6168_STAR_16_mars_2021_(6168)_avis.pdf
HAS/2021-04-13_CNEDIMTS-6169_STAR_16_mars_2021_(6169)_avis.pdf
HAS/2021-04-13_CNEDIMTS-6265_INTERSTIM MICRO SURESCAN MRI_20_octobre_2020_(6265)_avis.pdf
HAS/2021-04-13_CNEDIMTS-6442_VARIMATE_5_janvier_2021_(6442)_avis.pdf
HAS/2021-04-13_CNEDIMTS-6500_BAHA 6 MAX_9_mars_2021_(6500)_avis.pdf
HAS/2021-04-13_CNEDIMTS-6518_BAHA 4_9_mars_2021_(6518)_avis.pdf
HAS/2021-04-13_reco404_cadrage_risque_cardiovasculaire_premier_recours_vf.pdf
HAS/2021-04-13_reco_rr_suivi_ambulatoire_cd_8_04_21_v2_mel.pdf
HAS/2021-04-16_CNEDIMTS-6370_ROSIDAL KOMPACT KIT_30_mars_2021_(6370)_avis.pdf
HAS/2021-04-16_has_methodological_guidelines_outcome_indicators_2019.pdf
HAS/2021-04-16_iqss_has_methode_developpement_ir_2019.3.pdf
HAS/2021-04-16_synthese_tests_antigeniques_automatises_sars-cov-2_vd.pdf
HAS/2021-04-19_CNEDIMTS-6426_ROADSAVER_09_mars_2021_ (6426)_avis.pdf
HAS/2021-04-19_CNEDIMTS-6427_CASPER_09_mars_2021_(6427)_avis.pdf
HAS/2021-04-19_obturateurs_vasculaires_dits__plugs_dembolisation__-_referentiel.pdf
HAS/2021-04-19_polyradiculoneuropathie_inflammatoire_demyelinisante_chronique_-_argumentaire.pdf
HAS/2021-04-19_polyradiculoneuropathie_inflammatoire_demyelinisante_chronique_-_pnds.pdf
HAS/2021-04-19_polyradiculoneuropathie_inflammatoire_demyelinisante_chronique_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2021-04-20_CNEDIMTS-6398_TALI_30_mars_2021_(6398)_avis.pdf
HAS/2021-04-21_programme_de_soins_psychiatriques_sans_consentement._guide.pdf
HAS/2021-04-21_programme_de_soins_psychiatriques_sans_consentement._synthese.pdf
HAS/2021-04-22_CT-19018_YESCARTA_PIC_REEV_AvisDef_CT19018.pdf
HAS/2021-04-22_CT-19040_KYMRIAH_LAL_B_PIC_REEV_AvisDef_CT19040.pdf
HAS/2021-04-22_CT-19042_KYMRIAH_LDGCB_PIC_REEV_AvisDef_CT19042.pdf
HAS/2021-04-22_CT-19149_ROACTEMRA_PIC_REEV_AvisDef_CT19149.pdf
HAS/2021-04-22_kymriah_contribution_france_lymphome_espoir_ct19042.pdf
HAS/2021-04-22_kymriah_lal_b_03032021_transcription_ct19040.pdf
HAS/2021-04-22_kymriah_lal_b_24032021_synthese_ct19040.pdf
HAS/2021-04-22_kymriah_ldgcb_03032021_transcription_ct19042.pdf
HAS/2021-04-22_kymriah_ldgcb_24032021_synthese_ct19042.pdf
HAS/2021-04-22_roactemra_24032021_synthese_ct19149.pdf
HAS/2021-04-22_roactemra_24032021_transcription_ct19149.pdf
HAS/2021-04-22_roactemra_240321_summary_ct19149.pdf
HAS/2021-04-22_yescarta_03032021_transcription_ct19018.pdf
HAS/2021-04-22_yescarta_24032021_synthese_ct19018.pdf
HAS/2021-04-22_yescarta_240321_summary_ct19018.pdf
HAS/2021-04-22_yescarta_contribution_france_lymphome_espoir_ct19018.pdf
HAS/2021-04-23_acidurie_glutarique_type_1_-_argumentaire.pdf
HAS/2021-04-23_acidurie_glutarique_type_1_-_pnds.pdf
HAS/2021-04-23_acidurie_glutarique_type_1_-_synthese_de_pnds_a_destination_du_medecin_traitant.pdf
HAS/2021-04-23_pe_psy_mel_vf.pdf
HAS/2021-04-26_CT-18976_Planning CT fin 2020-2021.pdf
HAS/2021-04-26_CT-18978_Planning CT fin 2020-2021.pdf
HAS/2021-04-26_rekambys_21042021_synthese_ct18976.pdf
HAS/2021-04-26_rekambys_summary_ct18976.pdf
HAS/2021-04-26_rekambys_vocabria_17022021_transcription_ct1897618978.pdf
HAS/2021-04-26_rekambys_vocabria_21042021_transcription_ct1897618978.pdf
HAS/2021-04-26_rekambys_vocabria_contribution_collectif_interassociatif_trt-5-chv_ct1897618978.pdf
HAS/2021-04-26_synthese_tests_ag_nasal_vd.pdf
HAS/2021-04-26_vocabria_21042021_synthese_ct18978.pdf
HAS/2021-04-28_reco_435__reponse_rapide_prep_au_vih_150421_cd_vudoc_am_pg_vd_mel_v0.pdf
HAS/2021-04-29_fimarad_pnds_pxe_argumentaire_mars_2021.pdf
HAS/2021-04-29_fimarad_pnds_pxe_mars_2021.pdf
HAS/2021-04-29_pseudoxanthome_elastique_pxe_-_synthese_du_pnds_a_destination_du_medecin_traitant.pdf
HAS/2021-04-30_CT-17521_KARDEGIC_PIC_EI_AvisDef_CT17521.pdf
HAS/2021-04-30_CT-17819_CLOMIPRAMINE_CHLORHYDRATE_MYLAN_PIS_INS_AvisDef_CT17819.pdf
HAS/2021-04-30_CT-18847_LIBMELDY_PIC_INS_AvisDef_CT18847_EPI713.pdf
HAS/2021-04-30_CT-18944_DONASERT_PIS_INS_AvisDef_CT18944.pdf
HAS/2021-04-30_CT-19002_ARIKAYCE_LIPOSOMAL_PIC_INS_AvisDef_CT19002.pdf
HAS/2021-04-30_CT-19034_ENSTILAR_PIS_INS_CG_AvisDef_CT19034.pdf
HAS/2021-04-30_CT-19036_ENSTILAR_PIS_RCP_TTentretien_AvisDef_CT19036.pdf
HAS/2021-04-30_CT-19049_CHAMPIX_PIS_INS_AvisDef_CT19049.pdf
HAS/2021-04-30_CT-19058_FIBRYGA_PIS_INS_AvisDef_CT19058.pdf
HAS/2021-04-30_CT-19060_DUPIXENT_enfant_DA_PIC_EI_AvisDef_CT19060.pdf
HAS/2021-04-30_CT-19069_BRIMONIDINE_OMNIVISION_PIS_INS_AvisDef_CT19069.pdf
HAS/2021-04-30_CT-19119_FIXAPOST_PIS_INS_CG_AvisDef_CT19119.pdf
HAS/2021-04-30_CT-19138_SOLUMEDROL_PIS_INS_CG_AvisDef_CT19138.pdf
HAS/2021-04-30_CT-19143_SIMVASTATINE_MYLAN_PIS_INS_AvisDef_CT19143.pdf
HAS/2021-04-30_CT-19146_CIFLOX_MONOFLOCET_OFLOCET_PIS_REEV_AvisDef_CT19146&19142.pdf
HAS/2021-04-30_CT-19177_OXOMEMAZINE_CRISTERS_PIS_INS_AvisDef_CT19177.pdf
HAS/2021-04-30_CT-19198_CHLORHEXIDINE_DIGLUCONATE_ALCOOL_ISOPROPYLIQUE_GILBERT_PIS_INS_AvisDef_CT19198.pdf
HAS/2021-04-30_CT-19210_OCTAPLASLG_PIS_INS_AvisDef_CT19210.pdf
HAS/2021-04-30_CT-19224_CONFEROPORT_PIS_INS_AvisDef_CT19224.pdf
HAS/2021-04-30_actualisation_des_facteurs_de_risque_de_formes_graves_de_la_covid-19_et_des_reco_sur_la_strategie_de_priorisation_des_popula.pdf
HAS/2021-04-30_annexes__actualisation_des_facteurs_de_risque_de_formes_graves_de_la_covid-19_et_des_recommandations_sur_la_strategie_de_pri.pdf
HAS/2021-04-30_arikayce_liposomal_03032021_transcription_ct19002.pdf
HAS/2021-04-30_arikayce_liposomal_21042021_synthese_ct19002.pdf
HAS/2021-04-30_arikayce_liposomal_21042021_transcription_ct19002.pdf
HAS/2021-04-30_dupixent_06072021__avis_eco_transcription_ceesp.pdf
HAS/2021-04-30_dupixent_06072021_avis_economique.pdf
HAS/2021-04-30_dupixent_21042021_transcription_ct19060.pdf
HAS/2021-04-30_dupixent_24032021_transcription_ct19060.pdf
HAS/2021-04-30_dupixent_contribution_association_francaise_de_l_eczema_ct19060.pdf
HAS/2021-04-30_dupixent_enfant_da_21042021_synthese_ct19060.pdf
HAS/2021-04-30_fibryga_contribution_afh_ct19058.pdf
HAS/2021-04-30_kardegic_24032021_synthese_ct17521.pdf
HAS/2021-04-30_kardegic_24032021_transcription_ct17521.pdf
HAS/2021-04-30_libmeldy_17022021_transcription_ct18847.pdf
HAS/2021-04-30_libmeldy_21042021_synthese_ct18847.pdf
HAS/2021-04-30_libmeldy_21042021_transcription_ct18847.pdf
HAS/2021-04-30_libmeldy_contribution_ela_france_ct18847.pdf
HAS/2021-04-30_npad_decret_criteres_classification_avisdef_cteval523.pdf
HAS/2021-04-30_reco361_cadrage_antibiogrammes_cibles_coi_2021_03_10_v1__mel_sabine.pdf
HAS/2021-04-30_recommandation_relative_a_la_vaccination_contre_la_covid_19_de_lentourage_de_certaines_populations_vulnerables.pdf
HAS/2021-04-30_strategie_de_vaccination_contre_la_covid-19_-vaccination_prioritaire_de_lentourage_des_personnes_immunodeprimees_contre_le_s.pdf
HAS/2021-05-03_CNEDIMTS-6484_IFUSE 3D_16_février_2021_(6484)_avis.pdf
HAS/2021-05-03_CNEDIMTS-6490_PERLE_16_février_2021_(6490)_avis.pdf
HAS/2021-05-03_CNEDIMTS-6503_SALTO_09_mars_2021_(6503)_avis.pdf
HAS/2021-05-03_CNEDIMTS-6504_KETO-DIASTIX_09_03_2021_(6504)_avis.pdf
HAS/2021-05-03_CNEDIMTS-6514_DIZG_16_mars_2021_(6514)_avis.pdf
HAS/2021-05-03_CNEDIMTS-6521_DYNASTEP_30_mars_2021_(6521)_avis.pdf
HAS/2021-05-03_CNEDIMTS-6522_DYNASTAR_30_mars_2021_(6522)_avis.pdf
HAS/2021-05-03_argumentaire_pnds_msud.pdf
HAS/2021-05-03_pnds_msud_vf.docx.pdf
HAS/2021-05-03_synthese_mg_leucinose.pdf
HAS/2021-05-04_CNEDIMTS-6470_PINK PERFECT_30_mars_6470_avis.pdf
HAS/2021-05-04_CNEDIMTS-6526_PROMENADE_30_mars_2021_(6526)_avis.pdf
HAS/2021-05-04_CNEDIMTS-6527_SENATOR_30_mars_2021_(6527)_avis.pdf
HAS/2021-05-04_CNEDIMTS-6528_SILHOUETTE_30_mars_2021_(6528)_avis.pdf
HAS/2021-05-04_CNEDIMTS-6529_TERION_30_mars_2021_(6529)_avis.pdf
HAS/2021-05-04_ctba_16_mars_2021_6512_avis.pdf
HAS/2021-05-06_CNEDIMTS-6342_COMPRILAN_16_mars_2021_(6342)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6428_ONYSTER_9_mars_2021_(6428)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6451_TITAN OPTIMAX_13_avril_2021_(6451)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6457_E-VITA OPEN NEO_16_mars_2021_ (6457)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6458_COMPRIHAFT_16_mars_2021_ (6458)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6474_AXS VECTA_30_mars_2021_(6474)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6476_SYSTANE_COMPLETE_16_mars_2021_(6476)_avis.pdf
HAS/2021-05-06_CNEDIMTS-6477_FREDX_16_mars_2021_(6477)_avis.pdf
HAS/2021-05-06_mitraclip_g4-ntw_6446.pdf
HAS/2021-05-06_pnds_iop_argumentaire_avril_2021_vf.pdf
HAS/2021-05-06_pnds_iop_avril_2021_vf.pdf
HAS/2021-05-06_synthese_mg_insuffisance_ovarienne_prematuree.pdf
HAS/2021-05-07_CT-18567_FLAMMAZINE_PIC_REEV_AvisDef_CT18567.pdf
HAS/2021-05-07_CT-18989_FORXIGA_PIC_EI_AvisDef_CT18989.pdf
HAS/2021-05-07_CT-19004_SERILIA_PIC_INS_AvisDef_CT19004.pdf
HAS/2021-05-07_CT-19009_CALQUENCE_PIC_INS_AvisDef_CT19009.pdf
HAS/2021-05-07_CT-19011_ADAKVEO_PIC_INS_AvisDef_CT19011_EPI729.pdf
HAS/2021-05-07_CT-19027_LYNPARZA_PIC_EI_AvisDef_CT19027.pdf
HAS/2021-05-07_CT-19057_LYNPARZA_prostate_PIC_EI_AvisDef_CT19057.pdf
HAS/2021-05-07_CT-19070_VIMPAT_PIC_EI_AvisDef_CT19070.pdf
HAS/2021-05-07_CT-19116_ISTURISA_PIC_INS_AvisDef_CT19116_EPI716.pdf
HAS/2021-05-07_CT-19171_DEXAMETHASONE_MYLAN_PIS_INS_AvisDef_CT19171.pdf
HAS/2021-05-07_CT-19185_DOTAREM_PIS_INS_AvisDef_CT19185.pdf
HAS/2021-05-07_CT-19193_PROHANCE_PIS_INS_AvisDef_CT19193.pdf
HAS/2021-05-07_CT-19242_PEMETREXED_HOSPIRA_PIS_INS_AvisDef_CT19242.pdf
HAS/2021-05-07_CT-19243_CHAMPIX_PIS_INS_AvisDef_CT19243.pdf
HAS/2021-05-07_CT-19251_DEXAMETHASONE_PANPHARMA_PIS_INS_AvisDef_CT19251&19252.pdf
HAS/2021-05-07_CT-19257_MONOXYDE_AZOTE_MESSER_PIS_INS_AvisDef_CT19257.pdf
HAS/2021-05-07_adakveo_05052021_synthese_ct19011.pdf
HAS/2021-05-07_adakveo_05052021_transcription_ct19011.pdf
HAS/2021-05-07_adakveo_24032021_transcription_ct19011.pdf
HAS/2021-05-07_adakveo_contribution_federation_fmdt_sos_globi_ct19011.pdf
HAS/2021-05-07_calquence_05052021_synthese_ct19009.pdf
HAS/2021-05-07_calquence_05052021_transcription_ct19009.pdf
HAS/2021-05-07_calquence_13042021_avis_eco_transcription_ceesp.pdf
HAS/2021-05-07_calquence_13042021_avis_economique.pdf
HAS/2021-05-07_calquence_24032021_transcription_ct19009.pdf
HAS/2021-05-07_flammazine_07042021_transcription_ct18567.pdf
HAS/2021-05-07_flammazine_21042021_synthese_ct18567.pdf
HAS/2021-05-07_forxiga_03032021_transcription_ct18989.pdf
HAS/2021-05-07_forxiga_24032021_synthese_ct18989.pdf
HAS/2021-05-07_isturisa_05052021_synthese_ct19116.pdf
HAS/2021-05-07_isturisa_05052021_transcription_ct19116.pdf
HAS/2021-05-07_isturisa_24032021_transcription_ct19116.pdf
HAS/2021-05-07_isturisa_contribution_association_surrenales_ct19116_.pdf
HAS/2021-05-07_lynparza_05052021_synthese_ct19057.pdf
HAS/2021-05-07_lynparza_05052021_transcription_ct19057.pdf
HAS/2021-05-07_lynparza_21042021_synthese_ct19027.pdf
HAS/2021-05-07_lynparza_21042021_transcription_ct19027.pdf
HAS/2021-05-07_lynparza_24032021_transcription_ct19057.pdf
HAS/2021-05-07_lynparza_contribution_imagyn_ct19027.pdf
HAS/2021-05-07_serilia_07042021_transcription_ct19004.pdf
HAS/2021-05-07_serilia_21042021_synthese_ct19004.pdf
HAS/2021-05-07_serilia_210421_summary_ct19004.pdf
HAS/2021-05-07_vimpat_07042021_synthese_ct19070.pdf
HAS/2021-05-07_vimpat_07042021_transcription_ct19070.pdf
HAS/2021-05-12_CT-19043_TECARTUS_PIC_INS_AvisDef_CT19043_EPI727.pdf
HAS/2021-05-12_CT-19047_KYPROLIS_PIC_EI_AvisDef_CT19047.pdf
HAS/2021-05-12_CT-19204_SUNITINIB_BIOGARAN_PIS_INS_AvisDef_CT19204.pdf
HAS/2021-05-12_kyprolis_05052021_synthese_ct19047.pdf
HAS/2021-05-12_kyprolis_05052021_transcription_ct19047.pdf
HAS/2021-05-12_kyprolis_24032021_transcription_ct19047.pdf
HAS/2021-05-12_tecartus_07042021_transcription_ct19043.pdf
HAS/2021-05-12_tecartus_08062021_avis_economique.pdf
HAS/2021-05-12_tecartus_21042021_synthese_ct19043.pdf
HAS/2021-05-12_tecartus_210421_summary_ct19043.pdf
HAS/2021-05-12_tecartus_ceesp_080621_transcription_ceesp.pdf
HAS/2021-05-12_tecartus_ceesp_11052021_transcription_ceesp.pdf
HAS/2021-05-12_tecartus_contribution_france_lymphome_espoir_ct19043.pdf
HAS/2021-05-18_CT-19044_RINVOQ_SA_PIC_EI_AvisDef_CT19044.pdf
HAS/2021-05-18_CT-19091_GILENYA_PIS_RCP_AvisDef_CT19091.pdf
HAS/2021-05-18_CT-19092_TECFIDERA_PIS_RCP_AvisDef_CT19092.pdf
HAS/2021-05-18_charte_ev_sces_gpev_gar_i119.pdf
HAS/2021-05-18_livret_accueil_ev_sces_gpev_gar_i118.pdf
HAS/2021-05-18_parcours_developpement_competences_ev_gpev_for_i113.pdf
HAS/2021-05-18_rinvoq_050521_summary_ct19044.pdf
HAS/2021-05-18_rinvoq_21042021_transcription_ct19044.pdf
HAS/2021-05-18_rinvoq_contribution_aflar_ct1904419045.pdf
HAS/2021-05-18_rinvoq_sa_05052021_synthese_ct19044.pdf
HAS/2021-05-21_CNEDIMTS-6376_CARDIOMEMS_27_avril_2021_(6376)_avis.pdf
HAS/2021-05-21_CT-19287_DEXAMETHASONE_MEDISOL_PIS_INS_AvisDef_CT19287.pdf
HAS/2021-05-21_cardiomems_12012021_avis_eco_transcription_ceesp_2021-06-07_17-23-10_478.pdf
HAS/2021-05-21_cardiomems_12012021_avis_economique.pdf
HAS/2021-05-21_slenyto_rtu_reco_autosaisine_has_sem_cteval527.pdf
HAS/2021-05-27__reco323__indications__lactarium__fiche_memo__mel.pdf
HAS/2021-05-27__reco323__indications__lactarium__rapport_elaboration__mel.pdf
HAS/2021-05-27__reco323_indications_lactarium___fiche_outil_mel.pdf
HAS/2021-05-31_CT-19239_DOSTINEX_PIS_INS_AvisDef_CT19239.pdf
HAS/2021-06-02_CT-19109_DELTYBA_PIC_EI_AvisDef_CT19109.pdf
HAS/2021-06-02_deltyba_19052021_synthese_ct19109.pdf
HAS/2021-06-02_deltyba_19052021_transcription_ct19109.pdf
HAS/2021-06-03_CT-19096_FINTEPLA_PIC_INS_AvisDef_CT19096_EPI731.pdf
HAS/2021-06-03_argumentaire_pnds_ucd_vf.pdf
HAS/2021-06-03_fintepla_05052021_transcription_ct19096.pdf
HAS/2021-06-03_fintepla_19052021_synthese_ct19096.pdf
HAS/2021-06-03_fintepla_contribution_alliance_syndrome_de_dravet_ct19096.pdf
HAS/2021-06-03_pnds_ucd_vf.pdf
HAS/2021-06-03_reco408_cadrage_neuromusculaire_coi_2021_03_24_mel.pdf
HAS/2021-06-03_strategie_de_vaccination_contre_la_covid-19_-_place_du_vaccin_a_arnm_comirnaty_chez_les_12-15_ans_-_recommandation.pdf
HAS/2021-06-03_strategie_de_vaccination_contre_la_covid-19_-_place_du_vaccin_a_arnm_comirnaty_chez_les_12-15_ans_-_synthese.pdf
HAS/2021-06-03_synthese_mg_deficits_du_cycle_de_l_uree.pdf
HAS/2021-06-07_CT-18776_ENBREL_PIC_REEV_Psobioteq_AvisDef_CT18776.pdf
HAS/2021-06-07_CT-18932_STELARA_PIC_REEV_Psobioteq_AvisDef_CT18932.pdf
HAS/2021-06-07_CT-19118_HUMIRA_PIC_REEV_Psobioteq_AvisDef_CT19118.pdf
HAS/2021-06-07_CT-19141_REMICADE_PIC_REEV_Psobioteq_AvisDef_CT19141.pdf
HAS/2021-06-07_enbrel_05052021_synthese_ct18776.pdf
HAS/2021-06-07_humira_05052021_synthese_ct19118.pdf
HAS/2021-06-07_rapport_reevaluation_psobioteq_3ans_pic_avisdef_ct18876189321911819141.pdf
HAS/2021-06-07_reevaluation_psobioteq_07042021_transcription_ct18776191181914118932.pdf
HAS/2021-06-07_remicade_05052021_synthese_ct19141.pdf
HAS/2021-06-07_stelara_05052021_synthese_ct18932.pdf
HAS/2021-06-09_CT-19121_KESIMPTA_PIC_INS_AvisDef_CT19121_EPI728.pdf
HAS/2021-06-09_kesimpta_02062021_synthese_ct19121.pdf
HAS/2021-06-09_kesimpta_02062021_transcription_ct19121.pdf
HAS/2021-06-09_kesimpta_08062021_avis_economique.pdf
HAS/2021-06-09_kesimpta_21042021_transcription_ct19121.pdf
HAS/2021-06-09_kesimpta_avis_eco_0862021_transcriptions_ceesp.pdf
HAS/2021-06-09_kesimpta_avis_eco_11052021_transcriptions_ceesp.pdf
HAS/2021-06-09_kesimpta_contribution_lfsp_ct19121.pdf
HAS/2021-06-09_reco329_argumentaire__prolapsus_post_cd_2021_05_06_vlg.pdf
HAS/2021-06-09_reco329_recommandation_prolapsus_cd_2021_05_06_lg.pdf
HAS/2021-06-09_reco329_synthese_evaluation_prolapsus_cd_2021_05_06_v2_g.pdf
HAS/2021-06-09_reco329_synthese_prise_en_charge_prolapsus_cd_2021_05_06_v2_lg.pdf
HAS/2021-06-10_CNEDIMTS-6508_AMOENA ESSENTIAL LIGHT et ADAPT LIGHT_27_avril_2021_(6508)_avis.pdf
HAS/2021-06-10_CNEDIMTS-6547_EAKIN_CONTOUR_FLANGE_EXTENDERS_27_avril_2021_(6547)_avis.pdf
HAS/2021-06-10_CNEDIMTS-6557_VELVETY LITESHELL_27_avril_2021_(6557)_avis.pdf
HAS/2021-06-10_CT-18163_TALTZ_PIS_MCI_AvisDef_CT18163.pdf
HAS/2021-06-10_CT-18980_COSENTYX_PIS_MCI_AvisDef_CT18980.pdf
HAS/2021-06-10_CT-19045_RINVOQ_RP_PIC_EI_AvisDef_CT19045.pdf
HAS/2021-06-10_CT-19117_TREMFYA_RP_PIC_EI_AvisDef_CT19117.pdf
HAS/2021-06-10_CT-19305_DEXAMETHASONE_MEDISOL_PIS_INS_AvisDef_CT19305.pdf
HAS/2021-06-10_cosentyx_19052021_transcription_ct18980.pdf
HAS/2021-06-10_rinvoq_19052021_synthese_ct19045.pdf
HAS/2021-06-10_rinvoq_19052021_transcription_ct19045.pdf
HAS/2021-06-10_rinvoq_190521_summary_ct19045.pdf
HAS/2021-06-10_rinvoq_contribution_aflar_ct1904419045.pdf
HAS/2021-06-10_spa_113__guide_engager_le_patient_pacte_vd.pdf
HAS/2021-06-10_taltz_19052021_transcription_ct18163.pdf
HAS/2021-06-10_tremfya_19052021_synthese_ct19117.pdf
HAS/2021-06-10_tremfya_19052021_transcription_ct19117.pdf
HAS/2021-06-10_tremfya_contribution_france_psoriasis_ct19117.pdf
HAS/2021-06-11_CNEDIMTS-5895_ANACONDA LoPro90_15_décembre_2020_(5895)_avis.pdf
HAS/2021-06-11_CNEDIMTS-6494_ACURATE NEO_11_mai_2021_(6494)_avis.pdf
HAS/2021-06-14_reco411_cadrage_grossesse_vulnerabilites_post_coi_2021_05_05_pg_090621.pdf
HAS/2021-06-16_CNEDIMTS-6391_PHOENIX FORME MINÉRALISÉE ET DÉMINÉRALISÉE_27_avril_2021_(6391)_avis.pdf
HAS/2021-06-18_CT-19080_DROPIZAL_PIC_INS_AvisDef_CT19080.pdf
HAS/2021-06-18_CT-19095_RETSEVMO_PIC_INS_AvisDef_CT19095.pdf
HAS/2021-06-18_CT-19115_RUKOBIA_PIC_INS_AvisDef_CT19115.pdf
HAS/2021-06-18_CT-19132_ECALTA_PIC_INS_AvisDef_CT19132.pdf
HAS/2021-06-18_CT-19147_KEYTRUDA_PIC_EI_AvisDef_CT19147.pdf
HAS/2021-06-18_CT-19212_LEPTAX_PIS_INS_AvisDef_CT19212.pdf
HAS/2021-06-18_dropizal_02062021_synthese_ct19080.pdf
HAS/2021-06-18_dropizal_19052021_transcription_ct19080.pdf
HAS/2021-06-18_ecalta_02062021_summary_ct19132.pdf
HAS/2021-06-18_ecalta_02062021_synthese_ct19132.pdf
HAS/2021-06-18_ecalta_02062021_transcription_ct19132.pdf
HAS/2021-06-18_flash__surgical_safety._a_quick_check_is_better_than_a_big_shock_.pdf
HAS/2021-06-18_keytruda_02062021_synthese_ct19147.pdf
HAS/2021-06-18_keytruda_19052021_transcription_ct19147.pdf
HAS/2021-06-18_respifil_pnds_mpc_2021.pdf
HAS/2021-06-18_respifil_pnds_mpc_as_2021.pdf
HAS/2021-06-18_retsevmo_02062021_synthese_ct19095.pdf
HAS/2021-06-18_retsevmo_19052021_transcription_ct19095.pdf
HAS/2021-06-18_retsevmo_contribution_association_vivre_sans_thyroide_ct19095.pdf
HAS/2021-06-18_rukobia_02062021_synthese_ct19115.pdf
HAS/2021-06-18_rukobia_02062021_transcription_ct19115.pdf
HAS/2021-06-18_rukobia_020621_summary_ct19115.pdf
HAS/2021-06-18_spa_167__flash_check-list_bloc_cd_2021_06_03_v0.pdf
HAS/2021-06-18_synthese_mg_malformations_pulmonaires_congenitales.pdf
HAS/2021-06-21_CNEDIMTS-5919_GORE EXCLUDER_15_décembre_2020_(5919)_avis.pdf
HAS/2021-06-21_CNEDIMTS-5925_ENDURANT II_(5925)_ENDURANTIIs_(5926)_15_décembre_2020_avis.pdf
HAS/2021-06-21_CNEDIMTS-5926_ENDURANT II_(5925)_ENDURANTIIs_(5926)_15_décembre_2020_avis.pdf
HAS/2021-06-21_CNEDIMTS-5953_ANACONDA_15_décembre_2020_(5953)_avis.pdf
HAS/2021-06-21_CNEDIMTS-5979_GORE EXCLUDER CONFORMABLE_15_décembre_2020_(5979)_avis.pdf
HAS/2021-06-21_inahta_brief_hipec.pdf
HAS/2021-06-21_rapport_chip.pdf
HAS/2021-06-22_annexes_bexsero_juin_2021.pdf
HAS/2021-06-22_annexes_trumenba_juin_2021.pdf
HAS/2021-06-22_strategie_de_vaccination_pour_la_prevention_des_infections_invasives_a_meningocoques_-_le_serogroupe_b_et_la_place_de_trumen.pdf
HAS/2021-06-22_strategie_de_vaccination_pour_la_prevention_des_infections_invasives_a_meningocoques_le_serogroupe_b_et_la_place_de_bexsero.pdf
HAS/2021-06-23_ac_2021_0042_actualisation_tests_serologique_covid-19.pdf
HAS/2021-06-24_CNEDIMTS-6252_VELVETY_27_avril_2021_(6252)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6318_SYNERGY_13_avril_2021_(6318)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6319_SYNERGY MEGATRON_13_avril_2021_(6319)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6320_SYNERGY XD_13_avril_2021_(6320)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6358_SYNERGY XD 48 mm_9_mars_2021_(6358)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6374_VISUEVO DRY EYE_02_février_2021_( 6374)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6378_VISUEVO CATARACTE_02_février_2021_(6378)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6456_ONYX LES_13_avril_2021_(6456)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6459_JOBST COMPRI2_27_avril_2021_(6459)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6466_MEDPOR CCI_19_janvier_2021_(6466)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6491_STELLAREX_13_avril_2021_(6491)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6505_BIOFREEDOM ULTRA_27_avril_2021_ (6505)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6532_THEALOSE UD_13_avril_(6532)_avis.pdf
HAS/2021-06-24_CNEDIMTS-6550_THEALOSE_13_avril_2021_(6550)_avis.pdf
HAS/2021-06-24_CT-18987_HUMIRA_RCH_pediatrique_PIC_EI_AvisDef_CT18987_EPI732.pdf
HAS/2021-06-24_CT-19032_FYCOMPA_PIC_EI_AvisDef_CT19032.pdf
HAS/2021-06-24_CT-19067_CRYSVITA_PIC_EI_AvisDef_CT19067.pdf
HAS/2021-06-24_CT-19098_ENHERTU_PIC_INS_AvisDef_CT19098.pdf
HAS/2021-06-24_CT-19134_XARELTO_PIC_INS_AvisDef_CT19134_EPI734.pdf
HAS/2021-06-24_CT-19172_TUKYSA_PIC_INS_AvisDef_CT19172.pdf
HAS/2021-06-24_crysvita_02062021_synthese_ct19067.pdf
HAS/2021-06-24_crysvita_19052021_transcription_ct19067.pdf
HAS/2021-06-24_enhertu_06072021_avis_economique.pdf
HAS/2021-06-24_enhertu_16062021_synthese_ct19098.pdf
HAS/2021-06-24_enhertu_16062021_transcription_ct19098.pdf
HAS/2021-06-24_enhertu_21042021_transcription_ct19098.pdf
HAS/2021-06-24_enhertu_ceesp_06072021_transcription_ceesp.pdf
HAS/2021-06-24_fycompa_02062021_synthese_ct19032.pdf
HAS/2021-06-24_fycompa_02062021_transcription_ct19032.pdf
HAS/2021-06-24_fycompa_contribution_efappe_ct19032.pdf
HAS/2021-06-24_humira_19052021_summary_ct18987.pdf
HAS/2021-06-24_humira_19052021_synthese_ct18987.pdf
HAS/2021-06-24_humira_19052021_transcription_ct18987.pdf
HAS/2021-06-24_tukysa_02062021_synthese_ct19172.pdf
HAS/2021-06-24_tukysa_02062021_transcription_ct19172.pdf
HAS/2021-06-24_tukysa_020621_summary_ct19172.pdf
HAS/2021-06-24_tukysa_06072021_avis_economique.pdf
HAS/2021-06-24_tukysa_ceesp_06072021_transcription_ceesp.pdf
HAS/2021-06-24_xarelto_02062021_synthese_ct19134.pdf
HAS/2021-06-24_xarelto_020621_summary_ct19134.pdf
HAS/2021-06-24_xarelto_19052021_transcription_ct19134.pdf
HAS/2021-06-28_CT-19230_SKYRIZI_150mg_PIS_INS_AvisDef_CT19230.pdf
HAS/2021-06-28_guide_methodologique_pour_le_developpement_clinique_des_dispositifs_medicaux.pdf
HAS/2021-06-28_guide_methodology_for_the_clinical_development_of_md.pdf
HAS/2021-06-30_assessment_of_apps_in_the_mobile_health_mhealth_sector._overview_and_quality_criteria_of_medical_content.pdf
HAS/2021-06-30_criteres_de_qualite_du_contenu_medical_referencement_mhealth_ens_2021-06-30_10-58-28_773.pdf
HAS/2021-06-30_guide_etude_en_vie_reelle_medicaments__dm.pdf
HAS/2021-06-30_has_ref_apps_oc.pdf
HAS/2021-06-30_real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf
HAS/2021-07-01_recommandation_vaccinale_strategie_de_vaccination_contre_le_sars_cov2_-_role_des_facteurs_socio-economiques_et_professionnel.pdf
HAS/2021-07-02_flash_high-alert_medications._underestimating_the_risk_is_risky.pdf
HAS/2021-07-02_flash_medicament_risque_sous-estimer_le_risque_cest_risque.pdf
HAS/2021-07-02_fsp_kcl_2021_06_24_vf_suite_cd.pdf
HAS/2021-07-02_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2021-07-05_flash_medicament_risque_sous-estimer_le_risque_cest_risque.pdf
HAS/2021-07-05_flash_who_says_potassium_kci_says_maximum_vigilance.pdf
HAS/2021-07-05_fsp_kcl_2021_06_24_vf_suite_cd.pdf
HAS/2021-07-05_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2021-07-08_rr_pims-version_finale_2021_07_06._version4_pourinsertionlogos.pdf
HAS/2021-07-09_rapport_recueil_satisfation_des_personnes_en_ehpad_et_en_structures_du_handicap.pdf
HAS/2021-07-12_optune_13042021_avis_economique.pdf
HAS/2021-07-12_optune_20210413_avis_eco_transcription_ceesp.pdf
HAS/2021-07-12_rbpp_retour_en_famille.docx.pdf
HAS/2021-07-12_rbpp_retour_en_famille_synthese.pdf
HAS/2021-07-12_retour_en_famille_-_argumentaire.pdf
HAS/2021-07-16_fiche_sam_inca_afatinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_bosutinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_ceritinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_cobimetinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_crizotinib_2021_07_08_vf_2021-07-13_23-36-24_47.pdf
HAS/2021-07-16_fiche_sam_inca_dabrafenib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_dasatinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_erolotinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_gefitinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_imatinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_lenalidomide_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_nilotinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_pomalidomide_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_ponatinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_ruxolitinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_thalidomide_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_trametinib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_vemurafenib_2021_07_08_vf.pdf
HAS/2021-07-16_fiche_sam_inca_vismodegib_2021_07_08_vf.pdf
HAS/2021-07-19_dispositifs_dassistance_circulatoire_mecanique_dacm_feuille_de_route.pdf
HAS/2021-07-19_rapport_assistance_circulatoire_mecanique.pdf
HAS/2021-07-19_rapport_sur_les_dispositifs_dassistance_circulatoire_mecanique.pdf
HAS/2021-07-19_rapport_sur_les_dispositifs_dassistance_circulatoire_mecanique_texte_court.pdf
HAS/2021-07-21_pertinence_de_limagerie_en_cas_de_gonalgie_chez_ladulte_-_note_de_cadrage.pdf
HAS/2021-07-23_has-76_feuille_route_hta_renforce_engagement_usagers.pdf
HAS/2021-07-23_opdivo_yervoy_rtu_reco_autosaisine_has_sem_cteval534.pdf
HAS/2021-07-26_reevaluation_des_defibrillateurs_cardiaques_automatiques_implantables_avec_sondes_endocavitaires_note_de_cadrage.pdf
HAS/2021-07-28_argumentaire_pnds_hpp.pdf
HAS/2021-07-28_argumentaire_pnds_syndromes_thalassemiques_majeurs_et_intermediaires.pdf
HAS/2021-07-28_argumentaire_spherocytose_hereditaire_et_autres_anemies_hemol_par_anomalie_mb_gr.pdf
HAS/2021-07-28_atrophie_optique_dominante_opa1_-_argumentaire.pdf
HAS/2021-07-28_atrophie_optique_dominante_opa1_-_pnds.pdf
HAS/2021-07-28_iqss117_steps_developing_care_pathway_quality_indicators_vdef.pdf
HAS/2021-07-28_maculopathies_genetiques_-_argumentaire.pdf
HAS/2021-07-28_maculopathies_genetiques_-_pnds.pdf
HAS/2021-07-28_neuropathies_optiques_hereditaires_-_argumentaire.pdf
HAS/2021-07-28_neuropathies_optiques_hereditaires_-_pnds.pdf
HAS/2021-07-28_pnds_hpp_-_version_finale.pdf
HAS/2021-07-28_pnds_spherocytose_hereditaire_et_autres_anemies_hemol_par_anomalie_mb_gr.pdf
HAS/2021-07-28_pnds_syndromes_thalassemiques_majeurs_et_intermediaires.pdf
HAS/2021-07-28_rapport_rt-lamp_salivaire_sars-cov-2.pdf
HAS/2021-07-28_recovac_moderna_adolescents.pdf
HAS/2021-07-28_respifil_pnds_fpi_2021.pdf
HAS/2021-07-28_respifil_pnds_fpi_as_2021.pdf
HAS/2021-07-28_synthese_de_la_strategie_de_vaccination_contre_la_covid19_-_place_du_vaccin_a_arnm_spikevax_de_moderna_chez_les_12_a_17_ans.pdf
HAS/2021-07-28_synthese_mg_atrophie_optique_dominante_opa1.pdf
HAS/2021-07-28_synthese_mg_fibrose_pulmonaire_idiopathique.pdf
HAS/2021-07-28_synthese_mg_hypophosphatasie.pdf
HAS/2021-07-28_synthese_mg_maculopathies_genetiques.pdf
HAS/2021-07-28_synthese_mg_neuropathies_optiques_hereditaires.pdf
HAS/2021-07-28_synthese_mg_spherocytose_hereditaire_et_autres_anemies_hemol_par_anomalie_mb_gr.pdf
HAS/2021-07-28_synthese_mg_syndromes_thalassemiques_majeurs_et_intermediaires.pdf
HAS/2021-07-29_argumentaire_oberar_19072021.pdf
HAS/2021-07-29_pnds_satb2.pdf
HAS/2021-07-29_pnds_satb2_argumentaire.pdf
HAS/2021-07-29_synthese_mg_generique_obesites_de_causes_rares.pdf
HAS/2021-07-29_synthese_mg_syndrome_associe_au_gene_satb2_sas.pdf
HAS/2021-07-29_texte_pnds_oberar19072021.pdf
HAS/2021-08-05_CT-17770_MANTADIX_PIC_REEV_Avis Def_CT17770.pdf
HAS/2021-08-05_CT-17799_TIXTAR_TARGAXAN_PIC_REEV_AvisDéf_CT19280.pdf
HAS/2021-08-05_CT-19063_REBLOZYL_SMD_PIC_INS_AvisDef_CT19063.pdf
HAS/2021-08-05_CT-19114_SKYRIZI_REEVAL_ASMR_Pso_PIC_Avisdéf_CT19114.pdf
HAS/2021-08-05_CT-19123_ATENATIV_PIS_INS_AvisDef_CT19123.pdf
HAS/2021-08-05_CT-19135_TRIMBOW_PIC__INS_EXT_Avis DEF_CT19135.pdf
HAS/2021-08-05_CT-19167_REMICADE_PIC_REEV_AvisDef_CT19167.pdf
HAS/2021-08-05_CT-19218_INFLECTRA_PIC_REEV_AvisDef_CT19218.pdf
HAS/2021-08-05_CT-19221_ZAVICEFTA_PIC_EIpédiatrie_AvisDef_CT19221.pdf
HAS/2021-08-05_CT-19246_MANTADIX_PIS_RAD_Avis DEF_CT19246.pdf
HAS/2021-08-05_CT-19263_ULTOMIRIS_PIS_INS_COMPLEMENT_GAMME_Avis Def_CT19263.pdf
HAS/2021-08-05_CT-19268_TRUMENBA_PIC_INS_AvisDef_CT19268.pdf
HAS/2021-08-05_CT-19280_TIXTAR_TARGAXAN_PIC_REEV_AvisDéf_CT19280.pdf
HAS/2021-08-05_CT-19284_PLAVIX_PIS_RAD_AvisDef_CT19284.pdf
HAS/2021-08-05_CT-19286_HYDROXYZINE_BLUEFISH_PIS_INS_AvisDef_CT19286.pdf
HAS/2021-08-05_CT-19299_MAVIRET_PIC_INS_AvisDef_CT19299_CT19330.pdf
HAS/2021-08-05_CT-19306_ADONTEX_PIS_COMPLEMENT_GAMME_AvisDef_CT19306.pdf
HAS/2021-08-05_CT-19314_ZUBSOLV_PIS_COMPLEMENT_GAMME_AvisDef_CT19314.pdf
HAS/2021-08-05_CT-19328_PLACYNOX_MESSER_PIS_INS_Avisdef_CT19328.pdf
HAS/2021-08-05_CT-19329_BIKTARVY_PIS_INS_AvisDef_CT19329.pdf
HAS/2021-08-05_CT-19361_LIDOCAINE AGUETTANT_PIS_INS_Avisdef_CT19361.pdf
HAS/2021-08-05_bexsero_pic_rcp_avisdef_ct_17951ct19381_2021-07-30_16-04-19_936.pdf
HAS/2021-08-05_bortezomib_fresenius_kabi_pis_ins_hybr_avisdef_ct19309.pdf
HAS/2021-08-05_ccm_questionnaire_has_contrib_asso_med_1_.pdf
HAS/2021-08-05_contribution_skyrizi.pdf
HAS/2021-08-05_inflectra_23062021_synthese_ct19218.pdf
HAS/2021-08-05_mantadix_07072021_synthese_ct17770.pdf
HAS/2021-08-05_mantadix_23062021_transcription_ct_17770_ct19246.pdf
HAS/2021-08-05_mantadix_23062021_transcription_ct_17770_ct19246_2021-08-12_14-10-28_959.pdf
HAS/2021-08-05_maviret_07072021_synthese_ct19299_ct19330.pdf
HAS/2021-08-05_maviret_ct19330_19299_has_transcription.pdf
HAS/2021-08-05_questionnaire_has_contrib_fp__mantadix.pdf
HAS/2021-08-05_reblozyl_-thal_16062021_synthese_ct19062_2021-08-12_14-18-30_35.pdf
HAS/2021-08-05_reblozyl_-thal_160621_summary_ct19062.pdf
HAS/2021-08-05_reblozyl_02062021_synthese_ct19063.pdf
HAS/2021-08-05_reblozyl_020621_summary_ct19063.pdf
HAS/2021-08-05_reblozyl__-thalassemie_02062021_transcription_ct19062_2021-08-12_14-18-30_32.pdf
HAS/2021-08-05_reblozyl_smd_02062021_transcription_ct19063.pdf
HAS/2021-08-05_reblozyl_ss-thal_pic_ins_avisdef_ct19062.pdf
HAS/2021-08-05_remicade_23062021_synthese_ct19167.pdf
HAS/2021-08-05_remicade_ct_230621_transcription.pdf
HAS/2021-08-05_ropivacaine_23062021_synthese_ct19267.pdf
HAS/2021-08-05_ropivacaine_b._braun_23062021_transcription_ct19267.pdf
HAS/2021-08-05_ropivacaine_pic_ei_avis_definitif_ct19267.pdf
HAS/2021-08-05_skyrizi_07072021_synthese_ct19114.pdf
HAS/2021-08-05_skyrizi_07072021_transcription_ct19114.pdf
HAS/2021-08-05_tivicay_07072021_avis_ct19244.pdf
HAS/2021-08-05_tivicay_07072021_synthese_ct19244.pdf
HAS/2021-08-05_tivicay_07072021_transcription_ct19244.pdf
HAS/2021-08-05_tixtar__targaxan_23062021_transcription_ct17799_ct19280.pdf
HAS/2021-08-05_tixtar_targaxan_23062021_synthese_ct19280.pdf
HAS/2021-08-05_trimbow_07072021_synthese_ct19135.pdf
HAS/2021-08-05_trimbow_asthme_07072021_ct19135_transcription.pdf
HAS/2021-08-05_trumenba_07072021_synthese_ct19268.pdf
HAS/2021-08-05_trumenba_bexsero_ct17951_transcription.pdf
HAS/2021-08-06_aap_ronapreve_avis_conforme_ansm_20210730_2021-08-04_18-19-24_303.pdf
HAS/2021-08-06_ctap01_put-rd_ronapreve_preexposition.pdf
HAS/2021-08-06_ctap01_ronapreve_aap_preexp_pic.pdf
HAS/2021-08-06_ctap02__ronapreve_aap_postexp_pic.pdf
HAS/2021-08-06_ctap02_put-rd_ronapreve_postexposition.pdf
HAS/2021-08-06_ronapreve_acces-precoce_contribution_association_renaloo.pdf
HAS/2021-08-06_ronapreve_acces-precoce_contribution_association_renaloo_2021-08-11_16-04-33_467.pdf
HAS/2021-08-06_ronapreve_acces_precoce_-_contribution_associations_unaopecle.pdf
HAS/2021-08-06_ronapreve_acces_precoce_-_contribution_associations_unaopecle_2021-08-06_09-48-41_956.pdf
HAS/2021-08-17_2021_02_04_pnds_x_fragile.pdf
HAS/2021-08-17_2021_02_04_pnds_x_fragile_argumentaire.pdf
HAS/2021-08-17_CT-18966_ESKETAMINE_IDD_PIC_INS_Avisdef_CT18966.pdf
HAS/2021-08-17_CT-19211_XYREM _PIC_EI _AvisDef_CT19211.pdf
HAS/2021-08-17_esketamine_02062021_transcription_ct18966.pdf
HAS/2021-08-17_esketamine_21072021_synthese_ct18966.pdf
HAS/2021-08-17_esketamine_21072021_transcription_ct18966.pdf
HAS/2021-08-17_pnds_autres_deficits_argumentaire_2021.08.pdf
HAS/2021-08-17_pnds_chiari_argumentaire_formathas.pdf
HAS/2021-08-17_pnds_chiari_texte_formathas.pdf
HAS/2021-08-17_synthese_mg_deficits_rares_de_la_coagulation.pdf
HAS/2021-08-17_synthese_mg_malformation_de_chiari.pdf
HAS/2021-08-17_synthese_mg_syndrome_de_l_x_fragile.pdf
HAS/2021-08-17_xyrem_21072021_transcription_ct19211.pdf
HAS/2021-08-17_xyrem__21072021_synthese_ct19211.pdf
HAS/2021-08-26_230621_transcription_inflectra__remsima_ct19218.pdf
HAS/2021-08-26_CNEDIMTS-6440_Amoena_11_mai_2021_(6440)_avis.pdf
HAS/2021-08-26_CNEDIMTS-6471_PEPTAMEN HN_27_avril_2021_(6471)_avis.pdf
HAS/2021-08-26_CNEDIMTS-6472_PEPTAMEN_27_avril_2021_(6472)_avis.pdf
HAS/2021-08-26_CNEDIMTS-6544_SKY_CI_M90_11_mai_2021_(6544)_avis.pdf
HAS/2021-08-26_CNEDIMTS-6545_NAIDA_CI_M90_11_mai_2021_(6545)_avis.pdf
HAS/2021-08-26_CNEDIMTS-6559_ANITA PME_11_mai_2021_(6559)_avis.pdf
HAS/2021-08-26_CT-19102_ORFADIN_PIC_INS_Avisdef_CT19102_EPI735.pdf
HAS/2021-08-26_CT-19182_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520 (1).pdf
HAS/2021-08-26_CT-19188_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-08-26_CT-19189_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-08-26_CT-19190_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-08-26_CT-19192_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-08-26_CT-19232_REMSIMA_PIC_REEV_AvisDef_CT19232.pdf
HAS/2021-08-26_CT-19236_ROZLYTREK_Tumeurs solides_INS_AvisDef_CT19236.pdf
HAS/2021-08-26_CT-19285_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-08-26_a_gp1_16062021_transcription_ct19190.pdf
HAS/2021-08-26_a_gp1_16062021_transcription_ct19190_2021-08-20_10-21-8_797.pdf
HAS/2021-08-26_a_gp1_16062021_transcription_ct19190_2021-08-20_10-25-45_686.pdf
HAS/2021-08-26_a_gp1_16062021_transcription_ct19190_2021-08-20_10-30-57_714.pdf
HAS/2021-08-26_a_gp1_16062021_transcription_ct19190_2021-08-20_10-35-4_194.pdf
HAS/2021-08-26_elzonris_02062021_transcription_ct19220.pdf
HAS/2021-08-26_elzonris_16062021_synthese_ct19220_2021-08-17_09-46-51_930.pdf
HAS/2021-08-26_elzonris_21072021_transcription_ct19220.pdf
HAS/2021-08-26_elzonris_pic_ins_avisdef_ct19220.pdf
HAS/2021-08-26_gliptine_glp1_transcription_cteval520.pdf
HAS/2021-08-26_orfadin_02062021_transcription_ct19102.pdf
HAS/2021-08-26_orfadin_21072021_synthese_ct19102.pdf
HAS/2021-08-26_ozempic_21072021_synthese_cteval520.pdf
HAS/2021-08-26_remsima_23062021_synthese_ct19232.pdf
HAS/2021-08-26_rozlytrek_21072021_synthese_ct19236.pdf
HAS/2021-08-26_rozlytrek_21072021_transcription_ct19236.pdf
HAS/2021-08-26_rozlytrek_210721_summary_ct19236.pdf
HAS/2021-08-26_rozlytrek_30062021_transcription_ct19236.pdf
HAS/2021-08-26_suliqua_21072021_synthese_cteval520.pdf
HAS/2021-08-26_trulicity_21072021_synthese_cteval520.pdf
HAS/2021-08-26_victoza_21072021_synthese_cteval520.pdf
HAS/2021-08-26_vipidia_vipdomet_synthese_cteval520.pdf
HAS/2021-08-26_xultophy_21072021_synthese_cteval520.pdf
HAS/2021-08-27_fiche_memo_abces_cutanes_durees_antibiotherapies.pdf
HAS/2021-08-27_fiche_memo_dhbnn_adulte_durees_antibiotherapies__annule_et_remplace_.pdf
HAS/2021-08-27_fiche_memo_dhbnn_enfant_durees_antibiotherapies.pdf
HAS/2021-08-27_fiche_memo_diverticulite__durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2021-08-27_fiche_memo_furoncle_adulte_enfant_durees_antibiotherapies.pdf
HAS/2021-08-27_fiche_memo_furonculoses_durees_antibiotherapies.pdf
HAS/2021-08-27_fiche_memo_helicobacter_guide_durees_antibiotherapies.pdf
HAS/2021-08-27_fiche_memo_helicobacter_probabiliste_durees_antibiotherapies.pdf
HAS/2021-08-27_fiche_memo_impetigo_durees_antibiotherapies.pdf
HAS/2021-08-27_rapport_elaboration__durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2021-08-27_reco360_synthese_durees_antibiotherapies_coi_2021_07_15_v2.pdf
HAS/2021-08-30_CT-19180_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-08-30_CT-19181_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-08-30_CT-19194_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-08-30_CT-19195_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-08-30_CT-19238_ROZLYTREK_PIC_EI_AvisDef_CT19238.pdf
HAS/2021-08-30_gliptine_glp1_transcription_cteval520_2021-08-30_15-01-57_728.pdf
HAS/2021-08-30_gliptine_glp1_transcription_cteval520_2021-08-30_15-11-4_373.pdf
HAS/2021-08-30_gliptine_glp1_transcription_cteval520_2021-08-30_15-17-13_284.pdf
HAS/2021-08-30_gliptine_glp1_transcription_cteval520_2021-08-30_15-52-40_435.pdf
HAS/2021-08-30_jentadueto_synthese_cteval520.pdf
HAS/2021-08-30_komboglyze_synthese_cteval520.pdf
HAS/2021-08-30_onglyza_synthese_cteval520.pdf
HAS/2021-08-30_rozlytrek_21072021_synthese_ct19238.pdf
HAS/2021-08-30_rozlytrek_cpnpc_21072021_transcription_ct19238_cpnpc.pdf
HAS/2021-08-30_trajenta_synthese_cteval520.pdf
HAS/2021-08-31_CT-19202_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-08-31_gliptine_glp1_transcription_cteval520_2021-08-30_16-02-16_963.pdf
HAS/2021-08-31_remsima_16062021_avis_ct19274.pdf
HAS/2021-08-31_remsima_16062021_synthese__ct19274.pdf
HAS/2021-08-31_xelevia_synthese_cteval520.pdf
HAS/2021-09-02_format_argumentaire_pnds.pdf
HAS/2021-09-02_pndsnf1finalv2.pdf
HAS/2021-09-02_synthese_mg_neurofibromatose_1.pdf
HAS/2021-09-03_CT-19184_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-09-03_gliptine_glp1_transcription_cteval520.pdf
HAS/2021-09-03_janumet_synthese_cteval520.pdf
HAS/2021-09-06_CNEDIMTS-6112_EMBOSPHERE_6_juillet_2021_(6112)_EMBOGOLD_6_juillet_2021_(6113)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6113_EMBOSPHERE_6_juillet_2021_(6112)_EMBOGOLD_6_juillet_2021_(6113)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6297_SEQUENT PLEASE NEO_25_mai_2021_(6297)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6417_ZENITH FENESTRATED_27_avril_2021_(6417)-avis.pdf
HAS/2021-09-06_CNEDIMTS-6468_STIMROUTER_22_juin_2021_(6468)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6473_CYRANOSE GLOBAL SYSTEM_27_avril_2021_(6473)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6492_TENDYNE_08_juin_2021_(6492)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6499_CGUARD_11_mai_2021_(6499)_avis.pdf
HAS/2021-09-06_CNEDIMTS-6510_COROFLEX ISAR NEO_13_avril_2021_(6510)_avis.pdf
HAS/2021-09-06_CT-18983_VENCLYXTO_PIC_EI_AvisDef_CT18983.pdf
HAS/2021-09-06_CT-19186_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-09-06_CT-19187_GLIPTINES_REEVAL_PIC_ Avis def_CTEVAL520.pdf
HAS/2021-09-06_CT-19191_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-09-06_CT-19196_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-09-06_CT-19197_A_GLP-1_PIC_REEVAL_Avisdef_CTEVAL520.pdf
HAS/2021-09-06_CT-19312_ADCETRIS_PIC_REEV_AvisDef_CT19312.pdf
HAS/2021-09-06_a_gp1_16062021_transcription_ct19190.pdf
HAS/2021-09-06_a_gp1_16062021_transcription_ct19190_2021-09-03_16-45-17_939.pdf
HAS/2021-09-06_a_gp1_16062021_transcription_ct19190_2021-09-03_16-49-3_960.pdf
HAS/2021-09-06_a_gp1_16062021_transcription_ct19190_2021-09-03_16-54-19_234.pdf
HAS/2021-09-06_a_gp1_21072021_synthese_cteval520.pdf
HAS/2021-09-06_a_gp1_21072021_synthese_cteval520_2021-09-03_16-45-17_942.pdf
HAS/2021-09-06_a_gp1_21072021_synthese_cteval520_2021-09-03_16-49-3_964.pdf
HAS/2021-09-06_a_gp1_21072021_synthese_cteval520_2021-09-03_16-54-19_235.pdf
HAS/2021-09-06_adcetris_21072021_synthese_ct19312.pdf
HAS/2021-09-06_adcetris_21072021_transcription__ct19312.pdf
HAS/2021-09-06_avis_conforme_ansm_aap_trovelvy_20210824_2021-09-07_09-55-12_109.pdf
HAS/2021-09-06_dc_2021_0228_trodelvy_cd_20210902_vd.pdf
HAS/2021-09-06_galvus_synthese_cteval520.pdf
HAS/2021-09-06_gliptine_glp1_transcription_cteval520_2021-09-03_16-25-41_544.pdf
HAS/2021-09-06_pnds_aplasie_majeure_doreille-argumentaire-juillet_2021.pdf
HAS/2021-09-06_pnds_aplasie_majeure_doreille-argumentaire-juillet_2021_2021-09-02_16-54-48_469.pdf
HAS/2021-09-06_pnds_aplasie_majeure_doreille-texte-juillet_2021.pdf
HAS/2021-09-06_pnds_aplasie_majeure_doreille-texte-juillet_2021_2021-09-02_16-54-48_467.pdf
HAS/2021-09-06_pnds_pca_vf_juin_2021.pdf
HAS/2021-09-06_pnds_pca_vf_juin_2021_argumentaire.pdf
HAS/2021-09-06_pnds_smith-magenis_2021.pdf
HAS/2021-09-06_pnds_smith-magenis_argumentaire_2021.pdf
HAS/2021-09-06_rybelsus_21072021_transcription_ct19196.pdf
HAS/2021-09-06_synthese_mg_aplasie_majeure_d_oreille.pdf
HAS/2021-09-06_synthese_mg_aplasie_majeure_d_oreille_2021-09-02_16-54-48_465.pdf
HAS/2021-09-06_synthese_mg_polychondrite_chronique_atrophiante.pdf
HAS/2021-09-06_synthese_mg_syndrome_de_smith_magenis.pdf
HAS/2021-09-06_trodelvy_ap_aut_avisdef_ctap5_2021-09-06_10-58-55_480.pdf
HAS/2021-09-06_trodelvy_ap_contribution_patients__rose_up_.pdf
HAS/2021-09-06_trodelvy_ap_contribution_patients__triplettes_2021-09-07_10-28-48_260.pdf
HAS/2021-09-06_venclyxto_28092021_transcription_ceesp.pdf
HAS/2021-09-06_venclyxto_280921_avis_economique.pdf
HAS/2021-09-06_venclyxto_30062021_synthese_ct18983.pdf
HAS/2021-09-06_venclyxto_30062021_transcription_ct_18983.pdf
HAS/2021-09-06_venclyxto_300621_summary_ct18983.pdf
HAS/2021-09-07_CT-19290_PONVORY_PIC_INS_AvisDef_CT19290.pdf
HAS/2021-09-07_app_357_guide_parcours_scc.pdf
HAS/2021-09-07_app_357_points_critiques_parcours_scc.pdf
HAS/2021-09-07_fiche_pertinence_scc.pdf
HAS/2021-09-07_nalador_21072021_avis_ct19364.pdf
HAS/2021-09-07_ponvory_21072021_synthese_ct19290.pdf
HAS/2021-09-07_ponvory_21072021_transcription_ct19290.pdf
HAS/2021-09-07_ponvory_contribution_ct19290.pdf
HAS/2021-09-09_CNEDIMTS-6267_HOT AXIOS_28_juillet_2021_(6267)_avis_occultation.pdf
HAS/2021-09-09_CNEDIMTS-6360_RESTORELLE_08_juin_2021_(6360)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6365_UPSYLON_8_juin_2021_(6365)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6381_GYNECARE GYNEMESH PS_08_juin_2021_(6381)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6385_DUALIS TRIPOD_22_juin_2021_(6385_6605)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6404_S-SWIFT_08_juin_2021_(6404)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6433_PRO-SWING PS2_08_juin_2021_(6433)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6434_PRO-SWING PS4_08_juin_2021_(6434)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6437_SACROMESH_PROMESH_08_juin_2021_(6437)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6478_PELVI STOP 6478.pdf
HAS/2021-09-09_CNEDIMTS-6483_MOBI-C PLUG & FIT_22_juin_2021_(6483)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6506_POROUSITI_06_juillet_2021_(6506)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6517_JAZZY ZT8_16_mars_2021_(6517)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6543_VANINA_HV_22_juin_2021_(6543)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6546_DELYA_HV_22_juin_2021_(6546)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6568_ANITA_22_juin_2021_(6568)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6586_VOLUME 1046X2_22_juin_2021_(6586)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6587_NEOCATE ADVANCE_22_juin_2021_(6587)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6594_ANITA Radiation_22_juin_2021_(6594)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6600_MENIX-MENIX DUO_06_juillet_2021_(6600)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6603_FAST-FIX FLEX_06_juillet_2021_(6603)_avis.pdf
HAS/2021-09-09_CNEDIMTS-6605_DUALIS TRIPOD_22_juin_2021_(6385_6605)_avis.pdf
HAS/2021-09-09_elaboration_de_cahiers_des_charges_fonctions_et_organisation_des_soins_pour_certains_dispositifs_med_2021-09-08_16-40-57_998.pdf
HAS/2021-09-10_CNEDIMTS-5984_JARVIK_2000 _20_juillet_2021_(5984)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6202_REVEAL XT_20_juillet_2021_(6202)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6315_ATOPICLAIR_6_juillet_2021_(6315)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6453_XIENCE XPEDITION 48_22_juin_2021_(6453)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6455_ONYX_08_juin_2021_(6455)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6486_SENTIVA_SENTIVA DUO_22_juin_2021_(6486)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6516_SORBACT mèche_11_mai_2021_(6516)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6519_NEOVASC REDUCER_20_juillet_2021_(6519)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6525_ATOMISOR AERODJINN ATOMISOR NL9M_8_juin_2021_(6525)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6533_CAROTID WALLSTENT MONORAIL_6_juillet_2021_(6533)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6540_ALIZEA DR 1600_22_juin_2021_(6540)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6541_ALIZEA SR 1300_22_juin_2021_(6541)_avis.pdf
HAS/2021-09-10_CNEDIMTS-6548_THERABITE 6548.pdf
HAS/2021-09-10_CNEDIMTS-6565_ABRE_20_juillet_2021_(6565)_avis.pdf
HAS/2021-09-15_CNEDIMTS-6537_ROTAPRO_22_juin_2021_(6537)_avis.pdf
HAS/2021-09-15_CNEDIMTS-6555_IALUSET ABSORB FINE_20_juillet_2021_(6555)_avis.pdf
HAS/2021-09-15_CNEDIMTS-6585_EVOLUT_PRO PLUS_22_juin_2021_(6585)_avis.pdf
HAS/2021-09-15_CNEDIMTS-6593_OPTIVE_22_juin_2021_(6593)_avis.pdf
HAS/2021-09-15_CT-18189_EPIDYOLEX_PIC_INS_AvisDef_CT18189.pdf
HAS/2021-09-15_CT-18386_TAREG_PIC_EI_AvisDef_CT18386.pdf
HAS/2021-09-15_annexes_tests_compagnons.pdf
HAS/2021-09-15_mns_412_fiche__sam_tareg_solution_buvable_sem_vf.pdf
HAS/2021-09-15_mns_413_fiche__sam_epidyolex_solution_buvable_sem_vf.pdf
HAS/2021-09-15_rapport_tests_compagnons.pdf
HAS/2021-09-15_restoration_adm_x3_07_septembre_2021_6588_avis.pdf
HAS/2021-09-17_CNEDIMTS-6562_SONDALIS HP 2 KCAL_08_juin_2021_(6562)_avis.pdf
HAS/2021-09-17_nervfix_07_septembre_2021_6479_avis.pdf
HAS/2021-09-17_sondalis_hp_2kcal_fibre_6590.pdf
HAS/2021-09-17_xact_07_septembre_2021_6633_avis.pdf
HAS/2021-09-20_rm_classic_07_septembre_2021_6572_avis.pdf
HAS/2021-09-20_rm_pressfit_07_septembre_2021_6571_avis.pdf
HAS/2021-09-20_rm_pressfit_vitamys_07_septembre_2021_6570_avis.pdf
HAS/2021-09-21_CT-19064_OPDIVO_PIC_REEV_AvisDef_CT19064.pdf
HAS/2021-09-21_misoprostol_mifepristone_rtu_reco_autosaisine_has_sem_cteval537.pdf
HAS/2021-09-21_misoprostol_rtu_reco_autosaisine_has_sem_cteval538.pdf
HAS/2021-09-21_opdivo_02062021_synthese_ct19064.pdf
HAS/2021-09-21_opdivo_02062021_transcription_ct19064.pdf
HAS/2021-09-21_optune_20_juillet_2021_6489_avis.pdf
HAS/2021-09-22_CT-19144_ULTOMIRIS_SHUa_PIC_EI_AvisDef_CT19144_EPI730.pdf
HAS/2021-09-22_ultomiris_16062021_transcription_ct19144.pdf
HAS/2021-09-22_ultomiris_21042021_transcription_ct19144.pdf
HAS/2021-09-22_ultomiris_contribution_airg_france_ct19144.pdf
HAS/2021-09-22_ultomiris_shua_16062021_synthese_ct19144_epi730.pdf
HAS/2021-09-23__argumentaire_rbpp_scolarite_final.pdf
HAS/2021-09-23__rbpp_parcours_scolaires_final.pdf
HAS/2021-09-24_CNEDIMTS-6617_SYNCHRONY 2-S VECTOR_7_septembre_2021_(6617)_avis.pdf
HAS/2021-09-24_CT-19056_OXLUMO_PIC_INS_AvisDef_CT19056_EPI726.pdf
HAS/2021-09-24_CT-19158_KALYDECO_SYMKEVI_PIC_INS_EI_AvisDef_CT19159_19157_19156_19158.pdf
HAS/2021-09-24_CT-19248_COAGADEX_PIC_INS_Avisdef_CT19248.pdf
HAS/2021-09-24_CT-19368_CLOXACILLINE STRAGEN_Avisdef_CT19368.pdf
HAS/2021-09-24_CT-19423_CLAMOXYL_PIS_Avisdef_CT19423.pdf
HAS/2021-09-24_CT-19430_SIMVASTATINE MYLAN PHARMA_PIS_AvisDef_CT19430.pdf
HAS/2021-09-24_coagadex_07072021_summary_ct19248.pdf
HAS/2021-09-24_coagadex_07072021_synthese_ct19248.pdf
HAS/2021-09-24_coagadex_1311444_transcription_ct19248.pdf
HAS/2021-09-24_coagadex_contribution_ct19248.pdf
HAS/2021-09-24_onureg_ap_aut_postamm_avisdef_ctap3.pdf
HAS/2021-09-24_opdivo-yervoy_ap_aut_postamm_avisdef_ctap6.pdf
HAS/2021-09-24_oxlumo_07042021_transcription_ct19056.pdf
HAS/2021-09-24_oxlumo_11052021__avis_eco_transcription_ceesp.pdf
HAS/2021-09-24_oxlumo_11052021_avis_economique.pdf
HAS/2021-09-24_oxlumo_21042021_synthese_ct19056.pdf
HAS/2021-09-24_oxlumo_contribution_airg_france_ct19056.pdf
HAS/2021-09-24_symkevi_30062021_synthese_ct19158.pdf
HAS/2021-09-24_symkevi_30062021_transcription_ct19158.pdf
HAS/2021-09-24_symkevi__contribution_ct19158.pdf
HAS/2021-09-24_xarelto_ap_aut_avisdef_ctap4.pdf
HAS/2021-09-27_CNEDIMTS-5964_SYNCARDIA TAH-T 70CC_20 juillet_2021_(5964)_avis.pdf
HAS/2021-09-27_CNEDIMTS-6390_AGENT_7_septembre_2021_(6390)_avis.pdf
HAS/2021-09-27_CNEDIMTS-6621_HANCOCK HC150_7_septembre_2021_(6621)_avis.pdf
HAS/2021-09-27_CNEDIMTS-6622_HANCOCK HC105_7_septembre_2021_(6622)_avis.pdf
HAS/2021-09-27_CNEDIMTS-6627_XIENCE SKYPOINT_7_septembre_2021_(6627)_avis.pdf
HAS/2021-09-27_cadrage_biopsies_ciblees.pdf
HAS/2021-09-27_pantera_lux_20_juillet_2021_6295_avis.pdf
HAS/2021-09-28_CT-19410_TEPADINA_PIS_Avisdef_CT19410.pdf
HAS/2021-09-28_algorithme_-_strategie_dexploration_dun_nodule_thyroidien.pdf
HAS/2021-09-28_document_dinformation_des_patients_nodule_de_la_thyroide_-_comment_lexplorer.pdf
HAS/2021-09-28_fiche_exploration_des_pathologies_thyroidiennes_chez_ladulte_pertinence_et_criteres_de_qualite_de_lechographie_pertinence_de.pdf
HAS/2021-09-28_outil_quiz_sur_lexploration_dun_nodule_thyroidien__outil_dauto-evaluation_pour_les_professionnels_de_sante.pdf
HAS/2021-09-28_rapport_delaboration_-_exploration_des_pathologies_thyroidiennes_chez_ladulte_pertinence_et_criteres_de_qualite_de_lechograp.pdf
HAS/2021-09-29_doctrine_de_la_ceesp.pdf
HAS/2021-09-29_doctrine_de_la_ceesp_version_anglaise_2021-09-29_11-14-2_803.pdf
HAS/2021-09-29_fiche_sam_fluoropyrimidines_vf.pdf
HAS/2021-09-30_2021_04_02_cr_analyse_des_questions_anonymise.pdf
HAS/2021-09-30_30062021_transcription_ct_19219_doptelet.pdf
HAS/2021-09-30_CT-19105_OZURDEX_PIC_rééval_EPI_Avisdéfinitif_CT19105.pdf
HAS/2021-09-30_CT-19165_PEMAZYRE_PIC_INS_AvisDef_CT19165.pdf
HAS/2021-09-30_CT-19219_DOPTELET_PIC_EI_Avisdef_CT19219.pdf
HAS/2021-09-30_CT-19226_EYLEA_PIC_REEVAL_EPI_OMD_Avisdéfinitif_CT19226.pdf
HAS/2021-09-30_CT-19266_EVRYSDI_PIC_AVIS DEF_CT19266.pdf
HAS/2021-09-30_CT-19448_OPTIRAY_PIS_Avisdef_CT19448.pdf
HAS/2021-09-30_doptelet_08092021_synthese_ct19219.pdf
HAS/2021-09-30_doptelet_08092021_transcription_ct19219.pdf
HAS/2021-09-30_doptelet_21072021_transcription_ct19219.pdf
HAS/2021-09-30_doptelet_contribution.pdf
HAS/2021-09-30_evrysdi_08092021_synthese_ct19266.pdf
HAS/2021-09-30_evrysdi_20072021_avis_economique.pdf
HAS/2021-09-30_evrysdi_21072021_transcription_ct19266.pdf
HAS/2021-09-30_evrysdi_ceesp_06072021_transcription_ceesp.pdf
HAS/2021-09-30_eylea_07072021_synthese_ct19226.pdf
HAS/2021-09-30_eylea_23062021_transcription_ct19226.pdf
HAS/2021-09-30_note_cadrage_has_precarite_troubles_psychiques.pdf
HAS/2021-09-30_ozurdex_07072021_synthese_ct19105.pdf
HAS/2021-09-30_ozurdex_23062021_transcription_ct19105.pdf
HAS/2021-09-30_pemazyre_08092021_synthese_ct19165.pdf
HAS/2021-09-30_pemazyre_08092021_transcription_ct19165.pdf
HAS/2021-09-30_pemazyre_21072021_transcription_ct19165.pdf
HAS/2021-09-30_pemazyre_30062021_transcription_ct19165.pdf
HAS/2021-09-30_reco348_argumentaire_idees_conduites_suicidaires_2021_09_29.pdf
HAS/2021-09-30_reco348_recommandations_idees_conduites_suicidaires_cd_2021_09_29_v1.pdf
HAS/2021-09-30_reco348_synthese__idees_conduites_suicidaires_1re_ligne_2021_09_29_v3.pdf
HAS/2021-09-30_reco348_synthese__idees_conduites_suicidaires_1re_ligne_2021_09_29_v3_en_vd.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_decideurs_2021_09_29.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_decideurs_2021_09_29_en_vd.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_hospitaliere_et_2e_ligne_2021_09_09.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_hospitaliers_et_2e_ligne_2021_09_09_en_vd.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_non_clinicien_2021_09_09.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_non_clinicien_2021_09_09_en.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_urgences_2021_09_13.pdf
HAS/2021-09-30_reco348_synthese_idees_conduites_suicidaires_urgences_2021_09_13_en_vd.pdf
HAS/2021-10-01_CNEDIMTS-6625_VANTA_7_septembre_2021_(6625)_avis.pdf
HAS/2021-10-01_fiche__mrc.pdf
HAS/2021-10-01_guide__mrc.pdf
HAS/2021-10-01_leveen_poumon_21_septembre_2021_6558_avis.pdf
HAS/2021-10-01_pnds_rasopathies_-_argumentaire_inculant_2016_sept21_2021-10-01_09-53-19_891.pdf
HAS/2021-10-01_pnds_rasopathies_texte_sept21_2021-10-01_09-53-19_890.pdf
HAS/2021-10-01_synthese_mg_rasopathies__syndromes_de_noonan_cardio_facio_cutane_et_apparentes_2021-10-01_09-53-19_889.pdf
HAS/2021-10-01_synthese_mrc.pdf
HAS/2021-10-04_CNEDIMTS-6554_ELIXYA_25_mai_2021_6554_avis.pdf
HAS/2021-10-04_CNEDIMTS-6634_RX ACCULINK_7_septembre_2021_(6634)_avis.pdf
HAS/2021-10-04_CT-19126_KALYDECO_PIC_EI_AvisDef_CT19126.pdf
HAS/2021-10-04_CT-19201_EXACYL_PIC_ EI_Avisdef_CT19201.pdf
HAS/2021-10-04_CT-19203_PERISOC_PIC_INS_Avisdef_CT19203.pdf
HAS/2021-10-04_exacyl_30062021_synthese_ct19201.pdf
HAS/2021-10-04_exacyl_30062021_transcription_ct19201.pdf
HAS/2021-10-04_kalydeco_30062021_synthese_ct19126.pdf
HAS/2021-10-04_kalydeco_30062021_transcription_ct19126.pdf
HAS/2021-10-04_kalydeco_4-6_mois_contribution_vaincre_la_muco_19mars21__ct19126.pdf
HAS/2021-10-04_opdivo_aap_postamm_pic_avisdef_ctap7.pdf
HAS/2021-10-04_perisoc_08092021_synthese_ct19203.pdf
HAS/2021-10-04_perisoc_08092021_transcription_ct19203.pdf
HAS/2021-10-04_perisoc_ct19203_transcription.pdf
HAS/2021-10-04_silima_et_serena_21_septembre_2021_6681_avis.pdf
HAS/2021-10-05_CT-19125_OPDIVO_PIC_EI_AvisDéf_CT19125.pdf
HAS/2021-10-05_CT-19214_DEFITELIO_PIC_reeval_EPI_Avisdef_CT19214.pdf
HAS/2021-10-05_defitelio_30062021_synthese_ct19214.pdf
HAS/2021-10-05_defitelio_30062021_transcription_ct19214.pdf
HAS/2021-10-05_opdivo_21072021_transcription_ct19125.pdf
HAS/2021-10-05_opdivo_pic_ei_synthese_ct19125.pdf
HAS/2021-10-06_CT-19157_KALYDECO_SYMKEVI_PIC_INS_EI_AvisDef_CT19159_19157_19156_19158.pdf
HAS/2021-10-06_CT-19273_KEYTRUDA_PIC_EI_AvisDef_CT19273.pdf
HAS/2021-10-06_CT-19336_BORTEZOMIB_ACCORD_PIS_AVISdef_CT19336.pdf
HAS/2021-10-06_CT-19373_ELAPRASE_PIS_InsSS_Avisdef_CT19373.pdf
HAS/2021-10-06_CT-19421_FIVASA_1g_suppo_PIS_Avisdéf_CT19421.pdf
HAS/2021-10-06_CT-19438_DIACOMIT_100mg_gélule_PIS_AvisDef_CT19438.pdf
HAS/2021-10-06_avis_n2021.0061.ac.seesp_du_23_aout_2021_du_college_de_la_has_sur_la_campagne_de_rappel_vaccinal_contre_la_covid_19.pdf
HAS/2021-10-06_contrib_fle_keytruda_finale.pdf
HAS/2021-10-06_kalydeco_symkevi_30062021_synthese_ct19159_19157_19156_19158.pdf
HAS/2021-10-06_keytruda_pic_synthese_ct19273.pdf
HAS/2021-10-06_place_d_un_rappel_par_le_vaccin_a_arnm_comirnaty_dans_la_strategie_vaccinale_contre_la_covid_19_reco_2021-10-15_12-57-50_448.pdf
HAS/2021-10-06_place_d_un_rappel_par_le_vaccin_a_arnm_comirnaty_dans_la_strategie_vaccinale_contre_la_covid_19_synt_2021-10-15_12-57-50_451.pdf
HAS/2021-10-06_symkevi_kalydeco_30062021_transcription_ct19159.pdf
HAS/2021-10-07_CT-19005_OPDIVO_YERVOY_PIC_EI_AvisDef_CT19005&19006.pdf
HAS/2021-10-07_has_50_cadrage_cadre_cooperation_usagers_coi_2021_09_vmel.pdf
HAS/2021-10-07_opdivo_yervoy_07042021_transcription_ct1900519006.pdf
HAS/2021-10-07_opdivo_yervoy_16062021_synthese_ct1900519006.pdf
HAS/2021-10-07_opdivo_yervoy_16062021_transcription_ct19005_ct19006.pdf
HAS/2021-10-07_opdivo_yervoy_contribution_de_lair_ct1900519006.pdf
HAS/2021-10-08_CT-19362_VITRAKVI_PIS_AVIS_CT19362 ANNULE ET REMPLACE.pdf
HAS/2021-10-08_CT-19502_ASCOFER_PIS_ Avis DEF_CT19502.pdf
HAS/2021-10-11_CT-19420_CABAZITAXEL ZENTIVA_PIS_Avisdef_CT19420.pdf
HAS/2021-10-11_CT-19426_KILATIM_PIS_Avis Def_CT19426.pdf
HAS/2021-10-11_speedicath_compact_set_21_septembre_2021_6576_avis.pdf
HAS/2021-10-12_flash_samu_13_sept.pdf
HAS/2021-10-12_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2021-10-12_perfusion_a_domicile_05_octobre_2021_dm_eval_296_avis.pdf
HAS/2021-10-12_rapport_etat_des_lieux_eigs_declares_concernant_samu_smur_2020.pdf
HAS/2021-10-13_CNEDIMTS-6534_PRECISION NOVI_27_avril_2021_(6534)_avis.pdf
HAS/2021-10-13_CNEDIMTS-6561_SENSIGHT_25_mai_2021_(6561)_avis_occultation.pdf
HAS/2021-10-13_CNEDIMTS-6574_PENUMBRAJETD_21_septembre_2021_(6574)_avis.pdf
HAS/2021-10-13_CNEDIMTS-6577_PENUMBRA3MAXC_21_septembre_2021_(6577)_avis.pdf
HAS/2021-10-13_CNEDIMTS-6579_PENUMBRA ACE 60 et ACE 68_21_septembre_2021_(6579)_avis.pdf
HAS/2021-10-13_CNEDIMTS-6580_PENUMBRAJET 7_21_septembre_2021_(6580)_avis.pdf
HAS/2021-10-13_advazorb_heel_21_septembre_2021_6128_avis.pdf
HAS/2021-10-13_advazorb_sacral_21_septembre_2021_6216_avis.pdf
HAS/2021-10-13_heartware_05_octobre_2021_6694_avis.pdf
HAS/2021-10-13_precision_novi_21_septembre_2021_6678_avis.pdf
HAS/2021-10-13_spa_187_note_cadrage_auto_administration_coi__2021__09_06_vd.pdf
HAS/2021-10-13_treo_21_septembre_2021_6535_avis.pdf
HAS/2021-10-14_1._protocole_national_de_diagnostic_et_de_soins_syndrome_du_qt_long_cardiogen_isabelle_denjoy.pdf
HAS/2021-10-14_1_texte_pnds_spw.pdf
HAS/2021-10-14_2._argumentaire_scientifique_pnds_syndrome_du_qt_long_cardiogen_isabelle_denjoy.pdf
HAS/2021-10-14_2_argumentaire_pnds_spw.pdf
HAS/2021-10-14_app_457_note_cadrage_annonce_diag_psy.pdf
HAS/2021-10-14_argumentaire_-_fichier_texte.pdf
HAS/2021-10-14_argumentaire_da_et_dg_septembre_2021_vcd.pdf
HAS/2021-10-14_argumentaire_pnds_ald_vf.pdf
HAS/2021-10-14_argumentaire_pnds_faods_v11-07-21.pdf
HAS/2021-10-14_argumentaire_pnds_frda.pdf
HAS/2021-10-14_argumentaire_pnds_pam_pgr_touraine.pdf
HAS/2021-10-14_argumentaire_scientifique_et_analyse_critique_.pdf
HAS/2021-10-14_argumentaire_scientifique_pnds_syndrome_de_brugada_cardiogen_vincent_probst.pdf
HAS/2021-10-14_pnds-dyrk1a_argumentaire_final-sept2021.pdf
HAS/2021-10-14_pnds-dyrk1a_manuscrit_final-sept2021.pdf
HAS/2021-10-14_pnds_-_trps_-_fin_-_septembre_2021.pdf
HAS/2021-10-14_pnds_ald_vf.pdf
HAS/2021-10-14_pnds_cryoglobulinemies_1.pdf
HAS/2021-10-14_pnds_cryoglobulinemies_argumentaire.pdf
HAS/2021-10-14_pnds_da_et_dg_septembre_2021vcd.pdf
HAS/2021-10-14_pnds_faod_synthese_medecin_traitant_vf02-07-21.pdf
HAS/2021-10-14_pnds_faod_texte_vf11-07-21.pdf
HAS/2021-10-14_pnds_hai__vf.pdf
HAS/2021-10-14_pnds_hai_argumentaire_vf.pdf
HAS/2021-10-14_pnds_kleefstra-argumentaire-2021.pdf
HAS/2021-10-14_pnds_kls_argumentaire.pdf
HAS/2021-10-14_pnds_kls_texte_vf.pdf
HAS/2021-10-14_pnds_mowat-wilson_argumentaire_2021.pdf
HAS/2021-10-14_pnds_mowat-wilson_texte_2021.pdf
HAS/2021-10-14_pnds_pam_pgr_touraine.pdf
HAS/2021-10-14_pnds_syndrome_de_kleefstra-sept2021.pdf
HAS/2021-10-14_pnds_syndrome_dheimler_-_argumentaire.pdf
HAS/2021-10-14_pnds_syndrome_dheimler_-_texte_du_pnds.pdf
HAS/2021-10-14_pnds_syndrome_wagr.pdf
HAS/2021-10-14_protocole_national_de_diagnostic_et_de_soins_syndrome_de_brugada_cardiogen_vincent_probst.pdf
HAS/2021-10-14_respifil_pnds_abpa.pdf
HAS/2021-10-14_respifil_pnds_as_abpa.pdf
HAS/2021-10-14_respifil_pnds_as_lam.pdf
HAS/2021-10-14_respifil_pnds_bronchiectasie.pdf
HAS/2021-10-14_respifil_pnds_bronchiectasie_as.pdf
HAS/2021-10-14_respifil_pnds_lam.pdf
HAS/2021-10-14_respifil_pnds_mt_lam.pdf
HAS/2021-10-14_synthese_mg_adrenoleucodystrophie.pdf
HAS/2021-10-14_synthese_mg_aspergillose_broncho_pulmonaire_allergique_hors_mucoviscidose.pdf
HAS/2021-10-14_synthese_mg_ataxie_de_friedreich.pdf
HAS/2021-10-14_synthese_mg_bronchectasie_de_l_enfant_diagnostic_et_prise_en_charge.pdf
HAS/2021-10-14_synthese_mg_cryoglobulinemies.pdf
HAS/2021-10-14_synthese_mg_dysplasies_geleophysiques_et_dysplasies_acromicriques.pdf
HAS/2021-10-14_synthese_mg_hepatite_auto_immune.pdf
HAS/2021-10-14_synthese_mg_polyadenomatose_mammaire.pdf
HAS/2021-10-14_synthese_mg_syndrome_d_heimler.pdf
HAS/2021-10-14_synthese_mg_syndrome_de_brugada.pdf
HAS/2021-10-14_synthese_mg_syndrome_de_kleefstra.pdf
HAS/2021-10-14_synthese_mg_syndrome_de_mowat_wilson.pdf
HAS/2021-10-14_synthese_mg_syndrome_du_qt_long.pdf
HAS/2021-10-14_synthese_mg_syndrome_dyrk1a.pdf
HAS/2021-10-14_synthese_mg_syndrome_kleine_levin.pdf
HAS/2021-10-14_synthese_mg_syndrome_prader_willi.pdf
HAS/2021-10-14_synthese_mg_syndrome_trichorhinophalangien__trps.pdf
HAS/2021-10-14_synthese_mg_syndrome_wagr.pdf
HAS/2021-10-14_texte_pnds_frda.pdf
HAS/2021-10-18_argumentaire_pnds_huntington.pdf
HAS/2021-10-18_pnds_huntington_vf.pdf
HAS/2021-10-18_synthese_mg_maladie_de_huntington.pdf
HAS/2021-10-19_CNEDIMTS-6495_COBAN 2_21_septembre_2021_(6495)_avis.pdf
HAS/2021-10-19_CNEDIMTS-6607_AQUALEG_21_septembre_2021_(6607)_avis.pdf
HAS/2021-10-19_CNEDIMTS-6632_3M TEGADERM_21_septembre_2021_(6632)_avis.pdf
HAS/2021-10-19_CT-19206_TIVICAY_PIS_AvisDef_CT19206.pdf
HAS/2021-10-19_CT-19209_JULUCA_PIS_AVISDef_CT19209.pdf
HAS/2021-10-19_CT-19225_LUCENTIS_PIC_Rééval_EPI_Avisdéfinitif_ANNULE ET REMPLACE_CT19225.pdf
HAS/2021-10-19_CT-19264_TRIMBOW_PIC_INS_Avis def_CT19264.pdf
HAS/2021-10-19_CT-19351_TRUVADA_PIS_AvisDef_CT19351.pdf
HAS/2021-10-19_CT-19378_ZYMAD_PIS_Avisdef_CT19378.pdf
HAS/2021-10-19_CT-19422_BIMATOPROST_IDIFARMA_PIS_AvisDEF_CT19422.pdf
HAS/2021-10-19_CT-19466_KETAZED_PIS_Avisdef_CT19466.pdf
HAS/2021-10-19_excor_05_octobre_2021_6044_avis.pdf
HAS/2021-10-19_heartmate_3_05_octobre_2021_5955_avis.pdf
HAS/2021-10-19_heartmate_ii_v2_05_octobre_2021_6062_avis.pdf
HAS/2021-10-19_lucentis_07072021_synthese_ct19225.pdf
HAS/2021-10-19_lucentis_23062021_transcription_ct19225.pdf
HAS/2021-10-19_trimbow_07072021_synthese_ct19264.pdf
HAS/2021-10-19_trimbow_07072021_transcription_ct19264.pdf
HAS/2021-10-20_1_pnds_agenesie_transversale_avant-bras_cerefam_sept2021.pdf
HAS/2021-10-20_2020-12-10-rapport-annuel-eigs_vd.pdf
HAS/2021-10-20_2021_06_argumentaire_scientifique_hypocholesterolemie_intestinale_genetique_vf.pdf
HAS/2021-10-20_2021_06_pnds_hypocholesterolemie_intestinale_genetique_vf.pdf
HAS/2021-10-20_3_argumentaire_pnds_agenesie_transversale_avant-bras_cerefam_sept2021.pdf
HAS/2021-10-20_argumentaire_pnds_anodevcdh1_version_finale.pdf
HAS/2021-10-20_argumentaire_pnds_arthrogryposesmultiplescongenitales.pdf
HAS/2021-10-20_argumentaire_pnds_narcolepsies.pdf
HAS/2021-10-20_argumentaire_pnds_syndrome_de_grele_court_adulte_2021-09_vf.pdf
HAS/2021-10-20_cadre_general_devaluation_des_demarches_danalyse_des_eias_-_novembre_2016.pdf
HAS/2021-10-20_fiche_information_patients.pdf
HAS/2021-10-20_fimarad_pnd_xp_argumentaire_v3_29092021.pdf
HAS/2021-10-20_fimarad_pnd_xp_synthese_v3_29092021.pdf
HAS/2021-10-20_guide_lanalyse_des_evenements_indesirables_associes_aux_soins_eias.pdf
HAS/2021-10-20_guide_rmm_juin_09.pdf
HAS/2021-10-20_ichtyoseargumentaire2.pdf
HAS/2021-10-20_ichtyosetextepnds.pdf
HAS/2021-10-20_nplate_rtu_reco_autosaisine_has_sem_cteval541.pdf
HAS/2021-10-20_pheochromocytomes_et_paragangliomes_pnds.pdf
HAS/2021-10-20_pnds-anodevcdh1_version_finale.pdf
HAS/2021-10-20_pnds-mcap_sept_2021.pdf
HAS/2021-10-20_pnds_mcap-_argumentaire-sept_2021.pdf
HAS/2021-10-20_pnds_pheochromocytomes_et_paragangliomes-argumentaire_29092021.pdf
HAS/2021-10-20_pnds_sequence_de_pierre_robin-argumentaire_scientifique-septembre_2021.pdf
HAS/2021-10-20_pnds_sequence_de_pierre_robin-texte-septembre_2021.pdf
HAS/2021-10-20_pnds_syndrome_du_grele_court_chez_ladulte_vf.pdf
HAS/2021-10-20_rapport_annuel_eigs_2018_vd-avecinfo.pdf
HAS/2021-10-20_rex_comprendre_mettre_en_oeuvre.pdf
HAS/2021-10-20_synthese_mg_agenesie_transversale_avant_bras.pdf
HAS/2021-10-20_synthese_mg_anomalies_du_developpement_liees_aux_variants_de_cdh1.pdf
HAS/2021-10-20_synthese_mg_arthrogryposes_multiples_congenitales.pdf
HAS/2021-10-20_synthese_mg_hypocholesterolemies_genetiques_intestinales.pdf
HAS/2021-10-20_synthese_mg_ichthyoses_hereditaires.pdf
HAS/2021-10-20_synthese_mg_narcolepsie_de_type_1_et_2.pdf
HAS/2021-10-20_synthese_mg_pheochromocytomes_et_paragangliomes.pdf
HAS/2021-10-20_synthese_mg_sequence_de_pierre_robin.pdf
HAS/2021-10-20_synthese_mg_syndrome_du_grele_court_chez_l_adulte.pdf
HAS/2021-10-20_synthese_mg_syndrome_mcap.pdf
HAS/2021-10-20_synthese_mg_xeroderma_pigmentosum.pdf
HAS/2021-10-20_texte_pnds_arthrogryposesmultiplescongenitales.pdf
HAS/2021-10-20_texte_pnds_narcolepsies_annexes.pdf
HAS/2021-10-21_argumentaire_pnds_tvc.pdf
HAS/2021-10-21_argumentaire_scientifique_pnds_cvda_cardiogen_estelle_gandjbakhch.pdf
HAS/2021-10-21_note_cadrage_psdm.pdf
HAS/2021-10-21_pnds__stb_argumentaire_30_09_2021.pdf
HAS/2021-10-21_pnds__stb_versionfinale_30_09_2021.pdf
HAS/2021-10-21_protocole_national_de_diagnostic_et_de_soins_cvda_cardiogen_estelle_gandjbakhch.pdf
HAS/2021-10-21_synthese_mg_cardiomyopathie_ventriculaire_droite_arythmogene_.pdf
HAS/2021-10-21_synthese_mg_sclerose_tubereuse_de_bourneville.pdf
HAS/2021-10-21_synthese_mg_thrombose_veineuse_cerebrale_de_l_enfant.pdf
HAS/2021-10-21_texte_pnds_tvc.pdf
HAS/2021-10-22_CT-19208_DOVATO_PIS_AVISDef_CT19208.pdf
HAS/2021-10-22_CT-19498_RETSEVMO_PIS_INS_COMPLEMENT_GAMME_AVISDéf_CT19498.pdf
HAS/2021-10-22_fimarad_pnd_nmg_argumentaire_v3.0_29092021.pdf
HAS/2021-10-22_fimarad_pnd_nmg_synthese_v3.0_29092021.pdf
HAS/2021-10-22_pnds_syndrome_charge-argumentaire_scientifique-septembre_2021.pdf
HAS/2021-10-22_pnds_syndrome_charge-texte-septembre_2021.pdf
HAS/2021-10-22_synthese_mg_naevus_congenital.pdf
HAS/2021-10-22_synthese_mg_syndrome_charge.pdf
HAS/2021-10-25_forxiga_ap_contribution_patients_renaloo.pdf
HAS/2021-10-25_forxiga_avis_ap_aut_post_amm_ctap11.pdf
HAS/2021-10-27_CT-19222_CORTIMENT_EI_AVIS DEF_CT19222.pdf
HAS/2021-10-27_CT-19511_IRINOTECAN SUN_PIS_AVIS DEF_HYBRIDE_CT19511.pdf
HAS/2021-10-27_concentrateurs_doxygene_mobiles_referentiel.pdf
HAS/2021-10-27_contribution_vml_acces_precoces_lidmeldy.pdf
HAS/2021-10-27_cortiment_06102021_synthese_ct19222.pdf
HAS/2021-10-27_cortiment_22092021_transcription_ct19222.pdf
HAS/2021-10-27_dekas_essential_19_octobre_2021_6704_avis.pdf
HAS/2021-10-27_dekas_plus_19_octobre_2021_6583_avis.pdf
HAS/2021-10-27_inpact_admiral_-_avis_de_la_cnedimts_du_27_07_2021.pdf
HAS/2021-10-27_libmeldy_avis_aap_postamm_ctap16.pdf
HAS/2021-10-27_tiloop_6_juillet_2021_6388_avis.pdf
HAS/2021-10-29_CT-19301_ZOLGENSMA_PIC_rééval_AVIS DEF_CT19301.pdf
HAS/2021-10-29_afm_2020_09_zolgensma_has.pdf
HAS/2021-10-29_zolgensma_08092021_synthese_ct19301.pdf
HAS/2021-10-29_zolgensma_21072021_transcription_ct19301.pdf
HAS/2021-11-02_CT-18151_TARDYFERON_FEROGRAD_TIMOFEROL_PIC_REEVAL_AvisDef_CT18151_18167_18534.pdf
HAS/2021-11-02_CT-19026_SIMPONI_PIC_REEV_AvisDef_CT19026.pdf
HAS/2021-11-02_CT-19237_CABLIVI_PIC_EI_AVIS def_CT19234_19237.pdf
HAS/2021-11-02_CT-19461_MENQUADFI_PIC_INS_Avisdef_CT19461.pdf
HAS/2021-11-02_cablivi_06102021_synthese_ct19234_19237_2021-11-02_10-31-7_814.pdf
HAS/2021-11-02_cablivi_22092021_transcription_ct19237_c19234_2021-11-02_10-31-7_816.pdf
HAS/2021-11-02_cablivi_questionnaire_has_contrib_asso_med_1v1.pdf
HAS/2021-11-02_menquadfi_06102021_synthese_ct19461.pdf
HAS/2021-11-02_menquadfi_nimenrix_06102021_transcription_ct19461_ct15972_ct18128.pdf
HAS/2021-11-02_questionnaire_menquadfi_ct19461.pdf
HAS/2021-11-02_questionnaire_simponi_ct19026.pdf
HAS/2021-11-02_simponi_06102021_synthese_ct19026.pdf
HAS/2021-11-02_simponi_roactemra_orencia_06102021_transcription_ct19026_ct18896_19419.pdf
HAS/2021-11-02_tardyferon__fero-grad_vitamine_c__timoferol_23062021_transcription_ct18167_ct_18151__ct18534.pdf
HAS/2021-11-02_tardyferon_ferograd_timoferol_23062021_synthese_ct18151_18167_18534.pdf
HAS/2021-11-03_argumentaire_scientifique_pnds_cmh_cardiogen_n_mansencal_p_charron.pdf
HAS/2021-11-03_fimarad_argumentaire_pnds_ebh_v3__lq_20102021.pdf
HAS/2021-11-03_fimarad_synthese_pnds_ebh_v3_chb30092021_final.pdf
HAS/2021-11-03_ontozry_08092021_avis_ct19275.pdf
HAS/2021-11-03_ontozry_08092021_synthese_ct19275.pdf
HAS/2021-11-03_ontozry_08092021_transcription_ct19275.pdf
HAS/2021-11-03_ontozry_21072021_transcription_ct19275.pdf
HAS/2021-11-03_protocole_national_de_diagnostic_et_de_soins_cmh_cardiogen_n_mansencal_p_charron.pdf
HAS/2021-11-03_synthese_mg_cardiomyopathie_hypertrophique.pdf
HAS/2021-11-03_synthese_mg_epidermolyses_bulleuses_hereditaires.pdf
HAS/2021-11-04_2021_defiscience_pnds_cdkl5_argumentaire.pdf
HAS/2021-11-04_2021_defiscience_pnds_cdkl5_texte_pnds.pdf
HAS/2021-11-04_2021_defiscience_pnds_coffin_siris_argumentaire.pdf
HAS/2021-11-04_2021_defiscience_pnds_coffin_siris_texte_pnds.pdf
HAS/2021-11-04_2021_defiscience_pnds_pitt_hopkins_argumentaire.pdf
HAS/2021-11-04_2021_defiscience_pnds_pitt_hopkins_texte_pnds.pdf
HAS/2021-11-04_2021_defiscience_pnds_syndrome_catatonique_argumentaire.pdf
HAS/2021-11-04_2021_defiscience_pnds_syndrome_catatonique_texte_pnds.pdf
HAS/2021-11-04_argumentaire_pnds_syndrome_de_phelan_mc_dermid_30sept2021.pdf
HAS/2021-11-04_mi_argumentaire_final.pdf
HAS/2021-11-04_pnds_eepocs-argumentaire_vf.pdf
HAS/2021-11-04_pnds_eepocs_texte_vf.pdf
HAS/2021-11-04_pnds_ibm_version_finale_octobre_2021.pdf
HAS/2021-11-04_pnds_lithiase_argumentaire_30092021.pdf
HAS/2021-11-04_pnds_lithiase_texte_30032021.pdf
HAS/2021-11-04_pnds_silverrussell_argumentaire_vf.pdf
HAS/2021-11-04_pnds_silverrussell_vf.pdf
HAS/2021-11-04_pnds_syndrome_charge-argumentaire_scientifique-septembre_2021_2021-10-20_15-07-9_118.pdf
HAS/2021-11-04_pnds_syndrome_charge-texte-septembre_2021_2021-10-20_15-07-9_116.pdf
HAS/2021-11-04_pnds_syndrome_de_phelan_mc_dermid_30sept2021.pdf
HAS/2021-11-04_synthese_mg__encephalopathie_epileptique_avec_pointe.pdf
HAS/2021-11-04_synthese_mg__syndromes_de_coffin_siris_et_de_nicolaides_baraitser_bafopathies.pdf
HAS/2021-11-04_synthese_mg_cdkl5_deficiency_disorder_encephalopathie_epileptique_liee_a_cdkl5.pdf
HAS/2021-11-04_synthese_mg_lithiase_urinaire_de_l_enfant.pdf
HAS/2021-11-04_synthese_mg_myosite_a_inclusions_sporadique.pdf
HAS/2021-11-04_synthese_mg_syndrome_catatonique.pdf
HAS/2021-11-04_synthese_mg_syndrome_charge_2021-10-20_15-07-9_108.pdf
HAS/2021-11-04_synthese_mg_syndrome_de_phelan_mcdermid.pdf
HAS/2021-11-04_synthese_mg_syndrome_de_pitt_hopkins_pths.pdf
HAS/2021-11-04_synthese_mg_syndrome_de_silver_russell.pdf
HAS/2021-11-05_CNEDIMTS-6648_ACURATE NEO_5_octobre_2021_(6648)_avis.pdf
HAS/2021-11-05_CT-19308_JEMPERLI_PIC_AVIS Def_CT19308.pdf
HAS/2021-11-05_ap23_keytruda_contribution_patients_mt_mrcs_vdef.pdf
HAS/2021-11-05_imagyn_jemperli_questionnaire_has_contrib_asso_med_1.pdf
HAS/2021-11-05_jemperli_06102021_synthese_ct19308.pdf
HAS/2021-11-05_jemperli_22092021_transcription_ct19308.pdf
HAS/2021-11-05_keytruda__ap_post_amm-_avis_ct_ap_23.pdf
HAS/2021-11-05_optive_advance_19_octobre_2021_6652_avis.pdf
HAS/2021-11-08_CT-19276_CABOMETYX_PIC_EI_AvisDéf_CT19276.pdf
HAS/2021-11-08_cabometyx_22092021_synthese_ct19276.pdf
HAS/2021-11-08_strategie_de_vaccination_contre_la_covid_19_place_du_vaccin_a_arnm_spikevax_recommandation.pdf
HAS/2021-11-08_strategie_de_vaccination_contre_la_covid_19_place_du_vaccin_a_arnm_spikevax_synthese.pdf
HAS/2021-11-09_CT-19281_OPDIVO_PIC_EI_AvisDéf_CT19281.pdf
HAS/2021-11-09_CT-19403_OPDIVO_YERVOY_PIC_AvisDef_CT19403_19404.pdf
HAS/2021-11-09_opdivo_22092021_synthese_ct19281.pdf
HAS/2021-11-09_opdivo_yervoy_03112021_synthese_ct19403_19404.pdf
HAS/2021-11-10_argumentaire_denutrition_pa_10_nov_2021_v2.pdf
HAS/2021-11-10_format_argumentaire_envoi_final_has.pdf
HAS/2021-11-10_npad_decret_criteres_classification_avis1_saisine2_cteval523_ct29092021.pdf
HAS/2021-11-10_pnds-ibg-5xi2021.pdf
HAS/2021-11-10_pnds_pca_vf_juin_2021_2021-07-19_20-43-21_647.pdf
HAS/2021-11-10_pnds_pca_vf_juin_2021_argumentaire_2021-07-19_20-43-21_650.pdf
HAS/2021-11-10_reco368_fiche_outil_denutrition_pa_cd_20211110_v1.pdf
HAS/2021-11-10_reco368_recommandations_denutrition_pa_cd_20211110_v1.pdf
HAS/2021-11-10_synthese_mg_angiooedeme_hereditaire.pdf
HAS/2021-11-10_synthese_mg_polychondrite_chronique_atrophiante_2021-07-19_20-43-21_645.pdf
HAS/2021-11-15_CT-18167_TARDYFERON_FEROGRAD_TIMOFEROL_PIC_REEVAL_AvisDef_CT18151_18167_18534.pdf
HAS/2021-11-15_CT-18534_TARDYFERON_FEROGRAD_TIMOFEROL_PIC_REEVAL_AvisDef_CT18151_18167_18534.pdf
HAS/2021-11-15_actes-pose-reprise-prothese-hanche-genou-atih_mars2019.pdf
HAS/2021-11-15_adtralza_ap12_contribution_patients_afe.pdf
HAS/2021-11-15_adtralza_ap_aut_postamm_avis_ctap12.pdf
HAS/2021-11-15_cr_reunion_parties_prenantes_psi12_pth_ptg_vf.pdf
HAS/2021-11-15_fiche_descriptive_ete_ortho_2020.pdf
HAS/2021-11-15_guide_lecture_funnel_iso_ortho_has_2018.pdf
HAS/2021-11-15_iqss_2020_rapport_developpement_ete_pth_ptg_2020.pdf
HAS/2021-11-15_iqss_2020_rapport_resultats_ete_ortho_2020.pdf
HAS/2021-11-15_iqss_courrier_es_info_generale_2020.pdf
HAS/2021-11-15_iqss_has_methode_developpement_ir_2019.3.pdf
HAS/2021-11-15_iqss_rapport_complet_2019.pdf
HAS/2021-11-15_iqss_rapport_ete_ortho_2019.pdf
HAS/2021-11-15_note_de_cadrage_psi_12_pth_ptg_coi_2015_03_19_vdpourmiseenligne.pdf
HAS/2021-11-15_plaquette_ete_pth_ptg_vd.pdf
HAS/2021-11-15_rapport_complet_resultats_campagne_2020_pdf.pdf
HAS/2021-11-15_rapport_developpement_ete_ortho_2017.pdf
HAS/2021-11-15_rapport_ete_ortho_2018.pdf
HAS/2021-11-15_rapport_iqss_2018.pdf
HAS/2021-11-15_rapport_resultats_ete_ortho_2017.pdf
HAS/2021-11-15_tardyferon__fero-grad_vitamine_c__timoferol_23062021_transcription_ct18167_ct_18151__ct18534_2021-11-15_10-21-53_963.pdf
HAS/2021-11-15_tardyferon__fero-grad_vitamine_c__timoferol_23062021_transcription_ct18167_ct_18151__ct18534_2021-11-15_10-27-48_850.pdf
HAS/2021-11-15_tardyferon_ferograd_timoferol_23062021_synthese_ct18151_18167_18534_2021-11-15_10-21-53_966.pdf
HAS/2021-11-15_tardyferon_ferograd_timoferol_23062021_synthese_ct18151_18167_18534_2021-11-15_10-27-48_852.pdf
HAS/2021-11-16_CT-19207_TRIUMEQ_PIS_AvisDef_CT19207.pdf
HAS/2021-11-17_CNEDIMTS-6668_PME THUASNE_21_septembre_2021_(6668)_avis.pdf
HAS/2021-11-17_CT-18128_NIMENRIX_PIC_EI_Avisdef_CT18128_15972.pdf
HAS/2021-11-17_CT-18896_ROACTEMRA_PIC_REEV_AvisDef_CT18896.pdf
HAS/2021-11-17_CT-19100_ILUVIEN_uvéite_prévention_EIT_PIC_Avisdéf_CT19100.pdf
HAS/2021-11-17_CT-19283_Acide_ fusidique_génériques_REEVAL_AVIS DEF_CT19283_CT19288_CT19293_CT19302_CT19407_CT19453_CT19457.pdf
HAS/2021-11-17_CT-19293_Acide_ fusidique_génériques_REEVAL_AVIS DEF_CT19283_CT19288_CT19293_CT19302_CT19407_CT19453_CT19457.pdf
HAS/2021-11-17_CT-19407_Acide_ fusidique_génériques_REEVAL_AVIS DEF_CT19283_CT19288_CT19293_CT19302_CT19407_CT19453_CT19457.pdf
HAS/2021-11-17_CT-19419_ORENCIA_PIC_REEV_AvisDef_CT19419.pdf
HAS/2021-11-17_CT-19453_Acide_ fusidique_génériques_REEVAL_AVIS DEF_CT19283_CT19288_CT19293_CT19302_CT19407_CT19453_CT19457.pdf
HAS/2021-11-17_CT-19457_Acide_ fusidique_génériques_REEVAL_AVIS DEF_CT19283_CT19288_CT19293_CT19302_CT19407_CT19453_CT19457.pdf
HAS/2021-11-17_CT-19474_ACTISKENAN_PIS_Avisdef_CT19474.pdf
HAS/2021-11-17_CT-19483_CEFUROXIME_PIS_ Avisdef_CT19483.pdf
HAS/2021-11-17_acide__fusidique_generiques_synthese_ct19283_ct19288_ct19293_ct19302_ct19407_ct19453_ct19457.pdf
HAS/2021-11-17_acide__fusidique_generiques_synthese_ct19283_ct19288_ct19293_ct19302_ct19407_ct19453_ct19457_2021-11-16_16-42-28_110.pdf
HAS/2021-11-17_acide_fusidique_29092021_transcription_ct19283_ct19288_ct19293_ct19302_ct19407_ct19453_ct19457.pdf
HAS/2021-11-17_acide_fusidique_29092021_transcription_ct19283_ct19288_ct19293_ct19302_ct19407_ct19453_ct19457_2021-11-16_16-42-28_106.pdf
HAS/2021-11-17_acromegalie_-_argumentaire.pdf
HAS/2021-11-17_acromegalie_-_pnds.pdf
HAS/2021-11-17_argumentaire_pnds_turner_22_10.pdf
HAS/2021-11-17_has-_tocilizumab_-_janvier_2021_-_final_roactemra.pdf
HAS/2021-11-17_iluvien_22092021_synthese_ct19100.pdf
HAS/2021-11-17_iluvien_22092021_transcription_ct19100.pdf
HAS/2021-11-17_menquadfi_nimenrix_06102021_transcription_ct19461_ct15972_ct18128_2021-11-16_16-04-6_509.pdf
HAS/2021-11-17_mitraclip_g4-nt_5_octobre_2021_6608_avis_occultations.pdf
HAS/2021-11-17_mitraclip_g4-ntw_5_octobre_2021_6609_avis_occultations.pdf
HAS/2021-11-17_mitraclip_g4-xt_5_octobre_2021_6610_avis_occultations.pdf
HAS/2021-11-17_mitraclip_g4-xtw_5_octobre_2021_6611_avis_occultations.pdf
HAS/2021-11-17_nimenrix_06102021_synthese_ct18128_15972.pdf
HAS/2021-11-17_orencia_06102021_synthese_ct19419.pdf
HAS/2021-11-17_pnds_argumentaire_09_2021_troubles_du_rythme_et_de_la_conduction_des_ccc_chez_ladulte.pdf
HAS/2021-11-17_pnds_bartter_argumentaire_05102021.pdf
HAS/2021-11-17_pnds_bartter_texte_05102021.pdf
HAS/2021-11-17_pnds_cc_et_grossesse2021_argumentaire.pdf
HAS/2021-11-17_pnds_ccc_et_grossesse2021texte.pdf
HAS/2021-11-17_pnds_myh9_argumentaire.pdf
HAS/2021-11-17_pnds_myh9_texte-court.pdf
HAS/2021-11-17_pnds_texte_09_2021_troubles_du_rythme_et_de_la_conduction_des_ccc_chez_ladulte.pdf
HAS/2021-11-17_pnds_turner_29_10.pdf
HAS/2021-11-17_questionnaire_has_contrib_debra_acide_fusidique.pdf
HAS/2021-11-17_quikclot_02_novembre_2021_6425_avis.pdf
HAS/2021-11-17_roactemra_06102021_synthese_ct18896.pdf
HAS/2021-11-17_simponi_roactemra_orencia_06102021_transcription_ct19026_ct18896_19419_2021-11-16_15-39-46_502.pdf
HAS/2021-11-17_simponi_roactemra_orencia_06102021_transcription_ct19026_ct18896_19419_2021-11-16_15-50-46_911.pdf
HAS/2021-11-17_synthese_mg_acromegalie.pdf
HAS/2021-11-17_synthese_mg_prise_en_charge_de_la_grossesse_chez_les_patientes_avec_une_cardiopathie_congenitale_complexe.pdf
HAS/2021-11-17_synthese_mg_prise_en_charge_des_troubles_du_rythme_ou_de_la_conduction_lors_des_cardiopathies_congenitales_complexes_chez_l_.pdf
HAS/2021-11-17_synthese_mg_syndrome_de_bartter.pdf
HAS/2021-11-17_synthese_mg_syndrome_de_turner.pdf
HAS/2021-11-17_synthese_mg_syndrome_myh9.pdf
HAS/2021-11-17_wallstent_uni_19_octobre_2021_6601_avis.pdf
HAS/2021-11-18_CNEDIMTS-6564_SYSTEME MINIMED 780G_19_octobre_2021_(6564)_avis.pdf
HAS/2021-11-18_CT-19235_XTANDI_PIC_EI_Avis version définitive_CT19235.pdf
HAS/2021-11-18_cnedimts_assessment_of_the_mri_compatibility_of_implantable_medical_devices.pdf
HAS/2021-11-18_evaluation_de_la_compatibilite_irm_des_dispositifs_medicaux_implantables_-_note_de_cadrage.pdf
HAS/2021-11-18_guide_devaluation_de_la_compatibilite_irm_des_dispositifs_medicaux_par_la_cnedimts.pdf
HAS/2021-11-18_xtandi_21072021_synthese_ct19235.pdf
HAS/2021-11-18_xtandi_21072021_transcription_ct19235.pdf
HAS/2021-11-19_flash_dispositifs_medicaux_18_nov_vd.pdf
HAS/2021-11-19_flash_dispositifs_medicaux_version_anglaise.pdf
HAS/2021-11-19_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2021-11-19_pnds_tarlov.pdf
HAS/2021-11-19_pnds_tarlov_argumentaire_scientifique.pdf
HAS/2021-11-19_synthese_mg_les_kystes_de_tarlov.pdf
HAS/2021-11-22_CNEDIMTS-6513_P64_20_juillet 2021_(6513)_avis.pdf
HAS/2021-11-22_CT-19111_SOVALDI_HARVONI_VOSEVI_EPCLUSA_ZEPATIER_MAVIRET_PIS_EPI_Avisdef.pdf
HAS/2021-11-22_CT-19249_SOVALDI_HARVONI_VOSEVI_EPCLUSA_ZEPATIER_MAVIRET_PIS_EPI_Avisdef.pdf
HAS/2021-11-22_CT-19371_LIBTAYO_POUMON_PIC_EI_AvisDef_CT19371.pdf
HAS/2021-11-22_CT-19453_Acide_ fusidique_génériques_REEVAL_AVIS DEF_CT19283_CT19288_CT19293_CT19302_CT19407_CT19453_CT19457.pdf
HAS/2021-11-22_CT-19463_MIDAZOLAM_ACCORD_PIC_EI_AvisDef_CT19463.pdf
HAS/2021-11-22_CT-19470_MIDAZOLAM_MYLAN_PIC_EI_AvisDef_CT19470.pdf
HAS/2021-11-22_CT-19484_FLUTICASONE SALMETEROL ZENTIVA_50_125_250_SUSP_PIS_INS_AvisDèf_CT19484.pdf
HAS/2021-11-22_CT-19497_FLUTICASONE SALMETEROL BIOGARAN_100_250_500_PDRE_PIS_INS_AvisDèf_CT19497.pdf
HAS/2021-11-22_CT-19538_SOVALDI_HARVONI_VOSEVI_EPCLUSA_ZEPATIER_MAVIRET_PIS_EPI_Avisdef.pdf
HAS/2021-11-22_CT-19539_SOVALDI_HARVONI_VOSEVI_EPCLUSA_ZEPATIER_MAVIRET_PIS_EPI_Avisdef.pdf
HAS/2021-11-22_CT-19540_SOVALDI_HARVONI_VOSEVI_EPCLUSA_ZEPATIER_MAVIRET_PIS_EPI_Avisdef.pdf
HAS/2021-11-22_acide__fusidique_generiques_synthese_ct19283_ct19288_ct19293_ct19302_ct19407_ct19453_ct19457_2021-11-19_09-51-24_52.pdf
HAS/2021-11-22_acide_fusidique_29092021_transcription_ct19283_ct19288_ct19293_ct19302_ct19407_ct19453_ct19457_2021-11-19_09-51-24_56.pdf
HAS/2021-11-22_amo_19_octobre_2021_6569_avis.pdf
HAS/2021-11-22_annexes_angiomammographie.pdf
HAS/2021-11-22_bylvay_13102021_transcription_ct19310.pdf
HAS/2021-11-22_bylvay_27102021_avis_ct19310.pdf
HAS/2021-11-22_bylvay_27102021_synthese_ct19310.pdf
HAS/2021-11-22_inahta_brief_contrast_enhanced_mammography_.pdf
HAS/2021-11-22_libtayo_06102021_transcription_ct19371.pdf
HAS/2021-11-22_libtayo_synthese_ct19371.pdf
HAS/2021-11-22_midazolam_06102021_transcription_ct19463_ct19470.pdf
HAS/2021-11-22_midazolam_06102021_transcription_ct19463_ct19470_2021-11-19_16-37-5_468.pdf
HAS/2021-11-22_midazolam_accord_20102021_synthese_ct19463.pdf
HAS/2021-11-22_midazolam_mylan_20102021_synthese_ct19470.pdf
HAS/2021-11-22_mitraclip_ntr_5_octobre_2021_6612_avis_occultations.pdf
HAS/2021-11-22_mitraclip_xtr_5_octobre_2021_6613_avis_occultations.pdf
HAS/2021-11-22_questionnaire_bylvay_-amfe-pfic-_doc_adresse_a_lhas.pdf
HAS/2021-11-22_questionnaire_has_contrib_cnspfv_midazolam.pdf
HAS/2021-11-22_questionnaire_has_contrib_cnspfv_midazolam_2021-11-19_16-37-5_470.pdf
HAS/2021-11-22_questionnaire_has_contrib_debra_acide_fusidique_2021-11-19_09-51-24_55.pdf
HAS/2021-11-22_rapport_angiomammographie.pdf
HAS/2021-11-22_sequent_please_neo_16_novembre_2021_6628_avis.pdf
HAS/2021-11-22_somnodent_19_octobre_2021_6536_avis.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_06102021_transcription.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_06102021_transcription_2021-11-19_14-16-29_960.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_06102021_transcription_2021-11-19_14-20-9_976.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_06102021_transcription_2021-11-19_14-31-41_678.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_06102021_transcription_2021-11-19_14-35-48_917.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_synthese.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_synthese_2021-11-19_14-16-29_962.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_synthese_2021-11-19_14-20-9_978.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_synthese_2021-11-19_14-31-41_680.pdf
HAS/2021-11-22_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_synthese_2021-11-19_14-35-48_919.pdf
HAS/2021-11-22_tecentriq_13102021_synthese_ct19346.pdf
HAS/2021-11-22_tecentriq_13102021_transcription_ct19346.pdf
HAS/2021-11-22_tecentriq_pic_ei_avisdef_ct19346.pdf
HAS/2021-11-23_CT-19468_XIOP_INS_PIS_AvisDéf_CT19468.pdf
HAS/2021-11-23_fluad_tetra_dans_la_strategie_de_vaccination_contre_la_grippe_saisonniere_chez_les_personnes_de_65_ans_et_plus_recommandatio.pdf
HAS/2021-11-25_CNEDIMTS-6584_PICO 7_5_octobre_2021_(6584)_avis.pdf
HAS/2021-11-25_utilisation_du_vaccin_contre_la_grippe_saisonniere_influvac_tetra_chez_les_enfants_de_6_a_35_mois_recommandation.pdf
HAS/2021-11-26_rinvoq_ap18_contribution_patients_afe.pdf
HAS/2021-11-26_rinvoq_ap_postamm_avisdef_ap-18.pdf
HAS/2021-11-29_CT-19241_TYSABRI_PIS_INS_CG_AvisDef_CT19241.pdf
HAS/2021-11-29_cadrage_pec_buccodentaire_17_11_21_coi_mel.pdf
HAS/2021-12-01_2021_11_argumentaire_pnds_poic_enfant_vf.pdf
HAS/2021-12-01_2021_11_pnds_poic_enfant_nov_2021_vf.pdf
HAS/2021-12-01_6_def._mar_argumentaire_pnds_crmr_marep_malformations_ano_rectales_de_0_a_6_ans.pdf
HAS/2021-12-01_6_def._pnds_crmr_marep_malformations_ano_rectales_de_0_a_6_ans.pdf
HAS/2021-12-01_analyse_critique_de_la_litterature_-_pnds_maladie_de_fabry_-_20211115.pdf
HAS/2021-12-01_argumentaire__affections_liees_ou_associees_a_cftr_vf.pdf
HAS/2021-12-01_argumentaire_pnds_angelman_vf.pdf
HAS/2021-12-01_argumentaire_pnds_borjeson_forssman_lehman_final.pdf
HAS/2021-12-01_argumentaire_pnds_deficit_hypophysaire_congenital.pdf
HAS/2021-12-01_argumentaire_scientifique_pnds_lipomes_du_filum_terminal_cmavem_necker_nov2021.pdf
HAS/2021-12-01_borjeson_forssman_lehman-final.pdf
HAS/2021-12-01_format_argumentaire_pnds_-crnk_2021_20211119.pdf
HAS/2021-12-01_pnds_affections_liees_ou_associees_a_cftr-vf.pdf
HAS/2021-12-01_pnds_agenesies_dentaires_multiples-argumentaire-novembre_2021.pdf
HAS/2021-12-01_pnds_agenesies_dentaires_multiples-texte-novembre_2021.pdf
HAS/2021-12-01_pnds_angelman_vf_.doc.pdf
HAS/2021-12-01_pnds_de_la_maladie_de_fabry_-_version_finale_-_20211115.pdf
HAS/2021-12-01_pnds_deficit_hypophysaire_congenital.pdf
HAS/2021-12-01_pnds_fentes_labiales_etou_palatines-argumentaire-novembre_2021.pdf
HAS/2021-12-01_pnds_fentes_labiales_etou_palatines-texte-novembre_2021.pdf
HAS/2021-12-01_pnds_hl_has_15112021_global.pdf
HAS/2021-12-01_pnds_hl_has_15112021revue_litterature.pdf
HAS/2021-12-01_pnds_joubert_argumentaire_nov21.pdf
HAS/2021-12-01_pnds_joubert_texte_2m2c_nov21.pdf
HAS/2021-12-01_pnds_keratocone_sensgene__15_nov_2021_vfinale.pdf
HAS/2021-12-01_pnds_microsomies_craniofaciales-argumentaire-novembre_2021.pdf
HAS/2021-12-01_pnds_microsomies_craniofaciales-texte-novembre_2021.pdf
HAS/2021-12-01_protocole_national_de_diagnostic_et_de_soins_lipome_du_filum_terminal_cmavem_necker_nov2021_.pdf
HAS/2021-12-01_synthese_mg_agenesies_dentaires_multiples_oligodontie_et_anodontie.pdf
HAS/2021-12-01_synthese_mg_deficit_hypophysaire_congenital.pdf
HAS/2021-12-01_synthese_mg_evaluation_diagnostique_et_prise_en_charge_des_affections_liees_ou_associees_a_cftr.pdf
HAS/2021-12-01_synthese_mg_fentes_labiales_et_ou_palatines.pdf
HAS/2021-12-01_synthese_mg_histiocytose_langerhansienne_enfant_de_moins_de_18_ans.pdf
HAS/2021-12-01_synthese_mg_keratocone.pdf
HAS/2021-12-01_synthese_mg_malformations_ano_rectales_isolees.pdf
HAS/2021-12-01_synthese_mg_microsomies_craniofaciales.pdf
HAS/2021-12-01_synthese_mg_prise_en_charge_des_lipomes_du_filum_terminal.pdf
HAS/2021-12-01_synthese_mg_pseudo_obstructions_intestinales_chroniques_poic__chez_l_enfant.pdf
HAS/2021-12-01_synthese_mg_syndrome_borjeson_forssman_lehmann.pdf
HAS/2021-12-01_synthese_mg_syndrome_d_angelman.pdf
HAS/2021-12-01_synthese_mg_syndrome_de_joubert.pdf
HAS/2021-12-01_synthese_mgt_maladie_de_fabry.pdf
HAS/2021-12-02_CNEDIMTS-6637_PERISTEEN PLUS_5_octobre_2021_(6637)_avis.pdf
HAS/2021-12-02_CNEDIMTS-6649_VENOTRAIN ULCERTEC 39_5_octobre_2021_(6649)_avis.pdf
HAS/2021-12-02_CNEDIMTS-6650_VENOTRAIN ULCERTEC 46_5_octobre_2021_(6650)_avis.pdf
HAS/2021-12-02_argumentaire_cbp_vf_has.pdf
HAS/2021-12-02_argumentaire_pnds___gangliosidoses_a_gm2_27.10.2021.pdf
HAS/2021-12-02_argumentaire_pnds_mavsuperficielle_nov2021.pdf
HAS/2021-12-02_argumentaire_pnds_nf2-2021_1_definitif_004_-_copie_-_copie.pdf
HAS/2021-12-02_argumentaire_pnds_sgb.pdf
HAS/2021-12-02_argumentairepnds.pdf
HAS/2021-12-02_eclypse_adherent_sacral_02_novembre_2021_6229_avis.pdf
HAS/2021-12-02_eclypse_boot_02_novembre_2021_6226_avis.pdf
HAS/2021-12-02_eclypse_contour_02_novembre_2021_6228_avis.pdf
HAS/2021-12-02_eclypse_foot_02_novembre_2021_6227_avis.pdf
HAS/2021-12-02_fimarad_pnd_sle_v2.2_argumentaire.pdf
HAS/2021-12-02_fimarad_pnd_sle_v2.2_synthese.pdf
HAS/2021-12-02_glucomen_day_cgm_02_novembre_2021_6482_avis.pdf
HAS/2021-12-02_latera_02_novembre_2021_6467_avis.pdf
HAS/2021-12-02_marvu_pnds_vup_argumentaire_v2_12112021.pdf
HAS/2021-12-02_marvu_pnds_vup_synthese_v2_12112021.pdf
HAS/2021-12-02_pnds_cbp_vf_has.pdf
HAS/2021-12-02_pnds_gangliosidoses_a_gm2_27.10.2021.pdf
HAS/2021-12-02_pnds_mav_superficielle_-_nov2021.pdf
HAS/2021-12-02_pnds_mrkh_argumentaire_2021-11-14_final.pdf
HAS/2021-12-02_pnds_mrkh_texte_2021-11-14_final.pdf
HAS/2021-12-02_pnds_nf2-sept_2021mk_version_definitive.pdf
HAS/2021-12-02_pnds_npc_argumentaire_final_12-11-21.pdf
HAS/2021-12-02_pnds_npc_document_final_12-11-21.pdf
HAS/2021-12-02_pndsversionjuin2021.pdf
HAS/2021-12-02_proteor_sierra_02_novembre_2021_6596_avis.pdf
HAS/2021-12-02_synthese_mg_cholangite_biliaire_primitive.pdf
HAS/2021-12-02_synthese_mg_gangliosidoses_a_gm2.pdf
HAS/2021-12-02_synthese_mg_maladie_de_niemann_pick_de_type_c.pdf
HAS/2021-12-02_synthese_mg_malformations_arterioveineuses_superficielles.pdf
HAS/2021-12-02_synthese_mg_necrolyses_epidermiques_chez_l_enfant_.pdf
HAS/2021-12-02_synthese_mg_neurofibromatose_de_type_2.pdf
HAS/2021-12-02_synthese_mg_spina_bifida_dysraphismes.pdf
HAS/2021-12-02_synthese_mg_syndrome_de_guillain_barre.pdf
HAS/2021-12-02_synthese_mg_syndrome_de_mayer_rokitansky_kuster_hauser.pdf
HAS/2021-12-02_synthese_mg_valves_de_l_uretre_posterieur.pdf
HAS/2021-12-02_texte_pnds_sgb.pdf
HAS/2021-12-03_aap14_abecma_contributon_patients_association_af3m.pdf
HAS/2021-12-03_abecma_aap_postamm_avisdef_ctap14_.pdf
HAS/2021-12-06__reco355_argumentaire_paralysie_cerebrale_cd_2021_10_21_post-endossement_lg.pdf
HAS/2021-12-06_modification_des_modalites_d_inscriptions_des_implants_d_embolisation_arterielle_22_juin_2021_dm-eval_265_avis.pdf
HAS/2021-12-06_pre_mel_reco450_tdah_adulte_cadrage.pdf
HAS/2021-12-06_premel_reco432_tdah_enfant_cadrage.pdf
HAS/2021-12-06_reco355_rbp_paralysie_cerebrale_cd_2021_10_21_lg_v0_post_endossement_lg.pdf
HAS/2021-12-06_reco355_synthese_paralysie_cerebrale_cd_2021_10_21.pdf
HAS/2021-12-07_CT-19108_SOVALDI_HARVONI_VOSEVI_EPCLUSA_ZEPATIER_MAVIRET_PIS_EPI_Avisdef.pdf
HAS/2021-12-07_CT-19327_DENGVAXIA_PIC_INS_AvisDef_CT19327.pdf
HAS/2021-12-07_CT-19350_DAKIN COOPER STABILISE_PIS_RAD_Avisdéf_CT19350.pdf
HAS/2021-12-07_CT-19452_KAFTRIO KALYDECO_PIC_EI_Avis def_CT19451_19452.pdf
HAS/2021-12-07_CT-19471_PEMETREXED SUN_PIS_INS_HYBRIDE_AVIS PC_CT19471.pdf
HAS/2021-12-07_CT-19517_MAVIRET_PIS_INS_COMPLEMENT_GAMME_AVIS DEF_CT19517.pdf
HAS/2021-12-07_CT-19535_COSENTYX_75mg_PIS_INS_COMPLEMENT_GAMME_AVIS DEF_CT19535.pdf
HAS/2021-12-07_dengvaxia_03112021_transcription_ct19327.pdf
HAS/2021-12-07_dengvaxia_29092021_transcription_ct19327.pdf
HAS/2021-12-07_dengvaxia_synthese_ct19327.pdf
HAS/2021-12-07_kaftrio_kalydeco_27102021_transcription_ct19451_ct19452_.pdf
HAS/2021-12-07_kaftrio_kalydeco_synthese_ct19451_19452.pdf
HAS/2021-12-07_questionnaire_has_contrib_vaincre_la_muco_kaftrio_heterozygotef508del_septembre_2021_vf.pdf
HAS/2021-12-07_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_06102021_transcription.pdf
HAS/2021-12-07_sovaldi_harvoni_vosevi_epclusa_zepatier_maviret_synthese.pdf
HAS/2021-12-08_CT-19278_RAGWIZAX_PIC_AVIS def_CT19278.pdf
HAS/2021-12-08_CT-19326_ORLADEYO_INS_PIC_Avisdef_modifie le 16112021_CT19326.pdf
HAS/2021-12-08_orladeyo_08092021_transcription_ct19326.pdf
HAS/2021-12-08_orladeyo_22092021_synthese_ct19326.pdf
HAS/2021-12-08_questionnaire_has_contrib_asso_orladeyo_1_5.pdf
HAS/2021-12-08_ragwizax_22092021_transcription_ct19278.pdf
HAS/2021-12-08_ragwizax_synthese_ct19278.pdf
HAS/2021-12-09_cadrage_chirurgie_metabolique_vd.pdf
HAS/2021-12-09_note_de_cadrage_obesite.pdf
HAS/2021-12-10_annexe_1._avis_ansm_aap_evusheld_03122021.pdf
HAS/2021-12-10_annexe_2._cosv_-_recommandations_pour_la_protection_des_personnes_severement_immunodeprimees_-_19_novembre_2021.pdf
HAS/2021-12-10_annexe_anrs-mie_molnupiravir.pdf
HAS/2021-12-10_ap37-lagevrio_contribution_patients_afca.pdf
HAS/2021-12-10_avis_ansm_aap_molnupiravir.pdf
HAS/2021-12-10_azd7442-evusheld_ap32_contribution_patients_afca.pdf
HAS/2021-12-10_azd7442__evusheld_ap32_contribution_patients_appf.pdf
HAS/2021-12-10_azd7442__evusheld_ap32_contribution_patients_asf.pdf
HAS/2021-12-10_azd7442__evusheld_ap32_contribution_patients_france_vascularites.pdf
HAS/2021-12-10_azd7442__evusheld_ap32_contribution_patients_renaloo.pdf
HAS/2021-12-10_ctap32_evusheld_aap_avisdef.pdf
HAS/2021-12-10_ctap37_lagevrio_aap_avisdef.pdf
HAS/2021-12-13_CNEDIMTS-6647_LIBRA&LIBRA XP_5_octobre_2021_(6647)_avis.pdf
HAS/2021-12-13_CNEDIMTS-6675_TRIANON_5_octobre_2021_(6675)_avis.pdf
HAS/2021-12-13_CNEDIMTS-6688_VERCISE PC_5_octobre_2021_(6688)_avis.pdf
HAS/2021-12-13_annexes_hysterectomie_robot-assistee.pdf
HAS/2021-12-13_fitbone_16_novembre_2021_6645_avis.pdf
HAS/2021-12-13_gore_cardioform_16_novembre_2021_6654_avis.pdf
HAS/2021-12-13_home_monitoring_16_novembre_2021_6639_avis.pdf
HAS/2021-12-13_navitor_16_novembre_2021_6719_avis.pdf
HAS/2021-12-13_rapport_hysterectomie_robot-assistee.pdf
HAS/2021-12-14_CT-19265_SPRAVATO_PIC__EI_AvisDef_CT19265.pdf
HAS/2021-12-14_CT-19367_BOTOX_EI_PIC_AvisDef_CT19367.pdf
HAS/2021-12-14_CT-19451_KAFTRIO KALYDECO_PIC_EI_Avis def_CT19451_19452.pdf
HAS/2021-12-14_CT-19491_DEXMEDETOMIDINE_PIS_INS_AVIS DEF_CT19491.pdf
HAS/2021-12-14_CT-19545_TECENTRIQ_PIS_INS_Avis def_CT19545.pdf
HAS/2021-12-14_CT-19561_EPHEDRINE_AGUETTANT_PIS_INS_AVIS DEF_CT19561.pdf
HAS/2021-12-14_CT-19578_CHLORHEXIDINE ARROW_PIS_INS_AVIS DEF_CT19578.pdf
HAS/2021-12-14_ap20_contribution_patients_voxzogo_appt.pdf
HAS/2021-12-14_botox_27102021_transcription_ct19367.pdf
HAS/2021-12-14_botox_synthese_ct19367.pdf
HAS/2021-12-14_contribution_botox_-_la_voix_des_migraineux_juillet_2021.pdf
HAS/2021-12-14_kaftrio_kalydeco_27102021_transcription_ct19451_ct19452__2021-12-09_18-07-59_683.pdf
HAS/2021-12-14_kaftrio_kalydeco_synthese_ct19451_19452_2021-12-09_18-07-59_684.pdf
HAS/2021-12-14_questionnaire_has_contrib_vaincre_la_muco_kaftrio_heterozygotef508del_septembre_2021_vf_2021-12-09_18-07-59_687.pdf
HAS/2021-12-14_sondage_2020_la_voix_des_migraineux_-_resultats_et_analyse.pdf
HAS/2021-12-14_spravato_03112021_transcription_ct19265.pdf
HAS/2021-12-14_spravato_08092021_transcription_ct19265.pdf
HAS/2021-12-14_spravato_22092021_synthese_ct19265.pdf
HAS/2021-12-14_systeme_neovasc_reducer_30_novembre_2021_6712_avis.pdf
HAS/2021-12-14_voxzogo_aap_postamm_avisdef_ctap20.pdf
HAS/2021-12-16_CT-19179_MYOZYME_PIC_REEVAL_AvisDéf_CT19179.pdf
HAS/2021-12-16_actes-pose-reprise-prothese-hanche-genou-atih_mars2019.pdf
HAS/2021-12-16_afm_2021_04_contribution_myozyme.pdf
HAS/2021-12-16_cadrage_endomicro_pancreas_vd.pdf
HAS/2021-12-16_iqss_2020_rapport_developpement_ete_pth_ptg_2020.pdf
HAS/2021-12-16_iqss_2021_-_brochure_ete_ptg_2021.pdf
HAS/2021-12-16_iqss_2021_-_brochure_ete_pth_2021.pdf
HAS/2021-12-16_iqss_2021_-_fiche_descriptive_ete_ptg_has_2021.pdf
HAS/2021-12-16_iqss_2021_-_fiche_descriptive_ete_pth_has_2021.pdf
HAS/2021-12-16_iqss_2021_-_guide_lecture_funnel_plot_complications_chir_ortho_has_2021.pdf
HAS/2021-12-16_iqss_2021_rapport_complet_resultats_campagnes_2021_national.pdf
HAS/2021-12-16_iqss_2021_rapport_resultats_nationaux_ete_ptg_2021.pdf
HAS/2021-12-16_iqss_has_methode_developpement_ir_2019.3.pdf
HAS/2021-12-16_iqss_iqss_rapport-resultats_nationaux_ete_pth_2021.pdf
HAS/2021-12-16_myozyme_06102021_transcription_ct19179.pdf
HAS/2021-12-16_myozyme_17112021_transcription_ct19179.pdf
HAS/2021-12-16_myozyme_synthese_ct19179.pdf
HAS/2021-12-17_2016_has_fiche_descriptive_icatb_2.pdf
HAS/2021-12-17_2016_has_fiche_descriptive_icsha_3.pdf
HAS/2021-12-17_CNEDIMTS-6523_PODIABETES PALMYRE & PARADIS_25_mai_2021_(6523)_avis.pdf
HAS/2021-12-17_CNEDIMTS-6657_OPTIVE_FUSION_5_octobre_2021_(6657)_avis.pdf
HAS/2021-12-17_annexes_rapport_arn_hpv_vd.pdf
HAS/2021-12-17_dc_2018_iqss81_rapport_des_campagnes_des_iqss_2018_cd_2018_12_05.pdf
HAS/2021-12-17_fiche_descriptive-pcc_2020.pdf
HAS/2021-12-17_fiche_descriptive_atbir_2020.pdf
HAS/2021-12-17_icsha_fiche_descriptive_2021.pdf
HAS/2021-12-17_iqss_2020_analyse_impact_covid_esatis_2020.pdf
HAS/2021-12-17_iqss_2020_rapport_resultats_esatis48h_2020.pdf
HAS/2021-12-17_iqss_2020_rapport_resultats_esatismcoca_2020.pdf
HAS/2021-12-17_iqss_2021_rapport_complet_resultats_campagnes_2021_national.pdf
HAS/2021-12-17_iqss_2021_rapport_resultats_campagnes_2021_volontaire_ias.pdf
HAS/2021-12-17_iqss_2021_rapport_resultats_nationaux_e-satis_ssr_2021.pdf
HAS/2021-12-17_iqss_2021_rapport_resultats_nationaux_esatis48hmco_2021.pdf
HAS/2021-12-17_iqss_2021_rapport_resultats_nationaux_esatismcoca_2021.pdf
HAS/2021-12-17_iqss_rapport_complet_2019.pdf
HAS/2021-12-17_iqss_rapport_esatis48h_2019.pdf
HAS/2021-12-17_iqss_rapport_esatis_ca_2019.pdf
HAS/2021-12-17_iqss_rapport_ias_icsha_mcohadssr_2019.pdf
HAS/2021-12-17_iqss_rapport_ias_icsha_psy_2019.pdf
HAS/2021-12-17_leukotac_aap_preamm_avisdef_ctap21.pdf
HAS/2021-12-17_leukotac_avis_ansm_ap21.pdf
HAS/2021-12-17_plaquette_ias_vf.pdf
HAS/2021-12-17_rapport_2016_ias_vf.pdf
HAS/2021-12-17_rapport_arn_hpv_vd.pdf
HAS/2021-12-17_rapport_complet_resultats_campagne_2020_pdf.pdf
HAS/2021-12-17_rapport_esatis48h_2018.pdf
HAS/2021-12-17_rapport_esatis_mco_ca_2018.pdf
HAS/2021-12-17_rapport_ias_2017.pdf
HAS/2021-12-17_rapport_ias_2018.pdf
HAS/2021-12-17_rapport_iqss_2018.pdf
HAS/2021-12-17_synthese_esatis_2016_vf.pdf
HAS/2021-12-17_synthese_essatis_2017.pdf
HAS/2021-12-20_argumentaire_arn_vih-2.pdf
HAS/2021-12-20_modification_des_modalites_de_prise_en_charge_des_pompes_insulines_externes_portables_et_programmables_-_avis_de_la_cnedimts.pdf
HAS/2021-12-20_strategie_de_vaccination_contre_la_covid-19_placee_du_vaccin_a_arnm_comirnaty_chez_les_5-11_ans.pdf
HAS/2021-12-27_format_argumentaire_pnds_amyloses_cardiaques_versionfinale_26092021_td.pdf
HAS/2021-12-27_pnds_amyloses_cardiaques_v20_version_finale_31082021.pdf
HAS/2021-12-27_pnds_argumentaire_prise_en_charge_des_dysraphismes_en_periode_perinatale.pdf
HAS/2021-12-27_pnds_melas_argumentaire_septembre_2021.pdf
HAS/2021-12-27_pnds_melas_texte_septembre_2021.pdf
HAS/2021-12-27_pnds_texte_prise_en_charge_des_dysraphismes_en_periode_perinatale.pdf
HAS/2021-12-27_pnds_wilson_argumentaire_8nov21.pdf
HAS/2021-12-27_pnds_wilson_texte_8nov21.pdf
HAS/2021-12-27_synthese_mg_amylose_cardiaque.pdf
HAS/2021-12-27_synthese_mg_maladie_de_wilson.pdf
HAS/2021-12-27_synthese_mg_maladies_mitochondriales__apparentees_au_melas.pdf
HAS/2021-12-27_synthese_mg_prise_en_charge_des_dysraphismes_en_periode_perinatale.pdf
HAS/2022-01-06_CT-19370_FORXIGA_PIC_EI_Avis def_CT19370.pdf
HAS/2022-01-06_CT-19447_VIANT_PIC_Avis définitif_CT194478.pdf
HAS/2022-01-06_forxiga_09112021__avis_eco_transcription_ceesp.pdf
HAS/2022-01-06_forxiga_12102021__avis_eco_transcription_ceesp_vf.pdf
HAS/2022-01-06_forxiga_13102021_transcription_ct19370.pdf
HAS/2022-01-06_forxiga_9112022_avis_economique_biffe.pdf
HAS/2022-01-06_forxiga_synthese__ct19370.pdf
HAS/2022-01-06_viant_17112021_transcription_ct19447.pdf
HAS/2022-01-06_viant_synthese_ct194478.pdf
HAS/2022-01-07_actes-pose-reprise-prothese-hanche-genou-atih_mars2019.pdf
HAS/2022-01-07_ctap08_xevudy_aap_post_amm_avisdef.pdf
HAS/2022-01-07_iqss_2020_rapport_developpement_iso_pth_ptg_2020.pdf
HAS/2022-01-07_iqss_2020_rapport_retour_aux_dossiers_iso_ortho_2020.pdf
HAS/2022-01-07_iqss_2021_-_brochure_iso_ptg_2021.pdf
HAS/2022-01-07_iqss_2021_-_brochure_iso_pth_2021.pdf
HAS/2022-01-07_iqss_2021_-_fiche_descriptive_iso_ptg_has_2021.pdf
HAS/2022-01-07_iqss_2021_-_fiche_descriptive_iso_pth_has_2021.pdf
HAS/2022-01-07_iqss_2021_-_guide_lecture_funnel_plot_complications_chir_ortho_has_2021.pdf
HAS/2022-01-07_iqss_2021_rapport_complet_resultats_campagnes_2021_national.pdf
HAS/2022-01-07_iqss_2021_rapport_resultats_nationaux_iso_ptg_2021.pdf
HAS/2022-01-07_iqss_2021_rapport_resultats_nationaux_iso_pth_2021.pdf
HAS/2022-01-07_iqss_has_methode_developpement_ir_2019.3.pdf
HAS/2022-01-10_CT-19173_CARDIOGEN_PIC_INS_Avisdef_CT19173.pdf
HAS/2022-01-10_CT-19233_EPIDYOLEX_PIC_EI_AvisDef Modifié 09122021_CT19233_EPI740.pdf
HAS/2022-01-10_CT-19256_SARCLISA_PIC_EI_AvisDéf_modifiele16112021_CT19256.pdf
HAS/2022-01-10_CT-19342_CHLORYDRATE_AZELASTINE_PIC_INS_Avisdef_CT19342.pdf
HAS/2022-01-10_CT-19397_LIBTAYO_AVIS Def__REEVAL_CT19397.pdf
HAS/2022-01-10_CT-19405_RITALINE LP_PIC_EI_AvisDef_CT19405.pdf
HAS/2022-01-10_CT-19429_ONUREG_PIC_INS_Avisdef_CT19429.pdf
HAS/2022-01-10_CT-19433_ADTRALZA_PIC_INS_Avisdéf_CT19433.pdf
HAS/2022-01-10_CT-19541_TRIXEO_PIS_INS_AVIS def_CT19541.pdf
HAS/2022-01-10_CT-19559_XELJANZ 11mg_PIS_INS_Avis Def_CT_19559.pdf
HAS/2022-01-10_adtralza_27102021_synthese_ct19433.pdf
HAS/2022-01-10_adtralza_27102021_transcrption_ct19433.pdf
HAS/2022-01-10_adtralza_contribution.pdf
HAS/2022-01-10_cardiogen_20102021_synthese_ct19173.pdf
HAS/2022-01-10_cardiogen_20102021_transcription_ct19173.pdf
HAS/2022-01-10_ccm_questionnaire_patient-onureg.pdf
HAS/2022-01-10_chlorhydrate_d_azelastine_17112021_transcription_ct19342.pdf
HAS/2022-01-10_chlorydrate_azelastine_synthese_ct19342.pdf
HAS/2022-01-10_enquete_stb_en_vue_livre_blanc.pdf
HAS/2022-01-10_epidyolex_01122021_synthese_ct19233.pdf
HAS/2022-01-10_epidyolex_01122021_transcription_ct19233.pdf
HAS/2022-01-10_epidyolex_1311444_transcription_ct_19233.pdf
HAS/2022-01-10_epidyolex_20102021_transcription_ct19233.pdf
HAS/2022-01-10_libtayo_17112021_synthese_ct19397.pdf
HAS/2022-01-10_libtayo_27102021_transcription_ct19397.pdf
HAS/2022-01-10_onureg_27102021_transcription_ct19429.pdf
HAS/2022-01-10_onureg_synthese_170112021_ct19429.pdf
HAS/2022-01-10_questionnaire_has_cemiplimab.pdf
HAS/2022-01-10_questionnaire_has_contrib_asso_med_1_astb_epidyolex.pdf
HAS/2022-01-10_questionnaire_has_contrib_asso_ritaline_lp.pdf
HAS/2022-01-10_ritaline_lp_17112021_synthese_ct19405.pdf
HAS/2022-01-10_ritaline_lp_27102021_transcription_ct19405.pdf
HAS/2022-01-10_sarclisa_06102021_transcription_ct19256.pdf
HAS/2022-01-10_sarclisa_20102021_synthese_ct19256.pdf
HAS/2022-01-13_acces_precoces_-_doctrine.pdf
HAS/2022-01-13_guide_etude_en_vie_reelle_medicaments__dm.pdf
HAS/2022-01-13_iqss_2019_aide_utilisation_proms_eds.pdf
HAS/2022-01-13_iqss_2021_guide_proms_specifiques_scc.pdf
HAS/2022-01-13_iqss_guide_proms_general_2021.pdf
HAS/2022-01-13_iqss_guide_proms_specifiques_bpco_2021.pdf
HAS/2022-01-13_note_cadrage_e_satis_commentaires_patients_2021.pdf
HAS/2022-01-13_panorama-proms-prems_note_de_cadrage.pdf
HAS/2022-01-13_rapport_panorama_proms_prems_2021.pdf
HAS/2022-01-14_CT-19537_COSENTYX_PIS_EI_AVISDef_CT19537.pdf
HAS/2022-01-14_strategie_de_vaccination_contre_la_covid-19__place_du_vaccin_nuvaxovid_recommandation.pdf
HAS/2022-01-14_strategie_de_vaccination_contre_la_covid-19__place_du_vaccin_nuvaxovid_synthese.pdf
HAS/2022-01-17_cotyle_double_mobilite_07_decembre_2021_6754_avis.pdf
HAS/2022-01-17_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2022-01-17_proteor_dynadapt_07_decembre_2021_6595_avis.pdf
HAS/2022-01-17_spa_205_flash_calcul_doses_cd_2021_12_16_v1.pdf
HAS/2022-01-17_systeme_bonebridge_30_novembre_2021_6599_avis.pdf
HAS/2022-01-17_terion_k2_07_decembre_2021_6732_avis.pdf
HAS/2022-01-17_zsi_375_pf_14_decembre_2021_6631_avis.pdf
HAS/2022-01-18_diagnostic_et_prise_en_charge_de_la_tendinopathie_de_lepaule_-_note_de_cadrage.pdf
HAS/2022-01-18_note_de_cadrage_-_degenerescence_maculaire_liee_a_lage_-_fiche_memo.pdf
HAS/2022-01-18_pnds_type_3_3_11_2021.pdf
HAS/2022-01-18_synthese_mg_maladie_de_willebrand_type_3_.pdf
HAS/2022-01-19_CT-19315_CALQUENCE_PIC_REEV_Avis définitif_CT19315.pdf
HAS/2022-01-19_calquence_15122021_synthese_ct19315.pdf
HAS/2022-01-19_calquence_15122021_transcription_ct19315.pdf
HAS/2022-01-19_calquence_17112021_transcription_ct19315.pdf
HAS/2022-01-19_imcivree_20220119_decision_college_2022.0026_et_avisdef_ct.pdf
HAS/2022-01-20_CNEDIMTS-6713_TRIANON_6713_19_octobre_2021_(6713)_avis.pdf
HAS/2022-01-20_infographie_rapport_eigs_cd_20211209_v0_uodif.pdf
HAS/2022-01-20_pdf_abreiges.pdf
HAS/2022-01-20_pdf_cahier_technique.pdf
HAS/2022-01-20_pdf_retour_experience_national.pdf
HAS/2022-01-20_spa-141_rapport_eigs_chute_20211119_vdef.pdf
HAS/2022-01-21_2021.12.24_pnds_dmfsh.pdf
HAS/2022-01-21_2021.12.24_pnds_dmfsh_argumentaire.pdf
HAS/2022-01-21_2022_01_20_flash_samu_vd.pdf
HAS/2022-01-21_argumentaire_pnds_app_vf.pdf
HAS/2022-01-21_contribution_ccm_ap_paxlovid.pdf
HAS/2022-01-21_note_de_cadrage_flash_securite_patient_-_fevrier_2021.pdf
HAS/2022-01-21_paxlovid_decision_et_avis_ct_et_annexes.pdf
HAS/2022-01-21_pnds_app_vf.pdf
HAS/2022-01-21_pnds_nmdar.pdf
HAS/2022-01-21_pnds_nmdar_argumentaire.pdf
HAS/2022-01-21_pnds_pm_microcephalies_primitives_argumentaire_2021-12-31.pdf
HAS/2022-01-21_pnds_pm_microcephalies_primitives_texte_2021-12-31.pdf
HAS/2022-01-21_rapport_etat_des_lieux_eigs_declares_concernant_samu_smur_2020.pdf
HAS/2022-01-21_reco458_fiche_rr_paxlovid_mel.pdf
HAS/2022-01-21_synthese_mg_aphasies_primaires_progressives.pdf
HAS/2022-01-21_synthese_mg_dystrophie_musculaire_facio_scapulo_humerale.pdf
HAS/2022-01-21_synthese_mg_encephalites_a_anticorps_anti_nmdar.pdf
HAS/2022-01-21_synthese_mg_microcephalies_primitives_aspm_wdr62_et_cdk5rap2.pdf
HAS/2022-01-24_decision_n_2022.0029dcsem_du_24_janvier_2022_et_avis_ct_19_janvier_2022.pdf
